PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Kofler, M; Matzak, H; Saltuari, L				Kofler, M; Matzak, H; Saltuari, L			The impact of intrathecal baclofen on gastrointestinal function	BRAIN INJURY			English	Article; Proceedings Paper	4th World Congress on Brain Injury	2001	TURIN, ITALY				LOWER ESOPHAGEAL SPHINCTER; TRANSIENT LES RELAXATIONS; TRAUMATIC BRAIN INJURY; GABA(B) RECEPTORS; SPINAL-CORD; IMMUNOHISTOCHEMICAL DEMONSTRATION; NERVOUS-SYSTEM; IN-VITRO; NEURONS; MOTILITY	Intrathecal baclofen (ITB) application has become the first choice in the management of otherwise intractable generalized spasticity. The mechanism whereby ITB alleviates increased skeletal muscle tone is generally accepted; however, less is known about its effect on smooth muscles. The authors present two patients who developed a paralytic ileus during ITB infusion for supraspinal spasticity. In addition, they performed a retrospective chart analysis of another 12 patients receiving ITB with respect to their intestinal function. They calculated the cumulative sum of days without bowel movements plus the cumulative sum of interventions intended to promote intestinal peristalsis before and during ITB treatment. Intestinal function deteriorated in 10, remained unchanged in one, and improved in three patients compared to baseline, irrespective of concomitant oral baclofen medication. This is the first study addressing a previously unnoticed, but potentially deleterious side effect of ITB treatment. The findings suggest, however, that close observation of intestinal activity in conjunction with the generous use of prokinetic, laxantic or eubiotic drugs may allow for continuation of ITB treatment, even in particularly sensitive patients.	Hosp Hochzirl, Dept Neurol, A-6170 Zirl, Austria	Kofler, M (corresponding author), Hosp Hochzirl, Dept Neurol, Anna Dengel Haus, A-6170 Zirl, Austria.		Kofler, Markus/P-5585-2019	Kofler, Markus/0000-0002-2962-0903			ALLERTON CA, 1989, BRIT J PHARMACOL, V96, P29, DOI 10.1111/j.1476-5381.1989.tb11780.x; Altmayer T, 1996, ARCH PHYS MED REHAB, V77, P1093, DOI 10.1016/S0003-9993(96)90075-1; ANDREWS PLR, 1987, J PHYSIOL-LONDON, V388, P25, DOI 10.1113/jphysiol.1987.sp016599; ANDREWS PLR, 1986, BRIT J PHARMACOL, V89, P461, DOI 10.1111/j.1476-5381.1986.tb11145.x; ASHWORTH B, 1964, PRACTITIONER, V192, P540; AZOUVI P, 1993, J NEUROL NEUROSUR PS, V56, P515, DOI 10.1136/jnnp.56.5.515; BAETGE G, 1986, BRAIN RES BULL, V16, P421, DOI 10.1016/0361-9230(86)90066-3; BALDO A, 2000, GIORNALE ITALIANO ME, V14, P143; Becker R, 1999, J NEUROL NEUROSUR PS, V66, P114, DOI 10.1136/jnnp.66.1.114; Bernards CM, 1999, SPINAL DRUG DELIVERY, P239; Bertrand S, 1999, EUR J NEUROSCI, V11, P583, DOI 10.1046/j.1460-9568.1999.00473.x; Blackshaw LA, 1999, AM J PHYSIOL-GASTR L, V277, pG867; BOWERY NG, 1992, ARZNEIMITTELFORSCH, V42-1, P215; CURTIS DR, 1981, EXP BRAIN RES, V42, P158; DAVIDOFF RA, 1985, ANN NEUROL, V17, P107, DOI 10.1002/ana.410170202; DELHAAS EM, 1991, INT J CLIN PHARM TH, V29, P274; DRESSNANDT J, 1995, MUSCLE NERVE, V18, P103, DOI 10.1002/mus.880180114; FAIGLE JW, 1972, POSTGRAD MED J, V48, P9; FARGEAS MJ, 1988, EUR J PHARMACOL, V150, P163, DOI 10.1016/0014-2999(88)90763-7; FURNESS JB, 1995, GASTROENTEROLOGY, V108, P554, DOI 10.1016/0016-5085(95)90086-1; GENTILINI G, 1992, EUR J PHARMACOL, V217, P9, DOI 10.1016/0014-2999(92)90504-W; Gerstenbrand F., 1967, TRAUMATISCHE APALLIS; HEY JA, 1995, BRIT J PHARMACOL, V114, P735, DOI 10.1111/j.1476-5381.1995.tb13265.x; HILSON A, 1972, POSTGRAD MED J, V48, P25; HONG YG, 1991, EUR J PHARMACOL, V192, P55, DOI 10.1016/0014-2999(91)90068-2; JACKSON MD, 1989, ARCH PHYS MED REHAB, V70, P553; JESSEN KR, 1986, J NEUROSCI, V6, P1628; KOFLER M, 1992, NEUROLOGY, V42, P864, DOI 10.1212/WNL.42.4.864; KOFLER M, 1994, NEUROLOGY, V44, P25, DOI 10.1212/WNL.44.1.25; Kroin JS, 1992, PARENTERAL DRUG THER, P67; Lehmann A, 1999, GASTROENTEROLOGY, V117, P1147, DOI 10.1016/S0016-5085(99)70400-2; Li YW, 1996, AM J PHYSIOL-REG I, V271, pR1304; Lidums I, 2000, GASTROENTEROLOGY, V118, P7, DOI 10.1016/S0016-5085(00)70408-2; Lin HH, 1998, NEUROSCIENCE, V86, P211, DOI 10.1016/S0306-4522(97)00688-X; MISGELD U, 1995, PROG NEUROBIOL, V46, P423, DOI 10.1016/0301-0082(95)00012-K; Muller H., 1988, LOCAL SPINAL THERAPY, P223; Nakajima K, 1996, NEUROCHEM RES, V21, P211, DOI 10.1007/BF02529137; NANNINGA JB, 1989, J UROLOGY, V142, P101, DOI 10.1016/S0022-5347(17)38673-1; NICHOLS K, 1995, J AUTONOM NERV SYST, V50, P253, DOI 10.1016/0165-1838(94)00096-3; ONG J, 1982, EUR J PHARMACOL, V86, P9, DOI 10.1016/0014-2999(82)90390-9; Page AJ, 1999, J NEUROSCI, V19, P8597; PENCHEVA N, 1991, GEN PHARMACOL, V22, P159, DOI 10.1016/0306-3623(91)90327-3; PENN RD, 1992, J NEUROSURG, V77, P236, DOI 10.3171/jns.1992.77.2.0236; PINTO ODS, 1972, POSTGRAD MED J, V48, P18; Ruggiero DA, 2000, J AUTONOM NERV SYST, V79, P181, DOI 10.1016/S0165-1838(99)00097-1; RUMPL E, 1985, INTENSIVBEHANDLUNG, V10, P92; SALTUARI L, 1990, NEW ENGL J MED, V322, P1533; SALTUARI L, 1992, LANCET, V339, P373, DOI 10.1016/0140-6736(92)91697-7; SANDERSON P, 1994, BRIT J ANAESTH, V73, P744, DOI 10.1093/bja/73.6.744; Schutter N, 1995, Ned Tijdschr Geneeskd, V139, P1891; Smid SD, 2000, BRIT J PHARMACOL, V131, P624, DOI 10.1038/sj.bjp.0703602; Staunton E, 2000, AM J PHYSIOL-GASTR L, V279, pG157; STEERS WD, 1992, J UROLOGY, V148, P1849, DOI 10.1016/S0022-5347(17)37048-9; SUNDLER F, 1989, ACTA ONCOL, V28, P303, DOI 10.3109/02841868909111198; Takenaka K., 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS48, DOI 10.1111/j.1440-1681.1995.tb02966.x; TONINI M, 1989, BRIT J PHARMACOL, V98, P1109, DOI 10.1111/j.1476-5381.1989.tb12654.x; TRIPPENBACH T, 1994, CAN J PHYSIOL PHARM, V72, P1200, DOI 10.1139/y94-170; Wang FB, 2000, J COMP NEUROL, V421, P302; Yuan CS, 1998, J PHARMACOL EXP THER, V286, P736	59	21	21	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2002	16	9					825	836		10.1080/02699050210128898			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	585PD	WOS:000177532800008	12217208				2021-06-18	
J	Burton, CL; Hultsch, DF; Strauss, E; Hunter, MA				Burton, CL; Hultsch, DF; Strauss, E; Hunter, MA			Intraindividual variability in physical and emotional functioning: Comparison of adults with traumatic brain injuries and healthy adults	CLINICAL NEUROPSYCHOLOGIST			English	Article							REACTION-TIME; PERFORMANCE; CONSISTENCY; DEMENTIA; TEXT	Recent research has shown that individuals with certain neurological conditions demonstrate greater intraindividual variability on cognitive tasks compared to healthy controls. The present study investigated intraindividual variability in the domains of physical functioning and affect/stress in three groups: adults with mild head injuries, adults with moderate/severe head injuries, and healthy adults. Participants were assessed on 10 occasions and results indicated that (a) individuals with head injuries demonstrated greater variability in dominant finger dexterity and right grip strength than the healthy controls; (b) increased variability tended to be associated with poorer performance/report both within and across tasks; and (c) increased variability on one task was associated with increased variability on other tasks. The findings suggest that increased variability in physical function, as well as cognitive function, represents an indicator of neurological compromise.	Univ Victoria, Dept Psychol, Victoria, BC V8W 3P5, Canada	Burton, CL (corresponding author), Univ Victoria, Dept Psychol, POB 3050, Victoria, BC V8W 3P5, Canada.	clburton@uvic.ca					Anstey KJ, 1999, AGING NEUROPSYCHOL C, V6, P84, DOI 10.1076/anec.6.2.84.786; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; BOLGER N, 1989, J PERS SOC PSYCHOL, V57, P808, DOI 10.1037/0022-3514.57.5.808; BRUHN P, 1977, CORTEX, V13, P373, DOI 10.1016/S0010-9452(77)80018-X; Cohen J., 1977, STAT POWER ANAL BEHA, P1; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; EYSENCK HJ, 1982, MODEL INTELLIGENCE, P151; FERRANDEZ AM, 1996, CHANGES SENSORY MOTO, P53; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOZARD JL, 1994, J GERONTOL, V49, pP179, DOI 10.1093/geronj/49.4.P179; Goldstein IB, 1998, STROKE, V29, P765, DOI 10.1161/01.STR.29.4.765; Hendrickson AE, 1982, MODEL INTELLIGENCE, P151, DOI DOI 10.1007/978-3-642-68664-1_6; HERTZOG C, 1992, BRAIN LANG, V42, P248, DOI 10.1016/0093-934X(92)90100-S; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; IVERSON G, 1998, RECOVERY, V9, P4; IVERSON GL, 1991, LAW HUMAN BEHAV, V15, P667, DOI 10.1007/BF01065859; KNOTEK PC, 1990, BRAIN LANG, V38, P465, DOI 10.1016/0093-934X(90)90131-Y; Li SC, 1999, COGNITIVE NEUROSCIENCE OF MEMORY, P103; Li SC, 2001, GERONTOLOGY, V47, P100, DOI 10.1159/000052782; Nakamura T, 1997, ALZ DIS ASSOC DIS, V11, P132, DOI 10.1097/00002093-199709000-00005; NESSELROADE JR, 1991, VISIONS OF AESTHETICS, THE ENVIRONMENT & DEVELOPMENT : THE LEGACY OF JOACHIM F WOHLWILL, P213; NESSELROADE JR, 1992, BEST METHODS ANAL CH, P92; *PSYCH CORP, 1997, WAIS 3 TECHN MAN; Rabbitt P, 2001, Q J EXP PSYCHOL-A, V54, P981, DOI 10.1080/02724980042000534; Rabbitt PMA, 2000, DEBATES PSYCHOL, P160; SALTHOUSE TA, 1993, J GERONTOL, V48, pP263, DOI 10.1093/geronj/48.6.P263; SATTLER JM, 1999, ASSESSMENT CHILDREN; Slifkin AB, 1998, CURR DIR PSYCHOL SCI, V7, P170, DOI 10.1111/1467-8721.ep10836906; STRAUSS E, IN PRESS J INT NEURO; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	35	21	22	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG	2002	16	3					264	279		10.1076/clin.16.3.264.13854			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	664UZ	WOS:000182081500006	12607140				2021-06-18	
J	Mu, XJ; Azbill, RD; Springer, JE				Mu, XJ; Azbill, RD; Springer, JE			NBQX treatment improves mitochondrial function and reduces oxidative events after spinal cord injury	JOURNAL OF NEUROTRAUMA			English	Article						glutamate receptors; mitochondrial function; MK-801; NBQX; spinal cord injury	METHYL-D-ASPARTATE; CENTRAL-NERVOUS-SYSTEM; EXCITATORY AMINO-ACIDS; AMYLOID BETA-PEPTIDE; ANTIOXIDANT ENZYME-ACTIVITIES; LIPID-PEROXIDATION PRODUCT; NMDA RECEPTOR ANTAGONISTS; TRAUMATIC BRAIN INJURY; OXYGEN-FREE RADICALS; GLUTAMATE UPTAKE	The purpose of this study was to examine the effects of inhibiting ionotropic glutamate receptor subtypes on measures of oxidative stress events at acute times following traumatic spinal cord injury (SCI). Rats received a moderate contusion injury and 15 min later were treated with one of two doses of 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-benzol[f]quinoxaline-7-sulfonamide disodium (NBQX), MK-801, or the appropriate vehicle. At 4 h following injury, spinal cords were removed and a crude synaptosomal preparation obtained to examine mitochondrial function using the MTT assay, as well as measures of reactive oxygen species (ROS), lipid peroxidation, and glutamate and glucose uptake. We report here that intraspinal treatment with either 15 or 30 nmol of NBQX improves mitochondrial function and reduces the levels of ROS and lipid peroxidation products. In contrast, MK-801, given intravenously at doses of 1.0 or 5.0 mg/kg, was without effect on these same measures. Neither drug treatment had an effect on glutamate or glucose uptake, both of which are reduced at acute times following SCI. Previous studies have documented that drugs acting on non-N-methyl-D-aspartate (NMDA) receptors exhibit greater efficacy compared to NMDA receptor antagonists on recovery of function and tissue sparing following traumatic spinal cord injury. The results of this study provide a potential mechanism by which blockade of the non-NMDA ionotropic receptors exhibit positive effects following traumatic SCI.	Univ Kentucky, Med Ctr, Dept Anat & Neurobiol, Ctr Spinal Cord & Brain Injury Res, Lexington, KY 40536 USA; Univ Kentucky, Med Ctr, Dept Physiol, Ctr Spinal Cord & Brain Injury Res, Lexington, KY 40536 USA	Springer, JE (corresponding author), Univ Kentucky, Med Ctr, Dept Anat & Neurobiol, Ctr Spinal Cord & Brain Injury Res, 800 Rose St, Lexington, KY 40536 USA.			Azbill, David/0000-0001-7989-1771	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS040015, NS40015] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040015] Funding Source: NIH RePORTER		Agrawal SK, 1997, J NEUROSCI, V17, P1055; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; BARUT S, 1993, NEUROSURG REV, V16, P53, DOI 10.1007/BF00308614; Beal MF, 1996, CURR OPIN NEUROBIOL, V6, P661, DOI 10.1016/S0959-4388(96)80100-0; BONDY SC, 1993, FREE RADICAL BIO MED, V14, P633, DOI 10.1016/0891-5849(93)90144-J; BONDY SC, 1993, BRAIN RES, V610, P229, DOI 10.1016/0006-8993(93)91405-H; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BRAUGHLER JM, 1992, J NEUROTRAUMA, V9, P1; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P49; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DEMEDIUK P, 1989, J NEUROCHEM, V52, P1529, DOI 10.1111/j.1471-4159.1989.tb09204.x; DUGAN LL, 1995, J NEUROSCI, V15, P6377; DYKENS JA, 1994, J NEUROCHEM, V63, P584; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; FADEN AI, 1990, EUR J PHARMACOL, V175, P165, DOI 10.1016/0014-2999(90)90227-W; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faden AI, 1988, J NEUROTRAUM, V5, P33, DOI 10.1089/neu.1988.5.33; Farooque M, 1996, J NEUROCHEM, V66, P1125; Farooque M, 1997, EXP BRAIN RES, V113, P1, DOI 10.1007/BF02454136; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FLOYD RA, 1992, ANN NEUROL, V32, P22; FRIQUET B, 1994, J BIOL CHEM, V269, P21639; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOMEZPINILLA F, 1989, EXP NEUROL, V104, P118, DOI 10.1016/S0014-4886(89)80004-4; Goodman Y, 1996, J NEUROCHEM, V66, P869, DOI 10.1046/j.1471-4159.1996.66020869.x; GRAHAM SH, 1990, NEUROSCI LETT, V110, P124, DOI 10.1016/0304-3940(90)90799-F; GUNASEKAR PG, 1995, J NEUROCHEM, V65, P2016; Haghighi SS, 1996, NEUROL RES, V18, P509; HALL ED, 1992, J NEUROTRAUM, V9, pS165; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; HALL ED, 1989, CRIT CARE CLIN, V5, P793; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALL ED, 1992, J NEUROTRAUMA, V9, P425; Hall Edward D., 1993, Journal of Emergency Medicine, V11, P31; HENDERSON L, 1993, EUR J BIOCHEM, V217, P273; HEXUM TD, 1979, NEUROCHEM RES, V4, P73, DOI 10.1007/BF00963833; HOLTZ A, 1991, ACTA NEUROL SCAND, V84, P334, DOI 10.1111/j.1600-0404.1991.tb04964.x; IKEDA Y, 1989, Neurological Research, V11, P213; ILDAN F, 1995, NEUROSURG REV, V18, P35, DOI 10.1007/BF00416476; Jamme I, 1995, NEUROREPORT, V7, P333; Kanellopoulos GK, 2000, STROKE, V31, P1945, DOI 10.1161/01.STR.31.8.1945; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; Keller JN, 1997, J NEUROCHEM, V69, P273; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; KOOY NW, 1994, FREE RADICAL BIO MED, V16, P149, DOI 10.1016/0891-5849(94)90138-4; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Li SX, 2000, NEUROL RES, V22, P171, DOI 10.1080/01616412.2000.11758605; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; Liu SL, 1997, BRAIN RES, V756, P160, DOI 10.1016/S0006-8993(97)00137-6; Mark RJ, 1997, J NEUROCHEM, V68, P255; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; McAdoo DJ, 2000, BRAIN RES, V865, P283, DOI 10.1016/S0006-8993(00)02296-4; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; Mills CD, 2002, EXP NEUROL, V173, P153, DOI 10.1006/exnr.2001.7828; Mills CD, 2001, EXP NEUROL, V170, P244, DOI 10.1006/exnr.2001.7721; Mills CD, 2001, J NEUROCHEM, V79, P835, DOI 10.1046/j.1471-4159.2001.00630.x; MOYNER H, 1990, NEURON, V5, P121; Mu XJ, 2000, BRAIN RES, V870, P66, DOI 10.1016/S0006-8993(00)02402-1; Mu XJ, 2000, J NEUROTRAUM, V17, P773, DOI 10.1089/neu.2000.17.773; MUSSER DA, 1994, PHOTOCHEM PHOTOBIOL, V59, P621; NAG S, 1990, ACTA NEUROPATHOL, V81, P7, DOI 10.1007/BF00662631; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; Rosen CJ, 1999, J CLIN DENSITOM, V2, P3, DOI 10.1385/JCD:2:1:3; SHEARMAN MS, 1995, J NEUROCHEM, V65, P218, DOI 10.1046/j.1471-4159.1995.65010218.x; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; Springer JE, 1997, J NEUROCHEM, V68, P2469; SUN FY, 1994, BRAIN RES, V666, P88, DOI 10.1016/0006-8993(94)90285-2; TAOKA Y, 1995, PARAPLEGIA, V33, P450, DOI 10.1038/sc.1995.98; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; URCA G, 1990, BRAIN RES, V529, P7, DOI 10.1016/0006-8993(90)90805-L; VOLTERRA A, 1994, J NEUROSCI, V14, P2924; VOLTERRA A, 1994, ANN NY ACAD SCI, V738, P153; VONEULER M, 1994, EXP NEUROL, V129, P163, DOI 10.1006/exnr.1994.1157; Wada S, 1999, J NEUROSURG, V91, P98, DOI 10.3171/spi.1999.91.1.0098; Watanabe M, 1998, J NEUROTRAUM, V15, P285, DOI 10.1089/neu.1998.15.285; WRATHALL JR, 1992, BRAIN RES, V586, P140, DOI 10.1016/0006-8993(92)91384-Q; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012; Wrathall JR, 1997, EXP NEUROL, V145, P565, DOI 10.1006/exnr.1997.6506; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; WRATHALL JR, 1992, EUR J PHARMACOL, V218, P273, DOI 10.1016/0014-2999(92)90179-8; YEZIERSKI RP, 1993, NEUROSCI LETT, V157, P115, DOI 10.1016/0304-3940(93)90656-6; YEZIERSKI RP, 1993, J NEUROTRAUM, V10, P445, DOI 10.1089/neu.1993.10.445; Young Wise, 1993, Journal of Emergency Medicine, V11, P13	92	21	22	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2002	19	8					917	927		10.1089/089771502320317078			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	585JC	WOS:000177520800002	12225652				2021-06-18	
J	Khan, S; Khan, A; Feyz, M				Khan, S; Khan, A; Feyz, M			Decreased length of stay, cost savings and descriptive findings of enhanced patient care resulting from an integrated traumatic brain injury programme	BRAIN INJURY			English	Article							MODERATE HEAD-INJURY; COMPUTED-TOMOGRAPHY; REHABILITATION; PROGNOSIS; MEMORY	Traumatic brain injury (TBI) has enormous economic consequences. The primary objective was to evaluate the effect of implementation of an integrated TBI programme on patient-care. The research design was a retrospective institutional review for which 1875 patient records were reviewed, healthcare professionals were interviewed, patient care was observed, and a literature review of the prognostic variables for mild, moderate and severe TBI was conducted. The implementation of an integrated TBI programme has reduced the average length of stay from 30.5 to 12 days and resulted in tremendous cost savings of $21.8 million over 6 years. 'Blueprinting' the continuum of TBI patients' care identified the weakest links to be the transfer of patients from the tertiary-care TBI programme to rehabilitation institutions and provision of long-term rehabilitative care due to information asymmetry. This was addressed by the development of comprehensive on-line TBI transfer documents. This study emphasizes the importance of comprehensive neurotrauma programmes.	Montreal Gen Hosp, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada	Khan, S (corresponding author), 3477 Drummond St,Suite 205, Montreal, PQ H3G 1X6, Canada.						BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; *BRAIN TRAUM FDN A, 1995, GUID MAN SEV HEAD IN; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; COLLINS JG, 1990, VITAL HLTH STAT, V10, P175; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; HARRISONFELIX C, 1996, J HEAD TRAUMA REHAB, V11, P225; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; JANE JA, 1982, CLIN NEUR, V29, P346; JENNETT B, 1975, LANCET, V1, P480; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LIPPER MH, 1985, AM J ROENTGENOL, V144, P483, DOI 10.2214/ajr.144.3.483; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; Miller JR, 1989, MILD MODERATE HEAD I, P125; Pitts L H, 1995, New Horiz, V3, P546; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; STEIN SC, 1993, NEUROSURGERY, V32, P30; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TENNANT A, 1995, BRAIN INJURY, V9, P595, DOI 10.3109/02699059509008218; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1996, WESTERN J MED, V165, P192; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774	31	21	21	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2002	16	6					537	554		10.1080/02699050110119862			18	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	569RK	WOS:000176615800008	12148505				2021-06-18	
J	Schlund, MW				Schlund, MW			Effects of acquired brain injury on adaptive choice and the role of reduced sensitivity to contingencies	BRAIN INJURY			English	Article							ANTICIPATORY BEHAVIOR DEFICITS; CLOSED-HEAD-INJURY; PREFRONTAL CORTEX; SELF-CONTROL; REINFORCEMENT; LESIONS; DENSITY; DAMAGE	The present investigation examined the proposal that brain injury reduces sensitivity to consequences. On a laboratory task, controls and subjects with brain injury made repeated choices between a small amount of money and a larger amount of money followed by a post-reinforcer delay of 3, 12, 18, or 24 seconds. Increasing delays lowered reinforcement densities (i.e. money available per minute) associated with large reinforcers. Consequently, choosing large reinforcers became less adaptive. Results showed subjects with brain injury made less adaptive choices and earned significantly less money than controls, because of a preference for large reinforcers with low reinforcement densities. Maladaptive choice was not attributable to deficits in discriminating reinforcer magnitudes or delays. Results suggest individuals with brain injury may remain sensitive to consequences but fail to discriminate among significant response-consequence relations (i.e. contingencies). This view, emphasizing basic learning processes, may account for some problems in skill acquisition and adaptive choice.	Kennedy Krieger Inst, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Schlund, MW (corresponding author), Kennedy Krieger Inst, 333 Cassell Dr,Triad Technol Bldg Suite 4200, Baltimore, MD 21224 USA.						Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; [Anonymous], 1993, GUIDE UNIFORM DATA S; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BLEIBERG J, 1985, INT J CLIN NEUROPSYC, V7, P153; Damasio A. R., 1993, CLIN NEUROPSYCHOLOGY, V3, P409; FLORA SR, 1992, J EXP ANAL BEHAV, V57, P201, DOI 10.1901/jeab.1992.57-201; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; Hayes S.C., 1996, ADV PSYCHOL, P279; Heaton R., 1993, WISCONSIN CARD SORTI; Ito M, 1998, J EXP ANAL BEHAV, V69, P87, DOI 10.1901/jeab.1998.69-87; KOSMIDIS MH, 1995, J CLIN EXP NEUROPSYC, V17, P622, DOI 10.1080/01688639508405150; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Logue A. W., 1998, LEARNING BEHAV THERA, P252; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; *NO CA NEUR GROUP, 1995, MAN COGN; Reitan RM, 1979, MANUAL ADM NEUROPSYC; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Schlund MW, 2002, BRAIN INJURY, V16, P347, DOI 10.1080/02699050110103977; Schlund MW, 2001, BRAIN INJURY, V15, P1061, DOI 10.1080/02699050110086887; Schlund MW, 2000, BRAIN INJURY, V14, P573, DOI 10.1080/026990500120475; Schlund MW, 2000, BEHAV INTERVENT, V15, P155, DOI 10.1002/1099-078X(200007/09)15:3<155::AID-BIN53>3.0.CO;2-F; Shallice T, 1993, ATTENTION SELECTION, P171; Skinner BF, 1938, BEHAV ORGANISMS	24	21	21	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2002	16	6					527	535		10.1080/02699050110113679			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	569RK	WOS:000176615800007	12119088				2021-06-18	
J	Leong, B				Leong, B			The vegetative and minimally conscious states in children: spasticity, muscle contracture and issues for physiotherapy treatment	BRAIN INJURY			English	Article							INTRATHECAL BACLOFEN INFUSION; SELECTIVE POSTERIOR RHIZOTOMY; TRAUMATIC BRAIN-INJURY; BOTULINUM-TOXIN-A; UPPER EXTREMITY SPASTICITY; RECIPROCAL INHIBITION; PRESYNAPTIC INHIBITION; PHENOL BLOCK; DOUBLE-BLIND; FOREARM MUSCLES	The neuropathology of the vegetative (VS) and minimally conscious (MCS) states and the pathophysiology of spasticity are reviewed. Current treatment options available in the physical management of children in a low-level state and factors influencing the physiotherapy treatment of children in a low-level state will be discussed. The complex neuropathology of VS and MCS helps to explain the varied clinical presentations of children in VS and MCS. Spasticity and muscle contracture are common motor sequelae of VS and MCS. Loss of inhibition by descending motor pathways is thought to result in increased muscle tone or spasticity. However, secondary changes in muscle fibre structure and periarticular connective tissue may be an additional component to increased muscle tone. A multi-modal approach combining physical, pharmacological and surgical interventions is likely to be the most effective. Knowledge of the likelihood of recovery from VS and MCS can be helpful in determining the frequency and intensity of physiotherapy. Ethical issues in the management of children in a low-level state include a consideration of the benefits to the child and the child's family and the costs to the health care team and the medical institution.	Sunny Hill Hlth Ctr Children, Therapy Dept, Vancouver, BC V5M 3E8, Canada	Leong, B (corresponding author), Sunny Hill Hlth Ctr Children, Therapy Dept, 3644 Slocan St, Vancouver, BC V5M 3E8, Canada.	bnleong@cw.bc.cd					Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; AKESON WH, 1987, CLIN ORTHOP RELAT R, P28; ALBRIGHT AL, 1995, PEDIATR NEUROSURG, V23, P82; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; ARTIEDA J, 1991, NEUROLOGY, V41, P286, DOI 10.1212/WNL.41.2_Part_1.286; Ashford S, 2000, Physiother Res Int, V5, P202, DOI 10.1002/pri.199; ASHWAL S, 1994, PEDIATR NEUROL, V10, P27, DOI 10.1016/0887-8994(94)90063-9; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; ASHWAL S, 1992, ANN NEUROL, V32, P570, DOI 10.1002/ana.410320414; Aymard C, 2000, BRAIN, V123, P1688, DOI 10.1093/brain/123.8.1688; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Bogen JE, 1997, SEMIN NEUROL, V17, P95, DOI 10.1055/s-2008-1040918; BOTTE MJ, 1988, CLIN ORTHOP RELAT R, V233, P7; BROWN P, 1994, J NEUROL NEUROSUR PS, V57, P773, DOI 10.1136/jnnp.57.7.773; Burke D, 1988, Adv Neurol, V47, P401; CASTLE ME, 1979, CLIN ORTHOP RELAT R, P223; Chambers HG, 1997, MUSCLE NERVE, pS121; CHAPMAN CE, 1982, PHYSIOTHER CAN, V34, P125; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; CONINE TA, 1990, ARCH PHYS MED REHAB, V71, P310; Corry IS, 1998, J PEDIATR ORTHOPED, V18, P304, DOI 10.1097/00004694-199805000-00006; DELWAIDE PJ, 1994, NEUROLOGY, V44, P21; DELWAIDE PJ, 1988, J NEUROL NEUROSUR PS, V51, P1546, DOI 10.1136/jnnp.51.12.1546; DELWAIDE PJ, 1973, NEW DEV ELECTROMYOGR, P508; DIETZ V, 1981, BRAIN, V104, P431, DOI 10.1093/brain/104.3.431; DIETZ V, 1986, J NEUROL SCI, V75, P89, DOI 10.1016/0022-510X(86)90052-3; DONATELLI R, 1981, J ORTHOP SPORT PHYS, V3, P67, DOI DOI 10.2519/J0SPT.1981.3.2.67; ENNEKING WF, 1972, J BONE JOINT SURG AM, VA 54, P973, DOI 10.2106/00004623-197254050-00003; FAIST M, 1994, BRAIN, V117, P1449, DOI 10.1093/brain/117.6.1449; Flett PJ, 1999, J PAEDIATR CHILD H, V35, P71, DOI 10.1046/j.1440-1754.1999.00330.x; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P243; Gerszten PC, 1998, J NEUROSURG, V88, P1009, DOI 10.3171/jns.1998.88.6.1009; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; GIVEN JD, 1995, J NEUROL NEUROSUR PS, V59, P271, DOI 10.1136/jnnp.59.3.271; Gracies JM, 1997, MUSCLE NERVE, pS92; Gracies JM, 1997, MUSCLE NERVE, pS61; Harburn K L, 1995, Electromyogr Clin Neurophysiol, V35, P149; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HILL J, 1994, AM J OCCUP THER, V48, P219, DOI 10.5014/ajot.48.3.219; HUFSCHMIDT A, 1985, J NEUROL NEUROSUR PS, V48, P676, DOI 10.1136/jnnp.48.7.676; Ito J, 1996, BRAIN DEV-JPN, V18, P299, DOI 10.1016/0387-7604(96)00006-X; Jacobs HE, 1986, J HEAD TRAUMA REHAB, V1, P55; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; KATZ R, 1982, BRAIN, V105, P103, DOI 10.1093/brain/105.1.103; Katz R, 1999, J PHYSIOLOGY-PARIS, V93, P379, DOI 10.1016/S0928-4257(00)80065-0; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P340, DOI 10.1016/0363-5023(90)90120-G; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; Kirazli Y, 1998, AM J PHYS MED REHAB, V77, P510, DOI 10.1097/00002060-199811000-00012; Klepper H, 1997, CAMB Q HEALTHC ETHIC, V6, P306, DOI 10.1017/S0963180100008008; KRIEL RL, 1993, PEDIATR NEUROL, V9, P362, DOI 10.1016/0887-8994(93)90104-K; Lance J. W., 1980, SPASTICITY DISORDERE, P485; LEHMKUHL LD, 1990, J HEAD TRAUMA REHAB, V5, P23, DOI DOI 10.1097/00001199-199012000-00005; LEONARD CT, 1990, DEV MED CHILD NEUROL, V32, P974; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Lin JP, 1999, DEV MED CHILD NEUROL, V41, P534, DOI 10.1017/S0012162299001152; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P155, DOI 10.1053/apmr.2001.19246; Moseley AM, 1997, PHYS THER, V77, P240, DOI 10.1093/ptj/77.3.240; NOTH J, 1991, J NEUROL, V238, P131, DOI 10.1007/BF00319679; ODwyer NJ, 1996, CURR OPIN NEUROL, V9, P451, DOI 10.1097/00019052-199612000-00010; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Okuma Y, 1996, CAN J NEUROL SCI, V23, P15, DOI 10.1017/S0317167100039135; On AY, 1999, AM J PHYS MED REHAB, V78, P344, DOI 10.1097/00002060-199907000-00010; PANIZZA M, 1995, AM J PHYS MED REHAB, V74, P357; Payne SK, 1997, SEMIN NEUROL, V17, P257, DOI 10.1055/s-2008-1040937; PEACOCK WJ, 1991, J NEUROSURG, V74, P380, DOI 10.3171/jns.1991.74.3.0380; Peter KS, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199608000-00003; Pierrot-Deseilligny E, 1985, CLIN NEUROPHYSIOL, P63; Pierson SH, 1996, ARCH PHYS MED REHAB, V77, P717, DOI 10.1016/S0003-9993(96)90015-5; Pilon M, 1996, BRAIN INJURY, V10, P421, DOI 10.1080/026990596124287; POWERS RK, 1988, ANN NEUROL, V23, P115, DOI 10.1002/ana.410230203; POWERS RK, 1989, ANN NEUROL, V25, P32, DOI 10.1002/ana.410250106; ROSE J, 1994, J ORTHOP RES, V12, P758, DOI 10.1002/jor.1100120603; Schmit BD, 2000, ARCH PHYS MED REHAB, V81, P269; Sim J, 1997, Physiother Res Int, V2, P7, DOI 10.1002/pri.86; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; SINKJAER T, 1994, BRAIN, V117, P355, DOI 10.1093/brain/117.2.355; Smyth MD, 2000, MUSCLE NERVE, V23, P153, DOI 10.1002/(SICI)1097-4598(200002)23:2<153::AID-MUS3>3.0.CO;2-4; Steinbok P, 1997, DEV MED CHILD NEUROL, V39, P178; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; TABARY JC, 1981, MUSCLE NERVE, V4, P198, DOI 10.1002/mus.880040305; THILMANN AF, 1991, J NEUROL NEUROSUR PS, V54, P134, DOI 10.1136/jnnp.54.2.134; TREMBLAY F, 1990, SCAND J REHABIL MED, V22, P171; Van Schaeybroeck P, 2000, NEUROSURGERY, V46, P603, DOI 10.1097/00006123-200003000-00017; WIESENDANGER M, 1985, CLIN NEUROPHYSIOL, P1; WILLIAMS PE, 1973, J ANAT, V116, P45; Wright FV, 1998, DEV MED CHILD NEUROL, V40, P239; WRIGHT J, 1990, CLIN ORTHOP RELAT R, V253, P12; Yablon SA, 1996, NEUROLOGY, V47, P939, DOI 10.1212/WNL.47.4.939; YARKONY GM, 1987, CLIN ORTHOP RELAT R, P93; YOUNG RR, 1994, NEUROLOGY, V44, P12; YOUNG RR, 1987, CLIN ORTHOP RELAT R, V219, P50; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	100	21	21	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2002	16	3					217	230		10.1080/02699050110103283			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	526HP	WOS:000174124800004	11874615				2021-06-18	
J	Al-Abdulla, NA; Martin, LJ				Al-Abdulla, NA; Martin, LJ			Projection neurons and interneurons in the lateral geniculate nucleus undergo distinct forms of degeneration ranging from retrograde and transsynaptic apoptosis to transient atrophy after cortical ablation in rat	NEUROSCIENCE			English	Article						Alzheimer's disease; amyotrophic lateral sclerosis; axotomy; cell death; DNA damage; traumatic brain injury	FIMBRIA-FORNIX TRANSECTION; ACID DECARBOXYLASE GAD; CELL-DEATH; CAT; NEURODEGENERATION; IDENTIFICATION; CORTEX; SEPTUM; BRAIN	The cytological responses of thalamic interneurons to selective degeneration of thalamocortical projection neurons after cortical damage in the adult brain are poorly understood. We used a unilateral neocortical lesion model (occipital cortex ablation) in the adult rat to test the hypothesis that interneurons and projection neurons in the lateral geniculate nucleus undergo distinct forms of degeneration. In situ nuclear DNA fragmentation in neurons in the lateral geniculate occurs maximally at 7 days postlesion. Geniculocortical projection neurons that are identified by the retrograde tracer Fluorogold die primarily with a morphology of endstage apoptosis prominent at 7 days postlesion. In contrast, interneurons, identified by their particular nuclear ultrastructure and by glutamic acid decarboxylase immunoreactivity, undergo an atrophic vacuolar pathology starting early during the period of projection neuron death and peaking after the projection neuron death is complete. This degeneration of interneurons is transient, because these neurons exhibit structural recovery and their numbers are not changed significantly postlesion. A rare subset of interneurons (less than one in 100 interneurons and less than one in 100 apoptotic cells) undergoes apoptosis concurrently with the projection neurons. We conclude that different types of neurons within the same thalamic nucleus respond differently to focal cortical target deprivation. Unlike the apoptosis-prone projection neurons, most interneurons undergo transient transsynaptic atrophy and recovery rather than cell death. Nevertheless, a small subset of lateral geniculate interneurons undergoes transsynaptic apoptosis in response to projection neuron apoptosis. The pathological responses of thalamic neurons to cortical trauma vary depending on cell type. (C) 2002 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neurosci, Baltimore, MD 21205 USA	Martin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, 558 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG016282] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG16282] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34100] Funding Source: Medline		Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Al-Abdulla NA, 1998, NEUROSCIENCE, V86, P191, DOI 10.1016/S0306-4522(98)00014-1; Al-Abdulla NA, 1998, AM J PATHOL, V153, P447, DOI 10.1016/S0002-9440(10)65588-5; BARRON KD, 1967, J NEUROPATH EXP NEUR, V26, P300, DOI 10.1097/00005072-196704000-00007; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; FRY FJ, 1972, J COMP NEUROL, V144, P1, DOI 10.1002/cne.901440102; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; Ginsberg SD, 1998, NEUROSCIENCE, V86, P1259, DOI 10.1016/S0306-4522(98)00136-5; Ginsberg SD, 1999, NEUROSCIENCE, V88, P1059, DOI 10.1016/S0306-4522(98)00288-7; GIOLLI RA, 1971, J COMP NEUROL, V142, P351, DOI 10.1002/cne.901420306; Lashley KS, 1941, J COMP NEUROL, V75, P67, DOI 10.1002/cne.900750105; LEVAY S, 1979, BRAIN RES, V164, P304, DOI 10.1016/0006-8993(79)90026-X; MADARASZ M, 1983, EXP BRAIN RES, V52, P363; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.0.CO;2-#; Martin LJ, 1997, ANN NEUROL, V42, P335, DOI 10.1002/ana.410420310; Martin LJ, 2001, J COMP NEUROL, V433, P299, DOI 10.1002/cne.1141; Martin LJ, 2001, INT J MOL MED, V7, P455; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; MONTERO VM, 1985, EXP BRAIN RES, V59, P151; OHARA PT, 1983, NEUROSCIENCE, V8, P189, DOI 10.1016/0306-4522(83)90060-X; POWELL TPS, 1952, BRAIN, V75, P571, DOI 10.1093/brain/75.4.571; Wang YZ, 1998, EXP NEUROL, V154, P389, DOI 10.1006/exnr.1998.6965; WEBER AJ, 1983, J COMP NEUROL, V220, P336, DOI 10.1002/cne.902200307	24	21	21	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2002	115	1					7	14	PII S0306-4522(02)00363-9	10.1016/S0306-4522(02)00363-9			8	Neurosciences	Neurosciences & Neurology	615DX	WOS:000179231500002	12401317				2021-06-18	
J	Lourido, J; Ederoth, P; Sundvall, N; Ungerstedt, U; Nordstrom, CH				Lourido, J; Ederoth, P; Sundvall, N; Ungerstedt, U; Nordstrom, CH			Correlation between blood glucose concentration and glucose concentration in subcutaneous adipose tissue evaluated with microdialysis during intensive care	SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION			English	Article						adipose tissue; glucose; glycerol; lactate; microdialysis	HUMAN SKELETAL-MUSCLE; INTRACEREBRAL MICRODIALYSIS; VOLUME REGULATION; HEAD-INJURY; HYPERGLYCEMIA; PRINCIPLES; LEVEL; METABOLISM; MORBIDITY; MORTALITY	Background: Hyper- as well as hypoglycemia may be detrimental for brain energy metabolism and even a moderate increase in blood glucose concentration can affect outcome adversely. During physiological conditions, glucose concentration obtained from microdialysis of subcutaneous adipose tissue adequately reflects plasma glucose concentration. This study examines whether this correlation is also obtained during intensive care in patients with severe injuries. Methods.. The study included 62 patients with severe traumatic brain injuries. All patients received one 30 mm microdialysis catheter (CMA 60, CMA Microdialysis) inserted into periumbilical subcutaneous adipose tissue. The probe was perfused (0.3 mul/min) with a Ringer solution from a microinfusion Pump and analyzed for glucose, lactate, and glycerol. The Study included 2.434 simultaneous analyses of glucose concentration in arterial blood and subcutaneous adipose tissue. Results.' The correlation coefficient for glucose concentration in blood and interstitial fluid was 0.743 for the whole material. The cot-relation was relatively poor for 1-6h after insertion of the probes, During this period. a continuous increase in the Subcutaneous level Of glucose and decreases in lactate and glycerol were noted. Conclusions: The correlation between blood glucose concentration and glucose Concentration in subcutaneous adipose tissue was not as good during intensive care as in normal humans. The poor correlation during the first 6h probably reflects a stress reaction (and possibly local vasoconstriction). Microdialysis of subcutaneous adipose tissue permits frequent bedside analyses of the biochemical composition of the extracellular fluid and may be of value during routine intensive care provided the methodological limitations are recognized.	Hosp Univ Canarias, Dept Neurosurg, Tenerife, Spain; Univ Lund Hosp, Dept Anesthesiol, S-22185 Lund, Sweden; Univ Lund Hosp, Dept Clin Neurosci, S-22185 Lund, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Nordstrom, CH (corresponding author), Univ Lund Hosp, Dept Neurosurg, SE-22185 Lund, Sweden.	carl-henrik.nordstrom@swipnet.se					ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BOLINDER J, 1993, LANCET, V342, P1080, DOI 10.1016/0140-6736(93)92063-Y; BOLINDER J, 1989, SCAND J CLIN LAB INV, V49, P465, DOI 10.3109/00365518909089123; BOLINDER J, 1992, DIABETOLOGIA, V35, P1177, DOI 10.1007/BF00401374; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; BUNGAY PM, 1990, LIFE SCI, V46, P105, DOI 10.1016/0024-3205(90)90043-Q; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; FELLANDER G, 1994, EUR J SURG, V160, P87; FELLANDER G, 1994, J CLIN ENDOCR METAB, V78, P150, DOI 10.1210/jc.78.1.150; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; HUTCHINSON PJ, 1999, ACTA NEUROCHIR SUPP, V75, P75; JANSSON PA, 1988, AM J PHYSIOL, V255, pE218; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Moberg E, 1997, DIABETOLOGIA, V40, P1320, DOI 10.1007/s001250050827; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; PENTELENYI T, 1977, INJURY, V8, P264, DOI 10.1016/0020-1383(77)90099-7; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rosdahl H, 1998, AM J PHYSIOL-ENDOC M, V274, pE936; ROSDAHL H, 1993, J PHYSIOL-LONDON, V471, P637, DOI 10.1113/jphysiol.1993.sp019920; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Ungerstedt U., 1974, B SCHWEIZ AKAD MED, V1278, P1; UNGERSTEDT U, 1999, J INTENSIVE CARE, V6, P102; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; WOO E, 1988, STROKE, V19, P185, DOI 10.1161/01.STR.19.2.185; WOO J, 1990, ARCH NEUROL-CHICAGO, V47, P1174, DOI 10.1001/archneur.1990.00530110028011; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	30	21	24	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0036-5513	1502-7686		SCAND J CLIN LAB INV	Scand. J. Clin. Lab. Invest.		2002	62	4					285	292		10.1080/003655102760145843			8	Medicine, Research & Experimental	Research & Experimental Medicine	578WN	WOS:000177144200006	12476927				2021-06-18	
J	Johnson, SM; Johnson, AC; Barton, RG				Johnson, SM; Johnson, AC; Barton, RG			Avalanche trauma and closed head injury: adding insult to injury	WILDERNESS & ENVIRONMENTAL MEDICINE			English	Article						avalanche; trauma; closed head injury; skiing; snowboarding; snowmobile		Objective.-The incidence of fatal closed head injury (CHI) and nonfatal CHI causing an altered level of consciousness in avalanche victims is unknown. The purpose of this study was to assess the incidence and potential significance of CHI in avalanche-related deaths. Methods.-The records of the state medical examiner and hospital records of all victims killed in avalanches in the state of Utah from October 1, 1992 through April 30, 1999 were reviewed for a cause of death and for the presence of CHI. Closed head injury was described as "present" or "severe," depending on whether the degree of CHI was sufficient to have caused or directly contributed to death, as determined by the medical examiner. Results.-In this review, 28 avalanche-related deaths were identified, of which 22 (79%) were due to asphyxia. Seventeen victims (61%) had evidence of some degree of CHI. Six victims (21%) had evidence of severe CHI. One of 7 snowmobile riders sustained a severe CHI, whereas 4 of 16 skiers or snowboarders sustained a severe CIE (P = not significant). Conclusion.-Although asphyxiation was the cause of death in most avalanche victims, evidence of CHI was present in 61% of the cases studied. While avalanche-associated CHI may not be sufficient to cause death in many cases, a depressed level of consciousness might render a victim incapable of self-rescue and predispose to asphyxia. Helmet use may help prevent avalanche-associated CHI and thus be a useful safety adjunct.	Univ Utah, Sch Med, Dept Surg, Salt Lake City, UT USA	Johnson, SM (corresponding author), 426 10th Ave, Salt Lake City, UT 84103 USA.						Brugger H, 1996, RESUSCITATION, V31, P11, DOI 10.1016/0300-9572(95)00913-2; FALK M, 1994, NATURE, V368, P21, DOI 10.1038/368021a0; Grissom CK, 2000, JAMA-J AM MED ASSOC, V283, P2266, DOI 10.1001/jama.283.17.2266; GROSSMAN MD, 1989, J TRAUMA, V29, P1705, DOI 10.1097/00005373-198912000-00021; Page CE, 1999, WILD ENVIRON MED, V10, P146, DOI 10.1580/1080-6032(1999)010[0146:ADITUS]2.3.CO;2; Rostrup Morten, 1993, Tidsskrift for den Norske Laegeforening, V113, P1100; Tschirky F, 2000, AVALANCHE RESCUE SYS; WILLIAMS K, 1995, WILDERNESS MED MANAG, P617	8	21	21	0	0	WILDERNESS MEDICAL SOC	COLORADO SPRINGS	3595 E FOUNTAIN BLVD, STE A1, COLORADO SPRINGS, CO 80910 USA	1080-6032			WILD ENVIRON MED	Wildern. Environ. Med.	WIN	2001	12	4					244	247		10.1580/1080-6032(2001)012[0244:ATACHI]2.0.CO;2			4	Public, Environmental & Occupational Health; Sport Sciences	Public, Environmental & Occupational Health; Sport Sciences	505NR	WOS:000172919300006	11769920				2021-06-18	
J	Martin, C; Viguier, D; Deloche, G; Dellatolas, G				Martin, C; Viguier, D; Deloche, G; Dellatolas, G			Subjective experience after traumatic brain injury	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; FOLLOW-UP; DEPRESSED MOOD; RELATIVES; INDIVIDUALS; ADJUSTMENT; SEQUELAE; DISTRESS; DISORDER; CAREGIVERS	The present investigation aims to show which specific difficulties are reported with greater frequency in traumatic brain injury (TBI) patients than in controls, and in hetero-assessment than in self-assessment. Ninety-seven patients with severe TBI were compared to 97 controls matched for age and gender. The 63-item European Brain Injury Questionnaire (EBIQ) was completed by patients, close relatives and controls. A principal component analysis showed three main factors: 'depressive mood', 'cognitive difficulties', and 'difficulties in social interactions'. Relatives scored higher than patients for items concerning the three domains. Patients scored higher than controls for 'depressive mood' and 'cognitive difficulties', but not for 'difficulties in social interactions', which included items related to both self-assertion and lack of self-control. After TBI, emotional problems and, especially, depressive mood associated to cognitive difficulties have an important impact in everyday life and family functioning. Difficulties in social interactions are not specific of TBI patients.	INSERM, U472, F-94807 Villejuif, France	Dellatolas, G (corresponding author), INSERM, U472, 16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	dellatolas@vjf.inserm.fr					Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Borg I., 1987, MULTIDIMENSIONAL SIM; Deloche G., 1996, Annales de Readaptation et de Medecine Physique, V39, P1, DOI 10.1016/0168-6054(96)88044-5; DELOCHE G, 1997, HANDICAPS INADAPTATI, V75, P101; Derogatis LR, 1983, SCL 90 R ADM SCORING; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FAHY TJ, 1967, LANCET, V2, P475; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GURNS S, 1994, BRAIN INJURY, V8, P413, DOI 10.3109/02699059409150993; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kraus Jess F., 1994, P3; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; LEVIN HS, 1989, HDB NEUROPSYCHOLOGY, P183; Lezak M. D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI [10.1097/00001199-198703000-00009, DOI 10.1097/00001199-198703000-00009]; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Olver JH, 1995, CURR OPIN NEUROL, V8, P443, DOI 10.1097/00019052-199512000-00008; PANTING A, 1976, REHABILITATION, V82, P33; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Prigatano G. P., 1990, CLIN NEUROPSYCHOL, V4, P163, DOI [10.1080/13854049008401509, DOI 10.1080/13854049008401509]; PRIGATANO GP, 1993, NEUROPSYCHOL REHABIL, P55; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Spatt J, 1997, ACTA NEUROL SCAND, V95, P173, DOI 10.1111/j.1600-0404.1997.tb00091.x; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Thomsen I V, 1989, Brain Inj, V3, P157, DOI 10.3109/02699058909004547; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460	49	21	21	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2001	15	11					947	959		10.1080/02699050110065655			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	490VF	WOS:000172073900002	11689093				2021-06-18	
J	Marquardt, TP; Rios-Brown, M; Richburg, T				Marquardt, TP; Rios-Brown, M; Richburg, T			Comprehension and expression of affective sentences in traumatic brain injury	APHASIOLOGY			English	Article; Proceedings Paper	30th Annual Clinical Aphasiology Conference	MAY, 2000	WAIKOLON, HAWAII					The comprehension and production of affective prosody and facial expression was investigated in subjects with traumatic brain injury and matched normal subjects. Performance on tasks designed to assess the ability to recognise affect in congruous, neutral, and ambiguous sentences and the ability to portray emotions in affectively neutral sentences revealed significant impairments for the subjects with traumatic brain injury. Analysis of correct responses to ambiguous sentences found increased reliance of brain-injured subjects on verbal compared to paralinguistic cues in interpreting the emotion of the sentence. The clinical implications of the findings relative to counselling, compensation strategies, and direct intervention for patients with traumatic brain injury are discussed.	Univ Texas, Dept Commun Sci & Disorders, Austin, TX 78712 USA; Univ Calif San Diego, San Diego, CA 92103 USA; Univ Memphis, Memphis, TN 38152 USA	Marquardt, TP (corresponding author), Univ Texas, Dept Commun Sci & Disorders, Austin, TX 78712 USA.						Antonak R. F., 1993, J HEAD TRAUMA REHAB, V8, P87, DOI DOI 10.1097/00001199-199312000-00009; Borod J., 1993, NEUROPSYCHOLOGY, V7, P445, DOI DOI 10.1037/0894-4105.7.4.445; Braun C M, 1989, Brain Inj, V3, P345, DOI 10.3109/02699058909004559; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Hartley L. L., 1995, COGNITIVE COMMUNICAT; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; PATTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139; PRIGATANO GP, 1982, J PERCEPTUAL MOTOR S, V54, P859; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Wechsler D., 2008, WECHSLER ADULT INTEL; WEDDELL RA, 1990, NEUROPSYCHOLOGIA, V28, P49, DOI 10.1016/0028-3932(90)90085-3; Ylvisaker M., 1987, COMMUNITY REENTRY HE, P137	14	21	21	0	2	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology	OCT-NOV	2001	15	10-11					1091	1101		10.1080/02687040143000429			11	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	483EW	WOS:000171621600018					2021-06-18	
J	Sylvia, FR; Drake, AI; Wester, DC				Sylvia, FR; Drake, AI; Wester, DC			Transient vestibular balance dysfunction after primary blast injury	MILITARY MEDICINE			English	Article							BOMB EXPLOSION; TERRORIST	Explosive munitions are used routinely in support of military operations. Moreover, service personnel are increasingly being deployed to regions where active conflict, terrorism, and land mines pose significant threats. Despite aggressive protective measures and safety practices, blast injury is an inherent risk. In contrast to secondary and tertiary blast injuries, primary blast injuries are generally limited to the air-filled organs of the respiratory, gastrointestinal, and auditory systems. We report the case of a Marine who entered the back-blast arc of a shoulder-launched multipurpose assault weapon at close range. Despite the magnitude of the blast, he sustained none of the classic findings suggestive of severe primary blast injury. However, he manifested unique vestibular balance abnormalities that precluded his return to full duty for several months. This suggests that personnel who sustain even a mild traumatic brain injury with vestibular manifestations may need prolonged observation and modified duty in certain military occupational specialties.	REIN, Regimental Aid Stn, Marine Div 1, REIN, Camp Pendleton, CA 92055 USA; USN, Ctr Med, Dept Neurol, San Diego, CA 92134 USA; USN, Med Ctr, Dept Def Vestibular Balance Lab, San Diego, CA 92134 USA	Sylvia, FR (corresponding author), REIN, Regimental Aid Stn, Marine Div 1, REIN, Fleet Marine Force,Box 555401, Camp Pendleton, CA 92055 USA.						Benzinger T., 1950, GERMAN AVIATION MED, V2, P1225; BRISMAR B, 1982, J TRAUMA, V22, P216, DOI 10.1097/00005373-198203000-00007; DESAGA H, 1950, GERMAN ACTIVATION ME, P1274; HADDEN WA, 1978, BRIT J SURG, V65, P525, DOI 10.1002/bjs.1800650802; KATZ E, 1989, ANN SURG, V209, P484, DOI 10.1097/00000658-198904000-00016; KERR AG, 1978, PRACTITIONER, V221, P677; Krohn PL, 1942, LANCET, V1, P252; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Mellor S G, 1988, Br J Hosp Med, V39, P536; PAHOR AL, 1981, J LARYNGOL OTOL, V95, P399, DOI 10.1017/S0022215100090873; PHILIPS YY, 1985, 5 INT WOUND BALL S S; PHILLIPS YY, 1986, ANN EMERG MED, V15, P1446, DOI 10.1016/S0196-0644(86)80940-4; Pyper PC, 1982, INJURY, V14, P332; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; ROSSLE R, 1950, GERMAN AVIATION MED, P1260; SCHARDIN H, 1950, GERMAN AVIATION MED, P1207; Wilson JV, 1943, LANCET, V1, P257; ZIV M, 1973, MIL MED, V8, P811	18	21	23	1	1	ASSN MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	OCT	2001	166	10					918	920					3	Medicine, General & Internal	General & Internal Medicine	653DG	WOS:000181419500023	11603248				2021-06-18	
J	Demakis, GJ; Sweet, JJ; Sawyer, TP; Moulthrop, M; Nies, K; Clingerman, S				Demakis, GJ; Sweet, JJ; Sawyer, TP; Moulthrop, M; Nies, K; Clingerman, S			Discrepancy between predicted and obtained WAIS-R IQ scores discriminates between traumatic brain injury and insufficient effort	PSYCHOLOGICAL ASSESSMENT			English	Article; Proceedings Paper	Annual Meeting of the American-Psychological-Association	AUG 18-24, 1999	BOSTON, MA	Amer Psychol Assoc			ESTIMATING PREMORBID INTELLIGENCE; INCOMPLETE EFFORT; CROSS-VALIDATION; SIMULATION INDEX; MEMORY; PERFORMANCE; LITIGATION	This study examines how well the discrepancy between predicted and obtained Wechsler Adult Intelligence Scale- Revised (WAIS-R) scores discriminate between insufficient effort (IE) and traumatic brain injury (TBI). The 27 IE patients performed significantly more poorly on the WAIS-R than the 48 moderate-severe TBI patients. Premorbid IQs were calculated with formulae that use demographics (Barona Index) or demographics and WAIS-R performance (Best-3 and the Oklahoma Premorbid Intelligence Estimation). Predictions were similar on the Barona, but IE patients' predicted IQs were lower than TBIs for measures with a performance component, IE patients demonstrated a greater discrepancy score (i.e., predicted IQ - obtained IQ) than TBIs; variable levels of sensitivity and specificity were obtained when discriminate functions were developed on these scores. The potential advantage of using discrepancy scores Versus performance-based measures to detect insufficient effort is discussed.	Elmhurst Coll, Dept Psychol, Elmhurst, IL 60126 USA; Northwestern Univ, Evanston Hosp, Dept Psychiat & Behav Sci, Evanston, IL 60201 USA; Northwestern Univ, Sch Med, Evanston, IL USA; Cook Cty Hosp, Dept Psychiat, Chicago, IL 60612 USA	Demakis, GJ (corresponding author), Elmhurst Coll, Dept Psychol, 190 Prospect Ave, Elmhurst, IL 60126 USA.	georged@elmhurst.edu					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ARNETT PA, 1995, CLIN NEUROPSYCHOL, V9, P17, DOI 10.1080/13854049508402052; Axelrod BN, 1999, J CLIN EXP NEUROPSYC, V21, P368, DOI 10.1076/jcen.21.3.368.916; Axelrod BN, 1999, ARCH CLIN NEUROPSYCH, V14, P341, DOI 10.1016/S0887-6177(98)00028-6; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Cullum C, 1991, FORENSIC NEUROPSYCHO, P141; Demakis GJ, 1999, ARCH CLIN NEUROPSYCH, V14, P401, DOI 10.1016/S0887-6177(98)00039-0; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; EPPINGER MG, 1987, J CONSULT CLIN PSYCH, V55, P86, DOI 10.1037/0022-006X.55.1.86; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; GOUVIER WD, 1983, INT J CLIN NEUROPSYC, V5, P119; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Milanovich JR, 1996, ARCH CLIN NEUROPSYCH, V11, P53, DOI 10.1016/0887-6177(95)00016-X; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; PAOLO AM, 1992, ARCH CLIN NEUROPSYCH, V7, P135; Psychological Corporation, 1997, WAIS 3 WMS 3 TECHN M; Putnam SH, 1999, STUD NEUROPSYCHOL DE, P39; Rawling P, 1990, NEUROPSYCHOLOGY, V4, P223, DOI 10.1037/0894-4105.4.4.223; Reitan RM, 1997, CLIN NEUROPSYCHOL, V11, P69, DOI 10.1080/13854049708407031; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; ROGERS R, 1990, PROF PSYCHOL-RES PR, V21, P182; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; SmithSeemiller L, 1997, ARCH CLIN NEUROPSYCH, V12, P739, DOI 10.1016/S0887-6177(97)00047-4; SQUIRE LR, 1989, J NEUROSCI, V9, P828; Stevens K B, 1999, Appl Neuropsychol, V6, P68, DOI 10.1207/s15324826an0602_2; Strauss E, 2000, PSYCHOL ASSESSMENT, V12, P237, DOI 10.1037/1040-3590.12.3.237; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Tulsky DS, 2000, PSYCHOL ASSESSMENT, V12, P253, DOI 10.1037//1040-3590.12.3.253; Vanderploeg RD, 1996, PSYCHOL ASSESSMENT, V8, P404, DOI 10.1037/1040-3590.8.4.404; Wechsler D., 1981, WAIS R MANUAL WECHSL; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	44	21	22	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	2001	13	2					240	248		10.1037//1040-3590.13.2.240			9	Psychology, Clinical	Psychology	470VV	WOS:000170892600007	11433798				2021-06-18	
J	Williams, KR; Galas, J; Light, D; Pepper, C; Ryan, C; Kleinmann, AE; Burright, R; Donovick, P				Williams, KR; Galas, J; Light, D; Pepper, C; Ryan, C; Kleinmann, AE; Burright, R; Donovick, P			Head injury and alexithymia: implications for family practice care	BRAIN INJURY			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Neuroscience	1998	NEW ORLEANS, LOUISIANA	Soc Neurosci			TRAUMATIC BRAIN INJURY; HEALTH-CARE; SCALE; PREVALENCE; DISORDERS; VALIDITY; DISEASE; ALCOHOL	Background: Alexithymia, a deficit in emotional information processing, and a history of head injury have both been found to be related to high rates of psychosomatic illness, substance abuse, depression, and utilization of primary care services. To date, no study has examined the potential comorbidity of alexithymia and head injury in a family practice setting, a necessary step in evaluating the aetiologic role of head injury in the development of alexithymia. The goals of this study are to establish prevalence of head injury and alexithymia in a family practice setting and to evaluate the relation, if present, between the two. Methods: Patients (n = 135) of a family practice residency facility were screened using the Traumatic Brain Injury Questionnaire and the Toronto Alexithymia Scale-20. Results: Forty-nine per cent of the participants reported a history of head injury and 18% were alexithymic. Those with a history of head injury had significantly higher scores of alexithymia. Chi-square analysis indicated a relation between head injury and alexithymia. Conclusions: The high rates of self-reported history of head injury in family practice settings, particularly in the context of alexithymia, may adversely affect a physician's ability to care for these patients. Increasing physicians' awareness of head injury and the potential mediating role of alexithymia in medical and psychological illness may facilitate effective diagnosis and patient-physician communication.	SUNY Binghamton, Dept Psychol, Mood & Depress Lab, Binghamton, NY 13902 USA; Wilson Family Practice Residency, New York, NY USA; SUNY Binghamton, Hlth Sci Ctr, Binghamton, NY USA	Williams, KR (corresponding author), SUNY Binghamton, Dept Psychol, Mood & Depress Lab, POB 6000, Binghamton, NY 13902 USA.						BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; BAGBY RM, 1988, PSYCHOTHER PSYCHOSOM, V50, P29; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLANCHARD EB, 1981, PSYCHOTHER PSYCHOSOM, V35, P64, DOI 10.1159/000287479; Burg JS, 1996, J CLIN PSYCHOL MED S, V3, P243, DOI 10.1007/BF01993910; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; Crane A. A., 1991, BEHAV RESIDENTIAL TR, V6, P65; *DEP ED, 1987, REHABILITATION TRAUM; DIRKS JF, 1981, PSYCHOTHER PSYCHOSOM, V36, P63, DOI 10.1159/000287527; ELLIOTT FA, 1984, NEUROL CLIN, V2, P113, DOI 10.1016/S0733-8619(18)31119-8; Gallacher JEJ, 1999, PSYCHOSOM MED, V61, P446, DOI 10.1097/00006842-199907000-00007; HAVILAND MG, 1996, J PEROSNAL ASSESSMEN, V66, P117; JESTE DV, 1988, BRIT J PSYCHIAT, V153, P444, DOI 10.1192/bjp.153.4.444; Joukamaa M, 1996, PSYCHOTHER PSYCHOSOM, V65, P199, DOI 10.1159/000289075; JOUKAMAA M, 1995, J PSYCHOSOM RES, V39, P833, DOI 10.1016/0022-3999(95)00020-1; KAPLAN SP, 1993, REHABIL COUNS BULL, V36, P151; KAPLAN SP, 1990, REHABILITATION COUNS, V34, P17; Kauhanen J, 1996, J PSYCHOSOM RES, V41, P541, DOI 10.1016/S0022-3999(96)00226-7; KAUHANEN J, 1994, PSYCHOSOM MED, V56, P237, DOI 10.1097/00006842-199405000-00010; KENYON LW, 1991, CIRCULATION, V84, P1969, DOI 10.1161/01.CIR.84.5.1969; KRAUS JF, 1989, MILD HEAD INJURY, P8; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V13, P1; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; Miller L., 1990, COGN REHABIL, V8, P14; PASINI A, 1992, COMPR PSYCHIAT, V33, P42, DOI 10.1016/0010-440X(92)90078-5; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; RYBAKOWSKI J, 1988, DRUG ALCOHOL DEPEN, V21, P133, DOI 10.1016/0376-8716(88)90058-0; Sifneos PE, 1994, NEW TRENDS EXP CLIN, V10, P193; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sosin DM, 1996, BRAIN INJURY, V10, P47; Taylor G. J., 1997, DISORDERS AFFECT REG; Taylor G.J., 1994, NEW TRENDS EXP CLIN, V10, P61; WISE TN, 1988, PSYCHOTHER PSYCHOSOM, V50, P68, DOI 10.1159/000288102	36	21	21	0	4	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2001	15	4					349	356		10.1080/026990501750111319			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	420ZK	WOS:000168035000006	11299135				2021-06-18	
J	Glass, TF; Fabian, MJ; Schweitzer, JB; Weinberg, JA; Proctor, KG				Glass, TF; Fabian, MJ; Schweitzer, JB; Weinberg, JA; Proctor, KG			The impact of hypercarbia on the evolution of brain injury in a porcine model of traumatic brain injury and systemic hemorrhage	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Annual Meeting of the Pediatric-Academic-Societies	MAY 01-04, 1999	SAN FRANCISCO, CA	Pediat Acad Soc		carbon dioxide; cerebral blood flow; cerebral metabolism; hemorrhagic shock; multiple trauma; resuscitation	CEREBRAL BLOOD-FLOW; HEAD-INJURY; RATS	Carbon dioxide is perhaps the most potent available modulator of cerebrovascular tone and thus cerebral blood flow (CBF). These experiments evaluate the impact of induced hypercarbia on the matching of blood flow and metabolism in the injured brain. We explore the hypothesis that hypercarbia will restore the relationship of CBF to metabolic demand, resulting in improved outcome following traumatic brain injury (TBI) and hemorrhage, A behavioral outcome score, hemodynamic, metabolic, and pathologic parameters were assessed in anesthetized and ventilated juvenile pigs, Animals were assigned to either normocarbia or hypercarbia and subdivided into TBI (via fluid percussion) with or without hemorrhage, The experimental groups were TBI; TBI + 40% hemorrhage (40%H); TBI + hypercarbia (CO2); and TBI + 40%H + CO2. Hemorrhaged animals were resuscitated with blood and crystalloid, Hypercarbia was induced immediately following TBI using 10% FiCO(2). The normocarbic group demonstrated disturbance of the matching of CBF to metabolism evidenced by statistically significant increases in cerebral oxygen and glucose extraction. Hypercarbic animals showed falls in the same parameters, demonstrating improvement in the matching of CBF to metabolic demand. Parenchymal injury was significantly decreased in hypercarbic animals: 3/10 hypercarbic versus 6/8 normocarbic animals showed cerebral contusions at the gray/white interface (p = 0.05). The hypercarbic group had significantly better behavioral outcome scores, 10.5, versus 7.3 for the normocarbic groups (p = 0.005). The decreased incidence of cerebral contusion and improved behavioral outcome scores in our experiments appear to be mediated by better matching of cerebral metabolism and blood flow, suggesting that manipulations modulating the balance of blood flow and metabolism in injured brain may improve outcomes from TBI.	Childrens Hosp, Med Ctr, Dept Pediat Emergency Med OSB4, Div Pediat Emergency Med, Cincinnati, OH 45229 USA; Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Anat, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Neurobiol, Memphis, TN 38163 USA; Lebonheur Childrens Hosp & Med Ctr, Memphis, TN USA	Glass, TF (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat Emergency Med OSB4, Div Pediat Emergency Med, 3333 Burnett Ave, Cincinnati, OH 45229 USA.	glast0@chmcc.org					Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Boswell WC, 1996, SOUTHERN MED J, V89, P218, DOI 10.1097/00007611-199602000-00012; Bouma G J, 1995, New Horiz, V3, P384; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; DEDEYNE C, 1996, EUR J EMERG MED, V2, P69; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; HILTON DL, 1993, J NEUROTRAUM, V10, P121, DOI 10.1089/neu.1993.10.121; HOVDA DA, 1990, ACT NEUR S, V51, P331; KATSURA K, 1994, J CEREBR BLOOD F MET, V14, P243, DOI 10.1038/jcbfm.1994.31; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; KRISTIAN T, 1995, J CEREBR BLOOD F MET, V15, P78, DOI 10.1038/jcbfm.1995.9; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Marion D W, 1995, New Horiz, V3, P439; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MILLEN JE, 1980, J APPL PHYSIOL, V49, P856; MILLEN JE, 1983, J APPL PHYSIOL, V54, P666; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; SCHWEITZER JB, 1993, ACTA NEUROPATHOL, V85, P503; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; SIESJO BK, 1978, J NEURAL TRANSM-SUPP, V14, P17; SIKES PJ, 1994, CRIT CARE NURS Q, V1, P9; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Stoffel M, 1997, ACT NEUR S, V70, P91; UNTERBERG AW, 1997, J TRAUMA S, V5, pS32; Wei JN, 1998, BRAIN RES, V791, P146, DOI 10.1016/S0006-8993(98)00089-4	41	21	21	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2001	18	1					57	71		10.1089/089771501750055776			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	390EU	WOS:000166283400006	11200250				2021-06-18	
J	Maughan, PH; Scholten, KJ; Schmidt, RH				Maughan, PH; Scholten, KJ; Schmidt, RH			Recovery of water maze performance in aged versus young rats after brain injury with the impact acceleration model	JOURNAL OF NEUROTRAUMA			English	Article						aging; cholinergic neurons; impact acceleration injury; traumatic brain injury; water maze	SPATIAL MEMORY PERFORMANCE; CONTROLLED CORTICAL IMPACT; FLUID-PERCUSSION INJURY; LONG-TERM POTENTIATION; FOREBRAIN CHOLINERGIC NEURONS; COGNITIVE IMPAIRMENT; ANTICHOLINERGIC SENSITIVITY; ACETYLCHOLINE SYNTHESIS; GLUTAMATE RECEPTORS; EVOKED RELEASE	Clinically, elderly patients have a higher cognitive morbidity from head trauma than young patients. We have modeled injury in aged rats in an effort to elucidate the pathophysiology of this enhanced sensitivity and, in particular, to determine if there are susceptibility differences in forebrain cholinergic innervation in young versus aged rats. Aged (20-23 months) and young (2-3 months) rats were subjected to injury under halothane anesthesia using the Marmarou impact acceleration model. Injury parameters required adjustment downward for the aged rats (323 g at 1.61 m versus 494 g at 2.06 m) to provide equivalent mortality (30% versus 20%) and loss of righting-reflex times (10-12 min average). At 1 week following injury, the aged animals were markedly more impaired in water maze performance than were young rats, and this difference persisted at least up to 5 weeks following injury, The extent of improvement in performance from 1 to 5 weeks was markedly worse for aged animals compared to young animals, Forebrain synaptosomal choline uptake was decreased in aged injured rats by 8-14% at 1, 3, and 5 weeks postinjury, but not decreased in young injured rats. No differences were noted in entorhinal cortex or hippocampal choline uptake. This model effectively demonstrates the markedly increased susceptibility of older animals to head injury and their decreased capacity for recovery. The neurophysiological basis for this difference is presently unknown, but the differences in cognitive dysfunction between young and aged rats appears to be much greater than would seem to be explained by the small differences in forebrain cholinergic innervation.	Univ Utah, Dept Neurosurg, Salt Lake City, UT 84132 USA	Schmidt, RH (corresponding author), Univ Utah, Dept Neurosurg, 50 N Med Dr, Salt Lake City, UT 84132 USA.	rhs@suzy.med.utah.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 01866] Funding Source: Medline		ABDULLA FA, 1995, NEUROBIOL AGING, V16, P41, DOI 10.1016/0197-4580(95)80006-D; Baxter MG, 1999, NEUROSCIENCE, V89, P771, DOI 10.1016/S0306-4522(98)00374-1; BLUSZTAJN JK, 1983, SCIENCE, V221, P614, DOI 10.1126/science.6867732; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P197, DOI 10.1162/089892900561832; Cabeza R, 1997, NEUROREPORT, V8, P3479, DOI 10.1097/00001756-199711100-00013; Colombo PJ, 1998, NEUROBIOL LEARN MEM, V70, P314, DOI 10.1006/nlme.1998.3857; COOPER JR, 1994, J NEUROCHEM, V63, P395; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Dawson R, 1999, BRAIN RES BULL, V48, P319, DOI 10.1016/S0361-9230(99)00003-9; Dixon C. E., 1995, Society for Neuroscience Abstracts, V21, P762; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; FISCHER W, 1992, NEUROBIOL AGING, V13, P9, DOI 10.1016/0197-4580(92)90003-G; Flood JF, 1998, MECH AGEING DEV, V105, P173, DOI 10.1016/S0047-6374(98)00098-0; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Foster TC, 1999, BRAIN RES REV, V30, P236, DOI 10.1016/S0165-0173(99)00017-X; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Granger R, 1996, SYNAPSE, V22, P332, DOI 10.1002/(SICI)1098-2396(199604)22:4<332::AID-SYN4>3.0.CO;2-C; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hersi AI, 2000, MOL BRAIN RES, V76, P336, DOI 10.1016/S0169-328X(00)00015-2; INGRAM DK, 1994, LIFE SCI, V55, P2037, DOI 10.1016/0024-3205(94)00384-X; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JOPE RS, 1979, BRAIN RES REV, V1, P313, DOI 10.1016/0165-0173(79)90009-2; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lanahan A, 1997, J NEUROSCI, V17, P2876; LAPCHAK PA, 1988, J NEUROCHEM, V50, P58, DOI 10.1111/j.1471-4159.1988.tb13229.x; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Lynch MA, 1998, PROG NEUROBIOL, V56, P571, DOI 10.1016/S0301-0082(98)00054-9; Magnusson KR, 1998, MECH AGEING DEV, V104, P227, DOI 10.1016/S0047-6374(98)00076-1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MCENTEE WJ, 1993, PSYCHOPHARMACOLOGY, V111, P391, DOI 10.1007/BF02253527; MEYER EM, 1984, NEUROBIOL AGING, V5, P315, DOI 10.1016/0197-4580(84)90008-3; Meyer RC, 1998, ANN NY ACAD SCI, V854, P307, DOI 10.1111/j.1749-6632.1998.tb09911.x; NILSSON OG, 1993, NEUROBIOL AGING, V14, P487, DOI 10.1016/0197-4580(93)90107-M; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Sarter M, 1998, BRAIN RES REV, V27, P143, DOI 10.1016/S0165-0173(98)00003-4; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Shukitt-Hale B, 1998, EXP GERONTOL, V33, P615, DOI 10.1016/S0531-5565(98)00024-2; SIMON JR, 1976, J NEUROCHEM, V26, P909, DOI 10.1111/j.1471-4159.1976.tb06472.x; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stemmelin J, 2000, NEUROSCIENCE, V96, P275, DOI 10.1016/S0306-4522(99)00561-8; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37	60	21	22	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2000	17	12					1141	1153		10.1089/neu.2000.17.1141			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	379MB	WOS:000165644900003	11186228				2021-06-18	
J	Quinn, B; Sullivan, SJ				Quinn, B; Sullivan, SJ			The identification by physiotherapists of the physical problems resulting from a mild traumatic brain injury	BRAIN INJURY			English	Article							MINOR HEAD-INJURY; CLINICAL NURSING RESEARCH; DELPHI SURVEY; PRIORITIES; RECOVERY; VARIABLES; SYMPTOMS; ADULTS	In New Zealand, over 9000 people are diagnosed with a traumatic brain injury (TBI) each year, with at least 80% being classified as mild. The cognitive deficits resulting from mild traumatic brain injury (MTBI) have been well documented, but this is not the case for the physical problems. As a result, the physical problems are not well understood and few people with a MTBI are referred for physiotherapy. The aim of this research was to use a modified Delphi Technique to gain consensus amongst physiotherapists working with TBI clients with regard to: (1) The common motor performance problems associated with MTBI; (2) The importance of assessing these motor performance problem; and (3) Whether these motor performance problems should be used in a formal assessment (FA) or included as a screening measure (SM). Following a pilot study to establish face validity and clarity of instructions, a national sample of 52 physiotherapists with a minimum of 1 year's experience working with TBI clients was recruited. In Round 1, 42 physiotherapists listed 424 physical problems which, in their clinical experience, may occur in people with a recent MTBI. A planning committee developed these listed problems into 33 items. In Round 2, these items were then rated by the physiotherapists as to their importance of being included in an assessment. Using 75% consensus criteria, 31 items were deemed as being at least 'important' for inclusion. In Round 3, the physiotherapists were asked whether these items should be used in a FA or used as a SM. Of the 31 items which were retained, seven reached consensus for FA (balance with unstable, reduced or changing base of support; dynamic standing balance; high level balance activities; quality of movement; ballistic activities; gait; proprioception). Five items reached consensus for being used as a SM (attention; behaviour; sport and leisure activities; vocational activities; quality of movement). Consensus of classification was not reached for the remaining 19 items which had previously been identified in Round 2 as being at least 'important' to be assessed. These results form the foundation for the development of an assessment/management protocol for physiotherapists working with adults with MTBI.	Univ Otago, Sch Physiotherapy, Dunedin, New Zealand; HealthCare Otago, ISIS Ctr, Community Rehabil Ctr, Dunedin, New Zealand	Sullivan, SJ (corresponding author), Univ Otago, Sch Physiotherapy, POB 56, Dunedin, New Zealand.	jsullivan@gandalf.otago.ac.nz					Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINKLEY J, 1993, PHYS THER, V73, P138, DOI 10.1093/ptj/73.3.138; BOND S, 1982, J ADV NURS, V7, P565, DOI 10.1111/j.1365-2648.1982.tb00277.x; COUPER MR, 1994, ADV NURS SCI, V7, P72; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DUFFIELD C, 1989, AUSTR J ADV NURSING, V6, P41; Everett A, 1993, Prof Nurse, V9, P181; Flanagan S, 1999, MT SINAI J MED, V66, P152; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; GRONWALL D, 1974, LANCET, V2, P605; HALL KM, 1994, ARCH PHYSICAL MED RE, V75; HERDMAN SJ, 1993, PHYS MED REHABIL STA, V7, P559; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LINDEMAN CA, 1975, NURS RES, V24, P434, DOI 10.1097/00006199-197511000-00006; Linstone HA., 1975, DELPHI METHOD TECHNI; MCKENNA HP, 1994, J ADV NURS, V19, P1221, DOI 10.1111/j.1365-2648.1994.tb01207.x; MILESTAPPING C, 1990, PHYS THER, V70, P448, DOI 10.1093/ptj/70.7.448; PILON M, 1995, BRAIN INJURY, V9, P365, DOI 10.3109/02699059509005776; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Schmitz Thomas J., 1994, P97; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; SWAINE BR, 1994, BRAIN INJURY, V8, P323, DOI 10.3109/02699059409150983; Veltman R H, 1993, J Neurosci Nurs, V25, P367; Vitale AE, 1996, BRAIN INJURY, V10, P367, DOI 10.1080/026990596124377; Zasler N., 1993, J HEAD TRAUMA REHAB, V8, P13	34	21	23	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2000	14	12					1063	1076					14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	380YW	WOS:000165736100004	11147579				2021-06-18	
J	Feinstein, A; Rapoport, M				Feinstein, A; Rapoport, M			Mild traumatic brain injury: The silent epidemic	CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE			English	Article							RANDOMIZED CONTROLLED TRIAL; ROUTINE FOLLOW-UP		Univ Toronto, Sunnybrook & Womens Coll, Ctr Hlth Sci, Dept Psychiat,Dept Neuropsychiat, Toronto, ON M4N 3M5, Canada	Feinstein, A (corresponding author), Univ Toronto, Sunnybrook & Womens Coll, Ctr Hlth Sci, Dept Psychiat,Dept Neuropsychiat, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.		Rapoport, Mark/AAD-8581-2020				ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BERROL S, 1992, PHYSICAL MED REHABIL, V6, P1; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; GRONWALL D, 1975, LANCET, V2, P995; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; MCCULLAGH S, 2000, IN PRESS ANN M AM PS; *SMART RISK MIN HL, 1999, EC BURD UN INJ ONT; *STAT CAN, 1996, NAT POP HLTH SURV 19; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177	12	21	21	0	0	CANADIAN PUBLIC HEALTH ASSOC	OTTAWA	1565 CARLING AVE, SUITE 400, OTTAWA, ONTARIO K1Z 8R1, CANADA	0008-4263			CAN J PUBLIC HEALTH	Can. J. Public Health-Rev. Can. Sante Publ.	SEP-OCT	2000	91	5					325	326		10.1007/BF03404799			2	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	373JN	WOS:000165286000002	11089281	Green Published, Bronze			2021-06-18	
J	Bauman, RA; Widholm, JJ; Petras, JM; McBride, K; Long, JB				Bauman, RA; Widholm, JJ; Petras, JM; McBride, K; Long, JB			Secondary hypoxemia exacerbates the reduction of visual discrimination accuracy and neuronal cell density in the dorsal lateral geniculate nucleus resulting from fluid percussion injury	JOURNAL OF NEUROTRAUMA			English	Article						fluid percussion injury; secondary hypoxemia; visual discrimination	TRAUMATIC BRAIN INJURY; CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; COGNITIVE DEFICITS; MEMORY DYSFUNCTION; OXIDATIVE STRESS; NERVOUS-SYSTEM; RATS; HYPOXIA; HIPPOCAMPUS	The purpose of this study was to determine the impact of secondary hypoxemia on visual discrimination accuracy after parasagittal fluid percussion injury (FPI). Rats lived singly in test cages, where they were trained to repeatedly execute a flicker-frequency visual discrimination for food. After learning was complete, all rats were surgically prepared and then retested over the following 4-5 days to ensure recovery to presurgery levels of performance. Rats were then assigned to one of three groups [FPI + Hypoxia (IPI), FPI + Normoxia (IN), or Sham Injury + Hypoxia (SH)] and were anesthetized with halothane delivered by compressed air. Immediately after injury or sham injury, rats in groups IH and SH were switched to a 13% O-2 source to continue halothane anesthesia for 30 min before being returned to their test cages. Anesthesia for rats in group IN was maintained using compressed air for 30 min after injury. FPI significantly reduced visual discrimination accuracy and food intake, and increased incorrect choices. Thirty minutes of immediate posttraumatic hypoxemia significantly (1) exacerbated the PBI-induced reductions of visual discrimination accuracy and food intake, (2) further increased numbers of incorrect choices, and (3) delayed the progressive recovery of visual discrimination accuracy. Thionine stains of midbrain coronal sections revealed that, in addition to the loss of neurons seen in several thalamic nuclei following FPI, cell loss in the ipsilateral dorsal lateral geniculate nucleus (dLG) was significantly greater after FPI and hypoxemia than after FPI alone. In contrast, neuropathological changes were not evident following hypoxemia alone. These results show that, although hypoxemia alone was without effect, posttraumatic hypoxemia exacerbates FPI-induced reductions in visual discrimination accuracy and secondary hypoxemia interferes with control of the rat's choices by flicker frequency, perhaps in part as a result of neuronal loss and fiber degeneration in the dLG. These results additionally confirm the utility of this visual discrimination procedure as a sensitive, noninvasive means of assessing behavioral function after experimental traumatic brain injury.	Walter Reed Army Med Ctr, Walter Reed Army Inst Res, Div Neurosci, Washington, DC 20307 USA; Univ Illinois, Dept Vet Med, Urbana, IL 61801 USA; American Univ, Dept Psychol, Washington, DC 20016 USA	Bauman, RA (corresponding author), Dept Neurobehav Assessment, Div Neurosci, Washington, DC 20307 USA.	richard.bauman@na.amedd.army.mil					Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; BAUMAN R, 1991, J EXP ANAL BEHAV, V56, P33, DOI 10.1901/jeab.1991.56-33; Bauman RA, 1996, J EXP ANAL BEHAV, V65, P401, DOI 10.1901/jeab.1996.65-401; Bauman RA, 1998, PHYSIOL BEHAV, V64, P507, DOI 10.1016/S0031-9384(98)00102-4; BAUMAN RA, 1995, PHYSIOL BEHAV, V57, P1187, DOI 10.1016/0031-9384(95)00038-K; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1997, NEUROL EMERG, V15, P581; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Cohen N.J., 1994, MEMORY AMNESIA HIPPO; Cooper R M, 1995, Int J Neurosci, V81, P27, DOI 10.3109/00207459509015296; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Fix AS, 1996, TOXICOL PATHOL, V24, P291, DOI 10.1177/019262339602400305; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; KITA H, 1994, ACTA NEUROCHIR, P452; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; LAEMLE LK, 1986, NEUROSCI LETT, V63, P207, DOI 10.1016/0304-3940(86)90357-5; LEMAGNEN J, 1983, PHYSIOL REV, V63, P314; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; McIntosh TK, 1996, LAB INVEST, V74, P315; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Ross JF, 1996, BRAIN RES, V725, P137; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Swanson L.W., 1996, BRAIN MAPS STRUCTURE; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Tobe EH, 1999, J NEUROPSYCH CLIN N, V11, P504, DOI 10.1176/jnp.11.4.504; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yamaki T, 1997, BRAIN RES, V752, P151, DOI 10.1016/S0006-8993(96)01469-2; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500	59	21	21	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2000	17	8					679	693		10.1089/089771500415427			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	347WF	WOS:000088951600005	10972244				2021-06-18	
J	Koizumi, MS; Lebrao, ML; De Mello-Jorge, MHP; Primerano, V				Koizumi, MS; Lebrao, ML; De Mello-Jorge, MHP; Primerano, V			Morbidity and mortality due to traumatic brain injury in Sao Paulo city, Brazil, 1997	ARQUIVOS DE NEURO-PSIQUIATRIA			Portuguese	Article						epidemiology; morbidity; mortality; head injury	HEAD-INJURY; EPIDEMIOLOGY	There are few epidemiological studies on traumatic brain injury (TBI), and those that allow broad comparative analyses of this problem are even more scarce, due to methodological obstacles. Usually, the studies address head injury (they include the cranial envelopments and content) but are reported as TBI, given the difficulty of mutual exclusion. It is also common for them to be centered at specific severity levels, only for hospitalized victims or according to the external cause, such as traffic accidents. With full respect to these limits, this study had as its objective the estimation of the TBI incidence in patients resident and in-hospital, in the hospital network in the city of Sao Paulo, Brazil, in 1997, as well as the estimation of TBI-caused mortality amongst external causes, at this same time and locale. Data for the study consisted of Ministerio da Saude data on hospital discharges, analyzed based on Autorizacoes de Internacao Hospitalar (AIH) and obituary data on external causes, contained in the Programa de Aprimoramenta das Informacoes de Mortatidade (PROAIM) data base. It was found that 29 717 patients were hospitalized due to lesions and poisoning; of these 3 635 (12%) had TB I; the hospitalization rate was 0.36/1000 pop.;and hospital mortality was 10%. The mortality coefficient due to external causes was 87.3/100 000 pop. Minimum TBI mortality rate is estimated at a minimum of 26.2 and a maximum of 39.3/100 000 pop.	EEUSP, Grp Estudos Neurotrauma, BR-05403000 Sao Paulo, Brazil; Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, Sao Paulo, Brazil							Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; ANDRADE SM, 1998, THESIS U SAO PAULO; BARROS JL, 1994, ARQ BRAS NEUROCIRURG, V13, P64; Colli BO, 1997, ARQ NEURO-PSIQUIAT, V55, P91, DOI 10.1590/S0004-282X1997000100015; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; GAWRYSZEWSKI VP, 1995, THESIS U SAO PAULO; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Henry P C, 1992, J Neurosci Nurs, V24, P311; *IBGE, 1996, CONT POP 1996 MUN SA; JORGE MHP, 1988, THESIS U SAO PAULO; JORGE MHP, 1979, THESIS U SAO PAULO S; Kraus JF, 1993, HEAD INJURY, P1; LADEIRA RM, 1995, THESIS U FEDERAL MIN; LEVCOVITZ E, 1993, SIH SUS SISTEMA AIH; Martinez G, 1997, SIGNAL PROCESS-IMAGE, V9, P175, DOI 10.1016/S0923-5965(96)00018-5; Masini M, 1994, J BRAS NEUROCIRURG, V5, P61; MESQUITA MAF, 1998, THESIS U FEDERAL SAO; *ORG MUND SAUD, 1978, CLASS INT DOENC 1975, P475; *ORG MUND SAUD, 1998, CLASS EST INT DOENC, P969; SANTO AH, 1988, THESIS U SAO PAULO S; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Semple PL, 1998, S AFR MED J, V88, P440; SOSIN D, 1989, JAMA-J AM MED ASSOC, V262, P251; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133	26	21	29	0	3	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAR	2000	58	1					81	89		10.1590/S0004-282X2000000100013			9	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	296HK	WOS:000086018800013	10770871	DOAJ Gold			2021-06-18	
J	Hegel, MT; Ferguson, RJ				Hegel, MT; Ferguson, RJ			Differential reinforcement of other behavior (DRO) to reduce aggressive behavior following traumatic brain injury	BEHAVIOR MODIFICATION			English	Article								Severe brain injury can result in significant neurobehavioral and social functioning impairment. In rehabilitation settings, behavioral problems of aggression and nonadherence to therapeutic activities can pose barriers to maximal recovery of function. Behavioral interventions seem to be effective in reducing problem behavior among individuals recovering from severe brain trauma. but well-controlled studies examining the efficacy of such interventions are sparse. This article presents a single-case. multiple-baseline study of a differential reinforcement of other behavior (DRO) procedure in a 28-year-old, brain-injured male with aggressive behavior problems. The procedure successfully reduced the frequency of problem behavior by up to 74%, maintained at 1-month follow-up. Implications of this intervention for individuals with brain injury are discussed, and testing of this procedure using a between-group design seems indicated.	Dartmouth Med Sch, Lebanon, NH 03756 USA	Hegel, MT (corresponding author), Dartmouth Med Sch, Lebanon, NH 03756 USA.						Annoni J M, 1992, Disabil Rehabil, V14, P23; CALLON EB, 1995, HDB HLTH REHABILITAT; Chambless DL, 1996, CLIN PSYCHOL-SCI PR, V3, P230, DOI 10.1111/j.1468-2850.1996.tb00074.x; CHAMBLESS DL, 1994, TREATMENT PANIC DISO, P248; FOSTER K, 1988, COGNITIVE REHABILITA, V6, P16; GOLDSTEIN LH, 1985, BRIT J CLIN PSYCHOL, V24, P13, DOI 10.1111/j.2044-8260.1985.tb01309.x; GOUVIER WD, 1985, ARCH PHYS MED REHAB, V66, P113; Hegel M T, 1988, Brain Inj, V2, P333, DOI 10.3109/02699058809150904; HERSEN M, 1983, SINGLE CASE EXPT DES; *MED DIS SOC GREAT, 1988, MAN TRAUM BRAIN INJ; PAGE TJ, 1992, BEHAV RES TREAT, V7, P169; Van Hasselt V. B., 1996, SOURCEBOOK PSYCHOL T	12	21	21	1	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0145-4455			BEHAV MODIF	Behav. Modificat.	JAN	2000	24	1					94	101		10.1177/0145445500241005			8	Psychology, Clinical	Psychology	271TM	WOS:000084609600005	10641369				2021-06-18	
J	Jiang, XB; Ohno, K; Qian, L; Tominaga, B; Kuroiwa, T; Nariai, T; Hirakawa, K				Jiang, XB; Ohno, K; Qian, L; Tominaga, B; Kuroiwa, T; Nariai, T; Hirakawa, K			Changes in local cerebral blood flow, glucose utilization, and mitochondrial function following traumatic brain injury in rats	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						brain injury; cerebral blood flow; cerebral glucose utilization; lateral fluid percussion injury; mitochondria; succinate dehydrogenase	TOMOGRAPHY	The pathophysiology of secondary brain damage following experimental traumatic brain injury was investigated by measuring local cerebral blood flow (ICBF), local cerebral glucose utilization (lCGU), and activity of succinate dehydrogenase (SDH), which Is a mitochondrial enzyme of the tricarboxylic acid cycle, in the rat brain after moderate lateral fluid percussion injury. Measurements used autoradiography for lCBF and lCGU with [C-14]iodoantipyrine and [C-14]2-deoxyglucose, respectively. Regional SDH activity was determined using quantitative imaging of formazan produced from 2,3,5-triphenyl tetrazolium chloride by SDH. lCBF decreased at 1 hour after injury and was significantly lower than the preinjury level in almost all regions of both hemispheres at 6 and 24 hours, and remained low at 2 weeks. lCGU increased 1 hour after injury but was significantly decreased at 6 and 24 hours, and at 2 weeks in most regions of both hemispheres. The ipsilateral hemisphere showed a significant decrease in the activity of SDH in the cortices, hippocampus, thalamus, and caudate/putamen, most conspicuously 72 hours after injury, whereas no significant decrease was observed in the contralateral hemisphere at any time. Necrosis in the injured cortex and reduction of the number of neurons in the ipsilateral hippocampus were observed 2 weeks after injury. The present study showed that a decrease in lCBF and mitochondrial dysfunction occur with glucose hypermetabolism around 1 hour after lateral fluid percussion injury, and that lCBF, lCGU, and mitochondrial function all deteriorate after 6 hours. This suggests that ICBF and cellular metabolism may change dynamically during the several hours following traumatic brain injury, and afterwards neuronal damage may result in an irreversible change in the areas with depressed glucose hypermetabolism in the early period after injury in combination with mitochondrial dysfunction.	Tokyo Med & Dent Univ, Dept Neurosurg, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Med & Dent Univ, Dept Neuropathol, Bunkyo Ku, Tokyo 1138519, Japan	Ohno, K (corresponding author), Tokyo Med & Dent Univ, Dept Neurosurg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.						Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DEWITT DS, 1992, J NEUROSURG, V67, P110; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOVDA DA, 1995, J NEUROSURG, V82, pA376; INGLIS FM, 1990, ACT NEUR S, V51, P277; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; Kuroiwa T, 1996, NEUROSCI LETT, V206, P117, DOI 10.1016/S0304-3940(96)12439-3; LEWEN A, 1988, J NEUROTRAUM, V15, P521; MATHEW P, 1994, ACTA NEUROCHIR, P428; Nakamura T, 1987, Neurol Med Chir (Tokyo), V27, P396, DOI 10.2176/nmc.27.396; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; Qian L, 1996, ACTA NEUROCHIR, V138, P90, DOI 10.1007/BF01411731; Qian Liang, 1996, Bulletin of Tokyo Medical and Dental University, V43, P53; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59; SHAR K, 1983, NEUROSCI LETT, V40, P287; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	32	21	21	0	3	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	JAN	2000	40	1					16	28		10.2176/nmc.40.16			13	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	275WX	WOS:000084844100002	10721252	Bronze			2021-06-18	
J	Prieto, M; Chauvet, N; Alonso, G				Prieto, M; Chauvet, N; Alonso, G			Tanycytes transplanted into the adult rat spinal cord support the regeneration of lesioned axons	EXPERIMENTAL NEUROLOGY			English	Article						glial cells; cell culture; regeneration; astrocyte; immunocytochemistry	ENSHEATHING GLIA TRANSPLANTS; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; MEDIOBASAL HYPOTHALAMUS; NEURITE OUTGROWTH; ASTROCYTES; CELLS; NEURONS; INJURY; BRAIN	During past years a number of therapeutic strategies have been developed in order to stimulate axonal regeneration after traumatic injuries of the spinal cord. Recently, encouraging data have been obtained by grafting specific glial cells such as Schwann cells or olfactory ensheathing glial cells, known to support the regeneration of peripheral or central axons, respectively. In a recent series of studies, we have shown that tanycytes, a particular glial cell type present in the mediobasal hypothalamus, were able to support the regeneration of a variety of axons innervating this region. The aim of the present study was to determine whether tanycytes could also support the regeneration of lesioned spinal axons. Cultured hypothalamic tanycytes and cortical astrocytes were prelabeled with Fast blue (FB) and grafted into the thoracic spinal cord of adult rats. Three weeks after the transplantation, the animals were fixed and spinal cord sections treated for multiple fluorescence detection of the FB-labeled transplanted cells on the one hand and of various glial and neuronal markers on the other hand. We show here that in all the spinal cords examined, transplanted tanycytes or astrocytes formed large spherical clusters of about 0.5 mm in diameter, located in the mediolateral spinal cord layer. The immunodetection of glial markers showed that transplanted astrocytes exhibited intense immunostaining for both glial fibrillary acidic protein (GFAP) and vimentin (VIM), whereas transplanted tanycytes were intensely immunostained for VIM, but GFAP negative. The immunodetection of axonal markers showed that contrasting with astrocyte transplants, tanycyte transplants were invaded by numerous axonal fibers. These data indicate that tanycyte transplants may represent a useful therapeutic tool for the reparation of the lesioned spinal axons. (C) Academic Press.	Univ Montpellier, INSERM, U336, Montpellier 5, France	Prieto, M (corresponding author), Univ Montpellier, INSERM, U336, Montpellier 5, France.		Chauvet, Norbert/D-7333-2016	Chauvet, Norbert/0000-0003-4388-6422			Aguado A, 1982, ADV CELL NEUROBIOL, V3, P215; ALONSO G, 1993, J NEUROSCI RES, V34, P510, DOI 10.1002/jnr.490340504; BODEGA G, 1990, ANAT EMBRYOL, V181, P567; Carbonetto S, 1991, Curr Opin Neurobiol, V1, P407, DOI 10.1016/0959-4388(91)90062-C; CHAUVET N, 1995, J NEUROSCI RES, V41, P129, DOI 10.1002/jnr.490410115; Chauvet N, 1996, GLIA, V18, P211, DOI 10.1002/(SICI)1098-1136(199611)18:3<211::AID-GLIA5>3.0.CO;2-1; Chauvet N, 1998, EXP NEUROL, V151, P1, DOI 10.1006/exnr.1998.6784; Chernoff EAG, 1996, INT J DEV BIOL, V40, P823; DANIEL PM, 1970, ACTA ENDOCRINOL-COP, V64, P696, DOI 10.1530/acta.0.0640696; DELLMANN HD, 1973, INT REV CYTOL, V36, P215, DOI 10.1016/S0074-7696(08)60219-3; GIBSON SJ, 1984, J NEUROSCI, V4, P3101, DOI 10.1523/jneurosci.04-12-03101.1984; GUENARD V, 1992, J NEUROSCI, V12, P3310; HOKFELT T, 1976, MED BIOL, V54, P427; Kikuchi Kenji, 1993, Neurologia Medico-Chirurgica, V33, P682, DOI 10.2176/nmc.33.682; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; Li Y, 1998, J NEUROSCI, V18, P10514; Martin D, 1996, J NEUROSCI RES, V45, P588; MILLER RH, 1986, J NEUROCYTOL, V15, P187, DOI 10.1007/BF01611655; NONA SN, 1995, J NEUROSCI RES, V42, P350, DOI 10.1002/jnr.490420309; ONTENIENTE B, 1983, J COMP NEUROL, V215, P427, DOI 10.1002/cne.902150407; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; Prieto M, 1999, EXP NEUROL, V155, P118, DOI 10.1006/exnr.1998.6970; RAISMAN G, 1973, J COMP NEUROL, V147, P181, DOI 10.1002/cne.901470204; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099; REIER PJ, 1986, J COMP NEUROL, V247, P275, DOI 10.1002/cne.902470302; REIER PJ, 1983, DEV BRAIN RES, V10, P201, DOI 10.1016/0165-3806(83)90137-2; Reier PJ, 1983, SPINAL CORD RECONSTR, P163; REIER PJ, 1988, ADV NEUROLOGY FUNCTI, P163; SASAKI H, 1981, J COMP NEUROL, V198, P13, DOI 10.1002/cne.901980104; Schwab ME, 1996, PHYSIOL REV, V76, P319; SILVER J, 1994, J NEUROL, V242, pS22, DOI 10.1007/BF00939236; SMITH GM, 1990, DEV BIOL, V138, P377, DOI 10.1016/0012-1606(90)90204-V; SMITH GM, 1986, J COMP NEUROL, V251, P23, DOI 10.1002/cne.902510103; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1; WUNDERLICH G, 1994, GLIA, V10, P49, DOI 10.1002/glia.440100107; Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309; XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113; YAMADA H, 1995, ZOOL SCI, V12, P325, DOI 10.2108/zsj.12.325; ZEMAN W, 1963, CRAIGIES NEUROANATOM, P50; Zompa EA, 1997, J NEUROTRAUM, V14, P479, DOI 10.1089/neu.1997.14.479; ZOTTOLI SJ, 1994, NEURAL REGEN, P219	44	21	26	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2000	161	1					27	37		10.1006/exnr.1999.7223			11	Neurosciences	Neurosciences & Neurology	290FU	WOS:000085666300003	10683271				2021-06-18	
J	Goksoy, EO; McKinstry, LJ; Wilkins, LJ; Parkman, I; Phillips, A; Richardson, RI; Anil, MH				Goksoy, EO; McKinstry, LJ; Wilkins, LJ; Parkman, I; Phillips, A; Richardson, RI; Anil, MH			Broiler stunning and meat quality	POULTRY SCIENCE			English	Article						electrical stunning; concussion stunning; broiler meat quality	BROKEN BONES; CHICKENS; BREAST; TENDERNESS	The effects of electrical and concussion stunning on meat and carcass quality of broilers were compared. Broiler chickens (n = 165) were subjected to treatments: 1) electrical stunning with no fibrillation, 2) electrical stunning with fibrillation, 3) concussion stunning with restraint, or 4) concussion stunning with no restraint. Electrical stunning (100 V, 80 mA, 50 Hz sinusoidal waveform alternating current) was applied for 3 s. Concussion was applied using a nonpenetrative captive bolt gun with or without restraint. We assessed broken bones, hemorrhages, meat quality defects, blood loss, pH at 10 min and 24 h, and texture from breasts filleted 3 h and 24 h postmortem. Electrically stunned birds showed a significantly higher incidence of broken bones (P < 0.0001), coracoid and furculum bone hemorrhages (P < 0.0001), and nonbone hemorrhages (P < 0.0001) than birds stunned by concussion. However, the incidence of red wing tips (P < 0.005) and shoulder hemorrhages was significantly higher (P < 0.05) in concussion-stunned birds than electrically stunned birds. Electrically stunned and nonfibrillated birds had the fastest blood loss rate. The pH value at 10 min was the lowest in concussion-stunned and unrestrained birds. Breast muscles from concussion-stunned birds that were filleted at 3 h postmortem were more tender than those from birds stunned electrically (P < 0.05). We concluded that concussion stunning could be advantageous for early filleting.	Univ Bristol, Dept Vet Clin Sci, Bristol BS40 5DU, Avon, England	Anil, MH (corresponding author), Univ Bristol, Dept Vet Clin Sci, Bristol BS40 5DU, Avon, England.		Goksoy, Ergun O/J-7267-2013	Goksoy, Ergun O/0000-0001-9165-5894			Bilgili S. F., 1992, J APPL POULTRY RES, V1, P135; BLACKMORE DK, 1979, VET REC, V20, P372; DALY CC, 1987, BRIT VET J, V143, P574, DOI 10.1016/0007-1935(87)90049-2; DAVIS LL, 1954, POULTRY SCI, V33, P616, DOI 10.3382/ps.0330616; GREGORY NG, 1989, J SCI FOOD AGR, V47, P13, DOI 10.1002/jsfa.2740470103; GREGORY NG, 1990, BRIT POULTRY SCI, V31, P59, DOI 10.1080/00071669008417231; GREGORY NG, 1990, BRIT POULTRY SCI, V31, P53, DOI 10.1080/00071669008417230; GREGORY NG, 1990, VET REC, V126, P570; GREGORY NG, 1989, VET REC, V124, P530, DOI 10.1136/vr.124.20.530; GREGORY NG, 1987, TURKEYS, V35, P19; Gregory NG, 1989, PROCESSING POULTRY, P31, DOI 10.1007/978-1-4615-2059-7_2; HARRIS CE, 1977, POULTRY SCI, V56, P1827, DOI 10.3382/ps.0561827; Hillebrand SJW, 1996, POULTRY SCI, V75, P664, DOI 10.3382/ps.0750664; KETTLEWELL PJ, 1990, J AGR ENG RES, V47, P139, DOI 10.1016/0021-8634(90)80036-T; KHAN AW, 1970, J FOOD SCI, V35, P266, DOI 10.1111/j.1365-2621.1970.tb12157.x; KOTULA AW, 1966, POULTRY SCI, V45, P404, DOI 10.3382/ps.0450404; LYON CE, 1985, POULTRY SCI, V64, P307, DOI 10.3382/ps.0640307; NEWELL GW, 1950, POULTRY SCI, V29, P271, DOI 10.3382/ps.0290271; PAPINAHO PA, 1995, POULTRY SCI, V74, P1533, DOI 10.3382/ps.0741533; RAJ ABM, 1992, VET REC, V130, P325, DOI 10.1136/vr.130.15.325; SMITH MC, 1969, J FOOD SCI, V34, P42, DOI 10.1111/j.1365-2621.1969.tb14358.x; VEERKAMP CH, 1988, POULT MISSET     JUN, P30; WABECK C, 1988, POULTRY INT      FEB, P48; *WASK, 1955, WELF AN SLAUGHT KILL; Wilkins L. J., 1987, Meat Hygienist, P31	25	21	22	0	7	POULTRY SCIENCE ASSOC INC	SAVOY	1111 NORTH DUNLAP AVE, SAVOY, IL 61874 USA	0032-5791			POULTRY SCI	Poult. Sci.	DEC	1999	78	12					1796	1800		10.1093/ps/78.12.1796			5	Agriculture, Dairy & Animal Science	Agriculture	268KV	WOS:000084413600022	10626658	Other Gold			2021-06-18	
J	Chorny, I; Bsorai, R; Artru, AA; Talmor, D; Benkoviz, V; Roytblat, L; Shapira, Y				Chorny, I; Bsorai, R; Artru, AA; Talmor, D; Benkoviz, V; Roytblat, L; Shapira, Y			Albumin or hetastarch improves neurological outcome and decreases volume of brain tissue necrosis but not brain edema following closed-head trauma in rats	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						brain edema; brain protection; closed-head trauma; hemodilution; neurological outcome; rat	FOCAL CEREBRAL-ISCHEMIA; CROSS-LINKED HEMOGLOBIN; COLLOID ONCOTIC PRESSURE; MOLECULAR-WEIGHT DEXTRAN; HYPERVOLEMIC HEMODILUTION; 5-PERCENT DEXTROSE; LACTATED RINGERS; RAPID INFUSION; CANINE MODEL; BLOOD-FLOW	The present study examined whether hemodilution with 20% human serum albumin (HSA) or 10% hydroxyethyl starch (HES) improved the outcome from closed-head trauma (CHT) in rats. Rats anesthetized with halothane were given one of three hemodilution solutions (i.e., 20% HSA, 10% HES, or control [0.9% saline]) after CHT or sham surgery. CHT was delivered using a weight drop impact of 0.5 J onto the closed cranium. The hemodilution solution (volume = 1% of body weight) was given just after determining the neurological severity score (NSS) at 1 hour following CHT. The NSS was determined again at 24, 48, and 72 hours following CHT. At 72 hours, brains were removed, and brain edema and brain tissue necrosis volume were determined. Solutions of 20% HSA and 10% HES significantly improved brain tissue necrosis volume (143 +/- 72 mm(3) and 104 +/- 53 mm(3) as compared to 271 +/- 65 mm(3) in controls, mean +/- SD) and NSS (12 +/- 2 and 9 +/- 2 as compared to 15 +/- 2 in controls at 72 hours, median +/- range) but not brain edema. The hematocrit decreased similarly in all groups during hemodilution. Hemodilution with 20% HSA and 10% HES following CHT in rats did not decrease brain edema but did decrease brain tissue necrosis volume and NSS (improved neurological function), suggesting that the beneficial effect of hemodilution resulted not from decreased edema formation but rather from effects not measured in this study such as improved perfusion of the salvageable brain tissue surrounding the core injury.	Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Anesthesiol,Div Anesthesiol, IL-84101 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Orthoped Surg, IL-84101 Beer Sheva, Israel; Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA	Shapira, Y (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Anesthesiol,Div Anesthesiol, IL-84101 Beer Sheva, Israel.						ARTRU AA, 1997, TXB NEUROANESTHESIA, P61; ASPLUND K, 1987, STROKE, V18, P691; ASPLUND K, 1988, STROKE, V19, P464; BARNETT HJM, 1987, CEREBRAL BLOOD FLOW, P593; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; CANDELISE L, 1988, LANCET, V1, P318; Cole DJ, 1996, ANESTH ANALG, V83, P342, DOI 10.1097/00000539-199608000-00024; COLE DJ, 1993, ANESTHESIOLOGY, V78, P335, DOI 10.1097/00000542-199302000-00018; COLE DJ, 1990, AM J PHYSIOL, V259, pH211; COLE DJ, 1990, STROKE, V21, P1333, DOI 10.1161/01.STR.21.9.1333; COLE DJ, 1994, ARTIF CELL BLOOD SUB, V22, P813, DOI 10.3109/10731199409117915; Dixon CE, 1996, NEUROTRAUMA, P1337; Drummond JC, 1998, ANESTHESIOLOGY, V88, P993, DOI 10.1097/00000542-199804000-00020; Edvinsson L, 1993, CEREBRAL BLOOD FLOW, P3; EWING JR, 1987, CEREBRAL BLOOD FLOW, P202; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; GOSLINGA H, 1992, STROKE, V23, P181, DOI 10.1161/01.STR.23.2.181; Gurevich B, 1998, J NEUROSURG, V88, P1066, DOI 10.3171/jns.1998.88.6.1066; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; KEE DB, 1987, CEREBRAL BLOOD FLOW, P173; KOLLER M, 1990, STROKE, V21, P1429, DOI 10.1161/01.STR.21.10.1429; LEE SH, 1994, J NEUROSURG, V80, P469, DOI 10.3171/jns.1994.80.3.0469; MARMAROU A, 1978, J NEUROSURG, V49, P503; MATSUI T, 1993, NEUROSURGERY, V33, P293, DOI 10.1227/00006123-199308000-00017; MILDE LN, 1998, CLIN NEUROANAESTHESI, P177; POOLE GV, 1986, CRIT CARE MED, V14, P629, DOI 10.1097/00003246-198607000-00009; Povlishock JT., 1996, NEUROTRAUMA, P1325; Rosner M., 1987, CEREBRAL BLOOD FLOW, P425; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1993, J CEREBR BLOOD F MET, V13, P962, DOI 10.1038/jcbfm.1993.120; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Talmor D, 1998, ANESTH ANALG, V87, P574, DOI 10.1097/00000539-199809000-00014; TODD M M, 1984, Anesthesiology (Hagerstown), V61, pA123, DOI 10.1097/00000542-198409001-00123; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; WISNER D, 1989, J SURG RES, V46, P49, DOI 10.1016/0022-4804(89)90181-9; WOOD JH, 1984, NEUROLOGY, V34, P24, DOI 10.1212/WNL.34.1.24; WOOD JH, 1983, J NEUROSURG, V59, P500, DOI 10.3171/jns.1983.59.3.0500; Yanaka K, 1996, STROKE, V27, P906, DOI 10.1161/01.STR.27.5.906; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011; ZORNOW MH, 1988, ANESTHESIOLOGY, V69, P180, DOI 10.1097/00000542-198808000-00005; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010; Zornow MH, 1997, TXB NEUROANESTHESIA, P117; ZORNOW MH, 1994, ANESTHESIA NEUROSURG, P247	47	21	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	1999	11	4					273	281		10.1097/00008506-199910000-00008			9	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	241LL	WOS:000082884700008	10527147				2021-06-18	
J	Gong, QZ; Phillips, LL; Lyeth, BG				Gong, QZ; Phillips, LL; Lyeth, BG			Metabotropic glutamate receptor protein alterations after traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						fluid percussion; TBI; metabotropic; glutamate; immunohistochemistry; Western blot	FLUID-PERCUSSION MODEL; PHENYLGLYCINE DERIVATIVES; NEURONAL INJURY; NMDA-RECEPTORS; AMINO-ACIDS; AGONIST; BINDING; DEATH; MGLUR; ANTAGONISTS	Glutamate toxicity, mediated via ion channel-linked receptors, plays a key role in traumatic brain injury (TBI) pathophysiology. Excessive glutamate release after TBI also activates protein G-linked metabotropic glutamate receptors (mGluRs), We performed Western blot and immunohistochemical analysis with antibodies for group 1 and 2 mGluRs in hippocampal and cortex tissue at 7 and 15 days after lateral fluid-percussion TBI in rats, Protein homogenates of brain tissue were separated on 7.5% sodium dodecyl sulfate (SDS)-polyacrylamide gels, transferred to nitrocellulose, and incubated with either antibodies recognizing both mGluR2 and mGluR3 or antibodies against mGluR5, Equivalent protein loading of lanes was confirmed by using beta-actin antibody. Immunoreactive proteins were revealed with enhanced chemiluminescence and relative optical density of Western blots quantified by computerized image analysis. At 7 days after TBI, mGluR3 immunobinding ipsilateral to the fluid-percussion injury was reduced by 28% in hippocampus and 25% in cortex in comparison with the contralateral hemisphere (p <.05), mGluR5 immunobinding ipsilateral to the fluid-percussion injury was reduced by 20% in hippocampus and 27% in cortex (p <.05). At 15 days after TBI, the decreases in immunobinding were no longer significant, Immunohistochemical staining with the same antibodies revealed density changes congruent with the Western blot results. These data suggest that TBI produces an alteration in receptor protein expression that spontaneously recovers by 15 days after injury.	Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Anat, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA	Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1515 Newton Court,1 Shields Ave, Davis, CA 95616 USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 29995] Funding Source: Medline		Akbar MT, 1996, MOL BRAIN RES, V43, P105, DOI 10.1016/S0169-328X(96)00162-3; Attwell PJE, 1998, BRAIN RES, V787, P286, DOI 10.1016/S0006-8993(97)01500-X; Bond A, 1998, NEUROREPORT, V9, P1191, DOI 10.1097/00001756-199804200-00042; BRUNO V, 1994, EUR J PHARMACOL, V256, P109, DOI 10.1016/0014-2999(94)90624-6; BUISSON A, 1995, NEUROPHARMACOLOGY, V34, P1081, DOI 10.1016/0028-3908(95)00073-F; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faden AI, 1997, J NEUROTRAUM, V14, P885, DOI 10.1089/neu.1997.14.885; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GONG QZ, 1995, BRAIN RES, V700, P299, DOI 10.1016/0006-8993(95)01081-6; HAYASHI Y, 1994, J NEUROSCI, V14, P3370; HAYES RL, 1988, J NEUROTRAUM, V5, P287; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Mukhin A, 1996, J NEUROSCI, V16, P6012; Mukhin AG, 1997, NEUROREPORT, V8, P2561, DOI 10.1097/00001756-199707280-00028; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; ROBERTS PJ, 1995, NEUROPHARMACOLOGY, V34, P813, DOI 10.1016/0028-3908(95)00094-M; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; ROSDAHL D, 1994, NEUROREPORT, V5, P593, DOI 10.1097/00001756-199401000-00015; SCHOEPP DD, 1993, TRENDS PHARMACOL SCI, V14, P13, DOI 10.1016/0165-6147(93)90107-U; WATKINS J, 1994, TRENDS PHARMACOL SCI, V15, P333, DOI 10.1016/0165-6147(94)90028-0	34	21	21	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1999	16	10					893	902		10.1089/neu.1999.16.893			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	246JD	WOS:000083159900004	10547098				2021-06-18	
J	Armstead, WM				Armstead, WM			Age-dependent impairment of K-ATP channel function following brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral circulation; cyclic nucleotides; endothelin; K+ channel; newborn	CEREBRAL BLOOD-FLOW; POTASSIUM CHANNELS; METABOLISM; CATS; RAT; HEMORRHAGE; NEWBORN; ARTERY; ADULT; TONE	Previous studies observed that endothelin-l (ET-1) contributed to ATP-sensitive K+ (K-ATP) channel impairment 1 h following fluid percussion brain injury (FPI) in the newborn pig. The present study was designed to determine the effect of FPI on KATP channel activity as a function of time in newborn (1-5 days old) and juvenile (3-4 weeks old) pigs equipped with a closed cranial window. FPI of moderate severity (1.9-2.1 atm) was produced by using a pendulum to strike a piston on a saline-filled cylinder that was fluid coupled to the brain via a hollow screw inserted through the cranium. Cromakalim, a K-ATP agonist, produced dilation that was blunted for at least 72 h post FPI, but dilator responsiveness was restored within 168 h post FPI in the newborn pig (15 +/- 1% and 27 +/- 2% vs. 5 +/- 1% and 11 +/- 1% vs. 13 +/- 1% and 26 +/- 2% for responses to 10(-8), 10(-6) M cromakalim before, and 72 and 168 h after FPI). Similar inhibited responses were observed for calcitonin gene-related peptide, 8-Bromo cGMP, and the nitric oxide (NO) releasers SNP and SNAP. In contrast, cromakalim-induced dilation was blunted for at least 4 h, but dilator responsiveness was restored within 8 h post FPI in the juvenile pig (15 +/- 1% and 27 +/- 1% vs. 9 +/- 1% and 15 +/- 2% vs. 18 +/- 1% and 28 +/- 1% for 10(-8), 10(-6) M cromakalim before, and 4 and 8 h post FPI). Similar inhibition of dilations of other agonists also occurred in the juvenile. CSF ET-1 increased to a greater level and remained elevated for a longer period of time in the newborn compared to the juvenile pig. BQ123, an ET-1 antagonist, pretreatment partially restored decremented agonist induced dilation following FPI in the newborn and juvenile pig (5 +/- 1% and 11 +/- 1% vs. 11 +/- 1% and 21 +/- 1% for responses to 10(-8), 10-6 M cromakalim 72 h post FPI in the newborn in the absence and presence of BQ123). These data indicate that K-ATP channel function is impaired to a greater extent and for a longer time period in the newborn versus the juvenile pig. These data also show that ET-1 contributes to such impaired vascular responsiveness to a greater extent in the newborn versus the juvenile pig. These data furthermore suggest that the newborn is more sensitive to traumatic vascular injury than the juvenile.	Childrens Hosp Philadelphia, Dept Anesthesia, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	Armstead, WM (corresponding author), Childrens Hosp Philadelphia, Dept Anesthesia, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.						Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Armstead WM, 1996, AM J PHYSIOL-HEART C, V270, pH1272; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Armstead WM, 1996, AM J PHYSIOL-HEART C, V270, pH423; Bari F, 1996, J CEREBR BLOOD F MET, V16, P1158, DOI 10.1097/00004647-199611000-00010; BRAUN LD, 1980, J NEUROCHEM, V34, P147, DOI 10.1111/j.1471-4159.1980.tb04633.x; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; CLOZEL M, 1993, LIFE SCI, V52, P825, DOI 10.1016/0024-3205(93)90081-D; CROCKARD HA, 1977, SURG NEUROL, V7, P281; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Kasemsri T, 1997, AM J PHYSIOL-HEART C, V273, pH2639; KITAZONO T, 1995, STROKE, V26, P1713, DOI 10.1161/01.STR.26.9.1713; KITAZONO T, 1993, AM J PHYSIOL, V265, pH581; Kontos HA, 1996, AM J PHYSIOL-HEART C, V271, pH1498; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P223; MIYOSHI Y, 1992, CIRC RES, V70, P612, DOI 10.1161/01.RES.70.3.612; NELSON MT, 1993, TRENDS CARDIOVAS MED, V3, P54, DOI 10.1016/1050-1738(93)90037-7; NELSON MT, 1995, AM J PHYSIOL, V268, P799; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Satoh H, 1995, GEN PHARMACOL, V26, P1549, DOI 10.1016/0306-3623(95)00046-1; SHANKAR V, 1995, AM J PHYSIOL-HEART C, V269, pH997; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693; Tepas J J 3rd, 1995, Semin Pediatr Surg, V4, P120; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	31	21	21	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	1999	16	5					391	402		10.1089/neu.1999.16.391			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	200WC	WOS:000080562200005	10369559				2021-06-18	
J	Raabe, A; Czosnyka, M; Piper, I; Seifert, V				Raabe, A; Czosnyka, M; Piper, I; Seifert, V			Monitoring of intracranial compliance: Correction for a change in body position	ACTA NEUROCHIRURGICA			English	Article						intracranial compliance; pressure-volume index; constant term; body position	PRESSURE-VOLUME INDEX; FLUID PRESSURE; HEAD-INJURY	The objectives of our study were 1. to investigate whether the intracranial compliance changes with body position; 2. to test if the pressure-volume index (PVI) calculation is affected by different body positions; 3. to define the optimal parameter to correct PVI for changes in body position and 4. to investigate the physiological meaning of the constant term (P-0) in the model of the intracranial volume-pressure relationship. Thirteen patients were included in this study. All patients were subjected to 2 to 3 different body positions. In each position, either classic bolus injection was performed for measurement of intracranial compliance and calculation of PVI or the new Spiegelberg compliance monitor was used to calculate PVI continuously. Four different models were used for calculating the constant pressure term P-0 and the P-0 corrected PVI values. Pressure volume index not corrected for the constant term P-0 significantly decreased with elevating the patients head (r = 0.70. p < 0.0001). In contrast, volume-pressure response and ICP pulse amplitude did not change with position. Using the constant term P-0 to correct the PVI we found no changes between the different body positions. Our results suggest that during the variation in body position there is no change in intracranial compliance but a change in hydrostatic offset pressure which causes a shifting of the volume-pressure curve along the pressure axis without its shape being affected. PVI measurements should either be performed only with the patient in the 0 degrees recumbent position or that the PVI calculation should be corrected for the hydrostatic difference between the level of the ICP transducer and the hydrostatic indifference point of the craniospinal system close to the third thoracic vertebra.	Univ Leipzig, Dept Neurosurg, D-04103 Leipzig, Germany; Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2QQ, England; Univ Glasgow, So Gen Hosp, Dept Neurosurg, Glasgow, Lanark, Scotland	Raabe, A (corresponding author), Univ Leipzig, Dept Neurosurg, Johannisallee 34, D-04103 Leipzig, Germany.						Avezaat C, 1984, CEREBROSPINAL FLUID; AVEZAAT CJJ, 1976, INTRACRANIAL PRESSUR, P308; Czosnyka M, 1996, J NEUROL NEUROSUR PS, V60, P549, DOI 10.1136/jnnp.60.5.549; GJERRIS F, 1989, OUTFLOW CEREBROSPINA; LEECH P, 1974, J NEUROL NEUROSUR PS, V37, P1099, DOI 10.1136/jnnp.37.10.1099; LEECH P, 1974, J NEUROL NEUROSUR PS, V37, P1105, DOI 10.1136/jnnp.37.10.1105; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P599; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MILLER JD, 1973, ARCH NEUROL-CHICAGO, V28, P265, DOI 10.1001/archneur.1973.00490220073011; MILLER JD, 1974, INJURY, V5, P265, DOI 10.1016/S0020-1383(74)80021-5; OTT EO, 1974, NEUROLOGY, V24, P1117, DOI 10.1212/WNL.24.12.1117; PIPER IR, 1990, ACT NEUR S, V51, P387; Raabe A, 1998, NEUROSURGERY, V42, P74, DOI 10.1097/00006123-199801000-00015; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SULLIVAN HG, 1978, SURG NEUROL, V9, P47; TANS JTJ, 1983, J NEUROSURG, V59, P810, DOI 10.3171/jns.1983.59.5.0810	20	21	22	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1999	141	1					31	35		10.1007/s007010050263			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	166AW	WOS:000078554900011	10071684				2021-06-18	
J	Cherian, L; Goodman, JC; Robertson, CS				Cherian, L; Goodman, JC; Robertson, CS			Effect of glucose administration on contusion volume after moderate cortical impact injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						contusional change; neuronal loss; rats; systemic hyperglycemia; traumatic brain injury	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; BRAIN INJURY; PARENTERAL-NUTRITION; HYPERGLYCEMIC RATS; VASOGENIC EDEMA; ISCHEMIA; DAMAGE; VELOCITY; INCREASE	Previous studies had shown that pre- and postinjury glucose administration increased brain injury caused by a mild cortical impact injury only when the traumatic injury was complicated by a secondary ischemic insult. The purpose of this study was to examine the effect of pre- and postinjury glucose administration on a more severe cortical impact injury, where primary ischemia occurs at the site of the impact, Long Evans rats who were fasted overnight and anesthetized with isoflurane were subjected to a 5-m/sec, 2.5-mm impact injury. The animals were randomly assigned one of the following treatments: (1) 2.2 g/kg glucose in 4 mi of saline, 20 min prior to injury; (2) 2.0 g/kg glucose in 4 mi of saline, 20 min after injury; or (3) 4 mi of saline either 20 min before injury or 20 min after the injury, At 2 weeks, the animals were sacrificed and the brains were examined for contusion volume and for neuronal loss in CA1 and CA3 regions of the hippocampus. Contusion volume was increased from a median value of 23 mm(3) in the saline-infused animals to 34 mm(3) in the preimpact glucose infusion animals (p = 0.005), Postimpact glucose infusion had no effect on contusion volume, Neuron density in CA1 and CA3 regions of the hippocampus was similar in all three treatment groups. These studies support the hypothesis that glucose administration adversely affects experimental traumatic brain injury in those circumstances where the trauma is complicated by primary cerebral ischemia, such as around cortical contusions.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Cherian, L (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline		BACK T, 1995, J CEREBR BLOOD F MET, V15, P566, DOI 10.1038/jcbfm.1995.70; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI KT, 1994, BRAIN RES, V642, P104; COMBS DJ, 1989, J NEUROSURG, V70, P623, DOI 10.3171/jns.1989.70.4.0623; Duckrow RB, 1995, BRAIN RES, V703, P145, DOI 10.1016/0006-8993(95)01077-7; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; HSU SSF, 1991, AM J PHYSIOL, V261, pH398; Katsura K, 1996, BRAIN RES, V726, P57, DOI 10.1016/0006-8993(96)00317-4; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MYERS RE, 1976, J NEUROPATH EXP NEUR, V35, P301, DOI 10.1097/00005072-197605000-00011; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SIEMKOWICZ E, 1978, ACTA NEUROL SCAND, V58, P1; Siesjo BK, 1996, ACT NEUR S, V66, P8; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; WATERS DC, 1986, J NEUROSURG, V64, P460, DOI 10.3171/jns.1986.64.3.0460; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YOSHINO A, 1992, J CEREBR BLOOD F MET, V12, P996, DOI 10.1038/jcbfm.1992.137; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	35	21	21	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	1998	15	12					1059	1066		10.1089/neu.1998.15.1059			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	148FW	WOS:000077495200006	9872462				2021-06-18	
J	Grabb, PA				Grabb, PA			Traumatic intraventricular hemorrhage treated with intraventricular recombinant-tissue plasminogen activator: Technical case report	NEUROSURGERY			English	Article						brain injury; hydrocephalus; intraventricular hemorrhage; thrombolysis	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; CLOT LYSIS; POSTHEMORRHAGIC HYDROCEPHALUS; UROKINASE; PREVENTION; INFUSION; TRIAL	OBJECTIVE AND IMPORTANCE: Traumatic intraventricular hemorrhage (IVH) can result in association with acute obstructive hydrocephalus, repetitive malfunction of external ventricular drains (EVDs), and uncontrollable increased intracranial pressure. We report a case showing the safe and effective use of intraventricular recombinant-tissue plasminogen activator in a child with severe brain injury and acute hydrocephalus from IVH. CLINICAL PRESENTATION: A 15-year-old male patient presented to us after a motor vehicle accident with bilateral extensor posturing, intracerebral and IVH, and acute obstructive hydrocephalus. INTERVENTION: A right EVD was placed and functioned only transiently. A left EVD was placed and functioned only transiently. Because of the inability to maintain ventricular drainage, rising intracranial pressure, and worsening clinical status, 5 mg of recombinant-tissue plasminogen activator was injected through each EVD. Excellent EVD function was obtained quickly, with control of intracranial pressure and improvement in clinical status and without hemorrhagic complication. CONCLUSION: With obstructive hydrocephalus secondary to acute traumatic IVH that cannot be controlled with EVD because of recurrent obstruction from intraventricular blood, intraventricular recombinant-tissue plasminogen activator can be effective and safe, despite preexisting multiple hemorrhagic intracranial injuries.	Univ Alabama, Childrens Hosp, Div Neurosurg, Tuscaloosa, AL 35487 USA	Grabb, PA (corresponding author), Univ Alabama, Childrens Hosp, Div Neurosurg, ACC 400,1600 7th Ave, Tuscaloosa, AL 35487 USA.						AKDEMIR H, 1995, NEUROSURG REV, V18, P95, DOI 10.1007/BF00417665; BERRY K, 1994, AM J FOREN MED PATH, V15, P132, DOI 10.1097/00000433-199406000-00008; BRINKER T, 1992, NEUROSURGERY, V31, P306, DOI 10.1227/00006123-199208000-00016; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; FINDLAY JM, 1995, NEUROSURGERY, V37, P168, DOI 10.1227/00006123-199507000-00041; FUJITSU K, 1988, NEUROSURGERY, V23, P423, DOI 10.1227/00006123-198810000-00003; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; HUDGINS RJ, 1994, PEDIATR NEUROSURG, V20, P190, DOI 10.1159/000120786; Kajimoto Y, 1997, NEUROSURGERY, V40, P572, DOI 10.1097/00006123-199703000-00029; KIM CH, 1981, SURG NEUROL, V16, P415, DOI 10.1016/0090-3019(81)90233-0; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; LITTLE JR, 1977, SURG NEUROL, V8, P143; Luciano R, 1997, CHILD NERV SYST, V13, P73, DOI 10.1007/s003810050045; MAYFRANK L, 1993, ACTA NEUROCHIR, V122, P32, DOI 10.1007/BF01446983; MULLER H, 1987, SURG NEUROL, V27, P398, DOI 10.1016/0090-3019(87)90021-8; PANG D, 1986, NEUROSURGERY, V19, P553, DOI 10.1227/00006123-198610000-00010; TODO T, 1991, J NEUROSURG, V74, P81, DOI 10.3171/jns.1991.74.1.0081; ZUCCARELLO M, 1981, ACTA NEUROCHIR, V55, P283, DOI 10.1007/BF01808444	19	21	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0148-396X			NEUROSURGERY	Neurosurgery	OCT	1998	43	4					966	969		10.1097/00006123-199810000-00150			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	121MT	WOS:000076018200133	9766330				2021-06-18	
J	Kahabuka, FK; Willemsen, W; van't Hof, M; Ntabaye, MK; Burgersdijk, R; Frankenmolen, F; Plasschaert, A				Kahabuka, FK; Willemsen, W; van't Hof, M; Ntabaye, MK; Burgersdijk, R; Frankenmolen, F; Plasschaert, A			Initial treatment of traumatic dental injuries by dental practitioners	ENDODONTICS & DENTAL TRAUMATOLOGY			English	Article						dental education; dental injuries; dental trauma		The aim of this study was to investigate the nature of initial treatment provided by dental practitioners to children aged 1-17 years with various types of traumatic dental injuries at public dental clinics in Tanzania. Questionnaires on initial treatment were mailed to 188 practitioners and returned by 138 (73%). The reported treatments were analyzed in relation to the dental practitioners' qualifications and area of practice. Extraction of injured teeth was frequently reported for 64% of the injuries and prescription of antibiotics was reported by 67%, 48% and 46% of the practitioners for soft tissue injuries, concussion, and alveolar fracture respectively. Practitioners working at the Faculty of Dentistry were less involved in treating dental trauma than those at urban and rural clinics (P=0.001), while no significant association was found with the level of education of the practitioners. Equal proportions of practitioners, about one-third each, reported correct, unnecessary and wrong treatment options. The quality of the treatments provided could not be explained by background variables. It can be concluded that dental practitioners in Tanzania provide a lot of overtreatment for traumatic dental injuries. Therefore, it is suggested that efforts should be made to improve and standardize treatment methods in Tanzania.	Muhimbili Univ, Coll Hlth Sci, Fac Dent, Dar Es Salaam, Tanzania	Kahabuka, FK (corresponding author), Muhimbili Univ, Coll Hlth Sci, Fac Dent, POB 65014, Dar Es Salaam, Tanzania.		Kahabuka, Febronia/M-7080-2019				ANDREASEN JO, 1994, TXB COLOR ATLAS TRAU, P219; [Anonymous], 1995, Dent Clin North Am, V39, P221; Hamilton FA, 1997, BRIT DENT J, V182, P91, DOI 10.1038/sj.bdj.4809313; MCTIGUE DJ, 1994, PEDIAT DENT INFANCY, P209; RUSMAH M, 1990, AUST DENT J, V35, P430	5	21	22	0	2	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0109-2502			ENDOD DENT TRAUMATOL	Endod. Dent. Traumatol.	OCT	1998	14	5					206	209					4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	132QE	WOS:000076640400002	9855797				2021-06-18	
J	Boglioli, LR; Taff, ML; Harleman, G				Boglioli, LR; Taff, ML; Harleman, G			Child homicide caused by commotio cordis	PEDIATRIC CARDIOLOGY			English	Article						commotio cordis; blunt force chest trauma; myocardial concussion; myocardial contusion; sudden cardiac death; cardiac arrhythmia; child abuse; homicide	DEATH	Cardiac concussion, previously known as commotio cordis, occurs in structurally normal hearts without gross or microscopic injury to the myocardium, cardiac valves. or coronary arteries, as opposed to other sports-related deaths known to occur more frequently in structural or congenital heart disease. We describe the sudden cardiac death of a 2-year-old child, who died as a result of a blunt force impact to the chest. A thorough medicolegal investigation was necessary to determine that the child died as a result of foul play.	Lenox Hill Hosp, Cardiol Sect, New York, NY 10021 USA; CUNY Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; Suffolk Cty Med Examiners Off, Hauppauge, NY 11787 USA	Taff, ML (corresponding author), 511 Hempstead Ave,Suite 2, W Hempstead, NY 11552 USA.						ABRUNZO TJ, 1991, AM J DIS CHILD, V145, P1279, DOI 10.1001/archpedi.1991.02160110071023; BESSON A, 1983, COLOR ATLAS CHEST TR, V1, P86; BROWN GG, 1995, NEUROPSYCHOLOGY, V9, P27, DOI 10.1037/0894-4105.9.1.27; CLINZ W, 1981, CHEST TRAUMA DIAGNOS, P191; DUBROW TJ, 1989, SURGERY, V106, P267; Jackimczyk Kenneth, 1993, Emergency Medicine Clinics of North America, V11, P81; LOWN B, 1969, AM J MED, V46, P705, DOI 10.1016/0002-9343(69)90022-9; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; NIRGIOTIS J G, 1990, Journal of Emergency Medicine, V8, P617, DOI 10.1016/0736-4679(90)90459-9; RODRIGUEZ A, 1990, MANAGEMENT CARDIOTHO, P261; SABBAH HN, 1988, CATHETER CARDIO DIAG, V15, P155, DOI 10.1002/ccd.1810150305; Sadow S H, 1983, Mo Med, V80, P567; Schlomka G, 1932, Z GES EXP MED, V81, P43; SMIRK FH, 1960, AM J CARDIOL, V6, P620, DOI 10.1016/0002-9149(60)90265-4; SYMBAS PN, 1991, CURRENT PROBLEMS CAR, P542; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641	16	21	21	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0172-0643			PEDIATR CARDIOL	Pediatr. Cardiol.	SEP-OCT	1998	19	5					436	438		10.1007/s002469900347			3	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	110QF	WOS:000075391300014	9703576				2021-06-18	
J	Cohen, JE; Eger, K; Montero, A; Israel, Z				Cohen, JE; Eger, K; Montero, A; Israel, Z			Rapid spontaneous resolution of acute subdural hematoma and HIV related cerebral atrophy: Case report	SURGICAL NEUROLOGY			English	Article						acute subdural hematoma; brain trauma; cerebral atrophy; HIV		BACKGROUND The natural history of a traumatic acute subdural hematoma is usually interrupted by its prompt surgical removal. Rapid spontaneous resolution within 48 hours, although infrequently reported, may be, underestimated and demonstrates a benign course of this condition. To our knowledge, this is the first case of rapid spontaneous resolution of an acute subdural hematoma in a patient with HIV encephalopathy and cerebral atrophy. METHODS AND RESULTS This 27-year-old man, an intravenous drug user with AIDS-related complex and HIV encephalopathy, suffered an acute subdural hematoma due to head injury in a car accident. The hematoma spontaneously resolved within 12 hours, resulting in a favorable outcome with nonoperative treatment. CONCLUSIONS AIDS related cerebral atrophy may not only have predisposed the patient to the development of an extracerebral collection, but may have also favorably influenced the spontaneous resolution of the hematoma. The mechanism of the hematoma resolution and the influence of HIV related cerebral atrophy is discussed. (C) 1998 by Elsevier Science Inc.	Hosp Emergencias Dr Clemente Alvarez, Dept Neurocirugia, Rosario, Santa Fe, Argentina; Univ Jena, Ausbildungsstandort, Klinikum Erfurt, Neurol Klin, Erfurt, Germany; Hosp Emergencias Dr Clemente Alvarez, Dept Immunodeficiencias, Rosario, Santa Fe, Argentina; Hadassah Univ Hosp, Dept Neurosurg, IL-91120 Jerusalem, Israel	Cohen, JE (corresponding author), Dorrego 851, RA-2000 Rosario, Santa Fe, Argentina.		Israel, Zvi/S-5814-2016	Israel, Zvi/0000-0002-0060-5769			AOKI N, 1990, ACTA NEUROCHIR, V103, P76, DOI 10.1007/BF01420196; CARDOSO ER, 1989, ACTA NEUROCHIR, V97, P40, DOI 10.1007/BF01577738; *CDC, 1987, MMWR-MORBID MORTAL W, V36, pS3; CHOKROVERTY S, 1968, DIS NERV SYST, V29, P704; CUATICO W, 1991, NEUROSURG SCI, V35, P139; DELAMONTE SM, 1987, NEUROLOGY, V37, P562, DOI 10.1212/WNL.37.4.562; DOHERTY DL, 1988, ARCH PHYS MED REHAB, V69, P542; Dymecki J, 1976, Neurol Neurochir Pol, V10, P497; FUJIOKA S, 1990, Neurologia Medico-Chirurgica, V30, P827, DOI 10.2176/nmc.30.827; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, MANAGEMENT HEAD INJU, P153; Joki Tatsuhiro, 1992, Neurological Surgery, V20, P915; KAUFMAN HH, 1986, NEUROSURGERY, V19, P446; KUROIWA T, 1993, J NEUROSURG, V78, P126, DOI 10.3171/jns.1993.78.1.0126; MAKIYAMA Y, 1985, Nihon University Journal of Medicine, V27, P123; MCARTHUR JC, 1992, CLIN NEUROBIOLOGY, V2, P1312; NAGANUMA H, 1986, NEUROSURGERY, V19, P794, DOI 10.1227/00006123-198611000-00013; NAGAO T, 1986, NEUROSURGERY, V19, P465, DOI 10.1227/00006123-198609000-00024; Niikawa S, 1989, Neurol Med Chir (Tokyo), V29, P820, DOI 10.2176/nmc.29.820; PERLMUTTER I, 1961, JAMA-J AM MED ASSOC, V176, P212, DOI 10.1001/jama.1961.63040160001006; POLMAN CH, 1986, NEUROSURGERY, V19, P446, DOI 10.1227/00006123-198609000-00019; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; TEASDALE G, 1974, LANCET, V2, P81; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121	24	21	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0090-3019			SURG NEUROL	Surg. Neurol.	SEP	1998	50	3					241	244		10.1016/S0090-3019(97)00026-8			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	117AK	WOS:000075757400024	9736087				2021-06-18	
J	Ferrera, PC; Pauze, DR; Chan, L				Ferrera, PC; Pauze, DR; Chan, L			Sagittal sinus thrombosis after closed head injury	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						superior sagittal sinus; thrombosis; traumatic	CEREBRAL VENOUS THROMBOSIS; DURAL SINUS; COMPUTED-TOMOGRAPHY; VEIN-THROMBOSIS; DIAGNOSIS; MRI	Superior sagittal sinus thrombosis (SSST) is an unusual disorder, most often attributed to hematological abnormalities, oral contraceptive use, or association with the puerperium. Although SSST secondary to trauma has been reported, it still remains an extremely rare entity. Antemortem diagnosis of SSST is made by findings on computed tomographic scanning, cerebral angiography, or magnetic resonance imaging. Prognosis is variable and spontaneous resolution has been reported. Successful treatment options of spontaneous cases include systemic anticoagulation and thrombolytic therapy along with supportive measures. There are currently no guidelines for the management of SSST associated with traumatic brain injury. This report describes a case of SSST in a man who sustained a closed head injury. (Am J Emerg Med 1998;16:382-385. Copyright a 1998 by W.B. Saunders Company).	Albany Med Ctr, Dept Emergency Med A 139, Albany, NY 12208 USA	Ferrera, PC (corresponding author), Albany Med Ctr, Dept Emergency Med A 139, Albany, NY 12208 USA.						Bagley C, 1934, SURG GYNECOL OBSTET, V58, P498; BARNETT HJM, 1953, BRAIN, V76, P36, DOI 10.1093/brain/76.1.36; BOUSSER MG, 1985, STROKE, V16, P199, DOI 10.1161/01.STR.16.2.199; CARRIE AW, 1954, J NEUROSURG, V11, P173, DOI 10.3171/jns.1954.11.2.0173; CRIMMINS TJ, 1984, J NEUROSURG, V60, P179, DOI 10.3171/jns.1984.60.1.0179; DAVELLA D, 1984, J NEUROSURG, V61, P1129, DOI 10.3171/jns.1984.61.6.1129; DIROCCO C, 1981, ARCH NEUROL-CHICAGO, V38, P431, DOI 10.1001/archneur.1981.00510070065011; GETTELFINGER DM, 1977, ARCH NEUROL-CHICAGO, V34, P2, DOI 10.1001/archneur.1977.00500130022004; GOLDBERG AL, 1986, J COMPUT ASSIST TOMO, V10, P16, DOI 10.1097/00004728-198601000-00003; HANLEY DF, 1988, STROKE, V19, P903, DOI 10.1161/01.STR.19.7.903; HESSELBROCK R, 1985, NEUROSURGERY, V16, P825, DOI 10.1227/00006123-198506000-00017; HIGASHIDA R T, 1989, AJNR, V10, pS4; Holmes G, 1915, Br Med J, V2, P493; LAINE FJ, 1995, AM J ROENTGENOL, V164, P763, DOI 10.2214/ajr.164.3.7863913; MACCHI PJ, 1986, J COMPUT ASSIST TOMO, V10, P10, DOI 10.1097/00004728-198601000-00002; NUSSEL F, 1989, NEURORADIOLOGY, V31, P307; PERSSON L, 1990, NEUROSURGERY, V26, P117, DOI 10.1227/00006123-199001000-00016; PROVENZALE JM, 1994, J COMPUT ASSIST TOMO, V18, P719, DOI 10.1097/00004728-199409000-00007; RAO KCVG, 1981, RADIOLOGY, V140, P391, DOI 10.1148/radiology.140.2.7255715; SALVATI CA, 1990, HEADACHE, V30, P650, DOI 10.1111/j.1526-4610.1990.hed3010650.x; Satoh Hideki, 1993, Neurological Surgery, V21, P953; SCHELL CL, 1988, WESTERN J MED, V149, P304; STRINGER WL, 1983, NEUROSURGERY, V12, P95; TOVI F, 1991, J ORAL MAXIL SURG, V49, P303, DOI 10.1016/0278-2391(91)90227-D; TSAI FY, 1992, AM J NEURORADIOL, V13, P1137; VIRAPONGSE C, 1987, RADIOLOGY, V162, P779, DOI 10.1148/radiology.162.3.3809494; VOGL TJ, 1994, AM J ROENTGENOL, V162, P1191, DOI 10.2214/ajr.162.5.8166009; WANG PY, 1995, NEURORADIOLOGY, V37, P447; YEAKLEY JW, 1988, J NEUROSURG, V69, P867, DOI 10.3171/jns.1988.69.6.0867	29	21	21	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	JUL	1998	16	4					382	385		10.1016/S0735-6757(98)90134-6			4	Emergency Medicine	Emergency Medicine	101LH	WOS:000074870100014	9672457				2021-06-18	
J	Terreni, L; De Simoni, MG				Terreni, L; De Simoni, MG			Role of the brain in interleukin-6 modulation	NEUROIMMUNOMODULATION			English	Article						interleukin-6; opioids; sympathetic nervous system; Alzheimer disease; lipopolysaccharide; interleukin-1 beta	TUMOR-NECROSIS-FACTOR; MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; GROWTH-FACTOR; INTRACEREBROVENTRICULAR INJECTION; NEUROTROPHIC FACTOR	High levels of interleukin 6 (IL-6) have been found in the brain tissue or cerebrospinal fluid (CSF) in several CNS disorders including Alzheimer's disease, AIDS dementia complex, multiple sclerois, stroke, Parkinson's disease, traumatic brain injuries, brain tumors and CNS infections. In these diseases, IL-6 is also found in blood showing that CNS conditions can elicit a peripheral immune response. A direct secretion of IL-6 from brain to blood has been shown to be a major mechanism by which the brain activates peripheral metabolic, endocrine and immune responses. However, this communication is not straightforward and other regulatory mechanisms are likely to be there. Several lines of evidence obtained in the laboratory have shown that the brain significantly modulates IL-6 production in the periphery. Evidence will be given that: (i) central inflammatory stimuli efficiently induce peripheral IL-6; (ii) central opioids are effective modulators of peripheral IL-6, and (iii) the sympathetic nervous system represents an inhibitory pathway to peripheral IL-6.	Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy	De Simoni, MG (corresponding author), Mario Negri Inst Pharmacol Res, Via Eritrea 62, I-20157 Milan, Italy.		De Simoni, Maria Grazia/I-6021-2012	De Simoni, Maria Grazia/0000-0001-6695-5297			AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; BARTON BE, 1993, INFECT IMMUN, V61, P1490; BEAMER NB, 1995, ANN NEUROL, V37, P800, DOI 10.1002/ana.410370614; BELLINGER DL, 1992, INT J IMMUNOPHARMACO, V14, P329, DOI 10.1016/0192-0561(92)90162-E; Bertolucci M, 1997, AM J PHYSIOL-REG I, V273, pR956; Bertolucci M, 1996, NEUROREPORT, V7, P1181, DOI 10.1097/00001756-199604260-00017; BIGLINO A, 1995, EUR J ENDOCRINOL, V133, P173, DOI 10.1530/eje.0.1330173; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; BRETT FM, 1995, J NEUROPATH EXP NEUR, V54, P766, DOI 10.1097/00005072-199511000-00003; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; CARR DJJ, 1991, P SOC EXP BIOL MED, V198, P710; Chai Z, 1996, J EXP MED, V183, P311, DOI 10.1084/jem.183.1.311; Chen GJ, 1997, ENDOCRINOLOGY, V138, P4830, DOI 10.1210/en.138.11.4830; De Luigi A, 1998, NEUROSCIENCE, V83, P1245, DOI 10.1016/S0306-4522(97)00381-3; DEKLOET ER, 1994, PSYCHONEUROENDOCRINO, V19, P121, DOI 10.1016/0306-4530(94)90002-7; DESIMONI MG, 1995, ENDOCRINOLOGY, V136, P897, DOI 10.1210/en.136.3.897; DESIMONI MG, 1993, AM J PHYSIOL, V265, pR739; DESIMONI MG, 1990, J EXP MED, V171, P1773, DOI 10.1084/jem.171.5.1773; DeSimoni MG, 1997, ENDOCRINOLOGY, V138, P5220, DOI 10.1210/en.138.12.5220; DESIMONI MG, 1992, PATHOPHYSIOLOGY PHAR, P143; Dodd J., 1991, PRINCIPLES NEURAL SC, V3, P761; FASSBENDER K, 1994, J NEUROL SCI, V122, P135, DOI 10.1016/0022-510X(94)90289-5; Fattori E, 1995, EUR J NEUROSCI, V7, P2441, DOI 10.1111/j.1460-9568.1995.tb01042.x; Fischer HG, 1997, EUR J IMMUNOL, V27, P1539, DOI 10.1002/eji.1830270633; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; FREIER DO, 1994, J PHARMACOL EXP THER, V270, P1127; Gadient RA, 1995, ANN NY ACAD SCI, V762, P403; GADIENT RA, 1994, NEUROSCI LETT, V182, P243, DOI 10.1016/0304-3940(94)90807-9; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; GANGULI R, 1993, ANN MED, V25, P489, DOI 10.3109/07853899309147317; Goujon E, 1996, MOL BRAIN RES, V36, P53, DOI 10.1016/0169-328X(95)00242-K; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; HSUEH CM, 1992, BRAIN RES, V578, P142, DOI 10.1016/0006-8993(92)90241-Z; HUELL M, 1995, ACTA NEUROPATHOL, V89, P544; IMAMURA K, 1993, ACTA NEUROL SCAND, V87, P281, DOI 10.1111/j.1600-0404.1993.tb05508.x; JONES TH, 1993, CYTOKINE, V5, P531, DOI 10.1016/S1043-4666(05)80001-8; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Loser SV, 1996, N-S ARCH PHARMACOL, V354, P192; Luheshi G, 1996, INT ARCH ALLERGY IMM, V109, P301, DOI 10.1159/000237256; MADDEN KS, 1995, PHYSIOL REV, V75, P77; MAES M, 1993, PSYCHIAT RES, V49, P11, DOI 10.1016/0165-1781(93)90027-E; MAES M, 1995, EUR ARCH PSY CLIN N, V245, P172, DOI 10.1007/BF02193091; MAIMONE D, 1993, J NEUROIMMUNOL, V47, P55, DOI 10.1016/0165-5728(93)90284-6; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; MASOTTO C, 1992, BRAIN RES BULL, V28, P161, DOI 10.1016/0361-9230(92)90175-W; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; MIGNAT C, 1995, LIFE SCI, V56, P793, DOI 10.1016/0024-3205(95)00010-4; MRAK RE, 1995, HUM PATHOL, V26, P816, DOI 10.1016/0046-8177(95)90001-2; NAKAFUKU M, 1992, J BIOL CHEM, V267, P19448; Navikas V, 1996, J NEUROIMMUNOL, V64, P63, DOI 10.1016/0165-5728(95)00155-7; Olsson T, 1994, Eur J Neurol, V1, P7, DOI 10.1111/j.1468-1331.1994.tb00045.x; PACIFICI R, 1995, EPILEPSIA, V36, P384, DOI 10.1111/j.1528-1157.1995.tb01013.x; PANERAI AE, 1995, J NEUROIMMUNOL, V58, P71, DOI 10.1016/0165-5728(94)00189-U; PETERSON PK, 1993, BIOCHEM PHARMACOL, V46, P343, DOI 10.1016/0006-2952(93)90508-T; RADULOVIC J, 1994, BRAIN RES, V661, P189, DOI 10.1016/0006-8993(94)91196-7; Romero LI, 1996, AM J PHYSIOL-REG I, V270, pR518; SAWADA M, 1992, BRAIN RES, V583, P296, DOI 10.1016/S0006-8993(10)80037-X; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; SINGH VK, 1994, MOL NEUROBIOL, V9, P73, DOI 10.1007/BF02816106; Sterneck E, 1996, J NEUROCHEM, V67, P1365; SUNDAR SK, 1989, P NATL ACAD SCI USA, V86, P6398, DOI 10.1073/pnas.86.16.6398; TAIWO YO, 1989, BRAIN RES, V492, P397, DOI 10.1016/0006-8993(89)90928-1; TARKOWSKI E, 1995, STROKE, V26, P1393, DOI 10.1161/01.STR.26.8.1393; Terrazzino S, 1997, LIFE SCI, V61, P695, DOI 10.1016/S0024-3205(97)00534-1; TILG H, 1994, BLOOD, V83, P113; Tilg H, 1997, IMMUNOL TODAY, V18, P428, DOI 10.1016/S0167-5699(97)01103-1; ULICH TR, 1991, AM J PATHOL, V138, P1097; Wagner JA, 1996, J EXP MED, V183, P2417, DOI 10.1084/jem.183.6.2417; WELLER M, 1991, J NEUROL SCI, V104, P215, DOI 10.1016/0022-510X(91)90313-V; WOODROOFE MN, 1993, CYTOKINE, V5, P583, DOI 10.1016/S1043-4666(05)80008-0	72	21	25	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401			NEUROIMMUNOMODULAT	Neuroimmunomodulation	MAY-AUG	1998	5	3-4					214	219		10.1159/000026339			6	Endocrinology & Metabolism; Immunology; Neurosciences	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	118EV	WOS:000075826200012	9730688				2021-06-18	
J	Hildebrandt, H; Zieger, A; Engel, A; Fritz, KW; Bussmann, B				Hildebrandt, H; Zieger, A; Engel, A; Fritz, KW; Bussmann, B			Differentiation of autonomic nervous activity in different stages of coma displayed by power spectrum analysis of heart rate variability	EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE			English	Article						coma; autonomous nervous system; neuromonitoring; heart rate variability; spectral analysis	CARDIOVASCULAR CONTROL; PROBE	The analysis of heart rate (HR) variability offers a noninvasive method to investigate autonomic nervous system activity in comatose patients, We analyzed three components of the KR variability in a group of comatose patients: the low-frequency band (LF), representing mainly sympathetic influence, the mid-frequency band (MF), representing sympathetic and parasympathetic influence, and the high-frequency band (HF), representing the parasympathetic influence. A value for sympathovagal balance was defined as LF/HF and MF/HF ratio, Moreover, the skin conductance level (SCL) and the skin conductance resistance (SCR) variability were recorded, The patient group consisted of 22 patients with traumatic brain injuries. Coma depth was assessed by the Glacow Coma Scale and artifact-free HR, SCL, and SCR were measured 75 times in the patient group. The results documented a significant gain in sympathetic nervous system activity corresponding with the state of emerging from coma. This gain was most pronounced in the HF component of the HR and in the sympathovagal balance between LF/HF. The findings in SCL and SCR variability endorsed this result, It is concluded that emerging from coma is accompanied by an increasing influence of the sympathetic nervous system on HR control. This leads to a change in the sympathovagal balance, i.e., a reintegration of parasympathetic and sympathetic activity.	Univ Oldenburg, Programme Neuropsychol, D-26111 Oldenburg, Germany; Rehabil Unit, D-26111 Oldenburg, Germany; Nordwest Hosp Sanderbusch, Dept Anesthesiol, D-26452 Sande, Germany	Hildebrandt, H (corresponding author), Univ Oldenburg, Programme Neuropsychol, D-26111 Oldenburg, Germany.						AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; ALCALAY M, 1991, NEUROSCI BIOBEHAV R, V15, P51, DOI 10.1016/S0149-7634(05)80091-0; BAHARAV A, 1995, NEUROLOGY, V45, P1183, DOI 10.1212/WNL.45.6.1183; BASAR E, 1985, INT J NEUROSCI, V26, P161; BESSER R, 1983, NEUROLOGIE PRAXIS KL, V1; DELETIS V, 1990, PHYS MED REHAB STATE, V4, P421; Freeman Edward, 1993, NEUROPSYCHOL REHABIL, V3, P139; Garcia A.L., 1994, NUMERICAL METHODS PH; GELSEMA AJ, 1985, PSYCHOPHYSIOLOGY CAR, P99; Hildebrandt H, 1996, EEG-EMG-Z ELEK ELEKT, V27, P126; HORN S, 1993, NEUROPSYCHOL REHABIL, V3, P121; JANIG W, 1987, PHYSL MENSCHEN, P349; JONES R, 1994, ARCH PHYS MED REHAB, V75, P164; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; LANGEWITZ W, 1991, HOMEOSTASIS HLTH DIS, V33, P23; LITSCHER G, 1994, EEG-EMG-Z ELEK ELEKT, V25, P200; LITSCHER G, 1994, MULTIVARIATE NICHT I; MIDDLETON HC, 1994, J PSYCHOPHARMACOL, V8, P1, DOI 10.1177/026988119400800101; MULDER G, 1981, PSYCHOPHYSIOLOGY, V18, P392, DOI 10.1111/j.1469-8986.1981.tb02470.x; MULDER LJM, 1992, BIOL PSYCHOL, V34, P205, DOI 10.1016/0301-0511(92)90016-N; PLUM F, 1993, ABNORMAL STATES BRAI, P29; PLUM F, 1974, DIAGNOSIS STUPOR COM; POECK K, 1992, NEUROLOGIE; Pruyn A., 1985, PSYCHOPHYSIOLOGY CAR, P865; TULEN JHM, 1994, PSYCHOPHARMACOLOGY, V114, P81, DOI 10.1007/BF02245447; VONCRAMON DY, 1984, UNKLARE BEWUSSTLOSIG, P3; ZHONG S, 1993, AM J PHYSIOL, V265, pR1026; ZIEGER A, 1997, FALLBUCH NEUROPSYCHO, P267; ZWIENER U, 1994, NEUROMONITORING ANAS, P17	29	21	23	0	2	DR DIETRICH STEINKOPFF VERLAG	DARMSTADT	PLATZ DER DEUTSCHEN EINHEIT 25, D-64293 DARMSTADT, GERMANY	0940-1334			EUR ARCH PSY CLIN N	Eur. Arch. Psych. Clin. Neurosci.	FEB	1998	248	1					46	52		10.1007/s004060050016			7	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	ZF622	WOS:000072915500006	9561352				2021-06-18	
J	Turkstra, LS; Holland, AL				Turkstra, LS; Holland, AL			Assessment of syntax after adolescent brain injury: Effects of memory on test performance	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						adolescent; brain; injury; memory; language	CLOSED-HEAD-INJURY; SERIAL-ORDER MEMORY; WORKING-MEMORY; CHILDREN; CHILDHOOD; DISCOURSE; TUMORS; SKILLS	In this study, we investigated the influence of working memory load on performance of a task designed to measure receptive syntax ability Subjects were 6 brain-injured adolescents and 6 hospitalized control subjects matched for age, sex, and general ability Each subject was administered the Listening/Grammar subtest of the Test of Adolescent Language (TOAL-3) and a modified version of this subtest with identical syntax and fewer response choices [i.e., a reduced working memory processing and storage load). The syntactic structures tested on these tasks also were measured in spontaneous narratives. The brain-injured subjects' performance was significantly worse than that of controls on both versions of the syntax comprehension subtest. There was a significant group-by-task interaction, as brain-injured subjects' performance was significantly worse on the Listening/Grammar subtest than the modified subtest, whereas Control subjects' performance did not differ across the two tasks. In their spontaneous narratives, subjects in both groups produced the syntactic structures tested on the receptive syntax tasks, with no between-groups difference in syntax production. The results are discussed in terms of test validity and the impact of measurement methods on test performance in disordered groups.	Univ Arizona, Natl Ctr Neurogen Commun Disorders, Tucson, AZ 85721 USA	Turkstra, LS (corresponding author), Case Western Reserve Univ, Dept Commun Sci, 11206 Euclid Ave, Cleveland, OH 44106 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P60DC001409] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC-01409] Funding Source: Medline		BADDELEY AD, 1974, ADV RES THEOR, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; CASKEY WE, 1986, LANG SPEECH HEAR SER, V17, P307; Daneman M, 1996, PSYCHON B REV, V3, P422, DOI 10.3758/BF03214546; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; DENNIS M, 1991, NEUROPSYCHOLOGIA, V29, P829, DOI 10.1016/0028-3932(91)90050-I; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; DENNIS M, 1992, NEUROPSYCHOLOGIA, V30, P257, DOI 10.1016/0028-3932(92)90004-6; Diller L., 1974, STUDIES COGNITION RE; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; GOLDMANRAKIC PS, 1988, BRAIN ORG MEMORY CEL; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; HAMMILL DD, 1994, TEST ADOLESCENT ADUL; JACOBSON MS, 1986, PEDIATRICS, V77, P236; JENNETT B, 1975, LANCET, V1, P480; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; JORDAN FM, 1993, APHASIOLOGY, V7, P503, DOI 10.1080/02687039308248626; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; LEVIN H, 1982, NEUROBEHAVIOR CONSEQ; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LIEBERMAN RJ, 1987, LANG SPEECH HEAR SER, V18, P250; LINEBARGER MC, 1983, COGNITION, V13, P391; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Newcomer P. L., 1988, TEST LANGUAGE DEV PR; Nippold M. A., 1993, LANG SPEECH HEAR SER, V24, P21; Plante E, 1996, LANG SPEECH HEAR SER, V27, P99, DOI 10.1044/0161-1461.2702.99; RICHARDSON JTE, 1996, WORKING MEMORY HUMAN, P3; ROCHON E, 1994, BRAIN LANG, V46, P329, DOI 10.1006/brln.1994.1018; Sabers DL, 1996, LANG SPEECH HEAR SER, V27, P102, DOI 10.1044/0161-1461.2702.102; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Scott C. M., 1988, LATER LANGUAGE DEV A, P49; SEMEL W, 1995, CLIN EVALUATION LANG; SHANKWEILER D, 1986, COGNITION, V24, P139, DOI 10.1016/0010-0277(86)90008-9; Slater E. J., 1989, J ADOLESCENT RES, V4, P371; STEPHENS MI, 1985, TOP LANG DISORD, V5, P21, DOI 10.1097/00011363-198506000-00005; STINNETT TA, 1992, J PSYCHOEDUC ASSESS, V10, P161, DOI 10.1177/073428299201000209; Swanson H. L., 1995, SWANSON COGNITIVE PR; TURKSTRA L, 1997, EFFECT STIMULUS PRES; TURKSTRA L, 1997, WORKING MEMORY CELF; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Ylvisaker M., 1989, MILD MODERATE HEAD I, P203	46	21	21	0	5	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	1092-4388			J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	FEB	1998	41	1					137	149		10.1044/jslhr.4101.137			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	YW272	WOS:000071915700012	9493740				2021-06-18	
J	Castejon, OJ				Castejon, OJ			Electron microscopic analysis of cortical biopsies in patients with traumatic brain injuries and dysfunction of neurobehavioural system	JOURNAL OF SUBMICROSCOPIC CYTOLOGY AND PATHOLOGY			English	Article						electron microscopy; neuron; neuroglial cells; brain trauma; neurobehavioural disorders	EDEMA; PATHOLOGY; DAMAGE; CAT	Cortical biopsies of eight patients with craniocerebral trauma complicated with subdural or epidural hematoma were examined with the transmission electron microscope. The patients showed posttraumatic neurobehavioural disorders and moderate or severe vasogenic brain edema. The capillary wall displayed increased vacuolar and vesicular endothelial transport, basement membrane thickening and vacuolization and swollen astrocytic end-feet. Pericapillary and parenchymatous hemorrhages were also observed. The extracellular space appeared considerably enlarged with presence of proteinaceous hematogenous edema fluid and fibrinous organization. Pyramidal and non-pyramidal neurons showed intracellular edema featured by irregular enlargement of rough endoplasmic reticulum, nuclear envelope and Golgi apparatus. The myelinated axons exhibited clear or black type axoplasmic degeneration, varicose fiber swelling, myelin sheath distortion, formation of myelin ovoids and increased amount of oligodendroglial ad-axonal layer. The dendrites also showed clear or dark and beaded shape degeneration. Synaptic degeneration was characterized by swollen and shrunken pre-and postsynaptic endings, clumping, enlargement and depletion of synaptic vesicles, synaptic membrane complex disassembly and detachment of glial ensheathment. Perivascular and perineuronal astrocytes appeared remarkably swollen. Phagocytic astrocytes were also found. Oligodendrocytes displayed hydropic and reactive changes. Reactive oligodendrocytes induced myelinolysis. The brain barrier dysfunction, the vasogenic and cytotoxic edema and the subsequent neuronal and neuroglial cell reactive and degeneration processes might represent the morphological substrate responsible for the post-traumatic neurobehavioural disorders.	Univ Zulia, Fac Med, Inst Invest Biol, Maracaibo 4011, Venezuela	Castejon, OJ (corresponding author), Univ Zulia, Fac Med, Inst Invest Biol, Apartado 526, Maracaibo 4011, Venezuela.						BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BAKAY L, 1965, CEREBRAL EDEMA, P12; BARRON KD, 1988, ACTA NEUROPATHOL, V75, P295, DOI 10.1007/BF00690538; BOWEN FP, 1968, ARCH NEUROL-CHICAGO, V19, P398, DOI 10.1001/archneur.1968.00480040064006; BRESNAHAN JC, 1996, SOC NEUR ABSTR, V2, P1185; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CASTEJON OJ, 1980, J NEUROPATH EXP NEUR, V39, P296, DOI 10.1097/00005072-198005000-00006; CASTEJON OJ, 1988, J SUBMICR CYTOL PATH, V20, P519; CASTEJON OJ, 1985, J SUBMICR CYTOL PATH, V17, P105; CASTEJON OJ, 1984, J SUBMICR CYTOL PATH, V16, P359; CASTEJON OJ, 1984, PATHOL RES PRACT, V179, P7, DOI 10.1016/S0344-0338(84)80054-0; CASTEJON OJ, 1984, J SUBMICR CYTOL PATH, V16, P601; Castejon OJ, 1997, BRAIN INJURY, V11, P363, DOI 10.1080/026990597123520; CASTEJON OJ, 1985, J SUBMICR CYTOL PATH, V17, P703; CASTRO C, 1995, AGROCHIMICA, V39, P1; Choi Byung Ho, 1993, Yonsei Medical Journal, V34, P1; DANIEL DG, 1989, SCHIZOPHR RES, V2, P465, DOI 10.1016/0920-9964(89)90015-7; DICKSON LR, 1990, HOSP COMMUNITY PSYCH, V41, P290; DIEFENBACHER A, 1994, SCHWEIZ ARCH NEUROL, V5, P7; Dunlop T W, 1991, J Neuropsychiatry Clin Neurosci, V3, P150; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; FORMISANO R, 1991, ACTA NEUROCHIR, V109, P1, DOI 10.1007/BF01405688; Garcia J H, 1978, Adv Neurol, V20, P141; GILES GM, 1994, AM J OCCUP THER, V48, P247, DOI 10.5014/ajot.48.3.247; Hilton G, 1994, Orthop Nurs, V13, P25, DOI 10.1097/00006416-199407000-00006; HIRANO A, 1969, STRUCTURE FUNCTION N, V2, P69; ISACSON O, 1992, EXP NEUROL, V117, P151, DOI 10.1016/0014-4886(92)90123-8; Kimelberg Harold K., 1995, P919; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; KIMELBERG HK, 1994, NEUROBIOLOGY CENTRAL, P193; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Kryzhanovskii G. N., 1992, Byulleten' Eksperimental'noi Biologii i Meditsiny, V113, P241; KUTKO II, 1988, ZH NEVROPATOL PSIKH, V88, P69; LAUTER H, 1991, ACTA PSYCHIAT SCAND, V83, P40, DOI 10.1111/j.1600-0447.1991.tb03108.x; LEININGER B E, 1991, Brain Injury, V5, P199, DOI 10.3109/02699059109008090; LIM M, 1994, HUA HSI I KO TA SHUC, V25, P138; LOMBARDI G, 1993, J NEUROCHEM, V60, P1317, DOI 10.1111/j.1471-4159.1993.tb03292.x; LONG DM, 1966, J NEUROPATH EXP NEUR, V25, P373, DOI 10.1097/00005072-196607000-00003; LUSE SA, 1960, J NEUROSURG, V17, P439, DOI 10.3171/jns.1960.17.3.0439; MANZ HJ, 1974, HUM PATHOL, V5, P291, DOI 10.1016/S0046-8177(74)80113-9; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; Nillson P, 1963, CEREBR BLOOD FLOW ME, V13, P183; Norenberg M. D., 1996, Society for Neuroscience Abstracts, V22, P231; PARKER RS, 1994, SEMIN NEUROL, V14, P67, DOI 10.1055/s-2008-1041061; PERSSON LI, 1978, ACTA NEUROL SCAND, V57, P405; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; POVLISHOCK JT, 1980, CEREBRAL MICROVASCUL, V131, P227; PROMYALOV MSH, 1992, VORP MED KHIM, V37, P57; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; SASAKI S, 1977, ACTA NEUROPATHOL, V40, P207, DOI 10.1007/BF00691955; Staub F, 1994, Anasthesiol Intensivmed Notfallmed Schmerzther, V29, P203, DOI 10.1055/s-2007-996719; STEWART JT, 1988, J CLIN PSYCHIAT, V49, P74; TRANEL D, 1992, PSYCHIAT CLIN N AM, V15, P283; TREXLER LE, 1988, BRAIN COGNITION, V8, P291, DOI 10.1016/0278-2626(88)90056-5; WILLMORE LJ, 1992, NEUROL CLIN, V10, P869	59	21	21	0	2	NUOVA IMMAGINE EDITRICE	SIENA	VIA SAN QUIRICO 13, SIENA, 53100, ITALY	1122-9497			J SUBMICR CYTOL PATH	J. Submicrosc. Cytol. Pathol.	JAN	1998	30	1					145	156					12	Pathology	Pathology	ZC265	WOS:000072559500014	9530862				2021-06-18	
J	Clarke, KS				Clarke, KS			Epidemiology of athletic head injury	CLINICS IN SPORTS MEDICINE			English	Article								Although more common in collision sports, head injuries (for this article confined to cerebral neurotrauma) may occur in virtually any form of athletics. A few such injuries result in death, especially the second-impact syndrome and subdural hematoma. Tl-le more minor cerebral injuries, mostly concussions, have widespread misunderstanding in definition and severity. These misunderstandings in the field have contributed to a paucity of reliable epidemiological information about its actual frequency. The concerns accompanying cerebral insult a-re discussed. more than studied, but much can be gained in principle from the history of attention to concussions in football.	SLE Worldwide Inc, Risk Anal, Sun City, CA 92585 USA	Clarke, KS (corresponding author), SLE Worldwide Inc, Risk Anal, 27751 Calle Rabano, Sun City, CA 92585 USA.						BIASCA N, 1995, UNFALLCHIRURG, V98, P283; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; Clarke K. S., 1977, P 2 NAT SPORTS SAF C, P41; CLARKE KS, 1979, MED SCI SPORT EXER, V11, P138; *COMM MED ASP SPOR, 1963, HEADS HELM TIPS ATHL, V5, P1; *CPSC DIR EP, 1990, CONSUMER PRODUCT SAF, V14, P7; Finvers KA, 1996, CLIN J SPORT MED, V6, P102, DOI 10.1097/00042752-199604000-00007; GERBERICH S, 1982, MINN MED         NOV, P691; Goldhaber Gerald M., 1993, Journal of Athletic Training, V28, P306; Henry P C, 1992, J Neurosci Nurs, V24, P311; MAROON JC, 1992, PHYSICIAN SPORTSMED, V20, P37, DOI 10.1080/00913847.1992.11710269; MUELLER F, 1996, ANN SURVEY FOOTBALL; SCHNEIDER R, 1965, CLIN NEUROSURG, V12, P226; *SUBC CLASS SPORTS, 1966, STAND NOM ATHL INJ, P20; 1962, JAMA, V180, P23	16	21	22	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JAN	1998	17	1					1	+		10.1016/S0278-5919(05)70056-9			13	Sport Sciences	Sport Sciences	YU153	WOS:000071687600002	9475966				2021-06-18	
J	Clarke, KS				Clarke, KS			Epidemiology of athletic neck injury	CLINICS IN SPORTS MEDICINE			English	Article							FOOTBALL	Neck injuries in sports are common, typically debilitating, and quite predictable in retrospect by mechanism of injury as to one of four natures-sprains/strains, fractures, brachial plexus pinches/stretches, and spinal cord injury.: Of these, the spinal cord injury, whether a concussion or contusion or physical disruption, is obviously the most severe and also, ironically, the best tracked because of its definition and notoriety when it is experienced. This article discusses the essence of what has been learned epidemiologically over recent decades since the advent of organized attention to spinal cord injuries among athletes.	SLE Worldwide Inc, Sun City, CA 92585 USA	Clarke, KS (corresponding author), SLE Worldwide Inc, 27751 Calle Rabano, Sun City, CA 92585 USA.						ADAMS J, 1993, NCAA FOOTBALL RULES; ALBRIGHT JP, 1976, JAMA-J AM MED ASSOC, V236, P1243, DOI 10.1001/jama.236.11.1243; *AM ALL HLTH PHYS, 1978, US TRAMP MIN PHYS ED; ASHARE A, 1996, AM HOCKEY MAGAZI JAN, P16; CHRISTENSEN C, 1983, 4 US GYMN SAF ASS; CLARKE K, 1979, MED SCI SPORTS EXERC, V10, P94; CLARKE K, 1983, SPORT RELATED PERMAN, P12; CLARKE K, 1980, SCI DIGEST       SUM, P16; CLARKE KS, 1966, J AMER MED ASSOC, V197, P894, DOI 10.1001/jama.197.11.894; CLARKE KS, 1979, MED SCI SPORT EXER, V11, P138; CLARKE KS, 1977, J SAFETY RES, V9, P140; Clarke KS, 1975, J SPORTS MED, V3, P292; *COMM ACC POIS PRE, 1997, TRAMP, P1; *COMM COMP SAF MED, 1978, US TRAMP DEV COMP SK, P2; *COMM MED ASP SPOR, 1963, HEADS HELM TIPS ATHL, V5, P1; *COMM MED ASP SPOR, 1963, SPEAR FOOTB TIPS ATH, V5, P1; Committee on Accident and Poison Prevention, 1981, PEDIATRICS, V67, P438; ELLIS WG, 1960, JAMA-J AM MED ASSOC, V174, P1673, DOI 10.1001/jama.1960.03030130001001; HAY J, 1974, SURVEY TRAMPOLINE IN, P27; HECK J, 1966, J ATHL TRAINING, V31, P31; MUELLER F, 1996, HUMAN KINETICS SPORT, V8, P114; MUELLER F, 1996, ANN SURVEY FOOTBALL; RAPP G, 1976, AM ORTH SOC SPORTS M; Rapp GF., 1978, AM J SPORT MED, V6, P269, DOI [10.1177/036354657800600508, DOI 10.1177/036354657800600508]; SCHIELDS C, 1978, PHYSICIAN SPORTSMED, V6, P71; Schneider R., 1973, HEAD NECK INJURIES F; SCHNEIDER R, 1965, CLIN NEUROSURG, V12, P226; TATOR C H, 1986, Physician and Sportsmedicine, V14, P157; TORG JS, 1979, JAMA-J AM MED ASSOC, V241, P1477, DOI 10.1001/jama.241.14.1477; TORG JS, 1977, J AM COLL HEALTH ASS, V25, P224; TORG JS, 1984, PEDIATRICS, V74, P804; YOUNG J, 1980, SCI DIGEST       SUM, P45; Young JA, 1982, SPINAL CORD INJURY S, P1; 1962, JAMA, V180, P23	34	21	22	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0278-5919			CLIN SPORT MED	Clin. Sports Med.	JAN	1998	17	1					83	+		10.1016/S0278-5919(05)70063-6			16	Sport Sciences	Sport Sciences	YU153	WOS:000071687600009	9475973				2021-06-18	
J	AharonPeretz, J; Kliot, D; AmyelZvi, E; Tomer, R; Rakier, A; Feinsod, M				AharonPeretz, J; Kliot, D; AmyelZvi, E; Tomer, R; Rakier, A; Feinsod, M			Neurobehavioural consequences of closed head injury in the elderly	BRAIN INJURY			English	Article							TRAUMATIC COMA; ADULT; SCALE; AGE	The assessment of neurobehavioural outcome after head injury in older patients (> 60 year old) has met with difficulties, due to the obstacles in finding subjects who would constitute an appropriate control group. In the present study, survivors of closed head injury (CHI) of this age group were compared to two control groups: (I) orthopaedic patients (OF) who were injured in similar circumstances hut did not sustain head injury and (2) healthy, age-matched volunteers (HC). Compared with HC, CHI and OP were impaired on word fluency, memory and reasoning. No differences were found between CHI and the OF. These results may indicate that, rather than resulting only from the head injury brought about by falling, the cognitive decline may predate the injury and increase the risk of accidents in old age.	RAMBAM MED CTR,DEPT NEUROSURG,HAIFA,ISRAEL	AharonPeretz, J (corresponding author), RAMBAM MED CTR,COGNIT NEUROL UNIT,HAIFA,ISRAEL.		tomer, rachel/E-5747-2013				ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; *CENTR BUR STAT, 1991, STAT ABSTR ISR F 42; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1989, MILD MODERATE HEAD I, P153; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAZZUCCHI A, 1992, J NEUROL, V239, P256; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; RAKIER A, 1995, BRAIN INJURY, V9, P187, DOI 10.3109/02699059509008191; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; TEASDALE G, 1974, LANCET, V2, P81; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Wechsler D, 1974, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wilson J A, 1987, Brain Inj, V1, P183, DOI 10.3109/02699058709034456	22	21	21	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	DEC	1997	11	12					871	875					5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	YG767	WOS:A1997YG76700003	9413621				2021-06-18	
J	Williams, JM				Williams, JM			The prediction of premorbid memory ability	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							CLOSED HEAD-INJURY; WAIS-R; DEMOGRAPHIC-VARIABLES; IQ; SCALE; PERFORMANCE; DISCREPANCIES; INTELLIGENCE; EDUCATION; JUDGMENT	An estimation of premorbid memory ability is necessary for clinical judgments of memory status following brain injury of illness. This paper describes the nature of clinical reasoning about memory ability and intelligence. The analysis of these reasoning problems has progressed from the simple contrast of clinical versus actuarial models to a theory that integrates all such models as applications of reasoning under uncertainty. This is followed by the first empirical study of the estimation of premorbid memory ability from demographic variables. The results of this analysis clearly suggest that demographic variables predict memory scores at a low level (R = .45); this result stands in contrast to the higher predictive power of demographics when IQ is the criterion. Practical suggestions are then proposed for establishing an empirical basis for clinical judgments of premorbid memory ability. (C) 1997 National Academy of Neuropsychology. Published by Elsevier Science Ltd.		Williams, JM (corresponding author), ALLEGHENY UNIV HLTH SCI,MAIL STOP 626,PHILADELPHIA,PA 19102, USA.						BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; BORNSTEIN RA, 1988, CLIN NEUROPSYCHOL, V2, P107, DOI DOI 10.1080/13854048808520093; BORNSTEIN RA, 1989, PSYCHOL ASSESSMENT J, V1, P203; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; Cohen R. J., 1988, PSYCHOL TESTING; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P275, DOI 10.1111/j.2044-8260.1989.tb01377.x; CRAWFORD JR, 1990, BRIT J CLIN PSYCHOL, V29, P435, DOI 10.1111/j.2044-8260.1990.tb00908.x; DAWES RM, 1986, CLIN PSYCHOL REV, V6, P425, DOI 10.1016/0272-7358(86)90030-9; Dunn L., 1981, PEABODY PICTURE VOCA; ELWOOD RW, 1991, CLIN NEUROPSYCHOL, V5, P329; ERICKSON RC, 1977, PSYCHOL BULL, V84, P1130, DOI 10.1037/0033-2909.84.6.1130; FIELDS FRJ, 1971, DIS NERV SYST, V32, P673; GOUVIER WD, 1983, CLIN NEUROPSYCHOLOGY, V5, P119; HALL JC, 1957, J CONSULT PSYCHOL, V21, P131, DOI DOI 10.1037/H0039695; HEILBRONNER RL, 1990, INT J CLIN NEUROPSYC, V12, P24; IVNIK RJ, 1991, PSYCHOL ASSESSMENT J, V3, P156; Jastak S, 1984, WIDE RANGE ACHIEVEME; KAHNEMAN D, 1972, COGNITIVE PSYCHOL, V3, P430, DOI 10.1016/0010-0285(72)90016-3; Kahneman D., 1982, JUDGMENT UNCERTAINTY; KAREKEN DA, 1995, ARCH CLIN NEUROPSYCH, V10, P147, DOI 10.1016/0887-6177(94)E0012-E; Kareken DA, 1994, PSYCHOL ASSESSMENT, V6, P83, DOI [10.1037/1040-3590.6.2.83, DOI 10.1037/1040-3590.6.2.83]; KARZMARK P, 1985, J CLIN EXP NEUROPSYC, V7, P412, DOI 10.1080/01688638508401273; Kaufman A. S., 1990, ASSESSING ADOLESCENT; KLESGES RC, 1985, INT J CLIN NEUROPSYC, V7, P1; LARRABEE GJ, 1987, J CLIN EXP NEUROPSYC, V9, P456, DOI 10.1080/01688638708405065; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MATARAZZO JD, 1984, J CLIN NEUROPSYCHOL, V6, P351, DOI 10.1080/01688638408401227; MATARAZZO JD, 1984, J CONSULT CLIN PSYCH, V52, P631, DOI 10.1037/0022-006X.52.4.631; MEEHL P, 1954, CLIN VERSUS STATISTI; MEEHL PE, 1973, PSYCHODIAGNOSIS SELE; MORTENSEN EL, 1991, J CLIN EXP NEUROPSYC, V13, P361, DOI 10.1080/01688639108401050; MOSS AR, 1991, BRIT J CLIN PSYCHOL, V30, P179, DOI 10.1111/j.2044-8260.1991.tb00934.x; OSCARBERMAN M, 1993, CLIN NEUROPSYCHOL, V7, P281, DOI 10.1080/13854049308401899; PRIFITERA A, 1985, J CONSULT CLIN PSYCH, V53, P564, DOI 10.1037/0022-006X.53.4.564; SOLOMON GS, 1986, J CLIN PSYCHOL, V42, P318, DOI 10.1002/1097-4679(198603)42:2<318::AID-JCLP2270420217>3.0.CO;2-3; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wedding D, 1991, Neuropsychol Rev, V2, P233, DOI 10.1007/BF01109046; Wedding D, 1989, Arch Clin Neuropsychol, V4, P233, DOI 10.1016/0887-6177(89)90016-4; WILLIAMS JM, 1992, MEMORY ASSESSMENT SC; WILLSHIRE D, 1991, J CLIN EXP NEUROPSYC, V13, P204, DOI 10.1080/01688639108401038	42	21	21	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	1997	12	8					745	756		10.1016/S0887-6177(97)00048-6			12	Psychology, Clinical; Psychology	Psychology	YH876	WOS:A1997YH87600005	14590651	Bronze			2021-06-18	
J	Rosenbluth, J; Schiff, R; Liang, WL; Menna, G; Young, W				Rosenbluth, J; Schiff, R; Liang, WL; Menna, G; Young, W			Xenotransplantation of transgenic oligodendrocyte-lineage cells into spinal cord-injured adult rats	EXPERIMENTAL NEUROLOGY			English	Article							TRANSPLANTED OLIGODENDROCYTES; SHIVERER MOUSE; REMYELINATION; AXONS; CAT; MIGRATION; LESION; TISSUE; BRAIN	Spinal cord trauma is associated not only with loss of nerve cells and fibers but also with damage to oligodendrocytes and demyelination. In order to assess the potential of transplanted oligodendrocyte-lineage cells to repair the demyelination that follows spinal cord injury, we have used donor glia derived from a transgenic mouse line containing the LacZ transgene under control of the myelin basic protein promoter (16). Glia derived from fetal or neonatal transgenic mice were injected into the spinal cords of immunosuppressed adult rats at the site of an experimental traumatic lesion 1-16 days after injury. Cells expressing LacZ were identified 15-18 days later in cryosections rostral and caudal to the transplant site, most conspicuously within white matter defects. Some of these cells within the dorsal columns gave rise to similar to 30- to 60-mu m processes, consistent with myelin segments, which are oriented parallel to the fiber tract. Glial transplantation may thus be a feasible means of replacing damaged host oligodendrocytes with donor oligodendrocyte-lineage cells capable of reforming myelin and potentially restoring function lost as a result of demyelination associated with spinal cord injury. (C) 1997 Academic Press.	NYU, SCH MED, RUSH INST REHABIL MED, DEPT PHYSIOL & NEUROSCI, NEW YORK, NY 10016 USA; NYU, SCH MED, DEPT NEUROSURG, NEW YORK, NY 10016 USA							BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BLAKEMORE WF, 1988, DEV NEUROSCI-BASEL, V10, P1, DOI 10.1159/000111949; BLAKEMORE WF, 1991, TRENDS NEUROSCI, V14, P323, DOI 10.1016/0166-2236(91)90155-N; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BLIGHT AR, 1992, J NEUROTRAUM, V9, pS83; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BLIGHT AR, 1983, NEUROSCIENCE, V10, P1471, DOI 10.1016/0306-4522(83)90128-8; BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7; BLIGHT AR, 1990, NEUROTRAUM, P87; BLIGHT AR, 1993, ADV NEUROL, V59, P91; CRANG AJ, 1991, GLIA, V4, P305, DOI 10.1002/glia.440040308; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; FRIEDRICH VL, 1993, J NEURAL TRANSP PLAS, V4, P139; GOUT O, 1988, NEUROSCI LETT, V87, P195, DOI 10.1016/0304-3940(88)90169-3; GOW A, 1992, J CELL BIOL, V119, P605, DOI 10.1083/jcb.119.3.605; GUMPEL M, 1983, NEUROSCI LETT, V37, P307, DOI 10.1016/0304-3940(83)90449-4; HUANG PP, 1994, J NEUROTRAUM, V11, P547, DOI 10.1089/neu.1994.11.547; LACHAPELLE F, 1994, EUR J NEUROSCI, V6, P814, DOI 10.1111/j.1460-9568.1994.tb00992.x; REIER PJ, 1986, J COMP NEUROL, V247, P275, DOI 10.1002/cne.902470302; ROSENBLUTH J, 1990, J NEUROCYTOL, V19, P718, DOI 10.1007/BF01188040; Rosenbluth J., 1996, P124, DOI 10.1017/CBO9780511570193.014; ROSENBLUTH J, 1995, J NEUROTRAUMA, V12, P972; ROSENBLUTH J, 1991, J NEUROCYTOL, V22, P967; Szuchet Sara, 1995, P23; TONTSCH U, 1994, P NATL ACAD SCI USA, V91, P11616, DOI 10.1073/pnas.91.24.11616; VIGNAIS L, 1993, INT J DEV NEUROSCI, V11, P603, DOI 10.1016/0736-5748(93)90049-J; WARRINGTON AE, 1993, J NEUROSCI RES, V34, P1, DOI 10.1002/jnr.490340102	28	21	21	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	SEP	1997	147	1					172	182		10.1006/exnr.1997.6583			11	Neurosciences	Neurosciences & Neurology	XV981	WOS:A1997XV98100018	9294414				2021-06-18	
J	Castejon, OJ; Valero, C; Diaz, M				Castejon, OJ; Valero, C; Diaz, M			Light and electron microscope study of nerve cells in traumatic oedematous human cerebral cortex	BRAIN INJURY			English	Article							HUMAN-BRAIN EDEMA; PATHOLOGY; INJURY	The cerebral cortex of eight patients with complicated head and brain traumatic injuries has been examined with light and transmission electron microscopes. The neuronal and neuroglial cell bodies and their processes have been examined to study the changes induced by the brain injury and the associated vasogenic and cytotoxic, moderate or severe, brain oedema. Light microscopy study showed oedematous and ischaemic neurons and neuroglial cells in both moderate and severe oedema, and breakdown of the blood-brain barrier with perivascular and parenchymatous haemorrhagic loci. Astrocytes and oligodendrocytes exhibited oedematous and reactive changes. At the electron microscope level oedematous changes were found in intraneuronal and glial somatic compartment. Myelinated axons showed clear and dark degenerative features. Beaded dendrites and clear and dense synaptic degeneration were also found. The extracellular space appeared distended, with the presence of clear and electron-dense haematogenous oedema fluid and fibrinous organization. Phagocytosis of degenerated myelinated axons and synaptic endings by neuroglial cells and non-nervous invading cells were observed. The clinical evolution time of traumatic brain injuries was considered in relation to nerve cell degenerative features.	POLICIN MARACAIBO, MARACAIBO, VENEZUELA	Castejon, OJ (corresponding author), UNIV ZULIA, INST INVEST BIOL, FAC MED, APARTADO POSTAL NO 526, MARACAIBO 4011, VENEZUELA.						ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BAKAY L, 1965, CEREBRAL EDEMA, P1; Birbamer G, 1994, Acta Neurol (Napoli), V16, P114; BOWEN FP, 1968, ARCH NEUROL-CHICAGO, V19, P398, DOI 10.1001/archneur.1968.00480040064006; BRODKEY JA, 1995, J NEUROSURG, V82, P106, DOI 10.3171/jns.1995.82.1.0106; Cammermeyer J., 1972, STRUCTURE FUNCTION N, V6, P131; CASTEJON OJ, 1980, J NEUROPATH EXP NEUR, V39, P296, DOI 10.1097/00005072-198005000-00006; CASTEJON OJ, 1984, J SUBMICR CYTOL PATH, V16, P359; CASTEJON OJ, 1984, PATHOL RES PRACT, V179, P7, DOI 10.1016/S0344-0338(84)80054-0; CASTEJON OJ, 1984, J SUBMICR CYTOL PATH, V16, P601; CASTEJON OJ, 1985, J SUBMICR CYTOL PATH, V17, P703; CASTRO C, 1995, AGROCHIMICA, V39, P1; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; Hardman J M, 1979, Adv Neurol, V22, P15; HIRANO A, 1969, STRUCTURE FUNCTION N, V11, P69; ISASSON O, 1992, EXPT NEUROLOGY, V177, P151; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Kryzhanovskii G. N., 1992, Byulleten' Eksperimental'noi Biologii i Meditsiny, V113, P241; KUSHI H, 1994, ACTA NEUROCHIR, P472; LIM M, 1994, HUA HSI I KO TA SHUC, V25, P138; LIM R, 1972, ARCH NEUROL-CHICAGO, V27, P314, DOI 10.1001/archneur.1972.00490160042006; LOMBARDI G, 1993, J NEUROCHEM, V60, P1317, DOI 10.1111/j.1471-4159.1993.tb03292.x; LONG DM, 1966, J NEUROPATH EXP NEUR, V25, P373, DOI 10.1097/00005072-196607000-00003; LUSE SA, 1960, J NEUROSURG, V17, P439, DOI 10.3171/jns.1960.17.3.0439; MANZ HJ, 1974, HUM PATHOL, V5, P291, DOI 10.1016/S0046-8177(74)80113-9; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; Nillson P, 1963, CEREBR BLOOD FLOW ME, V13, P183; Povlishock J T, 1980, Adv Exp Med Biol, V131, P227; Staub F, 1994, Anasthesiol Intensivmed Notfallmed Schmerzther, V29, P203, DOI 10.1055/s-2007-996719; Valsamis M P, 1994, Neurosurg Clin N Am, V5, P175; WAXMAN SG, 1988, CURRENT TISSUES NEUR, P3; WILLMORE LJ, 1992, NEUROL CLIN, V10, P869	32	21	22	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	1997	11	5					363	388		10.1080/026990597123520			26	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	WW455	WOS:A1997WW45500007	9146842				2021-06-18	
J	Suzuki, M; Nishina, M; Endo, M; Matsushita, K; Tetsuka, M; Shima, K; Okuyama, S				Suzuki, M; Nishina, M; Endo, M; Matsushita, K; Tetsuka, M; Shima, K; Okuyama, S			Decrease in cerebral free magnesium concentration following closed head injury and effects of VA-045 in rats	GENERAL PHARMACOLOGY			English	Article						closed head injury; free magnesium; VA-045; P-31-NMR; rat brain	FLUID-PERCUSSION MODEL; TRAUMATIC BRAIN INJURY; METABOLISM; TISSUES	1. We examined the alterations in cerebral free Mg2+ concentration in closed head in jury (CHI) in rats and the effects of VA-045, a novel apovincaminic acid derivative, on them with in vivo P-31-NMR. 2. Free Mg2+ decreased by about 30% within 20 min after head impact and, afterward, it gradually decreased further to reach about 60% of the control level after 3 hr. VA-045 inhibited the decrease. 3. In nonimpacted rats, VA-045 did not alter the free Mg2+ level. 4. The decrease in cerebral free Mg2+ following CHI may be a critical factor in the development of irreversible tissue injury, and VA-045 may prevent it. Copyright (C) 1997 Elsevier Science Inc.	SAITAMA MED SCH,DEPT MED ZOOL,MOROYAMA,SAITAMA 35004,JAPAN; NATL DEF MED COLL,DEPT NEUROSURG,TOKOROZAWA,SAITAMA 359,JAPAN; TAISHO PHARMACEUT CO LTD,MED RES LABS,OMIYA,SAITAMA 330,JAPAN	Suzuki, M (corresponding author), SAITAMA MED SCH,DEPT PHARMACOL,MOROYAMA,SAITAMA 35004,JAPAN.						DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GUPTA RK, 1984, ANNU REV BIOPHYS BIO, V13, P221; KAWASHIMA Y, 1993, J MED CHEM, V36, P815, DOI 10.1021/jm00059a004; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; OKUYAMA S, 1993, LIFE SCI, V53, P273; PRICHARD JW, 1986, ANNU REV NEUROSCI, V9, P61; SEO Y, 1983, J BIOCHEM-TOKYO, V94, P729, DOI 10.1093/oxfordjournals.jbchem.a134413; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; VELOSO D, 1973, J BIOL CHEM, V248, P4811; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757	15	21	21	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0306-3623			GEN PHARMACOL	Gen. Pharmacol.	JAN	1997	28	1					119	121		10.1016/S0306-3623(96)00148-6			3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	VZ130	WOS:A1997VZ13000019	9112087				2021-06-18	
J	Lyeth, BG; Gong, QZ; Dhillon, HS; Prasad, MR				Lyeth, BG; Gong, QZ; Dhillon, HS; Prasad, MR			Effects of muscarinic receptor antagonism on the phosphatidylinositol bisphosphate signal transduction pathway after experimental brain injury	BRAIN RESEARCH			English	Article						traumatic brain injury; fluid percussion; phosphatidylinositol bisphosphate; diacylglycerol; free fatty acid; arachidonic acid; scopolamine; muscarinic; rat	INCREASED PROSTAGLANDIN SYNTHESIS; EXPERIMENTAL HEAD-INJURY; EXCITATORY AMINO-ACIDS; REGIONAL LEVELS; RAT; SCOPOLAMINE; LACTATE; METABOLISM; BEHAVIOR; FLUID	Hippocampal levels of fatty acids extracted from phosphatidylinositol 4,5-bisphosphate (PIP,), free fatty acids (FFA), and lactate were measured after central fluid percussion traumatic brain injury (TBI) in rats. At 5 min after injury, there was a decrease in fatty acids extracted from PIP2 suggesting a decrease in PIP2. At the same time point, total FFA increased in saline-treated TBI rats. Levels of arachidonic acid were significantly decreased in PIP2, while at the same time arachidonic and stearic acids increased in FFA in saline-treated TBI rats. No significant alterations in PIP2-derived fatty acids or FFA were observed at 20 min after TBI. Hippocampal concentrations of lactate were significantly elevated at 5 and 20 min after injury in saline-treated rats. In general, these alterations were blunted by preinjury administration of the muscarinic antagonist, scopolamine. These results suggest that the PIP2 signal transduction pathway is activated in the hippocampus at the onset of central fluid percussion TBI and that the enhanced phospholipase C-catalyzed phosphodiestric breakdown of PIP2 is a major mechanism of liberation of FFA in these sites immediately after such injury. The blunting of PIP2 and FFA alterations in animals treated with scopolamine suggests that activation of muscarinic receptors significantly contributes to the phospholipase C (PLC) signal transduction pathophysiology in TBI. The attenuation of lactate accumulation in scopolamine-treated rats suggests that TBI-induced muscarinic receptor activation also contributes to increased glycolytic metabolism and/or ionic imbalances.	UNIV KENTUCKY,CHANDLER MED CTR,DEPT SURG,DIV NEUROSURG,LEXINGTON,KY	Lyeth, BG (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,POB 980693,RICHMOND,VA 23298, USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R55NS031816, P50NS012587, P01NS012587, R01NS029995, R01NS031816] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 31816, NS 29995, NS 12587] Funding Source: Medline		Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DELAHUNTY TM, 1995, NEUROCHEM RES, V20, P335; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; DHILLON HS, 1995, BRAIN RES, V698, P100, DOI 10.1016/0006-8993(95)00840-M; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FRANDSEN A, 1993, J NEUROCHEM, V60, P1202, DOI 10.1111/j.1471-4159.1993.tb03278.x; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; JOYCE JN, 1989, J NEUROSCI, V9, P2776; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KONTOS HA, 1985, CIRC RES, V57, P142, DOI 10.1161/01.RES.57.1.142; KUHR WG, 1988, J CEREBR BLOOD F MET, V8, P130, DOI 10.1038/jcbfm.1988.17; LAPETINA EG, 1987, METHOD ENZYMOL, V141, P176; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; PRASAD MR, 1994, J NEUROCHEM, V63, P773; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; SEISJO BK, 1988, NEUROCHEM PATHOL, V9, P31; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SOMJEN GG, 1984, BRAIN RES, V311, P186, DOI 10.1016/0006-8993(84)91416-1; TZIGARET C, 1993, J NEUROCHEM, V60, P827, DOI 10.1111/j.1471-4159.1993.tb03226.x; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617	42	21	21	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	DEC 2	1996	742	1-2					63	70		10.1016/S0006-8993(96)01002-5			8	Neurosciences	Neurosciences & Neurology	WC372	WOS:A1996WC37200008	9117422				2021-06-18	
J	Etcoff, LM; Kampfer, KM				Etcoff, LM; Kampfer, KM			Practical guidelines in the use of symptom validity and other psychological tests to measure malingering and symptom exaggeration in traumatic brain injury cases	NEUROPSYCHOLOGY REVIEW			English	Article						malingering; symptom validity; neuropsychological; forensic	SIMULATED MEMORY IMPAIRMENT; FORCED-CHOICE METHOD; REY 15-ITEM TEST; FAKE BAD SCALE; HEAD-INJURY; BASE RATES; MMPI-2; PERFORMANCE; DEFICITS; TASK	The detection of malingering or symptom exaggeration has become an essential component in forensic neuropsychological evaluations, particularly in cases involving-personal injury claims. Symptom Validity Tests refer to those measures that can be utilized to detect test performance that is so poor that it is below the level of probability, oftentimes even among brain-damaged populations. This article outlines legal standards for expert testimony in regard to forensic neuropsychological personal injury evaluations. The article provides an outline of specific Symptom Validity Tests and Indicators, and reviews literature supporting test sensitivity and validity. In addition the use of symptom checklists and questionnaires is discussed, as well as the appropriate use of Symptom Validity Tests and Indicators to establish the presence or absence of malingering or symptom exaggeration.								*AM AC NEUR, 1989, ETH PRINC PSYCH COD, V39, P1100; ARNETT PA, 1995, CLIN NEUROPSYCHOL, V9, P17, DOI 10.1080/13854049508402052; BAER RA, 1992, CLIN PSYCHOL REV, V12, P509, DOI 10.1016/0272-7358(92)90069-K; BAGBY RM, 1995, PSYCHOL ASSESSMENT, V7, P84; BAGBY RM, 1994, J PERS ASSESS, V62, P191, DOI 10.1207/s15327752jpa6202_2; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1993, ARCH CLIN NEUROPSYCH, V8, P539, DOI 10.1016/0887-6177(93)90054-5; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; BERRY DTR, 1991, CLIN PSYCHOL REV, V11, P585, DOI 10.1016/0272-7358(91)90005-F; BERRY DTR, 1991, PSYCHOL ASSESSMENT J, V3, P418, DOI DOI 10.1037/1040-3590.3.3.418; BINDER LM, 1993, ARCH CLIN NEUROPSYCH, V8, P137, DOI 10.1016/0887-6177(93)90031-U; BINDER LM, 1992, PORTLAND DIGIT RECOG; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BINDER LM, 1993, CLIN NEUROPSYCHOL, V7, P104, DOI DOI 10.1080/13854049308401892; BOLTER JF, 1985, ANN M NAT AC NEUR PH; BROWN S, 1994, AM PSYCH ASS DSM 4 S, V1, P319; Butcher J. N., 1993, MINNESOTA MULTIPHASI; Butcher JN, 1995, PSYCHOL ASSESSMENT, V7, P320, DOI 10.1037/1040-3590.7.3.320; CENTOFANTI C, 1979, SINGLE DOUBLE SIMULT; Cope D., 1993, J HEAD TRAUMA REHAB, V8, P1; Delis DC, 1987, CALIFORNIA VERBAL LE; DOERR HO, 1991, FORENSIC NEUROPSYCHO; DUNN JT, 1993, 13 ANN C NAT AC NEUR; EPSTEIN CM, 1994, NEUROLOGY, V44, P1566, DOI 10.1212/WNL.44.9.1566; FAUST D, 1991, Neuropsychology Review, V2, P205, DOI 10.1007/BF01109045; FAUST D, 1993, ETHICS BEHAV, V3, P359; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; GOLDBERG JO, 1986, J CLIN PSYCHOL, V42, P792, DOI 10.1002/1097-4679(198609)42:5<792::AID-JCLP2270420519>3.0.CO;2-8; GOLDING SL, 1991, LAW HUMAN BEHAV, V15, P655; Graham JR, 1993, MMPI 2 ASSESSING PER; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Halstead WC, 1947, BRAIN INTELLIGENCE; HAYS JR, 1993, PERCEPT MOTOR SKILL, V76, P1331, DOI 10.2466/pms.1993.76.3c.1331; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; IVERSON GL, 1995, PSYCHOL ASSESSMENT, V7, P118, DOI 10.1037/1040-3590.7.1.118; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kerlinger FN, 1973, MULTIPLE REGRESSION; Lamb DG, 1994, PSYCHOL ASSESSMENT, V6, P8; Lee G.P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI [10.1037/1040-3590.4.1.43, DOI 10.1037/1040-3590.4.1.43]; Lees-Haley P. R., 1992, FORENSIC REPORTS, V5, P385; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEESHALEY PR, 1989, PSYCHOL REP, V65, P1203, DOI 10.2466/pr0.1989.65.3f.1203; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; McCaffrey R. J., 1993, J HEAD TRAUMA REHAB, V8, P38; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; MILLIS SR, 1995, CLIN NEUROPSYCHOL, V9, P241, DOI 10.1080/13854049508400486; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; Newman R, 1991, Neuropsychol Rev, V2, P241, DOI 10.1007/BF01109047; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; NUWER MR, 1994, NEUROLOGY, V44, P1998, DOI 10.1212/WNL.44.11.1998; OGLOFF JRP, 1990, BEHAV SCI LAW, V8, P27; PANKRATZ L, 1979, J CONSULT CLIN PSYCH, V47, P409, DOI 10.1037/0022-006X.47.2.409; Pankratz L., 1988, CLIN ASSESSMENT MALI, P169; PRIGATANO GP, 1993, J CLIN EXP NEUROPSYC, V15, P537, DOI 10.1080/01688639308402577; REITAN RM, 1955, J COMP PHYSIOL PSYCH, V48, P474, DOI 10.1037/h0048581; REITAN RM, 1988, TRAUMATIC BRAIN INJU; Reitan RM., 1985, HALSTEAD REITAN NEUR; Rey A, 1964, EXAMEN CLIN PSYCHOL; ROGERS R, 1988, CLIN ASSESSMENT MALI, P19; SBORDONNE RJ, 1991, NEUROPSYCHOLOGY ATTO; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; SHAPIRO DL, 1991, FORENSIC PSYCHOL ASS; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wetter M. W., 1992, PSYCHOL ASSESSMENT, V4, P369, DOI 10.1037/1040-3590.4.3.369; Wetter M. W., 1993, PSYCHOL ASSESSMENT, V5, P317; WIGGINS EC, 1988, LAW HUMAN BEHAV, V12, P57, DOI 10.1007/BF01064274; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	88	21	22	1	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1040-7308	1573-6660		NEUROPSYCHOL REV	Neuropsychol. Rev.	DEC	1996	6	4					171	201		10.1007/BF01874896			31	Psychology, Clinical; Neurosciences	Psychology; Neurosciences & Neurology	WZ229	WOS:A1996WZ22900001	9159771				2021-06-18	
J	Melot, C; Berre, C; Moraine, JJ; Kahn, RJ				Melot, C; Berre, C; Moraine, JJ; Kahn, RJ			Estimation of cerebral blood flow at bedside by continuous jugular thermodilution	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						nitrous oxide; cerebral blood flow; jugular blood flow; continuous thermodilution; cerebral vasoreactivity; carbon dioxide	TRAUMATIC BRAIN-LESIONS; ACUTE HEAD-INJURY; CARBON-DIOXIDE; COMATOSE PATIENTS; NITROUS-OXIDE; DOPPLER; VASOREACTIVITY; METABOLISM; VELOCITY; PRESSURE	The Kety-Schmidt technique can be regarded as the reference method for the measurement of cerebral blood flow (CBF). However, the method is somewhat cumbersome for routine use in the intensive care unit (ICU) at the bedside. The continuous thermodilution technique developed many years ago for the measurement of coronary sinus blood flow can be applied for the measurement of jugular blood now (JBF). However, the measurement of JBF by thermodilution has never been validated using the Kety-Schmidt reference method. We first validate the continuous thermodilution in vitro by comparison with a volumetric flow. The thermodilution method is accurate for flows between 50 and 900 ml min(-1) with a mean difference volumetric-thermodilution flow of -1 +/- 18 ml min(-1) (mean +/- SD), and precise with a coefficient of variability ranging between 1.21% and 2.50%. In vivo accuracy was assessed by comparing in 15 comatose patients CBF measured using the Kety-Schmidt (CBFKS) method and estimated from JBF measured by thermodilution (CBFTH) at four levels of arterial P(a)co(2) (25, 30, 35, and 40 mm Hg). The mean difference CBFKS - CBFTH is -0.9 +/- 3.6 ml min(-1) 100 g(-1). In vivo precision of the method was good, with a coefficient of variability of 4.1% in mean. We conclude that jugular continuous thermodilution technique is a reliable method for estimating CBF at the bedside. This technique allows repeated measurements jugular bulb blood sampling for brain metabolic studies.		Melot, C (corresponding author), ERASME UNIV HOSP,DEPT INTENS CARE,ROUTE LENNIK 808,B-1070 BRUSSELS,BELGIUM.		Moraine, Jean-Jacques/O-3364-2014	MELOT, Christian/0000-0002-6172-0330			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; ALEXANDER SC, 1964, J APPL PHYSIOL, V19, P561; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; COHAN SL, 1989, STROKE, V20, P761, DOI 10.1161/01.STR.20.6.761; COLD GE, 1989, ACTA NEUROCHIR, V96, P100, DOI 10.1007/BF01456166; DEGUEVARA OL, 1987, J CHROMATOGR, V403, P350, DOI 10.1016/S0021-9673(00)96375-1; DOMINO KB, 1993, ANESTHESIOLOGY, V78, P91, DOI 10.1097/00000542-199301000-00014; Dumke PR, 1943, AM J PHYSIOL, V138, P0421; Eckenhoff J E, 1966, Ann R Coll Surg Engl, V39, P67; EDVINSSON L, 1993, CEREBRAL BLOOD FLOW, P497; EPSTEIN HM, 1970, ANESTHESIOLOGY, V32, P332, DOI 10.1097/00000542-197004000-00007; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; FRONEK A, 1960, CIRC RES, V8, P175, DOI 10.1161/01.RES.8.1.175; GANZ W, 1971, CIRCULATION, V44, P181, DOI 10.1161/01.CIR.44.2.181; JAKOBSEN M, 1989, J CEREBR BLOOD F MET, V9, P717, DOI 10.1038/jcbfm.1989.101; JENNETT B, 1975, LANCET, V1, P480; KETY SS, 1948, J BIOL CHEM, V173, P487; KETY SS, 1945, AM J PHYSIOL, V143, P53; KETY SS, 1951, PHARMACOL REV, V3, P1; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; KOZAM RL, 1970, J APPL PHYSIOL, V29, P593; LASSEN NA, 1965, CIRC RES, V26, P26; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MEYER JOHN S., 1963, TRANS AMER NEUROL ASSOC, V88, P78; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; Olesen J, 1971, STROKE, V2, P519, DOI 10.1161/01.STR.2.6.519; POON CS, 1988, J APPL PHYSIOL, V64, P854; PROUGH DS, 1991, CRITICAL CARE STATE, P157; REIVICH M, 1964, AM J PHYSIOL, V206, P25; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; SHARPLES PM, 1991, ARCH DIS CHILD, V66, P1326, DOI 10.1136/adc.66.11.1326; SHENKIN HA, 1948, ARCH NEURO PSYCHIATR, V60, P240, DOI 10.1001/archneurpsyc.1948.02310030021002; SIMONSON SG, 1995, CURR OPIN CRIT CARE, V1, P217; Spann W, 1965, Dtsch Z Gesamte Gerichtl Med, V56, P299, DOI 10.1007/BF00574453; SWENSON ER, 1994, AM J RESP CRIT CARE, V149, P1563, DOI 10.1164/ajrccm.149.6.8004314; TEASDALE G, 1974, LANCET, V2, P81; TOMINAGA S, 1976, STROKE, V7, P507, DOI 10.1161/01.STR.7.5.507; VANDERLINDEN J, 1991, J THORAC CARDIOV SUR, V102, P95; Waltz AG, 1970, STROKE, V1, P27, DOI 10.1161/01.STR.1.1.27; Wilson EM, 1970, STROKE, V1, P348, DOI 10.1161/01.STR.1.5.348; Wilson EM, 1972, STROKE, V3, P300, DOI 10.1161/01.STR.3.3.300; WINER BJ, 1971, STATISTICAL PRINCIPL, P514; YANG SP, 1995, J CEREBR BLOOD F MET, V15, P115, DOI 10.1038/jcbfm.1995.13; YOUNG WL, 1994, ANESTHESIA NEUROSURG, P17	49	21	21	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	1996	16	6					1263	1270		10.1097/00004647-199611000-00022			8	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	VP540	WOS:A1996VP54000022	8898700	Bronze			2021-06-18	
J	Barth, JT; Diamond, R; Errico, A				Barth, JT; Diamond, R; Errico, A			Mild head injury and post concussion syndrome: Does anyone really suffer?	CLINICAL ELECTROENCEPHALOGRAPHY			English	Article; Proceedings Paper	Annual Spring Review Course and Meeting of the American-Medical-EEG-Association	FEB   24, 1996	CHARLESTON, SC	Amer Med EEG Assoc		concussion; mild head injury; mild traumatic brain injury; neuropsychological assessment; post concussion syndrome; psychosocial factors; recovery curves; shear-strain	BEHAVIORAL SEQUELAE; TOMOGRAPHY		UNIV VIRGINIA,DEPT PSYCHIAT MED,CHARLOTTESVILLE,VA 22901; HLTH S REHABIL HOSP,LARGO,FL							Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 1989, MILD HEAD INJURY; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; GRONWALL D, 1974, LANCET, V2, P604; GRONWALL D, 1980, PSYCHOL EFFECTS CONC; Holbourn AHS, 1943, LANCET, V2, P438; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruff R.M., 1989, MILD HEAD INJURY, P176; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; SMITH RJ, HDB HUMAN BRAIN FUNC, V3; SYMONDS C, 1962, LANCET, V1, P1; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	23	21	21	0	1	CLINICAL EEG	ELM GROVE	850 ELM GROVE RD,SUITE 11, ELM GROVE, WI 53122	0009-9155			CLIN ELECTROENCEPHAL	Clin. Electroencephalogr.	OCT	1996	27	4					183	186					4	Engineering, Biomedical; Clinical Neurology	Engineering; Neurosciences & Neurology	XA211	WOS:A1996XA21100003	9465281				2021-06-18	
J	Clark, E				Clark, E			Children and adolescents with traumatic brain injury: Reintegration challenges in educational settings	JOURNAL OF LEARNING DISABILITIES			English	Article							CLOSED-HEAD-INJURY; FOLLOW-UP; SEQUELAE; SEVERITY; DEFICITS; SCHOOL; COHORT	Changes in federal law have paved the way for students with traumatic brain injury (TBI) to receive special educational services. Although not all students with TBI need special education, many will need careful planning for reintegration into the classroom. The present article presents information about the range of services that need to be considered for these students and the problems that can affect students' academic and social functioning. Characteristics that distinguish this group of students from peers with special learning needs are highlighted and specific suggestions are made to help educators work more effectively with these students when they return to school. A case study is used to highlight the issues discussed.		Clark, E (corresponding author), UNIV UTAH,DEPT EDUC PSYCHOL,SCH PSYCHOL PROGRAM,327 MILTON BENNION HALL,SALT LAKE CITY,UT 84112, USA.						ANDERSON N, 1995, THESIS U UTAH SALT L; BAER R, 1992, ONE YEAR FOLLOW UP U; BEGALI V, 1992, HEAD INJURY CHILDREN; BIJUR PE, 1990, PEDIATRICS, V86, P337; BLOSSER JL, 1989, TOP LANG DISORD, V9, P67, DOI 10.1097/00011363-198903000-00007; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; CARNEY J, 1990, Pediatrician, V17, P222; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; DEPOMPEI R, 1991, NEUROREHABILITATION, V1, P29; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; GOLDEN CJ, 1985, LURIANEBRASKA NEUROP; Goldstein FC, 1985, DEV NEUROPSYCHOL, V1, P195, DOI 10.1080/87565648509540310; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KATSIYANNIS A, 1994, REM SPEC EDUC, V15, P319, DOI 10.1177/074193259401500507; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LANSER JB, 1988, HEADACHE, P176; LASH M, 1994, FAMILIES STUDENTS GE; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LONG CJ, 1992, HDB HEAD TRAUM A; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; MIRA MP, 1991, FOCUS EXCEPT CHILD, V23, P1; MIRA MP, 1988, DIAGNOSTIQUE, V13, P174; MORGAN D, 1988, TEACHING BEHAV DISOR; MURPHY LL, 1994, TESTS PRINT, V4; PAPAS B, 1993, HEADLINES, V4, P2; Reitan R.M., 1993, HALSTEADREITAN NEURO; REYNOLDS CR, 1994, TESTS MEMORY LEARNIN; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; SAVAGE R, 1985, SURVEY TRAUMATICALLY; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; SAVAGE RC, 1988, ED MANUAL WHAT ED NE; SAVAGE RC, 1994, ED DIMENSIONS ACQUIR; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; *USOE, 1993, GUID SERV STUD TRAUM; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; Ylvisaker M, 1989, J HEAD TRAUMA REHAB, V4, P51; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48; ZASLER ND, 1991, NEUROREHABILITATION, V1, P29	51	21	21	0	4	PRO-ED INC	AUSTIN	8700 SHOAL CREEK BLVD, AUSTIN, TX 78757-6897	0022-2194			J LEARN DISABIL	J. Learn. Disabil.	SEP	1996	29	5					549	560		10.1177/002221949602900509			12	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	VJ057	WOS:A1996VJ05700009	8870524				2021-06-18	
J	Jackowski, MM; Sturr, JF; Taub, HA; Turk, MA				Jackowski, MM; Sturr, JF; Taub, HA; Turk, MA			Photophobia in patients with traumatic brain injury: Uses of light-filtering lenses to enhance contrast sensitivity and reading rate	NEUROREHABILITATION			English	Article						traumatic brain injury; reading rate; contrast sensitivity; light-filtering lenses	VISUAL PERCEPTUAL DYSFUNCTION; HIERARCHICAL MODEL; HEAD-INJURY; SOUND	Patients who have sustained traumatic brain injury (TBI) often experience a new, intense and chronic photophobia. Photophobia, an intolerance to light, is an incompletely understood, subjective symptom, which has bren divided into ocular and central types. Various commercial sources of light-filtering lenses have been developed, which have proven to be successful in diminishing visual symptoms expressed by patients who are photophobic. However, despite the many subjective reports of improved visual performance and comfort with use of these filters, there has been little documentation of actual enhanced visual sensitivity/efficiency. Letter contrast sensitivity (CS) and reading rate were measured in patients with TBI, who, despite good ocular health, experienced significant light intolerance. These patients exhibited up to two fold increases (0.3 log units) in binocular letter contrast sensitivity, as measured with the Pelli-Robson Letter CS Chart, in the presence of selected Coming Photochromic Filters (CPF), as compared to performance in the absence of CPF filters, or to that of similarly treated normal observers. These same patients demonstrated reading rates enhanced up to 39% above that measured in the presence of nearpoint optical correction alone, Reading performance of normal observers was unaffected by similar light filtration. These data provide objective evidence for improvement of visual function provided by light-filtering lenses in patients who become photophobic after TBI. Contrast sensitivity testing and assessment of reading rate add objective criteria for the clinical selection of light-filtering lenses in the treatment of TBI-induced photophobia.	SYRACUSE UNIV,DEPT PSYCHOL,SYRACUSE,NY 13244; CENT NEW YORK RES CORP,NEW YORK,NY; VET ADM MED CTR,PSYCHOL SERV,SYRACUSE,NY 13210; SUNY HLTH SCI CTR,DEPT PHYS MED & REHABIL,SYRACUSE,NY 13210	Jackowski, MM (corresponding author), SUNY HLTH SCI CTR,DEPT OPHTHALMOL,550 HARRISON CTR,SYRACUSE,NY 13202, USA.						BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; DOHN AH, 1991, INVEST OPHTH VIS SCI, V32, P815; HUBER A, 1976, EYE SIGNS BRAIN TUMO; Lebensohn JE, 1934, ARCH OPHTHALMOL-CHIC, V12, P380; LEGGE GE, 1986, CONTRAST POLARITY LO; LIDVALL HE, 1974, ACTA NEUROL SCAND  S, V50, P56; Padula W. V., 1988, BEHAV VISION APPROAC; PADULA WV, 1988, N ENGL J OPTOM   DEC, P16; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; WARREN M, 1993, AM J OCCUP THER, V47, P42, DOI 10.5014/ajot.47.1.42; WARREN M, 1993, AM J OCCUP THER, V47, P55, DOI 10.5014/ajot.47.1.55; WILKINS AJ, 1994, OPHTHAL PHYSL OPT, V14, P365, DOI 10.1111/j.1475-1313.1994.tb00126.x	12	21	21	1	11	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JUN	1996	6	3					193	201		10.1016/1053-8135(96)00165-5			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	UK480	WOS:A1996UK48000005	24525771				2021-06-18	
J	Mesenge, C; Verrecchia, C; Allix, M; Boulu, RR; Plotkine, M				Mesenge, C; Verrecchia, C; Allix, M; Boulu, RR; Plotkine, M			Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors	JOURNAL OF NEUROTRAUMA			English	Article						head injury; L-NAME; nitric oxide; 7-nitro indazole; mice	FOCAL CEREBRAL-ISCHEMIA	This study investigates the effect of the NO synthase inhibitors, N-G-nitro L-arginine methyl ester (L-NAME) and 7-nitro indazole (7-NI), on the neurological deficit 24 h after a moderate closed head injury in mice. Low doses of L-NAME or 7-NI given soon after the injury significantly reduced the neurological deficit compared to the vehicle-treated group. L-Arginine (300 mg/kg) did not alter the neurological deficit, but reversed the protective effects of both L-NAME and 7-NI when given at the same time. Both L-NAME and 7-NI had dose-related effects. The neuroprotective effects of L-NAME and 7-NI occurred when the drugs were given 5, 30, or 60 min after brain injury, but not when treatment was begun 2 h after brain injury, suggesting a short therapeutic window for both drugs. These results suggest that NO synthesis by neuronal NO synthase plays an important role in the early neurotoxic cascade leading to neurological deficit following traumatic brain injury.		Mesenge, C (corresponding author), UNIV PARIS 05,PHARMACOL LAB,4 AVE OBSERV,F-75270 PARIS 06,FRANCE.		MARCHAND-LEROUX, Catherine/L-7453-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348			BABBEDGE RC, 1993, BRIT J PHARMACOL, V110, P225, DOI 10.1111/j.1476-5381.1993.tb13796.x; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; BUISSON A, 1992, BRIT J PHARMACOL, V106, P766, DOI 10.1111/j.1476-5381.1992.tb14410.x; CARREAU A, 1994, EUR J PHARMACOL, V256, P241, DOI 10.1016/0014-2999(94)90549-5; DAWSON DA, 1994, CEREBROVAS BRAIN MET, V6, P299; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GREENWOOD J, 1991, NEURORADIOLOGY, V33, P95, DOI 10.1007/BF00588242; Hall E.D., 1995, CENTRAL NERVOUS SYST, P213; HALL ED, 1987, BRAIN RES, V435, P174, DOI 10.1016/0006-8993(87)91599-X; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; IADECOLA C, 1994, NEUROCHEM RES, V19, P501, DOI 10.1007/BF00967330; IADECOLA C, 1994, J CEREBR BLOOD F MET, V14, P175, DOI 10.1038/jcbfm.1994.25; MACKENZIE GM, 1994, NEUROREPORT, V5, P1993, DOI 10.1097/00001756-199410000-00039; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MONCADA S, 1991, PHARMACOL REV, V43, P109; NATHAN C, 1992, FASEB J, V6, P3051; NOWICKI JP, 1991, EUR J PHARMACOL, V204, P339, DOI 10.1016/0014-2999(91)90862-K; SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125, DOI 10.1016/0165-6147(91)90526-X; YOSHIDA T, 1994, J CEREBR BLOOD F MET, V14, P924, DOI 10.1038/jcbfm.1994.123; ZHANG FY, 1995, J CEREBR BLOOD F MET, V15, P595, DOI 10.1038/jcbfm.1995.73	22	21	21	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	1996	13	1					11	16		10.1089/neu.1996.13.11			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	TW167	WOS:A1996TW16700002	8714858				2021-06-18	
J	KLONOFF, PS; LAGE, GA				KLONOFF, PS; LAGE, GA			SUICIDE IN PATIENTS WITH TRAUMATIC BRAIN INJURY - RISK AND PREVENTION	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						SUICIDE; TRAUMATIC BRAIN INJURY	HEAD-INJURY; IMPACT	Many patients sustaining traumatic brain injury (TBI) experience multiple deficits affecting cognition, personality, and physical independence. Often there is a dramatic and permanent change in work status, income, family life, support network, and quality of life. Clinical experience indicates that this can predispose patients to significant depressive reactions and increased risk of suicide. This article will describe clinical evaluation and treatment techniques that attempt to address suicide in TBI patients participating in an outpatient milieu-oriented rehabilitation program. Historical theories and research on suicide will be reviewed. Risk factors for TBI and their similarity to suicide will be explored. Preliminary clinical findings from a retrospective study of 111 TBI program participants will also be provided.		KLONOFF, PS (corresponding author), ST JOSEPHS HOSP,ADULT DAY HOSP NEUROL REHABIL,BARROW NEUROL INST,222 W THOMAS RD,PHOENIX,AZ 85013, USA.						BARRACLOUGH BM, 1987, ACTA PSYCHIAT SCAND, V76, P339, DOI 10.1111/j.1600-0447.1987.tb05616.x; BERMAN AL, 1991, ADOLESCENT SUICIDE A; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; BOND MR, 1983, REHABILITATION HEAD; BOWLBY J, 1908, SECURE BASE; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROWN HN, 1987, COMPR PSYCHIAT, V28, P101, DOI 10.1016/0010-440X(87)90075-7; Farberow N. L., 1961, CRY HELP; GARLAND AF, 1993, AM PSYCHOL, V48, P169, DOI 10.1037/0003-066X.48.2.169; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; GOLDSTEIN LS, 1984, AM J PSYCHOTHER, V38, P392; HYDE MO, 1991, SUICIDE; Jourard S. M., 1971, TRANSPARENT SELF; KLONOFF P, 1987, COMMUNITY REENTRY HE; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KLONOFF PS, 1993, B MENNINGER CLIN, V57, P227; KLONOFF PS, 1994, ANAL UNDERSTANDING P; Kohut H., 1972, PSYCHOANAL STUD C, V27, P360, DOI DOI 10.1080/00797308.1972.11822721; KOHUT H, 1971, ANALYSIS SELF; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LITMAN RE, 1965, AM J PSYCHOTHER, V19, P570; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MACKENZIE TB, 1987, INT J PSYCHIAT MED, V17, P3; Maltsberger J. T., 1986, SUICIDE RISK FORMULA; MARSHALL KA, 1980, SUICIDE LIFE-THREAT, V10, P29; Miller A., 1990, YOUR OWN GOOD HIDDEN; NAUGLE RI, 1990, TRAUMATIC BRAIN INJU; OYEBODE F, 1986, BRIT J HOSP MED, V36, P104; Petzel S V, 1978, Adolesc Psychiatry, V6, P239; PIGATANO GP, 1986, NEUROPSYCHOLOGICAL R; Prigatano G. P., 1994, J HEAD TRAUMA REHAB, V9, P91, DOI [DOI 10.1097/00001199-199403000-00011, 10.1097/00001199-199403000-00011]; SADOWSKI C, 1993, J CONSULT CLIN PSYCH, V61, P121, DOI 10.1037/0022-006X.61.1.121; Schneidman ES, 1969, INT PSYCHIAT CLIN, V6, P225; SCHNUR DB, 1985, J PSYCHIAT EDUC, V9, P127; SCHWABER EA, 1979, MAR STAFF PSYCH; SHAFFER D, 1988, J AM ACAD CHILD PSY, V27, P675, DOI 10.1097/00004583-198811000-00001; STEVENSON EK, 1972, DIS NERV SYST, V33, P112; Stuss D.T., 1986, FRONTAL LOBES; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; TABACKNICK ND, 1961, CRY HELP; TEFFT BM, 1977, ARCH GEN PSYCHIAT, V34, P1155; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WOLF E, 1988, SUICIDE	43	21	21	2	4	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1995	10	6					16	24		10.1097/00001199-199512000-00005			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	TJ661	WOS:A1995TJ66100005					2021-06-18	
J	HIGH, WM; GORDON, WA; LEHMKUHL, LD; NEWTON, CN; VANDERGOOT, D; THOI, L; COURTNEY, L				HIGH, WM; GORDON, WA; LEHMKUHL, LD; NEWTON, CN; VANDERGOOT, D; THOI, L; COURTNEY, L			PRODUCTIVITY AND SERVICE UTILIZATION FOLLOWING TRAUMATIC BRAIN INJURY - RESULTS OF A SURVEY BY THE RSA REGIONAL TBI CENTERS	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							REHABILITATION	Four regional TBI rehabilitation and prevention centers funded by the Rehabilitation Services Administration surveyed constituents concerning their participation in productive activities and the medical and rehabilitation services they had utilized within the preceding month. Analysis revealed that both productivity and service utilization were affected by geographical location, age at time of survey, educational level, gender, severity of injury, and time since injury. Persons who were most severely injured were more likely to be less productive and to utilize more services. The relationship between productivity and service utilization requires further systematic research.	INST REHABIL & RES,SW REG BRAIN INJURY REHABIL & PREVENT CTR,BRAIN INJURY RES CTR,HOUSTON,TX; MT SINAI SCH MED,DEPT PHYS MED & REHABIL,COMPREHENS REG TRAUMAT BRAIN INJURY REHABIL & PRE,NEW YORK,NY; CTR ESSENTIAL MANAGEMENT SERV,LONG ISL,NY	HIGH, WM (corresponding author), BAYLOR COLL MED,DEPT PHYS MED & REHABIL,HOUSTON,TX 77030, USA.						BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; HANDLER B, 1993, AM REHABIL, V19, P29; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Kreutzer JS, 1993, J HEAD TRAUMA REHAB, V8, P47; Kreutzer JS, 1990, COMMUNITY INTEGRATIO; LEHMKUHL LD, 1993, AM REHABIL, V19, P2; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; MIKRUT SL, 1993, AM REHABIL, V19, P39; MURPHY L D, 1990, Brain Injury, V4, P95, DOI 10.3109/02699059009026153; Prigatano G. P., 1994, J HEAD TRAUMA REHAB, V9, P91, DOI [DOI 10.1097/00001199-199403000-00011, 10.1097/00001199-199403000-00011]; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; SELLS J, 1993, AM REHABILITATION, V19, P6; SISK C, 1993, AM REHABIL, V19, P20; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 1980, INT CLASS IMP DIS HA; YOUNG ME, 1993, AM REHABIL, V19, P33	22	21	21	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1995	10	4					64	80		10.1097/00001199-199508000-00007			17	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	RN010	WOS:A1995RN01000007					2021-06-18	
J	REGAN, RF; PANTER, SS				REGAN, RF; PANTER, SS			TRAUMATIC NEURONAL INJURY IN CORTICAL CELL-CULTURE IS ATTENUATED BY 21-AMINOSTEROIDS	BRAIN RESEARCH			English	Article						CELL CULTURE; CEREBRAL CORTEX; EXCITOTOXICITY; FREE RADICAL; GLUTAMATE; HEAD TRAUMA; LIPID PEROXIDATION	SPINAL-CORD INJURY; INDUCED LIPID-PEROXIDATION; BRAIN INJURY; U74006F; ACID; METHYLPREDNISOLONE; ISCHEMIA; EDEMA; HEAD; RATS	The effect of the 21-aminosteroids U74500A and U74389F, alone and in combination with the NMDA receptor antagonist MK-801, on traumatic neuronal injury was quantitatively assessed in murine neocortical cell cultures. Consistent with prior observations, a mechanical insult to the culture monolayer resulted in widespread neuronal death over the following 24 h. Treatment with either U74500A or U74389F provided moderate protection, reducing neuronal death as measured by lactate dehydrogenase release by 25-50%. This effect was most consistent when these agents were preincubated for 2 h prior to injury. Combined treatment with a 21-aminosteroid plus the NMDA receptor antagonist MK-801 reduced injury more than either drug alone. Approximately 40% of the neuronal death occurring in the presence of MK-801 was blocked by concomitant treatment with 10 mu M U74500A or U74389F. These results suggest that free radicals may contribute to cell death in this in vitro model of traumatic neuronal injury.	UNIV CALIF SAN FRANCISCO,DEPT NEUROSURG,SAN FRANCISCO,CA 94143	REGAN, RF (corresponding author), THOMAS JEFFERSON UNIV,DIV EMERGENCY MED,1020 WALNUT ST,PHILADELPHIA,PA 19107, USA.						ANDERSON DK, 1988, J NEUROSURG, V69, P562, DOI 10.3171/jns.1988.69.4.0562; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; BRAUGHLER JM, 1987, J BIOL CHEM, V262, P10438; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DEMOPOULOS HB, 1982, CAN J PHYSIOL PHARM, V60, P1415, DOI 10.1139/y82-210; Dugan L. L., 1994, Society for Neuroscience Abstracts, V20, P1532; GOLDBERG M P, 1991, Neurology, V41, P390; HAGHIGHI SS, 1993, NEUROL RES, V15, P321; Hall E D, 1994, Adv Pharmacol, V28, P221, DOI 10.1016/S1054-3589(08)60497-4; HALL E D, 1989, Journal of Neurotrauma, V6, P169, DOI 10.1089/neu.1989.6.169; HALL ED, 1988, J NEUROSURG, V68, P462, DOI 10.3171/jns.1988.68.3.0462; HALL ED, 1982, J NEUROSURG, V57, P247, DOI 10.3171/jns.1982.57.2.0247; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; Halliwell B, 1989, FREE RADICALS BIOL M; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Lynch J. J. Iii, 1992, Society for Neuroscience Abstracts, V18, P1453; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; MCKENNA R, 1991, ANAL BIOCHEM, V196, P443, DOI 10.1016/0003-2697(91)90492-C; MEANS ED, 1983, J NEUROPATH EXP NEUR, V42, P707, DOI 10.1097/00005072-198311000-00009; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; MURAD F, 1990, GOODMAN GILMANS PHAR, P774; PAZDERNIK TL, 1992, NEUROCHEM RES, V17, P11, DOI 10.1007/BF00966860; PIETRONIGRO DD, 1983, J NEUROCHEM, V41, P1072, DOI 10.1111/j.1471-4159.1983.tb09053.x; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; Regan R. F., 1994, Society for Neuroscience Abstracts, V20, P192; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; SANADA T, 1993, J NEUROTRAUM, V10, P65, DOI 10.1089/neu.1993.10.65; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16	33	21	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUN 5	1995	682	1-2					144	150		10.1016/0006-8993(95)00330-S			7	Neurosciences	Neurosciences & Neurology	RE222	WOS:A1995RE22200018	7552305				2021-06-18	
J	KISHI, Y; ROBINSON, RG; FORRESTER, AW				KISHI, Y; ROBINSON, RG; FORRESTER, AW			COMPARISON BETWEEN ACUTE AND DELAYED-ONSET MAJOR DEPRESSION AFTER SPINAL-CORD INJURY	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article							TRAUMATIC BRAIN INJURY; STROKE PATIENTS; RAPHE NUCLEI; PROJECTIONS; STEM	Sixty patients with spinal cord injury were examined to assess major depression during the in-hospital period and at 3- and 6-month follow-up. Thirteen patients had depression during the initial in-hospital evaluation (acute onset depression) and eight had depression first diagnosed at either 3- or 6-month follow-up (delayed onset depression). Acute onset depression was related to the severity of impairment and premorbid history of psychiatric disorder, suggesting a psychological reaction to impairment or premorbid vulnerability as a possible mechanism for developing depression. Delayed onset depression was not related to severity of physical impairment but was associated with more rostral spinal injury, suggesting the possibility that neurophysiological response to injury more proximal to the brain may play a role in delayed onset depression. These data also suggest that the etiology and pathophysiology of these two types of depression may be different.	NIPPON MED COLL,DEPT NEUROPSYCHIAT,TOKYO,JAPAN; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205	KISHI, Y (corresponding author), UNIV IOWA,COLL MED,DEPT PSYCHIAT,200 HAWKINS DR,2887 JPP,IOWA CITY,IA 52242, USA.		Robinson, Robert/AAF-6191-2021; Kishi, Yasuhiro/T-4047-2019		NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH040355] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH 00163, MH 40355] Funding Source: Medline		BOWKER RM, 1983, BRAIN RES, V288, P33, DOI 10.1016/0006-8993(83)90079-3; Claus-Walker J, 1972, Paraplegia, V10, P142; CLAUSWALKER J, 1982, ARCH PHYS MED REHAB, V63, P628; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; CRUSE JM, 1992, IMMUNOL RES, V11, P104, DOI 10.1007/BF02918615; CULPEPPERMORGAN JA, 1992, METABOLISM, V41, P578, DOI 10.1016/0026-0495(92)90048-F; DAVIDSON J, 1986, BRIT J PSYCHIAT, V148, P442, DOI 10.1192/bjp.148.4.442; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORRESTER AW, 1992, INT J PSYCHIAT MED, V22, P33, DOI 10.2190/CJ9D-32C2-8CM7-FT3D; FRANK RG, 1988, AM J PHYS MED REHAB, V67, P128, DOI 10.1097/00002060-198806000-00008; FRANK RG, 1985, AM J PSYCHIAT, V142, P252; FULLERTON DT, 1981, ARCH GEN PSYCHIAT, V38, P1361; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HANCOCK KM, 1993, PARAPLEGIA, V31, P349, DOI 10.1038/sc.1993.59; HOLSTEGE JC, 1987, NEUROSCIENCE, V23, P809, DOI 10.1016/0306-4522(87)90160-6; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JUDD FK, 1989, BRIT J PSYCHIAT, V154, P668, DOI 10.1192/bjp.154.5.668; KAZAKOV VN, 1993, NEUROSCIENCE, V56, P157, DOI 10.1016/0306-4522(93)90570-6; KISHI Y, 1994, J NEUROPSYCH CLIN N, V6, P237; LEICHNETZ GR, 1978, NEUROSCI LETT, V8, P119, DOI 10.1016/0304-3940(78)90184-2; MCDANIEL JW, 1971, HORMONAL BEHAV, V2, P56; MORRIS PLP, 1990, INT J PSYCHIAT MED, V20, P349, DOI 10.2190/N8VU-6LWU-FLJN-XQKV; RABINS PV, 1982, BRIT J PSYCHIAT, V140, P149, DOI 10.1192/bjp.140.2.149; ROBINSON RG, 1981, BRAIN LANG, V14, P282, DOI 10.1016/0093-934X(81)90080-8; ROBINSON RG, 1983, COMPR PSYCHIAT, V24, P555, DOI 10.1016/0010-440X(83)90024-X; Sartorius N, 1974, MEASUREMENT CLASSIFI; Starr L B, 1982, Soc Work Res Abstr, V18, P28; TOHYAMA M, 1979, BRAIN RES, V176, P215, DOI 10.1016/0006-8993(79)90980-6; TWIST DJ, 1992, AM J PHYS MED REHAB, V71, P156, DOI 10.1097/00002060-199206000-00006; WOODRICH F, 1983, J REHABIL, V49, P26	32	21	21	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	MAY	1995	183	5					286	292		10.1097/00005053-199505000-00002			7	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	QY286	WOS:A1995QY28600002	7745381				2021-06-18	
J	GUALTIERI, CT				GUALTIERI, CT			THE PROBLEM OF MILD BRAIN INJURY	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						BRAIN INJURY; CLOSED HEAD INJURY; MILD BRAIN INJURY; CONCUSSION; POSTCONCUSSION SYNDROME; OUTCOME; DIASCHISIS; SOMATOFORM DISORDER; COMPENSATION NEUROSIS; MALINGERING	MINOR HEAD-INJURY; DIFFUSE AXONAL INJURY; COMPUTERIZED-TOMOGRAPHY; CEREBRAL CONCUSSION; SEQUELAE; SYMPTOMS; SPECT; TIME; IMPAIRMENT; POPULATION	It is estimated that 2,000,000 traumatic brain injuries (TBIs) occur in the U.S.A. each year; 90% are classified as ''mild brain injuries'' (MBIs). The epidemiology, pathophysiology, and diagnosis of MBI and the ''postconcussion syndrome'' (PCS) are reviewed, with particular attention to outcome data and factors that predict outcome. Symptoms of PCS may be quite severe, but severe symptoms are almost invariably transient. Persistent deficits may arise from MBI, but persistent problems are usually mild and are rarely disabling. Catastrophic outcomes related to MBI do occur, in the following situations. (a) What appears to be an MBI is really a severe injury. (b) PCS evolves into a posttraumatic depression that is unrecognized and untreated. (c) A premorbid psychiatric condition is mobilized around the MBI as a focal (but not a causative) event. (d) A patient shows signs of a ''functional'' condition, i.e., conversion disorder (hysteria), somatoform pain disorder, compensation neurosis, or malingering.		GUALTIERI, CT (corresponding author), N CAROLINA NEUROPSYCHIAT CLIN, 500 FRANKLIN SQ, CHAPEL HILL, NC 27514 USA.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; AMPHOUX M, 1977, REV MED TRAVAIL, V5, P53; ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; Azmitia E. C., 1987, PSYCHOPHARMACOLOGY 3, P61; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BARTH JT, 1993, J HEAD TRAUMA REHAB, V8, P1; BELL DS, 1992, MED LEGAL ASSESSMENT; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BOLLA KI, 1992, ARCH NEUROL-CHICAGO, V49, P1021, DOI 10.1001/archneur.1992.00530340037015; BOURKE RS, 1988, HEAD INJURY; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Carlsson A., 1987, PSYCHOPHARMACOLOGY 3, P39; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; CASSON IR, 1982, J NEUROL NEUROSUR PS, V45, P170, DOI 10.1136/jnnp.45.2.170; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cook J B, 1972, Scand J Rehabil Med, V4, P27; Cook J. B, 1969, LATE EFFECTS HEAD IN, P408; CROVITZ HF, 1983, CORTEX, V19, P407, DOI 10.1016/S0010-9452(83)80009-4; Denker P., 1944, NY STATE J MED, V44, P379; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DREIFUSS FE, 1992, EPILEPSIA S, V1, pS7; EAMES P, 1992, J NEUROL NEUROSUR PS, V55, P1046, DOI 10.1136/jnnp.55.11.1046; Eisenberg H. M., 1989, MILD HEAD INJURY, P133; EPSTEIN CM, 1994, NEUROLOGY, V44, P1566, DOI 10.1212/WNL.44.9.1566; EVANS RW, 1992, PHYSICAL MED REHAB C, V3, P427; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; FEE CRA, 1987, ARCH EMERG MED, V4, P159; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; Gennarelli T.A., 1986, MECHANISMS SECONDARY, P15; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GIANNOTTA SL, 1987, HEAD INJURY, P464; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; GRAY BG, 1992, J NUCL MED, V33, P52; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1989, MILD HEAD INJURY, P153; GUALTIERI CT, 1993, PSYCHIATRIC CARE MED, P517; GUALTIERI CT, 1990, NEUROPSYCHIATRY BEHA; Hayes RL, 1989, MILD HEAD INJURY, P54; HOFF JT, 1989, MILD MODERATE HEAD I; HORN LJ, 1992, REHABILITATION POSTC; JACOBSON SA, 1969, LATE EFFECTS HEAD IN, P35; JAKOBSEN J, 1987, ACTA NEUROL SCAND, V75, P341, DOI 10.1111/j.1600-0404.1987.tb05456.x; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jennett B, 1989, MILD HEAD INJURY, P23; KASTE M, 1982, LANCET, V2, P1186; KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; KOZOL HL, 1946, ARCH NEURO PSYCHIATR, V56, P245, DOI 10.1001/archneurpsyc.1946.02300200002001; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1989, MILD HEAD INJURY, P8; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Levin HS, 1989, MILD HEAD INJURY; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; MACH A, 1989, TRAUMATIC BRAIN INJU, P13; MANDEL S, 1992, MINOR HEAD TRAUMA AS; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; Meltzer H. Y., 1987, PSYCHOPHARMACOLOGY 3, P513; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; NOY P, 1975, NEW DIMENSIONS PSYCH, P162; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1969, LANCET, V2, P237; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1989, MILD HEAD INJURY, P37; RAO N, 1984, ARCH PHYS MED REHAB, V65, P780; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Ruff R.M., 1989, MILD HEAD INJURY, P176; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; Rutherford W. H., 1989, MILD HEAD INJURY, P217; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; SEKINO H, 1981, Neurologia Medico-Chirurgica, V21, P677; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; STEADMAN JH, 1970, P ROY SOC MED, V63, P23, DOI 10.1177/003591577006300109; STEIN SC, 1993, BRAIN INJURY, V7, P425, DOI 10.3109/02699059309029685; STENGEL E, 1949, RECENT PROG PSYCHIAT, V11, P1; SYMONDS C, 1962, LANCET, V1, P1; Symonds CP, 1943, LANCET, V1, P7; Teuber H-L, 1969, LATE EFFECTS HEAD IN, P13; Trimble MR, 1981, POSTTRAUMATIC NEUROS; WHITLOCK FA, 1967, ACTA PSYCHIAT SCAND, V43, P144, DOI 10.1111/j.1600-0447.1967.tb11023.x; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	100	21	21	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	APR	1995	8	2					127	136					10	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	QU199	WOS:A1995QU19900007					2021-06-18	
J	GOLDSTEIN, FC; LEVIN, HS				GOLDSTEIN, FC; LEVIN, HS			NEUROBEHAVIORAL OUTCOME OF TRAUMATIC BRAIN INJURY IN OLDER ADULTS - INITIAL FINDINGS	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						GERIATRICS; NEUROBEHAVIORAL OUTCOME; TRAUMATIC BRAIN INJURY	CLOSED HEAD-INJURY; ALZHEIMERS-DISEASE; ELDERLY PERSONS; RISK-FACTORS; FOLLOW-UP; COMMUNITY; RELATIVES; SURVIVAL; RECOVERY; DEMENTIA	This article examines the outcome of traumatic brain injury (TBI) in adults 50 years and older. The literature concerning prognostic variables such as age and severity of injury is reviewed in relation to mortality and morbidity. Research is then presented on the cognitive and behavioral sequelae identified by the authors in their two-center study. Findings on the early stages of recovery indicate that older adults display impairments in attention, memory, language, and executive processing. Moreover, family members observe changes involving cognition, mood, and social functioning. It is concluded that although TBI poses a significant problem for older adults, little systematic data have been collected focusing on their sequelae, recovery patterns, and rehabilitation needs. The neurobehavioral outcome of TBI in this subpopulation deserves extensive study because of injury and extra-injury differences such as pathophysiology, medical comorbidities, and psychosocial supports that differentiate these patients from young survivors.	UNIV MARYLAND,SCH MED,DIV NEUROL SURG,BALTIMORE,MD 21201	GOLDSTEIN, FC (corresponding author), EMORY UNIV,SCH MED,DEPT NEUROL,NEUROBEHAV PROGRAM,WESLEY WOODS GERIATR REHABI,ATLANTA,GA, USA.						ADAMS JH, 1982, J CLIN PATHOL, V33, P1132; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; AMACHER AL, 1987, NEUROSURGERY, V20, P954; Benton A, 1989, MULTILINGUAL APHASIA; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; BOLLOK I, 1983, NEUROPEPTIDES, V3, P263; Brooks N., 1984, CLOSED HEAD INJURY P; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; DAVIS CS, 1988, J AM GERIATR SOC, V36, P225, DOI 10.1111/j.1532-5415.1988.tb01805.x; DELIS DC, 1988, COMMUNICATION; DEMARIA EJ, 1987, ANN SURG, V206, P738, DOI 10.1097/00000658-198712000-00009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; FRANKOWSKI RF, 1985, CENTRAL NERVOUS SYST; FRENCH LR, 1985, AM J EPIDEMIOL, V121, P414, DOI 10.1093/oxfordjournals.aje.a114013; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; GOODMAN H, 1992, PHYSICAL MED REHABIL; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; GRONWALL D, 1975, LANCET, V2, P995; Gustafson L, 1990, Adv Neurol, V51, P65; HANNAY HJ, 1988, CONTINUOUS RECOGNITI; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; JENNETT B, 1975, LANCET, V1, P480; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; KRAUS JF, 1987, HEAD INJURY; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1979, J NERV MENT DIS, V167, P667; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; MAZZUCCHI A, 1992, J NEUROL, V239, P256; MILLER BL, 1991, NEUROLOGY, V41, P1374, DOI 10.1212/WNL.41.9.1374; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; NEARY D, 1988, J NEUROL NEUROSUR PS, V51, P353, DOI 10.1136/jnnp.51.3.353; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Ross A M, 1992, J Neurosci Nurs, V24, P88; ROY CW, 1986, INJURY, V17, P220, DOI 10.1016/0020-1383(86)90222-6; RUDELLI R, 1982, ARCH NEUROL-CHICAGO, V39, P570, DOI 10.1001/archneur.1982.00510210040009; SCHWARTZ GE, 1983, PSYCHOL REP, V53, P479, DOI 10.2466/pr0.1983.53.2.479; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; TEASDALE G, 1974, LANCET, V2, P81; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; VOLLMER DG, 1991, J NEUROSURG S, pS37; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wilson J A, 1987, Brain Inj, V1, P183, DOI 10.3109/02699058709034456; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; YSEVAGE JA, 1983, J PSYCHIAT RES, V17, P37	63	21	21	0	6	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1995	10	1					57	73		10.1097/00001199-199502000-00007			17	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	QF163	WOS:A1995QF16300006					2021-06-18	
S	Myseros, JS; Bullock, R		Trembly, B; Slikker, W		Myseros, JS; Bullock, R			The rationale for glutamate antagonists in the treatment of traumatic brain injury	NEUROPROTECTIVE AGENTS: CLINICAL AND EXPERIMENTAL ASPECTS	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	2nd International Conference on Neuroprotective Agents - Clinical and Experimental Aspects	JUL 31-AUG 03, 1994	LAKE GEORGE, NY	FDA, Natl Ctr Toxicol Res, Jefferson, Arkansas, Dept Vet Affairs Med Ctr, Togus, Maine			ACUTE SUBDURAL-HEMATOMA; CEREBRAL-ARTERY OCCLUSION; ISCHEMIC NEURONAL DAMAGE; RAT-BRAIN; GLUCOSE-UTILIZATION; BLOOD-FLOW; RECEPTORS; PATHOLOGY; BLOCKADE; RELEASE			Myseros, JS (corresponding author), DIV NEUROSURG,MCV STN,BOX 980631,RICHMOND,VA 23298, USA.						Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; BECKER DP, 1989, J CEREB BLOOD FLO S1, V9, pS302; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; BULLOCK R, 1991, J CEREB BLOOD FLO S2, V11, pS109; BULLOCK R, 1990, VINKEN BRUYNS HDB CL, V24, P249; BUTCHER SP, 1990, STROKE, V21, P1727, DOI 10.1161/01.STR.21.12.1727; CHAPMAN A, 1990, EXCITATORY AMINO ACI, P265; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GENTLEMAN D, 1981, LANCET, V2, P853; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; INGLIS FM, 1990, 8TH P INT S BRAIN OE, P277; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; KURODA Y, 1992, J NEUROSURG, V76, P944; LYETH B G, 1989, Society for Neuroscience Abstracts, V15, P1113; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MELDRUM B, 1990, CEREBROVAS BRAIN MET, V2, P27; MELDRUM B, 1992, P OFFICIAL SATELLITE, P15; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; NEHLS DG, 1990, BRAIN RES, V511, P271, DOI 10.1016/0006-8993(90)90172-8; PINARD E, 1992, P OFFICIAL SATELLITE, P93; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHIRAISHI K, 1989, J CEREBR BLOOD F MET, V9, P765, DOI 10.1038/jcbfm.1989.110; Smith D.H., 1991, J CEREB BLOOD FLO S2, V11, pS300; SMITH DH, 1990, SOC NEUR ABSTR, V2, P779; SMITH DH, 1990, FASEB J, V4, P773; SMITH JA, 1991, J MED ETHICS, V17, P167, DOI 10.1136/jme.17.3.167; STONE JL, 1983, SURG NEUROL, V19, P216, DOI 10.1016/S0090-3019(83)80005-6; TAKIZAWA S, 1991, J CEREBR BLOOD F MET, V11, P786, DOI 10.1038/jcbfm.1991.136; WALLACE MC, 1992, J NEUROSURG, V76, P127, DOI 10.3171/jns.1992.76.1.0127	44	21	21	0	2	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021	0077-8923		0-89766-945-2	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1995	765						262	271		10.1111/j.1749-6632.1995.tb16583.x			10	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	BE39D	WOS:A1995BE39D00022	7486612				2021-06-18	
J	SUN, FY; FADEN, AI				SUN, FY; FADEN, AI			N-METHYL-D-ASPARTATE RECEPTORS MEDIATE POSTTRAUMATIC INCREASES OF PROTEIN-KINASE-C IN RAT-BRAIN	BRAIN RESEARCH			English	Article						TRAUMATIC BRAIN INJURY; PROTEIN KINASE C; PHORBOL ESTER; NMDA RECEPTOR; MK-801; BRAIN	H-3 PHORBOL 12,13-DIBUTYRATE; EXCITATORY AMINO-ACIDS; SPINAL-CORD INJURY; FOREBRAIN ISCHEMIA; NEURONAL DAMAGE; AUTORADIOGRAPHIC ANALYSIS; BINDING; HIPPOCAMPUS; MK-801; ESTERS	Male Sprague-Dawley rats were subjected to traumatic brain injury (TBI) using a lateral fluid percussion-induced injury model. Effects of varying severities of TBI (mild = 1.1 +/- 0.1 atm; moderate = 2.2 +/- 0.2 atm; severe = 2.9 +/- 0.1 atm) on the levels of protein kinase C in rat cerebral cortex and hippocampus were investigated by quantitative autoradiography using [H-3]phorboldibutyrate ester ([H-3]PDBu) binding as a marker. Binding of [H-3]PDBu in the cerebral cortex and hippocampus was increased bilaterally following TBI, with changes related to injury severity. Significant increases were observed in hippocampus of injured animals, as compared to sham-operated controls, at 1 h after trauma. Maximum levels of binding in both cerebral cortex and hippocampus were reached by 3 h, with a return to control levels at 6 h and 72 h, respectively. Treatment with MK-801 (1 mg/kg, i.v.) administered 15 min before trauma prevented the injury-induced increase of [H-3]PDBu binding in hippocampus and cerebral cortex. These results demonstrate that TBI induces bilateral, time-dependent increases of protein kinase C in the hippocampus and cerebral cortex that are related to injury severity. Changes are mediated by actions at NMDA receptors, probably reflecting post-traumatic release of glutamate.	GEORGETOWN UNIV, MED CTR, SCH MED, DEPT NEUROL, WASHINGTON, DC 20007 USA; GEORGETOWN UNIV, SCH MED, DEPT PHARMACOL, WASHINGTON, DC 20007 USA					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027849] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01/NS27849] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR306634] Funding Source: Medline		ALBERS GW, 1989, ANN NEUROL, V25, P398, DOI 10.1002/ana.410250412; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BUCHAN A, 1990, J NEUROSCI, V10, P311; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; CARDELL M, 1990, NEUROSCI LETT, V119, P228, DOI 10.1016/0304-3940(90)90840-6; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; DAG KJE, 1993, EUR J PHARMACOL, V233, P95; DOMANSKAJANIK K, 1992, J NEUROCHEM, V58, P1432, DOI 10.1111/j.1471-4159.1992.tb11360.x; DRIEDGER PE, 1980, P NATL ACAD SCI-BIOL, V77, P567, DOI 10.1073/pnas.77.1.567; ETOH S, 1991, NEUROSCI LETT, V126, P119, DOI 10.1016/0304-3940(91)90533-Y; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAVARON M, 1990, P NATL ACAD SCI USA, V87, P1983, DOI 10.1073/pnas.87.5.1983; GILL R, 1988, NEUROSCIENCE, V25, P847, DOI 10.1016/0306-4522(88)90040-1; HARA H, 1990, J CEREBR BLOOD F MET, V10, P646, DOI 10.1038/jcbfm.1990.117; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HORSBURGH K, 1993, NEUROSCI LETT, V151, P166, DOI 10.1016/0304-3940(93)90012-A; HSU L, 1985, NEUROSCI LETT, V62, P283, DOI 10.1016/0304-3940(85)90369-6; JORGENSEN MB, 1989, NEUROSCI LETT, V103, P219, DOI 10.1016/0304-3940(89)90579-X; KACZMAREK LK, 1987, TRENDS NEUROSCI, V10, P30, DOI 10.1016/0166-2236(87)90122-6; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MANEV H, 1992, FIDIA RES F S SERIES, V9, P103; MATTSON MP, 1991, EXP NEUROL, V112, P95, DOI 10.1016/0014-4886(91)90118-V; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCINTOSH TK, 1992, FIDIA RES F S SERIES, V9, P247; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; Montz H P, 1985, Brain Res, V355, P150; MURASE K, 1993, NEUROSCI LETT, V149, P229, DOI 10.1016/0304-3940(93)90778-J; NIEDEL JE, 1983, P NATL ACAD SCI-BIOL, V80, P36, DOI 10.1073/pnas.80.1.36; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NISHIZUKA Y, 1991, PROG BRAIN RES, V89, P125; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; ONODERA H, 1989, BRAIN RES, V481, P1, DOI 10.1016/0006-8993(89)90478-2; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PARENT A, 1993, BRAIN RES, V607, P23, DOI 10.1016/0006-8993(93)91485-B; SAITO N, 1988, J NEUROSCI, V8, P369; SHOYAB M, 1980, NATURE, V288, P451, DOI 10.1038/288451a0; SIMON W, 1992, CLASSICAL QUANT GRAV, V9, P241, DOI 10.1088/0264-9381/9/1/022; TANAKA K, 1992, EXP NEUROL, V117, P254, DOI 10.1016/0014-4886(92)90134-C; VACCARINO F, 1987, P NATL ACAD SCI USA, V84, P8707, DOI 10.1073/pnas.84.23.8707; VACCARINO FM, 1991, J NEUROCHEM, V57, P391, DOI 10.1111/j.1471-4159.1991.tb03765.x; WIELOCH T, 1991, J NEUROCHEM, V56, P1227, DOI 10.1111/j.1471-4159.1991.tb11415.x; WORLEY PF, 1986, J NEUROSCI, V6, P199; WORLEY PF, 1986, P NATL ACAD SCI USA, V83, P4053, DOI 10.1073/pnas.83.11.4053; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; YOKOTA M, 1992, BRAIN RES, V587, P123, DOI 10.1016/0006-8993(92)91436-I	51	21	21	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 24	1994	661	1-2					63	69		10.1016/0006-8993(94)91181-9			7	Neurosciences	Neurosciences & Neurology	PM463	WOS:A1994PM46300009	7834386				2021-06-18	
J	GALE, SD; JOHNSON, SC; BIGLER, ED; BLATTER, DD				GALE, SD; JOHNSON, SC; BIGLER, ED; BLATTER, DD			TRAUMATIC BRAIN INJURY AND TEMPORAL HORN ENLARGEMENT - CORRELATES WITH TESTS OF INTELLIGENCE AND MEMORY	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						TRAUMATIC BRAIN INJURY; INTELLIGENCE TESTS; NEUROPSYCHOLOGICAL TESTS; VENTRICLE; BRAIN RATIOS	ABNORMALITIES; LOBE	Temporal horn volume, an indirect measure of hippocampal atrophy, based on postinjury magnetic resonance (MR) studies was calculated in a group of 61 traumatic brain injury (TBI) patients and 90 control subjects that were age- and gender-matched. Additionally, ventricle:brain ratios (VBRs), based on total ventricular volume corrected for head size, were calculated. Anatomic comparisons indicated that the ventricular system in TBI patients was significantly dilated. Enlargement of the temporal horns showed an inverse relationship to some neuropsychological test findings; however, the hypothesis that verbal memory tasks would relate specifically to the left temporal horn, and visual memory tasks to the right was not supported. Results are discussed in terms of the current conceptual framework of mesial temporal lobe damage in TBI and disruption of memory performance.	BRIGHAM YOUNG UNIV,DEPT PSYCHOL,PROVO,UT 84602; LDS HOSP,SALT LAKE CITY,UT							Amaral DG, 1987, HDB PHYSL NERVOUS SY, P211; BARTZOKIS G, 1993, MAGN RESON IMAGING, V11, P993, DOI 10.1016/0730-725X(93)90218-3; BEAURAIN J, 1994, MAGN RESON IMAGING, V12, P139, DOI 10.1016/0730-725X(94)92361-2; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; BIGLER ED, 1988, DIAGNOSTIC CLIN NEUR; BLATTER DD, IN PRESS AM J NEUROR; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Evans RW., 1992, PROGNOSIS NEUROLOGIC, P97; FERGUSON GA, 1989, STATISTICAL ANAL PSY; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; NAIDICH TP, 1987, CRANIAL SPINAL MAGNE, P83; PRESS GA, 1989, NATURE, V341, P54, DOI 10.1038/341054a0; RAUSCH R, 1993, ARCH NEUROL-CHICAGO, V50, P812, DOI 10.1001/archneur.1993.00540080023008; Rey A, 1964, EXAMEN CLIN PSYCHOL; ROBB RA, 1990, 3D IMAGING MED, P333; Roberts M, 1970, ATLAS HUMAN BRAIN SE; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; SQUIRE LR, 1987, HDB PHYSL 1, V5, P295; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th	23	21	21	0	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	JUL	1994	7	3					160	165					6	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	PC765	WOS:A1994PC76500003					2021-06-18	
J	MAYR, J; GAISL, M; PURTSCHER, K; NOERES, H; SCHIMPL, G; FASCHING, G				MAYR, J; GAISL, M; PURTSCHER, K; NOERES, H; SCHIMPL, G; FASCHING, G			BABY WALKERS AN UNDERESTIMATED HAZARD FOR OUR CHILDREN	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						BABY WALKER; HEAD INJURY; SKULL FRACTURE; COMPLICATIONS; INJURY PREVENTION	INJURY	Baby walkers (BWs) continue to be a frequent cause of head injuries in young children. A random sample survey of 240 families with children aged 2-6 years revealed a use rate of baby walkers of 55%. Of the children using baby walkers 20% were found to have suffered a BW-related accident. In a retrospective study we reviewed 172 case reports of infants who suffered a BW-related injury between January 1990 and June 1993. We observed 19 skull fractures, 23 concussions of the brain and 125 contusions and lacerations of the head including 4 teeth luxations and 3 fractures or distorsions of the upper extremity. BW-related injuries represent the third most common mode of injury in children aged 7-14 months. We conclude that despite previous warnings BW still represent a frequent cause of severe head injuries in young children. We recommend a general ban on the sale and manufacture of BWs		MAYR, J (corresponding author), GRAZ UNIV,LANDESKRANKENHAUS GRAZ,KINDERCHIRUG KLIN,AUENBRUGGERPLATZ 34,A-8036 GRAZ,AUSTRIA.						BUTERBAUGH L, 1992, 1992 INT M AM MED AS; GLEADHILL DNS, 1987, ARCH DIS CHILD, V62, P491, DOI 10.1136/adc.62.5.491; HOLM VA, 1983, AM J DIS CHILD, V137, P1189, DOI 10.1001/archpedi.1983.02140380049016; JAFFE D, 1991, NEW ENGL J MED, V324, P1477; KAUFFMAN IB, 1977, PERCEPT MOTOR SKILL, V45, P1323, DOI 10.2466/pms.1977.45.3f.1323; PARTINGTON MD, 1991, ANN EMERG MED, V20, P652, DOI 10.1016/S0196-0644(05)82386-8; RIEDER MJ, 1986, PEDIATRICS, V78, P488	7	21	24	0	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0340-6199			EUR J PEDIATR	Eur. J. Pediatr.	JUL	1994	153	7					531	534		10.1007/BF01957011			4	Pediatrics	Pediatrics	NU967	WOS:A1994NU96700014	7957373				2021-06-18	
J	POLISSAR, NL; FAY, GC; JAFFE, KM; LIAO, S; MARTIN, KM; SHURTLEFF, HA; RIVARA, JB; WINN, HR				POLISSAR, NL; FAY, GC; JAFFE, KM; LIAO, S; MARTIN, KM; SHURTLEFF, HA; RIVARA, JB; WINN, HR			MILD PEDIATRIC TRAUMATIC BRAIN INJURY - ADJUSTING SIGNIFICANCE LEVELS FOR MULTIPLE COMPARISONS	BRAIN INJURY			English	Article							HEAD-INJURIES; SEVERITY; CHILDREN	The outcome following mild traumatic brain injury (TBI) is controversial. We addressed this topic in a study of neurobehavioural and 'real-world' functioning among 53 children with mild TBI and their matched controls, using statistical methods recently developed for multiple comparisons. Because the study involved calculation of 414 p-values, four methods of adjustment for multiple comparisons, including the Bonferroni method, were used to avoid 'false-positive' statistical significance. The additional three methods allowed greater insight into the data than provided by the standard Bonferroni adjustment. Results showed that at initial testing, three areas of 'real-world' functioning (eating, domestic and home/community living skills) had weak but statistically significant associations with mild injury. No other specific areas of neurobehavioural or 'real-world' functioning had plausible associations with the injury either initially, at 1 year, or when changes over the year were considered. However, the adjustment for multiple comparisons provided additional results. There were statistically significant associations of the injury with the entire domain of neurobehavioural variables both initially and at 1 year. These results suggest that the injury affects a spectrum of neurobehavioural skills weakly, rather than a single area substantially. The gain froin using multiple comparison methods is discussed.	CHILDENS HOSP & MED CTR,DEPT REHABIL MED,POB 5371,480 SAND POINT WAY NE,SEATTLE,WA 98105; UNIV WASHINGTON,DEPT REHABIL MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195; STAT & EPIDEMIOL RES CORP,SEATTLE,WA; UNIV WASHINGTON,DEPT PSYCHIAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT NEUROL SURG,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BEHAV SCI,SEATTLE,WA 98195; UNIV WASHINGTON,CHILDRENS HOSP & MED CTR,SCH SOCIAL WORK,DEPT REHABIL MED,SEATTLE,WA 98195; UNIV WASHINGTON,CTR QUANTITAT SCI,SEATTLE,WA 98195				Shurtleff, Hillary/0000-0003-0959-2842	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR002299] Funding Source: Medline		ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; Achenbach TM, 1986, MANUAL TEACHERS REPO; Bruininks R.H., 1984, SCALES INDEPENDENT B; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Conover W.J., 1980, PRACTICAL NONPARAMET; DELIS DC, 1989, CALIFORNIA VERBAL LE; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FAY GC, IN PRESS ARCH PHYSIC; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, IN PRESS ARCH PHYSIC; Jastak S, 1984, WIDE RANGE ACHIEVEME; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Miller R. G., 1981, SIMULTANEOUS STAT IN; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; PRENTICE RL, 1984, BIOMETRICS, V40, P653, DOI 10.2307/2530908; REITMAN RM, 1974, CLIN NEUROPSYCHOLOGY; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; Wechsler D., 1974, MANUAL WECHSLER INTE	21	21	21	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1994	8	3					249	263		10.3109/02699059409150977			15	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	ND714	WOS:A1994ND71400006	8004083				2021-06-18	
J	MOSCATO, BS; TREVISAN, M; WILLER, BS				MOSCATO, BS; TREVISAN, M; WILLER, BS			THE PREVALENCE OF TRAUMATIC BRAIN INJURY AND COOCCURRING DISABILITIES IN A NATIONAL HOUSEHOLD SURVEY OF ADULTS	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							CLOSED HEAD-INJURY; HUMAN-MEMORY; EPIDEMIOLOGY; POPULATION; COMMUNITY; COUNTY	This original point prevalence study provides sociodemographic characteristics and Canadian household prevalence rates of adults (15 years and older) with disability who have survived a traumatic brain injury (TBI) and the type, number, and prevalence rates of co-occurring disabilities. This report is based on the Health and Activity Limitation Survey, a national survey conducted by Statistics Canada in 1986-87. The overall household prevalence rate of TBI is 62.31100,000 adults (95% confidence interval = 54.0,70.5). Gender-specific rates are 81.31100,000 males and 44.2/100,000 females, with a 1.8:1 male-to-female ratio. Rates are highest in the 45-64 age range, 3 times those in the 15-24 age group. Eighty-four percent of adults with TBI have co-occurring disabilities (median = 2), the most prevalent being limited mobility and agility.	SUNY BUFFALO,DEPT PSYCHIAT,BUFFALO,NY 14260	MOSCATO, BS (corresponding author), SUNY BUFFALO,SCH MED & BIOMED SCI,DEPT SOCIAL & PREVENT MED,270 FARBER HALL,BUFFALO,NY 14214, USA.						ANDERSON DW, 1980, J NEUROSURG, V53, pS11; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; [Anonymous], 1980, INT CLASSIFICATION I; Bryden J, 1989, MODELS BRAIN INJURY, P17; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; DOLSON D, 1987, SUURVEY METHODOLOGY, V13, P93; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; FIELD JH, 1976, EPIDEMIOLOGY HEAD IN; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; FURRIE AD, 1987, NATIONAL DATABASE DI; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KELLYHAYES M, 1992, AM J PUBLIC HEALTH, V82, P841, DOI 10.2105/AJPH.82.6.841; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS JF, 1980, J NEUROSURG, V53, pS35; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1991, NEUROEPIDEMIOLOGY TR, P333; KRAUS JF, 1987, HEAD INJURY, P1; Last JM., 1988, DICT EPIDEMIOLOGY, V2nd ed; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MCDOWELL I, 1988, DISABILITY SCORE HLT; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; PARKINSON D, 1985, CAN J SURG, V28, P79; POPE AM, 1991, DISABIITY AM NATIONA; RICHARDSON JTE, 1985, COGNITIVE NEUROPSYCH, V2, P149, DOI 10.1080/02643298508252864; RICHARDSON JTE, 1984, COGN NEUROPSYCHOL, V1, P217, DOI 10.1080/02643298408252023; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P119; SELECKI BR, 1981, INJURIES HEAD SPINE; THEBERGE A, 1988, WEIGHTING HLTH ACTIV; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; WILLER B, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P18; 1990, 82602 STAT CAN CAT; 1991, 82615 STAT CAN CAT, V4; 1988, VITAL HLTH STATIS 13, V95; 1988, PROFILES URBAN RUR 1; 1989, HALS HOUSEHOLD DATA; 1989, STATISTICS CANADA DA; 1988, DISABILITY DATABASE	41	21	21	0	1	AMER PSYCHIATRIC ASSOCIATION	WASHINGTON	1400 K ST NW, WASHINGTON, DC 20005	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	1994	6	2					134	142					9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	NJ963	WOS:A1994NJ96300005	8044034				2021-06-18	
J	WHITEGBADEBO, D; HAMM, RJ				WHITEGBADEBO, D; HAMM, RJ			CHRONIC CORTICOSTERONE TREATMENT POTENTIATES DEFICITS FOLLOWING TRAUMATIC BRAIN INJURY IN RATS - IMPLICATIONS FOR AGING	JOURNAL OF NEUROTRAUMA			English	Article							ADRENOCORTICAL STRESS-RESPONSE; GLUCOCORTICOID TOXICITY; NEURONAL VULNERABILITY; AGE; HIPPOCAMPUS; BASAL; YOUNG	The present study examined the effect of chronic corticosterone exposure on motor and cognitive deficits following traumatic brain injury (TBI). Adults rats were treated with either corticosterone acetate (15 ug/ml) added to their drinking water or vehicle (0.5% alcohol) for 3 months. Following this 3-month treatment, corticosterone-treated rats (n = 8) and vehicle-treated rats (n = 10) were injured at a mild level of fluid percussion injury (1.7-1.8 atm). Additional corticosterone-treated (n = 8) and vehicle-treated rats (n = 8) were surgically prepared for injury but were not injured. Both motor (beam balance and beam walking) and cognitive (Morris water maze) performances were assessed following injury. Motor deficits were transiently enhanced following injury in rats treated with corticosterone. Rats treated with corticosterone were also slower in learning the Morris water maze than vehicle-treated rats. These findings demonstrate that elevated corticosterone levels potentiate the behavioral deficits observed after traumatic brain injury. Applied to aging research, these results suggest that the elevated basal levels of corticosterone present in aged animals may mediate the enhanced vulnerability of aged animals to traumatic brain injury.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,BOX 2018,RICHMOND,VA 23298					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587] Funding Source: Medline		DEKOSKY ST, 1984, NEUROENDOCRINOLOGY, V38, P33, DOI 10.1159/000123862; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; HAMM R J, 1991, Society for Neuroscience Abstracts, V17, P167; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; ISSA AM, 1990, J NEUROSCI, V10, P3247; KATAYAMA T, 1990, J NEUROSURG, V73, P899; LANDFIELD PW, 1978, SCIENCE, V202, P1098, DOI 10.1126/science.715460; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MCEWEN BS, 1968, NATURE, V220, P911, DOI 10.1038/220911a0; MEANEY MJ, 1992, NEUROENDOCRINOLOGY, V55, P204, DOI 10.1159/000126116; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Sapolsky R.M., 1985, J NEUROSCI, V5, P1221; SAPOLSKY RM, 1985, BRAIN RES, V359, P300, DOI 10.1016/0006-8993(85)91440-4; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; SAPOLSKY RM, 1983, EXP GERONTOL, V18, P55, DOI 10.1016/0531-5565(83)90051-7; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1228; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; SCHEFF SW, 1980, EXP NEUROL, V68, P195, DOI 10.1016/0014-4886(80)90077-1; STEINBOK P, 1979, NEUROSURGERY, V5, P559, DOI 10.1227/00006123-197911000-00003; STEWART J, 1988, ENDOCRINOLOGY, V123, P1934, DOI 10.1210/endo-123-4-1934; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x	25	21	21	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	FAL	1993	10	3					297	306		10.1089/neu.1993.10.297			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	MC021	WOS:A1993MC02100006	8258842				2021-06-18	
J	LEVINE, MJ; VANHORN, KR; CURTIS, AB				LEVINE, MJ; VANHORN, KR; CURTIS, AB			DEVELOPMENTAL MODELS OF SOCIAL COGNITION IN ASSESSING PSYCHOSOCIAL ADJUSTMENTS IN HEAD-INJURY	BRAIN INJURY			English	Article								This study compared the levels of conceptual responses involved in the processing of two parameters of social cognition in a group of 40 adult patients with closed-head injury (CHI) and a group of 26 normal controls. The two parameters, interpersonal negotiation strategies (INS) and self understanding (self) were examined in the framework of Selman's model of social perspective taking and Damon and Hart's multidimensional model of self understanding. Differences among the components of the INS conflict dilemmas and aspects of self descriptions were observed in a structure interview. Results supported the hypothesis that the CHI group would respond at lower levels on the development measures of social cognition. The results of the present study are in agreement with the conclusions in the initial study. This study also extended the study of social cognition to the Tennessee Self Concept Scale and the Neurobehavioral Rating Scale, in addition to incorporating a control group. These studies support the view that psychosocial adjustment is a multidimensional construct and developmental social cognition methods appear to advance our understanding of this concept in CHI patients.	CENT MICHIGAN UNIV,DEPT PSYCHOL,MT PLEASANT,MI 48859; NEW ENGLAND REHABIL HOSP,WOBURN,MA							Damon W., 1988, SELF UNDERSTANDING C; DAMON W, 1988, UNPUB SCORING MANUAL; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; FITTS NH, 1972, RES MONOGRAPHY D WAL, V4; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; HOLOSKO MJ, 1989, J REHABIL, V2, P145; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lezak M. D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI [10.1097/00001199-198703000-00009, DOI 10.1097/00001199-198703000-00009]; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MCCLELLAND RJ, 1988, BRIT J PSYCHIAT, V153, P141, DOI 10.1192/bjp.153.2.141; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; SELMAN RL, 1986, DEV PSYCHOL, V22, P450, DOI 10.1037/0012-1649.22.4.450; SELMAN RL, 1986, UNPUB INTERVIEW METH; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Van Horn K R, 1992, Brain Inj, V6, P15, DOI 10.3109/02699059209008118; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21	17	21	21	0	8	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAR-APR	1993	7	2					153	167		10.3109/02699059309008169			15	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	KZ726	WOS:A1993KZ72600007	8453413				2021-06-18	
J	SAZBON, L; GROSWASSER, Z				SAZBON, L; GROSWASSER, Z			MEDICAL COMPLICATIONS AND MORTALITY OF PATIENTS IN THE POSTCOMATOSE UNAWARENESS (PC-U) STATE	ACTA NEUROCHIRURGICA			English	Article						VEGETATIVE STATE; APALLIC SYNDROME; POSTCOMATOSE UNAWARENESS; MORTALITY; COMPLICATIONS; ETHICAL PROBLEMS; ECONOMIC ASPECTS	PROLONGED POSTTRAUMATIC UNAWARENESS; VEGETATIVE-STATE; CONSCIOUSNESS; PROGNOSIS	Almost half of all patients with traumatic brain injury who remain unconscious for more than one month will not recover consciousness and will remain in a state of prolonged postcomatose unawareness (PC-U). The aim of this work is to present the survival rate and medical complications of such patients. The survival time of the 62 patients studied ranged from 2 to 115 months, with a median of 15.5 +/- 22 months. Cumulative mortality figures were 15% at 3 months, 40% at 6 months and 60% and the end of the first year. The figures at the end of the second, third and fifth years were 86%, 87% and 94%, respectively. This type of data may aid in decisions regarding the management of these patients. The longer survival with better treatment of patients in a state of PC-U poses severe ethical, medical, legal and economic problems with which society will have to deal.	TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL	SAZBON, L (corresponding author), LOEWENSTEIN HOSP & REHABIL CTR,POB 3,IL-43100 RAANANA,ISRAEL.						BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; GROSWASSER Z, 1990, J NEUROSURG, V72, P81, DOI 10.3171/jns.1990.72.1.0081; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; JENNET B, 1981, MANAGEMENT HEAD INJU, P312; Levy D E, 1978, Ann N Y Acad Sci, V315, P293, DOI 10.1111/j.1749-6632.1978.tb50347.x; NAJENSON T, 1983, 1ST INT C ASS REH CO, P109; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Sazbon L, 1991, Brain Inj, V5, P1, DOI 10.3109/02699059108998504	9	21	21	0	1	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1991	112	3-4					110	112		10.1007/BF01405137			3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GW761	WOS:A1991GW76100008	1776511				2021-06-18	
J	DELBIGIO, MR; JOHNSON, GE				DELBIGIO, MR; JOHNSON, GE			CLINICAL PRESENTATION OF SPINAL-CORD CONCUSSION	SPINE			English	Article										DELBIGIO, MR (corresponding author), UNIV MANITOBA,FAC MED,NEUROSURG SECT,730 WILLIAM AVE,WINNIPEG R3E 0W8,MANITOBA,CANADA.			Del Bigio, Marc/0000-0001-8366-0394				0	21	21	0	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0362-2436			SPINE	SPINE	JAN	1989	14	1					37	40		10.1097/00007632-198901000-00007			4	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	R8671	WOS:A1989R867100007	2913666				2021-06-18	
J	DRUDGE, OW; WILLIAMS, JM; KESSLER, M; GOMES, FB				DRUDGE, OW; WILLIAMS, JM; KESSLER, M; GOMES, FB			RECOVERY FROM SEVERE CLOSED HEAD-INJURIES - REPEAT TESTINGS WITH THE HALSTEAD-REITAN NEUROPSYCHOLOGICAL BATTERY	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article									MED CTR HOSP VERMONT,BURLINGTON,VT 05401	DRUDGE, OW (corresponding author), UNIV VERMONT,BURLINGTON,VT 05405, USA.						BARNES GW, 1974, J NERV MENT DIS, V158, P50, DOI 10.1097/00005053-197401000-00007; BECKER B, 1977, J CLIN PSYCHOL, V47, P307; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOLL TJ, 1981, HDB CLIN NEUROPSYCHO; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; DYE OA, 1981, J CLIN PSYCHOL, V37, P472, DOI 10.1002/1097-4679(198107)37:3<472::AID-JCLP2270370304>3.0.CO;2-Q; Klove H, 1972, Scand J Rehabil Med, V4, P55; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MATARAZZO JD, 1974, J NERV MENT DIS, V158, P37, DOI 10.1097/00005053-197401000-00006; MATARAZZO JD, 1976, J CLIN PSYCHOL, V32, P338, DOI 10.1002/1097-4679(197604)32:2<338::AID-JCLP2270320230>3.0.CO;2-O; Matthews CG, 1966, CORTEX, V2, P244; REITAN R M, 1955, AMA Arch Neurol Psychiatry, V73, P28; Reitan RM., 1969, MANUAL ADM NEUROPSYC; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Wechsler D., 1955, MANUAL WECHSLER ADUL; WILLIAMS JM, 1981, 5TH ANN C REH BRAIN	21	21	21	0	0	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.		1984	40	1					259	265		10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C			7	Psychology, Clinical	Psychology	SH419	WOS:A1984SH41900048	6746939				2021-06-18	
J	SCHNITKER, MT				SCHNITKER, MT			A SYNDROME OF CEREBRAL CONCUSSION IN CHILDREN	JOURNAL OF PEDIATRICS			English	Article																Beekman F, 1928, ANN SURG, V87, P355, DOI 10.1097/00000658-192803000-00002; BROCK S, 1942, J MT SINAI HOSP, V9, P349; CAMPBELL JB, IN PRESS J NEUROSURG; DANDY WE, 1946, B JOHNS HOPKINS HOSP, V79, P34; DAVISON C, 1945, ARCH NEURO PSYCHIATR, V54, P241, DOI 10.1001/archneurpsyc.1945.02300100013002; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Jefferson G, 1944, BRIT MED J, V1944, P1; Kahn Edgar, COMMUNICATION; Penfield W, 1938, ARCH NEURO PSYCHIATR, V40, P417, DOI 10.1001/archneurpsyc.1938.02270090011001; Vance BM, 1927, ARCH SURG-CHICAGO, V14, P1023, DOI 10.1001/archsurg.1927.01130170071005	10	21	21	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.		1949	35	5					557	560		10.1016/S0022-3476(49)80138-7			4	Pediatrics	Pediatrics	UP117	WOS:A1949UP11700004	15393434				2021-06-18	
J	Linthicum, FH; Rand, CW				Linthicum, Fred H.; Rand, Carl W.			NEURO-OTOLOGICAL OBSERVATIONS IN CONCUSSION OF THE BRAIN	ARCHIVES OF OTOLARYNGOLOGY			English	Article																AMBERG E, 1914, J MICHIGAN M SOC, V13, P84; Brunner H, 1925, MSCHR OHRENHEILK, V59, P697; BRUNNER H, 1925, MONATSCHR OHRENH, V59, P763; BRUNNER H, 1925, MONATSCHR OHRENH, V59, P922; Fletcher HA, 1922, J AMER MED ASSOC, V79, P529, DOI 10.1001/jama.1922.02640070017005; GOTTLIEB MJ, 1922, LARYNGOSCOPE, V32, P783; Greenacre P, 1917, B JOHNS HOPKINS HOSP, V28, P86; Grove WE, 1928, ARCHIV OTOLARYNGOL, V8, P249; HALSZ H, 1901, WIEN MED WCHNSCHR, V51, P1538; HOFMANN L, 1925, ANN MAL OREILLE LARY, V44, P1254; Hubby LM, 1927, ARCHIV OTOLARYNGOL, V6, P405; LINTHICUM FH, 1923, T PAC COAST OT SOC; MYGIND SH, 1918, ACTA OTO-LARYNGOL, V1, P513; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; PASSOW KA, 1905, VERLETZUNGEN GEHOROR; RHESE, 1906, Z OHRENH, V52, P320; RISK EJE, 1890, BRIT MED J, V1, P234; SCHUSTER FB, 1927, SW MED, V11, P116; STENGER, 1909, ARCH OHRENHEILK, V79, P43; ZACHS MA, 1928, LARYNGOSCOPE, V38, P288	20	21	21	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0276-0673			ARCHIV OTOLARYNGOL	Arch. Otolaryngol.	JUN	1931	13	6					785	821					37	Otorhinolaryngology	Otorhinolaryngology	V06LR	WOS:000207195600001					2021-06-18	
J	Iverson, GL; Wojtowicz, M; Brooks, BL; Maxwell, BA; Atkins, JE; Zafonte, R; Berkner, PD				Iverson, Grant L.; Wojtowicz, Magdalena; Brooks, Brian L.; Maxwell, Bruce A.; Atkins, Joseph E.; Zafonte, Ross; Berkner, Paul D.			High School Athletes With ADHD and Learning Difficulties Have a Greater Lifetime Concussion History	JOURNAL OF ATTENTION DISORDERS			English	Article						adolescent ADHD; concussion; learning disabilities; athletes	TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PSYCHIATRIC-ILLNESS; HEAD-INJURY; CHILDREN; ADOLESCENTS; PREDICTORS; RISK	Objective: Examine lifetime history of concussions in adolescents who have developmental problems in comparison with those with no developmental problems. Method: Thirty-two thousand four hundred eighty-seven adolescent athletes completed baseline/pre-season evaluations. Based on self-reported histories, athletes were divided into four groups: ADHD only, ADHD and learning difficulties (LD), LD only, and controls. Results: Athletes with ADHD, LD, or ADHD plus LD reported a greater prevalence of prior concussions than athletes without these developmental conditions (ps < .05). When adjusting for sex differences in concussion prevalence rates (boys are greater than girls), there was an increase in prevalence of prior injuries in those with ADHD, and ADHD plus learning difficulties compared with those with LD only. This pattern was found for both girls and boys. There was no additive effect of having both conditions. Conclusion: Developmental conditions in adolescent athletes, such as ADHD and learning difficulties, are associated with a greater prevalence rate of prior concussion.	[Iverson, Grant L.; Wojtowicz, Magdalena; Zafonte, Ross] Harvard Med Sch, 101 Merrimac 250, Boston, MA 02115 USA; [Iverson, Grant L.; Wojtowicz, Magdalena; Zafonte, Ross] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.; Wojtowicz, Magdalena; Zafonte, Ross] MassGen Hosp Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.; Wojtowicz, Magdalena; Zafonte, Ross] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.; Wojtowicz, Magdalena; Zafonte, Ross] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Calgary, AB, Canada; [Maxwell, Bruce A.; Atkins, Joseph E.; Berkner, Paul D.] Colby Coll, Waterville, ME 04901 USA; [Zafonte, Ross] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Zafonte, Ross] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Wojtowicz, M (corresponding author), Harvard Med Sch, 101 Merrimac 250, Boston, MA 02115 USA.	mwojtowicz@mgh.harvard.edu			Goldfarb Center for Public Policy and Civic Engagement/Colby College; Bill and Joan Alfond Foundation; Harvard Integrated Program to Protect and Improve the Health of NFLPA Members	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded in part by the Goldfarb Center for Public Policy and Civic Engagement/Colby College, and the Bill and Joan Alfond Foundation. Ross Zafonte was supported in part by the Harvard Integrated Program to Protect and Improve the Health of NFLPA Members.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Gerring J, 2000, BRAIN INJURY, V14, P205; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kaya A, 2008, J INT MED RES, V36, P9, DOI 10.1177/147323000803600102; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Lam L T, 2002, J Atten Disord, V6, P77, DOI 10.1177/108705470200600204; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1997, J AM ACAD CHILD PSY, V36, P404, DOI 10.1097/00004583-199703000-00020; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Sabuncuoglu O, 2005, DENT TRAUMATOL, V21, P249, DOI 10.1111/j.1600-9657.2005.00317.x; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Shilon Y, 2012, CHILD CARE HLTH DEV, V38, P366, DOI 10.1111/j.1365-2214.2011.01278.x; Swensen, 2004, J ADOLESCENT HEALTH, V35, DOI [DOI 10.1016/J.JAD0HEALTH.2003.12.003, 10.1016/j.jadohealth.2003.12.003]	28	20	20	2	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0547	1557-1246		J ATTEN DISORD	J. Atten. Disord.	JUN	2020	24	8			SI		1095	1101		10.1177/1087054716657410			7	Psychology, Developmental; Psychiatry	Psychology; Psychiatry	LM6VB	WOS:000532386800001	27431932				2021-06-18	
J	Long, XB; Yao, XL; Jiang, Q; Yang, YP; He, XJ; Tian, WD; Zhao, K; Zhang, HQ				Long, Xiaobing; Yao, Xiaolong; Jiang, Qian; Yang, Yiping; He, Xuejun; Tian, Weidong; Zhao, Kai; Zhang, Huaqiu			Astrocyte-derived exosomes enriched with miR-873a-5p inhibit neuroinflammation via microglia phenotype modulation after traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Exosome; Traumatic brain injury; Microglia; Astrocyte; M1; M2; miR-873a-5p	CONTRIBUTES; GROWTH	Background The interaction between astrocytes and microglia plays a vital role in the damage and repair of brain lesions due to traumatic brain injury (TBI). Recent studies have shown that exosomes act as potent mediators involved in intercellular communication. Methods In the current study, the expression of inflammatory factors and miR-873a-5p in the lesion area and oedema area was evaluated in 15 patients with traumatic brain injury. Exosomes secreted by astrocytes were detected by immunofluorescence, Western blot and electron microscopy. A mouse model of TBI and an in vitro model of LPS-induced primary microglia were established to study the protective mechanism of exosomes from miR-873a-5p overexpressing in TBI-induced nerve injury. Results We discovered that exosomes derived from activated astrocytes promote microglial M2 phenotype transformation following TBI. More than 100 miRNAs were detected in these astrocyte-derived exosomes. miR-873a-5p is a major component that was highly expressed in human traumatic brain tissue. Moreover, miR-873a-5p significantly inhibited LPS-induced microglial M1 phenotype transformation and the subsequent inflammation through decreased phosphorylation of ERK and NF-kappa B p65. This effect also greatly improved the modified neurological severity score (mNSS) and attenuated brain injury in a strictly controlled cortical impact mouse model. Conclusions Taken together, our research indicates that miRNAs in the exosomes derived from activated astrocytes play a key role in the astrocyte-microglia interaction. miR-873a-5p, as one of the main components of these astrocyte-derived exosomes, attenuated microglia-mediated neuroinflammation and improved neurological deficits following TBI by inhibiting the NF-kappa B signalling pathway. These findings suggest a potential role for miR-873a-5p in treating traumatic brain injury.	[Long, Xiaobing; Yao, Xiaolong; Jiang, Qian; Yang, Yiping; He, Xuejun; Tian, Weidong; Zhao, Kai; Zhang, Huaqiu] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430030, Peoples R China; [Tian, Weidong] Shihezi Univ, Med Coll, Affiliated Hosp 1, Dept Neurosurg, Shihezi, Peoples R China	Zhang, HQ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurosurg, Wuhan 430030, Peoples R China.	zhanghq_04@yahoo.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371381]; National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81602204]	This article was founded by the National Natural Science Foundation of China (No.81371381) and the National Natural Science Foundation for Youth of China (No. 81602204).	Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chivet M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00145; Cui J, 2015, ONCOGENE, V34, P3895, DOI 10.1038/onc.2014.430; Dickens AM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai7696; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Gao YS, 2015, AM J TRANSL RES, V7, P2519; Hu GK, 2020, J NEUROIMMUNE PHARM, V15, P538, DOI 10.1007/s11481-019-09869-8; Hu GK, 2018, MOL THER-NUCL ACIDS, V13, P450, DOI 10.1016/j.omtn.2018.09.019; Jang E, 2013, J IMMUNOL, V191, P5204, DOI 10.4049/jimmunol.1301637; Lafourcade C, 2016, J EXP NEUROSCI, V10, P1, DOI 10.4137/JEN.S39916; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu XM, 2014, J BIOL CHEM, V289, P28971, DOI 10.1074/jbc.M114.577429; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; Quek C, 2017, BIOCHEM BIOPH RES CO, V483, P1178, DOI 10.1016/j.bbrc.2016.09.090; Sobue A, 2018, GLIA, V66, P1034, DOI 10.1002/glia.23299; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Wang LQ, 2019, J CELL COMMUN SIGNAL, V13, P549, DOI 10.1007/s12079-019-00522-w; Wang Q, 2019, EXP THER MED, V18, P1291, DOI 10.3892/etm.2019.7713; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Xia CY, 2015, INT IMMUNOPHARMACOL, V25, P377, DOI 10.1016/j.intimp.2015.02.019; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xu LL, 2019, BRAIN RES, V1717, P66, DOI 10.1016/j.brainres.2019.04.009; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Zhang YY, 2019, AM J CANCER RES, V9, P927	30	20	21	6	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	MAR 19	2020	17	1							89	10.1186/s12974-020-01761-0			15	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	KX6NS	WOS:000521996500003	32192523	DOAJ Gold, Green Published			2021-06-18	
J	Krizman, J; Kraus, N				Krizman, Jennifer; Kraus, Nina			Analyzing the FFR: A tutorial for decoding the richness of auditory function	HEARING RESEARCH			English	Article							FREQUENCY-FOLLOWING-RESPONSE; HUMAN BRAIN-STEM; MUSICAL EXPERIENCE; NEURAL REPRESENTATION; SPEECH-PERCEPTION; PHASE-LOCKING; PITCH; CHILDREN; HEARING; SOUND	The frequency-following response, or FFR, is a neurophysiological response to sound that precisely reflects the ongoing dynamics of sound. It can be used to study the integrity and malleability of neural encoding of sound across the lifespan. Sound processing in the brain can be impaired with pathology and enhanced through expertise. The FFR can index linguistic deprivation, autism, concussion, and reading impairment, and can reflect the impact of enrichment with short-term training, bilingualism, and musicianship. Because of this vast potential, interest in the FFR has grown considerably in the decade since our first tutorial. Despite its widespread adoption, there remains a gap in the current knowledge of its analytical potential. This tutorial aims to bridge this gap. Using recording methods we have employed for the last 20 + years, we have explored many analysis strategies. In this tutorial, we review what we have learned and what we think constitutes the most effective ways of capturing what the FFR can tell us. The tutorial covers FFR components (timing, fundamental frequency, harmonics) and factors that influence FFR (stimulus polarity, response averaging, and stimulus presentation/recording jitter). The spotlight is on FFR analyses, including ways to analyze FFR timing (peaks, autocorrelation, phase consistency, cross-phaseogram), magnitude (RMS, SNR, FFT), and fidelity (stimulus-response correlations, response-to-response correlations and response consistency). The wealth of information contained within an FFR recording brings us closer to understanding how the brain reconstructs our sonic world. (C) 2019 Elsevier B.V. All rights reserved.	[Krizman, Jennifer; Kraus, Nina] Northwestern Univ, Dept Commun Sci & Disorders, Auditory Neurosci Lab, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Kraus, N (corresponding author), Northwestern Univ, 2240 Campus Dr, Evanston, IL 60208 USA.	nkraus@northwestern.edu			National Science FoundationNational Science Foundation (NSF) [BCS-1430400]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD069414]; National Association of Music Merchants; Dana Foundation; Knowles Hearing Center, Northwestern University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069414] Funding Source: NIH RePORTER	The authors thank everyone in the Auditory Neuroscience Laboratory, past and present, for their help with data collection and processing. The authors also thank Trent Nicol and Travis White-Schwoch for their comments on an earlier version of the manuscript. This work was supported by the National Science Foundation (BCS-1430400), National Institutes of Health (R01 HD069414), the National Association of Music Merchants, the Dana Foundation, and the Knowles Hearing Center, Northwestern University. The authors declare no conflicts of interest.	Aiken SJ, 2008, HEARING RES, V245, P35, DOI 10.1016/j.heares.2008.08.004; Akhoun I, 2008, CLIN NEUROPHYSIOL, V119, P922, DOI 10.1016/j.clinph.2007.12.010; Anderson S, 2013, J ACOUST SOC AM, V133, P3030, DOI 10.1121/1.4799804; Anderson S, 2013, P NATL ACAD SCI USA, V110, P4357, DOI 10.1073/pnas.1213555110; Anderson S, 2010, HEARING RES, V270, P151, DOI 10.1016/j.heares.2010.08.001; Anderson S, 2010, J NEUROSCI, V30, P4922, DOI 10.1523/JNEUROSCI.0107-10.2010; Assaneo MF, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao3842; Ayala YA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16774-8; Banai K, 2009, CEREB CORTEX, V19, P2699, DOI 10.1093/cercor/bhp024; Bidelman GM, 2018, NEUROIMAGE, V175, P56, DOI 10.1016/j.neuroimage.2018.03.060; Bidelman GM, 2015, HEARING RES, V323, P68, DOI 10.1016/j.heares.2015.01.011; BinKhamis G, 2019, EAR HEARING, V40, P659, DOI 10.1097/AUD.0000000000000648; Bonacina S, 2018, ANN NY ACAD SCI, V1423, P338, DOI 10.1111/nyas.13704; Carcagno S, 2011, JARO-J ASSOC RES OTO, V12, P89, DOI 10.1007/s10162-010-0236-1; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; Chen JR, 2019, AUTISM RES, V12, P1022, DOI 10.1002/aur.2110; Coffey EBJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11070; Etard O, 2019, NEUROIMAGE, V200, P1, DOI 10.1016/j.neuroimage.2019.06.029; Forte AE, 2017, ELIFE, V6, DOI 10.7554/eLife.27203; Galbraith GC, 1998, NEUROREPORT, V9, P1889, DOI 10.1097/00001756-199806010-00041; Galbraith GC, 1995, NEUROREPORT, V6, P2363, DOI 10.1097/00001756-199511270-00021; Galbraith GC, 1997, ELECTROEN CLIN NEURO, V102, P46, DOI 10.1016/S0013-4694(96)96006-X; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gama N, 2017, J NEUROSCI METH, V280, P47, DOI 10.1016/j.jneumeth.2017.01.016; GORGA MP, 1988, J SPEECH HEAR RES, V31, P87, DOI 10.1044/jshr.3101.87; Greenberg S., 1998, P 11 INT S HEAR, P257; GREENWOOD D, 1961, J ACOUST SOC AM, V33, P1344, DOI 10.1121/1.1908437; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Hornickel J, 2012, HEARING RES, V284, P52, DOI 10.1016/j.heares.2011.12.005; Hornickel J, 2009, P NATL ACAD SCI USA, V106, P13022, DOI 10.1073/pnas.0901123106; Jeng FC, 2011, EAR HEARING, V32, P699, DOI 10.1097/AUD.0b013e31821cc0df; John MS, 2000, HEARING RES, V141, P57, DOI 10.1016/S0378-5955(99)00209-9; Johnson KL, 2008, CLIN NEUROPHYSIOL, V119, P2623, DOI 10.1016/j.clinph.2008.07.277; Kachlicka M, 2019, BRAIN LANG, V192, P15, DOI 10.1016/j.bandl.2019.02.004; KIMBERLEY BP, 1993, J ACOUST SOC AM, V94, P1343, DOI 10.1121/1.408162; King C, 2002, NEUROSCI LETT, V319, P111, DOI 10.1016/S0304-3940(01)02556-3; Kraus N., 2016, SCI REP, V97, pe11; Kraus N., 2016, MAKING SENSE SOUND B; Kraus N, 2017, SPRINGER HANDB AUDIT, V61, P1, DOI 10.1007/978-3-319-47944-6_1; Kraus N, 2017, NEUROSCIENTIST, V23, P287, DOI 10.1177/1073858416653593; Kraus N, 2017, NEUROSCI LETT, V646, P21, DOI 10.1016/j.neulet.2017.03.008; Kraus N, 2015, TRENDS COGN SCI, V19, P642, DOI 10.1016/j.tics.2015.08.017; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krishnan A, 2005, COGNITIVE BRAIN RES, V25, P161, DOI 10.1016/j.cogbrainres.2005.05.004; Krishnan A, 2004, HEARING RES, V189, P1, DOI 10.1016/S0378-5955(03)00402-7; Krishnan A, 2002, HEARING RES, V166, P192, DOI 10.1016/S0378-5955(02)00327-1; Krishnan A, 2009, BRAIN LANG, V110, P135, DOI 10.1016/j.bandl.2009.03.005; Krizman J, 2019, HEARING RES, V380, P166, DOI 10.1016/j.heares.2019.07.002; Krizman J, 2016, DEVELOPMENTAL SCI, V19, P881, DOI 10.1111/desc.12347; Krizman J, 2015, NEUROSCI LETT, V585, P48, DOI 10.1016/j.neulet.2014.11.011; Krizman J, 2014, BRAIN LANG, V128, P34, DOI 10.1016/j.bandl.2013.11.006; Krizman J, 2012, P NATL ACAD SCI USA, V109, P7877, DOI 10.1073/pnas.1201575109; Krizman J, 2012, CLIN NEUROPHYSIOL, V123, P590, DOI 10.1016/j.clinph.2011.07.037; Krizman J, 2010, AUDIOL NEURO-OTOL, V15, P332, DOI 10.1159/000289572; Kumar V, 2013, 2013 ACM/IEEE INTERNATIONAL CONFERENCE ON INFORMATION PROCESSING IN SENSOR NETWORKS (IPSN), P3, DOI 10.1109/IPSN.2013.6917551; Kuwada Shigeyuki, 2002, J Am Acad Audiol, V13, P188; Liu LF, 2006, J NEUROPHYSIOL, V95, P1926, DOI 10.1152/jn.00497.2005; Lyon R. F., 1982, Proceedings of ICASSP 82. IEEE International Conference on Acoustics, Speech and Signal Processing, P1282; Maggu AR, 2018, INTERSPEECH, P1437, DOI 10.21437/Interspeech.2018-2130; Malmierca M.S., 2015, ANATOMY PHYSL MAMMAL, P155; Malmierca MS, 2019, NEUROIMAGE, V184, P889, DOI 10.1016/j.neuroimage.2018.10.012; Malmierca MS, 2011, AUDITORY CORTEX, P189, DOI 10.1007/978-1-4419-0074-6_9; Mansour Y, 2019, HEARING RES, V377, P234, DOI 10.1016/j.heares.2019.04.004; Marmel F, 2013, JARO-J ASSOC RES OTO, V14, P757, DOI 10.1007/s10162-013-0402-3; Musacchia G., 2019, J PERINATOL, DOI [10.1038/541372-019-0421-y, DOI 10.1038/541372-019-0421-Y]; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Neef NE, 2017, DEV COGN NEUROS-NETH, V24, P63, DOI 10.1016/j.dcn.2017.01.008; Nishida T, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON AGENTS (ICA), P126, DOI 10.1109/AGENTS.2018.8460069; Omote A, 2017, CORTEX, V93, P146, DOI 10.1016/j.cortex.2017.05.005; Otto-Meyer S, 2018, EXP BRAIN RES, V236, P733, DOI 10.1007/s00221-017-5164-4; PALMER AR, 1986, HEARING RES, V24, P1, DOI 10.1016/0378-5955(86)90002-X; Parbery-Clark A, 2013, J NEUROSCI, V33, P16741, DOI 10.1523/JNEUROSCI.5700-12.2013; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Ribas-Prats T, 2019, HEARING RES, V371, P28, DOI 10.1016/j.heares.2018.11.001; Roque L, 2019, J SPEECH LANG HEAR R, V62, P1099, DOI 10.1044/2018_JSLHR-H-ASCC7-18-0076; RUGGERO MA, 1987, J NEUROPHYSIOL, V58, P379; Ruggles D, 2012, CURR BIOL, V22, P1417, DOI 10.1016/j.cub.2012.05.025; Russo N, 2004, CLIN NEUROPHYSIOL, V115, P2021, DOI 10.1016/j.clinph.2004.04.003; Russo NM, 2008, CLIN NEUROPHYSIOL, V119, P1720, DOI 10.1016/j.clinph.2008.01.108; Sanfins MD, 2018, J INT ADV OTOL, V14, P100, DOI 10.5152/iao.2018.3574; Selinger L, 2016, J NEUROSCI, V36, P10782, DOI 10.1523/JNEUROSCI.1595-16.2016; Skoe E., 2010, PLOS ONE, V243, P104; Skoe E., 2013, NEUROSCIENCE; Skoe E, 2017, NEUROSCIENCE, V349, P278, DOI 10.1016/j.neuroscience.2017.02.049; Skoe E, 2015, CEREB CORTEX, V25, P1415, DOI 10.1093/cercor/bht311; Skoe E, 2013, J NEUROSCI, V33, P17221, DOI 10.1523/JNEUROSCI.2102-13.2013; Skoe E, 2011, J NEUROSCI METH, V196, P308, DOI 10.1016/j.jneumeth.2011.01.020; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; SOHMER H, 1977, ELECTROEN CLIN NEURO, V42, P656, DOI 10.1016/0013-4694(77)90282-6; Song JH, 2008, J COGNITIVE NEUROSCI, V20, P1892, DOI 10.1162/jocn.2008.20131; Song JH, 2011, CLIN NEUROPHYSIOL, V122, P346, DOI 10.1016/j.clinph.2010.07.009; Strait DL, 2014, CEREB CORTEX, V24, P2512, DOI 10.1093/cercor/bht103; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; Tichko P, 2017, HEARING RES, V348, P1, DOI 10.1016/j.heares.2017.01.014; Tierney A., 2015, P NATL ACAD SCI USA; Tierney A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00855; Tierney A, 2013, J NEUROSCI, V33, P14981, DOI 10.1523/JNEUROSCI.0612-13.2013; Warrier CM, 2011, HEARING RES, V282, P108, DOI 10.1016/j.heares.2011.09.001; Werff KRV, 2017, EAR HEARING, V38, pE200, DOI 10.1097/AUD.0000000000000411; White-Schwoch T, 2019, J NEUROPHYSIOL, V122, P844, DOI 10.1152/jn.00112.2019; White-Schwoch T, 2017, CEREB CORTEX, V27, P5095, DOI 10.1093/cercor/bhw293; White-Schwoch T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002196; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Zhao TC, 2019, BRAIN LANG, V194, P77, DOI 10.1016/j.bandl.2019.05.002; Zhu L, 2013, J ACOUST SOC AM, V134, P384, DOI 10.1121/1.4807498	105	20	20	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	OCT	2019	382								107779	10.1016/j.heares.2019.107779			16	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	JF2KL	WOS:000491214200003	31505395	Green Accepted			2021-06-18	
J	Izzy, S; Liu, Q; Fang, Z; Lule, S; Wu, LM; Chung, JY; Sarro-Schwartz, A; Brown-Whalen, A; Perner, C; Hickman, SE; Kaplan, DL; Patsopoulos, NA; El Khoury, J; Whalen, MJ				Izzy, Saef; Liu, Qiong; Fang, Zhou; Lule, Sevda; Wu, Limin; Chung, Joon Yong; Sarro-Schwartz, Aliyah; Brown-Whalen, Alexander; Perner, Caroline; Hickman, Suzanne E.; Kaplan, David L.; Patsopoulos, Nikolaos A.; El Khoury, Joseph; Whalen, Michael J.			Time-Dependent Changes in Microglia Transcriptional Networks Following Traumatic Brain Injury	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						traumatic brain injury; microglia; transcriptome; neurodegeneration; mice; neuroimmunology; neuroinflammation	CONTROLLED CORTICAL IMPACT; INFLAMMATORY RESPONSE; COGNITIVE DEFICITS; CD40 LIGAND; CELL-DEATH; EXPRESSION; HYPOXIA; NEUROINFLAMMATION; ACTIVATION; MECHANISM	The neuroinflammatory response to traumatic brain injury (TBI) is critical to both neurotoxicity and neuroprotection, and has been proposed as a potentially modifiable driver of secondary injury in animal and human studies. Attempts to broadly target immune activation have been unsuccessful in improving outcomes, in part because the precise cellular and molecular mechanisms driving injury and outcome at acute, subacute, and chronic time points after TBI remain poorly defined. Microglia play a critical role in neuroinflammation and their persistent activation may contribute to long-term functional deficits. Activated microglia are characterized by morphological transformation and transcriptomic changes associated with specific inflammatory states. We analyzed the temporal course of changes in inflammatory genes of microglia isolated from injured brains at 2, 14, and 60 days after controlled cortical impact (CCI) in mice, a well-established model of focal cerebral contusion. We identified a time dependent, injury-associated change in the microglial gene expression profile toward a reduced ability to sense tissue damage, perform housekeeping, and maintain homeostasis in the early stages following CCI, with recovery and transition to a specialized inflammatory state over time. This later state starts at 14 days post-injury and is characterized by a biphasic pattern of IFN gamma, IL-4, and IL-10 gene expression changes, with concurrent proinflammatory and anti-inflammatory gene changes. Our transcriptomic data sets are an important step to understand microglial role in TBI pathogenesis at the molecular level and identify common pathways that affect outcome. More studies to evaluate gene expression at the single cell level and focusing on subacute and chronic timepoint are warranted.	[Izzy, Saef; Sarro-Schwartz, Aliyah] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Izzy, Saef; Brown-Whalen, Alexander; Perner, Caroline; Hickman, Suzanne E.; El Khoury, Joseph] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA; [Izzy, Saef; Lule, Sevda; Wu, Limin; Chung, Joon Yong; Brown-Whalen, Alexander; Perner, Caroline; Hickman, Suzanne E.; El Khoury, Joseph; Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Charlestown, MA USA; [Izzy, Saef; Fang, Zhou; Sarro-Schwartz, Aliyah; Perner, Caroline; Hickman, Suzanne E.; Patsopoulos, Nikolaos A.; El Khoury, Joseph; Whalen, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Liu, Qiong] Fudan Univ, Sch Basic Med Sci, Dept Anat Histol & Embryol, Shanghai, Peoples R China; [Liu, Qiong] Shanghai Key Lab Med Imaging Comp & Comp Assisted, Shanghai, Peoples R China; [Fang, Zhou; Patsopoulos, Nikolaos A.] Brigham & Womens Hosp, Dept Neurol, Syst Biol & Comp Sci Program, Ann Romney Ctr Neurol Dis, Boston, MA USA; [Fang, Zhou; Patsopoulos, Nikolaos A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Fang, Zhou; Patsopoulos, Nikolaos A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Fang, Zhou; Patsopoulos, Nikolaos A.] Broad Inst Harvard, Cambridge, MA USA; [Patsopoulos, Nikolaos A.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02115 USA; [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	El Khoury, J (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA.; El Khoury, J; Whalen, MJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Charlestown, MA USA.; El Khoury, J; Whalen, MJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Whalen, MJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02115 USA.	jelkhoury@mgh.harvard.edu; MWHALEN@mgh.harvard.edu	; Lule, Sevda/N-8229-2017	Perner, Caroline/0000-0002-0851-1759; Lule, Sevda/0000-0001-7066-6471; Chung, Joon Yong/0000-0002-3980-2065	National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1RF1AG051506, R01NS092847-01]; National Natural Science Fund of ChinaNational Natural Science Foundation of China (NSFC) [31871029]	This work was supported by the National Institute on Aging (NIA) Grant 1RF1AG051506 (to JK), the R01NS092847-01 (to DK), and National Natural Science Fund of China 31871029 (to QL).	Aarts SABM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01791; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bizet AA, 2011, BBA-MOL CELL RES, V1813, P742, DOI 10.1016/j.bbamcr.2011.01.028; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Brait VH, 2019, CIRC RES, V124, P279, DOI 10.1161/CIRCRESAHA.118.313818; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Calingasan NY, 2002, NEUROBIOL AGING, V23, P31, DOI 10.1016/S0197-4580(01)00246-9; Carbonell WS, 2005, J NEUROSCI, V25, P7040, DOI 10.1523/JNEUROSCI.5171-04.2005; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Chung JY, 2019, J NEUROTRAUM, V36, P370, DOI 10.1089/neu.2018.5659; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clarkson BDS, 2014, J EXP MED, V211, P595, DOI 10.1084/jem.20131377; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Hanamsagar R, 2017, GLIA, V65, P1504, DOI 10.1002/glia.23176; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Hickman SE, 2014, BIOCHEM PHARMACOL, V88, P495, DOI 10.1016/j.bcp.2013.11.021; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Higashida T, 2011, CURR NEUROVASC RES, V8, P44, DOI 10.2174/156720211794520251; Hirbec HE, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00227; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Huang RQ, 2010, NEUROSCI LETT, V473, P22, DOI 10.1016/j.neulet.2010.02.011; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jing J, 2013, J IMMUNOL, V190, P6360, DOI 10.4049/jimmunol.1202942; Joy MT, 2019, CELL, V176, P1143, DOI 10.1016/j.cell.2019.01.044; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laporte V, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-3; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Moran LB, 2007, J NEUROIMMUNOL, V183, P1, DOI 10.1016/j.jneuroim.2006.10.023; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Nishihara T, 2011, EXP NEUROL, V229, P507, DOI 10.1016/j.expneurol.2011.04.006; O'Neil SM, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0636-8; Oflazoglu E, 2009, ADV EXP MED BIOL, V647, P174, DOI 10.1007/978-0-387-89520-8_12; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ransohoff RM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020560; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; Samal BB, 2015, J MOL NEUROSCI, V57, P282, DOI 10.1007/s12031-015-0626-2; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith DE, 2009, IMMUNITY, V30, P817, DOI 10.1016/j.immuni.2009.03.020; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Spencer NG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162497; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szmydynger-Chodobska J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167677; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Takeuchi H, 2006, NEUROBIOL DIS, V22, P33, DOI 10.1016/j.nbd.2005.09.014; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; von Bernhardi R, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00426; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Waggott D, 2012, BIOINFORMATICS, V28, P1546, DOI 10.1093/bioinformatics/bts188; Wang H, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw677; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; White TE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2412-0; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wong YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020216; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; Yan JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027798; Zhang M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02751	98	20	20	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	AUG 8	2019	13								307	10.3389/fncel.2019.00307			16	Neurosciences	Neurosciences & Neurology	IO2YK	WOS:000479247500001	31440141	DOAJ Gold, Green Published			2021-06-18	
J	Samuels, JM; Moore, EE; Silliman, CC; Banerjee, A; Cohen, MJ; Ghasabyan, A; Chandler, J; Coleman, JR; Sauaia, A				Samuels, Jason M.; Moore, Ernest E.; Silliman, Christopher C.; Banerjee, Anirban; Cohen, Mitchell J.; Ghasabyan, Arsen; Chandler, James; Coleman, Julia R.; Sauaia, Angela			Severe traumatic brain injury is associated with a unique coagulopathy phenotype	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						TBI; hyperfibrinolysis; trauma-induced coagulopathy; thrombelastography	TISSUE FACTOR; VENOUS THROMBOEMBOLISM; FIBRINOLYSIS SHUTDOWN; PHYSIOLOGICAL FIBRINOLYSIS; POSTINJURY FIBRINOLYSIS; BLOOD-TRANSFUSION; AMERICAN-COLLEGE; TRANEXAMIC ACID; HYPOPERFUSION; HYPERFIBRINOLYSIS	BACKGROUND Traumatic brain injury (TBI) patients present on a spectrum from hypocoagulability to hypercoagulability, depending on the injury complexity, severity, and time since injury. Prior studies have found a unique coagulopathy associated with TBI using conventional coagulation assays such as INR; however, few studies have assessed the association of TBI and coagulopathy using viscoelastic assays that comprehensively evaluate the coagulation in whole blood. This study aims to reevaluate the TBI-specific trauma-induced coagulopathy using arrival thrombelastography. Because brain tissue is high in key procoagulant molecules, we hypothesize that isolated TBI is associated with procoagulant and hypofibrinolytic profiles compared with injuries of the torso, extremities, and polytrauma, including TBI. METHODS Data are from the prospective Trauma Activation Protocol study. Activated clotting time (ACT), angle, maximum amplitude (MA), 30-minute percent lysis after MA (LY30), and functional fibrinogen levels (FFLEV) were recorded. Patients were categorized into isolated severe TBI (I-TBI), severe TBI with torso and extremity injuries (TBI + TORSO/EXTREMITIES), and isolated torso and extremity injuries (I-TORSO/EXTREMITIES). Poisson regression was used to adjust for multiple confounders. RESULTS Overall, 572 patients (48 I-TBI, 45 TBI + TORSO/EXTREMITIES, 479 I-TORSO/EXTREMITIES) were included in this analysis. The groups differed in INR, ACT, angle, MA, and FFLEV but not in 30-minute percent lysis. When compared with I-Torso/Extremities, after adjustment for confounders, severe I-TBI was independently associated with ACT less than 128 seconds (relative risk [RR], 1.5; 95% confidence interval [CI], 1.1-2.2), angle less than 65 degrees (RR, 2.2; 95% CI, 1.4-3.6), FFLEV less than 356 (RR, 1.7; 95% CI, 1.2-2.4) but not MA less than 55 mm, hyperfibrinolysis, fibrinolysis shutdown, or partial thromboplastin time (PTT) greater than 30. CONCLUSION Severe I-TBI was independently associated with a distinct coagulopathy with delayed clot formation but did not appear to be associated with fibrinolysis abnormalities. Low fibrinogen and longer ACT values associated with I-TBI suggest that early coagulation factor replacement may be indicated in I-TBI patients over empiric antifibrinolytic therapy. Mechanisms triggering coagulopathy in TBI are unique and warrant further investigation.	[Samuels, Jason M.; Banerjee, Anirban; Coleman, Julia R.] Univ Colorado, Dept Surg, Denver, CO USA; [Moore, Ernest E.; Cohen, Mitchell J.; Ghasabyan, Arsen; Chandler, James] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Sauaia, Angela] Univ Colorado, Sch Publ Hlth, Dept Pediat, Aurora, CO USA	Sauaia, A (corresponding author), Univ Colorado, Sch Publ Hlth, 13001 E 17th Pl,B119 Bldg 500,E3309, Aurora, CO 80045 USA.	angela.sauaia@ucdenver.edu		Samuels, Jason/0000-0001-5427-3117	National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM008315, P50 GM049222]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM 1HL 120877]; Department of Defense (USAMRAA)United States Department of Defense [W81XWH-12-2-0028]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1HL120877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008315, P50GM049222] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health (T32 GM008315 and P50 GM049222), The National Heart, Lung, and Blood Institute (UM 1HL 120877) and the Department of Defense (USAMRAA, W81XWH-12-2-0028). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (or other sponsors of the project).	[Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; BACH R, 1986, BIOCHEMISTRY-US, V25, P4007, DOI 10.1021/bi00362a005; Balvers- K, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00024; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Brandt MM, 2007, AM J SURG, V193, P383; Brown JB, 2012, J TRAUMA ACUTE CARE, V73, P1395, DOI 10.1097/TA.0b013e31825b9f05; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DEFOUW NJ, 1988, THROMB HAEMOSTASIS, V60, P328; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; DRAKE TA, 1989, AM J PATHOL, V134, P1087; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Einersen PM, 2017, J TRAUMA ACUTE CARE, V82, P114, DOI 10.1097/TA.0000000000001270; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harr JN, 2013, SHOCK, V39, P45, DOI 10.1097/SHK.0b013e3182787122; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Holcomb JB, 2013, J TRAUMA ACUTE CARE, V75, pS31, DOI 10.1097/TA.0b013e31828fa3ed; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Meizoso JP, 2017, J AM COLL SURGEONS, V224, P575, DOI 10.1016/j.jamcollsurg.2016.12.018; Moore FA, 1997, ARCH SURG-CHICAGO, V132, P620; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Morrison JJ, 2013, JAMA SURG, V148, P218, DOI 10.1001/jamasurg.2013.764; Oaxaca Ronald, 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Schreiber MA, 2014, J TRAUMA ACUTE CARE, V77, P817; Schrieber M, 2007, J TRAUMA, V63, P1261; Shackford SR, 2004, ANN SURG, V240, P496; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Stettler GR, 2018, J TRAUMA ACUTE CARE; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Stewart RM, 2003, J TRAUMA, V54, P1; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V77, P238, DOI 10.1097/TA.0000000000000294	51	20	20	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2019	86	4					686	693		10.1097/TA.0000000000002173			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	HR5QD	WOS:000463201000017	30601456	Green Accepted			2021-06-18	
J	Fadiman, J; Korb, S				Fadiman, James; Korb, Sophia			Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration	JOURNAL OF PSYCHOACTIVE DRUGS			English	Article						Psychedelics; microdosing; LSD; psilocybin		Albert Hoffman suggested that low doses of LSD might be an appropriate alternative to Ritalin. Following this possibility, a systematic exploration of the effects of "microdoses," comprising hundreds of lengthy descriptive reports, was undertaken. Based on these reports, using a psychedelic in the microdose range (10 micrograms) every three days was determined to be safe across a wide variety of individuals and conditions. Over 18 months, more than a thousand individuals from 59 countries did a daily evaluation of negative and positive emotional state using the PANAS checklist plus written reports for between one week and four months. Participant reports suggested that spaced but repeated microdoses were followed by improvements in negative moods, especially depression, and increases in positive moods. Increased energy, improved work effectiveness, and improved health habits were observed in clinical and non-clinical populations. Smaller samples described alleviation of symptoms in migraine headaches, pre-menstrual syndromes, traumatic brain injury, shingles, and other conditions not previously associated with psychedelic use.	[Fadiman, James] Sofia Univ, Dept Psychol, Palo Alto, CA USA; [Korb, Sophia] Coll St Womens Ctr Hlth Educ & Counselling, Toronto, ON, Canada	Fadiman, J (corresponding author), Sofia Univ, Palo Alto, CA 94303 USA.	jfadiman@gmail.com					Cerletti A., 2005, LSD MY PROBLEM CHILD, P85; Fadiman J., 2016, PSYCHEDELIC PRESS J, V15, P1; Fadiman J, 2019, ADV PSYCHEDELIC MED, P318; Gasser P, 2015, J PSYCHOPHARMACOL, V29, P57, DOI 10.1177/0269881114555249; Grob C., 2002, HALLUCINOGENS READER, P17; Hofmann A, 2005, LSD MY PROBLEM CHILD; Knowles R., 2018, 38 ANN C SOC ANTHR C; Madsen M., 2018, 1 C PSYCH PSYCH STOC; Passie T., 2018, SCI MICRODOSING PSYC; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216	10	20	20	8	26	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0279-1072	2159-9777		J PSYCHOACTIVE DRUGS	J. Psychoact. Drugs		2019	51	2			SI		118	122		10.1080/02791072.2019.1593561		MAR 2019	5	Psychology, Clinical; Substance Abuse	Psychology; Substance Abuse	IC5EA	WOS:000467762200001	30925850				2021-06-18	
J	Gallagher, MJ; Hogg, FRA; Zoumprouli, A; Papadopoulos, MC; Saadoun, S				Gallagher, Mathew J.; Hogg, Florence R. A.; Zoumprouli, Argyro; Papadopoulos, Marios C.; Saadoun, Samira			Spinal Cord Blood Flow in Patients with Acute Spinal Cord Injuries	JOURNAL OF NEUROTRAUMA			English	Article						blood flow; blood pressure; laser speckle contrast imaging; spinal cord injury; spinal cord ischemia	INTRASPINAL PRESSURE; PERFUSION-PRESSURE; BRAIN-DAMAGE; MECHANISMS; PROFILE	The effect of traumatic spinal cord injury (TSCI) on spinal cord blood flow (SCBF) in humans is unknown. Whether intervention to achieve the recommended mean arterial pressure (MAP) guideline of 85-90mm Hg improves SCBF is also unclear. Here, we use laser speckle contrast imaging intraoperatively to visualize blood flow at the injury site in 22 patients with acute, severe spinal cord injuries (American Spinal Injuries Association Impairment Scale, grades A-C). In 17 of 22 patients, injury-site metabolism was also monitored with a microdialysis catheter placed intradurally on the surface of the injured cord. We observed three different SCBF patterns, characterized by distinct injury-site metabolic signatures, which we term necrosis-penumbra, hyperperfusion, and patchy-perfusion. The necrosis-penumbra pattern, only observed in thoracic injuries, had a core of low blood flow (necrosis) with regions of intermediate blood flow on either side (penumbra). The hyperperfusion pattern, only observed in cervical injuries, had very high blood flow throughout the injury site. The patchy-perfusion pattern, found in cervical and thoracic injuries, had irregular regions of low, intermediate, and high blood flow. Though intervention to increase MAP by 20mm Hg increased overall blood flow at the injury site, in 5 of 22 patients, blood flow increased in some regions, but, surprisingly, decreased in other regions. We term this phenomenon blood pressure-induced local steal. In 7 of 19 patients with MAP 85-90mm Hg, parts of the injury site were only perfused in systole, but not in diastole, which we term diastolic ischemia. We conclude that acute, severe TSCI produces three pathological blood flow patterns at the injury site. Intervention to increase blood pressure may elicit potentially detrimental SCBF responses in some patients.	[Gallagher, Mathew J.; Hogg, Florence R. A.; Papadopoulos, Marios C.; Saadoun, Samira] St Georges Univ London, Acad Neurosurg Unit, Cranmer Terrace, London SW17 0RE, England; [Zoumprouli, Argyro] St George Hosp, Neurointens Care Unit, London, England	Saadoun, S (corresponding author), St Georges Univ London, Acad Neurosurg Unit, Cranmer Terrace, London SW17 0RE, England.	ssaadoun@sgul.ac.uk		Zoumprouli, Argyro/0000-0003-0890-690X; Saadoun, Samira/0000-0002-5480-5678; Papadopoulos, Marios/0000-0001-9174-4176	Wings for Life Spinal Cord Research Foundation; Fletcher Fund; Neurosciences Research Foundation; London Deanery	This work was supported by the Wings for Life Spinal Cord Research Foundation, the Fletcher Fund, the Neurosciences Research Foundation, and the London Deanery.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Benton RL, 2009, CURR NEUROVASC RES, V6, P124, DOI 10.2174/156720209788185678; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Cao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12643; Chen SL, 2017, J NEUROTRAUM, V34, P2941, DOI 10.1089/neu.2017.4982; Chen SL, 2016, J NEUROCHEM, V139, P700, DOI 10.1111/jnc.13854; Davis MA, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086001; Dubory A, 2015, JOVE-J VIS EXP, DOI 10.3791/52536; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; Fassbender JM, 2011, EXP NEUROL, V227, P302, DOI 10.1016/j.expneurol.2010.12.002; FRIED LC, 1974, ANAT REC, V178, P41, DOI 10.1002/ar.1091780105; Gallagher MJ, 2018, CRIT CARE MED, V46, P1150, DOI 10.1097/CCM.0000000000003134; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hecht N, 2016, J CEREBR BLOOD F MET, V36, P1022, DOI 10.1177/0271678X15612487; Hecht N, 2013, J CEREBR BLOOD F MET, V33, P1000, DOI 10.1038/jcbfm.2013.42; Hecht N, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09148; HEISS WD, 1994, CURR OPIN NEUROL, V7, P11, DOI 10.1097/00019052-199402000-00004; Ideguchi M, 2017, J NEUROSURG, V126, P274, DOI 10.3171/2016.1.JNS152067; Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Klijn E, 2013, J NEUROSURG, V118, P280, DOI 10.3171/2012.10.JNS1219; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lenehan B, 2010, SPINE, V35, pS174, DOI 10.1097/BRS.0b013e3181f32c82; Ma ZW, 2016, EXP NEUROL, V279, P261, DOI 10.1016/j.expneurol.2016.02.008; Muradov JM, 2013, J NEUROTRAUM, V30, P840, DOI 10.1089/neu.2012.2670; NEDERGAARD M, 1988, ACTA NEUROL SCAND, V77, P81, DOI 10.1111/j.1600-0404.1988.tb05878.x; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2016, J NEUROSURG-SPINE, V25, P398, DOI 10.3171/2016.1.SPINE151317; Saadoun S, 2017, J NEUROL NEUROSUR PS, V88, P452, DOI 10.1136/jnnp-2016-314600; Saadoun S, 2016, BRIT J NEUROSURG, V30, P582, DOI 10.3109/02688697.2016.1173191; Safar ME, 2004, HYPERTENSION, V44, P121, DOI 10.1161/01.HYP.0000135448.73199.75; Soubeyrand M, 2014, EUR SPINE J, V23, P658, DOI 10.1007/s00586-013-3086-9; Strauch JT, 2007, ANN THORAC SURG, V83, P2130, DOI 10.1016/j.athoracsur.2007.01.060; Streijger F, 2017, J NEUROTRAUM, V34, P3336, DOI 10.1089/neu.2017.5034; Streijger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078765; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; Werndle MC, 2016, ACTA NEUROCHIR SUPPL, V122, P323, DOI 10.1007/978-3-319-22533-3_64; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Werndle MC, 2012, J NEUROTRAUM, V29, P880, DOI 10.1089/neu.2011.2038	41	20	20	2	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2019	36	6					919	929		10.1089/neu.2018.5961			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HR6BH	WOS:000463232300008	30351245				2021-06-18	
J	Zhou, JY; Deng, YY; Li, F; Yin, CX; Shi, JS; Gong, QH				Zhou, Jiayin; Deng, Yuanyuan; Li, Fei; Yin, Caixia; Shi, Jingshan; Gong, Qihai			Icariside II attenuates lipopolysaccharide-induced neuroinflammation through inhibiting TLR4/MyD88/NF-kappa B pathway in rats	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Icariside II; Lipopolysaccharide; Neuroinflammation; Toll-like 4; Brain	LPS-INDUCED NEUROINFLAMMATION; EPIMEDIUM-BREVICORNUM; COGNITIVE DEFICITS; MAJOR CONSTITUENT; INDUCED APOPTOSIS; INFLAMMATION; ACTIVATION; ICARIIN; MICE	Inflammation in central nervous system (CNS) plays a vital role in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Lewy body dementia (DLB), HIV-related dementia and traumatic brain injury. Icariside II (ICS II), an active flavonoid compound derived from a Chinese herbal medicine Epimedium brevicornum Maxim, has been shown to possess a neuroprotective effect on AD model. However, whether ICS II has a directly protective effect on acute neuroinflammation remains still unclear. Therefore, the current study was designed to investigate the possible protective effect of ICS II on acute neuroinflammation induced by intracerebroventricular (ICV) injection of lipopolysaccharide (LPS), and further to explore its possible mechanism. After ICS II was prophylactically administered for 7 days before LPS injection, the rats were randomly divided into five groups as follows: sham group (n = 9), sham + ICS II-H (10 mg/kg) (n = 9), LPS (n = 14), LPS + ICS II-L (3 mg/kg) (n = 14), LPS + ICS II-H (10 mg/kg) (n = 14) groups, respectively. As expected, LPS injection exhibited neuronal morphological damage, and ionized calcium binding adapter molecule 1 (IBA-1) of microglia and glial fibrillary acidic protein (GFAP) of astrocyte were activated. However, pre-treatment with ICS II not only inhibited the activation of microglia and astrocyte, but also significantly reversed the expressions of inflammatory factors such as interleukin-1 beta (IL-1 beta), tumor necrosis factor (TNF-alpha), cyclooxygenase-2 (COX-2), as well as the expressions of Toll-Like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88) and TNF receptor associated factor 6 (TRAF6). Furthermore, ICS II inhibited the degradation of I kappa B and the following activation of NF-kappa B. Hence it is concluded that ICS II attenuates LPS-induced neuroinflammation through inhibiting TLR4/MyD88/NF-kappa B pathway in rats, and it has potential value as a new therapeutic agent to treat neuroinflammation-related diseases, such as AD.	[Zhou, Jiayin; Deng, Yuanyuan; Li, Fei; Yin, Caixia; Shi, Jingshan; Gong, Qihai] Zunyi Med Univ, Minist Educ, Key Lab Basic Pharmacol, Zunyi 563000, Guizhou, Peoples R China; [Zhou, Jiayin; Deng, Yuanyuan; Li, Fei; Shi, Jingshan; Gong, Qihai] Zunyi Med Univ, Minist Educ, Joint Int Res Lab Ethnomed, Zunyi 563003, Guizhou, Peoples R China	Gong, QH (corresponding author), Zunyi Med Univ, 6 Xuefu West Rd, Zunyi 563000, Guizhou, Peoples R China.	gqh@zmc.edu.cn	Qihai, Gong/AAM-9343-2021; shan, Shi Jing/AAX-7736-2020	shan, Shi Jing/0000-0002-2537-1751; Deng, Yuanyuan/0000-0003-3366-165X	Program for excellent young talents of Zunyi Medical Uiverstity [15zy-002]; Science and Technology Innovation Talent Team of Guizhou Province [20154023]; "hundred" level of high-level innovative talents in Guizhou Province [QKHRCPT 20165684]; Program for Changjiang Scholars and Innovative Research Team in University, ChinaProgram for Changjiang Scholars & Innovative Research Team in University (PCSIRT) [IRT_17R113]	This work was supported by the Program for excellent young talents of Zunyi Medical Uiverstity (Grant No. 15zy-002), the Science and Technology Innovation Talent Team of Guizhou Province (Grant No. 20154023), the "hundred" level of high-level innovative talents in Guizhou Province (Grant No. QKHRCPT 20165684), and Program for Changjiang Scholars and Innovative Research Team in University, China (Grant No. IRT_17R113).	Azam F, 2017, J BIOMOL STRUCT DYN, V36, P1; Badshah H, 2016, SCI REP-UK, V6, DOI 10.1038/srep24493; Buttner-Ennever J., 1997, J ANAT, V191, P315, DOI [10.1046/j.1469-7580.1997.191203153.x, DOI 10.1046/J.1469-7580.1997.191203153.X]; Chang X, 2015, EXP CELL RES, V334, P136, DOI 10.1016/j.yexcr.2015.04.004; Cheng T, 2015, MOLECULES, V20, P21274, DOI 10.3390/molecules201219763; Chu SH, 2014, INT IMMUNOPHARMACOL, V19, P317, DOI 10.1016/j.intimp.2014.01.018; Deng YY, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00039; Dhull DK, 2012, J CHEM NEUROANAT, V43, P48, DOI 10.1016/j.jchemneu.2011.10.001; Fu SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094604; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Kempuraj D., 2016, J NEUROL NEUROSURG S, V1; Lee KS, 2009, CANCER LETT, V280, P93, DOI 10.1016/j.canlet.2009.02.024; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Li WX, 2015, PHARMACOL BIOCHEM BE, V138, P40, DOI 10.1016/j.pbb.2015.09.001; Lin ST, 2008, MOL CELL BIOCHEM, V315, P41, DOI 10.1007/s11010-008-9787-4; Liu LP, 2013, ACTA PHARMACOL SIN, V34, P455, DOI 10.1038/aps.2013.11; Ma J, 2017, ONCOTARGET, V8, P27676, DOI 10.18632/oncotarget.15398; Minghetti L, 2005, CURR OPIN NEUROL, V18, P315, DOI 10.1097/01.wco.0000169752.54191.97; Nasrallah FA, 2016, NEUROIMAGE, V127, P196, DOI 10.1016/j.neuroimage.2015.08.013; Niranjan R, 2013, MOL NEUROBIOL, V48, P412, DOI 10.1007/s12035-013-8428-4; QUAN N, 1994, J NEUROIMMUNOL, V49, P125, DOI 10.1016/0165-5728(94)90188-0; Ryan SM, 2016, AGEING RES REV, V27, P77, DOI 10.1016/j.arr.2016.03.007; Song J, 2017, MOL CARCINOGEN, V56, P36, DOI 10.1002/mc.22471; Song J, 2012, CHEM-BIOL INTERACT, V199, P9, DOI 10.1016/j.cbi.2012.05.005; Tweedie D, 2009, J NEUROSCI METH, V183, P182, DOI 10.1016/j.jneumeth.2009.06.034; Tyagi E, 2008, J NEUROIMMUNOL, V205, P51, DOI 10.1016/j.jneuroim.2008.08.015; Venezia S, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0195-7; Vullhorst D, 2017, J NEUROSCI, V37, P5232, DOI 10.1523/JNEUROSCI.2630-16.2017; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Woodling NS, 2016, ACS CHEM NEUROSCI, V7, P454, DOI 10.1021/acschemneuro.6b00016; Xia Y, 2006, BRAIN RES, V1095, P85, DOI 10.1016/j.brainres.2006.03.112; Yan BY, 2014, BRAIN RES, V1573, P63, DOI 10.1016/j.brainres.2014.05.023; Yan LL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00106; Yin CX, 2016, NEUROSCIENCE, V328, P69, DOI 10.1016/j.neuroscience.2016.04.022; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Yu Q, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8470381; Zhang Guo-Xia, 2013, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V29, P42; Zong N, 2016, BEHAV BRAIN RES, V313, P111, DOI 10.1016/j.bbr.2016.06.055	40	20	21	1	10	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	MAR	2019	111						315	324		10.1016/j.biopha.2018.10.201			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	HL5AK	WOS:000458737800034	30590319	Other Gold			2021-06-18	
J	Fernandes, FAO; de Sousa, RJA; Ptak, M; Migueis, G				Fernandes, Fabio A. O.; Alves de Sousa, Ricardo J.; Ptak, Mariusz; Migueis, Goncalo			Helmet Design Based on the Optimization of Biocomposite Energy-Absorbing Liners under Multi-Impact Loading	APPLIED SCIENCES-BASEL			English	Article						agglomerated cork; helmets; finite element head model; brain injuries; head trauma; cellular materials; protective devices; passive safety; traumatic brain injury; sustainable solutions	MOTORCYCLE HELMETS; AGGLOMERATED CORK; BICYCLE HELMETS; HEAD; PERFORMANCE; SIMULATION; RISK	Cellular materials have been used in many applications such as insulation, packaging, and protective gear. Expanded polystyrene has been widely used as energy-absorbing liner in helmets due to its excellent cost-benefit relation. This synthetic material can absorb reasonable amounts of energy via permanent deformation. However, in real-world accidents, helmets may be subjected to multi-impact scenarios. Additionally, oil-derived plastic is presently a major source of societal concern regarding pollution and waste. As a sustainable alternative, cork is a natural cellular material with great crashworthiness properties and it has the remarkable capacity to recover after compression, due to its viscoelastic behavior, which is a desired characteristic in multi-impact applications. Therefore, the main goal is to analyze the applicability of agglomerated cork as padding material in safety helmets. First, a finite element model of a motorcycle helmet available on the market was developed to assess its safety performance and to establish a direct comparison between expanded polystyrene and cork agglomerates as liners. Secondly, a new helmet model with a generic geometry was developed to assess the applicability of agglomerated cork as liner for different types of helmets, based on the head injury risk predictions by the finite element head model, YEt Another Head Model (YEAHM), developed by the authors. Several versions of helmet liners were created by varying its thickness and removing sections of material. In other words, this generic helmet was optimized by carrying out a parametric study, and by comparing its performance under double impacts. The results from these tests indicate that agglomerated cork liners are an excellent alternative to the synthetic ones. Thus, agglomerated cork can be employed in protective gear, improving its overall performance and capacity to withstand multi-impacts.	[Fernandes, Fabio A. O.; Alves de Sousa, Ricardo J.; Migueis, Goncalo] Univ Aveiro, TEMA Ctr Mech Technol & Automat, Dept Mech Engn, Campus Santiago, P-3810193 Aveiro, Portugal; [Ptak, Mariusz] Wroclaw Univ Sci & Technol, Fac Mech Engn, Dept Machine Design & Res, Lukasiewicza 7-9, PL-50371 Wroclaw, Poland	Fernandes, FAO (corresponding author), Univ Aveiro, TEMA Ctr Mech Technol & Automat, Dept Mech Engn, Campus Santiago, P-3810193 Aveiro, Portugal.	fabiofernandes@ua.pt; rsousa@ua.pt; mariusz.ptak@pwr.edu.pl; migueisgoncalo@ua.pt	de Sousa, Ricardo Alves/E-4405-2010; Fernandes, Fabio A.O./H-2680-2012; Ptak, Mariusz/B-1493-2013	de Sousa, Ricardo Alves/0000-0002-5848-6424; Fernandes, Fabio A.O./0000-0001-9751-8807; Ptak, Mariusz/0000-0001-8081-8336	Fundacao para a Ciencia e a Tecnologia (FCT)Portuguese Foundation for Science and TechnologyEuropean Commission [UID/EMS/00481/2013-FCT, CENTRO-01-0145-FEDER-022083, CEECIND/01192/2017]	The authors greatly acknowledge the support given by Fundacao para a Ciencia e a Tecnologia (FCT): UID/EMS/00481/2013-FCT, CENTRO-01-0145-FEDER-022083 and CEECIND/01192/2017.	ABNT (AssociacAo Brasileira de Normas Tecnicas), 2001, 74712001 ABNT NBR; [Anonymous], 2010, ABAQUS 6 10 DOC; de Oliveira NLB, 2011, REV LAT-AM ENFERM, V19, P403, DOI 10.1590/S0104-11692011000200024; Becker E.B., 2015, P IRCOBI C LYON FRAN; Bil M, 2018, SAFETY SCI, V105, P71, DOI 10.1016/j.ssci.2018.02.005; Bilston LE, 2011, BIOL MED PHYS BIOMED, P69, DOI 10.1007/978-1-4419-9997-9_4; Blanco DH, 2014, P I MECH ENG P-J SPO, V228, P95, DOI 10.1177/1754337113518748; Brugger O., 2010, SNOW SPORT HELMETS I; Caserta GD, 2011, COMPOS STRUCT, V93, P2748, DOI 10.1016/j.compstruct.2011.05.029; Coelho RM, 2013, MATER DESIGN, V43, P384, DOI 10.1016/j.matdes.2012.07.020; Cui L, 2009, MATER DESIGN, V30, P3414, DOI 10.1016/j.matdes.2009.03.044; Deck C, 2003, STRUCT MAT, V13, P319; DeMarco AL, 2016, ACCIDENT ANAL PREV, V92, P175, DOI 10.1016/j.aap.2016.03.027; Fay P.A., 2001, P IRCOBI C ISL MAN U, P1; Fernandes FAO, 2017, PROCEDIA MANUF, V13, P227, DOI 10.1016/j.promfg.2017.09.055; Fernandes FAO, 2015, MATER DESIGN, V82, P335, DOI 10.1016/j.matdes.2015.06.004; Fernandes FAO, 2014, MATER DESIGN, V58, P499, DOI 10.1016/j.matdes.2014.02.011; Fernandes FAO, 2013, ACCIDENT ANAL PREV, V56, P1, DOI 10.1016/j.aap.2013.03.011; Fernandes F. A. O., 2013, P IRCOBI C GOTH, P431; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P1, DOI 10.1007/978-3-319-89926-8_1; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P41, DOI 10.1007/978-3-319-89926-8_3; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P59, DOI 10.1007/978-3-319-89926-8_4; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P25, DOI 10.1007/978-3-319-89926-8_2; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Fernandes FAO, 2013, STRUCT ENG MECH, V48, P661, DOI 10.12989/sem.2013.48.5.661; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P1, DOI 10.1007/978-3-319-89926-8; Gadd C. W., 1966, P 10 STAPP CAR CRASH, P164; Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027; Goel R, 2011, THESIS; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Jardin RT, 2015, MATER DESIGN, V68, P121, DOI 10.1016/j.matdes.2014.12.016; Kaczynski P, 2019, INT J IMPACT ENG, V126, P109, DOI 10.1016/j.ijimpeng.2018.12.001; Khosroshahi SF, 2018, MATER TODAY COMMUN, V14, P312, DOI 10.1016/j.mtcomm.2018.02.002; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Klug C., 2015, P IRCOBI C LYON FRAN; Lin MR, 2008, ACCIDENT ANAL PREV, V40, P1653, DOI 10.1016/j.aap.2008.05.005; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mills NJ, 2009, INT J IMPACT ENG, V36, P913, DOI 10.1016/j.ijimpeng.2008.12.011; MILLS NJ, 1992, P ANN C ASS, P149; Morgan D.E., 2007, CONE HEAD TECHNOLOGY; Nahum AM., 1977, P 21 STAPP CAR CRASH, P339, DOI [10.4271/770922., DOI 10.4271/770922]; Pinnoji P.K., 2006, P IRCOBI C MADR, P159; Pinnoji PK, 2008, INT J CRASHWORTHINES, V13, P265, DOI 10.1080/13588260801933626; Post A., 2014, P IRCOBI C BERL GERM, P72; Pratellesi A, 2011, INT J CRASHWORTHINES, V16, P523, DOI 10.1080/13588265.2011.611397; Ptak M, 2017, INT J IMPACT ENG, V106, P238, DOI 10.1016/j.ijimpeng.2017.04.014; Ptak M, 2019, MATERIALS, V12, DOI 10.3390/ma12010151; Ren LH, 2017, INT CONF MEAS, P279, DOI [10.1109/ICMTMA.2017.73, 10.1109/ICMTMA.2017.0074]; Rice TM, 2016, ACCIDENT ANAL PREV, V91, P200, DOI 10.1016/j.aap.2016.03.002; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rueda MAF, 2009, MATER DESIGN, V30, P3405, DOI 10.1016/j.matdes.2009.03.037; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Santos PT, 2017, COMPOS STRUCT, V178, P277, DOI 10.1016/j.compstruct.2017.07.035; Shuaeib FM, 2007, MATER DESIGN, V28, P182, DOI 10.1016/j.matdes.2005.04.015; Smith T., 2014, THEORETICAL CALCULAT; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tinard V, 2012, MATER DESIGN, V37, P79, DOI 10.1016/j.matdes.2011.12.005; U. S. Department of Transportation Federal Motor Carrier Safety Administration, 218 US DEP TRANSP FE; Vallee H., 1984, IRCOBI C DELFT, P99; Vallee H., 1981, P IRCOBI C SALON DE, P176; World Health Organization, 2009, GLOB STAT REP ROAD S; Yang J, 2011, COMPUTATIONAL BIOMEC; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	68	20	20	0	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	FEB 2	2019	9	4							735	10.3390/app9040735			26	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Engineering; Materials Science; Physics	HO1UL	WOS:000460696500121		DOAJ Gold			2021-06-18	
J	Mocelin, R; Marcon, M; D'ambros, S; Mattos, J; Sachett, A; Siebel, AM; Herrmann, AP; Piato, A				Mocelin, Ricieri; Marcon, Matheus; D'ambros, Simone; Mattos, Juliane; Sachett, Adrieli; Siebel, Anna M.; Herrmann, Ana P.; Piato, Angelo			N-Acetylcysteine Reverses Anxiety and Oxidative Damage Induced by Unpredictable Chronic Stress in Zebrafish	MOLECULAR NEUROBIOLOGY			English	Article						N-acetylcysteine; Unpredictable chronic stress; Behavior; Oxidative status; Zebrafish	MANGANESE SUPEROXIDE-DISMUTASE; NEURODEGENERATIVE DISEASES; NITRIC-OXIDE; BRAIN-INJURY; MILD STRESS; DISORDERS; BEHAVIOR; DEPRESSION; INFLAMMATION; MECHANISMS	There is accumulating evidence on the use of N-acetylcysteine (NAC) in the treatment of patients with neuropsychiatric disorders. As a multi-target drug and a glutathione precursor, NAC is a promising molecule in the management of stress-related disorders, for which there is an expanding field of research investigating novel therapies targeting oxidative pathways. The deleterious effects of chronic stress in the central nervous system are a result of glutamatergic hyperactivation, glutathione (GSH) depletion, oxidative stress, and increased inflammatory response, among others. The aim of this study was to investigate the effects of NAC in zebrafish submitted to unpredictable chronic stress (UCS). Animals were initially stressed or not for 7days, followed by treatment with NAC (1mg/L, 10min) or vehicle for 7days. UCS decreased the number of entries and time spent in the top area in the novel tank test, which indicate increased anxiety levels. It also increased reactive oxygen species (ROS) levels and lipid peroxidation (TBARS) while decreased non-protein thiols (NPSH) and superoxide dismutase (SOD) activity. NAC reversed the anxiety-like behavior and oxidative damage observed in stressed animals. Additional studies are needed to investigate the effects of this agent on glutamatergic modulation and inflammatory markers related to stress. Nevertheless, our study adds to the existing body of evidence supporting the clinical evaluation of NAC in mood disorders, anxiety, post-traumatic stress disorder, and other conditions associated with stress.	[Mocelin, Ricieri; Marcon, Matheus; D'ambros, Simone; Mattos, Juliane; Sachett, Adrieli; Piato, Angelo] Univ Fed Rio Grande do Sul, Programa Posgrad Neurociencias, ICBS, Rua Sarmento Leite 500-305, BR-90050170 Porto Alegre, RS, Brazil; [Herrmann, Ana P.] Univ Fed Rio Grande do Sul, Programa Posgrad Farmacol & Terapeut, Rua Sarmento Leite 500-305, BR-90050170 Porto Alegre, RS, Brazil; [Siebel, Anna M.] Univ Comunitaria Regiao Chapeco, Programa Posgrad Ciencias Ambientais, Ave Senador Atilio Fontana 591E, BR-89809000 Chapeco, SC, Brazil; [Piato, Angelo] ZNRC, 309 Palmer Court, Slidell, LA 70458 USA	Piato, A (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Neurociencias, ICBS, Rua Sarmento Leite 500-305, BR-90050170 Porto Alegre, RS, Brazil.; Piato, A (corresponding author), ZNRC, 309 Palmer Court, Slidell, LA 70458 USA.	angelopiato@ufrgs.br	Mocelin, Ricieri Naue/E-4814-2015; Siebel, Anna M/D-1020-2013; , Matheus/L-1880-2018; Piato, Angelo/K-3444-2012; Siebel, Anna Maria/Y-7933-2019; Herrmann, Ana Paula/F-3694-2011	Mocelin, Ricieri Naue/0000-0001-7210-1247; Siebel, Anna M/0000-0002-7896-1456; , Matheus/0000-0002-1486-688X; Piato, Angelo/0000-0001-5109-7306; Siebel, Anna Maria/0000-0002-7896-1456; Herrmann, Ana Paula/0000-0002-0330-0741; Mattos, Juliane/0000-0001-9520-8098; Sachett, Adrieli/0000-0003-1058-6888	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [401162/2016-8, 302800/2017-4]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [17/2551-0000974-6]	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq, Proc. 401162/2016-8 and 302800/2017-4) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS, Proc. 17/2551-0000974-6).	Aschbacher K, 2013, PSYCHONEUROENDOCRINO, V38, P1698, DOI 10.1016/j.psyneuen.2013.02.004; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Barreiro E, 2005, EUR RESPIR J, V26, P1032, DOI 10.1183/09031936.05.00003705; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Berk M, 2014, J CLIN PSYCHIAT, V75, P628, DOI 10.4088/JCP.13m08454; Berk M, 2013, TRENDS PHARMACOL SCI, V34, P167, DOI 10.1016/j.tips.2013.01.001; Biala G, 2018, MOL NEUROBIOL, V55, P3270, DOI 10.1007/s12035-017-0585-4; Biala G, 2017, MOL NEUROBIOL, V54, P904, DOI 10.1007/s12035-016-9701-0; Cacciatore I, 2010, MOLECULES, V15, P1242, DOI 10.3390/molecules15031242; Chen S, 2014, NEUROPATH APPL NEURO, V40, P759, DOI 10.1111/nan.12103; Chen T, 2016, INFLAMMATION, V39, P483, DOI 10.1007/s10753-015-0272-4; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Collier A.D., 2017, RIGHTS WRONGS ZEBRAF, P45, DOI [10.1007/978-3-319-33774-6_3., DOI 10.1007/978-3-319-33774-6_3]; Cummings JL, 2006, NAT REV DRUG DISCOV, V5, P64, DOI 10.1038/nrd1928; de Andrade KQ, 2015, INT J MOL SCI, V16, P30269, DOI 10.3390/ijms161226225; Dean O, 2011, J PSYCHIATR NEUROSCI, V36, P78, DOI 10.1503/jpn.100057; Deepmala, 2015, NEUROSCI BIOBEHAV R, V55, P294, DOI 10.1016/j.neubiorev.2015.04.015; Duman RS, 2016, NAT MED, V22, P238, DOI 10.1038/nm.4050; Fernandes BS, 2016, J CLIN PSYCHIAT, V77, pE457, DOI 10.4088/JCP.15r09984; Filipovic D, 2009, GEN PHYSIOL BIOPHYS, V28, P53; Ortiz GG, 2017, ADV PROTEIN CHEM STR, V108, P1, DOI 10.1016/bs.apcsb.2017.01.003; Gawali NB, 2017, BRAIN RES, V1663, P66, DOI 10.1016/j.brainres.2017.03.004; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Herrmann AP, 2014, SCHIZOPHR RES, V155, P109, DOI 10.1016/j.schres.2014.03.012; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Keller JN, 1998, J NEUROSCI, V18, P687; Kowalczyk-Pachel D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147238; Kumar B, 2011, PSYCHOPHARMACOLOGY, V214, P819, DOI 10.1007/s00213-010-2094-2; Kysil EV, 2017, ZEBRAFISH, V14, P197, DOI 10.1089/zeb.2016.1415; MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004; Mao GW, 2016, MOL BIOL REP, V43, P31, DOI 10.1007/s11033-015-3935-1; Marcon M, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.176735; Marcon M, 2016, PSYCHOPHARMACOLOGY, V233, P3815, DOI 10.1007/s00213-016-4408-5; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Minarini A, 2017, EXPERT OPIN DRUG MET, V13, P279, DOI 10.1080/17425255.2017.1251580; Mocelin R, 2018, NEUROCHEM RES, V43, P458, DOI 10.1007/s11064-017-2442-2; Mocelin R, 2015, PHARMACOL BIOCHEM BE, V139, P121, DOI 10.1016/j.pbb.2015.08.006; Muller TE, 2017, PROG NEURO-PSYCHOPH, V79, P105, DOI 10.1016/j.pnpbp.2017.05.026; Musazzi L, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8389737; Nagata K, 2007, RESP MED, V101, P800, DOI 10.1016/j.rmed.2006.07.017; Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5; Olivenza R, 2000, J NEUROCHEM, V74, P785, DOI 10.1046/j.1471-4159.2000.740785.x; Park CS, 2015, ELIFE, V4, DOI 10.7554/eLife.10829; Peterlik D, 2016, CURR NEUROPHARMACOL, V14, P514, DOI 10.2174/1570159X13666150515234920; Piato AL, 2011, PROG NEURO-PSYCHOPH, V35, P561, DOI 10.1016/j.pnpbp.2010.12.018; Pittman J, 2017, RIGHTS WRONGS ZEBRAF, P33, DOI [10.1007/978-3-319-33774-6_2, DOI 10.1007/978-3-319-33774-6_2]; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Rambo CL, 2017, PHYSIOL BEHAV, V171, P50, DOI 10.1016/j.physbeh.2016.12.032; Sandi C, 2015, NAT REV NEUROSCI, V16, P290, DOI 10.1038/nrn3918; Santos P, 2017, BEHAV BRAIN RES, V317, P461, DOI 10.1016/j.bbr.2016.10.010; Schneider R, 2017, NEUROCHEM RES, V42, P2135, DOI 10.1007/s11064-017-2218-8; Schneider R, 2015, ALCOHOL, V49, P259, DOI 10.1016/j.alcohol.2015.01.009; Shahripour RB, 2014, BRAIN BEHAV, V4, P108, DOI 10.1002/brb3.208; SLOT JW, 1986, LAB INVEST, V55, P363; Song C, 2018, PROG NEURO-PSYCHOPH, V81, P384, DOI 10.1016/j.pnpbp.2017.08.021; Thakur T, 2017, INT IMMUNOPHARMACOL, V50, P236, DOI 10.1016/j.intimp.2017.07.002; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Yang YY, 2008, J HEPATOL, V49, P25, DOI 10.1016/j.jhep.2008.02.012	59	20	20	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	FEB	2019	56	2					1188	1195		10.1007/s12035-018-1165-y			8	Neurosciences	Neurosciences & Neurology	HN8TY	WOS:000460470300029	29876880				2021-06-18	
J	Kanser, RJ; Rapport, LJ; Bashem, JR; Hanks, RA				Kanser, Robert J.; Rapport, Lisa J.; Bashem, Jesse R.; Hanks, Robin A.			Detecting malingering in traumatic brain injury: Combining response time with performance validity test accuracy	CLINICAL NEUROPSYCHOLOGIST			English	Article						Traumatic brain injury; malingering; response time; performance validity	RECOGNITION MEMORY TEST; CLINICAL NEUROPSYCHOLOGY; AMERICAN ACADEMY; RETENTION TRIAL; CLASSIFICATION ACCURACY; BELIEFS; SCORES; SPECIFICITY; SENSITIVITY; SIMULATION	Objective: The present study examined the incremental utility of item-level response time (RT) variables on a traditional performance validity test in distinguishing adults with verified TBI from adults coached to feign neurocognitive impairment. Method: Participants were 45 adults with moderate to severe TBI, 45 healthy adults coached to feign neurocognitive impairment (SIM), and 61 healthy adult comparisons providing full effort (HC). All participants completed a computerized version of the Test of Memory Malingering (TOMM-C) in the context of a larger test battery. RT variables examined along with TOMM-C accuracy scores included mean RTs (Trial 1, Trial 2, correct and incorrect trials) and RT variability indices. Results: Several RT indices differed significantly across the groups. In general, SIM produced longer, more variable RTs than HC and TBI. Of the RT indices, average RT for Trial 1 and 2 were the best predictors of group membership; however, classification accuracies were greatly influenced by the groups being compared. Average RT for Trial 1 and 2 showed excellent discrimination of SIM and HC. All RT indices were less successful in discriminating SIM and TBI. Average RT for Trial 1 and 2 added incremental predictive value to TOMM-C accuracy in distinguishing SIM from TBI. Conclusion: Findings contribute to a limited body of research examining the incremental utility of combining RT with traditional PVTs in distinguishing feigned and bona fide TBI. Findings support the hypothesis that combining RT with TOMM-C accuracy can improve its diagnostic accuracy. Future research with other groups of clinical interest is recommended.	[Kanser, Robert J.; Rapport, Lisa J.; Bashem, Jesse R.] Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA	Kanser, RJ (corresponding author), Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA.	robert.kanser@wayne.edu			National Institute on Disability, Independent Living and Rehabilitation ResearchUnited States Department of Health & Human Services [90IFOO92]; Wayne State University Graduate School Thesis and Dissertation grants (Kanser, Bashem)	This research was supported by grants from the National Institute on Disability, Independent Living and Rehabilitation Research [grant number 90IFOO92, Rapport] and Wayne State University Graduate School Thesis and Dissertation grants (Kanser, Bashem).	Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Axelrod BN, 2002, INT J NEUROSCI, V112, P1479, DOI 10.1080/00207450290158377; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Bolan B, 2002, J CLIN EXP NEUROPSYC, V24, P154, DOI 10.1076/jcen.24.2.154.1000; Booksh RL, 2007, ARCH CLIN NEUROPSYCH, V22, P87, DOI 10.1016/j.acn.2006.11.002; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Essig SM, 2001, ARCH CLIN NEUROPSYCH, V16, P271, DOI 10.1016/S0887-6177(99)00065-7; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P117, DOI 10.1016/j.acn.2005.06.009; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hosmer D. W., 2000, APPL LOGISTIC REGRES, DOI [10. 1002/0471722146, DOI 10.1002/0471722146, 10.1002/0471722146]; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kireev M, 2013, INT J PSYCHOPHYSIOL, V90, P291, DOI 10.1016/j.ijpsycho.2013.09.005; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Pearson, 2009, WECHSL MEM SCAL; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Reicker LI, 2008, ARCH CLIN NEUROPSYCH, V23, P419, DOI 10.1016/j.acn.2008.02.003; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Schroeder RW, 2013, ARCH CLIN NEUROPSYCH, V28, P21, DOI 10.1093/arclin/acs094; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sun DL, 2015, CEREB CORTEX, V25, P927, DOI 10.1093/cercor/bht284; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Tabachnick B.G., 2012, USING MULTIVARIATE S; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 1996, TEST MEMORY MALINGER; Tombaugh TN, 2000, MANUAL COMPUTERIZED; Vagnini VL, 2008, J CLIN EXP NEUROPSYC, V30, P766, DOI 10.1080/13803390701754746; van Hooff JC, 2009, INT J PSYCHOPHYSIOL, V73, P246, DOI 10.1016/j.ijpsycho.2009.04.002; Vanderslice-Barr JL, 2011, APPL NEUROPSYCHOL, V18, P34, DOI 10.1080/09084282.2010.523377; Warrington EK., 1984, RECOGNITION MEMORY T; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595	58	20	21	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2019	33	1					90	107		10.1080/13854046.2018.1440006			18	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	HK9OC	WOS:000458320100006	29469640				2021-06-18	
J	Corrigan, JD; Yang, JZ; Singichetti, B; Manchester, K; Bogner, J				Corrigan, John D.; Yang, Jingzhen; Singichetti, Bhavna; Manchester, Kara; Bogner, Jennifer			Lifetime prevalence of traumatic brain injury with loss of consciousness	INJURY PREVENTION			English	Article						Traumatic Brain Injury; Concussion; Descriptive Epidemiology	UNITED-STATES; SUBSTANCE USE; POPULATION; HEALTH; IDENTIFICATION; RELIABILITY; DISABILITY; VALIDITY; HISTORY; TBI	Objective To determine the prevalence of lifetime history of traumatic brain injury (TBI) with loss of consciousness (LOC) among adult, non-institutionalised residents of Ohio. Methods We analysed data from 2014 Ohio Behavioral Risk Factor Surveillance System, which included a state-specific module designed to elicit lifetime history of TBI. Results Of non-institutionalised adults 18 years and over living in Ohio, 21.7% reported at least one lifetime TBI with LOC, 2.6% experienced at least one moderate or severe such injury, 9.1% experienced a TBI with LOC before age 15 years and 10.8% experienced either TBI with LOC before age 15 years or a moderate or severe injury. Males, those with lower incomes and those unable to work were more likely to have incurred at least one TBI with LOC, multiple TBIs with LOC, a moderate or severe TBI and a TBI with LOC before age15. Conclusions One in five adults experienced TBIs of sufficient severity to cause LOC; 3% experienced at least one moderate or severe TBI and almost 10% experienced a first TBI with LOC before the age of 15 years. The prevalence of lifetime TBI in the present study suggests that there may be a substantially greater burden of injury than concluded from previous prevalence estimates.	[Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA; [Yang, Jingzhen; Singichetti, Bhavna] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Columbus, OH USA; [Manchester, Kara] Ohio Dept Hlth, Violence & Injury Prevent Program, Columbus, OH 43266 USA	Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA.	corrigan.1@osu.edu	Corrigan, John D./E-2921-2011	Singichetti, Bhavna/0000-0002-2188-3979			[Anonymous], BEH RISK FACT SURV S; [Anonymous], 2015, OH 2013 BRFSS ANN RE; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bureau of Health Statistics and Data Management, 1998, NEW HAMPSH BEH RISK; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Centers for Disease Control and Prevention, 2015, C TRAUM BRAIN INJ US; Coronado V.G., 2012, BRAIN INJURY MED PRI; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2016, J HEAD TRAUMA REHAB, V31, pE36, DOI 10.1097/HTR.0000000000000075; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; IOM NRC, 2014, SPORTS RELATED CONCU; Janak JC, 2015, TRAUMATIC BRAIN INJU; King JB, 2016, NEUROIMAGE-CLIN, V11, P81, DOI 10.1016/j.nicl.2016.01.003; Lee T. A., 2013, DEV PROTOCOL OBSERVA; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Section HS, 2001, COL BEH RISK FACT SU; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Warner M, 2005, INJURY PREV, V11, P282, DOI 10.1136/ip.2004.006965; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Winqvist S., 2006, J ADOLESC HLTH, V39, DOI [10.1016/j.jadohealth.2005.12.019, DOI 10.1016/J.JADOHEALTH.2005.12.019]; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	40	20	20	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	DEC	2018	24	6					396	404		10.1136/injuryprev-2017-042371			9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	HD7XQ	WOS:000452767700002	28848057				2021-06-18	
J	Jang, C; Yadav, DK; Subedi, L; Venkatesan, R; Venkanna, A; Afzal, S; Lee, E; Yoo, J; Ji, E; Kim, SY; Kim, MH				Jang, Cheongyun; Yadav, Dharmendra K.; Subedi, Lalita; Venkatesan, Ramu; Venkanna, Arramshetti; Afzal, Sualiha; Lee, Eunhee; Yoo, Jaewook; Ji, Eunhee; Kim, Sun Yeou; Kim, Mi-hyun			Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN INJURY; AMYLOID-BETA-PEPTIDES; IN-VITRO EVALUATION; ALZHEIMERS-DISEASE; ACID-DERIVATIVES; HUMAN BUTYRYLCHOLINESTERASE; IMMUNOMODULATORY ACTIVITY; ANTICANCER ACTIVITY; PERIPHERAL SITE; GAMMA-SECRETASE	In this study, pharmacophore based 3D QSAR models for human acetylcholinesterase (AChE) inhibitors were generated, with good significance, statistical values (r(training)(2) = 0.73) and predictability (q(training)(2) = 0.67). It was further validated by three methods (Fischer's test, decoy set and Guner-Henry scoring method) to show that the models can be used to predict the biological activities of compounds without costly and time-consuming synthesis. The criteria for virtual screening were also validated by testing the selective AChE inhibitors. Virtual screening experiments and subsequent in vitro evaluation of promising hits revealed a novel and selective AChE inhibitor. Thus, the findings reported herein may provide a new strategy for the discovery of selective AChE inhibitors. The IC50 value of compounds 5c and 6a presented selective inhibition of AChE without inhibiting butyrylcholinesterase (BChE) at uM level. Molecular docking studies were performed to explain the potent AChE inhibition of the target compounds studies to explain high affinity.	[Kim, Mi-hyun] Gachon Univ, Coll Pharm, Gachon Inst Pharmaceut Sci, Incheon, South Korea; Gachon Univ, Coll Pharm, Dept Pharm, Incheon, South Korea	Kim, MH (corresponding author), Gachon Univ, Coll Pharm, Gachon Inst Pharmaceut Sci, Incheon, South Korea.	kmh0515@gachon.ac.kr	Subedi, Lalita/I-5943-2019; Kim, Mi-hyun/L-7805-2014; Yadav, Dharmendra Kumar/L-1846-2015	Subedi, Lalita/0000-0003-4851-7650; Kim, Mi-hyun/0000-0002-2718-5637; Yadav, Dharmendra Kumar/0000-0003-1102-1993	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2017R1E1A1A01076642, 2017R1C1B2003380]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry for Health and Welfare, Korea [HI14C1135]	This study was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (No.: 2017R1E1A1A01076642 and 2017R1C1B2003380). In addition, a grant was also provided by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry for Health and Welfare, Korea (HI14C1135).	Ahmed M, 2006, CHEM-BIOL INTERACT, V162, P165, DOI 10.1016/j.cbi.2006.06.002; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; ARIENS EJ, 1967, ANN NY ACAD SCI, V139, P606, DOI 10.1111/j.1749-6632.1967.tb41232.x; Babic T, 1999, J NEUROL NEUROSUR PS, V67, P558, DOI 10.1136/jnnp.67.4.558; BRISMAR K, 1987, ACTA MED SCAND, V221, P155; Cereto-Massague A, 2012, BIOINFORMATICS, V28, P1661, DOI 10.1093/bioinformatics/bts249; Cheung J, 2013, ACS MED CHEM LETT, V4, P1091, DOI 10.1021/ml400304w; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; Dinamarca MC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-4; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; DRAYER DE, 1987, PHARMACOTHERAPY, V7, P87; Dziedzic T, 2007, J NEUROL SCI, V252, P53, DOI 10.1016/j.jns.2006.10.007; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gadhe CG, 2015, ARCH PHARM RES, V38, P2008, DOI 10.1007/s12272-015-0607-6; Gadhe CG, 2015, MOL BIOSYST, V11, P618, DOI 10.1039/c4mb00568f; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gaur R, 2015, CURR TOP MED CHEM, V15, P1003, DOI 10.2174/1568026615666150317222059; Golbraikh A, 2002, J COMPUT AID MOL DES, V16, P357, DOI 10.1023/A:1020869118689; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; Hamblin JN, 2008, BIOORG MED CHEM LETT, V18, P4237, DOI 10.1016/j.bmcl.2008.05.052; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P13603, DOI 10.1073/pnas.0702756104; Igbavboa U, 2006, NEUROSCIENCE, V142, P655, DOI 10.1016/j.neuroscience.2006.06.056; Inestrosa NC, 1996, NEURON, V16, P881, DOI 10.1016/S0896-6273(00)80108-7; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Fernandez-Bachiller MI, 2010, J MED CHEM, V53, P4927, DOI 10.1021/jm100329q; Kihara T, 2004, ACTA NEUROBIOL EXP, V64, P99; Kim MH, 2015, CHEM-ASIAN J, V10, P1318, DOI 10.1002/asia.201403417; Kim MH, 2013, BIOORGAN MED CHEM, V21, P2271, DOI 10.1016/j.bmc.2013.02.021; Kim MH, 2013, BIOORG MED CHEM LETT, V23, P1639, DOI 10.1016/j.bmcl.2013.01.082; Kim MH, 2011, BIOORGAN MED CHEM, V19, P1915, DOI 10.1016/j.bmc.2011.01.067; Kirchmair J, 2008, J COMPUT AID MOL DES, V22, P213, DOI 10.1007/s10822-007-9163-6; Kryger G, 2000, ACTA CRYSTALLOGR D, V56, P1385, DOI 10.1107/S0907444900010659; Laowattana S, 2007, NEUROLOGY, V68, P509, DOI 10.1212/01.wnl.0000253186.23949.fd; Martinez A, 2006, EXPERT OPIN INV DRUG, V15, P1, DOI 10.1517/13543784.15.1.1; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mautes AEM, 2001, ACTA NEUROCHIR, V143, P51, DOI 10.1007/s007010170138; MCAINSH J, 1990, PHARMACOL THERAPEUT, V46, P163, DOI 10.1016/0163-7258(90)90092-G; MCGAHAN DJ, 1984, DRUG INTEL CLIN PHAR, V18, P601, DOI 10.1177/106002808401800709; MIDDLEMISS DN, 1977, NATURE, V267, P289, DOI 10.1038/267289a0; Minati L, 2009, AM J ALZHEIMERS DIS, V24, P95, DOI 10.1177/1533317508328602; Nachon F, 2013, BIOCHEM J, V453, P393, DOI 10.1042/BJ20130013; Nepovimova E, 2014, J MED CHEM, V57, P8576, DOI 10.1021/jm5010804; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Ochiai K, 2012, BIOORG MED CHEM LETT, V22, P5833, DOI 10.1016/j.bmcl.2012.07.088; Orhan I, 2004, J ETHNOPHARMACOL, V91, P57, DOI 10.1016/j.jep.2003.11.016; Ota T, 2010, CLIN NEUROPHARMACOL, V33, P74, DOI 10.1097/WNF.0b013e3181c71be9; PAYKEL ES, 1982, J CLIN PSYCHOPHARM, V2, P14, DOI 10.1097/00004714-198202000-00004; Prati F, 2013, BIOORG MED CHEM LETT, V23, P6254, DOI 10.1016/j.bmcl.2013.09.091; Rafii MS, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0297-4; Roberts BC, 2008, J CHEM INF MODEL, V48, P397, DOI 10.1021/ci700285e; RUFFOLO RR, 1995, J MED CHEM, V38, P3681, DOI 10.1021/jm00019a001; Savitz SI, 2000, J CEREBR BLOOD F MET, V20, P1197, DOI 10.1097/00004647-200008000-00005; Saxena A, 1997, BIOCHEMISTRY-US, V36, P14642, DOI 10.1021/bi971425+; SCHLEIFER SJ, 1991, AM HEART J, V121, P1397, DOI 10.1016/0002-8703(91)90144-7; Schrodinger L., 2013, SMALL MOL DRUG DISCO; Sheridan RP, 2001, J CHEM INF COMP SCI, V41, P1395, DOI 10.1021/ci0100144; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; STEINER TJ, 1988, HEADACHE, V28, P15, DOI 10.1111/j.1365-2524.1988.hed2801015.x; Sugimoto H, 2002, JPN J PHARMACOL, V89, P7, DOI 10.1254/jjp.89.7; Tripos S., 2007, MOL MODELING QSAR SO; Tumiatti V, 2010, CURR MED CHEM, V17, P1825, DOI 10.2174/092986710791111206; Veerasamy R., 2011, INT J DRUG DESIGN DI, V2, P511; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yadav DK, 2013, CURR COMPUT-AID DRUG, V9, P360, DOI 10.2174/1573409911309030012; Yadav DK, 2013, J CHEMOMETR, V27, P21, DOI 10.1002/cem.2488; Yadav DK, 2010, DRUG DES DEV THER, V4, P173; Yadav DK, 2014, CURR DRUG TARGETS, V15, P753, DOI 10.2174/1389450115666140630102711; Yadav DK, 2014, J CHEMOMETR, V28, P499, DOI 10.1002/cem.2606; Yadav DK, 2014, CURR MED CHEM, V21, P1160, DOI 10.2174/09298673113206660330; Yadav DK, 2013, MED CHEM, V9, P1073; Yadav DK, 2012, J MOL MODEL, V18, P2513, DOI 10.1007/s00894-011-1265-3; Yu NN, 2010, BRAIN RES, V1317, P305, DOI 10.1016/j.brainres.2009.12.087	79	20	21	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 8	2018	8								14921	10.1038/s41598-018-33354-6			21	Multidisciplinary Sciences	Science & Technology - Other Topics	GW0RP	WOS:000446577100023	30297729	DOAJ Gold, Green Published			2021-06-18	
J	Almeida, VM; Paiva, AE; Sena, IFG; Mintz, A; Magno, LAV; Birbrair, A				Almeida, Viviani M.; Paiva, Ana E.; Sena, Isadora F. G.; Mintz, Akiva; Magno, Luiz Alexandre V.; Birbrair, Alexander			Pericytes Make Spinal Cord Breathless after Injury	NEUROSCIENTIST			English	Article						pericytes; spinal cord injury; blood flow; microenvironment; scar	SKELETAL-MUSCLE; CAPILLARY PERICYTES; BLOOD-FLOW; MICROVASCULAR PERICYTES; VASCULAR MORPHOGENESIS; PERIVASCULAR CELLS; BONE-MARROW; BRAIN; TISSUE; REGENERATION	Traumatic spinal cord injury is a devastating condition that leads to significant neurological deficits and reduced quality of life. Therapeutic interventions after spinal cord lesions are designed to address multiple aspects of the secondary damage. However, the lack of detailed knowledge about the cellular and molecular changes that occur after spinal cord injury restricts the design of effective treatments. Li and colleagues using a rat model of spinal cord injury and in vivo microscopy reveal that pericytes play a key role in the regulation of capillary tone and blood flow in the spinal cord below the site of the lesion. Strikingly, inhibition of specific proteins expressed by pericytes after spinal cord injury diminished hypoxia and improved motor function and locomotion of the injured rats. This work highlights a novel central cellular population that might be pharmacologically targeted in patients with spinal cord trauma. The emerging knowledge from this research may provide new approaches for the treatment of spinal cord injury.	[Almeida, Viviani M.; Paiva, Ana E.; Sena, Isadora F. G.; Birbrair, Alexander] Univ Fed Minas Gerais, Dept Pathol, Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil; [Mintz, Akiva] Columbia Univ, Med Ctr, Dept Radiol, New York, NY USA; [Magno, Luiz Alexandre V.] Univ Fed Minas Gerais, Dept Mental Hlth, Belo Horizonte, MG, Brazil; [Birbrair, Alexander] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Birbrair, Alexander] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA	Birbrair, A (corresponding author), Univ Fed Minas Gerais, Dept Pathol, Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.	birbrair@icb.ufmg.br	Sena, Isadora/E-5373-2018; Magno, Alexandre/B-1552-2010; Magno, Luiz Alexandre V./AAJ-9839-2021; Birbrair, Alexander/H-2497-2012	Magno, Alexandre/0000-0003-3693-1897; Magno, Luiz Alexandre V./0000-0003-3693-1897; Birbrair, Alexander/0000-0003-1015-2561; Fernandes Gilson Sena, Isadora/0000-0002-4304-9707; Mendes de Almeida, Viviani/0000-0001-6061-8038	Pro-reitoria de Pesquisa/Universidade Federal de Minas Gerais (PRPq/UFMG); National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01CA179072-01A1]; American Cancer Society Mentored Research Scholar GrantAmerican Cancer Society [124443-MRSG-13-121-01-CDD]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA179072] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Alexander Birbrair is supported by a grant from Pro-reitoria de Pesquisa/Universidade Federal de Minas Gerais (PRPq/UFMG) (Edital 05/2016); Akiva Mintz is supported by the National Institute of Health (1R01CA179072-01A1) and by the American Cancer Society Mentored Research Scholar Grant (124443-MRSG-13-121-01-CDD).	Ahn SK, 2010, BRAIN RES, V1346, P92, DOI 10.1016/j.brainres.2010.05.057; ALLSOPP G, 1979, J ANAT, V128, P155; Andreotti JP, 2017, CELL STEM CELL, V21, P293, DOI 10.1016/j.stem.2017.08.005; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Asada N, 2017, NAT CELL BIOL, V19, P214, DOI 10.1038/ncb3475; Azevedo PO, NEUROSCIENCE; Bechmann I, 2001, EUR J NEUROSCI, V14, P1651, DOI 10.1046/j.0953-816x.2001.01793.x; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Biesecker KR, 2016, J NEUROSCI, V36, P9435, DOI 10.1523/JNEUROSCI.1782-16.2016; Birbrair A, 2017, STEM CELLS DEV, V26, P1013, DOI 10.1089/scd.2017.0044; Birbrair A, 2017, STEM CELL TRANSL MED, V6, P471, DOI 10.5966/sctm.2016-0007; Birbrair A, 2016, ANN NY ACAD SCI, V1370, P82, DOI 10.1111/nyas.13016; Birbrair A, 2015, STEM CELL REV REP, V11, P547, DOI 10.1007/s12015-015-9588-6; Birbrair A, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt512; Birbrair A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00245; Birbrair A, 2015, CLIN SCI, V128, P81, DOI 10.1042/CS20140278; Birbrair A, 2014, AM J PHYSIOL-CELL PH, V307, pC25, DOI 10.1152/ajpcell.00084.2014; Birbrair A, 2013, AM J PHYSIOL-CELL PH, V305, pC1098, DOI 10.1152/ajpcell.00171.2013; Birbrair A, 2013, STEM CELLS DEV, V22, P2298, DOI 10.1089/scd.2012.0647; Birbrair A, 2013, STEM CELL RES, V10, P67, DOI 10.1016/j.scr.2012.09.003; Birbrair A, 2013, EXP CELL RES, V319, P45, DOI 10.1016/j.yexcr.2012.09.008; Birbrair A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016816; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Borges I, 2017, STEM CELL REV REP, V13, P567, DOI 10.1007/s12015-017-9747-z; Castejon OJ, 2011, FOLIA NEUROPATHOL, V49, P162; Coatti GC, 2017, STEM CELL REV REP, V13, P686, DOI 10.1007/s12015-017-9752-2; Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x; Prazeres PHDM, 2017, DEV BIOL, V427, P6, DOI 10.1016/j.ydbio.2017.05.001; DIAZFLORES L, 1991, HISTOL HISTOPATHOL, V6, P269; Domingo A, 2012, J NEUROTRAUM, V29, P865, DOI 10.1089/neu.2011.2052; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Fisher M, 2009, STROKE, V40, pS13, DOI 10.1161/STROKEAHA.108.533117; Gaskill PJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-203; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; Khan JA, 2016, SCIENCE, V351, P176, DOI 10.1126/science.aad0084; Kim JA, 2006, J CEREBR BLOOD F MET, V26, P209, DOI 10.1038/sj.jcbfm.9600181; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; KUNZ J, 1994, J NEUROCHEM, V62, P2375; LI XM, 1992, J NEUROCHEM, V59, P1172, DOI 10.1111/j.1471-4159.1992.tb08363.x; Li YQ, 2017, NAT MED, V23, P733, DOI 10.1038/nm.4331; Licona-Limon I, 2015, J LEUKOCYTE BIOL, V98, P85, DOI 10.1189/jlb.2A0914-458R; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lousado L, CELL DEATH DIS; Massot O, 1999, NEUROPSYCHOPHARMACOL, V21, P530, DOI 10.1016/S0893-133X(99)00042-1; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Mishra A, 2016, NAT NEUROSCI, V19, P1619, DOI 10.1038/nn.4428; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Myers J, 2007, AM J PHYS MED REHAB, V86, P142, DOI 10.1097/PHM.0b013e31802f0247; NEHLS V, 1992, CELL TISSUE RES, V270, P469, DOI 10.1007/BF00645048; NEHLS V, 1991, J CELL BIOL, V113, P147, DOI 10.1083/jcb.113.1.147; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Paiva AE, NEOPLASIA; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Phillips AA, 2016, J CEREBR BLOOD F MET, V36, P647, DOI 10.1177/0271678X15617954; Phillips AA, 2013, BRAIN SCI, V3, P781, DOI 10.3390/brainsci3020781; Phillips AA, 2014, J CEREBR BLOOD F MET, V34, P794, DOI 10.1038/jcbfm.2014.3; Prazeres PHDM, CELL MOL NEUROBIOL; Razzaque Z, 2002, BRIT J CLIN PHARMACO, V53, P266, DOI 10.1046/j.0306-5251.2001.01536.x; Rossignol S, 2007, J NEUROSCI, V27, P11782, DOI 10.1523/JNEUROSCI.3444-07.2007; Rouget C, 1873, ARCH PHYSL NORM PATH, V5, P603; Santos GSP, EYE; Sena IFG, CELL CYCLE; Sena IFG, 2017, EXP HEMATOL, V54, P12, DOI 10.1016/j.exphem.2017.06.349; SHEPRO D, 1993, FASEB J, V7, P1031; Sims DE, 2000, CLIN EXP PHARMACOL P, V27, P842, DOI 10.1046/j.1440-1681.2000.03343.x; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Tu ZD, 2011, INVEST OPHTH VIS SCI, V52, P9005, DOI 10.1167/iovs.11-8008; Uhlirova H, 2016, ELIFE, V5, DOI [10.7554/elife.14315, 10.7554/eLife.14315]; Wanjare M, 2013, BIOTECHNOL J, V8, P434, DOI 10.1002/biot.201200199; WAXMAN SG, 1992, J NEUROTRAUM, V9, pS105; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Yotsumoto F, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.1001204; Zimmermann KW, 1923, Z ANAT ENTWICKLUNGS, V68, P29, DOI DOI 10.1007/BF02593544	79	20	20	4	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-8584	1089-4098		NEUROSCIENTIST	Neuroscientist	OCT	2018	24	5					440	447		10.1177/1073858417731522			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	GS2HP	WOS:000443368300004	29283016	Green Accepted			2021-06-18	
J	DeGrauw, X; Thurman, D; Xu, LK; Kancherla, V; DeGrauw, T				DeGrauw, Xinyao; Thurman, David; Xu, Likang; Kancherla, Vijaya; DeGrauw, Ton			Epidemiology of traumatic brain injury-associated epilepsy and early use of anti-epilepsy drugs: An analysis of insurance claims data, 2004-2014	EPILEPSY RESEARCH			English	Article						Traumatic brain injury; Epilepsy; Anti-epilepsy drug; Early seizure	LATE POSTTRAUMATIC SEIZURES; CUMULATIVE INCIDENCE; HEAD-INJURY; POPULATION; RISK; ACETAZOLAMIDE; PREVENTION	Background: About 2.8 million TBI-related emergency department visits, hospitalizations and deaths occurred in 2013 in the United States. Post-traumatic epilepsy (PTE) can be a disabling, life-long outcome of TBI. Objectives: The purpose of this study is to address the probability of developing PTE within 9 years after TBI, the risk factors associated with PTE, the prevalence of anti-epileptic drug (AEDs) use, and the effectiveness of using AEDs prophylactically after TBI to prevent the development of PTE. Methods: Using MarketScan((R)) databases covering commercial, Medicare Supplemental, and multi-state Medicaid enrollees from 2004 to 2014, we examined the incidence of early seizures (within seven days after TBI) and cumulative incidence of PTE, the hazard ratios (HR) of PTE by age, gender, TBI severity, early seizure and AED use (carbamazepine, clonazepam, divalproex sodium, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, phenytoin, pregabalin, topiramate, acetazolamide). We used backward selection to build the final Cox proportional hazard model and conducted multivariable survival analysis to obtain estimates of crude and adjusted HR (cHRs, aHRs) of PTE and 95% confidence intervals (CI). Results: The incidence of early seizure among TBI patients in our study was 0.5%. The cumulative incidence of PTE increased from 1.0% in one year to 4.0% in nine years. Most patients with TBI (93%) were not prescribed any AED. Gender was not associated with PTE. The risk of PTE was higher for individuals with older age, early seizures, and more severe TBI. Only individuals using prophylactic acetazolamide had significantly lower risk of PTE (aHR = 0.6, CI 0.4-0.9) compared to those not using any AED. Conclusion: The probability of developing PTE increased within the study period. The risk of developing PTE significantly increased with age, early seizure and TBI severity. Most of the individuals did not receive AED after TBI. There was no evidence suggesting AEDs helped to prevent PTE with the possible exception of acetazolamide. However, further studies may be needed to test the efficacy of acetazolamide in preventing PTE.	[DeGrauw, Xinyao] Snohomish Hlth Dist, 3020 Rucker Ave,Suite 206, Everett, WA 98201 USA; [Thurman, David] Emory Univ, Dept Neurol, 1648 Pierce Dr NE, Atlanta, GA 30307 USA; [Xu, Likang] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, 4700 Buford Highway, Atlanta, GA 30341 USA; [DeGrauw, Xinyao; Kancherla, Vijaya] Emory Univ, Rollins Sch Publ Hlth, 1518 Clifton Rd, Atlanta, GA 30322 USA; [DeGrauw, Ton] Childrens Healthcare Atlanta, 1405 Clifton Rd, Atlanta, GA 30322 USA; [DeGrauw, Ton] Emory Univ, Div Pediat Neurol, 1405 Clifton Rd, Atlanta, GA 30329 USA	DeGrauw, X (corresponding author), Snohomish Hlth Dist, 3020 Rucker Ave,Suite 206, Everett, WA 98201 USA.	xdegrauw@snohd.org		Thurman, David/0000-0002-0533-7062	Intramural CDC HHS [CC999999] Funding Source: Medline		ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Armitage P., 2008, STAT METHODS MED RES; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Baker S., 2012, INJURY RES THEORIES; BICKLER PE, 1988, J APPL PHYSIOL, V65, P422; Carney N, 2016, NEUROSURGERY; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Dauch WA, 1996, ZBL NEUROCHIR, V57, P190; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Glushakov AV, 2016, METHODS MOL BIOL, V1462, P481, DOI 10.1007/978-1-4939-3816-2_27; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hamidi S, 2015, NEUROPHARMACOLOGY, V95, P377, DOI 10.1016/j.neuropharm.2015.04.015; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; Helmers SL, 2015, EPILEPSIA, V56, P942, DOI 10.1111/epi.13001; International League Against Epilepsy C. o. E Prognosis, 1993, EPILEPSIA, V34; Kirmani BF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00032; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; McNamara James O, 2006, Sci STKE, V2006, pre12, DOI 10.1126/stke.3562006re12; Penman AD, 2008, COMPUT METH PROG BIO, V89, P50, DOI 10.1016/j.cmpb.2007.10.004; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Salazar A., 2014, HDB CLIN NEUROL, V128, P525; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Schierhout G., 2012, ANTIEPILEPTIC DRUGS; Sturdivant NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33330; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Thompson K., 2015, PHARM TREATMENTS PRE; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x	35	20	21	1	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	OCT	2018	146						41	49		10.1016/j.eplepsyres.2018.07.012			9	Clinical Neurology	Neurosciences & Neurology	GU3HY	WOS:000445168400007	30071385	Green Accepted			2021-06-18	
J	Shearer, GC; Walker, RE				Shearer, Gregory C.; Walker, Rachel E.			An overview of the biologic effects of omega-6 oxylipins in humans	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article							CYTOCHROME P450-DERIVED EICOSANOIDS; POLYUNSATURATED FATTY-ACIDS; SOLUBLE EPOXIDE HYDROLASE; CORONARY-ARTERY-DISEASE; ARACHIDONIC-ACID; LINOLEIC-ACID; EPOXYEICOSATRIENOIC ACIDS; INDUCED LIPOKINE; LIPID MEDIATORS; LIVER-DISEASE	Oxylipins are lipid mediators produced from polyunsaturated fatty acid (PUFA) metabolism, and are thought to be a molecular explanation for the diverse biological effects of PUFAs. Like PUFAs, oxylipins are distinguished by their omega-6 (n6) or omega-3 (n3) chemistry. We review the use of n6 oxylipins as biomarkers of disease and their use in diagnosis and risk assessment. We show cases where oxylipins derived from linoleate (LA) or arachidonate (AA) produced by the activities of lipoxygenase, cyclooxygenase, epoxygenase, omega/omega-1 hydroxylase, and autooxidation are useful as biomarkers or risk markers. HODEs, KODEs, EpOMEs, DiHOMEs, and other metabolites of LA as well as prostanoids, HETEs, KETEs, EpETrEs, and DiHETrEs, and other metabolites of AA were useful for understanding the different signaling environments in conditions from traumatic brain injury, to major coronary events, dyslipidemia, sepsis, and more. We next evaluate interventions that alter the concentrations of n6 oxylipins in plasma. We note the utility and response of each plasma fraction, and the generally increasing utility from the non-esterified, to the esterified, to the lipoprotein fractions. Finally, we review the effects which are specifically related to n6 oxylipins and most likely to be beneficial. Both n6 and n3 oxylipins work together in an exceedingly complex matrix to produce physiological effects. This overview should provide future investigators with important perspectives for the emerging utility of n6 oxylipins as products of n6 PUFAs in human health.	[Shearer, Gregory C.; Walker, Rachel E.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16801 USA	Shearer, GC (corresponding author), Penn State Univ, Dept Nutr Sci, University Pk, PA 16801 USA.	gcs13@psu.edu		Walker, Rachel/0000-0002-8845-858X	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1 R01 HL130099-01A1]	This publication was made possible in part by grant number 1 R01 HL130099-01A1 from the National Heart, Lung, and Blood Institute.	Akasaka T, 2016, AM J PHYSIOL-HEART C, V311, pH1409, DOI 10.1152/ajpheart.00473.2016; Al-Khudairy L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011094.pub2; Askari AA, 2014, BIOCHEM BIOPH RES CO, V446, P633, DOI 10.1016/j.bbrc.2014.03.020; BAER AN, 1991, BIOCHIM BIOPHYS ACTA, V1085, P45, DOI 10.1016/0005-2760(91)90230-F; Belury MA, 2018, PROSTAG LEUKOTR ESS, V132, P30, DOI 10.1016/j.plefa.2018.03.001; Boston RC, 2008, AM J PHYSIOL-REG I, V295, pR395, DOI 10.1152/ajpregu.90317.2008; Bruegel M, 2012, CRIT CARE MED, V40, P1478, DOI 10.1097/CCM.0b013e3182416f05; Burr GO, 1930, J BIOL CHEM, V86, P0587; Caligiuri SPB, 2017, CAN J PHYSIOL PHARM, V95, P961, DOI 10.1139/cjpp-2016-0615; CAMP RDR, 1985, BRIT J PHARMACOL, V85, P837, DOI 10.1111/j.1476-5381.1985.tb11082.x; Capdevila JH, 2000, J LIPID RES, V41, P163; Caro AA, 2006, FREE RADICAL BIO MED, V40, P364, DOI 10.1016/j.freeradbiomed.2005.10.044; Cui Y, 2017, INT J CANCER, V141, P2423, DOI 10.1002/ijc.31007; Deng BQ, 2017, P NATL ACAD SCI USA, V114, P12608, DOI 10.1073/pnas.1705615114; Dreisbach AW, 2008, HYPERTENSION, V51, P755, DOI 10.1161/HYPERTENSIONAHA.107.100123; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Feldstein AE, 2010, J LIPID RES, V51, P3046, DOI 10.1194/jlr.M007096; Fischer R, 2014, J LIPID RES, V55, P1150, DOI 10.1194/jlr.M047357; Fowler CJ, 2017, ADV PHARMACOL, V80, P31, DOI 10.1016/bs.apha.2017.03.006; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Gouveia-Figueira S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132042; Hamilton JA, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0696-4; Harris WS, 2018, PROSTAG LEUKOTR ESS, V132, P34, DOI 10.1016/j.plefa.2018.03.003; Holt RR, 2015, J NUTR BIOCHEM, V26, P1458, DOI 10.1016/j.jnutbio.2015.07.012; HONN KV, 1992, PROSTAGLANDINS, V44, P413, DOI 10.1016/0090-6980(92)90137-I; Innes JK, 2018, PROSTAG LEUKOTR ESS, V132, P41, DOI 10.1016/j.plefa.2018.03.004; Jamieson KL, 2017, PHARMACOL THERAPEUT, V179, P47, DOI 10.1016/j.pharmthera.2017.05.005; Jerschow E, 2017, J ALLER CL IMM-PRACT, V5, P998, DOI 10.1016/j.jaip.2016.11.021; Jiang HL, 2013, AM J HYPERTENS, V26, P271, DOI 10.1093/ajh/hps011; Kammerer I, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-222; Keenan AH, 2012, J LIPID RES, V53, P1662, DOI 10.1194/jlr.P025577; Lee YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26117; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liu JB, 2014, CHEST, V146, P670, DOI 10.1378/chest.13-2568; Lynes MD, 2017, NAT MED, V23, P631, DOI 10.1038/nm.4297; Maciejewska D, 2015, PROSTAG OTH LIPID M, V121, P184, DOI 10.1016/j.prostaglandins.2015.09.003; Mickleborough TD, 2006, CHEST, V129, P39, DOI 10.1378/chest.129.1.39; Newman JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111471; Nording ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076575; NUGTEREN DH, 1985, BIOCHIM BIOPHYS ACTA, V834, P429, DOI 10.1016/0005-2760(85)90017-7; Oni-Orisan A, 2016, J LIPID RES, V57, P109, DOI 10.1194/jlr.M061697; OZAWA T, 1986, BIOCHEM BIOPH RES CO, V134, P1071, DOI 10.1016/0006-291X(86)90360-8; Pickens CA, 2017, METABOLISM, V70, P177, DOI 10.1016/j.metabol.2017.01.034; Plenty NL, 2018, PROSTAG OTH LIPID M, V136, P15, DOI 10.1016/j.prostaglandins.2018.03.001; Polavarapu S, 2018, ARCH MED SCI, V14, P207, DOI 10.5114/aoms.2018.72244; Ramsden CE, 2016, MOL PAIN, V12, DOI 10.1177/1744806916636386; Ramsden CE, 2012, PROSTAG LEUKOTR ESS, V87, P135, DOI 10.1016/j.plefa.2012.08.004; Reis MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182381; Rodriguez-Blanco G, 2014, PROSTATE, V74, P618, DOI 10.1002/pros.22779; Santos JM, 2017, MED HYPOTHESES, V108, P81, DOI 10.1016/j.mehy.2017.07.033; Schebb NH, 2014, PROSTAG OTH LIPID M, V113, P21, DOI 10.1016/j.prostaglandins.2014.05.002; Schinzari F, 2017, ACTA PHYSIOL, V219, P124, DOI 10.1111/apha.12630; Schmocker C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010180; Schuck RN, 2013, ATHEROSCLEROSIS, V227, P442, DOI 10.1016/j.atherosclerosis.2013.01.034; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; SETTY BNY, 1987, BIOCHEM BIOPH RES CO, V148, P528, DOI 10.1016/0006-291X(87)90908-9; Shearer GC, 2018, PROSTAG LEUKOTR ESS, V128, P1, DOI 10.1016/j.plefa.2017.10.006; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; Shearer GC, 2008, PROSTAG LEUKOTR ESS, V79, P215, DOI 10.1016/j.plefa.2008.09.023; Shih PB, 2016, MOL PSYCHIATR, V21, P537, DOI 10.1038/mp.2015.26; Siangjong L, 2013, AM J PHYSIOL-HEART C, V304, pH382, DOI 10.1152/ajpheart.00690.2012; Sorokin A. V., 2018, J INVEST DERMATOL; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Spector AA, 2015, BBA-MOL CELL BIOL L, V1851, P356, DOI 10.1016/j.bbalip.2014.07.020; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stanford KI, 2018, CELL METAB, V27, P1111, DOI 10.1016/j.cmet.2018.03.020; Sun Y, 2016, J LIPID RES, V57, P1300, DOI 10.1194/jlr.P066423; Theken KN, 2012, ATHEROSCLEROSIS, V222, P530, DOI 10.1016/j.atherosclerosis.2012.03.022; Thompson DA, 2007, J BIOSCIENCES, V32, P279, DOI 10.1007/s12038-007-0028-x; Trostchansky A, 2013, ANTIOXID REDOX SIGN, V19, P1257, DOI 10.1089/ars.2012.5023; Virtanen JK, 2018, PROSTAG LEUKOTR ESS, V133, P8, DOI 10.1016/j.plefa.2018.04.002; Wagner K, 2014, PROSTAG OTH LIPID M, V113, P2, DOI 10.1016/j.prostaglandins.2014.09.001; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Wang YG, 2012, PROSTAG LEUKOTR ESS, V86, P79, DOI 10.1016/j.plefa.2011.10.006; Ward NC, 2011, CLIN SCI, V121, P501, DOI 10.1042/CS20110215; Xu XZ, 2016, ADV NUTR, V7, P1122, DOI 10.3945/an.116.012245; Yao X, 2015, PROSTAG OTH LIPID M, V118, P11, DOI 10.1016/j.prostaglandins.2015.03.005; Ye D, 2002, J PHARMACOL EXP THER, V303, P768, DOI 10.1124/jpet.303.2.768; Yi XY, 2016, STROKE, V47, P3045, DOI 10.1161/STROKEAHA.116.015146; Yoshida Y, 2015, J OLEO SCI, V64, P347, DOI 10.5650/jos.ess14281; Yu D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142848; Yuan DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096510; Zhang LJ, 2017, PROSTAG LEUKOTR ESS, V120, P25, DOI 10.1016/j.plefa.2017.04.003; Zhang YD, 2001, AM J PHYSIOL-HEART C, V280, pH2430; Zhang YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157035; Ziboh VA, 2000, PROSTAG OTH LIPID M, V63, P3, DOI 10.1016/S0090-6980(00)00093-9; Ziboh Vincent A, 2004, Clin Dev Immunol, V11, P13; Zu LY, 2016, THROMB RES, V144, P192, DOI 10.1016/j.thromres.2016.06.031; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160	90	20	20	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	OCT	2018	137						26	38		10.1016/j.plefa.2018.06.005			13	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	GX9BW	WOS:000448094500005	30293594				2021-06-18	
J	Hill, RL; Kulbe, JR; Singh, IN; Wang, JA; Hall, ED				Hill, Rachel L.; Kulbe, Jacqueline R.; Singh, Indrapal N.; Wang, Juan A.; Hall, Edward D.			Synaptic Mitochondria are More Susceptible to Traumatic Brain Injury-induced Oxidative Damage and Respiratory Dysfunction than Non-synaptic Mitochondria	NEUROSCIENCE			English	Article						lipid peroxidation; oxidative damage; synaptic mitochondria; non-synaptic mitochondria; traumatic brain injury	NEURONAL CYTOSKELETAL DEGRADATION; LIPID-PEROXIDATION; NITRIC-OXIDE; MOUSE MODEL; PROTEOMIC IDENTIFICATION; PERMEABILITY TRANSITION; CELL-DEATH; ANTIOXIDANT THERAPIES; AXONAL-TRANSPORT; RAT-BRAIN	Traumatic brain injury (TBI) results in mitochondrial dysfunction and induction of lipid peroxidation (LP). Lipid peroxidation-derived neurotoxic aldehydes such as 4-HNE and acrolein bind to mitochondrial proteins, inducing additional oxidative damage and further exacerbating mitochondrial dysfunction and LP. Mitochondria are heterogeneous, consisting of both synaptic and non-synaptic populations. Synaptic mitochondria are reported to be more vulnerable to injury; however, this is the first study to characterize the temporal profile of synaptic and non-synaptic mitochondria following TBI, including investigation of respiratory dysfunction and oxidative damage to mitochondria! proteins between 3 and 120 h following injury. These results indicate that synaptic mitochondria are indeed the more vulnerable population, showing both more rapid and severe impairments than non-synaptic mitochondria. By 24 h, synaptic respiration is significantly impaired compared to synaptic sham, whereas non-synaptic respiration does not decline significantly until 48 h. Decreases in respiration are associated with increases in oxidative damage to synaptic and non-synaptic mitochondria! proteins at 48 h and 72 h, respectively. These results indicate that the therapeutic window for mitochondria-targeted pharmacological neuroprotectants to prevent respiratory dysfunction is shorter for the more vulnerable synaptic mitochondria than for the non-synaptic population. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Hill, Rachel L.; Kulbe, Jacqueline R.; Singh, Indrapal N.; Wang, Juan A.; Hall, Edward D.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr SCoBIRC, 741 S Limestone St, Lexington, KY 40536 USA; [Kulbe, Jacqueline R.; Singh, Indrapal N.; Hall, Edward D.] Univ Kentucky, Dept Neurosci, Coll Med, 741 S Limestone St, Lexington, KY 40536 USA	Hall, ED (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Med Ctr, Chair Neurotrauma Res, 741 S Limestone St, Lexington, KY 40536 USA.; Hall, ED (corresponding author), Univ Kentucky, Neurosci Neurosurg & Neurol & Phys Med & Rehab, Med Ctr, 741 S Limestone St, Lexington, KY 40536 USA.	edhall@uky.edu	Hall, Edward D/F-8930-2013	Kulbe, Jacqueline/0000-0002-7070-9264	Kentucky Spinal Cord & Head Injury Research Trust (KSCHIRT) [5R01 NS083405, 5R01 NS084857, 5P30 NS0512220, F30 NS096876]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084857, R01NS083405, R01NS100093, T32NS077889] Funding Source: NIH RePORTER	This work was supported by 5R01 NS083405, 5R01 NS084857, 5P30 NS0512220, F30 NS096876, and funding from the Kentucky Spinal Cord & Head Injury Research Trust (KSCHIRT). Rachel Hill was responsible for optimizing the isolation protocol for the non-synaptic and synaptic mitochondria from cortical tissue, performed all the experiments, and carried out most of the data analysis and overall organization and presentation of the data as well as statistical analysis, wrote most of the manuscript, designed graphs/figures and performed statistical analyses. Jacqueline Kulbe contributed to writing of the manuscript and some analysis of respiration and western blot data. Indrapal Singh assisted in mitochondrial respiratory assays and Juan Wang (Amy) assisted with animal work. Edward Hall supervised the experiments in his lab and contributed to the writing and organization of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Balog J, 2016, J CEREBR BLOOD F MET, V36, P2022, DOI 10.1177/0271678X16671528; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; BOLANOS JP, 1994, J NEUROCHEM, V63, P910; Bolanos JP, 2016, J NEUROCHEM, V139, P115, DOI 10.1111/jnc.13486; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Bringold U, 2000, FREE RADICAL BIO MED, V29, P343, DOI 10.1016/S0891-5849(00)00318-X; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Carre E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00146; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Carroll RT, 2000, CHEM RES TOXICOL, V13, P294, DOI 10.1021/tx990159t; Cavallucci V, 2013, CURR PHARM DESIGN, V19, P6440, DOI 10.2174/1381612811319360005; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Clarkson AN, 2004, FASEB J, V18, P1114, DOI 10.1096/fj.03-1203fje; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Davey GP, 1997, J NEUROCHEM, V69, P2564; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; Du H, 2012, ANTIOXID REDOX SIGN, V16, P1467, DOI 10.1089/ars.2011.4277; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Gillardon F, 2007, PROTEOMICS, V7, P605, DOI 10.1002/pmic.200600728; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Gilmer LK, 2010, MECH AGEING DEV, V131, P133, DOI 10.1016/j.mad.2009.12.011; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall ED, 2016, J BIOENERG BIOMEMBR, V48, P169, DOI 10.1007/s10863-015-9600-5; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; HEALES SJR, 1994, BRAIN RES, V668, P243, DOI 10.1016/0006-8993(94)90530-4; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Ikegami K, 2003, NEUROSCIENCE, V122, P617, DOI 10.1016/j.neuroscience.2003.08.057; Jackson JG, 2014, J NEUROSCI, V34, P1613, DOI 10.1523/JNEUROSCI.3510-13.2014; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Jonas EA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00355; Ju WK, 2007, INVEST OPHTH VIS SCI, V48, P2145, DOI 10.1167/iovs.06-0573; Khanna P, 2007, CELL MOL NEUROBIOL, V27, P959, DOI 10.1007/s10571-007-9233-2; KIEDROWSKI L, 1995, MOL PHARMACOL, V47, P140; Kinnunen PKJ, 2012, BBA-BIOMEMBRANES, V1818, P2446, DOI 10.1016/j.bbamem.2012.04.008; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Kristian T, 2006, J NEUROSCI METH, V152, P136, DOI 10.1016/j.jneumeth.2005.08.018; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Kwon Seok-Kyu, 2016, Front Synaptic Neurosci, V8, P29; LAI JCK, 1977, J NEUROCHEM, V28, P625, DOI 10.1111/j.1471-4159.1977.tb10434.x; LAI JCK, 1976, BIOCHEM J, V154, P423, DOI 10.1042/bj1540423; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Llorente-Folch I, 2015, J PHYSIOL-LONDON, V593, P3447, DOI 10.1113/JP270254; LoPachin RM, 2008, NEUROTOXICOLOGY, V29, P871, DOI 10.1016/j.neuro.2008.04.016; Lopez-Fabuel I, 2016, P NATL ACAD SCI USA, V113, P13063, DOI 10.1073/pnas.1613701113; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; LOVAAS E, 1991, FREE RADICAL BIO MED, V11, P455, DOI 10.1016/0891-5849(91)90061-7; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; MacAskill AF, 2010, EUR J NEUROSCI, V32, P231, DOI 10.1111/j.1460-9568.2010.07345.x; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; Maciel EN, 2001, J NEUROCHEM, V79, P1237, DOI 10.1046/j.1471-4159.2001.00670.x; MAKAR TK, 1994, J NEUROCHEM, V62, P45; Manczak M, 2018, HUM MOL GENET, V27, P1332, DOI 10.1093/hmg/ddy042; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Miller DM, 2013, FREE RADICAL BIO MED, V57, P1, DOI 10.1016/j.freeradbiomed.2012.12.011; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Mungarro-Menchaca X, 2002, J NEUROSCI RES, V68, P89, DOI 10.1002/jnr.10193; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; NICHOLLS D, 1982, BIOCHIM BIOPHYS ACTA, V683, P57, DOI 10.1016/0304-4173(82)90013-1; Nicholls DG, 2007, J NEUROSCI RES, V85, P3206, DOI 10.1002/jnr.21290; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; NICHOLLS DG, 1985, PROG BRAIN RES, V63, P97; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Pandya JD, 2015, NEUROBIOL AGING, V36, P1903, DOI 10.1016/j.neurobiolaging.2015.01.018; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; Patel SP, 2009, J NEUROSCI RES, V87, P130, DOI 10.1002/jnr.21814; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; RAPS SP, 1989, BRAIN RES, V493, P398, DOI 10.1016/0006-8993(89)91178-5; Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Reed T, 2008, NEUROBIOL DIS, V30, P107, DOI 10.1016/j.nbd.2007.12.007; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Rintoul G. L., 2009, BIOCHIM BIOPHYS ACTA, V1802, P143; Rintoul GL, 2006, J NEUROCHEM, V97, P800, DOI 10.1111/j.1471-4159.2006.03788.x; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Rueda CB, 1837, BIOCHIM BIOPHYS ACTA, V2014, P1617; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; Sava IG, 2006, FREE RADICAL BIO MED, V41, P1272, DOI 10.1016/j.freeradbiomed.2006.07.008; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Sengpiel B, 1998, EUR J NEUROSCI, V10, P1903, DOI 10.1046/j.1460-9568.1998.00202.x; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Song Y, 2015, NEUROSCI J, V1-10; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Starkov AA, 2010, FEBS J, V277, P3652, DOI 10.1111/j.1742-4658.2010.07756.x; Stauch KL, 2014, J PROTEOME RES, V13, P2620, DOI 10.1021/pr500295n; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tan H, 2012, INT J NEUROPSYCHOPH, V15, P1275, DOI 10.1017/S1461145711001416; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Toescu EC, 2004, J CELL MOL MED, V8, P181, DOI 10.1111/j.1582-4934.2004.tb00273.x; Trushina E, 2016, NEURAL REGEN RES, V11, P900, DOI 10.4103/1673-5374.184477; Wang LZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154354; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Xiong YQ, 2009, FREE RADICAL RES, V43, P604, DOI 10.1080/10715760902977432; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yarana C, 2012, LIFE SCI, V90, P808, DOI 10.1016/j.lfs.2012.04.004	147	20	20	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 21	2018	386						265	283		10.1016/j.neuroscience.2018.06.028			19	Neurosciences	Neurosciences & Neurology	GO8GQ	WOS:000440325500022	29960045				2021-06-18	
J	Nasi, D; Dobran, M; Di Rienzo, A; di Somma, L; Gladi, M; Moriconi, E; Scerrati, M; Iacoangeli, M				Nasi, Davide; Dobran, Mauro; Di Rienzo, Alessandro; di Somma, Lucia; Gladi, Maurizio; Moriconi, Elisa; Scerrati, Massimo; Iacoangeli, Maurizio			Decompressive Craniectomy for Traumatic Brain Injury: The Role of Cranioplasty and Hydrocephalus on Outcome	WORLD NEUROSURGERY			English	Article						Cranioplasty; Decompressive craniectomy; Hydrocephalus; Traumatic brain injury	INTRACRANIAL HYPERTENSION; TRIAL	OBJECTIVE: After severe traumatic brain injury (sTBI) associated with uncontrollable high intracranial pressure (ICP), today the main challenge for neurosurgeons remains to identify who may obtain benefit from decompressive craniectomy (DC) and which factors after DC influence the prognosis of these patients. The aim of this paper was to identify the pre- and postoperative determinants of outcome after DC. METHODS: This retrospective study included all patients undergoing DC for sTBI from 2003 to 2011. The 6-month outcome, assessed using the Glasgow Outcome Scale (GOS), was dichotomized into favorable (GOS scores 4 and 5) and unfavorable (GOS scores 1-3) outcome. Predictors of outcome were identified by uni- and multivariate analysis. RESULTS: There were 190 patients who underwent DC for sTBI in this study. Sixty patients (31.6%) died within 30 days after DC. Independent prognostic factors for survival after 30 days were Glasgow Coma Scale score at admission greater than 5 (P = 0.002) and bilateral pupil reactivity (P < 0.0001). Thirty days after DC, 67 patients (51.5%) out of 130 had unfavorable outcome (GOS scores 1-3) and 63 patients (49.5%) presented favorable outcome (GOS scores 4 and 5). The independent preoperative prognostic factors for poor outcome were age over 65 years (P < 0.0001) and bilateral absence of pupil reactivity (P = 0.0165). After DC, onset of postoperative hydrocephalus and delayed cranioplasty (3 months after DC) was associated with unfavorable outcome at multivariate analysis (P = 0.002 and P < 0.0001, respectively). CONCLUSIONS: In our study, the development of hydrocephalus after DC for sTBI and delayed cranial reconstruction were associated with unfavorable outcome.	[Nasi, Davide; Dobran, Mauro; Di Rienzo, Alessandro; di Somma, Lucia; Gladi, Maurizio; Moriconi, Elisa; Scerrati, Massimo; Iacoangeli, Maurizio] Univ Politecn Marche, Umberto Gen Hosp 1, Dept Neurosurg, Ancona, Italy	Nasi, D (corresponding author), Univ Politecn Marche, Umberto Gen Hosp 1, Dept Neurosurg, Ancona, Italy.	davidenasi83@gmail.com		Nasi, Davide/0000-0002-7357-7455			Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Di Rienzo A, 2013, NEUROL MED-CHIR, V53, P329, DOI 10.2176/nmc.53.329; di Somma Lucia, 2016, Surg Neurol Int, V7, pS12, DOI 10.4103/2152-7806.173561; Honeybul S, 2017, J CLIN NEUROSCI, V43, P11, DOI 10.1016/j.jocn.2017.04.032; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iaccarino C, 2013, WORLD NEUROSURG, V79, P78, DOI 10.1016/j.wneu.2012.10.061; Khalili Hosseinali, 2017, Bull Emerg Trauma, V5, P190; Mahmoodpoor A, 2014, NEW ENGL J MED, V371, P971, DOI 10.1056/NEJMc1407775; Malcolm JG, 2018, NEUROSURGERY, V82, P278, DOI 10.1093/neuros/nyx182; Nasi D, 2016, WORLD NEUROSURG, V91, DOI 10.1016/j.wneu.2016.04.041; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Sharma R, 2017, NEUROSURGERY, V81, pE58, DOI 10.1093/neuros/nyx398; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0	16	20	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2018	116						E543	E549		10.1016/j.wneu.2018.05.028			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GN9GM	WOS:000439498500070	29772371				2021-06-18	
J	Tyson, AM; Duma, SM; Rowson, S				Tyson, Abigail M.; Duma, Stefan M.; Rowson, Steven			Laboratory Evaluation of Low-Cost Wearable Sensors for Measuring Head Impacts in Sports	JOURNAL OF APPLIED BIOMECHANICS			English	Article						concussion; unhelmeted sports; women's sports; youth sports	COLLEGIATE FOOTBALL PLAYERS; STATES HIGH-SCHOOL; ACCELERATION MEASUREMENT; HOCKEY HELMETS; BRAIN-INJURY; HYBRID III; CONCUSSION; SOCCER; EPIDEMIOLOGY; KINEMATICS	Advances in low-cost wearable head impact sensor technology provide potential benefits regarding sports safety for both consumers and researchers. However, previous laboratory evaluations are not directly comparable and do not incorporate test conditions representative of unhelmeted impacts. This study addresses those limitations. The xPatch by X2 Biosystems and the SIM-G by Triax Technologies were placed on a National Operating Committee on Standards for Athletic Equipment (NOCSAE) headform with a Hybrid III neck which underwent impact tests using a pendulum. Impact conditions included helmeted, padded impactor to bare head, and rigid impactor to bare head to represent long- and short-duration impacts seen in helmeted and unhelmeted sports. The wearable sensors were evaluated on their kinematic accuracy by comparing results to reference sensors located at the headform center of gravity. Statistical tests for equivalence were performed on the slope of the linear regression between wearable sensors and reference. The xPatch gave equivalent measurements to the reference in select longer-duration impacts, whereas the SIM-G had large variance leading to no equivalence. For the short-duration impacts. both wearable sensors underpredicted the reference. This error can be improved with increases in sampling rate from 1 to 1.5 kHz. Follow-up evaluations should be performed on the field to identify error in vivo.	[Tyson, Abigail M.; Duma, Stefan M.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA	Tyson, AM (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	amtyson@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	Lewis Family Foundation	The authors acknowledge the Lewis Family Foundation for funding this work. The authors have no conflicts of interest to disclose.	Alexander C., 2015, UNCS GUSKIEWICZ TALK; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; [Anonymous], 2012, RULES CHANGES REGARD; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Cobb BR, 2018, P I MECH ENG P-J SPO, V232, P176, DOI 10.1177/1754337117708092; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2011, EXERC SPORT SCI REV, V39, P2, DOI 10.1097/JES.0b013e318203dfdb; Foreman S, 2014, AM SOC TEST MATER, V1552, P3, DOI 10.1520/STP155220120156; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Funk James R, 2008, Biomed Sci Instrum, V44, P207; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hootman JM, 2007, J ATHL TRAINING, V42, P311; LaBella C., 2012, 2012 AAP NAT C EXH N; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; National Council of Youth Sports, 2008, REP TRENDS PART ORG; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; NCAA, STUD ATHL; Nevins D, 2016, PROCEDIA ENGINEER, V147, P186, DOI 10.1016/j.proeng.2016.06.211; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; Ovaska SJ, 1998, IEEE T INSTRUM MEAS, V47, P1211, DOI 10.1109/19.746585; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rowson B, 2018, P I MECH ENG P-J SPO, V232, P94, DOI 10.1177/1754337117707859; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Salzar RS, 2009, SAE INT J PASSEN CAR, V1, P1367, DOI 10.4271/2008-01-2978; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Triax Technologies, 2014, LAB VAL SIM G HEAD I; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Yoganandan Narayan, 2004, Traffic Inj Prev, V5, P368, DOI 10.1080/15389580490510336; Zhou YJ, 2015, MATER DESIGN, V88, P162, DOI 10.1016/j.matdes.2015.08.120	56	20	20	1	21	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	AUG	2018	34	4					320	326		10.1123/jab.2017-0256			7	Engineering, Biomedical; Sport Sciences	Engineering; Sport Sciences	GP5VF	WOS:000440942500011	29613824				2021-06-18	
J	Matei, N; Camara, J; McBride, D; Camara, R; Xu, NB; Tang, JP; Zhang, JH				Matei, Nathanael; Camara, Justin; McBride, Devin; Camara, Richard; Xu, Ningbo; Tang, Jiping; Zhang, John H.			Intranasal wnt3a Attenuates Neuronal Apoptosis through Frz1/PIWIL1a/FOXM1 Pathway in MCAO Rats	JOURNAL OF NEUROSCIENCE			English	Article						FOXM1; Frizzled-1; MCAO; PIWI1a; stroke; wnt3a	GLYCOGEN-SYNTHASE KINASE-3-BETA; CEREBRAL-ARTERY OCCLUSION; ISCHEMIC BRAIN-INJURY; SIGNALING PATHWAYS; NERVOUS-SYSTEM; STROKE; NEUROPROTECTION; RECEPTOR; CELLS; MODEL	After ischemic stroke, apoptosis of neurons is a primary factor in determining outcome. Wnt3a is a naturally occurring protein that has been shown to have protective effects in the brain for traumatic brain injury. Although wnt3a has been investigated in the phenomena of neurogenesis, anti-apoptosis, and anti-inflammation, it has never been investigated as a therapy for stroke. We hypothesized that the potential neuroprotective agent wnt3a would reduce infarction and improve behavior following ischemic stroke by attenuating neuronal apoptosis and promoting cell survival through the Frizzled-1/PIWI1a/FOXM1 pathway in middle cerebral artery occlusion (MCAO) rats. A total of 229 Sprague Dawley rats were assigned to male, female, and 9-month-old male MCAO or sham groups followed by reperfusion 2 h after MCAO. Animals assigned to MCAO were either given wnt3a or its control. To explore the downstream signaling of wnt3a, the following interventions were given: Frizzled-1 siRNA, PIWI1a siRNA, and PIWI1a-clustered regularly interspaced short palindromic repeats, along with the appropriate controls. Post-MCAO assessments included neurobehavioral tests, infarct volume, Western blot, and immunohistochemistry. Endogenous levels of wnt3a and Frizzled-1/PIWI1a/FOXM1 were lowered after MCAO. The administration of intranasal wnt3a, 1 h after MCAO, increased PIWIL1a and FOXM1 expression through Frizzled-1, reducing brain infarction and neurological deficits at 24 and 72 h. Frizzled-1 and PIWI1a siRNAs reversed the protective effects of wnt3a after MCAO. Restoration of PIWI1a after knockdown of Frizzled-1 increased FOXM1 survival protein and reduced cleaved caspase-3 levels. In summary, wnt3a decreases neuronal apoptosis and improves neurological deficits through Frizzled-1/PIWI1a/FOXM1 pathway after MCAO in rats. Therefore, wnt3a is a novel intranasal approach to decrease apoptosis after stroke.	[Matei, Nathanael; Camara, Justin; McBride, Devin; Camara, Richard; Xu, Ningbo; Tang, Jiping; Zhang, John H.] Loma Linda Univ, Dept Physiol & Pharmacol, Loma Linda, CA 92354 USA; [Zhang, John H.] Loma Linda Univ, Dept Anesthesiol, Loma Linda, CA 92354 USA; [Zhang, John H.] Loma Linda Univ, Dept Neurosurg, Loma Linda, CA 92354 USA; [McBride, Devin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Vivian L Smith Dept Neurosurg, Houston, TX USA	Zhang, JH (corresponding author), Loma Linda Univ, Sch Med, Dept Anesthesiol, Risley Hall,Room 219,11041 Campus St, Loma Linda, CA 92354 USA.; Zhang, JH (corresponding author), Loma Linda Univ, Sch Med, Dept Physiol, Risley Hall,Room 219,11041 Campus St, Loma Linda, CA 92354 USA.	Johnzhang3910@yahoo.com	Xu, Ningbo/Q-3820-2017; McBride, Devin/I-4872-2018	Xu, Ningbo/0000-0001-9055-3597; Tang, Jiping/0000-0002-2392-9280; McBride, Devin/0000-0001-8988-3353	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS081740]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS081740] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant NS081740 to J.H.Z.	Abe T, 2013, STROKE, V44, P2284, DOI 10.1161/STROKEAHA.113.001320; Arrazola MS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00166; Ayer RE, 2012, J NEUROSURG, V116, P246, DOI 10.3171/2011.8.JNS11883; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Candelario-Jalil E, 2009, CURR OPIN INVEST DR, V10, P644; Cerpa W, 2009, DRUG NEWS PERSPECT, V22, P579, DOI [10.1358/dnp.2009.22.10.1443391, 10.1358/dnp.2009.10.1436817]; Chacon MA, 2008, J CELL PHYSIOL, V217, P215, DOI 10.1002/jcp.21497; Chen CH, 2010, J NEUROSCI RES, V88, P2046, DOI 10.1002/jnr.22361; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Chen WQ, 2011, STROKE, V42, P764, DOI 10.1161/STROKEAHA.110.599118; Chen X, 2016, SCI REP-UK, V6, DOI 10.1038/srep20196; Chen YJ, 2015, STROKE, V46, P529, DOI 10.1161/STROKEAHA.114.007265; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Collino M, 2009, DIABETES, V58, P235, DOI 10.2337/db08-0691; Demagny H, 2014, CELL REP, V9, P688, DOI 10.1016/j.celrep.2014.09.020; Ferrer I, 2003, J NEUROPATH EXP NEUR, V62, P329, DOI 10.1093/jnen/62.4.329; Fisher M, 2003, STROKE, V34, P359, DOI 10.1161/01.STR.0000054627.69159.C2; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hu Q, 2009, EXP NEUROL, V216, P35, DOI 10.1016/j.expneurol.2008.11.007; Inestrosa NC, 2014, J MOL CELL BIOL, V6, P64, DOI 10.1093/jmcb/mjt051; Jiang LZ, 2014, INT J CLIN EXP PATHO, V7, P5450; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Kelly S, 2004, EXP NEUROL, V188, P378, DOI 10.1016/j.expneurol.2004.04.004; Kusaka I, 2004, AM J PHYSIOL-HEART C, V286, pH2442, DOI 10.1152/ajpheart.01169.2003; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Li C, 2017, SCI REP, V7; Lin SY, 2009, EXP NEUROL, V217, P361, DOI 10.1016/j.expneurol.2009.03.021; Liu LX, 2007, BLOOD, V110, P1191, DOI 10.1182/blood-2006-11-060103; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mackay J, 2004, ATLAS HEART DIS STRO; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McBride DW, 2016, ACTA NEUROCHIR SUPPL, V121, P103, DOI 10.1007/978-3-319-18497-5_18; Michalski D, 2012, EUR J HISTOCHEM, V56, P78, DOI [10.4081/ejh.2012.e14, 10.4081/ejh.2012.14]; Min J, 2013, CLIN INVESTIGATOR, V3, P1167, DOI DOI 10.4155/CLI.13.91; Minde DP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-101; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Oderup C, 2013, J IMMUNOL, V190, P6126, DOI 10.4049/jimmunol.1203002; Pang LJ, 2011, EXP CELL RES, V317, P1608, DOI 10.1016/j.yexcr.2011.02.004; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; R& D Systems, 2018, WNT REC PATHW; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Reeves Mark E, 2012, BMC Res Notes, V5, P239, DOI 10.1186/1756-0500-5-239; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Roth Jennifer M, 2011, Proc (Bayl Univ Med Cent), V24, P257; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Senda DM, 2011, BEHAV BRAIN RES, V216, P29, DOI 10.1016/j.bbr.2010.06.026; Shruster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040843; Song JL, 2015, CELL SIGNAL, V27, P1380, DOI 10.1016/j.cellsig.2015.03.018; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Ueno K, 2013, INT J CANCER, V132, P1731, DOI 10.1002/ijc.27746; Wang Y, 2017, J PLANT BIOCH PHYSL, V5, P2, DOI [10.4172/2329-9029.1000179, DOI 10.1080/16000889.2017.1299672]; Wu XL, 2014, INT J MOL SCI, V15, P5045, DOI 10.3390/ijms15035045; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhao YY, 2017, CELL TRANSPLANT, V26, P395, DOI 10.3727/096368916X694364	60	20	20	0	5	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JUL 25	2018	38	30					6787	6801		10.1523/JNEUROSCI.2352-17.2018			15	Neurosciences	Neurosciences & Neurology	GP1CI	WOS:000440550000015	29954850	Green Published, Bronze			2021-06-18	
J	Jha, KA; Pentecost, M; Lenin, R; Klaic, L; Elshaer, SL; Gentry, J; Russell, JM; Beland, A; Reiner, A; Jotterand, V; Sohl, N; Gangaraju, R				Jha, Kumar Abhiram; Pentecost, Mickey; Lenin, Raji; Klaic, Lada; Elshaer, Sally L.; Gentry, Jordy; Russell, John M.; Beland, Alex; Reiner, Anton; Jotterand, Veronique; Sohl, Nicolas; Gangaraju, Rajashekhar			Concentrated Conditioned Media from Adipose Tissue Derived Mesenchymal Stem Cells Mitigates Visual Deficits and Retinal Inflammation Following Mild Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						TBI; adult stem cells; TSG6; retinal ganglion cells; oxidative stress; TIMP1; microglia; trans-endothelial electrical resistance	STROMAL CELLS; GANGLION-CELLS; LUNG INJURY; MOUSE MODEL; INTRAVITREAL INJECTION; IFATS COLLECTION; RODENT MODEL; SPINAL-CORD; VISION LOSS; BLAST	Blast concussions are a common injury sustained in military combat today. Inflammation due to microglial polarization can drive the development of visual defects following blast injuries. In this study, we assessed whether anti-inflammatory factors released by the mesenchymal stem cells derived from adipose tissue (adipose stem cells, ASC) can limit retinal tissue damage and improve visual function in a mouse model of visual deficits following mild traumatic brain injury. We show that intravitreal injection of 1 mu L of ASC concentrated conditioned medium from cells pre-stimulated with inflammatory cytokines (ASC-CCM) mitigates loss of visual acuity and contrast sensitivity four weeks post blast injury. Moreover, blast mice showed increased retinal expression of genes associated with microglial activation and inflammation by molecular analyses, retinal glial fibrillary acidic protein (GFAP) immunoreactivity, and increased loss of ganglion cells. Interestingly, blast mice that received ASC-CCM improved in all parameters above. In vitro, ASC-CCM not only suppressed microglial activation but also protected against Tumor necrosis alpha (TNF alpha) induced endothelial permeability as measured by transendothelial electrical resistance. Biochemical and molecular analyses demonstrate TSG-6 is highly expressed in ASC-CCM from cells pre-stimulated with TNF alpha and IFN gamma but not from unstimulated cells. Our findings suggest that ASC-CCM mitigates visual deficits of the blast injury through their anti-inflammatory properties on activated pro-inflammatory microglia and endothelial cells. A regenerative therapy for immediate delivery at the time of injury may provide a practical and cost-effective solution against the traumatic effects of blast injuries to the retina.	[Jha, Kumar Abhiram; Lenin, Raji; Elshaer, Sally L.; Gentry, Jordy; Russell, John M.; Reiner, Anton; Gangaraju, Rajashekhar] Univ Tennessee, Dept Ophthalmol, Coll Med, Hlth Sci Ctr, Memphis, TN 38163 USA; [Pentecost, Mickey; Klaic, Lada; Beland, Alex; Jotterand, Veronique; Sohl, Nicolas] Cell Care Therapeut Inc, Monrovia, CA 91016 USA; [Reiner, Anton; Gangaraju, Rajashekhar] Univ Tennessee, Dept Anat & Neurobiol, Coll Med, Hlth Sci Ctr, Memphis, TN 38163 USA	Gangaraju, R (corresponding author), Univ Tennessee, Dept Ophthalmol, Coll Med, Hlth Sci Ctr, Memphis, TN 38163 USA.; Gangaraju, R (corresponding author), Univ Tennessee, Dept Anat & Neurobiol, Coll Med, Hlth Sci Ctr, Memphis, TN 38163 USA.	kjha@uthsc.edu; mickey.pentecost@gmail.com; rrajeshl@uthsc.edu; lklaic@cell-care.com; slelshaer@gmail.com; jgentr21@uthsc.edu; jrusse74@uthsc.edu; abeland16@students.kgi.edu; areiner@uthsc.edu; vjotterand@cell-care.com; nsohl@cell-care.com; sgangara@uthsc.edu	Reiner, Anton/AAG-8860-2020; Gangaraju, Rajashekhar/I-7852-2019	Reiner, Anton/0000-0002-2146-5232; Gangaraju, Rajashekhar/0000-0002-6664-8286	Department of DefenseUnited States Department of Defense [W81XWH-16-1-0761, W81XWH-16-1-0076]; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY023427]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Neuroscience Institute, UTHSC; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY023427] Funding Source: NIH RePORTER	This study was funded by grants from the Department of Defense (W81XWH-16-1-0761), National Eye Institute (EY023427), and unrestricted funds from Research to Prevent Blindness to R.G. and Department of Defense (W81XWH-16-1-0076) to A.R. K.A.J. is a recipient of postdoc fellowship award from Neuroscience Institute, UTHSC. The funders played no role in the conduct of the study, collection of data, management of the study, analysis of data, interpretation of data, or preparation of the manuscript.	Adutler-Lieber S, 2013, J CARDIOVASC PHARM T, V18, P78, DOI 10.1177/1074248412453875; Andreeva ER, 2018, J CELL PHYSIOL, V233, P1535, DOI 10.1002/jcp.26046; Bhattacharya Sujoy, 2017, Curr Mol Biol Rep, V3, P172, DOI 10.1007/s40610-017-0069-3; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1634/stemcells.stemcells.2008-0742, 10.1002/stem.20080742]; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chan TM, 2014, CELL TRANSPLANT, V23, P549, DOI 10.3727/096368914X678445; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Chung JY, 2012, J NEUROL SCI, V317, P40, DOI 10.1016/j.jns.2012.02.035; Dantuma E, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt37; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Duan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073768; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Harting MT, 2018, STEM CELLS, V36, P79, DOI 10.1002/stem.2730; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iandiev I, 2008, INVEST OPHTH VIS SCI, V49, P3559, DOI 10.1167/iovs.08-1723; Ionescu L, 2012, AM J PHYSIOL-LUNG C, V303, pL967, DOI 10.1152/ajplung.00144.2011; Jha KA, 2015, NEUROCHEM RES, V40, P2153, DOI 10.1007/s11064-015-1698-7; Jiang DS, 2013, BIOMATERIALS, V34, P2501, DOI 10.1016/j.biomaterials.2012.12.014; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kuriyan AE, 2017, NEW ENGL J MED, V376, P1047, DOI 10.1056/NEJMoa1609583; Landiev I, 2006, EXP EYE RES, V82, P449, DOI 10.1016/j.exer.2005.07.018; Lee MJ, 2010, J PROTEOME RES, V9, P1754, DOI 10.1021/pr900898n; Li W, 2013, STEM CELL RES, V10, P405, DOI 10.1016/j.scr.2013.01.005; Liu Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-135; Lu HY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0422-3; Mammadova N, 2017, AM J PATHOL, V187, P1459, DOI 10.1016/j.ajpath.2017.03.005; Marks PW, 2017, NEW ENGL J MED, V376, P1007, DOI 10.1056/NEJMp1613723; McGuckin CP, 2013, ARCH BIOCHEM BIOPHYS, V534, P88, DOI 10.1016/j.abb.2013.02.005; Mead B, 2016, CYTOTHERAPY, V18, P487, DOI 10.1016/j.jcyt.2015.12.002; Mead B, 2013, INVEST OPHTH VIS SCI, V54, P7544, DOI 10.1167/iovs.13-13045; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Newell KA, 2011, SEMIN IMMUNOPATHOL, V33, P91, DOI 10.1007/s00281-011-0255-y; Ostanin AA, 2011, B EXP BIOL MED+, V151, P133, DOI 10.1007/s10517-011-1275-2; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Potter DR, 2018, J TRAUMA ACUTE CARE, V84, P245, DOI 10.1097/TA.0000000000001744; Presley C, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.159; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Rajashekhar G, 2008, STEM CELLS, V26, P2674, DOI 10.1634/stemcells.2008-0277; Rajashekhar G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00059; Rajashekhar G, 2014, EXP EYE RES, V122, P77, DOI 10.1016/j.exer.2014.03.004; Rajashekhar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084671; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rodriguez TM, 2015, STEM CELL TRANSL MED, V4, P894, DOI 10.5966/sctm.2015-0012; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Sala E, 2015, GASTROENTEROLOGY, V149, P163, DOI 10.1053/j.gastro.2015.03.013; Saraf SS, 2017, OSLI RETINA, V48, P772, DOI 10.3928/23258160-20170829-16; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Shang QW, 2015, STEM CELLS DEV, V24, P2052, DOI 10.1089/scd.2014.0557; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Sugitani S, 2013, EXP EYE RES, V116, P254, DOI 10.1016/j.exer.2013.09.013; Tobita M, 2011, DISCOV MED, V11, P160; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Tzameret A, 2014, EXP EYE RES, V118, P135, DOI 10.1016/j.exer.2013.10.023; Vien L, 2017, OPTOMETRY VISION SCI, V94, P125, DOI 10.1097/OPX.0000000000000899; Volkman R, 2017, STEM CELLS, V35, P1867, DOI 10.1002/stem.2651; Wei X, 2009, NEUROSCI LETT, V462, P76, DOI 10.1016/j.neulet.2009.06.054; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Xie J, 2015, STEM CELLS, V33, P468, DOI 10.1002/stem.1851; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang Y, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0257-0; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106	76	20	21	0	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	JUL	2018	19	7							2016	10.3390/ijms19072016			22	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	GR6UX	WOS:000442807400195	29997321	DOAJ Gold, Green Published			2021-06-18	
J	Michinaga, S; Kimura, A; Hatanaka, S; Minami, S; Asano, A; Ikushima, Y; Matsui, S; Toriyama, Y; Fujii, M; Koyama, Y				Michinaga, Shotaro; Kimura, Akimasa; Hatanaka, Shunichi; Minami, Shizuho; Asano, Arisa; Ikushima, Yuki; Matsui, Shingo; Toriyama, Yoshiya; Fujii, Manami; Koyama, Yutaka			Delayed Administration of BQ788, an ETB Antagonist, after Experimental Traumatic Brain Injury Promotes Recovery of Blood-Brain Barrier Function and a Reduction of Cerebral Edema in Mice	JOURNAL OF NEUROTRAUMA			English	Article						astrocyte; blood-brain barrier; brain edema; endothelin	ENDOTHELIAL GROWTH-FACTOR; CLOSED-HEAD INJURY; RECEPTOR ANTAGONISTS; SUBARACHNOID HEMORRHAGE; CEREBROSPINAL-FLUID; RAT-BRAIN; VEGF-A; ACTIVATION; DISRUPTION; ASTROCYTES	Traumatic brain injury (TBI) is induced by immediate physical disruption of brain tissue, and causes death and disability. Studies on experimental TBI animal models show that disruption of the blood-brain barrier (BBB) underlies brain edema and neuroinflammation during the delayed phase of TBI. In neurological disorders, endothelin-1 (ET-1) is involved in BBB dysfunction and brain edema. In this study, the effect of ET antagonists on BBB dysfunction and brain edema were examined in a mouse focal TBI model using lateral fluid percussion injury (FPI). ET-1 and ETB receptors were increased at 2-7 days after FPI, which was accompanied by extravasation of Evans blue (EB) and brain edema. Repeated intracerebroventricular administration of BQ788 (15nmol/day), an ETB antagonist, from 2 days after FPI promoted recovery of EB extravasation and brain edema, while FR 139317, an ETA antagonist, had no effect. Delayed intravenous administration of BQ788 also promoted recovery from FPI-induced EB extravasation and brain edema. While FPI caused decreases in claudin-5, occludin, and zonula occludens-1 proteins, BQ788 reversed FPI-induced reductions of them. Immunohistochemical observation of the cerebrum after FPI showed that ETB receptors are predominantly expressed in glial fibrillary acidic protein (GFAP)-positive astrocytes. BQ788 reduced FPI-induced increases in GFAP-positive astrocytes. GFAP-positive astrocytes produced vascular endothelial growth factor-A (VEGF-A) and matrix metalloproteinase-9 (MMP9). FPI-induced increases in VEGF-A and MMP-9 production were reversed by BQ788. These results suggest that ETB receptor antagonism during the delayed phase of focal TBI promotes recovery of BBB function and reduction of brain edema.	[Michinaga, Shotaro; Kimura, Akimasa; Hatanaka, Shunichi; Minami, Shizuho; Asano, Arisa; Ikushima, Yuki; Matsui, Shingo; Toriyama, Yoshiya; Fujii, Manami] Osaka Ohtani Univ, Lab Pharmacol, Osaka, Japan; [Koyama, Yutaka] Kobe Pharmaceut Univ, Dept Pharmacol, Kobe, Hyogo, Japan	Koyama, Y (corresponding author), 4-19-1 Motoyama Kita, Kobe, Hyogo 6688558, Japan.	koyama-y@kobepharma-u.ac.jp			Japan Society for the Promotion of Science (JSPS)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [15K07981, 16K18890]	This work was supported by a Grant-in-Aid for Scientific Research (C; Grant Number: 15K07981) and Grant-in-Aid for Young Scientists (B; Grant Number: 16K18890) from the Japan Society for the Promotion of Science (JSPS). We also thank Rachel James, PhD, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript.	Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Asl SZ, 2013, J NEUROSURG, V119, P353, DOI 10.3171/2013.4.JNS121636; Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036001-00104; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Boroujerdi A, 2015, ANGIOGENESIS, V18, P255, DOI 10.1007/s10456-015-9464-7; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chatfield DA, 2011, NEUROCRIT CARE, V14, P55, DOI 10.1007/s12028-010-9413-7; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Gong D, 2011, J TRAUMA, V70, P1480, DOI 10.1097/TA.0b013e31821ac9e1; Hostenbach S, 2016, PROG NEUROBIOL, V144, P88, DOI 10.1016/j.pneurobio.2016.04.009; Kim JY, 2015, NEUROSCIENCE, V304, P355, DOI 10.1016/j.neuroscience.2015.07.065; Kim J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074458, 10.1371/journal.pone.0051986]; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Koyama Y, 2011, NEUROSCIENCE, V192, P689, DOI 10.1016/j.neuroscience.2011.05.058; Koyama Y, 1999, GLIA, V26, P268, DOI 10.1002/(SICI)1098-1136(199905)26:3<268::AID-GLIA8>3.0.CO;2-G; Koyama Yutaka, 2013, Biomol Concepts, V4, P335, DOI 10.1515/bmc-2013-0004; Koyama Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-51; Koyama Y, 2012, GLIA, V60, P1954, DOI 10.1002/glia.22411; Koyama Y, 2012, J PHARMACOL SCI, V118, P401, DOI 10.1254/jphs.11R13CP; Koyama Y, 2010, J PHARMACOL SCI, V114, P433, DOI 10.1254/jphs.10195FP; Laban KG, 2015, J CEREBR BLOOD F MET, V35, P1085, DOI 10.1038/jcbfm.2015.89; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maier B, 2007, SHOCK, V27, P610, DOI 10.1097/shk.0b013e31802f9eaf; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; Michinaga S, 2015, EUR J NEUROSCI, V42, P2356, DOI 10.1111/ejn.13020; Michinaga S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102009; Min H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0116-z; Moldes O, 2012, NEUROPHARMACOLOGY, V63, P1279, DOI 10.1016/j.neuropharm.2012.08.019; Morga E, 2000, J NEUROCHEM, V74, P603, DOI 10.1046/j.1471-4159.2000.740603.x; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Palmer J, 2011, PHARMACOL RES, V63, P525, DOI 10.1016/j.phrs.2010.12.008; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Petrov T, 2009, CAN J PHYSIOL PHARM, V87, P379, DOI [10.1139/y09-022, 10.1139/Y09-022]; Ranno E, 2014, NEUROBIOL DIS, V65, P160, DOI 10.1016/j.nbd.2014.01.002; Reinhold AK, 2017, PFLUG ARCH EUR J PHY, V469, P123, DOI 10.1007/s00424-016-1920-8; Reynolds CA, 2011, NEUROL RES, V33, P197, DOI 10.1179/016164111X12881719352499; Reynolds CA, 2011, NEUROL RES, V33, P192, DOI 10.1179/016164111X12881719352453; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Yang Y, 2013, J CEREBR BLOOD F MET, V33, P1104, DOI 10.1038/jcbfm.2013.56; Yang Y, 2011, METHODS MOL BIOL, V762, P333, DOI 10.1007/978-1-61779-185-7_24; Zhao J, 2012, J NEUROTRAUM, V29, P1209, DOI 10.1089/neu.2011.1858; Zuccarello M, 1998, STROKE, V29, P1924, DOI 10.1161/01.STR.29.9.1924	64	20	21	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	13					1481	1494		10.1089/neu.2017.5421			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GJ4CQ	WOS:000435328000006	29316834				2021-06-18	
J	Forstner, P; Rehman, R; Anastasiadou, S; Haffner-Luntzer, M; Sinske, D; Ignatius, A; Roselli, F; Knoll, B				Foerstner, Philip; Rehman, Rida; Anastasiadou, Sofia; Haffner-Luntzer, Melanie; Sinske, Daniela; Ignatius, Anita; Roselli, Francesco; Knoell, Bernd			Neuroinflammation after Traumatic Brain Injury Is Enhanced in Activating Transcription Factor 3 Mutant Mice	JOURNAL OF NEUROTRAUMA			English	Article						ATF3; chemokine; hematoma; RAG; traumatic brain injury	ADAPTIVE-RESPONSE GENE; CLOSED-HEAD INJURY; NEGATIVE REGULATOR; ATF3 EXPRESSION; ANIMAL-MODELS; INFLAMMATION; REGENERATION; NEURONS; CARDIOMYOCYTES; LIPOCALIN-2	Traumatic brain injury (TBI) induces a neuroinflammatory response resulting in astrocyte and microglia activation at the lesion site. This involves upregulation of neuroinflammatory genes, including chemokines and interleukins. However, so far, there is lack of knowledge on transcription factors (TFs) modulating this TBI-associated gene expression response. Herein, we analyzed activating transcription factor 3 (ATF3), a TF encoding a regeneration-associated gene (RAG) predominantly studied in peripheral nervous system (PNS) injury. ATF3 contributes to PNS axon regeneration and was shown before to regulate inflammatory processes in other injury models. In contrast to PNS injury, data on ATF3 in central nervous system (CNS) injury are sparse. We used Atf3 mouse mutants and a closed-head weight-drop-based TBI model in adult mice to target the rostrolateral cortex resulting in moderate injury severity. Post-TBI, ATF3 was upregulated already at early time points (i.e,. 1-4h) post-injury in the brain. Mortality and weight loss upon TBI were slightly elevated in Atf3 mutants. ATF3 deficiency enhanced TBI-induced paresis and hematoma formation, suggesting that ATF3 limits these injury outcomes in wild-type mice. Next, we analyzed TBI-associated RAG and inflammatory gene expression in the cortical impact area. In contrast to the PNS, only some RAGs (Atf3, Timp1, and Sprr1a) were induced by TBI, and, surprisingly, some RAG encoding neuropeptides were downregulated. Notably, we identified ATF3 as TF-regulating proneuroinflammatory gene expression, including CCL and CXCL chemokines (Ccl2, Ccl3, Ccl4, and Cxcl1) and lipocalin. In Atf3 mutant mice, mRNA abundance was further enhanced upon TBI compared to wild-type mice, suggesting immune gene repression by wild-type ATF3. In accord, more immune cells were present in the lesion area of ATF3-deficient mice. Overall, we identified ATF3 as a new TF-mediating TBI-associated CNS inflammatory responses.	[Foerstner, Philip; Anastasiadou, Sofia; Sinske, Daniela; Knoell, Bernd] Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany; [Rehman, Rida; Roselli, Francesco] Ulm Univ, Dept Neurol, Ulm, Germany; [Rehman, Rida] NUST, SMME, Dept Biomed Engn & Sci BMES, H-12, Islamabad, Pakistan; [Haffner-Luntzer, Melanie; Ignatius, Anita] Univ Ulm, Inst Orthopaed Res & Biomech, Ctr Trauma Res Ulm, Ulm, Germany	Knoll, B (corresponding author), Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	bernd.knoell@uni-ulm.de	Ignatius, Anita/M-6012-2013; Rehman, Rida/AAR-4811-2020; roselli, francesco/O-8847-2019; Haffner-Luntzer, Melanie/L-3562-2019	Ignatius, Anita/0000-0002-4782-1979; Rehman, Rida/0000-0003-0518-5051; roselli, francesco/0000-0001-9935-6899; Haffner-Luntzer, Melanie/0000-0002-3333-2613; Meyer zu Reckendorf, Sofia/0000-0001-6978-1915	Deutsche Forschungsgemeinschaft (DFG), Collaborative Research CenterGerman Research Foundation (DFG) [1149]; ERANET-NEURON initiative "External Insults to the Nervous System'', MICRONET consortium; Baustein Program of Ulm University; Ulm University-Bundeswehr Krankenhaus Ulm research initiative; Paul und Marlene Hepp-Stiftung	The work by A.I., B.K., and F.R. has been supported by the Deutsche Forschungsgemeinschaft (DFG) as part of the Collaborative Research Center 1149 "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma.'' F.R. is also supported by the ERANET-NEURON initiative "External Insults to the Nervous System'' as part of the MICRONET consortium and by the Baustein Program of Ulm University. B.K. is supported by an Ulm University-Bundeswehr Krankenhaus Ulm research initiative and Paul und Marlene Hepp-Stiftung.	Akram A, 2010, AM J RESP CRIT CARE, V182, P489, DOI 10.1164/rccm.200906-0925OC; Aung HH, 2016, J LIPID RES, V57, P955, DOI 10.1194/jlr.M061853; Boespflug ND, 2014, BLOOD, V123, P2084, DOI 10.1182/blood-2013-06-510909; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bulsara KR, 2002, SPINE, V27, P1946, DOI 10.1097/00007632-200209010-00030; Cartagena CM, 2013, NEUROMOL MED, V15, P504, DOI 10.1007/s12017-013-8236-z; Chandran V, 2016, NEURON, V89, P956, DOI 10.1016/j.neuron.2016.01.034; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Fagoe ND, 2015, HUM MOL GENET, V24, P6788, DOI 10.1093/hmg/ddv383; Fagoe ND, 2014, NEUROMOL MED, V16, P799, DOI 10.1007/s12017-014-8329-3; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Fazio EN, 2017, MOL BIOL CELL, V28, P2347, DOI 10.1091/mbc.E17-04-0254; Fernandez-Verdejo R, 2017, FASEB J, V31, P840, DOI 10.1096/fj.201600987R; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fukasawa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30918; Gey M, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160091; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hu CJ, 2017, J LEUKOCYTE BIOL, V101, P633, DOI 10.1189/jlb.2HI1115-491R; Hunt D, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00007; Isidro RA, 2016, AM J PHYSIOL-GASTR L, V311, pG59, DOI 10.1152/ajpgi.00123.2016; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Ka MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00500; Kalfon R, 2017, CARDIOVASC RES, V113, P134, DOI 10.1093/cvr/cvw228; Kawa L, 2016, EXP NEUROL, V279, P159, DOI 10.1016/j.expneurol.2016.02.019; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Khuu CH, 2007, MOL IMMUNOL, V44, P1598, DOI 10.1016/j.molimm.2006.08.006; Koren L, 2015, INT J CARDIOL, V198, P232, DOI 10.1016/j.ijcard.2015.06.099; Kruse F, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00026; Kwon MJ, 2016, NEURAL REGEN RES, V11, P1368, DOI 10.4103/1673-5374.191194; Labzin LI, 2015, J IMMUNOL, V195, P4446, DOI 10.4049/jimmunol.1500204; Lee LL, 2017, AM J PHYSIOL-CELL PH, V312, pC500, DOI 10.1152/ajpcell.00120.2016; Lim R, 2016, PLACENTA, V47, P63, DOI 10.1016/j.placenta.2016.09.006; Ma TC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00043; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Patodia S, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00008; Plunet W, 2002, J NEUROSCI RES, V68, P1, DOI 10.1002/jnr.10176; Qian LL, 2017, J CELL PHYSIOL, V232, P3727, DOI 10.1002/jcp.25849; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Rao J, 2015, AM J TRANSPLANT, V15, P76, DOI 10.1111/ajt.12954; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rynes J, 2012, MOL CELL BIOL, V32, P3949, DOI 10.1128/MCB.00429-12; Samal BB, 2015, J MOL NEUROSCI, V57, P282, DOI 10.1007/s12031-015-0626-2; Schreiber RC, 2001, NEUROREPORT, V12, P601, DOI 10.1097/00001756-200103050-00034; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Seijffers R, 2006, MOL CELL NEUROSCI, V32, P143, DOI 10.1016/j.mcn.2006.03.005; Seijffers R, 2014, P NATL ACAD SCI USA, V111, P1622, DOI 10.1073/pnas.1314826111; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Stern S, 2012, J NEUROINFLAMM, V9, DOI [10.1186/1742-2094-9-79, 10.1186/1742-2094-9-78]; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Suk K, 2016, PROG NEUROBIOL, V144, P158, DOI 10.1016/j.pneurobio.2016.08.001; Tedeschi A, 2012, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmo1.2011.00060; van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570; van Kesteren RE, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00046; van Landeghem FKH, 2007, ACTA NEUROPATHOL, V113, P683, DOI 10.1007/s00401-007-0208-7; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Vos BC, 2018, CLIN J SPORT MED, V28, P91, DOI 10.1097/JSM.0000000000000432; Wang L, 2012, NEUROSCIENCE, V220, P100, DOI 10.1016/j.neuroscience.2012.06.010; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhao YF, 2017, MOL IMMUNOL, V90, P27, DOI 10.1016/j.molimm.2017.06.037; Zmuda EJ, 2010, DIABETOLOGIA, V53, P1438, DOI 10.1007/s00125-010-1696-x; Zmuda EJ, 2010, MOL ENDOCRINOL, V24, P1423, DOI 10.1210/me.2009-0463	74	20	20	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	19					2317	2329		10.1089/neu.2017.5593		JUN 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GV3OA	WOS:000434224900001	29463176				2021-06-18	
J	Babl, FE; Oakley, E; Dalziel, SR; Borland, ML; Phillips, N; Kochar, A; Dalton, S; Cheek, JA; Gilhotra, Y; Furyk, J; Neutze, J; Donath, S; Hearps, S; Molesworth, C; Crowe, L; Bressan, S; Lyttle, MD				Babl, Franz E.; Oakley, Ed; Dalziel, Stuart R.; Borland, Meredith L.; Phillips, Natalie; Kochar, Amit; Dalton, Sarah; Cheek, John A.; Gilhotra, Yuri; Furyk, Jeremy; Neutze, Jocelyn; Donath, Susan; Hearps, Stephen; Molesworth, Charlotte; Crowe, Louise; Bressan, Silvia; Lyttle, Mark D.			Accuracy of Clinician Practice Compared With Three Head Injury Decision Rules in Children: A Prospective Cohort Study	ANNALS OF EMERGENCY MEDICINE			English	Article							CRANIAL COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; TRAUMA; PECARN; CHALICE; PREDICTION; CATCH; METHODOLOGY; DERIVATION	Study objective: Three clinical decision rules for head injuries in children (Pediatric Emergency Care Applied Research Network [PECARN], Canadian Assessment of Tomography for Childhood Head Injury [CATCH], and Children's Head Injury Algorithm for the Prediction of Important Clinical Events [CHALICE]) have been shown to have high performance accuracy. The utility of any of these in a particular setting depends on preexisting clinician accuracy. We therefore assess the accuracy of clinician practice in detecting clinically important traumatic brain injury. Methods: This was a planned secondary analysis of a prospective observational study of children younger than 18 years with head injuries at 10 Australian and New Zealand centers. In a cohort of children with mild head injuries (Glasgow Coma Scale score 13 to 15, presenting in <24 hours) we assessed physician accuracy (computed tomography [CT] obtained in emergency departments [EDs]) for the standardized outcome of clinically important traumatic brain injury and compared this with the accuracy of PECARN, CATCH, and CHALICE. Results: Of 20,137 children, 18,913 had a mild head injury. Of these patients, 1,579 (8.3%) received a CT scan during the ED visit, 160 (0.8%) had clinically important traumatic brain injury, and 24 (0.1%) underwent neurosurgery. Clinician identification of clinically important traumatic brain injury based on CT performed had a sensitivity of 158 of 160, or 98.8% (95% confidence interval [CI] 95.6% to 99.8%) and a specificity of 17,332 of 18,753, or 92.4% (95% CI 92.0% to 92.8%). Sensitivity of PECARN for children younger than 2 years was 42 of 42 (100.0%; 95% CI 91.6% to 100.0%), and for those 2 years and older, it was 117 of 118 (99.2%; 95% CI 95.4% to 100.0%); for CATCH (high/medium risk), it was 147 of 160 (91.9%; 95% CI 86.5% to 95.6%); and for CHALICE, 148 of 160 (92.5%; 95% CI 87.3% to 96.1%). Conclusion: In a setting with high clinician accuracy and a low CT rate, PECARN, CATCH, or CHALICE clinical decision rules have limited potential to increase the accuracy of detecting clinically important traumatic brain injury and may increase the CT rate.	[Babl, Franz E.; Oakley, Ed; Cheek, John A.] Royal Childrens Hosp, Emergency Dept, Parkville, Vic, Australia; [Babl, Franz E.; Oakley, Ed; Cheek, John A.; Donath, Susan; Hearps, Stephen; Molesworth, Charlotte; Crowe, Louise; Bressan, Silvia; Lyttle, Mark D.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Babl, Franz E.; Oakley, Ed; Donath, Susan] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Parkville, Vic, Australia; [Dalziel, Stuart R.] Univ Auckland, Emergency Dept Starship Childrens Hlth, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Borland, Meredith L.] Princess Margaret Hosp Children, Emergency Dept, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Paediat & Child Hlth, Crawley, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Primary Aboriginal & Rural Healthcare, Crawley, Australia; [Phillips, Natalie; Gilhotra, Yuri] Lady Cilento Childrens Hosp, Brisbane, Qld, Australia; [Phillips, Natalie; Gilhotra, Yuri] Univ Queensland, Child Hlth Res Ctr, Sch Med, South Brisbane, Qld, Australia; [Kochar, Amit] Womens & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, Sydney, NSW, Australia; [Cheek, John A.] Monash Med Ctr, Emergency Dept, Clayton, Vic, Australia; [Furyk, Jeremy] Townsville Hosp, Emergency Dept, Douglas, Qld, Australia; [Neutze, Jocelyn] Kidzfirst Middlemore Hosp, Emergency Dept, Auckland, New Zealand; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Lyttle, Mark D.] Univ West England, Emergency Dept, Bristol, Avon, England; [Lyttle, Mark D.] Univ West England, Acad Dept Emergency Care, Bristol, Avon, England	Babl, FE (corresponding author), Royal Childrens Hosp, Emergency Dept, Parkville, Vic, Australia.; Babl, FE (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.; Babl, FE (corresponding author), Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Parkville, Vic, Australia.	franz.babl@rch.org.au	Hearps, Stephen/L-6853-2016	Donath, Susan/0000-0003-2489-3977; Crowe, Louise/0000-0003-4619-9708; Lyttle, Mark/0000-0002-8634-7210	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [GNT1046727, GNT1058560]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation, Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation [3112011]; A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds, Perth, Australia; Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; Royal Children's Hospital Foundation, Melbourne, Australia; Melbourne Children's Clinician Scientist Fellowship, Melbourne, Australia; NHMRC Practitioner Fellowship, Canberra, Australia; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. The study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; and the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia. The study was also supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. Dr. Babl's time was partly funded by a grant from the Royal Children's Hospital Foundation, Melbourne, Australia; a Melbourne Children's Clinician Scientist Fellowship, Melbourne, Australia; and an NHMRC Practitioner Fellowship, Canberra, Australia. Dr. Dalziel's time was partly funded by the Health Research Council of New Zealand (HRC13/556).	Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Bossuyt PM, 2003, ACAD RADIOL, V10, P664, DOI 10.1016/S1076-6332(03)80086-7; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Green SM, 2014, ANN EMERG MED, V64, P286, DOI 10.1016/j.annemergmed.2014.01.016; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lockie FD, 2013, EMERG MED AUSTRALAS, V25, P75, DOI 10.1111/1742-6723.12019; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Lyttle MD, 2013, EMERG MED J, V30, P790, DOI 10.1136/emermed-2012-201887; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Oakley E, 2017, EMERG MED AUSTRALAS, V29, P192, DOI 10.1111/1742-6723.12732; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; Thiam DW, 2015, ANN ACAD MED SINGAP, V44, P335	29	20	20	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JUN	2018	71	6					703	710		10.1016/j.annemergmed.2018.01.015			8	Emergency Medicine	Emergency Medicine	GJ5NX	WOS:000435429300010	29452747				2021-06-18	
J	Ko, IG; Kim, SE; Hwang, L; Jin, JJ; Kim, CJ; Kim, BK; Kim, H				Ko, Il-Gyu; Kim, Sung-Eun; Hwang, Lakkyong; Jin, Jun-Jang; Kim, Chang-Ju; Kim, Bo-Kyun; Kim, Hong			Late starting treadmill exercise improves spatial leaning ability through suppressing CREP/BDNF/TrkB signaling pathway following traumatic brain injury in rats	JOURNAL OF EXERCISE REHABILITATION			English	Article						Traumatic brain injury; Treadmill exercise; Spatial learning ability; Brain-derived neurotrophic factor; cAMP-response element binding protein; Apoptosis	VOLUNTARY EXERCISE; GENE-EXPRESSION; UP-REGULATION; APOPTOSIS; RECOVERY; NEUROGENESIS; DYSFUNCTION; MEMORY	Traumatic brain injury (TBI) causes deficit in spatial learning and memory function. Physical activity ameliorates neurological dysfunction after TBI. We investigated the effect of late starting treadmill exercise on spatial learning ability in relation with cAMP-response element binding protein (CREB)/brain-derived neurotrophic factor (BDNF) signaling pathway using TBI rats. For this study, radial 8-arm maze test, TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) staining, caspase-3 immunohistochemistry, and western blot for Bax, Bcl-2, BDNF, tyrosine kinase B (TrkB), CREB, and phosphorylated CREP (p-CREB) were performed. TBI was induced by an electromagnetic-controlled cortical impact. The rats in the exercise groups were scheduled to run on a treadmill for 30 min once a day for 8 weeks starting 3 weeks after TBI. TBI impaired spatial learning ability and increased caspase-3 expression in the hippocampal dentate gyrus. TBI enhanced Bax expression and suppressed Bcl-2 expression in the hippocampus. TBI increased BDNF and TrkB expressions, resulted in the enhancement of p-CREB/CREB ratio in the hippocampus. However, treadmill exercise improved spatial learning ability, decreased caspase-3 expression, suppressed Bax expression, and increased Bcl-2 expression. Treadmill exercise alleviated TBI-induced over-expression of BDNF and TrkB, which suppressed phosphorylation of CREB in the hippocampus. In the present study, late starting treadmill exercise improved spatial learning ability through suppressing TBI-induced activation of CREB/BDNF/TrkB signaling pathway after TBI.	[Ko, Il-Gyu; Kim, Sung-Eun; Hwang, Lakkyong; Jin, Jun-Jang; Kim, Chang-Ju] Kyung Hee Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Ko, Il-Gyu; Kim, Sung-Eun; Hwang, Lakkyong; Jin, Jun-Jang; Kim, Chang-Ju] Kyung Hee Univ, Kohwang Med Res Inst, Seoul, South Korea; [Kim, Bo-Kyun] Gachon Univ, Coll Hlth Sci, Dept Emergency Technol, Incheon, South Korea; [Kim, Hong] Daegu Haany Univ, Coll Biomed Sci, Dept Oriental Sports Med, 1 Haanydae Ro, Gyongsan 38610, South Korea	Kim, H (corresponding author), Daegu Haany Univ, Coll Biomed Sci, Dept Oriental Sports Med, 1 Haanydae Ro, Gyongsan 38610, South Korea.	joshua@dhu.ac.kr		Hwang, Lakkyong/0000-0001-5173-1258	National Research Foundation of Korea (NRF) - Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of KoreaNational Research Foundation of Korea [NRF-2011-0021908]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2011-0021908).	Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Byun YH, 2005, J SPORT MED PHYS FIT, V45, P222; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Ji ES, 2015, J EXERC REHABIL, V11, P133, DOI 10.12965/jer.150212; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Kim YH, 2014, J EXERC REHABIL, V10, P209, DOI 10.12965/jer.140145; Ko IG, 2009, PHARMACOL BIOCHEM BE, V91, P629, DOI 10.1016/j.pbb.2008.10.009; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Park MS, 2014, J EXERC REHABIL, V10, P148, DOI 10.12965/jer.140109; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Shen XF, 2013, INT J MOL SCI, V14, P21598, DOI 10.3390/ijms141121598; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Wu CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108548; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739	26	20	21	0	0	KOREAN SOC EXERCISE REHABILITATION	SEOUL	264 BAEKJEGOBUN-RO, SONGPA-GU, SEOUL, 138-841, SOUTH KOREA	2288-176X	2288-1778		J EXERC REHABIL	J. Exerc. Rehabil.	JUN	2018	14	3					327	334		10.12965/jer.1836248.124			8	Rehabilitation	Rehabilitation	GL7FX	WOS:000437363700003	30018914	DOAJ Gold, Green Published			2021-06-18	
J	Fortenbaugh, FC; Rothlein, D; McGlinchey, R; DeGutis, J; Esterman, M				Fortenbaugh, Francesca C.; Rothlein, David; McGlinchey, Regina; DeGutis, Joseph; Esterman, Michael			Tracking behavioral and neural fluctuations during sustained attention: A robust replication and extension	NEUROIMAGE			English	Article						Continuous performance task; Vigilance; fMRI; Default mode network; Dorsal attention network	TRAUMATIC BRAIN-INJURY; DEFAULT-MODE; WORKING-MEMORY; TOP-DOWN; VIGILANCE; PERFORMANCE; INHIBITION; VARIABILITY; VETERANS; NETWORK	Novel paradigms have allowed for more precise measurements of sustained attention ability and fluctuations in sustained attention over time, as well as the neural basis of fluctuations and lapses in performance. However, in recent years, concerns have arisen over the replicability of neuroimaging studies and psychology more broadly, particularly given the typically small sample sizes. One recently developed paradigm, the gradual-onset continuous performance task (gradCPT) has been validated behaviorally in large samples of participants. Yet neuroimaging studies investigating the neural basis of performance on this task have only been collected in small samples. The present study completed both a robust replication of the original neuroimaging findings and extended previous results from the gradCPT task using a large sample of 140 Veteran participants. Results replicate findings that fluctuations in attentional stability are tracked over time by BOLD activity in task positive (e.g., dorsal and ventral attention networks) and task negative (e.g., default network) regions. Extending prior results, we relate this coupling between attentional stability and on-going brain activity to overall sustained attention ability and demonstrate that this coupling strength, along with across-network coupling, could be used to predict individual differences in performance. Additionally, the results extend previous findings by demonstrating that temporal dynamics across the default and dorsal attention networks are associated with lapse-likelihood on subsequent trials. This study demonstrates the reliability of the gradCPT, and underscores the utility of this paradigm in understanding attentional fluctuations, as well as individual variation and deficits in sustained attention.	[Fortenbaugh, Francesca C.; Rothlein, David; McGlinchey, Regina; DeGutis, Joseph; Esterman, Michael] VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, Boston, MA 02130 USA; [Fortenbaugh, Francesca C.; Rothlein, David; DeGutis, Joseph; Esterman, Michael] VA Boston Healthcare Syst, Boston Attent & Learning Lab, Boston, MA 02130 USA; [Fortenbaugh, Francesca C.; Rothlein, David; McGlinchey, Regina; DeGutis, Joseph; Esterman, Michael] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA 02130 USA; [Fortenbaugh, Francesca C.; McGlinchey, Regina] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Rothlein, David; Esterman, Michael] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [DeGutis, Joseph] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Fortenbaugh, FC (corresponding author), 150 S Huntington Ave, Boston, MA 02130 USA.	Francesca_Fortenbaugh@hms.harvard.edu			US Department of Veterans Affairs through the Translational Research Center for TBI and Stress DisordersUS Department of Veterans Affairs [B9254-C]; VA Rehabilitation Research AMP; Development Traumatic Brain Injury National Research Center; Department of Veterans Affairs Clinical Sciences Research and Development ServiceUS Department of Veterans Affairs [IK2CX000706-01A2]; National Institutes of Health NCCIH grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 AT009430-01]; Department of Veterans AffairsUS Department of Veterans Affairs; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21AT009430] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2CX000706, I01CX001327] Funding Source: NIH RePORTER	This research was support by the US Department of Veterans Affairs through the Translational Research Center for TBI and Stress Disorders (B9254-C), a VA Rehabilitation Research & Development Traumatic Brain Injury National Research Center, a Career Development award from the Department of Veterans Affairs Clinical Sciences Research and Development Service (IK2CX000706-01A2) to M.S.E., a National Institutes of Health NCCIH grant (R21 AT009430- 01) to R.M., and an Advanced Geriatric Fellowship from the Department of Veterans Affairs to F.C.F. The contents of this article do not represent the views of the Department of Veterans Affairs or the U.S. government.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Altpeter E, 2000, VISION RES, V40, P1539, DOI 10.1016/S0042-6989(00)00059-6; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Auerbach RP, 2014, PSYCHIAT RES, V220, P579, DOI 10.1016/j.psychres.2014.07.027; Avelar-Periera B., 2017, FRONT AGING NEUROSCI, V9, P1; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Berardi A, 2001, EXP AGING RES, V27, P19, DOI 10.1080/03610730126014; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Boekel W, 2015, CORTEX, V66, P115, DOI 10.1016/j.cortex.2014.11.019; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carriere JSA, 2010, PSYCHOL AGING, V25, P569, DOI 10.1037/a0019363; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Christoff K, 2016, NAT REV NEUROSCI, V17, P718, DOI 10.1038/nrn.2016.113; Clark L, 2002, BRIT J PSYCHIAT, V180, P313, DOI 10.1192/bjp.180.4.313; Clayton MS, 2015, TRENDS COGN SCI, V19, P188, DOI 10.1016/j.tics.2015.02.004; Conners C. K., 1994, CONNERS CONTINUOUS P; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Pasquale F., 2017, NEUROIMAGE, P1; Debettencourt MT, 2015, NAT NEUROSCI, V18, P470, DOI 10.1038/nn.3940; DeGutis J, 2015, J INT NEUROPSYCH SOC, V21, P342, DOI 10.1017/S1355617715000235; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Esterman M, 2017, CEREB CORTEX, V27, P4022, DOI 10.1093/cercor/bhw214; Esterman M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159741; Esterman M, 2015, NEUROIMAGE, V111, P542, DOI 10.1016/j.neuroimage.2015.01.044; Esterman M, 2014, J EXP PSYCHOL GEN, V143, P2287, DOI 10.1037/xge0000019; Esterman M, 2014, J NEUROSCI, V34, P1724, DOI 10.1523/JNEUROSCI.2658-13.2014; Esterman M, 2013, CEREB CORTEX, V23, P2712, DOI 10.1093/cercor/bhs261; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Forster S, 2015, CEREB CORTEX, V25, P609, DOI 10.1093/cercor/bht248; Fortenbaugh FC, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.684; Fortenbaugh FC, 2017, ANN NY ACAD SCI, V1396, P70, DOI 10.1111/nyas.13318; Fortenbaugh FC, 2017, VISION RES, V131, P26, DOI 10.1016/j.visres.2016.12.002; Fortenbaugh FC, 2015, PSYCHOL SCI, V26, P1497, DOI 10.1177/0956797615594896; Gao W, 2012, HUM BRAIN MAPP, V33, P192, DOI 10.1002/hbm.21204; Garrison KA, 2013, NEUROIMAGE, V81, P110, DOI 10.1016/j.neuroimage.2013.05.030; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Helton WS, 2011, EXP BRAIN RES, V212, P429, DOI 10.1007/s00221-011-2749-1; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Johnson BP, 2015, NEUROPSYCHOLOGIA, V72, P22, DOI 10.1016/j.neuropsychologia.2015.03.015; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Konishi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132209; Kucyi A, 2017, CEREB CORTEX, V27, P1831, DOI 10.1093/cercor/bhw029; Kucyi A, 2016, P NATL ACAD SCI USA, V113, P13899, DOI 10.1073/pnas.1611743113; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; LEVY F, 1980, J CHILD PSYCHOL PSYC, V21, P77, DOI 10.1111/j.1469-7610.1980.tb00018.x; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Park M, 2012, AGE AGEING, V41, P765, DOI 10.1093/ageing/afs084; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Riley E, 2017, CHRONOBIOL INT, V34, P993, DOI 10.1080/07420528.2017.1308951; Riley E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165100; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rosenberg M, 2013, ATTEN PERCEPT PSYCHO, V75, P426, DOI 10.3758/s13414-012-0413-x; Rosenberg MD, 2016, NAT NEUROSCI, V19, P165, DOI 10.1038/nn.4179; Rosenberg MD, 2015, NEUROIMAGE, V114, P249, DOI 10.1016/j.neuroimage.2015.03.032; Rosseel Y., 2012, LAVAAN R PACKAGE STR, V12, DOI [10.1152/jn.01316.2004, DOI 10.1152/JN.01316.2004]; Sadaghiani S, 2015, CEREB CORTEX, V25, P2763, DOI 10.1093/cercor/bhu072; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shalev L, 2011, NEUROPSYCHOLOGIA, V49, P2584, DOI 10.1016/j.neuropsychologia.2011.05.006; Silver H, 2005, J NEUROPSYCH CLIN N, V17, P391, DOI 10.1176/appi.neuropsych.17.3.391; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Staub B, 2014, ACTA PSYCHOL, V146, P51, DOI 10.1016/j.actpsy.2013.12.003; Staub B, 2013, AGEING RES REV, V12, P459, DOI 10.1016/j.arr.2012.12.001; Swick D, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00329; Swick D, 2013, NEUROPSYCHOLOGIA, V51, P3033, DOI 10.1016/j.neuropsychologia.2013.10.008; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Temple JG, 2000, HUM FACTORS, V42, P183, DOI 10.1518/001872000779656480; Thompson GJ, 2013, HUM BRAIN MAPP, V34, P3280, DOI 10.1002/hbm.22140; Van Vleet TM, 2013, CORTEX, V49, P679, DOI 10.1016/j.cortex.2012.03.020; Vatansever D, 2017, P NATL ACAD SCI USA, V114, P12821, DOI 10.1073/pnas.1710521114; Wechsler D., 2001, WECHSLER TEST ADULT; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	89	20	20	1	23	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAY 1	2018	171						148	164		10.1016/j.neuroimage.2018.01.002			17	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FZ5OJ	WOS:000427643700014	29307606	Green Accepted, Bronze			2021-06-18	
J	Norrholm, SD; Jovanovic, T				Norrholm, Seth Davin; Jovanovic, Tanja			Fear Processing, Psychophysiology, and PTSD	HARVARD REVIEW OF PSYCHIATRY			English	Article						fear conditioning; fear extinction; psychophysiology; PTSD; skin conductance; startle response	POSTTRAUMATIC-STRESS-DISORDER; VIRTUAL-REALITY EXPOSURE; COGNITIVE-BEHAVIORAL TREATMENT; RESEARCH DOMAIN CRITERIA; TRAUMATIC BRAIN-INJURY; POTENTIATED STARTLE; D-CYCLOSERINE; CONDITIONED FEAR; ANIMAL-MODELS; CONTEXTUAL MODULATION	The processing and regulation of fear is one of the key components of posttraumatic stress disorder (PTSD). Fear can involve both acute and potential threats that can manifest in different behaviors and result from activity within different neural nodes and networks. Fear circuits have been studied extensively in animal models for several decades and in human neuroimaging research for almost 20 years. Therefore, the centrality of fear processing to PTSD lends the disorder to be more tractable to investigation at the level of brain and behavior, and provides several observable phenotypes that can be linked to PTSD symptoms. Moreover, psychophysiological metrics of fear conditioning offer tools that can be used to shift diagnostic paradigms in psychiatry toward neurobiologyconsistent with a Research Domain Criteria approach to PTSD. In general, mammalian fear processing can be divided into fear learning (or acquisition), during which an association develops between previously neutral stimuli and aversive outcomes, and fear extinction, in which the latter associations are suppressed by a new form of learning. This review describes translational research in both fear acquisition and extinction, along with their relevance to PTSD and PTSD treatment, focusing specifically on the empirical value and potential clinical utility of psychophysiological methods.	[Norrholm, Seth Davin; Jovanovic, Tanja] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Norrholm, Seth Davin] Atlanta VA Med Ctr, Mental Hlth Serv Line, Decatur, GA USA	Jovanovic, T (corresponding author), 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA.	tjovano@emory.edu					Achesona DT, 2015, PSYCHONEUROENDOCRINO, V51, P495, DOI 10.1016/j.psyneuen.2014.09.030; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Amstadter AB, 2009, PSYCHIAT ANN, V39, P358, DOI 10.3928/00485713-20090526-01; Andero R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005656; Armony JL, 1997, CEREB CORTEX, V7, P157, DOI 10.1093/cercor/7.2.157; Bremner JD, 2005, PSYCHOL MED, V35, P791, DOI 10.1017/S0033291704003290; Bremner JD, 2004, BIOL PSYCHIAT, V55, P612, DOI 10.1016/j.biopsych.2003.10.001; Briscione MA, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00088; Broekman BFP, 2007, NEUROSCI BIOBEHAV R, V31, P348, DOI 10.1016/j.neubiorev.2006.10.001; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Chan Wan Yee Macy, 2010, Learn Mem, V17, P512, DOI 10.1101/lm.1912510; Costanzo ME, 2014, PSYCHOSOM MED, V76, P670, DOI 10.1097/PSY.0000000000000109; Cuthbert BN, 2014, ASIAN J PSYCHIATR, V7, P4, DOI 10.1016/j.ajp.2013.12.007; DAVIS M, 1990, PHARMACOL THERAPEUT, V47, P147, DOI 10.1016/0163-7258(90)90084-F; DAVIS M, 1992, TRENDS PHARMACOL SCI, V13, P35, DOI 10.1016/0165-6147(92)90014-W; Davis M., 1984, P287; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Diemer J, 2014, WORLD J BIOL PSYCHIA, V15, P427, DOI 10.3109/15622975.2014.892632; Diener SJ, 2016, PSYCHOPHYSIOLOGY, V53, P1460, DOI 10.1111/psyp.12699; Difede J, 2007, J CLIN PSYCHIAT, V68, P1639, DOI 10.4088/JCP.v68n1102; Dravid SM, 2010, J NEUROSCI, V30, P2741, DOI 10.1523/JNEUROSCI.5390-09.2010; Duits P, 2015, DEPRESS ANXIETY, V32, P239, DOI 10.1002/da.22353; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Fani N, 2012, PSYCHOL MED, V42, P533, DOI 10.1017/S0033291711001565; Fani N, 2015, CORTEX, V64, P249, DOI 10.1016/j.cortex.2014.11.006; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fitzgerald PJ, 2014, BRAIN RES BULL, V105, P46, DOI 10.1016/j.brainresbull.2013.12.007; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; FOA EB, 1995, BEHAV THER, V26, P487, DOI 10.1016/S0005-7894(05)80096-6; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Foa EB, 2011, DEPRESS ANXIETY, V28, P1043, DOI 10.1002/da.20907; Friedman MJ, 2010, NEW ENGL J MED, V362, P168, DOI 10.1056/NEJMe0911108; Galatzer-Levy IR, 2017, NEUROPHARMACOLOGY, V116, P188, DOI 10.1016/j.neuropharm.2016.12.023; Galatzer-Levy IR, 2013, PERSPECT PSYCHOL SCI, V8, P651, DOI 10.1177/1745691613504115; Galatzer-Levy IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070084; Galatzer-Levy IR, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00055; Garfinkel SN, 2014, J NEUROSCI, V34, P13435, DOI 10.1523/JNEUROSCI.4287-13.2014; Glenn DE, 2017, DEPRESS ANXIETY, V34, P723, DOI 10.1002/da.22642; Glover EM, 2015, BIOL PSYCHIAT, V78, P178, DOI 10.1016/j.biopsych.2015.02.007; Glover EM, 2012, BIOL PSYCHIAT, V72, P19, DOI 10.1016/j.biopsych.2012.02.031; Glover EM, 2011, DEPRESS ANXIETY, V28, P1058, DOI 10.1002/da.20880; Golkar A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00080; Greenberg T, 2013, DEPRESS ANXIETY, V30, P242, DOI 10.1002/da.22016; Griffin MG, 2012, J TRAUMA STRESS, V25, P25, DOI 10.1002/jts.21667; Grillon C, 1998, J PSYCHOPHYSIOL, V12, P329; Grillon C, 1997, PSYCHOPHYSIOLOGY, V34, P451, DOI 10.1111/j.1469-8986.1997.tb02389.x; Grillon C, 1999, J ABNORM PSYCHOL, V108, P134, DOI 10.1037/0021-843X.108.1.134; Grillon C, 2009, BIOL PSYCHIAT, V66, P47, DOI 10.1016/j.biopsych.2008.12.028; Guastella AJ, 2007, BEHAV RES THER, V45, P663, DOI 10.1016/j.brat.2006.07.005; Hinrichs R, 2017, DEPRESS ANXIETY, V34, P502, DOI 10.1002/da.22610; Hofmann SG, 2013, AM J PSYCHIAT, V170, P751, DOI 10.1176/appi.ajp.2013.12070974; Huff N.C., 2010, JOVE-J VIS EXP, V42, P1993; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Inslicht SS, 2013, J PSYCHIATR RES, V47, P64, DOI 10.1016/j.jpsychires.2012.08.027; Jovanovic T., 2016, NEUROBIOLOGY PTSD BR, P292; Jovanovic T, 2006, BEHAV NEUROSCI, V120, P995, DOI 10.1037/0735-7044.120.5.995; Jovanovic T, 2013, CORTEX, V49, P1884, DOI 10.1016/j.cortex.2012.08.011; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Jovanovic T, 2010, DEPRESS ANXIETY, V27, P244, DOI 10.1002/da.20663; Jovanovic T, 2009, PSYCHIAT RES, V167, P151, DOI 10.1016/j.psychres.2007.12.014; Kaczkurkin AN, 2017, AM J PSYCHIAT, V174, P125, DOI 10.1176/appi.ajp.2016.15121549; Keane T. M., 1985, BEHAV THERAPIST, V8, P9; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Kushner MG, 2007, BIOL PSYCHIAT, V62, P835, DOI 10.1016/j.biopsych.2006.12.020; LABAR KS, 1995, J NEUROSCI, V15, P6846; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; Ledgerwood L, 2003, BEHAV NEUROSCI, V117, P341, DOI 10.1037/0735-7044.117.2.341; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; LeDoux JE, 2016, AM J PSYCHIAT, V173, P1083, DOI 10.1176/appi.ajp.2016.16030353; LeDoux JE, 2014, P NATL ACAD SCI USA, V111, P2871, DOI 10.1073/pnas.1400335111; LeDoux JE, 2013, TRENDS COGN SCI, V17, P155, DOI 10.1016/j.tics.2013.02.004; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Liberzon I, 2003, STRESS, V6, P151, DOI 10.1080/1025389031000136242; Liberzon I, 2016, NEURON, V92, P14, DOI 10.1016/j.neuron.2016.09.039; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lissek S, 2008, BEHAV RES THER, V46, P678, DOI 10.1016/j.brat.2008.02.005; Lissek S, 2014, SOC COGN AFFECT NEUR, V9, P1134, DOI 10.1093/scan/nst096; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Lonsdorf TB, 2017, NEUROSCI BIOBEHAV R, V77, P247, DOI 10.1016/j.neubiorev.2017.02.026; Lonsdorf TB, 2010, BEHAV NEUROSCI, V124, P9, DOI 10.1037/a0018261; Maeng LY, 2017, CHRONIC STRESS, V1, P1; Maples-Keller JL, 2017, DEPRESS ANXIETY, V34, P610, DOI 10.1002/da.22626; Mataix-Cols D, 2017, JAMA PSYCHIAT, V74, P501, DOI 10.1001/jamapsychiatry.2016.3955; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Morey RA, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.196; Myers K.M., 2009, MEASUREMENT FEAR INH; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Norrholm SD, 2009, NEUROSCIENCE, V164, P272, DOI 10.1016/j.neuroscience.2009.06.036; Norrholm SD, 2006, LEARN MEMORY, V13, P681, DOI 10.1101/lm.393906; Norrholm SD, 2011, BIOL PSYCHIAT, V69, P556, DOI 10.1016/j.biopsych.2010.09.013; Norrholm SD, 2010, NEUROPSYCH DIS TREAT, V6, P517, DOI 10.2147/NDT.S10951; Norrholm SD, 2016, BEHAV RES THER, V82, P28, DOI 10.1016/j.brat.2016.05.002; Norrholm SD, 2015, INT J PSYCHOPHYSIOL, V98, P270, DOI 10.1016/j.ijpsycho.2014.11.005; Norrholm SD, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00361; Norrholm SD, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00030; Orcutt HK, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02031; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Otto MW, 2010, BIOL PSYCHIAT, V67, P365, DOI 10.1016/j.biopsych.2009.07.036; Pace-Schott EF, 2015, BIOL MOOD ANXIETY DI, V5, DOI 10.1186/s13587-015-0018-9; Pavlov I. P., 1927, CONDITIONED REFLEXES; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Pineles SL, 2016, J ABNORM PSYCHOL, V125, P349, DOI 10.1037/abn0000138; Pitman R K, 1999, Semin Clin Neuropsychiatry, V4, P234; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Price M, 2015, DEPRESS ANXIETY, V32, P392, DOI 10.1002/da.22354; Protopopescu X, 2005, BIOL PSYCHIAT, V57, P464, DOI 10.1016/j.biopsych.2004.12.026; Rabe S, 2006, APPL PSYCHOPHYS BIOF, V31, P315, DOI 10.1007/s10484-006-9027-1; Rauch SAM, 2015, DEPRESS ANXIETY, V32, P204, DOI 10.1002/da.22331; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rescorla RA, 1996, Q J EXP PSYCHOL-B, V49, P245; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Rhudy JL, 2010, J CLIN PSYCHOL, V66, P365, DOI 10.1002/jclp.20656; Rizzo A, 2010, ANN NY ACAD SCI, V1208, P114, DOI 10.1111/j.1749-6632.2010.05755.x; Robison-Andrew EJ, 2014, J ANXIETY DISORD, V28, P358, DOI 10.1016/j.janxdis.2014.04.002; Rodrigues H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093519; Rothbaum BO, 2014, AM J PSYCHIAT, V171, P640, DOI 10.1176/appi.ajp.2014.13121625; Rothbaum BO, 2002, AM J PSYCHOTHER, V56, P59; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Rothbaum BO, 2001, J CLIN PSYCHIAT, V62, P617, DOI 10.4088/JCP.v62n0808; Roy MJ, 2013, STUD HEALTH TECHNOL, V191, P115, DOI 10.3233/978-1-61499-282-0-115; Sarapas C, 2011, DIS MARKERS, V30, P101, DOI [10.1155/2011/328054, 10.3233/DMA-2011-0764]; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Sevenster D, 2013, SCIENCE, V339, P830, DOI 10.1126/science.1231357; Shiban Y, 2015, J BEHAV THER EXP PSY, V46, P133, DOI 10.1016/j.jbtep.2014.09.009; Shin LM, 2007, J TRAUMA STRESS, V20, P701, DOI 10.1002/jts.20231; Shvil E, 2014, NEUROBIOL LEARN MEM, V113, P101, DOI 10.1016/j.nlm.2014.02.003; Sijbrandij M, 2013, J PSYCHIATR RES, V47, P1991, DOI 10.1016/j.jpsychires.2013.09.008; Skelton K, 2012, NEUROPHARMACOLOGY, V62, P628, DOI 10.1016/j.neuropharm.2011.02.013; Soeter M, 2011, NEUROBIOL LEARN MEM, V96, P263, DOI 10.1016/j.nlm.2011.05.003; Soeter M, 2010, NEUROBIOL LEARN MEM, V94, P30, DOI 10.1016/j.nlm.2010.03.004; Steiger F, 2015, INT J PSYCHOPHYSIOL, V98, P584, DOI 10.1016/j.ijpsycho.2015.06.009; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stevens JS, 2017, BIOL PSYCHIAT, V81, P1023, DOI 10.1016/j.biopsych.2016.11.015; Stevens JS, 2013, J PSYCHIATR RES, V47, P1469, DOI 10.1016/j.jpsychires.2013.05.031; Stevens JS, 2014, P NATL ACAD SCI USA, V111, P3158, DOI 10.1073/pnas.1318954111; Telch MJ, 2010, S 6 WORLD C BEH COGN; Todd RM, 2015, BIOL PSYCHIAT, V78, P821, DOI 10.1016/j.biopsych.2015.05.011; Trimmel M, 2014, AVIAT SPACE ENVIR MD, V85, P550, DOI 10.3357/ASEM.3821.2014; van Rooij SJH, 2015, NEUROPSYCHOPHARMACOL, V40, P667, DOI 10.1038/npp.2014.220; VanElzakker MB, 2014, NEUROBIOL LEARN MEM, V113, P3, DOI 10.1016/j.nlm.2013.11.014; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Wangelin BC, 2015, DEPRESS ANXIETY, V32, P927, DOI 10.1002/da.22449; Waters AM, 2014, PSYCHIAT RES, V217, P93, DOI 10.1016/j.psychres.2014.01.047; Weike AI, 2008, BEHAV NEUROSCI, V122, P685, DOI 10.1037/0735-7044.122.3.685; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Wilhelm S, 2008, AM J PSYCHIAT, V165, P335, DOI 10.1176/appi.ajp.2007.07050776; Wingo AP, 2017, MOL PSYCHIATR, V22, P774, DOI 10.1038/mp.2016.143; Yehuda R, 2009, PSYCHONEUROENDOCRINO, V34, P1304, DOI 10.1016/j.psyneuen.2009.03.018; Zuj DV, 2016, NEUROSCI BIOBEHAV R, V69, P15, DOI 10.1016/j.neubiorev.2016.07.014	155	20	20	2	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1067-3229	1465-7309		HARVARD REV PSYCHIAT	Harv. Rev. Psychiatr.	MAY-JUN	2018	26	3					129	141		10.1097/HRP.0000000000000189			13	Psychiatry	Psychiatry	GF8YY	WOS:000432263700004	29734227				2021-06-18	
J	Reglodi, D; Tamas, A; Jungling, A; Vaczy, A; Rivnyak, A; Fulop, BD; Szabo, E; Lubics, A; Atlasz, T				Reglodi, D.; Tamas, A.; Jungling, A.; Vaczy, A.; Rivnyak, A.; Fulop, B. D.; Szabo, E.; Lubics, A.; Atlasz, T.			Protective effects of pituitary adenylate cyclase activating polypeptide against neurotoxic agents	NEUROTOXICOLOGY			English	Article							CEREBELLAR GRANULE NEURONS; RAT CORTICAL-NEURONS; MONOSODIUM GLUTAMATE TREATMENT; STRESS-INDUCED APOPTOSIS; INDUCED RETINAL DEGENERATION; NMDA-INDUCED EXCITOTOXICITY; SH-SY5Y CELLS IMPLICATION; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; PARKINSONS-DISEASE	Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide highly expressed in the central and peripheral nervous system, where it exerts several neuromodulatory functions and is an important trophic and protective factor. PACAP has been shown to activate several protective pathways, mainly through its specific PAC1 receptor and protein kinase A, C and MAP kinases downstream. It has been shown to have very potent neuroprotective actions against different neurotoxic agents both in vitro and in vivo. The aim of the present review is to provide an overview on the neurotoxic injuries against which PACAP exerts protection, and to give an insight into its protective mechanism. We give a summary of the neuroprotective effects against the most commonly used neurotoxic agents, such as 6-OHDA, MPTP, glutamate and some less well-known neurotoxic compounds. Also endogenous PACAP has neuroprotective effects, known from studies in PACAP knockout mice or from blocking endogenous effects by antagonists. Altogether, the vast amount of data for the neuroprotective effects of PACAP give a firm background for its endogenous role as part of the neuroprotective machinery and its possible future therapeutic use as a neuroprotective factor. (C) 2018 Elsevier B.V. All rights reserved.	[Reglodi, D.; Tamas, A.; Jungling, A.; Vaczy, A.; Rivnyak, A.; Fulop, B. D.; Szabo, E.; Lubics, A.; Atlasz, T.] Univ Pecs, Med Sch, MTA PTE PACAP Res Grp, Dept Anat, Pecs, Hungary; [Atlasz, T.] Univ Pecs, Szentagothai Res Ctr, Dept Sportbiol, Pecs, Hungary	Reglodi, D (corresponding author), Univ Pecs, Med Sch, Dept Anat, Szigeti U 12, H-7624 Pecs, Hungary.	dora.reglodi@aok.pte.hu			NAP [2017-1.2.1-NKP-2017-00002]; Bolyai ScholarshipHungarian Academy of Sciences; MTA-TKI [14016, EFOP-3.6.3-VEKOP-16-15 2017-00008, UNKP-16-4]; Centre for neuroscience, PTE AOK Research Grant [KA-2017-15, NKFIH119759]; PEPSYS [GINOP-2.3.2-15-2016-00050]	NAP 2017-1.2.1-NKP-2017-00002, Bolyai Scholarship, GINOP-2.3.2-15-2016-00050 "PEPSYS", MTA-TKI 14016, EFOP-3.6.3-VEKOP-16-15 2017-00008, UNKP-16-4. Centre for neuroscience, PTE AOK Research Grant KA-2017-15, NKFIH119759	Amato R, 2016, INVEST OPHTH VIS SCI, V57, P3066, DOI 10.1167/iovs.16-19285; ARIMURA A, 1994, ANN NY ACAD SCI, V739, P228, DOI 10.1111/j.1749-6632.1994.tb19825.x; Atlasz T., 2012, PITUITARY ADENYLATE; Atlasz T, 2016, PITUITARY ADENYLATE, V11, P501, DOI DOI 10.1007/978-3-319-35135-3_30; Atlasz T, 2006, ANN NY ACAD SCI, V1070, P143, DOI 10.1196/annals.1317.002; Atlasz T, 2008, J MOL NEUROSCI, V36, P97, DOI 10.1007/s12031-008-9059-5; Atlasz T, 2009, ANN NY ACAD SCI, V1163, P348, DOI 10.1111/j.1749-6632.2008.03650.x; Aubert N, 2008, NEUROBIOL DIS, V32, P66, DOI 10.1016/j.nbd.2008.06.014; Babai N, 2005, NEUROTOX RES, V8, P227, DOI 10.1007/BF03033976; Babai N, 2006, ANN NY ACAD SCI, V1070, P149, DOI 10.1196/annals.1317.003; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Botia B, 2011, NEUROTOX RES, V19, P423, DOI 10.1007/s12640-010-9186-y; Botia B, 2008, J MOL NEUROSCI, V36, P61, DOI 10.1007/s12031-008-9075-5; Brenneman DE, 2002, NEUROPEPTIDES, V36, P271, DOI 10.1016/S0143-4179(02)00045-8; Brifault C, 2016, PITUITARY ADENYLATE, V11, P583; Brown D, 2014, NEUROTOX RES, V26, P230, DOI 10.1007/s12640-014-9468-x; Brown D, 2013, J MOL NEUROSCI, V50, P600, DOI 10.1007/s12031-013-0015-7; Castel H, 2006, ANN NY ACAD SCI, V1070, P173, DOI 10.1196/annals.1317.008; Cheng HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108090; Chtourou Y, 2015, J MOL NEUROSCI, V56, P349, DOI 10.1007/s12031-015-0547-0; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; COLLINS MA, 1975, LIFE SCI, V16, P585; D'Amico AG, 2017, PEPTIDES, V97, P64, DOI 10.1016/j.peptides.2017.09.014; D'Amico AG, 2015, J MOL NEUROSCI, V57, P501, DOI 10.1007/s12031-015-0621-7; Deguil J, 2007, J NEUROSCI RES, V85, P2017, DOI 10.1002/jnr.21318; Deguil J, 2010, NEUROTOX RES, V17, P142, DOI 10.1007/s12640-009-9091-4; Delgado M, 2003, ANN NY ACAD SCI, V992, P141, DOI 10.1111/j.1749-6632.2003.tb03145.x; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Douiri S, 2016, J NEUROCHEM, V137, P913, DOI 10.1111/jnc.13614; Elmann A, 2017, J MOL NEUROSCI, V62, P99, DOI 10.1007/s12031-017-0916-y; Fabian E, 2012, J MOL NEUROSCI, V48, P493, DOI 10.1007/s12031-012-9812-7; Feher M, 2018, NEUROTOX RES, V33, P702, DOI 10.1007/s12640-017-9841-7; Ferencz A, 2009, J MOL NEUROSCI, V37, P168, DOI 10.1007/s12031-008-9132-0; Frechilla D, 2001, NEUROREPORT, V12, P919, DOI 10.1097/00001756-200104170-00011; Fulop B. D, 2016, PITUITARY ADENYLATE, P529; Gasz B, 2006, ANN NY ACAD SCI, V1070, P293, DOI 10.1196/annals.1317.029; Grumolato L, 2003, ENDOCRINOLOGY, V144, P2368, DOI 10.1210/en.2002-0106; Gui Lan-Run, 2003, Shengli Xuebao, V55, P42; Guillot TS, 2008, NEUROPEPTIDES, V42, P423, DOI 10.1016/j.npep.2008.04.003; Han PC, 2014, NEUROBIOL AGING, V35, P2064, DOI 10.1016/j.neurobiolaging.2014.03.022; Hartfield PJ, 1998, J NEUROCHEM, V71, P161; Horvath G., 2017, INT J PEPT RES THER, V65, P106; Horvath G, 2010, NEUROSCI LETT, V484, P148, DOI 10.1016/j.neulet.2010.08.039; Huang H, 2016, NEUROTOX RES, V30, P185, DOI 10.1007/s12640-016-9615-7; Illes A, 2017, NEUROPEPTIDES, V65, P106, DOI 10.1016/j.npep.2017.07.002; Ito Y, 1999, NEUROSCI RES, V35, P321, DOI 10.1016/S0168-0102(99)00097-8; Kasica N, 2016, NEUROTOX RES, V30, P633, DOI 10.1007/s12640-016-9659-8; Kiss P, 2006, ANN NY ACAD SCI, V1070, P365, DOI 10.1196/annals.1317.046; Kiss P, 2005, NEUROTOX RES, V8, P235, DOI 10.1007/BF03033977; Kong LY, 1999, NEUROSCIENCE, V91, P493, DOI 10.1016/S0306-4522(98)00606-X; Kraft AD, 2016, NEUROTOX RES, V30, P53, DOI 10.1007/s12640-016-9606-8; Kurnik-Lucka M, 2018, NEUROTOX RES, V33, P485, DOI 10.1007/s12640-017-9818-6; Lacaille H, 2017, MOL NEUROBIOL, V54, P7534, DOI 10.1007/s12035-016-0204-9; Lakk M, 2015, NEUROCHEM RES, V40, P1402, DOI 10.1007/s11064-015-1607-0; Lambuk L, 2017, NEUROTOX RES, V31, P31, DOI 10.1007/s12640-016-9658-9; Lamine A, 2016, NEUROPHARMACOLOGY, V108, P440, DOI 10.1016/j.neuropharm.2015.05.014; Lamine-Ajili A, 2016, BBA-MOL BASIS DIS, V1862, P688, DOI 10.1016/j.bbadis.2016.01.005; Liu GJ, 1998, BRAIN RES, V791, P290, DOI 10.1016/S0006-8993(97)01567-9; Castaneda-Cabral JL, 2017, J MOL NEUROSCI, V63, P17, DOI 10.1007/s12031-017-0952-7; Maasz G, 2017, DIS MODEL MECH, V10, P127, DOI 10.1242/dmm.027185; Manavalan S, 2017, NEUROTOX RES, V32, P8, DOI 10.1007/s12640-017-9727-8; Manecka D.L., 2016, PITUITARY ADENYLATE, P549; Mansouri S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170496; Mansouri S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156867; Mansouri S, 2012, J NEUROSCI RES, V90, P759, DOI 10.1002/jnr.22803; Masmoudi-Kouki O, 2011, J NEUROCHEM, V117, P403, DOI 10.1111/j.1471-4159.2011.07185.x; Maugeri G, 2017, J CELL PHYSIOL, V232, P1209, DOI 10.1002/jcp.25616; May V, 2010, J BIOL CHEM, V285, P9749, DOI 10.1074/jbc.M109.043117; Mei YA, 2004, EUR J NEUROSCI, V19, P1446, DOI 10.1111/j.1460-9568.2004.03227.x; Mester L, 2011, J MOL NEUROSCI, V43, P35, DOI 10.1007/s12031-010-9427-9; Miyamoto K, 2014, J MOL NEUROSCI, V54, P370, DOI 10.1007/s12031-014-0309-4; Moody TW, 2016, CURR OPIN ENDOCRINOL, V23, P38, DOI 10.1097/MED.0000000000000218; Morio H, 1996, BRAIN RES, V741, P82, DOI 10.1016/S0006-8993(96)00920-1; Morio H, 1996, ANN NY ACAD SCI, V805, P476; Morita Y, 2006, ANN NY ACAD SCI, V1070, P450, DOI 10.1196/annals.1317.060; Nakamachi T, 2011, CURR PHARM DESIGN, V17, P973, DOI 10.2174/138161211795589346; Nemeth A, 2014, NEUROTOX RES, V25, P57, DOI 10.1007/s12640-013-9428-x; Ohtaki H, 2010, J MOL NEUROSCI, V42, P397, DOI 10.1007/s12031-010-9350-0; Onoue S, 2002, PEPTIDES, V23, P1471, DOI 10.1016/S0196-9781(02)00085-2; Onoue S, 2002, FEBS LETT, V522, P65, DOI 10.1016/S0014-5793(02)02886-7; Pathakoti K, 2017, NEUROTOX RES, V31, P521, DOI 10.1007/s12640-016-9697-2; Pecoraro V, 2017, NEUROSCIENCE, V340, P551, DOI 10.1016/j.neuroscience.2016.10.061; Racz B, 2007, GEN COMP ENDOCR, V153, P115, DOI 10.1016/j.ygcen.2006.12.006; Racz B., 2007, EFFECTS PITUITARY AD; Racz B, 2006, REGUL PEPTIDES, V137, P20, DOI 10.1016/j.regpep.2006.02.009; Racz B, 2006, ANN NY ACAD SCI, V1070, P507, DOI 10.1196/annals.1317.070; Racz B, 2010, REGUL PEPTIDES, V160, P91, DOI 10.1016/j.regpep.2009.12.003; Rat D, 2011, FASEB J, V25, P3208, DOI 10.1096/fj.10-180133; Reglodi D, 2006, ANN NY ACAD SCI, V1070, P518, DOI 10.1196/annals.1317.072; Reglodi D, 2006, NEUROPEPTIDES, V40, P265, DOI 10.1016/j.npep.2006.06.001; Reglodi D, 2004, REGUL PEPTIDES, V123, P85, DOI 10.1016/j.regpep.2004.05.016; Reglodi D, 2004, REGUL PEPTIDES, V123, P51, DOI 10.1016/j.regpep.2004.05.012; Reglodi D, 2004, BEHAV BRAIN RES, V151, P303, DOI 10.1016/j.bbr.2003.09.007; Reglodi D, 2011, CURR PHARM DESIGN, V17, P962, DOI 10.2174/138161211795589355; Reglodi D, 2003, BEHAV BRAIN RES, V140, P131, DOI 10.1016/S0166-4328(02)00289-9; Reglodi D, 2016, PITUITARY ADENYLATE; Reglodi D, 2017, PROG NEUROBIOL, V155, P120, DOI 10.1016/j.pneurobio.2015.10.004; Rozzi SJ, 2017, NEUROTOX RES, V32, P723, DOI 10.1007/s12640-017-9776-z; Rozzi SJ, 2014, J MOL NEUROSCI, V54, P485, DOI 10.1007/s12031-014-0273-z; Said SI, 1998, ANN NY ACAD SCI, V865, P226, DOI 10.1111/j.1749-6632.1998.tb11182.x; Sanchez A, 2009, REGUL PEPTIDES, V152, P33, DOI 10.1016/j.regpep.2008.07.004; Sanchez A, 2008, NEUROSCI LETT, V448, P52, DOI 10.1016/j.neulet.2008.10.021; Segura-Aguilar J, 2015, NEUROTOX RES, V27, P328, DOI 10.1007/s12640-015-9519-y; Seki T, 2006, ANN NY ACAD SCI, V1070, P531, DOI 10.1196/annals.1317.074; Shieh PC, 2008, NEUROSCI LETT, V434, P1, DOI 10.1016/j.neulet.2007.12.032; Shintani N, 2005, REGUL PEPTIDES, V126, P123, DOI 10.1016/j.regpep.2004.08.014; Shintani N, 2007, YAKUGAKU ZASSHI, V127, P451, DOI 10.1248/yakushi.127.451; Shioda S, 2006, ANN NY ACAD SCI, V1070, P550, DOI 10.1196/annals.1317.080; Silveira MS, 2002, J BIOL CHEM, V277, P16075, DOI 10.1074/jbc.M110106200; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Somogyvari-Vigh A, 2004, CURR PHARM DESIGN, V10, P2861, DOI 10.2174/1381612043383548; Szabadfi K, 2016, NEUROTOX RES, V29, P432, DOI 10.1007/s12640-015-9593-1; Szabadfi K, 2014, NEUROCHEM INT, V64, P84, DOI 10.1016/j.neuint.2013.11.005; Szabadfi K, 2012, CELL TISSUE RES, V348, P37, DOI 10.1007/s00441-012-1349-0; Szabadfi K, 2009, BRAIN RES, V1259, P107, DOI 10.1016/j.brainres.2009.01.004; Tabuchi A, 2003, J NEUROSCI RES, V71, P504, DOI 10.1002/jnr.10505; Takei N, 1998, J NEUROSCI RES, V54, P698, DOI 10.1002/(SICI)1097-4547(19981201)54:5<698::AID-JNR15>3.0.CO;2-5; Tamas A, 2006, ANN NY ACAD SCI, V1070, P570, DOI 10.1196/annals.1317.083; Tamas A, 2004, NEUROSCI LETT, V372, P110, DOI 10.1016/j.neulet.2004.09.021; Tani K, 2016, NEUROTOX RES, V29, P35, DOI 10.1007/s12640-015-9563-7; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Teuchner B, 2011, ACTA OPHTHALMOL, V89, P670, DOI 10.1111/j.1755-3768.2009.01828.x; Tomimatsu N, 2008, J NEUROCHEM, V107, P628, DOI 10.1111/j.1471-4159.2008.05638.x; Varga B, 2011, J MOL NEUROSCI, V43, P44, DOI 10.1007/s12031-010-9406-1; Vaudry D, 2005, PEPTIDES, V26, P2518, DOI 10.1016/j.peptides.2005.05.015; Vaudry D, 2004, REGUL PEPTIDES, V123, P43, DOI 10.1016/j.regpep.2004.05.025; Vaudry D, 2003, J NEUROSCI RES, V72, P303, DOI 10.1002/jnr.10530; Vaudry D, 2002, EUR J NEUROSCI, V15, P1451, DOI 10.1046/j.1460-9568.2002.01981.x; Vaudry D, 2002, P NATL ACAD SCI USA, V99, P6398, DOI 10.1073/pnas.082112699; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Wada Y, 2013, J MOL NEUROSCI, V51, P493, DOI 10.1007/s12031-013-0017-5; Wang G, 2005, FEBS LETT, V579, P4005, DOI 10.1016/j.febslet.2005.06.013; Wang G, 2008, NEUROPEPTIDES, V42, P267, DOI 10.1016/j.npep.2008.03.002; Waschek JA, 2002, DEV NEUROSCI-BASEL, V24, P14, DOI 10.1159/000064942; Watanabe J, 2016, PITUITARY ADENYLATE, P65, DOI [10.1007/978-3-319-35135-3_6, DOI 10.1007/978-3-319-35135-3_6]; Watson MB, 2013, NEUROSCIENCE, V240, P277, DOI 10.1016/j.neuroscience.2013.03.002; Webb IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076365; Wilhelm I, 2014, J MOL NEUROSCI, V54, P469, DOI 10.1007/s12031-014-0260-4; Yang SJ, 2017, NEUROTOX RES, V32, P107, DOI 10.1007/s12640-017-9717-x; Yang SF, 2006, J PHARMACOL EXP THER, V319, P595, DOI 10.1124/jpet.106.102236; Yu JT, 2015, NEUROTOX RES, V28, P43, DOI 10.1007/s12640-015-9531-2; ZHANG D, 1995, NEUROSCIENCE, V67, P177, DOI 10.1016/0306-4522(94)00627-H; Zuo DY, 2016, NEUROTOX RES, V30, P159, DOI 10.1007/s12640-016-9611-y	143	20	20	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	MAY	2018	66						185	194		10.1016/j.neuro.2018.03.010			10	Neurosciences; Pharmacology & Pharmacy; Toxicology	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	GG2DK	WOS:000432499900021	29604313				2021-06-18	
J	Huijben, JA; Volovici, V; Cnossen, MC; Haitsma, IK; Stocchetti, N; Maas, AIR; Menon, DK; Ercole, A; Citerio, G; Nelson, D; Polinder, S; Steyerberg, EW; Lingsma, HF; van der Jagt, M				Huijben, Jilske A.; Volovici, Victor; Cnossen, Maryse C.; Haitsma, Iain K.; Stocchetti, Nino; Maas, Andrew I. R.; Menon, David K.; Ercole, Ari; Citerio, Giuseppe; Nelson, David; Polinder, Suzanne; Steyerberg, Ewout W.; Lingsma, Hester F.; van der Jagt, Mathieu		CTR-TBI Investigators Participants	Variation in general supportive and preventive intensive care management of traumatic brain injury: a survey in 66 neurotrauma centers participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study	CRITICAL CARE			English	Article						Intensive care unit; Traumatic brain injury; Glucose; Nutrition; Fever; Ventilation; Blood pressure; Seizure; Survey; Europe	CRITICALLY-ILL PATIENTS; HEAD-INJURY; INTRACRANIAL HYPERTENSION; MRC CRASH; GUIDELINES; MODERATE; OUTCOMES; RESUSCITATION; IMPROVEMENT; ALBUMIN	Background: General supportive and preventive measures in the intensive care management of traumatic brain injury (TBI) aim to prevent or limit secondary brain injury and optimize recovery. The aim of this survey was to assess and quantify variation in perceptions on intensive care unit (ICU) management of patients with TBI in European neurotrauma centers. Methods: We performed a survey as part of the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study. We analyzed 23 questions focused on: 1) circulatory and respiratory management; 2) fever control; 3) use of corticosteroids; 4) nutrition and glucose management; and 5) seizure prophylaxis and treatment. Results: The survey was completed predominantly by intensivists (n = 33, 50%) and neurosurgeons (n = 23, 35%) from 66 centers (97% response rate). The most common cerebral perfusion pressure (CPP) target was > 60 mmHg (n = 39, 60%) and/or an individualized target (n = 25, 38%). To support CPP, crystalloid fluid loading (n = 60, 91%) was generally preferred over albumin (n = 15, 23%), and vasopressors (n = 63, 96%) over inotropes (n = 29, 44%). The most commonly reported target of partial pressure of carbon dioxide in arterial blood (PaCO2) was 36-40 mmHg (4.8-5.3 kPa) in case of controlled intracranial pressure (ICP) < 20 mmHg (n = 45, 69%) and PaCO2 target of 30-35 mmHg (4-4.7 kPa) in case of raised ICP (n = 40, 62%). Almost all respondents indicated to generally treat fever (n = 65, 98%) with paracetamol (n = 61, 92%) and/or external cooling (n = 49, 74%). Conventional glucose management (n = 43, 66%) was preferred over tight glycemic control (n = 18, 28%). More than half of the respondents indicated to aim for full caloric replacement within 7 days (n = 43, 66%) using enteral nutrition (n = 60, 92%). Indications for and duration of seizure prophylaxis varied, and levetiracetam was mostly reported as the agent of choice for both seizure prophylaxis (n = 32, 49%) and treatment (n = 40, 61%). Conclusions: Practice preferences vary substantially regarding general supportive and preventive measures in TBI patients at ICUs of European neurotrauma centers. These results provide an opportunity for future comparative effectiveness research, since a more evidence-based uniformity in good practices in general ICU management could have a major impact on TBI outcome.	[Huijben, Jilske A.; Volovici, Victor; Cnossen, Maryse C.; Polinder, Suzanne; Steyerberg, Ewout W.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [Volovici, Victor; Haitsma, Iain K.] Erasmus MC, Erasmus MC Stroke Ctr, Dept Neurosurg, Off H 703, Rotterdam, Netherlands; [Volovici, Victor; Haitsma, Iain K.] Erasmus MC, Brain Tumor Ctr, Rotterdam, Netherlands; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplants, Milan, Italy; [Stocchetti, Nino] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Dept Anesthesia & Crit Care, Neurosci Intens Care Unit, Milan, Italy; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Menon, David K.; Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe] San Gerardo Hosp, ASST Monza, Neurointens Care, Monza, Italy; [Nelson, David] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [van der Jagt, Mathieu] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands; [van der Jagt, Mathieu] Erasmus MC, Erasmus MC Stroke Ctr, Rotterdam, Netherlands	Huijben, JA (corresponding author), Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands.	a.huijben@erasmusmc.nl	Lagares, Alfonso/B-2969-2011; Badenes, Rafael/K-6628-2019; Sahakian, Barbara/AAW-1198-2020; Ercole, Ari/B-6288-2009; Gomez, Pedro/N-5051-2019; Boogert, Hugo F den/B-2782-2016; Volovici, Victor/AAZ-8901-2020; Maas, Andrew IR/C-5584-2013; Castano-Leon, Ana M/ABF-6322-2020; Lanyon, Linda/L-9238-2019; Citerio, Giuseppe/B-1839-2015; Cooper, D. James/G-7961-2013; Raj, Rahul/K-7693-2012; Laureys, Steven/AAN-2097-2021; Sahuquillo, Juan/B-3577-2008; Bartels, R.H.M.A./L-4184-2015	Lagares, Alfonso/0000-0003-3996-0554; Badenes, Rafael/0000-0001-7017-0150; Sahakian, Barbara/0000-0001-7352-1745; Ercole, Ari/0000-0001-8350-8093; Gomez, Pedro/0000-0002-4185-5238; Volovici, Victor/0000-0002-5798-5360; Maas, Andrew IR/0000-0003-1612-1264; Castano-Leon, Ana M/0000-0002-7918-5049; Lanyon, Linda/0000-0002-0885-1825; Citerio, Giuseppe/0000-0002-5374-3161; Cooper, D. James/0000-0002-5872-9051; Raj, Rahul/0000-0003-4243-9591; Laureys, Steven/0000-0002-3096-3807; Sahuquillo, Juan/0000-0003-0713-5875; Kondziella, Daniel/0000-0001-5562-9808; Dippel, Diederik/0000-0002-9234-3515; Parizel, Paul M./0000-0002-0221-2854; Huijben, Jilske (Antonia)/0000-0002-2892-5406; Bullinger, Monika/0000-0001-8876-0159; Kolias, Angelos/0000-0003-3992-0587; Rossi, Sandra/0000-0002-9963-8121; czosnyka, marek/0000-0003-2446-8006; Hutchinson, Peter/0000-0002-2796-1835; Esser, Patrick/0000-0002-3227-0115; Dawes, Helen/0000-0002-2933-5213; Blaabjerg, Morten/0000-0001-6007-1861; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601; Pullens, Pim/0000-0003-2014-7248; Stewart, William/0000-0003-2199-2582; Sanchez-Porras, Renan/0000-0002-9084-8114; Newcombe, Virginia/0000-0001-6044-9035; Bartels, R.H.M.A./0000-0002-8638-4660	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [602150]	European Commission FP7 Framework Program 602150. Data used in the preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Commission 7th Framework program (602150). The funder had no role in the design of the study, the collection, analysis, and interpretation of data, or in writing the manuscript.	Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; American College of Surgeons, TRAUM QUAL IMPR PROG; Bonds BW, 2015, BRAIN INJURY, V29, P1642, DOI 10.3109/02699052.2015.1075157; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chiumello D, 2017, J CRIT CARE, V38, P245, DOI 10.1016/j.jcrc.2016.10.021; Cinotti R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0498-9; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Cormio M, 2007, NEUROCRIT CARE, V6, P82, DOI 10.1007/s12028-007-0002-3; Corp IBM, 2012, IBM SPSS STAT WIND M; Costello LAS, 2014, INJURY, V45, P1834, DOI 10.1016/j.injury.2014.06.004; Cnossen MC, 2017, CRIT CARE MED, V45, P660, DOI 10.1097/CCM.0000000000002263; Edwards P, 2005, LANCET, V365, P1957; European Commission/CARSA, 2007, REM RES PUBL PRIV SE; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Khan NR, 2016, NEUROSURGERY, V79, P775, DOI 10.1227/NEU.0000000000001445; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Majidi S, 2017, NEUROCRIT CARE, V27, P90, DOI 10.1007/s12028-016-0363-6; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Moore L, 2017, ANN SURG, V265, P212, DOI 10.1097/SLA.0000000000001614; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8	37	20	20	0	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	APR 13	2018	22								90	10.1186/s13054-018-2000-6			9	Critical Care Medicine	General & Internal Medicine	GC7NJ	WOS:000429979700001	29650049	DOAJ Gold, Green Published			2021-06-18	
J	Polich, G; Iaccarino, MA; Kaptchuk, TJ; Morales-Quezada, L; Zafonte, R				Polich, Ginger; Iaccarino, Mary Alexis; Kaptchuk, Ted J.; Morales-Quezada, Leon; Zafonte, Ross			Placebo Effects in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						dopamine; placebo effects; reward system; TBI; verbal suggestion	RANDOMIZED CONTROLLED-TRIAL; CATECHOL-O-METHYLTRANSFERASE; HEART-RATE-VARIABILITY; EARLY INTERVENTION; NONCONSCIOUS ACTIVATION; CONDITIONED PLACEBO; MAJOR DEPRESSION; SYMPTOMS; COMT; ANALGESIA	In recent years, several randomized controlled trials evaluating pharmaceutical treatments for traumatic brain injury (TBI) have failed to demonstrate efficacy over placebo, with both active and placebo arms improving at comparable rates. These findings could be viewed in opposing ways, suggesting on the one hand failure of the tested outcome, but on the other, representing evidence of robust placebo effects in TBI. In this article, we examine several of the primary psychological processes driving placebo effects (verbal suggestion, cognitive re-framing, interpersonal interactions, conditioning, therapeutic alliance, anxiety reduction) as well as placebo neurobiology (top-down cortical regulation, reward system activation, dopaminergic and serotonergic neurotransmission). We then extrapolate from the literature to explore whether something inherent in TBI makes it particularly responsive to placebos. Viewed as such here, placebos may indeed represent a powerful and effective treatment for a variety of post-TBI complaints.	[Polich, Ginger; Iaccarino, Mary Alexis; Morales-Quezada, Leon; Zafonte, Ross] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Charlestown, MA 02129 USA; [Iaccarino, Mary Alexis] MassGen Hosp, Children Sport Concuss Program, Boston, MA USA; [Iaccarino, Mary Alexis; Zafonte, Ross] Red Sox Fdn, Boston, MA USA; [Iaccarino, Mary Alexis; Zafonte, Ross] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Kaptchuk, Ted J.] Harvard Med Sch, Program Placebo Studies & Therapeut Encounter, Beth Israel Deaconess Med Ctr, Boston, MA USA	Polich, G (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Charlestown, MA 02129 USA.	gpolich@partners.org			National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AT000051, K24AT004095] Funding Source: NIH RePORTER; NCCIH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [T32 AT000051, K24 AT004095] Funding Source: Medline		Albring A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049477; Andre-Obadia N, 2011, PAIN, V152, P1233, DOI 10.1016/j.pain.2010.12.027; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Aslaksen PM, 2008, PSYCHOSOM MED, V70, P811, DOI 10.1097/PSY.0b013e31818105ed; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Ballou S, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1964-x; Bbel P, 2017, PLOS ONE, V12, pe0181856; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Benedetti F, 2006, PAIN, V121, P133, DOI 10.1016/j.pain.2005.12.016; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 2016, J PHYSIOL-LONDON, V594, P5647, DOI 10.1113/JP271322; Benedetti F, 2011, PATIENT EDUC COUNS, V84, P413, DOI 10.1016/j.pec.2011.04.034; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Birkhauer J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170988; Bouchet C, 1996, J CLIN EPIDEMIOL, V49, P15, DOI 10.1016/0895-4356(95)00540-4; BRANTHWAITE A, 1981, BRIT MED J, V282, P1576, DOI 10.1136/bmj.282.6276.1576; BUCKALEW LW, 1972, PSYCHOL REC, V22, P113, DOI 10.1007/BF03394068; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; Colagiuri B, 2015, NEUROSCIENCE, V307, P171, DOI 10.1016/j.neuroscience.2015.08.017; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Colloca L, 2011, PHILOS T R SOC B, V366, P1859, DOI 10.1098/rstb.2010.0398; Colloca L, 2010, PAIN, V151, P430, DOI 10.1016/j.pain.2010.08.007; Crum A, 2015, EMERGING TRENDS SOCI; Curie A., 2015, PLOS ONE, P10; Darragh M, 2015, PHYSIOL BEHAV, V145, P45, DOI 10.1016/j.physbeh.2015.03.043; de la Fuente-Fernandez R, 2004, BIOL PSYCHIAT, V56, P67, DOI 10.1016/j.biopsych.2003.11.019; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; de la Fuente-Fernandez R, 2009, PARKINSONISM RELAT D, V15, pS72, DOI 10.1016/S1353-8020(09)70785-0; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Diederich NJ, 2008, NEUROLOGY, V71, P677, DOI 10.1212/01.wnl.0000324635.49971.3d; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dossett ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136855; Espay AJ, 2015, NEUROLOGY, V84, P794, DOI 10.1212/WNL.0000000000001282; Fassler M, 2015, J CLIN EPIDEMIOL, V68, P442, DOI 10.1016/j.jclinepi.2014.11.018; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Freeman EW, 2015, PSYCHOSOM MED, V77, P167, DOI 10.1097/PSY.0000000000000143; Furmark T, 2008, J NEUROSCI, V28, P13066, DOI 10.1523/JNEUROSCI.2534-08.2008; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Graham DP, 2013, J PSYCHIATR RES, V47, P835, DOI 10.1016/j.jpsychires.2013.02.006; GRENCAVAGE LM, 1990, PROF PSYCHOL-RES PR, V21, P372, DOI 10.1037/0735-7028.21.5.372; Hall KT, 2015, TRENDS MOL MED, V21, P285, DOI 10.1016/j.molmed.2015.02.009; Hall KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048135; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Hrobjartsson A, 2004, J INTERN MED, V256, P91, DOI 10.1111/j.1365-2796.2004.01355.x; Jensen K, 2015, P NATL ACAD SCI USA, V112, P7863, DOI 10.1073/pnas.1504567112; Jensen KB, 2017, NEUROLOGY, V88, P1912, DOI 10.1212/WNL.0000000000003934; Jensen KB, 2015, CEREB CORTEX, V25, P3903, DOI 10.1093/cercor/bhu275; Jensen KB, 2012, P NATL ACAD SCI USA, V109, P15959, DOI 10.1073/pnas.1202056109; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kaptchuk TJ, 2015, NEW ENGL J MED, V373, P8, DOI 10.1056/NEJMp1504023; Kaptchuk TJ, 2011, PHILOS T R SOC B, V366, P1849, DOI 10.1098/rstb.2010.0385; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Kelley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094207; Kelley JM, 2009, PSYCHOSOM MED, V71, P789, DOI 10.1097/PSY.0b013e3181acee12; Kessner S, 2013, JAMA INTERN MED, V173, P1468, DOI 10.1001/jamainternmed.2013.6705; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Leuchter AF, 2009, J CLIN PSYCHOPHARM, V29, P372, DOI 10.1097/JCP.0b013e3181ac4aaf; Lidstone Sarah Christine, 2014, Handb Exp Pharmacol, V225, P139, DOI 10.1007/978-3-662-44519-8_8; Linde K, 2010, FORSCH KOMPLEMENTMED, V17, P259, DOI 10.1159/000320374; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Matuseviciene G, 2016, J REHABIL MED, V48, P19, DOI 10.2340/16501977-2025; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; McAllister T., 2013, WORLD PSYCHIAT, V7, P3; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Meissner Karin, 2014, Handb Exp Pharmacol, V225, P183, DOI 10.1007/978-3-662-44519-8_11; Meissner K, 2013, JAMA INTERN MED, V173, P1941, DOI 10.1001/jamainternmed.2013.10391; Meissner K, 2011, PHILOS T R SOC B, V366, P1808, DOI 10.1098/rstb.2010.0403; Meyer B, 2015, J NEUROSCI, V35, P7365, DOI 10.1523/JNEUROSCI.4793-14.2015; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Miciak M, 2012, SCAND J CARING SCI, V26, P394, DOI 10.1111/j.1471-6712.2011.00923.x; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Oken BS, 2008, BRAIN, V131, P2812, DOI 10.1093/brain/awn116; Papakostas GI, 2015, J CLIN PSYCHIAT, V76, P456, DOI [10.4088/JCP.13086ah1c, 10.4088/JCP.14r09297, 10.4088/JCP.13086tx5c]; Parker S, 2011, MEMORY, V19, P606, DOI 10.1080/09658211.2011.592500; PARSONS HM, 1974, SCIENCE, V183, P922, DOI 10.1126/science.183.4128.922; Pecina M., 2015, MOL PSYCHIATR, V7, P3; Pecina M, 2013, NEUROPSYCHOPHARMACOL, V38, P639, DOI 10.1038/npp.2012.227; Pollo A, 2003, PAIN, V102, P125, DOI 10.1016/S0304-3959(02)00345-7; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; RICKELS K, 1970, PSYCHOPHARMACOLOGIA, V16, P318, DOI 10.1007/BF00404738; Schafer SM, 2015, J PAIN, V16, P412, DOI 10.1016/j.jpain.2014.12.008; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2015, NEUROREHABILITATION, V36, P463, DOI 10.3233/NRE-151234; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Sorokin I, 2015, CURR UROL REP, V16, DOI 10.1007/s11934-015-0544-4; Suffoletto B, 2013, J HEAD TRAUMA REHAB, V28, P302, DOI 10.1097/HTR.0b013e3182847468; Takahashi Courtney, 2015, Handb Clin Neurol, V128, P539, DOI 10.1016/B978-0-444-63521-1.00034-0; Thompson JJ, 2009, CULT MED PSYCHIAT, V33, P112, DOI 10.1007/s11013-008-9122-2; Tiwari AK, 2013, INT J NEUROPSYCHOPH, V16, P771, DOI 10.1017/S1461145712000843; Varelmann D, 2010, ANESTH ANALG, V110, P868, DOI 10.1213/ANE.0b013e3181cc5727; Verheul W, 2010, PATIENT EDUC COUNS, V80, P300, DOI 10.1016/j.pec.2010.06.017; Vistisen ST, 2014, BRAIN INJURY, V28, P196, DOI 10.3109/02699052.2013.860477; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; VOUDOURIS NJ, 1989, PAIN, V38, P109, DOI 10.1016/0304-3959(89)90080-8; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Wager TD, 2015, NAT REV NEUROSCI, V16, P403, DOI 10.1038/nrn3976; Wang R., 2017, JCI INSIGHT, V2, P1; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; Weger UW, 2013, Q J EXP PSYCHOL, V66, P23, DOI 10.1080/17470218.2012.751117; Willmott C, 2014, J NEUROTRAUM, V31, P1507, DOI 10.1089/neu.2013.3308; Winkler E.A., 2017, J CLIN NEUROSCI, P35; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Wise RA, 2009, J ALLERGY CLIN IMMUN, V124, P436, DOI 10.1016/j.jaci.2009.05.041; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007; Yu RJ, 2014, HUM BRAIN MAPP, V35, P4583, DOI 10.1002/hbm.22496; Zimmermann-Viehoff F, 2016, J EVID-BASED INTEGR, V21, P3, DOI 10.1177/2156587215588642; Zubieta JK, 2009, ANN NY ACAD SCI, V1156, P198, DOI 10.1111/j.1749-6632.2009.04424.x	118	20	20	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2018	35	11					1205	1212		10.1089/neu.2017.5506		APR 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GG7EW	WOS:000429343100001	29343158	Green Published			2021-06-18	
J	Farhadi, HF; Kukreja, S; Minnema, A; Vatti, L; Gopinath, M; Prevedello, L; Chen, C; Xiang, HY; Schwab, JM				Farhadi, H. Francis; Kukreja, Sunil; Minnema, Amy; Vatti, Lohith; Gopinath, Meera; Prevedello, Luciano; Chen, Cheng; Xiang, Huiyun; Schwab, Jan M.			Impact of Admission Imaging Findings on Neurological Outcomes in Acute Cervical Traumatic Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						AIS conversion; cervical; intramedullary high-signal intensity; magnetic resonance imaging; spinal cord injury	INTRAMEDULLARY LESION EXPANSION; PREDICTION; BIOMARKERS; SEVERITY; IMPAIRMENT; RECOVERY; SURGERY; TRIALS; LENGTH; PHASE	Variable and unpredictable spontaneous recovery can occur after acute cervical traumatic spinal cord injury (tSCI). Despite the critical clinical and interventional trial planning implications of this tSCI feature, baseline measures to predict neurologic recovery accurately are not well defined. In this study, we used data derived from 99 consecutive patients (78 male, 21 female) with acute cervical tSCIs to assess the sensitivity and specificity of various clinical and radiological factors in predicting recovery at one year after injury. Categorical magnetic resonance imaging parameters included maximum canal compromise (MCC), maximum spinal cord compression (MSCC), longitudinal length of intramedullary lesion (IML), Brain and Spinal Injury Center (BASIC) score, and a novel derived Combined Axial and Sagittal Score (CASS). Logistic regression analysis of the area under the receiver operating characteristic curve (AUC) was applied to assess the differential predictive value of individual imaging markers. Admission American Spinal Injury Association Impairment Scale (AIS) grade, presence of a spinal fracture, and central cord syndrome were predictive of AIS conversion at one year. Both BASIC and IML were stronger predictors of AIS conversion compared with MCC and MSCC (p=0.0002 and p=0.04). The BASIC score demonstrated the highest overall predictive value for AIS conversion at one year (AUC 0.94). We conclude that admission intrinsic cord signal findings are robust predictive surrogate markers of neurologic recovery after cervical tSCI. Direct comparison of imaging parameters in this cohort of patients indicates that the BASIC score is the single best acute predictor of the likelihood of AIS conversion.	[Farhadi, H. Francis; Kukreja, Sunil; Minnema, Amy; Vatti, Lohith; Gopinath, Meera] Ohio State Univ, Wexner Med Ctr, Dept Neurol Surg, 410 W 10th Ave, Columbus, OH 43210 USA; [Prevedello, Luciano] Ohio State Univ, Wexner Med Ctr, Dept Radiol, Columbus, OH 43210 USA; [Xiang, Huiyun; Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Dept Neurol, Columbus, OH 43210 USA; [Chen, Cheng] Nationwide Childrens Hosp, Ctr Pediat Trauma Res, Columbus, OH USA	Farhadi, HF (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Neurol Surg, 410 W 10th Ave, Columbus, OH 43210 USA.	Francis.Farhadi@osumc.edu		Farhadi, H Francis/0000-0002-4668-8512; Schwab, Jan/0000-0001-6784-4919; Prevedello, Luciano/0000-0002-6768-6452	OSU Neurosignature Program; Else-Kroehner-Fresenius Foundation [2012_A32]; Wings-for-Life Spinal Cord Research Foundation [DE-047/14, DE-16/16]; Era-Net-NEURON Program of the European Union (EU) (SILENCE) [01EW1701A]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90SI5020]; W.E. Hunt and C.M. Curtis Endowment; Era-Net-NEURON Program of the European Union (EU) (SCI-Net) [01EW1710]	We thank all colleagues who have added data to the COTS and OSU IW, which serve as the basis for these analyses. We thank Dr. David Evans and the Trauma Service faculty. Moreover, we thank Dr. Sam Colachis for his work assessing recovery of patients after traumatic spinal cord injury. HFF received start-up funding support from the OSU Neurosignature Program. JMS received funding support from the Else-Kroehner-Fresenius Foundation (#2012_A32), the Wings-for-Life Spinal Cord Research Foundation (#DE-047/14, DE-16/16), the Era-Net-NEURON Program of the European Union (EU) (SILENCE #01EW1701A and SCI-Net #01EW1710), the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR #90SI5020), and by the W.E. Hunt and C.M. Curtis Endowment. JMS is a Discovery Theme Initiative Scholar of the Ohio State University (Brain Injury).	Aarabi B, 2017, NEUROSURGERY, V80, P610, DOI 10.1093/neuros/nyw053; Aarabi B, 2012, J NEUROSURG-SPINE, V17, P243, DOI 10.3171/2012.6.SPINE12122; Ahmad FU, 2014, WORLD NEUROSURG, V82, P207, DOI 10.1016/j.wneu.2013.01.008; Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; Bechtel Nancie, 2004, J Trauma Nurs, V11, P79; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Curt A, 2012, SPINAL CORD, V50, P352, DOI 10.1038/sc.2011.113; Curt A, 2017, JAMA NEUROL, V74, P635, DOI 10.1001/jamaneurol.2017.0318; Dalkilic T, 2018, J NEUROTRAUM, V35, P435, DOI 10.1089/neu.2017.5357; Dhall S.S., 2017, NEUROSURGERY; Dvorak MF, 2015, J NEUROTRAUM, V32, P645, DOI 10.1089/neu.2014.3632; Dvorak MF, 2014, J NEUROTRAUM, V31, P1540, DOI 10.1089/neu.2013.3278; Elizei SS, 2017, NEURAL REGEN RES, V12, P385, DOI 10.4103/1673-5374.202933; Facchinello Y., 2017, J NEUROTRAUMA; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Fehlings MG, 2006, SPINE, V31, P1719, DOI 10.1097/01.brs.0000224164.43912.e6; Fehlings Michael G, 2016, Neurosurgery, V63 Suppl 1, P196, DOI 10.1227/01.neu.0000489818.21218.72; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765; Haefeli J, 2017, AM J NEURORADIOL, V38, P648, DOI 10.3174/ajnr.A5021; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HAYASHI K, 1995, PARAPLEGIA, V33, P212, DOI 10.1038/sc.1995.47; Hosier H, 2015, J NEUROTRAUM, V32, P1633, DOI 10.1089/neu.2015.3892; Kaminski L, 2017, J NEUROTRAUM, V34, P2027, DOI 10.1089/neu.2016.4955; Kunte H, 2015, LANCET NEUROL, V14, P352, DOI 10.1016/S1474-4422(15)70013-X; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Le E, 2015, J NEUROSURG-SPINE, V22, P611, DOI 10.3171/2014.10.SPINE14576; Mahabaleshwarkar R, 2014, SPINAL CORD, V52, P139, DOI 10.1038/sc.2013.144; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Noonan VK, 2018, J NEUROTRAUM, V35, P478, DOI 10.1089/neu.2017.5036; SCHAEFER DM, 1992, J NEUROSURG, V76, P218, DOI 10.3171/jns.1992.76.2.0218; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Shanmuganathan K, 2017, J NEUROTRAUM, V34, P2964, DOI 10.1089/neu.2016.4901; Simard JM, 2012, EXP NEUROL, V233, P829, DOI 10.1016/j.expneurol.2011.11.048; Talbott JF, 2015, J NEUROSURG-SPINE, V23, P495, DOI 10.3171/2015.1.SPINE141033; Tanadini LG, 2015, NEUROREHAB NEURAL RE, V29, P867, DOI 10.1177/1545968315570322; Wilson JR, 2012, J NEUROTRAUM, V29, P2263, DOI 10.1089/neu.2012.2417; Yamazaki T, 2005, SURG NEUROL, V63, P95, DOI 10.1016/j.surneu.2004.03.020; Ydens E, 2017, MOL NEUROBIOL, V54, P1482, DOI 10.1007/s12035-016-9757-x	39	20	20	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2018	35	12					1398	1406		10.1089/neu.2017.5510		MAR 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GJ4ID	WOS:000428449400001	29361876				2021-06-18	
J	Foster, L; Peketi, P; Allen, T; Senior, T; Duncan, O; Alderson, A				Foster, Leon; Peketi, Prashanth; Allen, Thomas; Senior, Terry; Duncan, Olly; Alderson, Andrew			Application of Auxetic Foam in Sports Helmets	APPLIED SCIENCES-BASEL			English	Article						auxetic foam; helmet; concussion; sport; protection; impact attenuation	NEGATIVE POISSONS RATIO; DIFFUSE AXONAL INJURY; FINITE-ELEMENT MODEL; SAFETY APPLICATIONS; POLYURETHANE FOAMS; HEAD ACCELERATION; FOOTBALL PLAYERS; BRAIN-INJURY; CONCUSSION; FABRICATION	This investigation explored the viability of using open cell polyurethane auxetic foams to augment the conformable layer in a sports helmet and improve its linear impact acceleration attenuation. Foam types were compared by examining the impact severity on an instrumented anthropomorphic headform within a helmet consisting of three layers: a rigid shell, a stiff closed cell foam, and an open cell foam as a conformable layer. Auxetic and conventional foams were interchanged to act as the helmet's conformable component. Attenuation of linear acceleration was examined by dropping the combined helmet and headform on the front and the side. The helmet with auxetic foam reduced peak linear accelerations (p < 0.05) relative to its conventional counterpart at the highest impact energy in both orientations. Gadd Severity Index reduced by 11% for frontal impacts (38.9 J) and 44% for side impacts (24.3 J). The conformable layer within a helmet can influence the overall impact attenuating properties. The helmet fitted with auxetic foam can attenuate impact severity more than when fitted with conventional foam, and warrants further investigation for its potential to reduce the risk of traumatic brain injuries in sport specific impacts.	[Foster, Leon; Senior, Terry] Sheffield Hallam Univ, Ctr Sports Engn Res, Sheffield S1 1WB, S Yorkshire, England; [Peketi, Prashanth] Adidas Futures Team, Portland, OR 97217 USA; [Allen, Thomas] Manchester Metropolitan Univ, Sch Engn, Manchester M1 5GD, Lancs, England; [Duncan, Olly; Alderson, Andrew] Sheffield Hallam Univ, Mat & Engn Res Inst, Sheffield S1 1WB, S Yorkshire, England	Foster, L (corresponding author), Sheffield Hallam Univ, Ctr Sports Engn Res, Sheffield S1 1WB, S Yorkshire, England.	l.i.foster@shu.ac.uk; prashanth.peketi@adidas.com; t.allen@mmu.ac.uk; T.Senior@shu.ac.uk; Oliver.H.Duncan@student.shu.ac.uk; a.alderson@shu.ac.uk	Duncan, Olly/AAL-4259-2020	Duncan, Olly/0000-0001-9503-1464; Foster, Leon/0000-0002-1551-0316; Allen, Thomas/0000-0003-4910-9149			Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; Alderson A, 2005, Proceedings of the ASME Aerospace Division, P503; Allen T, 2015, PHYS STATUS SOLIDI B, V252, P1631, DOI 10.1002/pssb.201451715; Allen T., 2017, AUXETIC FOAM SNOW SP, P145; Allen T, 2017, PHYS STATUS SOLIDI B, V254, DOI 10.1002/pssb.201700596; Allen T, 2015, PROCEDIA ENGINEER, V112, P104, DOI 10.1016/j.proeng.2015.07.183; [Anonymous], 2014, 02210M12 NOCSAE DOC; [Anonymous], 2011, 00113M15 NOCSAE DOC; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Critchley R, 2013, PHYS STATUS SOLIDI B, V250, P1963, DOI 10.1002/pssb.201248550; Critchley R, 2013, ADV ENG MATER, V15, P980, DOI 10.1002/adem.201300030; Dickson TJ, 2017, SCAND J MED SCI SPOR, V27, P236, DOI 10.1111/sms.12642; DiMasi F.P., 1995, P 39 STAPP CAR CRASH; Duncan O, 2017, ACTA MATER, V126, P426, DOI 10.1016/j.actamat.2017.01.004; Duncan O., 2018, PROCEEDINGS, V2, P250, DOI DOI 10.3390/PROCEEDINGS2060250; Duncan O, 2016, PROCEDIA ENGINEER, V147, P384, DOI 10.1016/j.proeng.2016.06.323; Duncan O, 2016, SMART MATER STRUCT, V25, DOI 10.1088/0964-1726/25/5/054014; Ekeland A., 2017, INJURY TRENDS RECREA, P3; Gadd CW., 1966, 660793 SAE; Ge CF, 2013, J CELL PLAST, V49, P521, DOI 10.1177/0021955X13503844; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gibson L.J., 1997, CELLULAR SOLIDS STRU, P175, DOI DOI 10.1017/CBO9781139878326.007; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Honarmandi P., 2012, P ASME 2012 INT MECH, P883; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; King A., 2003, P IRCOBI C LISB PORT; Kis M, 2004, CAN J NEUROL SCI, V31, P499, DOI 10.1017/S031716710000370X; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038; Lisiecki J, 2013, PHYS STATUS SOLIDI B, V250, P1988, DOI 10.1002/pssb.201384232; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Martz EO, 1996, CELL POLYM, V15, P229; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McIntosh AS, 2012, P I MECH ENG P-J SPO, V226, P193, DOI 10.1177/1754337111431024; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Sanami M, 2014, PROCEDIA ENGINEER, V72, P453, DOI 10.1016/j.proeng.2014.06.079; Scarpa F, 2005, PHYS STATUS SOLIDI B, V242, P681, DOI 10.1002/pssb.200460386; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; U. S. Department of Transportation, 1999, FED MOT VEH SAF STAN, p208E; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; Vanden Bosche K., 2017, P I MECH ENG H, V23, P1; Von Holst H., 1999, Protective Helmet, Patent No. [US6658671B1, 6658671]	50	20	21	1	17	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-3417			APPL SCI-BASEL	Appl. Sci.-Basel	MAR	2018	8	3							354	10.3390/app8030354			12	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Engineering; Materials Science; Physics	GA5JI	WOS:000428369400037		DOAJ Gold, Green Accepted			2021-06-18	
J	Ondruschka, B; Schuch, S; Pohlers, D; Franke, H; Dressler, J				Ondruschka, Benjamin; Schuch, Sandra; Pohlers, Dirk; Franke, Heike; Dressler, Jan			Acute phase response after fatal traumatic brain injury	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Acute phase response; Cytokines; Fatal traumatic brain injury; Inflammation; Postmortem biochemistry	C-REACTIVE PROTEIN; CEREBROSPINAL-FLUID FERRITIN; SERUM; INTERLEUKIN-6; NECROSIS; APOPTOSIS; DIAGNOSIS; SEVERITY; RECEPTOR; CYTOKINES	An inflammatory response occurring after fatal traumatic brain injury (TBI) initiates time-dependent cascades of acute phase response. This may offer the potential to monitor postmortem biomarker levels of several pro-inflammatory cytokines to gain information about the cause of death and the trauma survival time. Cerebrospinal fluid (CSF) and serum samples were collected from forensic autopsies of 95 adult cadavers after postmortem intervals up to 6 days. The cases were divided according to their cause of death into fatal TBI (n = 46) with different survival times and age- and gender-matching non-TBI fatalities as controls (n = 49). Quantitative marker levels of interleukin-6 (IL-6), ferritin, soluble tumor necrosis factor receptor type 1, C-reactive protein, and lactate dehydrogenase were analyzed using immunoassays. Standardized statistical tests were performed to differentiate causes of death and survival time of TBI cases. The CSF IL-6, ferritin, and LDH levels after TBI were significantly higher than those in the controls (p < 0.001). Only serum IL-6 values showed comparable differences (p < 0.05). Both CSF and serum ferritin levels were discriminative between early and delayed death after TBI (p < 0.05). There were partly distinctive correlations between marker levels in both fluids with rising values after longer survival. There were up to moderate correlation between the marker levels and the postmortem interval due to postmortem hemolysis. However, neither CSF nor serum level ranges were affected by the age or gender of the subjects. This study is the first to measure all five proteins systematically in postmortem trauma cases. Ferritin and IL-6 proved themselves to be interesting postmortem biomarkers to provide specific information on the injury pattern and the survival time of traumatic fatalities. Such forensic investigations could serve as inexpensive and fast laboratory tests.	[Ondruschka, Benjamin; Schuch, Sandra; Dressler, Jan] Univ Leipzig, Inst Legal Med, Fac Med, Johannisallee 28, D-04103 Leipzig, Germany; [Pohlers, Dirk] Klinikum Chemnitz, Ctr Diagnost GmbH, Chemnitz, Germany; [Franke, Heike] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Fac Med, Leipzig, Germany	Ondruschka, B (corresponding author), Univ Leipzig, Inst Legal Med, Fac Med, Johannisallee 28, D-04103 Leipzig, Germany.	benjamin.ondruschka@medizin.uni-leipzig.de			German Ministry of Defense	This work was partly supported by the German Ministry of Defense.	Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Astrup BS, 2007, FORENSIC SCI INT, V172, P49, DOI 10.1016/j.forsciint.2006.10.021; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Carbonell T, 2007, CURR MED CHEM, V14, P857, DOI 10.2174/092986707780363014; Diniz BS, 2010, J ALZHEIMERS DIS, V22, P1305, DOI 10.3233/JAD-2010-100921; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Hans VHJ, 1999, NEUROREPORT, V10, P409; Hausmann R, 2004, INT J LEGAL MED, V118, P32, DOI 10.1007/s00414-003-0413-4; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hope S, 2013, SCHIZOPHR RES, V145, P36, DOI 10.1016/j.schres.2012.12.023; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; KEIR G, 1993, CLIN CHIM ACTA, V216, P153, DOI 10.1016/0009-8981(93)90148-W; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Li Dong-Ri, 2009, Leg Med (Tokyo), V11 Suppl 1, pS273, DOI 10.1016/j.legalmed.2009.02.042; Liao YG, 2013, PROCEEDINGS OF THE 2013 INTERNATIONAL WORKSHOP ON COMPUTER SCIENCE IN SPORTS, P10; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Maeda Hitoshi, 2009, Leg Med (Tokyo), V11 Suppl 1, pS46, DOI 10.1016/j.legalmed.2009.01.048; Maier B, 2006, SHOCK, V26, P122, DOI 10.1097/01.shk.0000223127.41641.f4; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Mimasaka S, 2001, TOHOKU J EXP MED, V193, P319, DOI 10.1620/tjem.193.319; Mulder SD, 2010, J ALZHEIMERS DIS, V22, P1073, DOI 10.3233/JAD-2010-100888; Muller K, 2006, CLIN CHEM LAB MED, V44, P1111, DOI 10.1515/CCLM.2006.211; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Newell E, 2015, PEDIATR CRIT CARE ME, V16, P549, DOI 10.1097/PCC.0000000000000400; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; OSUNA E, 1992, FORENSIC SCI INT, V52, P193, DOI 10.1016/0379-0738(92)90107-8; Palmiere C, 2012, INT J LEGAL MED, V126, P187, DOI 10.1007/s00414-011-0625-y; Papa L, 2017, J NEUROTRAUM, V34, P2187, DOI 10.1089/neu.2017.5030; Park YH, 2016, BMB REP, V49, P159, DOI 10.5483/BMBRep.2016.49.3.205; Petzold A, 2011, J STROKE CEREBROVASC, V20, P489, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.021; Roth P, 2000, Crit Care Nurs Q, V23, P14; SANCHEZRODRIGUEZ VF, 1995, AM J FOREN MED PATH, V16, P210, DOI 10.1097/00000433-199509000-00004; Schrag B, 2012, INT J LEGAL MED, V126, P505, DOI 10.1007/s00414-011-0596-z; Simon D, 2015, BRAIN INJURY, V29, P612, DOI 10.3109/02699052.2014.995228; Taniguchi T, 1999, AM J EMERG MED, V17, P548, DOI 10.1016/S0735-6757(99)90194-8; TEASDALE G, 1974, LANCET, V2, P81; Tsokos M, 2001, FORENSIC SCI INT, V119, P47, DOI 10.1016/S0379-0738(00)00391-1; Tsokos M, 2007, FORENSIC SCI INT, V165, P155, DOI 10.1016/j.forsciint.2006.05.015; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; YAMAUCHITAKIHARA K, 1995, CIRCULATION, V91, P1520, DOI 10.1161/01.CIR.91.5.1520; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	50	20	22	1	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	MAR	2018	132	2					531	539		10.1007/s00414-017-1768-2			9	Medicine, Legal	Legal Medicine	FV5WK	WOS:000424652900021	29306988				2021-06-18	
J	Mahler, B; Carlsson, S; Andersson, T; Tomson, T				Mahler, Benno; Carlsson, Sofia; Andersson, Tomas; Tomson, Torbjoern			Risk for injuries and accidents in epilepsy: A prospective population-based cohort study	NEUROLOGY			English	Article							SEIZURE-RELATED INJURIES; PSYCHIATRIC-DISORDERS; UNPROVOKED SEIZURES; CHILDREN; FRACTURES; FALLS; COMORBIDITIES; PEOPLE; ADULTS	ObjectiveTo study the risk for injuries/accidents in people with newly diagnosed epileptic seizures in relation to comorbidities.MethodsBetween September 1, 2001, and August 31, 2008, individuals in northern Stockholm with incident unprovoked seizures (epilepsy; n = 2,130) were included in a registry. For every epilepsy patient, 8 individuals matched for sex and inclusion year (n = 16,992) were randomly selected as references from the population of the catchment area. Occurrence of injuries/accidents was monitored through the national patient and cause of death registers until December 31, 2013. These registers also provided information on comorbidities (e.g., brain tumor, stroke, psychiatric disease, diabetes mellitus).ResultsInjury/accident was demonstrated in 1,033 epilepsy cases and 6,202 references (hazard ratio [HR] 1.71, 95% confidence interval 1.60-1.83). The excess risk was seen mainly during the first 2 years after diagnosis. Sex and educational status had no significant effect on HR. The risk was normal in children but increased in adults. Highest HR was seen for drowning, poisoning, adverse effect of medication, and severe traumatic brain injury. Compared to references without comorbidities, HR was 1.17 (1.07-1.28) in epilepsy without comorbidities, 4.52 (4.18-4.88) in references with comorbidities, and 7.15 (6.49-7.87) in epilepsy with comorbidities.ConclusionPresence of comorbidities should be considered when counseling patients with newly diagnosed epilepsy concerning risk for injuries/accidents. Early information is important, as the risk is highest during the first 2 years following seizure onset.	[Mahler, Benno; Tomson, Torbjoern] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Mahler, Benno; Carlsson, Sofia] Karolinska Inst, Inst Environm Med, Epidemiol Unit, Stockholm, Sweden; [Andersson, Tomas] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden	Mahler, B (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.; Mahler, B (corresponding author), Karolinska Inst, Inst Environm Med, Epidemiol Unit, Stockholm, Sweden.	benno.mahler@sll.se		carlsson, sofia/0000-0002-9497-2331	Stockholm County Council (ALF)Stockholm County Council; AFA Forsakring	No corporate sponsorship was received, but the study has received grants from the Stockholm County Council (ALF) and AFA Forsakring.	Adelow C, 2012, NEUROLOGY, V78, P396, DOI 10.1212/WNL.0b013e318245f461; Adelow C, 2009, EPILEPSIA, V50, P1094, DOI 10.1111/j.1528-1167.2008.01726.x; Andell E, 2015, EPILEPSY RES, V113, P140, DOI 10.1016/j.eplepsyres.2015.04.002; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; ANNEGERS JF, 1989, EPILEPSIA, V30, P348, DOI 10.1111/j.1528-1157.1989.tb05308.x; Appleton RE, 2002, EPILEPSIA, V43, P764, DOI 10.1046/j.1528-1157.2002.41101.x; Arron K, 2011, J INTELL DISABIL RES, V55, P109, DOI 10.1111/j.1365-2788.2010.01337.x; Beghi E, 2002, EPILEPSIA, V43, P1076, DOI 10.1046/j.1528-1157.2002.18701.x; Beghi E, 2009, EXPERT REV NEUROTHER, V9, P291, DOI 10.1586/14737175.9.2.291; Bell GS, 2008, NEUROLOGY, V71, P578, DOI 10.1212/01.wnl.0000323813.36193.4d; Buck D, 1997, EPILEPSIA, V38, P439, DOI 10.1111/j.1528-1157.1997.tb01733.x; Calvin CM, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2708; Chiba Y, 2009, AJIDD-AM J INTELLECT, V114, P225, DOI 10.1352/1944-7558-114.4:225-236; Czernuszenko A, 2009, CLIN REHABIL, V23, P176, DOI 10.1177/0269215508098894; Gedeborg R, 2008, EPIDEMIOLOGY, V19, P860, DOI 10.1097/EDE.0b013e318181319e; Josty IC, 2000, EPILEPSIA, V41, P453, DOI 10.1111/j.1528-1157.2000.tb00188.x; Kearney FC, 2013, DEMENT GERIATR COGN, V36, P20, DOI 10.1159/000350031; Keezer MR, 2016, LANCET NEUROL, V15, P106, DOI 10.1016/S1474-4422(15)00225-2; KIRBY S, 1995, EPILEPSIA, V36, P25, DOI 10.1111/j.1528-1157.1995.tb01660.x; Kirsch R, 2001, J CHILD NEUROL, V16, P100, DOI 10.2310/7010.2001.6916; Kwon C, 2011, NEUROLOGY, V76, P801, DOI 10.1212/WNL.0b013e31820e7b3b; Kwon CS, 2010, EPILEPSIA, V51, P2247, DOI 10.1111/j.1528-1167.2010.02697.x; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; NAKKEN KO, 1993, EPILEPSIA, V34, P836, DOI 10.1111/j.1528-1157.1993.tb02099.x; Neufeld MY, 1999, EPILEPSY RES, V34, P123, DOI 10.1016/S0920-1211(98)00105-3; ORLOWSKI JP, 1982, AM J DIS CHILD, V136, P777, DOI 10.1001/archpedi.1982.03970450019004; Persson HBI, 2002, EPILEPSIA, V43, P768, DOI 10.1046/j.1528-1157.2002.15801.x; Pi HY, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8612143; Nguyen R, 2009, NEUROL INT, V1, P72, DOI 10.4081/ni.2009.e20; RUSSELLJONES DL, 1989, J NEUROL NEUROSUR PS, V52, P659, DOI 10.1136/jnnp.52.5.659; Shadloo B, 2016, IRAN J PUBLIC HEALTH, V45, P623; Souverein PC, 2005, EPILEPSIA, V46, P304, DOI 10.1111/j.0013-9580.2005.23804.x; Stone CA, 2012, J CLIN ONCOL, V30, P2128, DOI 10.1200/JCO.2011.40.7791; Tellez-Zenteno JF, 2008, EPILEPSIA, V49, P954, DOI 10.1111/j.1528-1167.2007.01499.x; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Tomson T, 2004, EPILEPSY RES, V60, P1, DOI 10.1016/j.eplepsyres.2004.05.004; van den Broek M, 2004, EPILEPSIA, V45, P667, DOI 10.1111/j.0013-9580.2004.33903.x; Vestergaard P, 2005, ACTA NEUROL SCAND, V112, P277, DOI 10.1111/j.1600-0404.2005.00474.x; Wilson DA, 2014, EPILEPSY BEHAV, V32, P42, DOI 10.1016/j.yebeh.2013.12.035; Yau RK, 2013, DIABETES CARE, V36, P3985, DOI 10.2337/dc13-0429	40	20	20	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	FEB 27	2018	90	9					E779	+		10.1212/WNL.0000000000005035			12	Clinical Neurology	Neurosciences & Neurology	FZ7WQ	WOS:000427816000007	29386275				2021-06-18	
J	Zeiler, FA; Donnelly, J; Menon, DK; Smielewski, P; Hutchinson, PJA; Czosnyka, M				Zeiler, Frederick A.; Donnelly, Joseph; Menon, David K.; Smielewski, Peter; Hutchinson, Peter J. A.; Czosnyka, Marek			A Description of a New Continuous Physiological Index in Traumatic Brain Injury Using the Correlation between Pulse Amplitude of Intracranial Pressure and Cerebral Perfusion Pressure	JOURNAL OF NEUROTRAUMA			English	Article						cerebral compliance; cerebrovascular reactivity; ICP index; RAC	MULTIDISCIPLINARY CONSENSUS CONFERENCE; CEREBROVASCULAR REACTIVITY; BLOOD-FLOW; WAVE-FORM; AUTOREGULATION; STATEMENT	To describe a new continuous index of physiologic measurement in a traumatic brain injury (TBI) population, the moving correlation coefficient between intracranial pressure (ICP) pulse amplitude (AMP) and cerebral perfusion pressure (CPP), which we refer to as RAC. We use patient examples of sustained intracranial hypertension, systemic arterial hypotension, and plateau waves, as well as the retrospective analysis of 358 non-decompressive craniectomy (DC) TBI patients with high-frequency ICP and arterial blood pressure data, to explore the relationships of this new index, RAC, with AMP, ICP, CPP, RAP (correlation coefficient between AMP and ICP), pressure reactivity index (PRx), and pulse amplitude index (PAx). We compared the RAC-CPP relationship to that observed between CPP and both PRx and PAx. RAC displays temporal responsiveness to sustained increased ICP, arterial hypotension, and plateau waves, with positive values found during episodes of high ICP and low CPP. Analysis of AMP versus CPP and AMP versus ICP relationships in data from the entire non-DC cohort show lower breakpoints for AMP/CPP at CPP=40mm Hg and upper breakpoints for AMP/ICP at ICP = 50-60 mm Hg. RAC trends to positive values with increasing ICP, particularly with ICP values above the peak in AMP (ICP > 50 mm Hg), though its interpretation requires concomitant interpretation of AMP, RAP, and PRx/PAx to determine contributions of compensatory reserve and cerebrovascular responsiveness to the changes observed in RAC. There is a parabolic relationship between RAC versus CPP, with trends toward positive RAC values near (and beyond) limits for low and high CPPs, suggesting that RAC may be used in the determination of optimum CPP. RAC appears to carry information regarding both cerebrovascular responsiveness and cerebral compensatory reserve. This contributes to RAC's uniqueness and complex interpretation. Further prospective, clinical studies of RAC in CPP optimum estimation and outcome prediction in TBI are required.	[Zeiler, Frederick A.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, GB-1 820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Zeiler, Frederick A.; Donnelly, Joseph; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Hutchinson, Peter J. A.] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland	Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, GB-1 820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada.	umzeiler@myumanitoba.ca	Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Zeiler, Frederick/0000-0003-1737-0510; Hutchinson, Peter/0000-0002-2796-1835; czosnyka, marek/0000-0003-2446-8006	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; R. Samuel McLaughlin Research and Education Award; Manitoba Medical Service Foundation; University of Manitoba Faculty of Medicine Dean's Fellowship Fund; Woolf Fisher scholarship (New Zealand); National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre; NIHR Senior Investigator Award; NIHRNational Institute for Health Research (NIHR); European Union (CENTER-TBI) [602150]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277, G0502030, G0601025, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [12/35/57, 13/15/02, NIHR-RP-R3-12-013, II-C5-0715-20005, NF-SI-0512-10090] Funding Source: researchfish	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery, the University of Manitoba Clinician Investigator Program, R. Samuel McLaughlin Research and Education Award, the Manitoba Medical Service Foundation, and the University of Manitoba Faculty of Medicine Dean's Fellowship Fund.; J.D. is supported by the Woolf Fisher scholarship (New Zealand).; These studies were supported by National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award to D.K.M., and an NIHR Research Professorship to P.J.A.H. Authors were also supported by a European Union Framework Program 7 grant (CENTER-TBI; Grant Agreement No. 602150).	Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Donnelly J, 2017, J CEREBR BLOOD F MET, V37, P694, DOI 10.1177/0271678X16639060; LASSEN NA, 1959, PHYSIOL REV, V39, P183; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	17	20	20	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	7					963	974		10.1089/neu.2017.5241		FEB 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GC0NF	WOS:000424829100001	29212405				2021-06-18	
J	Fievisohn, E; Bailey, Z; Guettler, A; VandeVord, P				Fievisohn, Elizabeth; Bailey, Zachary; Guettler, Allison; VandeVord, Pamela			Primary Blast Brain Injury Mechanisms: Current Knowledge, Limitations, and Future Directions	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							INTRACRANIAL-PRESSURE RESPONSE; POSSIBLE DAMAGE MECHANISM; OPERATION IRAQI FREEDOM; INDUCED OCULAR TRAUMA; IMPACT ACCELERATION; FLUID PRESSURES; SHOCK-WAVE; INDUCED NEUROTRAUMA; OXIDATIVE STRESS; BOMB EXPLOSION	Mild blast traumatic brain injury (bTBI) accounts for the majority of brain injury in United States service members and other military personnel worldwide. The mechanisms of primary blast brain injury continue to be disputed with little evidence to support one or a combination of theories. The main hypotheses addressed in this review are blast wave transmission through the skull orifices, direct cranial transmission, skull flexure dynamics, thoracic surge, acceleration, and cavitation. Each possible mechanism is discussed using available literature with the goal of focusing research efforts to address the limitations and challenges that exist in blast injury research. Multiple mechanisms may contribute to the pathology of bTBI and could be dependent on magnitudes and orientation to blast exposure. Further focused biomechanical investigation with cadaver, in vivo, and finite element models would advance our knowledge of bTBI mechanisms. In addition, this understanding could guide future research and contribute to the greater goal of developing relevant injury criteria and mandates to protect our soldiers on the battlefield.	[Fievisohn, Elizabeth; Bailey, Zachary] Virginia Tech, Dept Biomed Engn & Mech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA; [Guettler, Allison] Virginia Tech, Dept Mech Engn, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA; [VandeVord, Pamela] Virginia Tech, Dept Biomed Engn & Mech, 317 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA; [VandeVord, Pamela] Salem Vet Affairs Med Ctr, Salem, VA 24153 USA	VandeVord, P (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, 317 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.; VandeVord, P (corresponding author), Salem Vet Affairs Med Ctr, Salem, VA 24153 USA.	lizf87@vt.edu; zbailey2@vt.edu; aguett@vt.edu; pvord@vt.edu	McNeil, Elizabeth/J-2972-2019				Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adams S, 2014, RESP PHYSIOL NEUROBI, V204, P112, DOI 10.1016/j.resp.2014.08.015; Agoston DVK, 2015, BRAIN NEUROTRAUMA MO; Akula P. K., 2013, ASME J MED DEVICE, V7; Akula P, 2015, BIOMED ENG LETT, V5, P281, DOI 10.1007/s13534-015-0204-0; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Aschkenasy-Steuer G, 2005, CRIT CARE, V9, P490, DOI 10.1186/cc3762; Assari S., 2013, IMECE201364992 ASME; Azhari H., 2010, BASICS BIOMEDICAL UL, P313, DOI DOI 10.1002/9780470561478.APP1/SUMMARY; Bailey Z. S., 2016, METHODS MOL BIOL, V1462; Bailey ZS, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00064; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; BILMES L, 2006, 12054 NAT BUR EC RES; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; BRISMAR B, 1982, J TRAUMA, V22, P216, DOI 10.1097/00005373-198203000-00007; Bushberg JT, 2011, ESSENTIAL PHYS MED I; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 1996, J TRAUMA, V40, pS148, DOI 10.1097/00005373-199603001-00032; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00119; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Choi Chul-Hee, 2012, Korean J Audiol, V16, P103, DOI 10.7874/kja.2012.16.3.103; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; CLEMEDSON C. J., 1954, MILITARY SURGEON, V114, P424; CLEMEDSON CJ, 1956, AM J PHYSIOL, V184, P119, DOI 10.1152/ajplegacy.1955.184.1.119; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336; Cohuet G, 2001, HYPERTENSION, V38, P1167, DOI 10.1161/hy1101.095995; COOPER GJ, 1983, J TRAUMA, V23, P955, DOI 10.1097/00005373-198311000-00001; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Cubano M.A., 2013, EM WAR SURG HDB, P257; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Regloix SB, 2017, J ROY ARMY MED CORPS, V163, P333, DOI 10.1136/jramc-2016-000733; DELIUS M, 1990, ULTRASOUND MED BIOL, V16, P467, DOI 10.1016/0301-5629(90)90169-D; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; DVBIC, 2016, DEP DEF NUMB TRAUM B; ELDER FK, 1952, J APPL PHYS, V23, P1065, DOI 10.1063/1.1701987; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; ENGIN AE, 1969, J BIOMECH, V2, P325, DOI 10.1016/0021-9290(69)90089-X; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gibbons AJ, 2011, J MIL VETERANS HEALT, V19, P15; Gilbert F. K., 1985, EXPLOSIVE SHOCKS AIR; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goldberg MS, 2010, MIL MED, V175, P220, DOI 10.7205/MILMED-D-09-00130; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; HADDEN WA, 1978, BRIT J SURG, V65, P525, DOI 10.1002/bjs.1800650802; HARVEY EN, 1947, J EXP MED, V85, P321, DOI 10.1084/jem.85.3.321; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hong Y, 2016, EXP MECH, V56, P97, DOI 10.1007/s11340-015-0024-2; Hosseini H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4867883; Johnston AM, 2015, AM J RESP CRIT CARE, V191, P1462, DOI 10.1164/rccm.201501-0063IM; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; KATZ E, 1989, ANN SURG, V209, P484, DOI 10.1097/00000658-198904000-00016; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovesdi E., 2012, FRONT NEUROL, V3, P11; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; KWON YW, 1993, COMPUT STRUCT, V48, P637, DOI 10.1016/0045-7949(93)90257-E; Leonardi AD, 2013, ANN BIOMED ENG, V41, P2488, DOI 10.1007/s10439-013-0850-2; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Maxwell AD, 2013, ULTRASOUND MED BIOL, V39, P449, DOI 10.1016/j.ultrasmedbio.2012.09.004; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Morley MG, 2010, DISASTER MED PUBLIC, V4, P154, DOI 10.1001/dmp.v4n2.hra10003; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Needham CE, 2010, SHOCK WAVE HIGH PRES, P9, DOI 10.1007/978-3-642-05288-0_3; Nusholtz G. S., 1984, 841657 SAE; NUSHOLTZ GS, 1987, AVIAT SPACE ENVIR MD, V58, P1157; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Owers C, 2011, BRIT J SURG, V98, P168, DOI 10.1002/bjs.7268; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; PERLMAN HB, 1945, LARYNGOSCOPE, V55, P427; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pinton G, 2012, MED PHYS, V39, P299, DOI 10.1118/1.3668316; Qureshi TA, 2017, J PAK MED ASSOC, V67, P1313; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Romba J., 1961, 1761 AB PROV GROUND; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sankowski R, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00028; Selvan V, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024132; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Shuker ST, 2010, J ORAL MAXIL SURG, V68, P93, DOI 10.1016/j.joms.2009.07.077; SHUPAK A, 1993, ARCH OTOLARYNGOL, V119, P1362; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Smith JE, 2011, PHILOS T R SOC B, V366, P291, DOI 10.1098/rstb.2010.0251; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P38; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P7; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P27; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Takeda S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00171; Tan L. B., 2017, INT J NUMER METH BIO, V33, P1; Toklu HZ, 2015, J CEREBR BLOOD F MET, V35, P1950, DOI 10.1038/jcbfm.2015.151; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; VandeVord PJ, 2016, METHODS MOL BIOL, V1462, P101, DOI 10.1007/978-1-4939-3816-2_7; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Vrselja Z, 2014, J CEREBR BLOOD F MET, V34, P578, DOI 10.1038/jcbfm.2014.7; WAHL M, 1993, ACTA NEUROCHIR, P3; Wang HCH, 2014, MIL MED, V179, P34, DOI 10.7205/MILMED-D-13-00504; Wani Imtiaz, 2009, World J Emerg Surg, V4, P46, DOI 10.1186/1749-7922-4-46; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wardlaw A, 2010, IFMBE PROC, V32, P34, DOI 10.1007/978-3-642-14998-6_9; Ware JB, 2016, RADIOLOGY, V280, P212, DOI 10.1148/radiol.2016151013; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Williams ST, 2017, MIL MED, V182, P226, DOI 10.7205/MILMED-D-16-00042; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Wood GW, 2013, INJURY PREV, V19, P19, DOI 10.1136/injuryprev-2011-040277; Xydakis MS, 2015, NEUROLOGY, V84, P1559, DOI 10.1212/WNL.0000000000001475; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zhong P, 2001, ULTRASOUND MED BIOL, V27, P119, DOI 10.1016/S0301-5629(00)00322-7; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	147	20	21	2	16	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	FEB	2018	140	2			SI				020806	10.1115/1.4038710			12	Biophysics; Engineering, Biomedical	Biophysics; Engineering	FV9NY	WOS:000424916500008	29222564				2021-06-18	
J	Hui, B; Zhang, LP; Zhou, QH; Hui, L				Hui, Bin; Zhang, Liping; Zhou, Qinhua; Hui, Ling			Pristimerin Inhibits LPS-Triggered Neurotoxicity in BV-2 Microglia Cells Through Modulating IRAK1/TRAF6/TAK1-Mediated NF-kappa B and AP-1 Signaling Pathways In Vitro	NEUROTOXICITY RESEARCH			English	Article						Pristimerin; Neuroinflammation; Neurotoxicity; IRAK1; TRAF6; TAK1	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN-INJURY; PROINFLAMMATORY CYTOKINES; ACTIVATED MICROGLIA; MURINE MACROPHAGES; NEURONAL DEATH; EXPRESSION; RESPONSES; KINASES; SYSTEM	Microglia plays a prominent role in the brain's inflammatory response to injury or infection by migrating to affected locations and secreting inflammatory molecules. However, hyperactivated microglial is neurotoxic and plays critical roles in the pathogenesis of neurodegenerative diseases. Pristimerin, a naturally occurring triterpenoid, possesses antitumor, antioxidant, and anti-inflammatory activities. However, the effect and the molecular mechanism of pristimerin against lipopolysaccharide (LPS)-induced neurotoxicity in microglia remain to be revealed. In the present study, using BV-2 microglial cultures, we investigated whether pristimerin modifies neurotoxicity after LPS stimulation and which intracellular pathways are involved in the effect of pristimerin. Here we show that pristimerin markedly suppressed the release of Regulated on Activation, Normal T Expressed and Secreted (RANTES), transforming growth factor-beta 1 (TGF-beta 1), IL-6, tumor necrosis factor-alpha (TNF-alpha), and nitric oxide (NO). Pristimerin also significantly inhibited migration of BV-2 microglia and alleviated the death of neuron-like PC12 cell induced by the conditioned medium from LPS-activated BV-2 microglial cells. Moreover, pristimerin reduced the expression and interaction of TNF Receptor-Associated Factor 6 (TRAF6) and Interleukin-1 Receptor-Associated Kinases (IRAK1), limiting TGF-beta activating kinase 1 (TAK1) activation, and resulting in an inhibition of IKK alpha/beta/NF-kappa B and MKK7/JNK/AP-1 signaling pathway in LPS-activated BV-2 microglia. Taken together, the anti-neurotoxicity action of pristimerin is mediated through the inhibition of TRAF6/IRAK1/TAK1 interaction as well as the related pathways: IKK alpha/beta/NF-kappa B and MKK7/JNK/AP-1 signaling pathways. These findings may suggest that pristimerin might serve as a new therapeutic agent for treating hyperactivated microglial induced neurodegenerative diseases.	[Hui, Bin; Zhou, Qinhua] Shanghai Univ Med Hlth Sci, Coll Pharm, Shanghai, Peoples R China; [Zhang, Liping] Shanghai Jiao Tong Univ, Dept Emergency Med, Peoples Hosp 6, Shanghai, Peoples R China; [Zhou, Qinhua] Jiaxing Univ, Dept Pharmacol, Coll Med, Jiaxing, Peoples R China; [Hui, Ling] Lanzhou Gen Hosp, Lanzhou Mil Command, Ctr Med Expt, Lanzhou, Gansu, Peoples R China	Zhou, QH (corresponding author), Shanghai Univ Med Hlth Sci, Coll Pharm, Shanghai, Peoples R China.; Zhou, QH (corresponding author), Jiaxing Univ, Dept Pharmacol, Coll Med, Jiaxing, Peoples R China.	zhouqh2016@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372177] Funding Source: Medline; Shanghai University of Medicine &amp; Health Sciences [HMSF-16-21-007] Funding Source: Medline; Foundation of Shanghai University of Medicine &amp; Health Sciences [JW-2014ZZBJ-px(YX)-GY01] Funding Source: Medline		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bellezza I, 2013, MOL IMMUNOL, V54, P347, DOI 10.1016/j.molimm.2013.01.003; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Chen CJ, 2004, BIOCHEM PHARMACOL, V67, P957, DOI 10.1016/j.bcp.2003.10.010; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cianciulli A, 2016, INT IMMUNOPHARMACOL, V36, P282, DOI 10.1016/j.intimp.2016.05.007; Cui Y, 2015, KOREAN J PHYSIOL PHA, V19, P219, DOI 10.4196/kjpp.2015.19.3.219; Cui YJ, 2012, EUR J PHARMACOL, V690, P4, DOI 10.1016/j.ejphar.2012.05.041; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Haas AH, 2008, GLIA, V56, P888, DOI 10.1002/glia.20663; Deng QD, 2015, INT IMMUNOPHARMACOL, V29, P302, DOI 10.1016/j.intimp.2015.11.001; Dirsch VM, 1997, EUR J PHARMACOL, V336, P211, DOI 10.1016/S0014-2999(97)01245-4; Drouin-Ouellet J, 2012, TRENDS PHARMACOL SCI, V33, P542, DOI 10.1016/j.tips.2012.07.002; dos Santos VADFM, 2010, MOLECULES, V15, P6956, DOI 10.3390/molecules15106956; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Gatheral T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042386; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; He Q, 2014, NEUROTOX RES, V26, P430, DOI 10.1007/s12640-014-9487-7; He W, 1998, BIOORG MED CHEM LETT, V8, P3659, DOI 10.1016/S0960-894X(98)00671-4; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hui B, 2008, J NEUROSCI RES, V86, P1169, DOI 10.1002/jnr.21566; [惠斌 Hui Bin], 2003, [中国药理学通报, Chinese Pharmacological Bulletin], V19, P656; Hui B, 2014, INT IMMUNOPHARMACOL, V21, P501, DOI 10.1016/j.intimp.2014.06.010; Hurley LL, 2013, NEUROTOX RES, V23, P131, DOI 10.1007/s12640-012-9348-1; Jung HW, 2007, EXP MOL MED, V39, P715, DOI 10.1038/emm.2007.78; Kang G, 2004, J PHARMACOL SCI, V94, P325, DOI 10.1254/jphs.94.325; Kim EA, 2014, INT IMMUNOPHARMACOL, V22, P73, DOI 10.1016/j.intimp.2014.06.022; Kim HJ, 2013, ARCH PHARM RES, V36, P495, DOI 10.1007/s12272-013-0054-1; Kim JS, 2006, PLANTA MED, V72, P65, DOI 10.1055/s-2005-873145; Kragelj J, 2015, P NATL ACAD SCI USA, V112, P3409, DOI 10.1073/pnas.1419528112; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Lee KW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-196; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lopez MR, 2011, PLANTA MED, V77, P726, DOI 10.1055/s-0030-1250500; Louboutin JP, 2013, CNS NEUROL DISORD-DR, V12, P815, DOI 10.2174/18715273113126660173; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Luo DQ, 2005, PEST MANAG SCI, V61, P85, DOI 10.1002/ps.953; Ma L, 2017, INT J MOL MED, V40, P31, DOI 10.3892/ijmm.2017.2987; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Morita H, 2008, BIOORG MED CHEM LETT, V18, P1050, DOI 10.1016/j.bmcl.2007.12.016; Nakamichi K, 2010, INT J NEUROSCI, V120, P252, DOI 10.3109/00207451003615763; Nam NH, 2006, MINI-REV MED CHEM, V6, P945, DOI 10.2174/138955706777934937; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; SARGENT JM, 1989, BRIT J CANCER, V60, P206, DOI 10.1038/bjc.1989.252; Suk K, 2003, J PHARMACOL EXP THER, V305, P638, DOI 10.1124/jpet.102.047373; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Von Bernhardi R, 2007, NEUROTOX RES, V12, P215, DOI 10.1007/BF03033906; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Wu CC, 2005, MOL CANCER THER, V4, P1277, DOI 10.1158/1535-7163.MCT-05-0027; Yoshioka Y, 2010, J PHARMACOL SCI, V113, P153, DOI 10.1254/jphs.10060FP; Yousef BA, 2016, ANTICANCER POTENTIAL; Yousef BA, 2016, ONCOL REP, V35, P1091, DOI 10.3892/or.2015.4457; Zeng KW, 2015, J CELL BIOCHEM, V116, P1286, DOI 10.1002/jcb.25084; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	58	20	22	0	38	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	FEB	2018	33	2					268	283		10.1007/s12640-017-9837-3			16	Neurosciences	Neurosciences & Neurology	FS8DN	WOS:000422640700005	29119451				2021-06-18	
J	Jacome, T; Tatum, D				Jacome, Tomas; Tatum, Danielle			Systemic Inflammatory Response Syndrome (SIRS) Score Independently Predicts Poor Outcome in Isolated Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; SIRS; Outcome; Systemic inflammatory response syndrome; Trauma	BETA-BLOCKER EXPOSURE; LENGTH-OF-STAY; HEAD-INJURY; IMPROVED SURVIVAL; COMA SCALE; CATECHOLAMINES; CLASSIFICATION; TEMPERATURE; HYPOTHERMIA; FEVER	Systemic inflammatory response syndrome (SIRS) is frequently observed after various types of acute cerebral injury and has been linked to clinical deterioration in non-traumatic brain injury (TBI). SIRS scores have also been shown to be predictive of length of stay and mortality in trauma patients. We aimed to determine the prognostic utility of SIRS present at admission in trauma patients with isolated TBI. This was a 5-year retrospective cohort study of adults (ae<yen>18 years) with isolated TBI admitted to a Level II trauma center. The prognostic value of SIRS, total SIRS scores, and each SIRS criterion was examined by I (2) and logistic regression analyses. Of the 330 patients identified, 50 (15.2%) met SIRS criteria. SIRS was significantly associated with poor outcome (P < 0.001). Relative risk of poor outcome was 2.7 times higher in patients with a SIRS score of 2 on admission (P = 0.007) and increased significantly to 6.5 times in patients with a SIRS score of 3 (P = 0.002). Logistic regression demonstrated SIRS and each criterion to be significant independent prognostic factors (SIRS, P = 0.030; body temperature, P = 0.006; tachypnea, P = 0.022, tachycardia P = 0.023). SIRS at admission is an independent predictor of poor outcome in isolated TBI patients. These data demonstrate SIRS to be an important clinical tool that may be used in facilitating prognostication, particularly in elderly trauma patients. Future prospective studies aimed at therapeutic interventions to mitigate SIRS in TBI patients are warranted. Prognostic, Level III.	[Jacome, Tomas; Tatum, Danielle] Our Lady Lake Reg Med Ctr, Trauma Specialist Program, 5000 Hennessey Blvd, Baton Rouge, LA 70808 USA	Tatum, D (corresponding author), Our Lady Lake Reg Med Ctr, Trauma Specialist Program, 5000 Hennessey Blvd, Baton Rouge, LA 70808 USA.	Danielle.Tatum@ololrmc.com					Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Balvers Kirsten, 2016, J Emerg Trauma Shock, V9, P97, DOI 10.4103/0974-2700.185276; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Childs C, 2006, NEUROCRIT CARE, V5, P10, DOI 10.1385/NCC:5:1:10; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Corso P, 2015, INJURY PREV, V21, P432, DOI [10.1136/ip.2005.010983rep, 10.1136/injuryprev-2015-041862]; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Enderson BL, 2007, J TRAUMA, V62, P33; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Madden LK, 2015, J NEUROSCI NURS, V47, P190, DOI 10.1097/JNN.0000000000000142; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Menger MD, 2004, LANGENBECK ARCH SURG, V389, P475, DOI 10.1007/s00423-004-0472-0; Mohseni S, 2015, WORLD J SURG, V39, P2076, DOI 10.1007/s00268-015-3039-z; Naito H, 2016, THER HYPOTHERMIA TEM, V6, P189, DOI 10.1089/ther.2016.0009; Napolitano LM, 2000, J TRAUMA, V49, P647, DOI 10.1097/00005373-200010000-00011; National Hospital Discharge Survey (NHDS), 2006, ALL DAT SOURC MAINT; NeSmith EG, 2009, AM J CRIT CARE, V18, P339, DOI 10.4037/ajcc2009267; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Sun Dong, 1999, Keio Journal of Medicine, V48, P28; TEASDALE G, 1974, LANCET, V2, P81; Thompson Hilaire J, 2010, J Trauma Nurs, V17, P173, DOI 10.1097/JTN.0b013e3181ff272e; Thompson HJ, 2003, J NEUROL NEUROSUR PS, V74, P614, DOI 10.1136/jnnp.74.5.614; Vila N, 2003, STROKE, V34, P671, DOI 10.1161/01.STR.0000057976.53301.69; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646; Zangbar B, 2016, J SURG RES, V200, P586, DOI 10.1016/j.jss.2015.08.020	41	20	20	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2018	28	1					110	116		10.1007/s12028-017-0410-y			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	FW9BQ	WOS:000425631100016	28547319				2021-06-18	
J	Merritt, C; Menon, K; Agus, MSD; Choong, K; McNally, D; O'Hearn, K; Watson, RS; Wong, HR; Duffett, M; Wypij, D; Zimmerman, JJ				Merritt, Courtney; Menon, Kusum; Agus, Michael S. D.; Choong, Karen; McNally, Dayre; O'Hearn, Katie; Watson, R. Scott; Wong, Hector R.; Duffett, Mark; Wypij, David; Zimmerman, Jerry J.			Beyond Survival: Pediatric Critical Care Interventional Trial Outcome Measure Preferences of Families and Healthcare Professionals	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						family preferences; pediatric critical illness interventional trials; outcome measures; study primary end points	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; ORGAN DYSFUNCTION SYNDROME; HOSPITAL CARDIAC-ARREST; FUNCTIONAL STATUS SCALE; TERM-FOLLOW-UP; INTENSIVE-CARE; SEVERE SEPSIS; SEPTIC SHOCK	Objectives: To identify, in addition to survival, preferred outcome measures of PICU family care providers and PICU healthcare professionals for interventional trials enrolling critically ill children, and to describe general attitudes of family care providers and healthcare professionals regarding research in the PICU. Design: Cross-sectional survey examining subject experience with clinical research and personal preferences for outcome measures for a hypothetical interventional clinical trial. Setting: PICUs within four academic children's hospitals in the United States and Canada. Subjects: Two cohorts including family members of critically ill children in PICUs (family care providers) and multidisciplinary staff working in the PICUs (healthcare professionals). Interventions: Administration of a short, deidentified survey. Measurements: Demographic data were collated for the two subject groups. Participants were queried regarding their attitudes related to research conducted in the PICU. In addition to survival, each group was asked to identify their three most important outcomes for an investigation examining whether or not an intervention helps seriously ill children recover. Main Results: Demographics for family care providers (n = 40) and healthcare professionals (n = 53) were similarly distributed. Female respondents (79.8%) predominated. Participants (98.9%) ascertained the importance of conducting research in the PICU, but significant challenges associated with this goal in the high stress PICU environment. Both quality of life and functioning after leaving the hospital were chosen as the most preferred outcome measure, with 77.5% of family care providers and 84.9% of healthcare professionals indicating this choice. Duration of organ dysfunction was identified by 70.0% of family care providers and 40.7% of healthcare professionals as the second most preferred outcome measure. Conclusions: In addition to survival, long-term quality of life/functional status and duration of organ dysfunction represent important interventional trial outcome measures for both families of critically ill children, as well as the multidisciplinary team who provides critical care.	[Merritt, Courtney; Watson, R. Scott; Zimmerman, Jerry J.] Univ Washington, Sch Med, Dept Pediat, Div Pediat Crit Care Med,Seattle Childrens Hosp, Seattle, WA 98195 USA; [Menon, Kusum; McNally, Dayre; O'Hearn, Katie] Univ Ottawa, Childrens Hosp Eastern Ontario, Div Pediat Crit Care, Ottawa, ON, Canada; [Agus, Michael S. D.; Wypij, David] Harvard Med Sch, Boston Childrens Hosp, Div Crit Care Med, Boston, MA USA; [Choong, Karen; Duffett, Mark] McMaster Univ, McMaster Childrens Hosp, Dept Pediat, Hamilton, ON, Canada; [Wong, Hector R.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Crit Care, Cincinnati, OH USA	Zimmerman, JJ (corresponding author), Univ Washington, Sch Med, Dept Pediat, Div Pediat Crit Care Med,Seattle Childrens Hosp, Seattle, WA 98195 USA.	jerry.zimmerman@seattlechildrens.org	Duffett, Mark/B-7524-2019	Duffett, Mark/0000-0003-1705-5422	Seattle Children's Hospital Research Institute; Academic Health - Sciences Alternate Funding Plan Innovation Grant; McMaster University; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Seattle Children's Hospital; University of WashingtonUniversity of Washington; PAS; University of Colorado; Society of Critical Care Medicine (SCCM); Centers for Disease ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH/National Institute of Child Health and Human Development and Immunexpress, Seattle, WA; Elsevier Publishing; SCCM	Supported, in part, by Seattle Children's Hospital Research Institute.; Dr. Choong's institution received funding from Academic Health - Sciences Alternate Funding Plan Innovation Grant, and she received funding from McMaster University. Dr. Watson's institution received funding from a National Institutes of Health (NIH) grant; he received funding for employment from Seattle Children's Hospital and University of Washington; funding for travel to attend meetings/lectures from PAS, University of Colorado, Society of Critical Care Medicine (SCCM), and the Centers for Disease Control; and received funding for honorariums from the NIH and University of Colorado. Dr. Wypij received several NIH grants to support other work unrelated to this. Dr. Zimmerman's institution received funding from NIH/National Institute of Child Health and Human Development and Immunexpress, Seattle, WA; and he received funding from Elsevier Publishing (textbook royalties) and SCCM (reimbursement of travel expenses to attend board meetings). The remaining authors have disclosed that they do not have any potential conflicts of interest.	Agus MSD, 2012, NEW ENGL J MED, V367, P1208, DOI 10.1056/NEJMoa1206044; Aspesberro F, 2016, PEDIATR CRIT CARE ME, V17, pE272, DOI 10.1097/PCC.0000000000000727; Aspesberro F, 2015, INTENS CARE MED, V41, P1235, DOI 10.1007/s00134-015-3780-7; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; BERNARD GR, 1995, AM J RESP CRIT CARE, V152, P4, DOI 10.1164/ajrccm.152.1.7599855; Bronner MB, 2009, PEDIATR CRIT CARE ME, V10, P636, DOI 10.1097/PCC.0b013e3181ae5c1a; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Buysse CMP, 2008, CRIT CARE MED, V36, P596, DOI 10.1097/01.CCM.0000299740.65484.CA; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; Colville GA, 2013, PEDIATR CRIT CARE ME, V14, pE85, DOI 10.1097/PCC.0b013e3182712997; Cunha F, 2013, PEDIATR CRIT CARE ME, V14, pE8, DOI 10.1097/PCC.0b013e31826012b4; Curley Martha A Q, 2005, Pediatr Crit Care Med, V6, pS150, DOI 10.1097/01.PCC.0000161582.63265.B6; Davies H, 2016, AUST CRIT CARE, V29, P27, DOI 10.1016/j.aucc.2015.04.002; Dinglas V, PRACTICAL RESOURCES; Ebrahim S, 2013, PEDIATR CRIT CARE ME, V14, P10, DOI 10.1097/PCC.0b013e31825b64b3; Epstein D, 2011, PEDIATRICS, V127, pE588, DOI 10.1542/peds.2010-0394; Farris RWD, 2013, PEDIATR CRIT CARE ME, V14, P835, DOI 10.1097/PCC.0b013e3182a551c8; FDA Administration, 2009, GUID IND PAT REP OUT; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hartman ME, 2017, PEDIATR CRIT CARE ME, V18, pE112, DOI 10.1097/PCC.0000000000001062; Holubkov R, 2015, PEDIATR CRIT CARE ME, V16, P1, DOI 10.1097/PCC.0000000000000272; Iwashyna TJ, 2014, JAMA-J AM MED ASSOC, V311, P1295, DOI 10.1001/jama.2014.2639; Jeschke MG, 2010, AM J RESP CRIT CARE, V182, P351, DOI 10.1164/rccm.201002-0190OC; Jones S, 2006, PEDIATRICS, V118, P2101, DOI 10.1542/peds.2006-1455; Kaplan R. M, 2001, QUALITY LIFE CHILD A, P89; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Kilburn LS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-379; Knoester H, 2008, INTENS CARE MED, V34, P1076, DOI 10.1007/s00134-008-1061-4; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Leteurtre S, 2013, CRIT CARE MED, V41, P1761, DOI 10.1097/CCM.0b013e31828a2bbd; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; Lin JC, 2017, PEDIATR CRIT CARE ME, V18, P8, DOI 10.1097/PCC.0000000000000978; Marino BS, 2009, PEDIATRICS, V123, pE708, DOI 10.1542/peds.2008-2572; Marshall JC, 2005, CRIT CARE MED, V33, P1708, DOI 10.1097/01.CCM.0000174478.70338.03; Menon K, 2017, PEDIATR CRIT CARE ME, V18, P505, DOI 10.1097/PCC.0000000000001121; Menon K, 2017, PEDIATR CRIT CARE ME, V18, pE146, DOI 10.1097/PCC.0000000000001078; Menon K, 2013, PEDIATR CRIT CARE ME, V14, P462, DOI 10.1097/PCC.0b013e31828a7287; Mesotten D, 2012, JAMA-J AM MED ASSOC, V308, P1641, DOI 10.1001/jama.2012.12424; Moler FW, 2017, NEW ENGL J MED, V376, P318, DOI 10.1056/NEJMoa1610493; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Morrison Anne L, 2002, Pediatr Crit Care Med, V3, P1, DOI 10.1097/00130478-200201000-00001; Morse J. M., 1991, STRATEGIES SAMPLING, P127; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; Namachivayam P, 2012, PEDIATR CRIT CARE ME, V13, P520, DOI 10.1097/PCC.0b013e31824fb989; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Ong C, 2016, PEDIATR CRIT CARE ME, V17, pE247, DOI 10.1097/PCC.0000000000000706; Pearson GA, 2003, LANCET, V362, P180, DOI 10.1016/S0140-6736(03)13948-7; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Robinson KA, 2007, J CLIN EPIDEMIOL, V60, P757, DOI 10.1016/j.jclinepi.2006.11.023; Stevens KJ, 2012, PEDIATR CRIT CARE ME, V13, P387, DOI 10.1097/PCC.0b013e318238969a; Tilford JM, 2007, NEUROCRIT CARE, V7, P64, DOI 10.1007/s12028-007-0037-5; Typpo KV, 2009, PEDIATR CRIT CARE ME, V10, P562, DOI 10.1097/PCC.0b013e3181a64be1; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; Villeneuve A, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0144-6; Vincent JL, 2004, CRIT CARE MED, V32, pS209, DOI 10.1097/01.CCM.0000126124.41743.86; Vincent KB, 2012, INT J MULT RES APPRO, V6, P4406; Visser IHE, 2013, INTENS CARE MED, V39, P942, DOI 10.1007/s00134-013-2857-4; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; Woolard RH, 2004, ACAD EMERG MED, V11, P859, DOI 10.1197/j.aem.2003.09.021	61	20	20	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	FEB	2018	19	2					E105	E111		10.1097/PCC.0000000000001409			7	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	FY8WT	WOS:000427146900005	29394234				2021-06-18	
J	Wettervik, TS; Lenell, S; Nyholm, L; Howells, T; Lewen, A; Enblad, P				Wettervik, Teodor Svedung; Lenell, Samuel; Nyholm, Lena; Howells, Tim; Lewen, Anders; Enblad, Per			Decompressive craniectomy in traumatic brain injury: usage and clinical outcome in a single centre	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Neurointensive care; Standardised treatment protocol; Decompressive craniectomy; Thiopental	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL HYPERTENSION; HEAD-INJURY; MANAGEMENT; SECONDARY; SCALE	Background Two randomised controlled trials (RCTs) of decompressive craniectomy (DC) in traumatic brain injury (TBI) have shown poor outcome, but there are considerations of how these protocols relate to real practice. The aims of this study were to evaluate usage and outcome of DC and thiopental in a single centre. Method The study included all TBI patients treated at the neurointensive care unit, Akademiska sjukhuset, Uppsala, Sweden, between 2008 and 2014. Of 609 patients aged 16 years or older, 35 treated with DC and 23 treated with thiopental only were studied in particular. Background variables, intracranial pressure (ICP) measures and global outcome were analysed. Results Of 35 DC patients, 9 were treated stepwise with thiopental before DC, 9 were treated stepwise with no thiopental before DC and 17 were treated primarily with DC. Six patients received thiopental after DC. For 23 patients, no DC was needed after thiopental. Eighty-eight percent of our DC patients would have qualified for the DECRA study and 38% for the Rescue-ICP trial. Favourable outcome was 44% in patients treated with thiopental before DC, 56% in patients treated with DC without prior thiopental, 29% in patients treated primarily with DC and 52% in patients treated with thiopental with no DC. Conclusions The place for DC in TBI management must be evaluated better, and we believe it is important that future RCTs should have clearer and less permissive ICP criteria regarding when thiopental should be followed by DC and DC followed by thiopental.	[Wettervik, Teodor Svedung; Lenell, Samuel; Nyholm, Lena; Howells, Tim; Lewen, Anders; Enblad, Per] Uppsala Univ, Uppsala Univ Hosp, Sect Neurosurg, Dept Neurosci, S-75185 Uppsala, Sweden	Wettervik, TS (corresponding author), Uppsala Univ, Uppsala Univ Hosp, Sect Neurosurg, Dept Neurosci, S-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se	Wettervik, Teodor Mikael Svedung/S-5356-2017; Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Lenell, Samuel/0000-0001-8914-5086			Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; Fischerstrom A, 2014, ACTA NEUROCHIR, V156, P177, DOI 10.1007/s00701-013-1932-5; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hutchinson P, LANCET; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kocher T., 1901, THERAPIE HIRNDRUCKES; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	21	20	21	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2018	160	2					229	237		10.1007/s00701-017-3418-3			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FS7ER	WOS:000419961200003	29234973	Other Gold, Green Published			2021-06-18	
J	Hazelton, I; Yates, A; Dale, A; Roodselaar, J; Akbar, N; Ruitenberg, MJ; Anthony, DC; Couch, Y				Hazelton, Isla; Yates, Abi; Dale, Ashley; Roodselaar, Jay; Akbar, Naveed; Ruitenberg, Marc J.; Anthony, Daniel C.; Couch, Yvonne			Exacerbation of Acute Traumatic Brain Injury by Circulating Extracellular Vesicles	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier; extracellular vesicles; inflammation; microglia; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; ACUTE-PHASE RESPONSE; LEUKOCYTE MOBILIZATION; INFLAMMATORY RESPONSE; FLOW-CYTOMETRY; SPINAL-CORD; MICROPARTICLES; NEUROINFLAMMATION; MICROVESICLES; MODEL	Inflammatory lesions in the brain activate a systemic acute-phase response (APR), which is dependent on the release of extracellular vesicles (EVs) into the circulation. The resulting APR is responsible for regulating leukocyte mobilization and subsequent recruitment to the brain. Factors that either exacerbate or inhibit the APR will also exacerbate or inhibit central nervous system (CNS) inflammation as a consequence and have the potential to influence ongoing secondary damage. Here, we were interested to discover how the circulating EV population changes after traumatic brain injury (TBI) and how manipulation of the circulating EV pool impacts on the outcome of TBI. We found the number of circulating EVs increased rapidly post-TBI, and this was accompanied by an increase in CNS and hepatic leukocyte recruitment. In an adoptive transfer study, we then evaluated the outcomes of TBI after administering EVs derived from either in vitro macrophage or endothelial cell lines stimulated with lipopolysaccharide (LPS), or from murine plasma from an LPS challenge using the air-pouch model. By manipulating the circulating EV population, we were able to demonstrate that each population of transferred EVs increased the APR. However, the characteristics of the response were dependent on the nature of the EVs; specifically, it was significantly increased when animals were challenged with macrophage-derived EVs, suggesting that the cellular origins of EVs may determine their function. Selectively targeting EVs from macrophage/monocyte populations is likely to be of value in reducing the impact of the systemic inflammatory response on the outcome of traumatic CNS injury.	[Hazelton, Isla; Yates, Abi; Dale, Ashley; Roodselaar, Jay; Anthony, Daniel C.] Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England; [Hazelton, Isla; Dale, Ashley; Ruitenberg, Marc J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Akbar, Naveed] Univ Oxford, RDM Invest Med, Dept Cardiovasc Med, Oxford, England; [Couch, Yvonne] Univ Oxford, RDM Invest Med, Acute Stroke Programme, Oxford, England	Anthony, DC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	daniel.anthony@pharm.ox.ac.uk	Anthony, Daniel C/F-7765-2010	Anthony, Daniel C/0000-0003-1380-6655; Akbar, Naveed/0000-0003-4620-6373; Roodselaar, Jay/0000-0002-9321-7836; Ruitenberg, Marc/0000-0002-6917-0708	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; Lundbeck FoundationLundbeckfonden; Spinal Research - Nathalie Rose Barr Award	The authors acknowledge the assistance of Dr. Errin Johnson (Bioimaging Facility, Dunn School, University of Oxford) for taking the EM images of our EVs. This work was funded by the Medical Research Council (to Y.C.), the Lundbeck Foundation (to N.A.), and Spinal Research - Nathalie Rose Barr Award (to D.A. and A.Y.).	Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Antonucci F, 2012, EMBO J, V31, P1231, DOI 10.1038/emboj.2011.489; Balusu S, 2016, EMBO MOL MED, V8, P1162, DOI 10.15252/emmm.201606271; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; Campbell SJ, 2008, J NEUROPATH EXP NEUR, V67, P223, DOI 10.1097/NEN.0b013e3181654957; Campbell SJ, 2007, J NEUROCHEM, V103, P2245, DOI 10.1111/j.1471-4159.2007.04928.x; Campbell SJ, 2007, NEUROBIOL DIS, V27, P151, DOI 10.1016/j.nbd.2007.04.013; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Chapman KZ, 2009, J CEREBR BLOOD F MET, V29, P1764, DOI 10.1038/jcbfm.2009.113; Chivet M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00145; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Couch Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09710-3; Couch Y, 2017, STROKE, V48, P2292, DOI 10.1161/STROKEAHA.117.017236; Couch Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130643; Couch Y, 2014, J NEUROIMMUNOL, V275, P57, DOI 10.1016/j.jneuroim.2014.08.150; Couch Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0178-3; Dickens AM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai7696; Dragovic RA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113266; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Joshi P, 2014, CELL DEATH DIFFER, V21, P582, DOI 10.1038/cdd.2013.180; Kanada M, 2015, P NATL ACAD SCI USA, V112, pE1433, DOI 10.1073/pnas.1418401112; Kox M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034431; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Nekludov M, 2014, J NEUROTRAUM, V31, P1927, DOI 10.1089/neu.2013.3168; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Paul D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0755-8; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rubartelli A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00099; Stoner SA, 2016, CYTOM PART A, V89A, P196, DOI 10.1002/cyto.a.22787; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Yamamoto S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08505; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Zhang B, 2014, EXP NEUROL, V258, P112, DOI 10.1016/j.expneurol.2014.04.007; Zhao ZL, 2017, PROTEIN CELL, V8, P801, DOI 10.1007/s13238-017-0414-6	41	20	20	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2018	35	4					639	651		10.1089/neu.2017.5049		JAN 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FV3OH	WOS:000419868800001	29149810				2021-06-18	
J	Bhowmick, S; D'Mello, V; Ponery, N; Abdul-Muneer, PM				Bhowmick, Saurav; D'Mello, Veera; Ponery, Nizmi; Abdul-Muneer, P. M.			Neurodegeneration and Sensorimotor Deficits in the Mouse Model of Traumatic Brain Injury	BRAIN SCIENCES			English	Article						traumatic brain injury; fluid percussion injury; neurodegeneration; apoptosis; sensorimotor deficit	NEUROINFLAMMATION; CLEAVAGE; GROWTH; CONNECTIVITY; EPIDEMIOLOGY; INFLAMMATION; ACTIVATION; INHIBITOR; APOPTOSIS; RECOVERY	Traumatic brain injury (TBI) can result in persistent sensorimotor and cognitive deficits, which occur through a cascade of deleterious pathophysiological events over time. In this study, we investigated the hypothesis that neurodegeneration caused by TBI leads to impairments in sensorimotor function. TBI induces the activation of the caspase-3 enzyme, which triggers cell apoptosis in an in vivo model of fluid percussion injury (FPI). We analyzed caspase-3 mediated apoptosis by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining and poly (ADP-ribose) polymerase (PARP) and annexin V western blotting. We correlated the neurodegeneration with sensorimotor deficits by conducting the animal behavioral tests including grid walk, balance beam, the inverted screen test, and the climb test. Our study demonstrated that the excess cell death or neurodegeneration correlated with the neuronal dysfunction and sensorimotor impairments associated with TBI.	[Bhowmick, Saurav; D'Mello, Veera; Ponery, Nizmi; Abdul-Muneer, P. M.] JFK Med Ctr, Neurosci Inst, Lab CNS Injury & Repair, 65 James St, Edison, NJ 08820 USA	Abdul-Muneer, PM (corresponding author), JFK Med Ctr, Neurosci Inst, Lab CNS Injury & Repair, 65 James St, Edison, NJ 08820 USA.	Sbhowmick@jfkhealth.org; veeradmello@gmail.com; nizmi.ponery@gmail.com; mmuneer@jfkhealth.org	Bhowmick, Saurav/Y-6011-2019	Abdul-Muneer, P. M/0000-0001-8231-4385	Neuroscience Institute at JFK Medical Center, Edison	This work was funded by the Neuroscience Institute at JFK Medical Center, Edison NJ to P.M. Abdul-Muneer.	Abdul-Muneer PM, 2017, MOL NEUROBIOL, V54, P3964, DOI 10.1007/s12035-016-9949-4; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abdul-Muneer P.M., 2017, MOL NEUROBIOL, DOI [10. 1007/s12035-017-0811-0 29128903, DOI 10.1007/S12035-017-0811-029128903]; Abdul-Muneer P.M., 2017, MOL NEUROBIOL, DOI [10. 1007/s12035-017-0812-z 29119534, DOI 10.1007/S12035-017-0812-Z29119534]; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Cardo-Vila M, 2003, MOL CELL, V11, P1151, DOI 10.1016/S1097-2765(03)00138-2; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; DEACON RMJ, 2013, JOVE J VIS EXP JUN, DOI DOI 10.3791/2610; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Enari M, 1998, NATURE, V391, P43; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fleming SM, 2013, JOVE-J VIS EXP, DOI 10.3791/50303; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Krstic J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/654594; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LEVASSEUR JE, 1989, J NEUROSURG, V71, P573, DOI 10.3171/jns.1989.71.4.0573; Luong T.N., 2011, JOVE-J VIS EXP, V10, DOI [10. 3791/2376 21445033, DOI 10.3791/237621445033]; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Muneer PMA, 2012, ARTERIOSCL THROM VAS, V32, P1167, DOI 10.1161/ATVBAHA.112.247668; Muneer PMA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-23; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Ohtake Y, 2014, BIOMATERIALS, V35, P4610, DOI 10.1016/j.biomaterials.2014.02.037; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Ouyang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171976; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; POSNER MI, 1984, J NEUROSCI, V4, P1863; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; PROTAIS P, 1976, PSYCHOPHARMACOLOGY, V50, P1, DOI 10.1007/BF00634146; Sakahira H, 1998, NATURE, V391, P96; Shin YS, 2014, NEUROTOXICOLOGY, V40, P111, DOI 10.1016/j.neuro.2013.12.006; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Simon-O'Brien E, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0687-3; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Yamaki T, 1997, BRAIN RES, V752, P151, DOI 10.1016/S0006-8993(96)01469-2	51	20	20	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JAN	2018	8	1							11	10.3390/brainsci8010011			11	Neurosciences	Neurosciences & Neurology	FU8IV	WOS:000424097400011	29316623	DOAJ Gold, Green Published			2021-06-18	
J	De Simoni, S; Jenkins, PO; Bourke, NJ; Fleminger, JJ; Hellyer, PJ; Jolly, AE; Patel, MC; Cole, JH; Leech, R; Sharp, DJ				De Simoni, Sara; Jenkins, Peter O.; Bourke, Niall J.; Fleminger, Jessica J.; Hellyer, Peter J.; Jolly, Amy E.; Patel, Maneesh C.; Cole, James H.; Leech, Robert; Sharp, David J.			Altered caudate connectivity is associated with executive dysfunction after traumatic brain injury	BRAIN			English	Article						traumatic brain injury; functional connectivity; executive dysfunction; corticostriatal; anterior cingulate cortex	DEFAULT MODE NETWORK; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; HUMAN CONNECTOME PROJECT; POSTERIOR CINGULATE CORTEX; RESTING-STATE FMRI; BASAL GANGLIA; FUNCTIONAL CONNECTIVITY; COGNITIVE CONTROL; HUMAN STRIATUM; SUBCORTICAL CONTRIBUTIONS	Traumatic brain injury often produces executive dysfunction. This characteristic cognitive impairment often causes long-term problems with behaviour and personality. Frontal lobe injuries are associated with executive dysfunction, but it is unclear how these injuries relate to corticostriatal interactions that are known to play an important role in behavioural control. We hypothesized that executive dysfunction after traumatic brain injury would be associated with abnormal corticostriatal interactions, a question that has not previously been investigated. We used structural and functional MRI measures of connectivity to investigate this. Corticostriatal functional connectivity in healthy individuals was initially defined using a data-driven approach. A constrained independent component analysis approach was applied in 100 healthy adult dataset from the Human Connectome Project. Diffusion tractography was also performed to generate white matter tracts. The output of this analysis was used to compare corticostriatal functional connectivity and structural integrity between groups of 42 patients with traumatic brain injury and 21 age-matched controls. Subdivisions of the caudate and putamen had distinct patterns of functional connectivity. Traumatic brain injury patients showed disruption to functional connectivity between the caudate and a distributed set of cortical regions, including the anterior cingulate cortex. Cognitive impairments in the patients were mainly seen in processing speed and executive function, as well as increased levels of apathy and fatigue. Abnormalities of caudate functional connectivity correlated with these cognitive impairments, with reductions in right caudate connectivity associated with increased executive dysfunction, information processing speed and memory impairment. Structural connectivity, measured using diffusion tensor imaging between the caudate and anterior cingulate cortex was impaired and this also correlated with measures of executive dysfunction. We show for the first time that altered subcortical connectivity is associated with large-scale network disruption in traumatic brain injury and that this disruption is related to the cognitive impairments seen in these patients.	[De Simoni, Sara; Jenkins, Peter O.; Bourke, Niall J.; Fleminger, Jessica J.; Jolly, Amy E.; Cole, James H.; Leech, Robert; Sharp, David J.] Imperial Coll London, Div Brain Sci, Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab, London, England; [Hellyer, Peter J.] Imperial Coll London, Dept Bioengn, London, England; [Patel, Maneesh C.] Charing Cross Hosp, Dept Imaging, London, England	De Simoni, S (corresponding author), Imperial Coll London, Dept Med, Div Brain Sci, C3NL, Du Cane Rd, London W12 0NN, England.	s.de-simoni@imperial.ac.uk	Leech, Robert/AAE-8254-2019; Cole, James H/I-5197-2019; Sharp, David J/A-2119-2013; Hellyer, Peter J/F-7112-2013	Leech, Robert/0000-0002-5801-6318; Cole, James H/0000-0003-1908-5588; Hellyer, Peter J/0000-0002-5139-3401; Jolly, Amy/0000-0002-7413-9772; Fleminger, Jessica/0000-0002-5744-5137	National Institute of Health Research Professorship [NIHR-RP-011-048]; NIHR CRF and BRC at Imperial College Healthcare NHS Trust; Guarantors of Brain Clinical Fellowship; Medical Research Council through a Clinician Scientist FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC); NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U54MH091657] Funding Source: NIH RePORTER; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/L022141/1, 1110783] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-011-048] Funding Source: researchfish	This paper presents independent research funded by a National Institute of Health Research Professorship (NIHR-RP-011-048) awarded to D.J.S. and supported by the NIHR CRF and BRC at Imperial College Healthcare NHS Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. P.O.J. is funded by Guarantors of Brain Clinical Fellowship. The research was also supported the Medical Research Council through a Clinician Scientist Fellowship awarded to D.J.S.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alsady TM, 2016, HUM BRAIN MAPP, V37, P3544, DOI 10.1002/hbm.23258; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Barnes KA, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00018; Bell PT, 2016, NEUROSCI BIOBEHAV R, V71, P313, DOI 10.1016/j.neubiorev.2016.08.036; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Casey BJ, 2007, AM J PSYCHIAT, V164, P1729, DOI 10.1176/appi.ajp.2007.06101754; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Choi EY, 2012, J NEUROPHYSIOL, V108, P2242, DOI 10.1152/jn.00270.2012; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Geranmayeh F, 2014, J NEUROSCI, V34, P8728, DOI 10.1523/JNEUROSCI.0428-14.2014; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Gordon EM, 2015, CEREB CORTEX, V25, P336, DOI 10.1093/cercor/bht229; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haber SN, 2016, DIALOGUES CLIN NEURO, V18, P7; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Ham TE, 2013, CEREB CORTEX, V23, P703, DOI 10.1093/cercor/bhs056; Hart H, 2013, JAMA PSYCHIAT, V70, P185, DOI 10.1001/jamapsychiatry.2013.277; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; KUNISHIO K, 1994, J COMP NEUROL, V350, P337, DOI 10.1002/cne.903500302; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Leunissen I, 2013, HUM BRAIN MAPP, V34, P1254, DOI 10.1002/hbm.21508; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malloy PF, 2001, FRONTAL SYSTEMS BEHA; McColgan P, 2015, BRAIN, V138, DOI 10.1093/brain/awv259; Mennes Maarten, 2011, Front Psychiatry, V2, P83, DOI 10.3389/fpsyt.2011.00083; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Pauli WM, 2016, P NATL ACAD SCI USA, V113, P1907, DOI 10.1073/pnas.1507610113; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Su TW, 2013, SCHIZOPHR RES, V148, P50, DOI 10.1016/j.schres.2013.05.005; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Unschuld PG, 2012, NEUROSCI LETT, V514, P204, DOI 10.1016/j.neulet.2012.02.095; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; YETERIAN EH, 1978, BRAIN RES, V139, P43, DOI 10.1016/0006-8993(78)90059-8	69	20	20	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN	2018	141		1				148	164		10.1093/brain/awx309			17	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FS2PD	WOS:000419619700023	29186356	Green Published, Other Gold			2021-06-18	
J	Fakharian, E; Abedzadeh-Kalahroudi, M; Atoof, F				Fakharian, Esmaeil; Abedzadeh-Kalahroudi, Masoumeh; Atoof, Fatemeh			Effect of Tranexamic Acid on Prevention of Hemorrhagic Mass Growth in Patients with Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Intracranial hemorrhage; Tranexamic acid; Traumatic brain injury	HEAD-INJURY	BACKGROUND: Intracranial hemorrhage is a common complication of traumatic brain injury (TBI). The purpose of this study is evaluation of the effect of tranexamic acid (TXA) on hemorrhagic mass growth in TBI patients. PATIENTS AND METHODS: In this randomized, doubleblind clinical trial, 149 patients with TBI and any kind of blood on their computed tomography scan enrolled in the study and were randomly allocated to receive TXA or placebo. After 24 hours, computed tomography scan was repeated for assessing the changes in hemorrhage, new bleeding, and mass effects of blood on brain tissue. The primary outcome was growth of the hemorrhagic lesion. Data were analyzed by SPSS software using Fisher exact, chi-square, and Mann-Whitney U tests, as well as linear and logistic regression models. FINDINGS: The incidence of hemorrhagic lesion growth was 20.5% in the TXA group and 22.7% in the placebo group. The difference was not significant (P = 0.87, RR = 0.89). The mean (standard deviation) of hemorrhagic lesion growth was 9.4 (15.3) in the TXA group and 10.2 (10.1) in the placebo group without significant difference (P =d 0.27). The frequency of deaths (2.7% vs. 4%), adverse outcome at discharge (10.8% vs. 17.3%), and 3 months later (6.8% vs. 14.7%) in the TXA group were lower than the placebo, but the difference was not statistically significant. No side effect was observed with the administration of TXA. CONCLUSION: Administration of a short dose of TXA does not lead to significant prevention of growth of posttraumatic hemorrhagic lesion or improvement of clinical outcomes.	[Fakharian, Esmaeil; Abedzadeh-Kalahroudi, Masoumeh; Atoof, Fatemeh] Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran	Abedzadeh-Kalahroudi, M (corresponding author), Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran.	Abedzadeh@kaums.ac.ir	Abedzadeh-Kalahroudi, Masoumeh/G-4114-2017	Abedzadeh-Kalahroudi, Masoumeh/0000-0002-7318-6294	Kashan University of Medical Sciences [91098]	We express our thanks to the staff of Trauma Research Center and Shahid Beheshti Hospital for their cooperation. This study was supported by the deputy of research, Kashan University of Medical Sciences (Grant No: 91098).	Arumugam A, 2015, MALAYS J MED SCI, V22, P62; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Edwards P, 2005, LANCET, V365, P1957; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Lobato RD, 2005, NEUROCIRUGIA, V16, P217; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Perel P, 2011, BMJ CLIN RES ED, V34, P1; Rahimi-Movaghar V, 2011, AM SURGEON, V77, pE112; Roberts I, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5839; ROOS YB, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001245, 10.1002/14651858.CD001245]; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; TEASDALE G, 1974, LANCET, V2, P81; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023; 2011, WHO TECHNICAL REPORT, P1	18	20	21	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2018	109						E748	E753		10.1016/j.wneu.2017.10.075			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FR4DD	WOS:000419015000093	29074420				2021-06-18	
J	Hanley, D; Prichep, LS; Badjatia, N; Bazarian, J; Chiacchierini, R; Curley, KC; Garrett, J; Jones, E; Naunheim, R; O'Neil, B; O'Neill, J; Wright, DW; Huff, JS				Hanley, Daniel; Prichep, Leslie S.; Badjatia, Neeraj; Bazarian, Jeffrey; Chiacchierini, Richard; Curley, Kenneth C.; Garrett, John; Jones, Elizabeth; Naunheim, Rosanne; O'Neil, Brian; O'Neill, John; Wright, David W.; Huff, J. Stephen			A Brain Electrical Activity Electroencephalographic-Based Biomarker of Functional Impairment in Traumatic Brain Injury: A Multi-Site Validation Trial	JOURNAL OF NEUROTRAUMA			English	Article						brain electrical activity; concussion; ED triage; EEG; functional impairment; mTBI; TBI	COLLEGIATE FOOTBALL PLAYERS; CONCUSSION; RECOVERY; CLASSIFICATION; 1ST	The potential clinical utility of a novel quantitative electroencephalographic (EEG)-based Brain Function Index (BFI) as a measure of the presence and severity of functional brain injury was studied as part of an independent prospective validation trial. The BFI was derived using quantitative EEG (QEEG) features associated with functional brain impairment reflecting current consensus on the physiology of concussive injury. Seven hundred and twenty adult patients (18-85 years of age) evaluated within 72h of sustaining a closed head injury were enrolled at 11 U.S. emergency departments (EDs). Glasgow Coma Scale (GCS) score was 15 in 97%. Standard clinical evaluations were conducted and 5 to 10min of EEG acquired from frontal locations. Clinical utility of the BFI was assessed for raw scores and percentile values. A multinomial logistic regression analysis demonstrated that the odds ratios (computed against controls) of the mild and moderate functionally impaired groups were significantly different from the odds ratio of the computed tomography (CT) postive (CT+, structural injury visible on CT) group (p=0.0009 and p=0.0026, respectively). However, no significant differences were observed between the odds ratios of the mild and moderately functionally impaired groups. Analysis of variance (ANOVA) demonstrated significant differences in BFI among normal (16.8%), mild TBI (mTBI)/concussed with mild or moderate functional impairment, (61.3%), and CT+ (21.9%) patients (p<0.0001). Regression slopes of the odds ratios for likelihood of group membership suggest a relationship between the BFI and severity of impairment. Findings support the BFI as a quantitative marker of brain function impairment, which scaled with severity of functional impairment in mTBI patients. When integrated into the clinical assessment, the BFI has the potential to aid in early diagnosis and thereby potential to impact the sequelae of TBI by providing an objective marker that is available at the point of care, hand-held, non-invasive, and rapid to obtain.	[Hanley, Daniel] Johns Hopkins Med Inst, Brain Injury Outcomes, Baltimore, MD 21205 USA; [Prichep, Leslie S.] NYU, Sch Med, Dept Psychiat, 1115 Broadway,Room 1082, New York, NY 10010 USA; [Prichep, Leslie S.] BrainScope Co Inc, Bethesda, MD USA; [Badjatia, Neeraj] R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Bazarian, Jeffrey] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Chiacchierini, Richard] RP Chiacchierini Consulting LLC, Gaithersburg, MD USA; [Curley, Kenneth C.] Iatrikos Res & Dev Strategies LLC, Tampa, FL USA; [Curley, Kenneth C.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Garrett, John] Baylor Univ, Med Ctr, Dallas, TX USA; [Jones, Elizabeth] Univ Texas Houston, Mem Hermann Hosp, Houston, TX USA; [Naunheim, Rosanne] Washington Univ, Barnes Jewish Med Ctr, St Louis, MO USA; [O'Neil, Brian] Detroit Receiving Hosp & Univ Hlth Ctr, Detroit, MI USA; [O'Neill, John] Allegheny Gen Hosp, Dept Emergency Med, Pittsburgh, PA 15212 USA; [Wright, David W.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Wright, David W.] Grady Mem Hosp, Atlanta, GA USA; [Huff, J. Stephen] Univ Virginia Hlth Syst, Charlottesville, VA USA	Prichep, LS (corresponding author), NYU, Sch Med, Dept Psychiat, 1115 Broadway,Room 1082, New York, NY 10010 USA.	leslie.prichep@nyumc.org			U.S ArmyUnited States Department of Defense [W81XWH-14-C-1405]	The authors acknowledge the contributions of all research staff at all the clinical sites and for their efforts toward the conduction of this study, and the patients who volunteer to participate. This study was funded in part by a research contract from the U.S Army, contract #W81XWH-14-C-1405. The views, opinions, and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy, or decision unless so designated by other documentation. In the conduct of research where humans were the subjects, the investigator(s) adhered to the policies regarding the protection of human subjects as prescribed by Code of Federal Regulations (CFR) Title 45, Volume 1, Part 46; Title 32, Chapter 1, Part 219; and Title 21, Chapter 1, Part 50 (Protection of Human Subjects).	Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Bigler E., 2014, CONCUSSIONS ATHLETIC, P181; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; DeRenzo E G, 1998, J Health Care Law Policy, V1, P66; Fakhran S, 2014, FUTUR NEUROL, V9, P517, DOI 10.2217/FNL.14.48; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Macmillan N. A., 2005, DETECTION THEORY USE; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Mihalik JP, 2017, MED SCI SPORT EXER, V49, P247, DOI 10.1249/MSS.0000000000001089; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Smith AM, 2017, CLIN J SPORT MED, V27, P503, DOI 10.1097/JSM.0000000000000412; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	34	20	20	0	20	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					41	47		10.1089/neu.2017.5004			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000419569700006	28599608				2021-06-18	
J	Jochems, D; van Wessem, KJP; Houwert, RM; Brouwers, HB; Dankbaar, JW; van Es, MA; Geurts, M; Slooter, AJC; Leenen, LPH				Jochems, D.; van Wessem, K. J. P.; Houwert, R. M.; Brouwers, H. B.; Dankbaar, J. W.; van Es, M. A.; Geurts, M.; Slooter, A. J. C.; Leenen, L. P. H.			Outcome in Patients with Isolated Moderate to Severe Traumatic Brain Injury	CRITICAL CARE RESEARCH AND PRACTICE			English	Article							WITHDRAWAL; CARE; RECOMMENDATIONS; DECISIONS; COMMON; IMPACT	Introduction. Traumatic brain injury (TBI) remains a major cause of death. Withdrawal of life-sustaining treatment (WLST) can be initiated if there is little anticipated chance of recovery to an acceptable quality of life. The aim of this study was firstly to investigate WLST rates in patients with moderate to severe isolated TBI and secondly to assess outcome data in the survivor group. Material and Methods. A retrospective cohort study was performed. Patients aged >= 18 years with moderate or severe isolated TBI admitted to the ICU of a single academic hospital between 2011 and 2015 were included. Exclusion criteria were isolated spinal cord injury and referrals to and from other hospitals. Gathered data included demographics, mortality, cause of death, WLST, and Glasgow Outcome Scale (GOS) score after three months. Good functional outcome was defined as GOS > 3. Results. Of 367 patients, 179 patients were included after applying inclusion and exclusion criteria. 55 died during admission (33%), of whom 45 (82%) after WLST. Patients undergoing WLST were older, had worse neurological performance at presentation, and had more radiological abnormalities than patients without WLST. The decision to withdraw life-sustaining treatment was made on the day of admission in 40% of patients. In 33% of these patients, this decision was made while the patient was in the Emergency Department. 71% of survivors had a good functional outcome after three months. No patient left hospital with an unresponsive wakefulness syndrome (UWS) or suffered from UWS after three months. One patient died within three months of discharge. Conclusion. In-hospital mortality in isolated brain injured patients was 33%. The vast majority died after a decision to withdraw life-sustaining treatment. None of the patients were discharged with an unresponsive wakefulness syndrome.	[Jochems, D.; van Wessem, K. J. P.; Houwert, R. M.; Leenen, L. P. H.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Trauma, Heidelberglaan 100, NL-3585 GA Utrecht, Netherlands; [Brouwers, H. B.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Neurosurg, Heidelberglaan 100, NL-3585 GA Utrecht, Netherlands; [Dankbaar, J. W.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Radiol, Heidelberglaan 100, NL-3585 GA Utrecht, Netherlands; [van Es, M. A.; Geurts, M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Neurol, Heidelberglaan 100, NL-3585 GA Utrecht, Netherlands; [Slooter, A. J. C.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Intens Care, Heidelberglaan 100, NL-3585 GA Utrecht, Netherlands	Jochems, D (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Trauma, Heidelberglaan 100, NL-3585 GA Utrecht, Netherlands.	d.jochems-3@umcutrecht.nl	Houwert, Roderick/K-7887-2019; Geurts, Marjolein/AAP-4148-2020; van+Es, Michael/AAC-5772-2021	Houwert, Roderick/0000-0003-3497-659X; van Es, Michael/0000-0002-7709-5883			Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Fraccaro P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004973; Geocadin RG, 2012, CRIT CARE MED, V40, P979, DOI 10.1097/CCM.0b013e3182410146; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Gunning AC, 2015, WORLD J SURG, V39, P2677, DOI 10.1007/s00268-015-3162-x; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Lilley EJ, 2018, JAMA SURG, V153, P44, DOI 10.1001/jamasurg.2017.3148; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Robertsen A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0385-x; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Sise MJ, 2012, J TRAUMA ACUTE CARE, V72, P1186, DOI 10.1097/TA.0b013e31824d0e57; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Verkade MA, 2012, NEUROCRIT CARE, V16, P130, DOI 10.1007/s12028-011-9567-y; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yurkovich M, 2015, J CLIN EPIDEMIOL, V68, P3, DOI 10.1016/j.jclinepi.2014.09.010	23	20	20	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-1305	2090-1313		CRIT CARE RES PRACT	Crit. Care Res. Pract.		2018	2018								3769418	10.1155/2018/3769418			7	Critical Care Medicine	General & Internal Medicine	GW3FL	WOS:000446779100001	30345113	DOAJ Gold, Green Published			2021-06-18	
J	Kosari-Nasab, M; Shokouhi, G; Ghorbanihaghjo, A; Abbasi, MM; Salari, AA				Kosari-Nasab, Morteza; Shokouhi, Ghaffar; Ghorbanihaghjo, Amir; Abbasi, Mehran Mesgari; Salari, Ali-Akbar			Anxiolytic- and antidepressant-like effects of Silymarin compared to diazepam and fluoxetine in a mouse model of mild traumatic brain injury	TOXICOLOGY AND APPLIED PHARMACOLOGY			English	Article						Depression; Anxiety; Traumatic brain injury; Inflammation; Silymarin	DEPRESSION-LIKE BEHAVIORS; NECROSIS-FACTOR-ALPHA; NEONATAL IMMUNE ACTIVATION; ANXIETY-LIKE BEHAVIORS; MAJOR DEPRESSION; TNF-ALPHA; OXIDATIVE STRESS; NEUROBEHAVIORAL ALTERATIONS; ANTIINFLAMMATORY CYTOKINES; INFLAMMATORY CYTOKINES	Clinical and experimental studies have shown that mild traumatic brain injury (mTBI) is associated with increased anxiety- and depression-related behaviors and inflammation in the brain. Unfortunately, there are no specific therapies for long-term behavioral consequences of mTBI. This study set out to determine whether silymarin treatment compared to diazepam (DZP) and fluoxetine (FLX) can reduce neuroinflammation, anxiety and depression-like behaviors after mTBI induction in mice. We used open field, elevated plus maze, light-dark box, zero maze, sucrose preference, forced swim, and tail suspension tests to assess anxiety and depression-like behaviors in mTBI-induced mice. The levels of tumor necrosis factor (TNF)-alpha protein, a marker of inflammation, in the prefrontal cortex and hippocampus was also measured. This study identified that the long-term treatment with DZP, FLX or SIL results in decreased anxiety and depression-like behaviors in mTBI-induced mice. The results also showed that these drugs reduced TNF-alpha levels in the prefrontal cortex and hippocampus. In addition, there were no significant differences between the effects of SIL and DZP or SIL and FLX on behavioral and cytokine levels in mTBI-induced mice. Our findings support the idea that mTBI could be a risk factor for anxiety and depression-related disorders and neuroinflammation in the brain. Taken together, this study demonstrates that DZP, FLX or SIL can significantly reduce anxiety- and depression-like symptoms, and neuroinflammation after mTBI induction in mice.	[Kosari-Nasab, Morteza; Shokouhi, Ghaffar; Ghorbanihaghjo, Amir; Abbasi, Mehran Mesgari; Salari, Ali-Akbar] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran; [Shokouhi, Ghaffar] Tabriz Univ Med Sci, Dept Neurosurg, Tabriz, Iran; [Shokouhi, Ghaffar] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran; [Ghorbanihaghjo, Amir] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz, Iran; [Salari, Ali-Akbar] SICBD, Alborz, Iran	Shokouhi, G; Salari, AA (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.	shokouhigh@yahoo.com; aa.salari@yahoo.com	Salari, Ali-Akbar/I-7843-2013; Tabrizi, Ghaffar Shokouhi/L-6326-2017	Salari, Ali-Akbar/0000-0002-4970-0337; Tabrizi, Ghaffar Shokouhi/0000-0001-5081-9928; Kosari-Nasab, Morteza/0000-0001-8454-5873; ghorbanihaghjo, amir/0000-0001-6742-0526	Drug Applied Research Center at Tabriz University of Medical Sciences [94/77]	This study was supported by a grant from the Drug Applied Research Center at Tabriz University of Medical Sciences (grant number 94/77).	Al-Drees AM, 2016, HISTOL HISTOPATHOL, V31, P1259, DOI 10.14670/HH-11-757; Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Amani M, 2013, NEUROPHARMACOLOGY, V73, P87, DOI 10.1016/j.neuropharm.2013.04.056; Amitai M, 2016, J CHILD ADOL PSYCHOP, V26, P727, DOI 10.1089/cap.2015.0147; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Ayatollahi A. M., 2017, NEUROL RES, P1; Babri S, 2014, BRAIN BEHAV IMMUN, V37, P164, DOI 10.1016/j.bbi.2013.12.003; Babri S, 2014, BEHAV BRAIN RES, V261, P305, DOI 10.1016/j.bbr.2013.12.037; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Bansal N, 2013, J PHARM INNOV, V5, P93; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bercik P, 2010, GASTROENTEROLOGY, V139, P2102, DOI 10.1053/j.gastro.2010.06.063; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Busse CS, 2004, NEUROPSYCHOPHARMACOL, V29, P1971, DOI 10.1038/sj.npp.1300540; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chtourou Y, 2010, BIOMETALS, V23, P985, DOI 10.1007/s10534-010-9345-x; da Silva GD, 2016, J PSYCHIATR RES, V75, P57, DOI 10.1016/j.jpsychires.2016.01.008; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Davies DR, 2016, FRONT BEHAV NEUROSCI, V10, DOI [10.3339/fnbeh.2015.00071, 10.3389/fnbeh.2016.00071]; De Jongh B. S. K. G., 1999, NEUROPSYCHOPHARMACOL, V20, P370; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Doosti MH, 2013, PROG NEURO-PSYCHOPH, V43, P55, DOI 10.1016/j.pnpbp.2012.12.003; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Enayati M, 2012, BRAIN RES BULL, V87, P295, DOI 10.1016/j.brainresbull.2011.08.015; Engin E, 2007, BEHAV PHARMACOL, V18, P365, DOI 10.1097/FBP.0b013e3282de7929; Epstein R. S., 1994, ANXIETY DISORDERS; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fiore M, 1998, PHYSIOL BEHAV, V63, P571, DOI 10.1016/S0031-9384(97)00514-3; Fiore M, 1996, BRAIN BEHAV IMMUN, V10, P126, DOI 10.1006/brbi.1996.0013; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Gharagozloo M, 2013, INT IMMUNOPHARMACOL, V16, P243, DOI 10.1016/j.intimp.2013.04.016; Gomes EPP, 2013, J PERIODONTAL RES, V48, P151, DOI 10.1111/j.1600-0765.2012.01515.x; Gupta OP, 2000, PHYTOMEDICINE, V7, P21, DOI 10.1016/S0944-7113(00)80017-3; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Higashi Y, 2014, J NEUROTRAUM, V31, P1689, DOI 10.1089/neu.2014.3331; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Isaac L, 2015, BIOL PSYCHOL, V105, P20, DOI 10.1016/j.biopsycho.2014.12.011; Jain NK, 2001, METHOD FIND EXP CLIN, V23, P441, DOI 10.1358/mf.2001.23.8.662131; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kaster MP, 2012, NEUROPHARMACOLOGY, V62, P419, DOI 10.1016/j.neuropharm.2011.08.018; Khoshnoodi M, 2015, PHARM BIOL, V53, P739, DOI 10.3109/13880209.2014.942787; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kraus J. F., 1999, REHABILITATION ADULT, P3; Krishnan R, 2007, BRIT J DERMATOL, V157, P1275, DOI 10.1111/j.1365-2133.2007.08205.x; Lavoie S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00634; Lazzarini R, 2006, LIFE SCI, V78, P3027, DOI 10.1016/j.lfs.2005.11.032; Lesniak A, 2017, BEHAV BRAIN RES, V326, P209, DOI 10.1016/j.bbr.2017.03.015; Lim CM, 2009, J NEUROSCI RES, V87, P1037, DOI 10.1002/jnr.21899; Loftis JM, 2010, NEUROBIOL DIS, V37, P519, DOI 10.1016/j.nbd.2009.11.015; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Majidi J, 2016, BRAIN RES BULL, V120, P1, DOI 10.1016/j.brainresbull.2015.10.009; Majidi-Zolbanin J, 2015, NEUROSCIENCE, V294, P69, DOI 10.1016/j.neuroscience.2015.03.016; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Moreno-Lopez L, 2016, BRAIN INJURY, V30, P1319, DOI 10.1080/02699052.2016.1186839; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morishima C, 2010, GASTROENTEROLOGY, V138, P671, DOI 10.1053/j.gastro.2009.09.021; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nazemian F, 2010, PHYTOTHER RES, V24, P1654, DOI 10.1002/ptr.3175; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Ravindran LN, 2010, J CLIN PSYCHIAT, V71, P839, DOI 10.4088/JCP.10r06218blu; Roumestan C, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-35; Sacre S, 2010, ARTHRITIS RHEUM-US, V62, P683, DOI 10.1002/art.27304; Salari AA, 2016, BEHAV BRAIN RES, V311, P354, DOI 10.1016/j.bbr.2016.05.062; Salari AA, 2015, EUR NEUROPSYCHOPHARM, V25, P1260, DOI 10.1016/j.euroneuro.2015.04.022; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; Schlumpf M, 1995, Arch Toxicol Suppl, V17, P261; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Shaker E, 2010, FOOD CHEM TOXICOL, V48, P803, DOI 10.1016/j.fct.2009.12.011; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Solati J, 2012, NEUROPHYSIOLOGY+, V44, P49, DOI 10.1007/s11062-012-9266-0; Solati J, 2011, NEUROCHEM J+, V5, P194, DOI 10.1134/S1819712411030081; Song C, 2009, PHARMACOPSYCHIATRY, V42, P182, DOI 10.1055/s-0029-1202263; Soo C, 2007, COCHRANE DB SYST REV, V18; Soon K. J., 2004, BIOCHEM PHARMACOL, V67, P175; Thakare VN, 2017, PHYSIOL BEHAV, V179, P401, DOI 10.1016/j.physbeh.2017.07.010; Thakare VN, 2016, PHARMACOL REP, V68, P1020, DOI 10.1016/j.pharep.2016.06.002; Toklu HZ, 2008, J SURG RES, V145, P214, DOI 10.1016/j.jss.2007.03.072; Torres SR, 2000, EUR J PHARMACOL, V408, P199, DOI 10.1016/S0014-2999(00)00760-3; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Tyring S, 2006, LANCET, V367, P29, DOI 10.1016/S0140-6736(05)67763-X; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Violle N, 2006, PHARMACOL BIOCHEM BE, V84, P517, DOI 10.1016/j.pbb.2006.06.017; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xia ZL, 1996, IMMUNOPHARMACOLOGY, V34, P27, DOI 10.1016/0162-3109(96)00111-7; Yamada K, 2000, J NEUROIMMUNOL, V111, P131, DOI 10.1016/S0165-5728(00)00375-1; Yirmiya R, 2001, NEUROPSYCHOPHARMACOL, V24, P531, DOI 10.1016/S0893-133X(00)00226-8; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang Feng, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS213, DOI 10.1016/S1353-8020(11)70066-9; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36; Zorrilla EP, 2001, BRAIN BEHAV IMMUN, V15, P199, DOI 10.1006/brbi.2000.0597	115	20	20	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0041-008X	1096-0333		TOXICOL APPL PHARM	Toxicol. Appl. Pharmacol.	JAN 1	2018	338						159	173		10.1016/j.taap.2017.11.012			15	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	FT1KI	WOS:000422894200016	29175455				2021-06-18	
J	Lichtenstein, JD; Erdodi, LA; Rai, JK; Mazur-Mosiewicz, A; Flaro, L				Lichtenstein, Jonathan D.; Erdodi, Laszlo A.; Rai, Jaspreet K.; Mazur-Mosiewicz, Anya; Flaro, Lloyd			Wisconsin Card Sorting Test embedded validity indicators developed for adults can be extended to children	CHILD NEUROPSYCHOLOGY			English	Article						Performance validity testing; Embedded validity indicators; WCST; Effort testing; Pediatric neuropsychological assessment; Pediatric PVTs	TRAUMATIC BRAIN-INJURY; FALSE-POSITIVE RATES; WORD MEMORY TEST; PERFORMANCE VALIDITY; DIGIT SPAN; NEUROPSYCHOLOGICAL EXAMINATIONS; NEUROLOGICAL DISORDERS; MALINGERING DETECTION; MULTIPLE PERFORMANCE; PATIENT SAMPLES	Past studies have examined the ability of the Wisconsin Card Sorting Test (WCST) to discriminate valid from invalid performance in adults using both individual embedded validity indicators (EVIs) and multivariate approaches. This study is designed to investigate whether the two most stable of these indicatorsfailures to maintain set (FMS) and the logistical regression equation S-B(LRE)can be extended to pediatric populations.The classification accuracy for FMS and S-B-LRE was examined in a mixed clinical sample of 226 children aged 7 to 17 years (64.6% male, MAge=13.6 years) against a combination of established performance validity tests (PVTs).The results show that at adult cutoffs, FMS and S-B-LRE produce an unacceptably high failure rate (33.2% and 45.6%) and low specificity (.55-.72), but an upward adjustment in cutoffs significantly improves classification accuracy. Defining Pass as <2 and Fail as 4 on FMS results in consistently good specificity (.89-.92) but low and variable sensitivity (.00-.33). Similarly, cutting the S-B-LRE distribution at 3.68 produces good specificity (.90-.92) but variable sensitivity (.06-.38). Passing or failing FMS or S-B-LRE is unrelated to age, gender and IQ.The data from this study suggest that in a pediatric sample, adjusted cutoffs on the FMS and S-B-LRE ensure good specificity, but with low or variable sensitivity. Thus, they should not be used in isolation to determine the credibility of a response set. At the same time, they can make valuable contributions to pediatric neuropsychology by providing empirically-supported, expedient and cost-effective indicators to enhance performance validity assessment.	[Lichtenstein, Jonathan D.] Geisel Sch Med Dartmouth, Dept Psychiat, Neuropsychol Serv, Lebanon, NH USA; [Erdodi, Laszlo A.; Rai, Jaspreet K.] Univ Windsor, Dept Psychol, Neuropsychol Track, Windsor, ON, Canada; [Mazur-Mosiewicz, Anya] Chicago Sch Profess Psychol, Dept Psychol, Chicago, IL USA; [Mazur-Mosiewicz, Anya] Oklahoma State Univ, Dept Psychiat & Behav Sci, Tulsa, OK USA	Lichtenstein, JD (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Psychiat, One Med Ctr Dr, Lebanon, NH 03756 USA.	jonathan.d.lichtenstein@dartmouth.edu					Ashendorf L, 2003, CLIN NEUROPSYCHOL, V17, P255, DOI 10.1076/clin.17.2.255.16502; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Batt K, 2008, J INT NEUROPSYCH SOC, V14, P1074, DOI 10.1017/S135561770808137X; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bilder RM, 2014, CLIN NEUROPSYCHOL, V28, P1212, DOI 10.1080/13854046.2014.969774; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Boone K. B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brooks BL, 2015, ARCH CLIN NEUROPSYCH, V30, P200, DOI 10.1093/arclin/acv017; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P858, DOI 10.1093/arclin/acs087; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Erdodi LA, 2017, APPL NEUROPSYCH-CHIL, V6, P355, DOI 10.1080/21622965.2016.1198908; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Gligorovic M, 2013, J INTELLECT DEV DIS, V38, P134, DOI 10.3109/13668250.2013.772956; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P., 2008, MANUAL NONVERBAL MED; Green P., 2003, MANUAL WORD MEMORY T; Green P., 2004, MANUAL GREENS MED SY; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Greve KW, 2002, J CLIN EXP NEUROPSYC, V24, P48, DOI 10.1076/jcen.24.1.48.968; Gunn D, 2010, CHILD NEUROPSYCHOL, V16, P105, DOI 10.1080/09297040903352564; Harrison AG, 2015, APPL NEUROPSYCH-CHIL, V4, P197, DOI 10.1080/21622965.2013.850581; Harrison AG, 2014, APPL NEUROPSYCH-CHIL, V3, P152, DOI 10.1080/21622965.2012.753570; Heaton R., 1993, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; IVERSON GL, 1998, 21 ITEM TEST RES MAN; Jodzio K, 2010, APPL NEUROPSYCHOL, V17, P267, DOI 10.1080/09084282.2010.525104; King JH, 2002, CLIN NEUROPSYCHOL, V16, P506, DOI 10.1076/clin.16.4.506.13912; Kirkwood M.W., 2015, VALIDITY TESTING CHI; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larrabee G. J, 2007, FORENSIC NEUROPSYCHO; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P695, DOI 10.1093/arclin/acu049; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Martin R. C., 1995, ARCH CLIN NEUROPSYCH, V10, P364, DOI [10.1093/arclin/10.4.364, DOI 10.1093/ARCLIN/10.4.364]; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Ploetz DM, 2016, CHILD NEUROPSYCHOL, V22, P133, DOI 10.1080/09297049.2014.986446; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; RETZLAFF P, 1992, J CLIN PSYCHOL, V48, P666, DOI 10.1002/1097-4679(199209)48:5<666::AID-JCLP2270480514>3.0.CO;2-J; Romine CB, 2004, ARCH CLIN NEUROPSYCH, V19, P1027, DOI 10.1016/j.acn.2003.12.009; Sherman E., 2015, CHILDREN ADOLESCENT; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Slick D., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Tombaugh TN, 1996, TEST MEMORY MALINGER; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063	61	20	20	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2018	24	2					247	260		10.1080/09297049.2016.1259402			14	Clinical Neurology	Neurosciences & Neurology	FU4JN	WOS:000423819500006	27892806				2021-06-18	
J	Salas, CE; Casassus, M; Rowlands, L; Pimm, S; Flanagan, DAJ				Salas, Christian E.; Casassus, Martin; Rowlands, Leanne; Pimm, Steve; Flanagan, Desmond A. J.			"Relating through sameness": a qualitative study of friendship and social isolation in chronic traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; friendship; social isolation; neuropsychological rehabilitation; identity	FOLLOW-UP; COMMUNITY INTEGRATION; LIFE SATISFACTION; PEOPLE; ADULTS; COMMUNICATION; INDIVIDUALS; ABILITIES; OUTCOMES; ISSUES	Social isolation has been described as a common problem among traumatic brain injury (TBI) survivors during the chronic phase. Due to physical, cognitive and behavioural changes, survivors become less socially active and experience a marked decrease in the number of friends. The goal of this investigation is to explore TBI survivors' subjective account of the challenges encountered in sustaining friendships, as well as gaining insight into their particular understanding of such difficulties. Using a thematic analysis approach, 11 survivors of TBI were interviewed in relation to their experience of social isolation and friendship during the chronic stage. Four main themes emerged from the interviews: (1) The impact of long-term cognitive and behavioural problems on relationships; (2) Loss of old friends; (3) Difficulties making new friends, and (4) Relating to other survivors in order to fight social isolation (sameness). Clinical implications of these findings, as well as their relevance in the design of long-term rehabilitation programmes, are discussed. Particular emphasis is placed on the need to acknowledge the value of relating to other survivors, as a way of resisting cultural discourses about disability, and as a source of self-cohesion in the process of identity re-construction.	[Salas, Christian E.] Univ Diego Portales, Fac Psicol, Lab Neurociencia Cognit & Social, Veragara 275, Santiago, Chile; [Salas, Christian E.; Casassus, Martin; Flanagan, Desmond A. J.] Head Forward Ctr, Manchester, Lancs, England; [Casassus, Martin] Univ Manchester, Div Neurosci & Expt Psychol, Manchester, Lancs, England; [Salas, Christian E.; Rowlands, Leanne] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Pimm, Steve] Rehabil Without Walls, Milton Keynes, Bucks, England	Salas, CE (corresponding author), Univ Diego Portales, Fac Psicol, Lab Neurociencia Cognit & Social, Veragara 275, Santiago, Chile.	salasriquelme@gmail.com		Casassus, Martin/0000-0002-7908-327X	CONICYT (Chile)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); Neuropsychoanalysis Foundation (New York, USA)	The first author of this article was supported by a Post-Doc grant from CONICYT (Chile) as well as a young researcher grant from the Neuropsychoanalysis Foundation (New York, USA).	Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Andrews S., 2005, TRAUMATIC BRAIN INJU, P539; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Carlsson E, 2007, QUAL HEALTH RES, V17, P1361, DOI 10.1177/1049732307306926; Coetzer B. R, 2004, ILLNESS CRISIS LOSS, V12, P171, DOI DOI 10.1177/1054137303262216; Coetzer R, 2014, REV CHIL NEUROPSICOL, V9, P8, DOI 10.5839/rcnp.2014.0901E.03; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Freeman A, 2015, NEUROPSYCHOL REHABIL, V25, P189, DOI 10.1080/09602011.2014.917686; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; GREENWOOD RJ, 1993, CLIN REHABIL, V7, P248; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hayes N., 1997, DOING QUALITATIVE AN, P93; Hoofien D, 2001, BRAIN INJURY, V15, P189; JUDD T, 1999, NEUROPSYCHOTHERAPY C; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Jumisko E, 2009, J CLIN NURS, V18, P2273, DOI 10.1111/j.1365-2702.2008.02738.x; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Karlovits T, 1999, BRAIN INJURY, V13, P845; Kinsella G, 1989, Int Disabil Stud, V11, P9; Klonoff P. S., 2005, BARROW Q, V21, P14; Klonoff PS, 2010, PSYCHOTHERAPY BRAIN; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kozloff R, 1987, J HEAD TRAUMA REHAB, V2, P14, DOI DOI 10.1097/00001199-198709000-00004; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Martelli MF, 2012, NEUROREHABILITATION, V31, P3, DOI 10.3233/NRE-2012-0770; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Miller L., 1993, PSYCHOTHERAPY BRAIN; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mukherjee D, 2003, WOMEN THER, V26, P3, DOI 10.1300/J015v26n01_01; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Paterson J., 2002, REHABILITATION NURSI, V27, P13, DOI [10.1002/j.2048-7940.2002.tb01973.x, DOI 10.1002/J.2048-7940.2002.TB01973.X]; Patton MQ., 1990, QUALITATIVE EVALUATI; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Roscigno CI, 2008, J NEUROSCI NURS, V40, P212, DOI 10.1097/01376517-200808000-00005; Rowlands A., 2000, BRAIN IMPAIR, V1, P151, DOI [10.1375/brim.1.2.151, DOI 10.1375/BRIM.1.2.151]; Salmon N, 2013, J INTELL DISABIL RES, V57, P347, DOI 10.1111/j.1365-2788.2012.01541.x; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Tate R, 2014, BRAIN IMPAIR, V15, P157, DOI 10.1017/BrImp.2014.28; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; YEATES GN, 2013, NEURODISABILITY PSYC, V1, P108	63	20	20	2	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	7					1161	1178		10.1080/09602011.2016.1247730			18	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	GM7WO	WOS:000438408000007	27802787				2021-06-18	
J	Shahid, AH; Mohanty, M; Singla, N; Mittal, BR; Gupta, SK				Shahid, Adnan Hussain; Mohanty, Manju; Singla, Navneet; Mittal, Bhagwant Rai; Gupta, Sunil Kumar			The effect of cranioplasty following decompressive craniectomy on cerebral blood perfusion, neurological, and cognitive outcome	JOURNAL OF NEUROSURGERY			English	Article						cranioplasty; GOS; GCS; decompressive craniectomy; SPECT; cognitive outcome; trauma	TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; PRACTICAL SCALE; HEAD-INJURY; FLOW; HEMICRANIECTOMY; MULTICENTER; IMPROVEMENT; METABOLISM; CT	OBJECTIVE Decompressive craniectomy is an established therapy for refractory intracranial hypertension. Cranioplasty following decompressive craniectomy not only provides protection to the brain along with cosmetic benefits, but also enhances rehabilitation with meaningful functional recovery of potentially reversible cortical and subcortical damaged areas of the affected as well as the contralateral hemisphere. The aim of the study was to assess neurological and cognitive outcome as well as cerebral blood flow after cranioplasty. METHODS Thirty-four patients admitted for replacement cranioplasty after decompressive craniectomy for head injury were studied prospectively. Clinical, neurological, and cognitive outcomes were assessed by the Glasgow Outcome Scale (GOS), the Glasgow Coma Scale, and a battery of cognitive tests, respectively. Simultaneously, cerebral blood perfusion was assessed by technetium-99m ethyl cysteinate dimer (Tc-99m-ECD) brain SPECT imaging 7 days prior to and 3 months after cranioplasty. RESULTS Prior to cranioplasty 9 patients (26.5%) had GOS scores of 5 and 25 patients (73.5%) had GOS scores of 4, whereas postcranioplasty all 34 patients (100%) improved to GOS scores of 5. Approximately 35.3%-90.9% patients showed cognitive improvement postcranioplasty in various tests. Also, on comparison with brain SPECT, 94% of patients showed improvement in cerebral perfusion in different lobes. CONCLUSIONS Cranioplasty remarkably improves neurological and cognitive outcomes supported by improvement in cerebral blood perfusion. https://thejns.org/doi/abs/10.3171/2016.10.JNS16678	[Shahid, Adnan Hussain; Mohanty, Manju; Singla, Navneet; Gupta, Sunil Kumar] Postgrad Inst Med Educ & Res, Dept Neurosurg, Secto 12, Chandigarh 160012, India; [Mittal, Bhagwant Rai] Postgrad Inst Med Educ & Res, Dept Nucl Med, Chandigarh, India	Gupta, SK (corresponding author), Postgrad Inst Med Educ & Res, Dept Neurosurg, Secto 12, Chandigarh 160012, India.	drguptasunil@gmail.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Benton A, 1989, MULTILINGUAL APHASIA; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Coelho F, 2014, NEUROPSYCH DIS TREAT, V10, P695, DOI 10.2147/NDT.S52875; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; Di Stefano C, 2016, BRAIN INJURY, V30, P164, DOI 10.3109/02699052.2015.1090013; Di Stefano C, 2012, BRIT J NEUROSURG, V26, P827, DOI 10.3109/02688697.2012.692838; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; Erdogan E, 2003, NEUROL INDIA, V51, P479; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Fodstad H, 1979, Acta Neurochir Suppl (Wien), V28, P514; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kumar GSS, 2004, NEUROL INDIA, V52, P504; Nievas MNCY, 2006, NEUROL RES, V28, P139, DOI 10.1179/016164106X98008; Pershad D, 1994, REVISED MANUAL PGI M; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Reitan R. M., 1992, TRAIL MAKING TEST MA; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Schmidt M., 1996, REY AUDITORY VERBAL; Schneider GH, 2002, ACT NEUR S, V81, P77; Singla N, 2014, ACTA NEUROCHIR, V156, P1369, DOI 10.1007/s00701-014-2071-3; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; Tanaka F, 2000, J NUCL MED, V41, P1456; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wen L, 2007, J CRANIOFAC SURG, V18, P526; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	40	20	23	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2018	128	1					229	235		10.3171/2016.10.JNS16678			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FR3AW	WOS:000418939300028	28298042				2021-06-18	
S	Sheehy, EJ; Cunniffe, GM; O'Brien, FJ		Barbosa, MA; Martins, MCL		Sheehy, E. J.; Cunniffe, G. M.; O'Brien, F. J.			Collagen-based biomaterials for tissue regeneration and repair	PEPTIDES AND PROTEINS AS BIOMATERIALS FOR TISSUE REGENERATION AND REPAIR	Woodhead Publishing Series in Biomaterials		English	Article; Book Chapter							BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-BETA; TRAUMATIC BRAIN-INJURY; ENGINEERING APPLICATIONS; CROSS-LINKING; GAG SCAFFOLDS; IN-VIVO; GLYCOSAMINOGLYCAN SCAFFOLDS; EXTRACELLULAR-MATRIX		[Sheehy, E. J.; O'Brien, F. J.] Royal Coll Surgeons Ireland, Dublin, Ireland; [Sheehy, E. J.; Cunniffe, G. M.; O'Brien, F. J.] Trinity Coll Dublin, Dublin, Ireland	Sheehy, EJ (corresponding author), Royal Coll Surgeons Ireland, Dublin, Ireland.; Sheehy, EJ (corresponding author), Trinity Coll Dublin, Dublin, Ireland.		Teixeira, Catia AS/B-5680-2011; O'Brien, Fergal/F-9485-2011	Teixeira, Catia AS/0000-0001-9506-3781; O'Brien, Fergal/0000-0003-2030-8005; Sheehy`, Eamon/0000-0002-2902-4562			Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010; Agren M S, 2001, J Wound Care, V10, P301; Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320; Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035; Arbelaez Maria Clara, 2009, Oman J Ophthalmol, V2, P33, DOI 10.4103/0974-620X.48420; Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.22.010305.104258; Baek J, 2016, TISSUE ENG PT A, V22, P436, DOI [10.1089/ten.tea.2015.0284, 10.1089/ten.TEA.2015.0284]; Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022; Bishop S M, 2003, J Wound Care, V12, P125; Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104; Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473; Brittberg M, 2010, AM J SPORT MED, V38, P1259, DOI 10.1177/0363546509346395; Bronzino J.D., 2015, BIOMEDICAL ENG HDB; Browne S, 2013, TISSUE ENG PT A, V19, P1491, DOI [10.1089/ten.TEA.2012.0721, 10.1089/ten.tea.2012.0721]; Bulleid NJ, 2000, BIOCHEM SOC T, V28, P350, DOI 10.1042/0300-5127:0280350; Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024; Carragee EJ, 2013, J BONE JOINT SURG AM, V95A, P1537, DOI 10.2106/JBJS.L.01483; Castano IM, 2015, J CONTROL RELEASE, V200, P42, DOI 10.1016/j.jconrel.2014.12.034; Catrina S, 2013, EUR J PHARM BIOPHARM, V85, P139, DOI 10.1016/j.ejpb.2013.03.030; Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3; Chattopadhyay S, 2014, BIOPOLYMERS, V101, P821, DOI 10.1002/bip.22486; Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017; Chen FM, 2016, PROG POLYM SCI, V53, P86, DOI 10.1016/j.progpolymsci.2015.02.004; Chen P, 2005, TISSUE ENG, V11, P1436, DOI 10.1089/ten.2005.11.1436; Chen RN, 2005, BIOMATERIALS, V26, P4229, DOI 10.1016/j.biomaterials.2004.11.012; Chwalek K, 2015, JOVE-J VIS EXP, DOI 10.3791/52970; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cunniffe GM, 2011, JOM-US, V63, P66, DOI 10.1007/s11837-011-0061-y; Curtin CM, 2015, ADV HEALTHC MATER, V4, P223, DOI 10.1002/adhm.201400397; Di Bella C, 2015, FRONT SURG, P2; Dickhut A, 2010, TISSUE ENG PT A, V16, P453, DOI [10.1089/ten.tea.2009.0168, 10.1089/ten.TEA.2009.0168]; Diederichs S, 2012, TISSUE ENG PT A, V18, P1140, DOI [10.1089/ten.TEA.2011.0426, 10.1089/ten.tea.2011.0426]; Donaghue V M, 1998, Adv Wound Care, V11, P114; Duan HM, 2016, ACTA BIOMATER, V45, P182, DOI 10.1016/j.actbio.2016.08.043; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Epstein Nancy E, 2011, Surg Neurol Int, V2, P10, DOI 10.4103/2152-7806.76147; Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459; Ferrario C, 2017, MAR ENVIRON RES, V128, P46, DOI 10.1016/j.marenvres.2016.03.007; Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014; Fitzgerald KA, 2015, BIOMATERIALS, V66, P53, DOI 10.1016/j.biomaterials.2015.07.019; Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4; Gannon AR, 2012, OSTEOARTHR CARTILAGE, V20, P1417, DOI 10.1016/j.joca.2012.08.005; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gleeson JP, 2010, EUR CELLS MATER, V20, P218; Gonzalez-Henriquez CM, 2017, MATERIALS, V10, DOI 10.3390/ma10030232; Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145; Grier WK, 2017, J MECH BEHAV BIOMED, V65, P295, DOI 10.1016/j.jmbbm.2016.08.034; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]; Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955; Herland A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150360; Huang C, 2012, PROG NAT SCI-MATER, V22, P108, DOI 10.1016/j.pnsc.2012.03.005; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Jacobi M, 2011, BMC SPORTS SCI MED R, V3, DOI 10.1186/1758-2555-3-10; Joanne P, 2016, BIOMATERIALS, V80, P157, DOI 10.1016/j.biomaterials.2015.11.035; Kempf M, 2011, BIOMATERIALS, V32, P4782, DOI 10.1016/j.biomaterials.2011.03.023; Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001; Koh CJ, 2004, J AM SOC NEPHROL, V15, P1113, DOI 10.1097/01.ASN.0000119683.59068.F0; Koide T, 2005, CONNECT TISSUE RES, V46, P131, DOI 10.1080/03008200591008518; Langer R, 2000, MOL THER, V1, P12, DOI 10.1006/mthe.1999.0003; Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9; Lee HJ, 2015, ADV HEALTHC MATER, V4, P1359, DOI 10.1002/adhm.201500193; Levingstone TJ, 2016, ACTA BIOMATER, V32, P149, DOI 10.1016/j.actbio.2015.12.034; Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030; Lu HX, 2011, BIOMATERIALS, V32, P9658, DOI 10.1016/j.biomaterials.2011.08.091; Lyons FG, 2014, CLIN ORTHOP RELAT R, V472, P1318, DOI 10.1007/s11999-013-3438-0; Mackie EJ, 2003, INT J BIOCHEM CELL B, V35, P1301, DOI 10.1016/S1357-2725(03)00107-9; Madduri S, 2010, J CONTROL RELEASE, V143, P168, DOI 10.1016/j.jconrel.2009.12.017; Madry H, 2014, TISSUE ENG PART B-RE, V20, P106, DOI [10.1089/ten.teb.2013.0271, 10.1089/ten.TEB.2013.0271]; Mandal A, 2012, COLLOID SURFACE B, V90, P191, DOI 10.1016/j.colsurfb.2011.10.021; Marsano A, 2016, STEM CELL TRANSL MED, V5, P1730, DOI 10.5966/sctm.2015-0321; Matsiko A, 2015, ADV HEALTHC MATER, V4, P1175, DOI 10.1002/adhm.201500053; Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u; Matthews JA, 2003, J BIOACT COMPAT POL, V18, P125, DOI 10.1177/0883911503018002003; Meena C, 1999, P INDIAN AS-CHEM SCI, V111, P319; Mironov V, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/022001; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Nannan D, 2016, BIOMED MATER, V11; Nisi Giuseppe, 2005, Chir Ital, V57, P465; Noth U, 2010, ADV DRUG DELIVER REV, V62, P765, DOI 10.1016/j.addr.2010.04.004; O Halloran DM, 2006, TISSUE ENG, V12, P1467, DOI 10.1089/ten.2006.12.1467; O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X; O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052; O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6; O'Leary C, 2016, BIOMATERIALS, V85, P111, DOI 10.1016/j.biomaterials.2016.01.065; O'Leary C, 2015, TISSUE ENG PART B-RE, V21, P323, DOI [10.1089/ten.TEB.2014.0525, 10.1089/ten.teb.2014.0525]; Ochiya Takahiro, 2001, Current Gene Therapy, V1, P31, DOI 10.2174/1566523013348887; Pacak CA, 2011, TISSUE ENG PART C-ME, V17, P879, DOI [10.1089/ten.tec.2010.0720, 10.1089/ten.TEC.2010.0720]; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x; Patel NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041024; Pawelec KM, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4871083; Pereira H, 2014, OSTEOARTHR CARTILAGE, V22, P1271, DOI 10.1016/j.joca.2014.07.001; Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197; Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3; Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030; Prabu P, 2008, MACROMOL RES, V16, P303, DOI 10.1007/BF03218521; Quinlan E, 2017, J TISSUE ENG REGEN M, V11, P1097, DOI 10.1002/term.2013; Quinlan E, 2015, J CONTROL RELEASE, V207, P112, DOI 10.1016/j.jconrel.2015.03.028; Quinlan E, 2015, J CONTROL RELEASE, V198, P71, DOI 10.1016/j.jconrel.2014.11.021; Raftery RM, 2016, ACTA BIOMATER, V43, P160, DOI 10.1016/j.actbio.2016.07.009; Raftery RM, 2016, ADV MATER, V28, P5447, DOI 10.1002/adma.201505088; Ramburrun P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/132350; Rihn JA, 2009, SPINE J, V9, P623, DOI 10.1016/j.spinee.2009.04.004; Rose JB, 2014, MATERIALS, V7, P3106, DOI 10.3390/ma7043106; Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X; Rutz AL, 2015, ADV MATER, V27, P1607, DOI 10.1002/adma.201405076; Ryan AJ, 2015, BIOMATERIALS, V73, P296, DOI 10.1016/j.biomaterials.2015.09.003; Shah SR, 2013, CHINESE SCI BULL, V58, P4342, DOI 10.1007/s11434-013-5780-8; Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/ten.2004.10.1510; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283; Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017; Sridharan R, 2015, MATER TODAY, V18, P313, DOI 10.1016/j.mattod.2015.01.019; Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048; Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481; Sun LP, 2015, CHEMBIOCHEM, V16, P1415, DOI 10.1002/cbic.201500205; Tan A, 2016, BIOMATER SCI-UK, V4, P1503, DOI 10.1039/c6bm00340k; Tani A, 2012, ANN OTO RHINOL LARYN, V121, P261, DOI 10.1177/000348941212100412; Tannoury CA, 2014, SPINE J, V14, P552, DOI 10.1016/j.spinee.2013.08.060; Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007; Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207; Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006; Tsaryk R, 2015, ACTA BIOMATER, V20, P10, DOI 10.1016/j.actbio.2015.03.041; Vasconcelos DP, 2015, BIOMATERIALS, V37, P116, DOI 10.1016/j.biomaterials.2014.10.035; Vavken J, 2016, EUR SPINE J, V25, P3979, DOI 10.1007/s00586-015-3870-9; Veiga AS, 2013, BIOPOLYMERS, V100, P637, DOI 10.1002/bip.22412; Veves A, 2002, ARCH SURG-CHICAGO, V137, P822, DOI 10.1001/archsurg.137.7.822; Vivian H. M. M., 2016, BIOFABRICATION, V8; Vrana NE, 2008, INVEST OPHTH VIS SCI, V49, P5325, DOI 10.1167/iovs.07-1599; Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06; WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815; WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108; Woo EJ, 2012, SPINE J, V12, P894, DOI 10.1016/j.spinee.2012.09.052; Wu ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24474; Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035; Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004; YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933; Yeo M, 2016, BIOMACROMOLECULES, V17, P1365, DOI 10.1021/acs.biomac.5b01764; Yeo M, 2011, BIOMACROMOLECULES, V12, P502, DOI 10.1021/bm1013052; Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009	141	20	20	0	3	WOODHEAD PUBL LTD	CAMBRIDGE	ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND	2049-9485		978-0-08-100852-2; 978-0-08-100803-4	WOODH PUBL SER BIOM			2018							127	150		10.1016/B978-0-08-100803-4.00005-X			24	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Materials Science, Biomaterials	Cell Biology; Biotechnology & Applied Microbiology; Materials Science	BJ0IY	WOS:000416869700006					2021-06-18	
J	Wright, DK; O'Brien, TJ; Mychasiuk, R; Shultz, SR				Wright, David K.; O'Brien, Terence J.; Mychasiuk, Richelle; Shultz, Sandy R.			Telomere length and advanced diffusion MRI as biomarkers for repetitive mild traumatic brain injury in adolescent rats	NEUROIMAGE-CLINICAL			English	Article						Biomarker; Concussion; Track weighted imaging; Animal model; Diffusion tensor imaging; MRI	TENSOR IMAGING FINDINGS; WHITE-MATTER; OXIDATIVE STRESS; REDUCES NEUROINFLAMMATION; HYPERPHOSPHORYLATED TAU; PROFESSIONAL FOOTBALL; REPEATED CONCUSSION; SODIUM SELENATE; GENE-EXPRESSION; ANIMAL-MODEL	Mild traumatic brain injuries (mTBI) are of worldwide concern in adolescents of both sexes, and repeated mTBI (RmTBI) may have serious long-term neurological consequences. As such, the study of RmTBI and discovery of objective biomarkers that can help guide medical decisions is an important undertaking. Diffusion-weighted MRI (DWI), which provides markers of axonal injury, and telomere length (TL) are two clinically relevant biomarkers that have been implicated in a number of neurological conditions, and may also be affected by RmTBI. Therefore, this study utilized the lateral impact injury model of RmTBI to investigate changes in diffusion MRI and TL, and how these changes relate to each other. Adolescent male and female rats received either three mTBIs or three sham injuries. The first injury was given on postnatal day 30 (P30), with the repeated injuries separated by four days each. Seven days after the final injury, a sample of ear tissue was collected for TL analysis. Rats were then euthanized and whole brains were collected and fixated for MRI analyses that included diffusion and high-resolution structural sequences. Compared to the sham-injured group, RmTBI rats had significantly shorter TL at seven days post-injury. Analysis of advanced DWI measures found that RmTBI rats had abnormalities in the corpus callosum and cortex at seven days post-injury. Notably, many of the DWI changes were correlated with TL. These findings demonstrate that TL and DWI measurements are changed by RmTBI and may represent clinically applicable biomarkers for this.	[Wright, David K.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Wright, David K.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Wright, David K.; O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia; [O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada	Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Alfred Ctr, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	sandy.shultz@monash.edu		O'Brien, Terence/0000-0002-7198-8621	Alberta Children's Hospital Foundation; Integrated Concussion Research Program; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1087172]	The authors thank the Alberta Children's Hospital Foundation, the Integrated Concussion Research Program and the National Health and Medical Research Council (1087172) for funding. We acknowledge the animal MRI facility at the Florey Institute of Neuroscience and Mental Health, a node of the National Imaging Facility.	Abdullah AI, 2012, MOL NEUROBIOL, V45, P586, DOI 10.1007/s12035-012-8277-6; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Back SA, 2011, ANN NEUROL, V70, P465, DOI 10.1002/ana.22484; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2004, CARCINOGENESIS, V25, P1083, DOI 10.1093/carcin/bgh185; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calamante F, 2012, NEUROIMAGE, V59, P2494, DOI 10.1016/j.neuroimage.2011.08.099; Cardenas AM, 2017, NEUROIMAGE-CLIN, V15, P200, DOI 10.1016/j.nicl.2017.04.024; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Demerath EW, 2004, HUM BIOL, V76, P127, DOI 10.1353/hub.2004.0018; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Eitan E, 2014, TRENDS NEUROSCI, V37, P256, DOI 10.1016/j.tins.2014.02.010; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Gilley D, 2008, MECH AGEING DEV, V129, P27, DOI 10.1016/j.mad.2007.10.010; Guan JZ, 2008, J GERONTOL A-BIOL, V63, P467, DOI 10.1093/gerona/63.5.467; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Holland, 2016, ADV PRECIS MED, V1, P66, DOI [10.18063/APM.2016.01.007, DOI 10.18063/APM.2016.01.007]; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Klapper W, 2001, MECH AGEING DEV, V122, P695, DOI 10.1016/S0047-6374(01)00223-8; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Pannek K, 2011, NEUROIMAGE, V55, P133, DOI 10.1016/j.neuroimage.2010.12.010; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Price LH, 2013, BIOL PSYCHIAT, V73, P15, DOI 10.1016/j.biopsych.2012.06.025; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Raffelt D, 2011, NEUROIMAGE, V56, P1171, DOI 10.1016/j.neuroimage.2011.02.014; Schallert T., 2002, PHARM CEREBRAL ISCHE, P201; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Willats L, 2014, NEUROIMAGE, V87, P18, DOI 10.1016/j.neuroimage.2013.11.016; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Yamakawa GR, 2017, EXP NEUROL, V295, P55, DOI 10.1016/j.expneurol.2017.06.001; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang B, 2010, J NEUROSCI RES, V88, P2859, DOI 10.1002/jnr.22450	78	20	20	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	18						315	324		10.1016/j.nicl.2018.01.033			10	Neuroimaging	Neurosciences & Neurology	GH1NG	WOS:000433169000031	29876252	DOAJ Gold, Green Published			2021-06-18	
J	Black, AM; Hagel, BE; Palacios-Derflingher, L; Schneider, KJ; Emery, CA				Black, Amanda M.; Hagel, Brent E.; Palacios-Derflingher, Luz; Schneider, Kathryn J.; Emery, Carolyn A.			The risk of injury associated with body checking among Pee Wee ice hockey players: an evaluation of Hockey Canada's national body checking policy change	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							4TH INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; NOVEMBER 2012; SPORT HELD; CONCUSSION; ZURICH; EPIDEMIOLOGY; REDUCTION	Background In 2013, Hockey Canada introduced an evidence-informed policy change delaying the earliest age of introduction to body checking in ice hockey until Bantam (ages 13-14) nationwide. Objective To determine if the risk of injury, including concussions, changes for Pee Wee (11-12 years) ice hockey players in the season following a national policy change disallowing body checking. Methods In a historical cohort study, Pee Wee players were recruited from teams in all divisions of play in 2011-2012 prior to the rule change and in 2013-2014 following the change. Baseline information, injury and exposure data for both cohorts were collected using validated injury surveillance. Results Pee Wee players were recruited from 59 teams in Calgary, Alberta (n=883) in 2011-2012 and from 73 teams in 2013-2014 (n=618). There were 163 game-related injuries (incidence rate (IR)=4.37/1000 game-hours) and 104 concussions (IR=2.79/1000 game-hours) in Alberta prior to the rule change, and 48 injuries (IR=2.16/1000 game-hours) and 25 concussions (IR=1.12/1000 game-hours) after the rule change. Based on multivariable Poisson regression with exposure hours as an offset, the adjusted incidence rate ratio associated with the national policy change disallowing body checking was 0.50 for all game-related injuries (95% CI 0.33 to 0.75) and 0.36 for concussion specifically (95% CI 0.22 to 0.58). Conclusions Introduction of the 2013 national body checking policy change disallowing body checking in Pee Wee resulted in a 50% relative reduction in injury rate and a 64% reduction in concussion rate in 11-year-old and 12-year-old hockey players in Alberta.	[Black, Amanda M.; Hagel, Brent E.; Palacios-Derflingher, Luz; Schneider, Kathryn J.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Black, Amanda M.; Schneider, Kathryn J.; Emery, Carolyn A.] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB, Canada; [Black, Amanda M.; Hagel, Brent E.; Schneider, Kathryn J.; Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Res Inst, Alberta Childrens Hosp, Calgary, AB, Canada; [Hagel, Brent E.; Emery, Carolyn A.] Univ Calgary, OBrien Inst Publ Hlth, Cumming Sch Med, Calgary, AB, Canada; [Hagel, Brent E.; Palacios-Derflingher, Luz; Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Community Hlth Sci, Calgary, AB, Canada; [Hagel, Brent E.; Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada	Black, AM (corresponding author), Fac Kinesiol, Sport Injury Res Prevent Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	ablack@ucalgary.ca	Black, Amanda/O-7675-2017; Hagel, Brent/AAK-3319-2020; Emery, Carolyn/AAI-2761-2020	Black, Amanda/0000-0001-5668-9706; Schneider, Kathryn/0000-0002-5951-5899	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Alberta Children's Hospital Research Institute; Alberta Innovates Health Solutions; Hotchkiss Brain Institute Dr T Chen Fong Doctoral Scholarship in Neuroscience; Alberta Children's Hospital Foundation Chair in Pediatric Rehabilitation; International Olympic Committee; Alberta Innovates [201201160] Funding Source: researchfish	This study was funded by the Canadian Institutes of Health Research (CIHR), Alberta Children's Hospital Research Institute and a grant from Alberta Innovates Health Solutions. AMB is supported by the Hotchkiss Brain Institute Dr T Chen Fong Doctoral Scholarship in Neuroscience. CAE is supported by an Alberta Children's Hospital Foundation Chair in Pediatric Rehabilitation. The University of Calgary Sport Injury Prevention Research Centre is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee. The role of the sponsors and funding bodies was to provide financial support for this research and the translation of the findings to all community partners.	Annual Report 2015-2016, 2016, ANN REP 2015 2016; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Emery CA, 2009, CLIN J SPORT MED, V19, P207, DOI 10.1097/JSM.0b013e31819d658e; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Hockey Canada, 2012, ANN REP 2012; Hockey Canada, 2013, ANN REP 2013; Hockey Canada, 2015, 2014 15 ANN REP; Hockey Canada, 2014, REF CAS BOOK RUL COM; International Ice Hockey Federation, 2013, NEWS ARCH; Juhn MS, 2002, CLIN J SPORT MED, V12, P46, DOI 10.1097/00042752-200201000-00014; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Matic GT, 2015, PHYSICIAN SPORTSMED, V43, P119, DOI 10.1080/00913847.2015.1035210; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI 10.1016/j.jocn.2009.02.002; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckay CD, 2014, CAN J PUBLIC HEALTH, V105, pE445, DOI 10.17269/cjph.105.4653; Meeuwisse WH, 1998, CLIN J SPORT MED, V8, P164, DOI 10.1097/00042752-199807000-00003; Richmond SA, 2014, BRIT J SPORT MED, V48, P941, DOI 10.1136/bjsports-2012-091921; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Slutzky CB, 2009, PSYCHOL SPORT EXERC, V10, P381, DOI 10.1016/j.psychsport.2008.09.006; StataCorp, 2015, STAT STAT SOFTW REL; USA Hockey, 2015, MEMB STAT; Zullig KJ, 2011, APPL RES QUAL LIFE, V6, P277, DOI 10.1007/s11482-010-9129-z	30	20	20	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	DEC	2017	51	24					1767	+		10.1136/bjsports-2016-097392			7	Sport Sciences	Sport Sciences	FN6SI	WOS:000416145900013	28279963				2021-06-18	
J	Davis-Hayes, C; Gossett, JD; Levine, WN; Shams, T; Harada, J; Mitnick, J; Noble, J				Davis-Hayes, Cecilia; Gossett, James D.; Levine, William N.; Shams, Tanzid; Harada, Jumpei; Mitnick, Jeremy; Noble, James			Sex-specific Outcomes and Predictors of Concussion Recovery	JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS			English	Article							SPORT-RELATED CONCUSSION; STATES HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; CONSENSUS STATEMENT; SYMPTOM RESOLUTION; PROLONGED RECOVERY; FOOTBALL PLAYERS; COLLEGIATE; EPIDEMIOLOGY	Introduction: Sports-related concussion (SRC) is a substantial concern in collegiate athletics. Some studies of SRC that make comparisons by sex are limited by sample size, follow-up duration, or referral bias. Sex-specific predictors of occurrence and recovery are uncertain. Methods: A 15-year retrospective cohort study identified 1,200 Columbia University varsity athletes (822 male [68.5%], 378 female [31.5%]) at risk of collegiate SRC. Results: A total of 228 athletes experienced at least one collegiate concussion, including 88 female athletes (23.3% of female athletes) and 140 male athletes (17.0% of male athletes) (P = 0.01); follow-up data were available on 97.8% of these athletes. Postconcussion symptoms were similar by sex, with the exception of sleep disturbance (29.3% of male athletes versus 42.0% of female athletes; P = 0.048) and memory impairment (43.6% of male athletes versus 30.7% of female athletes; P = 0.052), although the latter difference was not statistically significant. Risk factors for collegiate concussion included female sex (odds ratio [OR], 1.5; 95% confidence interval [CI], 1.1 to 2.0) or precollegiate concussion (OR, 2.9; 95% CI, 2.2 to 3.9). Prolonged recovery was predicted by the presence of eight or more postconcussion symptoms for all athletes (OR, 3.77; 95% CI, 1.68 to 8.46) and for female athletes only (OR, 8.24; 95% CI, 1.58 to 43.0); this finding was not statistically significant for male athletes. Discussion: Female athletes were more likely than male athletes to experience concussion. Increasing numbers of prior concussions predicted recurrence. Although most postconcussion symptoms were highly intercorrelated, the total number of symptoms predicted a prolonged recovery period. Conclusion: This study confirms sex-based differences in SRCs. Longitudinal studies of collegiate cohorts should attempt to limit follow-up bias and offer opportunities to clarify determinants of SRC.	[Davis-Hayes, Cecilia] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; [Gossett, James D.; Harada, Jumpei] Columbia Univ, Columbia Athlet, New York, NY USA; [Levine, William N.] Columbia Univ, Dept Orthopaed, New York, NY USA; [Noble, James] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Dept Neurol, New York, NY USA; [Noble, James] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Shams, Tanzid] East Tennessee State Univ, Quillen Coll Med, Dept Neurol, Johnson City, TN 37614 USA; [Mitnick, Jeremy] Univ Michigan, Dept Neurosci, Ann Arbor, MI 48109 USA	Davis-Hayes, C (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA.		Noble, James/AAA-4218-2020	Noble, James/0000-0003-0648-6702			[Anonymous], EST PROB COMP COLL A; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Erlanger DM, 2002, J HEAD TRAUMA REHAB, V17, P458, DOI 10.1097/00001199-200210000-00007; ERLANGER DM, 2002, HEADMINDER CONCUSSIO; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 1997, NEUROLOGY, V48, P581; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI 10.1016/j.jocn.2009.02.002; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; National Collegiate Athletic Association, STUD ATHL PART 1981; National Collegiate Athletic Association, 2013, 2013 2014 SPORTS MED; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Shams T, 2013, AM NEUR ASS 2013 ANN; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537	42	20	20	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1067-151X	1940-5480		J AM ACAD ORTHOP SUR	J. Am. Acad. Orthop. Surg.	DEC	2017	25	12					818	828		10.5435/JAAOS-D-17-00276			11	Orthopedics; Surgery	Orthopedics; Surgery	FS5EM	WOS:000419816400008	29176505				2021-06-18	
J	Won, SY; Dubinski, D; Brawanski, N; Strzelczyk, A; Seifert, V; Freiman, TM; Konczalla, J				Won, Sae-Yeon; Dubinski, Daniel; Brawanski, Nina; Strzelczyk, Adam; Seifert, Volker; Freiman, Thomas M.; Konczalla, Juergen			Significant increase in acute subdural hematoma in octo- and nonagenarians: surgical treatment, functional outcome, and predictors in this patient cohort	NEUROSURGICAL FOCUS			English	Article						acute subdural hematoma; elderly patient; octogenarian; nonagenarian; surgical treatment; functional outcome; predictor	TRAUMATIC BRAIN-INJURY; ELDERLY-PATIENTS; CLINICAL ARTICLE; ADULT PATIENTS; RISK-FACTORS; AGE; MORTALITY; SEIZURES; EVACUATION; DISCHARGE	OBJECTIVE Acute subdural hematoma (aSDH) is a common disease increasing in prevalence given the demographic growth of the aging population. Yet, the benefit of surgical treatment for aSDH and the subsequent functional outcome in elderly patients (age = 80 years) remain unclear. Therefore, the aims of this study were to evaluate the incidence of aSDH in patients 80 years or older, determine overall functional outcome, identify predictors of an unfavorable or favorable outcome, and establish specific risk factors for seizures. METHODS The authors retrospectively analyzed patients 80 years and older who presented with isolated aSDH in the past 10 years at their institution. The following parameters were assessed: baseline characteristics, clinical status on admission and 24 hours after surgery, and clinical course. Functional outcome was assessed at discharge and the 3-month follow-up (FU). RESULTS In the period from January 2007 to December 2016, 165 patients with aSDH were admitted to the authors' institution. Sixty-eight patients (41.2%) were 80 years old or older, and the mean age overall was 85 years (range 80-96 years). The incidence of aSDH in the elderly had significantly increased over past decade, with more than 50% of patients admitted to our institution for aSDH now being 80 years or older. The overall mortality rate was 28% at discharge and 48% at the FU. Independent predictors of an unfavorable outcome at discharge were a GCS score = 8 at 24 hours after operation (p < 0.001) and pneumonia (p < 0.02). At the FU, a GCS score = 8 at 24 hours after operation (p < 0.001) and cumulative comorbidities (= 5; p < 0.05) were significant independent predictors. All patients with more than 6 comorbidities had died by the FU. Surgical treatment in comatose compared to noncomatose patients had statistically significant, higher mortality rates at discharge and the FU. Still, 23% of the comatose patients and more than 50% of the noncomatose patients had a favorable outcome at the FU (p = 0.06). CONCLUSIONS The number of octo-and nonagenarians with aSDH significantly increased over the last decade. These patients can achieve a favorable outcome, especially those with a noncomatose status and fewer than 5 comorbidities. Surgical and nonsurgical treatment of octo-and nonagenarians during and after discharge should be optimized to increase clinical improvement.	[Won, Sae-Yeon; Dubinski, Daniel; Brawanski, Nina; Seifert, Volker; Freiman, Thomas M.; Konczalla, Juergen] Goethe Univ, Univ Hosp, Dept Neurosurg, Frankfurt, Germany; [Strzelczyk, Adam] Goethe Univ, Univ Hosp, Dept Neurol, Frankfurt, Germany; [Strzelczyk, Adam] Goethe Univ, Univ Hosp, Epilepsy Ctr Frankfurt Rhine Main, Frankfurt, Germany	Won, SY (corresponding author), Goethe Univ, Dept Neurosurg, 2-16 Schleusenweg, D-60528 Frankfurt, Hessen, Germany.	sae-yeon.won@kgu.de	Won, Sae-Yeon/AAK-3408-2020; Dubinski, Daniel/AAH-2910-2021; Brawanski, Nina/AAL-7455-2020; Konczalla, Juergen/AAJ-8528-2021	Dubinski, Daniel/0000-0001-5568-8429; Brawanski, Nina/0000-0003-1502-4980; Konczalla, Juergen/0000-0001-9771-7806; Strzelczyk, Adam/0000-0001-6288-9915			Busl KM, 2013, J NEUROSURG, V119, P1296, DOI 10.3171/2013.4.JNS122236; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; de Rooij SE, 2005, CRIT CARE, V9, pR307, DOI 10.1186/cc3536; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Hamed M, 2016, WORLD NEUROSURG, V94, P501, DOI 10.1016/j.wneu.2016.07.061; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; JENNETT B, 1975, J NEUROL NEUROSUR PS, V38, P378, DOI 10.1136/jnnp.38.4.378; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Khajavikhan J, 2016, J CLIN DIAGN RES, V10, pPC16, DOI 10.7860/JCDR/2016/16390.7294; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Leung GKK, 2012, INJURY, V43, P1419, DOI 10.1016/j.injury.2011.03.017; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mulligan P, 2013, J NEUROSCI RURAL PRA, V4, P250, DOI 10.4103/0976-3147.118760; Okazaki T, 2016, WORLD NEUROSURG, V93, P336, DOI 10.1016/j.wneu.2016.06.070; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; Pollandt S, 2017, J CLIN NEUROPHYSIOL, V34, P55, DOI 10.1097/WNP.0000000000000311; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Seifi A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-332; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Weimer JM, 2017, NEUROCRIT CARE, V26, P70, DOI 10.1007/s12028-016-0279-1; Won SY, 2016, WORLD NEUROSURG, V88, DOI 10.1016/j.wneu.2015.12.099	29	20	21	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2017	43	5							E10	10.3171/2017.7.FOCUS17417			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FL5JE	WOS:000414270800003	29088952	Bronze			2021-06-18	
J	Giuliano, S; Talarico, S; Bruno, L; Nicoletti, FB; Ceccotti, C; Belfiore, A				Giuliano, Stefania; Talarico, Serafina; Bruno, Lucia; Nicoletti, Francesco Beniamino; Ceccotti, Claudio; Belfiore, Antonino			Growth hormone deficiency and hypopituitarism in adults after complicated mild traumatic brain injury	ENDOCRINE			English	Article						Growth hormone deficiency in adults; Hypopituitarism; Complicated mild traumatic brain injury; GHD; Cardiovascular risk	ANTERIOR-PITUITARY FUNCTION; QUALITY-OF-LIFE; GH DEFICIENCY; CARDIOVASCULAR RISK; METABOLIC SYNDROME; POSTTRAUMATIC HYPOPITUITARISM; REPLACEMENT THERAPY; LIPID PROFILE; HEAD TRAUMA; LONG-TERM	Traumatic brain injury is considered the main cause of hypopituitarism in adults, and GH deficiency appears to be the most frequent pituitary deficit. Most of the available studies have included all degrees of severity of trauma. We aimed to assess pituitary function and GH deficiency in adult patients at different time lengths after complicated mild TBI according to Glasgow Coma Scale. We also aimed to evaluate whether mild TBI patients with GH deficiency had developed alterations in the glycolipid profile. Forty-eight patients (34 men and 14 women) with complicated mild TBI were included in the study. Twenty-three patients were evaluated at 1 year (Group A) and 25 patients at 5 years or longer after the injury (Group B). All patients underwent basal hormonal evaluation for pituitary function. GH deficiency was investigated by the combined test (GH releasing hormone + arginine). The glycolipid profile was also evaluated. GH deficiency occurred in 8/23 patients (34.7 %) of Group A and in 12/25 patients (48 %) of Group B. In addition, two patients, one in each group, showed evidence of central hypothyroidism. Patients with GH deficiency, especially in Group A, presented a higher frequency of visceral adiposity and adverse metabolic profile as compared to no-GH deficiency patients. Patients examined at 1 year or several years from complicated mild TBI had a similarly high occurrence of isolated GH deficiency, which was associated with visceral adiposity and metabolic alterations. Our findings suggest that patients undergone complicated mild TBI should be evaluated for GH deficiency even after several years from trauma.	[Giuliano, Stefania; Talarico, Serafina; Bruno, Lucia; Nicoletti, Francesco Beniamino; Ceccotti, Claudio; Belfiore, Antonino] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Endocrinol, Campus Univ,Viale Europa, I-88100 Catanzaro, Italy; [Nicoletti, Francesco Beniamino; Ceccotti, Claudio] Pugliese Ciaccio Hosp, Neurosurg Unit, Catanzaro, Italy	Belfiore, A (corresponding author), Magna Graecia Univ Catanzaro, Dept Hlth Sci, Endocrinol, Campus Univ,Viale Europa, I-88100 Catanzaro, Italy.	belfiore@unicz.it	Belfiore, Antonino/B-4652-2011	Belfiore, Antonino/0000-0002-6181-4193	Associazione Italiana per la Ricerca sul Cancro (AIRC)Fondazione AIRC per la ricerca sul cancro [IG 14066/2013]; Merck-SeronoMerck & Company	This work was supported in part by grant IG 14066/2013 to AB from the Associazione Italiana per la Ricerca sul Cancro (AIRC). SG has received financial support for educational programs from Merck-Serono.	Abdu TAM, 2001, CLIN ENDOCRINOL, V55, P209, DOI 10.1046/j.1365-2265.2001.01320.x; Abs R, 2013, EUR J ENDOCRINOL, V168, P297, DOI 10.1530/EJE-12-0807; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Amato MC, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/730827; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bondanelli M, 2010, J CLIN ENDOCR METAB, V95, P4660, DOI 10.1210/jc.2010-0611; Charmandari E, 2014, LANCET, V383, P2152, DOI 10.1016/S0140-6736(13)61684-0; Chaves VE, 2013, ENDOCRINE, V44, P293, DOI 10.1007/s12020-013-9904-3; Colao A, 2002, J CLIN ENDOCR METAB, V87, P1088, DOI 10.1210/jc.87.3.1088; Corneli G, 2007, EUR J ENDOCRINOL, V157, P701, DOI 10.1530/EJE-07-0384; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Di Somma C, 2010, J ENDOCRINOL INVEST, V33, P171, DOI [10.3275/6519, 10.1007/BF03346577]; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Giovannini L, 2015, ENDOCR J, V62, P1037, DOI 10.1507/endocrj.EJ15-0337; Gola M, 2005, J CLIN ENDOCR METAB, V90, P1864, DOI 10.1210/jc.2004-0545; Gotherstrom G, 2007, J CLIN ENDOCR METAB, V92, P1442, DOI 10.1210/jc.2006-1487; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelestimur Fahrettin, 2005, Pituitary, V8, P259, DOI 10.1007/s11102-006-6051-3; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Kreber LA, 2016, J NEUROTRAUM, V33, P1607, DOI 10.1089/neu.2015.4127; Lamberts SWJ, 1998, LANCET, V352, P127; Lissett CA, 2003, CLIN ENDOCRINOL, V59, P773, DOI 10.1046/j.1365-2265.2003.01884.x; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Prodam F, 2013, GROWTH HORM IGF RES, V23, P109, DOI 10.1016/j.ghir.2013.04.001; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Rizzo M, 2007, EUR J ENDOCRINOL, V156, P361, DOI 10.1530/EJE-06-0652; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; TEASDALE G, 1974, LANCET, V2, P81; van der Klaauw AA, 2007, EUR J ENDOCRINOL, V156, P455, DOI 10.1530/EJE-06-0699; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuen KCJ, 2016, ENDOCR PRACT, V22, P1235, DOI 10.4158/EP161407.DSCR	52	20	22	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1355-008X	1559-0100		ENDOCRINE	Endocrine	OCT	2017	58	1					115	123		10.1007/s12020-016-1183-3			9	Endocrinology & Metabolism	Endocrinology & Metabolism	FI0AH	WOS:000411580300015	27878771				2021-06-18	
J	Foks, KA; Cnossen, MC; Dippel, DWJ; Maas, AIR; Menon, D; van der Naalt, J; Steyerberg, EW; Lingsma, HF; Polinder, S				Foks, Kelly A.; Cnossen, Maryse C.; Dippel, Diederik W. J.; Maas, Andrew I. R.; Menon, David; van der Naalt, Joukje; Steyerberg, Ewout W.; Lingsma, Hester F.; Polinder, Suzanne		CTR-TBI Investigators Participants	Management of Mild Traumatic Brain Injury at the Emergency Department and Hospital Admission in Europe: A Survey of 71 Neurotrauma Centers Participating in the CENTER-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						admission; emergency department; guideline; survey; traumatic brain injury	MINOR HEAD-INJURY; SCANDINAVIAN GUIDELINES; COMPUTED-TOMOGRAPHY; INITIAL MANAGEMENT; EPIDEMIOLOGY; BIOMARKERS; CONSENSUS; ADULTS; RULE	Previous studies have indicated that there is no consensus about management of mild traumatic brain injury (mTBI) at the emergency department (ED) and during hospital admission. We aim to study variability between management policies for TBI patients at the ED and at the hospital ward across Europe. Centers participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study received questionnaires about different phases of TBI care. These questionnaires included 71 questions about TBI management at the ED and at the hospital ward. We found differences in how centers defined mTBI. For example, 40 centers (59%) defined mTBI as a Glasgow Coma Scale (GCS) score between 13 and 15 and 26 (38%) defined it as a GCS score between 14 and 15. At the ED various guidelines for the use of head computed tomography (CT) in mTBI patients were used; 32 centers (49%) used national guidelines, 10 centers (15%) local guidelines, and 14 centers (21%) used no guidelines at all. Also, differences in indication for admission between centers were found. After ED discharge, 7 centers (10%) scheduled a routine follow-up appointment, whereas 38 (54%) did so only after ward admission. In conclusion, large between-center variation exists in policies for diagnostics, admission, and discharge decisions in patients with mTBI at the ED and in the hospital. Guidelines are not always operational in centers, and reported policies systematically diverge from what is recommended in those guidelines. The results of this study may be useful in the understanding of mTBI care in Europe and show the need for further studies on the effectiveness of different policies on outcome.	[Foks, Kelly A.; Cnossen, Maryse C.; Steyerberg, Ewout W.; Lingsma, Hester F.; Polinder, Suzanne] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Foks, Kelly A.; Dippel, Diederik W. J.] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Menon, David] Univ Cambridge, Div Anaesthesia, Addenbrookes Hosp, Cambridge, England; [van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	Foks, KA (corresponding author), Erasmus MC, Dept Publ Hlth Na 2424, PO 2040, NL-3000 CA Rotterdam, Netherlands.	k.foks@erasmusmc.nl	Badenes, Rafael/K-6628-2019; Dippel, Diederik/AAJ-2192-2020; Maas, Andrew IR/C-5584-2013	Badenes, Rafael/0000-0001-7017-0150; Dippel, Diederik/0000-0002-9234-3515; Maas, Andrew IR/0000-0003-1612-1264	European Commission 7th Framework program [602150]	The authors would like to thank all the CENTER-TBI participants for completing the PP questionnaires. Data used in this article were obtained in the context of the CENTER-TBI study with support of the European Commission 7th Framework program (602150).	Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; de Kruijk JR, 2001, BRAIN INJURY, V15, P117, DOI 10.1080/026990501458353; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; National Institute for Health and Clinical Excellence: Guidance, 2014, HEAD INJ TRIAG ASS I; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pulhorn H, 2016, BRIT J NEUROSURG, V30, P536, DOI 10.1080/02688697.2016.1211249; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	22	20	20	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2529	2535		10.1089/neu.2016.4919			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200005	28398105	Green Accepted			2021-06-18	
J	Karimi, SA; Hosseinmardi, N; Janahmadi, M; Sayyah, M; Hajisoltani, R				Karimi, Seyed Asaad; Hosseinmardi, Narges; Janahmadi, Mahyar; Sayyah, Mohammad; Hajisoltani, Razieh			The protective effect of hydrogen sulfide (H2S) on traumatic brain injury (TBI) induced memory deficits in rats	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Cognitive dysfunction; Learning and memory; Hydrogen sulfide	CEREBRAL ISCHEMIA/REPERFUSION INJURY; LONG-TERM POTENTIATION; CORTICAL IMPACT MODEL; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; SIGNALING MOLECULE; NEURONAL CELLS; NEURODEGENERATION; SUPPRESSION; DISRUPTION	Traumatic brain injury (TBI), as an expanding public health epidemic, is a common cause of death among youth. TBI is associated with cognitive deficits and memory impairment. Hydrogen sulfide (H2S), a novel gaseous mediator, has been recognized as an important neuromodulator and neuroprotective agent in the central nervous system. In the present study the potential neuroprotective role of sodium hydrosulfide (NaHS), an H2S donor on TBI induced memory deficit in a rat model of controlled cortical impact (CCI) injury was investigated. CCI model was used to induce TBI. Male rats were randomly assigned into the following groups: control, sham, sham treated with NaHS, TBI, and TBI treated with NaHS (3 and 5 mg/kg). NaHS was injected intraperitoneally 5 min before TBI induction. Learning and memory were assessed using Morris water maze (MWM) on days 8-12 following injury. CCI resulted in MWM deficits. Injured animals showed a slower rate of acquisition with respect to the sham-operated animals [F (1, 24) = 13.97, P < 0.01, two-way ANOVA]. NaHS improved spatial memory impairment of injured rats. Treatment with NaHS (5 mg/kg) decreased the escape latency [F (1, 24) = 7.559, P < 0.05, two-way ANOVA] and traveled distance [F (1, 12) = 6.398, P < 0.05, Two way ANOVA)]. In probe test, injured animals spent less time in target zone (P < 0.05, unpaired t-test) and NaHS did not have any effect on this parameter (p > 0.05, one way ANOVA). These findings suggest that NaHS has a neuroprotective effect on TBI-induced memory impairment in rats.	[Karimi, Seyed Asaad; Hosseinmardi, Narges; Janahmadi, Mahyar; Hajisoltani, Razieh] Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran; [Karimi, Seyed Asaad; Hosseinmardi, Narges; Janahmadi, Mahyar; Hajisoltani, Razieh] Shahid Beheshti Univ Med Sci, Sch Med, Neurophysiol Res Ctr, Tehran, Iran; [Sayyah, Mohammad] Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran	Hosseinmardi, N (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Physiol, Tehran, Iran.	nhosseinmardi@sbmu.ac.ir	Hosseinmardi, Narges/V-5835-2019; Karimi, Seyed Asaad/V-9287-2018; Sayyah, Mohammad/K-4871-2017	Hosseinmardi, Narges/0000-0003-4661-1248; Sayyah, Mohammad/0000-0003-0603-2444; hajisoltani, razieh/0000-0003-2821-4556; Karimi, Seyed Asaad/0000-0002-8663-6485	Shahid Beheshti University of Medical Sciences; Pasteur Institute, Tehran, Iran	The authors wish to express their appreciation to Dr. Hamid Gholamipour-Badie, Jafar Doost Mohammadpour and elham ghanbari for their excellent technical assistance. The research was supported in part by grants of Shahid Beheshti University of Medical Sciences and Pasteur Institute, Tehran, Iran.	Abe K, 1996, J NEUROSCI, V16, P1066; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Benetti LR, 2013, EUR J PHARMACOL, V698, P463, DOI 10.1016/j.ejphar.2012.11.025; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chai W, 2012, J SURG RES, V176, P210, DOI 10.1016/j.jss.2011.07.016; Chu QJ, 2013, J SURG RES, V183, P330, DOI 10.1016/j.jss.2012.12.003; Coronado VG, 2006, JAMA-J AM MED ASSOC, V295, P1764; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Dai H.-B., 2015, MOL NEUROBIOL, P1; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; Ganster F, 2010, CRIT CARE, V14, DOI 10.1186/cc9257; Gheibi S, 2014, J MOL NEUROSCI, V54, P264, DOI 10.1007/s12031-014-0284-9; Gong QH, 2010, PHARMACOL BIOCHEM BE, V96, P52, DOI 10.1016/j.pbb.2010.04.006; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hu LF, 2011, ANTIOXID REDOX SIGN, V15, P405, DOI 10.1089/ars.2010.3517; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Karlsson O, 2011, BEHAV BRAIN RES, V219, P310, DOI 10.1016/j.bbr.2011.01.056; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li T., 2016, BRAIN PATHOL; Li XJ, 2015, NEURAL REGEN RES, V10, P932, DOI 10.4103/1673-5374.158353; Liu YY, 2013, NEUROCHEM INT, V62, P603, DOI 10.1016/j.neuint.2012.12.010; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Lu M, 2010, NEUROSCI RES, V66, P92, DOI 10.1016/j.neures.2009.09.1713; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Luo YG, 2013, NEUROCHEM INT, V63, P826, DOI 10.1016/j.neuint.2013.06.004; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; Mohammadpour JD, 2015, PHARMACOL BIOCHEM BE, V132, P33, DOI 10.1016/j.pbb.2015.02.012; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sa T., 2019, EMERGEN MED, DOI [DOI 10.4172/2165-7548.1000229, 10.4172/2165-7548.1000229]; Shao JL, 2011, J MOL NEUROSCI, V43, P453, DOI 10.1007/s12031-010-9464-4; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Tan BH, 2010, NEUROCHEM INT, V56, P3, DOI 10.1016/j.neuint.2009.08.008; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yang Guangdong, 2011, Expert Rev Clin Pharmacol, V4, P33, DOI 10.1586/ecp.10.131; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	57	20	20	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	SEP	2017	134						177	182		10.1016/j.brainresbull.2017.07.014			6	Neurosciences	Neurosciences & Neurology	FI3HA	WOS:000411847400023	28739248				2021-06-18	
J	McDonough, A; Lee, RV; Noor, S; Lee, C; Le, T; Iorga, M; Phillips, JLH; Murphy, S; Moller, T; Weinstein, JR				McDonough, Ashley; Lee, Richard V.; Noor, Shahani; Lee, Chungeun; Le, Thu; Iorga, Michael; Phillips, Jessica L. H.; Murphy, Sean; Moller, Thomas; Weinstein, Jonathan R.			Ischemia/Reperfusion Induces Interferon-Stimulated Gene Expression in Microglia	JOURNAL OF NEUROSCIENCE			English	Article						hypoxia; interferons; ischemia; microglia; reperfusion	TOLL-LIKE RECEPTOR; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; ALPHA RECEPTOR; INFLAMMATORY RESPONSES; ARTERY OCCLUSION; NEURONAL INJURY; DOWN-REGULATION; I INTERFERONS	Innate immune signaling is important in the pathophysiology of ischemia/reperfusion (stroke)-induced injury and recovery. Several lines of evidence support a central role for microglia in these processes. Recent work has identified Toll-like receptors (TLRs) and type I interferon (IFN) signaling in both ischemia/reperfusion-induced brain injury and ischemic preconditioning-mediated neuroprotection. To determine the effects of "ischemia/reperfusion-like" conditions on microglia, we performed genomic analyses on wild-type (WT) and TLR4(-/-) cultured microglia after sequential exposure to hypoxia/hypoglycemia and normoxia/normoglycemia (H/H-N/N). We observed increased expression of type 1 IFN-stimulated genes (ISGs) as the predominant transcriptomal feature of H/H-N/N-exposed WT, but not TLR4(-/-), microglia. Microarray analysis on ex vivo sorted microglia from ipsilateral male mouse cortex after a transient in vivo ischemic pulse also demonstrated robust expression of ISGs. Type 1 IFNs, including the IFN-alpha s and IFN-beta, activate the interferon-alpha/beta receptor (IFNAR) complex. We confirmed both in vitro H/H-N/N-and in vivo ischemia/reperfusion-induced microglial ISG responses by quantitative real-time PCR and demonstrated that both were dependent on IFNAR1. We characterized the effects of hypoxia/hypoglycemia on phosphorylation of signal transducer and activator of transcription 1 (STAT1), release of type 1 IFNs, and surface expression of IFNAR1 in microglia. We demonstrated that IFN-beta induces dose-dependent secretion of ISG chemokines in cultured microglia and robust ISG expression in microglia both in vitro and in vivo. Finally, we demonstrated that the microglial ISG chemokine responses to TLR4 agonists were dependent on TLR4 and IFNAR1. Together, these data suggest novel ischemia/reperfusion-induced pathways for both TLR4-dependent and -independent, IFNAR1-dependent, type 1 IFN signaling in microglia.	[McDonough, Ashley; Lee, Richard V.; Noor, Shahani; Lee, Chungeun; Le, Thu; Iorga, Michael; Phillips, Jessica L. H.; Moller, Thomas; Weinstein, Jonathan R.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; [Murphy, Sean; Weinstein, Jonathan R.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA	Weinstein, JR (corresponding author), Univ Washington, Dept Neurol, Box 356465,1959 NE Pacific St, Seattle, WA 98195 USA.	jweinste@u.washington.edu	Moller, Thomas/W-8974-2019	Weinstein, Jonathan/0000-0001-6080-9758; McDonough, Ashley/0000-0003-3864-9449; /0000-0003-3386-8212	National Institute of Neurological Disorders and Stroke-National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS065008, NS076620, NS100245]; UW Center on Human Development and Disability; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS100245, K02NS065008, R01NS076620] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke-National Institutes of Health (Grants NS065008 and NS076620 to J.R.W. and Grant NS100245 to A.M.). We thank Anna Conti, Jamie Colman, Diana Chao, and Rona Lee for assistance with the middle cerebral artery occlusion surgery; Theo Bammler, Richard P. Beyer, and Michael Coon at the University of Washington (UW) Functional Genomics and Proteomics Core for excellent technical assistance with processing our microarrays and bioinformatics analysis; and the UW Center on Human Development and Disability for their support of our genomics work.	Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Benarroch EE, 2013, NEUROLOGY, V81, P1079, DOI 10.1212/WNL.0b013e3182a4a577; Beutner C, 2013, GLIA, V61, P1429, DOI 10.1002/glia.22524; Bhattacharya S, 2011, J BIOL CHEM, V286, P22069, DOI 10.1074/jbc.M111.238766; Brendecke SM, 2012, J LEUKOCYTE BIOL, V92, P479, DOI 10.1189/jlb.0112043; Buskiewicz IA, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf1933; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cadena-Herrera Daniela, 2015, Biotechnol Rep (Amst), V7, P9, DOI 10.1016/j.btre.2015.04.004; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chmiest D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13476; Chou SY, 2008, J NEUROSCI, V28, P3277, DOI 10.1523/JNEUROSCI.0116-08.2008; Crotti A., 2016, J NEUROINFLAMM, V44, P505; Esen N, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-10; Fitts DA, 2010, BEHAV RES METHODS, V42, P3, DOI 10.3758/BRM.42.1.3; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Gesuete R, 2014, J NEUROPATH EXP NEUR, V73, P378, DOI 10.1097/NEN.0000000000000068; Gesuete R, 2012, J NEUROCHEM, V123, P75, DOI 10.1111/j.1471-4159.2012.07946.x; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Hamner MA, 2015, J NEUROSCI, V35, P15599, DOI 10.1523/JNEUROSCI.2544-15.2015; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Holm TH, 2012, GLIA, V60, P630, DOI 10.1002/glia.22296; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Inacio AR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0427-0; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Janeway C.A., 2005, IMMUNOBIOLOGY IMMUNE, VSixth; Janova H, 2016, GLIA, V64, P635, DOI 10.1002/glia.22955; Kapil P, 2012, GLIA, V60, P1555, DOI 10.1002/glia.22375; Kariko K, 2004, J CEREBR BLOOD F MET, V24, P1288, DOI 10.1097/01.WCB.0000145666.68576.71; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2003, EMBO J, V22, P5480; Kuo P. C., 2016, J AM HEART ASS, V5; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Lin RT, 1999, MOL CELL BIOL, V19, P959; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu SM, 2006, J CEREBR BLOOD F MET, V26, P1274, DOI 10.1038/sj.jcbfm.9600277; Liu SM, 2004, J CEREBR BLOOD F MET, V24, P343, DOI 10.1097/01.WCB.0000110047.43905.01; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luu K, 2014, IMMUNOL CELL BIOL, V92, P761, DOI 10.1038/icb.2014.51; Marsh B, 2009, J NEUROSCI, V29, P9839, DOI 10.1523/JNEUROSCI.2496-09.2009; Marsh BJ, 2008, CURR OPIN PHARMACOL, V8, P8, DOI 10.1016/j.coph.2007.09.009; McDonough A, 2016, NEUROTHERAPEUTICS, V13, P748, DOI 10.1007/s13311-016-0465-z; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Mohr J, 2010, STROKE PATHOPHYSIOLO; Moller T, 2000, J NEUROCHEM, V75, P1539, DOI 10.1046/j.1471-4159.2000.0751539.x; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Owens T, 2014, GLIA, V62, P339, DOI 10.1002/glia.22608; Parajuli B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-268	64	20	20	0	5	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	AUG 23	2017	37	34					8292	8308		10.1523/JNEUROSCI.0725-17.2017			17	Neurosciences	Neurosciences & Neurology	FE5JE	WOS:000408247000022	28747383	Green Published, Bronze			2021-06-18	
J	Churchill, NW; Hutchison, MG; Di Battista, AP; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Di Battista, Alex P.; Graham, Simon J.; Schweizer, Tom A.			Strutural, Functional, and Metabolic Brain Markers Differentiate Collision versus Contact and Non-Contact Athletes	FRONTIERS IN NEUROLOGY			English	Article						concussion; subconcussive; contact sports; diffusion tensor imaging; magnetic resonance spectroscopy; functional magnetic resonance imaging	COLLEGIATE FOOTBALL PLAYERS; CHRONIC TRAUMATIC ENCEPHALOPATHY; MAGNETIC-RESONANCE-SPECTROSCOPY; SUBCONCUSSIVE HEAD TRAUMA; SPORTS-RELATED CONCUSSION; PARTIAL LEAST-SQUARES; DEFAULT-MODE NETWORK; HIGH-SCHOOL FOOTBALL; RECURRENT CONCUSSION; TEMPORAL WINDOW	There is growing concern about how participation in contact sports affects the brain. Retrospective evidence suggests that contact sports are associated with long-term negative health outcomes. However, much of the research to date has focused on former athletes with significant health problems. Less is known about the health of current athletes in contact and collision sports who have not reported significant medical issues. In this cross-sectional study, advanced magnetic resonance imaging (MRI) was used to evaluate multiple aspects of brain physiology in three groups of athletes participating in non-contact sports (N = 20), contact sports (N = 22), and collision sports (N = 23). Diffusion tensor imaging was used to assess white matter microstructure based on measures of fractional anisotropy (FA) and mean diffusivity (MD); resting-state functional MRI was used to evaluate global functional connectivity; single-voxel spectroscopy was used to compare ratios of neural metabolites, including N-acetyl aspartate (NAA), creatine (Cr), choline, and myo-inositol. Multivariate analysis revealed structural, functional, and metabolic measures that reliably differentiated between sport groups. The collision group had significantly elevated FA and reduced MD in white matter, compared to both contact and non-contact groups. In contrast, the collision group showed significant reductions in functional connectivity and the NAA/Cr metabolite ratio, relative to only the non-contact group, while the contact group overlapped with both non-contact and collision groups. For brain regions associated with contact sport participation, athletes with a history of concussion also showed greater alterations in FA and functional connectivity, indicating a potential cumulative effect of both contact exposure and concussion history on brain physiology. These findings indicate persistent differences in brain physiology for athletes participating in contact and collision sports, which should be considered in future studies of concussion and subconcussive impacts.	[Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Di Battista, Alex P.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada	Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada.; Churchill, NW (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.	nchurchill.research@gmail.com		Di Battista, Alex/0000-0002-3325-6833	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN294001-367456]; Defence Research and Development Canada (DRDC); Canadian Institutes of Military and Veterans Health (CIMVHR) [W7714-145967]; Siemens Canada, Ltd.	This work was supported by the Canadian Institutes of Health Research (CIHR) [grant number RN294001-367456], the Defence Research and Development Canada (DRDC), and the Canadian Institutes of Military and Veterans Health (CIMVHR) [grant number W7714-145967] and pilot funding from Siemens Canada, Ltd.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Breedlove KM., 2014, ATHLETIC TRAIN SPORT, V6, P119, DOI [10.3928/19425864-20140507-02, DOI 10.3928/19425864-20140507-02]; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164912; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McIntosh AR, 2004, NEUROIMAGE, V23, P764, DOI 10.1016/j.neuroimage.2004.05.018; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Weir Dr, 2009, NATL FOOTBALL LEAGUE; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	58	20	21	1	24	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 22	2017	8								390	10.3389/fneur.2017.00390			11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FE6MD	WOS:000408322700001	28878729	DOAJ Gold, Green Published			2021-06-18	
J	Zhang, DF; Xue, Q; Chen, JG; Dong, Y; Hou, LJ; Jiang, Y; Wang, JY				Zhang, Danfeng; Xue, Qiang; Chen, Jigang; Dong, Yan; Hou, Lijun; Jiang, Ying; Wang, Junyu			Decompressive craniectomy in the management of intracranial hypertension after traumatic brain injury: a systematic review and meta-analysis	SCIENTIFIC REPORTS			English	Article							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; BLOOD-FLOW; METABOLISM; DISABILITY; CHILDREN; TRIAL; ICP	We aim to perform a systematic review and meta-analysis to examine the prognostic value of decompressive craniectomy (DC) in patients with traumatic intracranial hypertension. PubMed, EMBASE, Cochrane Controlled Trials Register, Web of Science, http://clinicaltrials.gov/were searched for eligible studies. Ten studies were included in the systematic review, with four randomized controlled trials involved in the meta-analysis, where compared with medical therapies, DC could significantly reduce mortality rate [risk ratio (RR), 0.59; 95% confidence interval (CI), 0.47-0.74, P < 0.001], lower intracranial pressure (ICP) [mean difference (MD), -2.12 mmHg; 95% CI, -2.81 to -1.43, P < 0.001], decrease the length of ICU stay (MD, -4.63 days; 95% CI, -6.62 to -2.65, P < 0.001) and hospital stay (MD, -14.39 days; 95% CI, -26.00 to -2.78, P = 0.02), but increase complications rate (RR, 1.94; 95% CI, 1.31-2.87, P < 0.001). No significant difference was detected for Glasgow Outcome Scale at six months (RR, 0.85; 95% CI, 0.61-1.18, P = 0.33), while in subgroup analysis, early DC would possibly result in improved prognosis (P = 0.04). Results from observational studies supported pooled results except prolonged length of ICU and hospital stay. Conclusively, DC seemed to effectively lower ICP, reduce mortality rate but increase complications rate, while its benefit on functional outcomes was not statistically significant.	[Zhang, Danfeng; Xue, Qiang; Chen, Jigang; Dong, Yan; Hou, Lijun; Jiang, Ying; Wang, Junyu] Changzheng Hosp, Dept Neurosurg, Shanghai Neurosurg Inst, Shanghai, Peoples R China	Hou, LJ; Jiang, Y; Wang, JY (corresponding author), Changzheng Hosp, Dept Neurosurg, Shanghai Neurosurg Inst, Shanghai, Peoples R China.	smmulijunhou@163.com; yiyijijiji@gmail.com; junyuwang2016@126.com					Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS91; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Grindlinger GA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3251-9; Harscher S, 2006, ACTA NEUROCHIR, V148, P31, DOI 10.1007/s00701-005-0617-0; Higgins J. P., 2010, COCHRANE HDB SYSTEMA, V2011, pS38; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Mahmoodpoor A, 2014, NEW ENGL J MED, V371, P971, DOI 10.1056/NEJMc1407775; Marmarou A, 2005, ACT NEUR S, V95, P149; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1016/j.ijsu.2010.02.007]; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Timofeev I, 2012, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Wang R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001733	31	20	20	2	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	AUG 18	2017	7								8800	10.1038/s41598-017-08959-y			10	Multidisciplinary Sciences	Science & Technology - Other Topics	FE1LP	WOS:000407980000054	28821777	DOAJ Gold, Green Published			2021-06-18	
J	Doig, RLO; Chiha, W; Giacci, MK; Yates, NJ; Bartlett, CA; Smith, NM; Hodgetts, SI; Harvey, AR; Fitzgerald, M				Doig, Ryan L. O'Hare; Chiha, Wissam; Giacci, Marcus K.; Yates, Nathanael J.; Bartlett, Carole A.; Smith, Nicole M.; Hodgetts, Stuart I.; Harvey, Alan R.; Fitzgerald, Melinda			Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma	BMC NEUROSCIENCE			English	Article						Secondary degeneration; Neurotrauma; Traumatic injury; Ion channel inhibitor; Axonal degeneration; Node of Ranvier; Lipid peroxidation; Oligodendrocyte precursor cells; Oxidative stress	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; ACID RECEPTOR ANTAGONIST; PEROXIDATION BY-PRODUCT; OPTIC-NERVE TRANSECTION; NOGO-A EXPRESSION; OXIDATIVE STRESS; WHITE-MATTER; LIPID-PEROXIDATION; ALZHEIMERS-DISEASE	Background: Following partial injury to the central nervous system, cells beyond the initial injury site undergo secondary degeneration, exacerbating loss of neurons, compact myelin and function. Changes in Ca2+ flux are associated with metabolic and structural changes, but it is not yet clear how flux through specific ion channels contributes to the various pathologies. Here, partial optic nerve transection in adult female rats was used to model secondary degeneration. Treatment with combinations of three ion channel inhibitors was used as a tool to investigate which elements of oxidative and structural damage related to long term functional outcomes. The inhibitors employed were the voltage gated Ca2+ channel inhibitor Lomerizine (Lom), the Ca2+ permeable AMPA receptor inhibitor YM872 and the P2X(7) receptor inhibitor oxATP. Results: Following partial optic nerve transection, hyper-phosphorylation of Tau and acetylated tubulin immunoreactivity were increased, and Nogo-A immunoreactivity was decreased, indicating that axonal changes occurred acutely. All combinations of ion channel inhibitors reduced hyper-phosphorylation of Tau and increased Nogo-A immunoreactivity at day 3 after injury. However, only Lom/oxATP or all three inhibitors in combination significantly reduced acetylated tubulin immunoreactivity. Most combinations of ion channel inhibitors were effective in restoring the lengths of the paranode and the paranodal gap, indicative of the length of the node of Ranvier, following injury. However, only all three inhibitors in combination restored to normal Ankyrin G length at the node of Ranvier. Similarly, HNE immunoreactivity and loss of oligodendrocyte precursor cells were only limited by treatment with all three ion channel inhibitors in combination. Conclusions: Data indicate that inhibiting any of a range of ion channels preserves certain elements of axon and node structure and limits some oxidative damage following injury, whereas ionic flux through all three channels must be inhibited to prevent lipid peroxidation and preserve Ankyrin G distribution and OPCs.	[Doig, Ryan L. O'Hare; Chiha, Wissam; Giacci, Marcus K.; Yates, Nathanael J.; Bartlett, Carole A.; Smith, Nicole M.; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia; [Doig, Ryan L. O'Hare; Chiha, Wissam; Hodgetts, Stuart I.; Harvey, Alan R.] Univ Western Australia, Sch Human Sci, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia; [Smith, Nicole M.] Univ Western Australia, Sch Chem & Biochem, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia; [Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Hodgetts, Stuart I.; Harvey, Alan R.; Fitzgerald, Melinda] Perron Inst Neurol & Translat Sci, Verdun St, Nedlands, WA 6009, Australia	Fitzgerald, M (corresponding author), Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Crawley, WA 6009, Australia.; Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia.; Fitzgerald, M (corresponding author), Perron Inst Neurol & Translat Sci, Verdun St, Nedlands, WA 6009, Australia.	lindy.fitzgerald@curtin.edu.au	Smith, Nicole/L-2502-2013; Yates, Nathanael J/K-8358-2018; Doig, Ryan O'Hare/AAG-7585-2019; Fitzgerald, Melinda/C-4235-2011	Smith, Nicole/0000-0002-5519-8152; Yates, Nathanael J/0000-0003-2742-6952; Fitzgerald, Melinda/0000-0002-4823-8179; Hodgetts, Stuart/0000-0002-3318-0410; Giacci, Marcus/0000-0002-8330-678X; , Alan/0000-0002-2590-831X	National Health and Medical Research Council (NHMRC), AustraliaNational Health and Medical Research Council of Australia [APP1061791]; NHMRC Career Development FellowshipNational Health and Medical Research Council of Australia [APP1087114]	We acknowledge financial support from the National Health and Medical Research Council (NHMRC), Australia (APP1061791). MF is supported by an NHMRC Career Development Fellowship (APP1087114). The funding body had no role in the design of the study, collection, analysis, and interpretation of data or in writing the manuscript.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Agrawal SK, 1996, J NEUROSCI, V16, P545; Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; Allred RP, 2010, BEHAV NEUROSCI, V124, P124, DOI 10.1037/a0018457; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Arancibia-Carcamo IL, 2014, ACTA NEUROPATHOL, V128, P161, DOI 10.1007/s00401-014-1305-z; Back SA, 1998, J NEUROSCI, V18, P6241; Bartholdi D, 1998, GLIA, V23, P278, DOI 10.1002/(SICI)1098-1136(199807)23:3<278::AID-GLIA10>3.0.CO;2-Q; Blanc EM, 1998, GLIA, V22, P149, DOI 10.1002/(SICI)1098-1136(199802)22:2<149::AID-GLIA6>3.0.CO;2-2; Bodhinathan K, 2010, J NEUROPHYSIOL, V104, P2586, DOI 10.1152/jn.00577.2010; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Butt AM, 2004, EYE, V18, P1110, DOI 10.1038/sj.eye.6701595; Cheatwood JL, 2008, STROKE, V39, P2091, DOI 10.1161/STROKEAHA.107.507426; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Choudhary S, 2006, BASIC CLIN PHARMACOL, V98, P447, DOI 10.1111/j.1742-7843.2006.pto_270.x; Chouliaras L, 2013, NEUROBIOL AGING, V34, P2091, DOI 10.1016/j.neurobiolaging.2013.02.021; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Doig RLO, 2016, NEUROSCIENCE, V339, P450, DOI 10.1016/j.neuroscience.2016.10.005; Doig RLO, 2015, DISCOV MED, V19, P41; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; FEHLINGS MG, 1989, J NEUROSURG, V71, P403, DOI 10.3171/jns.1989.71.3.0403; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Fortune B, 2004, INVEST OPHTH VIS SCI, V45, P1854, DOI 10.1167/iovs.03-1411; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gard AL, 2001, MICROSC RES TECHNIQ, V52, P709, DOI 10.1002/jemt.1055; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Hartigan JA, 1999, J BIOL CHEM, V274, P21395, DOI 10.1074/jbc.274.30.21395; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Huber AB, 2002, J NEUROSCI, V22, P3553; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Klein KU, 2010, BEST PRACT RES-CLIN, V24, P535, DOI 10.1016/j.bpa.2010.10.008; Kozlowski P, 2008, J NEUROTRAUM, V25, P653, DOI 10.1089/neu.2007.0462; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Limbrick DD, 2003, CELL CALCIUM, V33, P69, DOI 10.1016/S0143-4160(02)00054-4; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Lozic I, 2014, METALLOMICS, V6, P455, DOI 10.1039/c3mt00336a; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Mattson MP, 1997, NEUROREPORT, V8, P2275, DOI 10.1097/00001756-199707070-00036; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McCracken E, 2000, J CEREBR BLOOD F MET, V20, P1529, DOI 10.1097/00004647-200011000-00002; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Merrick SE, 1996, J BIOL CHEM, V271, P5589, DOI 10.1074/jbc.271.10.5589; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Montine TJ, 1996, AM J PATHOL, V148, P89; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; Neumann B, 2014, CELL REP, V6, P93, DOI 10.1016/j.celrep.2013.12.004; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Pandey K, 2011, J MOL NEUROSCI, V45, P1, DOI 10.1007/s12031-011-9506-6; Paschen W, 2001, CELL CALCIUM, V29, P1, DOI 10.1054/ceca.2000.0162; Payne SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065710; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Picklo MJ, 1999, J NEUROCHEM, V72, P1617, DOI 10.1046/j.1471-4159.1999.721617.x; Popko B, 2000, GLIA, V29, P149, DOI 10.1002/(SICI)1098-1136(20000115)29:2<149::AID-GLIA8>3.0.CO;2-4; Ritter J, 2013, J NEUROSCI, V33, P8990, DOI 10.1523/JNEUROSCI.5528-12.2013; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Siems WG, 1996, FREE RADICAL BIO MED, V20, P215, DOI 10.1016/0891-5849(95)02041-1; Stirling DP, 2014, ANN NEUROL, V75, P220, DOI 10.1002/ana.24099; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Takahashi M, 1998, J PHARMACOL EXP THER, V287, P559; Takahashi M, 2002, CNS DRUG REV, V8, P337; Tamaki Y, 2003, INVEST OPHTH VIS SCI, V44, P4864, DOI 10.1167/iovs.02-1173; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tymianski M, 1996, NEUROSURGERY, V38, P1176; VONBLANKENFELD G, 1993, GLIA, V7, P322, DOI 10.1002/glia.440070407; Wang JW, 2015, NEURAL REGEN RES, V10, P225, DOI 10.4103/1673-5374.152375; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Woolf CJ, 2003, NEURON, V38, P153, DOI 10.1016/S0896-6273(03)00233-2; Yu W, 2016, J NEUROSCI, V36, P11084, DOI 10.1523/JNEUROSCI.2273-16.2016; Zhang ZS, 2016, J PHYSIOL-LONDON, V594, P39, DOI 10.1113/JP271207	92	20	21	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	AUG 14	2017	18								62	10.1186/s12868-017-0380-1			16	Neurosciences	Neurosciences & Neurology	FD5PC	WOS:000407581300001	28806920	DOAJ Gold, Green Published			2021-06-18	
J	Carlozzi, NE; Goodnight, S; Casaletto, KB; Goldsmith, A; Heaton, RK; Wong, AWK; Baum, CM; Gershon, R; Heinemann, AW; Tulsky, DS				Carlozzi, N. E.; Goodnight, S.; Casaletto, K. B.; Goldsmith, A.; Heaton, R. K.; Wong, A. W. K.; Baum, C. M.; Gershon, R.; Heinemann, A. W.; Tulsky, D. S.			Validation of the NIH Toolbox in Individuals with Neurologic Disorders	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Cognition; Emotion; Motor; Sensory; NIHTB; Disability; Spinal cord injury; Traumatic brain injury; Stroke; Assessment; Outcomes assessment (health care)	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; MEASURING EPISODIC MEMORY; OF-THE-LITERATURE; COGNITION BATTERY; HEAD-INJURY; PROCESSING SPEED; EXECUTIVE FUNCTION; STROKE PATIENTS; DEPRESSIVE SYMPTOMS	Objective: Individuals with spinal cord injury (SCI), traumatic brain injury (TBI), and stroke experience a variety of neurologically related deficits across multiple domains of function. The NIH Toolbox for the Assessment of Neurological and Behavioral Function (NIHTB) examines motor, sensation, cognition, and emotional functioning. The purpose of this paper is to establish the validity of the NIHTB in individuals with neurologic conditions. Methods: Community-dwelling individuals with SCI (n = 209), TBI (n = 184), or stroke (n = 211) completed the NIHTB. Relative risks for impaired performance were examined relative to a matched control groups. Results: The largest group differences were observed on the Motor domain and for the Fluid Cognition measures. All groups were at increased risk for motor impairment relative to normative standards and matched controls. Fluid cognitive abilities varied across groups such that individuals with stroke and TBI performed more poorly than individuals with SCI; increased relative risks for impaired fluid cognition were seen for individuals in the stroke and TBI groups, but not for those in the SCI group. All three neurologic groups performed normally on most measures in the Sensation Battery, although TBI participants evidenced increased risk for impaired odor identification and the stroke group showed more vision difficulties. On the Emotion Battery, participants in all three groups showed comparably poor psychological well-being, social satisfaction, and self-efficacy, whereas the TBI group also evidenced slightly increased negative affect. Conclusions: Data provide support for the validity of the NIHTB in individuals with neurologic conditions.	[Carlozzi, N. E.; Goodnight, S.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Casaletto, K. B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94122 USA; [Goldsmith, A.; Heinemann, A. W.] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; [Heaton, R. K.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA; [Wong, A. W. K.; Baum, C. M.] Washington Univ, Occupat Therapy, St Louis, MO 63108 USA; [Wong, A. W. K.; Baum, C. M.] Washington Univ, Dept Neurol, St Louis, MO 63108 USA; [Gershon, R.] Northwestern Univ, Dept Med Social Sci, Chicago, IL 60611 USA; [Gershon, R.] Northwestern Univ, Dept Preventat Med, Chicago, IL 60611 USA; [Heinemann, A. W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Tulsky, D. S.] Univ Delaware, Dept Phys Therapy, Ctr Assessment Res & Translat, Newark, DE 19713 USA; [Tulsky, D. S.] Kessler Fdn, W Orange, NJ 07052 USA	Carlozzi, NE (corresponding author), Dept Phys Med & Rehabil, North Campus Res Complex,Bldg 14, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Tulsky, David/0000-0002-4335-4509; Wong, Alex/0000-0002-4423-2685	NIDILRR RRTC on Improving Measurement of Medical Rehabilitation Outcomes [H133B090024]; Federal funds from the Blueprint for Neuroscience Research, National Institutes of Health [HHS-N-260-2006-00007-C]; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [F31-DA035708]; Foundation for Rehabilitation Psychology Dissertation Award; Craig H. Neilsen Foundation [290474]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U2CCA186878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062512] Funding Source: NIH RePORTER	This study was supported by the NIDILRR RRTC on Improving Measurement of Medical Rehabilitation Outcomes (Award number: H133B090024, PI: Heinemann). This project was also supported in part with Federal funds from the Blueprint for Neuroscience Research, National Institutes of Health, under Contract No. HHS-N-260-2006-00007-C. Co-Author, Kaitlin Casaletto, was supported in part by NIDA F31-DA035708 and the Foundation for Rehabilitation Psychology Dissertation Award. Co-Author, Alex Wong, was supported in part by the Craig H. Neilsen Foundation (Award number: 290474, PI: Wong).	Alschuler KN, 2013, J SPINAL CORD MED, V36, P483, DOI 10.1179/2045772312Y.0000000072; Babakhanyan I., 2016, J INT NEUROPSYCHO S1, V22, P65; Barker-Collo S, 2010, NEUROEPIDEMIOLOGY, V35, P255, DOI 10.1159/000319894; Barrett AM, 2014, CURR OPIN NEUROL, V27, P653, DOI 10.1097/WCO.0000000000000148; Bauer PJ, 2013, MONOGR SOC RES CHILD, V78, P34, DOI 10.1111/mono.12033; Beaumont JL, 2013, NEUROLOGY, V80, pS87, DOI 10.1212/WNL.0b013e3182872e70; BOTHIG S, 1989, INT J EPIDEMIOL, V18, pS29; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Burns Anthony S, 2012, Handb Clin Neurol, V109, P47, DOI 10.1016/B978-0-444-52137-8.00003-6; Carlozzi N. E., 2017, VALIDATING NIH TOOLB; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Carlozzi NE, 2013, J CLIN EXP NEUROPSYC, V35, P906, DOI 10.1080/13803395.2013.833178; Carlozzi NE, 2013, MONOGR SOC RES CHILD, V78, P88, DOI 10.1111/mono.12036; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen M. L., REHABILITAT IN PRESS; Coldwell SE, 2013, NEUROLOGY, V80, pS20, DOI 10.1212/WNL.0b013e3182872e38; Cook KF, 2013, NEUROLOGY, V80, pS49, DOI 10.1212/WNL.0b013e3182872e80; Cyranowski JM, 2013, HEALTH PSYCHOL, V32, P293, DOI 10.1037/a0028586; Dalton P, 2013, NEUROLOGY, V80, pS32, DOI 10.1212/WNL.0b013e3182872eb4; Dancause N, 2002, NEUROPSYCHOLOGIA, V40, P1313, DOI 10.1016/S0028-3932(01)00218-4; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2014, J INT NEUROPSYCH SOC, V20, P611, DOI 10.1017/S1355617714000460; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DITUNNO JF, 1992, ARCH PHYS MED REHAB, V73, P431; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Droste DW, 2014, CLIN MED INSIGHTS-CA, V8, P9, DOI 10.4137/CMC.S15225; Dudley-Javoroski S, 2006, DISABIL REHABIL, V28, P103, DOI 10.1080/09638280500163828; Dunn W, 2013, NEUROLOGY, V80, pS41, DOI 10.1212/WNL.0b013e3182872c54; Enderby P M, 1987, Int Rehabil Med, V8, P166; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Gefen A, 2014, OSTOMY WOUND MANAG, V60, P34; Gershon RC, 2014, J INT NEUROPSYCH SOC, V20, P642, DOI 10.1017/S1355617714000411; Gershon RC, 2013, MONOGR SOC RES CHILD, V78, P49, DOI 10.1111/mono.12034; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Haisma J, 2007, CLIN REHABIL, V21, P932, DOI 10.1177/0269215507079134; Heaton R. K., 2004, REV COMPREHENSIVE NO; Heaton RK, 2014, J INT NEUROPSYCH SOC, V20, P588, DOI 10.1017/S1355617714000241; Hess MJ, 2003, J SPINAL CORD MED, V26, P335, DOI 10.1080/10790268.2003.11753702; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Huang CY, 2015, SPINAL CORD, V53, P413, DOI 10.1038/sc.2014.158; Ivnik RJ, 2001, CLIN NEUROPSYCHOL, V15, P114, DOI 10.1076/clin.15.1.114.1904; Jones C, 2013, NEUROREHABILITATION, V32, P351, DOI 10.3233/NRE-130855; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P399, DOI 10.1016/S0003-9993(95)80567-2; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Krueger H, 2013, SPINAL CORD, V51, P260, DOI 10.1038/sc.2013.3; Kupst MJ, 2015, ANXIETY STRESS COPIN, V28, P531, DOI 10.1080/10615806.2014.994204; Lazzaro I, 2013, J CLIN NEUROPHYSIOL, V30, P59, DOI 10.1097/WNP.0b013e31827edb0c; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Li YQ, 2012, J REHABIL MED, V44, P534, DOI 10.2340/16501977-1005; Lightbody CE, 2007, J ADV NURS, V60, P595, DOI 10.1111/j.1365-2648.2007.04508.x; Lightbody CE, 2007, J ADV NURS, V57, P505, DOI 10.1111/j.1365-2648.2006.04135.x; Loranger M, 2000, PSYCHOL REP, V87, P893, DOI 10.2466/PR0.87.7.893-900; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Murray RF, 2007, SPINAL CORD, V45, P429, DOI 10.1038/sj.sc.3102022; Narayan R. K., 1990, REHABILITATION ADULT; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Pilkonis PA, 2013, PSYCHIAT RES, V206, P88, DOI 10.1016/j.psychres.2012.09.034; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Recio AC, 2012, J SPINAL CORD MED, V35, P58, DOI 10.1179/2045772311Y.0000000044; Reuben DB, 2013, NEUROLOGY, V80, pS65, DOI 10.1212/WNL.0b013e3182872e01; Ribaric-Jankes K, 2009, SPINAL CORD, V47, P401, DOI 10.1038/sc.2008.163; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; Rine RM, 2013, NEUROLOGY, V80, pS25, DOI 10.1212/WNL.0b013e3182872c6a; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Rothwell K, 2013, CLIN REHABIL, V27, P264, DOI 10.1177/0269215512457403; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Salsman JM, 2014, QUAL LIFE RES, V23, P205, DOI 10.1007/s11136-013-0452-3; Salsman JM, 2013, NEUROLOGY, V80, pS76, DOI 10.1212/WNL.0b013e3182872e11; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Sharma B, 2014, J REHABIL MED, V46, P370, DOI 10.2340/16501977-1261; Sigurdardottir S, 2016, NEUROPSYCHOLOGY, V30, P98, DOI 10.1037/neu0000206; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Soekadar S. R., 2014, NEUROBIOLOGY DIS; Steuer E, 2014, J NEUROTRAUM, V31, P1277, DOI 10.1089/neu.2013.3296; Su CY, 2015, ARCH CLIN NEUROPSYCH, V30, P148, DOI 10.1093/arclin/acu057; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Traumatic Brain Injury Model Systems National Data Center, 2006, TRAUM BRAIN INJ MOD; Tulsky D., 2017, VALIDATING NIH TOOLB; Tulsky DS, 2014, J INT NEUROPSYCH SOC, V20, P599, DOI 10.1017/S135561771400040X; Tulsky DS, 2013, MONOGR SOC RES CHILD, V78, P70, DOI 10.1111/mono.12035; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Varma R, 2013, NEUROLOGY, V80, pS37, DOI 10.1212/WNL.0b013e3182876e0a; Wang YC, 2011, J HAND THER, V24, P313, DOI 10.1016/j.jht.2011.05.001; Waters R L, 1998, J Spinal Cord Med, V21, P195; WATERS RL, 1993, ARCH PHYS MED REHAB, V74, P242; WATERS RL, 1992, ARCH PHYS MED REHAB, V73, P784; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P67; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Westermann A, 2012, PAIN, V153, P1537, DOI 10.1016/j.pain.2012.02.031; Whyte J, 2005, PHYS MED REHABILITAT; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; World Health Organization, 1990, WHO MONICA PROJ; Zelazo PD, 2014, J INT NEUROPSYCH SOC, V20, P620, DOI 10.1017/S1355617714000472; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032	113	20	21	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2017	32	5					555	573		10.1093/arclin/acx020			19	Psychology, Clinical; Psychology	Psychology	FC8RL	WOS:000407108500005	28334392	Green Published, Bronze			2021-06-18	
J	Anderson, V; Beauchamp, MH; Yeates, KO; Crossley, L; Ryan, N; Hearps, SJC; Catroppa, C				Anderson, Vicki; Beauchamp, Miriam H.; Yeates, Keith Owen; Crossley, Louise; Ryan, Nicholas; Hearps, Stephen J. C.; Catroppa, Cathy			Social Competence at Two Years after Childhood Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						behavior; children; recovery; social skills; traumatic brain injury	PROBLEM-SOLVING SKILLS; CLOSED-HEAD-INJURY; PSYCHOSOCIAL OUTCOMES; SELF-REGULATION; CHILDREN; ADJUSTMENT; RECOVERY; ADOLESCENTS; FRIENDSHIP; TERM	Children with traumatic brain injury (TBI) are at risk for social impairment, but research has yet to document the trajectory of these skills post-injury and factors that may predict social problems. This study addressed these gaps in knowledge, reporting on findings from a prospective, longitudinal follow-up study that investigated social outcomes post-injury and explored factors contributing to these outcomes at two years post-injury. The sample included 113 children, 74 with TBI and 39 typically developing (TD) controls. TBI participants were recruited on presentation to the hospital. Parents rated pre-injury function at that time, and all children underwent magnetic resonance imaging (MRI). Participants were followed up at two years post-injury. Outcomes were social adjustment, social participation, social relationships, and social cognition. Predictors of social outcomes examined included brain lesion characteristics, child cognition (6 months post-TBI), and behavior and environmental factors (pre-injury and two years). Reduced social adjustment (p=0.011) and social participation (p<0.001) were evident in children with TBI compared with TD controls. Poor social adjustment was predicted by externalizing behavior problems and younger age at injury. Reduced social participation was linked to internalizing behavior problems. Greater lesion volume, lower socioeconomic status, and family burden contributed to poorer social relationships, whereas age at injury predicted social cognition. Within the TBI group, 23% of children exhibited social impairments. Younger age at injury, greater pre-injury, and current behavior problems and family dysfunction, and poorer intelligence quotient (IQ), processing speed, and empathy were linked to impairment. Further follow-up is required to track social recovery and the influences of cognition, brain, and environment over time.	[Anderson, Vicki; Crossley, Louise; Ryan, Nicholas; Hearps, Stephen J. C.; Catroppa, Cathy] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Anderson, Vicki; Catroppa, Cathy] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Anderson, Vicki; Ryan, Nicholas; Catroppa, Cathy] Univ Melbourne, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] St Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Cumming Sch Med, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada	Anderson, V (corresponding author), Murdoch Childrens Res Inst, Child Neuropsychol, 4 West Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	Ryan, Nicholas/K-5445-2019; Yeates, Keith/AAJ-4223-2020; Hearps, Stephen/L-6853-2016	Ryan, Nicholas/0000-0002-0878-8889; Yeates, Keith/0000-0001-7680-2892	Victorian Neurotrauma Initiative; Victorian Government Operational Infrastructure Scheme; NHMRCNational Health and Medical Research Council of Australia	This research was supported by the Victorian Neurotrauma Initiative and the Victorian Government Operational Infrastructure Scheme. Vicki Anderson was supported by an NHMRC Senior Practitioner fellowship.	Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Ackerman BP, 2006, ADV CHILD DEV BEHAV, V34, P91, DOI 10.1016/S0065-2407(06)80005-4; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Anderson V, 2014, SOC NEUROSCI-UK, V9, P471, DOI 10.1080/17470919.2014.932308; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P341, DOI 10.1097/01.HTR.0000336850.29574.7a; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Bell HC, 2010, BEHAV BRAIN RES, V207, P7, DOI 10.1016/j.bbr.2009.09.029; Belsky J, 2011, J CHILD PSYCHOL PSYC, V52, P409, DOI 10.1111/j.1469-7610.2010.02281.x; Blakemore SJ, 2010, NEURON, V65, P744, DOI 10.1016/j.neuron.2010.03.004; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Bos KJ, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.016.2009; Bowlby J., 1962, DEPRIVATION MATERNAL; Bulotsky-Shearer RJ, 2008, DEV PSYCHOL, V44, P139, DOI 10.1037/0012-1649.44.1.139; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Burgess KB, 2006, CHILD DEV, V77, P371, DOI 10.1111/j.1467-8624.2006.00876.x; Burnett S., 2012, DEV SOCIAL NEUROSCIE, P45; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; COFFEY CE, 1991, PSYCHOPATHOLOGY BRAI; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; de la Vega A, 2016, J NEUROSCI, V36, P6553, DOI 10.1523/JNEUROSCI.4402-15.2016; Dennis M, 1998, BRAIN LANG, V61, P450, DOI 10.1006/brln.1997.1886; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dennis M., 2012, J INT NEUROPSYCH SOC, V18, P1; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Epstein N. B., 2003, NORMAL FAMILY PROCES, P581, DOI DOI 10.4324/9780203428436_CHAPTER_21; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Genc S, 2017, J NEUROTRAUM, V34, P798, DOI 10.1089/neu.2016.4584; Hanten G., 2008, NEUROIMAGE, V31, P429; Harrison P., 2003, ADAPTIVE BEHAV ASSES; Heverly-Fitt S, 2014, J INT NEUROPSYCH SOC, V20, P684, DOI 10.1017/S1355617714000393; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Jackson C, 2007, OCCUP MED-OXFORD, V57, P79, DOI 10.1093/occmed/kql169; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kaldoja ML, 2012, BRAIN INJURY, V26, P1005, DOI 10.3109/02699052.2012.660516; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Leventer RJ, 1999, NEUROLOGY, V53, P715, DOI 10.1212/WNL.53.4.715; Manly T., 1999, TEST EVERYDAY ATTENT; Masten AS, 1999, DEV PSYCHOPATHOL, V11, P143, DOI 10.1017/S0954579499001996; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Moran LM, 2015, BRAIN INJURY, V29, P1682, DOI 10.3109/02699052.2015.1075140; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Parker J. G., 1989, FRIENDSHIP QUALITY Q; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; RUBIN KH, 1995, DEV PSYCHOPATHOL, V7, P751, DOI 10.1017/S0954579400006829; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; Sullivan MC, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/657923; Tabachnick B.G., 2000, USING MULTIVARIATE S, V4th; TEASDALE G, 1974, LANCET, V2, P81; Terrell-Deutsch B., 1999, LONELINESS CHILDHOOD, P11; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; UCLA: Academic Technology Services, 2012, STAT DAT AN EX TOB A; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 1999, ANUAL WECHSLER ABBRE; Wigg E. H., 1989, TEST LANGUAGE COMPET; Woods D, 2015, SOCIAL CARE NEURODIS, V5, P70, DOI [DOI 10.1108/SCN-01-2014-0001, 10.1108/SCN-01-2014-0001]; Woods D., 2014, SOCIAL CARE NEURODIS, V5, P51, DOI [10.1108/SCN-01-2013-0002, DOI 10.1108/SCN-01-2013-0002]; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	79	20	20	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2017	34	14					2261	2271		10.1089/neu.2016.4692			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EZ8RQ	WOS:000404995000009	28177265				2021-06-18	
J	Sun, DD; Gu, G; Wang, JH; Chai, Y; Fan, YS; Yang, MC; Xu, X; Gao, WW; Li, F; Yin, DP; Zhou, S; Chen, X; Zhang, JN				Sun, Dongdong; Gu, Gang; Wang, Jianhao; Chai, Yan; Fan, Yueshan; Yang, Mengchen; Xu, Xin; Gao, Weiwei; Li, Fei; Yin, Dongpei; Zhou, Shuai; Chen, Xin; Zhang, Jianning			Administration of Tauroursodeoxycholic Acid Attenuates Early Brain Injury via Akt Pathway Activation	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						traumatic brain injury (TBI); tauroursodeoxycholic acid (TUDCA); endoplasmic reticulum stress (ER stress); apoptosis; Akt signal pathway	UNFOLDED PROTEIN RESPONSE; URSODEOXYCHOLIC ACID; SIGNALING PATHWAY; OXIDATIVE STRESS; CELL-DEATH; ER STRESS; RATS; MODEL; INHIBITION; IMPROVES	Traumatic brain injury (TBI) is one of the leading causes of trauma-induced mortality and disability, and emerging studies have shown that endoplasmic reticulum (ER) stress plays an important role in the pathophysiology of TBI. Tauroursodeoxycholic acid (TUDCA), a hydrophilic bile acid, has been reported to act as an ER stress inhibitor and chemical chaperone and to have the potential to attenuate apoptosis and inflammation. To study the effects of TUDCA on brain injury, we subjected mice to TBI with a controlled cortical impact (CCI) device. Using western blotting, we first examined TBI-induced changes in the expression levels of GRP78, an ER stress marker, p-PERK, PERK, p-eIF2a, eIF2a, ATF4, p-Akt, Akt, Pten, Bax, Bcl-2, Caspase-12 and CHOP, as well as changes in the mRNA levels of Akt, GRP78, Caspase-12 and CHOP using RT-PCR. Neuronal cell death was assessed by a terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-labeling (TUNEL) assay, and CHOP expression in neuronal cells was detected by double-immunofluorescence staining. Neurological and motor deficits were assessed by modified neurological severity scores (mNSS) and beam balance and beam walking tests, and brain water content was also assessed. Our results indicated that ER stress peaked at 72 h after TBI and that TUDCA abolished ER stress and inhibited p-PERK, p-eIF2a, ATF4, Pten, Caspase-12 and CHOP expression levels. Moreover, our results show that TUDCA also improved neurological function and alleviated brain oedema. Additionally, TUDCA increased p-Akt expression and the Bcl-2/Bax ratio. However, the administration of the Akt inhibitor MK2206 or siRNA targeting of Akt abolished the beneficial effects of TUDCA. Taken together, our results indicate that TUDCA may attenuate early brain injury via Akt pathway activation.	[Sun, Dongdong; Gu, Gang; Wang, Jianhao; Chai, Yan; Fan, Yueshan; Yang, Mengchen; Xu, Xin; Gao, Weiwei; Li, Fei; Yin, Dongpei; Zhou, Shuai; Chen, Xin; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Sun, Dongdong; Gu, Gang; Wang, Jianhao; Chai, Yan; Fan, Yueshan; Yang, Mengchen; Xu, Xin; Gao, Weiwei; Li, Fei; Yin, Dongpei; Zhou, Shuai; Chen, Xin; Zhang, Jianning] Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China	Chen, X; Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.; Chen, X; Zhang, JN (corresponding author), Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China.	xinchentianjin@me.com; jianningzhang@hotmail.com		Xu, Xin/0000-0003-3395-9923; Dongpei, Yin/0000-0003-2572-3689	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [813300151, 81501704, 81671902, 81370029]; Tianjin Research Program of Application Foundation and Advanced Technology [13JCQNJC10500, 17JCYBJC25200]	This work was supported by grants from the National Natural Science Foundation of China (grant nos. 813300151, 81501704, 81671902 and 81370029) and the Tianjin Research Program of Application Foundation and Advanced Technology (grant no. 13JCQNJC10500 and 17JCYBJC25200). We are grateful to Guoqiang Chang, Guili Yang, Weiyun Cui, Lei Zhou and Li Liu from the Tianjin Neurological Institute for providing technical support.	Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Beuers U, 1996, GASTROENTEROLOGY, V110, P1553, DOI 10.1053/gast.1996.v110.pm8613063; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Castro-Caldas M, 2012, MOL NEUROBIOL, V46, P475, DOI 10.1007/s12035-012-8295-4; Chen CH, 2009, NEUROBIOL DIS, V33, P509, DOI 10.1016/j.nbd.2008.12.010; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen X, 2010, NEUROL RES, V32, P1097, DOI 10.1179/016164110X12681290831162; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Cuello-Carrion FD, 1999, J HISTOCHEM CYTOCHEM, V47, P837, DOI 10.1177/002215549904700614; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fonseca I, 2017, MOL NEUROBIOL, V54, P6120, DOI 10.1007/s12035-016-0228-1; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Jindal A, 2017, NEUROCHEM INT, V111, P3, DOI 10.1016/j.neuint.2016.12.004; Keene CD, 2002, P NATL ACAD SCI USA, V99, P10671, DOI 10.1073/pnas.162362299; Kumar R, 2001, J NEUROCHEM, V77, P1418, DOI 10.1046/j.1471-4159.2001.00387.x; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Lim SC, 2010, INT J CANCER, V126, P1582, DOI 10.1002/ijc.24853; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Nakka VP, 2016, MOL NEUROBIOL, V53, P532, DOI 10.1007/s12035-014-9029-6; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Rodrigues CMP, 2000, J NEUROCHEM, V75, P2368, DOI 10.1046/j.1471-4159.2000.0752368.x; Rodrigues TMP, 2002, J CEREBR BLOOD F MET, V22, P463, DOI 10.1097/00004647-200204000-00010; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Seyhun E, 2011, AM J PHYSIOL-GASTR L, V301, pG773, DOI 10.1152/ajpgi.00483.2010; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Wang ZF, 2017, BIOCHEM BIOPH RES CO, V482, P948, DOI 10.1016/j.bbrc.2016.11.138; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yan F, 2017, MOL NEUROBIOL, V54, P1808, DOI 10.1007/s12035-016-9790-9; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Yanguas-Casas N, 2017, MOL NEUROBIOL, V54, P6737, DOI 10.1007/s12035-016-0142-6; Yanguas-Casas N, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-50; Zhang C, 2014, BRAIN RES, V1555, P1, DOI 10.1016/j.brainres.2014.01.051; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zhao ZL, 2016, J NEUROL SCI, V364, P12, DOI 10.1016/j.jns.2016.03.007	45	20	22	0	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JUL 6	2017	11								193	10.3389/fncel.2017.00193			13	Neurosciences	Neurosciences & Neurology	EZ9UG	WOS:000405074900001	28729823	DOAJ Gold, Green Published			2021-06-18	
J	Georgoff, PE; Nikolian, VC; Halaweish, I; Chtraklin, K; Bruhn, PJ; Eidy, H; Rasmussen, M; Li, YQ; Srinivasan, A; Alam, HB				Georgoff, Patrick E.; Nikolian, Vahagn C.; Halaweish, Ihab; Chtraklin, Kiril; Bruhn, Peter J.; Eidy, Hassan; Rasmussen, Monica; Li, Yongqing; Srinivasan, Ashok; Alam, Hasan B.			Resuscitation with Lyophilized Plasma Is Safe and Improves Neurological Recovery in a Long-Term Survival Model of Swine Subjected to Traumatic Brain Injury, Hemorrhagic Shock, and Polytrauma	JOURNAL OF NEUROTRAUMA			English	Article						fresh frozen plasma; hemorrhagic shock; lyophilized plasma; polytrauma; traumatic brain injury	FRESH-FROZEN PLASMA; LARGE ANIMAL-MODEL; FREEZE-DRIED PLASMA; DAMAGE CONTROL RESUSCITATION; RED-BLOOD-CELLS; PROVIDES NEUROPROTECTION; VALPROIC ACID; NORMAL SALINE; TRANSFUSION; COAGULOPATHY	We have shown previously that fresh frozen plasma (FFP) and lyophilized plasma (LP) decrease brain lesion size and improve neurological recovery in a swine model of traumatic brain injury (TBI) and hemorrhagic shock (HS). In this study, we examine whether these findings can be validated in a clinically relevant model of severe TBI, HS, and polytrauma. Female Yorkshire swine were subjected to TBI (controlled cortical impact), hemorrhage (40% volume), grade III liver and splenic injuries, rib fracture, and rectus abdominis crush. The animals were maintained in a state of shock (mean arterial pressure 30-35mm Hg) for 2 h, and then randomized to resuscitation with normal saline (NS), FFP, or LP (n = 5 swine/group). Animals were recovered and monitored for 30 d, during which time neurological recovery was assessed. Brain lesion sizes were measured via magnetic resonance imaging (MRI) on post-injury days (PID) three and 10. Animals were euthanized on PID 30. The severity of shock and response to resuscitation was similar in all groups. When compared with NS-treated animals, plasma-treated animals (FFP and LP) had significantly lower neurologic severity scores (PID 1-7) and a faster return to baseline neurological function. There was no significant difference in brain lesion sizes between groups. LP treatment was well tolerated and similar to FFP. In this clinically relevant large animal model of severe TBI, HS, and polytrauma, we have shown that plasma-based resuscitation strategies are safe and result in neurocognitive recovery that is faster than recovery after NS-based resuscitation.	[Georgoff, Patrick E.; Nikolian, Vahagn C.; Halaweish, Ihab; Chtraklin, Kiril; Bruhn, Peter J.; Eidy, Hassan; Rasmussen, Monica; Li, Yongqing; Alam, Hasan B.] Univ Michigan, Dept Surg, Neuroradiol Sect, Ann Arbor, MI 48109 USA; [Srinivasan, Ashok] Univ Michigan, Dept Radiol, Neuroradiol Sect, Ann Arbor, MI 48109 USA	Alam, HB (corresponding author), Univ Michigan Hosp, Gen Surg Sect, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu			US Army Materiel and Research Command [W81XWH-09-1-0520]	This work was supported by the US Army Materiel and Research Command, Contract W81XWH-09-1-0520.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bux J, 2013, TRANSFUSION, V53, P3203, DOI 10.1111/trf.12191; Cancelas J., 2011, TRANSFUSION S, V51, pS85; Cartotto R, 2016, CRIT CARE CLIN, V32, P507, DOI 10.1016/j.ccc.2016.06.002; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; DB K., 1964, BLOOD PROGRAM WORLD; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Glassberg E, 2013, SHOCK, V40, P444, DOI 10.1097/SHK.0000000000000047; Glassberg E, 2013, J TRAUMA ACUTE CARE, V75, pS111, DOI 10.1097/TA.0b013e318299d217; Gokhale SG, 2016, J ROY ARMY MED CORPS, V162, P63, DOI 10.1136/jramc-2014-000361; Halaweish I, 2016, J TRAUMA ACUTE CARE, V81, P1080, DOI 10.1097/TA.0000000000001204; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; Imam A, 2015, J NEUROTRAUM, V32, P307, DOI 10.1089/neu.2014.3535; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Keller-Stanislawski B, 2009, TRANSFUSION MED, V19, P340, DOI 10.1111/j.1365-3148.2009.00947.x; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Martinaud C, 2012, ANESTHESIOLOGY, V117, P339, DOI 10.1097/ALN.0b013e3182608cdd; Martinaud C, 2011, J TRAUMA, V71, P1761, DOI 10.1097/TA.0b013e31822f1285; May AK, 1997, AM SURGEON, V63, P233; McCully SP, 2015, J TRAUMA ACUTE CARE, V78, P231, DOI 10.1097/TA.0000000000000524; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Pusateri AE, 2016, TRANSFUSION, V56, pS128, DOI 10.1111/trf.13580; Pusateri AE, 2016, TRANSFUSION, V56, pS16, DOI 10.1111/trf.13331; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Sailliol A, 2013, TRANSFUSION, V53, p65S, DOI 10.1111/trf.12038; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Sillesen M, 2017, J AM COLL SURGEONS, V224, P49, DOI 10.1016/j.jamcollsurg.2016.09.015; Sillesen M, 2013, SURGERY, V154, P197, DOI 10.1016/j.surg.2013.04.002; Spinella PC, 2012, TRANSFUSION, V52, P1146, DOI 10.1111/j.1537-2995.2012.03594.x; Sunde GA, 2015, J TRAUMA ACUTE CARE, V78, pS26, DOI 10.1097/TA.0000000000000633; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Van PY, 2011, J TRAUMA, V71, P20, DOI 10.1097/TA.0b013e3182214f44; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	49	20	20	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2017	34	13					2167	2175		10.1089/neu.2016.4859			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EZ2HM	WOS:000404530400455	28228060				2021-06-18	
J	Abdelgadir, J; Smith, ER; Punchak, M; Vissoci, JR; Staton, C; Muhindo, A; Kitya, D; Park, LP; Haglund, MM				Abdelgadir, Jihad; Smith, Emily R.; Punchak, Maria; Vissoci, Joao Ricardo; Staton, Catherine; Muhindo, Alex; Kitya, David; Park, Lawrence P.; Haglund, Michael M.			Epidemiology and Characteristics of Neurosurgical Conditions at Mbarara Regional Referral Hospital	WORLD NEUROSURGERY			English	Article						Africa; Epidemiology; Global surgery; Neurosurgery; Uganda	TRAUMATIC BRAIN-INJURY; UGANDA; CARE; CHALLENGES; COUNTRIES; SURGERY	BACKGROUND: The unmet surgical need, specifically neurosurgical need, in Uganda is significant, yet only 2 public hospitals currently perform neurosurgery in the country. This study examines the epidemiology and outcomes of neurosurgical conditions presenting to 1 of 12 regional referral hospitals in Uganda, in an effort to understand the neurosurgical needs of this population. METHODS: The study was conducted at Mbarara Regional Referral Hospital (MRRH), in southwestern Uganda. Demographics, clinical characteristics, and outcomes were retrospectively collected for all patients who presented to MRRH with a neurosurgical condition between January 2012 and September 2015. RESULTS: During the study period, 1854 patients presented to MRRH with a neurosurgical condition. More than half of the patients were between 19 and 40 years old, and the majority were males (76.1%). The overall median length of stay was 5 days (interquartile range: 2.5-10). The majority of admissions were due to trauma (87%), with almost 60% due to road traffic incidents. The overall mortality rate was 12.8%. A multivariable Cox proportional hazards model revealed that age, closed head injury, and admission Glasgow Coma Scale have a strong positive correlation with mortality while getting a diagnostic image and neurosurgical procedure were negatively correlated with mortality. CONCLUSION: Traumatic brain injury represented the majority of neurosurgical admissions at MRRH, disproportionately affecting young males. Age, closed head injury, admission Glasgow Coma Scale, getting a diagnostic image, and neurosurgical procedure were all independent predictors of mortality. Resource appropriate interventions throughout the health system are needed to meet the demand and improve outcomes.	[Abdelgadir, Jihad; Smith, Emily R.; Punchak, Maria; Vissoci, Joao Ricardo; Staton, Catherine; Haglund, Michael M.] Duke Univ, Div Global Neurosurg & Neurol, Durham, NC 27708 USA; [Abdelgadir, Jihad; Smith, Emily R.; Vissoci, Joao Ricardo; Staton, Catherine; Park, Lawrence P.; Haglund, Michael M.] Duke Univ, Global Hlth Inst, Durham, NC USA; [Vissoci, Joao Ricardo; Staton, Catherine] Duke Univ, Dept Emergency Med, Durham, NC USA; [Park, Lawrence P.] Duke Univ, Dept Med, Div Infect Dis, Durham, NC USA; [Haglund, Michael M.] Duke Univ, Dept Neurosurg, Durham, NC USA; [Punchak, Maria] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Muhindo, Alex] Mulago Natl Referral Hosp, Dept Neurosurg, Kampala, Uganda; [Kitya, David] Mbarara Reg Referral Hosp, Dept Neurosurg, Mbarara, Uganda	Smith, ER (corresponding author), Duke Univ, Div Global Neurosurg & Neurol, Durham, NC 27708 USA.	emily.smith1@duke.edu		Smith, Emily/0000-0002-1745-5728; Staton, Catherine/0000-0002-6468-2894	Duke Global Health Institute, Duke University, Department of Neurosurgery, Division of Global Neurosurgery and Neuroscience; Fogarty International Center, National Institute of Health, US [K01 TW010000-01A1]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010000] Funding Source: NIH RePORTER	Role of Funding Sources: Funding was provided by the Duke Global Health Institute, Duke University, Department of Neurosurgery, Division of Global Neurosurgery and Neuroscience. Dr. Staton received salary support funding from the Fogarty International Center, National Institute of Health, US (Staton, K01 TW010000-01A1). Funding sources played no role in study design, data collection, data analysis, or writing of the manuscript. All authors had full access to the data and had final responsibility for the decision to submit for publication.	Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; Basso A, 2001, WORLD J SURG, V25, P1174; Capone-Neto A, 2009, CURR OPIN CRIT CARE, V15, P290, DOI 10.1097/MCC.0b013e32832e383e; Contini Sandro, 2007, Acta Biomed, V78, P4; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; El Khamlichi Abdeslam, 2005, Clin Neurosurg, V52, P214; Fuller A, 2015, NEUROSURGICAL OUTCOM; Fuller Anthony, 2016, eNeurologicalSci, V3, P1, DOI 10.1016/j.ensci.2015.10.003; Balanzar GG, 2010, WORLD NEUROSURG, V74, P41, DOI 10.1016/j.wneu.2010.03.001; Haglund MM, 2011, WORLD J SURG, V35, P1175, DOI 10.1007/s00268-011-1080-0; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jayaraman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006955; Linden AF, 2012, WORLD J SURG, V36, P1056, DOI 10.1007/s00268-012-1482-7; Meara JG, 2016, INT J OBSTET ANESTH, V25, P75, DOI 10.1016/j.ijoa.2015.09.006; Meara JG, 2014, LANCET, V383, P12, DOI 10.1016/S0140-6736(13)62345-4; Mock C, 2012, WORLD J SURG, V36, P959, DOI 10.1007/s00268-012-1459-6; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saidi H., 2014, J TRAUMA MANAG OUTCO, V8, P1; StataCorp, 2012, STAT STAT SOFTW REL; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Warf BC, 2013, WORLD NEUROSURG S, V79; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877	25	20	20	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2017	102						526	532		10.1016/j.wneu.2017.03.019			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	FA5HA	WOS:000405472500067	28342925				2021-06-18	
J	Abbey, EL; Wright, CJ; Kirkpatrick, CM				Abbey, Elizabeth Lea; Wright, Cynthia Joy; Kirkpatrick, Christina M.			Nutrition practices and knowledge among NCAA Division III football players	JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION			English	Article						Nutrition source; Dietary recommendation; Football linemen; Registered dietitian nutritionist	TRAUMATIC BRAIN-INJURY; CARDIOVASCULAR-DISEASE; DOCOSAHEXAENOIC ACID; ATHLETIC TRAINERS; COGNITIVE FUNCTION; AMERICAN FOOTBALL; DIETARY PRACTICES; COLLEGE; CONSUMPTION; RISK	Background: Participation in collegiate American football is physically demanding and may have long-term health implications, particularly in relation to cardiovascular and neurological health. National Collegiate Athletic Association (NCAA) Division III (DIII) football players are a relatively unstudied population, particularly in terms of their dietary habits and knowledge. The aim of the present study was to descriptively evaluate the dietary intake of DIII football players including a subset of linemen and assess the nutritional knowledge and sources of information of these athletes. Methods: The study sample was 88 DIII football players including a subset of nine linemen. All participants completed a food frequency questionnaire, and a nutritional knowledge questionnaire that included a quiz and questions about their main sources of nutrition information. Heights and body masses were also recorded. The linemen submitted written 3-day diet records for assessment of their dietary intake. Results: Of the 88 participants, >50% reported consuming starches/grains, meat and dairy daily, but <50% reported consuming fruits and vegetables daily. Protein powders were the most commonly used supplements (33% reported daily use). Compared to dietary recommendations, linemen consumed high amounts of total fat, saturated fat, dietary cholesterol, sodium, and potassium, but were low in carbohydrates, fiber, and essential fats. The mean nutrition knowledge quiz score for the 88 participants was 55.2%. Those who had taken a nutrition or health course in college scored significantly higher on the quiz than those who had not. Participants reported relying primarily on coaches, websites, and athletic trainers (ATs) for nutritional guidance; ATs were the most trusted source. Conclusions: DIII football players had dietary habits that may both mitigate and increase their risk of chronic diseases. These athletes have room to improve their nutrition knowledge. Their reliance on athletic team staff for nutrition guidance highlights the importance of nutrition education for both athletes and staff and the potential role of a registered dietitian nutritionist.	[Abbey, Elizabeth Lea; Wright, Cynthia Joy; Kirkpatrick, Christina M.] Whitworth Univ, 300 W Hawthorne Rd, Spokane, WA 99251 USA	Abbey, EL (corresponding author), Whitworth Univ, 300 W Hawthorne Rd, Spokane, WA 99251 USA.	eabbey@whitworth.edu			Whitworth University Faculty and Research Development Committee; Whitworth Health Sciences Department	This research was funded by a summer research grant from the Whitworth University Faculty and Research Development Committee and the Whitworth Health Sciences Department.	Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Buell JL, 2008, J ATHL TRAINING, V43, P608, DOI 10.4085/1062-6050-43.6.608; Burke LM, 2011, J SPORT SCI, V29, pS17, DOI 10.1080/02640414.2011.585473; Burns RD, 2004, J AM DIET ASSOC, V104, P246, DOI 10.1016/j.jada.2003.11.013; Casa DJ, 2000, J ATHL TRAINING, V35, P212; Cho SS, 2013, AM J CLIN NUTR, V98, P594, DOI 10.3945/ajcn.113.067629; Cole CR, 2005, J STRENGTH COND RES, V19, P490; Dobrosielski DA, 2011, J AM COLL HEALTH, V59, P224, DOI 10.1080/07448481.2010.483719; Gay HC, 2016, HYPERTENSION, V67, P733, DOI 10.1161/HYPERTENSIONAHA.115.06853; Godek SF, 2010, J ATHL TRAINING, V45, P364, DOI 10.4085/1062-6050-45.4.364; Heaney S, 2011, INT J SPORT NUTR EXE, V21, P248, DOI 10.1123/ijsnem.21.3.248; Hoffman JR, 2011, J STRENGTH COND RES, V25, P2351, DOI 10.1519/JSC.0b013e31821743df; Jahns L, 2014, NUTRIENTS, V6, P6060, DOI 10.3390/nu6126060; James L, 2012, MED SPORT SCI, V59, P120, DOI 10.1159/000341958; Jonnalagadda SS, 2001, J STRENGTH COND RES, V15, P507; Judge LW, 2016, J STRENGTH COND RES, V2016; Kell J., 2016, FORTUNE; Kesse-Guyot E, 2011, J NUTR HEALTH AGING, V15, P115, DOI 10.1007/s12603-011-0023-7; Kirwan RD, 2012, INT J SPORT NUTR EXE, V22, P444, DOI 10.1123/ijsnem.22.6.444; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Liu RH, 2013, ADV NUTR, V4, p384S, DOI 10.3945/an.112.003517; Lynch NA, 2007, MED SCI SPORT EXER, V39, P1124, DOI 10.1249/01.mss.0b013e3180557466; Malik VS, 2015, J AM COLL CARDIOL, V66, P1615, DOI 10.1016/j.jacc.2015.08.025; Mathews EM, 2008, J AM COLL HEALTH, V57, P33, DOI 10.3200/JACH.57.1.33-38; Michas G, 2014, ATHEROSCLEROSIS, V234, P320, DOI 10.1016/j.atherosclerosis.2014.03.013; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Rosenbloom CA, 2002, J AM DIET ASSOC, V102, P418, DOI 10.1016/S0002-8223(02)90098-2; Schober ME, 2016, J NEUROTRAUM, V33, P390, DOI 10.1089/neu.2015.3945; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Simon JE, 2014, AM J SPORT MED, V42, P423, DOI 10.1177/0363546513510393; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P502, DOI 10.3945/ajcn.2008.26285; Spronk I, 2014, BRIT J NUTR, V111, P1713, DOI 10.1017/S0007114514000087; Stuempfle KJ, 2003, J STRENGTH COND RES, V17, P238; Thomas D Travis, 2016, Med Sci Sports Exerc, V48, P543, DOI 10.1249/MSS.0000000000000852; Torres-McGehee TM, 2012, J ATHL TRAINING, V47, P205; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; West DS, 2006, OBESITY, V14, P1825, DOI 10.1038/oby.2006.210; Widmer RJ, 2015, AM J MED, V128, P229, DOI 10.1016/j.amjmed.2014.10.014; Wilkerson GB, 2010, J ATHL TRAINING, V45, P67, DOI 10.4085/1062-6050-45.1.67; World Health Organization, OB OV FACT SHEET; Wu AG, 2014, NEUROREHAB NEURAL RE, V28, P75, DOI 10.1177/1545968313498650; Yamamoto Joelle B, 2008, Res Sports Med, V16, P111, DOI 10.1080/15438620802103320	43	20	21	0	26	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1550-2783			J INT SOC SPORT NUTR	J. Int. Soc. Sport Nutr.	MAY 19	2017	14									10.1186/s12970-017-0170-2			9	Nutrition & Dietetics; Sport Sciences	Nutrition & Dietetics; Sport Sciences	EW3WR	WOS:000402434500001	28529463	DOAJ Gold, Green Published			2021-06-18	
J	McCrea, MA; Nelson, LD; Guskiewicz, K				McCrea, Michael A.; Nelson, Lindsay D.; Guskiewicz, Kevin			Diagnosis and Management of Acute Concussion	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Concussion; Mild traumatic brain injury; Acquired brain injury; Sports injuries	COLLEGIATE FOOTBALL PLAYERS; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT; NCAA CONCUSSION; METAANALYSIS; STATEMENT; RECOVERY; REST	Over the past 2 decades, there have been major advances in the basic and clinical science of concussion and mild traumatic brain injury. These advances now provide a more evidence-informed approach to the definition, diagnosis, assessment, and management of acute concussion. Standardized clinical tools have been developed and validated for assessment of acute concussion across injury settings (eg, civilian, sport, military). Consensus guidelines now provide guidance regarding injury management and approaches to ensure safe return to activity after acute concussion. This article provides a brief, high-level overview of approaches to best practice in diagnosis, assessment, and management of acute concussion.	[McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Guskiewicz, Kevin] Univ North Carolina Chapel Hill, Coll Arts & Sci, Dept Exercise & Sport Sci, 2207 Stallings, Chapel Hill, NC 27599 USA	McCrea, MA (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mmccrea@mcw.edu					Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Furger R.E., 2016, CONCUSSION, V1; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Putukian M, 2013, BRIT J SPORT MED, V47, P285, DOI 10.1136/bjsports-2013-092158; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	23	20	20	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2017	28	2					271	+		10.1016/j.pmr.2016.12.005			17	Rehabilitation	Rehabilitation	EU5AJ	WOS:000401043700007	28390513				2021-06-18	
J	Townsend, JM; Dennis, SC; Whitlow, J; Feng, Y; Wang, JX; Andrews, B; Nudo, RJ; Detamore, MS; Berkland, CJ				Townsend, Jakob M.; Dennis, S. Connor; Whitlow, Jonathan; Feng, Yi; Wang, Jinxi; Andrews, Brian; Nudo, Randolph J.; Detamore, Michael S.; Berkland, Cory J.			Colloidal Gels with Extracellular Matrix Particles and Growth Factors for Bone Regeneration in Critical Size Rat Calvarial Defects	AAPS JOURNAL			English	Article						colloidal gel; decellularized cartilage; extracellular matrix; hyaluronic acid; hydroxyapatite	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; DUAL DELIVERY; IN-VITRO; HYDROGELS; SCAFFOLDS; MODEL; MINERALIZATION; COMPLICATIONS; BIOMATERIALS	Colloidal gels encapsulating natural materials and exhibiting paste-like properties for placement are promising for filling complex geometries in craniofacial bone regeneration applications. Colloidal materials have demonstrated modest clinical outcomes as bone substitutes in orthopedic applications, but limited success in craniofacial applications. As such, development of a novel colloidal gel will fill a void in commercially available products for use in craniofacial reconstruction. One likely application for this technology is cranial reconstruction. Currently, traumatic brain injury (TBI) is often treated with a hemicraniectomy, a procedure in which half the cranium is removed to allow the injured brain to swell and herniate beyond the enclosed cranial vault. The use of colloidal gels would allow for the design of a pliable material capable of expansion during brain swelling and facilitate cranial bone regeneration alleviating the need for a second surgery to replace the previously removed hemi-cranium. In the current study, colloidal nanoparticles of hydroxyapatite (HAp), demineralized bone matrix (DBM), and decellularized cartilage (DCC) were combined with hyaluronic acid (HA) to form colloidal gels with desirable rheological properties (tau(y) >= 100 Pa). BMP-2 and VEGF growth factors were included to assess extracellular matrix (ECM) contribution of DBM and DCC. The HA-HAp (BMP-2) and HA-HAp-DCC group had 89 and 82% higher bone regeneration compared to the sham group, respectively (p < 0.01). Material retention issues observed may be alleviated by implementing chemical crosslinking. Overall, DCC may be a promising material for bone regeneration in general, and colloidal gels may hold significant potential in craniofacial applications.	[Townsend, Jakob M.; Detamore, Michael S.] Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA; [Dennis, S. Connor; Whitlow, Jonathan; Berkland, Cory J.] Univ Kansas, Bioengn Program, Lawrence, KS 66047 USA; [Feng, Yi; Wang, Jinxi] Univ Kansas, Med Ctr, Dept Orthoped Surg, Kansas City, KS 66160 USA; [Andrews, Brian] Univ Kansas, Med Ctr, Dept Plast Surg, Kansas City, KS 66160 USA; [Nudo, Randolph J.] Univ Kansas, Med Ctr, Dept Rehabil Med, Kansas City, KS 66160 USA; [Berkland, Cory J.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA	Berkland, CJ (corresponding author), Univ Kansas, Bioengn Program, Lawrence, KS 66047 USA.; Berkland, CJ (corresponding author), Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA.	berkland@ku.edu	Townsend, Jakob/AAH-9637-2019		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 DE022472]; Kansas Bioscience Authority Rising Star Award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE022472] Funding Source: NIH RePORTER	The authors would like to thank Dr. Emily Beck for her assistance with the cartilage decellularization process. We would like to recognize funding from the National Institutes of Health (R01 DE022472) and from the Kansas Bioscience Authority Rising Star Award.	Alexander C., 2015, NATL GEOGR, P1; Beck EC, 2015, ANN BIOMED ENG, V43, P2569, DOI 10.1007/s10439-015-1277-8; Bijlenga P, 2007, J NEUROL NEUROSUR PS, V78, P430, DOI 10.1136/jnnp.2006.099242; Converse GL, 2012, ACTA BIOMATER, V8, P2722, DOI 10.1016/j.actbio.2012.03.047; Cowan CM, 2007, TISSUE ENG, V13, P501, DOI 10.1089/ten.2006.0141; Dennis SC, 2015, TISSUE ENG PART B-RE, V21, P247, DOI [10.1089/ten.TEB.2014.0419, 10.1089/ten.teb.2014.0419]; Dennis SC, 2014, LANGMUIR, V30, P3528, DOI 10.1021/la4041985; Dennis SC, 2016, LANGMUIR; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Fakhari A, 2014, J BIOMED MATER RES B, V102, P612, DOI 10.1002/jbm.b.33041; Ferreira JR, 2013, TISSUE ENG PT A, V19, P1803, DOI [10.1089/ten.tea.2012.0520, 10.1089/ten.TEA.2012.0520]; Gawlitta D, 2015, TISSUE ENG PT A, V21, P694, DOI [10.1089/ten.tea.2014.0117, 10.1089/ten.TEA.2014.0117]; Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008; Guvendiren M, 2012, SOFT MATTER, V8, P260, DOI 10.1039/c1sm06513k; Lu HD, 2012, BIOMATERIALS, V33, P2145, DOI 10.1016/j.biomaterials.2011.11.076; Marquez-Rivas J, 2013, J NEUROSURG, V119, P1657, DOI 10.3171/2013.5.JNS131034; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Oladunjoye AO, 2013, J NEUROSURG, V118, P776, DOI 10.3171/2013.1.JNS121475; Omary R, 2013, J MOL NEUROSCI, V49, P157, DOI 10.1007/s12031-012-9922-2; Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019; Renth AN, 2012, TISSUE ENG PART B-RE, V18, P341, DOI 10.1089/ten.teb.2012.0080; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sutherland AJ, 2015, MACROMOL BIOSCI, V15, P979, DOI 10.1002/mabi.201400472; Sutherland AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121966; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Visser J, 2015, BIOMATERIALS, V37, P174, DOI 10.1016/j.biomaterials.2014.10.020; Vo TN, 2016, BIOMATERIALS, V83, P1, DOI 10.1016/j.biomaterials.2015.12.026; Vo TN, 2015, J CONTROL RELEASE, V205, P25, DOI 10.1016/j.jconrel.2014.11.028; Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099; Wang Q, 2013, TISSUE ENG PT A, V19, P2586, DOI [10.1089/ten.tea.2013.0075, 10.1089/ten.TEA.2013.0075]; Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000; Wang Q, 2010, BIOMATERIALS, V31, P4980, DOI 10.1016/j.biomaterials.2010.02.052; Wu ZZ, 2015, TISSUE ENG PT A, V21, P390, DOI [10.1089/ten.tea.2013.0260, 10.1089/ten.TEA.2013.0260]; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510	37	20	20	1	24	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1550-7416			AAPS J	AAPS J.	MAY	2017	19	3					703	711		10.1208/s12248-017-0045-0			9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	ET8QM	WOS:000400565300011	28138909	Green Accepted			2021-06-18	
J	Weng, L; Xie, QY; Zhao, L; Zhang, RB; Ma, Q; Wang, JJ; Jiang, W; He, YB; Chen, Y; Li, CH; Ni, XX; Xu, Q; Yu, RH; Huang, RW				Weng, Ling; Xie, Qiuyou; Zhao, Ling; Zhang, Ruibin; Ma, Qing; Wang, Junjing; Jiang, Wenjie; He, Yanbin; Chen, Yan; Li, Changhong; Ni, Xiaoxiao; Xu, Qin; Yu, Ronghao; Huang, Ruiwang			Abnormal structural connectivity between the basal ganglia, thalamus, and frontal cortex in patients with disorders of consciousness	CORTEX			English	Article						Network-based statistic; Fractional anisotropy; Head motion; Fronto-parietal network; Basal ganglia-thalamo-cortical; network	TRAUMATIC BRAIN-INJURY; ANTERIOR FOREBRAIN MESOCIRCUIT; PROBABILISTIC DIFFUSION TRACTOGRAPHY; WHITE-MATTER INTEGRITY; DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; FRONTOPARIETAL NETWORK; VEGETATIVE STATE; RESTING-STATE; MRI	Consciousness loss in patients with severe brain injuries is associated with reduced functional connectivity of the default mode network (DMN), fronto-parietal network, and thalamo-cortical network. However, it is still unclear if the brain white matter connectivity between the above mentioned networks is changed in patients with disorders of consciousness (DOC). In this study, we collected diffusion tensor imaging (DTI) data from 13 patients and 17 healthy controls, constructed whole-brain white matter (WM) structural networks with probabilistic tractography. Afterward, we estimated and compared topological properties, and revealed an altered structural organization in the patients. We found a disturbance in the normal balance between segregation and integration in brain structural networks and detected significantly decreased nodal centralities primarily in the basal ganglia and thalamus in the patients. A network-based statistical analysis detected a subnetwork with uniformly significantly decreased structural connections between the basal ganglia, thalamus, and frontal cortex in the patients. Further analysis indicated that along the WM fiber tracts linking the basal ganglia, thalamus, and frontal cortex, the fractional anisotropy was decreased and the radial diffusivity was increased in the patients compared to the controls. Finally, using the receiver operating characteristic method, we found that the structural connections within the NBS-derived component that showed differences between the groups demonstrated high sensitivity and specificity (>90%). Our results suggested that major consciousness deficits in DOC patients may be related to the altered WM connections between the basal ganglia, thalamus, and frontal cortex. (C) 2017 Elsevier Ltd. All rights reserved.	[Weng, Ling; Zhao, Ling; Wang, Junjing; Jiang, Wenjie; Li, Changhong; Xu, Qin; Huang, Ruiwang] South China Normal Univ, Ctr Study Appl Psychol, Guangdong Key Lab Mental Hlth & Cognit Sci, Sch Psychol,Inst Brain Sci & Rehabil, Guangzhou 510631, Guangdong, Peoples R China; [Xie, Qiuyou; Ma, Qing; He, Yanbin; Chen, Yan; Ni, Xiaoxiao; Yu, Ronghao] Guangzhou Gen Hosp Guangzhou Mil Command, Ctr Hyperbar Oxygen & Neurorehabil, Guangzhou 510010, Guangdong, Peoples R China; [Zhang, Ruibin] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China	Huang, RW (corresponding author), South China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou 510631, Guangdong, Peoples R China.; Yu, RH (corresponding author), Guangzhou Gen Hosp Guangzhou Mil Command, Coma Res Grp, Ctr Hyperbar Oxygen & Neurorehabil, Guangzhou 510010, Guangdong, Peoples R China.	gesund@21cn.com; ruiwang.huang@gmail.com		Li, Changhong/0000-0001-9067-4110	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271548, 81371535, 81428013, 81471654]; Natural Science Foundation of Guangdong Province, ChinaNational Natural Science Foundation of Guangdong Province [2015A030313609]	This work was supported by funding from the National Natural Science Foundation of China (Grant numbers: 81271548, 81371535, 81428013, and 81471654), Natural Science Foundation of Guangdong Province, China (2015A030313609)). The authors express appreciation to Drs. Rhoda E. and Edmund F. Perozzi for editing assistance. The authors thank the two anonymous reviewers for their constructive comments and their suggestions.	Akeju O, 2014, ELIFE, V3, DOI 10.7554/eLife.04499; Andersen SM, 2010, NEUROIMAGE, V53, P78, DOI 10.1016/j.neuroimage.2010.06.003; Annen J, 2016, HUM BRAIN MAPP, V37, P3707, DOI 10.1002/hbm.23269; Bagnato S., 2016, J NEUROTRAUMA; Barttfeld P, 2015, P NATL ACAD SCI USA, V112, P887, DOI 10.1073/pnas.1418031112; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beaulieu C., 2013, DIFFUSION MRI QUANTI, P1; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Borst JP, 2013, P NATL ACAD SCI USA, V110, P1628, DOI 10.1073/pnas.1221572110; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Cao QJ, 2013, J NEUROSCI, V33, P10676, DOI 10.1523/JNEUROSCI.4793-12.2013; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Cauda F, 2009, J NEUROL NEUROSUR PS, V80, P429, DOI 10.1136/jnnp.2007.142349; Cavaliere C, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01028; Cavinato M, 2015, BRAIN TOPOGR, V28, P570, DOI 10.1007/s10548-014-0383-5; Caviness VS, 1996, J COGNITIVE NEUROSCI, V8, P566, DOI 10.1162/jocn.1996.8.6.566; Chatelle C, 2016, ARCH PHYS MED REHAB, V97, P1295, DOI 10.1016/j.apmr.2016.02.009; Chatelle C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00917; Chennu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003887; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cortese MD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0455-5; Crone JS, 2015, NEUROIMAGE, V110, P101, DOI 10.1016/j.neuroimage.2015.01.037; Crone JS, 2014, NEUROIMAGE-CLIN, V4, P240, DOI 10.1016/j.nicl.2013.12.005; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; de Reus MA, 2013, NEUROIMAGE, V80, P397, DOI 10.1016/j.neuroimage.2013.03.053; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Demertzi A, 2013, CURR OPIN NEUROBIOL, V23, P239, DOI 10.1016/j.conb.2012.12.003; Desco M, 2001, HUM BRAIN MAPP, V14, P16, DOI 10.1002/hbm.1038; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Duff EP, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3008438; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Eickhoff SB, 2015, HUM BRAIN MAPP, V36, P4771, DOI 10.1002/hbm.22933; Estraneo A, 2015, CLIN REHABIL, V29, P803, DOI 10.1177/0269215514556002; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Farrer C, 2008, CEREB CORTEX, V18, P254, DOI 10.1093/cercor/bhm050; Fernandez-Espejo D, 2013, NAT REV NEUROSCI, V14, P801, DOI 10.1038/nrn3608; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Fernandez-Espejo D, 2010, J NEUROTRAUM, V27, P1187, DOI 10.1089/neu.2010.1297; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gosseries O, 2014, ANNU REV NEUROSCI, V37, P457, DOI 10.1146/annurev-neuro-062012-170339; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hagmann P., 2005, THESIS, DOI [10.5075/epfl-thesis-323, DOI 10.5075/EPFL-THESIS-323]; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Ishai A, 2000, J COGNITIVE NEUROSCI, V12, P35, DOI 10.1162/089892900564055; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lant ND, 2016, NEUROIMAGE-CLIN, V10, P27, DOI 10.1016/j.nicl.2015.11.004; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S., 2011, NEUROLOGY CONSCIOUSN; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Long JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep38866; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Lutkenhoff ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115551; Luyt CE, 2012, ANESTHESIOLOGY, V117, P1311, DOI 10.1097/ALN.0b013e318275148c; MacDonald AA, 2015, TRENDS COGN SCI, V19, P100, DOI 10.1016/j.tics.2014.12.005; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Owen AM, 2013, ANNU REV PSYCHOL, V64, P109, DOI 10.1146/annurev-psych-113011-143729; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Posnansky O, 2011, INT J IMAG SYST TECH, V21, P271, DOI 10.1002/ima.20292; Proix T, 2016, NEUROIMAGE, V142, P135, DOI 10.1016/j.neuroimage.2016.06.016; Renier LA, 2010, NEURON, V68, P138, DOI 10.1016/j.neuron.2010.09.021; Ripolles P, 2012, NEUROIMAGE, V60, P1296, DOI 10.1016/j.neuroimage.2012.01.094; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salazar RF, 2012, SCIENCE, V338, P1097, DOI 10.1126/science.1224000; Schiff ND, 2000, J CLIN NEUROPHYSIOL, V17, P438, DOI 10.1097/00004691-200009000-00002; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff ND, 2007, CURR OPIN NEUROL, V20, P638, DOI 10.1097/WCO.0b013e3282f1c6e4; Schiff ND, 2016, J NEURAL TRANSM, V123, P797, DOI 10.1007/s00702-016-1547-0; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Shadlen M.N., 2011, CONSCIOUSNESS DECISI; Silva S, 2015, NEUROLOGY, V85, P2036, DOI 10.1212/WNL.0000000000002196; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Telesford QK, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00067; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van der Eerden AW, 2014, RADIOLOGY, V270, P506, DOI 10.1148/radiol.13122720; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Wendelken C., 2015, CEREBRAL CORTEX; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wu XH, 2015, J NEUROSCI, V35, P12932, DOI 10.1523/JNEUROSCI.0415-15.2015; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zanto TP, 2013, TRENDS COGN SCI, V17, P602, DOI 10.1016/j.tics.2013.10.001; Zhang RB, 2015, BRAIN STRUCT FUNCT, V220, P1145, DOI 10.1007/s00429-014-0706-z; Zheng ZS, 2017, HUM BRAIN MAPP, V38, P431, DOI 10.1002/hbm.23370; Zhong SY, 2015, HUM BRAIN MAPP, V36, P1995, DOI 10.1002/hbm.22751	113	20	20	2	24	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	MAY	2017	90						71	87		10.1016/j.cortex.2017.02.011			17	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	EX2BG	WOS:000403029900007	28365490				2021-06-18	
J	Zeleznikow-Johnston, A; Burrows, EL; Renoir, T; Hannan, AJ				Zeleznikow-Johnston, Ariel; Burrows, Emma L.; Renoir, Thibault; Hannan, Anthony J.			Environmental enrichment enhances cognitive flexibility in C57BL/6 mice on a touchscreen reversal learning task	NEUROPHARMACOLOGY			English	Article						Cognitive stimulation; Physical activity; Cognition; Brain reserve; Metabotropic glutamate receptor 5; Cognitive enhancers	MEDIAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL NEUROGENESIS; WORKING-MEMORY; SPATIAL MEMORY; PATTERN SEPARATION; TESTING METHOD; MOUSE MODEL; DOPAMINE; EXERCISE	Environmental enrichment (EE) is any positive modification of the 'standard housing' (SH) conditions in which laboratory animals are typically held, usually involving increased opportunity for cognitive stimulation and physical activity. EE has been reported to enhance baseline performance of wild-type animals on traditional cognitive behavioural tasks. Recently, touchscreen operant testing chambers have emerged as a way of performing rodent cognitive assays, providing greater reproducibility, translatability and automatability. Cognitive tests in touchscreen chambers are performed over numerous trials and thus experimenters have the power to detect subtle enhancements in performance. We used touchscreens to analyse the effects of EE on reversal learning, visual discrimination and hippocampal-dependent spatial pattern separation and working memory. We hypothesized that EE would enhance the performance of mice on cognitive touchscreen tasks. Our hypothesis was partially supported in that EE induced enhancements in cognitive flexibility as observed in visual discrimination and reversal learning improvements. However, no other significant effects of EE on cognitive performance were observed. EE decreased the activity level of mice in the touchscreen chambers, which may influence the enrichment level of the animals. Although we did not see enhancements on all hypothesized parameters, our testing paradigm is capable of detecting EE-induced improved cognitive flexibility in mice, which has implications for both understanding the mechanisms of EE and improving screening of putative cognitive-enhancing therapeutics.(C) 2017 Elsevier Ltd. All rights reserved.	[Zeleznikow-Johnston, Ariel; Burrows, Emma L.; Renoir, Thibault; Hannan, Anthony J.] Univ Melbourne, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Hannan, Anthony J.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia	Hannan, AJ (corresponding author), Univ Melbourne, Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.	anthony.hannan@florey.edu.au		Zeleznikow-Johnston, Ariel/0000-0002-7497-8242; Hannan, Anthony/0000-0001-7532-8922	National Health and Medical Research Council (NHMRC) Australian Research Council (ARC) Dementia Research Development FellowshipAustralian Research Council; ARC FT3 Future FellowshipAustralian Research Council [FT100100835]; Australian Government Research Training Program ScholarshipAustralian GovernmentDepartment of Industry, Innovation and Science; NHMRCNational Health and Medical Research Council of Australia [GNT1126885]; State Government of Victoria	ELB is supported by a National Health and Medical Research Council (NHMRC) Australian Research Council (ARC) Dementia Research Development Fellowship. AJH is an NHMRC Principal Research Fellow (GNT1117148) and has been supported by an ARC FT3 Future Fellowship (FT100100835). TR is an ARC DECRA Fellow. AZJ is supported by the Australian Government Research Training Program Scholarship. This work was supported by an NHMRC Project Grant (GNT1126885). We would also like to acknowledge the operational infrastructure support from the State Government of Victoria. The authors declare no conflict of interest.	Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Birch AM, 2013, HIPPOCAMPUS, V23, P437, DOI 10.1002/hipo.22103; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Bussey TJ, 2008, LEARN MEMORY, V15, P516, DOI 10.1101/lm.987808; Cain ME, 2006, BEHAV PROCESS, V73, P360, DOI 10.1016/j.beproc.2006.08.007; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Clemenson GD, 2015, HIPPOCAMPUS, V25, P385, DOI 10.1002/hipo.22380; COMERY TA, 1995, NEUROBIOL LEARN MEM, V63, P217, DOI 10.1006/nlme.1995.1025; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; Del Arco A, 2007, BEHAV BRAIN RES, V176, P267, DOI 10.1016/j.bbr.2006.10.006; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Engmann O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10099; Garthe A, 2016, HIPPOCAMPUS, V26, P261, DOI 10.1002/hipo.22520; Graybeal C, 2011, NAT NEUROSCI, V14, P1507, DOI 10.1038/nn.2954; Guzzetta A, 2009, J NEUROSCI, V29, P6042, DOI 10.1523/JNEUROSCI.5548-08.2009; Hannan AJ, 2014, NEUROPATH APPL NEURO, V40, P13, DOI 10.1111/nan.12102; Harati H, 2011, NEUROBIOL AGING, V32, P718, DOI 10.1016/j.neurobiolaging.2009.03.012; Horner AE, 2013, NAT PROTOC, V8, P1961, DOI 10.1038/nprot.2013.122; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kent BA, 2015, CURR OPIN BEHAV SCI, V4, P179, DOI 10.1016/j.cobeha.2015.06.009; Kim CH, 2015, PSYCHOPHARMACOLOGY, V232, P3935, DOI 10.1007/s00213-015-4017-8; Kim MS, 2016, J CEREBR BLOOD F MET, V36, P2122, DOI 10.1177/0271678X15613525; Kishi T, 2015, INT HEART J, V56, P110, DOI 10.1536/ihj.14-168; Lambert TJ, 2005, NEUROBIOL LEARN MEM, V83, P206, DOI 10.1016/j.nlm.2004.12.001; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Makowiecki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048703; Mallien AS, 2016, HORM BEHAV, V81, P97, DOI 10.1016/j.yhbeh.2016.03.009; McAllister KAL, 2013, NEUROBIOL LEARN MEM, V101, P120, DOI 10.1016/j.nlm.2013.01.010; McOmish CE, 2007, EXPERT OPIN THER TAR, V11, P899, DOI 10.1517/14728222.11.7.899; Mora-Gallegos A, 2015, NEUROBIOL LEARN MEM, V118, P96, DOI 10.1016/j.nlm.2014.11.012; Mustroph ML, 2012, NEUROSCIENCE, V219, P62, DOI 10.1016/j.neuroscience.2012.06.007; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Quene H, 2004, SPEECH COMMUN, V43, P103, DOI 10.1016/j.specom 2004.02.004; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; Rampon C, 2000, NAT NEUROSCI, V3, P238; Roedel A, 2006, LAB ANIM-UK, V40, P371, DOI 10.1258/002367706778476343; Rogers J, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.52; Sampedro-Piquero P, 2015, NEUROSCIENCE, V307, P14, DOI 10.1016/j.neuroscience.2015.08.038; Sampedro-Piquero P, 2013, BRAIN RES BULL, V98, P1, DOI 10.1016/j.brainresbull.2013.06.006; Schrijver NCA, 2004, BEHAV BRAIN RES, V152, P307, DOI 10.1016/j.bbr.2003.10.016; Segovia G, 2008, BEHAV BRAIN RES, V187, P304, DOI 10.1016/j.bbr.2007.09.024; Shepherd A., 2016, J MOL NEUROSCI, P1; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Talpos JC, 2010, NEUROBIOL LEARN MEM, V94, P341, DOI 10.1016/j.nlm.2010.07.006; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Thiriet N, 2008, BRAIN RES, V1222, P31, DOI 10.1016/j.brainres.2008.05.030; Varty GB, 2000, BIOL PSYCHIAT, V47, P864, DOI 10.1016/S0006-3223(99)00269-3; Waltz JA, 2007, SCHIZOPHR RES, V93, P296, DOI 10.1016/j.schres.2007.03.010; Zhu J, 2005, J NEUROCHEM, V93, P1434, DOI 10.1111/j.1471-4159.2005.03130.x	54	20	20	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	MAY 1	2017	117						219	226		10.1016/j.neuropharm.2017.02.009			8	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	ET8FG	WOS:000400533800021	28196627				2021-06-18	
J	Milikovsky, DZ; Weissberg, I; Kamintsky, L; Lippmann, K; Schefenbauer, O; Frigerio, F; Rizzi, M; Sheintuch, L; Zelig, D; Ofer, J; Vezzani, A; Friedman, A				Milikovsky, Dan Z.; Weissberg, Itai; Kamintsky, Lyn; Lippmann, Kristina; Schefenbauer, Osnat; Frigerio, Federica; Rizzi, Massimo; Sheintuch, Liron; Zelig, Daniel; Ofer, Jonathan; Vezzani, Annamaria; Friedman, Alon			Electrocorticographic Dynamics as a Novel Biomarker in Five Models of Epileptogenesis	JOURNAL OF NEUROSCIENCE			English	Article						biomarker; EEG; epilepsy; epileptogenesis; stroke; traumatic brain injury	TEMPORAL-LOBE EPILEPSY; HIGH-FREQUENCY OSCILLATIONS; INDUCED STATUS EPILEPTICUS; BRAIN-BARRIER DYSFUNCTION; HIPPOCAMPAL THETA RHYTHM; GAMMA-OSCILLATIONS; KAINIC ACID; MEDIATES EPILEPTOGENESIS; PILOCARPINE MODEL; ACQUIRED EPILEPSY	Postinjury epilepsy (PIE) is a devastating sequela of various brain insults. While recent studies offer novel insights into the mechanisms underlying epileptogenesis and discover potential preventive treatments, the lack of PIE biomarkers hinders the clinical implementation of such treatments. Here we explored the biomarker potential of different electrographic features in five models of PIE. Electrocorticographic or intrahippocampal recordings of epileptogenesis (from the insult to the first spontaneous seizure) from two laboratories were analyzed in three mouse and two rat PIE models. Time, frequency, and fractal and nonlinear properties of the signals were examined, in addition to the daily rate of epileptiform spikes, the relative power of five frequency bands (theta, alpha, beta, low gamma, and high gamma) and the dynamics of these features over time. During the latent pre-seizure period, epileptiform spikes were more frequent in epileptic compared with nonepileptic rodents; however, this feature showed limited predictive power due to high inter-and intra-animal variability. While nondynamic rhythmic representation failed to predict epilepsy, the dynamics of the theta band were found to predict PIE with a sensitivity and specificity of > 90%. Moreover, theta dynamics were found to be inversely correlated with the latency period (and thus predict the onset of seizures) and with the power change of the high-gamma rhythm. In addition, changes in theta band power during epileptogenesis were associated with altered locomotor activity and distorted circadian rhythm. These results suggest that changes in theta band during the epileptogenic period may serve as a diagnostic biomarker for epileptogenesis, able to predict the future onset of spontaneous seizures.	[Milikovsky, Dan Z.; Weissberg, Itai; Kamintsky, Lyn; Schefenbauer, Osnat; Sheintuch, Liron; Zelig, Daniel; Ofer, Jonathan; Friedman, Alon] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Physiol & Cell Biol, IL-84105 Beer Sheva, Israel; [Milikovsky, Dan Z.; Weissberg, Itai; Kamintsky, Lyn; Schefenbauer, Osnat; Sheintuch, Liron; Zelig, Daniel; Ofer, Jonathan; Friedman, Alon] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Cognit & Brain Sci, IL-84105 Beer Sheva, Israel; [Kamintsky, Lyn; Friedman, Alon] Dalhousie Univ, Dept Med Neurosci, Halifax, NS B3H 4R2, Canada; [Lippmann, Kristina] Charite, Inst Neurophysiol, D-10117 Berlin, Germany; [Frigerio, Federica; Rizzi, Massimo; Vezzani, Annamaria] Ist Ric Farmacol Mario Negri, IRCCS, Dept Neurosci, Expt Neurol, I-20156 Milan, Italy; [Lippmann, Kristina] Univ Leipzig, Carl Ludwig Inst Physiol, D-04103 Leipzig, Germany; [Sheintuch, Liron] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Friedman, A (corresponding author), Dalhousie Univ, Dept Med Neurosci, Halifax, NS B3H 4R2, Canada.	alon.friedman@dal.ca	Rizzi, Massimo/ABF-2116-2020; Lippmann, Kristina/AAA-6709-2019; Vezzani, Annamaria/AAB-1882-2020	Vezzani, Annamaria/0000-0003-0573-6175; Rizzi, Massimo/0000-0002-5477-2263; , Alon/0000-0003-4780-8456; Milikovsky, Dan Z/0000-0002-4826-5273; Lippmann, Kristina/0000-0001-7719-0437; Kamintsky, Lyna/0000-0001-6776-0969			Adeli H, 2003, J NEUROSCI METH, V123, P69, DOI 10.1016/S0165-0270(02)00340-0; Aeschbach D, 1997, NEUROSCI LETT, V239, P121, DOI 10.1016/S0304-3940(97)00904-X; Arabadzisz D, 2005, EXP NEUROL, V194, P76, DOI 10.1016/j.expneurol.2005.01.029; Bankstahl M, 2012, BEHAV BRAIN RES, V230, P182, DOI 10.1016/j.bbr.2012.02.004; Bar-Klein G, 2014, ANN NEUROL, V75, P864, DOI 10.1002/ana.24147; Bastlund JF, 2005, EPILEPSIA, V46, P934, DOI 10.1111/j.1528-1167.2005.63204.x; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; BRAGIN A, 1995, J NEUROPHYSIOL, V73, P1691; Butler JL, 2016, J NEUROSCI, V36, P4155, DOI 10.1523/JNEUROSCI.3150-15.2016; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; CANT BR, 1976, NEW ZEAL MED J, V83, P416; Chauviere L, 2009, J NEUROSCI, V29, P5402, DOI 10.1523/JNEUROSCI.4699-08.2009; Choi SJ, 2016, EPILEPSY RES, V120, P19, DOI 10.1016/j.eplepsyres.2015.11.010; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; DEMENT W, 1957, ELECTROEN CLIN NEURO, V9, P673, DOI 10.1016/0013-4694(57)90088-3; El-Hassar L, 2007, J PHYSIOL-LONDON, V578, P193, DOI 10.1113/jphysiol.2006.119297; Engel J, 2012, PROG NEUROBIOL, V98, P316, DOI 10.1016/j.pneurobio.2012.02.001; Friedman A, 2014, EXPERT REV NEUROTHER, V14, P1365, DOI 10.1586/14737175.2014.972945; Goldenholz DM, 2012, NEUROLOGY, V78, P224, DOI 10.1212/01.wnl.0000410956.29629.4d; GOTMAN J, 1991, CAN J NEUROL SCI, V18, P573, DOI 10.1017/S031716710003273X; Helmstaedter C, 2003, ANN NEUROL, V54, P425, DOI 10.1002/ana.10692; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Inoue T, 2008, BRAIN DEV-JPN, V30, P321, DOI 10.1016/j.braindev.2007.10.003; Jukic MM, 2015, NEUROPSYCHOPHARMACOL, V40, P839, DOI 10.1038/npp.2014.244; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Ketzef M, 2011, NEUROSCIENCE, V189, P108, DOI 10.1016/j.neuroscience.2011.05.030; Kobayashi K, 2004, EPILEPSIA, V45, P488, DOI 10.1111/j.0013-9580.2004.45703.x; Kobayashi K, 2010, EPILEPSIA, V51, P2190, DOI 10.1111/j.1528-1167.2010.02565.x; Kohling R, 2000, J NEUROSCI, V20, P6820, DOI 10.1523/JNEUROSCI.20-18-06820.2000; Lapilover EG, 2012, NEUROBIOL DIS, V48, P495, DOI 10.1016/j.nbd.2012.06.024; Levy N, 2015, J IMMUNOL, V195, P1713, DOI 10.4049/jimmunol.1401446; Lippmann K, 2017, J CEREBR BLOOD F MET, V37, P1803, DOI 10.1177/0271678X16652631; Maheshwari A, 2016, EPILEPSIA, V57, P79, DOI 10.1111/epi.13265; Marcelin B, 2009, NEUROBIOL DIS, V33, P436, DOI 10.1016/j.nbd.2008.11.019; McLin JP, 2006, EUR J NEUROSCI, V24, P2191, DOI 10.1111/j.1460-9568.2006.05111.x; Medvedev A, 2000, BRAIN RES BULL, V52, P89, DOI 10.1016/S0361-9230(00)00239-2; Medvedev AV, 2002, BRAIN RES BULL, V58, P115, DOI 10.1016/S0361-9230(02)00768-2; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Noe FM, 2013, NEUROBIOL DIS, V59, P183, DOI 10.1016/j.nbd.2013.07.015; Noe F, 2008, BRAIN, V131, P1506, DOI 10.1093/brain/awn079; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pascente R, 2016, NEUROBIOL DIS, V93, P146, DOI 10.1016/j.nbd.2016.05.001; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; POWELL MJD, 1977, MATH PROGRAM, V12, P241, DOI 10.1007/BF01593790; Pung T, 2006, EPILEPSIA, V47, P111, DOI 10.1111/j.1528-1167.2006.00707.x; Quigg M, 2016, EPILEPSY RES, V122, P91, DOI 10.1016/j.eplepsyres.2016.02.014; Rechtschaffen A, 1968, MANUAL STANDARDIZED; Rizzi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31129; Roseman E, 1944, RES PUBL ASSOC RES N, V25, P200; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Schauwecker PE, 2012, NEUROBIOL DIS, V45, P297, DOI 10.1016/j.nbd.2011.08.013; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Strijkstra AM, 2003, NEUROSCI LETT, V340, P17, DOI 10.1016/S0304-3940(03)00033-8; Swanson L., 2004, BRAIN MAPS 3 STRUCTU; Tarasiuk A, 2014, SLEEP, V37, P987, DOI 10.5665/sleep.3676; Traub RD, 2005, J NEUROPHYSIOL, V94, P1225, DOI 10.1152/jn.00069.2005; van Vliet EA, 2012, EPILEPSIA, V53, P1254, DOI 10.1111/j.1528-1167.2012.03513.x; Vyazovskiy VV, 2005, BRAIN RES, V1050, P64, DOI 10.1016/j.brainres.2005.05.022; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Weissberg I., 2011, EPILEPSY RES TREAT, V2011, DOI DOI 10.1155/2011/143908; Weissberg I, 2015, NEUROBIOL DIS, V78, P115, DOI 10.1016/j.nbd.2015.02.029; White A, 2010, EPILEPSIA, V51, P371, DOI 10.1111/j.1528-1167.2009.02339.x; WHITNEY AW, 1971, IEEE T COMPUT, VC 20, P1100, DOI 10.1109/T-C.1971.223410; Willoughby JO, 2003, J NEUROL NEUROSUR PS, V74, P51, DOI 10.1136/jnnp.74.1.51; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; WINSON J, 1974, ELECTROEN CLIN NEURO, V36, P291, DOI 10.1016/0013-4694(74)90171-0; Wu JY, 2008, EPILEPSY RES, V82, P99, DOI 10.1016/j.eplepsyres.2008.07.010; Yaari Y, 2007, J PHYSIOL-LONDON, V580, P435, DOI 10.1113/jphysiol.2007.127670; Yamazaki M, 2009, EPILEPSY RES, V83, P198, DOI 10.1016/j.eplepsyres.2008.11.008; Yang J, 2005, NEUROSCIENCE, V131, P853, DOI 10.1016/j.neuroscience.2004.09.064; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009	75	20	20	0	4	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	APR 26	2017	37	17					4450	4461		10.1523/JNEUROSCI.2446-16.2017			12	Neurosciences	Neurosciences & Neurology	EU4YQ	WOS:000401038400004	28330876	Green Published, Bronze			2021-06-18	
J	Shahim, P; Tegner, Y; Marklund, N; Hoglund, K; Portelius, E; Brody, DL; Blennow, K; Zetterberg, H				Shahim, Pashtun; Tegner, Yelverton; Marklund, Niklas; Hoeglund, Kina; Portelius, Erik; Brody, David L.; Blennow, Kaj; Zetterberg, Henrik			Astroglial activation and altered amyloid metabolism in human repetitive concussion	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; INTERNATIONAL-CONFERENCE; POSTCONCUSSION SYNDROME; HEAD-INJURY; BIOMARKERS; AFTERMATH; STATEMENT; ENCEPHALOPATHY; DISEASE	Objective: To determine whether postconcussion syndrome (PCS) due to repetitive concussive traumatic brain injury (rcTBI) is associated with CSF biomarker evidence of astroglial activation, amyloid deposition, and blood-brain barrier (BBB) impairment. Methods: A total of 47 participants (28 professional athletes with PCS and 19 controls) were assessed with lumbar puncture (median 1.5 years, range 0.25-12 years after last concussion), standard MRI of the brain, and Rivermead Post-Concussion Symptoms Questionnaire (RPQ). The main outcome measures were CSF concentrations of astroglial activation markers (glial fibrillary acidic protein [GFAP] and YKL-40), markers reflecting amyloid precursor protein metabolism (A beta 38, A beta 40, A beta 42, sAPPa, and sAPPb), and BBB function (CSF: serum albumin ratio). Results: Nine of the 28 athletes returned to play within a year, while 19 had persistent PCS.1 year. Athletes with PCS.1 year had higher RPQ scores and number of concussions than athletes with PCS,1 year. Median concentrations of GFAP and YKL-40 were higher in athletes with PCS.1 year compared with controls, although with an overlap between the groups. YKL-40 correlated with RPQ score and the lifetime number of concussions. Athletes with rcTBI had lower concentrations of A beta 40 and A beta 42 than controls. The CSF: serum albumin ratio was unaltered. Conclusions: This study suggests that PCS may be associated with biomarker evidence of astroglial activation and b-amyloid (A beta) dysmetabolism in the brain. There was no clear evidence of Ab deposition as A beta 40 and A beta 42 were reduced in parallel. The CSF: serum albumin ratio was unaltered, suggesting that the BBB is largely intact in PCS.	[Shahim, Pashtun; Hoeglund, Kina; Portelius, Erik; Blennow, Kaj; Zetterberg, Henrik] Gothenburg Univ, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, S-41124 Gothenburg, Sweden; [Shahim, Pashtun; Hoeglund, Kina; Portelius, Erik; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Tegner, Yelverton] Lulea Univ Technol, Dept Hlth Sci, Div Med Sci, Lulea, Sweden; [Marklund, Niklas] Uppsala Univ, Dept Neurosci Neurosurg, Uppsala, Sweden; [Brody, David L.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England	Shahim, P (corresponding author), Gothenburg Univ, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, S-41124 Gothenburg, Sweden.	pashtun.shahim@neuro.gu.se		Hoglund, Kina/0000-0002-1213-9953; Marklund, Niklas/0000-0002-9797-5626; Tegner, Yelverton/0000-0003-3628-0705	Swedish Research CouncilSwedish Research CouncilEuropean Commission; European Research CouncilEuropean Research Council (ERC)European Commission; Centrum for Idrottsforskning; Torsten Soderberg Foundation; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; Frimurarestiftelsen	The study was supported by grants from the Swedish Research Council, the European Research Council, Centrum for Idrottsforskning, the Torsten Soderberg Foundation, the Knut and Alice Wallenberg Foundation, and Frimurarestiftelsen. The funding source had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Augutis K, 2013, MULT SCLER J, V19, P543, DOI 10.1177/1352458512460603; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Blennow K, 2015, TRENDS PHARMACOL SCI, V36, P297, DOI 10.1016/j.tips.2015.03.002; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Ho KM, 2014, J NEUROSURG, V121, P674, DOI 10.3171/2014.6.JNS132838; Jeppsson A, 2013, NEUROLOGY, V80, P1385, DOI 10.1212/WNL.0b013e31828c2fda; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Palmqvist S, 2016, BRAIN, V139, P1226, DOI 10.1093/brain/aww015; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wiley CA, 2015, NEUROPATHOLOGY, V35, P95, DOI 10.1111/neup.12158; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; WISNIEWSKI K, 1979, ANN NEUROL, V5, P288, DOI 10.1002/ana.410050311	27	20	21	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 11	2017	88	15					1400	1407		10.1212/WNL.0000000000003816			8	Clinical Neurology	Neurosciences & Neurology	ER3CW	WOS:000398674100008	28283595	Green Published			2021-06-18	
J	Bachstetter, AD; Ighodaro, ET; Hassoun, Y; Aldeiri, D; Neltner, JH; Patel, E; Abner, EL; Nelson, PT				Bachstetter, Adam D.; Ighodaro, Eseosa T.; Hassoun, Yasmin; Aldeiri, Danah; Neltner, Janna H.; Patel, Ela; Abner, Erin L.; Nelson, Peter T.			Rod-shaped microglia morphology is associated with aging in 2 human autopsy series	NEUROBIOLOGY OF AGING			English	Article						Aging; Microglia activation; Neurodegeneration; Neuroinflammation; Neuropathology; Hippocampus; Alzheimer's disease; Traumatic brain injury	FRACTALKINE RECEPTOR; ALZHEIMERS-DISEASE; BRAIN-INJURY; IMPAIRMENT; PATHOLOGY; DEMENTIA; NEURONS; RISK; MICE	A subtype of microglia is defined by the morphological appearance of the cells as rod shaped. Little is known about this intriguing cell type, as there are only a few case reports describing rod-shaped microglia in the neuropathological literature. Rod-shaped microglia were shown recently to account for a substantial proportion of the microglia cells in the hippocampus of both demented and cognitively intact aged individuals. We hypothesized that aging could be a defining feature in the occurrence of rodshaped microglia. To test this hypothesis, 2 independent series of autopsy cases (total n 168 cases), which covered the adult lifespan from 20 to 100_ years old, were included in the study. The presence or absence of rod-shaped microglia was scored on IBA1 immunohistochemically stained slides for the hippocampus and cortex. We found that age was one of the strongest determinants for the presence of rod-shaped microglia in the hippocampus and the cortex. We found no association with the presence of rod-shaped microglia and a self-reported history of a TBI. Alzheimer's diseaseerelated pathology was found to influence the presence of rod-shaped microglia, but only in the parietal cortex and not in the hippocampus or temporal cortex. Future studies are warranted to determine the functional relevance of rod-shaped microglia in supporting the health of neurons in the aged brain, and the signaling processes that regulate the formation of rod-shaped microglia. (C) 2017 Elsevier Inc. All rights reserved.	[Bachstetter, Adam D.; Ighodaro, Eseosa T.; Hassoun, Yasmin; Aldeiri, Danah] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Bachstetter, Adam D.] Univ Kentucky, Dept Neurosci, Lexington, KY USA; [Ighodaro, Eseosa T.; Neltner, Janna H.; Patel, Ela; Abner, Erin L.; Nelson, Peter T.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Neltner, Janna H.; Nelson, Peter T.] Univ Kentucky, Dept Pathol & Lab Med, Div Neuropathol, Lexington, KY USA; [Abner, Erin L.] Univ Kentucky, Dept Epidemiol, Lexington, KY USA	Bachstetter, AD (corresponding author), Univ Kentucky, Dept Neurosci, Spinal Cord & Brain Injury Res Ctr, B459 BBSRB,741 S Limestone St, Lexington, KY 40536 USA.	adam.bachstetter@uky.edu		Bachstetter, Adam/0000-0003-4646-6757	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AG028383, R00 AG044445]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F30NS090714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG028383, R00AG044445] Funding Source: NIH RePORTER	The authors are profoundly grateful to all of the study participants who made this research possible. The corresponding author, Adam Bachstetter, PhD, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Research reported in this publication was supported by National Institutes of Health under award numbers P30 AG028383, R00 AG044445. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.	Abner EL, 2016, ALZHEIMERS DEMENT, V12, P882, DOI 10.1016/j.jalz.2015.12.006; Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Ackman JB, 2006, J NEUROSCI, V26, P11413, DOI 10.1523/JNEUROSCI.3340-06.2006; Bachstetter AD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0209-z; Bachstetter AD, 2011, NEUROBIOL AGING, V32, P2030, DOI 10.1016/j.neurobiolaging.2009.11.022; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Corona AW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-93; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; de Hoz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083733; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Ighodaro ET, 2017, J CEREBR BLOOD F MET, V37, P201, DOI 10.1177/0271678X15621574; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Nelson PT, 2010, J NEUROL, V257, P1875, DOI 10.1007/s00415-010-5630-4; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Yuan TF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10788; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	25	20	20	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	APR	2017	52						98	105		10.1016/j.neurobiolaging.2016.12.028			8	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	EP1UE	WOS:000397169000011	28131016	Green Accepted, Green Published			2021-06-18	
J	Cheah, CF; Kofler, M; Schiefecker, AJ; Beer, R; Klug, G; Pfausler, B; Helbok, R				Cheah, Chun Fai; Kofler, Mario; Schiefecker, Alois Josef; Beer, Ronny; Klug, Gert; Pfausler, Bettina; Helbok, Raimund			Takotsubo Cardiomyopathy in Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Myocardial dysfunction; Takotsubo cardiomyopathy; Monitoring; Echocardiography	NEUROGENIC STUNNED MYOCARDIUM; TAKO-TSUBO CARDIOMYOPATHY; SUBARACHNOID HEMORRHAGE; HEART-FAILURE; STRESS; FEATURES; OUTCOMES	Takotsubo cardiomyopathy (TC) is a well-known complication after aneurysmal subarachnoid hemorrhage and has been rarely described in patients with traumatic brain injury (TBI). Case report and review of literature. Here, we report a 73-year-old woman with mild traumatic brain injury (TBI) presenting in cardiogenic shock. Takotsubo cardiomyopathy (TC) was diagnosed by repeated echocardiography. Cardiovascular support by inotropic agents led to hemodynamic stabilization after initiation of levosimendan. Cardiac function fully recovered within 21 days. We performed an in-depth literature review and identified 16 reported patients with TBI and TC. Clinical course and characteristics are discussed in the context of our patient. Takotsubo cardiomyopathy is under-recognized after TBI and may negatively impact outcome if left untreated.	[Cheah, Chun Fai; Kofler, Mario; Schiefecker, Alois Josef; Beer, Ronny; Pfausler, Bettina; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Anichstr 35, A-6020 Innsbruck, Austria; [Cheah, Chun Fai] Hosp Pulau Pinang, Dept Neurol, Jalan Residensi, Georgetown 10990, Pulau Pinang, Malaysia; [Klug, Gert] Med Univ Innsbruck, Univ Clin Internal Med 3, Cardiol & Angiol, Anichstr 35, A-6020 Innsbruck, Austria	Helbok, R (corresponding author), Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Anichstr 35, A-6020 Innsbruck, Austria.	Raimund.Helbok@tirol-kliniken.at	Helbok, Raimund/AAA-8361-2021	Klug, Gert/0000-0002-4737-0979	University of Innsbruck; Medical University of Innsbruck	Paul Rhomberg, MD, Department of Neuroradiology, Medical University of Innsbruck Anichstrasse 35, 6020 Innsbruck, Austria provided neuroimaging data. Open access funding provided by University of Innsbruck and Medical University of Innsbruck.	Bahloul M, 2006, AM J CRIT CARE, V15, P462; Bailen MR, 2003, J CRIT CARE, V18, P245, DOI 10.1016/j.jcrc.2003.10.008; Banki N, 2006, J NEUROSURG, V105, P15, DOI 10.3171/jns.2006.105.1.15; Bonacchi M, 2015, INTERACT CARDIOV TH, V20, P365, DOI 10.1093/icvts/ivu421; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010; Deleu D, 2007, SAUDI MED J, V28, P283; Divekar A, 2006, PEDIATR CARDIOL, V27, P376, DOI 10.1007/s00246-005-1263-2; Finsterer J, 2014, INT J CARDIOL, V177, P322, DOI 10.1016/j.ijcard.2014.08.101; Hasanin A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0246-z; Hong J, 2014, ANN PEDIAT CHILD HLT, V2, P1029; Kilbourn KJ, 2013, CLIN NEUROL NEUROSUR, V115, P909, DOI 10.1016/j.clineuro.2012.09.006; Krishnamoorthy V, 2013, CASE REP ANAESTHESIO, V2013, P1; Krpata DM, 2013, J PEDIATR SURG, V48, P876, DOI 10.1016/j.jpedsurg.2013.01.042; Lee VH, 2006, J NEUROSURG, V105, P264, DOI 10.3171/jns.2006.105.2.264; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Lyon AR, 2016, EUR J HEART FAIL, V18, P8, DOI 10.1002/ejhf.424; Marechaux S, 2009, EUR J ECHOCARDIOGR, V10, P332, DOI 10.1093/ejechocard/jen250; Palac Robert T, 2003, Prog Transplant, V13, P42; Parissis JT, 2009, HEART FAIL REV, V14, P265, DOI 10.1007/s10741-008-9128-4; Park JH, 2005, CHEST, V128, P296, DOI 10.1378/chest.128.1.296; Paur H, 2012, CIRCULATION, V126, P697, DOI 10.1161/CIRCULATIONAHA.112.111591; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Riera M, 2010, J TRAUMA, V68, P13; Samol A, 2011, INJURY EXTRA, V42, P54; Santoro F, 2013, CARDIOVASC THER, V31, pE133, DOI 10.1111/1755-5922.12047; Taccone FS, 2013, INTENS CARE MED, V39, P1497, DOI 10.1007/s00134-013-2945-5; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; Vergez M, 2009, RESUSCITATION, V80, P1074, DOI 10.1016/j.resuscitation.2009.05.021; Wippermann J, 2008, ASIAN CARDIOVASC THO, V16, P30; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046	31	20	21	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2017	26	2					284	291		10.1007/s12028-016-0334-y			8	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	EN5EV	WOS:000396029300018	28000134	Green Published			2021-06-18	
J	Chuang, JY; Kao, TJ; Lin, SH; Wu, AC; Lee, PT; Su, TP; Yeh, SH; Lee, YC; Wu, CC; Chang, WC				Chuang, Jian-Ying; Kao, Tzu-Jen; Lin, Shu-Hui; Wu, An-Chih; Lee, Pin-Tse; Su, Tsung-Ping; Yeh, Shiu-Hwa; Lee, Yi-Chao; Wu, Chung-Che; Chang, Wen-Chang			Specificity protein 1-zinc finger protein 179 pathway is involved in the attenuation of oxidative stress following brain injury	REDOX BIOLOGY			English	Article						Zinc finger protein 179; Specificity protein 1; Reactive oxygen species; Traumatic brain injury; Nerve growth factor	GENE-EXPRESSION; SP1; TRANSCRIPTION; ZNF179; DIFFERENTIATION; ISCHEMIA; FAMILY; HDAC1	After sudden traumatic brain injuries, secondary injuries may occur during the following days or weeks, which leads to the accumulation of reactive oxygen species (ROS). Since ROS exacerbate brain damage, it is important to protect neurons against their activity. Zinc finger protein 179 (Znf179) was shown to act as a neuroprotective factor, but the regulation of gene expression under oxidative stress remains unknown. In this study, we demonstrated an increase in Znf179 protein levels in both in vitro model of hydrogen peroxide (H2O2)-induced ROS accumulation and animal models of traumatic brain injury. Additionally, we examined the sub-cellular localization of Znf179, and demonstrated that oxidative stress increases Znf179 nuclear shuttling and its interaction with specificity protein 1 (Sp1). Subsequently, the positive autoregulation of Znf179 expression, which is Sp1-dependent, was further demonstrated using luciferase reporter assay and green fluorescent protein (GFP)-Znf179-expressing cells and transgenic mice. The upregulation of Sp1 transcriptional activity induced by the treatment with nerve growth factor (NGF) led to an increase in Znf179 levels, which further protected cells against H2O2-induced damage. However, Sp1 inhibitor, mithramycin A, was shown to inhibit NGF effects, leading to a decrease in Znf179 expression and lower cellular protection. In conclusion, the results obtained in this study show that Znf179 autoregulation through Sp1-dependent mechanism plays an important role in neuroprotection, and NGF-induced Sp1 signaling may help attenuate more extensive (ROS-induced) damage following brain injury.	[Chuang, Jian-Ying; Kao, Tzu-Jen; Lin, Shu-Hui; Wu, An-Chih; Lee, Yi-Chao] Taipei Med Univ, Grad Inst Neural Regenerat Med, Taipei 110, Taiwan; [Chuang, Jian-Ying; Kao, Tzu-Jen; Lee, Yi-Chao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 110, Taiwan; [Lin, Shu-Hui; Wu, An-Chih; Chang, Wen-Chang] Taipei Med Univ, Grad Inst Med Sci, Taipei 110, Taiwan; [Lee, Pin-Tse; Su, Tsung-Ping] Natl Inst Drug Abuse, Cellular Pathobiol Sect, Intramural Res Program, Baltimore, MD 21224 USA; [Yeh, Shiu-Hwa] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli 350, Taiwan; [Wu, Chung-Che] Taipei Med Univ, Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan	Chang, WC (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei 110, Taiwan.; Wu, CC (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan.	chuangcy@tmu.edu.tw; geokao@tmu.edu.tw; linivy9@yahoo.com.tw; anchinwu@gmail.com; pin-tse.lee@nih.gov; TSU@intra.nida.nih.gov; bau9763@nhri.org.tw; yc590626@gmail.com; johnwu@tmu.edu.tw; wcchang@tmu.edu.tw		Lee, Yi-Chao/0000-0003-3451-183X	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 103-2320-B-038-046, MOST 105-2320-B-038-063, MOST 105-2911-I-038-503, MOST 104-2923-B-038-002]; Taipei Medical University Hospital [104TMU-TMUH-01]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [ZIADA000549, ZIADA000206] Funding Source: NIH RePORTER	This work was supported by the Ministry of Science and Technology, Taiwan [grant numbers MOST 103-2320-B-038-046, MOST 105-2320-B-038-063, MOST 105-2911-I-038-503, and MOST 104-2923-B-038-002] and Taipei Medical University Hospital [grant numbers 104TMU-TMUH-01].	Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Chan PH, 2005, ANN NY ACAD SCI, V1042, P203, DOI 10.1196/annals.1338.022; Chang WC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-94; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Chuang JY, 2012, ONCOGENE, V31, P4946, DOI 10.1038/onc.2011.649; Chuang JY, 2011, FREE RADICAL BIO MED, V51, P2309, DOI 10.1016/j.freeradbiomed.2011.10.001; Chuang JY, 2011, BIOCHEM BIOPH RES CO, V407, P587, DOI 10.1016/j.bbrc.2011.03.068; Evangelopoulos ME, 2005, ONCOGENE, V24, P3309, DOI 10.1038/sj.onc.1208494; Formisano L, 2015, J NEUROSCI, V35, P7332, DOI 10.1523/JNEUROSCI.2174-14.2015; Kimura T, 1997, AM J MED GENET, V69, P320; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Lee J, 2006, FASEB J, V20, P2375, DOI 10.1096/fj.06-5957fje; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lin DY, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-98; Lin Y, 2015, BIOMATERIALS, V69, P148, DOI 10.1016/j.biomaterials.2015.08.010; Lomash RM, 2015, CELL REP, V12, P743, DOI 10.1016/j.celrep.2015.06.064; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Pao PC, 2011, CELL DEATH DIFFER, V18, P1791, DOI 10.1038/cdd.2011.52; Rojo AI, 2006, FREE RADICAL BIO MED, V41, P247, DOI 10.1016/j.freeradbiomed.2006.04.002; Ryu H, 2003, J NEUROSCI, V23, P3597; Seki N, 1999, DNA Res, V6, P353, DOI 10.1093/dnares/6.5.353; Seo SJ, 1996, GENE, V178, P177, DOI 10.1016/0378-1119(96)00383-6; Sobue S, 2005, J NEUROCHEM, V95, P940, DOI 10.1111/j.1471-4159.2005.03399.x; Su TC, 2016, NEUROPHARMACOLOGY, V105, P1, DOI 10.1016/j.neuropharm.2016.01.015; Tsai SYA, 2015, P NATL ACAD SCI USA, V112, pE6562, DOI 10.1073/pnas.1518894112; Tsou J. H., 2016, MOL NEUROBIOL; Ugoya SO, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/141624; Valsecchi V, 2011, STROKE, V42, P754, DOI 10.1161/STROKEAHA.110.597583; Wang SM, 2015, MOL NEUROBIOL, V51, P370, DOI 10.1007/s12035-014-8714-9; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu Y, 2002, BIOCHEM J, V362, P401, DOI 10.1042/0264-6021:3620401; Yeh SH, 2011, NUCLEIC ACIDS RES, V39, P5412, DOI 10.1093/nar/gkr161; Zhuang YF, 2013, ASIAN PAC J TROP MED, V6, P383, DOI 10.1016/S1995-7645(13)60043-7	36	20	22	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2213-2317			REDOX BIOL	Redox Biol.	APR	2017	11						135	143		10.1016/j.redox.2016.11.012			9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	EQ6RY	WOS:000398212000015	27918959	DOAJ Gold, Green Published			2021-06-18	
J	Robel, S				Robel, Stefanie			Astroglial Scarring and Seizures: A Cell Biological Perspective on Epilepsy	NEUROSCIENTIST			English	Article						epilepsy; seizures; astroglial scar; astrogliosis; astrocytes; reactive astrocytes; astrocyte physiology; hyperexcitability	BLOOD-BRAIN-BARRIER; TEMPORAL-LOBE EPILEPSY; NEURONAL CHLORIDE CONCENTRATION; IMPERMEANT ANIONS ESTABLISH; CHONDROITIN SULFATE PROTEOGLYCANS; POSTNATAL SUBVENTRICULAR ZONE; AMYOTROPHIC-LATERAL-SCLEROSIS; GLUTAMATE TRANSPORTER GLT-1; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY	Epilepsy is among the most prevalent chronic neurological diseases and affects an estimated 2.2 million people in the United States alone. About one third of patients are resistant to currently available antiepileptic drugs, which are exclusively targeting neuronal function. Yet, reactive astrocytes have emerged as potential contributors to neuronal hyperexcitability and seizures. Astrocytes react to any kind of CNS insult with a range of cellular adjustments to form a scar and protect uninjured brain regions. This process changes astrocyte physiology and can affect neuronal network function in various ways. Traumatic brain injury and stroke, both conditions that trigger astroglial scar formation, are leading causes of acquired epilepsies and surgical removal of this glial scar in patients with drug-resistant epilepsy can alleviate the seizures. This review will summarize the currently available evidence suggesting that epilepsy is not a disease of neurons alone, but that astrocytes, glial cells in the brain, can be major contributors to the disease, especially when they adopt a reactive state in response to central nervous system insult.	[Robel, Stefanie] Virginia Tech Caril Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA; [Robel, Stefanie] Virginia Tech Sch Neurosci, Blacksburg, VA USA	Robel, S (corresponding author), Virginia Tech Caril Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA.	srobel@vtc.vt.edu	Robel, Stefanie/AAA-7166-2019		Epilepsy Foundation; American Brain Tumor Association	The author(s) disclosed receipt of the following financial support for the research, authorship, and publication of this article: SR was funded by the Epilepsy Foundation and the American Brain Tumor Association.	Alvestad S, 2013, EPILEPSY RES, V105, P30, DOI 10.1016/j.eplepsyres.2013.01.006; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Asher RA, 2000, J NEUROSCI, V20, P2427; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Bayraktar OA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020362; Bazargani N, 2016, NAT NEUROSCI, V19, P182, DOI 10.1038/nn.4201; Bedner P, 2013, NEUROCHEM INT, V63, P682, DOI 10.1016/j.neuint.2013.01.011; Behrendt G, 2013, GLIA, V61, P273, DOI 10.1002/glia.22432; Bellesi M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0176-7; Ben-Ari Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00035; Berry JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061177; Binder DK, 2013, NEUROCHEM INT, V63, P635, DOI 10.1016/j.neuint.2013.09.004; Binder DK, 2012, GLIA, V60, P1203, DOI 10.1002/glia.22317; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Bordey A, 2000, GLIA, V30, P27, DOI 10.1002/(SICI)1098-1136(200003)30:1<27::AID-GLIA4>3.0.CO;2-#; Bordey A, 1997, J NEUROPHYSIOL, V78, P461; Bragg AD, 2006, GLIA, V53, P879, DOI 10.1002/glia.20347; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; Bringmann A, 1999, INVEST OPHTH VIS SCI, V40, P3316; Bringmann A, 2000, GLIA, V29, P35, DOI 10.1002/(SICI)1098-1136(20000101)29:1<35::AID-GLIA4>3.0.CO;2-A; Bringmann A, 2012, OPHTHALMOLOGICA, V227, P1, DOI 10.1159/000328979; Buckingham SC, 2013, NEUROCHEM INT, V63, P696, DOI 10.1016/j.neuint.2013.01.027; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Campbell SL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00425; Cao ZY, 2013, J BIOL CHEM, V288, P13831, DOI 10.1074/jbc.M112.441055; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Chever O, 2010, J NEUROSCI, V30, P15769, DOI 10.1523/JNEUROSCI.2078-10.2010; Cristina A, 2007, MOL PHARMACOL, V72, P1228, DOI 10.1124/mol.107.037127; Crunelli V, 2015, NEUROSCIENTIST, V21, P62, DOI 10.1177/1073858414523320; Cudkowicz ME, 2014, LANCET NEUROL, V13, P1083, DOI 10.1016/S1474-4422(14)70222-4; Dalloz C, 2003, HUM MOL GENET, V12, P1543, DOI 10.1093/hmg/ddg170; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Delekate A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6422; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dibaj P, 2007, J NEUROCHEM, V103, P2620, DOI 10.1111/j.1471-4159.2007.04979.x; Dityatev A, 2008, NEURON GLIA BIOL, V4, P235, DOI 10.1017/S1740925X09000118; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Dyck SM, 2015, EXP NEUROL, V269, P169, DOI 10.1016/j.expneurol.2015.04.006; Eid T, 2005, P NATL ACAD SCI USA, V102, P1193, DOI 10.1073/pnas.0409308102; England MJ, 2012, EPILEPSY SPECTRUM PR; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Frigerio F, 2012, EPILEPSIA, V53, P1887, DOI 10.1111/j.1528-1167.2012.03666.x; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Goodwin F, 1997, Eur J Paediatr Neurol, V1, P115, DOI 10.1016/S1090-3798(97)80042-6; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Gorter JA, 2015, EPILEPSY BEHAV, V49, P13, DOI 10.1016/j.yebeh.2015.04.047; Gupta RK, 2013, BIOGERONTOLOGY, V14, P531, DOI 10.1007/s10522-013-9459-y; Haj-Yasein NN, 2011, GLIA, V59, P1635, DOI 10.1002/glia.21205; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311; Hendriksen RGF, 2015, NEUROSCI BIOBEHAV R, V51, P255, DOI 10.1016/j.neubiorev.2015.01.023; Heuser K, 2012, J NEUROPATH EXP NEUR, V71, P814, DOI 10.1097/NEN.0b013e318267b5af; Higashimori H, 2007, GLIA, V55, P1668, DOI 10.1002/glia.20574; Hoogland TM, 2010, CEREBELLUM, V9, P264, DOI 10.1007/s12311-009-0139-z; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Jahan N, 2015, EXP NEUROL, V263, P372, DOI 10.1016/j.expneurol.2014.10.023; Janigro D, 2012, EPILEPSIA, V53, P26, DOI 10.1111/j.1528-1167.2012.03472.x; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; Kim KJ, 2015, J NEUROSCI, V35, P8245, DOI 10.1523/JNEUROSCI.4486-14.2015; Kim Y, 2011, BRAIN RES, V1389, P194, DOI 10.1016/j.brainres.2011.03.037; Kimbrough IF, 2015, BRAIN, V138, P3716, DOI 10.1093/brain/awv327; Kovacs R, 2009, J NEUROSCI, V29, P8565, DOI 10.1523/JNEUROSCI.5698-08.2009; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lacar B, 2012, J NEUROSCI, V32, P16435, DOI 10.1523/JNEUROSCI.1457-12.2012; Lee DJ, 2012, EXP NEUROL, V235, P246, DOI 10.1016/j.expneurol.2012.02.002; Liu XX, 2006, GLIA, V54, P394, DOI 10.1002/glia.20392; Loscher W, 2012, NAT REV NEUROL, V8, P661, DOI 10.1038/nrneurol.2012.222; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Ma HT, 2013, CEREB CORTEX, V23, P885, DOI 10.1093/cercor/bhs079; MacFarlane SN, 1997, J NEUROSCI, V17, P7316; Mehler MF, 2000, BRAIN RES REV, V32, P277, DOI 10.1016/S0165-0173(99)00090-9; Merlini M, 2011, ACTA NEUROPATHOL, V122, P293, DOI 10.1007/s00401-011-0834-y; Minkel HR, 2015, GLIA, V63, P2285, DOI 10.1002/glia.22893; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Na I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073476; Newman EA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0195; Nicholson KJ, 2014, J NEUROSCI RES, V92, P116, DOI 10.1002/jnr.23295; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Noell S, 2009, CELL TISSUE RES, V337, P185, DOI 10.1007/s00441-009-0812-z; Nwaobi SE, 2014, GLIA, V62, P411, DOI 10.1002/glia.22613; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Olsen ML, 2007, J NEUROPHYSIOL, V98, P786, DOI 10.1152/jn.00340.2007; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Olsen ML, 2015, J NEUROSCI, V35, P13827, DOI 10.1523/JNEUROSCI.2603-15.2015; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Otahal J, 2014, INT REV NEUROBIOL, V114, P209, DOI 10.1016/B978-0-12-418693-4.00009-1; Pappas AC, 2015, J NEUROSCI, V35, P13375, DOI 10.1523/JNEUROSCI.1551-15.2015; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Ricotti V, 2016, DEV MED CHILD NEUROL, V58, P77, DOI 10.1111/dmcn.12922; Robel S, 2016, NAT NEUROSCI, V19, P28, DOI 10.1038/nn.4184; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Robel S, 2009, GLIA, V57, P1630, DOI 10.1002/glia.20876; Rosenegger DG, 2015, J NEUROSCI, V35, P13463, DOI 10.1523/JNEUROSCI.1780-15.2015; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rothstein JD, 1996, CLIN NEUROSCI, V3, P348; Roycik MD, 2013, CURR MOL MED, V13, P1299, DOI 10.2174/15665240113139990067; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Schroder W, 2000, EPILEPSIA, V41, pS181, DOI 10.1111/j.1528-1157.2000.tb01578.x; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2014, COLD SPRING HARB PER, V7; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; Soni N, 2014, PHARMACOL BIOCHEM BE, V127, P70, DOI 10.1016/j.pbb.2014.10.001; Swann John W, 2008, Epilepsy Curr, V8, P168, DOI 10.1111/j.1535-7511.2008.00282.x; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Takano T, 2007, ANN NY ACAD SCI, V1097, P40, DOI 10.1196/annals.1379.004; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Thrane AS, 2012, P NATL ACAD SCI USA, V109, P18974, DOI 10.1073/pnas.1209448109; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Voipio J, 2014, SCIENCE, V345, DOI [10.1126/science.1252978, 10.1126/science.1255337]; Watanabe T, 1999, BRAIN RES, V845, P92, DOI 10.1016/S0006-8993(99)01945-9; Watkins S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5196; Weng HR, 2014, EXP NEUROL, V252, P18, DOI 10.1016/j.expneurol.2013.11.018; Wilcock DM, 2009, NEUROSCIENCE, V159, P1055, DOI 10.1016/j.neuroscience.2009.01.023; Wolburg H, 2009, NEUROSCIENTIST, V15, P180, DOI 10.1177/1073858408329509; Wong M, 2003, ANN NEUROL, V54, P251, DOI 10.1002/ana.10648; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yang J, 2011, J ALZHEIMERS DIS, V27, P711, DOI 10.3233/JAD-2011-110725; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang XL, 2011, AM J PHYSIOL-CELL PH, V301, pC729, DOI 10.1152/ajpcell.00334.2010; Zhao MR, 2007, EPILEPSIA, V48, P2059, DOI 10.1111/j.1528-1167.2007.01229.x; Zhou Yun, 2013, Front Endocrinol (Lausanne), V4, P165, DOI 10.3389/fendo.2013.00165; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	154	20	21	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-8584	1089-4098		NEUROSCIENTIST	Neuroscientist	APR	2017	23	2					152	168		10.1177/1073858416645498			17	Clinical Neurology; Neurosciences	Neurosciences & Neurology	EQ4LN	WOS:000398048800009	27118807				2021-06-18	
J	Tso, MK; Lee, MM; Ball, CG; Morrish, WF; Mitha, AP; Kirkpatrick, AW; Wong, JH				Tso, Michael K.; Lee, Myunghyun M.; Ball, Chad G.; Morrish, William F.; Mitha, Alim P.; Kirkpatrick, Andrew W.; Wong, John H.			Clinical utility of a screening protocol for blunt cerebrovascular injury using computed tomography angiography	JOURNAL OF NEUROSURGERY			English	Article						blunt cerebrovascular injury; stroke; trauma; computed tomography angiography; screening	10-YEAR RETROSPECTIVE ANALYSIS; CAROTID-ARTERY INJURIES; TRAUMATIC GRADE 1; OUTCOMES; DIAGNOSIS; ASSOCIATION; CENTER.	OBJECTIVE Blunt cerebrovascular injury (BCVI) occurs in approximately 1% of the blunt trauma population and may lead to stroke and death. Early vascular imaging in asymptomatic patients at high risk of having BCVI may lead to earlier diagnosis and possible stroke prevention. The objective of this study was to determine if the implementation of a formalized asymptomatic BCVI screening protocol with CT angiography (CTA) would lead to improved BCVI detection and stroke prevention. METHODS Patients with vascular imaging studies were identified from a prospective trauma registry at a single Level 1 trauma center between 2002 and 2008. Detection of BCVI and stroke rates were compared during the 3-year periods before and after implementation of a consensus-based asymptomatic BCVI screening protocol using CTA in 2005. RESULTS A total of 5480 patients with trauma were identified. The overall BCVI detection rate remained unchanged postprotocol compared with preprotocol (0.8% [24 of 3049 patients] vs 0.9% [23 of 2431 patients]; p = 0.53). However, postprotocol there was a trend toward a decreased risk of stroke secondary to BCVI on a trauma population basis (0.23% [7 of 3049 patients] vs 0.53% [13 of 2431 patients]; p = 0.06). Overall, 75% (35 of 47) of patients with BCVI were treated with antiplatelet agents, but no patient developed new or progressive intracranial hemorrhage despite 70% of these patients having concomitant traumatic brain injury. CONCLUSIONS The results of this study suggest that a CTA screening protocol for BCVI may be of clinical benefit with possible reduction in ischemic complications. The treatment of BCVI with antiplatelet agents appears to be safe.	[Tso, Michael K.; Mitha, Alim P.; Wong, John H.] Univ Calgary, Dept Clin Neurosci, Div Neurosurg, Foothills Med Ctr, Calgary, AB, Canada; [Ball, Chad G.; Kirkpatrick, Andrew W.] Univ Calgary, Dept Surg, Foothills Med Ctr, Calgary, AB, Canada; [Morrish, William F.; Mitha, Alim P.; Wong, John H.] Univ Calgary, Dept Diagnost Imaging, Foothills Med Ctr, Div Neuroradiol, Calgary, AB, Canada; [Lee, Myunghyun M.] Univ Toronto, Div Cardiac Surg, Toronto, ON M5S 1A1, Canada	Wong, JH (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Div Neurosurg,Foothills Med Ctr, 1403 29 St NW, Calgary, AB T2N 2T9, Canada.	jwong@ucalgary.ca			Calgary Surgical Research Development Fund; Kinetic Concepts, Inc.; Synthes, Inc.; Life Cell Corporation; Acelity Corporation	This study obtained funding from the Calgary Surgical Research Development Fund. This study received the Synthes Craniofacial Award at the 2012 American Association of Neurological Surgeons Annual Scientific Meeting. Dr. Kirkpatrick is the principal investigator of a randomized controlled trial funded by Kinetic Concepts, Inc., and has received travel compensation to Cadaver Labs from Synthes, Inc., and Life Cell Corporation. Dr. Kirkpatrick received non study-related clinical or research support from Acelity Corporation and is a consultant for Innovative Trauma Care Corporation.	Biffl WL, 2011, ANN SURG, V253, P451, DOI 10.1097/SLA.0b013e31820d990a; Biffl WL, 2009, J TRAUMA, V67, P1150, DOI 10.1097/TA.0b013e3181c1c1d6; Biffl WL, 2006, J TRAUMA, V60, P745, DOI 10.1097/01.ta.0000204034.94034.c4; Biffl WL, 2002, ANN SURG, V235, P699, DOI 10.1097/00000658-200205000-00012; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Burlew CC, 2012, J TRAUMA ACUTE CARE, V72, P330, DOI 10.1097/TA.0b013e31823de8a0; Cook A, 2011, J TRAUMA, V71, P114, DOI 10.1097/TA.0b013e31821c350f; Cothren CC, 2009, ARCH SURG-CHICAGO, V144, P685, DOI 10.1001/archsurg.2009.111; Cothren CC, 2005, ARCH SURG-CHICAGO, V140, P480, DOI 10.1001/archsurg.140.5.480; DiCocco JM, 2011, J AM COLL SURGEONS, V212, P549, DOI 10.1016/j.jamcollsurg.2010.12.035; DiCocco JM, 2011, ANN SURG, V253, P444, DOI 10.1097/SLA.0b013e31820d946b; Eastman AL, 2009, J TRAUMA, V67, P551, DOI 10.1097/TA.0b013e3181b84408; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Malhotra AK, 2007, ANN SURG, V246, P632, DOI 10.1097/SLA.0b013e3181568cab; McKevitt EC, 2002, AM J SURG, V183, P566, DOI 10.1016/S0002-9610(02)00845-0; McKevitt EC, 2002, J TRAUMA, V53, P472, DOI 10.1097/00005373-200209000-00013; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Miller PR, 2001, J TRAUMA, V51, P279, DOI 10.1097/00005373-200108000-00009; O'Kelly CJ, 2010, CAN J NEUROL SCI, V37, P549, DOI 10.1017/S0317167100010659; Roberts DJ, 2013, ANN SURG, V257, P621, DOI 10.1097/SLA.0b013e318288c514; Rogers FB, 1999, J TRAUMA, V46, P380, DOI 10.1097/00005373-199903000-00005; Schneidereit NP, 2006, J TRAUMA, V60, P209, DOI 10.1097/01.ta.0000195651.60080.2c; Scott WW, 2015, J NEUROSURG, V122, P1196, DOI 10.3171/2015.1.JNS14642; Scott WW, 2015, J NEUROSURG, V122, P1202, DOI 10.3171/2014.9.JNS1461; Scott WW, 2015, J NEUROSURG, V122, P610, DOI 10.3171/2014.10.JNS14875; Scott WW, 2014, J NEUROSURG, V121, P450, DOI 10.3171/2014.4.JNS132235	28	20	20	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2017	126	4					1033	1041		10.3171/2016.1.JNS151545			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EQ1NX	WOS:000397837900002	27104846	Bronze			2021-06-18	
J	Fernandez-Calle, R; Vicente-Rodriguez, M; Gramage, E; Pita, J; Perez-Garcia, C; Ferrer-Alcon, M; Uribarri, M; Ramos, MP; Herradon, G				Fernandez-Calle, Rosalia; Vicente-Rodriguez, Marta; Gramage, Esther; Pita, Jimena; Perez-Garcia, Carmen; Ferrer-Alcon, Marcel; Uribarri, Maria; Ramos, Maia P.; Herradon, Gonzalo			Pleiotrophin regulates microglia-mediated neuroinflammation	JOURNAL OF NEUROINFLAMMATION			English	Article						Microgliosis; Microglia activation; Midkine; Neuroimmune response; Neuroinflammation; Pleiotrophin; TLR4	TOLL-LIKE RECEPTORS; STRIATAL DOPAMINERGIC DENERVATION; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; PARKINSONS-DISEASE; SIGNALING PATHWAY; MIDKINE; OVEREXPRESSION; NEUROTOXICITY; INACTIVATION	Background: Pleiotrophin (PTN) is a cytokine found highly upregulated in the brain in different disorders characterized by overt neuroinflammation such as neurodegenerative diseases, drug addiction, traumatic injury, and ischemia. In the present work, we have explored whether PTN modulates neuroinflammation and if Toll-like receptor 4 (TLR4), crucial in the initiation of an immune response, is involved. Methods: In immunohistochemistry assays, we studied lipopolysaccharide (LPS, 7.5 mg/kg i.p.)-induced changes in glial fibrillary acidic protein (GFAP, astrocyte marker) and ionized calcium-binding adaptor molecule 1 (Iba1, microglia marker) expression in the prefrontal cortex (PFC) and striatum of mice with transgenic PTN overexpression in the brain (PTN-Tg) and in wild-type (WT) mice. Cytokine protein levels were assessed in the PFC by X-MAP technology. The influence of TLR4 signaling in LPS effects in both genotypes was assessed by pretreatment with the TLR4 antagonist (TAK-242, 3.0 mg/kg i.p.). Murine BV2 microglial cells were treated with PTN (0.5 mu g/ml) and LPS (1.0 mu g/ml) and assessed for the release of nitric oxide (NO). Results: We found that LPS-induced microglial activation is significantly increased in the PFC of PTN-Tg mice compared to that of WT mice. The levels of TNF-alpha, IL-6, and MCP-1 in response to LPS were significantly increased in the PFC of PTN-Tg mice compared to that of WT mice. Pretreatment with TAK-242 efficiently blocked increases in cytokine contents in a similar manner in both genotypes. Concomitant incubation of BV2 cells with LPS and PTN significantly potentiated the production of NO compared to cells only treated with LPS. Conclusions: Our findings identify for the first time that PTN is a novel and potent regulator of neuroinflammation. Pleiotrophin potentiates LPS-stimulated microglia activation. Our results suggest that regulation of the PTN signaling pathways may constitute new therapeutic opportunities particularly in those neurological disorders characterized by increased PTN cerebral levels and neuroinflammation.	[Fernandez-Calle, Rosalia; Vicente-Rodriguez, Marta; Gramage, Esther; Perez-Garcia, Carmen; Herradon, Gonzalo] Univ CEU San Pablo, Fac Farm, Dept Pharmaceut & Hlth Sci, Pharmacol Lab, Urb Monteprincipe, Madrid 28668, Spain; [Pita, Jimena; Uribarri, Maria] Univ CEU San Pablo, Fac Farm, Dept Chem & Biochem, Biochem & Mol Biol Lab, Madrid, Spain; [Ferrer-Alcon, Marcel; Uribarri, Maria] SL, BRAINco Biopharma, Bizkaia Technology Pk, Vizcaya, Spain	Herradon, G (corresponding author), Univ CEU San Pablo, Fac Farm, Dept Pharmaceut & Hlth Sci, Pharmacol Lab, Urb Monteprincipe, Madrid 28668, Spain.	herradon@ceu.es	Herradon, Gonzalo/C-8305-2012; Perez-Garcia, Carmen/K-2377-2014; Rodriguez, Marta Vicente/K-2354-2014; Ramos-Alvarez, M.Pilar/B-6359-2011; Gramage, Esther/K-6441-2014	Herradon, Gonzalo/0000-0002-1578-3744; Perez-Garcia, Carmen/0000-0003-4441-0071; Ramos-Alvarez, M.Pilar/0000-0002-7727-7783; Gramage, Esther/0000-0002-5134-1273; Vicente-Rodriguez, Marta/0000-0002-4426-5161	Ministerio de Economia y Competitividad of Spain [SAF2014-56671-R]; National Plan on Drug abuse, Ministerio de Sanidad of Spain [PNSD001I2015]; Universidad CEU San Pablo and Banco de Santander [USP-BS-APP03/2014]	SAF2014-56671-R (Ministerio de Economia y Competitividad of Spain), PNSD001I2015 (National Plan on Drug abuse, Ministerio de Sanidad of Spain), and USP-BS-APP03/2014 (Universidad CEU San Pablo and Banco de Santander).	Achour A, 2008, BIOCHIMIE, V90, P1791, DOI 10.1016/j.biochi.2008.04.010; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Akira S, 2004, CR BIOL, V327, P581, DOI 10.1016/j.crvi.2004.04.002; Alguacil Luis F, 2015, Recent Pat CNS Drug Discov, V10, P28; Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Asari A, 2010, J BIOL CHEM, V285, P24751, DOI 10.1074/jbc.M110.104950; Barbierato M, 2013, CNS NEUROL DISORD-DR, V12, P608; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chen ZH, 2016, J NEUROCHEM, V136, P10, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]; Clark KH, 2013, NEUROTOX RES, V23, P174, DOI 10.1007/s12640-012-9334-7; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Curtin K, 2015, DRUG ALCOHOL DEPEN, V146, P30, DOI 10.1016/j.drugalcdep.2014.10.027; Ezquerra L, 2008, GROWTH FACTORS, V26, P44, DOI 10.1080/08977190801987711; Ferrer-Alcon M, 2012, NEW NONCLASSICAL TRA; Frey D, 2015, NEUROPEDIATRICS, V46, P321, DOI 10.1055/s-0035-1562924; Gramage E, 2011, NEUROSCIENCE, V190, P307, DOI 10.1016/j.neuroscience.2011.06.014; Gramage E, 2010, NEUROSCIENCE, V170, P308, DOI 10.1016/j.neuroscience.2010.06.078; Gramage E, 2011, CURR PHARM DESIGN, V17, P449, DOI 10.2174/138161211795164103; Gramage E, 2010, ADDICT BIOL, V15, P403, DOI 10.1111/j.1369-1600.2009.00202.x; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Herradon G, 2014, BRIT J PHARMACOL, V171, P837, DOI 10.1111/bph.12312; Herradon G, 2009, MINI-REV MED CHEM, V9, P440, DOI 10.2174/138955709787847895; Hida H, 2003, EUR J NEUROSCI, V17, P2127, DOI 10.1046/j.1460-9568.2003.02661.x; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hwang Onyou, 2013, Exp Neurobiol, V22, P11, DOI 10.5607/en.2013.22.1.11; Lastres-Becker I, 2016, ANTIOXID REDOX SIGN, V25, P61, DOI 10.1089/ars.2015.6549; Le Greves P, 2005, BRAIN RES BULL, V65, P529, DOI 10.1016/j.brainresbull.2005.03.010; Luo XL, 2016, EUR J PHARMACOL, V774, P135, DOI 10.1016/j.ejphar.2016.02.013; MAILLEUX P, 1994, NEUROSCI LETT, V175, P25, DOI 10.1016/0304-3940(94)91069-3; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marchionini DM, 2007, BRAIN RES, V1147, P77, DOI 10.1016/j.brainres.2007.02.028; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Miao JY, 2012, NEUROSCI RES, V74, P269, DOI 10.1016/j.neures.2012.09.001; Moratalla R, 2015, PROG NEUROBIOL, DOI [10.1016/j.pneurobio.2015.09.011, DOI 10.1016/J.PNEUROBIO.2015.09.011.]; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Nimmo Alan J, 2009, Recent Pat CNS Drug Discov, V4, P86; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; Panicker N, 2015, J NEUROSCI, V35, P10058, DOI 10.1523/JNEUROSCI.0302-15.2015; Pariser H, 2005, BIOCHEM BIOPH RES CO, V332, P664, DOI 10.1016/j.bbrc.2005.05.007; Peria FM, 2007, J NEURO-ONCOL, V84, P255, DOI 10.1007/s11060-007-9379-2; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Silva AP, 2003, CURR DRUG ABUSE REV, V3, P239; Silver K, 2012, GROWTH FACTORS, V30, P258, DOI 10.3109/08977194.2012.693920; Torika N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155823; Vicente-Rodriguez M, 2016, EUR NEUROPSYCHOPHARM, V26, P1794, DOI 10.1016/j.euroneuro.2016.09.002; Vicente-Rodriguez M, 2015, CHEM RES TOXICOL, V28, P1443, DOI 10.1021/acs.chemrestox.5b00130; Vicente-Rodriguez M, 2014, J NEUROCHEM, V131, P688, DOI 10.1111/jnc.12841; Vicente-Rodriguez M, 2014, BEHAV BRAIN RES, V274, P258, DOI 10.1016/j.bbr.2014.08.023; Wisniewski T, 1996, NEUROREPORT, V7, P667, DOI 10.1097/00001756-199601310-00068	49	20	20	0	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	MAR 4	2017	14								46	10.1186/s12974-017-0823-8			10	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	EP1NI	WOS:000397151200001	28259175	DOAJ Gold, Green Published			2021-06-18	
J	Crescenzi, R; DeBrosse, C; Nanga, RPR; Byrne, MD; Krishnamoorthy, G; D'Aquilla, K; Nath, H; Morales, KH; Iba, M; Hariharan, H; Lee, VMY; Detre, JA; Reddy, R				Crescenzi, Rachelle; DeBrosse, Catherine; Nanga, Ravi P. R.; Byrne, Matthew D.; Krishnamoorthy, Guruprasad; D'Aquilla, Kevin; Nath, Hari; Morales, Knashawn H.; Iba, Michiyo; Hariharan, Hari; Lee, Virginia M. Y.; Detre, John A.; Reddy, Ravinder			Longitudinal Imaging Reveals Subhippocampal Dynamics in Glutamate Levels Associated with Histopathologic Events in a Mouse Model of Tauopathy and Healthy Mice	HIPPOCAMPUS			English	Article						tauopathy; CEST; synapse; glutamate; glia	MILD COGNITIVE IMPAIRMENT; LONG-TERM POTENTIATION; CHRONIC TRAUMATIC ENCEPHALOPATHY; TAU TRANSGENIC MICE; ALZHEIMERS-DISEASE; SYNAPSE LOSS; BINDING-SITES; IN-VIVO; FUNCTIONAL DOMAINS; PREFRONTAL CORTEX	Tauopathies are neurodegenerative disorders characterized by abnormal intracellular aggregates of tau protein, and include Alzheimer's disease, corticobasal degeneration, frontotemporal dementia, and traumatic brain injury. Glutamate metabolism is altered in neurodegenerative disorders manifesting in higher or lower concentrations of glutamate, its transporters or receptors. Previously, glutamate chemical exchange saturation transfer (GluCEST) magnetic resonance imaging (MRI) demonstrated that glutamate levels are reduced in regions of synapse loss in the hippocampus of a mouse model of late-stage tauopathy. We performed a longitudinal GluCEST imaging experiment paired with a cross-sectional study of histologic markers of tauopathy to determine whether (1) early GluCEST changes are associated with synapse loss before volume loss occurs in the hippocampus, and whether (2) subhippocampal dynamics in GluCEST are associated with histopathologic events related to glutamate alterations in tauopathy. Live imaging of the hippocampus in three serial slices was performed without exogenous contrast agents, and subregions were segmented based on a k-means cluster model. Subregions of the hippocampus were analyzed (cornu ammonis CA1, CA3, dentate gyrus DG, and ventricle) in order to associate local MRIobservable changes in glutamate with histological measures of glial cell proliferation (GFAP), synapse density (synaptophysin, VGlut1) and glutamate receptor (NMDA-NR1) levels. Early differences in GluCEST between healthy and tauopathy mice were measured in the CA1 and DG subregions (30% reduction, P <= 0.001). Synapse density was also significantly reduced in every subregion of the hippocampus in tauopathy mice by 6 months. Volume was not significantly reduced in any subregion until 13 months. Further, a gradient in glutamate levels was observed in vivo along hippocampal axes that became polarized as tauopathy progressed. Dynamics in hippocampal glutamate levels throughout lifetime were most closely correlated with combined changes in synaptophysin and GFAP, indicating that GluCEST imaging may be a surrogate marker of glutamate concentration in glial cells and at the synaptic level. (C) 2016 Wiley Periodicals, Inc.	[Crescenzi, Rachelle; DeBrosse, Catherine] Univ Penn, Dept Biochem & Mol Biophys BMB, Philadelphia, PA 19104 USA; [Crescenzi, Rachelle; DeBrosse, Catherine; Nanga, Ravi P. R.; Krishnamoorthy, Guruprasad; D'Aquilla, Kevin; Nath, Hari; Hariharan, Hari; Reddy, Ravinder] Univ Penn, CMROI, Philadelphia, PA 19104 USA; [Byrne, Matthew D.; Iba, Michiyo; Lee, Virginia M. Y.] Univ Penn, CNDR, Philadelphia, PA 19104 USA; [Morales, Knashawn H.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, CfN, Philadelphia, PA 19104 USA	Crescenzi, R (corresponding author), Univ Penn, Dept Biochem & Mol Biophys BMB, CMROI, B1 Stellar Chance Lab,422 Curie Blvd, Philadelphia, PA 19104 USA.	rachelle.cre-scenzi@gmail.com			NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015893S1]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG17586]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087516]; National Center for Research Resources, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1TR000003]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000003, UL1TR001878] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U54HL117798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG017586] Funding Source: NIH RePORTER	Grant sponsor: NIBIB; Grant number: P41EB015893S1; Grant sponsor: NIA; Grant number: P01AG17586; Grant sponsor: NINDS; Grant number: R01NS087516; Grant sponsor: National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health; Grant number: UL1TR000003.	Adler DH, 2014, NEUROIMAGE, V84, P505, DOI 10.1016/j.neuroimage.2013.08.067; Alsop DC, 2008, NEUROIMAGE, V42, P1267, DOI 10.1016/j.neuroimage.2008.06.006; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Aronica E, 1998, NEUROSCIENCE, V82, P979; Bell KFS, 2007, J NEUROSCI, V27, P10810, DOI 10.1523/JNEUROSCI.3269-07.2007; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BENJAMIN AM, 1975, J NEUROCHEM, V25, P197, DOI 10.1111/j.1471-4159.1975.tb06953.x; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chen Y, 2011, NEUROLOGY, V77, P1977, DOI 10.1212/WNL.0b013e31823a0ef7; Chohan MO, 2011, NEUROBIOL AGING, V32, P1420, DOI 10.1016/j.neurobiolaging.2009.08.008; Chong SA, 2011, NEUROBIOL DIS, V44, P284, DOI 10.1016/j.nbd.2011.07.006; Clare R, 2010, J NEUROSCI RES, V88, P2083, DOI 10.1002/jnr.22392; Crescenzi R, 2014, NEUROIMAGE, V101, P185, DOI 10.1016/j.neuroimage.2014.06.067; Dai WY, 2009, RADIOLOGY, V250, P856, DOI 10.1148/radiol.2503080751; David JP, 1997, NEUROSCI LETT, V235, P53, DOI 10.1016/S0304-3940(97)00708-8; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Denk F, 2009, NEUROBIOL AGING, V30, P1, DOI 10.1016/j.neurobiolaging.2007.05.010; DEWAR D, 1991, BRAIN RES, V553, P58, DOI 10.1016/0006-8993(91)90230-S; DOLPHIN AC, 1982, NATURE, V297, P496, DOI 10.1038/297496a0; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gong YS, 2010, AM J ALZHEIMERS DIS, V25, P547, DOI 10.1177/1533317510382893; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; Haley GE, 2010, AGE, V32, P283, DOI 10.1007/s11357-010-9137-9; Haris M, 2013, NMR BIOMED, V26, P386, DOI 10.1002/nbm.2875; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.3.CO;2-E; Hochgrafe K, 2013, FEBS J, V280, P4371, DOI 10.1111/febs.12250; Hoover BR, 2011, NIH PUBLIC ACCESS, V68, P1067, DOI [10.1016/j.neuron.2010.11.030, DOI 10.1016/J.NEURON.2010.11.030.TAU]; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hu WT, 2010, NEUROLOGY, V75, P881, DOI 10.1212/WNL.0b013e3181f11e35; Hunsberger HC, 2015, J NEUROCHEM, V132, P169, DOI 10.1111/jnc.12967; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; JANSEN KLR, 1990, NEUROSCIENCE, V39, P613, DOI 10.1016/0306-4522(90)90246-Z; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Kashani A, 2008, NEUROBIOL AGING, V29, P1619, DOI 10.1016/j.neurobiolaging.2007.04.010; Kirvell SL, 2006, J NEUROCHEM, V98, P939, DOI 10.1111/j.1471-4159.2006.03935.x; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; KOHAMA SG, 1995, NEUROBIOL AGING, V16, P59, DOI 10.1016/0197-4580(95)80008-F; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Landau SM, 2011, NEUROBIOL AGING, V32, P1207, DOI 10.1016/j.neurobiolaging.2009.07.002; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leung KK, 2015, NEUROIMAGE, V107, P46, DOI 10.1016/j.neuroimage.2014.11.049; Li Y, 2008, EUR J NUCL MED MOL I, V35, P2169, DOI 10.1007/s00259-008-0833-y; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Martens U, 1998, ANAT EMBRYOL, V198, P195, DOI 10.1007/s004290050177; Maurin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087605; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; Nicholls DG, 1998, BBA-BIOENERGETICS, V1366, P97, DOI 10.1016/S0005-2728(98)00123-6; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Nilsen LH, 2014, NEUROCHEM RES, V39, P305, DOI 10.1007/s11064-013-1222-x; Nilsen LH, 2014, J CEREBR BLOOD F MET, V34, P906, DOI 10.1038/jcbfm.2014.37; Pennanen L, 2006, GENES BRAIN BEHAV, V5, P369, DOI 10.1111/j.1601-183X.2005.00165.x; PENNEY JB, 1990, J NEUROL NEUROSUR PS, V53, P314, DOI 10.1136/jnnp.53.4.314; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; Robinson JL, 2014, BRAIN, V137, P2578, DOI 10.1093/brain/awu190; Rocher AB, 2010, EXP NEUROL, V223, P385, DOI 10.1016/j.expneurol.2009.07.029; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sasaki K, 2009, FEBS LETT, V583, P2194, DOI 10.1016/j.febslet.2009.06.015; Schousboe A, 1981, Int Rev Neurobiol, V22, P1, DOI 10.1016/S0074-7742(08)60289-5; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Snyder JS, 2011, NEUROBIOL AGING, V32, P1149, DOI 10.1016/j.neurobiolaging.2009.05.022; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Staresina BP, 2012, NAT NEUROSCI, V15, P1167, DOI 10.1038/nn.3154; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Sydow A, 2011, J MOL NEUROSCI, V45, P432, DOI 10.1007/s12031-011-9604-5; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thibodeau MP, 2009, CANADIAN REV ALZHEIM, V12, P4; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Van der Jeugd A, 2012, ACTA NEUROPATHOL, V123, P787, DOI 10.1007/s00401-012-0987-3; Vemuri P, 2008, NEUROIMAGE, V42, P559, DOI 10.1016/j.neuroimage.2008.05.012; Volgyi K, 2015, CURR ALZHEIMER RES, V12, P655, DOI 10.2174/1567205012666150710095035; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Wells JA, 2015, NEUROIMAGE, V111, P369, DOI 10.1016/j.neuroimage.2015.02.023; WESTERGAARD N, 1995, DEV NEUROSCI-BASEL, V17, P203, DOI 10.1159/000111288; YASUDA RP, 1995, BRAIN RES, V678, P161, DOI 10.1016/0006-8993(95)00178-S; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang B, 2012, J NEUROSCI, V32, P3601, DOI 10.1523/JNEUROSCI.4922-11.2012; Zheng BW, 2010, NMR BIOMED, V23, P1061, DOI 10.1002/nbm.1533	86	20	22	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	MAR	2017	27	3					285	302		10.1002/hipo.22693			18	Neurosciences	Neurosciences & Neurology	EP5FB	WOS:000397403300007	27997993	Green Accepted			2021-06-18	
J	Teel, EF; Marshall, SW; Shankar, V; McCrea, M; Guskiewicz, KM				Teel, Elizabeth F.; Marshall, Stephen W.; Shankar, Viswanathan; McCrea, Michael; Guskiewicz, Kevin M.			Predicting Recovery Patterns After Sport-Related Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; return to play; Standardized Assessment of Concussion; Balance Error Scoring System	PROFESSIONAL FOOTBALL PLAYERS; HIGH-SCHOOL; POSTURAL STABILITY; RECURRENT CONCUSSION; PROLONGED RECOVERY; NCAA CONCUSSION; COLLEGIATE; PERFORMANCE; SYMPTOMS; STATEMENT	Context: Clinicians sometimes treat concussed individuals who have amnesia, loss of consciousness (LOC), a concussion history, or certain symptom types more conservatively, but it is unclear whether recovery patterns differ in individuals with these characteristics. Objective: To determine whether (1) amnesia, LOC, and concussion history influence the acute recovery of symptoms, cognition, and balance; and (2) cognition and balance are influenced by acute symptom type. Design: Cohort study. Setting: Seven sports at 26 colleges and 210 high schools. Patients or Other Participants: A total of 8905 collegiate (n = 1392) and high school (n = 7513) athletes. Main Outcome Measure(s): The Graded Symptom Checklist, Standardized Assessment of Concussion, and Balance Error Scoring System were administered to all athletes during the preseason. To allow us to track recovery patterns, athletes diagnosed with a concussion (n = 375) repeated these assessments immediately after the injury, 3 hours postinjury, 1 day postinjury, and at 2, 3, 5, 7, and 90 days after injury. Results: Athletes who experienced amnesia had markedly greater deficits in and a slower recovery trajectory on measures of symptoms, cognition, and balance. Athletes with 2 or more prior concussions demonstrated poorer balance than those with no previous history. Otherwise, LOC and concussion history largely did not affect symptoms, cognition, or balance. Greater deficits in balance scores were observed in athletes with all symptom types. Regardless of these characteristics, most athletes recovered within 7 to 10 days. Conclusions: Athletes who experienced amnesia had more symptoms and greater deficits in cognition and balance. Symptoms and cognitive or balance deficits were not consistently associated with LOC or concussion history. Acute symptoms had a strong influence on balance scores and, to a lesser extent, on cognition. However, we found no evidence to support more cautious return-to-play decisions for athletes with these characteristics, as group recovery occurred within normal timelines. Our study supports current clinical practice: recommending that athletes be withheld from activity until they are asymptomatic, followed by a graduated return-to-play progression.	[Teel, Elizabeth F.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Sch Med,Dept Allied Hlth Sci, Dept Exercise & Sport Sci & Curriculum Human Move, Chapel Hill, NC USA; [Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Shankar, Viswanathan] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA	Guskiewicz, KM (corresponding author), Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Campus Box 8700, Chapel Hill, NC 27599 USA.	gus@email.unc.edu	Viswanathan, Shankar/AAX-5281-2020	Teel, Elizabeth/0000-0002-2846-5884; Viswanathan, Shankar/0000-0003-3349-9090	Centers for Disease Control and Prevention (Atlanta, GA)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); National Collegiate Athletic Association (Indianapolis, IN)	This study was supported in part by grants from the Centers for Disease Control and Prevention (Atlanta, GA), the National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), and the National Collegiate Athletic Association (Indianapolis, IN).	[Anonymous], CONC GUID; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Dick RW, 2008, MED SCI SPORT EXER, V40, pS231, DOI 10.1249/01.mss.0000322493.95532.98; Diggle P., 2002, ANAL LONGITUDINAL DA; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Patel AV, 2007, J ATHL TRAINING, V42, P66; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Plummer P, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00225; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Thurman DJ, 1999, TRAUMATIC BRAIN INJU; Yardley L, 2001, J ANXIETY DISORD, V15, P107, DOI 10.1016/S0887-6185(00)00045-1	47	20	20	0	7	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2017	52	3					288	298		10.4085/1062-6050-52.1.12			11	Sport Sciences	Sport Sciences	ES0NE	WOS:000399222500013	28387552	Green Published, Bronze			2021-06-18	
J	Wang, CQ; Ye, Y; Chen, F; Han, WC; Sun, JM; Lu, X; Guo, R; Cao, K; Zheng, MJ; Liao, LC				Wang, C. -Q.; Ye, Y.; Chen, F.; Han, W. -C.; Sun, J. -M.; Lu, X.; Guo, R.; Cao, K.; Zheng, M. -J.; Liao, L. -C.			POSTTRAUMATIC ADMINISTRATION OF A SUB-ANESTHETIC DOSE OF KETAMINE EXERTS NEUROPROTECTION VIA ATTENUATING INFLAMMATION AND AUTOPHAGY	NEUROSCIENCE			English	Article						mTOR; autophagy; traumatic brain injury; ketamine	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; UP-REGULATION; MEMORY; RATS; REGENERATION; DEPRESSION; ISCHEMIA; RECEPTOR; RELEASE	As a complex disease, traumatic brain injury (TBI) can result in long-term psychiatric changes and sensorimotor and cognitive impairments. The TBI-induced loss of memory and long-term cognitive dysfunction are related to mechanistic factors including an increased inflammatory response, autophagy, edema, and ischemia. Many published studies have offered evidence for the neuroprotective effects and anti-inflammatory properties of ketamine for TBI patients. Nonetheless, there is a limited understanding of the accurate mechanism that underlies the potential neuroprotective effects of ketamine. Herein, it can be shown that posttraumatic administration of ketamine at a sub anesthetic dose (10 mg/kg ketamine, every 24 h up to 7 days) can prevent the TBI-induced production of IL-6 and TNF-alpha, attenuate deficits of dendrites and spines and exert beneficial effects on memory and behavior. Moreover, studies show that ketamine may activate the mTOR signaling pathway by p-mTOR induction to down-regulate the expression of crucial autophagic proteins such as LC3 and Beclin-1. According to these findings, ameliorating secondary brain injury and anti-inflammatory properties is closely related to the neuroprotection of ketamine, which supports the use of ketamine as a potential therapy for patients with TBI to alleviate functional deficits. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Wang, C. -Q.; Ye, Y.; Chen, F.; Lu, X.; Guo, R.; Liao, L. -C.] Sichuan Univ, Coll Basic & Forens Med, Chengdu 610041, Sichuan, Peoples R China; [Wang, C. -Q.; Han, W. -C.; Sun, J. -M.; Cao, K.; Zheng, M. -J.] Xuzhou Med Coll, Dept Pathol, Xuzhou 221004, Jiangsu, Peoples R China	Liao, LC (corresponding author), Sichuan Univ, Coll Basic & Forens Med, Chengdu 610041, Sichuan, Peoples R China.	linchuanliao@scu.edu.cn			National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81373239]	This work was supported by National Natural Sciences Foundation of China (81373239).	Adams SD, 2008, J TRAUMA, V65, P170, DOI 10.1097/TA.0b013e31805824ca; Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Amini M, 2013, J NEUROSCI, V33, P5773, DOI 10.1523/JNEUROSCI.4247-12.2013; [Anonymous], 2016, GLOBAL HLTH OBSERVAT; [Anonymous], 2016, DOD WORLDWIDE NUMBER; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bhutta AT, 2012, PEDIATR CRIT CARE ME, V13, P328, DOI 10.1097/PCC.0b013e31822f18f9; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; Chang ML, 2002, NEUROSCI LETT, V322, P137, DOI 10.1016/S0304-3940(01)02520-4; Chang Y, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/705379; DeClue AE, 2008, AM J VET RES, V69, P228, DOI 10.2460/ajvr.69.2.228; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fletcher PC, 2006, TRENDS COGN SCI, V10, P167, DOI 10.1016/j.tics.2006.02.008; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Himmelseher S, 1996, ANESTH ANALG, V83, P505, DOI 10.1097/00000539-199609000-00011; Himmelseher S, 2000, J NEUROSURG ANESTH, V12, P84, DOI 10.1097/00008506-200004000-00003; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Krystal JH, 2013, BIOL PSYCHIAT, V73, P1133, DOI 10.1016/j.biopsych.2013.03.026; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lodge D, 2015, BRIT J PHARMACOL, V172, P4254, DOI 10.1111/bph.13222; LUCAS J H, 1990, Journal of Neurotrauma, V7, P229, DOI 10.1089/neu.1990.7.229; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; Morgan CJA, 2006, PSYCHOPHARMACOLOGY, V188, P408, DOI 10.1007/s00213-006-0572-3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; ROTHMAN SM, 1987, NEUROSCIENCE, V21, P673, DOI 10.1016/0306-4522(87)90028-5; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Semchenko V V, 2006, Neurosci Behav Physiol, V36, P613, DOI 10.1007/s11055-006-0065-1; Silva-Gomez AB, 2003, BRAIN RES, V983, P128, DOI 10.1016/S0006-8993(03)03042-7; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang CY, 2002, NEUROSCI LETT, V328, P265, DOI 10.1016/S0304-3940(02)00543-8; Zhao YD, 2013, J NEUROSCI RES, V91, P1165, DOI 10.1002/jnr.23247	46	20	21	1	22	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 20	2017	343						30	38		10.1016/j.neuroscience.2016.11.029			9	Neurosciences	Neurosciences & Neurology	EJ5PB	WOS:000393269100004	27916727				2021-06-18	
J	Byrne, JP; Geerts, W; Mason, SA; Gomez, D; Hoeft, C; Murphy, R; Neal, M; Nathens, AB				Byrne, James P.; Geerts, William; Mason, Stephanie A.; Gomez, David; Hoeft, Christopher; Murphy, Ryan; Neal, Melanie; Nathens, Avery B.			Effectiveness of low-molecular-weight heparin versus unfractionated heparin to prevent pulmonary embolism following major trauma: A propensity-matched analysis	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	75th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / Clinical Congress of Acute Care Surgery	SEP 14-17, 2016	Waikoloa, HI	Amer Assoc Surg Trauma		Low-molecular-weight heparin; pulmonary embolism; trauma; Trauma Quality Improvement Program; unfractionated heparin	VENOUS THROMBOEMBOLISM PROPHYLAXIS; RISK-ASSESSMENT; COHORT; IMPROVEMENT; ENOXAPARIN; MANAGEMENT; THROMBOSIS; PROGRAM; DISEASE; EVENTS	BACKGROUND: Pulmonary embolism (PE) is a leading cause of delayed mortality in patients with severe injury. While low-molecular-weight heparin (LMWH) is often favored over unfractionated heparin (UH) for thromboprophylaxis, evidence is lacking to demonstrate an effect on the occurrence of PE. This study compared the effectiveness of LMWH versus UH to prevent PE in patients following major trauma. METHODS: Data for adults with severe injury who received thromboprophylaxis with LMWH or UH were derived from the American College of Surgeons Trauma Quality Improvement Program (2012-2015). Patients who died or were discharged within 5 days were excluded. Rates of PE were compared between propensity-matched LMWH and UH groups. Subgroup analyses included patients with blunt multisystem injury, penetrating truncal injury, shock, severe traumatic brain injury, and isolated orthopedic injury. A center-level analysis was performed to determine if practices with respect to choice of prophylaxis type influence hospital PE rates. RESULTS: We identified 153,474 patients at 217 trauma centers who received thromboprophylaxis with LMWH or UH. Low-molecular-weight heparin was given in 74% of patients. Pulmonary embolism occurred in 1.8%. Propensity score matching yielded a well-balanced cohort of 75,920 patients. After matching, LMWH was associated with a significantly lower rate of PE compared with UH (1.4% vs. 2.4%; odds ratio, 0.56; 95% confidence interval, 0.50-0.63). This finding was consistent across injury subgroups. Trauma centers in the highest quartile of LMWH utilization (median LMWH use, 95%) reported significantly fewer PE compared with centers in the lowest quartile (median LMWH use, 39%; 1.2% vs. 2.0%; odds ratio, 0.59; 95% confidence interval, 0.48-0.74). CONCLUSIONS: Thromboprophylaxis with LMWH (vs. UH) was associated with significantly lower risk of PE. Trauma centers favoring LMWH-based prophylaxis strategies reported lower rates of PE. Low-molecular-weight heparin should be the anticoagulant agent of choice for prevention of PE in patients with major trauma. (Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.) LEVEL OF EVIDENCE: Therapeutic study, level III.	[Byrne, James P.; Geerts, William; Mason, Stephanie A.; Nathens, Avery B.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Byrne, James P.; Mason, Stephanie A.; Nathens, Avery B.] Univ Toronto, Clin Epidemiol Program, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Byrne, James P.; Mason, Stephanie A.; Gomez, David; Nathens, Avery B.] Univ Toronto, Div Gen Surg, Toronto, ON, Canada; [Geerts, William; Nathens, Avery B.] Univ Toronto, Dept Surg, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Hoeft, Christopher; Murphy, Ryan; Neal, Melanie; Nathens, Avery B.] Amer Coll Surgeons, Trauma Qual Improvement Program, Chicago, IL USA	Byrne, JP (corresponding author), Sunnybrook Hlth Sci Ctr, Room D-574,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	jpbyrne@gmail.com		Byrne, James/0000-0002-3760-8509; Gomez, David/0000-0002-0926-2547	De Souza Chair in Trauma Research	This work was supported by funds from the De Souza Chair in Trauma Research (A.B.N.).	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; American College of Surgeons Committee on Trauma, 2015, NAT TRAUM DAT STAND; Amin AN, 2009, THROMB HAEMOSTASIS, V102, P321, DOI 10.1160/TH09-03-0147; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bandle J, 2014, J TRAUMA ACUTE CARE, V76, P213, DOI 10.1097/TA.0b013e3182aa2fa9; Barrera LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008303.pub2; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Cook D, 2014, J CRIT CARE, V29; CORRIGAN TP, 1974, BRIT J SURG, V61, P320; Dossett LA, 2011, J TRAUMA, V70, P1066, DOI 10.1097/TA.0b013e31821282d5; Fowler RA, 2014, JAMA-J AM MED ASSOC, V312, P2135, DOI 10.1001/jama.2014.15101; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hegsted D, 2013, AM J SURG, V205, P517, DOI 10.1016/j.amjsurg.2013.01.022; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Ho KM, 2010, BRIT J ANAESTH, V105, P596, DOI 10.1093/bja/aeq254; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Knudson MM, 2011, ANN SURG, V254, P625, DOI 10.1097/SLA.0b013e3182300209; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Machado-Aranda DA, 2015, J AM COLL SURGEONS, V221, P661, DOI 10.1016/j.jamcollsurg.2015.05.006; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Martel N, 2005, BLOOD, V106, P2710, DOI 10.1182/blood-2005-04-1546; McGowan KE, 2016, BLOOD, V127, P1954, DOI 10.1182/blood-2015-07-660001; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Olson EJ, 2015, J TRAUMA ACUTE CARE, V79, P961, DOI 10.1097/TA.0000000000000750; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Rogers FB, 2012, J TRAUMA ACUTE CARE, V73, P511, DOI 10.1097/TA.0b013e3182588b54; Rogers SO, 2007, J TRAUMA, V62, P562; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 2010, AM J OPHTHALMOL, V149, P7, DOI 10.1016/j.ajo.2009.08.024; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Thirugnanam S, 2012, CRIT CARE, V16, DOI 10.1186/cc11241; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V76, P1270, DOI 10.1097/TA.0000000000000233; Velmahos GC, 2009, ARCH SURG-CHICAGO, V144, P928, DOI 10.1001/archsurg.2009.97; Yuan Y, 2011, J STAT SOFTW, V45, P1	40	20	20	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2017	82	2					252	260		10.1097/TA.0000000000001321			9	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	EJ8GO	WOS:000393463600005	27906870				2021-06-18	
J	Chang, R; Folkerson, LE; Sloan, D; Tomasek, JS; Kitagawa, RS; Choi, HA; Wade, CE; Holcomb, JB				Chang, Ronald; Folkerson, Lindley E.; Sloan, Duncan; Tomasek, Jeffrey S.; Kitagawa, Ryan S.; Choi, H. Alex; Wade, Charles E.; Holcomb, John B.			Early plasma transfusion is associated with improved survival after isolated traumatic brain injury in patients with multifocal intracranial hemorrhage	SURGERY			English	Article							FRESH-FROZEN PLASMA; LARGE ANIMAL-MODEL; DAMAGE CONTROL; RESUSCITATION; MORTALITY; SHOCK; INFLAMMATION; RATIO	Background. Plasma-based resuscitation improves outcomes in trauma patients with hemorrhagic shock, while large-animal and limited clinical data suggest that it also improves outcomes and is neuroprotective in the setting of combined hemorrhage and traumatic brain injury. However; the choice of initial resuscitation fluid, including the role of plasma, is unclear for patients after isolated traumatic brain injury. Methods. We reviewed adult trauma patients admitted from January 2011 to July 2015 with isolated traumatic brain injury. "Early plasma" was defined as transfusion of plasma within 4 hours. Purposeful multiple logistic regression modeling was performed to analyze the relationship of early plasma and inhospital survival. After testing for interaction, subgroup analysis was performed based on the pattern of brain injury on initial head computed tomography: epidural hematoma, intraparenchymal contusion, subarachnoid hemorrhage, subdural hematoma, or multifocal intracranial hemorrhage. Results. Of the 633 isolated traumatic brain injury patients included, 178 (28 %) who received early plasma were injured more severely coagulopathic, hypoperfused, and hypotensive on admission. Survival was similar in the early plasma versus no early plasma groups (78% vs 84%, P = .08). After adjustment for covariates, early plasma was not associated with improved survival (odds ratio 1.18, 95% confidence interval 0.71-1.96). On subgroup analysis, multifocal intracranial hemorrhage was the largest subgroup with 242 patients. Of these, 61 (25 %) received plasma within 4 hours. Within-group logistic regression analysis with adjustment for covariates found that early plasma was associated with improved survival (odds ratio 3.34, 95% confidence interval 1.20-9.35). Conclusion. Although early plasma transfusion was not associated with improved in-hospital survival for all isolated traumatic brain injury patients, early plasma was associated with increased in-hospital survival in those with multifocal intracranial hemorrhage.	[Chang, Ronald; Folkerson, Lindley E.; Sloan, Duncan; Tomasek, Jeffrey S.; Wade, Charles E.; Holcomb, John B.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, 6410 Fannin St Suite 1100, Houston, TX 77030 USA; [Chang, Ronald; Folkerson, Lindley E.; Sloan, Duncan; Tomasek, Jeffrey S.; Wade, Charles E.; Holcomb, John B.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, 6410 Fannin St Suite 1100, Houston, TX 77030 USA; [Kitagawa, Ryan S.; Choi, H. Alex] Univ Texas Hlth Sci Ctr Houston, Dept Neurosurg, Houston, TX 77030 USA	Chang, R (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, 6410 Fannin St Suite 1100, Houston, TX 77030 USA.; Chang, R (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Surg, 6410 Fannin St Suite 1100, Houston, TX 77030 USA.	ronald.chang@uth.tmc.edu		chang, ronald/0000-0002-8947-0054; holcomb, john/0000-0001-8312-9157	National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5T32GM-008792]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER	R.C. is supported by a T32 fellowship (grant no. 5T32GM-008792) from the National Institute of General Medical Sciences.	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cotton BA, 2011, ANN SURG, V254, P598, DOI 10.1097/SLA.0b013e318230089e; Cotton BA, 2011, J TRAUMA, V71, P407, DOI 10.1097/TA.0b013e31821e1bf0; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2015, PREHOSP EMERG CARE, V19, P1, DOI 10.3109/10903127.2014.923077; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Marion DW, 2006, NEUROSURGERY, V58, P655; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Peng ZL, 2013, SHOCK, V40, P195, DOI 10.1097/SHK.0b013e31829f91fc; Potter DR, 2015, J TRAUMA ACUTE CARE, V78, pS7, DOI 10.1097/TA.0000000000000630; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Radwan ZA, 2013, JAMA SURG, V148, P170, DOI 10.1001/jamasurgery.2013.414; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Spinella PC, 2011, J TRAUMA, V71, pS343, DOI 10.1097/TA.0b013e318227ef2d; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	33	20	20	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	FEB	2017	161	2					538	545		10.1016/j.surg.2016.08.023			8	Surgery	Surgery	EJ0MT	WOS:000392904400034	27776795	Green Accepted			2021-06-18	
J	Ramsey, C; Dziura, J; Justice, AC; Altalib, HH; Bathulapalli, H; Burg, M; Decker, S; Driscoll, M; Goulet, J; Haskell, S; Kulas, J; Wang, KH; Mattocks, K; Brandt, C				Ramsey, Christine; Dziura, James; Justice, Amy C.; Altalib, Hamada Hamid; Bathulapalli, Harini; Burg, Matthew; Decker, Suzanne; Driscoll, Mary; Goulet, Joseph; Haskell, Sally; Kulas, Joseph; Wang, Karen H.; Mattocks, Kristen; Brandt, Cynthia			Incidence of Mental Health Diagnoses in Veterans of Operations Iraqi Freedom, Enduring Freedom, and New Dawn, 2001-2014	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; GENDER-DIFFERENCES; AFGHANISTAN VETERANS; US VETERANS; 1ST YEAR; RISK; SERVICE; ONSET; CARE	Objectives. To evaluate gender, age, and race/ethnicity as predictors of incident mental health diagnoses among Operations Iraqi Freedom, Enduring Freedom, and New Dawn veterans. Methods. We used US Veterans Health Administration (VHA) electronic health records from 2001 to 2014 to examine incidence rates and sociodemographic risk factors for mental health diagnoses among 888 142 veterans. Results. Posttraumatic stress disorder (PTSD) was the most frequently diagnosed mental health condition across gender and age groups. Incidence rates for all mental health diagnoses were highest at ages 18 to 29 years and declined thereafter, with the exceptions of major depressive disorder (MDD) in both genders, and PTSD among women. Risk of incident bipolar disorder and MDD diagnoses were greater among women; risk of incident schizophrenia, and alcohol-and drug-use disorders diagnoses were greater in men. Compared with Whites, risk incident PTSD, MDD, and alcohol-use disorder diagnoses were lower at ages 18 to 29 years and higher at ages 45 to 64 years for both Hispanics and African Americans. Conclusions. Differentiating high-risk demographic and gender groups can lead to improved diagnosis and treatment of mental health diagnoses among veterans and other high-risk groups.	[Ramsey, Christine; Justice, Amy C.; Altalib, Hamada Hamid; Bathulapalli, Harini; Burg, Matthew; Decker, Suzanne; Driscoll, Mary; Goulet, Joseph; Haskell, Sally; Kulas, Joseph; Wang, Karen H.; Mattocks, Kristen; Brandt, Cynthia] VA Connecticut Hlth Care Syst, West Haven, CT USA; [Ramsey, Christine; Dziura, James; Justice, Amy C.; Altalib, Hamada Hamid; Bathulapalli, Harini; Burg, Matthew; Decker, Suzanne; Driscoll, Mary; Goulet, Joseph; Haskell, Sally; Kulas, Joseph; Wang, Karen H.; Mattocks, Kristen; Brandt, Cynthia] Yale Univ, Sch Med, New Haven, CT USA	Ramsey, C (corresponding author), 300 George St,Room 780A, New Haven, CT 06511 USA.	christine.ramsey@yale.edu	Altalib, Hamada/B-9656-2018	Altalib, Hamada/0000-0001-7154-1400	VA Health Service Research and Development Project [IIR-12-118]; Veterans AffairsUS Department of Veterans Affairs [I01HX000915] Funding Source: NIH RePORTER	This study was supported by VA Health Service Research and Development Project IIR-12-118 (PI: S. H.).	AKISKAL HS, 1995, ARCH GEN PSYCHIAT, V52, P114; Baker DG, 2009, MIL MED, V174, P773; Blow FC, 2004, SOC PSYCH PSYCH EPID, V39, P841, DOI 10.1007/s00127-004-0824-7; Chen YH, 2011, PSYCHOL MED, V41, P1271, DOI 10.1017/S0033291710001819; Cieslak K, 2016, AM J MED GENET B, V171, P506, DOI 10.1002/ajmg.b.32350; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Crum-Cianflone NF, 2014, EPIDEMIOL REV, V36, P5, DOI 10.1093/epirev/mxt005; Cully Jeffrey A, 2008, Psychol Serv, V5, P320, DOI 10.1037/a0013719; Eaton WW, 1997, ARCH GEN PSYCHIAT, V54, P993; Goldberg JF, 2001, AM J PSYCHIAT, V158, P1265, DOI 10.1176/appi.ajp.158.8.1265; Gray Matt J, 2004, Prehosp Disaster Med, V19, P64; Harpaz-Rotem I, 2014, J NERV MENT DIS, V202, P97, DOI 10.1097/NMD.0000000000000078; Haskell SG, 2011, WOMEN HEALTH ISS, V21, P92, DOI 10.1016/j.whi.2010.08.001; Kessler R C, 1997, Epidemiol Psichiatr Soc, V6, P4; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P768; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kline A, 2010, AM J PUBLIC HEALTH, V100, P276, DOI 10.2105/AJPH.2009.162925; Koo KH, 2015, PSYCHIAT RES, V229, P724, DOI 10.1016/j.psychres.2015.08.013; Koo KH, 2015, PSYCHIAT SERV, V66, P507, DOI 10.1176/appi.ps.201300498; LURIE N, 1992, HOSP COMMUNITY PSYCH, V43, P69; Maguen S, 2012, PSYCHIAT SERV, V63, P1206, DOI 10.1176/appi.ps.201200051; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Martin E.M, 2008, J TRAUMA NURS, V15, P100; Martin Elisabeth Moy, 2008, J Trauma Nurs, V15, P94, DOI 10.1097/01.JTN.0000337149.29549.28; Miller SC, 2015, OCCUP ENVIRON MED, V72, P560, DOI 10.1136/oemed-2014-102646; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Office of Public Health Post-Deployment Health Group Veterans Health Administration Department of Veterans Affairs, 2014, AN VA HLTH CAR UT OP; Office of Public Health Post-Deployment Health Group Veterans Health Administration Department of Veterans Affairs, 2013, AN VA HLTH CAR UT OP; Prigerson HG, 2001, J NERV MENT DIS, V189, P99, DOI 10.1097/00005053-200102000-00005; Rosen CS, 2011, J NERV MENT DIS, V199, P879, DOI 10.1097/NMD.0b013e3182349ea5; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; US Department of Veterans Affairs, 2013, INCR VA HLTH CAR US; Yano EM, 2010, J GEN INTERN MED, V25, P56, DOI 10.1007/s11606-009-1116-4	36	20	20	1	15	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	FEB	2017	107	2					329	335		10.2105/AJPH.2016.303574			7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	EO9XG	WOS:000397040800043	27997229	Green Published			2021-06-18	
J	Bagnato, S; Boccagni, C; Sant'Angelo, A; Fingelkurts, AA; Fingelkurts, AA; Galardi, G				Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Fingelkurts, Alexander A.; Fingelkurts, Andrew A.; Galardi, Giuseppe			Longitudinal Assessment of Clinical Signs of Recovery in Patients with Unresponsive Wakefulness Syndrome after Traumatic or Nontraumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						Coma Recovery Scale Revised; disorders of consciousness; MCS; TBI; vegetative state	MINIMALLY CONSCIOUS STATE; DISORDERS	Although clinical examination is the gold standard for differential diagnosis between unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS), clinical signs denoting the first occurrence of conscious behavior in patients with UWS have not been clarified. In this prospective single-center cohort study, 31 consecutive patients with UWS after traumatic brain injury (TBI) (17 patients) or non-TBI were assessed with the Coma Recovery Scale Revised (CRS-R) at admission to a rehabilitation department and after 1, 2, 3, 6, and 12 months. Of the 21 patients who recovered consciousness during the study, 90.5% recovered consciousness within the first 3 months. At the first diagnosis of emergence from UWS, 52.4% of patients showed signs of awareness in only one CRS-R subscale. In particular, 42.9% of patients showed conscious behaviors on the visual CRS-R subscale (23.8% showed visual fixation and 19.1% showed visual pursuit), and 9.5% showed conscious behaviors on the motor CRS-R subscale (half showed localization to a noxious stimulus and half showed object manipulation). Moreover, 23.8% of patients had conscious behaviors on two CRS subscales, always involving the visual and motor CRS-R subscales. The remaining patients showed conscious behaviors on more than two CRS-R subscales. In conclusion, visual fixation and visual pursuit are the commonest early clinical signs denoting MCS. When emerging from UWS, patients with TBI often showed more signs of consciousness and had higher CRS-R scores than patients with non-TBI.	[Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Galardi, Giuseppe] Fdn Ist San Raffaele G Giglio, Rehabil Dept, Unit Neurophysiol, I-90015 Cefalu, PA, Italy; [Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Galardi, Giuseppe] Fdn Ist San Raffaele G Giglio, Rehabil Dept, Unit Severe Acquired Brain Injuries, I-90015 Cefalu, PA, Italy; [Fingelkurts, Alexander A.; Fingelkurts, Andrew A.] BM Sci Brain & Mind Technol Res Ctr, Espoo, Finland	Bagnato, S (corresponding author), Fdn Ist San Raffaele G Giglio, Rehabil Dept, Unit Neurophysiol, I-90015 Cefalu, PA, Italy.; Bagnato, S (corresponding author), Fdn Ist San Raffaele G Giglio, Rehabil Dept, Unit Severe Acquired Brain Injuries, I-90015 Cefalu, PA, Italy.	sergiobagnato@gmail.com	Bagnato, Sergio/H-6842-2013	Bagnato, Sergio/0000-0002-6289-1887			Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Estraneo A, 2015, CLIN REHABIL, V29, P803, DOI 10.1177/0269215514556002; Fingelkurts Alexander A, 2013, Suppl Clin Neurophysiol, V62, P81; Fingelkurts Alexander A, 2007, Cogn Process, V8, P183, DOI 10.1007/s10339-007-0175-x; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Royal College of Physicians, 2013, PROL DIS CONSC NAT C; Royal College of Physicians, 2003, PERM VEG STAT GUID D; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218	11	20	20	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					535	539		10.1089/neu.2016.4418			5	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800029					2021-06-18	
J	Mannix, R; Berkner, J; Mei, ZR; Alcon, S; Hashim, J; Robinson, S; Jantzie, L; Meehan, WP; Qiu, JH				Mannix, Rebekah; Berkner, Justin; Mei, Zhengrong; Alcon, Sasha; Hashim, Jumana; Robinson, Shenandoah; Jantzie, Lauren; Meehan, William P., III; Qiu, Jianhua			Adolescent Mice Demonstrate a Distinct Pattern of Injury after Repetitive Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						age; pediatric brain injury; TBI	CONTROLLED CORTICAL IMPACT; FOOTBALL-LEAGUE PLAYER; HEAD-INJURY; ALZHEIMERS-DISEASE; ADULT MICE; ENCEPHALOPATHY; RECEPTOR; NR2B; AGE; EPIDEMIOLOGY	Recently, there has been increasing interest in outcomes after repetitive mild traumatic brain injury (rmTBI) (e.g., sports concussions). Although most of the scientific attention has focused on elite athlete populations, the sequelae of rmTBI in children and young adults have not been well studied. Prior TBI studies have suggested that developmental differences in response to injury, including differences in excitotoxicity and inflammation, could result in differences in functional and histopathological outcomes after injury. The purpose of this study is to compare outcomes in adolescent (5-week-old) versus adult (4-month-old) mice in a clinically relevant model of rmTBI. We hypothesized that functional and histopathological outcomes after rmTBI would differ in developing adolescent brains compared with mature adult brains. Male adolescent and adult (C57Bl/6) mice were subjected to a weight drop model of rmTBI (n = 10-16/group). Loss of consciousness (LOC) after each injury was measured. Functional outcomes were assessed including tests of balance (rotorod), spatial memory (Morris water maze), and impulsivity (elevated plus maze). After behavioral testing, brains were assessed for histopathological outcomes including microglial immunolabeling and N-methyl-d-aspartate (NMDA) receptor subunit expression. Injured adolescent mice had longer LOC than injured adult mice compared with their respective sham controls. Compared with sham mice, adolescent and adult mice subjected to rmTBI had impaired balance, increased impulsivity, and worse spatial memory that persisted up to 3 months after injury, and the effect of injury was worse in adolescent than in adult mice in terms of spatial memory. Three months after injury, adolescent and adult mice demonstrated increased ionized calcium binding adaptor 1 (IbA1) immunolabeling compared with sham controls. Compared with sham controls, NMDA receptor subtype 2B (NR2B) expression in the hippocampus was reduced by similar to 20% in both adolescent and adult injured mice. The data suggest that injured adolescent mice may show a distinct pattern of functional deficits after injury that warrants further mechanistic studies.	[Mannix, Rebekah; Berkner, Justin; Alcon, Sasha; Hashim, Jumana; Meehan, William P., III; Qiu, Jianhua] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Robinson, Shenandoah] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Micheli Ctr Sports Injury Prevent, Boston, MA USA; [Meehan, William P., III] Boston Childrens Hosp, Sports Concuss Clin, Div Sports Med, Boston, MA USA; [Mannix, Rebekah; Robinson, Shenandoah; Meehan, William P., III; Qiu, Jianhua] Harvard Med Sch, Boston, MA USA; [Mei, Zhengrong] Guangzhou Med Univ, Affiliated Hosp 3, Dept Pharm, Guangzhou, Guangdong, Peoples R China; [Jantzie, Lauren] Univ New Mexico, Off Pediat Res, Dept Pediat & Neurosci, Albuquerque, NM 87131 USA	Mannix, R (corresponding author), Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA.	Rebekah.Mannix@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020		Guangzhou Medical College Research Grant [1201421151]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128] Funding Source: NIH RePORTER	Boston Children's Hospital Intellectual and Developmental Disabilities Research Center, Rebekah Mannix is supported by T32 HD40128-11A1, and Zhongrong Mei is supported by a Guangzhou Medical College Research Grant (1201421151).	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bi H, 2002, J NEUROL SCI, V200, P11, DOI 10.1016/S0022-510X(02)00087-4; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Brewer GJ, 1998, NEUROBIOL AGING, V19, P561, DOI 10.1016/S0197-4580(98)00091-8; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Cernak I, 2010, DEV NEUROSCI-BASEL, V32, P442, DOI 10.1159/000320085; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Ferreira JS, 2015, J NEUROSCI, V35, P8462, DOI 10.1523/JNEUROSCI.3567-14.2015; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Jantzie LL, 2015, CEREB CORTEX, V25, P482, DOI 10.1093/cercor/bht246; Jantzie LL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-131; Kriz PK, 2016, J PEDIATR-US, V171, P234, DOI 10.1016/j.jpeds.2015.12.006; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muller T, 2009, LEARN MEMORY, V16, P395, DOI 10.1101/lm.1398709; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Zhang Xueqing, 2013, Proceedings of the CSEE, V33, P33	31	20	20	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					495	504		10.1089/neu.2016.4457			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800025	27368354	Green Published			2021-06-18	
J	Naci, L; Sinai, L; Owen, AM				Naci, Lorina; Sinai, Leah; Owen, Adrian M.			Detecting and interpreting conscious experiences in behaviorally non-responsive patients	NEUROIMAGE			English	Article							INDEPENDENT COMPONENT ANALYSIS; NATURAL VIEWING CONDITIONS; TRAUMATIC BRAIN-INJURY; SPATIAL NORMALIZATION; SUSTAINED ATTENTION; DISORDERS; AWARENESS; STATE; ACCURACY; CORTEX	Decoding the contents of consciousness from brain activity is one of the most challenging frontiers of cognitive neuroscience. The ability to interpret mental content without recourse to behavior is most relevant for understanding patients who may be demonstrably conscious, but entirely unable to speak or move willfully in any way, precluding any systematic investigation of their conscious experience. The lack of consistent behavioral responsivity engenders unique challenges to decoding any conscious experiences these patients may have solely based on their brain activity. For this reason, paradigms that have been successful in healthy individuals cannot serve to interpret conscious mental states in this patient group. Until recently, patient studies have used structured instructions to elicit willful modulation of brain activity according to command, in order to decode the presence of willful brain-based responses in this patient group. In recent work, we have used naturalistic paradigms, such as watching a movie or listening to an audio-story, to demonstrate that a common neural code supports conscious experiences in different individuals. Moreover, we have demonstrated that this code can be used to interpret the conscious experiences of a patient who had remained non-responsive for several years. This approach is easy to administer, brief, and does not require compliance with task instructions. Rather, it engages attention naturally through meaningful stimuli that are similar to the real-world sensory information in a patient's environment. Therefore, it may be particularly suited to probing consciousness and revealing residual brain function in highly impaired, acute, patients in a comatose state, thus helping to improve diagnostication and prognostication for this vulnerable patient group from the critical early stages of severe brain-injury. (C) 2015 Elsevier Inc. All rights reserved.	[Naci, Lorina; Sinai, Leah; Owen, Adrian M.] Univ Western ON, Dept Psychol, Brain & Mind Inst, London, ON N6A 5B7, Canada	Naci, L (corresponding author), Univ Western ON, Dept Psychol, Brain & Mind Inst, London, ON N6A 5B7, Canada.	lnaci@uwo.ca		Naci, Lorina/0000-0001-9630-3978	Canada Excellence Research Chairs (CERC) program [215063]	We thank Conor Wild and Rhodri Cusack for their help with the stimuli. This research was supported by the Canada Excellence Research Chairs (CERC) (215063) program.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Bardin JC, 2012, ARCH NEUROL-CHICAGO, V69, P176, DOI 10.1001/archneurol.2011.892; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Bartels A, 2004, NEUROIMAGE, V22, P419, DOI 10.1016/j.neuroimage.2004.01.007; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beisteiner R, 2010, HUM BRAIN MAPP, V31, P1951, DOI 10.1002/hbm.20990; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Chennu S, 2013, NEUROIMAGE-CLIN, V3, P450, DOI 10.1016/j.nicl.2013.10.008; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Chung CSY, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008391.pub2; Collette F, 2005, COGNITIVE BRAIN RES, V24, P237, DOI 10.1016/j.cogbrainres.2005.01.023; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; Cruse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049933; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Datta A., 2007, COMPUT INTELL NEUROS, V2007; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dmochowski JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5567; Dmochowski JP, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00112; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fernandez-Espejo D, 2013, NAT REV NEUROSCI, V14, P801, DOI 10.1038/nrn3608; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2008, PROJECTIONS, V2, P1, DOI 10.3167/proj.2008.020102; Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011; Hasson U, 2009, AUTISM RES, V2, P220, DOI 10.1002/aur.89; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; MacDonald AA, 2015, TRENDS COGN SCI, V19, P100, DOI 10.1016/j.tics.2014.12.005; Malinen S, 2007, NEUROIMAGE, V35, P131, DOI 10.1016/j.neuroimage.2006.11.015; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mizuno K, 2012, NEUROPSYCHOLOGIA, V50, P1998, DOI 10.1016/j.neuropsychologia.2012.04.025; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Naci L., 2015, SOC NEUR ANN M CHIC; Naci L, 2014, P NATL ACAD SCI USA, V111, P14277, DOI 10.1073/pnas.1407007111; Naci L, 2013, JAMA NEUROL, V70, P1235, DOI 10.1001/jamaneurol.2013.3686; Naci L, 2013, J NEUROSCI, V33, P9385, DOI 10.1523/JNEUROSCI.5577-12.2013; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Owen AM, 2008, FUNCT NEUROL, V23, P189; Pettit LD, 2013, BRAIN, V136, P3290, DOI 10.1093/brain/awt243; Plum F., 1966, DIAGNOSIS STUPOR COM; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Young GB, 2009, ANN NY ACAD SCI, V1157, P32, DOI 10.1111/j.1749-6632.2009.04471.x	60	20	20	0	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JAN 15	2017	145		B		SI		304	313		10.1016/j.neuroimage.2015.11.059			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EG3WU	WOS:000390976200015	26679327				2021-06-18	
J	Strain, JF; Didehbani, N; Spence, J; Conover, H; Bartz, EK; Mansinghani, S; Jeroudi, MK; Rao, NK; Fields, LM; Kraut, MA; Cullum, CM; Hart, J; Womack, KB				Strain, Jeremy F.; Didehbani, Nyaz; Spence, Jeffrey; Conover, Heather; Bartz, Elizabeth K.; Mansinghani, Sethesh; Jeroudi, Myrtle K.; Rao, Neena K.; Fields, Lindy M.; Kraut, Michael A.; Cullum, C. Munro; Hart, John, Jr.; Womack, Kyle B.			White Matter Changes and Confrontation Naming in Retired Aging National Football League Athletes	JOURNAL OF NEUROTRAUMA			English	Article						concussion; DTI; naming; National Football League; TBSS; white matter	TRAUMATIC BRAIN-INJURY; COGNITIVE DYSFUNCTION; RECURRENT CONCUSSION; COMPREHENSION; DEPRESSION; INTEGRITY; DEFICITS; PLAYERS; FMRI	Using diffusion tensor imaging (DTI), we assessed the relationship of white matter integrity and performance on the Boston Naming Test (BNT) in a group of retired professional football players and a control group. We examined correlations between fractional anisotropy (FA) and mean diffusivity (MD) with BNT T-scores in an unbiased voxelwise analysis processed with tract-based spatial statistics (TBSS). We also analyzed the DTI data by grouping voxels together as white matter tracts and testing each tract's association with BNT T-scores. Significant voxelwise correlations between FA and BNT performance were only seen in the retired football players (p < 0.02). Two tracts had mean FA values that significantly correlated with BNT performance: forceps minor and forceps major. White matter integrity is important for distributed cognitive processes, and disruption correlates with diminished performance in athletes exposed to concussive and subconcussive brain injuries, but not in controls without such exposure.	[Strain, Jeremy F.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Didehbani, Nyaz; Spence, Jeffrey; Conover, Heather; Bartz, Elizabeth K.; Mansinghani, Sethesh; Rao, Neena K.; Fields, Lindy M.; Kraut, Michael A.; Hart, John, Jr.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, Dallas, TX USA; [Didehbani, Nyaz; Jeroudi, Myrtle K.; Cullum, C. Munro; Hart, John, Jr.; Womack, Kyle B.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Didehbani, Nyaz; Jeroudi, Myrtle K.; Cullum, C. Munro; Hart, John, Jr.; Womack, Kyle B.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA; [Kraut, Michael A.] Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD USA	Womack, KB (corresponding author), UT Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Kyle.Womack@UTSouthwestern.edu	Cullum, C. Munro/AAC-2496-2019; Womack, Kyle/O-5422-2018	Cullum, C. Munro/0000-0001-9706-5465; Womack, Kyle/0000-0002-6060-9075; Didehbani, Nyaz/0000-0001-6121-5759	BrainHealth Institute for Athletes at the Center for BrainHealth, a research center at the University of Texas at Dallas; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [5K23AG030006]	This work was made possible by support from the BrainHealth Institute for Athletes at the Center for BrainHealth, a research center at the University of Texas at Dallas. We also express our sincerest gratitude to the retired NFL athletes who participated in our study. No author involved in this project has a financial conflict of interest regarding this study or the reported data. This project was partially funded by National Institute on Aging grant 5K23AG030006.	Alosco Michael L., 2016, ALZHEIMERS DEMENTIA; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Binder DK, 2009, J NEUROSURG, V111, P1283, DOI 10.3171/2009.3.JNS081366; Binder JR, 2011, NEUROIMAGE, V54, P1465, DOI 10.1016/j.neuroimage.2010.09.048; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Crosson B, 1999, CEREB CORTEX, V9, P307, DOI 10.1093/cercor/9.4.307; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hart J, 1998, P NATL ACAD SCI USA, V95, P6498, DOI 10.1073/pnas.95.11.6498; Hart J, 2000, NEUROPSY NEUROPSY BE, V13, P1; HART J, 1990, ANN NEUROL, V27, P226, DOI 10.1002/ana.410270303; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Heaton RK, 2004, REVISED COMPREHENSIV; Huang H, 2012, NEUROBIOL AGING, V33, P2029, DOI 10.1016/j.neurobiolaging.2011.06.027; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jou RJ, 2011, AM J NEURORADIOL, V32, P1607, DOI 10.3174/ajnr.A2558; Kaplan E., 1983, BOSTON NAMING TEST; Kelly JP, 1997, NEUROLOGY, V48, P581; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kraut M, 1997, NEUROLOGY, V48, P1416, DOI 10.1212/WNL.48.5.1416; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Moritz-Gasser S, 2013, NEUROPSYCHOLOGIA, V51, P1814, DOI 10.1016/j.neuropsychologia.2013.06.007; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Obler LK, 2010, BRAIN LANG, V113, P113, DOI [10.1016/j.band1.2010.03.001, 10.1016/j.bandl.2010.03.001]; Papagno C, 2011, CURR NEUROL NEUROSCI, V11, P553, DOI 10.1007/s11910-011-0219-6; Peltier J, 2012, J NEUROL, V259, P1860, DOI 10.1007/s00415-012-6421-x; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; Ralph MAL, 2010, P NATL ACAD SCI USA, V107, P2717, DOI 10.1073/pnas.0907307107; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Thomason ME, 2011, ANNU REV CLIN PSYCHO, V7, P63, DOI 10.1146/annurev-clinpsy-032210-104507; Vernooij MW, 2009, ARCH GEN PSYCHIAT, V66, P545, DOI 10.1001/archgenpsychiatry.2009.5; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Wang Y, 2008, J NEUROTRAUM, V25, P1187, DOI 10.1089/neu.2008.0542	52	20	20	0	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					372	+		10.1089/neu.2016.4446			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800012	27297660	Green Published			2021-06-18	
J	Banks, WA; Kovac, A; Majerova, P; Bullock, KM; Shi, M; Zhang, J				Banks, William A.; Kovac, Andrej; Majerova, Petra; Bullock, Kristin M.; Shi, Min; Zhang, Jing			Tau Proteins Cross the Blood-Brain Barrier	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; blood-brain barrier; tau protein; tauopathy	PAIRED HELICAL FILAMENT; ALZHEIMERS-DISEASE; P-GLYCOPROTEIN; ALPHA-SYNUCLEIN; DISORDERED PROTEINS; CEREBROSPINAL-FLUID; EFFLUX TRANSPORT; CLEARANCE; PATHOLOGY; PEPTIDE	Tauopathies are a hallmark of many neurodegenerative diseases, including Alzheimer's disease and traumatic brain injuries. It has been demonstrated that amyloid-beta peptides, alpha-synuclein, and prion proteins cross the blood-brain barrier (BBB), contributing to their abilities to induce disease. Very little is known about whether tau proteins can cross the BBB. Here we systematically characterized several key forms of tau proteins to cross the BBB, including Tau-441 (2N4R), Tau-410 (2N3R), truncated tau 151-391 (0N4R), and truncated tau 121-227. All of these tau proteins crossed the BBB readily and bidirectonally; however, only Tau-410 had a saturable component to its influx. The tau proteins also entered the blood after their injection into the brain, with Tau 121-227 having the slowest exit from brain. The tau proteins varied in regards to their enzymatic stability in brain and blood and in their peripheral pharmacokinetics. These results show that blood-borne tau proteins could contribute to brain tauopathies. The result also suggest that the CNS can contribute to blood levels of tau, raising the possibility that, as suggested for other misfolded proteins, blood levels of tau proteins could be used as a biomarker of CNS disease.	[Banks, William A.; Bullock, Kristin M.] Vet Affairs Puget Sound Hlth Care Syst, Res & Dev, Seattle, WA USA; [Banks, William A.] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Kovac, Andrej; Majerova, Petra] Slovak Acad Sci, Inst Neuroimmunol, Bratislava, Slovakia; [Kovac, Andrej] Univ Vet Med & Pharm, Dept Pharmacol & Toxicol, Kosice, Slovakia; [Majerova, Petra] AXON Neurosci SE, Bratislava, Slovakia; [Shi, Min; Zhang, Jing] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Zhang, Jing] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing, Peoples R China; [Zhang, Jing] Peking Univ, Hosp 3, Beijing, Peoples R China	Banks, WA (corresponding author), VAPSHCS, 1660S ColumbianWay, Seattle, WA 98108 USA.	wabanks1@uw.edu	Banks, William A/K-1330-2017; Shi, Min/G-6165-2012	Banks, William A/0000-0002-0496-3619; Shi, Min/0000-0002-6901-2558; Zhang, Jing/0000-0002-9224-6299	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG046619]; Alzheimer's Association grantAlzheimer's Association [2015-NIRG-342009]; Veterans AffairsUS Department of Veterans Affairs; APVV-14-0547	Supported by APVV-14-0547, Veterans Affairs, Alzheimer's Association grant 2015-NIRG-342009, and NIH R01 AG046619.	Banks WA, 2004, BIOCHEM BIOPH RES CO, V318, P125, DOI 10.1016/j.bbrc.2004.04.009; BANKS WA, 1988, J PHARMACOL EXP THER, V244, P579; BANKS WA, 1992, PROG BRAIN RES, V91, P139; Banks WA, 2005, EFFLUX TRANSPORTERS AND THE BLOOD-BRAIN BARRIER, P21; Barthelemy NR, 2016, J PROTEOME RES, V15, P667, DOI 10.1021/acs.jproteome.5b01001; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Blair LJ, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0186-2; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Csokova N, 2004, PROTEIN EXPRES PURIF, V35, P366, DOI 10.1016/j.pep.2004.01.012; Davson H, 1996, PHYSL CSF BLOOD BRAI, P573; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Erickson MA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-150; Greig NH, 1995, NEW CONCEPTS OF A BLOOD-BRAIN BARRIER, P251; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Jadhav S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00024; Jaeger LB, 2009, J ALZHEIMERS DIS, V17, P553, DOI 10.3233/JAD-2009-1074; Kakee A, 1996, J PHARMACOL EXP THER, V277, P1550; Krajciova G, 2008, ANAL BIOCHEM, V383, P343, DOI 10.1016/j.ab.2008.09.022; Lam FC, 2001, J NEUROCHEM, V76, P1121, DOI 10.1046/j.1471-4159.2001.00113.x; Maness LM, 1996, PEPTIDES, V17, P247, DOI 10.1016/0196-9781(95)02135-3; MANESS LM, 1994, LIFE SCI, V55, P1643, DOI 10.1016/0024-3205(94)00331-9; Merlini M, 2016, ACTA NEUROPATHOL, V131, P737, DOI 10.1007/s00401-016-1560-2; Michalicova A, 2016, CURR ALZHEIMER RES; Morales R, 2015, VIRUS RES, V207, P106, DOI 10.1016/j.virusres.2014.12.031; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Pan WH, 2001, J NEUROIMMUNOL, V115, P64, DOI 10.1016/S0165-5728(01)00256-9; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Sagare AP, 2013, J ALZHEIMERS DIS, V33, pS87, DOI 10.3233/JAD-2012-129037; Salkeni MA, 2009, J NEUROIMMUNE PHARM, V4, P276, DOI 10.1007/s11481-008-9138-y; Shi M, 2016, ALZHEIMERS DEMENT, V12, P1125, DOI 10.1016/j.jalz.2016.04.003; Shi M, 2014, ACTA NEUROPATHOL, V128, P639, DOI 10.1007/s00401-014-1314-y; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Sui YT, 2014, PEPTIDES, V62, P197, DOI 10.1016/j.peptides.2014.09.018; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vasudevaraju P, 2012, J PHARM BIOALLIED SC, V4, P112, DOI 10.4103/0975-7406.94811; Vogelgesang S, 2002, PHARMACOGENETICS, V12, P535, DOI 10.1097/00008571-200210000-00005; Vogelgesang S, 2011, CURR PHARM DESIGN, V17, P2778, DOI 10.2174/138161211797440168; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Yu CH, 2008, CELL PHYSIOL BIOCHEM, V22, P745, DOI 10.1159/000185558; Zilka N, 2012, BIOCHEM SOC T, V40, P681, DOI 10.1042/BST20120015; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	48	20	20	1	30	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2017	55	1					411	419		10.3233/JAD-160542			9	Neurosciences	Neurosciences & Neurology	EB8WI	WOS:000387671600032	27662303				2021-06-18	
J	Carter, CJ				Carter, Chris J.			Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer's Disease	JOURNAL OF ALZHEIMERS DISEASE REPORTS			English	Article						Alzheimer's disease; bacteria; blood-brain barrier; fungi; gene/environment; immune system; inflammation; microbes; virus		Diverse pathogens are detected in Alzheimer's disease (AD) brains. A bioinformatics survey showed that AD genome-wide association study (GWAS) genes (localized in bone marrow, immune locations and microglia) relate to multiple host/pathogen interactomes (Candida albicans, Cryptococcus neoformans, Bornavirus, Borrelia burgdorferri, cytomegalovirus, Ebola virus, HSV-1, HERV-W, HIV-1, Epstein-Barr, hepatitis C, influenza, Chlamydia pneumoniae, Porphyrymonas gingivalis, Helicobacter pylori, Toxoplasma gondii, Trypanosoma cruzi). These interactomes also relate to the AD hippocampal transcriptome and to plaque or tangle proteins. Upregulated AD hippocampal genes match those upregulated by multiple bacteria, viruses, fungi, or protozoa in immunocompetent cells. AD genes are enriched in GWAS datasets reflecting pathogen diversity, suggesting selection for pathogen resistance, as supported by the old age of AD patients, implying resistance to earlier infections. APOE4 is concentrated in regions of high parasitic burden and protects against childhood tropical infections and hepatitis C. Immune/inflammatory gain of function applies to APOE4, CR1, and TREM2 variants. AD genes are also expressed in the blood-brain barrier (BBB), which is disrupted by AD risk factors (age, alcohol, aluminum, concussion, cerebral hypoperfusion, diabetes, homocysteine, hypercholesterolemia, hypertension, obesity, pesticides, pollution, physical inactivity, sleep disruption, smoking) and by pathogens, directly or via olfactory routes to basal-forebrain BBB control centers. The BBB benefits from statins, NSAIDs, estrogen, melatonin, memantine, and the Mediterranean diet. Polymicrobial involvement is supported by upregulation of bacterial, viral, and fungal sensors/defenders in the AD brain, blood, or cerebrospinal fluid. AD serum amyloid-beta autoantibodies may attenuate its antimicrobial effects favoring microbial survival and cerebral invasion leading to activation of neurodestructive immune/inflammatory processes, which may also be augmented by age-related immunosenescence. AD may thus respond to antibiotic, antifungal, or antiviral therapy.	[Carter, Chris J.] PolygenicPathways, Flat 2,40 Baldslow Rd, Hastings TN34 2EY, E Sussex, England	Carter, CJ (corresponding author), PolygenicPathways, Flat 2,40 Baldslow Rd, Hastings TN34 2EY, E Sussex, England.	chris_car@yahoo.com		Carter, Christopher/0000-0003-1368-4205			Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Abu-Qare AW, 2003, J TOXICOL ENV HEAL B, V6, P41, DOI 10.1080/10937400390155481; ADACHI T, 1990, BRAIN RES, V514, P163, DOI 10.1016/0006-8993(90)90452-H; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Ako-Adjei D, 2015, NUCLEIC ACIDS RES, V43, pD566, DOI 10.1093/nar/gku1126; Ala TA, 2004, J ALZHEIMERS DIS, V6, P503; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Alenquer M, 2015, VIRUSES-BASEL, V7, P5066, DOI 10.3390/v7092862; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Alonso R, 2017, J ALZHEIMERS DIS, V58, P55, DOI [10.3233/JAD-170058, 10.3233/jad-170058]; Alonso R, 2015, J ALZHEIMERS DIS, V47, P873, DOI 10.3233/JAD-150382; Alonso R, 2014, J ALZHEIMERS DIS, V41, P301, DOI 10.3233/JAD-132681; Arnold SE, 2010, ANN NEUROL, V67, P462, DOI 10.1002/ana.21910; Attems J, 2005, J ALZHEIMERS DIS, V7, P149; Aucan C, 2004, J MED GENET, V41, P21, DOI 10.1136/jmg.2003.011981; Badhwar A, 2014, J CEREBR BLOOD F MET, V34, P1033, DOI 10.1038/jcbfm.2014.52; Balbuena P, 2011, NEUROTOXICOLOGY, V32, P58, DOI 10.1016/j.neuro.2010.10.004; Banks WA, 1999, J NEUROVIROL, V5, P538, DOI 10.3109/13550289909021284; Baranyai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145686; Barichello T, 2015, AGING DIS, V6, P342, DOI 10.14336/AD.2015.0521; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beard RS, 2011, BLOOD, V118, P2007, DOI 10.1182/blood-2011-02-338269; BECKER Y, 1995, VIRUS GENES, V10, P217, DOI 10.1007/BF01701811; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergen AA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2159-z; Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-643; BIESOLD D, 1989, NEUROSCI LETT, V98, P39, DOI 10.1016/0304-3940(89)90370-4; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Boelen E, 2007, ACTA NEUROPATHOL, V114, P255, DOI 10.1007/s00401-007-0252-3; Bourgade K, 2016, J ALZHEIMERS DIS, V50, P1227, DOI 10.3233/JAD-150652; Bourgade K, 2015, BIOGERONTOLOGY, V16, P85, DOI 10.1007/s10522-014-9538-8; Branco FJ, 2005, J VIROL, V79, P9019, DOI 10.1128/JVI.79.14.9019-9025.2005; Branger P, 2016, NEUROBIOL AGING, V41, P107, DOI 10.1016/j.neurobiolaging.2016.02.009; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Brinkworth JF, 2014, CURR OPIN IMMUNOL, V31, P66, DOI 10.1016/j.coi.2014.09.008; Brison E, 2014, J VIROL, V88, P1548, DOI 10.1128/JVI.02972-13; Brkic M, 2015, J NEUROSCI, V35, P12766, DOI 10.1523/JNEUROSCI.0006-15.2015; Brunnstrom HR, 2009, EUR J NEUROL, V16, P488, DOI 10.1111/j.1468-1331.2008.02503.x; Bu XL, 2015, EUR J NEUROL, V22, P1519, DOI 10.1111/ene.12477; Bynoe MS, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0017-7; Caggiu E, 2016, J NEUROIMMUNOL, V291, P110, DOI 10.1016/j.jneuroim.2016.01.007; Cagliani Rachele, 2013, Int J Evol Biol, V2013, P204240, DOI 10.1155/2013/204240; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2015, J ALZHEIMERS DIS, V48, P1065, DOI 10.3233/JAD-150415; Camargo LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115369; Candelario-Jalil E, 2008, PHARMACOL RES, V57, P266, DOI 10.1016/j.phrs.2008.03.003; Carbone I, 2014, NEUROBIOL AGING, V35, P122, DOI 10.1016/j.neurobiolaging.2013.06.024; Cardinali DP, 2014, ANTIOXIDANTS, V3, P245, DOI 10.3390/antiox3020245; Carlisle MD, 2009, J INNATE IMMUN, V1, P118, DOI 10.1159/000181015; Carter CJ, 2013, J PATHOG, V2013, DOI 10.1155/2013/965046; Carter CJ, 2011, NEUROCHEM INT, V58, P301, DOI 10.1016/j.neuint.2010.12.003; Carter Chris, 2011, Int J Alzheimers Dis, V2011, P501862, DOI 10.4061/2011/501862; Carter CJ, 2013, PATHOG DIS, V69, P240, DOI 10.1111/2049-632X.12077; Carter CJ, 2011, ISRN NEUROL, V2011; Cattaneo A, 2017, NEUROBIOL AGING, V49, P60, DOI 10.1016/j.neurobiolaging.2016.08.019; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Chang YP, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/175729; Chen N, 2000, VIROLOGY, V276, P44, DOI 10.1006/viro.2000.0562; Chen XS, 2010, J ALZHEIMERS DIS, V20, pS127, DOI 10.3233/JAD-2010-1376; Chetelat G, 2016, BRAIN, V139, P2528, DOI 10.1093/brain/aww159; Chiu WC, 2014, EUR J NEUROL, V21, P1068, DOI 10.1111/ene.12317; Cho SW, 2013, J BIOL CHEM, V288, P6814, DOI 10.1074/jbc.M112.393363; Christen-Zaech S, 2003, CAN J NEUROL SCI, V30, P20, DOI 10.1017/S0317167100002389; Ciaramella A, 2010, J ALZHEIMERS DIS, V19, P559, DOI 10.3233/JAD-2010-1257; Cochran JN, 2015, HUM MOL GENET, V24, P6667, DOI 10.1093/hmg/ddv371; Colasanti T, 2010, AUTOIMMUN REV, V9, P807, DOI 10.1016/j.autrev.2010.07.008; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Czygan M, 1999, J INFECT DIS, V180, P1695, DOI 10.1086/315068; Da Mesquita S, 2016, NEUROSCI BIOBEHAV R, V68, P547, DOI 10.1016/j.neubiorev.2016.06.014; de Chaves EP, 2008, FUTURE LIPIDOL, V3, P505, DOI 10.2217/17460875.3.5.505; de la Torre JC, 2010, NEURODEGENER DIS, V7, P116, DOI 10.1159/000285520; de Senna PN, 2015, BRAIN RES, V1618, P75, DOI 10.1016/j.brainres.2015.05.026; Delahaye NF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-452; Di Marco LY, 2015, NEUROBIOL DIS, V82, P593, DOI 10.1016/j.nbd.2015.08.014; Dumurgier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053587; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Efthymiou AG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0184-x; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Emamian F, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00078; Emery DC, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00195; Engler-Chiurazzi EB, 2016, BRAIN RES, V1633, P96, DOI 10.1016/j.brainres.2015.12.044; Esiri MM, 1998, J NEUROL NEUROSUR PS, V65, P29, DOI 10.1136/jnnp.65.1.29; Feart C, 2015, CURR OPIN CLIN NUTR, V18, P51, DOI 10.1097/MCO.0000000000000131; Feldman HH, 2008, STROKE, V39, P2894, DOI 10.1161/STROKEAHA.107.510826; Ferencz B, 2014, PSYCHOL AGING, V29, P440, DOI 10.1037/a0035465; Ferreira PC, 2008, REV LAT-AM ENFERM, V16, P151, DOI 10.1590/S0104-11692008000100023; Finch CE, 2016, EVOLUTIONARY THINKIN, P277; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fonseca MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149792; Fujihashi K, 2009, TRENDS IMMUNOL, V30, P334, DOI 10.1016/j.it.2009.04.004; Fujioka H, 2013, J HEALTH CARE POOR U, V24, P70, DOI 10.1353/hpu.2014.0009; Fulop T, 2017, CLIN EXP IMMUNOL, V187, P35, DOI 10.1111/cei.12836; Fulop T, 2016, BIOGERONTOLOGY, V17, P147, DOI 10.1007/s10522-015-9615-7; Fumagalli M, 2014, CURR OPIN IMMUNOL, V30, P9, DOI 10.1016/j.coi.2014.05.001; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Fumagalli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-264; Fumagalli M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000849; Gagliano SA, 2016, ANN CLIN TRANSL NEUR, V3, P924, DOI 10.1002/acn3.369; Gale SC, 2014, J ALLERGY CLIN IMMUN, V134, P127, DOI 10.1016/j.jaci.2014.01.032; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Gies U, 2001, NEUROREPORT, V12, P3767, DOI 10.1097/00001756-200112040-00033; Gies U, 1998, BRAIN PATHOL, V8, P39; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gulbahce N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002531; Harris SA, 2015, J ALZHEIMERS DIS, V48, P319, DOI 10.3233/JAD-142853; He JY, 2014, J NEUROSCI, V34, P14697, DOI 10.1523/JNEUROSCI.2111-14.2014; Helen G, 2014, FREE RADICAL BIO MED, V75, pS15, DOI 10.1016/j.freeradbiomed.2014.10.591; Hempel P, 2016, THER APHER DIAL, V20, P523, DOI 10.1111/1744-9987.12415; Hendrie HC, 2015, ETHNIC DIS, V25, P345, DOI 10.18865/ed.25.3.345; HENKE H, 1983, BRAIN RES, V267, P281, DOI 10.1016/0006-8993(83)90880-6; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Heron M, 2013, NATL VITAL STAT REPO, V65, P1; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Himi T, 2011, ADV OTO-RHINO-LARYNG, V72, P28, DOI 10.1159/000324590; Hintermann E, 2002, INFECT IMMUN, V70, P5846, DOI 10.1128/IAI.70.10.5846-5856.2002; Hoffmann M, 2009, J ALZHEIMERS DIS, V16, P517, DOI 10.3233/JAD-2009-0985; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Hu RF, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00098; Hussain M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00045; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; Inoue Y, 2016, AM J NEURORADIOL, V37, P223, DOI 10.3174/ajnr.A4496; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Itzhaki RF, 2016, J ALZHEIMERS DIS, V51, P979, DOI 10.3233/JAD-160152; Janeway CA, 2011, IMMUNE SYSTEM HLTH D; Jiang QH, 2017, MOL NEUROBIOL, V54, P594, DOI 10.1007/s12035-015-9670-8; Jiang XZ, 2011, J VIROL, V85, P2325, DOI 10.1128/JVI.01791-10; Jiang Xijuan, 2012, Int J Alzheimers Dis, V2012, P109324, DOI 10.1155/2012/109324; Johnson DC, 2002, CURR TOP MICROBIOL, V269, P101; Kageyama Mitsuyo, 2008, Asia Pac J Public Health, V20 Suppl, P111; Kalamvoki M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0518-2; Kalinin S, 2006, EUR J NEUROSCI, V24, P3393, DOI 10.1111/j.1460-9568.2006.05223.x; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kamer AR, 2015, NEUROBIOL AGING, V36, P627, DOI 10.1016/j.neurobiolaging.2014.10.038; Kang R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003511; KAPUR N, 1994, J NEUROL NEUROSUR PS, V57, P1334, DOI 10.1136/jnnp.57.11.1334; Karch Celeste M, 2015, Biol Psychiatry, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Katz J, 2000, INFECT IMMUN, V68, P1441, DOI 10.1128/IAI.68.3.1441-1449.2000; Kellner A, 2009, ANN NEUROL, V65, P24, DOI 10.1002/ana.21475; Kiernan J A, 2012, Epilepsy Res Treat, V2012, P176157, DOI 10.1155/2012/176157; Kim YK, 2016, YONSEI MED J, V57, P5, DOI 10.3349/ymj.2016.57.1.5; Kornhuber HH, 1996, EUR ARCH PSY CLIN N, V246, P108, DOI 10.1007/BF02274902; Kountouras J, 2009, J NEUROL, V256, P758, DOI 10.1007/s00415-009-5011-z; Koyuncu E, 2014, MBIO, V5, DOI 10.1128/mBio.02249-14; Kraft P, 2013, EXP NEUROL, V247, P80, DOI 10.1016/j.expneurol.2013.03.026; Kristen H, 2015, NEUROBIOL AGING, V36, P2737, DOI 10.1016/j.neurobiolaging.2015.06.014; KRISTENSSON K, 1969, ACTA NEUROPATHOL, V14, P38, DOI 10.1007/BF00687701; Kumar DKV, 2016, NEURODEGENER DIS MAN, V6, P345, DOI 10.2217/nmt-2016-0035; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Kusuhara H, 2004, ADV DRUG DELIVER REV, V56, P1741, DOI 10.1016/j.addr.2004.07.007; Latruffe N, 2013, CURR PHARM DESIGN, V19, P6053, DOI 10.2174/1381612811319340002; Lecler A, 2017, RADIOLOGY, V282, P923, DOI 10.1148/radiol.2017162578; Lee J, 2002, NEUROMOL MED, V2, P29; Lee JH, 2012, J PEDIAT HEMATOL ONC, V34, P491, DOI 10.1097/MPH.0b013e318266c0ef; Lehmann M, 2003, DEMENT GERIATR COGN, V16, P145, DOI 10.1159/000071002; Leira Y, 2017, NEUROEPIDEMIOLOGY, V48, P21, DOI 10.1159/000458411; Lembo D, 2016, MOL ASPECTS MED, V49, P23, DOI 10.1016/j.mam.2016.04.003; Li SM, 2010, J GEN VIROL, V91, P858, DOI 10.1099/vir.0.015719-0; Li XW, 2015, FASEB J, V29, P1754, DOI 10.1096/fj.14-262683; Lia LJ, 2004, J BIOL CHEM, V279, P37061, DOI 10.1074/jbc.M403672200; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin FC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002143; Little CS, 2004, NEUROBIOL AGING, V25, P419, DOI 10.1016/S0197-4580(03)00127-1; Liu TB, 2012, VIRULENCE, V3, P173, DOI 10.4161/viru.18685; Loeb MB, 2004, J AM GERIATR SOC, V52, P381, DOI 10.1111/j.1532-5415.2004.52109.x; Loef M, 2012, BRIT J NUTR, V107, P7, DOI 10.1017/S000711451100376X; Lurain NS, 2013, J INFECT DIS, V208, P564, DOI 10.1093/infdis/jit210; MacIntyre A, 2003, J NEUROSCI RES, V71, P740, DOI 10.1002/jnr.10519; MacKenzie CR, 2007, CURR DRUG METAB, V8, P237, DOI 10.2174/138920007780362518; Maftei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068996; Maggioli E, 2016, BRAIN BEHAV IMMUN, V51, P212, DOI 10.1016/j.bbi.2015.08.020; Maheshwari P, 2015, J ALZHEIMERS DIS, V43, P957, DOI 10.3233/JAD-140621; Mahmoudvand H, 2016, J PARASITOL, V102, P629, DOI 10.1645/16-28; Maizels RM, 2014, CLIN EXP IMMUNOL, V177, P38, DOI 10.1111/cei.12353; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Martinez-Pinilla E, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00030; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mayerhofer R, 2017, BRAIN BEHAV IMMUN, V60, P174, DOI 10.1016/j.bbi.2016.10.011; MCCLURE CL, 1992, AM FAM PHYSICIAN, V45, P2691; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; McManus RM, 2014, NEUROBIOL AGING, V35, P109, DOI 10.1016/j.neurobiolaging.2013.07.025; Mechelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063300; Meckes DG, 2015, J VIROL, V89, P5200, DOI 10.1128/JVI.02470-14; Mehraj V, 2015, INT J TRYPTOPHAN RES, V8, P41, DOI 10.4137/IJTR.S26862; Menon PK, 2012, CNS NEUROL DISORD-DR, V11, P40; Mielke MM, 2010, NEUROLOGY, V75, P1888, DOI 10.1212/WNL.0b013e3181feb2bf; MIKLOSSY J, 1993, NEUROREPORT, V4, P841, DOI 10.1097/00001756-199307000-00002; Miklossy J, 2006, NEUROBIOL AGING, V27, P228, DOI 10.1016/j.neurobiolaging.2005.01.018; Miklossy J, 2016, J ALZHEIMERS DIS, V53, P1459, DOI 10.3233/JAD-160451; Mohle L, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0293-8; Mohagheghi F, 2010, THESCIENTIFICWORLDJO, V10, P1180, DOI 10.1100/tsw.2010.128; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Moreira A, 2016, J ALZHEIMERS DIS, V53, P85, DOI 10.3233/JAD-160142; Mori I, 2015, ACTA VIROL, V59, P338, DOI 10.4149/av_2015_04_338; Mouton CP, 2001, AM FAM PHYSICIAN, V63, P257; Mueller T, 2016, LIVER INT, V36, P1267, DOI 10.1111/liv.13094; NADAL D, 1990, LUNG, V168, P379, DOI 10.1007/BF02718155; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Oakley R, 2014, AGING DIS, V5, P114, DOI 10.14336/AD.2014.0500114; Okin D, 2012, CURR BIOL, V22, pR733, DOI 10.1016/j.cub.2012.07.029; Oria RB, 2005, PEDIATR RES, V57, P310, DOI 10.1203/01.PDR.0000148719.82468.CA; Oria RB, 2007, MED HYPOTHESES, V68, P1099, DOI 10.1016/j.mehy.2006.09.036; Palomares JA, 2015, J NEUROIMAGING, V25, P900, DOI 10.1111/jon.12288; Park SC, 2016, BIOCHEM BIOPH RES CO, V478, P924, DOI 10.1016/j.bbrc.2016.08.052; Parran DK, 2005, NEUROTOXICOLOGY, V26, P77, DOI 10.1016/j.neuro.2004.07.003; Parron T, 2011, TOXICOL APPL PHARM, V256, P379, DOI 10.1016/j.taap.2011.05.006; Pase MP, 2017, ALZHEIMERS DEMENT, V13, P955, DOI 10.1016/j.jalz.2017.01.024; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; Patnaik R, 2000, ACTA NEUROCHIR SUPPL, V76, P535; PATRICK D, 1992, J INFECT DIS, V165, P865, DOI 10.1093/infdis/165.5.865; Pellicano M, 2010, J ALZHEIMERS DIS, V21, P181, DOI 10.3233/JAD-2010-091714; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Persidsky Y, 2011, BRAIN BEHAV IMMUN, V25, pS61, DOI 10.1016/j.bbi.2011.03.001; Pike CJ, 2009, FRONT NEUROENDOCRIN, V30, P239, DOI 10.1016/j.yfrne.2009.04.015; Pires PW, 2013, AM J PHYSIOL-HEART C, V304, pH1598, DOI 10.1152/ajpheart.00490.2012; Pisa D, 2015, SCI REP-UK, V5, DOI 10.1038/srep15015; Pizza V, 2011, CNS NEUROL DISORD-DR, V10, P621, DOI 10.2174/187152711796235014; Poole S, 2013, J ALZHEIMERS DIS, V36, P665, DOI 10.3233/JAD-121918; Popadiak K, 2007, J IMMUNOL, V178, P7242, DOI 10.4049/jimmunol.178.11.7242; Power C, 2009, CAN J NEUROL SCI, V36, P285, DOI 10.1017/S0317167100007009; Pozzoli U, 2010, TRENDS GENET, V26, P95, DOI 10.1016/j.tig.2009.12.010; Prasad Shikha, 2014, J Pharmacovigil, V2, P125; Pretorius E, 2016, J ALZHEIMERS DIS, V53, P1237, DOI 10.3233/JAD-160318; Pulzova L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00086; Qosa H, 2016, J ALZHEIMERS DIS, V53, P1499, DOI 10.3233/JAD-151179; Raj T, 2012, AM J HUM GENET, V90, P720, DOI 10.1016/j.ajhg.2012.02.022; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rawji KS, 2016, BRAIN, V139, P653, DOI 10.1093/brain/awv395; REICHMAN HR, 1986, J NEUROSURG, V65, P233, DOI 10.3171/jns.1986.65.2.0233; Reis PA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003099; Reniewicz Patryk, 2016, Postepy Hig Med Dosw (Online), V70, P337; Reynolds E H, 2014, Handb Clin Neurol, V120, P927, DOI 10.1016/B978-0-7020-4087-0.00061-9; Richards RI, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00193; Richardson JR, 2014, JAMA NEUROL, V71, P284, DOI 10.1001/jamaneurol.2013.6030; Roberts RO, 2016, JAMA NEUROL, V73, P93, DOI 10.1001/jamaneurol.2015.2952; Roher AE, 2003, ARTERIOSCL THROM VAS, V23, P2055, DOI 10.1161/01.ATV.0000095973.42032.44; Roher AE, 2000, ANN NY ACAD SCI, V903, P366, DOI 10.1111/j.1749-6632.2000.tb06388.x; Romano JD, 2013, EUKARYOT CELL, V12, P265, DOI 10.1128/EC.00313-12; Rondeau V, 2009, AM J EPIDEMIOL, V169, P489, DOI 10.1093/aje/kwn348; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Roussos P, 2015, ALZHEIMERS DEMENT, V11, P1163, DOI 10.1016/j.jalz.2014.10.013; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Russell KL, 2014, PROSTAG LEUKOTR ESS, V90, P5, DOI 10.1016/j.plefa.2013.11.003; RYTIK PG, 1991, AIDS RES HUM RETROV, V7, P89, DOI 10.1089/aid.1991.7.89; Saavedra JM, 2016, CELL MOL NEUROBIOL, V36, P259, DOI 10.1007/s10571-015-0327-y; Safouris A, 2015, CURR ALZHEIMER RES, V12, P736, DOI 10.2174/1567205012666150710114430; Sajja RK, 2016, J CEREBR BLOOD F MET, V36, P539, DOI 10.1177/0271678X15616978; Sanchez-Barcelo EJ, 2010, CURR MED CHEM, V17, P2070, DOI 10.2174/092986710791233689; Santiago-Tirado FH, 2017, MBIO, V8, DOI 10.1128/mBio.02183-16; Saresella M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0088-1; SARMENTO A, 1994, ACTA NEUROCHIR, V127, P215, DOI 10.1007/BF01808769; Sato A, 2001, INT J DEV NEUROSCI, V19, P327, DOI 10.1016/S0736-5748(01)00017-X; Schain M, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0733-2; SCHEIBEL AB, 1989, ANN MED, V21, P103, DOI 10.3109/07853898909149194; Schmitz TW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13249; Scholtissek C, 1998, ANTIVIR RES, V37, P83, DOI 10.1016/S0166-3542(97)00061-2; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schwerk C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00080; Seker FB, 2016, NUTR NEUROSCI, V19, P55, DOI 10.1179/1476830514Y.0000000154; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Seske LM, 2017, MATERN CHILD HLTH J, V21, P727, DOI 10.1007/s10995-016-2159-x; Sheets SA, 2005, INFECT IMMUN, V73, P1543, DOI 10.1128/IAI.73.3.1543-1552.2005; Shin JA, 2016, FREE RADICAL BIO MED, V92, P78, DOI 10.1016/j.freeradbiomed.2016.01.010; Shindler-Itskovitch T, 2016, J ALZHEIMERS DIS, V52, P1431, DOI 10.3233/JAD-160132; Simpson RJ, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18374; SIMS NR, 1980, LANCET, V1, P333; Singhrao SK, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2016.1270602; Slonska A, 2012, POSTEP HIG MED DOSW, V66, P810, DOI 10.5604/17322693.1016360; SMITH SP, 1992, PHARMACOTHERAPY, V12, pS11; Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014; Sohn JH, 2009, FRONT BIOSCI-LANDMRK, V14, P3879, DOI 10.2735/3496; Song Y, 2008, NEUROSCI LETT, V445, P42, DOI 10.1016/j.neulet.2008.08.081; Soontornniyomkij V, 2012, AIDS, V26, P2327, DOI 10.1097/QAD.0b013e32835a117c; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Spindler KR, 2012, TRENDS MICROBIOL, V20, P282, DOI 10.1016/j.tim.2012.03.009; Srinivasan V, 2012, RECENT PATENTS ENDOC, V6, P30, DOI 10.2174/187221412799015317; Stahl T, 2006, EUR J NEUROSCI, V24, P1923, DOI 10.1111/j.1460-9568.2006.05069.x; Steel AJ, 2015, J ALZHEIMERS DIS, V47, P351, DOI 10.3233/JAD-140822; Stern JL, 2017, MOL BIOL CELL, V28, P1079, DOI 10.1091/mbc.E16-10-0728; Storace D, 2010, ARCH NEUROL-CHICAGO, V67, P867, DOI 10.1001/archneurol.2010.137; Sugimoto N, 2014, NUTR CANCER, V66, P419, DOI 10.1080/01635581.2013.877497; Sun DM, 2013, ADV DRUG DELIVER REV, V65, P342, DOI 10.1016/j.addr.2012.07.002; Takechi R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-73; Tan IL, 2012, CNS DRUGS, V26, P123, DOI 10.2165/11597770-000000000-00000; Ting M, 2016, EUR J ORAL SCI, V124, P4, DOI 10.1111/eos.12239; Trumble BC, 2017, FASEB J, V31, P1508, DOI 10.1096/fj.201601084R; Tucsek Z, 2014, J GERONTOL A-BIOL, V69, P1212, DOI 10.1093/gerona/glt177; Tufano A, 2012, SEMIN THROMB HEMOST, V38, P515, DOI 10.1055/s-0032-1315759; Tyler KM, 2005, CELL MICROBIOL, V7, P1579, DOI 10.1111/j.1462-5822.2005.00576.x; van de Haar HJ, 2016, RADIOLOGY, V281, P527, DOI 10.1148/radiol.2016152244; van de Haar HJ, 2016, NEUROBIOL AGING, V45, P190, DOI 10.1016/j.neurobiolaging.2016.06.006; van der Wal FJ, 2002, CURR TOP MICROBIOL, V269, P37; van Exel E, 2009, ARCH GEN PSYCHIAT, V66, P1263, DOI 10.1001/archgenpsychiatry.2009.146; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Vincents B, 2011, FASEB J, V25, P3741, DOI 10.1096/fj.11-187799; Volzke H, 2006, ATHEROSCLEROSIS, V184, P108, DOI 10.1016/j.atherosclerosis.2004.10.048; Vu K, 2014, MBIO, V5, DOI 10.1128/mBio.01101-14; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Wang X, 2014, NEUROSCIENCE, V271, P99, DOI 10.1016/j.neuroscience.2014.04.030; Wang XL, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00066; Wei HD, 2015, J MOL NEUROSCI, V55, P872, DOI 10.1007/s12031-014-0441-1; WELTER D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI [DOI 10.1093/NAR/GKT1229, 10.1093/nar/gkt1229]; White MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101364; Witt Ken A, 2014, Adv Pharmacol, V71, P361, DOI 10.1016/bs.apha.2014.06.018; Wolff G, 2015, BIOCHEM BIOPH RES CO, V463, P811, DOI 10.1016/j.bbrc.2015.04.153; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wolters FJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002143; Wong CW, 2016, DRUG AGING, V33, P451, DOI 10.1007/s40266-016-0372-3; Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271; Wozniak MA, 2003, J MED GENET, V40, P348, DOI 10.1136/jmg.40.5.348; Wu HL, 2012, CELL MICROBIOL, V14, P546, DOI 10.1111/j.1462-5822.2011.01740.x; Wu Yun-Chun, 2015, Alzheimers Dement (Amst), V1, P220, DOI 10.1016/j.dadm.2014.11.015; Wu Z, 2017, BRAIN BEHAV IMMUN, V65, P350, DOI 10.1016/j.bbi.2017.06.002; Xu CY, 2014, J INT MED RES, V42, P85, DOI 10.1177/0300060513504365; Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548; Yang CH, 2015, J SURG RES, V194, P591, DOI 10.1016/j.jss.2014.11.030; Yang Dongmei, 2013, J Behav Brain Sci, V3, P100; Yates PA, 2014, NEUROLOGY, V82, P1266, DOI 10.1212/WNL.0000000000000285; Yin Z, 2014, CHEM BIOL, V21, P481, DOI 10.1016/j.chembiol.2014.02.009; Yun PLW, 2001, INFECT IMMUN, V69, P5650, DOI 10.1128/IAI.69.9.5650-5660.2001; Zahid Aliya, 2004, J Coll Physicians Surg Pak, V14, P256; Zhan XH, 2016, NEUROLOGY, V87, P2324, DOI 10.1212/WNL.0000000000003391; Zhang N, 2016, ALLERGY, V71, P295, DOI 10.1111/all.12809; Zhang PY, 2015, CAN J NEUROL SCI, V42, P213, DOI 10.1017/cjn.2015.39; Zhang RZ, 2013, J NEUROIMMUNOL, V256, P38, DOI 10.1016/j.jneuroim.2013.01.002; Zhang WT, 2016, NEUROBIOL DIS, V91, P37, DOI 10.1016/j.nbd.2016.02.020; Zhang ZG, 2015, ARCH IMMUNOL THER EX, V63, P333, DOI 10.1007/s00005-015-0351-0; Zhao ZH, 2017, ONCOTARGET, V8, P30030, DOI 10.18632/oncotarget.16273; Zhao ZH, 2014, EXP MOL PATHOL, V97, P386, DOI 10.1016/j.yexmp.2014.09.006	337	20	20	3	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS		2542-4823		J ALZHEIMERS DIS REP	J. Alzheimers Dis. Rep.		2017	1	1					125	157		10.3233/ADR-170017			33	Neurosciences	Neurosciences & Neurology	VK0AM	WOS:000651067800014	30480234	Green Published			2021-06-18	
J	Chien, DK; Hwang, HF; Lin, MR				Chien, Ding-Kuo; Hwang, Hei-Fen; Lin, Mau-Roung			Injury severity measures for predicting return-to-work after a traumatic brain injury	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Traumatic brain injury; Employment; Return-to-work; Injury severity; AIS; ISS	GLASGOW-OUTCOME-SCALE; COMA SCALE; COMMUNITY INTEGRATION; COGNITIVE STATUS; EMPLOYMENT; IMPACT; SCORE; REHABILITATION; INDIVIDUALS; MORTALITY	This study compared the ability of five injury severity measures, namely the Abbreviated Injury Scale to the Head (AIS-H), Glasgow Coma Scale (GCS), Glasgow Outcome Scale (GOS), Extended Glasgow Outcome Scale (GOSE), and Injury Severity Score (ISS), to predict return-to-work after a traumatic brain injury (TBI). Furthermore, factors potentially associated with return-to-work were investigated. In total, 207 individuals aged <= 65 years newly diagnosed with a TBI and employed at the time of injury were recruited and followed-up for 1 year by telephone every 3 months. A bivariate proportional hazards model analysis revealed that all five injury severity measures were significantly associated with return-to-work after a TBI. The AIS-H and non-head ISS explained 23.8% of the variation in the duration of returning to work from discharge after hospitalization for a TBI; similarly, the GCS, GOS, GOSE, and ISS respectively accounted for 4.7%, 21.4%,12.9%, and 48.4% of the variation. A multivariable analysis revealed that individuals with higher injury severity as measured by the ISS (hazard ratio [HR], 0.94; 95% confidence interval [CI], 0.92-0.97), a lack of autonomy in transportation (HR, 2.55; 95% CI, 1.23-5.32), cognitive impairment (HR, 0.47; 95% CI, 0.28-0.79), and depression (HR, 0.97; 95% CI, 0.95-0.99) were significantly less likely to be employed after a TBI. In conclusion, of the five injury severity measures, the ISS may be the most capable measure of predicting return-to-work after a TBI. In addition to injury severity, autonomy in transportation, cognitive function, and the depressive status may also influence the employment status during the first year after a TBI. (C) 2016 Elsevier Ltd. All rights reserved.	[Chien, Ding-Kuo; Lin, Mau-Roung] Taipei Med Univ, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 110, Taiwan; [Chien, Ding-Kuo] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Chien, Ding-Kuo] Mackay Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Hwang, Hei-Fen] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan; [Lin, Mau-Roung] Taipei Med Univ, Coll Nursing, Masters Program Long Term Care, Taipei, Taiwan	Lin, MR (corresponding author), Taipei Med Univ, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 110, Taiwan.	mrlin@tmu.edu.tw			Ministry of Technology and Science, Taiwan [MOST103-2314-B-038-012, MOST104-2627-M-038-001]; National Health Research Institutes, TaiwanNational Health Research Institutes - Taiwan [NHRI-EX104-10317PI]	This work was funded by the Ministry of Technology and Science (MOST103-2314-B-038-012 and MOST104-2627-M-038-001) and the National Health Research Institutes (NHRI-EX104-10317PI), Taiwan.	[Anonymous], 2000, J Neurotrauma, V17, P563; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Chien C P, 1985, Seishin Shinkeigaku Zasshi, V87, P335; Chiou HC, 1997, CHINESE J PUBLIC HLT, V16, P119, DOI DOI 10.6288/CJPH1997-16-02-02; Chiu W. T., 1996, NEUROTRAUMA, P905; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; COX DR, 1972, J R STAT SOC B, V34, P187; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Des Plain I. L., 1990, ABBREVIATED INJURY S; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Fleming J, 1999, BRAIN INJURY, V13, P417; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; KENT JT, 1988, BIOMETRIKA, V75, P525, DOI 10.2307/2336603; Knopman DS, 2010, NEUROEPIDEMIOLOGY, V34, P34, DOI 10.1159/000255464; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larsson J, 2010, SCAND J PUBLIC HEALT, V38, P541, DOI 10.1177/1403494810371143; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; TEASDALE G, 1974, LANCET, V2, P81; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Yu DSF, 2004, RES NURS HEALTH, V27, P135, DOI 10.1002/nur.20008	47	20	20	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JAN	2017	98						101	107		10.1016/j.aap.2016.09.025			7	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	EG3SR	WOS:000390965500011	27716491				2021-06-18	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Symptom correlates of cerebral blood flow following acute concussion	NEUROIMAGE-CLINICAL			English	Article						Sport concussion; Cerebral blood flow; ASL; Symptoms	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; PERFUSION; RECOVERY; FMRI; TIME	Concussion is associated with significant symptoms within hours to days post-injury, including disturbances in physical function, cognition, sleep and emotion. However, little is known about how subjective impairments correlate with objective measures of cerebrovascular function following brain injury. This study examined the relationship between symptoms and cerebral blood flow (CBF) in individuals following sport-related concussion. Seventy university level athletes had CBF measured using Arterial Spin Labelling (ASL), including 35 with acute concussion and 35 matched controls and their symptoms were assessed using the Sport Concussion Assessment Tool 3 (SCAT3). For concussed athletes, greater total symptom severity was associated with elevated posterior cortical CBF, although mean CBF was not significantly different from matched controls (p = 0.46). Examining symptom clusters, athletes reporting greater cognitive symptoms also had lower frontal and subcortical CBF, relative to athletes with greater somatic symptoms. The "cognitive" and "somatic" subgroups also exhibited significant differences in CBF relative to controls (p <= 0.026). This study demonstrates objective CBF correlates of symptoms in recently concussed athletes and shows that specific symptom clusters may have distinct patterns of altered CBF, significantly extending our understanding of the neurobiology of concussion and traumatic brain injury.	[Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Sunnybrook Hosp, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada	Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada.; Churchill, NW (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada.	ChurchillN@smh.ca; michael.hutchison@utoronto.ca; sgraham@sri.utoronto.ca; schweizert@smh.ca			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN294001-367456]; Defence Research and Development Canada (DRDC); Canadian Institutes of Military and Veterans Health (CIMVHR) [W7714-145967]; Siemens Canada Ltd.	This work was supported by the Canadian Institutes of Health Research (CIHR) [grant number RN294001-367456]; the Defence Research and Development Canada (DRDC) and the Canadian Institutes of Military and Veterans Health (CIMVHR) [grant number W7714-145967]; and pilot funding from Siemens Canada Ltd.	Barlow K. M., 2016, J NEUROTRAUMA; Becelewski J., 2002, NEUROL NEUROCHIR POL, V37, P339; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Marchal G, 1996, BRAIN, V119, P409, DOI 10.1093/brain/119.2.409; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Wang Y, 2015, J NEUROTRAUMA	33	20	21	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	16						234	239		10.1016/j.nicl.2017.07.019			6	Neuroimaging	Neurosciences & Neurology	FK1IU	WOS:000413235100025	28794982	DOAJ Gold, Green Published			2021-06-18	
J	French, CJ; Glassford, NJ; Gantner, D; Higgins, AM; Cooper, DJ; Nichol, A; Skrifvars, MB; Imberger, G; Presneill, J; Bailey, M; Bellomo, R				French, Craig J.; Glassford, Neil J.; Gantner, Dashiell; Higgins, Alisa M.; Cooper, David James; Nichol, Alistair; Skrifvars, Markus B.; Imberger, Georgina; Presneill, Jeffrey; Bailey, Michael; Bellomo, Rinaldo			Erythropoiesis-stimulating Agents in Critically Ill Trauma Patients A Systematic Review and Meta-analysis	ANNALS OF SURGERY			English	Article						critical illness; epoetin alfa; erythropoiesis-stimulating agents; trauma	RECOMBINANT-HUMAN-ERYTHROPOIETIN; ISCHEMIA-REPERFUSION INJURY; TRIAL SEQUENTIAL-ANALYSIS; BRAIN-INJURY; DOUBLE-BLIND; EPOETIN-ALPHA; TRANSFUSION; PROTECTS; RECOVERY; EFFICACY	Objective: To perform a meta-analysis of all relevant randomized controlled trials assessing the effect of erythropoiesis-stimulating agents (ESAs) in critically ill trauma patients. Background: ESAs have effects beyond erythropoiesis. The administration of the ESA epoetin alfa to critically ill trauma patients has been associated with a reduction in mortality. Methods: We performed a systematic review and meta-analysis with trial sequential analysis. We searched Medline, Medline in Process, and other nonindexed citations, EMBASE, and the Cochrane Database from inception until September 9, 2015, for randomized controlled trials comparing ESAs to placebo (or no ESA). Results: We identified 9 eligible studies that randomly assigned 2607 critically ill patients after trauma to an ESA or placebo (or no ESA). Compared with placebo (or no ESA), ESA therapy was associated with a substantial reduction in mortality [risk ratio (RR) 0.63, 95% confidence interval (CI) 0.49-0.79, P = 0.0001, I-2 = 0%). In patients with traumatic brain injury, ESA therapy did not increase the number of patients surviving with moderate disability or good recovery (RR 1.00, 95% CI 0.88-1.15, P = 0.95, I-2 = 0%). With the dosing regimens employed in the included studies, ESA therapy did not increase the risk of lower limb proximal deep venous thrombosis (RR 0.97, 95% CI 0.72-1.29, P = 0.78, I-2 = 0%). Conclusions: The administration of ESAs to critically ill trauma patients is associated with a significant improvement in mortality without an increase in the rate of lower limb proximal deep venous thrombosis. Given the worldwide public health significance of these findings research to validate or refute them is required.	[French, Craig J.; Gantner, Dashiell; Imberger, Georgina] Western Hlth, Dept Anaesthesia, Gordon St, Melbourne, Vic, Australia; [French, Craig J.; Gantner, Dashiell; Imberger, Georgina] Western Hlth, Dept Intens Care, Gordon St, Melbourne, Vic, Australia; [Glassford, Neil J.; Bellomo, Rinaldo] Austin Hosp, Dept Intens Care, Melbourne, Vic, Australia; [French, Craig J.; Glassford, Neil J.; Gantner, Dashiell; Higgins, Alisa M.; Cooper, David James; Nichol, Alistair; Skrifvars, Markus B.; Presneill, Jeffrey; Bailey, Michael; Bellomo, Rinaldo] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Cooper, David James] The Alfred, Dept Intens Care, Melbourne, Vic, Australia; [Nichol, Alistair] St Vincents Univ Hosp, Dublin, Ireland; [Presneill, Jeffrey] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [French, Craig J.; Bellomo, Rinaldo] Univ Melbourne, Melbourne, Vic, Australia; [Skrifvars, Markus B.] Helsinki Univ Hosp, Div Intens Care, Dept Anesthesiol Intens Care & Pain Med, Helsinki, Finland; [Skrifvars, Markus B.] Univ Helsinki, Helsinki, Finland	French, CJ (corresponding author), Western Hlth, Dept Intens Care, Gordon St, Footscray, Vic 3011, Australia.	Craig.French@wh.org.au	Cooper, D. James/G-7961-2013; French, Craig/ABF-5087-2020; Higgins, Alisa/AAM-8088-2020; Bailey, Michael J/A-4499-2012	Cooper, D. James/0000-0002-5872-9051; French, Craig/0000-0003-1363-9711; Higgins, Alisa/0000-0001-8295-7559; Bailey, Michael J/0000-0002-5551-1401; Nichol, Alistair/0000-0002-4689-1238; Bellomo, Rinaldo/0000-0002-1650-8939; Nichol, Alistair Dualta/0000-0002-4771-5615; Glassford, Neil/0000-0003-1647-3745			Abrishamkar S, 2012, J RES MED SCI, V17, P51; Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Corwin HL, 2014, J TRAUMA ACUTE CARE, V77, P774, DOI 10.1097/TA.0000000000000442; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; [Герасимов Лев Владимирович Gerasimov L.V.], 2012, [Общая реаниматология, Obshchaya reanimatologiya], VVIII, P11; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hojman P, 2009, CYTOKINE, V45, P154, DOI 10.1016/j.cyto.2008.12.005; Joyeux-Faure M, 2012, FUND CLIN PHARMACOL, V26, P761, DOI 10.1111/j.1472-8206.2011.00992.x; Kaukonen KM, 2014, CRIT CARE RESUSC, V16, P255; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Luchette FA, 2012, AM J SURG, V203, P508, DOI 10.1016/j.amjsurg.2011.08.006; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Menon DK, 2015, LANCET, V386, P2452, DOI 10.1016/S0140-6736(15)00387-6; MIYAKE T, 1977, J BIOL CHEM, V252, P5558; Napolitano LM, 2008, J TRAUMA, V65, P285, DOI 10.1097/TA.0b013e31817f2c6e; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Ogunshola Omolara O, 2013, Methods Mol Biol, V982, P13, DOI 10.1007/978-1-62703-308-4_2; Ozawa T, 2010, CIRC J, V74, P1415, DOI 10.1253/circj.CJ-10-0109; Peden M, 2002, INJURY CHART BOOK GR; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sepodes B, 2006, TRANSPL INT, V19, P919, DOI 10.1111/j.1432-2277.2006.00366.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Solling C, 2011, ACTA ANAESTH SCAND, V55, P185, DOI 10.1111/j.1399-6576.2010.02369.x; Solling C, 2012, BASIC CLIN PHARMACOL, V110, P113, DOI 10.1111/j.1742-7843.2011.00820.x; Thorlund K. E. J., 2011, USER MANUAL TRIAL SE; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Turner RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059202; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Wu HW, 2006, EUR J CARDIO-THORAC, V29, P902, DOI 10.1016/j.ejcts.2006.02.036; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	40	20	20	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	JAN	2017	265	1					54	62		10.1097/SLA.0000000000001746			9	Surgery	Surgery	EH9QS	WOS:000392106500017	27070933				2021-06-18	
J	Naess-Schmidt, ET; Blicher, JU; Eskildsen, SF; Tietze, A; Hansen, B; Stubbs, PW; Jespersen, S; Ostergaard, L; Nielsen, JF				Naess-Schmidt, Erhard Trillingsgaard; Blicher, Jakob Udby; Eskildsen, Simon Fristed; Tietze, Anna; Hansen, Brian; Stubbs, Peter William; Jespersen, Sune; Ostergaard, Leif; Nielsen, Jorgen Feldbaek			Microstructural changes in the thalamus after mild traumatic brain injury: A longitudinal diffusion and mean kurtosis tensor MRI study	BRAIN INJURY			English	Article						mTBI; concussion; mean kurtosis tensor; diffusion MRI	RISK-FACTORS; HEAD-INJURY; CONCUSSION; SYMPTOMS; METAANALYSIS; INTEGRITY; RECOVERY; STROKE; MODEL	Primary objective: The primary aim of this study was to assess microstructural changes in the thalamus, hippocampus and corpus callosum with a fast mean kurtosis tensor (MKT) technique, in the acute and sub-acute phase after mTBI. It was hypothesized that MKT would differ between baseline and follow-up in patients. The secondary aim was to relate diffusion measures to symptoms of mTBI.Research design: A longitudinal case-control study.Methods and procedures: Twenty-seven patients with mTBI and 27 age- and gender-matched healthy controls were enrolled in the study. Patients were scanned within 2 weeks and 3 months after mTBI, while the controls were scanned once.Main outcomes and results: MKT decreased significantly (p = 0.02) from baseline to follow-up in the thalamus in patients. Compared to healthy subjects, thalamic MKT values were significantly larger in patients at baseline (p = 0.048). Secondary analysis revealed a significant decrease (p = 0.01) in fractional anisotropy in the splenium of corpus callosum from baseline to follow-up.Conclusions: The current study indicates microstructural changes in the thalamus and corpus callosum from within 14 days to 3 months after mTBI and suggests MKT as a potential biomarker after mTBI.	[Naess-Schmidt, Erhard Trillingsgaard; Blicher, Jakob Udby; Stubbs, Peter William; Nielsen, Jorgen Feldbaek] Hammel Neurorehabil Ctr, Aarhus, Denmark; [Naess-Schmidt, Erhard Trillingsgaard; Blicher, Jakob Udby; Stubbs, Peter William; Nielsen, Jorgen Feldbaek] Univ Res Clin, Aarhus, Denmark; [Naess-Schmidt, Erhard Trillingsgaard; Blicher, Jakob Udby; Eskildsen, Simon Fristed; Tietze, Anna; Hansen, Brian; Jespersen, Sune; Ostergaard, Leif] Inst Clin Med, Ctr Functionally Integrat Neurosci, Aarhus, Denmark; [Tietze, Anna; Ostergaard, Leif] Aarhus Univ Hosp, Dept Neuroradiol, Aarhus, Denmark; [Stubbs, Peter William] Neurosci Res Australia, Randwick, NSW, Australia	Naess-Schmidt, ET (corresponding author), Hammel Neurorehabil Ctr, 15 Voldbyvej, DK-8450 Hammel, Denmark.; Naess-Schmidt, ET (corresponding author), Inst Clin Med, Univ Res Clin, 15 Voldbyvej, DK-8450 Hammel, Denmark.	erhanaes@rm.dk	Jespersen, Sune Norhoj/B-1914-2008; Ostergaard, Leif/A-9281-2008; Nass-Schmidt, Erhard T/E-8425-2019; Stubbs, Peter William/AAH-7179-2019; Ostergaard, Lars/AAA-3020-2020; Stubbs, Peter William/AAH-6598-2019; Nass-Schmidt, Erhard/AAP-8212-2021; Eskildsen, Simon/K-3934-2019; Nielsen, Jorgen Feldbak/AAR-6384-2021	Jespersen, Sune Norhoj/0000-0003-3146-4329; Ostergaard, Leif/0000-0003-2930-6997; Nass-Schmidt, Erhard T/0000-0002-2539-0362; Ostergaard, Lars/0000-0003-2459-0511; Nass-Schmidt, Erhard/0000-0002-2539-0362; Eskildsen, Simon/0000-0003-4242-9158; Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Ostergaard, Lars/0000-0002-7619-605X; /0000-0003-4555-8019; Blicher, Jakob/0000-0003-3443-4790			Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bhushan C, 2015, NEUROIMAGE, V115, P269, DOI 10.1016/j.neuroimage.2015.03.050; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2014, ARCH PHYS MED REHAB, V95, P265; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Coupe P, 2011, NEUROIMAGE, V54, P940, DOI 10.1016/j.neuroimage.2010.09.018; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Glenn GR, 2015, NMR BIOMED, V28, P448, DOI 10.1002/nbm.3271; Granziera C, 2014, HUM BRAIN MAPP, V35, P1461, DOI 10.1002/hbm.22266; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24389, 10.1002/mrm.24743]; Herron TJ, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00025; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hovda DA, 2014, PROG NEUROL SURG, V28, P28, DOI 10.1159/000358749; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Munivenkatappa A., 2015, BRAIN INJURY, P1; Naess-Schmidt E, 2016, INT J COMPUT ASS RAD, V11, P1979, DOI 10.1007/s11548-016-1433-0; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Sun PZ, 2014, NMR BIOMED, V27, P1413, DOI 10.1002/nbm.3188; Tietze A, 2015, AM J NEURORADIOL, V36, P1; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vestergaard-Poulsen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020653; Weber RA, 2015, STROKE, V46, P545, DOI 10.1161/STROKEAHA.114.006782; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	37	20	20	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	2					230	236		10.1080/02699052.2016.1229034			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EM2RO	WOS:000395163500011	28055267				2021-06-18	
J	Shapiro, LA				Shapiro, Lee A.			Altered Hippocampal Neurogenesis during the First 7 Days after a Fluid Percussion Traumatic Brain Injury	CELL TRANSPLANTATION			English	Article						stem cells; hilar ectopic granule cells; doublecortin	DENTATE GRANULE CELLS; HILAR BASAL DENDRITES; STEM-CELLS; BORN; NEURONS; TRANSPLANTATION; PROLIFERATION; RECOVERY; GYRUS	Traumatic brain injury (TBI) is a devastating disorder causing negative outcomes in millions of people each year. Despite the alarming number of brain injuries and the long-term detrimental outcomes that can be associated with TBI, treatment options are lacking. Extensive investigation is underway, in hopes of identifying effective treatment strategies. Among the most state-of-the-art strategies is cell replacement therapy. TBI is a seemingly good candidate for cell replacement studies because there is often loss of neurons. However, translation of this therapy has not yet been successful. It is possible that a better understanding of endogenous neurogenic mechanisms after TBI could lead to more efficacious study designs using exogenous cell replacement strategies. Therefore, this study was designed to examine the number and migration of immature neurons at 1 and 7 d after a fluid percussion TBI. The results show that the number of immature neurons increases from 7 d after a fluid percussion injury (FPI), and there is ectopic migration of doublecortin (DCX+) immature neurons into the hilar region of the dentate gyrus. These results add important data to the current understanding of the endogenous neurogenic niche after TBI. Follow-up studies are needed to better understand the functional significance of elevated neurogenesis and aberrant migration into the hilus.	[Shapiro, Lee A.] Texas A&M Hlth Sci Ctr, Dept Surg, 702 SW HK Dodgen Loop, Temple, TX 76504 USA	Shapiro, LA (corresponding author), Texas A&M Hlth Sci Ctr, Dept Surg, 702 SW HK Dodgen Loop, Temple, TX 76504 USA.	lshapiro@medicine.tamhsc.edu					Ahmed AI, 2016, J ROY ARMY MED CORPS, V162, P98, DOI 10.1136/jramc-2015-000475; Arisi GM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0347-z; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Cheng JP, 2016, BRAIN RES, V1640, P5, DOI 10.1016/j.brainres.2015.11.026; Clausi MG, 2016, NEURAL REGEN RES, V11, P45, DOI 10.4103/1673-5374.175041; Darkazalli A, 2016, J NEUROTRAUMA; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Hattiangady B, 2008, EPILEPSIA, V49, P26, DOI 10.1111/j.1528-1167.2008.01635.x; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Myers CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068208; Patel K, 2016, BRAIN RES, V1640, P104, DOI 10.1016/j.brainres.2016.01.055; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pierce JP, 2005, EXP NEUROL, V196, P316, DOI 10.1016/j.expneurol.2005.08.007; Robinson C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1347987; Shapiro LA, 2006, EPILEPSY RES, V69, P53, DOI 10.1016/j.eplepsyres.2005.12.003; Shapiro LA, 2005, NEUROSCIENCE, V136, P823, DOI 10.1016/j.neuroscience.2005.03.059; Shapiro LA, 2005, BRAIN RES, V1040, P81, DOI 10.1016/j.brainres.2005.01.098; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Shapiro LA, 2007, EUR J NEUROSCI, V26, P583, DOI 10.1111/j.1460-9568.2007.05662.x; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Sun D, 2016, NEURAL REGEN RES, V11, P18, DOI 10.4103/1673-5374.169605; Sun D, 2016, EXP NEUROL, V275, P405, DOI 10.1016/j.expneurol.2015.04.017; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5; Villasana LE, 2014, EXP NEUROL, V261, P156, DOI 10.1016/j.expneurol.2014.05.016; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919	33	20	20	0	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2017	26	7					1314	1318		10.1177/0963689717714099			5	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Cell Biology; Research & Experimental Medicine; Transplantation	EZ4GO	WOS:000404671800017	28933222	DOAJ Gold, Green Published			2021-06-18	
J	Udy, AA; Jarrett, P; Lassig-Smith, M; Stuart, J; Starr, T; Dunlop, R; Deans, R; Roberts, JA; Senthuran, S; Boots, R; Bisht, K; Bulmer, AC; Lipman, J				Udy, Andrew A.; Jarrett, Paul; Lassig-Smith, Melissa; Stuart, Janine; Starr, Therese; Dunlop, Rachel; Deans, Renae; Roberts, Jason A.; Senthuran, Siva; Boots, Robert; Bisht, Kavita; Bulmer, Andrew C.; Lipman, Jeffrey			Augmented Renal Clearance in Traumatic Brain Injury: A Single-Center Observational Study of Atrial Natriuretic Peptide, Cardiac Output, and Creatinine Clearance	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; clinical management of CNS injury; traumatic brain injury	INADEQUATE ANTIMICROBIAL TREATMENT; CRITICALLY-ILL PATIENTS; INFECTIONS; VANCOMYCIN; ENOXAPARIN; PLASMA; EDEMA	Augmented renal clearance (ARC) is being increasingly described in neurocritical care practice. The mechanisms driving this phenomenon are largely unknown. The aim of this project was therefore to explore changes in renal function, cardiac output (CO), and atrial natriuretic peptide (ANP) concentrations in patientswith isolated traumatic brain injury (TBI). This prospective observational cohort study was conducted in a tertiary-level, university-affiliated intensive care unit (ICU). Patients with normal plasma creatinine concentrations (<120 mu mol/L) at admission and no history of chronic kidney disease, admitted with isolated TBI, were eligible for enrollment. Continuous CO measures were obtained using arterial pulse waveform analysis. Eight-hour urinary creatinine clearances (CLCR) were used to quantify renal function. ANP concentrations in plasma were measured on alternate days. Data were collected from study enrollment until ICU discharge, death, or day 15, which ever came first. Eleven patients, contributing 100 ICU days of physiological data, were enrolled into the study. Most participants were young men, requiring mechanical ventilation. Median ICU length of stay was 9.6 [7.8-13.0] days. Elevated CLCR measures (>150 mL/min) were frequent and appeared to parallel changes in CO. Plasma ANP concentrations were also significantly elevated over the study period (minimum value =243 pg/mL). These data suggest that ARC is likely to complicate the care of TBI patients with normal plasma creatinine concentrations, and may be driven by associated cardiovascular changes and/or elevated plasma ANP concentrations. However, significant additional research is required to further understand these findings.	[Udy, Andrew A.] Alfred, Dept Intens Care & Hyperbar Med, Level 3 East Block,Commercial Rd, Prahran, Vic 3181, Australia; [Udy, Andrew A.] Monash Univ, Alfred Ctr, Sch Publ Hlth & Prevent Med, Fac Med Nursing & Hlth Sci, Prahran, Vic, Australia; [Jarrett, Paul; Lassig-Smith, Melissa; Stuart, Janine; Starr, Therese; Dunlop, Rachel; Deans, Renae; Roberts, Jason A.; Boots, Robert; Lipman, Jeffrey] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Herston, Qld, Australia; Royal Brisbane & Womens Hosp, Dept Pharm, Herston, Qld, Australia; [Roberts, Jason A.; Lipman, Jeffrey] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Herston, Qld, Australia; [Senthuran, Siva] Townsville Hosp, Intens Care Unit, 2nd Floor North Block, Douglas, Qld, Australia; [Bisht, Kavita; Bulmer, Andrew C.] Griffith Univ, Menzies Hlth Inst Queensland, Heart Fdn Res Ctr, Gold Coast, Qld, Australia	Udy, AA (corresponding author), Alfred, Dept Intens Care & Hyperbar Med, Level 3 East Block,Commercial Rd, Prahran, Vic 3181, Australia.	a.udy@alfred.org.au	Lipman, Jeffrey/G-2211-2010; Roberts, Jason A/F-6272-2010; Bisht, Kavita/AAB-8117-2019; Udy, Andrew/S-1314-2016	Lipman, Jeffrey/0000-0002-5965-9876; Roberts, Jason A/0000-0001-6218-435X; Bisht, Kavita/0000-0002-4073-0804; Udy, Andrew/0000-0002-6284-2022	RBWH Research Foundation	This study was funded by a Project Grant provided to A/Prof. Andrew Udy by the RBWH Research Foundation.	Baptista JP, 2012, INT J ANTIMICROB AG, V39, P420, DOI 10.1016/j.ijantimicag.2011.12.011; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Carlier M, 2013, CRIT CARE, V17, DOI 10.1186/cc12705; Clerico A, 1998, J ENDOCRINOL INVEST, V21, P170, DOI 10.1007/BF03347297; CLIFTON G L, 1989, Neurosurgical Review, V12, P465, DOI 10.1007/BF01790692; Cook AM, 2013, NEUROCRIT CARE, V19, P210, DOI 10.1007/s12028-013-9837-y; Dias C, 2015, NEUROCRIT CARE, V22, P192, DOI 10.1007/s12028-014-0045-1; EDWARDS BS, 1988, CIRC RES, V62, P191, DOI 10.1161/01.RES.62.2.191; Fukui S, 2004, J CLIN NEUROSCI, V11, P507, DOI 10.1016/S0967-5868(03)00111-5; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kleindienst Andrea, 2012, Acta Neurochir Suppl, V114, P277, DOI 10.1007/978-3-7091-0956-4_54; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lautrette A, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-124; Lonsdale DO, 2013, J NEUROSURG, V118, P297, DOI 10.3171/2012.10.JNS12883; Malinoski D, 2010, J TRAUMA, V68, P874, DOI 10.1097/TA.0b013e3181d32271; MARINGREZ M, 1986, NATURE, V324, P473, DOI 10.1038/324473a0; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; NARUSE S, 1991, STROKE, V22, P61, DOI 10.1161/01.STR.22.1.61; Robinson S, 2010, CRIT CARE, V14, DOI 10.1186/cc8924; TANAKA I, 1984, BIOCHEM BIOPH RES CO, V124, P663, DOI 10.1016/0006-291X(84)91606-1; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0657-z; Udy AA, 2013, INTENS CARE MED, V39, P2070, DOI 10.1007/s00134-013-3088-4; Udy AA, 2012, CHEST, V142, P30, DOI 10.1378/chest.11-1671; Udy AA, 2011, NAT REV NEPHROL, V7, P539, DOI 10.1038/nrneph.2011.92; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; YANDLE TG, 1986, LIFE SCI, V38, P1827, DOI 10.1016/0024-3205(86)90137-2	30	20	20	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					137	144		10.1089/neu.2015.4328			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100017	27302851				2021-06-18	
J	Walker, MS; Kaimal, G; Gonzaga, AML; Myers-Coffman, KA; DeGraba, TJ				Walker, Melissa S.; Kaimal, Girija; Gonzaga, Adele M. L.; Myers-Coffman, Katherine A.; DeGraba, Thomas J.			Active-duty military service members' visual representations of PTSD and TBI in masks	INTERNATIONAL JOURNAL OF QUALITATIVE STUDIES ON HEALTH AND WELL-BEING			English	Article						Post-traumatic stress disorder; traumatic brain injury; art therapy; masks; active duty military	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; ART-THERAPY; GROUP-PSYCHOTHERAPY; WAR VETERANS; COMBAT; PERSONNEL; EMOTIONS; COHORT; VIDEO	Active-duty military service members have a significant risk of sustaining physical and psychological trauma resulting in traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). Within an interdisciplinary treatment approach at the National Intrepid Center of Excellence, service members participated in mask making during art therapy sessions. This study presents an analysis of the mask-making experiences of service members (n = 370) with persistent symptoms from combat and mission-related TBI, PTSD, and other concurrent mood issues. Data sources included mask images and therapist notes collected over a five-year period. The data were coded and analyzed using grounded theory methods. Findings indicated that mask making offered visual representations of the self related to individual personhood, relationships, community, and society. Imagery themes referenced the injury, relational supports/losses, identity transitions/questions, cultural metaphors, existential reflections, and conflicted sense of self. These visual insights provided an increased understanding of the experiences of service members, facilitating their recovery.	[Walker, Melissa S.; DeGraba, Thomas J.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Kaimal, Girija; Gonzaga, Adele M. L.; Myers-Coffman, Katherine A.] Drexel Univ, Coll Nursing & Hlth Profess, Philadelphia, PA 19104 USA	Walker, MS (corresponding author), Natl Intrepid Ctr Excellence, Bldg 51,4860 S Palmer Rd, Bethesda, MD 20889 USA.	melissa.s.walker12.civ@mail.mil		Walker, Melissa/0000-0001-9375-567X	National Endowment for the Arts	This work was supported by the National Endowment for the Arts.	Agberia J. T., 2006, J ASIAN AFR STUD, V41, P249, DOI [10.1177/0021909606063880, DOI 10.1177/0021909606063880]; AKPAN JJ, 1994, AFR ARTS, V27, P48, DOI 10.2307/3337318; Akpan Joseph, 1994, AFR ARTS, V19, P94, DOI DOI 10.2307/3337318; American Art Therapy Association, 2009, US ART THER TREATM V; Andrew E. H., 2014, CROSS CULTURAL COMMU, V10, P211; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Blakeley K, 2013, POSTTR STRESS DIS ME; Chen D., 2016, THESE POWERFUL MASKS; Coll JE, 2011, SOC WORK HEALTH CARE, V50, P487, DOI 10.1080/00981389.2010.528727; Collie K, 2006, ART THER, V23, P157, DOI 10.1080/07421656.2006.10129335; Corbin J., 2014, BASICS QUALITATIVE R; David IR, 1999, THESIS; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW NUMB TBI; Diakparomre A. M., 2010, J ASIAN AFR STUD, V45, P467, DOI [10.1177/0021909610373220, DOI 10.1177/0021909610373220]; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Dursa EK, 2014, J TRAUMA STRESS, V27, P542, DOI 10.1002/jts.21956; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Fiet L., 2014, CARIBBEAN Q, V60, P58, DOI [10.1080/00086495.2014.11672526, DOI 10.1080/00086495.2014.11672526]; Frenz M., 2007, THESIS; FRYREAR JL, 1988, ART PSYCHOTHER, V15, P227, DOI 10.1016/0197-4556(88)90007-X; Furuki K, 2011, EURAMERICA, V41, P949; GOLUB D, 1985, ART PSYCHOTHER, V12, P285, DOI 10.1016/0197-4556(85)90041-3; HERMAN JL, 1992, J TRAUMA STRESS, V5, P377, DOI 10.1002/jts.2490050305; Hines-Martin V P, 1993, J Psychosoc Nurs Ment Health Serv, V31, P29; HINZ LD, 1990, ART PSYCHOTHER, V17, P259, DOI 10.1016/0197-4556(90)90009-F; Hogan S., 2001, HEALING ARTS HIST AR; Hyatt KS, 2015, J NURS SCHOLARSHIP, V47, P300, DOI 10.1111/jnu.12143; Jain S, 2012, MIL MED, V177, P1015, DOI 10.7205/MILMED-D-11-00290; Jiachiao L., 2013, CROSS CULTURAL COMMU, V9, P47; Kopytin A, 2013, ART THER, V30, P20, DOI 10.1080/07421656.2013.757758; Kroch R., 2009, THESIS; Lande RG, 2010, ART PSYCHOTHER, V37, P42, DOI 10.1016/j.aip.2009.09.007; Lawrence D., 2012, INVESTIGATE USE ART; Lobban J., 2014, INT J ART THERAPY, V19, P3, DOI DOI 10.1080/17454832.2012.725547; Lobban J., 2016, ART THERAPY MILITARY; Malchiodi CA, 2012, HDB ART THERAPY, P320; Martinez R., 2013, THESIS; Medina V., 2009, COOLABAH, V3, P235; Nanda U, 2010, ENVIRON BEHAV, V42, P376, DOI 10.1177/0013916510361874; North Atlanta Treaty Organization, 2016, NATO AFGHANISTAN; Pachalska M, 2013, ACTA NEUROPSYCHOL, V11, P435; PAOLETTI JT, 1992, ART BULL, V74, P423, DOI 10.2307/3045891; POLLOCK D, 1995, J ROY ANTHROPOL INST, V1, P581, DOI 10.2307/3034576; Reijnen A, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.05.003; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Rubin DC, 2004, APPL COGNITIVE PSYCH, V18, P17, DOI 10.1002/acp.950; Sargent PD, 2013, PSYCHIAT ANN, V43, P181, DOI 10.3928/00485713-20130403-10; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Toblin RL, 2012, J AFFECT DISORDERS, V136, P469, DOI 10.1016/j.jad.2011.10.048; U.S. Government Accountability Office, 2011, VA MENT HLTH NUM VET; Van der Kolk BA, 2014, BODY KEEPS SCORE BRA; Walker MS, 2016, ART PSYCHOTHER, V49, P10, DOI 10.1016/j.aip.2016.05.015; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zinzow HM, 2013, MIL PSYCHOL, V25, P514, DOI 10.1037/mil0000015	56	20	20	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1748-2623	1748-2631		INT J QUAL STUD HEAL	Int. J. Qual. Stud. Health Well-Being		2017	12								1267317	10.1080/17482631.2016.1267317			12	Public, Environmental & Occupational Health; Nursing; Social Sciences, Biomedical	Public, Environmental & Occupational Health; Nursing; Biomedical Social Sciences	EN7EY	WOS:000396166100001	28452610	DOAJ Gold, Green Published			2021-06-18	
J	Wilson, L; Marsden-Loftus, I; Koskinen, S; Bakx, W; Bullinger, M; Formisano, R; Maas, A; Neugebauer, E; Powell, J; Sarajuuri, J; Sasse, N; von Steinbuechel, N; von Wild, K; Truelle, JL				Wilson, Lindsay; Marsden-Loftus, Isaac; Koskinen, Sanna; Bakx, Wilbert; Bullinger, Monika; Formisano, Rita; Maas, Andrew; Neugebauer, Edmund; Powell, Jane; Sarajuuri, Jaana; Sasse, Nadine; von Steinbuechel, Nicole; von Wild, Klaus; Truelle, Jean-Luc			Interpreting Quality of Life after Brain Injury Scores: Cross-Walk with the Short Form-36	JOURNAL OF NEUROTRAUMA			English	Article						GOSE; health-related quality of life; outcome measures; QOLIBRI; SF-36; TBI	ITEM SELECTION; HEALTH SURVEY; QOLIBRI; SCALE; VALIDATION; TBI	The Quality of Life after Brain Injury (QOLIBRI) instruments are traumatic brain injury (TBI)-specific assessments of health-related quality of life (HRQoL), with established validity and reliability. The purpose of the study is to help improve the interpretability of the two QOLIBRI summary scores (the QOLIBRI Total score and the QOLBRI Overall Scale [OS] score). An analysis was conducted of 761 patients with TBI who took part in the QOLIBRI validation studies. A cross-walk between QOLIBRI scores and the SF-36 Mental Component Summary norm-based scoring system was performed using geometric mean regression analysis. The exercise supports a previous suggestion that QOLIBRI Total scores <60 indicate low or impaired HRQoL and indicate that the corresponding score on the QOLIBRI-OS is <52. The percentage of cases in the sample that fell into the "impaired HRQoL'' category was 36% for the Mental Component Summary, 38% for the QOLIBRI Total, and 39% for the QOLIBRI-OS. Relationships between the QOLIBRI scales and the Glasgow Outcome Scale-Extended (GOSE), as a measure of global function, are presented in the form of means and standard deviations that allow comparison with other studies, and data on age and sex are presented for the QOLIBRI-OS. While bearing in mind the potential imprecision of the comparison, the findings provide a framework for evaluating QOLIBRI summary scores in relation to generic HRQoL that improves their interpretability.	[Wilson, Lindsay; Marsden-Loftus, Isaac] Univ Stirling, Div Psychol, Stirling FK9 4LA, Scotland; [Koskinen, Sanna] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Bakx, Wilbert] Hoensbroek & Maastricht Univ, Dept Brain Injury, Adelante Adult Rehabil, Maastricht, Netherlands; [Bullinger, Monika] Univ Hosp Eppendorf, Dept Med Psychol, Hamburg, Germany; [Formisano, Rita] Santa Lucia Fdn, Rehabil Hosp, IRCCS, Rome, Italy; [Maas, Andrew] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Maas, Andrew] Univ Antwerp, Antwerp, Belgium; [Neugebauer, Edmund] Witten Herdecke Univ Campus, Cologne, Germany; [Powell, Jane] Goldsmiths Coll, Dept Psychol, London, England; [Sarajuuri, Jaana] Validia Rehabil Helsinki, Dept Clin Neuropsychol & Psychol, Helsinki, Finland; [Sasse, Nadine; von Steinbuechel, Nicole] Georg August Univ, Dept Med Psychol & Med Sociol, Gottingen, Germany; [von Wild, Klaus] Westfalian Wilhelms Univ Munster, Clemens Hosp, Dept Neurosurg & Early Neurotraumatol Rehabil, Munster, Germany; [Truelle, Jean-Luc] CHU Raymond Poincare, Serv Med Phys & Readapt, Garches, France	Wilson, L (corresponding author), Univ Stirling, Div Psychol, Stirling FK9 4LA, Scotland.	J.T.L.Wilson@stir.ac.uk	Wilson, Lindsay/O-8883-2019; Sarajuuri, Jaana/AAD-8665-2019; Wilson, Lindsay/A-3659-2009	Wilson, Lindsay/0000-0003-4113-2328; Sarajuuri, Jaana/0000-0002-6432-0295; Wilson, Lindsay/0000-0003-4113-2328; Bullinger, Monika/0000-0001-8876-0159; Koskinen, Sanna/0000-0002-3453-5084	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [602150-2]	The work was performed in the context of CENTER-TBI, supported by the European Commission 7th Framework programme (Grant Number 602150-2).	Brazier JE, 2010, EUR J HEALTH ECON, V11, P215, DOI 10.1007/s10198-009-0168-z; Fayers PM, 2014, VALUE HEALTH, V17, P261, DOI 10.1016/j.jval.2013.12.002; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Giustini M, 2014, FUNCT NEUROL, V29, P167, DOI 10.11138/FNeur/2014.29.3.167; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Lin YN, 2014, J HEAD TRAUMA REHAB, V29, pE37, DOI 10.1097/HTR.0b013e3182816363; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mitchell AJ, 2010, J AFFECT DISORDERS, V126, P335, DOI 10.1016/j.jad.2010.01.067; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Richardson J., 2012, 78 MON CTR HLTH EC; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE., 1993, SF 36 HLTH SURVEY MA; Ware JE, 2007, USERS MANUAL SF 36V2; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wong GKC, 2014, J CLIN NEUROSCI, V21, P954, DOI 10.1016/j.jocn.2013.09.010	21	20	20	1	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					59	65		10.1089/neu.2015.4287			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100008	27297289	Green Accepted			2021-06-18	
J	Wright, WG; Tierney, RT; McDevitt, J				Wright, W. G.; Tierney, R. T.; McDevitt, J.			Visual-vestibular processing deficits in mild traumatic brain injury	JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION			English	Article						Concussion; near point convergence; optokinetic stimulation; virtual reality; posture	SPORTS-RELATED CONCUSSION; OPTOKINETIC NYSTAGMUS; POSTURAL CONTROL; HEAD-INJURY; FOOTBALL; MOTION; REHABILITATION; STIMULATION; ASSESSMENTS; ENVIRONMENT	BACKGROUND: The search for reliable and valid signs and symptoms of mild traumatic brain injury (mTBI), commonly synonymous with concussion, has lead to a growing body of evidence that individuals with long-lasting, unremitting impairments often experience visual and vestibular symptoms, such as dizziness, postural and gait disturbances. OBJECTIVE: Investigate the role of visual-vestibular processing deficits following concussion. METHODS: A number of clinically accepted vestibular, oculomotor, and balance assessments as well as a novel virtual reality (VR)-based balance assessment device were used to assess adults with post-acute concussion (n = 14) in comparison to a healthy age-matched cohort (n = 58). RESULTS: Significant between-group differences were found with the VR-based balance device (p = 0.001), with dynamic visual motion emerging as the most discriminating balance condition. The symptom reports collected after performing the oculomotor and vestibular tests: rapid alternating horizontal eye saccades, optokinetic stimulation, and gaze stabilization, were all sensitive to health status (p < 0.05), despite the absence of oculomotor abnormalities being observed, except for near-point convergence. The BESS, King-Devick, and Dynamic Visual Acuity tests did not detect between-group differences. CONCLUSION: Postural and visual-vestibular tasks most closely linked to spatial and self-motion perception had the greatest discriminatory outcomes. The current findings suggest that mesencephalic and parieto-occipital centers and pathways may be involved in concussion.	[Wright, W. G.; McDevitt, J.] Temple Univ, Dept Phys Therapy, Neuromotor Sci Program, Philadelphia, PA 19122 USA; [Wright, W. G.] Temple Univ, Dept Bioengn, Philadelphia, PA 19122 USA; [Tierney, R. T.] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [McDevitt, J.] East Stroudsburg Univ, Dept Athlet Training, East Stroudsburg, PA USA	Wright, WG (corresponding author), Coll Publ Hlth, Dept PT, 3307N Broad St 215-204-5152 Lab Main Campus, Philadelphia, PA 19140 USA.	wrightw@temple.edu			Department of Defense, Army Rapid Innovation FundUnited States Department of Defense [W81XWH-13-C-0189]	This study was funded, in part, by the Department of Defense, Army Rapid Innovation Fund Award No. W81XWH-13-C-0189 (WGW).	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alosco ML, 2012, INT J ATHL THER TRAI, V17, P22, DOI 10.1123/ijatt.17.5.22; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Baker C.S., 2014, PHYSL REP, V2, P1; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Buttner-Ennever JA, 1997, CURR OPIN NEUROBIOL, V7, P872, DOI 10.1016/S0959-4388(97)80149-3; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Ciuffreda KJ, 2009, OPTOM VIS DEV, V40, P16; COHEN B, 1977, J PHYSIOL-LONDON, V270, P321, DOI 10.1113/jphysiol.1977.sp011955; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Dieterich M, 2008, BRAIN, V131, P2538, DOI 10.1093/brain/awn042; Dubnov-Raz G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00780; Eichner ER, 1998, INT J SPORTS MED, V19, pS150, DOI 10.1055/s-2007-971983; Field A., 1998, BRIT PSYCHOL SOC MAT, V6, P13; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Keshner EA, 2000, J VESTIBUL RES-EQUIL, V10, P207; Keshner EA, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-18; Kirsch V, 2016, BRAIN STRUCT FUNCT, V221, P1291, DOI 10.1007/s00429-014-0971-x; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; LONGRIDGE NS, 1984, OTOLARYNG HEAD NECK, V92, P671, DOI 10.1177/019459988409200614; Mays LE, 1995, CURR OPIN NEUROBIOL, V5, P763, DOI 10.1016/0959-4388(95)80104-9; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; NeuroCom. A division of Natus, SETT STAND BAL MOB S; Previc F H, 1992, J Vestib Res, V2, P285; Rabago CA, 2011, J NEUROL PHYS THER, V35, P185, DOI 10.1097/NPT.0b013e318235d7e6; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; VANDIE GC, 1986, BRAIN RES, V383, P185, DOI 10.1016/0006-8993(86)90019-3; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wares JR, 2015, J REHABIL RES DEV, V52, P591, DOI 10.1682/JRRD.2014.08.0197; Wenzel R, 1996, BRAIN, V119, P101, DOI 10.1093/brain/119.1.101; Wright W. G., DISABILITY REHABILIT, V10, P1; Wright WG, 2015, 2015 INTERNATIONAL CONFERENCE ON VIRTUAL REHABILITATION PROCEEDINGS (ICVR), P72, DOI 10.1109/ICVR.2015.7358591; Wright WG, 2009, IEEE ENG MED BIO, P1157, DOI 10.1109/IEMBS.2009.5333425; Wright WG, 2005, J VESTIBUL RES-EQUIL, V15, P185; Wright WG, 2003, ANN NY ACAD SCI, V1004, P531, DOI 10.1196/annals.1303.069	58	20	21	0	25	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0957-4271	1878-6464		J VESTIBUL RES-EQUIL	J. Vestib. Res.-Equilib. Orientat.		2017	27	1					27	37		10.3233/VES-170607			11	Neurosciences; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	ES3LW	WOS:000399432100004	28387693				2021-06-18	
J	Zuckerman, A; Ram, O; Ifergane, G; Matar, MA; Sagi, R; Ostfeld, I; Hoffman, JR; Kaplan, Z; Sadot, O; Cohen, H				Zuckerman, Amitai; Ram, Omri; Ifergane, Gal; Matar, Michael A.; Sagi, Ram; Ostfeld, Ishay; Hoffman, Jay R.; Kaplan, Zeev; Sadot, Oren; Cohen, Hagit			Controlled Low-Pressure Blast-Wave Exposure Causes Distinct Behavioral and Morphological Responses Modelling Mild Traumatic Brain Injury, Post-Traumatic Stress Disorder, and Comorbid Mild Traumatic Brain Injury-Post-Traumatic Stress Disorder	JOURNAL OF NEUROTRAUMA			English	Article						animal model; blast-wave; PTSD; mTBI	ANIMAL-MODEL; DENDRITIC MORPHOLOGY; SPATIAL MEMORY; CA3 NETWORK; HIPPOCAMPUS; SEQUELAE; PLACE; CELLS; PROJECTIONS; SUBREGION	The intense focus in the clinical literature on the mental and neurocognitive sequelae of explosive blast-wave exposure, especially when comorbid with post-traumatic stress-related disorders (PTSD) is justified, and warrants the design of translationally valid animal studies to provide valid complementary basic data. We employed a controlled experimental blast-wave paradigm in which unanesthetized animals were exposed to visual, auditory, olfactory, and tactile effects of an explosive blast-wave produced by exploding a thin copper wire. By combining cognitive-behavioral paradigms and ex vivo brain MRI to assess mild traumatic brain injury (mTBI) phenotype with a validated behavioral model for PTSD, complemented by morphological assessments, this study sought to examine our ability to evaluate the biobehavioral effects of low-intensity blast overpressure on rats, in a translationally valid manner. There were no significant differences between blast-and sham-exposed rats on motor coordination and strength, or sensory function. Whereas most male rats exposed to the blast-wave displayed normal behavioral and cognitive responses, 23.6% of the rats displayed a significant retardation of spatial learning acquisition, fulfilling criteria for mTBI-like responses. In addition, 5.4% of the blastexposed animals displayed an extreme response in the behavioral tasks used to define PTSD-like criteria, whereas 10.9% of the rats developed both long-lasting and progressively worsening behavioral and cognitive "symptoms,'' suggesting comorbid PTSD-mTBI-like behavioral and cognitive response patterns. Neither group displayed changes on MRI. Exposure to experimental blast-wave elicited distinct behavioral and morphological responses modelling mTBI-like, PTSD-like, and comorbid mTBI-PTSD-like responses. This experimental animal model can be a useful tool for elucidating neurobiological mechanisms underlying the effects of blast-wave-induced mTBI and PTSD and comorbid mTBI-PTSD.	[Zuckerman, Amitai; Matar, Michael A.; Kaplan, Zeev; Cohen, Hagit] Ben Gurion Univ Negev, Fac Hlth Sci, Minist Hlth, Anxiety & Stress Res Unit, Beer Sheva, Israel; [Ram, Omri; Sadot, Oren] Ben Gurion Univ Negev, Dept Mech Engn, Beer Sheva, Israel; [Ifergane, Gal] Ben Gurion Univ Negev, Headache Clin, Soroka Med Ctr, Dept Neurol, Beer Sheva, Israel; [Sagi, Ram; Ostfeld, Ishay] Israel Def Forces Med Corps, Tel Aviv, Israel; [Hoffman, Jay R.] Univ Cent Florida, Inst Exercise Physiol & Wellness Sport & Exercise, Orlando, FL 32816 USA	Cohen, H (corresponding author), Ben Gurion Univ Negev, Anxiety & Stress Res Unit, Minist Hlth, Mental Hlth Ctr,Fac Hlth Sci, POB 4600, IL-84170 Beer Sheva, Israel.	hagitc@bgu.ac.il	ostfeld, ishay/AAC-3781-2020; Hoffman, Jay/AAF-2005-2019; Ifergane, Gal/AAD-3653-2019	Hoffman, Jay/0000-0002-0073-6603; Sadot, Oren/0000-0002-2627-550X	Israel Defense Forces (IDF) Medical Corps; Directorate of Defense and Development, Israeli Ministry of Defense (IMOD DDRD); Adelis Brain Research Awards	This study was supported by a grant from the Israel Defense Forces (IDF) Medical Corps and Directorate of Defense and Development, Israeli Ministry of Defense (IMOD DDR&D) and by the Adelis Brain Research Awards.	Bains JS, 1999, NAT NEUROSCI, V2, P720; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Centers for Disease Control and Prevention (CDC), 2015, GUID WRIT TRAUM BRAI; Cherubini E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00019; Cohen H, 2005, BIOL PSYCHIAT, V58, P640, DOI 10.1016/j.biopsych.2005.04.002; Cohen H, 2004, NEUROPSYCHOPHARMACOL, V29, P1962, DOI 10.1038/sj.npp.1300523; Cohen H, 2003, BIOL PSYCHIAT, V53, P463, DOI 10.1016/S0006-3223(02)01909-1; Cohen H, 2004, ANN NY ACAD SCI, V1032, P167, DOI 10.1196/annals.1314.014; Cohen H, 2013, CURR PROTOC NEUROSCI, DOI 10.1002/0471142301.ns0945s64; Cohen H, 2008, BIOL PSYCHIAT, V64, P708, DOI 10.1016/j.biopsych.2008.05.025; Cohen H, 2012, NEUROPHARMACOLOGY, V62, P715, DOI 10.1016/j.neuropharm.2011.04.023; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Diehl LA, 2012, NEUROCHEM RES, V37, P700, DOI 10.1007/s11064-011-0660-6; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FILE SE, 1993, PHYSIOL BEHAV, V54, P1109, DOI 10.1016/0031-9384(93)90333-B; FITCH JM, 1989, BRAIN RES, V479, P105, DOI 10.1016/0006-8993(89)91340-1; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Gilbert PE, 2009, PROG NEURO-PSYCHOPH, V33, P774, DOI 10.1016/j.pnpbp.2009.03.037; Gilbert PE, 2003, BEHAV NEUROSCI, V117, P1385, DOI 10.1037/0735-7044.117.6.1385; GREEN EJ, 1985, EXP BRAIN RES, V59, P582; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hunsaker MR, 2006, BEHAV NEUROSCI, V120, P1252, DOI 10.1037/0735-7044.120.6.1252; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Pavlidis P, 2000, J NEUROSCI, V20, P4497, DOI 10.1523/JNEUROSCI.20-12-04497.2000; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Ram O, 2012, EXP FLUIDS, V53, P1335, DOI 10.1007/s00348-012-1339-8; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Renno-Costa C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003641; Riedel G, 1999, NAT NEUROSCI, V2, P898; Rolls ET, 2007, LEARN MEMORY, V14, P714, DOI 10.1101/lm.631207; Rolls ET, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00098; ROLLS ET, 1989, J NEUROSCI, V9, P1835; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; SHOLL DA, 1956, PROG NEUROBIOL, V2, P324; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Zola-Morgan S, 1991, Hippocampus, V1, P207, DOI 10.1002/hipo.450010208	70	20	20	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					145	164		10.1089/neu.2015.4310			20	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100018	26885687				2021-06-18	
J	An, CR; Jiang, XY; Pu, HJ; Hong, DD; Zhang, WT; Hu, XM; Gao, YQ				An, Chengrui; Jiang, Xiaoyan; Pu, Hongjian; Hong, Dandan; Zhang, Wenting; Hu, Xiaoming; Gao, Yanqin			Severity-Dependent Long-Term Spatial Learning-Memory Impairment in a Mouse Model of Traumatic Brain Injury	TRANSLATIONAL STROKE RESEARCH			English	Article						Traumatic brain injury; Long-term spatial learning-memory deficits; White matter injury; Hippocampus	WHITE-MATTER INTEGRITY; POSTTRAUMATIC-STRESS-DISORDER; VASCULAR COGNITIVE IMPAIRMENT; CONTROLLED CORTICAL IMPACT; HEAD-INJURY; RECOVERY; IMPROVES; DEFICITS; STROKE; DAMAGE	Traumatic brain injury (TBI) is a major cause of death and disability in young adults. Long-term mental disability often occurs in patients suffering moderate and severe TBI while not as frequent in the victims of mild TBI. To explore the potential mechanism underlying this severity-dependent cognitive deficit, we subjected C57/BL6 mice to different severities of controlled cortical impact (CCI) and assessed their learning-memory functions. The mice subjected to moderate and severe TBI exhibited significantly impaired long-term spatial learning-memory ability, which was accompanied by marked white matter injury and hippocampus damage. In contrast, long-term learning-memory deficits or structural abnormalities within the hippocampus or white matter were not significant in the case of mild TBI. According to a correlation analysis, the hippocampus or white matter injury severity was more relevant to Morris water maze outcome than tissue volume. This study revealed that long-term spatial learning-memory deficits are dependent on the severity of destruction in the white matter and hippocampus. Therapeutic strategies targeting both the white matter and hippocampus may be needed to improve the neurological functions in TBI victims.	[An, Chengrui; Jiang, Xiaoyan; Pu, Hongjian; Zhang, Wenting; Hu, Xiaoming; Gao, Yanqin] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [An, Chengrui; Jiang, Xiaoyan; Pu, Hongjian; Zhang, Wenting; Hu, Xiaoming; Gao, Yanqin] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200032, Peoples R China; [Jiang, Xiaoyan; Pu, Hongjian; Hong, Dandan; Hu, Xiaoming; Gao, Yanqin] Univ Pittsburgh, Sch Med, Ctr Cerebrovasc Dis Res, Pittsburgh, PA 15213 USA	Gao, YQ (corresponding author), Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China.; Gao, YQ (corresponding author), Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200032, Peoples R China.; Gao, YQ (corresponding author), Univ Pittsburgh, Sch Med, Ctr Cerebrovasc Dis Res, Pittsburgh, PA 15213 USA.	yqgao@shmu.edu.cn	Gao, Yanqin/I-6790-2016; Pu, Hongjian/AAW-3322-2020	Gao, Yanqin/0000-0002-4915-9819; 	Chinese Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81171149, 81371306, 81571285, 81471332]; Shanghai Committee of Science and Technology Support Program [14431907002]; American Heart Associat ion Scientist DevelopmentAmerican Heart Association [13SDG14570025]	This project was supported by the Chinese Natural Science Foundation grants 81171149, 81371306, 81571285 (to Dr. Gao), and 81471332 (to Dr. Zhang); the Shanghai Committee of Science and Technology Support Program 14431907002 (to Dr. Gao); and the American Heart Associat ion Scientist Development grant 13SDG14570025 (to Dr. Hu).	Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Chen QW, 2015, TRANSL STROKE RES, V6, P125, DOI 10.1007/s12975-014-0367-5; Clark AL, 2016, BRAIN INJURY, V30, P864, DOI 10.3109/02699052.2016.1144894; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; d'Esterre CD, 2015, TRANSL STROKE RES, V6, P234, DOI 10.1007/s12975-015-0394-x; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Harris AL, 2014, TRANSL STROKE RES, V5, P292, DOI 10.1007/s12975-013-0293-y; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hill BD, 2013, ARCH CLIN NEUROPSYCH, V28, P640, DOI 10.1093/arclin/act045; Hill D, 2015, TRANSL STROKE RES, V6, P410, DOI 10.1007/s12975-015-0420-z; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Kemmotsu N, 2011, EPILEPSIA, V52, P2257, DOI 10.1111/j.1528-1167.2011.03278.x; Khan MB, 2015, TRANSL STROKE RES, V6, P69, DOI 10.1007/s12975-014-0374-6; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Liu P, 2013, BRAIN RES, V1522, P67, DOI 10.1016/j.brainres.2013.05.032; MAHUT H, 1982, J NEUROSCI, V2, P1214; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Pignataro G, 2014, TRANSL STROKE RES, V5, P145, DOI 10.1007/s12975-013-0308-8; Pringsheim T, 2014, NEUROLOGY, V83, P1661, DOI 10.1212/WNL.0000000000000929; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Qiu MG, 2011, NEUROREHAB NEURAL RE, V25, P275, DOI 10.1177/1545968310389183; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Sebastian V, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00038; Sehba FA, 2014, TRANSL STROKE RES, V5, P660, DOI 10.1007/s12975-014-0368-4; Song MK, 2014, TRANSL STROKE RES, V5, P17, DOI 10.1007/s12975-013-0314-x; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Turner MJ, 2015, J NEUROIMMUNOL, V285, P4, DOI 10.1016/j.jneuroim.2015.05.018; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Wong GKC, 2014, TRANSL STROKE RES, V5, P286, DOI 10.1007/s12975-013-0284-z; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Yu YW, 2016, J NEUROTRAUM, V33, P2044, DOI 10.1089/neu.2015.4229; Yuan L, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150129; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhao H, 2014, TRANSL STROKE RES, V5, P128, DOI 10.1007/s12975-013-0286-x; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y; Zuloaga KL, 2015, TRANSL STROKE RES, V6, P390, DOI 10.1007/s12975-015-0412-z	59	20	20	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	DEC	2016	7	6					512	520		10.1007/s12975-016-0483-5			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	EA1VJ	WOS:000386379800007	27539574				2021-06-18	
J	Brooks, BL; Mannix, R; Maxwell, B; Zafonte, R; Berkner, PD; Iverson, GL				Brooks, Brian L.; Mannix, Rebekah; Maxwell, Bruce; Zafonte, Ross; Berkner, Paul D.; Iverson, Grant L.			Multiple Past Concussions in High School Football Players: Are There Differences in Cognitive Functioning and Symptom Reporting?	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						child; adolescent; traumatic brain injury; sports; postconcussion syndrome	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION-LIKE SYMPTOMS; PROFESSIONAL SOCCER PLAYERS; HEAD IMPACT EXPOSURE; BASE-LINE; ELECTROPHYSIOLOGICAL ABNORMALITIES; NEUROPSYCHOLOGICAL PERFORMANCE; NONCLINICAL SAMPLE; SPORT CONCUSSION; 1ST EXPOSURE	Background: There is increasing concern about the possible long-term effects of multiple concussions, particularly on the developing adolescent brain. Whether the effect of multiple concussions is detectable in high school football players has not been well studied, although the public health implications are great in this population. Purpose: To determine if there are measureable differences in cognitive functioning or symptom reporting in high school football players with a history of multiple concussions. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Participants included 5232 male adolescent football players (mean [SD] age, 15.5 1.2 years) who completed baseline testing between 2009 and 2014. On the basis of injury history, athletes were grouped into 0 (n = 4183), 1 (n = 733), 2 (n = 216), 3 (n = 67), or 4 (n = 33) prior concussions. Cognitive functioning was measured by the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) battery, and symptom ratings were obtained from the Post-Concussion Symptom Scale. Results: There were no statistically significant differences between groups (based on the number of reported concussions) regarding cognitive functioning. Athletes with 3 prior concussions reported more symptoms than did athletes with 0 or 1 prior injury. In multivariate analyses, concussion history was independently related to symptom reporting but less so than developmental problems (eg, attention or learning problems) or other health problems (eg, past treatment for psychiatric problems, headaches, or migraines). Conclusion: In the largest study to date, high school football players with multiple past concussions performed the same on cognitive testing as those with no prior concussions. Concussion history was one of several factors that were independently related to symptom reporting.	[Brooks, Brian L.; Mannix, Rebekah; Maxwell, Bruce; Zafonte, Ross; Berkner, Paul D.; Iverson, Grant L.] Colby Coll, Waterville, ME 04901 USA; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program Brain Injury & Rehabil, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Mannix, Rebekah] Boston Childrens Hosp, Brain Injury Ctr, Div Emergency Med, Boston, MA USA; [Maxwell, Bruce] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Boston, MA USA; [Zafonte, Ross; Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Zafonte, Ross; Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Berkner, Paul D.] Colby Coll, Hlth Serv & Dept Biol, Waterville, ME 04901 USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Children, Sport Concuss Program, Boston, MA USA	Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@albertahealthservices.ca	Mannix, Rebekah/AAD-8702-2020	Iverson, Grant/0000-0001-7348-9570	Goldfarb Center for Public Affairs and Civic Engagement at Colby College; Bill and Joan Alfond Foundation; Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members; Department of Defense of the Harvard Clinical Consortium Post-traumatic Stress Disorder/Traumatic Brain Injury Study Site (INTRuST) [USAMRMC W81XWH-08-2-0159]; ImPACT Applications Inc; Mooney-Reed Charitable Foundation;  [NIH/EKS-NICHD 1 R24 HD065688]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128, R24HD065688] Funding Source: NIH RePORTER	One or more of the authors has declared the following potential conflict of interest or source of funding: This study was funded by the Goldfarb Center for Public Affairs and Civic Engagement at Colby College and the Bill and Joan Alfond Foundation. B.L.B. receives royalties for the sales of a pediatric forensic textbook and pediatric neuropsychological tests; he has previously received support (in-kind test credits) from a different computerized cognitive test publisher. R.Z. was supported in part by the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members. Funding for R.Z. includes the Improving Outcome Measurement for Medical Rehabilitation Clinical Trials (NIH/EKS-NICHD 1 R24 HD065688) and the Department of Defense (USAMRMC W81XWH-08-2-0159) of the Harvard Clinical Consortium Post-traumatic Stress Disorder/Traumatic Brain Injury Study Site (INTRuST); he is also an investigator on the Football Players Health Study at Harvard University. G.L.I. has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild traumatic brain injuries (MTBIs) and sport-related concussions at meetings, scientific conferences, and symposiums; he has a clinical practice in forensic neuropsychology involving patients who have sustained MTBIs (including athletes); he has received honoraria for serving on research panels that provide scientific peer reviews of programs; he is a coinvestigator, collaborator, or consultant on grants relating to MTBIs funded by several organizations; and he has received research support from test publishing companies in the past including ImPACT Applications Inc (not in the past 5 years). R.Z. and G.L.I. acknowledge support from the Mooney-Reed Charitable Foundation.	Balasundaram AP, 2013, PHYS THER SPORT, V14, P253, DOI 10.1016/j.ptsp.2013.06.002; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Connery AK, 2014, NEUROSURGERY, V75, P31, DOI 10.1227/NEU.0000000000000346; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; ImPACT Applications Inc., 2011, TECHN MAN ONL IMPACT; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/316575; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Maroon JC, 2000, NEUROSURGERY, V47, P669; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckay CD, 2014, J ORTHOP SPORT PHYS, V44, P329, DOI 10.2519/jospt.2014.5053; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Pedhazur E.J., 1997, MULTIPLE REGRESSION, V3rd ed.; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P9, DOI 10.1080/21622965.2014.902762; Tsushima WT, 2013, APPL NEUROPSYCH-CHIL, V2, P13, DOI 10.1080/09084282.2011.643967; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	78	20	20	1	38	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	DEC	2016	44	12					3243	3251		10.1177/0363546516655095			9	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	EE8VS	WOS:000389905400029	27474382	Green Accepted			2021-06-18	
J	Ledwidge, PS; Molfese, DL				Ledwidge, Patrick S.; Molfese, Dennis L.			Long-Term Effects of Concussion on Electrophysiological Indices of Attention in Varsity College Athletes: An Event-Related Potential and Standardized Low-Resolution Brain Electromagnetic Tomography Approach	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; electrophysiology; cognitive function; neuropsychology; traumatic brain injury	AUDITORY ODDBALL TASK; PROFESSIONAL FOOTBALL PLAYERS; SPORT-RELATED CONCUSSION; WORKING-MEMORY TASK; COGNITIVE CONTROL; FUNCTIONAL MRI; RECURRENT CONCUSSION; PERSISTENT INFLUENCE; CORTICAL GENERATORS; P300 COMPONENT	This study investigated the effects of a past concussion on electrophysiological indices of attention in college athletes. Forty-four varsity football athletes (22 with at least one past concussion) participated in three neuropsychological tests and a two-tone auditory oddball task while undergoing high-density event-related potential (ERP) recording. Athletes previously diagnosed with a concussion experienced their most recent injury approximately 4 years before testing. Previously concussed and control athletes performed equivalently on three neuropsychological tests. Behavioral accuracy and reaction times on the oddball task were also equivalent across groups. However, athletes with a concussion history exhibited significantly larger N2 and P3b amplitudes and longer P3b latencies. Source localization using standardized low-resolution brain electromagnetic tomography indicated that athletes with a history of concussion generated larger electrical current density in the left inferior parietal gyrus compared to control athletes. These findings support the hypothesis that individuals with a past concussion recruit compensatory neural resources in order to meet executive functioning demands. High-density ERP measures combined with source localization provide an important method to detect long-term neural consequences of concussion in the absence of impaired neuropsychological performance.	[Ledwidge, Patrick S.; Molfese, Dennis L.] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Ledwidge, Patrick S.; Molfese, Dennis L.] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA	Ledwidge, PS (corresponding author), Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA.	pledwidge@huskers.unl.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01EB007684]	This research was partially supported by funding from The National Institutes of Health (1R01EB007684).	Barwick F, 2012, CLIN NEUROPHYSIOL, V123, P278, DOI 10.1016/j.clinph.2011.06.027; Brazdil M, 2005, NEUROIMAGE, V26, P285, DOI 10.1016/j.neuroimage.2005.01.051; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Curran T, 1999, NEUROPSYCHOLOGIA, V37, P771, DOI 10.1016/S0028-3932(98)00133-X; Curry S H, 1980, Prog Brain Res, V54, P507, DOI 10.1016/S0079-6123(08)61668-4; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Dien J., 2005, EVENT RELATED POTENT, P57; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Donchin E, 1986, PSYCHOPHYSIOLOGY SYS, P244; DUNCANJOHNSON CC, 1981, PSYCHOPHYSIOLOGY, V18, P207; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Ferree TC, 2000, IEEE T BIO-MED ENG, V47, P1584, DOI 10.1109/10.887939; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Greene SJ, 2010, NEUROBIOL AGING, V31, P1304, DOI 10.1016/j.neurobiolaging.2010.04.026; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; JOHNSON R, 1993, PSYCHOPHYSIOLOGY, V30, P90; JOHNSON R, 1989, PSYCHOPHYSIOLOGY, V26, P633, DOI 10.1111/j.1469-8986.1989.tb03165.x; Juckel G, 2012, NEUROIMAGE, V60, P2027, DOI 10.1016/j.neuroimage.2012.02.019; Junghofer M, 1997, BRAIN TOPOGR, V9, P203, DOI 10.1007/BF01190389; Key APF, 2005, DEV NEUROPSYCHOL, V27, P183, DOI 10.1207/s15326942dn2702_1; Kota S, 2013, NEUROREPORT, V24, P437, DOI 10.1097/WNR.0b013e3283616512; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Mathalon DH, 2003, BIOL PSYCHOL, V64, P119, DOI 10.1016/S0301-0511(03)00105-4; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Molfese DL, 2015, DEV NEUROPSYCHOL, V40, P1, DOI 10.1080/87565641.2015.1006479; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Mulert C, 2004, EUR ARCH PSY CLIN N, V254, P190, DOI 10.1007/s00406-004-0469-2; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; POLICH J, 1986, ELECTROEN CLIN NEURO, V63, P251, DOI 10.1016/0013-4694(86)90093-3; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reitan R., 1988, HALSTEAD REITAN NEUR; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; Saliasi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063701; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Song J, 2014, I S BIOMED IMAGING, P620, DOI 10.1109/ISBI.2014.6867947; Spencer KM, 1999, PSYCHOPHYSIOLOGY, V36, P409, DOI 10.1017/S0048577299981180; Srinivasan R, 1998, BEHAV RES METH INS C, V30, P8, DOI 10.3758/BF03209412; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3	81	20	20	2	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2081	2090		10.1089/neu.2015.4251			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800003	27025905	Green Published			2021-06-18	
J	Xuan, WJ; Huang, LY; Hamblin, MR				Xuan, Weijun; Huang, Liyi; Hamblin, Michael R.			Repeated transcranial low-level laser therapy for traumatic brain injury in mice: biphasic dose response and long-term treatment outcome	Journal of Biophotonics			English	Article						Traumatic brain injury; controlled cortical impact mouse model; photobiomodulation; LLLT; biphasic dose response; Morris water maze; glial fibrillary acidic protein; reactive gliosis	FIBRILLARY ACIDIC PROTEIN; LIGHT THERAPY; NEUROLOGICAL DEFICITS; CEREBRAL-ISCHEMIA; UNITED-STATES; GFAP; SYNAPTOGENESIS; ACTIVATION; ASTROCYTES; RECOVERY	We previously showed that near-infrared laser photobiomodulation (PBM) (810 nm, CW, 18 J/cm(2), 25 mW/cm(2)) delivered to the mouse daily for 3-days after a controlled cortical impact traumatic brain injury (TBI) gave a significant improvement in neurological/cognitive function. However the same parameters delivered 14X daily gave significantly less benefit. This biphasic dose response intrigued us, and we decided to follow the mice that received 3X or 14X laser treatments out to 56-days post-TBI. We found the 14X group showed worse neurological function than the no-treatment TBI group at 2-weeks, but started to improve steadily during the next 6-weeks, and by 56-days were significantly better than the no-treatment TBI mice, but still worse than the 3X mice. A marker of activated glial cells (GFAP) was significantly increased in the brain regions (compared to both untreated TBI and 3X groups) at 4-weeks in the 14X group, but the GFAP had fallen to low levels in both 3X and 14X groups by 8-weeks. We conclude that an excessive number of laser-treatments delivered to mice can temporarily inhibit the process of brain repair stimulated by tPBM, but then the inhibitory effect ceases, and brain repair can resume. The mechanism may be temporary induction of reactive gliosis. [GRAPHICS] .	[Xuan, Weijun] Guangxi Univ Chinese Med, Dept Otorhinolaryngol Head & Neck Surg, Ruikang Clin Med Coll, Nanning, Peoples R China; [Xuan, Weijun; Huang, Liyi; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Xuan, Weijun; Huang, Liyi; Hamblin, Michael R.] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA; [Hamblin, Michael R.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Hamblin, MR (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.; Hamblin, MR (corresponding author), Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA.; Hamblin, MR (corresponding author), Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	Hamblin@helix.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019	Hamblin, Michael R/0000-0001-6431-4605	Air Force Office of Scientific ResearchUnited States Department of DefenseAir Force Office of Scientific Research (AFOSR) [FA9550-13-1-0068]; US Army Medical Research Acquisition Activity [W81XWH-09-1-0514]; US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0067]; US NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AI050875]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI050875] Funding Source: NIH RePORTER	This work was supported by Air Force Office of Scientific Research grant FA9550-13-1-0068, by US Army Medical Research Acquisition Activity grant W81XWH-09-1-0514, and by US Army Medical Research and Materiel Command grant W81XWH-13-2-0067. MRH was supported by US NIH grant R01AI050875. We are grateful to Jie Zhao of the Photopathology Core of Wellman Center for Photomedicine for help with pathology.	Aiba I, 2012, J PHYSIOL-LONDON, V590, P5877, DOI 10.1113/jphysiol.2012.234476; Ando T., 2011, PLOS ONE, V6; Ando T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026212; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Calabrese EJ, 2013, ENVIRON POLLUT, V182, P452, DOI 10.1016/j.envpol.2013.07.046; Castano AP, 2007, LASER SURG MED, V39, P543, DOI 10.1002/lsm.20516; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Demidova-Rice TN, 2007, LASER SURG MED, V39, P706, DOI 10.1002/lsm.20549; Dong TT, 2015, J CEREBR BLOOD F MET, V35, P1435, DOI 10.1038/jcbfm.2015.87; Dringen R, 2015, NEUROCHEM RES, V40, P2570, DOI 10.1007/s11064-014-1481-1; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Giacci MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104565; Goldshmit Y, 2014, BRAIN BEHAV, V4, P187, DOI 10.1002/brb3.172; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Henderson Theodore A, 2015, Adv Mind Body Med, V29, P27; Henderson TA, 2015, NEUROPSYCH DIS TREAT, V11, P2191, DOI 10.2147/NDT.S78182; Huang LJ, 2014, INT J MED SCI, V11, P344, DOI 10.7150/ijms.8140; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Jones OD, 2015, NEUROSCIENCE, V309, P113, DOI 10.1016/j.neuroscience.2015.08.035; Castejon OJ, 2015, FOLIA NEUROPATHOL, V53, P173, DOI 10.5114/fn.2015.54419; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Laskowitz D., 2016, TRANSLATIONAL RES TR; Leo P., 2016, TRANSLATIONAL RES TR; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Messing A, 2003, GLIA, V43, P87, DOI 10.1002/glia.10219; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser MA, 2015, PHOTOMED LASER SURG, V33, P443, DOI 10.1089/pho.2015.3986; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2012, J NEUROTRAUM, V29, P401, DOI 10.1089/neu.2011.2062; Oron U, 2001, LASER SURG MED, V28, P204, DOI 10.1002/lsm.1039; Overman JJ, 2012, P NATL ACAD SCI USA, V109, pE2230, DOI 10.1073/pnas.1204386109; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P5347, DOI 10.1167/iovs.10-7119; Sullivan SM, 2014, J NEUROCHEM, V130, P729, DOI 10.1111/jnc.12754; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Zhang Q, 2014, J CEREBR BLOOD F MET, V34, P1391, DOI 10.1038/jcbfm.2014.95	54	20	22	1	11	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	DEC	2016	9	11-12			SI		1263	1272		10.1002/jbio.201500336			10	Biochemical Research Methods; Biophysics; Optics	Biochemistry & Molecular Biology; Biophysics; Optics	EJ0QS	WOS:000392915800015	26990361	Green Accepted			2021-06-18	
J	Wilde, EA; Li, XQ; Hunter, JV; Narayana, PA; Hasan, K; Biekman, B; Swank, P; Robertson, C; Miller, E; McCauley, SR; Chu, ZD; Faber, J; McCarthy, J; Levin, HS				Wilde, Elisabeth A.; Li, Xiaoqi; Hunter, Jill V.; Narayana, Ponnada A.; Hasan, Khader; Biekman, Brian; Swank, Paul; Robertson, Claudia; Miller, Emmy; McCauley, Stephen R.; Chu, Zili David; Faber, Jessica; McCarthy, James; Levin, Harvey S.			Loss of Consciousness Is Related to White Matter Injury in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; loss of consciousness; mild traumatic brain injury	DIFFUSE AXONAL INJURY; IDENTIFICATION TEST AUDIT; TENSOR IMAGING FINDINGS; ABUSE SCREENING-TEST; PRACTICAL SCALE; ABNORMALITIES; ASSOCIATION; VALIDATION; CONCUSSION; ANISOTROPY	To study the relation of loss of consciousness (LOC) to white matter integrity after mild traumatic brain injury (mTBI), we acquired diffusion tensor imaging (DTI) at 3 Tesla in 79 participants with mTBI and normal computed tomography (age 18 to 50 years) whom we imaged after a mean post-injury interval of 25.9 h (standard deviation = 12.3) and at 3 months. For comparison, 64 participants with orthopedic injury (OI) underwent DTI at similar intervals. Quantitative tractography was used to measure fractional anisotropy (FA) and mean diffusivity (MD) in the left and right uncinate fasciculus (UF), left and right inferior frontal occipital fasciculus (IFOF), and the genu of the corpus callosum. Generalized estimating equation models assessed the association between LOC and both MD and FA across time after mTBI and compared their DTI metrics with the OI group. LOC was significantly related to MD in UF and IFOF (p values ranged from p < 0.0001 to 0.0270) and to FA in left UF (p = 0.0104) and right UF (p = 0.0404). Between-group differences in MD were significant for left UF, left and right IFOF, and the genu of the corpus callosum on initial DTI, but not at 3 months post-injury, and these differences were specific to the mTBI subgroup with LOC. Groups did not differ in FA at either occasion. Early DTI may provide a biomarker for mTBI with LOC, even in patients whose consciousness recovers by arrival in the emergency department. MD better differentiates mTBI from OI than FA on early DTI, but this is specific to mTBI with LOC. DTI findings support a continuum of white matter injury in early mTBI.	[Wilde, Elisabeth A.; McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Li, Xiaoqi; Biekman, Brian; Faber, Jessica] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Hunter, Jill V.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Chu, Zili David] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Narayana, Ponnada A.; Hasan, Khader; McCarthy, James] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Imaging, Houston, TX 77030 USA; [Swank, Paul] Univ Texas Sch Publ Hlth, Houston, TX USA; [Miller, Emmy] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA	Levin, HS (corresponding author), Baylor Coll Med, One Baylor Plaza BCM637, Houston, TX 77030 USA.	hlevin@bcm.edu	Hasan, Khader M./ABB-5767-2020		Department of DefenseUnited States Department of Defense [W81XWH-08-2-0133, PT074693P2]	This work was supported by the Congressionally Directed Medical Research Program by the Department of Defense (W81XWH-08-2-0133, PT074693P2). The funding source had no role in the interpretation of data, writing of this paper, or in the decision to submit for publication. The contents of this paper are solely the responsibility of the authors and do not represent the official views of the Department of Defense. The authors wish to thank James Montier and English Pratts, Baylor College of Medicine, for their assistance in the preparation of this manuscript. We also are indebted to the research staff in the Mission Connect consortium and to the patients who participated in the project.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; *ASS ADV AUT MED, 2001, ABBR INJ SCAL 1990 R; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Bohn M.J., VALIDITY DRUG ABUSE; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chaim TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110199; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hasan KM, 2007, MAGN RESON IMAGING, V25, P1196, DOI 10.1016/j.mri.2007.02.011; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Hayes J.P., 2015, NAT REV NEUROL, V11, P247; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kaya A, 2008, J INT MED RES, V36, P9, DOI 10.1177/147323000803600102; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Martino J, 2014, CLIN ANAT, V27, P563, DOI 10.1002/ca.22321; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; TEASDALE G, 1974, LANCET, V2, P81; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Xydakis MS, 2012, ANN NEUROL, V72, P673, DOI 10.1002/ana.23757; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	50	20	20	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2016	33	22					2000	2010		10.1089/neu.2015.4212			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EC4OL	WOS:000388112300003	26801471				2021-06-18	
J	Licastro, F; Hrelia, S; Porcellini, E; Malaguti, M; Di Stefano, C; Angeloni, C; Carbone, I; Simoncini, L; Piperno, R				Licastro, Federico; Hrelia, Silvana; Porcellini, Elisa; Malaguti, Marco; Di Stefano, Cristina; Angeloni, Cristina; Carbone, Ilaria; Simoncini, Laura; Piperno, Roberto			Peripheral Inflammatory Markers and Antioxidant Response during the Post-Acute and Chronic Phase after Severe Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; inflammation; oxidative stress; cytokines plasma levels; follow-up; cognitive outcome	TUMOR-NECROSIS-FACTOR; OXIDATIVE STRESS; CEREBROSPINAL-FLUID; COGNITIVE DECLINE; DIFFUSION-TENSOR; NEURODEGENERATIVE DISEASES; MICROGLIAL ACTIVATION; LONGITUDINAL CHANGES; NORMATIVE VALUES; HEAD-INJURY	Traumatic brain injury (TBI) is a mechanical insult to the brain caused by external forces and associated with inflammation and oxidative stress. The patients may show different profiles of neurological recovery and a combination of oxidative damage and inflammatory processes can affect their courses. It is known that an overexpression of cytokines can be seen in peripheral blood in the early hours/days after the injury, but little is known about the weeks and months encompassing the post-acute and chronic phases. In addition, no information is available about the antioxidant responses mediated by the major enzymes that regulate reactive oxygen species levels: superoxide dismutase, catalase, peroxidases, and GSH-related enzymes. This study investigates the 6-month trends of inflammatory markers and antioxidant responses in 22 severe TBI patients with prolonged disorders of consciousness, consecutively recruited in a dedicated neurore-habilitation facility. Patients with a high degree of neurological impairment often show an uncertain outcome. In addition, the profiles of plasma activities were related to the neurological recovery after 12 months. Venous peripheral blood samples were taken blindly as soon as clinical signs and laboratory markers confirmed the absence of infections, 3 and 6 months later. The clinical and neuropsychological assessment continued up to 12 months. Nineteen patients completed the follow-up. In the chronic phase, persistent high plasma levels of cytokines can interfere with cognitive functioning and higher post-acute levels of cytokines [ interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, IL1b, IL6] are associated with poorer cognitive recoveries 12 months later. Moreover, higher IFN-gamma, higher TNF-alpha, and lower glutathione peroxidase activity are associated with greater disability. The results add evidence of persistent inflammatory response, provide information about long-term imbalance of antioxidant activity, and suggest that the over-production of cytokines and the alteration of the redox homeostasis in the post-acute phase might adversely affect the neurological and functional recovery. Inflammatory and antioxidant activity markers might offer a feasible way to highlight some of the processes opposing recovery after a severe TBI.	[Licastro, Federico; Porcellini, Elisa; Carbone, Ilaria] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Hrelia, Silvana; Malaguti, Marco; Angeloni, Cristina] Univ Bologna, Dept Life Qual Studies, Rimini, Italy; [Di Stefano, Cristina; Simoncini, Laura; Piperno, Roberto] Maggiore Hosp, Emergency Dept, Neurorehabil Unit, Bologna, Italy	Piperno, R (corresponding author), Maggiore Hosp, Emergency Dept, Neurorehabil Unit, Bologna, Italy.	roberto.piperno@ausl.bologna.it	Piperno, Roberto/AAC-3000-2021; Porcellini, Elisa/K-5346-2016	Piperno, Roberto/0000-0002-2251-9191; Porcellini, Elisa/0000-0003-3991-5294	"Fondazione del Monte di Bologna e Ravenna" (Italy); MIUR-FIRBMinistry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB) [RBAP11HSZS]; "Centro Studi per la Ricerca sul Coma - Amici di Luca ONLUS" of Bologna (Italy)	This work was supported by "Fondazione del Monte di Bologna e Ravenna" (Italy), by MIUR-FIRB (project RBAP11HSZS), and by "Centro Studi per la Ricerca sul Coma - Amici di Luca ONLUS" of Bologna (Italy).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Barone E, 2015, J NEUROSCI RES, V93, P1728, DOI 10.1002/jnr.23627; Basso A, 1987, Funct Neurol, V2, P189; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Block ML, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S8; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Caffarra P, 2002, NEUROL SCI, V22, P443, DOI 10.1007/s100720200003; Carlesimo G. A., 1995, Archivio di Psicologia Neurologia e Psichiatria, V56, P471; Chen W, 2014, NEUROCHEM INT, V68, P28, DOI 10.1016/j.neuint.2014.01.015; Ciaramelli E, 2006, GIORNALE ITALIANO PS, V33, P607, DOI DOI 10.1421/22765; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Granger CV, 1986, GUIDE USE UNIFORM DA; Hagen C., 1972, LEVELS COGNITIVE FUN; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Jha MK, 2015, EXPERT OPIN THER PAT, V25, P241, DOI 10.1517/13543776.2014.972937; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Juurlink BHJ, 1997, NEUROSCI BIOBEHAV R, V21, P151, DOI 10.1016/S0149-7634(96)00005-X; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; Laiacona M, 2000, NEUROL SCI, V21, P279, DOI 10.1007/s100720070065; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Licastro F, 2010, CURR PHARM DESIGN, V16, P783, DOI 10.2174/138161210790883543; Licastro F, 2010, NEUROBIOL AGING, V31, P257, DOI 10.1016/j.neurobiolaging.2008.03.019; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lo TYM, 2010, J NEUROTRAUM, V27, P2139, DOI 10.1089/neu.2010.1387; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; Lu XY, 2014, J SURG RES, V188, P206, DOI 10.1016/j.jss.2013.11.1106; Maffei F, 2011, MUTAT RES-FUND MOL M, V714, P88, DOI 10.1016/j.mrfmmm.2011.06.016; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Malaguti M, 2008, INT J SPORT NUTR EXE, V18, P301, DOI 10.1123/ijsnem.18.3.301; Malaguti M, 2009, J APPL PHYSIOL, V107, P1028, DOI 10.1152/japplphysiol.00293.2009; Marsland AL, 2006, PSYCHOSOM MED, V68, P895, DOI 10.1097/01.psy.0000238451.22174.92; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Mooijaart SP, 2013, J INTERN MED, V274, P77, DOI 10.1111/joim.12052; Motori E, 2013, CELL METAB, V18, P844, DOI 10.1016/j.cmet.2013.11.005; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Orsini A, 2003, WAIS RETERZA ETA NAT; Orsini A, 1997, DISEGNO CON CUBI WAI; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ravaglia G, 2007, NEUROBIOL AGING, V28, P1810, DOI 10.1016/j.neurobiolaging.2006.08.012; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; RUFF RM, 1991, J NEUROSURG, V75, pS50, DOI 10.3171/sup.1991.75.1s.0s50; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Spinnler H., 1987, STANDARDIZZAZIONE TA; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; Tai LM, 2015, J NEUROCHEM, V133, P465, DOI 10.1111/jnc.13072; TEASDALE G, 1974, LANCET, V2, P81; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Valentini L, 2015, CLIN NUTR, V34, P593, DOI 10.1016/j.clnu.2014.09.023; Wiendl H, 2013, NAT REV NEUROL, V9, P125, DOI 10.1038/nrneurol.2013.2; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Yang T, 2014, CELL MOL NEUROBIOL, V34, P797, DOI 10.1007/s10571-014-0070-9; Zaghloul N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108168; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zimmermann P, 1994, BATTERIA TEST ESAME	86	20	20	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 2	2016	7								189	10.3389/fneur.2016.00189			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	EA6EG	WOS:000386718000001	27853449	DOAJ Gold, Green Published			2021-06-18	
J	Campolettano, ET; Rowson, S; Duma, SM				Campolettano, Eamon T.; Rowson, Steven; Duma, Stefan M.			Drill-specific head impact exposure in youth football practice	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; biomechanics; linear; rotational; acceleration; pediatrics; trauma	HIGH-SCHOOL FOOTBALL; PLAYERS; INJURY; ACCELERATION; CONCUSSIONS; KINEMATICS; MAGNITUDE; LOCATION; GAME	OBJECTIVE Although 70% of football players in the United States are youth players (6-14 years old), most research on head impacts in football has focused on high school, collegiate, or professional populations. The objective of this study was to identify the specific activities associated with high-magnitude (acceleration > 40g) head impacts in youth football practices. METHODS A total of 34 players (mean age 9.9 +/- 0.6 years) on 2 youth teams were equipped with helmet-mounted accelerometer arrays that recorded head accelerations associated with impacts in practices and games. Videos of practices and games were used to verify all head impacts and identify specific drills associated with each head impact. RESULTS A total of 6813 impacts were recorded, of which 408 had accelerations exceeding 40g (6.0%). For each type of practice drill, impact rates were computed that accounted for the length of time that teams spent on each drill. The tackling drill King of the Circle had the highest impact rate (95% CI 25.6-68.3 impacts/hr). Impact rates for tackling drills (those conducted without a blocker [95% CI 14.7-21.9 impacts/hr] and those with a blocker [95% CI 10.5-23.1 impacts/hr]) did not differ from game impact rates (95% CI 14.2-21.6 impacts/hr). Tackling drills were observed to have a greater proportion (between 40% and 50%) of impacts exceeding 60g than games (25%). The teams in this study participated in tackling or blocking drills for only 22% of their overall practice times, but these drills were responsible for 86% of all practice impacts exceeding 40g. CONCLUSIONS In youth football, high-magnitude impacts occur more often in practices than games, and some practice drills are associated with higher impact rates and accelerations than others. To mitigate high-magnitude head impact exposure in youth football, practices should be modified to decrease the time spent in drills with high impact rates, potentially eliminating a drill such as King of the Circle altogether.	[Campolettano, Eamon T.; Rowson, Steven; Duma, Stefan M.] Virginia Tech, Dept Biomed Engn & Mech, 343 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA	Rowson, S (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, 343 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	srowson@vt.edu	Rowson, Steven/B-1270-2012; Duma, Stefan/A-8368-2012	Rowson, Steven/0000-0002-3227-0596; 	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award No. R01NS094410. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We gratefully acknowledge the Blacksburg Juniors football teams for their participation in this study.	Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; BRESLOW N.E., 1987, STAT METHODS CANC RE, VII; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2011, EXERC SPORT SCI REV, V39, P2, DOI 10.1097/JES.0b013e318203dfdb; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pop Warner National Office, 2012, POP WARNER NEWS 0613; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	27	20	20	0	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2016	18	5					536	541		10.3171/2016.5.PEDS1696			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	DZ8FL	WOS:000386106200003	27550390	Green Accepted, Bronze			2021-06-18	
J	Hawryluk, GWJ; Phan, N; Ferguson, AR; Morabito, D; Derugin, N; Stewart, CL; Knudson, MM; Manley, G; Rosenthal, G				Hawryluk, Gregory W. J.; Phan, Nicolas; Ferguson, Adam R.; Morabito, Diane; Derugin, Nikita; Stewart, Campbell L.; Knudson, M. Margaret; Manley, Geoffrey; Rosenthal, Guy			Brain tissue oxygen tension and its response to physiological manipulations: influence of distance from injury site in a swine model of traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; oxygen monitor; optimal location; licox; in vivo	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; COMATOSE PATIENTS; PARTIAL-PRESSURE; INSPIRED OXYGEN; REACTIVITY; HYPEROXIA; THERAPY; HYPOXIA; PO2	OBJECTIVE The optimal site for placement of tissue oxygen probes following traumatic brain injury (TBI) remains unresolved. The authors used a previously described swine model of focal TBI and studied brain tissue oxygen tension (PbtO2) at the sites of contusion, proximal and distal to contusion, and in the contralateral hemisphere to determine the effect of probe location on PbtO2 and to assess the effects of physiological interventions on PbtO2 at these different sites. METHODS A controlled cortical impact device was used to generate a focal lesion in the right frontal lobe in 12 anesthetized swine. PbtO2 was measured using Licox brain tissue oxygen probes placed at the site of contusion, in pericontusional tissue (proximal probe), in the right parietal region (distal probe), and in the contralateral hemisphere. PbtO2 was measured during normoxia, hyperoxia, hypoventilation, and hyperventilation. RESULTS Physiological interventions led to expected changes, including a large increase in partial pressure of oxygen in arterial blood with hyperoxia, increased intracranial pressure (ICP) with hypoventilation, and decreased ICP with hyperventilation. Importantly, PbtO2 decreased substantially with proximity to the focal injury (contusion and proximal probes), and this difference was maintained at different levels of fraction of inspired oxygen and partial pressure of carbon dioxide in arterial blood. In the distal and contralateral probes, hypoventilation and hyperventilation were associated with expected increased and decreased PbtO2 values, respectively. However, in the contusion and proximal probes, these effects were diminished, consistent with,loss of cerebrovascular CO2 reactivity at and near the injury site. Similarly, hyperoxia led to the expected rise in PbtO2 only in the distal and contralateral probes, with little or no effect in the proximal and contusion probes, respectively. CONCLUSIONS PbtO2 measurements are strongly influenced by the distance from the site of focal injury. Physiological alterations, including hyperoxia, hyperventilation, and hypoventilation substantially affect PbtO2 values distal to the site of injury but have little effect in and around the site of contusion. Clinical interpretations of brain tissue oxygen measurements should take into account the spatial relation of probe position to the site of injury. The decision of where to place a brain tissue oxygen probe in TBI patients should also take these factors into consideration.	[Hawryluk, Gregory W. J.] Univ Utah, Dept Neurol Surg, Salt Lake City, UT USA; [Hawryluk, Gregory W. J.; Ferguson, Adam R.; Morabito, Diane; Derugin, Nikita; Manley, Geoffrey; Rosenthal, Guy] Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Rm 101, San Francisco, CA 94110 USA; [Hawryluk, Gregory W. J.; Phan, Nicolas; Ferguson, Adam R.; Morabito, Diane; Derugin, Nikita; Manley, Geoffrey] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Knudson, M. Margaret] Univ Calif San Francisco, Dept Gen Surg, San Francisco, CA 94143 USA; [Phan, Nicolas] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Neurol Surg, Toronto, ON, Canada; [Stewart, Campbell L.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Rosenthal, Guy] Hadassah Hebrew Univ, Med Ctr, Dept Neurosurg, Jerusalem, Israel	Manley, G (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 1001 Potrero Ave,Rm 101, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu		Ferguson, Adam/0000-0001-7102-1608	CDC grant R49 [CCR903697]; ONR grant [N00014002-1-0203]	We would like to thank Larry Carbone, DVM, PhD, and Ron Bairuther for their assistance with the large-animal studies. Kotaro Oshio MD, PhD, and Ken Monson, PhD, also made important contributions to the technical aspects of this study. This, work was supported by CDC grant R49, CCR903697, and ONR grant N00014002-1-0203.	Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Andrade KC, 2006, ARQ NEURO-PSIQUIAT, V64, P895, DOI 10.1590/S0004-282X2006000600001; Bardt TF, 1998, ACT NEUR S, V71, P153; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; COLE SL, 1956, JAMA-J AM MED ASSOC, V161, P1454, DOI 10.1001/jama.1956.02970150022005; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Fandino J, 1999, ACTA NEUROCHIR, V141, P825, DOI 10.1007/s007010050383; Haitsma I, 2008, ACTA NEUROCHIR SUPPL, V102, P197, DOI 10.1007/978-3-211-85578-2_39; HANSEN AJ, 1985, PHYSIOL REV, V65, P101; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Holzschuh M, 1998, BRAIN INJURY, V12, P191, DOI 10.1080/026990598122665; Hutchinson PJ, 2005, HEAD INJURY PATHOPHY, P216; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kiening KL, 1998, ACT NEUR S, V71, P172; Kirkpatrick PJ, 1996, NEUROSURGERY, V39, P714, DOI 10.1097/00006123-199610000-00013; Longhi L, 2002, ACT NEUR S, V81, P315; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rohlwink UK, 2010, CHILD NERV SYST, V26, P453, DOI 10.1007/s00381-009-1033-1; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Rosenthal G, 2008, J NEUROSURG, V108, P59, DOI 10.3171/JNS/2008/108/01/0059; Rossi S, 2000, ACTA NEUROCHIR SUPPL, V76, P243; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; SCHNEIDER GH, 1995, ACTA NEUROCHIR, V134, P71, DOI 10.1007/BF01428507; Soustiel Jean F., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P131; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van der Zande FHR, 2005, NEURORADIOLOGY, V47, P114, DOI 10.1007/s00234-004-1274-3; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025	53	20	20	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2016	125	5					1217	1228		10.3171/2015.7.JNS15809			12	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DZ8FK	WOS:000386106100022	26848909				2021-06-18	
J	Stojanovic, MP; Fonda, J; Fortier, CB; Higgins, DM; Rudolph, JL; Milberg, WP; McGlinchey, RE				Stojanovic, Milan P.; Fonda, Jennifer; Fortier, Catherine Brawn; Higgins, Diana M.; Rudolph, James L.; Milberg, William P.; McGlinchey, Regina E.			Influence of Mild Traumatic Brain Injury (TBI) and Posttraumatic Stress Disorder (PTSD) on Pain Intensity Levels in OEF/OIF/OND Veterans	PAIN MEDICINE			English	Article						Traumatic Brain Injury; Post-Traumatic Stress Disorder; Chronic Pain	SLEEP QUALITY INDEX; HEAD-INJURY; VALIDITY; RELIABILITY; EXPERIENCES; PREVALENCE; DISABILITY; INSOMNIA; IRAQ	Objective. Mild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD) are common among US veterans of Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND). We postulated that these injuries may modulate pain processing in these individuals and affect their subjective pain levels. Design. Cross-sectional. Subjects. 310 deployed service members of OEF/OIF/OND without a lifetime history of moderate or severe TBI were included in this study. Methods. All participants completed a comprehensive evaluation for Blast Exposure, mTBI, PTSD, and Pain Levels. The Boston Assessment of TBI-Lifetime Version (BAT-L) was used to assess blast exposure and potential brain injury during military service. The Clinician-Administered PTSD Scale (CAPS) characterized presence and severity of PTSD. The Visual Analog Scale (VAS) was used to assess pain intensity over the previous month before the interview, with higher scores indicative of worse pain. Statistical analysis was performed by ANOVA and results were adjusted for co-morbidities, clinical characteristics and demographic data. Results. In comparison to control participants (veterans without mTBI or current PTSD), veterans with both current PTSD and mTBI reported the highest pain intensity levels, followed by veterans with PTSD only (P<0.0001 and P=0.0005, respectively). Pain levels in veterans with mTBI only were comparable to control participants. Conclusions. Comorbid PTSD and mTBI is associated with increased self-reported pain intensity.mTBI alone was not associated with increased pain.	[Stojanovic, Milan P.; Higgins, Diana M.] VA Boston Healthcare Syst, Anesthesiol Crit Care & Pain Med Serv, Boston, MA USA; [Fonda, Jennifer; Fortier, Catherine Brawn; Rudolph, James L.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Fonda, Jennifer; Fortier, Catherine Brawn; Rudolph, James L.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, GRECC, Boston, MA USA; [Fonda, Jennifer] Boston Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA USA; [Fortier, Catherine Brawn; Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Higgins, Diana M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Rudolph, James L.] Brigham & Womens Hosp, Div Aging, 75 Francis St, Boston, MA 02115 USA	Stojanovic, MP (corresponding author), VA Boston Healthcare Syst, Pain Med Anesthesiol Crit Care & Pain Med Serv, 150 South Huntington Ave, Boston, MA 02130 USA.	mpstojanovic@gmail.com			Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development (RR&D) Traumatic Brain Injury Center of Excellence [B9254-C]	This research was supported by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development (RR&D) Traumatic Brain Injury Center of Excellence (B9254-C).	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2011, AN VA HEALTHC UT OP; Blake D. D., 1990, BEHAV THER, V13, P187; Bosco MA, 2013, HEADACHE, V53, P1518, DOI 10.1111/head.12172; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Department of Defense, 2012, DEM PROF MIL COMM; Department of Veterans Affairs, 2012, AN VA HLTH CAR UT OP; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; First M.B., 1996, STRUCTURED CLIN INTE; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Games PA, 1976, J EDUCATIONAL STATIS, V1, P113, DOI DOI 10.2307/1164979; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Janke EA, 2007, J REHABIL RES DEV, V44, P245, DOI 10.1682/JRRD.2006.06.0060; Jaramillo CA, HEADACHE IN PRESS; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Krebs EE, 2009, J GEN INTERN MED, V24, P733, DOI 10.1007/s11606-009-0981-1; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Mersky H, 1994, INT ASS STUDY PAIN T, P226; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; *NAT HEART LUNG BL, 1998, CLIN GUID ID EV TREA; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Von Korff M, 2005, PSYCHOSOM MED, V67, P233, DOI 10.1097/01.psy.0000155662.82621.50; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Wasserberg J, 2002, BMJ-BRIT MED J, V325, P454, DOI 10.1136/bmj.325.7362.454	39	20	20	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1526-2375	1526-4637		PAIN MED	Pain Med.	NOV	2016	17	11					2017	2025		10.1093/pm/pnw042			9	Anesthesiology; Medicine, General & Internal	Anesthesiology; General & Internal Medicine	ER4DA	WOS:000398748100007	27040665	Bronze			2021-06-18	
J	Tlustos, SJ; Kirkwood, MW; Taylor, HG; Stancin, T; Brown, TM; Wade, SL				Tlustos, Sarah J.; Kirkwood, Michael W.; Taylor, H. Gerry; Stancin, Terry; Brown, Tanya M.; Wade, Shari L.			A Randomized Problem-Solving Trial for Adolescent Brain Injury: Changes in Social Competence	REHABILITATION PSYCHOLOGY			English	Article						social adjustment; traumatic brain injury; closed head injury; adolescence	EXECUTIVE FUNCTION DEFICITS; BEHAVIOR RATING INVENTORY; CHILDHOOD HEAD-INJURY; COMPLICATED MILD; NEUROSCIENCE PERSPECTIVE; ACADEMIC-ACHIEVEMENT; FUNCTIONAL OUTCOMES; EMOTION PERCEPTION; CLINICAL-TRIAL; CHILDREN	Purpose/Objective: Traumatic brain injury (TBI) in adolescence has well documented effects on social competence. Few studies have examined the effects of behavioral interventions on social competence or identified factors associated with changes in social competence after injury. Research Method/Design: Adolescents with moderate to severe TBI ages 12-17 years were randomized within 6 months of injury to either a problem solving and communication (CAPS) group that received online counseling (n = 65) or an Internet resources comparison (IRC) group (n = 67) for a comparative effectiveness trial. Parent-report measures of social competence (Child Behavior Checklist, CBCL; Home and Community Social Behavior Scales, HCSBS; Behavioral and Emotional Rating Scale, BERS-2) were administered at baseline (preintervention) and approximately 6 months later. Analyses examined these measures in relation to treatment group, TBI severity, and age. Regression analyses were also conducted to examine baseline measures of cognition as predictors of social competence after TBI. Results: CAPS had a more positive effect than the comparison condition on the HCSBS and BERS-2 for younger teens with moderate TBI and older teens with severe TBI. More parent-rated executive dysfunction at baseline was related to both lower concurrent levels of social competence and less positive gains in competence over time, whereas higher baseline IQ predicted greater gains in competence. Conclusions/Implications: CAPS may be effective for improving social competence for teens after TBI, with benefits dependent on the teen's age and injury severity. Parent-rated executive dysfunction, moreover, has utility in predicting both lower concurrent levels of social competence and subsequent postinjury gains in competence.	[Tlustos, Sarah J.; Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, 13123 East 16th Ave,B285, Aurora, CO 80045 USA; [Tlustos, Sarah J.; Kirkwood, Michael W.] Univ Colorado, Sch Med, Boulder, CO 80309 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp, Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Brown, Tanya M.] Mayo Coll Med, Dept Psychol, Rochester, MI USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Medicine, Cincinnati, OH 45221 USA	Tlustos, SJ (corresponding author), Childrens Hosp Colorado, Dept Phys Med & Rehabil, 13123 East 16th Ave,B285, Aurora, CO 80045 USA.	sarah.tlustos@childrenscolorado.org	Stancin, Terry/L-7993-2019		National Institutes of Health from the National Institute of Mental Health [R01-MH073764]; Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; National Institute of Disability and Rehabilitation Research, Department of Education [H133B090010]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported in part by a National Institutes of Health Grant R01-MH073764 from the National Institute of Mental Health, a grant from the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program, and by Grant H133B090010, to Dr. Shari L. Wade, from the National Institute of Disability and Rehabilitation Research, Department of Education. The authors acknowledge the contributions of Mary Ann Toth, Kendra McMullen, Robert Blaha, Elizabeth Hagesfeld, Michelle Jacobs, Daniel Maier, and Nina Fox in data collection and entry, Amy Cassedy in data management, and John Stullenberger in website support. The authors also acknowledge the contributions of the therapists JoAnne Carey, PsyD, Britt Nielsen, PsyD, and Brad Jackson, PhD.	Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P220, DOI 10.1097/01.HTR.0000327254.61751.e7; Bedell GM, 2011, ARCH PHYS MED REHAB, V92, P765, DOI 10.1016/j.apmr.2010.12.029; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Caldarella, 2002, HOME COMMUNITY SOCIA; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Centers for Disease Control and Prevention, 2009, YOUTH RISK BEH SURV; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chen XY, 1997, DEV PSYCHOL, V33, P518, DOI 10.1037/0012-1649.33.3.518; Clark C, 2002, J CHILD PSYCHOL PSYC, V43, P785, DOI 10.1111/1469-7610.00084; DeRosier ME, 2010, READ WRIT Q, V27, P25, DOI 10.1080/10573569.2011.532710; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Dzurilla T.J., 2004, SOCIAL PROBLEM SOLVI, P11, DOI DOI 10.1037/10805-001; EPSTEIN MH, 2002, THE JOURNAL OF BEHAV, V29, P208, DOI DOI 10.1007/BF02287707; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Guy S.C., 2004, BRIEF SR BEHAV RATIN; Hessler DM, 2010, J ADOLESCENCE, V33, P241, DOI 10.1016/j.adolescence.2009.04.007; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Luna B, 2004, ANN NY ACAD SCI, V1021, P296, DOI 10.1196/annals.1308.035; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Narad ME, 2015, J DEV BEHAV PEDIATR, V36, P700, DOI 10.1097/DBP.0000000000000208; Nelson EE, 2005, PSYCHOL MED, V35, P163, DOI 10.1017/S0033291704003915; Parker J. G., 2006, DEV PSYCHOPATHOLOGY, P419, DOI DOI 10.1002/9780470939383.CH12; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Petranovich CL, 2015, J PEDIATR PSYCHOL, V40, P680, DOI 10.1093/jpepsy/jsv001; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Redpath SJ, 2004, BRAIN INJURY, V18, P861, DOI 10.1080/02699050410001671838; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rockhill CM, 2009, J ADOLESCENCE, V32, P535, DOI 10.1016/j.adolescence.2008.06.011; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; TEASDALE G, 1974, LANCET, V2, P81; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P1132, DOI 10.1017/S1355617711001202; TURKSTRA LS, 2001, THE JOURNAL OF HEAD, V16, P469, DOI DOI 10.1097/00001199-200110000-00006; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; WADE SL, 2006, THE JOURNAL OF HEAD, V21, P57, DOI DOI 10.1097/00001199-200601000-00006; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	76	20	20	0	19	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2016	61	4					347	357		10.1037/rep0000098			11	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	EC3BK	WOS:000387999200001	27831729	Green Accepted, Bronze			2021-06-18	
J	Tuominen, M; Stuart, MJ; Aubry, M; Kannus, P; Tokola, K; Parkkari, J				Tuominen, Markku; Stuart, Michael J.; Aubry, Mark; Kannus, Pekka; Tokola, Kari; Parkkari, Jari			Injuries in women's international ice hockey: an 8-year study of the World Championship tournaments and Olympic Winter Games	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							PLAYERS; 7-YEAR; RATES; RISK; MENS	Background We report the incidence, type, mechanism and severity of ice hockey injuries in women's international ice hockey championships. Methods All injuries in the International Ice Hockey Federation World Women's Championship, World Women's under-18 Championship and Olympic Winter Games tournaments were analysed over an 8-year period using a strict injury definition, standardised reporting and team physician diagnosis. Results 168 injuries were recorded in 637 games over an 8-year period resulting in an injury rate (IR) of 6.4 per 1000 player-games and 22.0/1000 player-game hours. The IRs were 2.7/1000 player-games for the lower body, 1.4 for the upper body, 1.3 for the head and face and 0.9 for the spine and trunk. Contusion was the most common injury followed by a sprain. The most commonly injured site was the knee (48.6% of lower body injuries; IR 1.3/1000 player-games). The Medial collateral ligament sprain occurred in 37.1% and ACL rupture in 11.4% of knee injuries. A concussion (74.3%; IR 1.0/1000 player-games) was the most common head injury. Conclusions and recommendations The risk of injury to female ice hockey players at World Championship and Olympic tournaments was about half of that observed in the men's Championships. Full facial protection decreases the risk of lacerations and should be continued in all future female tournaments. More effective prevention strategies for knee, ankle and shoulder injuries are needed in women's ice hockey. Improved concussion education is necessary to promote more consistent diagnosis and return to play protocols.	[Tuominen, Markku] Medisport Ltd, Keskisenkatu 5, Tampere 33710, Finland; [Stuart, Michael J.] Mayo Clin, Dept Orthoped, Rochester, MN USA; [Aubry, Mark] Ottawa Sport Med Ctr, Ottawa, ON, Canada; [Kannus, Pekka; Tokola, Kari] UKK Inst, Injury & Osteoporosis Res Ctr, Tampere, Finland; [Parkkari, Jari] UKK Inst, Tampere Res Ctr Sports Med, Tampere, Finland	Tuominen, M (corresponding author), Medisport Ltd, Keskisenkatu 5, Tampere 33710, Finland.	markku.tuominen@medisport.fi			International Ice Hockey Federation; Finnish Ministry of Education and Culture	This study was financially supported by The International Ice Hockey Federation and the Finnish Ministry of Education and Culture.	Agel J, 2010, CAN J SURG, V53, P319; Clarsen B, 2014, BRIT J SPORT MED, V48, P510, DOI 10.1136/bjsports-2013-093297; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; Engebretsen L, 2014, BRIT J SPORT MED, V48, P1270, DOI 10.1136/bjsports-2014-093992; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Junge A, 2013, BRIT J SPORT MED, V47, P782, DOI 10.1136/bjsports-2013-092205; Junge A, 2007, BRIT J SPORT MED, V41, pI3, DOI 10.1136/bjsm.2007.036020; Langevoort G, 2007, SCAND J MED SCI SPOR, V17, P400, DOI 10.1111/j.1600-0838.2006.00587.x; LAPRADE RF, 1995, AM J SPORT MED, V23, P773, DOI 10.1177/036354659502300624; LaPrade RF, 2014, BRIT J SPORT MED, V48, P4, DOI 10.1136/bjsports-2013-093020; Leppanen M, 2014, SPORTS MED, V44, P473, DOI 10.1007/s40279-013-0136-8; Pasanen K, 2008, SCAND J MED SCI SPOR, V18, P49, DOI 10.1111/j.1600-0838.2007.00640.x; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Stuart MJ, 2000, AM SOC TEST MATER, V1341, P19, DOI 10.1520/STP15224S; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688	15	20	20	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	NOV	2016	50	22					1406	1412		10.1136/bjsports-2015-094647			7	Sport Sciences	Sport Sciences	EC2XV	WOS:000387988700014	26153516				2021-06-18	
J	Vynorius, KC; Paquin, AM; Seichepine, DR				Vynorius, Kyle C.; Paquin, Alyssa M.; Seichepine, Daniel R.			Lifetime Multiple Mild Traumatic Brain Injures Are Associated with Cognitive and Mood Symptoms in Young Healthy College Students	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; neuropsychology; executive function; cognition	FOOTBALL; IMPAIRMENT	Background/objectives: Repetitive mild traumatic brain injury (mTBI, also known as concussion) has been associated with a range of long-term mood and cognitive deficits, including executive dysfunction. Previous research in athletes suggests that cognitive and mood problems are associated with a history of repetitive mTBI. However, to date, no studies have examined the impact of a lifetime accumulation of repetitive mTBIs on cognition, particularly executive functioning, and mood in a sample of young adults who were not athletes. Therefore, the present study looked at potential effects of repetitive mTBIs on self-reported cognitive complaints, executive functioning, and mood in young adults. Methods: Eighty-four total students responded, and 26 of those were excluded from analyses due to reporting only 1 mTBI. The final sample consisted of 58 healthy young adults (mean age = 22.84, STD = 4.88) who completed the Cognitive Complaint Index (CCI), the Behavior Rating Inventory of Executive Function, adult version (BRIEF-A), and the Beck Depression Inventory, second edition (BDI-II). Twenty-nine participants denied having an mTBI history, and 29 reported 2 or more lifetime mTBIs (range 2-7). Results: Young otherwise healthy adults with a lifetime history of repetitive mTBI compared to those that reported no history of mTBI reported more change in cognitive functioning over the past 5 years, worse executive functioning, and more symptoms of depression. As the number of lifetime mTBIs increased, scores on the CCI, BRIEF-A, and BDI-II also increased, indicating worse functioning. Conclusion: These findings suggest that a lifetime accumulation of two or more mTBIs as compared to a history of no reported mTBIs may result in worse cognitive functioning and symptoms of depression in young adults.	[Vynorius, Kyle C.; Paquin, Alyssa M.; Seichepine, Daniel R.] Univ New Hampshire Manchester, Neuropsychol Lab, Manchester, NH USA	Seichepine, DR (corresponding author), Univ New Hampshire Manchester, Neuropsychol Lab, Manchester, NH USA.	daniel.seichepine@unh.edu			UNH, Manchester's Manchester Undergraduate Project Support Grant	Portions of this study were supported by UNH, Manchester's Manchester Undergraduate Project Support Grant.	Beck AT., 1996, BECK DEPRESSION INVE, V2; Centers for Disease Control and Prevention, 2015, C TRAUM BRAIN INJ US; Centers for Disease Control and Prevention Division of Laboratory Science, 2003, CLIA METH, P1; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Defense and Veterans Brain Injury Center, 2016, DOD WORLDW NUMB TBI; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Roth R., 2005, BRIEF A BEHAV RATING; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Tapper A, 2017, J SPORT SCI, V35, P231, DOI 10.1080/02640414.2016.1161214; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Ware JB, 2016, RADIOLOGY, V280, P212, DOI 10.1148/radiol.2016151013	24	20	20	1	24	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 31	2016	7								188	10.3389/fneur.2016.00188			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	EA3UH	WOS:000386530300001	27843436	DOAJ Gold, Green Published			2021-06-18	
J	Catenaccio, E; Caccese, J; Wakschlag, N; Fleysher, R; Kim, N; Kim, M; Buckley, TA; Stewart, WF; Lipton, RB; Kaminski, T; Lipton, ML				Catenaccio, E.; Caccese, J.; Wakschlag, N.; Fleysher, R.; Kim, N.; Kim, M.; Buckley, T. A.; Stewart, W. F.; Lipton, R. B.; Kaminski, T.; Lipton, M. L.			Validation and calibration of HeadCount, a self-report measure for quantifying heading exposure in soccer players	RESEARCH IN SPORTS MEDICINE			English	Article						Soccer; head injuries; sex differences; self-report	PHYSICAL-ACTIVITY QUESTIONNAIRE; NEUROCOGNITIVE PERFORMANCE; SCHOOL SOCCER; FOOTBALLERS; FREQUENCY; RELIABILITY; CONCUSSIONS; VALIDITY; IMPACTS; SEASON	The long-term effects of repetitive head impacts due to heading are an area of increasing concern, and exposure must be accurately measured; however, the validity of self-report of cumulative soccer heading is not known. In order to validate HeadCount, a 2-week recall questionnaire, the number of player-reported headers was compared to the number of headers observed by trained raters for a men's and a women's collegiate soccer teams during an entire season of competitive play using Spearman's correlations and intraclass correlation coefficients (ICCs), and calibrated using a generalized estimating equation. The average Spearman's rho was 0.85 for men and 0.79 for women. The average ICC was 0.75 in men and 0.38 in women. The calibration analysis demonstrated that men tend to report heading accurately while women tend to overestimate. HeadCount is a valid instrument for tracking heading behaviour, but may have to be calibrated in women.	[Catenaccio, E.; Wakschlag, N.; Fleysher, R.; Kim, N.; Lipton, R. B.; Lipton, M. L.] Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, New York, NY USA; [Caccese, J.] Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE USA; [Fleysher, R.; Kim, N.; Lipton, M. L.] Albert Einstein Coll Med, Dept Radiol, New York, NY USA; [Kim, M.; Lipton, R. B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Buckley, T. A.; Kaminski, T.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Stewart, W. F.] Sutter Hlth, Sacramento, CA USA; [Lipton, R. B.] Montefiore Med Ctr, Dept Neurol, New York, NY USA; [Lipton, R. B.; Lipton, M. L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, New York, NY USA; [Lipton, M. L.] Montefiore Med Ctr, Dept Radiol, New York, NY USA; [Lipton, M. L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA	Lipton, ML (corresponding author), Albert Einstein Coll Med, MRRC, Jack & Pearl Resnick Campus,1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.lipton@einstein.yu.edu	Catenaccio, Eva/M-7250-2019; Lipton, Richard B/B-5060-2011; Buckley, Thomas A/B-7525-2016; Caccese, Jaclyn B./AAH-4571-2020	Catenaccio, Eva/0000-0003-0550-207X; Buckley, Thomas A/0000-0002-0515-0150; Caccese, Jaclyn B./0000-0003-2329-3603	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS082432]; Dana Foundation David Mahoney Neuroimaging Program; Albert Einstein College of Medicine Research Fellowship Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082432] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health [grant number R01 NS082432], the Dana Foundation David Mahoney Neuroimaging Program, and the Albert Einstein College of Medicine Research Fellowship Program.	Atienza AA, 2005, RES Q EXERCISE SPORT, V76, P358; Babwah T, 2014, RES SPORTS MED, V22, P334, DOI 10.1080/15438627.2014.945644; Ciuti G, 2015, SENSORS-BASEL, V15, P6441, DOI 10.3390/s150306441; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Elbin RJ, 2015, RES SPORTS MED, V23, P203, DOI 10.1080/15438627.2015.1005293; Friedenreich CM, 2006, AM J EPIDEMIOL, V163, P959, DOI 10.1093/aje/kwj112; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Johnson-Kozlow M, 2007, AM J HEALTH BEHAV, V31, P193, DOI 10.5993/AJHB.31.2.8; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Montenigro P. H., 2016, J NEUROTRAUM, V33, P1; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rutherford A, 2005, APPL COGNITIVE PSYCH, V19, P477, DOI 10.1002/acp.1091; Salinas CM, 2009, J CLIN SPORT PSYCHOL, V3, P15, DOI 10.1123/jcsp.3.1.15; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	36	20	20	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	OCT-DEC	2016	24	4			SI		416	425		10.1080/15438627.2016.1234472			10	Sport Sciences	Sport Sciences	EB8NX	WOS:000387648900012	27788599	Green Accepted			2021-06-18	
J	Smith, NA; Chounthirath, T; Xiang, HY				Smith, Nicholas A.; Chounthirath, Thiphalak; Xiang, Huiyun			Soccer-Related Injuries Treated in Emergency Departments: 1990-2014	PEDIATRICS			English	Article							HIGH-SCHOOL SPORTS; CRUCIATE LIGAMENT INJURIES; LOWER-EXTREMITY INJURIES; STATES HIGH-SCHOOL; RISK-FACTORS; ADOLESCENT SOCCER; HEAD-INJURIES; YOUTH SOCCER; EPIDEMIOLOGY; CONCUSSIONS	OBJECTIVE: To investigate the epidemiology of youth soccer-related injuries treated in emergency departments in the United States. METHODS: A retrospective analysis was conducted of soccer-related injuries among children 7 through 17 years of age from 1990 through 2014 with data from the National Electronic Injury Surveillance System. Injury rates were calculated from soccer participation data. RESULTS: An estimated 2 995 765 (95% confidence interval [CI], 2 309 112-3 682 418) children 7 through 17 years old were treated in US emergency departments for soccer-related injuries during the 25-year study period, averaging 119 831 (95% CI, 92 364-147 297) annually. The annual injury rate per 10 000 soccer participants increased significantly, by 111.4%, from 1990 to 2014. Patients 12 to 17 years old accounted for 72.7% of injuries, 55.5% of patients were male, and most injuries occurred in a place of sport or recreation (68.5%) or school (25.7%). Struck by (38.5%) and fell (28.7%) were the leading mechanisms of injury. Injuries most commonly were diagnosed as sprain or strain (34.6%), fracture (23.2%), and soft tissue injury (21.9%), and occurred to the upper extremity (20.7%), ankle (17.8%), and head or neck (17.7%). Concussions or other closed head injuries accounted for 7.3% of the injuries, but the annual rate of concussions/closed head injuries per 10 000 participants increased significantly, by 1595.6%, from 1990 to 2014. CONCLUSIONS: This study is the first to comprehensively investigate soccer-related injuries and calculate injury rates based on soccer participation data among children at the national level. The increasing number and rate of pediatric soccer-related injuries, especially soccer-related concussions/closed head injuries, underscore the need for increased efforts to prevent these injuries.	[Smith, Nicholas A.; Chounthirath, Thiphalak; Xiang, Huiyun] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA; [Xiang, Huiyun] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	Xiang, HY (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	huiyun.xiang@nationwidechildrens.org					Adams AL, 2006, ACAD EMERG MED, V13, P571, DOI [10.1111/j.1553-2712.2006.tb01010.x, 10.1197/j.aem.2005.12.015]; Anderson SJ, 2000, PEDIATRICS, V105, P659, DOI 10.1542/peds.105.3.640; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bayt DR, 2016, INJURY PREV, V22, P361, DOI 10.1136/injuryprev-2015-041757; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Caine D, 2005, MED SPORT SCI, V48, P1, DOI [10.1159/000084274, 10.1159/000085330]; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dai BY, 2014, J SPORT HEALTH SCI, V3, P299, DOI 10.1016/j.jshs.2014.06.002; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Emery CA, 2006, AM J SPORT MED, V34, P1636, DOI 10.1177/0363546506288018; Esquivel AO, 2015, SPORTS HEALTH, V7, P366, DOI 10.1177/1941738115579854; Fernandez WG, 2007, ACAD EMERG MED, V14, P641, DOI [10.1197/j.aem.2007.03.1354, 10.1111/j.1553-2712.2007.tb01851.x]; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Jacobson NA, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113517860; Joseph AM, 2013, J ATHL TRAINING, V48, P810, DOI 10.4085/1062-6050-48.6.03; Junge A, 2002, AM J SPORT MED, V30, P652, DOI 10.1177/03635465020300050401; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Koutures CG, 2010, PEDIATRICS, V125, P410, DOI 10.1542/peds.2009-3009; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Monfort SM, 2015, AM J SPORT MED, V43, P802, DOI 10.1177/0363546514564541; National Sporting Goods Association, STAT ABSTR US PART S; National Sporting Goods Association, PROQUEST STAT ABSTR; Pickett W, 2005, BRIT J SPORT MED, V39, P226, DOI 10.1136/bjsm.2004.013169; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Swenson DM, 2013, CLIN J SPORT MED, V23, P190, DOI 10.1097/JSM.0b013e31827d21fe; Swenson DM, 2013, MED SCI SPORT EXER, V45, P462, DOI 10.1249/MSS.0b013e318277acca; Tourny C, 2014, J SPORT MED PHYS FIT, V54, P526; United States Soccer Federation, 2015, US SOCC CONC GUID; *US CONS PROD SAF, NEISS SAMPL DES IMPL; US Youth Soccer, KEY STAT US YOUTH SO; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047	41	20	20	1	17	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	OCT	2016	138	4							e20160346	10.1542/peds.2016-0346			9	Pediatrics	Pediatrics	DX3ZT	WOS:000384317700017		Bronze			2021-06-18	
J	Hunt, AW; Paniccia, M; Reed, N; Keightley, M				Williams Hunt, Anne; Paniccia, Melissa; Reed, Nick; Keightley, Michelle			Concussion-Like Symptoms in Child and Youth Athletes at Baseline: What Is "Typical''?	JOURNAL OF ATHLETIC TRAINING			English	Article						brain injuries; pediatrics; symptoms; baseline testing	SPORTS-RELATED CONCUSSION; PHYSICAL-ACTIVITY; NORMATIVE DATA; ICE HOCKEY; ADOLESCENTS; METAANALYSIS; COGNITION; HEADACHE; INJURY; SAMPLE	Context: After a concussion, guidelines emphasize that an athlete should be asymptomatic before starting a return-to-play protocol. However, many concussion symptoms are nonspecific and may be present in individuals without concussion. Limited evidence exists regarding the presence of "typical'' or preinjury (baseline) symptoms in child and youth athletes. Objective: To describe the frequency of symptoms reported at baseline by child and youth athletes and identify how age, sex, history of concussion, and learning factors influence the presence of baseline symptoms. Design: Cross-sectional cohort study. Setting: Baseline testing was conducted at a hospital research laboratory or in a sport or school setting (eg, gym or arena). Patients or Other Participants: A total of 888 child (9 = 12 years old, n = 333) and youth (13 = 17 years old, n = 555) athletes participated (46.4% boys and 53.6% girls, average age = 13.09 6 1.83 years). Main Outcome Measure(s): Demographic and symptom data were collected as part of a baseline protocol. Ageappropriate versions of the Post-Concussion Symptom Inventory (a self-report concussion-symptoms measure with strong psychometric properties for pediatric populations) were administered. Demographic data (age, sex, concussion history, learning factors) were also collected. Results: Common baseline symptoms for children were feeling sleepier than usual (30% boys, 24% girls) and feeling nervous or worried (17% boys, 25% girls). Fatigue was reported by more than half of the youth group (50% boys, 67% girls). Nervousness was reported by 32% of youth girls. Headaches, drowsiness, and difficulty concentrating were each reported by 25% of youth boys and girls. For youths, a higher total symptom score was associated with increasing age and number of previous concussions, although these effects were small (age r(s) = 0.143, number of concussions r(s) = .084). No significant relationships were found in the child group. Conclusions: Children and youths commonly experienced symptoms at baseline, including fatigue and nervousness. Whether clinicians should expect complete symptom resolution after concussion is not clear.	[Williams Hunt, Anne; Reed, Nick; Keightley, Michelle] Holland Bloorview Kids Rehab Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada; [Paniccia, Melissa] Univ Toronto, Toronto, ON, Canada	Hunt, AW (corresponding author), Holland Bloorview Kids Rehab Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	ahunt@hollandbloorview.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TM1-127048]; Holland Chair in Acquired Brain Injury; Canadian Institutes of Health Research NeuroCare Team	This study was supported by a grant from the Canadian Institutes of Health Research #TM1-127048 and the Holland Chair in Acquired Brain Injury. Our sincere thanks to Ms Tali Dick, MScOT OT Reg (Ontario, Canada), for her assistance in the preparation of this manuscript; the Holland Bloorview Concussion Centre's baseline testing team for data collection; and the Canadian Institutes of Health Research NeuroCare Team for grant development and study design.	Abu-Arafeh I, 2010, DEV MED CHILD NEUROL, V52, P1088, DOI 10.1111/j.1469-8749.2010.03793.x; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Fricton J, 2009, CURR PAIN HEADACHE R, V13, P413, DOI 10.1007/s11916-009-0081-2; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Hillman CH, 2011, PREV MED, V52, pS21, DOI 10.1016/j.ypmed.2011.01.024; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Khan NA, 2014, PEDIATR EXERC SCI, V26, P138, DOI 10.1123/pes.2013-0125; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckay CD, 2014, ARCH CLIN NEUROPSYCH, V29, P141, DOI 10.1093/arclin/act116; Reed N, 2014, JOVE-J VIS EXP, DOI 10.3791/51892; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Tomporowski PD, 2011, PREV MED, V52, pS3, DOI 10.1016/j.ypmed.2011.01.028; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zemek R, GUIDELINES DIAGNOSIS	28	20	20	0	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2016	51	10					749	757		10.4085/1062-6050-51.11.12			9	Sport Sciences	Sport Sciences	EI9WR	WOS:000392860600001	27834505	Green Published, Bronze			2021-06-18	
J	Brady, RD; Grills, BL; Church, JE; Walsh, NC; McDonald, AC; Agoston, DV; Sun, MJ; O'Brien, TJ; Shultz, SR; McDonald, SJ				Brady, Rhys D.; Grills, Brian L.; Church, Jarrod E.; Walsh, Nicole C.; McDonald, Aaron C.; Agoston, Denes V.; Sun, Mujun; O'Brien, Terence J.; Shultz, Sandy R.; McDonald, Stuart J.			Closed head experimental traumatic brain injury increases size and bone volume of callus in mice with concomitant tibial fracture	SCIENTIFIC REPORTS			English	Article							ENHANCED OSTEOGENESIS; MINERAL DENSITY; MODEL; NEUROINFLAMMATION; EPIDEMIOLOGY; OUTCOMES; ADULTS; RAT	Concomitant traumatic brain injury (TBI) and long bone fracture are commonly observed in multitrauma and polytrauma. Despite clinical observations of enhanced bone healing in patients with TBI, the relationship between TBI and fracture healing remains poorly understood, with clinical data limited by the presence of several confounding variables. Here we developed a novel trauma model featuring closed-skull weight-drop TBI and concomitant tibial fracture in order to investigate the effect of TBI on fracture healing. Male mice were assigned into Fracture + Sham TBI (FX) or Fracture + TBI (MULTI) groups and sacrificed at 21 and 35 days post-injury for analysis of healing fractures by micro computed tomography (mu CT) and histomorphometry. mu CT analysis revealed calluses from MULTI mice had a greater bone and total tissue volume, and displayed higher mean polar moment of inertia when compared to calluses from FX mice at 21 days post-injury. Histomorphometric results demonstrated an increased amount of trabecular bone in MULTI calluses at 21 days post-injury. These findings indicate that closed head TBI results in calluses that are larger in size and have an increased bone volume, which is consistent with the notion that TBI induces the formation of a more robust callus.	[Brady, Rhys D.; Grills, Brian L.; Church, Jarrod E.; McDonald, Aaron C.; McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia; [Walsh, Nicole C.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia; [Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Sun, Mujun; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia	McDonald, SJ (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia.	stuart.mcdonald@latrobe.edu.au		O'Brien, Terence/0000-0002-7198-8621; McDonald, Stuart/0000-0001-5190-3179; Sun, Mujun/0000-0002-9923-9913	NHMRCNational Health and Medical Research Council of Australia; CIHRCanadian Institutes of Health Research (CIHR); La Trobe University Understanding Disease RFA; La Trobe University School of Life Science Postgraduate Publication Award	Acknowledgements This work was supported by grants to SS and TO from the NHMRC, a fellowship to SS from CIHR, funding from La Trobe University Understanding Disease RFA to SM and La Trobe University School of Life Science Postgraduate Publication Award to RB. The authors are particularly grateful to Aaron Schindeler, David Little, Lauren Peacock and Kathy Mikulec for their help in implementing the fracture procedure in our laboratory.	Al-Thani H., 2014, J ENV PUBLIC HLTH, V2014; Baldock PA, 2014, J BONE MINER RES, V29, P2238, DOI 10.1002/jbmr.2205; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI200214588; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; Beaupre GS, 2006, AM J PHYS MED REHAB, V85, P464, DOI 10.1097/01.phm.0000214275.69286.7a; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Brady RD, 2015, J NEUROTRAUMA; Brady RD, 2014, J ORTHOP RES, V32, P1277, DOI 10.1002/jor.22686; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Genet F, 2015, J PATHOL, V236, P229, DOI 10.1002/path.4519; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Liu XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054077; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Menetrez Jennifer S, 2002, Phys Med Rehabil Clin N Am, V13, P67, DOI 10.1016/S1047-9651(03)00072-X; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; MUELLER M, 1991, J BONE MINER RES, V6, P401; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Oppl B, 2014, J BONE MINER RES, V29, P1096, DOI 10.1002/jbmr.2122; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521; Rosen CJ, 2008, CELL METAB, V7, P7, DOI 10.1016/j.cmet.2007.12.004; Schindeler A, 2008, J ORTHOP RES, V26, P1053, DOI 10.1002/jor.20628; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Smith E, 2016, IRISH J MED SCI, V185, P473, DOI 10.1007/s11845-016-1399-5; Smith EM, 2009, ARCH PHYS MED REHAB, V90, P1127, DOI 10.1016/j.apmr.2008.09.578; SMITH R, 1987, J BONE JOINT SURG BR, V69, P518; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525; Swift JM, 2013, MED SCI SPORT EXER, V45, P1665, DOI 10.1249/MSS.0b013e31828d39bc; Takeda S, 2005, BIOCHEM BIOPH RES CO, V328, P697, DOI 10.1016/j.bbrc.2004.11.071; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Wang L, 2011, CHIN J TRAUMATOL, V14, P7, DOI 10.3760/cma.j.issn.1008-1275.2011.01.002; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Wildburger R, 2001, WIEN KLIN WOCHENSCHR, V113, P119; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang LC, 2013, MED HYPOTHESES, V81, P713, DOI 10.1016/j.mehy.2013.07.034	42	20	22	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 29	2016	6								34491	10.1038/srep34491			9	Multidisciplinary Sciences	Science & Technology - Other Topics	DX2IM	WOS:000384191800001	27682431	DOAJ Gold, Green Published			2021-06-18	
J	Merchant-Borna, K; Lee, H; Wang, D; Bogner, V; van Griensven, M; Gill, J; Bazarian, JJ				Merchant-Borna, Kian; Lee, Hyunhwa; Wang, Dan; Bogner, Viktoria; van Griensven, Martijn; Gill, Jessica; Bazarian, Jeffrey J.			Genome-Wide Changes in Peripheral Gene Expression following Sports-Related Concussion	JOURNAL OF NEUROTRAUMA			English	Article						gene network; IPA; longitudinal study; mild traumatic brain injury; mTBI; PBMC; sports-related concussion	TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; BLOOD MONONUCLEAR-CELLS; ACTIVATION; IMMUNITY; INNATE; INTERLEUKIN-12; PROFILES; CYTOKINE; IMPACT	We conducted a prospective study to identify genome-wide changes in peripheral gene expression before and after sportsrelated concussion (SRC). A total of 253 collegiate contact athletes underwent collection of peripheral blood mononuclear cells (PBMCs) before the sport season (baseline). Sixteen athletes who subsequently developed an SRC, along with 16 non-concussed teammate controls, underwent repeat collection of PBMCs within 6 h of injury (acutely). Concussed athletes underwent additional sample collection at 7 days post-injury (sub-acutely). Messenger RNA (mRNA) expression at baseline was compared with mRNA expression acutely and sub-acutely post-SRC. To estimate the contribution of physical exertion to gene changes, baseline samples from athletes who subsequently developed an SRC were compared with samples from uninjured teammate controls collected at the acute time-point. Clinical outcome was determined by changes in post-concussive symptoms, postural stability, and cognition from baseline to the sub-acute time-point. SRC athletes had significant changes in mRNA expression at both the acute and sub-acute time-points. There were no significant expression changes among controls. Acute transcriptional changes centered on interleukins 6 and 12, toll-like receptor 4, and NF-kappa B. Sub-acute gene expression changes centered on NF-kappa B, follicle stimulating hormone, chorionic gonadotropin, and protein kinase catalytic subunit. All SRC athletes were clinically back to baseline by Day 7. In conclusion, acute post-SRC transcriptional changes reflect regulation of the innate immune response and the transition to adaptive immunity. By 7 days, transcriptional activity is centered on regulating the hypothalamic-pituitary-adrenal axis. Future efforts to compare expressional changes in fully recovered athletes with those who do not recover from SRC could suggest putative targets for therapeutic intervention.	[Merchant-Borna, Kian; Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA; [Lee, Hyunhwa] Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA; [Wang, Dan; Gill, Jessica] NINR, NIH, Bethesda, MD 20892 USA; [Bogner, Viktoria] Univ Munich, Munich, Germany; [van Griensven, Martijn] Tech Univ Munich, Klinikum Rechts Isar, Dept Trauma Surg, Munich, Germany	Bazarian, JJ (corresponding author), Univ Rochester, Sch Med & Dent, 265 Elmwood Ave, Rochester, NY 14642 USA.	jeff_bazarian@urmc.rochester.edu	Gill, Gill M/Q-2020-2017; van Griensven, Martijn/F-5808-2012	van Griensven, Martijn/0000-0001-5104-9881; Lee, Hyunhwa/0000-0002-5625-3141	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD064754] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000033] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24 HD064754] Funding Source: Medline		Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Connolly PH, 2004, J APPL PHYSIOL, V97, P1461, DOI 10.1152/japplphysiol.00316.2004; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; De Boever P, 2014, GENOMICS, V103, P31, DOI 10.1016/j.ygeno.2013.11.006; Eady JJ, 2005, PHYSIOL GENOMICS, V22, P402, DOI 10.1152/physiolgenomics.00080.2005; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Glatt SJ, 2013, AM J MED GENET B, V162B, P313, DOI 10.1002/ajmg.b.32167; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kanof M E, 2001, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0703s00; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McIntosh LJ, 1996, NEUROTOXICOLOGY, V17, P873; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; MURPHY TL, 1995, MOL CELL BIOL, V15, P5258; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Park C, 2008, NEUROSCI LETT, V431, P123, DOI 10.1016/j.neulet.2007.11.057; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Segman RH, 2005, MOL PSYCHIATR, V10, P514, DOI [10.1038/sj.mp.4001636, 10.1038/sj.mp.4001654]; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; Stahel PF, 1998, NEUROSCI LETT, V249, P123, DOI 10.1016/S0304-3940(98)00410-8; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; YANG KY, 1995, NEUROSCI LETT, V197, P101, DOI 10.1016/0304-3940(95)11919-N; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Zhao W, 2013, J ALZHEIMERS DIS, V34, P417, DOI 10.3233/JAD-121894	54	20	21	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2016	33	17					1576	1585		10.1089/neu.2015.4191			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DU6EH	WOS:000382306300003	27035221	Green Published			2021-06-18	
J	Myrga, JM; Failla, MD; Ricker, JH; Dixon, CE; Conley, YP; Arenth, PM; Wagner, AK				Myrga, John M.; Failla, Michelle D.; Ricker, Joseph H.; Dixon, C. Edward; Conley, Yvette P.; Arenth, Patricia M.; Wagner, Amy K.			A Dopamine Pathway Gene Risk Score for Cognitive Recovery Following Traumatic Brain Injury: Methodological Considerations, Preliminary Findings, and Interactions With Sex	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; dopamine; genetics; Rehabilomics; traumatic brain injury	CATECHOL-O-METHYLTRANSFERASE; COMT VAL(158)MET POLYMORPHISM; PREFRONTAL CORTEX; MOLECULAR HETEROSIS; TRANSPORTER EXPRESSION; GENDER-DIFFERENCES; HEALTHY-ADULTS; WORKING-MEMORY; FEMALE RATS; RECEPTOR	Objectives: With evidence of sexual dimorphism involving the dopamine (DA)-pathway, and the importance of DA pathways in traumatic brain injury (TBI) recovery, we hypothesized that sex x DA-gene interactions may influence cognition post-TBI. Participants: Adult survivors of severe TBI (n = 193) consecutively recruited from a level 1 trauma center. Design: Risk allele assignments were made for multiple DA pathway genes using a sex-specific stratified approach. Genetic risk alleles, and their impacts on cognition, were assessed at 6 and 12 months postinjury using unweighted, semiweighted, and weighted gene risk score (GRS) approaches. Main Measures: A cognitive composite score generated from 8 standardized neuropsychological tests targeting multiple cognitive domains. Results: A significant sex x gene interaction was observed at 6 and 12 months for ANKK1 rs1800497 (6M: P =.002, 12M: P =.001) and COMT rs4680 (6M: P =.048; 12M: P =.004); DRD2 rs6279 (P =.001) and VMAT rs363226 (P =.043) genotypes were independently associated with cognition at 6 months, with trends for a sex x gene interaction at 12 months. All GRS methods were significant predictors of cognitive performance in multivariable models. Weighted GRS multivariate models captured the greatest variance in cognition: R-2 = 0.344 (6 months); R-2 = 0.441 (12 months), significantly increasing the variance captured from the base prediction models. Conclusions: A sex-specific DA-pathway GRS may be a valuable tool when predicting cognitive recovery post-TBI. Future work should validate these findings and explore how DA-pathway genetics may guide therapeutic intervention.	[Myrga, John M.; Failla, Michelle D.; Dixon, C. Edward; Arenth, Patricia M.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Failla, Michelle D.; Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Ctr Neurosci, Pittsburgh, PA USA; [Ricker, Joseph H.] NYU, Sch Med, Dept Rehabil Med, New York, NY USA; [Dixon, C. Edward] Vet Affairs Pittsburgh Hlth Care Syst, Educ & Clin Ctr, Geriatr Res, Pittsburgh, PA USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15260 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Hlth Promot & Dev, Pittsburgh, PA 15261 USA; [Dixon, C. Edward; Conley, Yvette P.; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA	Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Failla, Michelle/AAI-3788-2021	Failla, Michelle/0000-0001-9734-3373; Conley, Yvette/0000-0002-1784-6067; Ricker, Joseph/0000-0003-3415-991X	NIDILRRUnited States Department of Health & Human Services [H133A120087]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD048162, R01 NR013342]; DODUnited States Department of Defense [W81XWH-071-0701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013342] Funding Source: NIH RePORTER	This research was supported by the following: NIDILRR: H133A120087; NIH: R01 HD048162; DOD: W81XWH-071-0701; NIH: R01 NR013342.	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Altar CA, 2015, PHARMACOGENOMICS J, V15, P443, DOI 10.1038/tpj.2014.85; Amstadter AB, 2012, J PSYCHIATR RES, V46, P940, DOI 10.1016/j.jpsychires.2012.04.010; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Backman L, 2000, AM J PSYCHIAT, V157, P635; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barnett JH, 2007, AM J PSYCHIAT, V164, P142, DOI 10.1176/appi.ajp.164.1.142; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; BECKER JB, 1990, NEUROSCI LETT, V118, P169, DOI 10.1016/0304-3940(90)90618-J; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Brighina L, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.020; Centers for Disease Control and Prevention, TBI US REP TRAUM BRA; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chen CH, 2011, NEUROPSYCHOPHARMACOL, V36, P1593, DOI 10.1038/npp.2011.39; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019454; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CILIAX BJ, 1995, J NEUROSCI, V15, P1714; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Colzato LS, 2010, NEUROPSYCHOLOGIA, V48, P2764, DOI 10.1016/j.neuropsychologia.2010.04.023; Comings DE, 2000, MOL GENET METAB, V71, P19, DOI 10.1006/mgme.2000.3015; Comings DE, 1999, MOL PSYCHIATR, V4, P213, DOI 10.1038/sj.mp.4000500; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Cross DS, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-51; Delis D. C., 2001, D KEFS EXAMINERS MAN; Delis DC, 2000, CALIFORNIA VERBAL LE; Dluzen DE, 2008, NEUROSCIENCE, V154, P1488, DOI 10.1016/j.neuroscience.2008.04.051; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Failla MD, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.0000000000000118, DOI 10.1097/HTR.0000000000000118.]; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Glatt CE, 2006, HUM MOL GENET, V15, P299, DOI 10.1093/hmg/ddi445; GOLDMAN D, 1993, ALCOHOL CLIN EXP RES, V17, P199, DOI 10.1111/j.1530-0277.1993.tb00749.x; Goldman-Rakic PS, 2004, PSYCHOPHARMACOLOGY, V174, P3, DOI 10.1007/s00213-004-1793-y; GORDON JH, 1980, BRAIN RES BULL, V5, P679, DOI 10.1016/0361-9230(80)90205-1; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Gurvich C, 2015, BEHAV BRAIN RES, V281, P96, DOI 10.1016/j.bbr.2014.11.045; Haghgoo SM, 2015, EUR J PHARMACOL, V754, P88, DOI 10.1016/j.ejphar.2015.02.029; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P620, DOI 10.1038/sj.npp.1300070; Harrison PJ, 2008, NEUROPSYCHOPHARMACOL, V33, P3037, DOI 10.1038/sj.npp.1301543; Harun R, 2015, J NEUROTRAUM, V32, pA97; HRUSKA RE, 1982, PHARMACOL BIOCHEM BE, V16, P285, DOI 10.1016/0091-3057(82)90162-9; Jacobs E, 2011, J NEUROSCI, V31, P5286, DOI 10.1523/JNEUROSCI.6394-10.2011; Janssens ACJW, 2011, EUR J HUM GENET, V19, P833, DOI 10.1038/ejhg.2011.25; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Kazantseva A, 2011, PROG NEURO-PSYCHOPH, V35, P1033, DOI 10.1016/j.pnpbp.2011.02.013; Kerkhof HJM, 2014, ANN RHEUM DIS, V73, P2116, DOI 10.1136/annrheumdis-2013-203620; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kritzer MF, 2008, J NEUROSCI, V28, P9525, DOI 10.1523/JNEUROSCI.2637-08.2008; Lang UE, 2007, NEUROPSYCHOPHARMACOL, V32, P1950, DOI 10.1038/sj.npp.1301335; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Lavalaye J, 2000, EUR J NUCL MED, V27, P867, DOI 10.1007/s002590000279; Lee HS, 2003, AM J MED GENET B, V118B, P55, DOI 10.1002/ajmg.b.10036; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Lohoff FW, 2010, METHODS MOL BIOL, V637, P165, DOI 10.1007/978-1-60761-700-6_9; Madan A, 2015, PHARMACOGENOMICS, V16, P433, DOI [10.2217/PGS.15.9, 10.2217/pgs.15.9]; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Masel BE, 2015, J NEUROTRAUM, V32, P1902, DOI 10.1089/neu.2014.3526; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Munro CA, 2006, BIOL PSYCHIAT, V59, P966, DOI 10.1016/j.biopsych.2006.01.008; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; O'Hara R, 2006, NEUROSCI LETT, V409, P205, DOI 10.1016/j.neulet.2006.09.047; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; REITAN R, 1985, HELSTEAD REITAN NEUR; RIVEST R, 1995, BRAIN RES, V692, P269, DOI 10.1016/0006-8993(95)00611-S; Rosa EC, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-53; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Seamans JK, 2010, RECEPT SER, P373, DOI 10.1007/978-1-60327-333-6_14; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sesack SR, 1998, J NEUROSCI, V18, P2697; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Simons CJP, 2013, SCHIZOPHRENIA BULL, V39, P848, DOI 10.1093/schbul/sbs067; Soeiro-de-Souza MG, 2013, MOL MED REP, V8, P837, DOI 10.3892/mmr.2013.1564; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Tunbridge EM, 2013, NEUROIMAGE, V68, P49, DOI 10.1016/j.neuroimage.2012.11.059; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; van der Net JB, 2009, AM J CARDIOL, V103, P375, DOI 10.1016/j.amjcard.2008.09.093; Verhaaren BFJ, 2013, BIOL PSYCHIAT, V73, P429, DOI 10.1016/j.biopsych.2012.04.009; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; White TP, 2014, NEUROPSYCHOPHARMACOL, V39, P2560, DOI 10.1038/npp.2014.107; Willmott C, 2014, J NEUROTRAUM, V31, P1507, DOI 10.1089/neu.2013.3308; XIAO L, 1994, NEUROSCI LETT, V180, P155, DOI 10.1016/0304-3940(94)90510-X; Xie T, 1999, MOL PHARMACOL, V56, P31; Yaffe K, 2002, BIOL PSYCHIAT, V51, P677, DOI 10.1016/S0006-3223(01)01289-6; Yaffe K, 2009, NEUROBIOL AGING, V30, P607, DOI 10.1016/j.neurobiolaging.2007.08.003; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Zai CC, 2013, J PSYCHIATR RES, V47, P1760, DOI 10.1016/j.jpsychires.2013.07.025; Zawarynski P, 1998, FEBS LETT, V441, P383, DOI 10.1016/S0014-5793(98)01588-9	102	20	20	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					E15	E29		10.1097/HTR.0000000000000199			15	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600003	26580694				2021-06-18	
J	Sigakis, MJG; Leffert, LR; Mirzakhani, H; Sharawi, N; Rajala, B; Callaghan, WM; Kuklina, EV; Creanga, AA; Mhyre, JM; Bateman, BT				Sigakis, Matthew J. G.; Leffert, Lisa R.; Mirzakhani, Hooman; Sharawi, Nadir; Rajala, Baskar; Callaghan, William M.; Kuklina, Elena V.; Creanga, Andreea A.; Mhyre, Jill M.; Bateman, Brian T.			The Validity of Discharge Billing Codes Reflecting Severe Maternal Morbidity	ANESTHESIA AND ANALGESIA			English	Article							ADMINISTRATIVE DATA; ACCURACY; IDENTIFICATION; VALIDATION; DIAGNOSES	BACKGROUND: Discharge diagnoses are used to track national trends and patterns of maternal morbidity. There are few data regarding the validity of the International Classification of Diseases (ICD) codes used for this purpose. The goal of our study was to try to better understand the validity of administrative data being used to monitor and assess trends in morbidity. METHODS: Hospital stay billing records were queried to identify all delivery admissions at the Massachusetts General Hospital for the time period 2001 to 2011 and the University of Michigan Health System for the time period 2005 to 2011. From this, we identified patients with ICD-9-Clinical Modification (CM) diagnosis and procedure codes indicative of severe maternal morbidity. Each patient was classified with 1 of 18 different medical/obstetric categories (conditions or procedures) based on the ICD-9-CM code that was recorded. Within each category, 20 patients from each institution were selected at random, and the corresponding medical charts were reviewed to determine whether the ICD-9-CM code was assigned correctly. The percentage of correct codes for each of 18 preselected clinical categories was calculated yielding a positive predictive value (PPV) and 99% confidence interval (CI). RESULTS: The overall number of correctly assigned ICD-9-CM codes, or PPV, was 218 of 255 (86%; CI, 79%-90%) and 154 of 188 (82%; CI, 74%-88%) at Massachusetts General Hospital and University of Michigan Health System, respectively (combined PPV, 372/443 [84%; CI, 79-88%]). Codes within 4 categories (Hysterectomy, Pulmonary edema, Disorders of fluid, electrolyte and acid-base balance, and Sepsis) had a 99% lower confidence limit >= 75%. Codes within 8 additional categories demonstrated a 99% lower confidence limit between 74% and 50% (Acute respiratory distress, Ventilation, Other complications of obstetric surgery, Disorders of coagulation, Cardiomonitoring, Acute renal failure, Thromboembolism, and Shock). Codes within 6 clinical categories demonstrated a 99% lower confidence limit <50% (Puerperal cerebrovascular disorders, Conversion of cardiac rhythm, Acute heart failure [includes arrest and fibrillation], Eclampsia, Neurotrauma, and Severe anesthesia complications). CONCLUSIONS: ICD-9-CM codes capturing severe maternal morbidity during delivery hospitalization demonstrate a range of PPVs. The PPV was high when objective supportive evidence, such as laboratory values or procedure documentation supported the ICD-9-CM code. The PPV was low when greater judgment, interpretation, and synthesis of the clinical data (signs and symptoms) was required to support a code, such as with the category Severe anesthesia complications. As a result, these codes should be used for administrative research with more caution compared with codes primarily defined by objective data.	[Sigakis, Matthew J. G.; Sharawi, Nadir; Rajala, Baskar] Univ Michigan, Sch Med, Dept Anesthesiol, 1H247 UH,SPC 5048,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA; [Leffert, Lisa R.; Bateman, Brian T.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Div Obstet Anesthesia, Boston, MA 02114 USA; [Mirzakhani, Hooman] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Callaghan, William M.; Creanga, Andreea A.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA; [Kuklina, Elena V.] Ctr Dis Control & Prevent, Epidemiol & Surveillance Branch, Div Heart Dis & Stroke Prevent, Atlanta, GA USA; [Mhyre, Jill M.] Univ Arkansas Med Sci, Dept Anesthesiol, Little Rock, AR 72205 USA	Sigakis, MJG (corresponding author), Univ Michigan, Sch Med, Dept Anesthesiol, 1H247 UH,SPC 5048,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA.	msigakis@med.umich.edu	Kuklina, Elena/AAF-3532-2020	Mirzakhani, Hooman/0000-0002-2290-4436	Intramural CDC HHS [CC999999] Funding Source: Medline		[Anonymous], 2013, OBSTET GYNECOL, V122, P957, DOI 10.1097/AOG.0b013e3182a603bb; Berthelsen C L, 2000, Top Health Inf Manage, V21, P10; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Callaghan WM, 2014, OBSTET GYNECOL, V123, P978, DOI 10.1097/AOG.0000000000000218; Callaghan WM, 2012, OBSTET GYNECOL, V120, P1029, DOI [10.1097/AOG.0b013e31826d60c5, http://10.1097/AOG.0b013e31826d60c5]; Callaghan WM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.12.020; Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22; Centers for Disease Control and Prevention, 2016, CLASS DIS INT CLASS; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Creanga AA, 2014, J WOMENS HEALTH, V23, P3, DOI 10.1089/jwh.2013.4617; Geller SE, 2004, AM J OBSTET GYNECOL, V190, P1629, DOI 10.1016/j.ajog.2004.03.061; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; Kilpatrick SJ, 2014, OBSTET GYNECOL, V124, P361, DOI 10.1097/AOG.0000000000000397; Kuklina EV, 2009, OBSTET GYNECOL, V113, P293, DOI 10.1097/AOG.0b013e3181954e5b; Lain SJ, 2012, MED CARE, V50, pE7, DOI 10.1097/MLR.0b013e31821d2b1d; McIsaac DI, 2015, ANESTHESIOLOGY, V123, P253, DOI 10.1097/ALN.0000000000000692; Mhyre JM, 2011, ANESTHESIOLOGY, V115, P963, DOI 10.1097/ALN.0b013e318233042d; Neuman MD, 2015, ANESTHESIOLOGY, V123, P243, DOI 10.1097/ALN.0000000000000691; Pinyavat T, 2015, ANESTHESIOLOGY, V122, P55, DOI 10.1097/ALN.0000000000000467; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Romano PS, 2005, OBSTET GYNECOL, V106, P717, DOI 10.1097/01.AOG.0000179552.36108.6d; Romano PS, 2002, MED CARE, V40, P856, DOI 10.1097/00005650-200210000-00004; Ronsmans C, 2009, BEST PRACT RES CL OB, V23, P305, DOI 10.1016/j.bpobgyn.2009.01.001; Say L, 2004, REPROD HLTH, V1, P3, DOI [10.1186/1742-4755-1-3, DOI 10.1186/1742-4755-1-3]; Severe Maternal Morbidity, 2016, SEVERE MATERNAL MORB; Wanderer JP, 2013, CRIT CARE MED, V41, P1844, DOI 10.1097/CCM.0b013e31828a3e24; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058	28	20	20	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	SEP	2016	123	3					731	738		10.1213/ANE.0000000000001436			8	Anesthesiology	Anesthesiology	DT9RA	WOS:000381838800025	27387839	Green Accepted			2021-06-18	
J	Vargas, JLC; Belforte, N; Di Polo, A				Vargas, Jorge L. Cueva; Belforte, Nicolas; Di Polo, Adriana			The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling	NEUROBIOLOGY OF DISEASE			English	Article						Gliosis; Neurodegeneration; cAMP Phosphodiesterase inhibitor; Optic nerve; Ocular hypertension	CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; MIGRATION INHIBITORY FACTOR; SOLUBLE ADENYLYL-CYCLASE; TRAUMATIC BRAIN-INJURY; DBA/2J MOUSE MODEL; SPINAL-CORD-INJURY; OPTIC-NERVE HEAD; INTRAOCULAR-PRESSURE; NEURODEGENERATIVE DISEASES; MICROGLIAL ACTIVATION	Glaucoma is a neurodegenerative disease and the leading cause of irreversible blindness worldwide. Vision deficits in glaucoma result from the selective loss of retinal ganglion cells (RGC). Glial cell-mediated neuroinflammation has been proposed to contribute to disease pathophysiology, but whether this response is harmful or beneficial for RGC survival is not well understood. To test this, we characterized the role of ibudilast, a clinically approved cAMP phosphodiesterase (PDE) inhibitor with preferential affinity for PDE type 4 (PDE4). Here, we demonstrate that intraocular administration of ibudilast dampened macroglia and microglia reactivity in the retina and optic nerve hence decreasing production of proinflammatory cytokines in a rat model of ocular hypertension. Importantly, ibudilast promoted robust RGC soma survival, prevented axonal degeneration, and improved anterograde axonal transport in glaucomatous eyes without altering intraocular pressure. Intriguingly, ocular hypertension triggered upregulation of PDE4 subtype A in Muller glia, and ibudilast stimulated CAMP accumulation in these cells. Co-administration of ibudilast with Rp-cAMPS, a cell-permeable and non-hydrolysable cAMP analog that inhibits protein kinase A (PICA), completely blocked ibudilast-induced neuroprotection. Collectively, these data demonstrate that ibudilast, a safe and well-tolerated glial cell modulator, attenuates gliosis, decreases levels of proinflammatory mediators, and enhances neuronal viability in glaucoma through activation of the cAMP/PICA pathway. This study provides insight into PDE4 signaling as a potential target to counter the harmful effects associated with chronic gliosis and neuroinflammation in glaucoma. (C) 2016 Elsevier Inc. All rights reserved.	Univ Montreal, Dept Neurosci, Montreal, PQ H2X 0A9, Canada; Univ Montreal, Ctr Rech Univ Montreal CRCHUM, Montreal, PQ H2X 0A9, Canada	Di Polo, A (corresponding author), Univ Montreal, Dept Neurosci, CRCHUM, 900 Rue St Denis,Room R09-720, Montreal, PQ H2X 0A9, Canada.	adriana.di.polo@umontreal.ca		Cueva-Vargas, Jorge Luis/0000-0002-8332-9404	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR-VIH-105439]; Groupe de recherche sur le systeme nerveux central at the Universite de Montreal; Fonds de recherche Quebec-Sante (FRQS)	We thank Dr. Timothy Kennedy (McGill University) for helpful comments on the manuscript. This work was supported by a grant from the Canadian Institutes of Health Research (CIHR-VIH-105439). N.B. is the recipient of a H. H. Jasper Postdoctoral Research Fellowship in Neurosciences from the Groupe de recherche sur le systeme nerveux central at the Universite de Montreal, and a Postdoctoral Fellowship from the Fonds de recherche Quebec-Sante (FRQS) A.D.P. is a Chercheur National of FRQS.	Abbott CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114546; Ahlers KE, 2015, GLIA, V63, P1694, DOI 10.1002/glia.22835; Ahmed F, 2004, INVEST OPHTH VIS SCI, V45, P1247, DOI 10.1167/iovs.03-1123; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Almasieh M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.23; Almasieh M, 2013, INVEST OPHTH VIS SCI, V54, P3171, DOI 10.1167/iovs.12-11481; Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Ba J, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S86269; Bacher M, 2010, MOL MED, V16, P116, DOI 10.2119/molmed.2009.00123; BAUSHER LP, 1995, EXP EYE RES, V60, P43, DOI 10.1016/S0014-4835(05)80082-X; BODE DC, 1993, J PHARMACOL EXP THER, V267, P1286; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Cen LP, 2015, NEUROSCIENCE, V311, P56, DOI 10.1016/j.neuroscience.2015.09.067; CHARBONNEAU H, 1986, P NATL ACAD SCI USA, V83, P9308, DOI 10.1073/pnas.83.24.9308; Chidlow G, 2012, NEUROBIOL DIS, V48, P568, DOI 10.1016/j.nbd.2012.07.026; Chong RS, 2015, CURR OPIN OPHTHALMOL, V26, P73, DOI 10.1097/ICU.0000000000000125; Corredor RG, 2012, J NEUROSCI, V32, P7734, DOI 10.1523/JNEUROSCI.5288-11.2012; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Dal Piaz V, 2000, EUR J MED CHEM, V35, P463, DOI 10.1016/S0223-5234(00)00179-3; Dengler-Crish CM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00290; DOSTMANN WRG, 1995, FEBS LETT, V375, P231, DOI 10.1016/0014-5793(95)01201-O; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; Fujino H, 2009, ACTA NEUROPATHOL, V117, P75, DOI 10.1007/s00401-008-0440-9; Galindo-Romero C, 2013, INVEST OPHTH VIS SCI, V54, P974, DOI 10.1167/iovs.12-11207; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Gibson LCD, 2006, EUR J PHARMACOL, V538, P39, DOI 10.1016/j.ejphar.2006.02.053; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Gramlich OW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057557; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Howell G.R., 2014, COLD SPRING HARB PER, V4; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Huang Z, 2006, LIFE SCI, V78, P2663, DOI 10.1016/j.lfs.2005.10.026; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Inoue N, 2008, ARZNEIMITTELFORSCH, V58, P277, DOI 10.1055/s-0031-1296507; Iona S, 1998, MOL PHARMACOL, V53, P23; Johnson EC, 2009, J GLAUCOMA, V18, P341, DOI 10.1097/IJG.0b013e31818c6ef6; Kuehn MH, 2008, EXP EYE RES, V87, P89, DOI 10.1016/j.exer.2008.04.012; Lebrun-Julien F, 2010, P NATL ACAD SCI USA, V107, P3817, DOI 10.1073/pnas.0909276107; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Lebrun-Julien F, 2009, MOL CELL NEUROSCI, V40, P410, DOI 10.1016/j.mcn.2008.12.005; Lee YS, 2014, J OCUL PHARMACOL TH, V30, P138, DOI 10.1089/jop.2013.0199; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.126; Li YM, 2003, J NEUROSCI, V23, P7830; Mali RS, 2011, EXP EYE RES, V92, P528, DOI 10.1016/j.exer.2011.03.017; Matsuda A, 1997, J NEUROIMMUNOL, V77, P85, DOI 10.1016/S0165-5728(97)00061-1; Mehats C, 2002, TRENDS ENDOCRIN MET, V13, P29, DOI 10.1016/S1043-2760(01)00523-9; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184; Morrison JC, 2015, EXP EYE RES, V141, P23, DOI 10.1016/j.exer.2015.05.012; MOUTON PR, 2002, PRINCIPLES PRACTICES; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; NATHANSON JA, 1980, P NATL ACAD SCI-BIOL, V77, P7420, DOI 10.1073/pnas.77.12.7420; Noguchi M, 2009, BIOL PHARM BULL, V32, P1924, DOI 10.1248/bpb.32.1924; Park YH, 2015, EXP EYE RES, V132, P136, DOI 10.1016/j.exer.2015.01.026; Paterniti I, 2014, CURR MED CHEM, V21, P2830, DOI 10.2174/0929867321666140217102428; Pearce W, 2015, CURR OPIN OPHTHALMOL, V26, P233, DOI 10.1097/ICU.0000000000000143; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; PENFOLD PL, 1991, VISUAL NEUROSCI, V7, P383, DOI 10.1017/S0952523800004879; Popp J, 2009, J PSYCHIATR RES, V43, P749, DOI 10.1016/j.jpsychires.2008.10.006; Poulsen Jeppe N, 2014, Int J Physiol Pathophysiol Pharmacol, V6, P1; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Ren LZ, 2010, ADV EXP MED BIOL, V703, P95, DOI 10.1007/978-1-4419-5635-4_7; Rodgers KM, 2014, J NEUROTRAUM, V31, P487, DOI [10.1089/NEU.2013.3090, 10.1089/neu.2013.3090]; Rojas B, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-133; Rolan P, 2009, EXPERT OPIN PHARMACO, V10, P2897, DOI 10.1517/14656560903426189; Ruzafa N, 2015, Arch Soc Esp Oftalmol, V90, P522, DOI 10.1016/j.oftal.2015.03.009; Sachs BD, 2007, BIOCHEM SOC T, V35, P1273, DOI 10.1042/BST0351273; Sanchez RN, 2003, INVEST OPHTH VIS SCI, V44, P4006, DOI 10.1167/iovs.03-0040; Sanchez-Guajardo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008784; Schaal SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043634; Schwartz M, 2008, PROG BRAIN RES, V173, P375, DOI 10.1016/S0079-6123(08)01126-6; Schwartz Michal, 2009, J Ocul Biol Dis Infor, V2, P73; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Stasi K, 2006, INVEST OPHTH VIS SCI, V47, P1024, DOI 10.1167/iovs.05-0830; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stewart MW, 2015, DIABETES METAB SYNDR, V8, P473, DOI 10.2147/DMSO.S72792; Sun D, 2013, GLIA, V61, P1218, DOI 10.1002/glia.22507; Suzumura A, 1999, BRAIN RES, V837, P203, DOI 10.1016/S0006-8993(99)01666-2; Tezel G, 2004, BRAIN RES, V996, P202, DOI 10.1016/j.brainres.2003.10.029; Tezel G, 2013, CURR OPIN PHARMACOL, V13, P23, DOI 10.1016/j.coph.2012.09.013; Tezel G, 2012, INVEST OPHTH VIS SCI, V53, P4220, DOI 10.1167/iovs.11-9101; Tezel G, 2010, INVEST OPHTH VIS SCI, V51, P5071, DOI 10.1167/iovs.10-5289; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Travaglione S, 2002, TOXICOL IN VITRO, V16, P405, DOI 10.1016/S0887-2333(02)00028-0; Vargas JLC, 2015, J NEUROSCI, V35, P12088, DOI 10.1523/JNEUROSCI.1273-15.2015; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003; Wang L, 2002, INVEST OPHTH VIS SCI, V43, P1088; Wang MH, 2014, J NEUROSCI, V34, P3793, DOI 10.1523/JNEUROSCI.3153-13.2014; Watanabe M, 2003, NEUROSCIENCE, V116, P733, DOI 10.1016/S0306-4522(02)00562-6; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Whitaker CM, 2009, NEUROSCIENCE, V163, P1277, DOI 10.1016/j.neuroscience.2009.07.045; Wilson GN, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0399-0; Wohl SG, 2010, INVEST OPHTH VIS SCI, V51, P2686, DOI 10.1167/iovs.09-4537; Yang XJ, 2011, INVEST OPHTH VIS SCI, V52, P8442, DOI 10.1167/iovs.11-8152; Yoshioka A, 1998, J NEUROCHEM, V70, P2416; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104; Zhou Y, 2005, MOL THER, V12, P402, DOI 10.1016/j.ymthe.2005.04.004; Zhu J, 2001, CNS DRUG REV, V7, P387	113	20	21	0	17	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	SEP	2016	93						156	171		10.1016/j.nbd.2016.05.002			16	Neurosciences	Neurosciences & Neurology	DQ8IE	WOS:000379452600016	27163643				2021-06-18	
J	Dong, TT; Zhi, L; Bhayana, B; Wu, MX				Dong, Tingting; Zhi, Liang; Bhayana, Brijesh; Wu, Mei X.			Cortisol-induced immune suppression by a blockade of lymphocyte egress in traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						TBI; T lymphocytes; Cortisol; Inflammation; cAMP	SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; SPHINGOSINE 1-PHOSPHATE; T-CELLS; TREATMENT STRATEGIES; CONTROLLED-TRIAL; PROGESTERONE; METHYLPREDNISOLONE; NEUROGENESIS; RECEPTORS	Background: Acute traumatic brain injury (TBI) represents one of major causes of mortality and disability in the USA. Neuroinflammation has been regarded both beneficial and detrimental, probably in a time-dependent fashion. Methods: To address a role for neuroinflammation in brain injury, C57BL/6 mice were subjected to a closed head mild TBI (mTBI) by a standard controlled cortical impact, along with or without treatment of sphingosine 1-phosphate (S1P) or rolipram, after which the brain tissue of the impact site was evaluated for cell morphology via histology, inflammation by qRT-PCR and T cell staining, and cell death with Caspase-3 and TUNEL staining. Circulating lymphocytes were quantified by flow cytometry, and plasma hydrocortisone was analyzed by LC-MS/MS. To investigate the mechanism whereby cortisol lowered the number of peripheral T cells, T cell egress was tracked in lymph nodes by intravital confocal microscopy after hydrocortisone administration. Results: We detected a decreased number of circulating lymphocytes, in particular, T cells soon after mTBI, which was inversely correlated with a transient and robust increase of plasma cortisol. The transient lymphocytopenia might be caused by cortisol in part via a blockade of lymphocyte egress as demonstrated by the ability of cortisol to inhibit T cell egress from the secondary lymphoid tissues. Moreover, exogenous hydrocortisone severely suppressed periphery lymphocytes in uninjured mice, whereas administering an egress-promoting agent SIP normalized circulating T cells in mTBI mice and increased T cells in the injured brain. Likewise, rolipram, a cAMP phosphodiesterase inhibitor, was also able to elevate cAMP levels in T cells in the presence of hydrocortisone in vitro and abrogate the action of cortisol in mTBI mice. The investigation demonstrated that the number of circulating T cells in the early phase of TBI was positively correlated with T cell infiltration and inflammatory responses as well as cell death at the cerebral cortex and hippocampus beneath the impact site. Conclusions: Decreases in intracellular cAMP might be part of the mechanism behind cortisol-mediated blockade of T cell egress. The study argues strongly for a protective role of cortisol-induced immune suppression in the early stage of TBI.	[Dong, Tingting; Zhi, Liang; Bhayana, Brijesh; Wu, Mei X.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Dermatol, Wellman Ctr Photomed, 50 Blossom St, Boston, MA 02114 USA	Wu, MX (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Dermatol, Wellman Ctr Photomed, 50 Blossom St, Boston, MA 02114 USA.	mwu5@mgh.harvard.edu			Department of Defense/Air Force Office of Scientific Research Militory Photomedicine Program; Department of DefenseUnited States Department of Defense; CDMRP/BAA; Wellman Center for Photomedicine;  [FA9550-11-1-0415];  [FA9550-13-1-0068];  [W81XWH-13-2-0067]	This work is supported by FA9550-11-1-0415 and FA9550-13-1-0068, Department of Defense/Air Force Office of Scientific Research Militory Photomedicine Program, W81XWH-13-2-0067, Department of Defense, CDMRP/BAA, and the fund of Wellman Center for Photomedicine to MXW.	BOLTON PM, 1979, AUST J EXP BIOL MED, V57, P479, DOI 10.1038/icb.1979.49; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; BRADBURY MWB, 1993, EXP PHYSIOL, V78, P453, DOI 10.1113/expphysiol.1993.sp003698; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; COX JH, 1982, CELL IMMUNOL, V66, P407, DOI 10.1016/0008-8749(82)90190-3; De KIoet ER, 2004, ANN NY ACAD SCI, V1018, P1; Dong TT, 2015, J CEREBR BLOOD F MET, V35, P1435, DOI 10.1038/jcbfm.2015.87; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Kim P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2839043; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; O'Brien N, 2009, J LIPID RES, V50, P2245, DOI 10.1194/jlr.M900048-JLR200; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Reichardt HM, 1998, MOL CELL ENDOCRINOL, V146, P1, DOI 10.1016/S0303-7207(98)00208-1; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sensken SC, 2011, J IMMUNOL, V186, P3432, DOI 10.4049/jimmunol.1002169; Sinha RK, 2009, IMMUNITY, V30, P434, DOI 10.1016/j.immuni.2008.12.018; Soares HD, 1995, J NEUROSCI, V15, P8223; Thompson BD, 2007, J BIOL CHEM, V282, P9547, DOI 10.1074/jbc.M610931200; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zhang Q, 2014, J CEREBR BLOOD F MET, V34, P1391, DOI 10.1038/jcbfm.2014.95; Zhi L, 2011, J IMMUNOL, V187, P2244, DOI 10.4049/jimmunol.1100670; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	50	20	20	0	11	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	AUG 25	2016	13								197	10.1186/s12974-016-0663-y			13	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	DV3QI	WOS:000382837500002	27561600	DOAJ Gold, Green Published			2021-06-18	
J	Hua, Z; Liu, LP; Shen, J; Cheng, K; Liu, AJ; Yang, J; Wang, LN; Qu, TY; Yang, HN; Li, Y; Wu, HY; Narouze, J; Yin, Y; Cheng, JG				Hua, Zhen; Liu, LiPing; Shen, Jun; Cheng, Katherine; Liu, Aijun; Yang, Jing; Wang, Lina; Qu, Tingyu; Yang, HongNa; Li, Yan; Wu, Haiyan; Narouze, John; Yin, Yan; Cheng, Jianguo			Mesenchymal Stem Cells Reversed Morphine Tolerance and Opioidinduced Hyperalgesia	SCIENTIFIC REPORTS			English	Article							OPIOID-INDUCED HYPERALGESIA; TRAUMATIC BRAIN-INJURY; BONE-MARROW; STROMAL CELLS; NEUROPATHIC PAIN; ANALGESIC TOLERANCE; THERMAL HYPERALGESIA; NERVE INJURY; SPINAL-CORD; MECHANISMS	More than 240 million opioid prescriptions are dispensed annually to treat pain in the US. The use of opioids is commonly associated with opioid tolerance (OT) and opioid-induced hyperalgesia (OIH), which limit efficacy and compromise safety. The dearth of effective way to prevent or treat OT and OIH is a major medical challenge. We hypothesized that mesenchymal stem cells (MSCs) attenuate OT and OIH in rats and mice based on the understanding that MSCs possess remarkable anti-inflammatory properties and that both OT and chronic pain are associated with neuroinflammation in the spinal cord. We found that the development of OT and OIH was effectively prevented by either intravenous or intrathecal MSC transplantation (MSC-TP), which was performed before morphine treatment. Remarkably, established OT and OIH were significantly reversed by either intravenous or intrathecal MSCs when cells were transplanted after repeated morphine injections. The animals did not show any abnormality in vital organs or functions. Immunohistochemistry revealed that the treatments significantly reduced activation level of microglia and astrocytes in the spinal cord. We have thus demonstrated that MSC-TP promises to be a potentially safe and effective way to prevent and reverse two of the major problems of opioid therapy.	[Hua, Zhen; Liu, LiPing; Shen, Jun; Cheng, Katherine; Liu, Aijun; Yang, Jing; Wang, Lina; Wu, Haiyan; Narouze, John; Yin, Yan; Cheng, Jianguo] Cleveland Clin, Lerner Res Inst & Anaesthesiol Inst, Dept Pain Management, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Hua, Zhen; Liu, LiPing; Shen, Jun; Cheng, Katherine; Liu, Aijun; Yang, Jing; Wang, Lina; Wu, Haiyan; Narouze, John; Yin, Yan; Cheng, Jianguo] Cleveland Clin, Lerner Res Inst & Anaesthesiol Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA; Beijing Hosp, Dept Anesthesiol, 1 Dahua Rd, Beijing 100730, Peoples R China; [Qu, Tingyu; Yang, HongNa; Li, Yan] Univ Illinois, Coll Med, Inst Psychiat, Dept Psychiat, Chicago, IL USA	Cheng, JG (corresponding author), Cleveland Clin, Lerner Res Inst & Anaesthesiol Inst, Dept Pain Management, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Cheng, JG (corresponding author), Cleveland Clin, Lerner Res Inst & Anaesthesiol Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.	chengj@ccf.org	Cheng, Jianguo/I-1990-2019; aijun, liu/X-6413-2019	Cheng, Jianguo/0000-0002-2318-0812; 	Department of DefenseUnited States Department of Defense [10669042]; Cleveland Clinic Anesthesiology Institute	This work is supported by grants from the Department of Defense (10669042) and Cleveland Clinic Anesthesiology Institute. We thank Richard Rosenquist, MD, and Daniel Sessler, MD, for commenting on an earlier version of the letter and David Brown, MD, for supporting the project, Yan Li, PhD, for assisting with MSC isolation and characterization, and Judith Drazba, PhD, for providing excellent Imaging Core Service.	[Anonymous], 2011, RELIEVING PAIN AM; Atoui R, 2012, EXPERT OPIN BIOL TH, V12, P1293, DOI 10.1517/14712598.2012.711307; Ballantyne JC, 2003, NEW ENGL J MED, V349, P1943, DOI 10.1056/NEJMra025411; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503; BEITNERJOHNSON D, 1993, J NEUROCHEM, V61, P1766, DOI 10.1111/j.1471-4159.1993.tb09814.x; Bekhit MH, 2010, AM J THER, V17, P498, DOI 10.1097/MJT.0b013e3181ed83a0; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chen G, 2015, J CLIN INVEST, V125, P3226, DOI 10.1172/JCI80883; Chu LF, 2012, PAIN, V153, P1583, DOI 10.1016/j.pain.2012.02.028; Chu LF, 2006, J PAIN, V7, P43, DOI 10.1016/j.jpain.2005.08.001; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; De Miguel MP, 2012, CURR MOL MED, V12, P574; DeLeo JA, 2004, NEUROSCIENTIST, V10, P40, DOI 10.1177/1073858403259950; Eidson LN, 2013, J PAIN, V14, P393, DOI 10.1016/j.jpain.2012.12.010; Ellis A, 2013, BRIT J ANAESTH, V111, P26, DOI 10.1093/bja/aet128; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Guo W, 2011, STEM CELLS, V29, P1294, DOI 10.1002/stem.667; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hoogduijn MJ, 2007, STEM CELLS DEV, V16, P597, DOI 10.1089/scd.2006.0110; Hosseini M, 2015, BIOL BLOOD MARROW TR, V21, P1537, DOI 10.1016/j.bbmt.2015.05.008; Huang K, 2014, STEM CELL REP, V2, P36, DOI 10.1016/j.stemcr.2013.11.003; Inoue M, 2003, GLIA, V44, P111, DOI 10.1002/glia.10285; Katsuno T, 2013, J CLIN BIOCHEM NUTR, V53, P170, DOI 10.3164/jcbn.13-68; Keating A, 2008, CELL STEM CELL, V2, P106, DOI 10.1016/j.stem.2008.01.007; Kim EJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.2; Lennon DP, 2006, EXP HEMATOL, V34, P1606, DOI 10.1016/j.exphem.2006.07.015; Li Y, 2012, BLOOD, V120, P3436, DOI 10.1182/blood-2012-03-420612; Liechty K. W., 2000, J AM COLL SURGEONS, V191, pS96, DOI DOI 10.1016/S1072-7515(00)00675-X; Liu LP, 2006, J IMMUNOL, V177, P17, DOI 10.4049/jimmunol.177.1.17; Liu LP, 2010, J NEUROSCI, V30, P9074, DOI 10.1523/JNEUROSCI.1238-10.2010; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Lu Y, 2004, ANESTH ANALG, V98, P414, DOI 10.1213/01.ANE.0000094334.12027.06; Maestroni GJM, 1998, EXP HEMATOL, V26, P1172; Mao JR, 2002, J NEUROSCI, V22, P7650; Matsushita Y, 2013, CURR PHARM DESIGN, V19, P7355; Mayer DJ, 1999, P NATL ACAD SCI USA, V96, P7731, DOI 10.1073/pnas.96.14.7731; Mazzini L, 2006, NEUROL RES, V28, P523, DOI 10.1179/016164106X116791; Monsel A, 2014, ANESTHESIOLOGY, V121, P1099, DOI 10.1097/ALN.0000000000000446; Pal R, 2009, CYTOTHERAPY, V11, P897, DOI 10.3109/14653240903253857; Patel A., 2011, STEM CELLS CLONING A, V61; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raghavendra V, 2002, J NEUROSCI, V22, P9980, DOI 10.1523/jneurosci.22-22-09980.2002; Sanna MD, 2015, PAIN, V156, P1265, DOI 10.1097/j.pain.0000000000000164; Schafer S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0157-8; Shen J, 2013, PAIN MED, V14, P516, DOI 10.1111/pme.12057; Shen J, 2012, ANESTHESIOLOGY, V117, P365, DOI 10.1097/ALN.0b013e318260de41; Shibata T, 2008, DIABETES, V57, P3099, DOI 10.2337/db08-0031; Sondergaard CS, 2010, ANN THORAC SURG, V90, P796, DOI 10.1016/j.athoracsur.2010.04.080; Song P, 2001, NEUROSCI RES, V39, P281, DOI 10.1016/S0168-0102(00)00226-1; Togel FE, 2010, NAT REV NEPHROL, V6, P179, DOI 10.1038/nrneph.2009.229; Vanderah TW, 2001, J NEUROSCI, V21, P279, DOI 10.1523/JNEUROSCI.21-01-00279.2001; Vawda R, 2012, INDIAN J ORTHOP, V46, P10, DOI 10.4103/0019-5413.91629; Venkataramana NK, 2010, TRANSL RES, V155, P62, DOI 10.1016/j.trsl.2009.07.006; Volarevic V, 2011, STEM CELLS, V29, P5, DOI 10.1002/stem.556; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou QH, 2014, ACTA NEUROPSYCHIATR, V26, P218, DOI 10.1017/neu.2013.57	68	20	21	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 24	2016	6								32096	10.1038/srep32096			12	Multidisciplinary Sciences	Science & Technology - Other Topics	DT9VG	WOS:000381849800001	27554341	DOAJ Gold, Green Published			2021-06-18	
J	Krewer, C; Schneider, M; Schneider, HJ; Kreitschmann-Andermahr, I; Buchfelder, M; Faust, M; Berg, C; Wallaschofski, H; Renner, C; Uhl, E; Koenig, E; Jordan, M; Stalla, GK; Kopczak, A				Krewer, Carmen; Schneider, Manfred; Schneider, Harald Joern; Kreitschmann-Andermahr, Ilonka; Buchfelder, Michael; Faust, Michael; Berg, Christian; Wallaschofski, Henri; Renner, Caroline; Uhl, Eberhard; Koenig, Eberhard; Jordan, Martina; Stalla, Guenter Karl; Kopczak, Anna			Neuroendocrine Disturbances One to Five or More Years after Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage: Data from the German Database on Hypopituitarism	JOURNAL OF NEUROTRAUMA			English	Article						hypopituitarism; neuroendocrinology; SAH; TBI	ANTERIOR-PITUITARY FUNCTION; GROWTH-HORMONE DEFICIENCY; LONG-TERM; PRACTICAL SCALE; FOLLOW-UP; PREVALENCE; DYSFUNCTION; SURVIVORS; STRESS; ADULTS	Neuroendocrine disturbances are common after traumatic brain injury (TBI) and aneurysmal subarachnoid hemorrhage (SAH), but only a few data exist on long-term anterior pituitary deficiencies after brain injury. We present data from the Structured Data Assessment of Hypopituitarism after TBI and SAH, a multi-center study including 1242 patients. We studied a subgroup of 351 patients, who had sustained a TBI (245) or SAH (106) at least 1 year before endocrine assessment (range 1-55 years) in a separate analysis. The highest prevalence of neuroendocrine disorders was observed 1-2 years post-injury, and it decreased over time only to show another maximum in the long-term phase in patients with brain injury occurring >= 5 years prior to assessment. Gonadotropic and somatotropic insufficiencies were most common. In the subgroup from 1 to 2 years after brain injury (n = 126), gonadotropic insufficiency was the most common hormonal disturbance (19%, 12/63 men) followed by somatotropic insufficiency (11.5%, 7/61), corticotropic insufficiency (9.2%, 11/119), and thyrotropic insufficiency (3.3%, 4/122). In patients observed >= 5 years after brain injury, the prevalence of somatotropic insufficiency increased over time to 24.1%, whereas corticotropic and thyrotrophic insufficiency became less frequent (2.5% and 0%, respectively). The prevalence differed regarding the diagnostic criteria (laboratory values vs. physician's diagnosis vs. stimulation tests). Our data showed that neuroendocrine disturbances are frequent even years after TBI or SAH, in a cohort of patients who are still on medical treatment.	[Krewer, Carmen; Schneider, Manfred; Koenig, Eberhard] Schon Klin Bad Aibling, Bad Aibling, Germany; [Schneider, Harald Joern] Univ Munich, Univ Hosp Innenstadt, Munich, Germany; [Kreitschmann-Andermahr, Ilonka] Univ Duisburg Essen, Dept Neurosurg, Essen, Germany; [Buchfelder, Michael] Univ Erlangen Nurnberg, Dept Neurosurg, Erlangen, Germany; [Faust, Michael] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med, Cologne, Germany; [Berg, Christian] Evangel Hosp Mettmann, Dept Internal Med, Mettmann, Germany; [Wallaschofski, Henri] Specialized Med Practice Diabet & Hormonal Disord, Erfurt, Germany; [Renner, Caroline] Univ Leipzig, NRZ Neurol Rehabil Ctr, Leipzig, Germany; [Uhl, Eberhard] Univ Hosp Giessen, Dept Neurosurg, Giessen, Germany; [Jordan, Martina] ClinSupport GmbH, Erlangen, Germany; [Stalla, Guenter Karl; Kopczak, Anna] Max Planck Inst Psychiat, Clin Neuroendocrinol Grp, D-80804 Munich, Germany	Kopczak, A (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany.	anna_kopczak@psych.mpg.de	Krewer, Carmen/H-2845-2019	Krewer, Carmen/0000-0002-4153-0791; Kopczak, Anna/0000-0002-5037-2342			Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Bondanelli M, 2008, J Endocrinol Invest, V31, P16; Boonen E, 2014, CURR OPIN ENDOCRINOL, V21, P185, DOI 10.1097/MED.0000000000000066; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Dusick JR, 2012, PITUITARY, V15, P2, DOI 10.1007/s11102-008-0130-6; Fernandez-Rodriguez E, 2015, ENDOCRIN METAB CLIN, V44, P151, DOI 10.1016/j.ecl.2014.10.012; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Hannon MJ, 2015, CLIN ENDOCRINOL, V82, P115, DOI 10.1111/cen.12533; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; HOFFMAN DM, 1994, LANCET, V344, P482, DOI 10.1016/S0140-6736(94)91821-X; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; JENNETT B, 1975, LANCET, V1, P480; Kalantaridou SN, 2004, J REPROD IMMUNOL, V62, P61, DOI 10.1016/j.jri.2003.09.004; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2011, EXP CLIN ENDOCR DIAB, V119, P15, DOI 10.1055/s-0030-1253414; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nemes O, 2015, HORM-INT J ENDOCRINO, V14, P383, DOI 10.14310/horm.2002.1564; Poll EM, 2013, STRESS, V16, P153, DOI 10.3109/10253890.2012.697946; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; TEASDALE G, 1974, LANCET, V2, P81; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; van der Eerden AW, 2010, EUR J ENDOCRINOL, V162, P19, DOI 10.1530/EJE-09-0436	48	20	20	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2016	33	16					1544	1553		10.1089/neu.2015.4109			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DU6ED	WOS:000382305900008	26914840				2021-06-18	
J	Hefter, D; Kaiser, M; Weyer, SW; Papageorgiou, IE; Both, M; Kann, O; Muller, UC; Draguhn, A				Hefter, Dimitri; Kaiser, Martin; Weyer, Sascha W.; Papageorgiou, Ismini E.; Both, Martin; Kann, Oliver; Mueller, Ulrike C.; Draguhn, Andreas			Amyloid Precursor Protein Protects Neuronal Network Function after Hypoxia via Control of Voltage-Gated Calcium Channels	JOURNAL OF NEUROSCIENCE			English	Article						APP; hippocampus; hypoxia; L-type calcium channels; neuroprotection; nifedipine	TRAUMATIC BRAIN-INJURY; RAT HIPPOCAMPAL SLICE; WAVE-RIPPLE COMPLEXES; ALZHEIMERS-DISEASE; APPS-ALPHA; ACTIVITY PATTERNS; SECRETED FORMS; BETA; INTERNEURONS; ISCHEMIA	Acute cerebral ischemia and chronic neurovascular diseases share various common mechanisms with neurodegenerative diseases, such as disturbed cellular calcium and energy homeostasis and accumulation of toxic metabolites. A link between these conditions may be constituted by amyloid precursor protein (APP), which plays a pivotal role in the pathogenesis of Alzheimer's disease, but has also been associated with the response to acute hypoxia and regulation of calcium homeostasis. We therefore studied hypoxia-induced loss of function and recovery upon reoxygenation in hippocampal slices of mice lacking APP (APP(-/-)) or selectively expressing its soluble extracellular domain (APPs alpha-KI). Transient hypoxia disrupted electrical activity at the network and cellular level. In mice lacking APP, these impairments were significantly more severe, showing increased rise of intracellular calcium, faster loss of function, and higher incidence of spreading depression. Likewise, functional recovery upon reoxygenation was much slower and less complete than in controls. Most of these deficits were rescued by selective expression of the soluble extracellular fragment APPs alpha, or by pharmacological block of L-type calcium channels. We conclude that APP supports neuronal resistance toward acute hypoxia. This effect is mediated by the secreted APPs alpha-domain and involves L-type calcium channels.	[Hefter, Dimitri; Kaiser, Martin; Papageorgiou, Ismini E.; Both, Martin; Kann, Oliver; Draguhn, Andreas] Heidelberg Univ, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69210 Heidelberg, Germany; [Weyer, Sascha W.; Mueller, Ulrike C.] Heidelberg Univ, Dept Bioinformat & Funct Genom, Inst Pharm & Mol Biotechnol, D-69210 Heidelberg, Germany	Draguhn, A (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Neuenheimer Feld 326, D-69210 Heidelberg, Germany.	andreas.draguhn@physiologie.uniheidelberg.de	Papageorgiou, Ismini/AAI-7329-2020; Hefter, Dimitri/AAD-3732-2021; Kann, Oliver/M-4302-2019	Papageorgiou, Ismini/0000-0001-5810-0483; Kann, Oliver/0000-0003-4365-8067	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [MU 1457/9-1, MU 1457/9-2, DRA 326/7-2]	This work was supported by the Deutsche Forschungsgemeinschaft Grants MU 1457/9-1, MU 1457/9-2, and DRA 326/7-2.	Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514; Anekonda TS, 2011, BBA-MOL BASIS DIS, V1812, P1584, DOI 10.1016/j.bbadis.2011.08.013; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; Aydin D, 2012, EXP BRAIN RES, V217, P423, DOI 10.1007/s00221-011-2861-2; Bahner F, 2011, P NATL ACAD SCI USA, V108, pE607, DOI 10.1073/pnas.1103546108; Bahmani P, 2011, J CEREBR BLOOD F MET, V31, P1311, DOI 10.1038/jcbfm.2010.233; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Both M, 2008, HIPPOCAMPUS, V18, P899, DOI 10.1002/hipo.20446; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Clarke J, 2007, EUR J NEUROSCI, V26, P1845, DOI 10.1111/j.1460-9568.2007.05807.x; Cousins SL, 2009, J NEUROCHEM, V111, P1501, DOI 10.1111/j.1471-4159.2009.06424.x; Csicsvari J, 1999, J NEUROSCI, V19, P274; De La Torre JC, 2002, ANN NY ACAD SCI, V977, P196; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Fol R, 2016, ACTA NEUROPATHOL, V131, P247, DOI 10.1007/s00401-015-1498-9; Foster KA, 2005, NEUROSCIENCE, V132, P645, DOI 10.1016/j.neuroscience.2005.01.040; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Hick M, 2015, ACTA NEUROPATHOL, V129, P21, DOI 10.1007/s00401-014-1368-x; Hoyer A, 2005, J NEURAL TRANSM, V112, P239, DOI 10.1007/s00702-004-0176-1; Huchzermeyer C, 2013, J CEREBR BLOOD F MET, V33, P263, DOI 10.1038/jcbfm.2012.165; Kann O, 2014, J CEREBR BLOOD F MET, V34, P1270, DOI 10.1038/jcbfm.2014.104; Kann O, 2012, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00090; KIRINO T, 1992, J CEREBR BLOOD F MET, V12, P408, DOI 10.1038/jcbfm.1992.58; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; Koike MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042665; Li ZW, 1996, P NATL ACAD SCI USA, V93, P6158, DOI 10.1073/pnas.93.12.6158; Liotta A, 2012, J CEREBR BLOOD F MET, V32, P2076, DOI 10.1038/jcbfm.2012.116; LOBNER D, 1993, J NEUROSCI, V13, P4861; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; MARTIN RL, 1994, TRENDS NEUROSCI, V17, P251, DOI 10.1016/0166-2236(94)90008-6; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Milosch N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.352; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nimmrich V, 2005, J PHYSIOL-LONDON, V563, P663, DOI 10.1113/jphysiol.2004.079558; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pfeiffer T, 2014, NEUROIMAGE, V94, P239, DOI 10.1016/j.neuroimage.2014.03.030; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Reichinnek S, 2010, J NEUROSCI, V30, P15441, DOI 10.1523/JNEUROSCI.2535-10.2010; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Sanchez MM, 2011, J ALZHEIMERS DIS, V26, P29, DOI 10.3233/JAD-2011-0050; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Schurr A, 1999, METHODS, V18, P117, DOI 10.1006/meth.1999.0765; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Somjen GG, 2001, PHYSIOL REV, V81, P1065; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Webster NJ, 2006, NEUROBIOL AGING, V27, P439, DOI 10.1016/j.neurobiolaging.2005.02.002; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Yang L, 2009, J NEUROSCI, V29, P15660, DOI 10.1523/JNEUROSCI.4104-09.2009; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Zhang CY, 2002, NEUROSCI LETT, V328, P265, DOI 10.1016/S0304-3940(02)00543-8; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061198; Zhang X, 2010, EXP NEUROL, V223, P299, DOI 10.1016/j.expneurol.2009.07.033	65	20	20	0	9	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	AUG 10	2016	36	32					8356	8371		10.1523/JNEUROSCI.4130-15.2016			16	Neurosciences	Neurosciences & Neurology	DU6GQ	WOS:000382312700008	27511009	Green Published, Bronze			2021-06-18	
J	Borgialli, DA; Mahajan, P; Hoyle, JD; Powell, EC; Nadel, FM; Tunik, MG; Foerster, A; Dong, L; Miskin, M; Dayan, PS; Holmes, JF; Kuppermann, N				Borgialli, Dominic A.; Mahajan, Prashant; Hoyle, John D., Jr.; Powell, Elizabeth C.; Nadel, Frances M.; Tunik, Michael G.; Foerster, Adele; Dong, Lydia; Miskin, Michelle; Dayan, Peter S.; Holmes, James F.; Kuppermann, Nathan		Pediat Emergency Care Appl Res Net	Performance of the Pediatric Glasgow Coma Scale Score in the Evaluation of Children With Blunt Head Trauma	ACADEMIC EMERGENCY MEDICINE			English	Article							YOUNG-CHILDREN; INJURY; CONSCIOUSNESS; INFANTS; LEVEL	Objective: The objective was to compare the accuracy of the pediatric Glasgow Coma Scale (GCS) score in preverbal children to the standard GCS score in older children for identifying those with traumatic brain injuries (TBIs) after blunt head trauma. Methods: This was a planned secondary analysis of a large prospective observational multicenter cohort study of children with blunt head trauma. Clinical data were recorded onto case report forms before computed tomography (CT) results or clinical outcomes were known. The total and component GCS scores were assigned by the physician at initial emergency department evaluation. The pediatric GCS was used for children <2 years old and the standard GCS for those >= 2 years old. Outcomes were TBI visible on CT and clinically important TBI (ciTBI), defined as death from TBI, neurosurgery, intubation for more than 24 hours for the head injury, or hospitalization for 2 or more nights for the head injury in association with TBI on CT. We compared the areas under the receiver operating characteristic (ROC) curves between age cohorts for the association of GCS and the TBI outcomes. Results: We enrolled 42,041 patients, of whom 10,499 (25.0%) were <2 years old. Among patients <2 years, 313/3,329 (9.4%, 95% confidence interval [CI] = 8.4% to 10.4%) of those imaged had TBIs on CT and 146/10,499 (1.4%, 95% CI = 1.2% to 1.6%) had ciTBIs. In patients >= 2 years, 773/11,977 (6.5%, 95% CI = 6.0% to 6.9%) of those imaged had TBIs on CT and 572/31,542 (1.8%, 95% CI = 1.7% to 2.0%) had ciTBIs. For the pediatric GCS in children <2 years old, the area under the ROC curve was 0.61 (95% CI = 0.59 to 0.64) for TBI on CT and 0.77 (95% CI = 0.73 to 0.81) for ciTBI. For the standard GCS in older children, the area under the ROC curve was 0.71 (95% CI = 0.70 to 0.73) for TBI on CT scan and 0.81 (95% CI = 0.79 to 0.83) for ciTBI. Conclusions: The pediatric GCS for preverbal children was somewhat less accurate than the standard GCS for older children in identifying those with TBI on CT. However, the pediatric GCS for preverbal children and the standard GCS for older children were equally accurate for identifying ciTBI. (C) 2016 by the Society for Academic Emergency Medicine	[Borgialli, Dominic A.] Hurley Med Ctr, Dept Emergency Med, Flint, MI USA; [Borgialli, Dominic A.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Mahajan, Prashant] Wayne State Univ, Sch Med, Dept Pediat, Div Pediat Emergency Med, Detroit, MI 48201 USA; [Hoyle, John D., Jr.] Helen DeVos Childrens Hosp, Div Emergency Med, E Lansing, MI USA; [Hoyle, John D., Jr.] Michigan State Univ, Dept Emergency Med, E Lansing, MI 48824 USA; [Hoyle, John D., Jr.] Western Michigan Univ, Sch Med, Dept Emergency Med, Kalamazoo, MI 49008 USA; [Hoyle, John D., Jr.] Western Michigan Univ, Sch Med, Dept Pediat, Kalamazoo, MI 49008 USA; [Powell, Elizabeth C.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Div Pediat Emergency Med, Chicago, IL 60611 USA; [Nadel, Frances M.] Univ Penn, Sch Med, Dept Pediat, Div Pediat Emergency Med, Philadelphia, PA 19104 USA; [Tunik, Michael G.] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Tunik, Michael G.] NYU, Sch Med, Dept Emergency Med, New York, NY USA; [Foerster, Adele] Holy Cross Hosp, Silver Spring Emergency Phys, Silver Spring, MD USA; [Dong, Lydia; Miskin, Michelle] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Dong, Lydia; Miskin, Michelle] PECARN Data Coordinating Ctr, Salt Lake City, UT USA; [Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Morgan Stanley Childrens Hosp, Div Pediat Emergency Med, 630 W 168th St, New York, NY 10032 USA; [Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA	Kuppermann, N (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA.; Kuppermann, N (corresponding author), Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA.	nkuppermann@ucdavis.edu		Powell, Elizabeth/0000-0003-3147-9889; Tunik, Michael/0000-0002-2368-5933	Health Resources and Services Administration/Maternal and Child Health Bureau (HRSA/MCHB), Division of Research, Education, and TrainingUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); Emergency Medical Services of Children (EMSC) Program [R40MC02461]; HRSAUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); MCHB; EMSC Network Development Demonstration Program [U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, U03MC22685]	This work was supported by a grant from the Health Resources and Services Administration/Maternal and Child Health Bureau (HRSA/MCHB), Division of Research, Education, and Training, and the Emergency Medical Services of Children (EMSC) Program (R40MC02461). This project was also supported in part by HRSA, MCHB, and the EMSC Network Development Demonstration Program under cooperative agreements U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, and U03MC22685. The information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.	Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Force Joint Task, 1993, APLS PEDIAT EMERGENC; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; Gedeit R, 2001, Pediatr Rev, V22, P118, DOI 10.1542/pir.22-4-118; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; MORRAY JP, 1984, CRIT CARE MED, V12, P1018, DOI 10.1097/00003246-198412000-00002; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Riechers RG, 2005, J NEUROTRAUM, V22, P1327, DOI 10.1089/neu.2005.22.1327; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; Tatman A, 1997, ARCH DIS CHILD, V77, P519, DOI 10.1136/adc.77.6.519; TEASDALE G, 1974, LANCET, V2, P81; Van de Voorde P, 2008, RESUSCITATION, V76, P175, DOI 10.1016/j.resuscitation.2007.07.007; YAGER JY, 1990, AM J DIS CHILD, V144, P1088, DOI 10.1001/archpedi.1990.02150340032019	21	20	20	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	AUG	2016	23	8					878	884		10.1111/acem.13014			7	Emergency Medicine	Emergency Medicine	DW1BQ	WOS:000383378200005	27197686	Bronze, Green Published			2021-06-18	
J	Majd, S; Power, JHT; Koblar, SA; Grantham, HJM				Majd, Shohreh; Power, John H. T.; Koblar, Simon A.; Grantham, Hugh J. M.			Early glycogen synthase kinase-3 and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						adenosine monophosphate kinase protein; glycogen synthase kinase-3; microtubule-associated protein; neuronal energy stress; phosphorylation; protein phosphatase 2A	ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; TRANSGENIC MICE; NEUROFIBRILLARY DEGENERATION; HYPERPHOSPHORYLATED TAU; PHOSPHORYLATION; RAT; STROKE; PP2A; NEURODEGENERATION	Abnormal tau phosphorylation (p-tau) has been shown after hypoxic damage to the brain associated with traumatic brain injury and stroke. As the level of p-tau is controlled by Glycogen Synthase Kinase (GSK)-3, Protein Phosphatase 2A (PP2A) and Adenosine Monophosphate Kinase (AMPK), different activity levels of these enzymes could be involved in tau phosphorylation following ischaemia. This study assessed the effects of global brain ischaemia/reperfusion on the immediate status of p-tau in a rat model of cardiac arrest (CA) followed by cardiopulmonary resuscitation (CPR). We reported an early dephosphorylation of tau at its AMPK sensitive residues, Ser(396) and Ser(262)after 2min of ischaemia, which did not recover during the first two hours of reperfusion, while the tau phosphorylation at GSK-3 sensitive but AMPK insensitive residues, Ser(202)/Thr(205) (AT8), as well as the total amount of tau remained unchanged. Our data showed no alteration in the activities of GSK-3 and PP2A during similar episodes of ischaemia of up to 8min and reperfusion of up to 2h, and 4weeks recovery. Dephosphorylation of AMPK followed the same pattern as tau dephosphorylation during ischaemia/reperfusion. Catalase, another AMPK downstream substrate also showed a similar pattern of decline to p-AMPK, in ischaemic/reperfusion groups. This suggests the involvement of AMPK in changing the p-tau levels, indicating that tau dephosphorylation following ischaemia is not dependent on GSK-3 or PP2A activity, but is associated with AMPK dephosphorylation. We propose that a reduction in AMPK activity is a possible early mechanism responsible for tau dephosphorylation.	[Majd, Shohreh; Grantham, Hugh J. M.] Flinders Univ South Australia, Sch Med, Ctr Neurosci, Neuronal Injury & Repair Lab, Adelaide, SA 5042, Australia; [Power, John H. T.] Flinders Univ South Australia, Sch Med, Dept Human Physiol, Adelaide, SA, Australia; [Koblar, Simon A.] Univ Adelaide, Sch Med, Queen Elizabeth Hosp TQEH Campus, Adelaide, SA, Australia	Majd, S (corresponding author), Flinders Univ South Australia, Sch Med, Ctr Neurosci, Neuronal Injury & Repair Lab, Adelaide, SA 5042, Australia.	shohreh.majd@flinders.edu.au		Grantham, Hugh/0000-0003-1700-190X; Koblar, Simon/0000-0002-8667-203X	Australian Resuscitation Council; Flinders University Establishment grant	This study was supported by the Australian Resuscitation Council and Flinders University Establishment grant. The authors thank the Biomedical Engineering Department of Flinders University specially Mark McEwen and Noel Kitto for their technical support, the Proteomics Facility of Flinders University specially Dr. Tim Chataway, the Animal Facility of Flinders University, Professor Neil Sims from Medical Biochemistry Department and from the Alzheimer's and Parkinson diseases' lab especially Fariba Chegini for their enthusiastic discussions and support. All authors involved in the study design and development of the model. SM and HG were responsible for completing the experiments. The initial draft was written by SM and reviewed by HG and JP.	Awad H, 2014, PEDIATR PULM, V49, P885, DOI 10.1002/ppul.22919; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bright NJ, 2008, J BIOL CHEM, V283, P14946, DOI 10.1074/jbc.M710381200; Brywe KG, 2005, EUR J NEUROSCI, V21, P1489, DOI 10.1111/j.1460-9568.2005.03982.x; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen MH, 2007, AM J EMERG MED, V25, P623, DOI 10.1016/j.ajem.2006.11.033; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; DEWAR D, 1995, BRAIN RES, V684, P70, DOI 10.1016/0006-8993(95)00417-O; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Ferrer I, 2002, ACTA NEUROPATHOL, V104, P583, DOI 10.1007/s00401-002-002-0587-8; Castro-Alvarez JF, 2011, BEHAV NEUROSCI, V125, P465, DOI 10.1037/a0023167; GEDDES JW, 1994, J CEREBR BLOOD F MET, V14, P554, DOI 10.1038/jcbfm.1994.69; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Guerra-Araiza C, 2007, DEV NEUROBIOL, V67, P510, DOI 10.1002/dneu.20383; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hanger Diane P, 2011, Int J Alzheimers Dis, V2011, P352805, DOI 10.4061/2011/352805; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hernandez F, 2013, J ALZHEIMERS DIS, V33, pS141, DOI 10.3233/JAD-2012-129025; Iijima K, 2010, HUM MOL GENET, V19, P2947, DOI 10.1093/hmg/ddq200; Iijima-Ando K, 2010, HUM MOL GENET, V19, P1930, DOI 10.1093/hmg/ddq068; Iqbal K, 1998, J NEURAL TRANSM-SUPP, P169; Kins S, 2001, J BIOL CHEM, V276, P38193; Koh Phil-Ok, 2011, Lab Anim Res, V27, P73, DOI 10.5625/lar.2011.27.1.73; Li J, 2007, STROKE, V38, P2992, DOI 10.1161/STROKEAHA.107.490904; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Liu R, 2008, J CELL MOL MED, V12, P241, DOI 10.1111/j.1582-4934.2008.00249.x; Lovell MA, 2004, J ALZHEIMERS DIS, V6, P659; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Madureira S, 2001, EUR J NEUROL, V8, P621, DOI 10.1046/j.1468-1331.2001.00332.x; Mailliot C, 2000, J CEREBR BLOOD F MET, V20, P543, DOI 10.1097/00004647-200003000-00013; Martin L, 2013, AGEING RES REV, V12, P39, DOI 10.1016/j.arr.2012.06.008; Mateen FJ, 2011, NEUROLOGY, V77, P1438, DOI 10.1212/WNL.0b013e318232ab33; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Noble W, 2011, EXPERT OPIN DRUG DIS, V6, P797, DOI 10.1517/17460441.2011.586690; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Pei JJ, 2006, FEBS LETT, V580, P107, DOI 10.1016/j.febslet.2005.11.059; Pohjasvaara T, 1998, STROKE, V29, P75, DOI 10.1161/01.STR.29.1.75; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Ramamurthy S, 2006, J PHYSIOL-LONDON, V574, P85, DOI 10.1113/jphysiol.2006.110122; Rudrabhatla P, 2011, CURR ALZHEIMER RES, V8, P623, DOI 10.2174/156720511796717168; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Shackelford DA, 1998, MOL CHEM NEUROPATHOL, V34, P103, DOI 10.1007/BF02815073; Song B, 2013, NEURAL REGEN RES, V8, P3173, DOI 10.3969/j.issn.1673-5374.2013.34.001; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; Takashima A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P309; TATEMICHI TK, 1992, NEUROLOGY, V42, P1185, DOI 10.1212/WNL.42.6.1185; Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485; Trinczek B, 2004, J BIOL CHEM, V279, P5915, DOI 10.1074/jbc.M304528200; van der Harg JM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.354; Virdee K, 2007, FEBS LETT, V581, P2657, DOI 10.1016/j.febslet.2007.05.009; Yoshida H, 2012, J NEUROCHEM, V120, P165, DOI 10.1111/j.1471-4159.2011.07523.x	56	20	22	1	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	AUG	2016	44	3					1987	1997		10.1111/ejn.13277			11	Neurosciences	Neurosciences & Neurology	DS9HG	WOS:000381093000008	27177932	Green Published, Other Gold			2021-06-18	
J	Mutch, WAC; Ellis, MJ; Ryner, LN; Morissette, MP; Pries, PJ; Dufault, B; Essig, M; Mikulis, DJ; Duffin, J; Fisher, JA				Mutch, W. Alan C.; Ellis, Michael J.; Ryner, Lawrence N.; Morissette, Marc P.; Pries, Philip J.; Dufault, Brenden; Essig, Marco; Mikulis, David J.; Duffin, James; Fisher, Joseph A.			Longitudinal Brain Magnetic Resonance Imaging CO2 Stress Testing in Individual Adolescent Sports-Related Concussion Patients: A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						sports-related concussion; adolescent; post-concussion syndrome; magnetic resonance imaging; blood oxygen level-dependent imaging; cerebrovascular reactivity; longitudinal	CEREBROVASCULAR REACTIVITY IMPAIRMENT; POSTCONCUSSION SYNDROME; CHILDREN; SYMPTOMS; INJURY; RECOVERY	Background: Advanced neuroimaging studies in concussion have been limited to detecting group differences between concussion patients and healthy controls. In this small pilot study, we used brain magnetic resonance imaging (MRI) CO2 stress testing to longitudinally assess cerebrovascular responsiveness (CVR) in individual sports-related concussion (SRC) patients. Methods: Six SRC patients (three males and three females; mean age = 15.7, range = 15-17 years) underwent longitudinal brain MRI CO2 stress testing using blood oxygen level-dependent (BOLD) MRI and model-based prospective end-tidal CO2 targeting under isoxic conditions. First-level and second-level comparisons were undertaken using statistical parametric mapping (SPM) to score the scans and compare them to an atlas of 24 healthy control subjects. Results: All tests were well tolerated and without any serious adverse events. Anatomical MRI was normal in all study participants. The CO2 stimulus was consistent between the SRC patients and control subjects and within SRC patients across the longitudinal study. Individual SRC patients demonstrated both quantitative and qualitative patient-specific alterations in CVR (p < 0.005) that correlated strongly with clinical findings, and that persisted beyond clinical recovery. Conclusion: Standardized brain MRI CO2 stress testing is capable of providing a longitudinal assessment of CVR in individual SRC patients. Consequently, larger prospective studies are needed to examine the utility of brain MRI CO2 stress testing as a clinical tool to help guide the evaluation, classification, and longitudinal management of SRC patients.	[Mutch, W. Alan C.] Univ Manitoba, Dept Anesthesia & Perioperat Med, Winnipeg, MB, Canada; [Mutch, W. Alan C.; Ellis, Michael J.; Ryner, Lawrence N.; Pries, Philip J.; Dufault, Brenden; Essig, Marco] Univ Manitoba, Winnipeg, MB, Canada; [Mutch, W. Alan C.; Ryner, Lawrence N.; Essig, Marco] Hlth Sci Ctr, Winnipeg, MB, Canada; [Mutch, W. Alan C.; Ellis, Michael J.; Ryner, Lawrence N.; Essig, Marco] Canada North Concuss Network, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Neurosurg Sect, Winnipeg, MB, Canada; [Ellis, Michael J.; Morissette, Marc P.; Essig, Marco] Pan Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Childrens Hosp, Res Inst Manitoba, Winnipeg, MB, Canada; [Ellis, Michael J.; Morissette, Marc P.] Pan Clin Fdn, Winnipeg, MB, Canada; [Ryner, Lawrence N.; Essig, Marco] Univ Manitoba, Dept Radiol, Winnipeg, MB, Canada; [Pries, Philip J.] Univ Manitoba, Coll Med, Winnipeg, MB, Canada; [Dufault, Brenden] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Mikulis, David J.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Mikulis, David J.; Duffin, James; Fisher, Joseph A.] Univ Hlth Network, Cerebrovasc React Res Grp, Toronto, ON, Canada; [Duffin, James; Fisher, Joseph A.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Duffin, James; Fisher, Joseph A.] Univ Toronto, Toronto, ON, Canada; [Fisher, Joseph A.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada	Mutch, WAC (corresponding author), Univ Manitoba, Dept Anesthesia & Perioperat Med, Winnipeg, MB, Canada.; Mutch, WAC (corresponding author), Univ Manitoba, Winnipeg, MB, Canada.; Mutch, WAC (corresponding author), Hlth Sci Ctr, Winnipeg, MB, Canada.; Mutch, WAC (corresponding author), Canada North Concuss Network, Winnipeg, MB, Canada.	wacmutch@shaw.ca	Mikulis, David J/H-5167-2019	Mikulis, David/0000-0003-3956-0892; essig, marco/0000-0002-7964-2297; Morissette, Marc/0000-0002-5342-8938; Duffin, James/0000-0003-2270-7392	Health Sciences Center Foundation; Manitoba Health Research Council; Academic Oversight Committee, Winnipeg, MB, Canada	All phases of this study were supported by grants from the Health Sciences Center Foundation, the Manitoba Health Research Council and the Academic Oversight Committee, Winnipeg, MB, Canada.	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bhogal AA, 2015, NEUROIMAGE, V114, P239, DOI 10.1016/j.neuroimage.2015.04.014; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chan ST, 2015, BRAIN INJURY, V29, P403, DOI 10.3109/02699052.2014.974209; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00061; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Fierstra J, 2013, J PHYSIOL-LONDON, V591, P5809, DOI 10.1113/jphysiol.2013.259150; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132093, 10.3171/2013.12.JNS132090]; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Leung J, 2016, J PHYSIOL-LONDON, V594, P2681, DOI 10.1113/JP271056; Leung J, 2016, J MAGN RESON IMAGING, V43, P1191, DOI 10.1002/jmri.25063; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Mutch WAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102181; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sobczyk O, 2016, AM J NEURORADIOL, V37, P818, DOI 10.3174/ajnr.A4679; Thomas BP, 2013, NEUROIMAGE, V83, P505, DOI 10.1016/j.neuroimage.2013.07.005; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491	41	20	20	0	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 8	2016	7								107	10.3389/fneur.2016.00107			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DQ5AW	WOS:000379217800001	27458426	DOAJ Gold, Green Published			2021-06-18	
J	Lovstad, M; Sigurdardottir, S; Andersson, S; Grane, VA; Moberget, T; Stubberud, J; Solbakk, AK				Lovstad, M.; Sigurdardottir, S.; Andersson, S.; Grane, V. A.; Moberget, T.; Stubberud, J.; Solbakk, A. K.			Behavior Rating Inventory of Executive Function Adult Version in Patients with Neurological and Neuropsychiatric Conditions: Symptom Levels and Relationship to Emotional Distress	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Neuropsychology; Executive functioning; norms; assessment; BRIEF-A; emotional distress; neurological condition; neuropsychiatric condition	TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; BORDERLINE PERSONALITY-DISORDER; PERFORMANCE-BASED MEASURES; BRIEF-A; NEUROPSYCHOLOGICAL TESTS; ECOLOGICAL ASSESSMENT; WORKING-MEMORY; META-STRUCTURE; SELF-REPORT	Objectives: The present study explored the level of self-and informant reported executive functioning in daily living using the Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) in a large sample comprising healthy adults and patient cohorts with neurological and neuropsychiatric disorders. The relationship to neuropsychological test performance and self-reported emotional distress was explored, as well as the applicability of U.S. normative data. Methods: Scores on the self-and informant reported BRIEF-A are presented, along with scores on standardized cognitive tests, and on rating scales of self-reported emotional distress in a Norwegian healthy comparison group (n = 115), patients with severe traumatic brain injury (n = 125), focal frontal lobe damage (n = 29), focal cerebellar lesion (n = 24), Parkinson's disease (n = 42), attention deficit hyperactivity disorder (n = 34), type II bipolar disorder (n = 21), and borderline personality disorder (n = 18). Results: Strong associations were observed between the BRIEF-A and emotional distress in both the healthy group and in neurological groups, while no or weak relationships with IQ and performance-based tests of executive function were seen. The relationship between BRIEF-A and emotional distress was weaker in the neuropsychiatric patient groups, despite high symptom load in both domains. Healthy participants tended to have BRIEF-A scores 1/2-3/4 SD below the U.S. normative mean of T score = 50. Conclusions: The study demonstrates the need to interpret BRIEF-A results within a broad differential diagnostic context, where measures of psychological distress are included in addition to neuropsychological tests. Uncertainty about the appropriateness of U.S. normative data in non-U.S. countries adds to the need for interpretive caution.	[Lovstad, M.; Sigurdardottir, S.; Stubberud, J.] Sunnaas Rehabil Hosp, Res Dept, Nesoddtangen, Norway; [Lovstad, M.; Andersson, S.; Grane, V. A.; Solbakk, A. K.] Univ Oslo, Dept Psychol, N-0316 Oslo, Norway; [Sigurdardottir, S.] Oslo Univ Hosp, Div Surg & Clin Neurosci, Dept Phys Med & Rehabil, Oslo, Norway; [Andersson, S.] Oslo Univ Hosp, Dept Psychosomat Med, N-0450 Oslo, Norway; [Grane, V. A.; Solbakk, A. K.] Helgeland Hosp, Dept Neuropsychol, Mosjoen, Norway; [Moberget, T.] Oslo Univ Hosp, KG Jebsen Ctr Psychosis Res, Norwegian Ctr Mental Disorders Res NORMENT, Div Mental Hlth & Addict, N-0450 Oslo, Norway; [Moberget, T.] Sunnaas Rehabil Hosp, Reg Ctr Knowledge Translat Rehabil, Nesoddtangen, Norway; [Solbakk, A. K.] Natl Hosp Norway, Div Surg & Clin Neurosci, Dept Neurosurg, Oslo Univ Hosp, Oslo, Norway	Lovstad, M (corresponding author), Sunnaas Rehabil Hosp, Bjornemyrvn 11, N-1450 Nesoddtangen, Norway.	marianne.lovstad@sunnaas.no			sTBI: The Research Council of Norway [185267]; PFC: The South-Eastern Norway Regional Health Authority [SUN-001-SS, 2008047]; PFC: Research Council of Norway [186504/V50]; ADHD: The Northern Norway Regional Health Authority [5154/PEP1012-11]; CC: The South-Eastern Norway Regional Health Authority [3b-122]; PD: The South-Eastern Norway Regional Health Authority [2010053]; BP-II/BPD: The South-Eastern Norway Regional Health Authority (Norwegian Research Network On Mood Disorders)	We thank all participants and collaborators. The authors report no conflicts of interest. In addition to the author affiliations, the sub-studies have been funded by: sTBI: The Research Council of Norway (grant 185267). PFC: The South-Eastern Norway Regional Health Authority (grants SUN-001-SS and 2008047) and The Research Council of Norway (grant 186504/V50). ADHD: The Northern Norway Regional Health Authority (grant 5154/PEP1012-11). CC: The South-Eastern Norway Regional Health Authority (grant 3b-122). PD: The South-Eastern Norway Regional Health Authority (grant 2010053). BP-II/BPD: The South-Eastern Norway Regional Health Authority (Norwegian Research Network On Mood Disorders).	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Boen E, 2015, J AFFECT DISORDERS, V170, P104, DOI 10.1016/j.jad.2014.08.033; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Carpenter WT, 2009, PSYCHOL MED, V39, P2025, DOI 10.1017/S0033291709990286; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Delis DC, 2001, EXAMINERS MANUAL DEL; Derogatis L.R, 1994, SYMPTOM CHECKLIST 90; Donders J, 2016, ARCH CLIN NEUROPSYCH, V31, P29, DOI 10.1093/arclin/acv048; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Garlinghouse MA, 2010, SCHIZOPHR RES, V120, P71, DOI 10.1016/j.schres.2010.02.1067; Gioia G.A., 2002, BEHAV RATING INVENTO; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Goldberg DP, 2009, PSYCHOL MED, V39, P2071, DOI 10.1017/S0033291709990304; Grane VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115227; Hadjiefthyvoulou F, 2012, COGN BEHAV NEUROL, V25, P128, DOI 10.1097/WNN.0b013e318261459c; Hanssen KT, 2014, ACTA NEUROL SCAND, V129, P234, DOI 10.1111/ane.12177; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Hovik KT, 2017, J ATTEN DISORD, V21, P811, DOI 10.1177/1087054714550336; Isquith PK, 2014, APPL NEUROPSYCH-CHIL, V3, P197, DOI 10.1080/21622965.2013.870014; Knight R., 2002, PRINCIPLES FRONTAL L, P573, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; Koenigs M., 2006, ORBITOFRONTAL CORTEX, P597; Levine B., 2002, PRINCIPLES FRONTAL L, P448; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Lovstad M, 2012, J COGNITIVE NEUROSCI, V24, P378, DOI 10.1162/jocn_a_00099; MacAllister WS, 2012, CHILD NEUROPSYCHOL, V18, P404, DOI 10.1080/09297049.2011.613812; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Marchetta NDJ, 2008, NEUROPSYCHOLOGY, V22, P74, DOI 10.1037/0894-4105.22.1.74; Matheson L, 2010, WORK, V36, P413, DOI 10.3233/WOR-2010-1043; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Miranda A, 2017, J ATTEN DISORD, V21, P294, DOI 10.1177/1087054713507977; Moberget T, 2015, NEUROPSYCHOLOGIA, V69, P218, DOI 10.1016/j.neuropsychologia.2015.02.007; Narayanan NS, 2013, REV NEUROSCIENCE, V24, P267, DOI 10.1515/revneuro-2013-0004; Niendam TA, 2007, SCHIZOPHR RES, V93, P350, DOI 10.1016/j.schres.2007.03.009; Nigg JT, 2005, J ABNORM PSYCHOL, V114, P706, DOI 10.1037/0021-843X.114.3.706; Pham U, 2015, PARKINSONS DIS-US, V2015, DOI 10.1155/2015/490507; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rabin LA, 2006, ARCH CLIN NEUROPSYCH, V21, P721, DOI 10.1016/j.acn.2006.08.004; Reid RC, 2012, INT J NEUROSCI, V122, P500, DOI 10.3109/00207454.2012.673516; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Roth R.M., 2005, BEHAV RATING INVENTO; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Solsnes AE, 2014, J INT NEUROPSYCH SOC, V20, P506, DOI 10.1017/S1355617714000332; Tamnes CK, 2015, PEDIATR BLOOD CANCER, V62, P1027, DOI 10.1002/pbc.25386; Teunisse JP, 2012, J CLIN EXP NEUROPSYC, V34, P714, DOI 10.1080/13803395.2012.670209; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D, 1997, WAIS 3 ADM SCORING M; Woods SP, 2002, CLIN NEUROPSYCHOL, V16, P12, DOI 10.1076/clin.16.1.12.8336; Zald D. H., 2002, ORBITOFRONTAL CORTEX, P449; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	65	20	20	1	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2016	22	6					682	694		10.1017/S135561771600031X			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	DU8SM	WOS:000382484700011	27126218				2021-06-18	
J	Nordstrom, CH; Nielsen, TH; Schalen, W; Reinstrup, P; Ungerstedt, U				Nordstrom, Carl-Henrik; Nielsen, Troels Halfeld; Schalen, Wilhelm; Reinstrup, Peter; Ungerstedt, Urban			Biochemical indications of cerebral ischaemia and mitochondrial dysfunction in severe brain trauma analysed with regard to type of lesion	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Microdialysis; Ischaemia; Mitochondrial dysfunction; Lactate; Pyruvate; Cytoplasmatic redox	ENERGY-METABOLISM; PERFUSION-PRESSURE; INTRACEREBRAL MICRODIALYSIS; SUBARACHNOID HEMORRHAGE; GLYCOLYTIC METABOLITES; INTRACRANIAL-PRESSURE; BEDSIDE DIAGNOSIS; CYCLOSPORINE-A; AMINO-ACIDS; INJURY	The study focuses on three questions related to the clinical usefulness of microdialysis in severe brain trauma: (1) How frequently is disturbed cerebral energy metabolism observed in various types of lesions? (2) How often does the biochemical pattern indicate cerebral ischaemia and mitochondrial dysfunction? (3) How do these patterns relate to mortality? The study includes 213 consecutive patients with severe brain trauma (342 intracerebral microdialysis catheters). The patients were classified into four groups according to the type of lesion: extradural haematoma (EDH), acute subdural haematoma (SDH), cerebral haemorrhagic contusion (CHC) and no mass lesion (NML). Altogether about 150,000 biochemical analyses were performed during the initial 96 h after trauma. Compromised aerobic metabolism occurred during 38 % of the study period. The biochemical pattern indicating mitochondrial dysfunction was more common than that of ischaemia. In EDH and NML aerobic metabolism was generally close to normal. In SDH or CHC it was often severely compromised. Mortality was increased in SDH with impaired aerobic metabolism, while CHC did not exhibit a similar relation. Compromised energy metabolism is most frequent in patients with SDH and CHC (32 % and 49 % of the study period, respectively). The biochemical pattern of mitochondrial dysfunction is more common than that of ischaemia (32 % and 6 % of the study period, respectively). A correlation between mortality and biochemical data is obtained provided the microdialysis catheter is placed in an area where energy metabolism reflects tissue outcome in a large part of the brain.	[Nordstrom, Carl-Henrik; Nielsen, Troels Halfeld] Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense, Denmark; [Schalen, Wilhelm; Reinstrup, Peter; Ungerstedt, Urban] Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden	Nordstrom, CH (corresponding author), Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense, Denmark.	carl-henrik.nordstrom@med.lu.se	Nielsen, Troels Halfeld/G-3456-2015	Nielsen, Troels Halfeld/0000-0002-3943-8128			Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Dienel GA, 2014, J CEREBR BLOOD F MET, V34, P1736, DOI 10.1038/jcbfm.2014.153; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Jacobsen A, 2014, ACTA NEUROL SCAND, V130, P156, DOI 10.1111/ane.12258; Jacobsen R, 2016, INTENSIVE CARE MED E, V4, P3; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MACMILLAN VH, 1989, J CEREBR BLOOD F MET, V9, P156, DOI 10.1038/jcbfm.1989.23; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Nielsen TH, 2014, NEUROCRIT CARE, V21, P35, DOI 10.1007/s12028-013-9875-5; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; NORDSTROM CH, 1978, J NEUROCHEM, V30, P479, DOI 10.1111/j.1471-4159.1978.tb06553.x; NORDSTROM CH, 1978, STROKE, V9, P335, DOI 10.1161/01.STR.9.4.335; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Reinstrup P, 2011, NEUROCRIT CARE, V14, P441, DOI 10.1007/s12028-010-9486-3; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; SIESJO BK, 1978, BRAIN ENERGY METABOL, P192; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; TEASDALE G, 1974, LANCET, V2, P81; Thelin EP, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00159; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; UNGERSTEDT U, 1974, B SCHWEIZ AKAD MED, V30, P44; Ungerstedt U, 1997, PHYSIOLOGY, STRESS, AND MALNUTRITION, P361; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	36	20	21	0	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2016	158	7					1231	1240		10.1007/s00701-016-2835-z			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DO3YX	WOS:000377719800001	27188288				2021-06-18	
J	Hopp, S; Albert-Weissenberger, C; Mencl, S; Bieber, M; Schuhmann, MK; Stetter, C; Nieswandt, B; Schmidt, PM; Monoranu, CM; Alafuzoff, I; Marklund, N; Nolte, MW; Siren, AL; Kleinschnitz, C				Hopp, Sarah; Albert-Weissenberger, Christiane; Mencl, Stine; Bieber, Michael; Schuhmann, Michael K.; Stetter, Christian; Nieswandt, Bernhard; Schmidt, Peter M.; Monoranu, Camelia-Maria; Alafuzoff, Irina; Marklund, Niklas; Nolte, Marc W.; Siren, Anna-Leena; Kleinschnitz, Christoph			Targeting Coagulation Factor XII as a Novel Therapeutic Option in Brain Trauma	ANNALS OF NEUROLOGY			English	Article							MOLECULAR-WEIGHT HEPARIN; THROMBUS FORMATION; CEREBRAL-ISCHEMIA; IN-VIVO; INTRAVASCULAR COAGULATION; HEMODYNAMIC DEPRESSION; HEAD-INJURY; RATS; MICE; MODEL	Objective: Traumatic brain injury is a major global public health problem for which specific therapeutic interventions are lacking. There is, therefore, a pressing need to identify innovative pathomechanism-based effective therapies for this condition. Thrombus formation in the cerebral microcirculation has been proposed to contribute to secondary brain damage by causing pericontusional ischemia, but previous studies have failed to harness this finding for therapeutic use. The aim of this study was to obtain preclinical evidence supporting the hypothesis that targeting factor XII prevents thrombus formation and has a beneficial effect on outcome after traumatic brain injury. Methods: We investigated the impact of genetic deficiency of factor XII and acute inhibition of activated factor XII with a single bolus injection of recombinant human albumin-fused infestin-4 (rHA-Infestin-4) on trauma-induced microvascular thrombus formation and the subsequent outcome in 2 mouse models of traumatic brain injury. Results: Our study showed that both genetic deficiency of factor XII and an inhibition of activated factor XII in mice minimize trauma-induced microvascular thrombus formation and improve outcome, as reflected by better motor function, reduced brain lesion volume, and diminished neurodegeneration. Administration of human factor XII in factor XII-deficient mice fully restored injury-induced microvascular thrombus formation and brain damage. Interpretation: The robust protective effect of rHA-Infestin-4 points to a novel treatment option that can decrease ischemic injury after traumatic brain injury without increasing bleeding tendencies.	[Hopp, Sarah; Albert-Weissenberger, Christiane; Mencl, Stine; Bieber, Michael; Schuhmann, Michael K.; Kleinschnitz, Christoph] Univ Hosp Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany; [Hopp, Sarah; Albert-Weissenberger, Christiane; Stetter, Christian; Siren, Anna-Leena] Univ Hosp Wurzburg, Dept Neurosurg, D-97080 Wurzburg, Germany; [Bieber, Michael] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr DZHI, D-97080 Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, German Res Soc, Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Schmidt, Peter M.] CSL Ltd, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia; [Monoranu, Camelia-Maria] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Inst Pathol, Dept Neuropathol, D-97070 Wurzburg, Germany; [Alafuzoff, Irina] Uppsala Univ, Dept Immunol, Uppsala, Sweden; [Alafuzoff, Irina] Uppsala Univ, Dept Pathol, Uppsala, Sweden; [Marklund, Niklas] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Nolte, Marc W.] CSL Behring, Marburg, Germany	Kleinschnitz, C (corresponding author), Univ Hosp Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	christoph.kleinschnitz@uni-wuerzburg.de	Siren, Anna-Leena/AAE-1374-2019; Schmidt, Peter/V-3882-2019	Siren, Anna-Leena/0000-0002-2217-0081; Schmidt, Peter/0000-0003-1340-9086; Bieber, Michael/0000-0002-5535-6480; Kleinschnitz, Christoph/0000-0002-1650-8875; Marklund, Niklas/0000-0002-9797-5626	CSL Behring, Germany; Else Kroner-Fresenius Foundation, Germany; German Research FoundationGerman Research Foundation (DFG) [SFB 688 TP A13]; German Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF 01EW1502B]; Interdisciplinary Clinical Research Center Wurzburg [E-313]	This work was supported by CSL Behring, Germany, the Else Kroner-Fresenius Foundation, Germany, the German Research Foundation (SFB 688 TP A13), the German Federal Ministry of Education and Research under the framework of EU-ERA-NET NEURON CnsAFlame (BMBF 01EW1502B), and the Interdisciplinary Clinical Research Center Wurzburg (E-313).	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Albert-Weissenberger C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00269; Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; Chelladurai Yohalakshmi, 2013, F1000Res, V2, P132, DOI 10.12688/f1000research.2-132.v1; Chen JW, 2012, JACC-CARDIOVASC IMAG, V5, P1127, DOI 10.1016/j.jcmg.2012.01.025; Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918; Choudhri TF, 1997, STROKE, V28, P2296, DOI 10.1161/01.STR.28.11.2296; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Franchini M, 2006, HEMATOLOGY, V11, P307, DOI 10.1080/10245330600921964; Gailani D, 1997, BLOOD COAGUL FIBRIN, V8, P134, DOI 10.1097/00001721-199703000-00008; Hagedorn I, 2010, CIRCULATION, V121, P1510, DOI 10.1161/CIRCULATIONAHA.109.924761; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; HUBER A, 1993, INT J LEGAL MED, V106, P152, DOI 10.1007/BF01225238; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kim Luke, 2014, J Emerg Trauma Shock, V7, P141, DOI 10.4103/0974-2700.136846; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315; Lafuente JV, 1999, J NEUROTRAUM, V16, P425, DOI 10.1089/neu.1999.16.425; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/0897715042664885; Maeda T, 1997, ACT NEUR S, V70, P102; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Matafonov A, 2014, BLOOD, V123, P1739, DOI 10.1182/blood-2013-04-499111; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shen X, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000077; Shiina G, 1998, AM J NEURORADIOL, V19, P297; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; VANDERSANDE JJ, 1981, J NEUROSURG, V54, P21, DOI 10.3171/jns.1981.54.1.0021; Wright DW, 2014, ACAD EMERG MED, V21, P1414, DOI 10.1111/acem.12532	45	20	21	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	JUN	2016	79	6					970	982		10.1002/ana.24655			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DN0ST	WOS:000376775400011	27043916	Green Published, Other Gold			2021-06-18	
J	Hubscher, CH; Montgomery, LR; Fell, JD; Armstrong, JE; Poudyal, P; Herrity, AN; Harkema, SJ				Hubscher, Charles H.; Montgomery, Lynnette R.; Fell, Jason D.; Armstrong, James E.; Poudyal, Pradeepa; Herrity, April N.; Harkema, Susan J.			Effects of exercise training on urinary tract function after spinal cord injury	AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY			English	Article						bladder; kidney; locomotor training; contusion	MALE SEXUAL FUNCTION; H-REFLEX; VENTROLATERAL FUNICULUS; MECHANICAL-PROPERTIES; MOTONEURON PROPERTIES; LOCOMOTOR-ACTIVITY; NEURAL CIRCUITS; RENAL-FUNCTION; FOLLOW-UP; T-CELLS	Spinal cord injury (SCI) causes dramatic changes in the quality of life, including coping with bladder dysfunction which requires repeated daily and nightly catheterizations. Our laboratory has recently demonstrated in a rat SCI model that repetitive sensory information generated through task-specific stepping and/or loading can improve nonlocomotor functions, including bladder function (Ward PJ, Herrity AN, Smith RR, Willhite A, Harrison BJ, Petruska JC, Harkema SJ, Hubscher CH. J Neurotrauma 31: 819- 833, 2014). To target potential underlying mechanisms, the current study included a forelimb-only exercise group to ascertain whether improvements may be attributed to general activity effects that impact target organ-neural interactions or to plasticity of the lumbosacral circuitry that receives convergent somatovisceral inputs. Male Wistar rats received a T9 contusion injury and were randomly assigned to three groups 2 wk postinjury: quadrupedal locomotion, forelimb exercise, or a nontrained group. Throughout the study (including preinjury), all animals were placed in metabolic cages once a week for 24 h to monitor water intake and urine output. Following the 10-wk period of daily 1-h treadmill training, awake cystometry data were collected and bladder and kidney tissue harvested for analysis. Metabolic cage frequency-volume measurements of voiding and cystometry reveal an impact of exercise training on multiple SCI-induced impairments related to various aspects of urinary tract function. Improvements in both the quadrupedal and forelimb-trained groups implicate underlying mechanisms beyond repetitive sensory information from the hindlimbs driving spinal network excitability of the lumbosacral urogenital neural circuitry. Furthermore, the impact of exercise training on the upper urinary tract (kidney) underscores the health benefit of activity-based training on the entire urinary system within the SCI population.	[Hubscher, Charles H.; Montgomery, Lynnette R.; Fell, Jason D.; Armstrong, James E.; Poudyal, Pradeepa] Univ Louisville, Dept Anat Sci & Neurobiol, 511 S Floyd St, Louisville, KY 40202 USA; [Hubscher, Charles H.; Montgomery, Lynnette R.; Herrity, April N.; Harkema, Susan J.] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40202 USA; [Herrity, April N.; Harkema, Susan J.] Univ Louisville, Frazier Rehab Inst, Louisville, KY 40202 USA; [Harkema, Susan J.] Univ Louisville, Dept Neurol Surg, Louisville, KY 40202 USA	Hubscher, CH (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, 511 S Floyd St, Louisville, KY 40202 USA.	chhubs01@louisville.edu			Department of Defense GrantUnited States Department of Defense [W81XWH-11-1-0668]; National Institutes of Health/National Center for Research Resources Grant [P30 8P30GM103507]	This study was supported by Department of Defense Grant W81XWH-11-1-0668. This project utilized KSCIRC Neuroscience Core facilities supported by National Institutes of Health/National Center for Research Resources Grant P30 8P30GM103507.	Abbate M, 2002, AM J PATHOL, V161, P2179, DOI 10.1016/S0002-9440(10)64495-1; Anderson KD, 2007, SPINAL CORD, V45, P328, DOI 10.1038/sj.sc.3101977; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Balsara ZR, 2013, INFECT IMMUN, V81, P3018, DOI 10.1128/IAI.00255-13; Basoni C, 2005, FASEB J, V19, P822, DOI 10.1096/fj.04-3085fje; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beaumont E, 2008, NEUROSCI RES, V62, P147, DOI 10.1016/j.neures.2008.07.003; Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; Behrman AL, 2005, PHYS THER, V85, P1356, DOI 10.1093/ptj/85.12.1356; BIYANI A, 1993, INJURY, V24, P671, DOI 10.1016/0020-1383(93)90318-Z; BORDER WA, 1990, KIDNEY INT, V37, P689, DOI 10.1038/ki.1990.35; Button DC, 2008, J PHYSIOL-LONDON, V586, P529, DOI 10.1113/jphysiol.2007.141499; CARDENAS DD, 1995, ARCH PHYS MED REHAB, V76, P272, DOI 10.1016/S0003-9993(95)80615-6; CARP JS, 1994, J NEUROPHYSIOL, V72, P431; Cha J, 2007, J NEUROTRAUM, V24, P1000, DOI 10.1089/neu.2006.0233; Colombo G, 1998, ANN NY ACAD SCI, V860, P536, DOI 10.1111/j.1749-6632.1998.tb09097.x; COPE TC, 1986, J NEUROPHYSIOL, V55, P1202; de Groat W C, 1997, Adv Neurol, V72, P347; de Groat WC, 1998, BEHAV BRAIN RES, V92, P127, DOI 10.1016/S0166-4328(97)00185-X; DENNY-BROWN D., 1933, BRAIN, V56, P397, DOI 10.1093/brain/56.4.397; Dietz V, 2004, J APPL PHYSIOL, V96, P1954, DOI 10.1152/japplphysiol.00942.2003; Dietz V, 1997, TRENDS NEUROSCI, V20, P346; DIETZ V, 1987, J PHYSIOL-LONDON, V386, P149, DOI 10.1113/jphysiol.1987.sp016527; DIETZ V, 1994, LANCET, V344, P1260, DOI 10.1016/S0140-6736(94)90751-X; Dietz V, 1998, SPINAL CORD, V36, P380, DOI 10.1038/sj.sc.3100590; Ditunno PL, 2008, SPINAL CORD, V46, P500, DOI 10.1038/sj.sc.3102172; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Edgerton V R, 1991, J Am Paraplegia Soc, V14, P150; Ferrero SL, 2015, J NEUROTRAUM, V32, P200, DOI 10.1089/neu.2013.3247; Fischer MJ, 2012, AM J NEPHROL, V36, P542, DOI 10.1159/000345460; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P269, DOI 10.1111/j.1748-1716.1980.tb06533.x; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Furlan JC, 2009, SPINE, V34, P501, DOI 10.1097/BRS.0b013e31819712f5; Gardiner PF, 2006, EXERC SPORT SCI REV, V34, P54, DOI 10.1249/00003677-200604000-00003; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Gloeckner DC, 2002, J UROLOGY, V167, P2247, DOI 10.1016/S0022-5347(05)65137-3; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Goumenos DS, 2002, NEPHROL DIAL TRANSPL, V17, P2145, DOI 10.1093/ndt/17.12.2145; Grau JW, 2004, J NEUROTRAUM, V21, P1795, DOI 10.1089/neu.2004.21.1795; Gupta DS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00028; Hall BJ, 2010, J PAIN, V11, P864, DOI 10.1016/j.jpain.2009.12.008; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1588, DOI 10.1016/j.apmr.2012.04.032; Hew-Butler T, 2010, BRIT J SPORT MED, V44, P710, DOI 10.1136/bjsm.2008.051771; Horst M, 2013, J UROLOGY, V189, P747, DOI 10.1016/j.juro.2012.08.200; Hubscher C, 2015, 2015 ABSTRACT VIEWER; Hubscher CH, 2013, J NEUROPHYSIOL, V110, P1997, DOI 10.1152/jn.00297.2013; Hubscher CH, 2006, EXP NEUROL, V197, P177, DOI 10.1016/j.expneurol.2005.09.007; Hubscher CH, 1999, J NEUROPHYSIOL, V82, P1381; Hubscher CH, 2000, J NEUROPHYSIOL, V83, P2508; Jayaraman A, 2008, J SPINAL CORD MED, V31, P185, DOI 10.1080/10790268.2008.11760710; JOLESZ FA, 1982, SCIENCE, V216, P1243, DOI 10.1126/science.7200635; Kaddumi EG, 2006, J PHYSIOL-LONDON, V572, P393, DOI 10.1113/jphysiol.2005.102574; KHOKHAR AM, 1978, J ENDOCRINOL, V79, P375, DOI 10.1677/joe.0.0790375; Kilinc S, 1999, SPINAL CORD, V37, P332, DOI 10.1038/sj.sc.3100814; Kliesch WF, 1996, PARAPLEGIA, V34, P82, DOI 10.1038/sc.1996.14; Knikou M, 2009, INT J NEUROSCI, V119, P2056, DOI 10.1080/00207450903139747; Ku JH, 2005, UROL RES, V33, P435, DOI 10.1007/s00240-005-0504-4; KUHLEMEIER KV, 1984, J UROLOGY, V131, P439, DOI 10.1016/S0022-5347(17)50441-3; Leicht CA, 2013, EXERC IMMUNOL REV, V19, P144; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; MAGGI CA, 1986, J PHARMACOL METHOD, V15, P157, DOI 10.1016/0160-5402(86)90064-1; MAI J, 1976, ACTA NEUROL SCAND, V53, P395, DOI 10.1111/j.1600-0404.1976.tb04358.x; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; NIELSEN J, 1993, EXP BRAIN RES, V97, P173; Pagliacci MC, 2007, SPINAL CORD, V45, P404, DOI 10.1038/sj.sc.3101991; PEDERSEN E, 1986, J NEUROL NEUROSUR PS, V49, P273, DOI 10.1136/jnnp.49.3.273; PERUZZI WT, 1994, CRIT CARE MED, V22, P252, DOI 10.1097/00003246-199402000-00016; RABB H, 1994, AM J PHYSIOL-RENAL, V267, pF1052; Reed WR, 2009, BRAIN RES, V1302, P76, DOI 10.1016/j.brainres.2009.09.049; Rodriguez-Romero V, 2013, SPINAL CORD, V51, P528, DOI 10.1038/sc.2013.35; SATO A, 1977, NEUROSCIENCE, V2, P111, DOI 10.1016/0306-4522(77)90072-0; Schalow G, 2010, Electromyogr Clin Neurophysiol, V50, P155; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Shirreffs SM, 2004, BRIT J NUTR, V91, P951, DOI 10.1079/BJN20041149; Skinner RD, 1996, BRAIN RES, V729, P127, DOI 10.1016/S0006-8993(96)00556-2; Smith RR, 2009, J NEUROTRAUM, V26, P1017, DOI [10.1089/neu.2008.0829, 10.1089/neu.2008-0829]; Stover SL, 1999, ARCH PHYS MED REHAB, V80, P1365, DOI 10.1016/S0003-9993(99)90246-0; Tai CF, 2006, RESTOR NEUROL NEUROS, V24, P69; Timoszyk WK, 2005, BRAIN RES, V1050, P180, DOI 10.1016/j.brainres.2005.05.041; Toosi KK, 2008, ANN BIOMED ENG, V36, P1470, DOI 10.1007/s10439-008-9525-9; Trimble M H, 2001, J Spinal Cord Med, V24, P74; VISINTIN M, 1994, PARAPLEGIA, V32, P540, DOI 10.1038/sc.1994.86; Vizzard MA, 2006, PROG BRAIN RES, V152, P97, DOI 10.1016/S0079-6123(05)52007-7; WADE CE, 1984, MED SCI SPORT EXER, V16, P506, DOI 10.1249/00005768-198410000-00015; WADE CE, 1980, J APPL PHYSIOL, V49, P930; Wang J, 2012, SCAND J MED SCI SPOR, V22, P643, DOI 10.1111/j.1600-0838.2010.01288.x; Ward PJ, 2014, J NEUROTRAUM, V31, P819, DOI 10.1089/neu.2013.3082; Ward PJ, 2012, J NEUROTRAUM, V29, P2490, DOI 10.1089/neu.2012.2402; Yoshiyama M, 1999, UROLOGY, V54, P929, DOI 10.1016/S0090-4295(99)00234-4; Yoshiyama M, 2013, AM J PHYSIOL-RENAL, V304, pF390, DOI 10.1152/ajprenal.00574.2012; Yu L, 2003, KIDNEY INT, V64, P844, DOI 10.1046/j.1523-1755.2003.00162.x; Zhou TB, 2012, RENAL FAILURE, V34, P194, DOI 10.3109/0886022X.2011.643364; Zinck NDT, 2007, EXP NEUROL, V204, P777, DOI 10.1016/j.expneurol.2007.01.011	96	20	20	0	12	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	1931-857X	1522-1466		AM J PHYSIOL-RENAL	Am. J. Physiol.-Renal Physiol.	JUN 1	2016	310	11					F1258	F1268		10.1152/ajprenal.00557.2015			11	Physiology; Urology & Nephrology	Physiology; Urology & Nephrology	DN9YM	WOS:000377436600014	26984956	Green Published, Bronze			2021-06-18	
J	Kontos, AP; Reches, A; Elbin, RJ; Dickman, D; Laufer, I; Geva, AB; Shacham, G; DeWolf, R; Collins, MW				Kontos, Anthony P.; Reches, Amit; Elbin, R. J.; Dickman, Dalia; Laufer, Ilan; Geva, Amir B.; Shacham, Galit; DeWolf, Ryan; Collins, Michael W.			Preliminary evidence of reduced brain network activation in patients with post-traumatic migraine following concussion	BRAIN IMAGING AND BEHAVIOR			English	Article						Sport-related concussion; Brain network activation; Electroencephalography; Post-traumatic migraine	EVENT-RELATED POTENTIALS; HIGH-SCHOOL; RESPONSE-INHIBITION; EVOKED-POTENTIALS; RECOVERY; SPORT; IMPACT; OSCILLATIONS; IMPAIRMENT; PREDICTORS	Post-traumatic migraine (PTM) (i.e., headache, nausea, light and/or noise sensitivity) is an emerging risk factor for prolonged recovery following concussion. Concussions and migraine share similar pathophysiology characterized by specific ionic imbalances in the brain. Given these similarities, patients with PTM following concussion may exhibit distinct electrophysiological patterns, although researchers have yet to examine the electrophysiological brain activation in patients with PTM following concussion. A novel approach that may help differentiate brain activation in patients with and without PTM is brain network activation (BNA) analysis. BNA involves an algorithmic analysis applied to multichannel EEG-ERP data that provides a network map of cortical activity and quantitative data during specific tasks. A prospective, repeated measures design was used to evaluate BNA (during Go/NoGo task), EEG-ERP, cognitive performance, and concussion related symptoms at 1, 2, 3, and 4 weeks post-injury intervals among athletes with a medically diagnosed concussion with PTM (n=15) and without (NO-PTM) (n=22); and age, sex, and concussion history matched controls without concussion (CONTROL) (n=20). Participants with PTM had significantly reduced BNA compared to NO-PTM and CONTROLS for Go and NoGo components at 3 weeks and for NoGo component at 4 weeks post-injury. The PTM group also demonstrated a more prominent deviation of network activity compared to the other two groups over a longer period of time. The composite BNA algorithm may be a more sensitive measure of electrophysiological change in the brain that can augment established cognitive assessment tools for detecting impairment in individuals with PTM.	[Kontos, Anthony P.; DeWolf, Ryan; Collins, Michael W.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA; [Reches, Amit; Dickman, Dalia; Laufer, Ilan; Geva, Amir B.; Shacham, Galit] ElMindA Ltd, Tel Aviv, Israel; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA	Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu		Geva, Amir/0000-0003-3159-3673; Kontos, Anthony/0000-0002-3749-4310	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01 DC012332] Funding Source: Medline		Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Brier MR, 2010, INT J PSYCHOPHYSIOL, V78, P215, DOI 10.1016/j.ijpsycho.2010.07.011; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buodo G, 2004, CEPHALALGIA, V24, P554, DOI 10.1111/j.1468-2982.2003.00716.x; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chen W, 2007, CEPHALALGIA, V27, P139, DOI 10.1111/j.1468-2982.2006.01256.x; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Coppola G, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-20; Coppola G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-91; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fisher T, 2011, CLIN NEUROPHYSIOL, V122, P2390, DOI 10.1016/j.clinph.2011.05.010; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kawamata M, 2007, CLIN EEG NEUROSCI, V38, P193, DOI 10.1177/155005940703800403; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; LINDEN RD, 1987, ELECTROEN CLIN NEURO, V66, P145; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Morlet D, 2014, CLIN NEUROPHYSIOL, V125, P500, DOI 10.1016/j.clinph.2013.05.032; Reches A, 2014, NEUROIMAGE, V88, P228, DOI 10.1016/j.neuroimage.2013.11.020; Reches A, 2014, J MOL NEUROSCI, V54, P59, DOI 10.1007/s12031-014-0250-6; Shahaf G, 2012, CLIN NEUROPHYSIOL, V123, P1568, DOI 10.1016/j.clinph.2011.12.010; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Wang W, 1998, CEPHALALGIA, V18, P261, DOI 10.1046/j.1468-2982.1998.1805261.x	44	20	21	2	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2016	10	2					594	603		10.1007/s11682-015-9412-6			10	Neuroimaging	Neurosciences & Neurology	DU7JK	WOS:000382390000025	26091725	Green Accepted			2021-06-18	
J	Ritter, AC; Kammerer, CM; Brooks, MM; Conley, YP; Wagner, AK				Ritter, Anne C.; Kammerer, Candace M.; Brooks, Maria M.; Conley, Yvette P.; Wagner, Amy K.			Genetic variation in neuronal glutamate transport genes and associations with posttraumatic seizure	EPILEPSIA			English	Article						Traumatic brain injury; Epileptogenesis; Posttraumatic epilepsy; SLC1A1; SLC1A6	TRAUMATIC BRAIN-INJURY; CYSTEINE UPTAKE; EPILEPSY; EXPRESSION; HIPPOCAMPAL; EAAT4; REHABILITATION; EXCITOTOXICITY; LOCALIZATION; EAAT3/EAAC1	Objective: Posttraumatic seizures (PTS) commonly occur following severe traumatic brain injury (sTBI). Risk factors for PTS have been identified, but variability in who develops PTS remains. Excitotoxicity may influence epileptogenesis following sTBI. Glutamate transporters manage glutamate levels and excitatory neurotransmission, and they have been associated with both epilepsy and TBI. Therefore, we aimed to determine if genetic variation in neuronal glutamate transporter genes is associated with accelerated epileptogenesis and increased PTS risk after sTBI. Methods: Individuals (N = 253) 18-75 years of age with sTBI were assessed for genetic relationships with PTS. Single nucleotide polymorphisms (SNPs) within SLC1A1 and SLC1A6 were assayed. Kaplan-Meier estimates and log-rank statistics were used to compare seizure rates from injury to 3 years postinjury for SNPs by genotype. Hazard ratios (HRs) were estimated using Cox proportional hazards regression for SNPs significant in Kaplan-Meier analyses adjusting for known PTS risk factors. Results: Thirty-two tagging SNPs were examined (SLC1A1: n = 28, SLC1A6: n = 4). Forty-nine subjects (19.37%) had PTS. Of these, 18 (36.7%) seized within 7 days, and 31 (63.3%) seized between 8 days and 3 years post-TBI. With correction for multiple comparisons, genotypes at SNP rs10974620 (SLC1A1) were significantly associated with time to first seizure across the full 3-year follow-up (seizure rates: 77.1% minor allele homozygotes, 24.8% heterozygotes, 16.6% major allele homozygotes; p = 0.001). When seizure follow-up began day 2 postinjury, genotypes at SNP rs7858819 (SLC1A1) were significantly associated with PTS risk (seizure rates: 52.7% minor allele homozygotes, 11.8% heterozygotes, 21.1% major allele homozygotes; p = 0.002). After adjusting for covariates, we found that rs10974620 remained significant (p = 0.017, minor allele versus major allele homozygotes HR 3.4, 95% confidence interval [ CI] 1.3-9.3). rs7858819 also remained significant in adjusted models (p = 0.023, minor allele versus major allele homozygotes HR 3.4, 95% CI 1.1-10.5). Significance: Variations within SLC1A1 are associated with risk of epileptogenesis following sTBI. Future studies need to confirm findings, but variation within neuronal glutamate transporter genes may represent a possible pharmaceutical target for PTS prevention and treatment.	[Ritter, Anne C.; Brooks, Maria M.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Ritter, Anne C.; Wagner, Amy K.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA USA; [Kammerer, Candace M.] Univ Pittsburgh, Human Genet, Pittsburgh, PA USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Hlth Promot & Human Genet, Pittsburgh, PA USA; [Conley, Yvette P.; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA	Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		Brooks, Maria/0000-0002-2030-7873; Kammerer, Candace M/0000-0002-2841-4761; Conley, Yvette/0000-0002-1784-6067	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD048162, DODW81XWH-071-0701, NIH R01NR013342]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013342, R01NR008424] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health (NIH) R01HD048162, DODW81XWH-071-0701, and NIH R01NR013342. Thanks to Sandra Deslouches for support with genotyping and the subjects and their families for their generous participation. Thanks to the UPMC Trauma Registry for assisting with some elements of data collection.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bianchi MG, 2014, CELL MOL LIFE SCI, V71, P2001, DOI 10.1007/s00018-013-1484-0; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chen YM, 2003, J NEUROCHEM, V84, P1332, DOI 10.1046/j.1471-4159.2003.01630.x; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Coco S, 1997, EUR J NEUROSCI, V9, P1902, DOI 10.1111/j.1460-9568.1997.tb00757.x; Crino PB, 2002, EPILEPSIA, V43, P211, DOI 10.1046/j.1528-1157.2002.35001.x; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; Diamond ML, 2015, EPILEPSIA, V56, P1198, DOI 10.1111/epi.13044; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Doi T, 2009, NEUROCHEM RES, V34, P1324, DOI 10.1007/s11064-009-9912-0; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Furuta A, 2003, AM J PATHOL, V163, P779, DOI 10.1016/S0002-9440(10)63705-4; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Himi T, 2003, J NEURAL TRANSM, V110, P1337, DOI 10.1007/s00702-003-0049-z; Hu WH, 2003, GLIA, V44, P13, DOI 10.1002/glia.10268; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nieoullon A, 2006, J NEUROCHEM, V98, P1007, DOI 10.1111/j.1471-4159.2006.03978.x; Obrenovitch TP, 2000, INT J DEV NEUROSCI, V18, P281, DOI 10.1016/S0736-5748(99)00096-9; Proper EA, 2002, BRAIN, V125, P32, DOI 10.1093/brain/awf001; Rakhade SN, 2008, EPILEPSIA, V49, P226, DOI 10.1111/j.1528-1167.2007.01310.x; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0; Stewart SE, 2007, AM J MED GENET B, V144B, P1027, DOI 10.1002/ajmg.b.30533; Stichter JP, 2010, J AUTISM DEV DISORD, V40, P1067, DOI [10.1007/s10803-010-0959-1, 10.1007/s10803-010-0961-7]; Wendland JR, 2009, ARCH GEN PSYCHIAT, V66, P408, DOI 10.1001/archgenpsychiatry.2009.6; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; Yamamoto T, 1999, ACT NEUR S, V75, P17; Yamashita A, 2006, NEUROSCI RES, V55, P264, DOI 10.1016/j.neures.2006.03.007; Yi JH, 2007, BRAIN RES, V1154, P200, DOI 10.1016/j.brainres.2007.04.011; Zhang JP, 2014, 8TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING (ICBBE 2014), P1; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	45	20	21	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	JUN	2016	57	6					984	993		10.1111/epi.13397			10	Clinical Neurology	Neurosciences & Neurology	DR8MD	WOS:000380151100018	27153812	Green Accepted, Bronze			2021-06-18	
J	Whiting, SW; Potenza, MN; Park, CL; Mckee, SA; Mazure, CM; Hoff, RA				Whiting, Seth W.; Potenza, Marc N.; Park, Crystal L.; Mckee, Sherry A.; Mazure, Carolyn M.; Hoff, Rani A.			Investigating Veterans' Pre-, Peri-, and Post-Deployment Experiences as Potential Risk Factors for Problem Gambling	JOURNAL OF BEHAVIORAL ADDICTIONS			English	Article						deployment experiences; gambling; military; veterans	SEEKING PATHOLOGICAL GAMBLERS; PSYCHIATRIC COMORBIDITY; GENDER-DIFFERENCES; SOCIAL SUPPORT; PREVALENCE; DISORDERS; MILITARY; HEALTH; AFGHANISTAN; BEHAVIOR	Background and aims: Gambling disorder and its comorbid diagnoses are observed at higher rates in military veterans than in the general population. A significant research gap exists regarding the relationships of veterans' life and service experiences to problematic gambling. The present study explored pre-, peri-, and post-deployment factors associated with problem gambling in veterans.Methods: Veterans of Operation Iraqi Freedom, Operation Enduring Freedom, and Operation New Dawn (n = 738; 463 males, and 275 females) completed questionnaires via structured telephone interview. We conducted bivariate and multinomial logistic regression analyses exploring associations among problem-gambling severity and socio-demographic variables, psychiatric comorbidities, and 10 scales of the Deployment Risk and Resilience Inventory measuring experiences pre-, peri-, and post-deployment. Results: Approximately 4.2% of veterans indicated at-risk or probable pathological gambling (ARPG) postdeployment (two or more DSM-IV criteria for pathological gambling). Bivariate analyses found more severe gambling in males, higher frequencies of post-traumatic stress disorder, substance dependence, traumatic brain injury, panic disorder, and depression in veterans with ARPG, and higher general harassment during deployment, and lower social support and more stressful life events post-deployment in those with ARPG. In multivariable models, both post-deployment factors remained significantly associated with ARPG. Discussion: The study suggests that problem gambling among veterans is related to service experiences, and particularly to life experiences post-deployment. Conclusions: Adverse service and life experiences and lack of social support may contribute to the risk of problem gambling in military veterans. Investigation of how Veterans Affairs clinical settings may serve veterans following deployment to prevent behavioral addictions is warranted.	[Whiting, Seth W.; Hoff, Rani A.] VISN 1 Mental Illness Res Educ & Clin Ctr MIRECC, Dept Vet Affairs, West Haven, CT USA; [Whiting, Seth W.; Potenza, Marc N.; Mckee, Sherry A.; Mazure, Carolyn M.; Hoff, Rani A.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Potenza, Marc N.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Potenza, Marc N.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Park, Crystal L.] Univ Connecticut, Dept Psychol, Storrs, CT USA	Hoff, RA (corresponding author), NEPEC-182,950 Campbell Ave, West Haven, CT 06416 USA.	Rani.hoff@va.gov					American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Black DW, 1998, PSYCHIATR SERV, V49, P1434, DOI 10.1176/ps.49.11.1434; Boardman B., 2007, J SOCIO-ECON, V36, P789, DOI [10.1016/j.socec.2007.01.012, DOI 10.1016/J.SOCEC.2007.01.012]; BRAY RM, 1999, 1998 DEP DEFENSE SUR; Crockford DN, 1998, CAN J PSYCHIAT, V43, P43, DOI 10.1177/070674379804300104; Desai RA, 2008, SOC PSYCH PSYCH EPID, V43, P173, DOI 10.1007/s00127-007-0283-z; Edens EL, 2012, J GAMBL STUD, V28, P1, DOI 10.1007/s10899-011-9239-z; Ellenbogen S, 2007, J GAMBL STUD, V23, P133, DOI 10.1007/s10899-006-9048-y; Freimuth M., 2005, HIDDEN ADDICTIONS AS; George A., 2005, ADV PSYCHIAT TREATME, V11, P450, DOI [10.1192/apt.11.6.450, DOI 10.1192/APT.11.6.450]; Gerstein D., 1999, GAMBLING IMPACT BEHA; Grant B. F., 2000, ALCOHOL USE DISORDER; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Grant JE, 2010, COMPR PSYCHIAT, V51, P115, DOI 10.1016/j.comppsych.2009.04.002; Grinols E. L., 2004, GAMBLING AM COSTS BE; Gupta Rina, 1998, J Gambl Stud, V14, P319, DOI 10.1023/A:1023068925328; Hodgins DC, 2011, LANCET, V378, P1874, DOI 10.1016/S0140-6736(10)62185-X; Jacobs D, 1989, J GAMBLING BEHAV, V5, P261, DOI DOI 10.1007/BF01672427; Kausch O, 2003, J SUBST ABUSE TREAT, V25, P263, DOI 10.1016/S0740-5472(03)00117-X; Kennedy CH, 2005, MIL MED, V170, P683, DOI 10.7205/MILMED.170.8.683; Kessler RC, 2008, PSYCHOL MED, V38, P1351, DOI 10.1017/S0033291708002900; King LA, 1998, J PERS SOC PSYCHOL, V74, P420, DOI 10.1037/0022-3514.74.2.420; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Ledgerwood DM, 2004, J NERV MENT DIS, V192, P711, DOI 10.1097/01.nmd.0000142021.71880.ce; Lorenz V. C., 1988, J GAMBLING BEHAVIOR, V4, P13, DOI DOI 10.1007/BF01043525; Petry NM, 2009, AM J ADDICTION, V18, P402, DOI [10.3109/10550490903077861, 10.1080/10550490903077861]; Potenza MN, 2014, TRENDS COGN SCI, V18, P429, DOI 10.1016/j.tics.2014.03.007; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shaffer H J, 1994, J Gambl Stud, V10, P339, DOI 10.1007/BF02104901; Shaffer H J, 1996, J Gambl Stud, V12, P193, DOI 10.1007/BF01539174; Smith PH, 2014, J BEHAV ADDICT, V3, P214, DOI 10.1556/JBA.3.2014.4.2; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; TABER JI, 1987, INT J ADDICT, V22, P71, DOI 10.3109/10826088709027414; Toce-Gerstein M, 2003, ADDICTION, V98, P1661, DOI 10.1111/j.1360-0443.2003.00545.x; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; VOLBERG RA, 1994, AM J PUBLIC HEALTH, V84, P237, DOI 10.2105/AJPH.84.2.237; Westermeyer J, 2013, AM J ADDICTION, V22, P218, DOI 10.1111/j.1521-0391.2012.12011.x; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	40	20	20	0	5	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	2062-5871	2063-5303		J BEHAV ADDICT	J. Behav. Addict.	JUN	2016	5	2					213	220		10.1556/2006.5.2016.027			8	Psychiatry	Psychiatry	DQ6UC	WOS:000379339700006	27156377	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Atabaki, SM; Hoyle, JD; Schunk, JE; Monroe, DJ; Alpern, ER; Quayle, KS; Glass, TF; Badawy, MK; Miskin, M; Schalick, WO; Dayan, PS; Holmes, JF; Kuppermann, N				Atabaki, Shireen M.; Hoyle, John D., Jr.; Schunk, Jeff E.; Monroe, David J.; Alpern, Elizabeth R.; Quayle, Kimberly S.; Glass, Todd F.; Badawy, Mohamed K.; Miskin, Michelle; Schalick, Walton O.; Dayan, Peter S.; Holmes, James F.; Kuppermann, Nathan			Comparison of Prediction Rules and Clinician Suspicion for Identifying Children With Clinically Important Brain Injuries After Blunt Head Trauma	ACADEMIC EMERGENCY MEDICINE			English	Article							COMPUTED-TOMOGRAPHY USE; EMERGENCY-DEPARTMENT; RADIATION-EXPOSURE; DECISION RULES; UNITED-STATES; RISK; IMPROVEMENT; PHYSICIAN; JUDGMENT; PATIENT	Objective: Children with minor head trauma frequently present to emergency departments (EDs). Identifying those with traumatic brain injuries (TBIs) can be difficult, and it is unknown whether clinical prediction rules outperform clinician suspicion. Our primary objective was to compare the test characteristics of the Pediatric Emergency Care Applied Research Network (PECARN) TBI prediction rules to clinician suspicion for identifying children with clinically important TBIs (ciTBIs) after minor blunt head trauma. Our secondary objective was to determine the reasons for obtaining computed tomography (CT) scans when clinical suspicion of ciTBI was low. Methods: This was a planned secondary analysis of a previously conducted observational cohort study conducted in PECARN to derive and validate clinical prediction rules for ciTBI among children with minor blunt head trauma in 25 PECARN EDs. Clinicians recorded their suspicion of ciTBI before CT as <1, 1-5, 6-10, 11-50, or >50%. We defined ciTBI as 1) death from TBI, 2) neurosurgery, 3) intubation for more than 24 hours for TBI, or 4) hospital admission of 2 nights or more associated with TBI on CT. To avoid overfitting of the prediction rules, we performed comparisons of the prediction rules and clinician suspicion on the validation group only. On the validation group, we compared the test accuracies of clinician suspicion >1% versus having at least one predictor in the PECARN TBI age-specific prediction rules for identifying children with ciTBIs (one rule for children <2 years [preverbal], the other rule for children >2 years [verbal]). Results: In the parent study, we enrolled 8,627 children to validate the prediction rules, after enrolling 33,785 children to derive the prediction rules. In the validation group, clinician suspicion of ciTBI was recorded in 8,496/8,627 (98.5%) patients, and 87 (1.0%) had ciTBIs. CT scans were obtained in 2,857 (33.6%) patients in the validation group for whom clinician suspicion of ciTBI was recorded, including 2,099/7,688 (27.3%) of those with clinician suspicion of ciTBI of <1% and 758/808 (93.8%) of those with clinician suspicion >1%. The PECARN prediction rules were significantly more sensitive than clinician suspicion >1% of ciTBI for preverbal (100% [95% confidence interval {CI} = 86.3% to 100%] vs. 60.0% [95% CI = 38.7% to 78.9%]) and verbal children (96.8% [95% CI = 88.8% to 99.6%] vs. 64.5% [95% CI = 51.3% to 76.3%]). Prediction rule specificity, however, was lower than clinician suspicion >1% for preverbal children (53.6% [95% CI = 51.5% to 55.7%] vs. 92.4% [95% CI = 91.2% to 93.5%]) and verbal children (58.2% [95% CI = 56.9% to 59.4%] vs. 90.6% [95% CI = 89.8% to 91.3%]). Of the 7,688 patients in the validation group with clinician suspicion recorded as <1%, CTs were nevertheless obtained in 2,099 (27.3%). Three of 16 (18.8%) patients undergoing neurosurgery had clinician suspicion of ciTBI <1%. Conclusions: The PECARN TBI prediction rules had substantially greater sensitivity, but lower specificity, than clinician suspicion of ciTBI for children with minor blunt head trauma. Because CT ordering did not follow clinician suspicion of <1%, these prediction rules can augment clinician judgment and help obviate CT ordering for children at very low risk of ciTBI. (C) 2016 by the Society for Academic Emergency Medicine	[Atabaki, Shireen M.] George Washington Univ, Sch Med, Dept Pediat & Emergency Med, Washington, DC USA; [Hoyle, John D., Jr.] Michigan State Univ, Sch Med, Dept Emergency Med, Grand Rapids, MI USA; [Hoyle, John D., Jr.] Western Michigan Univ, Dept Emergency Med, Homer Stryker Sch Med, Kalamazoo, MI 49008 USA; [Hoyle, John D., Jr.] Western Michigan Univ, Dept Pediat, Homer Stryker Sch Med, Kalamazoo, MI 49008 USA; [Schunk, Jeff E.; Miskin, Michelle] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Monroe, David J.] Howard Cty Gen Hosp, Dept Emergency Med, Columbia, MD USA; [Alpern, Elizabeth R.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Alpern, Elizabeth R.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Quayle, Kimberly S.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Glass, Todd F.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Glass, Todd F.] Nemours Childrens Hosp, Dept Pediat, Orlando, FL USA; [Badawy, Mohamed K.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA; [Badawy, Mohamed K.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Badawy, Mohamed K.] Univ Texas SW Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA; [Schalick, Walton O.] Univ Wisconsin, Sch Med, Dept Orthoped Rehabil, Madison, WI USA; [Dayan, Peter S.] Columbia Univ, Dept Pediat, Coll Phys & Surg, New York, NY 10027 USA; [Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA	Atabaki, SM (corresponding author), George Washington Univ, Sch Med, Dept Pediat & Emergency Med, Washington, DC USA.	satabaki@childrensnational.org		Alpern, Elizabeth/0000-0001-7887-3563	Health Resources and Services Administration/Maternal and Child Health Bureau (HRSA/MCHB), Division of Research, Education, and Training (DRTE); Emergency Medical Services of Children (EMSC) Program [R40MC02461]; Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Network Development Demonstration Program [U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, U03MC22685]	This work was supported by a grant from the Health Resources and Services Administration/Maternal and Child Health Bureau (HRSA/MCHB), Division of Research, Education, and Training (DRTE) and the Emergency Medical Services of Children (EMSC) Program (R40MC02461). This project was also supported in part by the Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Network Development Demonstration Program under cooperative agreements U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, and U03MC22685. The information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.	American Academy of Pediatrics, 5 THINGS PHYS PAT SH; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Bandiera G, 2003, ANN EMERG MED, V42, P395, DOI 10.1016/S0196-0644(03)00422-0; Bergman DA, 1999, PEDIATRICS, V104, P1407; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Fan E, 2010, JAMA-J AM MED ASSOC, V304, P2279, DOI 10.1001/jama.2010.1692; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feigal DW, 2002, PEDIATR RADIOL, V32, P314, DOI 10.1007/s00247-002-0687-6; Finnerty NM, 2015, ACAD EMERG MED, V22, P1406, DOI 10.1111/acem.12828; GAUSCHE M, 1995, ANN EMERG MED, V25, P804, DOI 10.1016/S0196-0644(95)70212-1; Goske MJ, 2011, PEDIATR RADIOL, V41, P611, DOI [10.1007/s00247-010-1957-3, 10.1007/s00247-011-2133-0]; Graham ID, 1998, ACAD EMERG MED, V5, P134, DOI 10.1111/j.1553-2712.1998.tb02598.x; Hartling L, 2007, ACAD EMERG MED, V14, P968, DOI 10.1197/j.aem.2007.05.010; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Lodwick DL, 2015, PEDIATRICS, V136, pE1212, DOI 10.1542/peds.2015-1671; Maguire JL, 2011, PEDIATRICS, V128, pE666, DOI 10.1542/peds.2011-0043; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; Marin JR, 2014, ACAD EMERG MED, V21, P987, DOI 10.1111/acem.12458; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; *NAT CANC I, RAD RISKS PED COMP T; Natale JE, 2012, ARCH PEDIAT ADOL MED, V166, P732, DOI 10.1001/archpediatrics.2012.307; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Palchak MJ, 2009, PEDIATR EMERG CARE, V25, P61, DOI 10.1097/PEC.0b013e318196e9c0; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Schriger DL, 2012, ANN EMERG MED, V59, P219, DOI 10.1016/j.annemergmed.2011.08.015; Sheehan B, 2013, J BIOMED INFORM, V46, P905, DOI 10.1016/j.jbi.2013.07.005; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008	35	20	20	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAY	2016	23	5					566	575		10.1111/acem.12923			10	Emergency Medicine	Emergency Medicine	DL2TT	WOS:000375488800005	26825755				2021-06-18	
J	Chung, S; Rho, S; Kim, G; Kim, SR; Baek, KH; Kang, M; Lew, H				Chung, Sokjoong; Rho, Seungsoo; Kim, Gijin; Kim, So-Ra; Baek, Kwang-Hyun; Kang, Myungseo; Lew, Helen			Human umbilical cord blood mononuclear cells and chorionic plate-derived mesenchymal stem cells promote axon survival in a rat model of optic nerve crush injury	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						optic nerve; placenta; stem cells; traumatic optic neuropathy; umbilical cord blood mononuclear cells	BONE-MARROW; HUMAN-PLACENTA; BRAIN-INJURY; PARACRINE MECHANISMS; NEUROTROPHIC FACTORS; PROGENITOR CELLS; CEREBRAL-PALSY; ISCHEMIC-HEART; IN-VITRO; REGENERATION	The use of mesenchymal stem cells (MSCs) in cell therapy in regenerative medicine has great potential, particularly in the treatment of nerve injury. Umbilical cord blood (UCB) reportedly contains stem cells, which have been widely used as a hematopoietic source and may have therapeutic potential for neurological impairment. Although ongoing research is dedicated to the management of traumatic optic nerve injury using various measures, novel therapeutic strategies based on the complex underlying mechanisms responsible for optic nerve injury, such as inflammation and/or ischemia, are required. In the present study, a rat model of optic nerve crush (ONC) injury was established in order to examine the effects of transplanting human chorionic plate-derived MSCs (CP-MSCs) isolated from the placenta, as well as human UCB mononuclear cells (CB-MNCs) on compressed rat optic nerves. Expression markers for inflammation, apoptosis, and optic nerve regeneration were analyzed, as well as the axon survival rate by direct counting. Increased axon survival rates were observed following the injection of CB-MNCs at at 1 week post-transplantation compared with the controls. The levels of growth-associated protein-43 (GAP-43) were increased after the injection of CB-MNCs or CP-MSCs compared with the controls, and the expression levels of hypoxia-inducible factor-1 (HIF-1) were also significantly increased following the injection of CB-MNCs or CP-MSCs. ERM-like protein (ERMN) and SLIT-ROBO Rho GTPase activating protein 2 (SRGAP2) were found to be expressed in the optic nerves of the CP-MSC-injected rats with ONC injury. The findings of our study suggest that the administration of CB-MNCs or CP-MSCs may promote axon survival through systemic concomitant mechanisms involving GAP-43 and HIF-1. Taken together, these findings provide further understanding of the mechanisms repsonsible for optic nerve injury and may aid in the development of novel cell-based therapeutic strategies with future applications in regenerative medicine, particularly in the management of optic nerve disorders.	[Chung, Sokjoong; Rho, Seungsoo; Lew, Helen] CHA Univ, Dept Ophthalmol, CHA Bundang Med Ctr, 59 Yatap Ro, Songnam 463712, Gyeonggi Do, South Korea; [Kim, Gijin; Kim, So-Ra; Baek, Kwang-Hyun] CHA Univ, Dept Biomed Sci, CHA Bundang Med Ctr, Songnam 463712, Gyeonggi Do, South Korea; [Kang, Myungseo] CHA Univ, Dept Lab Med, CHA Bundang Med Ctr, Songnam 463712, Gyeonggi Do, South Korea; [Kang, Myungseo] CHA Med Ctr Cord Blood Bank, Songnam, Gyeonggi Do, South Korea	Lew, H (corresponding author), CHA Univ, Dept Ophthalmol, CHA Bundang Med Ctr, 59 Yatap Ro, Songnam 463712, Gyeonggi Do, South Korea.	eye@cha.ac.kr		Baek, Kwang-Hyun/0000-0001-7662-7190	National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2014R1A2A2A01002617]	The present study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (no. NRF-2014R1A2A2A01002617).	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Aoki H, 2008, GRAEF ARCH CLIN EXP, V246, P255, DOI 10.1007/s00417-007-0710-6; Benowitz LI, 2010, ARCH OPHTHALMOL-CHIC, V128, P1059, DOI 10.1001/archophthalmol.2010.152; Booij Judith C, 2010, PLoS One, V5, pe9341, DOI 10.1371/journal.pone.0009341; Bull ND, 2008, INVEST OPHTH VIS SCI, V49, P3449, DOI 10.1167/iovs.08-1770; Bull ND, 2009, INVEST OPHTH VIS SCI, V50, P4244, DOI 10.1167/iovs.08-3239; Canque B, 2000, BLOOD, V96, P3748, DOI 10.1182/blood.V96.12.3748.h8003748_3748_3756; Charalambous P, 2008, INVEST OPHTH VIS SCI, V49, P3513, DOI 10.1167/iovs.07-1473; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Ebneter A, 2012, CLIN EXP OPHTHALMOL, V40, P626, DOI 10.1111/j.1442-9071.2011.02741.x; Gijtenbeek JMM, 1999, J NEUROL, V246, P339, DOI 10.1007/s004150050360; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gornicka-Pawlak E, 2011, ACTA NEUROBIOL EXP, V71, P46; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hellwig-Burgel T, 2005, J INTERF CYTOK RES, V25, P297, DOI 10.1089/jir.2005.25.297; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Jung J, 2013, STEM CELLS, V31, P1584, DOI 10.1002/stem.1396; Kaneda M, 2010, ADV EXP MED BIOL, V664, P97, DOI 10.1007/978-1-4419-1399-9_12; Kao CH, 2008, SHOCK, V29, P49, DOI 10.1097/shk.0b013c31805cddce; Kato S, 1999, NEUROSCIENCE, V93, P907, DOI 10.1016/S0306-4522(99)00202-X; Kim CY, 2016, VET OPHTHALMOL, V19, P29, DOI 10.1111/vop.12247; Kim MJ, 2011, CELL TISSUE RES, V346, P53, DOI 10.1007/s00441-011-1249-8; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Koriyama Y, 2007, NEUROCHEM INT, V50, P749, DOI 10.1016/j.neuint.2007.01.012; Lee JM, 2012, INT IMMUNOPHARMACOL, V13, P219, DOI 10.1016/j.intimp.2012.03.024; Lee MJ, 2010, J CELL BIOCHEM, V111, P1453, DOI 10.1002/jcb.22873; Lee MW, 2010, INT J HEMATOL, V92, P45, DOI 10.1007/s12185-010-0619-4; Lee Y, 2013, J CELL BIOCHEM, V114, P79, DOI 10.1002/jcb.24303; Levkovitch-Verbin H, 2010, INVEST OPHTH VIS SCI, V51, P6394, DOI 10.1167/iovs.09-4310; Li CD, 2007, CELL TISSUE RES, V330, P437, DOI 10.1007/s00441-007-0504-5; Li JY, 2015, J CRANIOFAC SURG, V26, P548, DOI 10.1097/SCS.0000000000001348; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Meier C, 2006, PEDIATR RES, V59, P244, DOI 10.1203/01.pdr.0000197309.08852.f5; Min K, 2013, STEM CELLS, V31, P581, DOI 10.1002/stem.1304; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Newcomb JD, 2007, CELL TRANSPLANT, V16, P151; Nikolic WV, 2008, STEM CELLS DEV, V17, P423, DOI 10.1089/scd.2008.0018; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; O'Neill TJ, 2005, CIRC RES, V97, P1027, DOI 10.1161/01.RES.0000189259.69645.25; Papadopoulos KI, 2011, RESTOR NEUROL NEUROS, V29, P17, DOI 10.3233/RNN-2011-0572; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Rho S, 2014, CURR EYE RES, V39, P917, DOI 10.3109/02713683.2014.884597; Sanchez CG, 2011, CARCINOGENESIS, V32, P964, DOI 10.1093/carcin/bgr029; Sun J, 2010, TRANSFUSION, V50, P1980, DOI 10.1111/j.1537-2995.2010.02720.x; Tajima T, 2009, BIOCHEM BIOPH RES CO, V387, P789, DOI 10.1016/j.bbrc.2009.07.115; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Vollmer S, 2009, HEPATOLOGY, V50, P253, DOI 10.1002/hep.22928; Zhao TT, 2011, GRAEF ARCH CLIN EXP, V249, P1021, DOI 10.1007/s00417-011-1635-7	51	20	21	0	14	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	MAY	2016	37	5					1170	1180		10.3892/ijmm.2016.2532			11	Medicine, Research & Experimental	Research & Experimental Medicine	DK7FR	WOS:000375091000003	26986762	Green Published, Other Gold			2021-06-18	
J	Jungner, M; Siemund, R; Venturoli, D; Reinstrup, P; Schalen, W; Bentzer, P				Jungner, Marten; Siemund, Roger; Venturoli, Daniele; Reinstrup, Peter; Schalen, Wilhelm; Bentzer, Peter			Blood-brain barrier permeability following traumatic brain injury	MINERVA ANESTESIOLOGICA			English	Article						Blood-brain barrier; Brain injuries; Permeability; Linear models	PERFUSION CT ASSESSMENT; HEAD-INJURY; MICROVASCULAR PERMEABILITY; INTRACRANIAL HYPERTENSION; COMPUTED-TOMOGRAPHY; FLUID RESUSCITATION; CORTICAL CONTUSION; CEREBRAL CONTUSION; EDEMA FORMATION; DIFFUSION MRI	BACKGROUND: Brain edema and intracranial hypertension is deleterious after traumatic brain injury (TBI), but the underlying pathophysiology is complex and poorly understood. One major subject of controversy is the time course and extent of blood-brain barrier (BBB) dysfunction following trauma, and previous studies in humans have only provided semi-quantitative data. The objective of the present study was therefore to quantify changes in BBB-permeability in the early course of TBI, when brain edema is still evolving. METHODS: Sixteen non-consecutive brain trauma patients and two controls were included. Following i.v. injection of iohexol and CT perfusion scans, patients were scanned eight times from 4 to 25 minutes. Blood to brain transfer constant (K-i) for iohexol (molecular weight 821 D), reflecting permeability and available area for diffusion, was calculated offline by Patlak plot analysis of the enhancement curves of intracerebral large venous vessels and pericontusional brain parenchyma. RESULTS: In non-ischemic tissue surrounding contusions and hematomas K-i was increased 2- to 10-fold compared to normal tissue, reaching maximal values of 0.5 mL/min/ 100 g. In non-injured areas and in controls K-i was about 0.06 mL/min/ 100 g. The increase was more pronounced in the most severely injured patients, and was detectable within 24 hours after trauma and up to five days after. CONCLUSIONS: Our results suggest that traumatic brain injury is associated with early focal increases in small molecular BBB-permeability. The results indicate that in the injured brain, capillary hydrostatic and oncotic pressures may influence edema formation.	[Jungner, Marten; Venturoli, Daniele; Reinstrup, Peter; Bentzer, Peter] Lund Univ, Dept Anesthesiol & Intens Care, S-22185 Lund, Sweden; [Jungner, Marten; Siemund, Roger; Venturoli, Daniele; Reinstrup, Peter; Schalen, Wilhelm; Bentzer, Peter] Skane Univ Hosp, Lund, Sweden; [Siemund, Roger] Lund Univ, Dept Radiol, Lund, Sweden; [Schalen, Wilhelm] Lund Univ, Dept Neurosurg, Lund, Sweden	Bentzer, P (corresponding author), Lund Univ, Dept Anesthesiol & Intens Care, S-22185 Lund, Sweden.; Bentzer, P (corresponding author), Skane Univ Hosp, Lund, Sweden.	peter.bentzer@hotmail.com					Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BARTOLINI A, 1994, COMPUT MED IMAG GRAP, V18, P145, DOI 10.1016/0895-6111(94)90023-X; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, ACT NEUR S, V70, P243; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; BULLOCK R, 1990, ACT NEUR S, V51, P286; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Dankbaar JW, 2008, AM J NEURORADIOL, V29, P1671, DOI 10.3174/ajnr.A1203; Drummond JC, 1998, ANESTHESIOLOGY, V88, P993, DOI 10.1097/00000542-199804000-00020; FENSTERMACHER JD, 1981, PHARMACOL THERAPEUT, V14, P217, DOI 10.1016/0163-7258(81)90062-0; Fenstermacher JD, 1984, EDEMA; Fieselmann A, 2011, INT J BIOMED IMAGING, V2011, DOI 10.1155/2011/467563; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; GROOTHUIS DR, 1991, ANN NEUROL, V30, P581, DOI 10.1002/ana.410300411; GROOTHUIS DR, 1991, J CEREBR BLOOD F MET, V11, P939, DOI 10.1038/jcbfm.1991.159; Hom J, 2009, AM J NEURORADIOL, V30, P1366, DOI 10.3174/ajnr.A1592; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; KUSHI H, 1994, ACTA NEUROCHIR, P472; LANG DA, 1991, ACTA NEUROCHIR, V109, P5, DOI 10.1007/BF01405689; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; Lin K, 2007, AM J NEURORADIOL, V28, P1292, DOI 10.3174/ajnr.A0539; Lundblad C, 2004, J NEUROTRAUM, V21, P741, DOI 10.1089/0897715041269614; Maeda T, 1997, ACT NEUR S, V70, P102; Maeda T, 2003, ACT NEUR S, V86, P329; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Pasco A, 2006, EUR RADIOL, V16, P1501, DOI 10.1007/s00330-005-0086-0; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; TOMITA H, 1994, ACTA NEUROCHIR, P547; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Aken HK, 2012, CURR OPIN ANESTHESIO, V25, P563, DOI 10.1097/ACO.0b013e3283572274; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Wintermark M, 2001, EUR RADIOL, V11, P1220, DOI 10.1007/s003300000707	41	20	20	0	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	MAY	2016	82	5					525	533					9	Anesthesiology; Critical Care Medicine	Anesthesiology; General & Internal Medicine	EA6TG	WOS:000386761300008	26613239				2021-06-18	
J	Pardo, L; Schluter, A; Valor, LM; Barco, A; Giralt, M; Golbano, A; Hidalgo, J; Jia, PL; Zhao, ZM; Jove, M; Portero-Otin, M; Ruiz, M; Gimenez-Llort, L; Masgrau, R; Pujol, A; Galea, E				Pardo, Luis; Schlueter, Agatha; Valor, Luis M.; Barco, Angel; Giralt, Mercedes; Golbano, Arantxa; Hidalgo, Juan; Jia, Peilin; Zhao, Zhongming; Jove, Mariona; Portero-Otin, Manuel; Ruiz, Montserrat; Gimenez-Llort, Lydia; Masgrau, Roser; Pujol, Aurora; Galea, Elena			Targeted activation of CREB in reactive astrocytes is neuroprotective in focal acute cortical injury	GLIA			English	Article						astrocytes; CREB; mitochondria; neuroinflammation; traumatic brain injury	ELEMENT-BINDING PROTEIN; INTERFERON-GAMMA; GENE-EXPRESSION; BRAIN; MICE; CNS; STROKE; CCL2; INTERLEUKIN-6; INFILTRATION	The clinical challenge in acute injury as in traumatic brain injury (TBI) is to halt the delayed neuronal loss that occurs hours and days after the insult. Here we report that the activation of CREB-dependent transcription in reactive astrocytes prevents secondary injury in cerebral cortex after experimental TBI. The study was performed in a novel bitransgenic mouse in which a constitutively active CREB, VP16-CREB, was targeted to astrocytes with the Tet-Off system. Using histochemistry, qPCR, and gene profiling we found less neuronal death and damage, reduced macrophage infiltration, preserved mitochondria, and rescued expression of genes related to mitochondrial metabolism in bitransgenic mice as compared to wild type littermates. Finally, with meta-analyses using publicly available databases we identified a core set of VP16-CREB candidate target genes that may account for the neuroprotective effect. Enhancing CREB activity in astrocytes thus emerges as a novel avenue in acute brain post-injury therapeutics. GLIA 2016;64:853-874	[Pardo, Luis; Golbano, Arantxa; Masgrau, Roser; Galea, Elena] Univ Autonoma Barcelona, Inst Neurociencies, Fac Med, E-08193 Barcelona, Spain; [Pardo, Luis; Golbano, Arantxa; Masgrau, Roser; Galea, Elena] Univ Autonoma Barcelona, Unitat Bioquim, Fac Med, E-08193 Barcelona, Spain; [Schlueter, Agatha; Ruiz, Montserrat; Pujol, Aurora] ISCIII, Ctr Biomed Res Rare Dis CIBERER, Bellvitge Biomed Res Inst IDIBELL, Neurometabol Dis Lab, Barcelona 08907, Spain; [Valor, Luis M.; Barco, Angel] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante 03550, Spain; [Giralt, Mercedes; Hidalgo, Juan] Univ Autonoma Barcelona, Fac Biosci, Inst Neurociencies, E-08193 Barcelona, Spain; [Giralt, Mercedes; Hidalgo, Juan] Univ Autonoma Barcelona, Fac Biosci, Dept Cellular Biol Physiol & Immunol, E-08193 Barcelona, Spain; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Jove, Mariona; Portero-Otin, Manuel] Univ Lleida, Dept Expt Med, Biomed Res Inst Lleida, Lleida 25198, Spain; [Gimenez-Llort, Lydia] Univ Autonoma Barcelona, Sch Med, Inst Neurociences, Bellaterra 08193, Spain; [Gimenez-Llort, Lydia] Univ Autonoma Barcelona, Sch Med, Dept Psychiat & Forens Med, Bellaterra 08193, Spain; [Pujol, Aurora; Galea, Elena] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Galea, E (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain.	galea.inc@gmail.com	Galea, Elena/E-1362-2011; Masgrau, Roser/D-3047-2011; Gimenez-Llort, Lydia/I-3347-2015; Barco, Angel/C-3062-2008; Ruiz, Montse/N-4085-2014; Llort, Lydia Gimenez/AAS-7415-2020; Pujol, Aurora/N-4990-2014; Hidalgo, Juan/C-9082-2011; Schluter, Agatha/AAA-9665-2021; Portero-Otin, Manuel/B-7122-2009; Jove, Mariona/M-9104-2016; Pardo-Fernandez, Luis/AAB-3332-2020; Valor, Luis/ABG-1754-2020; Schluter, Agatha/N-4097-2014; Gimenez-Llort, Lydia/AAI-5182-2021	Galea, Elena/0000-0003-4537-9897; Masgrau, Roser/0000-0002-6722-5939; Barco, Angel/0000-0002-0653-3751; Ruiz, Montse/0000-0003-0466-2653; Pujol, Aurora/0000-0002-9606-0600; Hidalgo, Juan/0000-0003-0921-1122; Portero-Otin, Manuel/0000-0002-1823-0299; Jove, Mariona/0000-0001-5577-6162; Pardo-Fernandez, Luis/0000-0002-4355-1369; Schluter, Agatha/0000-0001-6732-1528; Gimenez-Llort, Lydia/0000-0002-4091-489X; Valor, Luis M./0000-0002-1229-0565	Ministerio de Economia y Competitividad, Spain - European Regional Development's Fund, FEDER [BFU2010-21921, BFU2012-38844, SAF2011-23272, SAF2011-22506, SAF2011-22855]; Instituto Carlos III, SpainInstituto de Salud Carlos III [ISC3 PI10/00283, PI11/01532]; Autonomous Government of Catalonia AGAUR [2014SGR1430, 2014SGR984]; Generalitat ValencianaGeneralitat ValencianaEuropean Commission [Prometeo/2012/005]; Brain & Behavior Research Foundation (NARSAD Independent Investigator Grant); Instituto de Neurociencias de Alicante is a "Centre of Excellence Severo Ochoa"; CIBER on Rare Diseases (CIBERER); ICREAICREA Funding Source: Custom	Grant sponsor: Ministerio de Economia y Competitividad, Spain; Grant numbers: BFU2010-21921, BFU2012-38844 (Co-funded with European Regional Development's Fund, FEDER), SAF2011-23272, SAF2011-22506, SAF2011-22855; Grant sponsor: Instituto Carlos III, Spain; Grant number: ISC3 PI10/00283, PI11/01532; Grant sponsor: Autonomous Government of Catalonia AGAUR; Grant number: 2014SGR1430, 2014SGR984; Grant sponsor: Generalitat Valenciana; Grant number: Prometeo/2012/005; Grant sponsors: Brain & Behavior Research Foundation (NARSAD Independent Investigator Grant, The Instituto de Neurociencias de Alicante is a "Centre of Excellence Severo Ochoa", CIBER on Rare Diseases (CIBERER).	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Almolda B, 2014, GLIA, V62, P1142, DOI 10.1002/glia.22668; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barco A, 2011, MOL NEUROBIOL, V44, P330, DOI 10.1007/s12035-011-8209-x; Bell KFS, 2013, J NEUROCHEM, V126, P274, DOI 10.1111/jnc.12176; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Burnside ER, 2014, NEUROPATH APPL NEURO, V40, P26, DOI 10.1111/nan.12114; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CANCILLA PA, 1992, J NEUROPATH EXP NEUR, V51, P560, DOI 10.1097/00005072-199209000-00011; Carriba P, 2012, GLIA, V60, P1330, DOI 10.1002/glia.22352; Corbin JG, 1996, MOL CELL NEUROSCI, V7, P354, DOI 10.1006/mcne.1996.0026; Cowley MJ, 2012, NUCL ACIDS RES, V40; Dong Y, 2014, TRENDS PHARMACOL SCI, V35, P374, DOI 10.1016/j.tips.2014.05.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Franceschini A. L., 2013, NUCL ACIDS RES, V41; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Heiman M, 2009, NIH PUBLIC ACCESS, V135, P738; Kaur H, 2013, PHARMACOLOGY, V92, P324, DOI 10.1159/000356320; Kim RY, 2014, J NEUROIMMUNOL, V274, P53, DOI 10.1016/j.jneuroim.2014.06.009; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Krupenko SA, 2009, CHEM-BIOL INTERACT, V178, P84, DOI 10.1016/j.cbi.2008.09.007; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lichtenstein MP, 2012, NEUROSIGNALS, V20, P86, DOI 10.1159/000330805; Lin WS, 2004, J NEUROSCI, V24, P10074, DOI 10.1523/JNEUROSCI.2604-04.2004; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Liu YY, 2014, J NEUROSCI, V34, P2813, DOI 10.1523/JNEUROSCI.3541-13.2014; Ma TC, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582460; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Moreno M, 2014, J NEUROSCI, V34, P8175, DOI 10.1523/JNEUROSCI.1137-14.2014; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park SA, 2003, EXP MOL MED, V35, P365, DOI 10.1038/emm.2003.48; Parra-Damas A, 2014, J NEUROSCI, V34, P5776, DOI 10.1523/JNEUROSCI.5288-13.2014; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Prado J, 2013, NEUROCHEM INT, V62, P70, DOI 10.1016/j.neuint.2012.11.008; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Tymianski M, 2013, STROKE, V44, P2942, DOI 10.1161/STROKEAHA.113.000731; Valor LM, 2010, CELL DEATH DIFFER, V17, P1636, DOI 10.1038/cdd.2010.40; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu LJ, 2011, NEUROSCI LETT, V488, P279, DOI 10.1016/j.neulet.2010.11.047; Xu LJ, 2010, GLIA, V58, P1042, DOI 10.1002/glia.20985; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zheng SY, 2012, GENOMICS, V99, P183, DOI 10.1016/j.ygeno.2011.12.005	63	20	20	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	MAY	2016	64	5					853	874		10.1002/glia.22969			22	Neurosciences	Neurosciences & Neurology	DI0OR	WOS:000373197000013	26880229				2021-06-18	
J	Shadloo, B; Motevalian, A; Rahimi-Movaghar, V; Amin-Esmaeili, M; Sharifi, V; Hajebi, A; Radgoodarzi, R; Hefazi, M; Rahimi-Movaghar, A				Shadloo, Behrang; Motevalian, Abbas; Rahimi-Movaghar, Vafa; Amin-Esmaeili, Masoumeh; Sharifi, Vandad; Hajebi, Ahmad; Radgoodarzi, Reza; Hefazi, Mitra; Rahimi-Movaghar, Afarin			Psychiatric Disorders Are Associated with an Increased Risk of Injuries: Data from the Iranian Mental Health Survey (Iran MHS)	IRANIAN JOURNAL OF PUBLIC HEALTH			English	Article						Injury; Mental health; Composite international diagnostic interview; Iran	TRAUMATIC BRAIN-INJURY; UNINTENTIONAL INJURY; MAJOR DEPRESSION; GLOBAL BURDEN; DRUG-USE; ALCOHOL; MEDICATION; SYMPTOMS; UPDATE	Background: Injuries and psychiatric disorders, notably both major public health concerns, are associated with a high burden and are believed to be bi-directionally correlated. Those inflicted with injuries face increased risks of mental illnesses. Psychiatric disorders may make the individual prone to injuries. The objective of the study was to assess the correlation of mental disorders with non-fatal injuries. Methods: A total of 7886 participants aged 15 to 64 yr were interviewed in a national household survey in 2011 in Iran. Composite International Diagnostic Interview (CIDI v2.1) was implemented to assess the prevalence of psychiatric disorders in the past twelve months. Injuries were assessed using Short Form Injury Questionnaire (SFIQ-7). Results: Injury was reported in 35.9% and 22.8% of participants in the past twelve and past three months, respectively. Using multivariate logistic regression analysis, mental disorders were significantly associated with injuries in the past three months (OR=1.6, 95% CI: 1.36-1.87), recurrent injuries (OR=1.7, 95% CI: 1.21-2.41) and road/traffic accidents (OR=2.4, 95% CI: 1.28-4.49). Conclusion: Psychiatric disorders were found to be associated with an increased risk of injuries. Early detection and treatment of mental illnesses can contribute to injury prevention.	[Shadloo, Behrang; Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Shadloo, Behrang; Amin-Esmaeili, Masoumeh; Radgoodarzi, Reza; Hefazi, Mitra; Rahimi-Movaghar, Afarin] Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Iranian Inst Reduct High Risk Behav, Tehran, Iran; [Motevalian, Abbas] Iran Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran; [Sharifi, Vandad] Univ Tehran Med Sci, Psychiat & Psychol Res Ctr, Tehran, Iran; [Hajebi, Ahmad] Iran Univ Med Sci, Mental Hlth Res Ctr, Tehran Psychiat Inst, Tehran, Iran	Amin-Esmaeili, M (corresponding author), Univ Tehran Med Sci, Iranian Natl Ctr Addict Studies, Iranian Inst Reduct High Risk Behav, Tehran, Iran.	m.aminesmaeeli@farabi.tums.ac.ir	Sharifi, Vandad/J-2003-2019; Sharifi, Vandad/J-7884-2019; Rahimi-Movaghar, Vafa/L-6339-2019; hajebi, ahmad/ABH-9175-2020; Rahimi-Movaghar, Afarin/E-9505-2011	Rahimi-Movaghar, Afarin/0000-0002-5761-1668; Motevalian, Seyed Abbas/0000-0002-0404-4495; Shadloo, Behrang/0000-0003-1884-9371			Alaghband Rad J., 2003, MENTAL HLTH EFFECTS; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Cameron CM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-114; Chen G, 2008, INJURY PREV, V14, P180, DOI 10.1136/ip.2007.016857; Dyster-Aas J, 2008, J TRAUMA, V64, P1349, DOI 10.1097/TA.0b013e318047e005; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Guillemont J, 2009, INT J INJ CONTROL SA, V16, P81, DOI 10.1080/17457300902836655; Hafezi-Nejad N, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041127; Haslam C, 2005, OCCUP ENVIRON MED, V62, P538, DOI 10.1136/oem.2004.016196; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Jahani MR, 2001, KOWSAR MED J, V5, P289; Kendrick D, 2001, PUBLIC HEALTH, V115, P103, DOI 10.1016/S0033-3506(01)00427-9; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McGee Kara, 2004, Inj Control Saf Promot, V11, P303, DOI 10.1080/156609704/233/327505; McGinty EE, 2013, INJURY PREV, V19, P32, DOI 10.1136/injuryprev-2011-040309; Motevalian SA, 2004, HAKIM RES J, V7, P1; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Naghavi Mohsen, 2009, Popul Health Metr, V7, P9, DOI 10.1186/1478-7954-7-9; Nordstrom DL, 2001, J TRAUMA, V51, P758, DOI 10.1097/00005373-200110000-00023; O'Donnell ML, 2009, J TRAUMA, V66, P470, DOI 10.1097/TA.0b013e31815d965e; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Palmu R, 2011, BURNS, V37, P601, DOI 10.1016/j.burns.2010.06.007; Patten SB, 2010, CAN J PSYCHIAT, V55, P313, DOI 10.1177/070674371005500507; Patterson DR, 2003, J BURN CARE REHABIL, V24, P347, DOI 10.1097/01.BCR.0000086070.91033.7F; Pickett W, 2002, ARCH PEDIAT ADOL MED, V156, P786, DOI 10.1001/archpedi.156.8.786; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Rahimi-Movaghar A, 2013, COCHRANE DB SYST REV, V1; Rahimi-Movaghar Afarin, 2014, Iran J Psychiatry, V9, P96; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Sharif-Alhoseini M, 2012, CHIN J TRAUMATOL, V15, P145, DOI 10.3760/cma.j.issn.1008-1275.2012.03.003; Soderstrom CA, 2001, ACCIDENT ANAL PREV, V33, P771, DOI 10.1016/S0001-4575(00)00091-9; Tiesman HM, 2006, INJURY PREV, V12, P172, DOI 10.1136/ip.2006.011544; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Visser E, 2007, ACCIDENT ANAL PREV, V39, P556, DOI 10.1016/j.aap.2006.09.012; Wadsworth EJK, 2003, HUM PSYCHOPHARM CLIN, V18, P535, DOI 10.1002/hup.516; Watt K, 2006, J STUD ALCOHOL, V67, P14, DOI 10.15288/jsa.2006.67.14; Watt Kerrianne, 2006, Emerg Med Australas, V18, P108, DOI 10.1111/j.1742-6723.2006.00817.x; World Health Organization (WHO), 2008, GLOB BURD DIS 2004 U	40	20	20	0	5	IRANIAN SCIENTIFIC SOCIETY MEDICAL ENTOMOLOGY	TEHRAN	SCHOOL PUBLIC HEALTH & INST HEALTH RESEARCH, TEHRAN UNIV MEDICAL SCIENCES, P O BOX  6446-14155, TEHRAN, 00000, IRAN	2251-6085	2251-6093		IRAN J PUBLIC HEALTH	Iran J. Public Health	MAY	2016	45	5					623	635					13	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	DY2PC	WOS:000384933500008	27398335				2021-06-18	
J	Song, SJ; Kong, XY; Acosta, S; Sava, V; Borlongan, C; Sanchez-Ramos, J				Song, Shijie; Kong, Xiaoyuan; Acosta, Sandra; Sava, Vasyl; Borlongan, Cesar; Sanchez-Ramos, Juan			Granulocyte colony-stimulating factor promotes behavioral recovery in a mouse model of traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						brain repair; neurotrophic factors; cytokines; astrocytosis; microgliosis; neurogenesis; radial arm water maze	REVERSES COGNITIVE IMPAIRMENT; FACTOR G-CSF; NEUROGENESIS; ADULT; MACROPHAGES; PROLIFERATION; RECRUITMENT; DECREASES; RATS	Hematopoietic growth factors such as granulocyte colony-stimulating factor (G-CSF) represent a novel approach for treatment of traumatic brain injury (TBI). After mild controlled cortical impact (CCI), mice were treated with G-CSF (100g/kg) for 3 consecutive days. The primary behavioral endpoint was performance on the radial arm water maze (RAWM), assessed 7 and 14 days after CCI. Secondary endpoints included 1) motor performance on a rotating cylinder (rotarod), 2) measurement of microglial and astroglial response, 3) hippocampal neurogenesis, and 4) measures of neurotrophic factors (brain-derived neurotrophic factor [BDNF] and glial cell line-derived neurotrophic factor [GDNF]) and cytokines in brain homogenates. G-CSF-treated animals performed significantly better than vehicle-treated mice in the RAWM at 1 and 2 weeks but not on the rotarod. Cellular changes found in the G-CSF group included increased hippocampal neurogenesis as well as astrocytosis and microgliosis in both the striatum and the hippocampus. Neurotrophic factors GDNF and BDNF, elaborated by activated microglia and astrocytes, were increased in G-CSF-treated mice. These factors along with G-CSF itself are known to promote hippocampal neurogenesis and inhibit apoptosis and likely contributed to improvement in the hippocampal-dependent learning task. Six cytokines that were modulated by G-CSF treatment following CCI were elevated on day 3, but only one of them remained altered by day 7, and all of them were no different from vehicle controls by day 14. The pro- and anti-inflammatory cytokines modulated by G-CSF administration interact in a complex and incompletely understood network involving both damage and recovery processes, underscoring the dual role of inflammation after TBI. (c) 2016 Wiley Periodicals, Inc.	[Song, Shijie; Kong, Xiaoyuan; Sava, Vasyl; Sanchez-Ramos, Juan] James Haley Vet Adm Res Serv, Tampa, FL USA; [Song, Shijie; Borlongan, Cesar] Univ S Florida, Dept Neurol, 13220 Laurel Dr, Tampa, FL 33612 USA; [Kong, Xiaoyuan; Acosta, Sandra; Sava, Vasyl; Sanchez-Ramos, Juan] Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL USA	Sanchez-Ramos, J (corresponding author), Univ S Florida, Dept Neurol, 13220 Laurel Dr, Tampa, FL 33612 USA.	jsramos@health.usf.edu	Sanchez-Ramos, Juan/O-7870-2014; Kaneko, Yuji/J-6447-2012; Sanchez-Ramos, Juan/A-1188-2009	Sanchez-Ramos, Juan/0000-0002-3391-7857	Veterans Administration Merit Review GrantUS Department of Veterans Affairs; Helen Ellis Research Endowment; Veterans AffairsUS Department of Veterans Affairs [I01BX004037, I01BX001407] Funding Source: NIH RePORTER	Contract grant sponsor: Veterans Administration Merit Review Grant (to S.S.); Contract grant sponsor: Helen Ellis Research Endowment (to J.S.-R.)	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Boku S, 2013, BIOCHEM BIOPH RES CO, V434, P779, DOI 10.1016/j.bbrc.2013.04.011; Boyd TD, 2010, J ALZHEIMERS DIS, V21, P507, DOI 10.3233/JAD-2010-091471; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen WF, 2011, PEDIATR RES, V70, P589, DOI 10.1203/PDR.0b013e3182324424; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Cheng XW, 2011, CELL RES, V21, P338, DOI 10.1038/cr.2010.141; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; FUENTES ME, 1995, J IMMUNOL, V155, P5769; Hartung T, 1998, Curr Opin Hematol, V5, P221, DOI 10.1097/00062752-199805000-00013; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schabitz WR, 2010, STROKE, V41, P2545, DOI 10.1161/STROKEAHA.110.579508; Schabitz WR, 2007, TRENDS PHARMACOL SCI, V28, P157, DOI 10.1016/j.tips.2007.02.007; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Six I, 2003, EUR J PHARMACOL, V458, P327, DOI 10.1016/S0014-2999(02)02785-1; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Song SJ, 2014, J NEUROSCI RES, V92, P975, DOI 10.1002/jnr.23378; Song SJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/205878; Tang Y., 2015, MOL NEUROBIOL; Tsai KJ, 2007, J EXP MED, V204, P1273, DOI 10.1084/jem.20062481; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Yamasaki R, 2010, J NEUROIMMUNOL, V229, P51, DOI 10.1016/j.jneuroim.2010.07.002; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001	38	20	20	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAY	2016	94	5					409	423		10.1002/jnr.23714			15	Neurosciences	Neurosciences & Neurology	DH6HT	WOS:000372892300006	26822127	Green Accepted			2021-06-18	
J	Wang, L; Fu, XW; Peng, X; Xiao, Z; Li, ZG; Chen, GJ; Wang, XF				Wang, Liang; Fu, Xinwei; Peng, Xi; Xiao, Zheng; Li, Zhonggui; Chen, Guojun; Wang, Xuefeng			DNA Methylation Profiling Reveals Correlation of Differential Methylation Patterns with Gene Expression in Human Epilepsy	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Human; Epilepsy; DNA methylation; Microarray; Gene expression	TRAUMATIC BRAIN-INJURY; INTRACTABLE EPILEPSY; PROMOTER METHYLATION; STATUS EPILEPTICUS; EPILEPTOGENESIS; EPIGENETICS; ACTIVATION; HYPOTHESIS; CARNOSINE; SEIZURES	DNA methylation plays important roles in regulating gene expression and has been reported to be related with epilepsy. This study aimed to define differential DNA methylation patterns in drug-refractory epilepsy patients and to investigate the role of DNA methylation in human epilepsy. We performed DNA methylation profiling in brain tissues from epileptic and control patients via methylated-cytosine DNA immunoprecipitation microarray chip. Differentially methylated loci were validated by bisulfite sequencing PCR, and the messenger RNA (mRNA) levels of candidate genes were evaluated by reverse transcriptase PCR. We found 224 genes that showed differential DNA methylation between epileptic patients and controls. Among the seven candidate genes, three genes (TUBB2B, ATPGD1, and HTR6) showed relative transcriptional regulation by DNA methylation. TUBB2B and ATPGD1 exhibited hypermethylation and decreased mRNA levels, whereas HTR6 displayed hypomethylation and increased mRNA levels in the epileptic samples. Our findings suggest that certain genes become differentially regulated by DNA methylation in human epilepsy.	[Wang, Liang; Fu, Xinwei; Xiao, Zheng; Li, Zhonggui; Chen, Guojun; Wang, Xuefeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Neurol, Dept Neurol, Chongqing 400016, Peoples R China; [Peng, Xi] Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, Chongqing 400010, Peoples R China	Wang, XF (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Neurol, Dept Neurol, Chongqing 400016, Peoples R China.	xfyp@163.com		Chen, Guo-Jun/0000-0001-8148-9810	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201003, 81271445]	This work was supported by the National Natural Science Foundation of China (grant numbers 81201003, 81271445). We thank the patients and their families for their participation in this study. We also thank the KangChen Bio-tech for the technical assistance with the MeDIP-chip.	Bagdy G, 2007, J NEUROCHEM, V100, P857, DOI 10.1111/j.1471-4159.2006.04277.x; Belhedi N, 2014, EPILEPSY RES, V108, P144, DOI 10.1016/j.eplepsyres.2013.10.007; Carr IM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm330; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; El-Osta A, 2000, GENE EXPRESSION, V9, P63; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Freitas RL, 2009, EXP NEUROL, V217, P16, DOI 10.1016/j.expneurol.2009.01.003; Gardiner J, 2010, NEUROSCIENTIST, V16, P28, DOI 10.1177/1073858409334422; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Kobow K, 2013, ACTA NEUROPATHOL, V126, P741, DOI 10.1007/s00401-013-1168-8; Kobow K, 2013, EPILEPSIA, V54, P41, DOI 10.1111/epi.12183; Kobow K, 2011, EPILEPSIA, V52, P15, DOI 10.1111/j.1528-1167.2011.03145.x; Kobow K, 2009, J NEUROPATH EXP NEUR, V68, P356, DOI 10.1097/NEN.0b013e31819ba737; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lundberg J, 2009, NEUROSCI LETT, V457, P8, DOI 10.1016/j.neulet.2009.03.105; Luo J, 2012, NEUROCHEM RES, V37, P1381, DOI 10.1007/s11064-012-0712-6; Machnes ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076299; Miller-Delaney SFC, 2012, J NEUROSCI, V32, P1577, DOI 10.1523/JNEUROSCI.5180-11.2012; Miyaji T, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-15; Movassagh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008564; Nateri AS, 2007, EMBO J, V26, P4891, DOI 10.1038/sj.emboj.7601911; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Ortiz RM, 2005, MOL BRAIN RES, V137, P272, DOI 10.1016/j.molbrainres.2005.03.008; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Scacheri PC, 2006, METHOD ENZYMOL, V411, P270, DOI 10.1016/S0076-6879(06)11014-9; Schumacher Axel, 2008, V439, P109, DOI 10.1007/978-1-59745-188-8_8; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Uribe V, 2010, Clin Genet, V77, P34; Xi ZQ, 2007, EUR J NEUROL, V14, P865, DOI 10.1111/j.1468-1331.2007.01777.x; Xi ZQ, 2009, SYNAPSE, V63, P1017, DOI 10.1002/syn.20681; Yuan J, 2010, J MOL NEUROSCI, V42, P53, DOI 10.1007/s12031-010-9330-4; Zhu Q, 2012, J MOL NEUROSCI, V46, P420, DOI 10.1007/s12031-011-9602-7; Zhu YY, 2007, NEUROSCI LETT, V416, P211, DOI 10.1016/j.neulet.2007.01.075	42	20	21	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAY	2016	59	1					68	77		10.1007/s12031-016-0735-6			10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	DL0JK	WOS:000375318500008	27067309				2021-06-18	
J	Zatzick, DF; Russo, J; Darnell, D; Chambers, DA; Palinkas, L; Van Eaton, E; Wang, J; Ingraham, LM; Guiney, R; Heagerty, P; Comstock, B; Whiteside, LK; Jurkovich, G				Zatzick, Douglas F.; Russo, Joan; Darnell, Doyanne; Chambers, David A.; Palinkas, Lawrence; Van Eaton, Erik; Wang, Jin; Ingraham, Leah M.; Guiney, Roxanne; Heagerty, Patrick; Comstock, Bryan; Whiteside, Lauren K.; Jurkovich, Gregory			An effectiveness-implementation hybrid trial study protocol targeting posttraumatic stress disorder and comorbidity	IMPLEMENTATION SCIENCE			English	Article						Traumatic injury; Multiple chronic conditions; Posttraumatic stress disorder; Depression; Suicidal ideation; Substance abuse; Effectiveness-implementation hybrid; Pragmatic clinical trial; American College of Surgeons; Policy	RANDOMIZED CONTROLLED-TRIAL; STEPPED COLLABORATIVE CARE; INJURED TRAUMA SURVIVORS; POLYTRAUMA-CLINICAL-TRIAD; TIME TRADE-OFF; BRIEF INTERVENTION; SUBSTANCE USE; PREVENTIVE INTERVENTIONS; FUNCTIONAL OUTCOMES; DEPRESSIVE SYMPTOMS	Background: Each year in the USA, 1.5-2.5 million Americans are so severely injured that they require inpatient hospitalization. Multiple conditions including posttraumatic stress disorder (PTSD), alcohol and drug use problems, depression, and chronic medical conditions are endemic among physical trauma survivors with and without traumatic brain injuries. Methods/design: The trauma survivors outcomes and support (TSOS) effectiveness-implementation hybrid trial is designed to test the delivery of high-quality screening and intervention for PTSD and comorbidities across 24 US level I trauma center sites. The pragmatic trial aims to recruit 960 patients. The TSOS investigation employs a stepped wedge cluster randomized design in which sites are randomized sequentially to initiate the intervention. Patients identified by a 10-domain electronic health record screen as high risk for PTSD are formally assessed with the PTSD Checklist for study entry. Patients randomized to the intervention condition will receive stepped collaborative care, while patients randomized to the control condition will receive enhanced usual care. The intervention training begins with a 1-day on-site workshop in the collaborative care intervention core elements that include care management, medication, cognitive behavioral therapy, and motivational-interviewing elements targeting PTSD and comorbidity. The training is followed by site supervision from the study team. The investigation aims to determine if intervention patients demonstrate significant reductions in PTSD and depressive symptoms, suicidal ideation, alcohol consumption, and improvements in physical function when compared to control patients. The study uses implementation science conceptual frameworks to evaluate the uptake of the intervention model. At the completion of the pragmatic trial, results will be presented at an American College of Surgeons' policy summit. Twenty-four representative US level I trauma centers have been selected for the study, and the protocol is being rolled out nationally. Discussion: The TSOS pragmatic trial simultaneously aims to establish the effectiveness of the collaborative care intervention targeting PTSD and comorbidity while also addressing sustainable implementation through American College of Surgeons' regulatory policy. The TSOS effectiveness-implementation hybrid design highlights the importance of partnerships with professional societies that can provide regulatory mandates targeting enhanced health care system sustainability of pragmatic trial results.	[Zatzick, Douglas F.; Russo, Joan; Darnell, Doyanne; Ingraham, Leah M.; Guiney, Roxanne] Univ Washington, Dept Psychiat & Behav Sci, 325 Ninth Ave,Box 359911, Seattle, WA 98104 USA; [Chambers, David A.] NCI, Div Canc Control & Populat Sci, BG 9609 MSC 9760,9609 Med Ctr Dr, Bethesda, MD 20892 USA; [Palinkas, Lawrence] Univ So Calif, Sch Social Work, Montgomery Ross Fisher Bldg,Room 339, Los Angeles, CA 90089 USA; [Van Eaton, Erik] Univ Washington, Dept Surg, 325 Ninth Ave,Box 359796, Seattle, WA 98104 USA; [Zatzick, Douglas F.; Wang, Jin] Univ Washington, Harborview Injury Prevent Res Ctr, 325 Ninth Ave,Box 359960, Seattle, WA 98104 USA; [Heagerty, Patrick; Comstock, Bryan] Univ Washington, Dept Biostat, 1705 NE Pacific St,Box 357232, Seattle, WA 98195 USA; [Whiteside, Lauren K.] Univ Washington, Div Emergency Med, 25 Ninth Ave,Box 359702, Seattle, WA 98104 USA; [Jurkovich, Gregory] Univ Calif Davis, Dept Surg, 2221 Stockton Blvd,Cypress 3111, Sacramento, CA 95817 USA	Zatzick, DF (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, 325 Ninth Ave,Box 359911, Seattle, WA 98104 USA.; Zatzick, DF (corresponding author), Univ Washington, Harborview Injury Prevent Res Ctr, 325 Ninth Ave,Box 359960, Seattle, WA 98104 USA.	dzatzick@uw.edu		Whiteside, Lauren/0000-0002-0284-5336	National Institutes of Health (NIH) Common Fund, through Office of Strategic Coordination within the Office of the NIH Director [U54 AT007748, 1UH2MH106338-01/4UH3MH106338-02]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [1 K24MH086814-01A1]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54AT007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [UH2MH106338, K24MH086814, UH3MH106338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K23DA039974] Funding Source: NIH RePORTER	This work is supported by the National Institutes of Health (NIH) Common Fund, through cooperative agreements (U54 AT007748, 1UH2MH106338-01/4UH3MH106338-02) from the Office of Strategic Coordination within the Office of the NIH Director, and the National Institute of Mental Health (1 K24MH086814-01A1). The views presented here are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.	Adams GA, 1998, PERS PSYCHOL, V51, P643, DOI 10.1111/j.1744-6570.1998.tb00255.x; Adams JG, 2013, JAMA-J AM MED ASSOC, V309, P1173, DOI 10.1001/jama.2013.2476; Allen Donner, 2000, DESIGN ANAL CLUSTER; American College of Surgeons Committee on Trauma, 2006, RES OPT CAR INJ PAT; American College of Surgeons Committee on Trauma, 2014, RES OPT CAR INJ PAT, V6th; [Anonymous], 1999, RES OPT CAR INJ PAT; Babor TF, 1989, ALCOHOL USE DISORDER; Badia X, 1999, QUAL LIFE RES, V8, P303, DOI 10.1023/A:1008952423122; Benner P., 1994, INTERPRETIVE PHENOME; BERGEN G, 2008, DHHS PUBLICATION; Bergman Karen, 2010, J Trauma Nurs, V17, P102, DOI 10.1097/JTN.0b013e3181ecc452; Bindman AB, 2013, JAMA-J AM MED ASSOC, V310, P1125, DOI 10.1001/jama.2013.276525; Bonnie R.J., 1999, REDUCING BURDEN INJU; Bosch M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-281; Boye KS, 2014, EXPERT REV PHARM OUT, V14, P437, DOI 10.1586/14737167.2014.912562; Bradley K, 2014, RESULTS POPULATION B; Bride BE, 2004, RES SOCIAL WORK PRAC, V14, P27, DOI 10.1177/1049731503254106; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Burke RE, 2013, JAMA INTERN MED, V173, P695, DOI 10.1001/jamainternmed.2013.171; Caldwell SD, 2004, J APPL PSYCHOL, V89, P868, DOI 10.1037/0021-9010.89.5.868; Creswell J., 2011, DESIGNING CONDUCTING; Creswell J.W., 2013, QUAL INQ; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Darnell D, 2016, J SUBST ABUSE TREAT, V60, P36, DOI 10.1016/j.jsat.2015.05.010; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; English M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-124; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Federal Coordinating Council for Comparative Effectiveness Research, 2009, REP PRES C; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Fixsen D. L., 2005, IMPLEMENTATION RES S; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frankel HL, 2012, J TRAUMA ACUTE CARE, V73, P20, DOI 10.1097/TA.0b013e31825a78d5; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Glasgow RE, 2012, CTS-CLIN TRANSL SCI, V5, P48, DOI 10.1111/j.1752-8062.2011.00383.x; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Hemming K, 2014, STATA J, V14, P363, DOI 10.1177/1536867X1401400208; Hogan SJ, 2014, J BUS RES, V67, P1609, DOI 10.1016/j.jbusres.2013.09.007; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hom P.W., 1995, EMPLOYEE TURNOVER; Hughes JP, 2015, CONTEMP CLIN TRIALS, V45, P55, DOI 10.1016/j.cct.2015.07.006; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Inst. Med, 2008, LEARN HEALTHC SYST C; Johnson KE, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6826; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P148, DOI 10.1097/TA.0000000000000271; Katon W, 1997, GEN HOSP PSYCHIAT, V19, P169, DOI 10.1016/S0163-8343(97)00016-9; Katon W, 2001, ARCH GEN PSYCHIAT, V58, P241, DOI 10.1001/archpsyc.58.3.241; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khoury AL, 2013, J TRAUMA ACUTE CARE, V75, P512, DOI 10.1097/TA.0b013e3182924977; Koepsell TD, 2011, AM J PREV MED, V40, P191, DOI 10.1016/j.amepre.2010.10.022; Krebs EE, 2010, MED CARE, V48, P1007, DOI 10.1097/MLR.0b013e3181eaf835; Krebs EE, 2009, J GEN INTERN MED, V24, P733, DOI 10.1007/s11606-009-0981-1; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, JAMA-J AM MED ASSOC, V304, P163, DOI 10.1001/jama.2010.944; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P2425, DOI 10.1001/jama.2013.6494; Love J, 2014, PSYCHIAT SERV, V65, P918, DOI 10.1176/appi.ps.201300399; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; MACKENZIE EJ, 1989, J TRAUMA, V29, P757, DOI 10.1097/00005373-198906000-00011; March J, 2010, NEUROPSYCHOPHARMACOL, V35, P2491, DOI 10.1038/npp.2010.115; McCaig LF, 1994, ADV DATA VITAL HLTH; Mdege ND, 2011, J CLIN EPIDEMIOL, V64, P936, DOI 10.1016/j.jclinepi.2010.12.003; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Miles M.B., 1994, QUALITATIVE DATA ANA; Mobley WH., 1982, EMPLOYEE TURNOVER CA; Murray, 1998, DESIGN ANAL GROUP RA; Murray DM, 2008, JNCI-J NATL CANCER I, V100, P483, DOI 10.1093/jnci/djn066; Murray DM, 2004, AM J PUBLIC HEALTH, V94, P423, DOI 10.2105/AJPH.94.3.423; National Center for Complementary and Alternative Medicine, 2012, RFARM12002 NAT CTR C; National Center for Injury Prevention, 2012, CDC 2012; National Institute of Neurological Disorders and Stroke, 2009, TRAUM BRAIN INJ HOP; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; O'Connor SS, 2014, SUICIDE LIFE-THREAT, V44, P473, DOI 10.1111/sltb.12085; Palinkas Lawrence A, 2004, Prehosp Disaster Med, V19, P113; Palinkas LA, 2011, PSYCHIAT SERV, V62, P255, DOI 10.1176/ps.62.3.pss6203_0255; Palinkas LA, 2011, ADM POLICY MENT HLTH, V38, P44, DOI 10.1007/s10488-010-0314-z; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; Peek C.J., 2011, COLLABORATIVE CARE L; Proctor E, 2010, ADM POLICY MENT HLTH; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Raghavan R., 2012, DISSEMINATION IMPLEM, P94; Ramstad SM, 2004, J TRAUMA STRESS, V17, P529, DOI 10.1007/s10960-004-5802-z; Raudenbush SW, 2000, PSYCHOL METHODS, V5, P199, DOI 10.1037//1082-989X.5.2.199; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Rice DP, 1989, COST INJURY US REPOR; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Richesson RL, 2013, J AM MED INFORM ASSN, V20, pE226, DOI 10.1136/amiajnl-2013-001926; Rogers E. M., 2010, DIFFUSION INNOVATION; Rollman BL, 2005, ARCH GEN PSYCHIAT, V62, P1332, DOI 10.1001/archpsyc.62.12.1332; Rollman BL, 2009, JAMA-J AM MED ASSOC, V302, P2095, DOI 10.1001/jama.2009.1670; Roy-Byrne P, 2010, JAMA-J AM MED ASSOC, V303, P1921, DOI 10.1001/jama.2010.608; Russo J, 2013, GEN HOSP PSYCHIAT, V35, P485, DOI 10.1016/j.genhosppsych.2013.04.016; Sacks GD, 2011, J TRAUMA, V71, P1011, DOI 10.1097/TA.0b013e3182092c27; Saldana L, 2014, CHILD YOUTH SERV REV, V39, P177, DOI 10.1016/j.childyouth.2013.10.006; Scrimshaw NS., 1992, RAPID ASSESSMENT PRO; Shafi S, 2012, J TRAUMA ACUTE CARE, V73, P1303, DOI 10.1097/TA.0b013e318265d219; Shafi S, 2010, J TRAUMA, V69, P1367, DOI 10.1097/TA.0b013e3181fb785d; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Soderstrom CA, 1997, JAMA-J AM MED ASSOC, V277, P1769, DOI 10.1001/jama.277.22.1769; Tavender EJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0264-7; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; TEASDALE G, 1974, LANCET, V2, P81; Terrell F, 2008, J AM COLL SURGEONS, V207, P630, DOI 10.1016/j.jamcollsurg.2008.05.021; The Johns Hopkins Health Services Research and Development Center, 1989, DET INJ SEV HOSP SIS; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI 10.1016/j.jclinepi.2008.12.011; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; United States. President's Commission on Care for America's Returning Wounded Warriors, 2007, SERV SUPP SIMPL REP; Unutzer J, 2002, PSYCHIATR SERV, V53, P671, DOI 10.1176/appi.ps.53.6.671; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; US Department of Health and Human Services, 2010, MULTIPLE CHRONIC CON; Van Eaton EG, 2014, J AM COLL SURGEONS, V219, P505, DOI 10.1016/j.jamcollsurg.2014.02.032; Vashi AA, 2013, JAMA-J AM MED ASSOC, V309, P364, DOI 10.1001/jama.2012.216219; Wallace RB, 2013, CENT DIS CONTROL PRE, V10, P5; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE., 1993, SF 36 HLTH SURVEY MA; Weathers F., 1996, MEASUREMENT STRESS T, P250; Weathers F.W., 1991, PTSD CHECKLIST CIVIL; Weathers FW, 1994, SAN ANT TX 9 ANN M I; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Woertman W, 2013, J CLIN EPIDEMIOL, V66, P752, DOI 10.1016/j.jclinepi.2013.01.009; World Health Organization, 2012, DIS INJ COUNTR EST; Wright DR, 2009, PHARMACOECONOMICS, V27, P713, DOI 10.2165/11317060-000000000-00000; Zatzick CD, 2003, ORGAN SCI, V14, P483, DOI 10.1287/orsc.14.5.483.16768; Zatzick CD, 2011, SAN TX AC MAN ANN M; Zatzick CD, 2013, HEALTH CARE MANAGE R, V38, P115, DOI 10.1097/HMR.0b013e318249aa60; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zatzick DF, 2006, CLIN PSYCHOL-SCI PR, V13, P53, DOI 10.1111/j.1468-2850.2006.00006.x; Zatzick DF, 2002, ARCH SURG-CHICAGO, V137, P200, DOI 10.1001/archsurg.137.2.200; Zatzick DF, 2002, AM J PSYCHIAT, V159, P941, DOI 10.1176/appi.ajp.159.6.941; Zatzick DF, 2001, MED CARE, V39, P327, DOI 10.1097/00005650-200104000-00004; Zatzick DF, 2001, GEN HOSP PSYCHIAT, V23, P114, DOI 10.1016/S0163-8343(01)00140-2; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8; Zatzick D, 2015, J TRAUMA STRESS, V28, P391, DOI 10.1002/jts.22041; Zatzick D, 2014, JAMA PEDIATR, V168, P532, DOI 10.1001/jamapediatrics.2013.4784; Zatzick D, 2014, ADDICTION, V109, P754, DOI 10.1111/add.12492; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313; Zatzick D, 2012, J SUBST ABUSE TREAT, V43, P410, DOI 10.1016/j.jsat.2012.08.009; Zatzick D, 2011, GEN HOSP PSYCHIAT, V33, P123, DOI 10.1016/j.genhosppsych.2011.01.001; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943; Zatzick DF, 2007, PSYCHIATRY, V70, P260, DOI 10.1521/psyc.2007.70.3.260; Zatzick DF, 2013, GEN HOSP PSYCHIAT, V35, P174, DOI 10.1016/j.genhosppsych.2012.11.012; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; Zatzick DF, 2009, PSYCHIATRY, V72, P346, DOI 10.1521/psyc.2009.72.4.346; Zwarenstein M, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2390	152	20	20	0	20	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1748-5908			IMPLEMENT SCI	Implement. Sci.	APR 30	2016	11								58	10.1186/s13012-016-0424-4			16	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	DK7MO	WOS:000375110000001	27130272	DOAJ Gold, Green Published			2021-06-18	
J	Karelina, K; Sarac, B; Freeman, LM; Gaier, KR; Weil, ZM				Karelina, Kate; Sarac, Benjamin; Freeman, Lindsey M.; Gaier, Kristopher R.; Weil, Zachary M.			Traumatic brain injury and obesity induce persistent central insulin resistance	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						anxiety; central metabolism; high-fat diet; insulin receptor; mouse; neuroinflammation	ENDOTHELIAL GROWTH-FACTOR; DIET-INDUCED OBESITY; ALZHEIMERS-DISEASE; GLUCOSE-HOMEOSTASIS; AKT PHOSPHORYLATION; OXIDATIVE STRESS; DIABETES-MELLITUS; CEREBRAL-ISCHEMIA; VASCULAR DEMENTIA; MATERNAL OBESITY	Traumatic brain injury (TBI)-induced impairments in cerebral energy metabolism impede tissue repair and contribute to delayed functional recovery. Moreover, the transient alteration in brain glucose utilization corresponds to a period of increased vulnerability to the negative effects of a subsequent TBI. In order to better understand the factors contributing to TBI-induced central metabolic dysfunction, we examined the effect of single and repeated TBIs on brain insulin signalling. Here we show that TBI induced acute brain insulin resistance, which resolved within 7days following a single injury but persisted until 28days following repeated injuries. Obesity, which causes brain insulin resistance and neuroinflammation, exacerbated the consequences of TBI. Obese mice that underwent a TBI exhibited a prolonged reduction of Akt (also known as protein kinase B) signalling, exacerbated neuroinflammation (microglial activation), learning and memory deficits, and anxiety-like behaviours. Taken together, the transient changes in brain insulin sensitivity following TBI suggest a reduced capacity of the injured brain to respond to the neuroprotective and anti-inflammatory actions of insulin and Akt signalling, and thus may be a contributing factor for the damaging neuroinflammation and long-lasting deficits that occur following TBI.	[Karelina, Kate] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Dept Neurosci, Wexner Med Ctr, Biomed Res Tower 618,460 West 12th Ave, Columbus, OH 43210 USA; Ohio State Univ, Wexner Med Ctr, Grp Behav Neuroendocrinol, Biomed Res Tower 618,460 West 12th Ave, Columbus, OH 43210 USA	Karelina, K (corresponding author), Ohio State Univ, Ctr Brain & Spinal Cord Repair, Dept Neurosci, Wexner Med Ctr, Biomed Res Tower 618,460 West 12th Ave, Columbus, OH 43210 USA.	Ekaterina.karelina@osumc.edu	Weil, Zachary M/B-5003-2008; Weil, Zachary M/A-2439-2008	Weil, Zachary M/0000-0003-3758-1809; Weil, Zachary M/0000-0003-3758-1809; Karelina Weil, Kate/0000-0002-6628-0768	OSU Neurological Institute Pilot Award;  [NS045758]	We are grateful to undergraduate research assistants Joseph Abraham, Katie Centner, Samuel Nicholson, Maya Prabhu, and Vanessa Wenger for their tireless assistance with these experiments. This work was supported by an OSU Neurological Institute Pilot Award and additional support for behavioural research was provided by NS045758.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Abr`amoff M.D., 2005, BIOPHOTONICS INT, V11, P36, DOI [10.1117/1.3589100, DOI 10.1117/1.3589100]; Adzovic L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0282-z; Aguliar-Valles A, 2014, MOL PSYCHIATR, V19, P599, DOI 10.1038/mp.2013.137; Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andre C, 2014, BRAIN BEHAV IMMUN, V41, P10, DOI 10.1016/j.bbi.2014.03.012; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Banks WA, 2004, EUR J PHARMACOL, V490, P5, DOI 10.1016/j.ejphar.2004.02.040; Banks WA, 2012, PHARMACOL THERAPEUT, V136, P82, DOI 10.1016/j.pharmthera.2012.07.006; Bateman JM, 2006, CELL MOL LIFE SCI, V63, P1701, DOI 10.1007/s00018-006-6036-4; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Bosco D, 2012, J NEUROL SCI, V315, P39, DOI 10.1016/j.jns.2011.12.008; Bouret SG, 2006, CLIN GENET, V70, P295, DOI 10.1111/j.1399-0004.2006.00684.x; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Cardoso S, 2009, J ALZHEIMERS DIS, V18, P483, DOI 10.3233/JAD-2009-1155; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Castanon N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00229; Dandona P, 2002, DIABETOLOGIA, V45, P924, DOI 10.1007/s00125-001-0766-5; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Duarte AI, 2008, BBA-MOL CELL RES, V1783, P994, DOI 10.1016/j.bbamcr.2008.02.016; Duarte AI, 2006, DIABETES, V55, P2863, DOI 10.2337/db06-0030; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Franke K, 2005, BRAIN RES, V1031, P276, DOI 10.1016/j.brainres.2004.11.006; Gerozissis K, 2008, EUR J PHARMACOL, V585, P38, DOI 10.1016/j.ejphar.2008.01.050; Ghasemi R, 2013, MOL NEUROBIOL, V47, P145, DOI 10.1007/s12035-012-8339-9; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Hopkins DFC, 1997, DIABETIC MED, V14, P1044, DOI 10.1002/(SICI)1096-9136(199712)14:12<1044::AID-DIA508>3.0.CO;2-F; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jin KL, 2000, NEUROSCIENCE, V100, P713, DOI 10.1016/S0306-4522(00)00331-6; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kamnaksh A., 2014, TRANSL PROTEOM, V3, P22, DOI [10.1016/j.trprot.2013.11.001, DOI 10.1016/J.TRPROT.2013.11.001]; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Lima MHM, 2002, ENDOCRINE, V18, P1, DOI 10.1385/ENDO:18:1:01; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Miyawaki T, 2009, NAT NEUROSCI, V12, P618, DOI 10.1038/nn.2299; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Piermartiri TCB, 2009, NEUROTOX RES, V16, P106, DOI 10.1007/s12640-009-9057-6; Piroli GG, 2007, NEUROENDOCRINOLOGY, V85, P71, DOI 10.1159/000101694; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Raygada M, 1998, J NUTR, V128, P2505; RAZAY G, 1994, AGE AGEING, V23, P396, DOI 10.1093/ageing/23.5.396; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Salkovic-Petrisic M., 2007, CENTRAL INSULIN RESI; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schulingkamp RJ, 2000, NEUROSCI BIOBEHAV R, V24, P855, DOI 10.1016/S0149-7634(00)00040-3; Sharma B, 2011, PHARMACOL BIOCHEM BE, V100, P320, DOI 10.1016/j.pbb.2011.08.020; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Watanabe T, 2005, J AM GERIATR SOC, V53, P1748, DOI 10.1111/j.1532-5415.2005.53524.x; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yamagishi S, 1999, MICROVASC RES, V57, P329, DOI 10.1006/mvre.1999.2145; Yu XR, 2006, ACTA BIOCH BIOPH SIN, V38, P241, DOI 10.1111/j.1745-7270.2006.00152.x; Zambrano E, 2013, NUTR REV, V71, pS42, DOI 10.1111/nure.12068; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zhao ZR, 2013, J CEREBR BLOOD F MET, V33, P1897, DOI 10.1038/jcbfm.2013.144	77	20	21	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	APR	2016	43	8					1034	1043		10.1111/ejn.13194			10	Neurosciences	Neurosciences & Neurology	DK1BA	WOS:000374645700005	26833850				2021-06-18	
J	Mittwede, PN; Clemmer, JS; Bergin, PF; Xiang, LS				Mittwede, Peter N.; Clemmer, John S.; Bergin, Patrick F.; Xiang, Lusha			OBESITY AND CRITICAL ILLNESS: INSIGHTS FROM ANIMAL MODELS	SHOCK			English	Article						Animal model; critical illness; hemorrhage; obese; sepsis; trauma	TRAUMATIC BRAIN-INJURY; DIET-INDUCED OBESITY; ACUTE KIDNEY INJURY; BODY-MASS INDEX; HIGH-FAT DIET; IMMUNE-RESPONSE; FUNCTIONAL VASODILATION; INFLAMMATORY RESPONSES; HEPATIC-DYSFUNCTION; INCREASED MORTALITY	Critical illness is a major cause of morbidity and mortality around the world. While obesity is often detrimental in the context of trauma, it is paradoxically associated with improved outcomes in some septic patients. The reasons for these disparate outcomes are not well understood. A number of animal models have been used to study the obese response to various forms of critical illness. Just as there have been many animal models that have attempted to mimic clinical conditions, there are many clinical scenarios that can occur in the highly heterogeneous critically ill patient population that occupies hospitals and intensive care units. This poses a formidable challenge for clinicians and researchers attempting to understand the mechanisms of disease and develop appropriate therapies and treatment algorithms for specific subsets of patients, including the obese. The development of new, and the modification of existing animal models, is important in order to bring effective treatments to a wide range of patients. Not only do experimental variables need to be matched as closely as possible to clinical scenarios, but animal models with pre-existing comorbid conditions need to be studied. This review briefly summarizes animal models of hemorrhage, blunt trauma, traumatic brain injury, and sepsis. It also discusses what has been learned through the use of obese models to study the pathophysiology of critical illness in light of what has been demonstrated in the clinical literature.	[Mittwede, Peter N.; Clemmer, John S.; Xiang, Lusha] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Bergin, Patrick F.] Univ Mississippi, Med Ctr, Dept Orthoped Surg, Jackson, MS 39216 USA	Xiang, LS (corresponding author), 2500 North State St, Jackson, MS 39216 USA.	Lxiang2@umc.edu		Clemmer, John/0000-0003-2250-2960	American Heart AssociationAmerican Heart Association [14PRE17810005, 14PRE20380069, 12SDG12050525]; Depuy-Synthes, Acumed, National Institutes of Health [P20GM104357]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20GM104357]; Orthopaedic Trauma Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM104357] Funding Source: NIH RePORTER	PNM: American Heart Association (14PRE17810005); Orthopaedic Trauma Association. JSC: American Heart Association (14PRE20380069). PFB: Depuy-Synthes, Acumed, National Institutes of Health (P20GM104357). LX: National Institutes of Health (P20GM104357); American Heart Association (12SDG12050525); Orthopaedic Trauma Association.	Andruszkow H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/345702; Bosarge Patrick L, 2013, Adv Surg, V47, P287; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Bussey CT, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0161-4; CHOBAN PS, 1991, J TRAUMA, V31, P1253, DOI 10.1097/00005373-199109000-00009; Clemmer JS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12215; Collier B, 2010, J TRAUMA, V68, P57, DOI 10.1097/TA.0b013e3181c40262; de Lima DC, 2008, METAB BRAIN DIS, V23, P361, DOI 10.1007/s11011-008-9101-x; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; Ditillo M, 2014, J TRAUMA ACUTE CARE, V76, P176, DOI 10.1097/TA.0b013e3182ab0d7c; Duburcq T, 2014, SHOCK, V41, P546, DOI 10.1097/SHK.0000000000000158; Dupuy V, 2012, SHOCK, V38, P351, DOI 10.1097/SHK.0b013e318268810f; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Frink M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/797383; Frisbee JC, 2006, J APPL PHYSIOL, V100, P465, DOI 10.1152/japplphysiol.01062.2005; Frisbee JC, 2014, AM J PHYSIOL-HEART C, V307, pH1714, DOI 10.1152/ajpheart.00605.2014; Gadek JE, 1999, CRIT CARE MED, V27, P1409, DOI 10.1097/00003246-199908000-00001; Gharib M, 2015, J TRAUMA ACUTE CARE, V78, P866, DOI 10.1097/TA.0000000000000597; Glance LG, 2014, ANN SURG, V259, P576, DOI 10.1097/SLA.0000000000000330; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Griffiths J, 2013, CRIT CARE, V28, P7; Guo RF, 2007, ANTIOXID REDOX SIGN, V9, P1991, DOI 10.1089/ars.2007.1785; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Henry ML, 2008, BLOOD COAGUL FIBRIN, V19, P124, DOI 10.1097/MBC.0b013e3282f41e56; Hoane MR, 2011, BEHAV BRAIN RES, V223, P119, DOI 10.1016/j.bbr.2011.04.028; Hogue CW, 2009, INTENS CARE MED, V35, P1152, DOI 10.1007/s00134-009-1424-5; Huttunen R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-13; Hwabejire JO, 2015, AM J SURG, V209, P659, DOI 10.1016/j.amjsurg.2014.12.016; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Jensen GL, 2012, CURR OPIN CRIT CARE, V18, P206, DOI 10.1097/MCC.0b013e328351683a; Kaplan JM, 2012, OBESITY, V20, P1995, DOI 10.1038/oby.2012.40; Kapoor JR, 2010, AM HEART J, V159, P75, DOI 10.1016/j.ahj.2009.10.026; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Khan M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/719853; Kobbe P, 2008, SHOCK, V30, P686, DOI 10.1097/SHK.0b013e31816f257e; Kobbe P, 2008, SHOCK, V30, P43, DOI [10.1097/SHK.0b013e31815d190b, 10.1097/SHK.0b013e318d190b]; Kumar MA, 2012, NEUROCRIT CARE, V16, P286, DOI 10.1007/s12028-011-9576-x; Kuperman EF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-377; Lasocki S, 2015, CRIT CARE MED, V43, P240, DOI 10.1097/CCM.0000000000000646; Lawrence CB, 2012, DIS MODEL MECH, V5, P649, DOI 10.1242/dmm.009068; Lichte P, 2012, CURR OPIN CRIT CARE, V18, P647, DOI 10.1097/MCC.0b013e328359fd57; Lilley E, 2015, SHOCK, V43, P304, DOI 10.1097/SHK.0000000000000318; Liu T, 2013, INJURY, V44, P1145, DOI 10.1016/j.injury.2012.10.038; Lomas-Niera JL, 2005, SHOCK, V24, P33, DOI 10.1097/01.shk.0000191411.48719.ab; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Lutz T.A., 2012, CURR PROT PHARM, V61, P1; Majde JA, 2003, J TRAUMA, V54, pS100, DOI 10.1097/01.TA.0000064503.24416.F4; Mariappan MM, 2014, AM J PHYSIOL-CELL PH, V306, pC202, DOI 10.1152/ajpcell.00144.2013; Marques MB, 2013, CRIT CARE MED, V41, P317, DOI 10.1097/CCM.0b013e318265f21c; Matheson PJ, 2012, J AM COLL SURGEONS, V214, P517, DOI 10.1016/j.jamcollsurg.2011.12.016; Matheson PJ, 2009, SURGERY, V146, P739, DOI 10.1016/j.surg.2009.06.037; McCully BH, 2014, J TRAUMA ACUTE CARE, V77, P873, DOI 10.1097/TA.0000000000000461; Medby C, 2014, SHOCK, V41, P47, DOI 10.1097/SHK.0000000000000117; Menzel CL, 2011, J SURG RES, V166, pE149, DOI 10.1016/j.jss.2010.11.914; Mittwede PN, 2015, CRIT CARE MED, V43, pE321, DOI 10.1097/CCM.0000000000000996; Mittwede PN, 2015, AM J PHYSIOL-RENAL, V308, pF157, DOI 10.1152/ajprenal.00537.2014; Nelson J, 2012, CRIT CARE, V16, DOI 10.1186/cc11334; Nilsson C, 2012, ACTA PHARMACOL SIN, V33, P173, DOI 10.1038/aps.2011.203; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Pickkers P, 2013, CRIT CARE MED, V41, P1878, DOI 10.1097/CCM.0b013e31828a2aa1; Pieracci F, 2008, SURG INFECT, V9, P121, DOI 10.1089/sur.2007.039; Pini M, 2013, CYTOKINE, V61, P71, DOI 10.1016/j.cyto.2012.08.027; Prescott HC, 2014, CRIT CARE MED, V42, P1766, DOI 10.1097/CCM.0000000000000336; Redl H, 2005, SHOCK, V24, P88, DOI 10.1097/01.shk.0000191339.46777.63; Robinson MK, 2015, CRIT CARE MED, V43, P87, DOI 10.1097/CCM.0000000000000602; Rogers FB, 2012, J TRAUMA ACUTE CARE, V73, P511, DOI 10.1097/TA.0b013e3182588b54; Sakai S, 2013, J SURG RES, V185, P353, DOI 10.1016/j.jss.2013.06.002; Schreihofer AM, 2005, AM J PHYSIOL-REG I, V288, pR253, DOI 10.1152/ajpregu.00498.2004; Sebai M, 2011, AM J PHYSIOL-HEART C, V301, pH1090, DOI 10.1152/ajpheart.00233.2011; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Siegl D, 2014, ANESTHESIOLOGY, V121, P98, DOI 10.1097/ALN.0000000000000192; Singer G, 2009, SHOCK, V31, P275, DOI 10.1097/SHK.0b013e3181834ab3; Singh P, 2013, CLIN EXP PHARMACOL P, V40, P138, DOI 10.1111/1440-1681.12036; Speakman J, 2007, OBES REV, V8, P55, DOI 10.1111/j.1467-789X.2007.00319.x; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; Straub RH, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4688; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tsukamoto T, 2009, SHOCK, V31, P3, DOI 10.1097/SHK.0b013e31817fdabf; Vachharajani V, 2007, MICROCIRCULATION, V14, P223, DOI 10.1080/10739680601139153; Vachharajani V, 2006, MICROCIRCULATION, V13, P477, DOI 10.1080/10739680600777599; Valparaiso AP, 2015, J SURG RES, V194, P220, DOI 10.1016/j.jss.2014.10.025; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Wacharasint P, 2013, CRIT CARE, V17, DOI 10.1186/cc12794; Winfield RD, 2014, NUTR CLIN PRACT, V29, P747, DOI 10.1177/0884533614553234; Winfield RD, 2013, J AM COLL SURGEONS, V216, P1193, DOI 10.1016/j.jamcollsurg.2013.01.055; Winfield RD, 2012, SHOCK, V37, P253, DOI 10.1097/SHK.0b013e3182449c0e; Winfield RD, 2010, CRIT CARE MED, V38, P51, DOI 10.1097/CCM.0b013e3181b08089; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Xiang LS, 2008, AM J PHYSIOL-HEART C, V294, pH1658, DOI 10.1152/ajpheart.01206.2007; Xiang LS, 2014, AM J PHYSIOL-HEART C, V307, pH621, DOI 10.1152/ajpheart.00208.2014; Xiang LS, 2014, AM J PHYSIOL-HEART C, V306, pH684, DOI 10.1152/ajpheart.00868.2013; Xiang LS, 2013, LIFE SCI, V93, P214, DOI 10.1016/j.lfs.2013.06.006; Xiang LS, 2010, MICROCIRCULATION, V17, P650, DOI 10.1111/j.1549-8719.2010.00061.x; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	100	20	20	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	APR	2016	45	4					349	358		10.1097/SHK.0000000000000512			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	DK2QY	WOS:000374760700003	26513706	Green Accepted			2021-06-18	
J	Zhao, S; Gao, X; Dong, WR; Chen, JH				Zhao, Shu; Gao, Xiang; Dong, Weiren; Chen, Jinhui			The Role of 7,8-Dihydroxyflavone in Preventing Dendrite Degeneration in Cortex After Moderate Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Dendrite; Degeneration; Brain-derived neurotrophic factor; 7,8-Dihydroxyflavone	SYNAPTIC PLASTICITY; MOUSE MODEL; NEUROTROPHIC FACTOR; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; MEMORY DEFICITS; TRKB AGONIST; CELLS; BDNF; RAT	Our previous research showed that traumatic brain injury (TBI) induced by controlled cortical impact (CCI) not only causes massive cell death, but also results in extensive dendrite degeneration in those spared neurons in the cortex. Cell death and dendrite degeneration in the cortex may contribute to persistent cognitive, sensory, and motor dysfunction. There is still no approach available to prevent cells from death and dendrites from degeneration following TBI. When we treated the animals with a small molecule, 7,8-dihydroxyflavone (DHF) that mimics the function of brain-derived neurotrophic factor (BDNF) through provoking TrkB activation reduced dendrite swellings in the cortex. DHF treatment also prevented dendritic spine loss after TBI. Functional analysis showed that DHF improved rotarod performance on the third day after surgery. These results suggest that although DHF treatment did not significantly reduced neuron death, it prevented dendrites from degenerating and protected dendritic spines against TBI insult. Consequently, DHF can partially improve the behavior outcomes after TBI.	[Zhao, Shu; Dong, Weiren] Southern Med Univ, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China; [Gao, Xiang; Chen, Jinhui] Indiana Univ, Spinal Cord & Brain Injury Res Grp, 950 W Walnut St, Indianapolis, IN 46202 USA; [Gao, Xiang; Chen, Jinhui] Indiana Univ, Stark Neurosci Res Inst, 950 W Walnut St, Indianapolis, IN 46202 USA; [Gao, Xiang; Chen, Jinhui] Indiana Univ, Dept Neurosurg, 950 W Walnut St, Indianapolis, IN 46202 USA; [Chen, Jinhui] Indiana Univ, Sch Med, 950 W Walnut St, Indianapolis, IN 46202 USA; [Dong, Weiren] 1838 North Guangzhou Blvd, Guangzhou 510515, Guangdong, Peoples R China	Chen, JH (corresponding author), Indiana Univ, Sch Med, 950 W Walnut St, Indianapolis, IN 46202 USA.; Dong, WR (corresponding author), 1838 North Guangzhou Blvd, Guangzhou 510515, Guangdong, Peoples R China.	wrdong@163.com; chen204@iupui.edu			Indiana Spinal Cord & Brain Injury Research Grants; Ralph W. and Grace M. Showalter Research Award; Indiana University Biological Research Grant; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RR025761, 1R21NS072631-01A]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS075733, R21NS072631] Funding Source: NIH RePORTER	This work was supported through funding from the Indiana Spinal Cord & Brain Injury Research Grants, the Ralph W. and Grace M. Showalter Research Award, Indiana University Biological Research Grant, and NIH grants RR025761 and 1R21NS072631-01A.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Andero R, 2012, HIPPOCAMPUS, V22, P399, DOI 10.1002/hipo.20906; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Chen J, 2009, J NEUROTRAUM, DOI [10.1089/neu.2008-0744, DOI 10.1089/NEU.2008-0744]; Chen J, 2011, NEUROSCI LETT, V499, P181, DOI 10.1016/j.neulet.2011.05.054; Chen LJ, 2010, J NEUROTRAUM, V27, P1657, DOI 10.1089/neu.2010.1308; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Gao X, 2008, J NEUROTRAUM, V25, P985, DOI 10.1089/neu.2008.0460; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Johnson RA, 2012, J APPL PHYSIOL, V112, P704, DOI 10.1152/japplphysiol.01361.2011; Kishino A, 1997, EXP NEUROL, V144, P273, DOI 10.1006/exnr.1996.6367; Liu X, 2010, J MED CHEM, V53, P8274, DOI 10.1021/jm101206p; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Park HY, 2012, ONCOL REP, V28, P353, DOI 10.3892/or.2012.1773; Park HY, 2012, INT J MOL MED, V29, P1146, DOI 10.3892/ijmm.2012.935; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Risher WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022351; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SHOLL DA, 1956, PROG NEUROBIOL, V2, P324; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.3.CO;2-K; Spencer JPE, 2008, P NUTR SOC, V67, P238, DOI 10.1017/S0029665108007088; Srivastava DP, 2013, NEUROSCIENCE, V239, P17, DOI 10.1016/j.neuroscience.2012.12.004; UYLINGS HBM, 1986, J NEUROSCI METH, V18, P127, DOI 10.1016/0165-0270(86)90116-0; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Zeng Y, 2012, J ALZHEIMERS DIS, V31, P765, DOI 10.3233/JAD-2012-120886; Zeng Y, 2012, J NEUROCHEM, V122, P800, DOI 10.1111/j.1471-4159.2012.07830.x; Zhang R, 2009, BIOL PHARM BULL, V32, P166, DOI 10.1248/bpb.32.166; Zhang ZT, 2014, NEUROPSYCHOPHARMACOL, V39, P638, DOI 10.1038/npp.2013.243; Zoladz JA, 2010, J PHYSIOL PHARMACOL, V61, P533	48	20	20	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	APR	2016	53	3					1884	1895		10.1007/s12035-015-9128-z			12	Neurosciences	Neurosciences & Neurology	DG7KQ	WOS:000372263600044	25801526	Green Accepted			2021-06-18	
J	Toth, A; Kovacs, N; Tamas, V; Kornyei, B; Nagy, M; Horvath, A; Rostas, T; Bogner, P; Janszky, J; Doczi, T; Buki, A; Schwarcz, A				Toth, Arnold; Kovacs, Noemi; Tamas, Viktoria; Kornyei, Balint; Nagy, Mate; Horvath, Andrea; Rostas, Tamas; Bogner, Peter; Janszky, Jozsef; Doczi, Tamas; Buki, Andras; Schwarcz, Attila			Microbleeds may expand acutely after traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Susceptibility weighted imaging; Traumatic brain injury; Diffuse axonal injury; Microbleed; Microhemorrhage; Magnetic resonance imaging	CEREBRAL MICROBLEEDS; AXONAL INJURY; INTRACEREBRAL HEMORRHAGE; ECHO MRI; LESIONS; PREDICTION; CHILDREN; CT	Background and purpose: Susceptibility weighted imaging (SWI) is a very sensitive tool for the detection of microbleeds in traumatic brain injury (TBI). The number and extent of such traumatic microbleeds (TMBs) have been shown to correlate with the severity of the injury and the clinical outcome. However, the acute dynamics of TMBs have not been revealed so far. Since TBI is known to constitute dynamic pathological processes, we hypothesized that TMBs are not constant in their appearance, but may progress acutely after injury. Materials and methods: We present here five closed moderate/severe (Glasgow coma scale <= 13) TBI patients who underwent SWI very early (average = 23.4 h), and once again a week (average = 185.8 h) after the injury. The TMBs were mapped at both time points by a conventional radiological approach and their numbers and volumes were measured with manual tracing tools by two observers. TMB counts and extents were compared between time points. Results: TMBs were detected in four patients, three of them displaying an apparent TMB change. In these patients, TMB confluence and apparent growth were detected in the corpus callosum, coronal radiation or subcortical white matter, while unchanged TMBs were also present. These changes caused a decrease in the TMB count associated with an increase in the overall TMB volume over time. Conclusion: We have found a compelling evidence that diffuse axonal injury-related microbleed development is not limited strictly to the moment of injury: the TMBs might expand in the acute phase of TBI. The timing of SWI acquisition may be relevant for optimizing the prognostic utility of this imaging biomarker. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Toth, Arnold; Kovacs, Noemi; Tamas, Viktoria; Kornyei, Balint; Nagy, Mate; Horvath, Andrea; Bogner, Peter; Doczi, Tamas; Buki, Andras; Schwarcz, Attila] Pecs Med Sch, Dept Neurosurg, Ret U 2, H-7623 Pecs, Hungary; [Horvath, Andrea; Doczi, Tamas] Diagnost Ctr Pecs, Ret U 2, H-7623 Pecs, Hungary; [Rostas, Tamas; Bogner, Peter] Pecs Med Sch, Dept Radiol, Ifjusag Str 13, H-7623 Pecs, Hungary; [Janszky, Jozsef] Pecs Med Sch, Dept Neurol, Ret U 2, H-7623 Pecs, Hungary; [Janszky, Jozsef; Doczi, Tamas; Buki, Andras; Schwarcz, Attila] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary	Toth, A (corresponding author), Dept Neurosurg, Ret U 2 Pecs, H-7623 Pecs, Hungary.	prsarn@gmail.com; noemi.kovacs5@gmail.com; tamas.viktoria@pte.hu; kornyei.balint@windowslive.com; nagy.mate@pte.hu; andrhorvath@gmail.com; rostas.tamas@pte.hu; peter.bogner@gmail.com; jozseEjanszky@gmail.com; doczi.tamas@pte.hu; 2saturn@pte.hu; schwarcz.attila@pte.hu	Kornyei, Balint/AAK-7548-2020		Hungarian Brain Research Program Grant [KTIA_13_NAP-A-II/8, KTIA_13_NAP-A-II/9, SROP-4.2.2.A-11/1/KONV-2012-0017]; Hungarian Scientific Research Fund Grant [OTKA/109132]	This study was funded by Hungarian Brain Research Program Grant No. KTIA_13_NAP-A-II/8, Grant No. KTIA_13_NAP-A-II/9, SROP-4.2.2.A-11/1/KONV-2012-0017 and Hungarian Scientific Research Fund Grant No. OTKA/109132.	Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Belayev L, 2007, BRAIN RES, V1157, P146, DOI 10.1016/j.brainres.2007.04.077; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Di Ieva A., 2015, J NEUROSURG, P1; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Gregg NM, 2015, JAMA NEUROL, V72, P1021, DOI 10.1001/jamaneurol.2015.1359; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Knight RA, 2008, STROKE, V39, P2596, DOI 10.1161/STROKEAHA.107.506683; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Liu WH, 2012, STROKE, V43, P2916, DOI 10.1161/STROKEAHA.112.658369; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Parizel PM, 2001, EUR RADIOL, V11, P1770, DOI 10.1007/s003300000800; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Ryan N.P., 2014, HUM BRAIN MAPP; Schaible E.V., 2013, ANTICOAGULATION PATI; Schoonjans F, 1995, COMPUT METH PROG BIO, V48, P257, DOI 10.1016/0169-2607(95)01703-8; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	33	20	21	1	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 23	2016	617						207	212		10.1016/j.neulet.2016.02.028			6	Neurosciences	Neurosciences & Neurology	DI5LB	WOS:000373539400035	26912192				2021-06-18	
J	Stemper, BD; Shah, AS; Budde, MD; Olsen, CM; Glavaski-Joksimovic, A; Kurpad, SN; McCrea, M; Pintar, FA				Stemper, Brian D.; Shah, Alok S.; Budde, Matthew D.; Olsen, Christopher M.; Glavaski-Joksimovic, Aleksandra; Kurpad, Shekar N.; McCrea, Michael; Pintar, Frank A.			Behavioral Outcomes Differ between Rotational Acceleration and Blast Mechanisms of Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						concussion; rotational acceleration; blast injuries; mechanism of injury; biomechanics	PROFESSIONAL FOOTBALL PLAYERS; HIPPOCAMPAL SLICE CULTURES; CONTROLLED CORTICAL IMPACT; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION; INDUCED NEUROTRAUMA; SHOCK-WAVE; RAT MODEL; EXPOSURE; OVERPRESSURE	Mild traumatic brain injury (mTBI) can result from a number of mechanisms, including blunt impact, head rotational acceleration, exposure to blast, and penetration of projectiles. Mechanism is likely to influence the type, severity, and chronicity of outcomes. The objective of this study was to determine differences in the severity and time course of behavioral outcomes following blast and rotational mTBI. The Medical College of Wisconsin (MCW) Rotational Injury model and a shock tube model of primary blast injury were used to induce mTBI in rats and behavioral assessments were conducted within the first week, as well as 30 and 60 days following injury. Acute recovery time demonstrated similar increases over protocol-matched shams, indicating acute injury severity equivalence between the two mechanisms. Post-injury behavior in the elevated plus maze demonstrated differing trends, with rotationally injured rats acutely demonstrating greater activity, whereas blast-injured rats had decreased activity that developed at chronic time points. Similarly, blast-injured rats demonstrated trends associated with cognitive deficits that were not apparent following rotational injuries. These findings demonstrate that rotational and blast injury result in behavioral changes with different qualitative and temporal manifestations. Whereas rotational injury was characterized by a rapidly emerging phenotype consistent with behavioral disinhibition, blast injury was associated with emotional and cognitive differences that were not evident acutely, but developed later, with an anxiety-like phenotype still present in injured animals at our most chronic measurements.	[Stemper, Brian D.; Shah, Alok S.; Budde, Matthew D.; Glavaski-Joksimovic, Aleksandra; Kurpad, Shekar N.; McCrea, Michael; Pintar, Frank A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Stemper, Brian D.; Budde, Matthew D.; Pintar, Frank A.] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA; [Stemper, Brian D.; Budde, Matthew D.; Olsen, Christopher M.] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Olsen, Christopher M.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA	Stemper, BD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.; Stemper, BD (corresponding author), Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA.; Stemper, BD (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA.	bstemper@mcw.edu	Kurpad, Shekar/V-2188-2019; Olsen, Christopher/G-9595-2013; Stemper, Brian/AAX-7611-2020	Olsen, Christopher/0000-0003-2700-0310; 	Merit Review Award from the United States (U.S.) Department of Veterans Affairs Rehabilitation Research and Development Service Program (PI: PAP) [RH RX000380]; Department of Neurosurgery, Medical College of Wisconsin; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R21DA039276] Funding Source: NIH RePORTER	This work was supported in part by Merit Review Award number RH RX000380 from the United States (U.S.) Department of Veterans Affairs Rehabilitation Research and Development Service Program (PI: PAP) and the Department of Neurosurgery, Medical College of Wisconsin.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Cheney JA, 2000, J NEUROTRAUM, V17, P83, DOI 10.1089/neu.2000.17.83; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Fijalkowski RJ, 2006, BIOMED SCI INSTRUM, V42, P108; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Kobeissy FH, 2015, BRAIN NEUROTRAUMA MO; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Li JR, 2007, BIOMED SCI INSTRUM, V43, P24; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 1967, 11 STAPP CAR CRASH C, P73; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; PHILLIPS YY, 1986, ANN EMERG MED, V15, P1446, DOI 10.1016/S0196-0644(86)80940-4; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Shah AS, 2011, ASME INT MECH ENG C; Shah Ms Alok S, 2012, Biomed Sci Instrum, V48, P393; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242	62	20	20	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 14	2016	7								31	10.3389/fneur.2016.00031			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DG5HM	WOS:000372108000001	27014184	DOAJ Gold, Green Published			2021-06-18	
J	Crupi, R; Impellizzeri, D; Bruschetta, G; Cordaro, M; Paterniti, I; Siracusa, R; Cuzzocrea, S; Esposito, E				Crupi, Rosalia; Impellizzeri, Daniela; Bruschetta, Giuseppe; Cordaro, Marika; Paterniti, Irene; Siracusa, Rosalba; Cuzzocrea, Salvatore; Esposito, Emanuela			Co-Ultramicronized Palmitoylethanolamide/Luteolin Promotes Neuronal Regeneration after Spinal Cord Injury	FRONTIERS IN PHARMACOLOGY			English	Article						luteolin; neurogenesis; palmitoylethanolamide; regeneration; spinal cord injury	NEURAL STEM-CELLS; ADULT SUBVENTRICULAR ZONE; TRAUMATIC BRAIN-INJURY; DORSAL VAGAL COMPLEX; NEUROTROPHIC FACTOR; FUNCTIONAL RECOVERY; RAT BRAIN; NEUROGENESIS; MICE; RECEPTOR	Spinal cord injury (SCI) stimulates activation of astrocytes and infiltration of immune cells at the lesion site; however, the mechanism that promotes the birth of new neurons is still under debate. Neuronal regeneration is restricted after spinal cord injury, but can be stimulated by experimental intervention. Previously we demonstrated that treatment co-ultramicronized palmitoylethanolamide and luteolin, namely co-ultraPEALut, reduced inflammation. The present study was designed to explore the neuroregenerative properties of co-ultraPEALut in an estabished murine model of SCI. A vascular clip was applied to the spinal cord dura at T5-18 to provoke injury. Mice were treated with co-ultraPEALut (1 mg/kg, intraperitoneally) daily for 72 h after SCI. Co-ultraPEALut increased the numbers of both bromodeoxyuridine-positive nuclei and doublecortin-immunoreactive cells in the spinal cord of injured mice. To correlate neuronal development with synaptic plasticity a Golgi method was employed to analyze dendritic spine density. Co-ultraPEALut administration stimulated expression of the neurotrophic factors brain-derived neurotrophic factor, glial cell-derived neurotrophic factor, nerve growth factor, and neurotrophin-3. These findings show a prominent effect of co-ultraPEALut administration in the management of survival and differentiation of new neurons and spine maturation, and may represent a therapeutic treatment for spinal cord and other traumatic diseases.	[Crupi, Rosalia; Impellizzeri, Daniela; Bruschetta, Giuseppe; Cordaro, Marika; Paterniti, Irene; Siracusa, Rosalba; Cuzzocrea, Salvatore; Esposito, Emanuela] Univ Messina, Dept Biol & Environm Sci, Messina, Italy; [Cuzzocrea, Salvatore] Univ Manchester, Manchester Royal Infirm, Sch Med, Manchester Biomed Res Ctr, Manchester M13 9WL, Lancs, England	Cuzzocrea, S (corresponding author), Univ Messina, Dept Biol & Environm Sci, Messina, Italy.; Cuzzocrea, S (corresponding author), Univ Manchester, Manchester Royal Infirm, Sch Med, Manchester Biomed Res Ctr, Manchester M13 9WL, Lancs, England.	salvator@unime.it	Crupi, Rosalia/U-4364-2019; Cordaro, Marika/K-7329-2016	Cordaro, Marika/0000-0002-3980-0043; Siracusa, Rosalba/0000-0001-7868-2505; Cuzzocrea, Salvatore/0000-0001-6131-3690; Impellizzeri, Daniela/0000-0001-9492-3161; Crupi, Rosalia/0000-0002-7629-3132	Italian Ministry of Instruction, University and Research grants (MIUR)Ministry of Education, Universities and Research (MIUR) [PON01_02512]	This study was supported by the Italian Ministry of Instruction, University and Research grants (MIUR; PON01_02512 grant)	Adhikary S, 2011, J NEUROTRAUM, V28, P2417, DOI 10.1089/neu.2011.1853; Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bauer S, 2005, NEUROSCIENCE, V130, P75, DOI 10.1016/j.neuroscience.2004.08.047; Berdyshev E, 1998, LIFE SCI, V63, pPL125, DOI 10.1016/S0024-3205(98)00324-5; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; BIFFO S, 1995, DEVELOPMENT, V121, P2461; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Butti E, 2012, BRAIN, V135, P3320, DOI 10.1093/brain/aws194; Ceruti S, 2009, BRAIN, V132, P2206, DOI 10.1093/brain/awp147; Chiu WT, 2010, ASIA-PAC J PUBLIC HE, V22, P9, DOI 10.1177/1010539509355470; Choi AY, 2010, NEUROCHEM INT, V57, P143, DOI 10.1016/j.neuint.2010.05.006; Coleman William P, 2004, Spine J, V4, P373, DOI 10.1016/j.spinee.2003.12.006; Crupi R, 2013, CNS NEUROL DISORD-DR, V12, P989, DOI 10.2174/18715273113129990084; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V319, P127, DOI 10.1124/jpet.106.108076; Darian-Smith C, 2009, NEUROSCIENTIST, V15, P149, DOI 10.1177/1073858408331372; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Esposito E, 2011, BRAIN BEHAV IMMUN, V25, P1099, DOI 10.1016/j.bbi.2011.02.006; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Furutani R, 2012, J NEUROTRAUM, V29, P1266, DOI 10.1089/neu.2010.1630; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Genovese T, 2006, NEUROSCI LETT, V393, P141, DOI 10.1016/j.neulet.2005.09.060; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Goncalves MB, 2008, MOL CELL NEUROSCI, V38, P526, DOI 10.1016/j.mcn.2008.05.001; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Iijima K, 2009, J UROLOGY, V182, P2504, DOI 10.1016/j.juro.2009.07.012; Kazanis I, 2009, BRAIN, V132, P2909, DOI 10.1093/brain/awp237; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Kozlova EN, 2003, EUR J NEUROSCI, V17, P782, DOI 10.1046/j.1460-9568.2003.02518.x; Lambert DM, 2002, CURR MED CHEM, V9, P663, DOI 10.2174/0929867023370707; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lin LZ, 2007, J AGR FOOD CHEM, V55, P1321, DOI 10.1021/jf0624796; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Moyse E, 2006, AUTON NEUROSCI-BASIC, V126, P50, DOI 10.1016/j.autneu.2006.03.006; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Nishimura Y, 2009, NEUROSCIENTIST, V15, P436, DOI 10.1177/1073858408331375; OKABE S, 1989, P NATL ACAD SCI USA, V86, P4127, DOI 10.1073/pnas.86.11.4127; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-20; Paterniti I, 2011, EUR J NEUROSCI, V33, P1411, DOI 10.1111/j.1460-9568.2011.07646.x; Pezet S, 2004, EXPERT OPIN THER TAR, V8, P391, DOI 10.1517/14728222.8.5.391; Rioux L, 2003, AM J PSYCHIAT, V160, P149, DOI 10.1176/appi.ajp.160.1.149; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; SHEA TB, 1994, BIOTECHNIQUES, V16, P1126; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Song XY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001707; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Uchida K, 2012, SPINE, V37, P2125, DOI 10.1097/BRS.0b013e3182600ef7; Velayudhan L, 2014, CURR PHARM DESIGN, V20, P2218, DOI 10.2174/13816128113199990434; Vessal M, 2010, J NEUROSCI, V30, P8613, DOI 10.1523/JNEUROSCI.5272-09.2010; Wallace M, 2006, BRAIN RES, V1126, P176, DOI 10.1016/j.brainres.2006.07.064; Xu B, 2010, EUR J PHARMACOL, V627, P99, DOI 10.1016/j.ejphar.2009.10.038; Yuan QJ, 2013, NEUROSCI BULL, V29, P509, DOI 10.1007/s12264-013-1356-5; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176	63	20	20	1	5	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	MAR 8	2016	7								47	10.3389/fphar.2016.00047			12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	DF8FF	WOS:000371592100001	27014061	DOAJ Gold, Green Published			2021-06-18	
J	Smith, NM; Gachulincova, I; Ho, DW; Bailey, C; Bartlett, CA; Norret, M; Murphy, J; Buckley, A; Rigby, PJ; House, MJ; Pierre, TS; Fitzgerald, M; Iyer, KS; Dunlop, SA				Smith, Nicole M.; Gachulincova, Ivana; Ho, Diwei; Bailey, Charlotte; Bartlett, Carole A.; Norret, Marck; Murphy, John; Buckley, Alysia; Rigby, Paul J.; House, Michael J.; Pierre, Timothy St.; Fitzgerald, Melinda; Iyer, K. Swaminathan; Dunlop, Sarah A.			An Unexpected Transient Breakdown of the Blood Brain Barrier Triggers Passage of Large Intravenously Administered Nanoparticles	SCIENTIFIC REPORTS			English	Article							SECONDARY DEGENERATION; DELIVERY; INJURY; CONTRIBUTE; TRANSPORT; IMMUNE; CELLS; CNS	The highly restrictive blood-brain barrier (BBB) plays a critically important role in maintaining brain homeostasis and is pivotal for proper neuronal function. The BBB is currently considered the main limiting factor restricting the passage of large (up to 200 nm) intravenously administered nanoparticles to the brain. Breakdown of the barrier occurs as a consequence of cerebrovascular diseases and traumatic brain injury. In this article, we report that remote injuries in the CNS are also associated with BBB dysfunction. In particular, we show that a focal partial transection of the optic nerve triggers a previously unknown transient opening of the mammalian BBB that occurs in the visual centres. Importantly, we demonstrate that this transient BBB breakdown results in a dramatic change in the biodistribution of intravenously administered large polymeric nanoparticles which were previously deemed as BBB-impermeable.	[Smith, Nicole M.; Gachulincova, Ivana; Bailey, Charlotte; Bartlett, Carole A.; Fitzgerald, Melinda; Dunlop, Sarah A.] Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Perth, WA 6009, Australia; [Smith, Nicole M.; Ho, Diwei; Norret, Marck; Iyer, K. Swaminathan] Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia; [Murphy, John; Buckley, Alysia; Rigby, Paul J.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia; [House, Michael J.; Pierre, Timothy St.] Univ Western Australia, Sch Phys, Perth, WA 6009, Australia	Dunlop, SA (corresponding author), Univ Western Australia, Sch Anim Biol, Expt & Regenerat Neurosci, Perth, WA 6009, Australia.; Iyer, KS (corresponding author), Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia.	swaminatha.iyer@uwa.edu.au; sarah.dunlop@uwa.edu.au	Smith, Nicole/L-2502-2013; House, Michael J/B-6477-2008; Fitzgerald, Melinda/C-4235-2011; St Pierre, Timothy G/A-5509-2008	Smith, Nicole/0000-0002-5519-8152; House, Michael J/0000-0002-1752-6274; Fitzgerald, Melinda/0000-0002-4823-8179; St Pierre, Timothy G/0000-0003-4682-4972; Dunlop, Sarah/0000-0002-1306-3962; Ho, Diwei/0000-0002-4560-1112	Australian Research Council (ARC)Australian Research Council; National Health & Medical Research Council (NHMRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council of Australia [NHMRC APP1028681, APP1087114]; Neurotrauma Research Program (NRP); Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterisation Analysis; University of Western Australia	We thank Dr. C.W. Evans for providing us with a schematic of the optic nerve. This work was funded by the Australian Research Council (ARC), the National Health & Medical Research Council (NH&MRC APP1028681 and APP1087114) and the Neurotrauma Research Program (NRP). The authors acknowledge the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterisation & Analysis, and The University of Western Australia, funded by the University, State and Commonwealth Governments.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Beggs S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-74; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; CHAN PH, 1984, NEUROLOGY, V34, P315, DOI 10.1212/WNL.34.3.315; del Valle J, 2008, J NEUROSCI METH, V174, P42, DOI 10.1016/j.jneumeth.2008.06.025; Ding D, 2013, SMALL, V9, P3093, DOI 10.1002/smll.201300171; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kerschensteiner M, 2003, ANN NEUROL, V53, P292, DOI 10.1002/ana.10446; Koffie RM, 2011, P NATL ACAD SCI USA, V108, P18837, DOI 10.1073/pnas.1111405108; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kreuter J, 2002, J DRUG TARGET, V10, P317, DOI 10.1080/10611860290031877; Kuffler DP, 2012, THER CLIN RISK MANAG, V8, P185, DOI 10.2147/TCRM.S16196; Laterra J, 1999, BASIC NEUROCHEMISTRY; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Lozic I, 2014, METALLOMICS, V6, P455, DOI 10.1039/c3mt00336a; Lu W, 2005, J CONTROL RELEASE, V107, P428, DOI 10.1016/j.jconrel.2005.03.027; Lu W, 2007, J CONTROL RELEASE, V118, P38, DOI 10.1016/j.jconrel.2006.11.015; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; MOLLGARD K, 1986, NEUROPATH APPL NEURO, V12, P337, DOI 10.1111/j.1365-2990.1986.tb00146.x; Nahirney PC, 2016, J CEREBR BLOOD F MET, V36, P413, DOI 10.1177/0271678X15608396; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Rao KS, 2008, BIOMATERIALS, V29, P4429, DOI 10.1016/j.biomaterials.2008.08.004; Savigni DL, 2013, NEUROPHARMACOLOGY, V75, P380, DOI 10.1016/j.neuropharm.2013.07.034; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; TENNANT M, 1992, VISUAL NEUROSCI, V9, P149, DOI 10.1017/S0952523800009615; TORNHEIM PA, 1984, J NEUROSURG, V60, P473, DOI 10.3171/jns.1984.60.3.0473; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wiley DT, 2013, P NATL ACAD SCI USA, V110, P8662, DOI 10.1073/pnas.1307152110	37	20	20	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 4	2016	6								22595	10.1038/srep22595			9	Multidisciplinary Sciences	Science & Technology - Other Topics	DF4UZ	WOS:000371348200001	26940762	DOAJ Gold, Green Published			2021-06-18	
J	Holcomb, EM; Schwartz, DJ; McCarthy, M; Thomas, B; Barnett, SD; Nakase-Richardson, R				Holcomb, Erin M.; Schwartz, Daniel J.; McCarthy, Marissa; Thomas, Bryan; Barnett, Scott D.; Nakase-Richardson, Risa			Incidence, Characterization, and Predictors of Sleep Apnea in Consecutive Brain Injury Rehabilitation Admissions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; rehabilitation; head injury; sleep	POSITIVE AIRWAY PRESSURE; COGNITIVE IMPAIRMENT; RISK-FACTOR; INPATIENT REHABILITATION; CARDIOVASCULAR-DISEASE; PRACTICE PARAMETERS; DISORDERS; STROKE; MORTALITY; ASSOCIATION	Objective: To prospectively examine the incidence and risk factors for sleep apnea in consecutive brain injury rehabilitation admissions. Setting: Inpatient neurorehabilitation hospital. Participants: Participants (n = 86) were consecutive neurorehabilitation admissions. Design: Retrospective analysis of prospectively collected data. Main Measures: Polysomnography. Results: Half (49%) of the sample was diagnosed with sleep apnea. For the full sample, univariate logistic regression revealed age (odds ratio: 1.08; 95% confidence interval: 1.04-1.11) and hypertension (odds ratio: 7.77; 95% confidence interval: 2.81-21.47) as significant predictors of sleep apnea diagnosis. Results of logistic regression conducted within the traumatic brain injury group revealed age (odds ratio: 1.07; 95% confidence interval: 1.02-1.13) as the only significant predictor of apnea diagnosis after adjustment for other variables. Hierarchical generalized linear regression models for the prediction of apnea severity (ie, apnea-hypopnea index found that Functional Independence Measure Cognition Score (P = .01) and age (P < .01) were significant predictors. Following adjustment for all other terms, only age (P < .01) remained significant. Conclusion: Sleep apnea is prevalent in acute neurorehabilitation admissions and traditional risk profiles for sleep apnea may not effectively screen for the disorder. Given the progressive nature of obstructive sleep apnea and morbidity associated with even mild obstructive sleep apnea, early identification and intervention may address comorbidities influencing acute and long-term outcome.	[Holcomb, Erin M.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Dept MHBS, Tampa, FL 33612 USA; [Schwartz, Daniel J.] James A Haley Vet Hosp, Dept Med, Tampa, FL 33612 USA; [McCarthy, Marissa; Thomas, Bryan] James A Haley Vet Hosp, Dept Rehabil Med, Tampa, FL 33612 USA; [Schwartz, Daniel J.; Nakase-Richardson, Risa] Univ S Florida, Dept Med, Tampa, FL USA; [McCarthy, Marissa; Thomas, Bryan] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [Barnett, Scott D.] James A Haley Vet Hosp, Dept Res, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Ctr Innovat Disabil Rehabil & Res CINDRR, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA	Holcomb, EM (corresponding author), James A Haley Vet Hosp, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Risa.Richardson@va.gov			Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research; VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), U.S. Department of Veterans Affairs [W91YTZ-13-C-0015, 1 I50 HX001233-01, W81XWH-13-2-0095]; General Dynamics Health Solutions from U.S. Department of Defense Congressionally Directed Medical Research Programs	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), U.S. Department of Veterans Affairs grants (1 I50 HX001233-01, W81XWH-13-2-0095), and U.S. Department of Defense Congressionally Directed Medical Research Programs. The authors acknowledge the contributions of Jeffrey Garofano, MA, William M. Anderson, MD, Courtney Lynn, MS, Carolos Diez-Sien, RPSGT, and Ryan Smith, RPSGT.	Aaronson JA, 2015, SLEEP MED, V16, P691; Alattar MA, 2009, SLEEP BREATH, V13, P201, DOI 10.1007/s11325-008-0221-7; Aloia MS, 2004, J INT NEUROPSYCH SOC, V10, P772, DOI 10.1017/S1355617704105134; American Physical Therapy Association NSTETF, 2012, REP TBI EDGE TASK FO; AncoliIsrael S, 1996, SLEEP, V19, P277, DOI 10.1093/sleep/19.4.277; ANCOLIISRAEL S, 1991, J AM GERIATR SOC, V39, P258, DOI 10.1111/j.1532-5415.1991.tb01647.x; [Anonymous], IBM SPSS STAT WIND V; Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; Balk EM, 2012, FUTURE RES NEEDS DIA; Bassetti C, 1999, SLEEP, V22, P217, DOI 10.1093/sleep/22.2.217; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Blackwell T, 2015, J AM GERIATR SOC, V63, P453, DOI 10.1111/jgs.13321; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; BRADLEY PA, 1995, THORAX, V50, P1201, DOI 10.1136/thx.50.11.1201; Bravata DM, 2011, SLEEP, V34, P1271, DOI 10.5665/SLEEP.1254; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Castronovo V, 2014, SLEEP, V37, P1465, DOI 10.5665/sleep.3994; Chang WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078655; Chesson AL, 2003, SLEEP, V26, P907, DOI 10.1093/sleep/26.7.907; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Cooke JR, 2009, J CLIN SLEEP MED, V5, P305; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Dhandapani SS, 2007, INDIAN J NEUROTRAUM, V4, P35, DOI 10.1016/S0973-0508(07)80009-8; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; El-Ad B, 2005, INT REV PSYCHIATR, V17, P277, DOI 10.1080/09540260500104508; Engleman HM, 1999, AM J RESP CRIT CARE, V159, P461, DOI 10.1164/ajrccm.159.2.9803121; Engleman HM, 2000, SLEEP, V23, pS102; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; FINDLEY LJ, 1986, CHEST, V90, P686, DOI 10.1378/chest.90.5.686; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Gimenez S, 2007, PSYCHOPHARMACOLOGY, V190, P507, DOI 10.1007/s00213-006-0633-7; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; HE J, 1988, CHEST, V94, P9, DOI 10.1378/chest.94.1.9; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; Javaheri S, 2010, CLIN CHEST MED, V31, P235, DOI 10.1016/j.ccm.2010.02.013; Jennum P, 2011, THORAX, V66, P560, DOI 10.1136/thx.2010.143958; Jobin V, 2007, J APPL PHYSIOL, V102, P1587, DOI 10.1152/japplphysiol.00439.2006; Johnson KG, 2010, J CLIN SLEEP MED, V6, P131; Jordan AS, 2003, SLEEP MED REV, V7, P377, DOI 10.1053/smrv.2002.0260; Kamba M, 2001, J NEUROL NEUROSUR PS, V71, P334, DOI 10.1136/jnnp.71.3.334; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kim H, 2013, SLEEP, V36, P709, DOI 10.5665/sleep.2632; Knauert MP, 2014, HEART LUNG, V43, P445, DOI 10.1016/j.hrtlng.2014.06.049; Kushida CA, 2006, SLEEP, V29, P240, DOI 10.1093/sleep/29.2.240; Lattimore JL, 2006, THORAX, V61, P491, DOI 10.1136/thx.2004.039164; Lee YC, 2013, J KOREAN MED SCI, V28, P1373, DOI 10.3346/jkms.2013.28.9.1373; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; MAN GCW, 1995, CHEST, V108, P388, DOI 10.1378/chest.108.2.388; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Martinez-Garcia MA, 2006, CHEST, V129, P238, DOI 10.1378/chest.129.2.238; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDermott CM, 2003, J NEUROSCI, V23, P9687; McEvoy R Doug, 2010, J Thorac Dis, V2, P138, DOI 10.3978/j.issn.2072-1439.2010.02.03.5; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, pe43; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Ng YS, 2007, ANN ACAD MED SINGAP, V36, P3; Nieto FJ, 2012, AM J RESP CRIT CARE, V186, P190, DOI 10.1164/rccm.201201-0130OC; O'Hara R, 2009, J REHABIL RES DEV, V46, P837, DOI 10.1682/JRRD.2008.10.0140; Ostermeier AM, 1997, ANESTH ANALG, V85, P452, DOI 10.1097/00000539-199708000-00037; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Parra O, 2000, AM J RESP CRIT CARE, V161, P375, DOI 10.1164/ajrccm.161.2.9903139; Parrino L, 1996, PSYCHOPHARMACOLOGY, V126, P1, DOI 10.1007/BF02246405; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Quan SF, 1999, SLEEP, V22, P662, DOI 10.1093/sleep/22.5.662; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Robbins J, 2005, J CLIN SLEEP MED, V1, P159; Rodenstein D, 2009, RESPIRATION, V78, P241, DOI 10.1159/000222811; ROTH T, 1987, J ALLERGY CLIN IMMUN, V80, P94, DOI 10.1016/S0091-6749(87)80197-5; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P421, DOI 10.1097/HTR.0b013e3181c13439; SAS Institute Inc, 2011, BAS SAS 9 2 PROC GUI; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; SHEPARD JW, 1992, CLIN CHEST MED, V13, P437; Sivertsen B, 2008, EUR RESPIR J, V32, P1497, DOI 10.1183/09031936.00044908; Sjosten N, 2009, RESP MED, V103, P1047, DOI 10.1016/j.rmed.2009.01.014; Sjosten N, 2009, CHEST, V136, P130, DOI 10.1378/chest.08-2201; Sobanski E, 2008, SLEEP, V31, P375, DOI 10.1093/sleep/31.3.375; Somers VK, 2008, CIRCULATION, V118, P1080, DOI [10.1161/CIRCULATIONAHA.107.189420, 10.1161/CIRCULATIONAHA.107.189375]; Strobel RJ, 1996, SLEEP, V19, P104, DOI 10.1093/sleep/19.2.104; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Thornton JD, 2010, SLEEP, V33, P1255, DOI 10.1093/sleep/33.9.1255; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; Tuomilehto H, 2014, SLEEP MED, V15, P329, DOI 10.1016/j.sleep.2013.11.786; Vaughn BV, 2008, CHEST, V134, P1310, DOI 10.1378/chest.08-0812; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Walker JM, 2007, J CLIN SLEEP MED, V3, P455; Wallace A, 2013, SLEEP, V36, P203, DOI 10.5665/sleep.2374; Wallace DM, 2012, INT J STROKE, V7, P231, DOI 10.1111/j.1747-4949.2011.00760.x; Wang X, 2013, INT J CARDIOL, V169, P207, DOI 10.1016/j.ijcard.2013.08.088; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Weaver TE, 2007, SLEEP MED REV, V11, P99, DOI 10.1016/j.smrv.2006.08.001; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yamadera H, 1998, PSYCHIAT CLIN NEUROS, V52, P439, DOI 10.1046/j.1440-1819.1998.00403.x; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Young Terry, 2009, WMJ, V108, P246; Zimmerman ME, 2006, J CLIN SLEEP MED, V2, P461; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	122	20	20	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		82	100		10.1097/HTR.0000000000000230			19	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DH7NO	WOS:000372981100002	26959663				2021-06-18	
J	Ismail, S; McIntosh, M; Kalynych, C; Joseph, M; Wylie, T; Butterfield, R; Smotherman, C; Kraemer, DF; Osian, SR				Ismail, Shareen; McIntosh, Mark; Kalynych, Colleen; Joseph, Madeline; Wylie, Todd; Butterfield, Ryan; Smotherman, Carmen; Kraemer, Dale F.; Osian, Sarah R.			IMPACT OF VIDEO DISCHARGE INSTRUCTIONS FOR PEDIATRIC FEVER AND CLOSED HEAD INJURY FROM THE EMERGENCY DEPARTMENT	JOURNAL OF EMERGENCY MEDICINE			English	Article						caregiver knowledge; discharge instructions; emergency medicine; emergency room; pediatrics	PATIENT LITERACY; COMMUNICATION; COMPREHENSION; UNDERSTAND	Background: Lack of understanding of diagnosis and disease process remains a major complaint of caregivers who bring their children to the pediatric emergency department (PED). Misunderstanding of diagnosis and discharge instructions can lead to unnecessary return visits and health disparities. Objective: We attempted to determine if video discharge instructions when added to standard of care written and verbal instruction improved caregivers' comprehension of their child's diagnosis, disease process, and discharge instructions. Methods: Caregivers who presented to the PED with a child's chief complaint of fever or closed head injury (CHI) were included and randomized into a control or intervention group. Each group received standard discharge instructions, and the intervention group additionally viewed a video. Participants completed a post-test on knowledge and were followed 2 weeks post-visit to determine follow-up care. Results: Sixty-three caregivers participated in the study. Eleven participants had less than a high school (HS) education and 52 had more than a HS education. Thirty-one children presented with fever and 32 with CHI. The intervention group had significantly higher percentage of correct answers on postintervention tests (median [Mdn] = 88.89) than the control (Mdn = 75.73; p < 0.0001). Participants in the intervention group with less than a HS education (Mdn = 89.47) and more than HS education (Mdn = 88.89) had similar test scores (p = 0.13), whereas those in the control group with less than a HS education (Mdn = 66.67) had significantly lower test scores than those with more than a HS education (Mdn = 77.78; p = 0.03). Conclusion: For caregivers with children who presented to the PED with fever and CHI, video discharge instructions improved caregiver comprehension of the child's diagnosis and disease process when added to verbal and written instructions. (C) 2016 Elsevier Inc.	[Ismail, Shareen; McIntosh, Mark; Kalynych, Colleen; Joseph, Madeline; Wylie, Todd] Univ Florida, Coll Med, Dept Emergency Med, 655 W 8th St, Jacksonville, FL 32209 USA; [Butterfield, Ryan; Smotherman, Carmen; Kraemer, Dale F.; Osian, Sarah R.] Univ Florida, Coll Med, Ctr Hlth Equ & Qual Res, Jacksonville, FL USA	Kalynych, C (corresponding author), Univ Florida, Coll Med, Dept Emergency Med, 655 W 8th St, Jacksonville, FL 32209 USA.						Alpern ER, 2006, TXB PEDIAT EMERGENCY, P295; Beagley L, 2011, J PERIANESTH NURS, V26, P331, DOI 10.1016/j.jopan.2011.06.002; Bloch SA, 2013, PEDIATR EMERG CARE, V29, P699, DOI 10.1097/PEC.0b013e3182955480; Clarke Collin, 2005, CJEM, V7, P5; DAVIS TC, 1994, PEDIATRICS, V93, P460; Eisenberg EM, 2005, COMMUN MONOGR, V72, P390, DOI 10.1080/03637750500322602; Engel K, 2010, J CLIN OUTCOMES MANA, V17, P449; Engel KG, 2012, ACAD EMERG MED, V19, pE1035, DOI 10.1111/j.1553-2712.2012.01425.x; Engel KG, 2009, ANN EMERG MED, V53, P454, DOI 10.1016/j.annemergmed.2008.05.016; Herndon JB, 2011, ANN EMERG MED, V57, P334, DOI 10.1016/j.annemergmed.2010.08.035; McLauglin HG, 1969, J READING, V12, P639; POWERS RD, 1988, ANN EMERG MED, V17, P124, DOI 10.1016/S0196-0644(88)80295-6; Samuels-Kalow ME, 2012, ANN EMERG MED, V60, P152, DOI 10.1016/j.annemergmed.2011.10.023; SPANDORFER JM, 1995, ANN EMERG MED, V25, P71, DOI 10.1016/S0196-0644(95)70358-6; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; Vashi A, 2011, ANN EMERG MED, V57, P315, DOI 10.1016/j.annemergmed.2010.08.024; Waisman Y, 2003, ISRAEL MED ASSOC J, V5, P567; Williams DM, 1996, AM J EMERG MED, V14, P19, DOI 10.1016/S0735-6757(96)90006-6	18	20	21	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	MAR	2016	50	3					E177	E183		10.1016/j.jemermed.2015.10.006			7	Emergency Medicine	Emergency Medicine	DI2BV	WOS:000373301600019	26806318				2021-06-18	
J	Olympia, RP; Ritter, JT; Brady, J; Bramley, H				Olympia, Robert P.; Ritter, Jed T.; Brady, Jodi; Bramley, Harry			Return to Learning After a Concussion and Compliance With Recommendations for Cognitive Rest	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						school health services; cerebral concussion; nurses	SPORT-RELATED CONCUSSION; UNITED-STATES; RECOVERY	Objective: To determine the compliance of schools and school nurses in the United States with national recommendations for cognitive rest in students who sustain a concussion. Design: Cross-sectional questionnaire based. Participants: Members of the National Association of School Nurses working at the high school level. Intervention: A questionnaire, developed by the authors and based on recommendations for cognitive rest, was electronically distributed 3 times during the 2012 to 2013 academic year. Main Outcome Measures: Self-reported responses were collected regarding demographics and compliance of schools and school nurses with recommendations for the management of the postconcussion student, including the presence of specific guidelines for individualized care and the responsibility of the nurse for the prevention, detection, and management of concussions. Results: Analysis was performed on 1033 completed questionnaires (36% usable response rate). Fifty-three percent of schools have guidelines to assist students when returning to school after a concussion. These guidelines include extension of assignment deadlines (87%), rest periods during the school day (84%), postponement or staggering of tests (75%), reduced workload (73%), and accommodation for light or noise sensitivity (64%). Sixty-six percent of nurses in our sample have had special training in the recognition and management of concussions. Nurses reported involvement in the following roles: identifying suspected concussions (80%), providing emotional support for recovering students dealing with concussion-related depression (59%), and guiding the student's postconcussion graduated academic and activity re-entry process (58%). Conclusions: We detected a wide variability in compliance of schools and school nurses with national recommendations for cognitive rest. Clinical Relevance: Ensuring that schools have policies established for a student's return to learning, having specific guidelines to provide an individualized approach to return to learning based on postconcussion signs/symptoms, training school nurses in the recognition and management of concussions, and involving school nurses in the re-entry process are identified areas for improvement. Schools in the United States should be aware of these recommendations to guide a student's postconcussion graduated academic re-entry process.	[Olympia, Robert P.] Penn State Hershey Med Ctr, Dept Emergency Med, 500 Univ Dr,POB 850, Hershey, PA 17033 USA; [Ritter, Jed T.] Penn State Coll Med, Hershey, PA USA; [Brady, Jodi; Bramley, Harry] Penn State Hershey Childrens Hosp, Dept Pediat, Hershey, PA USA	Olympia, RP (corresponding author), Penn State Hershey Med Ctr, Dept Emergency Med, 500 Univ Dr,POB 850, Hershey, PA 17033 USA.	rolympia@hmc.psu.edu					Choi BCK, 2005, PREV CHRONIC DIS; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; National Association of School Nurses, 2012, CONC ROL SCH NURS PO; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	14	20	20	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2016	26	2					115	119		10.1097/JSM.0000000000000208			5	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	DF4DM	WOS:000371297600004	25961156				2021-06-18	
J	Palmer, CP; Metheny, HE; Elkind, JA; Cohen, AS				Palmer, Christopher P.; Metheny, Hannah E.; Elkind, Jaclynn A.; Cohen, Akiva S.			Diminished amygdala activation and behavioral threat response following traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; mTBI; Amygdala; Cued fear; Threat response; Voltage-sensitive dye; Lateral fluid percussion; LFPI	IN-VITRO; ANIMAL-MODELS; FEAR; HIPPOCAMPUS; EMOTION; NETWORK; SLICES; STATES; MOUSE	Each year, approximately 3.8 million people suffer mild to moderate traumatic brain injuries (mTBI) that result in an array of neuropsychological symptoms and disorders. Despite these alarming statistics, the neurological bases of these persistent, debilitating neuropsychological symptoms are currently poorly understood. In this study we examined the effects of mTBI on the amygdala, a brain structure known to be critically involved in the processing of emotional stimuli. Seven days after lateral fluid percussion injury (LFPI), mice underwent a series of physiological and behavioral experiments to assess amygdala function. Brain-injured mice exhibited a decreased threat response in a cued fear conditioning paradigm, congruent with a decrease in amygdala excitability determined with basolateral amygdala (BLA) field excitatory post-synaptic potentials together with voltage-sensitive dye imaging (VSD). Furthermore, beyond exposing a general decrease in the excitability of the primary input of the amygdala, the lateral amygdala (LA), VSD also revealed a decrease in the relative strength or activation of inter nuclear amygdala circuit projections after LFPI. Thus, not only does activation of the LA require increased stimulation, but the proportion of this activation that is propagated to the primary output of the amygdala, the central amygdala, is also diminished following LFPI. Intracellular recordings revealed no changes in the intrinsic properties of BLA pyramidal neurons after LFPI. This data suggests that mild to moderate TBI has prominent effects on amygdala function and provides a potential neurological substrate for many of the neuropsychological symptoms suffered by TBI patients. (C) 2016 Elsevier Inc. All rights reserved.	[Palmer, Christopher P.] Univ Penn, Perelman Sch Med, Neurosci Grad Grp, 3451 Walnut St, Philadelphia, PA 19104 USA; [Metheny, Hannah E.; Elkind, Jaclynn A.; Cohen, Akiva S.] Childrens Hosp Philadelphia, Dept Anesthesiol, Crit Care Med, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Cohen, Akiva S.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care Med, 3451 Walnut St, Philadelphia, PA 19104 USA	Cohen, AS (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Rm 816H,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	cohena@email.chop.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37 HD059288, RO1 NS069629]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD059288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069629] Funding Source: NIH RePORTER	This work was supported in part by NIH grants R37 HD059288 and RO1 NS069629. The authors would like to thank Drs. Gordon Barr and Colin Smith for critiquing and earlier version of this manuscript.	Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; Avrabos C, 2013, J NEUROSCI, V33, P16262, DOI 10.1523/JNEUROSCI.2397-13.2013; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bourgeois EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108686; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carlson GC, 2008, NAT PROTOC, V3, P249, DOI 10.1038/nprot.2007.539; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Debiec J, 2010, NAT NEUROSCI, V13, P536, DOI 10.1038/nn.2520; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Johnson BN, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00435; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Juranek J, 2012, BRAIN IMAGING BEHAV, V6, P36, DOI 10.1007/s11682-011-9140-5; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; LEUNG LS, 1995, BRAIN RES, V697, P262; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; McAllister T.W, 1992, NAT NEUROSCI; Newton JR, 2004, NAT NEUROSCI, V7, P968, DOI 10.1038/nn1306; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Riggio S, 2010, PSYCHIAT CLIN N AM, V33, P807, DOI 10.1016/j.psc.2010.08.004; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tominaga T, 2000, J NEUROSCI METH, V102, P11, DOI 10.1016/S0165-0270(00)00270-3; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Tronson NC, 2012, TRENDS NEUROSCI, V35, P145, DOI 10.1016/j.tins.2011.10.003; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4	39	20	20	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2016	277						215	226		10.1016/j.expneurol.2016.01.004			12	Neurosciences	Neurosciences & Neurology	DF2ST	WOS:000371194800022	26791254	Green Accepted			2021-06-18	
J	Vuletic, S; Bell, KR; Jain, S; Bush, N; Temkin, N; Fann, JR; Stanfill, KE; Dikmen, S; Brockway, JA; He, F; Ernstrom, K; Raman, R; Grant, G; Stein, MB; Gahm, GA				Vuletic, S.; Bell, K. R.; Jain, S.; Bush, N.; Temkin, N.; Fann, J. R.; Stanfill, K. E.; Dikmen, S.; Brockway, J. A.; He, F.; Ernstrom, K.; Raman, R.; Grant, G.; Stein, M. B.; Gahm, G. A.		CONTACT Investigators	Telephone Problem-Solving Treatment Improves Sleep Quality in Service Members With Combat-Related Mild Traumatic Brain Injury: Results From a Randomized Clinical Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						military; traumatic brain injury; sleep; problem-solving treatment; insomnia	POSTTRAUMATIC-STRESS-DISORDER; MILITARY PERSONNEL; VETERANS; INSOMNIA; HEALTH; CONCUSSION; SYMPTOMS; PAIN; DISTURBANCE; SEVERITY	Objective: Evaluate sleep quality, its correlates, and the effect of telephone-based problem-solving treatment (PST) in active duty postdeployment service members with mild traumatic brain injury (mTBI) Setting: Randomized clinical trial. Participants: Active duty service members with combat-related mTBI. Study design: Education-only (EO) and PST groups (N = 178 each) received printed study materials and 12 educational brochures. The PST group additionally received up to 12 PST telephone calls addressing participant-selected issues. Outcomes were evaluated postintervention (6 months) and at 12 months. Main Measure: Pittsburgh Sleep Quality Index. Results: Sleep quality was manifestly poor in both groups at baseline (Pittsburgh Sleep Quality Index = 12.5 +/- 4). Overall sleep quality was significantly different between the PST and EO groups at 6 months (P = .003) but not at 12 months. Longitudinally, PST significantly improved sleep quality at 6 months (P = .001) but not over the follow-up. Low sleep quality was associated with concussion symptoms, pain, depression, and posttraumatic stress disorder at all time points (P < .0001). Conclusions: Sleep disorders, common in postdeployment service members with mTBI, are strongly associated with the presence of pain, posttraumatic stress disorder, and depression. Telephone-based PST may be an effective therapeutic approach for reducing sleep disorders in this population. Research should focus on maintenance of treatment gains.	[Vuletic, S.; Bush, N.; Stanfill, K. E.; Gahm, G. A.] Natl Ctr Telehealth & Technol T2, Tacoma, WA USA; [Bell, K. R.; Temkin, N.; Dikmen, S.; Brockway, J. A.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Temkin, N.; Dikmen, S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, N.; Fann, J. R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Fann, J. R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Bell, K. R.] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Jain, S.; He, F.; Ernstrom, K.; Raman, R.; Stein, M. B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Stein, M. B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Grant, G.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Gahm, G. A.] Def Ctr Excellence DCoE, 4124 41st LP SE, Olympia, WA 98501 USA	Gahm, GA (corresponding author), Def Ctr Excellence DCoE, 4124 41st LP SE, Olympia, WA 98501 USA.	gregory.a.gahm.civ@mail.mil		Bush, Nigel/0000-0002-8137-7998; Bell, Kathleen/0000-0002-0928-2046	US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-2-0159]	This research was supported by grant W81XWH-08-2-0159 from the US Army Medical Research and Materiel Command (USAMRMC). The authors are thankful to all study participants and their families; the CONTACT study team members: Wesley R. Cole, PhD (Womack Army Medical Center, Fort Bragg, North Carolina), Tessa Hart, PhD (Moss Rehabilitation Research Institute, Pennsylvania), Ariel J Lang, PhD, MPH (UCSD, La Jolla, California), Jef St. De Lore, MPH (University of Washington, Seattle, Washington), Jason Barber, MS (University of Washington, Seattle, Washington), Sara E. Fey-Hinckley, MA, LMFT, CBIS (University of Washington, Seattle, Washington), Jocelyn L. Savage, LICSW (University of Washington, Seattle, Washington), Michael Warren, MA (University of Washington, Seattle, Washington), Elissa Thomas (National Center for Telehealth and Technology, T2, Tacoma, Washington), Karina Boykin (National Center for Telehealth and Technology, T2, Tacoma, Washington); as well as Derek Smolensky, PhD, MPH (National Center for Telehealth and Technology, T2, Tacoma, Washington); and the Geneva Foundation (Tacoma, Washington), in particular Kasey Zink.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Babson KA, 2012, J TRAUMA STRESS, V25, P665, DOI 10.1002/jts.21757; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bell KR, 2015, CONTEMP CLIN TRIALS, V40, P54, DOI 10.1016/j.cct.2014.11.001; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Choe MC, 2015, SEMIN NEUROL, V35, P29, DOI 10.1055/s-0035-1544243; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; DePalma RG, 2015, BRAIN NEUROTRAUMA MO; Engdahl BE, 2000, BIOL PSYCHIAT, V47, P520, DOI 10.1016/S0006-3223(99)00201-2; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; Faraguna U, 2008, J NEUROSCI, V28, P4088, DOI 10.1523/JNEUROSCI.5510-07.2008; Farrell-Carnahan L, 2013, MIL MED, V178, P951, DOI 10.7205/MILMED-D-13-00037; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Ford ES, 2015, SLEEP MED, V16, P372, DOI 10.1016/j.sleep.2014.12.008; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Garthus-Niegel S, 2015, J AFFECT DISORDERS, V172, P146, DOI 10.1016/j.jad.2014.10.003; Germain A, 2005, J ANXIETY DISORD, V19, P233, DOI 10.1016/j.janxdis.2004.02.001; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Harvey AG, 2011, ANNU REV CLIN PSYCHO, V7, P297, DOI 10.1146/annurev-clinpsy-032210-104550; HEFEZ A, 1987, AM J PSYCHIAT, V144, P344; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kiernan PT, 2015, SEMIN NEUROL, V35, P20, DOI 10.1055/s-0035-1545080; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Lamarche LJ, 2007, J CLIN PSYCHIAT, V68, P1257, DOI 10.4088/JCP.v68n0813; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Miro J, 2016, EUR J PAIN, V20, P130, DOI 10.1002/ejp.704; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Mustafa Masroor, 2005, Sleep Breath, V9, P57, DOI 10.1007/s11325-005-0016-z; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; *NAT SLEEP FDN, SLEEP AM POLL SLEEP; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Onen SH, 2001, J SLEEP RES, V10, P35, DOI 10.1046/j.1365-2869.2001.00240.x; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Pigeon WR, 2013, J PSYCHOSOM RES, V75, P546, DOI 10.1016/j.jpsychores.2013.09.004; Reinsel RA, 2015, J CLIN SLEEP MED, V11, P1361, DOI 10.5664/jcsm.5264; Tello-Velasquez JR, 2015, CAD SAUDE PUBLICA, V31, P989, DOI 10.1590/0102-311X00010014; Riemann D, 2007, SLEEP MED, V8, pS15, DOI 10.1016/S1389-9457(08)70004-2; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Searle AK, 2015, INT J METH PSYCH RES, V24, P32, DOI 10.1002/mpr.1460; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Sheehan DV, 2006, INT CLIN PSYCHOPH S3, V11, P89; Sivertsen B, 2015, PAIN, V156, P1433, DOI 10.1097/j.pain.0000000000000131; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weathers F., 1991, PTSD CHECKLIST MILIT; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	72	20	21	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		147	157		10.1097/HTR.0000000000000221			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DH7NO	WOS:000372981100008	26959668				2021-06-18	
J	Ploetz, DM; Mazur-Mosiewicz, A; Kirkwood, MW; Sherman, EMS; Brooks, BL				Ploetz, Danielle M.; Mazur-Mosiewicz, Anya; Kirkwood, Michael W.; Sherman, Elisabeth M. S.; Brooks, Brian L.			Performance on the Test of Memory Malingering in children with neurological conditions	CHILD NEUROPSYCHOLOGY			English	Article						Performance validity; Symptom Validity; Effort Testing; Children; Adolescents; Malingering	SYMPTOM VALIDITY TEST; PEDIATRIC SAMPLE; TOMM; ADOLESCENTS	Despite increasing interest in the use of performance validity tests with youth, relatively little is known about how children and adolescents with neurological diagnoses perform on these measures. The purpose of this study was to examine performance on the Test of Memory Malingering (TOMM) in a general pediatric neurologic sample. Data were obtained from 266 consecutive patients (mean age=13.0, SD=3.7, range=5-18) referred for a neuropsychological assessment in a tertiary care pediatric hospital. As part of a broader neuropsychological battery, patients were administered the TOMM. In this sample, 94% of children passed the TOMM. Pass rate was 87% for 5-7year-olds but was 90% for all other ages. Children with a history of stroke had the lowest pass rate (86%), with other diagnostic groups scoring 90%, including epilepsy, traumatic brain injury, and hydrocephalus. Lower TOMM performance was related to slower processing speed and weaker memory performance. The results support using the TOMM with children and adolescents who have neurological diagnoses. Caution may still be warranted when interpreting scores in those who are younger and/or who have more significant cognitive difficulty.	[Ploetz, Danielle M.; Mazur-Mosiewicz, Anya; Sherman, Elisabeth M. S.; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Dept Neurosci, Brain Injury Program, Calgary, AB T3B 6A8, Canada; [Ploetz, Danielle M.; Mazur-Mosiewicz, Anya; Sherman, Elisabeth M. S.; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Rehabil Program, Calgary, AB T3B 6A8, Canada; [Mazur-Mosiewicz, Anya] Chicago Sch Profess Psychol, Clin Psychol Doctoral Program, Chicago, IL USA; [Kirkwood, Michael W.] Univ Colorado, Dept Phys Med & Rehabil, Sch Med, Aurora, CO USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO USA; [Sherman, Elisabeth M. S.] Copeman Healthcare Ctr, Calgary, AB, Canada; [Sherman, Elisabeth M. S.; Brooks, Brian L.] Univ Calgary, Dept Paediat, Cumming Sch Med, Calgary, AB T2N 1N4, Canada; [Sherman, Elisabeth M. S.; Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Cumming Sch Med, Calgary, AB, Canada; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Res Inst, Behav & Dev Brain Program, Calgary, AB T3B 6A8, Canada	Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Dept Neurosci, Brain Injury Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@albertahealthservices.ca					Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P858, DOI 10.1093/arclin/acs087; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2011, ARCH CLIN NEUROPSYCH, V26, P306, DOI 10.1093/arclin/acr030; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Courtney JC, 2003, CHILD NEUROPSYCHOL, V9, P109, DOI 10.1076/chin.9.2.109.14507; Cox, 1997, MANUAL COMPUTERIZED; Delis D, 1994, CALIFORNIA VERBAL LE; Delis DC, 2000, CALIFORNIA VERBAL LE; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P., 2008, MANUAL NONVERBAL MED; Green P., 2003, MANUAL WORD MEMORY T; Green P., 2004, MANUAL GREENS MED SY; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Gunn D, 2010, CHILD NEUROPSYCHOL, V16, P105, DOI 10.1080/09297040903352564; Hurley KE, 2006, MENT RETARD, V44, P112, DOI 10.1352/0047-6765(2006)44[112:AIMMUW]2.0.CO;2; IVERSON GL, 1998, 21 ITEM TEST RES MAN; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood M. W, 2012, PEDIAT FORENSIC NEUR, P136; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Loughan AR, 2014, APPL NEUROPSYCH-CHIL, V3, P26, DOI 10.1080/21622965.2012.670584; Loughan AR, 2012, ARCH CLIN NEUROPSYCH, V27, P716, DOI 10.1093/arclin/acs072; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Martin R. C., 1995, ARCH CLIN NEUROPSYCH, V10, P364, DOI [10.1093/arclin/10.4.364, DOI 10.1093/ARCLIN/10.4.364]; Perna RB, 2013, CHILD NEUROPSYCHOL, V19, P438, DOI 10.1080/09297049.2012.731500; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rienstra A, 2010, ARCH CLIN NEUROPSYCH, V25, P371, DOI 10.1093/arclin/acq035; Schmand B., 2004, AMSTERDAM SHORT TERM; Slick D., 1997, VICTORIA SYMPTOM VAL; Tombaugh TN, 1996, TEST MEMORY MALINGER; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wechsler D, 2004, WECHSLER PRESCHOOL P	41	20	20	0	38	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	FEB 17	2016	22	2					133	142		10.1080/09297049.2014.986446			10	Clinical Neurology	Neurosciences & Neurology	CW2GV	WOS:000364810400001	25495184				2021-06-18	
J	Scheenen, ME; de Koning, ME; van der Horn, HJ; Roks, G; Yilmaz, T; van der Naalt, J; Spikman, JM				Scheenen, Myrthe E.; de Koning, Myrthe E.; van der Horn, Harm J.; Roks, Gerwin; Yilmaz, Tansel; van der Naalt, Joukje; Spikman, Jacoba M.			Acute Alcohol Intoxication in Patients with Mild Traumatic Brain Injury: Characteristics, Recovery, and Outcome	JOURNAL OF NEUROTRAUMA			English	Article						alcohol; complaints; mild traumatic brain injury; outcome; recovery	GLASGOW COMA SCALE; ACUTE ETHANOL INTOXICATION; SYMPTOMS FOLLOWING MILD; PREDICTORS; IMPACT; LEVEL; MODEL; SCORE; AGE	A substantial number of patients (30% to 50%) sustains a mild traumatic brain injury (mTBI) while they are under the influence of alcohol. An acute alcohol intoxication (AAI) at the time of injury has been subject of research in severe TBI, but little is known about the relation between AAI and mTBI. This study aimed to describe the characteristics of this intoxicated subgroup and evaluate recovery and outcome in comparison to sober mTBI patients. We included 528 mTBI patients (Glasgow Coma Scale [GCS] score 13-15) admitted to two Level 1 trauma centers as part of a prospective follow-up study. We compared clinical characteristics, demographics, and injury mechanism between groups. Post-concussive complaints, mood disorders, and post-traumatic stress-related complaints were assessed at 2 weeks post-injury, and outcome at 6 months with the Glasgow Outcome Scale Extended (GOSE). Thirty-three percent of the mTBI patients were intoxicated. Results showed that the intoxicated group was younger (36 vs. 40 years; p=0.001) and were more frequently of male gender (78% vs. 60%; p<.001). The groups also differed in injury related characteristics, with intoxicated patients more frequently sustaining falls or violence-related injuries. The intoxicated group was assessed with a lower GCS score and had a higher hospital admission rate. However, at 2 weeks post-injury, intoxicated patients reported less complaints than the non-alcohol group and showed a better recovery at 6 months (average GOSE scores 7 vs. 7.3; p=0.030). We conclude that AAI in mTBI represents a characteristically different group, which has implications for prevention measures, as well as the course of recovery.	[Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Dept Neuropsychol, NL-9700 RB Groningen, Netherlands; [de Koning, Myrthe E.; van der Horn, Harm J.; van der Naalt, Joukje] Univ Groningen, Dept Neurol, NL-9700 RB Groningen, Netherlands; [Roks, Gerwin; Yilmaz, Tansel] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands	van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	j.van.der.naalt@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763			ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; [Anonymous], IBM SPSS STAT WIND V; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gilman JM, 2008, J NEUROSCI, V28, P4583, DOI 10.1523/JNEUROSCI.0086-08.2008; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Is M, 2005, NEUROSURG QUART, V15, P60, DOI 10.1097/01.wnq.0000152407.39871.c7; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; JURKOVICH GJ, 1992, ANN EMERG MED, V21, P704, DOI 10.1016/S0196-0644(05)82783-0; Kaysen DL, 2010, J TRAUMA STRESS, V23, P523, DOI 10.1002/jts.20542; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lange RT, 2010, BRAIN INJURY, V24, P919, DOI 10.3109/02699052.2010.489794; Lange RT, 2008, ARCH CLIN NEUROPSYCH, V23, P809, DOI 10.1016/j.acn.2008.07.004; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Mahler SA, 2010, J EMERG MED, V39, P685, DOI 10.1016/j.jemermed.2009.05.016; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Olson-Madden JH, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/174579; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; Puljula J, 2007, ALCOHOL ALCOHOLISM, V42, P474, DOI 10.1093/alcalc/agm003; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	20	21	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2016	33	4					339	345		10.1089/neu.2015.3926			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DD2NH	WOS:000369758800003	26230219				2021-06-18	
J	Alfano, CA; Lau, S; Balderas, J; Bunnell, BE; Beidel, DC				Alfano, Candice A.; Lau, Simon; Balderas, Jessica; Bunnell, Brian E.; Beidel, Deborah C.			The impact of military deployment on children: Placing developmental risk in context	CLINICAL PSYCHOLOGY REVIEW			English	Article						Children; Military families; Deployment; Mental health; Parents; Intervention	MENTAL-HEALTH-SERVICES; TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC STRESS SYMPTOMS; FAMILY COMMUNICATION; PARENTAL DEPLOYMENT; YOUNG-CHILDREN; SUBSTANCE USE; IRAQ; MALTREATMENT; ADOLESCENTS	During recent conflicts in the Middle East, U.S. military families have endured multiple separations, relocations, and alterations in family structure/routines, combined with other significant stressors. This review examines what is known about children's mental health and functioning in relation to parental military deployment during conflicts spanning the last 14 years. Findings are organized and considered by age group (i.e., toddlers and preschoolers, school age children, and adolescents) in an effort to highlight unique challenges and strengths present at different stages of development. Across all age groups, numerous studies document an increase in the number of military-connected children receiving mental health services in relation to parental deployment, though specific types of problems and long-term outcomes are not well understood. Evidence for a concerning increase in rates of child maltreatment related to parental deployment has also emerged. However, findings are largely based on aggregate data and the specific perpetrator is often unclear. Overall, we emphasize several critical next steps for research in this area including investigations characterized by greater methodological rigor, consideration of broader parental and contextual influences on child mental health, objective indicators of stress and coping, and longitudinal designs to examine persistence of child emotional/behavioral problems. A focus on adaptive/resilient outcomes is equally essential for understanding long-term outcomes and developing effective intervention programs. (C) 2015 Elsevier Ltd. All rights reserved.	[Alfano, Candice A.; Lau, Simon; Balderas, Jessica] Univ Houston, Dept Psychol, 4811 Calhoun Rd, Houston, TX 77204 USA; [Bunnell, Brian E.] Med Univ S Carolina, Dept Nursing, Charleston, SC 29425 USA; [Beidel, Deborah C.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA	Alfano, CA (corresponding author), Univ Houston, Dept Psychol, 4811 Calhoun Rd, Houston, TX 77204 USA.	caalfano@uh.edu	Bunnell, Brian/AAA-7202-2019	Bunnell, Brian/0000-0002-4964-0688			Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Acion L, 2013, ADDICTION, V108, P1418, DOI 10.1111/add.12161; Ainsworth M. D. S., 1978, PATTERNS ATTACHMENT; Allen ES, 2010, J FAM PSYCHOL, V24, P280, DOI 10.1037/a0019405; Amato PR, 2001, J FAM PSYCHOL, V15, P355, DOI 10.1037/0893-3200.15.3.355; Aranda MC, 2011, MIL MED, V176, P402, DOI 10.7205/MILMED-D-10-00202; Aronson KR, 2013, J CHILD FAM STUD, V22, P516, DOI 10.1007/s10826-012-9605-1; Averdijk M, 2012, CHILD PSYCHIAT HUM D, V43, P184, DOI 10.1007/s10578-011-0259-9; Barker LH, 2009, MIL MED, V174, P1033, DOI 10.7205/MILMED-D-04-1108; Barnes VA, 2007, MIL MED, V172, P40, DOI 10.7205/MILMED.172.1.40; Beardslee W, 2011, PREV SCI, V12, P339, DOI 10.1007/s11121-011-0234-5; Blow AJ, 2013, J FAM PSYCHOL, V27, P303, DOI 10.1037/a0031881; Britt T.W., 2006, MILITARY LIFE PSYCHO, P13; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Burton T, 2009, J AM ACAD NURSE PRAC, V21, P332, DOI 10.1111/j.1745-7599.2009.00411.x; Card NA, 2011, J FAM PSYCHOL, V25, P508, DOI 10.1037/a0024395; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Castaneda L.W., 2008, Deployment experiences of guard and reserve families: Implications for support and retention.; Cederbaum JA, 2014, J ADOLESCENT HEALTH, V54, P672, DOI 10.1016/j.jadohealth.2013.09.006; Chandra A., 2011, VIEWS HOMEFRONT EXPE; Chandra A., 2008, UNDERSTANDING IMPACT; Chandra A, 2010, J ADOLESCENT HEALTH, V46, P218, DOI 10.1016/j.jadohealth.2009.10.009; Chandra A, 2010, PEDIATRICS, V125, P16, DOI 10.1542/peds.2009-1180; Chartrand MM, 2008, ARCH PEDIAT ADOL MED, V162, P1009, DOI 10.1001/archpedi.162.11.1009; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Compas BE, 2001, PSYCHOL BULL, V127, P87, DOI 10.1037//0033-2909.127.1.87; Cozza SJ, 2010, J TRAUMA STRESS, V23, P112, DOI 10.1002/jts.20488; Creech SK, 2014, PROF PSYCHOL-RES PR, V45, P452, DOI 10.1037/a0035055; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; Demers A, 2011, J LOSS TRAUMA, V16, P160, DOI 10.1080/15325024.2010.519281; Department of Defense, 2010, REP IMP DEPL MEMB AR; Department of Defense Education Activity, 2013, MIL K 12 PARTN DODEA; Deputy Assistant Secretary of Defense, 2015, 2014 DEM PROF MIL CO; DeVore ER, 2005, CURR OPIN PEDIATR, V17, P460, DOI 10.1097/01.mop.0000170514.27649.c9; Drummet AR, 2003, FAM RELAT, V52, P279, DOI 10.1111/j.1741-3729.2003.00279.x; Eaton KM, 2008, MIL MED, V173, P1051, DOI 10.7205/MILMED.173.11.1051; Engel RC, 2010, ECON EDUC REV, V29, P73, DOI 10.1016/j.econedurev.2008.12.003; Evans BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061724; FERGUSSON DM, 1994, J CHILD PSYCHOL PSYC, V35, P1123, DOI 10.1111/j.1469-7610.1994.tb01813.x; Flake EM, 2009, J DEV BEHAV PEDIATR, V30, P271, DOI 10.1097/DBP.0b013e3181aac6e4; GARMEZY N, 1984, CHILD DEV, V55, P97, DOI 10.1111/j.1467-8624.1984.tb00276.x; Gavazzi SM, 2008, J YOUTH ADOLESCENCE, V37, P1071, DOI 10.1007/s10964-008-9306-7; Gewirtz AH, 2011, PROF PSYCHOL-RES PR, V42, P56, DOI 10.1037/a0022345; Gewirtz AH, 2010, J CONSULT CLIN PSYCH, V78, P599, DOI 10.1037/a0020571; Gibbs DA, 2007, JAMA-J AM MED ASSOC, V298, P528, DOI 10.1001/jama.298.5.528; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Gilreath TD, 2013, AM J PREV MED, V44, P150, DOI 10.1016/j.amepre.2012.09.059; Goff BSN, 2007, J FAM PSYCHOL, V21, P344, DOI 10.1037/0893-3200.21.3.344; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Gorman GH, 2010, PEDIATRICS, V126, P1058, DOI 10.1542/peds.2009-2856; Gorman LA, 2011, PSYCHIAT SERV, V62, P28, DOI 10.1176/ps.62.1.pss6201_0028; Hisle-Gorman E, 2014, MIL MED, V179, P573, DOI 10.7205/MILMED-D-13-00334; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Houston JB, 2013, J LOSS TRAUMA, V18, P103, DOI 10.1080/15325024.2012.684576; Huebner A. J., 2005, ADJUSTMENT ADOLESCEN; JELLINEK MS, 1988, J PEDIATR-US, V112, P201, DOI 10.1016/S0022-3476(88)80056-8; Juszczak L, 1999, Adolesc Med, V10, P1; Kelley M.L., 1994, MILITARY PSYCHOL TAY, V6, P163, DOI [10.1207/s15327876mp0603_2, DOI 10.1207/S15327876MP0603_2]; Kier C., 1997, J DIVORCE REMARRIAGE, V26, P185; Knobloch LK, 2014, J FAM COMMUN, V14, P291, DOI 10.1080/15267431.2014.945701; Knobloch LK, 2015, YOUTH SOC, V47, P319, DOI 10.1177/0044118X12462040; Lamberg L, 2008, JAMA-J AM MED ASSOC, V300, P644, DOI 10.1001/jama.300.6.644; Larson MJ, 2012, MED CARE, V50, P821, DOI 10.1097/MLR.0b013e31825516d8; Laser JA, 2011, CLIN SOC WORK J, V39, P28, DOI 10.1007/s10615-010-0310-5; Lester P, 2011, MIL MED, V176, P19, DOI 10.7205/MILMED-D-10-00122; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; Louie AD, 2014, PROF PSYCHOL-RES PR, V45, P496, DOI 10.1037/a0036603; Lyle DS, 2006, J LABOR ECON, V24, P319, DOI 10.1086/499975; MacDermid S. M., 2008, UNDERSTANDING PROMOT; Magnuson K, 2009, J MARRIAGE FAM, V71, P575, DOI 10.1111/j.1741-3737.2009.00620.x; Mansfield AJ, 2011, ARCH PEDIAT ADOL MED, V165, P999, DOI 10.1001/archpediatrics.2011.123; Mansfield AJ, 2010, NEW ENGL J MED, V362, P101, DOI 10.1056/NEJMoa0900177; McCarroll JE, 2008, CHILD ABUSE REV, V17, P108, DOI 10.1002/car.986; McCarthy RJ, 2015, PSYCHOL VIOLENCE, V5, P26, DOI 10.1037/a0035433; Military One Source, 2012, MIL DEPL GUID PREP Y; Millegan J, 2013, GEN HOSP PSYCHIAT, V35, P556, DOI 10.1016/j.genhosppsych.2013.04.015; Mmari K, 2009, YOUTH SOC, V40, P455, DOI 10.1177/0044118X08327873; Morris AS, 2009, J APPL DEV PSYCHOL, V30, P695, DOI 10.1016/j.appdev.2009.01.002; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Orthner D. K., 2005, ADJUSTMENT ARMY CHIL; Padden DL, 2011, MIL MED, V176, P26; Park N, 2011, AM PSYCHOL, V66, P65, DOI 10.1037/a0021249; Pfefferbaum B, 2011, J LOSS TRAUMA, V16, P291, DOI 10.1080/15325024.2010.519293; Pittman JF, 2004, FAM RELAT, V53, P249, DOI 10.1111/j.0197-6664.2004.0001.x; Rabenhorst MM, 2015, CHILD MALTREATMENT, V20, P61, DOI 10.1177/1077559514560625; Rai AA, 2003, J ADOLESCENT HEALTH, V33, P108, DOI 10.1016/S1054-139X(03)00179-4; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Reed SC, 2011, AM J PUBLIC HEALTH, V101, P1676, DOI 10.2105/AJPH.2011.300165; Rentz ED, 2007, AM J EPIDEMIOL, V165, P1199, DOI 10.1093/aje/kwm008; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Richardson A., 2011, EFFECTS SOLDIERS DEP; ROTTER JC, 1999, FAMILY J, V7, P379, DOI DOI 10.1177/1066480799074009; RUTTER M, 1972, J PSYCHOSOM RES, V16, P241, DOI 10.1016/0022-3999(72)90005-0; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Segal DR, 2004, POPUL BULL, V59, P3; SteelFisher GK, 2008, MIL MED, V173, P221, DOI 10.7205/MILMED.173.3.221; Sullivan R, 2011, CLIN PERINATOL, V38, P643, DOI 10.1016/j.clp.2011.08.011; Swedean SK, 2013, MIL MED, V178, P274, DOI 10.7205/MILMED-D-12-00171; Tan M., 2009, ARMY TIMES; Thompson D. E., 2015, YOUTH SOC; Thomsen CJ, 2014, PSYCHOL VIOLENCE, V4, P143, DOI 10.1037/a0031766; U. S. Medicine, 2009, DEP DEF REACH OUT CH; Waliski A, 2012, J HUM BEHAV SOC ENVI, V22, P653, DOI 10.1080/10911359.2012.655621; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Walsh TB, 2014, HEALTH SOC WORK, V39, P35, DOI 10.1093/hsw/hlu005; White House, 2011, STRENGTH OUR MIL FAM; Willerton E, 2011, J FAM PSYCHOL, V25, P521, DOI 10.1037/a0024511; Wilson SR, 2014, J FAM COMMUN, V14, P32, DOI 10.1080/15267431.2013.857325; Wilson SR, 2011, J APPL COMMUN RES, V39, P223, DOI 10.1080/00909882.2011.585399; Yosick T, 2012, REV POSTDEPLOYMENT R	114	20	20	0	25	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0272-7358	1873-7811		CLIN PSYCHOL REV	Clin. Psychol. Rev.	FEB	2016	43						17	29		10.1016/j.cpr.2015.11.003			13	Psychology, Clinical	Psychology	DC6UT	WOS:000369355800002	26655960				2021-06-18	
J	Lucas, S; Smith, BM; Temkin, N; Bell, KR; Dikmen, S; Hoffman, JM				Lucas, Sylvia; Smith, Brendon M.; Temkin, Nancy; Bell, Kathleen R.; Dikmen, Sureyya; Hoffman, Jeanne M.			Comorbidity of Headache and Depression After Mild Traumatic Brain Injury	HEADACHE			English	Article						headache; depression; mild traumatic brain injury; traumatic brain injury; posttraumatic headache	CHRONIC POSTTRAUMATIC HEADACHE; PREVALENCE; DISORDERS; SEVERITY; SYMPTOMS; PAIN; ASSOCIATION; FREQUENCY; VALIDITY; CHILDREN	ObjectiveTo examine headache and depression over time in individuals who sustained mild traumatic brain injury (mTBI). Prevalence of headache and depression early after mTBI and at 1 year postinjury as well as the relationship between the two are evaluated. BackgroundHeadache is the most common physical symptom and depression is among the most common psychiatric diagnosis after traumatic brain injury regardless of severity. Headache and depression have been found to be two independent factors related to poor outcome after mTBI, yet there appears to be a paucity of research exploring the comorbidity of these two conditions after injury. Method/DesignLongitudinal survey design over 1 year of 212 participants with mTBI who were admitted to a Level 1 trauma center for observation or other system injuries. Depression was based on a score 10 on the Patient Health Questionnaire-9. Headache was based on participant report of new or worse-than-preinjury headache since hospitalization (baseline) or within the previous 3 months at 1 year postinjury. ResultsThe prevalence of headache and depression at baseline was 64% (135/212) and 15% (31/212), respectively. The prevalence of headache and depression at 1 year was 68% (127/187) and 27% (50/187), respectively. The co-occurrence of headache and depression increased from 11% (23/212) at baseline to 25% (46/187) at 1 year. At 1 year, the risk ratio of individuals who had headache to be depressed was 5.43 (95% CI 2.05-14.40) compared to those without headache (P<.001). The corresponding risk ratio at baseline was 1.64 (95% CI .77-3.49; P=.23). ConclusionsWhile prevalence of headache is consistently high over the first year after injury, rate of depression increased over the first year for those who were followed. Given the high rate of comorbidity, those with headache may develop depression over time. Evaluation for possible depression in those with headache after mTBI should be conducted to address both conditions over the year following injury.	[Lucas, Sylvia; Temkin, Nancy; Dikmen, Sureyya; Hoffman, Jeanne M.] Univ Washington, 325 9th Ave,Box 359924, Seattle, WA 98195 USA; [Smith, Brendon M.] Albany Med Coll, Albany, NY 12208 USA; [Bell, Kathleen R.] Univ Texas Southwestern, Dallas, TX USA	Lucas, S (corresponding author), Univ Washington, 325 9th Ave,Box 359924, Seattle, WA 98195 USA.	lucass@uw.edu		Bell, Kathleen/0000-0002-0928-2046	Department of Education, National Institute on Disability Rehabilitation Research [H133G0900022]	This study was funded by the Department of Education, National Institute on Disability Rehabilitation Research, grant number H133G0900022.	Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BOURDON KH, 1992, PUBLIC HEALTH REP, V107, P663; Breslau N, 2000, NEUROLOGY, V54, P308, DOI 10.1212/WNL.54.2.308; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Gesztelyi G, 2005, CEPHALALGIA, V25, P598, DOI 10.1111/j.1468-2982.2005.00937.x; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lerman B, 2011, J NEUROTRAUM, V28, pA16; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Sawyer K, 2015, ARCH PHYS MED REHAB, V96, P2000, DOI 10.1016/j.apmr.2015.07.006; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Uebersax J, 2009, MCNEMAR TESTS MARGIN; Vaccarino AL, 2008, J AFFECT DISORDERS, V110, P270, DOI 10.1016/j.jad.2008.01.009; Vaccarino AL, 2009, PSYCHOSOM MED, V71, P159, DOI 10.1097/PSY.0b013e3181906572; Zwart JA, 2003, EUR J NEUROL, V10, P147, DOI 10.1046/j.1468-1331.2003.00551.x	35	20	20	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	FEB	2016	56	2					323	330		10.1111/head.12762			8	Clinical Neurology	Neurosciences & Neurology	DF1CV	WOS:000371076900009	26814846				2021-06-18	
J	Kelestemur, T; Yulug, B; Caglayan, AB; Beker, MC; Kilic, U; Caglayan, B; Yalcin, E; Gundogdu, RZ; Kilic, E				Kelestemur, Taha; Yulug, Burak; Caglayan, Ahmet Burak; Beker, Mustafa Caglar; Kilic, Ulkan; Caglayan, Berrak; Yalcin, Esra; Gundogdu, Reyhan Zeynep; Kilic, Ertugrul			Targeting different pathophysiological events after traumatic brain injury in mice: Role of melatonin and memantine	NEUROSCIENCE LETTERS			English	Article						Memantine; Melatonin; Traumatic Brain Injury; DNA fragmentation	FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE SYNTHASE; CLOSED-HEAD INJURY; RECEPTOR INHIBITION; KINASE PATHWAYS; NMDA RECEPTOR; RAT STRIATUM; IN-VITRO; ACTIVATION; NEUROPROTECTION	The tissue damage that emerges during traumatic brain injury (TBI) is a consequence of a variety of pathophysiological events, including free radical generation and over-activation of N-methyl-D-aspartate-type glutamate receptors (NMDAR). Considering the complex pathophysiology of TBI, we hypothesized that combination of neuroprotective compounds, targeting different events which appear during injury, may be a more promising approach for patients. In this context, both NMDAR antagonist memantine and free radical scavenger melatonin are safe in humans and promising agents for the treatment of TBI. Herein, we examined the effects of melatonin administered alone or in combination with memantine on the activation of signaling pathways, injury development and DNA fragmentation. Both compounds reduced brain injury moderately and the density of DNA fragmentation significantly. Notably, melatonin/memantine combination decreased brain injury and DNA fragmentation significantly, which was associated with reduced p38 and ERK-1/2 phosphorylation. As compared with melatonin and memantine groups, SAM/INK-1/2 phosphorylation was also reduced in melatonin/memantine combined animals. In addition, melatonin, memantine and their combination decreased iNOS activity significantly. Here, we provide evidence that melatonin/memantine combination protects brain from traumatic injury, which was associated with decreased DNA fragmentation, p38 phosphorylation and iNOS activity. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kelestemur, Taha; Caglayan, Ahmet Burak; Beker, Mustafa Caglar; Caglayan, Berrak; Yalcin, Esra; Gundogdu, Reyhan Zeynep; Kilic, Ertugrul] Univ Istanbul Medipol, Regenerat & Restorat Med Res Ctr, Dept Physiol, TR-34810 Istanbul, Turkey; [Yulug, Burak] Univ Istanbul Medipol, Dept Neurol, TR-34810 Istanbul, Turkey; [Kilic, Ulkan] Univ Istanbul Medipol, Dept Med Biol, TR-34810 Istanbul, Turkey	Kilic, E (corresponding author), Istanbul Medipol Univ, Dept Physiol, Ekinciler Cad 19, TR-34810 Istanbul, Turkey.	ekilic@medipol.edu.tr	Kilic, Ertugrul/W-4563-2018; Beker, Mustafa Caglar/ABH-2222-2020	Kilic, Ertugrul/0000-0001-6494-8923; Yalcin, Esra/0000-0002-1064-7989; Beker, Mustafa/0000-0002-9476-8488; Caglayan, Berrak/0000-0002-5072-132X; caglayan, ahmet burak/0000-0002-6242-3709; Kelestemur, Taha/0000-0003-3616-1204	EMBO (European Molecular Biology Organization)European Molecular Biology Organization (EMBO); Turkish Academy of Sciences (TUBA)Turkish Academy of Sciences	This work was supported by EMBO (European Molecular Biology Organization) installation grant and Turkish Academy of Sciences (TUBA).	Andresen L, 2014, NEUROBIOL DIS, V71, P305, DOI 10.1016/j.nbd.2014.08.022; Babu CS, 2011, INT J DEV NEUROSCI, V29, P93, DOI 10.1016/j.ijdevneu.2010.08.001; Beker MC, 2015, ONCOTARGET, V6, P30604, DOI 10.18632/oncotarget.5773; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; El-Sherif Y, 2002, BRAIN RES, V945, P191, DOI 10.1016/S0006-8993(02)02752-X; Escames G, 2004, J NEUROENDOCRINOL, V16, P929, DOI 10.1111/j.1365-2826.2004.01250.x; Fukunaga K, 2002, J NEUROSCI RES, V70, P799, DOI 10.1002/jnr.10400; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Hermann DM, 2001, NEUROBIOL DIS, V8, P964, DOI 10.1006/nbdi.2001.0448; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kilic E, 1999, J CEREBR BLOOD F MET, V19, P511, DOI 10.1097/00004647-199905000-00005; Kilic U, 2013, NEUROSCIENCE, V237, P268, DOI 10.1016/j.neuroscience.2013.01.059; Kim YW, 2010, ANN NUCL MED, V24, P363, DOI 10.1007/s12149-010-0360-3; Lal BK, 2001, MICROVASC RES, V62, P252, DOI 10.1006/mvre.2001.2338; Leon J, 1998, J NEUROENDOCRINOL, V10, P297, DOI 10.1046/j.1365-2826.1998.00203.x; Lipton SA, 2004, CELL DEATH DIFFER, V11, P18, DOI 10.1038/sj.cdd.4401344; Liu CH, 2009, BRAIN RES, V1282, P173, DOI 10.1016/j.brainres.2009.05.071; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Maroney AC, 1998, J NEUROSCI, V18, P104; Michinaga S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102009; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Otani N, 2003, ACT NEUR S, V86, P287; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Otani N., 2011, NEUROSCI MED, V11, P208; Otani N, 2007, J CLIN NEUROSCI, V14, P42, DOI 10.1016/j.jocn.2005.11.044; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Rao VLR, 2001, BRAIN RES, V911, P96; Reiter RJ, 2005, EXP BIOL MED, V230, P104; Reiter RJ, 2010, PROG BRAIN RES, V181, P127, DOI 10.1016/S0079-6123(08)81008-4; Robertson C. S., 2007, NITRIC OXIDE METABOL, P739; Turel MK, 2013, J CLIN NEUROSCI, V20, P593, DOI 10.1016/j.jocn.2012.06.009; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Volbracht C, 2006, EUR J NEUROSCI, V23, P2611, DOI 10.1111/j.1460-9568.2006.04787.x; Watanabe T, 2010, J NEUROSCI RES, V88, P1908, DOI 10.1002/jnr.22346; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zubkov AY, 2000, STROKE, V31, P526, DOI 10.1161/01.STR.31.2.526	45	20	22	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 26	2016	612						92	97		10.1016/j.neulet.2015.11.043			6	Neurosciences	Neurosciences & Neurology	DC8LU	WOS:000369471900016	26639427				2021-06-18	
J	Bourque, M; Morissette, M; Al Sweidi, S; Caruso, D; Melcangi, RC; Di Paolo, T				Bourque, Melanie; Morissette, Marc; Al Sweidi, Sara; Caruso, Donatella; Melcangi, Roberto C.; Di Paolo, Therese			Neuroprotective Effect of Progesterone in MPTP-Treated Male Mice	NEUROENDOCRINOLOGY			English	Article						Neuroprotection; Progesterone; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Dopamine; Neuroactive steroids	TRAUMATIC BRAIN-INJURY; INDUCED DOPAMINE DEPLETION; NEUROACTIVE STEROID-LEVELS; FEMALE RAT-BRAIN; PARKINSONS-DISEASE; CEREBRAL-ISCHEMIA; NERVOUS-SYSTEM; CLINICAL-TRIAL; MOUSE MODEL; ESTROGEN	Background: Numerous studies have reported on the neuroprotective activity of estradiol, whereas the effect of the other ovarian steroid, progesterone, is much less documented. Methods: This study sought to investigate neuroprotection with a low dose of progesterone (1 mu g) in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated male mice to model Parkinson's disease and compare it to the effect of this steroid in intact mice (experiment 1). We also investigated if high doses of progesterone could protect dopaminergic neurons already exposed to MPTP (experiment 2). We measured progesterone effects on various dopaminergic markers [dopamine and its metabolites, dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2)] and on neuroactive steroids in both plasma and the brain. Results: For experiment 1, our results showed that progesterone completely prevented the effect of MPTP toxicity on dopamine concentrations, on the increase in the 3-methoxytyramine/dopamine ratio, as well as on VMAT2-specific binding in the striatum and the substantia nigra. Progesterone decreased MPTP effects on 3,4-dihydroxyphenylacetic acid concentrations and DAT-specific binding in the lateral part of the anterior striatum and in the middle striatum (medial and lateral parts). Progesterone treatment of intact mice had no effect on the markers investigated. For experiment 2, measures of dopaminergic markers in the striatum showed that 8 mg/kg of progesterone was the most effective dose to reduce MPTP effects, and more limited effects were observed with 16 mg/kg. We found that progesterone treatment increases the levels of brain progesterone itself as well as of its metabolites. Conclusion: Our result showed that progesterone has neuroprotective effects on dopaminergic neurons in MPTP-treated male mice. (C) 2015 S. Karger AG, Basel	[Bourque, Melanie; Morissette, Marc; Al Sweidi, Sara; Di Paolo, Therese] Ctr Hosp Univ Laval, Ctr Hosp Univ Quebec, Neurosci Res Unit, Quebec City, PQ, Canada; [Bourque, Melanie; Al Sweidi, Sara; Di Paolo, Therese] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Caruso, Donatella; Melcangi, Roberto C.] Univ Milan, Dept Pharmacol & Biomol Sci, Ctr Excellence Neurodegenerat Dis, Milan, Italy	Di Paolo, T (corresponding author), Ctr Hosp Univ Quebec, Neurosci Res Unit, 2705 Laurier Blvd, Quebec City, PQ G1V 4G2, Canada.	therese.dipaolo@crchul.ulaval.ca		MELCANGI, COSIMO ROBERTO/0000-0003-0861-8967	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP-82692]	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR) MOP-82692 to T.D.P.	Adeosun SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050040; Aggarwal R, 2008, J PHARM PHARMACOL, V60, P731, DOI 10.1211/jpp.60.6.0008; AlDakheel A, 2014, NEUROTHERAPEUTICS, V11, P6, DOI 10.1007/s13311-013-0218-1; Aron L, 2011, TRENDS NEUROSCI, V34, P88, DOI 10.1016/j.tins.2010.11.001; Audet-Walsh E, 2011, J CLIN ENDOCR METAB, V96, pE330, DOI 10.1210/jc.2010-2050; Baraka AM, 2011, LIFE SCI, V88, P879, DOI 10.1016/j.lfs.2011.03.010; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bixo M, 1997, BRAIN RES, V764, P173, DOI 10.1016/S0006-8993(97)00455-1; Bourque M, 2014, NEUROBIOL AGING, V35, P2347, DOI 10.1016/j.neurobiolaging.2014.03.017; Bourque M, 2013, NEUROBIOL AGING, V34, P887, DOI 10.1016/j.neurobiolaging.2012.05.022; Bourque M, 2009, FRONT NEUROENDOCRIN, V30, P142, DOI 10.1016/j.yfrne.2009.04.014; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Caruso D, 2010, J NEUROENDOCRINOL, V22, P1137, DOI 10.1111/j.1365-2826.2010.02064.x; Caruso D, 2013, PSYCHONEUROENDOCRINO, V38, P2278, DOI 10.1016/j.psyneuen.2013.04.016; Casas S, 2011, PHARMACOL BIOCHEM BE, V99, P614, DOI 10.1016/j.pbb.2011.06.012; Chao OY, 2011, NEUROSCIENCE, V196, P228, DOI 10.1016/j.neuroscience.2011.08.043; Curran-Rauhut Meredith A., 2002, Gene Expression Patterns, V1, P151, DOI 10.1016/S1567-133X(02)00011-X; D'Astous M, 2003, SYNAPSE, V47, P10, DOI 10.1002/syn.10145; de Michele F, 2003, NEUROL SCI, V24, P172, DOI 10.1007/s10072-003-0115-1; DIPAOLO T, 1986, EUR J PHARMACOL, V125, P11, DOI 10.1016/0014-2999(86)90077-4; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Ekue A, 2002, J NEUROENDOCRINOL, V14, P731, DOI 10.1046/j.1365-2826.2002.00833.x; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Grandbois M, 2000, NEUROREPORT, V11, P343, DOI 10.1097/00001756-200002070-00024; Guerra-Araiza C, 2009, J NEUROSCI RES, V87, P470, DOI 10.1002/jnr.21848; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; Ishihara Y, 2013, J STEROID BIOCHEM, V135, P1, DOI 10.1016/j.jsbmb.2012.12.013; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Jeyaraj DA, 2001, ENDOCR RES, V27, P223, DOI 10.1081/ERC-100107183; Jodhka PK, 2009, ENDOCRINOLOGY, V150, P3162, DOI 10.1210/en.2008-1247; Kilbourn M, 1996, EUR J PHARMACOL, V307, P227, DOI 10.1016/0014-2999(96)00252-X; L'Episcopo F, 2011, NEUROBIOL DIS, V41, P508, DOI 10.1016/j.nbd.2010.10.023; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Lonstein JS, 2004, J NEUROENDOCRINOL, V16, P534, DOI 10.1111/j.1365-2826.2004.01198.x; Luchetti S, 2010, BRAIN PATHOL, V20, P945, DOI 10.1111/j.1750-3639.2010.00396.x; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Melcangi RC, 2012, J MOL NEUROSCI, V46, P177, DOI 10.1007/s12031-011-9570-y; Morissette M, 2007, NEUROPHARMACOLOGY, V52, P1509, DOI 10.1016/j.neuropharm.2007.02.004; Olanow CW, 2013, ANN NEUROL, V74, P337, DOI 10.1002/ana.24011; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; PETITCLERC M, 1995, PROG NEURO-PSYCHOPH, V19, P491, DOI 10.1016/0278-5846(95)00029-U; Radley E, 2012, NEUROSCI LETT, V506, P131, DOI 10.1016/j.neulet.2011.10.065; Ruffoli R, 2008, BRAIN RES, V1229, P218, DOI 10.1016/j.brainres.2008.06.116; Sanchez MG, 2010, CNS NEUROSCI THER, V16, pe43, DOI 10.1111/j.1755-5949.2010.00163.x; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Shulman LM, 2007, GENDER MED, V4, P8, DOI 10.1016/S1550-8579(07)80003-9; Singh M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00159; Singh S, 2010, PHARMACOL BIOCHEM BE, V94, P416, DOI 10.1016/j.pbb.2009.10.003; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Spark MJ, 2012, MATURITAS, V72, P192, DOI 10.1016/j.maturitas.2012.03.015; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Wong R, 2012, J PHARM PHARMACOL, V64, P1614, DOI 10.1111/j.2042-7158.2012.01537.x; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu HBK, 2006, BRAIN RES, V1126, P188, DOI 10.1016/j.brainres.2006.09.074; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yu L, 2000, J NEURAL TRANSM, V107, P1139, DOI 10.1007/s007020070027; Zheng P, 2009, PROG NEUROBIOL, V89, P134, DOI 10.1016/j.pneurobio.2009.07.001; Zuloaga DG, 2012, ENDOCRINOLOGY, V153, P4432, DOI 10.1210/en.2012-1469	67	20	20	1	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0028-3835	1423-0194		NEUROENDOCRINOLOGY	Neuroendocrinology		2016	103	3-4					300	314		10.1159/000438789			15	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	DL6RO	WOS:000375766500012	26227546	Green Published			2021-06-18	
J	Frasnelli, J; Lague-Beauvais, M; LeBlanc, J; Alturki, AY; Champoux, MC; Couturier, C; Anderson, K; Lamoureuxe, J; Marcoux, J; Tinawi, S; Dagher, J; Maleki, M; Feyz, M; de Guise, E				Frasnelli, J.; Lague-Beauvais, M.; LeBlanc, J.; Alturki, A. Y.; Champoux, M. C.; Couturier, C.; Anderson, K.; Lamoureuxe, J.; Marcoux, J.; Tinawi, S.; Dagher, J.; Maleki, M.; Feyz, M.; de Guise, E.			Olfactory function in acute traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Craniocerebral trauma; Smell; Olfaction; Olfactory perception	GLASGOW COMA SCALE; HEAD-INJURY; POSTTRAUMATIC AMNESIA; ODOR IDENTIFICATION; GALVESTON ORIENTATION; DYSFUNCTION; DISCRIMINATION; ANOSMIA; RECOVERY; REHABILITATION	Objective: Traumatic brain injury (TBI) represents a significant public health problem and is associated with a high rate of mortality and morbidity. Although TBI is amongst the most common causes of olfactory dysfunction the relationship between injury severity and olfactory problems has not yet been investigated with validated and standardized methods in the first days following the TBI. Methods: We measured olfactory function in 63 patients admitted with TBI within the first 12 days following the trauma by means of the Sniffin' Sticks identification test (quantitative assessment) and a parosmia questionnaire (qualitative assessment). TBI severity was determined by means of the Glasgow Coma Scale (GCS) and by duration of post-traumatic amnesia (PTA) as measured by the Galveston Orientation and Amnesia Test. Results: Poor olfactory scores correlated with a longer amnesia period, but not with GCS scores. Further, we observed higher parosmia scores in assault victims than in victims of falls or motor vehicle collisions. Conclusions: We show that PTA is intimately related to olfactory problems following a TBI. Thus, a thorough evaluation of olfaction is essential in order to detect posttraumatic olfactory dysfunction and to take appropriate actions early on to help the individual deal with this impairment. (C) 2015 Elsevier B.V. All rights reserved.	[Frasnelli, J.] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Frasnelli, J.] Univ Quebec Trois Rivieres, Dept Anat, UQTR Chemosensory Neuroanat, Trois Rivieres, PQ GA9 5H7, Canada; [Lague-Beauvais, M.; LeBlanc, J.; Champoux, M. C.; Couturier, C.; Tinawi, S.; Dagher, J.; Feyz, M.] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ, Canada; [Anderson, K.; de Guise, E.] Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada; [Lamoureuxe, J.] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [Alturki, A. Y.; Marcoux, J.; Maleki, M.; de Guise, E.] McGill Univ, Ctr Hlth, Neurol & Neurosurg Dept, Montreal, PQ, Canada; [Tinawi, S.; Dagher, J.] McGill Univ, Ctr Hlth, Phys Med & Rehabil Serv, Montreal, PQ, Canada; [Alturki, A. Y.] King Fahad Med City, Natl Neurosci Inst, Dept Neurosurg, Riyadh, Saudi Arabia	Frasnelli, J (corresponding author), Univ Quebec Trois Rivieres, Dept Anat, 3351 Blvd Forges, Trois Rivieres, PQ G9A 5H7, Canada.	johannes.a.frasnelli@uqtr.ca		Frasnelli, Johannes/0000-0002-8863-3982	Research Center of Sacre-Coeur Hospital, Montreal; University of Quebec in Trois-Rivieres; Natural Sciences and Engineering Research Council (Canada)Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de Recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec; University of Montreal; Research Institute of the McGill University Hospital Center	JF is supported by grants from the Research Center of Sacre-Coeur Hospital, Montreal, the University of Quebec in Trois-Rivieres, the Natural Sciences and Engineering Research Council (Canada), and the Fonds de Recherche du Quebec - Sante. EDG is supported by a start-up grant from the University of Montreal. We would like to thank the Research Institute of the McGill University Hospital Center for their support.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Aschenbrenner K, 2008, LARYNGOSCOPE, V118, P135, DOI 10.1097/MLG.0b013e318155a4b9; Auvray M, 2008, CONSCIOUS COGN, V17, P1016, DOI 10.1016/j.concog.2007.06.005; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Costanzo RM, 2000, CHEM SENSES, V25, P199, DOI 10.1093/chemse/25.2.199; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Frasnelli J, 2004, EUR ARCH OTO-RHINO-L, V261, P411, DOI 10.1007/s00405-003-0703-y; Frasnelli J, 2011, CHEM SENSES, V36, P405, DOI 10.1093/chemse/bjr001; Gautschi OP, 2013, CLIN NEUROL NEUROSUR, V115, P2482, DOI 10.1016/j.clineuro.2013.09.038; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hedner M, 2010, J CLIN EXP NEUROPSYC, V32, P1062, DOI 10.1080/13803391003683070; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2010, ARCH OTOLARYNGOL, V136, P347, DOI 10.1001/archoto.2010.27; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Landis BN, 2010, LARYNGOSCOPE, V120, P1707, DOI 10.1002/lary.20955; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Landis BN, 2003, CHEM SENSES, V28, P691, DOI 10.1093/chemse/bjg061; Leopold D, 2002, CHEM SENSES, V27, P611, DOI 10.1093/chemse/27.7.611; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nordin S, 2007, RHINOLOGY, V45, P50; Reden J, 2007, EUR ARCH OTO-RHINO-L, V264, P139, DOI 10.1007/s00405-006-0157-0; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sommer JB, 2013, J REHABIL MED, V45, P778, DOI 10.2340/16501977-1208; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Swann IJ, 2006, EMERG MED J, V23, P618, DOI 10.1136/emj.2005.029017; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	44	20	20	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JAN	2016	140						68	72		10.1016/j.clineuro.2015.11.013			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DD7HI	WOS:000370093900011	26658033				2021-06-18	
J	Minert, A; Devor, M				Minert, Anne; Devor, Marshall			Brainstem node for loss of consciousness due to GABA(A) receptor-active anesthetics	EXPERIMENTAL NEUROLOGY			English	Article						Brainstem; Coma; Concussion; General anesthesia; Loss-of-consciousness; MPTA	GENERAL-ANESTHESIA; INTRACEREBRAL MICROINJECTION; MESOPONTINE TEGMENTUM; RAT; MECHANISMS; ACTIVATION; PATHWAYS; PROPOFOL; SYSTEMS; NEURONS	The molecular agents that induce loss of consciousness during anesthesia are classically believed to act by binding to cognate transmembrane receptors widely distributed in the CNS and critically suppressing local processing and network connectivity. However, previous work has shown that microinjection of anesthetics into a localized region of the brainstem mesopontine tegmentum (MPTA) rapidly and reversibly induces anesthesia in the absence of global spread. This implies that functional extinction is determined by neural pathways rather than vascular distribution of the anesthetic agent. But does clinical (systemic-induced) anesthesia employ MPTA-linked circuitry? Here we show that cell-selective lesioning of the MPTA in rats does not, in itself, induce anesthesia or coma. However, it increases the systemic dose of pentobarbital required to induce anesthesia, in a manner proportional to the extent of the lesion. Such lesions also affect emergence, extending the duration of anesthesia. Off-target and sham lesions were ineffective. Combined with the prior microinjection data, we conclude that drug delivery to the MPTA is sufficient to induce loss-of-consciousness and that neurons in this locus are necessary for anesthetic induction at clinically relevant doses. Together, the results support an architecture for anesthesia with the MPTA serving as a key node in an endogenous network of dedicated pathways that switch between wake and unconsciousness. As such, the MPTA might also play a role in syncope, concussion and sleep. (C) 2015 Elsevier Inc. All rights reserved.	[Devor, Marshall] Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Dev Biol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Ctr Res Pain, IL-91904 Jerusalem, Israel	Devor, M (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Dev Biol, IL-91904 Jerusalem, Israel.	marshlu@mail.huji.ac.il		Devor, Marshall/0000-0001-8206-3301; Minert, Anne/0000-0002-8462-013X	Israeli Ministry of Health; Hebrew University Center for Research on Pain	This study was supported by grants from the Israeli Ministry of Health and the Hebrew University Center for Research on Pain. We thank Adi Goldenberg, Yelena Fishman Ph.D., Roni Jortner, Natalie Padon and Vladimir Zalkind for their assistance.	Abulafia R, 2009, J NEUROSCI, V29, P7053, DOI 10.1523/JNEUROSCI.1357-08.2009; Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; Antognini J.F., 2003, NEURAL MECH ANESTHES; Antognini JF, 1998, TOXICOL LETT, V101, P51, DOI 10.1016/S0378-4274(98)00164-7; Bleckwenn A, 2002, MOLECULAR AND BASIC MECHANISMS OF ANESTHESIA, P550; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Devor M, 2001, PAIN, V94, P101, DOI 10.1016/S0304-3959(01)00345-1; Faingold C., 1987, EPILEPSY RETICULAR F, P39; Fields HL, 2006, WALL MELZACKS TXB PA, P125; Finney D. J., 1971, PROBIT ANAL; FORD B, 1995, J COMP NEUROL, V363, P177, DOI 10.1002/cne.903630203; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Grasshoff C, 2005, CURR OPIN ANESTHESIO, V18, P386, DOI 10.1097/01.aco.0000174961.90135.dc; HAYES RL, 1984, SCIENCE, V223, P301, DOI 10.1126/science.6701514; JARRARD LE, 1989, J NEUROSCI METH, V29, P251, DOI 10.1016/0165-0270(89)90149-0; Joiner WJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003605; Kendig JJ, 2002, BRIT J ANAESTH, V89, P91, DOI 10.1093/bja/aef158; Leung LS, 2014, PROG NEUROBIOL, V122, P24, DOI 10.1016/j.pneurobio.2014.08.001; Lu J, 2008, J COMP NEUROL, V508, P648, DOI 10.1002/cne.21685; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Namjoshi DR, 2009, J NEUROPHYSIOL, V102, P700, DOI 10.1152/jn.90933.2008; Nunez A, 1998, BRAIN RES, V804, P144, DOI 10.1016/S0006-8993(98)00681-7; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Sandoval-Herrera V, 2011, HORM BEHAV, V60, P448, DOI 10.1016/j.yhbeh.2011.07.013; Scharf M. T., 2013, CURR ANESTHESIOL REP, V3, P1; Sukhotinsky I, 2005, J COMP NEUROL, V489, P425, DOI 10.1002/cne.20636; Sukhotinsky I, 2007, EUR J NEUROSCI, V25, P1417, DOI 10.1111/j.1460-9568.2007.05399.x; Sukhotinsky I, 2003, PROG PAIN RES MANAG, V24, P305; Tononi G, 2005, PROG BRAIN RES, V150, P109, DOI 10.1016/S0079-6123(05)50009-8; Voss LJ, 2005, ANAESTH INTENS CARE, V33, P373, DOI 10.1177/0310057X0503300313; WHELAN G, 1992, LAB ANIM-UK, V26, P153, DOI 10.1258/002367792780740602; YAMAMOTO S, 1961, ELECTROEN CLIN NEURO, V13, P248, DOI 10.1016/0013-4694(61)90141-9; Zeilhofer Hanns Ulrich, 2015, Adv Pharmacol, V73, P71, DOI 10.1016/bs.apha.2014.11.007	39	20	20	1	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2016	275		1				38	45		10.1016/j.expneurol.2015.10.001			8	Neurosciences	Neurosciences & Neurology	CZ9MA	WOS:000367420500005	26436687				2021-06-18	
J	O'Lynnger, TM; Shannon, CN; Le, TM; Greeno, A; Chung, D; Lamb, FS; Wellons, JC				O'Lynnger, Thomas M.; Shannon, Chevis N.; Le, Truc M.; Greeno, Amber; Chung, Dai; Lamb, Fred S.; Wellons, John C., III			Standardizing ICU management of pediatric traumatic brain injury is associated with improved outcomes at discharge	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						critical care; discharge; trauma; traumatic brain injury; protocol	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; INTENSIVE-CARE; CHILDREN; MORTALITY; RECOMMENDATIONS; SURVIVORS; IMPACT; SCALE	OBJECTIVE The goal of critical care in treating traumatic brain injury (TBI) is to reduce secondary brain injury by limiting cerebral ischemia and optimizing cerebral blood flow. The authors compared short-term outcomes as defined by discharge disposition and Glasgow Outcome Scale scores in children with TBI before and after the implementation of a protocol that standardized decision-making and interventions among neurosurgeons and pediatric intensivists. METHODS The authors performed a retrospective pre- and postprotocol study of 128 pediatric patients with severe TBI, as defined by Glasgow Coma Scale (GCS) scores < 8, admitted to a tertiary care center pediatric critical care unit between April 1, 2008, and May 31, 2014. The preprotocol group included 99 patients, and the postprotocol group included 29 patients. The primary outcome of interest was discharge disposition before and after protocol implementation, which took place on April 1, 2013. Ordered logistic regression was used to assess outcomes while accounting for injury severity and clinical parameters. Favorable discharge disposition included discharge home. Unfavorable discharge disposition included discharge to an inpatient facility or death. RESULTS Demographics were similar between the treatment periods, as was injury severity as assessed by GCS score (mean 5.43 preprotocol, mean 5.28 postprotocol; p = 0.67). The ordered logistic regression model demonstrated an odds ratio of 4.0 of increasingly favorable outcome in the postprotocol cohort (p = 0.007). Prior to protocol implementation, 63 patients (64%) had unfavorable discharge disposition and 36 patients (36%) had favorable discharge disposition. After protocol implementation, 9 patients (31%) had unfavorable disposition, while 20 patients (69%) had favorable disposition (p = 0.002). In the preprotocol group, 31 patients (31%) died while 6 patients (21%) died after protocol implementation (p = 0.04). CONCLUSIONS Discharge disposition and mortality rates in pediatric patients with severe TBI improved after implementation of a standardized protocol among caregivers based on best-practice guidelines.	[O'Lynnger, Thomas M.; Shannon, Chevis N.; Wellons, John C., III] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA; [Le, Truc M.; Lamb, Fred S.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Pediat Crit Care Med, Nashville, TN USA; [Greeno, Amber; Chung, Dai] Vanderbilt Univ, Med Ctr, Dept Pediat Surg, Nashville, TN 37232 USA	O'Lynnger, TM (corresponding author), Vanderbilt Univ, Med Ctr, Pediat Neurosurg, 9222 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA.	olynnger@vanderbilt.edu		Lamb, Fred/0000-0003-2955-5133	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000445] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000445] Funding Source: Medline		Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bell MJ, 2009, NEUROCRIT CARE, V10, P4, DOI 10.1007/s12028-008-9061-3; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cuschieri J, 2012, ANN SURG, V255, P993, DOI 10.1097/SLA.0b013e31824f1ebc; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Greenwald BD, 2015, J NEUROTRAUMA; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lane PL, 2000, CAN J SURG, V43, P442; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; SAUL TG, 1982, AM SURGEON, V48, P477; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Scaife ER, 2010, CURR OPIN PEDIATR, V22, P339, DOI 10.1097/MOP.0b013e3283395f2b; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Society of Critical Care Medicine, 2003, Crit Care Med, V31, pS407; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Xiang J, 2013, BRAIN INJURY, V27, P1555, DOI 10.3109/02699052.2013.831126	33	20	20	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JAN	2016	17	1					19	26		10.3171/2015.5.PEDS1544			8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CZ3TW	WOS:000367027900005	26451717				2021-06-18	
J	Pavliscsak, H; Little, JR; Poropatich, RK; McVeigh, FL; Tong, J; Tillman, JS; Smith, CH; Fonda, SJ				Pavliscsak, Holly; Little, Jeanette R.; Poropatich, Ronald K.; McVeigh, Francis L.; Tong, James; Tillman, Johnie S.; Smith, Challis H.; Fonda, Stephanie Jo			Assessment of patient engagement with a mobile application among service members in transition	JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION			English	Article						case management; traumatic brain injury; post-traumatic stress disorder; mobile health; patient engagement	MANAGEMENT; PROGRAM; INTERVENTIONS; EMPOWERMENT; OUTCOMES; PHONES; MODEL; CARE	Objective: This article examines engagement with a mobile application ("mCare") for wounded Service Members rehabilitating in their communities. Many had behavioral health problems, Traumatic Brain Injury (TBI), and/or post-traumatic stress disorder (PTS). The article also examines associations between Service Members' background characteristics and their engagement with mCare. Materials and Methods: This analysis included participants who received mCare (n = 95) in a randomized controlled trial. mCare participants received status questionnaires daily for up to 36 weeks. Participant engagement encompasses exposure to mCare, percentage of questionnaires responded to, and response time. Participants were grouped by health status-that is, presence/absence of behavioral health problems, PTS, and/or TBI. Histograms and regression analyses examined engagement by participants' health status and background characteristics. Results: Exposure to mCare did not differ by health status. Participants usually responded to >= 60% of the questionnaires weekly, generally in <= 10 h; however, participants with behavioral health problems had several weeks with <50% response and the longest response times. Total questionnaires responded to and response time did not differ statistically by health status. Older age and higher General Well-Being Schedule scores were associated with greater and faster response. Discussion: The sustained response to the questionnaires suggests engagement. Overall level of response surpassed trends reported for American's usage of mobile applications. With a few exceptions, Service Members engaged with mCare irrespective of health status. Conclusion: Mobile health has the potential to increase the quantity and quality of patient-provider communications in a community-based, rehabilitation care setting, above that of standard care.	[Pavliscsak, Holly] USAMRMC, TATRC, Mobile Hlth Care Innovat Ctr MHIC, Geneva Fdn, Ft Gordon, GA 30905 USA; [Little, Jeanette R.] US Army, Med Res & Mat Command, Telemed & Adv Technol Res Ctr, Mobile Hlth Innovat Ctr, Ft Gordon, GA 30905 USA; [Poropatich, Ronald K.] Univ Pittsburgh, Ctr Mil Med Res, Pittsburgh, PA USA; [McVeigh, Francis L.] US Army, Med Res & Mat Command, Telemed & Adv Technol Res Ctr, Adv Technol & Innovat Lab, Ft Detrick, MD USA; [Tong, James] Govt Solut, IMS Hlth, Washington, DC USA; [Tillman, Johnie S.] Integrated Disabil Evaluat Syst, Ft Gordon, GA USA; [Smith, Challis H.] Virginia Dept Behav Hlth & Dev Serv, Qual Management & Dev, Richmond, VA USA; [Fonda, Stephanie Jo] Walter Reed Natl Mil Med Ctr, Geneva Res Fdn, Dept Endocrinol, Bethesda, MD USA	Pavliscsak, H (corresponding author), USAMRMC, TATRC, Mobile Hlth Care Innovat Ctr MHIC, Geneva Fdn, Ft Gordon, GA 30905 USA.	holly.h.pavliscsak.ctr@mail.mil; jeanette.r.little.civ@mail.mil; rkp19@pitt.edu; francis.l.mcveigh.civ@mail.mil; jtong@us.imshealth.com; johnie.s.tillman.civ@mail.mil; chc.smith@us.army.mil; sfonda@genevausa.org			Office of Force Health Protection	This study was funded by the Office of Force Health Protection, and managed by the Mobile Health Innovation Center, an intramural laboratory of the Telemedicine and Advanced Technology Research Center, United States Army Medical Research and Material Command.	Agboola Stephen, 2013, J Diabetes Sci Technol, V7, P623; Ajay VS, 2012, GLOB HEART, V7, P167, DOI 10.1016/j.gheart.2012.03.004; Bailey JV, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007552; Boland P, 2007, J AMBUL CARE MANAG, V30, P126; Fazio A F, 1977, Vital Health Stat 2, P1; Feng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118011; Fox Brent I, 2014, Hosp Pharm, V49, P992, DOI 10.1310/hpj4910-992; Hadgkiss EJ, 2015, NEUROL SCI, V36, P845, DOI 10.1007/s10072-015-2089-1; Holtz B, 2012, TELEMED E-HEALTH, V18, P175, DOI 10.1089/tmj.2011.0119; Injury Prevention and Control, INJ PREV CONTR TRAUM; Irvine AB, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3130; Jones KR, 2014, WORLDV EVID-BASED NU, V11, P81, DOI 10.1111/wvn.12030; Laurance J, 2014, HEALTH AFFAIR, V33, P1627, DOI 10.1377/hlthaff.2014.0375; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Localytics, 2014, TIM APP INCR 21 ALL; Localytics, 2011, NUMB TIM MOB APPS WE; Makovsky Integrated Communications, 2015, 5 ANN PULS ONL HLTH; Mbuagbaw L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0654-6; MCDOWELL I, 1987, MEASURING HLTH GUIDE, P125; Musacchio N, 2011, DIABETIC MED, V28, P724, DOI 10.1111/j.1464-5491.2011.03253.x; National Institute of Mental Health, MAJ DEPR AD; Pena-Purcell NC, 2011, DIABETES EDUCATOR, V37, P770, DOI 10.1177/0145721711423319; Poston WSC, 1998, WOMEN HEALTH, V27, P51, DOI 10.1300/J013v27n03_04; Riley GA, 2015, BRAIN INJURY, P1; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; Tang TS, 2010, PATIENT EDUC COUNS, V79, P178, DOI 10.1016/j.pec.2009.09.029; Verwey R, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-93; Volpp KG, 2011, NEW ENGL J MED, V365, P388, DOI 10.1056/NEJMp1105966; Volpp Kevin G, 2009, LDI Issue Brief, V14, P1	29	20	20	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1067-5027	1527-974X		J AM MED INFORM ASSN	J. Am. Med. Inf. Assoc.	JAN	2016	23	1					110	118		10.1093/jamia/ocv121			9	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Health Care Sciences & Services; Information Science & Library Science; Medical Informatics	Computer Science; Health Care Sciences & Services; Information Science & Library Science; Medical Informatics	DJ4MK	WOS:000374179500015	26363048	Green Published, Bronze			2021-06-18	
J	Phillips, KM; Clark, ME; Gironda, RJ; McGarity, S; Kerns, RW; Elnitsky, CA; Andresen, EM; Collins, RC				Phillips, Kristin M.; Clark, Michael E.; Gironda, Ronald J.; McGarity, Suzanne; Kerns, Robert W.; Elnitsky, Christine A.; Andresen, Elena M.; Collins, Rose C.			Pain and psychiatric comorbidities among two groups of Iraq- and Afghanistan-era Veterans	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						Afghanistan; anxiety; blast injuries; chronic pain; combat disorders; comorbidities; depression; Iraq; postconcussive disorder; PTSD; sleep; substance use disorder; TBI; Veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; OPERATIONS ENDURING FREEDOM; PERSISTENT POSTCONCUSSIVE SYMPTOMS; DYADIC ADJUSTMENT SCALE; DEPRESSIVE SYMPTOMS; BLAST EXPOSURE; CARE; SOLDIERS; OUTCOMES	This study aimed to (1) identify the prevalence and severity of pain and psychiatric comorbidities among personnel who had been deployed during Operation Iraqi Freedom (OIF), Operation Enduring Freedom (OEF), and Operation New Dawn (OND) and (2) assess whether the Department of Veterans Affairs (VA) Polytrauma System of Care and an OIF/OEF/OND registry reflect real differences among patients. Participants (N = 359) were recruited from two VA hospitals. They completed a clinical interview, structured diagnostic interview, and self-report measures. Results indicated pain was the most common complaint, with 87% experiencing pain during the prior week and 56% reporting moderate or severe pain. Eighty percent of participants met criteria for at least one of seven assessed comorbid problems (moderate or severe pain, postconcussional disorder, posttraumatic stress disorder [PTSD], anxiety disorder, mood disorder, substance use disorder, psychosis), and 59 percent met criteria for two or more problems. PTSD and postconcussional disorder rarely occurred in the absence of pain or other comorbidities (0.3% and 0%, respectively). The Polytrauma group had more comorbid psychiatric conditions (chi(2) = 48.67, p < 0.05) and reported greater severity of symptoms (p < 0.05) than the Registry group. This study confirmed the high prevalence of pain and concurrent mental health problems among personnel returning from military deployment.	[Phillips, Kristin M.; Clark, Michael E.; Gironda, Ronald J.; McGarity, Suzanne] James A Haley Vet Hosp, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Clark, Michael E.; Gironda, Ronald J.] Univ S Florida, Tampa, FL USA; [Kerns, Robert W.] Dept Vet Affairs VA Connecticut Healthcare Syst, Pain Res Informat Multimorbid & Educ Ctr Innovat, West Haven, CT USA; [Kerns, Robert W.] Yale Univ, Sch Med, New Haven, CT USA; [Elnitsky, Christine A.] Univ N Carolina, Sch Nursing, Coll Hlth & Human Serv, Charlotte, NC 28223 USA; [Andresen, Elena M.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Andresen, Elena M.] Portland State Univ, Portland, OR 97207 USA; [Collins, Rose C.] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA	Phillips, KM (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Kristin.Phillips3@va.gov			VA Health Services Research DevelopmentUS Department of Veterans Affairs [SDR-07-047]; Health Services Research & Development Center of Innovation [CIN 13-407]	This material was based on work supported in part by VA Health Services Research & Development (award SDR-07-047) to M. E. Clark. R. W. Kerns is supported by the Health Services Research & Development Center of Innovation (CIN 13-407).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baker AJ, 2011, J TRAUMA, V71, pS472, DOI 10.1097/TA.0b013e318232e7da; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Beckham JC, 1997, BEHAV MED, V23, P138, DOI 10.1080/08964289709596370; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bosco MA, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/174728; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Caughey GE, 2010, J EPIDEMIOL COMMUN H, V64, P1036, DOI 10.1136/jech.2009.088260; Clark ME, 2004, PAIN MED, V5, P333, DOI 10.1111/j.1526-4637.2004.04059.x; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Clark ME, 2009, PAIN MED, V10, P456, DOI 10.1111/j.1526-4637.2009.00589.x; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Department of Veterans Affairs, 2013, AN VA HLTH CAR OP IR; Department of Veterans Affairs, 2005, POL REH CTR; Egede LE, 2007, J GEN INTERN MED, V22, P701, DOI 10.1007/s11606-007-0170-z; Elnitsky CA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-498; Elnitsky CA, 2013, MIL MED, V178, P775, DOI 10.7205/MILMED-D-13-00012; First MB., 2002, STRUCTURED CLIN INTE; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gironda RJ, 2007, J REHABIL RES DEV, V44, P223, DOI 10.1682/JRRD.2006.06.0058; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hagen C, 1979, REHABILITATION HEAD; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hunsley J, 2001, AM J FAM THER, V29, P325, DOI 10.1080/01926180152588734; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Jensen MP, 1999, PAIN, V83, P157, DOI 10.1016/S0304-3959(99)00101-3; Kalra R, 2008, FED PRACT, V25, P36; Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7; Kehle SM, 2012, PSYCHOL ADDICT BEHAV, V26, P42, DOI 10.1037/a0024663; Koike AK, 2002, AM J PSYCHIAT, V159, P1738, DOI 10.1176/appi.ajp.159.10.1738; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; McKellar JD, 2003, BRIT J CLIN PSYCHOL, V42, P27, DOI 10.1348/014466503762841995; Michelson H, 2000, QUAL LIFE RES, V9, P1093, DOI 10.1023/A:1016654621784; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Murphy JL, 2013, CLIN J PAIN, V29, P109, DOI 10.1097/AJP.0b013e3182579935; Office of the Deputy Undersecretary of Defense, 2009, DEM 2009 PROF MIL CO; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Peabody JW, 2004, MED CARE, V42, P1066, DOI 10.1097/00005650-200411000-00005; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; SHARPLEY CF, 1984, EDUC PSYCHOL MEAS, V44, P1045, DOI 10.1177/0013164484444029; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Spielberger CD., 1989, MANUAL STATE TRAIT A, V2; Stein KD, 1998, CANCER PRACT, V6, P143, DOI 10.1046/j.1523-5394.1998.006003143.x; Stein KD, 2004, J PAIN SYMPTOM MANAG, V27, P14, DOI 10.1016/j.jpainsymman.2003.06.003; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Townsend CO, 2008, PAIN, V140, P177, DOI 10.1016/j.pain.2008.08.005; Ullrich PM, 2013, ARCH PHYS MED REHAB, V94, P80, DOI 10.1016/j.apmr.2012.07.018; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Veterans Health Administration, 2012, ANAL VA HLTH CAR UT; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Williams JW, 2007, GEN HOSP PSYCHIAT, V29, P91, DOI 10.1016/j.genhosppsych.2006.12.003; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9	69	20	21	0	2	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	4					413	432		10.1682/JRRD.2014.05.0126			20	Rehabilitation	Rehabilitation	DS7YY	WOS:000381000600002	27532156	Bronze			2021-06-18	
J	Rhine, T; Babcock, L; Zhang, NH; Leach, J; Wade, SL				Rhine, Tara; Babcock, Lynn; Zhang, Nanhua; Leach, James; Wade, Shari L.			Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury?	BRAIN INJURY			English	Article						Paediatric; concussion; biomarkers; diagnosis	FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE-L1; INTRACRANIAL LESIONS; NEUROSURGICAL INTERVENTION; COMPUTED-TOMOGRAPHY; CONCUSSION; SCALE	Objectives: To compare serum biomarker levels between children with mild traumatic brain injury (mTBI) and orthopaedic injury (OI), acutely following injury. Secondarily, to explore the association between biomarker levels and symptom burden over 1 month post-injury.Methods: This was a prospective cohort study of children aged 11-16 years who presented to the emergency department within 6 hours of sustaining mTBI or isolated extremity OI. Serum was drawn at the time of study enrollment and levels of ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) and glial fibrillary acid protein (GFAP) were analysed. Symptom burden was assessed by the Post-Concussion Symptom Scale (PCSS) acutely following injury and at three subsequent time points over 1 month.Results: Twenty-five children with mTBI and 20 children with OI were enrolled. The average age for the overall cohort was 13 ( 1.6) years and the majority were male and injured playing sports. GFAP levels and PCSS scores were significantly higher acutely following mTBI vs OI (p < 0.01). There was not a significant group difference in UCH-L1 levels. Neither GFAP nor UCH-L1 were predictive of PCSS scores over the 1month post-injury.Conclusions: GFAP may be a promising diagnostic tool for children with mTBI. Additional approaches are needed to predict symptom severity and persistence.	[Rhine, Tara; Babcock, Lynn] Cincinnati Childrens Hosp Med Ctr, Div Pediat Emergency Med, Dept Pediat, Cincinnati, OH 45229 USA; [Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat, Dept Pediat, Cincinnati, OH 45229 USA; [Leach, James] Cincinnati Childrens Hosp Med Ctr, Div Med Imaging, Dept Pediat, Cincinnati, OH 45229 USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Dept Pediat, Cincinnati, OH 45229 USA	Rhine, T (corresponding author), Univ Cincinnati, Div Pediat Emergency Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,ML 2008, Cincinnati, OH 45229 USA.	tara.rhine@cchmc.org		Babcock, Lynn/0000-0002-2658-6893; Zhang, Nanhua/0000-0001-5796-3404	National Center for Research Resources, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000078 (KL2 RR026315)]; Cincinnati Children's Hospital Medical Center Division of Emergency Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000078] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR026315] Funding Source: NIH RePORTER	This study was funded in part by (1) National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2 TR000078 (KL2 RR026315) (Babcock); and (2) Cincinnati Children's Hospital Medical Center Division of Emergency Medicine. The additional authors have no funding sources or conflicts to disclose for this work.	Achenbach TM, 1983, MANUAL CHILD BEHAV C; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bergstrand M, 2009, AAPS J, V11, P371, DOI 10.1208/s12248-009-9112-5; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Kaiser D, 2015, BRAIN IMAGING BEHAV, V9, P32, DOI 10.1007/s11682-014-9327-7; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mannix R, 2014, J NEUROTRAUM, V31, P1072, DOI 10.1089/neu.2013.3265; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Obuchowski NA, 2000, AM J ROENTGENOL, V175, P603, DOI 10.2214/ajr.175.3.1750603; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zurek J, 2011, J TRAUMA, V71, P854, DOI 10.1097/TA.0b013e3182140c8c	28	20	20	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1231	1238		10.1080/02699052.2016.1178396			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300010	27416022	Green Accepted			2021-06-18	
J	Togher, L; McDonald, S; Tate, R; Rietdijk, R; Power, E				Togher, Leanne; McDonald, Skye; Tate, Robyn; Rietdijk, Rachael; Power, Emma			The effectiveness of social communication partner training for adults with severe chronic TBI and their families using a measure of perceived communication ability	NEUROREHABILITATION			English	Article						Communication; communication partner; traumatic brain injury; clinical; rehabilitation	TRAUMATIC BRAIN-INJURY; COGNITIVE-COMMUNICATION; CONTROLLED-TRIAL; HEAD-INJURY; PEOPLE; QUESTIONNAIRE; INTERVENTIONS; INTEGRATION; EXPERIENCE; MANAGEMENT	BACKGROUND: Training for communication partners of people with traumatic brain injury (TBI) is efficacious when using blinded independent ratings of casual conversations measured in the clinic. However, the question remains as to whether participants with TBI and their significant other perceive changes to everyday social communication as a result of training. OBJECTIVE: To determine whether treatment focused on improving the conversational skills of everyday communication partners of people with severe TBI using a program called TBI Express resulted in improvements in perceived communicative ability as measured by the La Trobe Communication Questionnaire (LCQ). METHODS: Non randomized controlled trial comparing treatment of people with TBI together with communication partners (JOINT) with treatment of people with TBI without partner involvement (TBI SOLO) and a waitlist control group (CTRL) with follow-up at 6 months post-treatment. Forty-four outpatients from brain injury units in Sydney with severe chronic acquired brain injuries were recruited. A further 27 eligible outpatients refused to participate or could not be contacted. A total of 41 people completed treatment and 38 completed 6 month follow up assessment. The measure of perceived communication ability is the report of the participant with TBI and their partner on the LCQ. RESULTS: Communication partner training (JOINT) improved conversational performance relative to training the person with TBI alone and a waitlist control group on the LCQ. The TBI SOLO group improved in terms of report on the LCQ relative to the CONTROL group. Results were maintained at six months post-training. CONCLUSION: Training communication partners of people with chronic severe TBI using TBI Express led to perceived improvements in everyday communication ability by both the person with TBI and their family member.	[Togher, Leanne; Rietdijk, Rachael; Power, Emma] Univ Sydney, Fac Hlth Sci, Speech Pathol, Sydney, NSW 2006, Australia; [McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Tate, Robyn] Univ Sydney, Fac Med, John Walsh Ctr Rehabil Res, Northern Clin Sch, Sydney, NSW 2006, Australia; [Togher, Leanne; McDonald, Skye; Tate, Robyn; Rietdijk, Rachael; Power, Emma] Ctr Res Excellence Brain Recovery, NHMRC, Sydney, NSW, Australia	Togher, L (corresponding author), Univ Sydney, Fac Hlth Sci, Speech Pathol, POB 170, Lidcombe, NSW 1825, Australia.	Leanne.togher@sydney.edu.au	Togher, Leanne/AAC-7083-2019; Rietdijk, Rachael/J-6573-2012; Power, Emma/A-9263-2015	Rietdijk, Rachael/0000-0003-4343-4039; Togher, Leanne/0000-0002-4518-6748; Power, Emma/0000-0002-2638-0406	NHMRCNational Health and Medical Research Council of Australia [402687]	We would like to acknowledge the contributions of the study participants, Dr Rob Heard for statistical advice, and Gaye Murrills, and the staff of the Brain Injury Rehabilitation Units at Liverpool Hospital, Royal Rehabilitation Centre Sydney and Westmead Hospital for their assistance with participant recruitment. The first author was supported by an NHMRC Senior Research Fellowship during the writing of this paper, and this project was funded by NHMRC Project Grant 402687.	Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Damico JS, 1985, COMMUNICATION SKILLS, P165; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2014, BRAIN IMPAIR, V15, P190, DOI 10.1017/BrImp.2014.25; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Eggins S., 1997, ANAL CASUAL CONVERSA; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Grice H., 1975, SYNTAX SEMANTICS, P41, DOI DOI 10.1111/J.1365-2664.2006.01229.X; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tate R., 2005, BRAIN IMPAIR, V6, P75, DOI DOI 10.1375/BRIM.2005.6.2.75; TATE RL, 1987, SCAND J REHABIL MED, V19, P19; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; TOGHER L, 1998, COMMUNITY POLI UNPUB; Togher L, 2011, TBI EXPRESS SOCIAL C; TOGHER L, 2001, COMMUNICATION TRAINI; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 1993, STAFF DEV CLIN INTER, P57; YLVISAKER M, 1998, TRAUMATIC BRAIN INJU, P303; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200	38	20	21	0	20	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	38	3					243	255		10.3233/NRE-151316			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DM5PV	WOS:000376403300004	27030901				2021-06-18	
J	Wells, EM; Goodkin, HP; Griesbach, GS				Wells, Elizabeth M.; Goodkin, Howard P.; Griesbach, Grace S.			Challenges in Determining the Role of Rest and Exercise in the Management of Mild Traumatic Brain Injury	JOURNAL OF CHILD NEUROLOGY			English	Article						concussion; rest; subthreshold exercise	VOLUNTARY EXERCISE; NEUROTROPHIC FACTOR; ACUTE CONCUSSION; UP-REGULATION; PATHOPHYSIOLOGY; REHABILITATION; SYMPTOMS; SPORT; TIME; RECOMMENDATIONS	Current consensus guidelines recommending physical and cognitive rest until a patient is asymptomatic after a sports concussion (ie, a mild traumatic brain injury) are being called into question, particularly for patients who are slower to recover and in light of preclinical and clinical research demonstrating that exercise aids neurorehabilitation. The pathophysiological response to mild traumatic brain injury includes a complex neurometabolic cascade of events resulting in a neurologic energy deficit. It has been proposed that this energy deficit leads to a period of vulnerability during which the brain is at risk for additional injury, explains why early postconcussive symptoms are exacerbated by cognitive and physical exertion, and is used to rationalize absolute rest until all symptoms have resolved. However, at some point, rest might no longer be beneficial and exercise might need to be introduced. At both extremes, excessive exertion and prolonged avoidance of exercise (physical and mental) have negative consequences. Individuals who have experienced a concussion need guidance for avoidance of triggers of severe symptoms and a plan for graduated exercise to promote recovery as well as optimal functioning (physical, educational, and social) during the postconcussion period.	[Wells, Elizabeth M.] George Washington Sch Med, Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Goodkin, Howard P.] UVA Healthsyst, Dept Neurol, Charlottesville, VA USA; [Goodkin, Howard P.] UVA Healthsyst, Dept Pediat, Charlottesville, VA USA; [Griesbach, Grace S.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA	Wells, EM (corresponding author), George Washington Sch Med, Childrens Natl Med Ctr, Dept Neurol, 111 Michigan Ave NW, Washington, DC 20010 USA.	EWells@childrensnational.org		Goodkin, Howard/0000-0003-0528-4949			Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Acocello S, 2014, J NEUROSCI METH, V221, P85, DOI 10.1016/j.jneumeth.2013.09.003; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Balasundaram AP, 2013, PHYS THER SPORT, V14, P253, DOI 10.1016/j.ptsp.2013.06.002; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; da Silva SG, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-61; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Grady MF, 2012, PEDIATR ANN, V41, P377, DOI 10.3928/00904481-20120827-12; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gronli J, 2006, PHARMACOL BIOCHEM BE, V85, P842, DOI 10.1016/j.pbb.2006.11.021; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Li HW, 2013, BRAIN RES, V1531, P1, DOI 10.1016/j.brainres.2013.07.041; Lovatel GA, 2013, NEUROBIOL LEARN MEM, V101, P94, DOI 10.1016/j.nlm.2013.01.007; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Reddy S, 2014, MED SCI SPORT EXER, V46, P429, DOI 10.1249/MSS.0000000000000140; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rodgers SP, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/698528; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Ryan PB, 2011, BRAIN INJURY, V25, P1019, DOI 10.3109/02699052.2011.597044; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Taylor J, 2011, OTOLARYNG CLIN N AM, V44, P309, DOI 10.1016/j.otc.2011.01.004; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vidal PG, 2012, PEDIATR ANN, V41, pE186, DOI 10.3928/00904481-20120827-10	61	20	20	0	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2016	31	1			SI		86	92		10.1177/0883073815570152			7	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CY8HW	WOS:000366650400009	25688071				2021-06-18	
J	McDevitt, J; Tierney, RT; Phillips, J; Gaughan, JP; Torg, JS; Krynetskiy, E				McDevitt, Jane; Tierney, Ryan Timothy; Phillips, Jacqueline; Gaughan, John P.; Torg, Joseph S.; Krynetskiy, Evgeny			Association between GRIN2A promoter polymorphism and recovery from concussion	BRAIN INJURY			English	Article							SPORT-RELATED CONCUSSION; HIGH-SCHOOL; RISK; PREDICTORS; STATEMENT; FOOTBALL; INJURY		[McDevitt, Jane; Tierney, Ryan Timothy; Phillips, Jacqueline] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Gaughan, John P.] Biostat Consulting Ctr, Philadelphia, PA USA; [Torg, Joseph S.] Temple Univ, Sch Med, Dept Orthoped Surg, Philadelphia, PA 19122 USA; [Krynetskiy, Evgeny] Temple Univ, Sch Pharm, Philadelphia, PA 19122 USA	McDevitt, J (corresponding author), 102 Linden Pl, Douglassville, PA 19518 USA.	jane.mcdevitt@temple.edu			Eastern Athletic Training Association (EATA) [p0219092]	The authors report no conflicts of interest. Funding was received in part by the Eastern Athletic Training Association (EATA) grant (award number p0219092).	Bao W, 2010, AM J EPIDEMIOL, V172, P631, DOI 10.1093/aje/kwq162; CHOI DW, 1987, J NEUROSCI, V7, P369; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Giza CC, 2001, J ATHL TRAINING, V36, P228; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Imle P, 2005, METH MOL B, V311, P139; Inoue H, 2010, GENES BRAIN BEHAV, V9, P269, DOI 10.1111/j.1601-183X.2009.00557.x; Itokawa M, 2003, NEUROSCI LETT, V345, P53, DOI 10.1016/S0304-3940(03)00501-9; Itokawa M, 2003, PHARMACOGENETICS, V13, P271, DOI 10.1097/00008571-200305000-00006; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iwayama-Shigeno Y, 2005, NEUROSCI LETT, V378, P102, DOI 10.1016/j.neulet.2004.12.013; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McDevitt JK, 2011, BRAIN INJURY, V25, P1108, DOI 10.3109/02699052.2011.607790; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Osteen CL, 2004, J NEUROTRAUM, V18, P141; Parkman HP, 2012, J CLIN GASTROENTEROL, V46, P494, DOI 10.1097/MCG.0b013e3182522624; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; ROTH SM, 2007, GENETICS PRIMER EXER; Rueda B, 2007, ARTHRITIS RHEUM-US, V56, P3953, DOI 10.1002/art.23048; Schaal K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019007; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Terrell TR, 2012, CLIN J SPORT MED, V22, P172; Thurman DJ, 2001, HEAD TRAUMA THERAPEU, P45; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81	43	20	20	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1674	1681		10.3109/02699052.2015.1075252			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800020	26502998				2021-06-18	
J	Arrey, EN; Kerr, ML; Fletcher, S; Cox, CS; Sandberg, DI				Arrey, Eliel N.; Kerr, Marcia L.; Fletcher, Stephen; Cox, Charles S., Jr.; Sandberg, David I.			Linear nondisplaced skull fractures in children: who should be observed or admitted?	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						nondisplaced; linear skull fracture; pediatric head trauma	TRAUMATIC BRAIN-INJURY; MINOR HEAD TRAUMA; POSTCONCUSSIVE SYMPTOMS; UNITED-STATES; MANAGEMENT; GUIDELINES	OBJECT In this study the authors reviewed clinical management and outcomes in a large series of children with isolated linear nondisplaced skull fractures (NDSFs). Factors associated with hospitalization of these patients and costs of management were also reviewed. METHODS After institutional review board approval, the authors retrospectively reviewed clinical records and imaging studies for patients between the ages of 0 and 16 years who were evaluated for NDSFs at a single children's hospital between January 2009 and December 2013. Patients were excluded if the fracture was open or comminuted. Additional exclusion criteria included intracranial hemorrhage, more than 1 skull fracture, or pneumocephalus. RESULTS Three hundred twenty-six patients met inclusion criteria. The median patient age was 19 months (range 2 weeks to 15 years). One hundred ninety-three patients (59%) were male and 133 (41%) were female. One hundred eighty-four patients (56%) were placed under 23-hour observation, 87 (27%) were admitted to the hospital, and 55 patients (17%) were discharged from the emergency department. Two hundred seventy-eight patients (85%) arrived by ambulance, 36(11%) arrived by car, and 12 (4%) were airlifted by helicopter. Two hundred fifty-seven patients (79%) were transferred from another institution. The mean hospital stay for patients admitted to the hospital was 46 hours (range 7-395 hours). The mean hospital stay for patients placed under 23-hour observation status was 18 hours (range 2-43 hours). The reasons for hospitalization longer than 1 day included Child Protective Services involvement in 24 patients and other injuries in 11 patients. Thirteen percent (n = 45) had altered mental status or loss of consciousness by history. No patient had any neurological deficits on examination, and none required neurosurgical intervention. Less than 16% (n = 50) had subsequent outpatient follow-up. These patients were all neurologically intact at the follow-up visit. CONCLUSIONS Hospitalization is not necessary for many children with NDSFs. Patients with mental status changes, additional injuries, or possible nonaccidental injury may require observation.	Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Pediat Surg, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Neurosurg, Houston, TX 77030 USA; Childrens Mem Hermann Hosp, Houston, TX USA	Sandberg, DI (corresponding author), Univ Texas Hlth Ctr Houston, Dept Pediat Neurosurg, 6431 Fannin St,MSB 5-144, Houston, TX 77030 USA.	david.i.sandberg@uth.tmc.edu			University of Texas Health-Science Center Summer Research Program Grant; National Institute of Neurological Diseases and Stroke (NTH) [5 T35 NS 64931-5]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T35NS064931] Funding Source: NIH RePORTER	The participation of Eliel N. Arrey, BS, in this project was supported by the University of Texas Health-Science Center Summer Research Program Grant. This grant is funded by the National Institute of Neurological Diseases and Stroke (NTH Award no. 5 T35 NS 64931-5)	Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beaudin M, 2007, J PEDIATR SURG, V42, P849, DOI 10.1016/j.jpedsurg.2006.12.038; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Ersahin Y, 1996, CHILD NERV SYST, V12, P323, DOI 10.1007/BF00301021; Graupman P, 2006, J NEUROSURG, V104, P245, DOI 10.3171/ped.2006.104.4.245; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Hassan SF, 2014, J TRAUMA ACUTE CARE, V77, P166, DOI 10.1097/TA.0000000000000256; Hung GR, 2011, TINTINALLIS EMERGENC; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Metzger RR, 2014, J PEDIATR SURG, V49, P1856, DOI 10.1016/j.jpedsurg.2014.09.038; Moran C., 2012, HOUSTON CHRONICLE; National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention, 2000, TRAUM BRAIN INJ US A; O'Halloran M, 2010, EXPENSE OUTRAGE COST; Rollins MD, 2011, J PEDIATR SURG, V46, P1342, DOI 10.1016/j.jpedsurg.2010.12.019; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	21	20	20	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2015	16	6					703	708		10.3171/2015.4.PEDS1545			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CX0FM	WOS:000365372300012	26339955	Bronze			2021-06-18	
J	Ulbrich, F; Kaufmann, K; Roesslein, M; Wellner, F; Auwarter, V; Kempf, J; Loop, T; Buerkle, H; Goebel, U				Ulbrich, Felix; Kaufmann, Kai; Roesslein, Martin; Wellner, Franziska; Auwaerter, Volker; Kempf, Juergen; Loop, Torsten; Buerkle, Hartmut; Goebel, Ulrich			Argon Mediates Anti-Apoptotic Signaling and Neuroprotection via Inhibition of Toll-Like Receptor 2 and 4	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NOBLE-GAS ARGON; NF-KAPPA-B; SH-SY5Y CELLS; DAMAGE; ACTIVATION; XENON; PATHWAYS; ROTENONE; RATS	Purpose Recently, the noble gas argon attracted significant attention due to its neuroprotective properties. However, the underlying molecular mechanism is still poorly understood. There is growing evidence that the extracellular regulated kinase 1/2 (ERK1/2) is involved in Argon's protective effect. We hypothesized that argon mediates its protective effects via the upstream located toll-like receptors (TLRs) 2 and 4. Methods Apoptosis in a human neuroblastoma cell line (SH-SY5Y) was induced using rotenone. Argon treatment was performed after induction of apoptosis with different concentrations (25, 50 and 75 Vol% in oxygen 21 Vol%, carbon dioxide and nitrogen) for 2 or 4 hours respectively. Apoptosis was analyzed using flow cytometry (annexin-V (AV)/propidiumiodide (PI)) staining, caspase-3 activity and caspase cleavage. TLR density on the cells' surface was analyzed using FACS and immunohistochemistry. Inhibition of TLR signaling and extracellular regulated kinase 1/2 (ERK1/2) were assessed by western blot, activity assays and FACS analysis. Results Argon 75 Vol% treatment abolished rotenone-induced apoptosis. This effect was attenuated dose-and time-dependently. Argon treatment was accompanied with a significant reduction of TLR2 and TLR4 receptor density and protein expression. Moreover, argon mediated increase in ERK1/2 phosphorylation was attenuated after inhibition of TLR signaling. ERK1/2 and TLR signaling inhibitors abolished the anti-apoptotic and cytoprotective effects of argon. Immunohistochemistry results strengthened these findings. Conclusion These findings suggest that argon-mediated anti-apoptotic and neuroprotective effects are mediated via inhibition of TLR2 and TLR4.	[Ulbrich, Felix; Kaufmann, Kai; Roesslein, Martin; Wellner, Franziska; Loop, Torsten; Buerkle, Hartmut; Goebel, Ulrich] Univ Med Ctr, Dept Anesthesiol & Intens Care Med, Freiburg, Germany; [Auwaerter, Volker; Kempf, Juergen] Univ Freiburg, Inst Forens Med, Forens Toxicol, D-79106 Freiburg, Germany	Ulbrich, F (corresponding author), Univ Med Ctr, Dept Anesthesiol & Intens Care Med, Freiburg, Germany.	felix.ulbrich@uniklinik-freiburg.de	Gobel, Ulrich/Q-7613-2016	Gobel, Ulrich/0000-0002-9991-3226	German Research Foundation (DFG)German Research Foundation (DFG); Albert Ludwigs University Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Alderliesten T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113575; Ali I, 2013, PULM CIRC, V3, P578, DOI 10.1086/674337; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Auwarter V, 2004, FORENSIC SCI INT, V143, P169, DOI 10.1016/j.forsciint.2004.02.043; Ben Mkaddem S, 2010, ONCOTARGET, V1, P741, DOI 10.18632/oncotarget.209; Brucken A, 2014, NEUROCRITICAL CARE; Brucken A, 2014, RESUSCITATION, V85, P826, DOI 10.1016/j.resuscitation.2014.02.014; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Condello S, 2011, J NEUROCHEM, V116, P67, DOI 10.1111/j.1471-4159.2010.07085.x; Cui WY, 2012, AMINO ACIDS, V43, P1157, DOI 10.1007/s00726-011-1171-0; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gan XQ, 2014, BONE, V62, P67, DOI 10.1016/j.bone.2014.01.018; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee H, 2013, CURR PROTEIN PEPT SC, V14, P33, DOI 10.2174/1389203711314010006; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Liu ZW, 2013, BIOL TRACE ELEM RES, V156, P262, DOI 10.1007/s12011-013-9857-7; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Monaghan TK, 2008, J MOL NEUROSCI, V36, P45, DOI 10.1007/s12031-008-9082-6; Spaggiari S, 2013, CELL CYCLE, V12, P2636, DOI 10.4161/cc.25650; Tan Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102195; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tymianski M, 2013, STROKE, V44, P2942, DOI 10.1161/STROKEAHA.113.000731; Ulbrich F, 2015, J NEUROCHEMISTRY; Ulbrich F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115984; Vaisid T, 2013, BBA-MOL CELL RES, V1833, P2369, DOI 10.1016/j.bbamcr.2013.06.006; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	33	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2015	10	12							e0143887	10.1371/journal.pone.0143887			17	Multidisciplinary Sciences	Science & Technology - Other Topics	CX7OL	WOS:000365891600067	26624894	DOAJ Gold, Green Published			2021-06-18	
J	Yang, LM; Tang, J; Chen, QW; Jiang, B; Zhang, B; Tao, YH; Li, L; Chen, Z; Zhu, G				Yang, Liming; Tang, Jun; Chen, Qianwei; Jiang, Bing; Zhang, Bo; Tao, Yihao; Li, Lin; Chen, Zhi; Zhu, Gang			Hyperbaric oxygen preconditioning attenuates neuroinflammation after intracerebral hemorrhage in rats by regulating microglia characteristics	BRAIN RESEARCH			English	Article						Intracerebral hemorrhage; Hyperbaric oxygen; Preconditioning; Neuroinflammation; Microglia; Brain edema	SPINAL-CORD-INJURY; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; ACTIVATION; EDEMA; INFLAMMATION; MODEL; CNS; NEURODEGENERATION	Intracerebral Hemorrhage (ICH) results in a detrimental neurologic disorder with complicated secondary brain injury. Hyperbaric oxygen preconditioning (HBOP) may be a safe and effective therapeutic method for ICH victims. Our previous studies have demonstrated that HBOP induces neuroprotection in cerebral ischemia and traumatic brain injury. This study aimed to investigate whether HBOP could alleviate neuroinflammation by regulating changes in microglia characteristics in a rat model of ICH. ICH was induced by autologous arterial blood injection, and animals were sacrificed at 12, 24, and 72 h post injury. We measured motor function and brain water content to evaluate the extent of inflammation. Fluoro-Jade C and TNF-alpha staining was used to characterize neuronal degeneration and neuroinflammatory cytokines, and immunofluorescence staining was performed for CD11b to show activated microglia and Iba-1 to show microglia. Our results indicate that motor dysfunction and brain water content are alleviated by HBOP, and Fluoro-Jade C staining demonstrates that neuron degeneration decreased in the HBOP group. The growth of Iba-1-positive microglia decreased in the HBOP group. Moreover, TNF-alpha was dynamically reduced in the HBOP group compared with the ICH group. CD11b-Iba-1 double staining demonstrated that the ratio of CD11b and Iba-1 was significantly decreased in the HBOP group. Overall, the data demonstrated that HBOP could significantly alleviate the ICH-induced neuroinflammation by regulating microglia characteristics changing. The phenomenon may propel the progress of the relation between microglia and HBOP and represent a novel target for ICH treatment. (C) 2015 Elsevier B.V. All rights reserved.	[Yang, Liming; Tang, Jun; Chen, Qianwei; Jiang, Bing; Zhang, Bo; Tao, Yihao; Li, Lin; Chen, Zhi; Zhu, Gang] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China	Zhu, G (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China.	gangzhu6666@sina.com		Chen, Zhi/0000-0002-8404-4937	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81571116]; NSFCNational Natural Science Foundation of China (NSFC) [81371440]; National key basic research development program (973 Program) of China [2014CB541606]	This study was supported by the National Natural Science Foundation of China (NSFC, NO. 81571116), (NSFC, NO. 81371440), and 2014CB541606 from the National key basic research development program (973 Program) of China.	Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Bilimoria PM, 2015, BRAIN RES, V1617, P7, DOI 10.1016/j.brainres.2014.11.032; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Chen QW, 2015, TRANSL STROKE RES, V6, P125, DOI 10.1007/s12975-014-0367-5; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; Cui GY, 2011, UNDERSEA HYPERBAR M, V38, P91; Geng CK, 2015, BRAIN RES, V1606, P68, DOI 10.1016/j.brainres.2015.01.029; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Hu S.L., 2014, MOL NEUROBIOL; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jadhav V, 2008, FRONT BIOSCI, V13, P3793, DOI 10.2741/2968; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Li N, 2013, STROKE, V44, P1144, DOI 10.1161/STROKEAHA.111.000056; Lu PG, 2012, NEUROL RES, V34, P944, DOI 10.1179/1743132812Y.0000000096; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Masuda T, 2010, BRAIN RES, V1355, P228, DOI 10.1016/j.brainres.2010.07.101; Matula C, 2000, STEREOT FUNCT NEUROS, V75, P142, DOI 10.1159/000048396; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Okauchi M, 2009, BRAIN RES, V1249, P229, DOI 10.1016/j.brainres.2008.10.035; Qin Z, 2008, ACTA NEUROCHIR SUPPL, V102, P317, DOI 10.1007/978-3-211-85578-2_60; Qin Z, 2008, ACTA NEUROCHIR SUPPL, V105, P113; Qu Y, 2007, J NEUROSURG, V106, P428, DOI 10.3171/jns.2007.106.3.428; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Shin JA, 2014, BRAIN BEHAV IMMUN, V40, P143, DOI 10.1016/j.bbi.2014.03.013; Tang J., 2015, MOL NEUROBIOL; Tang Y., 2015, MOL NEUROBIOL; Tao YH, 2015, BRAIN RES, V1602, P127, DOI 10.1016/j.brainres.2015.01.025; Valdearcos M, 2014, CELL REP, V9, P2124, DOI 10.1016/j.celrep.2014.11.018; Veltkamp R, 2005, STROKE, V36, P1679, DOI 10.1161/01.STR.0000173408.94728.79; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Yan WJ, 2011, BRAIN RES, V1402, P109, DOI 10.1016/j.brainres.2011.05.049; Yang J, 2015, STROKE, V46, P1009, DOI 10.1161/STROKEAHA.114.007154; Yang J, 2013, LIFE SCI, V93, P1033, DOI 10.1016/j.lfs.2013.10.015; Yang Z, 2014, MOL IMMUNOL, V60, P109, DOI 10.1016/j.molimm.2014.03.005; Yogaratnam JZ, 2010, CARDIOVASC REVASCULA, V11, P8, DOI 10.1016/j.carrev.2009.03.004	43	20	23	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 19	2015	1627						21	30		10.1016/j.brainres.2015.08.011			10	Neurosciences	Neurosciences & Neurology	CY2HC	WOS:000366228400003	26301824				2021-06-18	
J	Lorente, L; Martin, MM; Argueso, M; Ramos, L; Sole-Violan, J; Riano-Ruiz, M; Jimenez, A; Borreguero-Leon, JM				Lorente, Leonardo; Martin, Maria M.; Argueso, Monica; Ramos, Luis; Sole-Violan, Jordi; Riano-Ruiz, Marta; Jimenez, Alejandro; Borreguero-Leon, Juan M.			Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury	BMC NEUROLOGY			English	Article						Caspase-3; Patients; Mortality; Injury; Brain	CEREBROSPINAL-FLUID; CELL-DEATH; APOPTOSIS; INCREASES	Background: Different apoptosis pathways activate caspase-3. In a study involving 27 patients with traumatic brain injury (TBI), higher caspase-3 levels were found in contusion brain tissue resected from non-survivors than from survivors. The objective of this study was to determine whether there is an association in TBI patients between serum caspase-3 levels (thus using an easier, quicker, less expensive and less invasive procedure) and mortality, in a larger series of patients. Methods: We carried out a prospective, observational and multicenter study in six Spanish Hospital Intensive Care Units including 112 patients with severe TBI. All had Glasgow Coma Scale (GCS) scores lower than 9. Patients with an Injury Severity Score (ISS) in non-cranial aspects higher than 9 were excluded. Blood samples were collected on day 1 of TBI to measure serum caspas-3 levels. The endpoint was 30-day mortality. Results: We found that non-surviving patients (n = 31) showed higher (p = 0.003) serum caspase-3 levels compared to survivors (n = 81). Kaplan-Meier survival analysis showed a higher risk of death in TBI patients with serum caspase-3 levels > 0.20 ng/mL than in patients with lower concentrations (Hazard Ratio = 3.15; 95 % CI = 1.40 to 7.08; P < 0.001). Multiple logistic regression analysis showed that serum caspase-3 levels > 0.20 ng/mL were associated with mortality at 30 days in TBI patients controlling for Marshall CT classification, age and GCS (Odds ratio = 7.99; 95 % CI = 2.116 to 36.744; P = 0.001). Conclusions: The association between serum caspase-3 levels and mortality in TBI patients was the major novel finding of our study.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife 38010, Spain; [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Valencia 46004, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta 38713, La Palma, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, CIBERES, Las Palmas Gran Canaria 35010, Spain; [Riano-Ruiz, Marta] Complejo Hosp Univ Insular Maternoinfantil, Serv Bioquim Clin, Las Palmas Gran Canaria 35016, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Borreguero-Leon, Juan M.] Hosp Univ Canarias, Lab Dept, San Cristobal la Laguna 38320, Santa Cruz De T, Spain	Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain.	lorentemartin@msn.com		Argueso, Monica/0000-0001-5917-1056; Borreguero Leon, Juan Maria/0000-0001-7414-5278			Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Eberspacher E, 2006, ANESTH ANALG, V103, P1527, DOI 10.1213/01.ane.0000247803.30582.2d; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Hentze H, 2001, BIOCHEM BIOPH RES CO, V283, P1111, DOI 10.1006/bbrc.2001.4918; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mejia ROS, 2001, NEUROSURGERY, V48, P1393; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Shah SA, 2006, EXP GERONTOL, V41, P1201, DOI 10.1016/j.exger.2006.07.006; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; TEASDALE G, 1974, LANCET, V2, P81; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638	24	20	20	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	NOV 6	2015	15								228	10.1186/s12883-015-0485-z			6	Clinical Neurology	Neurosciences & Neurology	CW9CV	WOS:000365297000001	26545730	DOAJ Gold, Green Published			2021-06-18	
J	Chan, LG; Feinstein, A				Chan, Lai Gwen; Feinstein, Anthony			Persistent Sleep Disturbances Independently Predict Poorer Functional and Social Outcomes 1 Year After Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; concussion; mild traumatic brain injury; sleep disorders; traumatic brain injury; treatment outcome	MINOR HEAD-INJURY; SEVERITY SCORE; GENERAL HEALTH; SCALE; QUESTIONNAIRE; IMPACT; ADULTS; TBI; RELIABILITY; COMPLAINTS	Objective: To investigate the effect of sleep disturbances on functional and social outcomes after mild traumatic brain injury. Setting: Outpatient traumatic brain injury clinic in a tertiary trauma center. Participants: A total of 374 mild traumatic brain injury patients were assessed within 3 months of injury and followed up every 3 months for 1 year. Design: Analysis of a historical cohort in a naturalistic clinical setting. Main measures: At each visit, symptoms of concussion and psychological distress and indices of functional and social outcomes were measured with the Rivermead Postconcussion Questionnaire, 28-item General Health Questionnaire, and Rivermead Head Injury Follow-up Questionnaire, respectively. Changes in outcome scores over time were explored using repeated measures analysis of variance and compared between subjects with persistent (SD) and recovered (SR) sleep disturbances. Predictors of functional/social outcome were determined using linear regression. Results: The percentages of subjects reporting sleep disturbances at each time point were 71.9%, 57.2%, 55.1%, and 53.7%, respectively. For functional and social outcomes, significant effects of time (F3,315 = 9.54; P<. 001), group (SD vs SR) F1,317 = 5.32; P =.022, and time X group interaction F3,315 = 4.14; P =.007 were found. Persistent sleep disturbance (P = 0.011) and higher symptom burden at 6 months postinjury (P <.0001) were independent predictors of poorer outcome. Conclusion: Sleep disturbance, independent of psychological distress, is an important prognostic factor of functional and social outcomes after mild traumatic brain injury.	[Chan, Lai Gwen] Sunnybrook Hlth Sci Ctr, Dept Psychiat, Toronto, ON M4N 3M5, Canada; [Chan, Lai Gwen] Tan Tock Seng Hosp, Dept Psychol Med, Jalan Tan Tock Seng, Singapore 308433, Singapore; [Feinstein, Anthony] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Feinstein, Anthony] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	Chan, LG (corresponding author), Tan Tock Seng Hosp, Dept Psychol Med, Jalan Tan Tock Seng, Singapore 308433, Singapore.	lai_gwen_chan@ttsh.com.sg					American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belozertsev Yu A., 2012, Eksperimental'naya i Klinicheskaya Farmakologiya, V75, P31; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Cassidy JD, 2014, ARCH PHYS MED REHAB, V95, P299; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; De La Rue-Evans L, 2013, REHABIL NURS, V38, P2, DOI 10.1002/rnj.66; DJed Buysse, 2005, REV PSYCHIAT SERIES, V24; Goldberg D., 1978, MANUAL GEN HLTH QUES; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Marshall S, 2012, CAN FAM PHYSICIAN, V58, p[257, e128]; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663	42	20	20	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2015	30	6					E67	E75		10.1097/HTR.0000000000000119			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DD0JN	WOS:000369606300008	25931180				2021-06-18	
J	Chau, A; Salazar, AM; Krueger, F; Cristofori, I; Grafman, J				Chau, Aileen; Salazar, Andres M.; Krueger, Frank; Cristofori, Irene; Grafman, Jordan			The effect of claustrum lesions on human consciousness and recovery of function	CONSCIOUSNESS AND COGNITION			English	Article						Claustrum; Consciousness; Neurobehavioral function; Penetrating traumatic brain injury	PENETRATING HEAD-INJURY; BRAIN; SOFTWARE; EPILEPSY	Crick and Koch proposed that the claustrum plays a crucial role in consciousness. Their proposal was based on the structure and connectivity of the claustrum that suggested it had a role in coordinating a set of diverse brain functions. Given the few human studies investigating this claim, we decided to study the effects of claustrum lesions on consciousness in 171 combat veterans with penetrating traumatic brain injuries. Additionally, we studied the effects of claustrum lesions and loss of consciousness on long-term cognitive abilities. Claustrum damage was associated with the duration, but not frequency, of loss of consciousness, indicating that the claustrum may have an important role in regaining, but not maintaining, consciousness. Total brain volume loss, but not claustrum lesions, was associated with long-term recovery of neurobehavioral functions. Our findings constrain the current understanding of the neurobehavioral functions of the claustrum and its role in maintaining and regaining consciousness. (C) 2015 Elsevier Inc. All rights reserved.	[Chau, Aileen; Cristofori, Irene; Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res Program, Cognit Neurosci Lab, Chicago, IL 60611 USA; [Salazar, Andres M.] Oncovir Inc, Washington, DC USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Cristofori, Irene; Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Evanston, IL 60208 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Evanston, IL 60208 USA	Chau, A (corresponding author), Rehabil Inst Chicago, Brain Injury Res Program, Cognit Neurosci Lab, 345 East Super St, Chicago, IL 60611 USA.	achau@ric.org; asalazar@starpower.net; fkrueger@gmu.edu; irene.cristofori@northwestem.edu; jgrafman@northwestern.edu		Cristofori, Irene/0000-0003-2339-1457	National Naval Medical Center; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	We thank our Vietnam veterans for their participation in the study. We are grateful to V. Raymont, S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for testing and evaluating participants. The National Naval Medical Center and the National Institute of Neurological Disorders and Stroke provided their facilities and supported the research. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defense, or the U.S. Government.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; [Anonymous], 1960, ARMED FORCES QUALIFI; Beck AT., 1996, BECK DEPRESSION INVE, V2; BRAAK H, 1982, ANAT EMBRYOL, V163, P447, DOI 10.1007/BF00305558; Crick FC, 2005, PHILOS T R SOC B, V360, P1271, DOI 10.1098/rstb.2005.1661; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Duffau H, 2007, J NEURO-ONCOL, V81, P327, DOI 10.1007/s11060-006-9236-8; Ferandez-Miranda JC, 2008, J NEUROSURG, V108, P764, DOI 10.3171/JNS/2008/108/4/0764; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Kaplan E., 1983, BOSTON NAMING TEST; Koubeissi MZ, 2014, EPILEPSY BEHAV, V37, P32, DOI 10.1016/j.yebeh.2014.05.027; LEVIN HS, 1989, LANCET, V1, P1001; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Milardi D, 2015, CEREB CORTEX, V25, P406, DOI 10.1093/cercor/bht231; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Rahman FE, 2007, BRAIN RES, V1159, P94, DOI 10.1016/j.brainres.2007.05.011; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Remedios R., 2012, FRANC CRICK MEM C CA; SALAZAR AM, 1986, NEUROLOGY, V36, P178, DOI 10.1212/WNL.36.2.178; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Smith JB, 2010, J NEUROSCI, V30, P16832, DOI 10.1523/JNEUROSCI.4438-10.2010; Smythies J.R., 2014, CLAUSTRUM STRUCTURAL; Smythies J, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00053; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stiefel KM, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00020; Tian F, 2011, BEHAV BRAIN RES, V216, P626, DOI 10.1016/j.bbr.2010.09.005; Torgerson C. M., 2014, FRONTIERS NEUROINFOR, V8; Torgerson C. M., 2014, HUMAN BRAIN MAPPING; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volz KG, 2010, CONSCIOUS COGN, V19, P829, DOI 10.1016/j.concog.2010.05.014; Wechsler D, 1997, WAIS 3 ADM SCORING M; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004	35	20	21	0	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8100	1090-2376		CONSCIOUS COGN	Conscious. Cogn.	NOV	2015	36						256	264		10.1016/j.concog.2015.06.017			9	Psychology, Experimental	Psychology	CQ3PX	WOS:000360516100024	26186439				2021-06-18	
J	Gerrard, P; Kazis, LE; Ryan, CM; Shie, VL; Holavanahalli, R; Lee, A; Jette, A; Fauerbach, JA; Esselman, P; Herndon, D; Schneider, JC				Gerrard, Paul; Kazis, Lewis E.; Ryan, Colleen M.; Shie, Vivian L.; Holavanahalli, Radha; Lee, Austin; Jette, Alan; Fauerbach, James A.; Esselman, Peter; Herndon, David; Schneider, Jeffrey C.			Validation of the Community Integration Questionnaire in the adult burn injury population	QUALITY OF LIFE RESEARCH			English	Article						Community Integration Questionnaire; Burn outcomes; Rehabilitation; Burn injury; Community integration; Participation	TRAUMATIC BRAIN-INJURY; ITEM RESPONSE THEORY; PSYCHOMETRIC PROPERTIES; INTERNATIONAL CLASSIFICATION; REHABILITATION; DISABILITY; OUTCOMES; VALIDITY; HEALTH	Purpose With improved survival, long-term effects of burn injuries on quality of life, particularly community integration, are important outcomes. This study aims to assess the Community Integration Questionnaire's psychometric properties in the adult burn population. Methods Data were obtained from a multicenter longitudinal data set of burn survivors. The psychometric properties of the Community Integration Questionnaire (n = 492) were examined. The questionnaire items were evaluated for clinical and substantive relevance; validation procedures were conducted on different samples of the population; construct validity was assessed using exploratory factor analysis; internal consistency reliability was examined using Cronbach's alpha statistics; and item response theory was applied to the final models. Results The CIQ-15 was reduced by two questions to form the CIQ-13, with a two-factor structure, interpreted as self/family care and social integration. Item response theory testing suggests that Factor 2 captures a wider range of community integration levels. Cronbach's alpha was 0.80 for Factor 1, 0.77 for Factor 2, and 0.79 for the test as a whole. Conclusions The CIQ-13 demonstrates validity and reliability in the adult burn survivor population addressing issues of self/family care and social integration. This instrument is useful in future research of community reintegration outcomes in the burn population.	[Gerrard, Paul; Shie, Vivian L.; Schneider, Jeffrey C.] Harvard Univ, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Sch Med, Boston, MA 02114 USA; [Kazis, Lewis E.; Jette, Alan] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, CAPP, Boston, MA USA; [Ryan, Colleen M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Sumner Redstone Burn Ctr,Surg Serv, Boston, MA USA; [Holavanahalli, Radha] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Lee, Austin] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Fauerbach, James A.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Esselman, Peter] Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Seattle, WA 98104 USA; [Herndon, David] Univ Texas Med Branch, Dept Surg & Pediat, Galveston, TX 77555 USA; [Ryan, Colleen M.] Shriners Hosp Children Boston, Boston, MA USA	Schneider, JC (corresponding author), Harvard Univ, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Sch Med, 300 1st Ave, Boston, MA 02114 USA.	jcschneider@partners.org	Schneider, Jeffrey/AAO-2126-2020; Herndon, David/AAC-3354-2020	Ryan, Colleen/0000-0002-6455-936X			[Anonymous], 2013, R LANG ENV STAT COMP; CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297; Dalemans RJ, 2010, ARCH PHYS MED REHAB, V91, P395, DOI 10.1016/j.apmr.2009.10.021; Djikers M., 1997, J HEAD TRAUMA REHAB, V12, P74; Esselman PC, 2001, J BURN CARE REHABIL, V22, P221, DOI 10.1097/00004630-200105000-00007; Gomez M, 2008, J BURN CARE RES, V29, P130, DOI [10.1097/BCR.0b013e31815f6efd, 1097/BCR.0b013e31815f6efd]; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Jette AM, 2005, J REHABIL MED, V37, P339, DOI 10.1080/16501970500302793; Kamata A, 2008, STRUCT EQU MODELING, V15, P136, DOI 10.1080/10705510701758406; Klein MB, 2011, J BURN CARE RES, V32, P66, DOI 10.1097/BCR.0b013e318203336a; Kratz A. L., 2014, J SPINAL CORD MED; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Lequerica AH, 2013, J HEAD TRAUMA REHAB, V28, pE14, DOI 10.1097/HTR.0b013e31826e3ca8; Mair P., 2007, J STAT SOFTW, V20, P9, DOI DOI 10.18637/JSS.V020.I09; Revelle W., 2015, PSYCH PROCEDURES PSY, V1; Saeki S, 2006, J REHABIL MED, V38, P333, DOI 10.1080/16501970600780245; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Schneider JC, 2011, J BURN CARE RES, V32, P294, DOI 10.1097/BCR.0b013e31820aaf56; Stucki G, 2007, J REHABIL MED, V39, P286, DOI 10.2340/16501977-0044; TAKANE Y, 1987, PSYCHOMETRIKA, V52, P393, DOI 10.1007/BF02294363; Tan WH, 2012, J BURN CARE RES, V33, P110, DOI 10.1097/BCR.0b013e318234d91a; Wasiak J, 2011, BURNS, V37, P913, DOI 10.1016/j.burns.2011.02.012; World Health Organization ( WHO ), 2002, COMM LANG FUNCT DIS	23	20	21	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	NOV	2015	24	11					2651	2655		10.1007/s11136-015-0997-4			5	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	CS7TO	WOS:000362289300009	25986908				2021-06-18	
J	Xu, LY; Ryu, J; Nguyen, JV; Arena, J; Rha, E; Vranis, P; Hitt, D; Marsh-Armstrong, N; Koliatsos, VE				Xu, Leyan; Ryu, Jiwon; Nguyen, Judy V.; Arena, John; Rha, Elizabeth; Vranis, Pamela; Hitt, Devon; Marsh-Armstrong, Nicholas; Koliatsos, Vassilis E.			Evidence for accelerated tauopathy in the retina of transgenic P301S tau mice exposed to repetitive mild traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						CTE; Concussion; Diffuse axonal injury; Retina; Tau; Traumatic axonal injury	MOUSE MODEL; NEUROFIBRILLARY TANGLES; UNITED-STATES; AXONAL INJURY; BLAST INJURY; RAT MODEL; CONCUSSION; HEAD; ENCEPHALOPATHY; DEMENTIA	Chronic traumatic encephalopathy (CTE) is associated with repetitive mild traumatic brain injury (mTBI) in the context of contact and collision sports, but not all exposed individuals develop this condition. In addition, experiments in animal models in several laboratories have shown that non-transgenic mice do not develop tauopathy after exposure to repetitive mTBI schedules. It is thus reasonable to assume that genetic factors may play an etiological role in the development of CTE. More than 40 mutations in the tau gene are known to confer proneness to aggregation and are thought to cause neurodegenerative diseases including frontotemporal degeneration (FTD). Transgenic mice harboring these mutations can be used to ask the question whether repetitive mTBI can accelerate onset and course of tauopathy or worsen the outcomes of transgenic disease. In this study, we exposed mice harboring the tau P301S transgene associated with FTD to repetitive mTBI schedules by impact acceleration (IA) that we have previously characterized. We explored the progression of tauopathy in the retina and neocortex based on density of neuronal profiles loaded with tau pS422, a marker of advanced tau hyperphosphorylation. We found that the density of tau pS422 (+) retinal ganglion cells (RGCs) increased twenty fold with one mTBI hit, a little over fifty fold with four mTBI hits and sixty fold with 12 mTBI hits. The severity of mTBI burden (number of hits) was a significant factor in tauopathy outcome. On the other hand, we found no association between repetitive mTBI and density of pS422 ( +) neuronal profiles in neocortex, a region that is not featured by significant TAI in our repetitive mTBI model. We observed similar, but less prominent, trends in tauopathy-prone transgenic mice harboring all 6 isoforms of wild-type human tau without mouse tau. Our findings indicate that repetitive mTBI accelerates tauopathy under diverse genetic conditions predisposing to tau aggregation and suggest a vulnerability-stress model in understanding some cases of acquired neurodegenerative disease after repetitive mTBI. (C) 2015 Elsevier Inc. All rights reserved.	[Xu, Leyan; Ryu, Jiwon; Arena, John; Rha, Elizabeth; Vranis, Pamela; Hitt, Devon; Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Nguyen, Judy V.; Marsh-Armstrong, Nicholas] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Marsh-Armstrong, Nicholas] Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Xu, LY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, 720 Rutland Ave,Ross Res Bldg 558, Baltimore, MD 21205 USA.	lxu9@jhmi.edu; jryu4@jhmi.edu; judy.v.nguyen@gmail.com; jarena2@jhmi.edu; lizrha@gmail.com; pvranis1@jhu.edu; dhitt@sas.upenn.edu; marsh-armstrong@jhmi.edu; koliat@jhmi.edu		Hitt, Devon/0000-0002-4994-1392; Arena, John/0000-0002-4322-4472; Vranis, Pamela/0000-0002-7942-5380; Ryu, Jiwon/0000-0003-0251-7858	Maryland TEDCO [2011-MSCRF-11 0067-00, 110902]; Spyros N Lemos memorial gift	This work was supported by Maryland TEDCO (2011-MSCRF-11 0067-00; 110902) and funds from the Spyros N Lemos memorial gift to VEK.	Adams SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010810; Allen B, 2002, J NEUROSCI, V22, P9340; Ando K, 2011, AM J PATHOL, V178, P803, DOI 10.1016/j.ajpath.2010.10.034; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Basurto-Islas G, 2008, J NEUROPATH EXP NEUR, V67, P470, DOI 10.1097/NEN.0b013e31817275c7; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Bussiere T, 1999, ACTA NEUROPATHOL, V97, P221, DOI 10.1007/s004010050978; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Collin L, 2014, BRAIN, V137, P2834, DOI 10.1093/brain/awu213; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Denk F, 2009, NEUROBIOL AGING, V30, P1, DOI 10.1016/j.neurobiolaging.2007.05.010; Dujardin S, 2015, NEUROPATH APPL NEURO, V41, P59, DOI 10.1111/nan.12200; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Goedert M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006254; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Guillozet-Bongaarts AL, 2006, J NEUROCHEM, V97, P1005, DOI 10.1111/j.1471-4159.2006.03784.x; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hasegawa M, 1996, FEBS LETT, V384, P25, DOI 10.1016/0014-5793(96)00271-2; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Koliatsos V. E., 2015, BRAIN NEUROTRAUMA MO; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millspaugh J., 1937, US NAVAL MED B, V35, P297; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pennanen L, 2005, BIOCHEM BIOPH RES CO, V337, P1097, DOI 10.1016/j.bbrc.2005.09.168; Persky Rebecca W, 2010, Curr Cardiol Rep, V12, P6, DOI 10.1007/s11886-009-0080-2; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Ruitenberg A, 2001, NEUROBIOL AGING, V22, P575, DOI 10.1016/S0197-4580(01)00231-7; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Sosin DM, 1996, BRAIN INJURY, V10, P47; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Vana L, 2011, AM J PATHOL, V179, P2533, DOI 10.1016/j.ajpath.2011.07.044; Voss K, 2011, AM J PATHOL, V179, P2148, DOI 10.1016/j.ajpath.2011.08.020; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Wszolek ZK, 2003, ADV NEUROL, V91, P153; Xu L, 2014, EXP NEUROL; Xu LY, 2009, J COMP NEUROL, V514, P297, DOI 10.1002/cne.22022; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	69	20	21	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2015	273						168	176		10.1016/j.expneurol.2015.08.014			9	Neurosciences	Neurosciences & Neurology	CW7BB	WOS:000365151800016	26311071				2021-06-18	
J	Turner, RC; Lucke-Wold, BP; Logsdon, AF; Robson, MJ; Dashnaw, ML; Huang, JH; Smith, KE; Huber, JD; Rosen, CL; Petraglia, AL				Turner, Ryan C.; Lucke-Wold, Brandon P.; Logsdon, Aric F.; Robson, Matthew J.; Dashnaw, Matthew L.; Huang, Jason H.; Smith, Kelly E.; Huber, Jason D.; Rosen, Charles L.; Petraglia, Anthony L.			The quest to model chronic traumatic encephalopathy: a multiple model and injury paradigm experience	FRONTIERS IN NEUROLOGY			English	Article						chronic traumatic encephalopathy; tauopathy; animal models; cognitive performance; perivascular pathology	BRAIN-INJURY; MOUSE MODEL; COGNITIVE IMPAIRMENT; DEFICITS; TAU; DIAGNOSIS; PATHOLOGY; DISEASE; STRESS; BETA	Chronic neurodegeneration following a history of neurotrauma is frequently associated with neuropsychiatric and cognitive symptoms. In order to enhance understanding about the underlying pathophysiology linking neurotrauma to neurodegeneration, a multi-model preclinical approach must be established to account for the different injury paradigms and pathophysiologic mechanisms. We investigated the development of tau pathology and behavioral changes using a multi-model and multi-institutional approach, comparing the preclinical results to tauopathy patterns seen in post-mortem human samples from athletes diagnosed with chronic traumatic encephalopathy (GTE). We utilized a scaled and validated blast induced traumatic brain injury model in rats and a modified pneumatic closed-head impact model in mice. Tau hyperphosphorylation was evaluated by western blot and immunohistochemistry. Elevated-plus maze and Morris water maze were employed to measure impulsive like behavior and cognitive deficits respectively. Animals exposed to single blast (similar to 50 PSI reflected peak overpressure) exhibited elevated AT8 immunoreactivity in the contralateral hippocampus at 1 month compared to controls (q = 3.96, p < 0.05). Animals exposed to repeat blast (six blasts over 2 weeks) had increased AT8 (q = 8.12, p < 0.001) and AT270 (q = 4.03, p < 0.05) in the contralateral hippocampus at 1 month post-injury compared to controls. In the modified controlled closed-head impact mouse model, no significant difference in AT8 was seen at 7 days, however a significant elevation was detected at 1 month following injury in the ipsilateral hippocampus compared to control (q = 4.34, p < 0.05). Elevated-plus maze data revealed that rats exposed to single blast (q = 3.53, p < 0.05) and repeat blast (q = 4.21, p <0.05) spent more time in seconds exploring the open arms compared to controls. Morris water maze testing revealed a significant difference between groups in acquisition times on days 22-27. During the probe trial, single blast (t = 6.44, p < 0.05) and repeat blast (t = 8.00, p < 005) rats spent less time in seconds exploring where the platform had been located compared to controls. This study provides a multi-model example of replicating tau and behavioral changes in animals and provides a foundation for future investigation of GTE disease pathophysiology and therapeutic development.	[Turner, Ryan C.; Lucke-Wold, Brandon P.; Rosen, Charles L.] W Virginia Univ, Sch Med, Dept Neurosurg, Morgantown, WV 26506 USA; [Turner, Ryan C.; Lucke-Wold, Brandon P.; Logsdon, Aric F.; Huber, Jason D.; Rosen, Charles L.] W Virginia Univ, Ctr Neurosci, Sch Med, Morgantown, WV 26506 USA; [Logsdon, Aric F.; Smith, Kelly E.; Huber, Jason D.] W Virginia Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA; [Robson, Matthew J.] Vanderbilt Univ, Sch Med, Dept Pharm, Nashville, TN 37235 USA; [Dashnaw, Matthew L.] Univ Rochester, Sch Med & Dent, Dept Neurosurg, Rochester, NY USA; [Huang, Jason H.] Baylor Scott & White Hlth Syst, Dept Neurosurg, Temple, TX USA; [Petraglia, Anthony L.] Rochester Reg Hlth, Div Neurosurg, Rochester, NY 14621 USA	Petraglia, AL (corresponding author), Rochester Reg Hlth, Div Neurosurg, Rochester, NY 14621 USA.	anthony.petraglia@rochesterregional.org	Huang, Jason H/J-4739-2019; Robson, Matthew/H-3127-2013	Huang, Jason H/0000-0002-4426-0168; Robson, Matthew/0000-0002-3277-3062; Turner, Ryan/0000-0001-5523-0645; Fraser, Kelly/0000-0003-1563-050X	West Virginia University Research Funding Development grant; American Foundation of Pharmaceutical Education; American Medical Association Foundation; Neurosurgery Research and Education Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER	A West Virginia University Research Funding Development grant funded the project. An American Foundation of Pharmaceutical Education Pre-doctoral Fellowship supported Brandon Lucke-Wold and Aric Logsdon. An American Medical Association Foundation Seed Grant and a Neurosurgery Research and Education Foundation Medical Student Summer Research Fellowship supported Brandon Lucke-Wold	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gandy Sam, 2014, F1000Res, V3, P229, DOI 10.12688/f1000research.5372.1; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lucke-Wold BP, 2015, TRANSL RES, DOI [10.1016/j. trsl.2015.08.005, DOI 10.1016/J.TRSL.2015.05.005]; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Medeiros R, 2012, AM J PATHOL, V181, P616, DOI 10.1016/j.ajpath.2012.04.020; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Mosienko V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.44; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002	46	20	20	0	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 20	2015	6								222	10.3389/fneur.2015.00222			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CV0JW	WOS:000363938000001	26539159	DOAJ Gold, Green Published			2021-06-18	
J	Lu, HY; Kobilo, T; Robertson, C; Tong, S; Celnik, P; Pelled, G				Lu, Hongyang; Kobilo, Tali; Robertson, Courtney; Tong, Shanbao; Celnik, Pablo; Pelled, Galit			Transcranial magnetic stimulation facilitates neurorehabilitation after pediatric traumatic brain injury	SCIENTIFIC REPORTS			English	Article							WORKING-MEMORY; PLASTICITY; TERM; RAT; CHILDREN; MODERATE; OUTCOMES; CORTEX; SAFETY; MOTOR	Traumatic brain injury (TBI) is the leading cause of death and disability among children in the United States. Affected children will often suffer from emotional, cognitive and neurological impairments throughout life. In the controlled cortical impact (CCI) animal model of pediatric TBI (postnatal day 16-17) it was demonstrated that injury results in abnormal neuronal hypoactivity in the non-injured primary somatosensory cortex (S1). It materializes that reshaping the abnormal post-injury neuronal activity may provide a suitable strategy to augment rehabilitation. We tested whether high-frequency, non-invasive transcranial magnetic stimulation (TMS) delivered twice a week over a four-week period can rescue the neuronal activity and improve the long-term functional neurophysiological and behavioral outcome in the pediatric CCI model. The results show that TBI rats subjected to TMS therapy showed significant increases in the evoked-fMRI cortical responses (189%), evoked synaptic activity (46%), evoked neuronal firing (200%) and increases expression of cellular markers of neuroplasticity in the non-injured S1 compared to TBI rats that did not receive therapy. Notably, these rats showed less hyperactivity in behavioral tests. These results implicate TMS as a promising approach for reversing the adverse neuronal mechanisms activated post-TBI. Importantly, this intervention could readily be translated to human studies.	[Lu, Hongyang; Kobilo, Tali; Pelled, Galit] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD 21205 USA; [Lu, Hongyang; Kobilo, Tali; Pelled, Galit] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA; [Lu, Hongyang; Tong, Shanbao] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Robertson, Courtney] Johns Hopkins Univ, Dept Anesthesiol Crit Care Med & Pediat, Sch Med, Baltimore, MD USA; [Celnik, Pablo] Johns Hopkins Univ, Dept Phys Med & Rehabil, Sch Med, Baltimore, MD USA	Pelled, G (corresponding author), Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD 21205 USA.	Pelled@kennedykrieger.org		Lu, Hongyang/0000-0002-4077-6802	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072171]; China Scholarship CouncilChina Scholarship Council [201306230041]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072171] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R01NS072171 to G.P.). H.L. was supported by the China Scholarship Council (201306230041). The authors thank Dr. Manda Saraswati for technical assistance.	Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Benali A, 2011, J NEUROSCI, V31, P1193, DOI 10.1523/JNEUROSCI.1379-10.2011; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Cantore L, 2012, NEUROREHABILITATION, V30, P225, DOI 10.3233/NRE-2012-0749; Casanova MF, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00851; Celnik PA, 2004, RESTOR NEUROL NEUROS, V22, P261; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen R, 1997, ELECTROMYOGR MOTOR C, V105, P415, DOI 10.1016/S0924-980X(97)00036-2; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Di Battista A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101842; Duffau H, 2006, J CLIN NEUROSCI, V13, P885, DOI 10.1016/j.jocn.2005.11.045; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Frye RE, 2008, J CHILD NEUROL, V23, P79, DOI 10.1177/0883073807307972; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Garvey MA, 2004, EUR J PAEDIATR NEURO, V8, P7, DOI 10.1016/j.ejpn.2003.11.002; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Konrad KN, 2000, BRAIN INJURY, V14, P859; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Lefaucheur JP, 2004, J NEUROL NEUROSUR PS, V75, P612, DOI 10.1136/jnnp.2003.022236; Leo RJ, 2007, J PAIN, V8, P453, DOI 10.1016/j.jpain.2007.01.009; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Li N, 2014, J MOL NEUROSCI, V53, P553, DOI 10.1007/s12031-013-0221-3; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Matsumoto JH, 2013, EPILEPSY BEHAV, V27, P233, DOI 10.1016/j.yebeh.2013.01.024; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Mueller JK, 2014, NAT NEUROSCI, V17, P1130, DOI 10.1038/nn.3751; Nardone R, 2014, J SPINAL CORD MED, V37, P19, DOI 10.1179/2045772313Y.0000000140; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Pape TLB, 2006, J HEAD TRAUMA REHAB, V21, P437, DOI 10.1097/00001199-200609000-00063; PASCUALLEONE A, 1993, ELECTROEN CLIN NEURO, V89, P120, DOI 10.1016/0168-5597(93)90094-6; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Pashut T, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00145; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Ping X., 2015, J NEUROTRAUMA; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276; Prins ML, 2003, DEV BRAIN RES, V140, P93, DOI 10.1016/S0165-3806(02)00588-6; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Quintana H, 2005, J ECT, V21, P88, DOI 10.1097/01.yct.0000162556.02720.58; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Rosema S, 2015, J NEUROTRAUM, V32, P976, DOI 10.1089/neu.2014.3567; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Schulz R, 2013, NEUROPHARMACOLOGY, V64, P579, DOI 10.1016/j.neuropharm.2012.05.016; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Vlachos A, 2012, J NEUROSCI, V32, P17514, DOI 10.1523/JNEUROSCI.0409-12.2012; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a; Wassermann EM, 1996, ELECTROMYOGR MOTOR C, V101, P412; Wechsler B, 2005, J TRAUMA, V58, P940, DOI 10.1097/01.TA.0000162630.78386.98; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yukimasa T, 2006, PHARMACOPSYCHIATRY, V39, P52, DOI 10.1055/s-2006-931542	73	20	21	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 6	2015	5								14769	10.1038/srep14769			11	Multidisciplinary Sciences	Science & Technology - Other Topics	CS7PL	WOS:000362276700002	26440604	DOAJ Gold, Green Published			2021-06-18	
J	Glang, A; Ettel, D; Todis, B; Gordon, WA; Oswald, JM; Vaughn, SL; Connors, SH; Brown, M				Glang, Ann; Ettel, Deborah; Todis, Bonnie; Gordon, Wayne A.; Oswald, Jennifer M.; Vaughn, Susan L.; Connors, Susan H.; Brown, Margaret			Services and Supports for Students with Traumatic Brain Injury: Survey of State Educational Agencies	EXCEPTIONALITY			English	Article							CHILDREN; SCHOOL; TBI; DISABILITY	Long-term follow-up studies conducted during the K-12 school years suggest that challenges related to childhood traumatic brain injury (TBI) tend to persist or worsen over time. A 1999 survey of State Directors of Special Education revealed that most states had emerging initiatives for children with TBI and were expanding their capacity to serve this growing population. To determine whether significant changes in patterns of identification and service delivery had occurred, State Directors and brain injury consumer organizations were surveyed. Survey results show some improvement, but significant gaps remain. Most state education administrators perceive a gap between incidence of childhood TBI and identification of students with TBI to receive special education services. Recommendations for policy changes and research are provided.	[Glang, Ann; Todis, Bonnie] Univ Oregon, Eugene, OR 97401 USA; [Ettel, Deborah] Eugene Sch Dist 4J, Eugene, OR USA; [Gordon, Wayne A.; Oswald, Jennifer M.] Icahn Sch Med Mt Sinai, Mt Sinai Brain Injury Res Ctr, New York, NY 10029 USA; [Vaughn, Susan L.; Connors, Susan H.] Brain Injury Assoc Amer, Vienna, Austria; [Brown, Margaret] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Glang, A (corresponding author), Univ Oregon, Ctr Brain Injury Res & Training, 99 West 10th Ave,Suite 370, Eugene, OR 97401 USA.	aglang@uoregon.edu			National Institute on Disability and Rehabilitation Research to Cincinnati Children's Hospital Medical Center; Center on Brain Injury Research and Training [H133B090010]; Brain Injury Research Center of Mount Sinai; Department of Rehabilitation Medicine of the Icahn School of Medicine at Mount Sinai [H133A120084]	This research was supported in part by funding from the National Institute on Disability and Rehabilitation Research to Cincinnati Children's Hospital Medical Center and the Center on Brain Injury Research and Training [H133B090010], the Brain Injury Research Center of Mount Sinai, and the Department of Rehabilitation Medicine of the Icahn School of Medicine at Mount Sinai [H133A120084].	Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; Cleary M., 2010, J SCH HLTH, V81, P1; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Evans K, 2009, CONT ISSUES COMMUN S, V36, P166; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Glang A, 1999, MAKING IEP PROCESS W; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Glang A, 2006, J HEAD TRAUMA REHAB, V21, P411, DOI 10.1097/00001199-200609000-00013; Glang A, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P602; Glang A, 2008, NEUROREHABILITATION, V23, P477; Gordon W. A., 2013, STATE STATES M ED NE; Henry KL, 2012, J YOUTH ADOLESCENCE, V41, P156, DOI 10.1007/s10964-011-9665-3; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI DOI 10.1207/s15327035ex1403_5; Kozleski E., 2000, TEACHING EXCEPTIONAL, V20, P56; Markowitz J., 2001, TRAUMATIC BRAIN INJU; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; Wang MT, 2014, CHILD DEV, V85, P722, DOI 10.1111/cdev.12138; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Yeates KO, 2010, STUD NEUROPSYCHOL NE, P243; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	27	20	20	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0936-2835	1532-7035		EXCEPTIONALITY	Exceptionality	OCT 2	2015	23	4					211	224		10.1080/09362835.2014.986612			14	Education, Special	Education & Educational Research	CU1VH	WOS:000363309300001					2021-06-18	
J	Sauber-Schatz, EK; Thomas, AM; Cook, LJ				Sauber-Schatz, Erin K.; Thomas, Andrea M.; Cook, Lawrence J.			Motor Vehicle Crashes, Medical Outcomes, and Hospital Charges Among Children Aged 1-12 Years - Crash Outcome Data Evaluation System, 11 States, 2005-2008	MMWR SURVEILLANCE SUMMARIES			English	Article							PASSENGER SAFETY; UNITED-STATES; LINKAGE; SEATS	Problem: Motor vehicle crashes are a leading cause of death among children. Age-and size-appropriate restraint use is an effective way to prevent motor vehicle-related injuries and deaths. However, children are not always properly restrained while riding in a motor vehicle, and some are not restrained at all, which increases their risk for injury and death in a crash. Reporting Period: 2005-2008. Description of the System: The Crash Outcome Data Evaluation System (CODES) is a multistate program facilitated by the National Highway Traffic Safety Administration to probabilistically link police crash reports and hospital databases for traffic safety analyses. Eleven participating states (Connecticut, Georgia, Kentucky, Maryland, Minnesota, Missouri, Nebraska, New York, Ohio, South Carolina, and Utah) submitted data to CODES during the reporting period. Descriptive analysis was used to describe drivers and child passengers involved in motor vehicle crashes and to summarize crash and medical outcomes. Odds ratios and 95% confidence intervals were used to compare a child passenger's likelihood of sustaining specific types of injuries by restraint status (optimal, suboptimal, or unrestrained) and seating location (front or back seat). Because of data constraints, optimal restraint use was defined as car seat or booster seat use for children aged 1-7 years and seat belt use for children aged 8-12 years. Suboptimal restraint use was defined as seat belt use for children aged 1-7 years. Unrestrained was defined as no use of car a seat, booster seat, or seat belt for children aged 1-12 years. Results: Optimal restraint use in the back seat declined with child's age (1 year: 95.9%, 5 years: 95.4%, 7 years: 94.7%, 8 years: 77.4%, 10 years: 67.5%, 12 years: 54.7%). Child restraint use was associated with driver restraint use; 41.3% of children riding with unrestrained drivers also were unrestrained compared with 2.2% of children riding with restrained drivers. Child restraint use also was associated with impaired driving due to alcohol or drug use; 16.4% children riding with drivers suspected of alcohol or drug use were unrestrained compared with 2.9% of children riding with drivers not suspected of such use. Optimally restrained and suboptimally restrained children were less likely to sustain a traumatic brain injury than unrestrained children. The 90th percentile hospital charges for children aged 4-7 years who were in motor vehicle crashes were $1,630.00 and $1,958.00 for those optimally restrained in a back seat and front seat, respectively; $2,035.91 and $3,696.00 for those suboptimally restrained in a back seat and front seat, respectively; and $9,956.60 and $11,143.85 for those unrestrained in a back seat and front seat, respectively. Interpretation: Proper car seat, booster seat, and seat belt use among children in the back seat prevents injuries and deaths, as well as averts hospital charges. However, the number, severity, and cost of injuries among children in crashes who were not optimally restrained or who were seated in a front seat indicates the need for improvements in proper use of age-and size-appropriate car seats, booster seats, and seat belts in the back seat. Public Health Actions: Effective interventions for increasing proper child restraint use could be universally implemented by states and communities to prevent motor vehicle-related injuries among children and their resulting costs.	[Sauber-Schatz, Erin K.] CDC, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; [Sauber-Schatz, Erin K.] US PHS, Washington, DC 20201 USA; [Thomas, Andrea M.; Cook, Lawrence J.] Univ Utah, Dept Pediat, Salt Lake City, UT USA	Sauber-Schatz, EK (corresponding author), CDC, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.	esauberschatz@cdc.gov					[Anonymous], 2015, MOT VEH REL INJ PREV; Arbogast KB, 2009, PEDIATRICS, V124, P1281, DOI 10.1542/peds.2009-0908; Bergen G, 2014, MMWR-MORBID MORTAL W, V63, P894; CDC, 2014, VIT SIGNS FACT SHEET; Choi E-H, 2014, 812037 DOT HS NAT HI; Cook LJ, 2001, METHOD INFORM MED, V40, P196; Durbin DR, 2011, PEDIATRICS, V127, pE1050, DOI 10.1542/peds.2011-0215; Ehiri JE, 2006, COCHRANE DB SYST REV, V1; Eichelberger AH, 2012, TRAFFIC INJ PREV, V13, P631, DOI 10.1080/15389588.2012.660663; [Federal Motor Carrier Safety Administration Governors Highway Safety Association National Highway Traffic Safety Administration Federal Highway Administration], 2012, MMUCC GUID MOD MIN U; Gardner HG, 2011, PEDIATRICS, V127, P788, DOI 10.1542/peds.2011-0213; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; KAHANE CJ, 1986, EVALUATION CHILD PAS; McGlincy MH, 2004, ASA P JOINT STAT M, P4001; Milani J, 2015, ASSESSMENT CHARACTER; National Highway Traffic Safety Administration, 2011, CRASH OUTC DAT EV SY; National Highway Traffic Safety Administration, 2015, PAR CENTR; National Highway Traffic Safety Administration, 2014, NAT AUT SAMPL SYST N; National Highway Traffic Safety Administration, 2013, COUNT WORK HIGHW SAF; NHTSA, 1996, REV EST CHILD RESTR; NHTSA, 2015, TRAFF SAF FACTS 2013; Quinlan K, 2014, PEDIATRICS, V133, P966, DOI 10.1542/peds.2013-2318; Raghunathan TL., 2001, SURV METHODOL, V27, P85; SAS Institute, 2002, SAS SOFTW; Sauber-Schatz EK, 2014, MMWR-MORBID MORTAL W, V63, P113; Zaza S, 2001, AM J PREV MED, V21, P31, DOI 10.1016/S0749-3797(01)00377-4	26	20	20	0	8	CENTERS  DISEASE CONTROL	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1545-8636			MMWR SURVEILL SUMM	MMWR Surv. Summ.	OCT 2	2015	64	8					1	32					32	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CV6NL	WOS:000364386800001	26426527	Bronze			2021-06-18	
J	Hang, B; Babcock, L; Hornung, R; Ho, M; Pomerantz, WJ				Hang, Brian; Babcock, Lynn; Hornung, Richard; Ho, Mona; Pomerantz, Wendy J.			Can Computerized Neuropsychological Testing in the Emergency Department Predict Recovery for Young Athletes With Concussions?	PEDIATRIC EMERGENCY CARE			English	Article						athlete; concussion; ImPACT	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; POSTCONCUSSION SYNDROME; CONSENSUS STATEMENT; FOOTBALL PLAYERS; SYMPTOMS; ADOLESCENTS; CHILDREN	Objective The objective of this study was to determine if computerized neurocognitive testing (Immediate Post-Concussion Assessment and Cognitive Testing [ImPACT]) in the emergency department (ED) can be used as a prognostic tool to detect young athletes at risk of having protracted concussive symptoms. Methods This was a prospective cohort study of athletes aged 11 to 18 years who presented to an ED less than 24 hours after sustaining a sports-related concussion. ImPACT was administered in the ED, and performance was categorized as poor if the athlete had 3 (of 4) or greater low domain scores. Participants completed the Post-Concussion Symptom Scale (PCSS) in the ED and by phone at 1 and 2 weeks after injury. Athletes were symptomatic if their PCSS score was more than 6 in males and more than 8 in females. Results One hundred nine patients were enrolled; 60% and 36% remained symptomatic at 1 and 2 weeks after injury, respectively. Poor ImPACT performance was not particularly useful in predicting athletes with protracted symptoms (at 1 week: positive predictive value, 70.8%; negative predictive value, 43.5%; at 2 weeks: positive predictive value, 47.8%; negative predictive value, 68.9%). In bivariate analysis, a higher ED PCSS score was associated with protracted symptoms (at 1 week: odds ratio, 1.1 [confidence interval, 1.0-1.1]; at 2 weeks: odds ratio, 1.0 [confidence interval, 1.0-1.1]). Conclusions Computerized neurocognitive testing in the ED has limited usefulness in predicting protracted symptoms. Total acute symptom burden may be a useful prognostic tool in the ED evaluation of concussed young athletes, yet further research is necessary.	[Hang, Brian] Ann & Robert Lurie Childrens Hosp Chicago, Div Emergency Med, Pediat Emergency Med, Chicago, IL USA; [Babcock, Lynn; Hornung, Richard; Ho, Mona; Pomerantz, Wendy J.] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA; [Babcock, Lynn; Hornung, Richard; Pomerantz, Wendy J.] UC Dept Pediat, Cincinnati, OH USA	Babcock, L (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, 3333 Burnet Ave,ML 2008, Cincinnati, OH 45229 USA.	Lynn.Babcock@cchmc.org	Meijer, Anna/K-5118-2016	Babcock, Lynn/0000-0002-2658-6893	American College of Sports Medicine, Clinical Sports Medicine Research Endowment; Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425] Funding Source: NIH RePORTER	American College of Sports Medicine, Clinical Sports Medicine Research Endowment, 2011; and Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Flahault A, 2005, J CLIN EPIDEMIOL, V58, P859, DOI 10.1016/j.jclinepi.2004.12.009; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Iverson G.L., 2003, IMMEDIATE POSTCONCUS; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Janusz A, 2004, BRIT J SPORT MED, V38, P659; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Wiebe DJ, 2012, PEDIATR EMERG CARE, V28, P498, DOI 10.1097/PEC.0b013e3182586f76; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008	26	20	20	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	OCT	2015	31	10					688	693		10.1097/PEC.0000000000000438			6	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	CT3MH	WOS:000362710300002	26430968				2021-06-18	
J	da Costa, L; Robertson, A; Bethune, A; MacDonald, MJ; Shek, PN; Taylor, MJ; Pang, EW				da Costa, Leodante; Robertson, Amanda; Bethune, Allison; MacDonald, Matt J.; Shek, Pang N.; Taylor, Margot J.; Pang, Elizabeth W.			Delayed and disorganised brain activation detected with magnetoencephalography after mild traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							DEFAULT-MODE NETWORKS; FUNCTIONAL CONNECTIVITY; IMAGING APPROACH; MEG; SPECT; PATHOPHYSIOLOGY; CONCUSSION; DISORDER; HISTORY; CORTEX	Background Awareness to neurocognitive issues after mild traumatic brain injury (mTBI) is increasing, but currently no imaging markers are available for mTBI. Advanced structural imaging recently showed microstructural tissue changes and axonal injury, mild but likely sufficient to lead to functional deficits. Magnetoencephalography (MEG) has high temporal and spatial resolution, combining structural and electrophysiological information, and can be used to examine brain activation patterns of regions involved with specific tasks. Methods 16 adults with mTBI and 16 matched controls were submitted to neuropsychological testing (Wechsler Abbreviated Scale of Intelligence (WASI); Conners; Alcohol Use Disorders Identification Test (AUDIT); Generalised Anxiety Disorder Seven-item Scale (GAD-7); Patient Health Questionnaire (PHQ-9); Symptom Checklist and Symptom Severity Score (SCAT2)) and MEG while tested for mental flexibility (Intra-Extra Dimensional set-shifting tasks). Three-dimensional maps were generated using synthetic aperture magnetometry beamforming analyses to identify differences in regional activation and activation times. Reaction times and accuracy between groups were compared using 2x2 mixed analysis of variance. Findings While accuracy was similar, patients with mTBI reaction time was delayed and sequence of activation of brain regions disorganised, with involvement of extra regions such as the occipital lobes, not used by controls. Examination of activation time showed significant delays in the right insula and left posterior parietal cortex in patients with mTBI. Conclusions Patients with mTBI showed significant delays in the activation of important areas involved in executive function. Also, more regions of the brain are involved in an apparent compensatory effort. Our study suggests that MEG can detect subtle neural changes associated with cognitive dysfunction and thus, may eventually be useful for capturing and tracking the onset and course of cognitive symptoms associated with mTBI.	[da Costa, Leodante; Bethune, Allison] Univ Toronto, Sunnybrook Hosp, Div Neurosurg, Toronto, ON, Canada; [da Costa, Leodante] Univ Toronto, Dept Med Imaging, Sunnybrook Hosp, Toronto, ON, Canada; [Robertson, Amanda; MacDonald, Matt J.; Taylor, Margot J.; Pang, Elizabeth W.] SickKids Res Inst, Neurosci & Mental Hlth, Toronto, ON, Canada; [Shek, Pang N.] Def Res & Dev Canada, Mil Med Sect, Toronto, ON, Canada; [Taylor, Margot J.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada; [Taylor, Margot J.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Pang, Elizabeth W.] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Pang, Elizabeth W.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada	da Costa, L (corresponding author), Sunnybrook Hlth Sci Ctr, Div Neurosurg, 2075 Bayview Ave Room A1-37, Toronto, ON M4N 3M5, Canada.	leo.dacosta@sunnybrook.ca		MacDonald, Matthew/0000-0002-2595-5941	Defence Research and Development Canada [W7719-135182/001/TOR]	This work was supported by funding from Defence Research and Development Canada (Contract #: W7719-135182/001/TOR) to MJT and EWPang.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Chau W, 2004, NEUROIMAGE, V23, P983, DOI 10.1016/j.neuroimage.2004.07.007; Conners CK, 2008, COMPREHENSIVE BEHAV; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; Doesburg SM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00785; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Dorion AA, 2002, NEUROPSYCHOLOGIA, V40, P946, DOI 10.1016/S0028-3932(01)00150-6; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Gau SSF, 2010, J CHILD PSYCHOL PSYC, V51, P838, DOI 10.1111/j.1469-7610.2010.02215.x; GRAY BG, 1992, J NUCL MED, V33, P52; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132093, 10.3171/2013.12.JNS132090]; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; Kluetsch RC, 2014, ACTA PSYCHIAT SCAND, V130, P123, DOI 10.1111/acps.12229; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.2005.10.031; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; Monchi O, 2001, J NEUROSCI, V21, P7733; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oh A, 2014, BRAIN COGNITION, V86, P90, DOI 10.1016/j.bandc.2014.02.006; Pantelis C, 2009, SCHIZOPHR RES, V112, P104, DOI 10.1016/j.schres.2009.03.039; Perianez JA, 2004, NEUROIMAGE, V21, P687, DOI 10.1016/j.neuroimage.2003.10.008; Rogers RD, 2000, J COGNITIVE NEUROSCI, V12, P142, DOI 10.1162/089892900561931; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Singh KD, 2003, NEUROIMAGE, V19, P1589, DOI 10.1016/S1053-8119(03)00249-0; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Wechsler D., 2011, WECHLSER ABBREVIATED; World Health Organization, 2001, AUDIT ALCOHOL USE DI; Zouridakis G, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412400064	43	20	20	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	SEP	2015	86	9					1008	1015		10.1136/jnnp-2014-308571			8	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CO9IE	WOS:000359487500077	25324505	Green Published, Other Gold			2021-06-18	
J	Gardani, M; Morfiri, E; Thomson, A; O'Neill, B; McMillan, TM				Gardani, Maria; Morfiri, Eleni; Thomson, Allan; O'Neill, Brian; McMillan, Thomas M.			Evaluation of Sleep Disorders in Patients With Severe Traumatic Brain Injury During Rehabilitation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Circadian rhythm; Rehabilitation; Sleep; Sleep disorders; Sleep initiation and maintenance disorders	SCALE; INSOMNIA; DIFFICULTIES; DISTURBANCE; ACTIGRAPHY; COMPLAINTS; FATIGUE; INDEX	Objective: To explore the presence and types of sleep disorders in chronic patients with severe traumatic brain injury (TBI) undergoing inpatient rehabilitation using formal diagnostic criteria based on the International Classification of Sleep Disorders, 2nd edition. Design: Cross-sectional study. Setting: Inpatient brain injury rehabilitation units. Participants: Chronic inpatients with severe TBI (N=30) were evaluated during rehabilitation. Interventions: Not applicable. Main Outcome Measures: Participants wore an actiwatch for 7 days and completed self-report measures on sleep, mood, fatigue, pain, and daytime sleepiness. Results: Twenty participants (67%) had a sleep-wake cycle disturbance, of which 15 (50%) met diagnostic criteria for a sleep disorder. Diagnosed sleep disorders in the sample were insomnia (26.7%), posttraumatic hypersomnia (6.7%), delayed sleep phase syndrome (10%), irregular sleep-wake pattern disorder (3.3%), and periodic limb movement disorder (3.3%). Sleep quality was estimated by senior clinical staff as interfering with rehabilitation in 36.6% of the sample. Poor sleep quality was associated with greater anxiety, fatigue, and daytime sleepiness. Conclusions: Consistent with previous studies, the present study showed high levels of sleep-wake cycle disturbances in patients with severe TBI undergoing rehabilitation, which were associated with anxiety, fatigue, and daytime sleepiness. These findings highlight the importance of assessing and treating sleep problems in patients with TBI undergoing rehabilitation. (C) 2015 by the American Congress of Rehabilitation Medicine	[Gardani, Maria; McMillan, Thomas M.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 0XH, Lanark, Scotland; [Morfiri, Eleni] Natl Hlth Serv Greater Glasgow & Clyde, Glasgow, Lanark, Scotland; [Thomson, Allan] Natl Hlth Serv Fife, Kirkcaldy, Fife, Scotland; [O'Neill, Brian] Brain Injury Rehabil Trust, Glasgow, Lanark, Scotland; [O'Neill, Brian] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland	Gardani, M (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, Inst Hlth & Wellbeing, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	maria.gardani@glasgow.ac.uk	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Gardani, Maria/0000-0003-0975-5971	National Health Service Education Scotland; Sackler Foundation	Supported in part by National Health Service Education Scotland and the Sackler Foundation.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Ebrahim IO, 2013, ALCOHOL CLIN EXP RES, V37, DOI 10.1111/acer.12006; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Gardani M, 2014, BRAIN INJURY, V28, P773; ISD Scotland, 2014, DRUG MIS STAT SCOTL; ISD Scotland, 2011, ALC STAT SCOTL 2011; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Legros B, 2003, SLEEP MED, V4, P51, DOI 10.1016/S1389-9457(02)00217-4; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McMillan TM, 2013, J NEUROTRAUM, V30, P970, DOI 10.1089/neu.2012.2703; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; O'Neill B, 2014, BRAIN INJURY, V28, P378, DOI 10.3109/02699052.2013.865264; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; Waters F, 2011, J INT NEUROPSYCH SOC, V17, P571, DOI 10.1017/S1355617711000610; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	40	20	20	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2015	96	9					1691	1697		10.1016/j.apmr.2015.05.006			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CR1JT	WOS:000361081700018	26003285				2021-06-18	
J	Grossman, EJ; Kirov, II; Gonen, O; Novikov, DS; Davitz, MS; Lui, YW; Grossman, RI; Inglese, M; Fieremans, E				Grossman, Elan J.; Kirov, Ivan I.; Gonen, Oded; Novikov, Dmitry S.; Davitz, Matthew S.; Lui, Yvonne W.; Grossman, Robert I.; Inglese, Matilde; Fieremans, Els			N-acetyl-aspartate levels correlate with intra-axonal compartment parameters from diffusion MRI	NEUROIMAGE			English	Article						Diffusion MRI; Mild traumatic brain injury; Proton magnetic resonance spectroscopy; White matter tract integrity; NAA; Diffusion kurtosis imaging	TRAUMATIC BRAIN-INJURY; GAUSSIAN WATER DIFFUSION; WHITE-MATTER; AXONAL INJURY; TISSUE-MICROSTRUCTURE; RELAXATION-TIMES; KURTOSIS; SPECTROSCOPY; DENSITY; MODELS	Diffusion MRI combined with biophysical modeling allows for the description of a white matter (WM) fiber bundle in terms of compartment specific white matter tract integrity (WMTI) metrics, which include intra-axonal diffusivity (D-axon), extra-axonal axial diffusivity (D-e parallel to), extra-axonal radial diffusivity (D-e perpendicular to), axonal water fraction (AWF), and tortuosity (alpha) of extra-axonal space. Here we derive these parameters from diffusion kurtosis imaging to examine their relationship to concentrations of global WM N-acetyl-aspartate (NAA), creatine (Cr), choline (Cho) and myo-Inositol (mI), as measured with proton MR spectroscopy (H-1-MRS), in a cohort of 25 patients with mild traumatic brain injury (MTBI). We found statistically significant (p < 0.05) positive correlations between NAA and Daxon, AWF, a, and fractional anisotropy; negative correlations between NAA and D-e,D-perpendicular to and the overall radial diffusivity (D-perpendicular to). These correlations were supported by similar findings in regional analysis of the genu and splenium of the corpus callosum. Furthermore, a positive correlation in global WM was noted between Daxon and Cr, as well as a positive correlation between D-e parallel to and Cho, and a positive trend between D-e parallel to and mI. The specific correlations between NAA, an endogenous probe of the neuronal intracellular space, and WMTI metrics related to the intra-axonal space, combined with the specific correlations of D-e parallel to with mI and Cho, both predominantly present extra-axonally, corroborate the overarching assumption of many advanced modeling approaches that diffusion imaging can disentangle between the intra-and extra-axonal compartments in WM fiber bundles. Our findings are also generally consistent with what is known about the pathophysiology of MTBI, which appears to involve both intra-axonal injury (as reflected by a positive trend between NAA and D-axon) as well as axonal shrinkage, demyelination, degeneration, and/or loss (as reflected by correlations between NAA and D-e perpendicular to, AWF, and alpha). (C) 2015 Elsevier Inc. All rights reserved.	[Grossman, Elan J.; Kirov, Ivan I.; Gonen, Oded; Novikov, Dmitry S.; Lui, Yvonne W.; Grossman, Robert I.; Inglese, Matilde; Fieremans, Els] NYU, Dept Radiol, Sch Med, Ctr Biomed Imaging, New York, NY 10016 USA; [Grossman, Elan J.; Gonen, Oded] NYU, Sch Med, Dept Physiol & Neurosci, New York, NY USA; [Davitz, Matthew S.] NYU, Coll Arts & Sci, New York, NY USA; [Inglese, Matilde] Mt Sinai Sch Med, Dept Neurol Radiol & Neurosci, New York, NY USA; [Inglese, Matilde] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy	Inglese, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol Radiol & Neurosci, One Gustave L Levy Pl,Box 1137, New York, NY 10029 USA.	ejg279@nyu.edu; Ivan.Kirov@nyumc.org; Oded.Gonen@nyumc.org; Dmitry.Novikov@nyumc.org; md2773@nyu.edu; Yvonne.Lui@nyumc.org; Robert.Grossman@nyumc.org; matilde.inglese@mssm.edu; Els.Fieremans@nyumc.org	Kirov, Ivan/I-2792-2019; Inglese, Matilde/AAH-3189-2020	Kirov, Ivan/0000-0001-5641-8578; Inglese, Matilde/0000-0002-9610-0297; Fieremans, Els/0000-0002-1384-8591; Gonen, Oded/0000-0002-3148-2028; Novikov, Dmitry/0000-0002-4213-3050	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EB01015, NS050520, NS039135, NS051623]; Noto Foundation; Center for Advanced Imaging Innovation and Research; National Institute for Biomedical Imaging and Bioengineering Biomedical Technology Resource Center [P41EB017183]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB001015, P41EB017183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088040, R01NS050520, R01NS039135, R56NS051623, R01NS051623, R56NS050520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG008051] Funding Source: NIH RePORTER	The authors thank Jelle Veraart for assistance with image post-processing and James Babb for fruitful discussions on statistical analyses. This research was supported in part by the National Institutes of Health grant numbers EB01015, NS050520, NS039135, and NS051623, the Noto Foundation to M.I., and the Center for Advanced Imaging Innovation and Research, a National Institute for Biomedical Imaging and Bioengineering Biomedical Technology Resource Center, for grant number P41EB017183.	Alexander DC, 2008, MAGN RESON MED, V60, P439, DOI 10.1002/mrm.21646; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Basser P.J., 2007, MAGN RESON IMAGING, V25, P550; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benitez A, 2014, NEUROIMAGE-CLIN, V4, P64, DOI 10.1016/j.nicl.2013.11.001; Bennett KM, 2003, MAGNET RESON MED, V50, P727, DOI 10.1002/mrm.10581; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Burcaw L. M., 2014, P INT SOC MAGN RESON, V22, P4434; Burcaw LM, 2015, NEUROIMAGE, V114, P18, DOI 10.1016/j.neuroimage.2015.03.061; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Ethofer T, 2003, MAGN RESON MED, V50, P1296, DOI 10.1002/mrm.10640; Fieremans E, 2013, AM J NEURORADIOL, V34, P2105, DOI 10.3174/ajnr.A3553; Fieremans E., 2012, P 20 SCI M, P3600; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fieremans E, 2010, NMR BIOMED, V23, P711, DOI 10.1002/nbm.1577; Goelman G, 2007, MAGN RESON MED, V58, P167, DOI 10.1002/mrm.21251; Goelman G, 2006, MAGN RESON MED, V56, P34, DOI 10.1002/mrm.20942; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; HU J, 1995, J MAGN RESON SER B, V108, P213, DOI 10.1006/jmrb.1995.1126; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jelescu IO, 2015, NEUROIMAGE, V107, P242, DOI 10.1016/j.neuroimage.2014.12.009; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones D.K., 2010, DIFFUSION MRI THEORY; Kirov II, 2008, MAGN RESON MED, V60, P790, DOI 10.1002/mrm.21715; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kiselev V.G., 2010, DIFFUSION MRI THEORY; Kroenke CD, 2004, MAGN RESON MED, V52, P1052, DOI 10.1002/mrm.20260; Lazar M, 2014, NEUROIMAGE-CLIN, V4, P417, DOI 10.1016/j.nicl.2014.01.014; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Liu CL, 2004, MAGN RESON MED, V51, P924, DOI 10.1002/mrm.20071; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Maier SE, 2004, MAGN RESON MED, V51, P321, DOI 10.1002/mrm.10685; Mori S., 2005, MRI ATLAS HUMAN WHIT; Niendorf T, 1996, MAGN RESON MED, V36, P847, DOI 10.1002/mrm.1910360607; Nilsson M, 2013, MAGN RESON MATER PHY, V26, P345, DOI 10.1007/s10334-013-0371-x; Novikov D.S., 2015, P INT SOC MAG RESON, P469; Novikov DS, 2014, P NATL ACAD SCI USA, V111, P5088, DOI 10.1073/pnas.1316944111; Ozarslan E, 2013, NEUROIMAGE, V78, P16, DOI 10.1016/j.neuroimage.2013.04.016; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Panagiotaki E, 2009, LECT NOTES COMPUT SC, V5761, P329; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Soher BJ, 1998, MAGNET RESON MED, V40, P822, DOI 10.1002/mrm.1910400607; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Tal A, 2012, NMR BIOMED, V25, P1392, DOI 10.1002/nbm.2812; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wellcome Trust Centre for Neuroimaging U.C.L., 2010, STAT PAR MAPP SPM8 M; Wijtenburg SA, 2013, NEUROIMAGE, V66, P161, DOI 10.1016/j.neuroimage.2012.10.014; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	71	20	20	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	SEP	2015	118						334	343		10.1016/j.neuroimage.2015.05.061			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CQ5GB	WOS:000360630200032	26037050	Green Accepted			2021-06-18	
J	Gunther, M; Davidsson, J; Plantman, S; Norgren, S; Mathiesen, T; Risling, M				Gunther, Mattias; Davidsson, Johan; Plantman, Stefan; Norgren, Svante; Mathiesen, Tiit; Risling, Marten			Neuroprotective effects of N-acetylcysteine amide on experimental focal penetrating brain injury in rats	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Inflammation; N-acetylcysteine amide; Neuroprotection; Sprague-Dawley; Traumatic brain injury	TRAUMATIC BRAIN; THIOL ANTIOXIDANT; GLUTATHIONE; PROTECTS; SUPEROXIDE; NEURODEGENERATION; BIOENERGETICS; INFLAMMATION; ACTIVATION; EXPRESSION	We examined the effects of N-acetylcysteine amide (NACA) in the secondary inflammatory response following a novel method of focal penetrating traumatic brain injury (TBI) in rats. N-acetylcysteine (NAC) has limited but well-documented neuroprotective effects after experimental central nervous system ischemia and TBI, but its bioavailability is very low. We tested NACA, a modified form of NAC with higher membrane and blood-brain barrier permeability. Focal penetrating TBI was produced in male Sprague-Dawley rats randomly selected for NACA treatment (n = 5) and no treatment (n = 5). In addition, four animals were submitted to sham surgery. After 2 hours or 24 hours the brains were removed, fresh frozen, cut in 14 mu m coronal sections and subjected to immunohistochemistry, immunofluorescence, Fluoro-Jade and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) analyses. All treated animals were given 300 mg/kg NACA intraperitoneally (IP) 2 minutes post trauma. The 24 hour survival group was given an additional bolus of 300 mg/kg IF after 4 hours. NACA treatment decreased neuronal degeneration by Fluoro-Jade at 24 hours with a mean change of 35.0% (p < 0.05) and decreased TUNEL staining indicative of apoptosis at 2 hours with a mean change of 38.7% (p < 0.05). Manganese superoxide dismutase (MnSOD) increased in the NACA treatment group at 24 hours with a mean change of 35.9% (p < 0.05). Levels of migrating macrophages and activated microglia (Ox-42/CD11b), nitric oxide-producing inflammatory enzyme iNOS, peroxynitrite marker 3-nitrotyrosine, NF kappa B translocated to the nuclei, cytochrome C and Bcl-2 were not affected. NACA treatment decreased neuronal degeneration and apoptosis and increased levels of antioxidative enzyme MnSOD. The antiapoptotic effect was likely regulated by pathways other than cytochrome C. Therefore, NACA prevents brain tissue damage after focal penetrating TBI, warranting further studies towards a clinical application. (C) 2015 Elsevier Ltd. All rights reserved.	[Gunther, Mattias; Plantman, Stefan; Risling, Marten] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; [Davidsson, Johan] Chalmers Univ Technol, Div Vehicle Safety, Dept Appl Mech, S-41296 Gothenburg, Sweden; [Norgren, Svante] Karolinska Inst, Dept Womens & Childrens Hlth, SE-17177 Stockholm, Sweden; [Mathiesen, Tiit] Karolinska Inst, Dept Clin Neurosci, SE-17177 Stockholm, Sweden	Gunther, M (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8,B1 5, SE-17177 Stockholm, Sweden.	mattias.gunther@ki.se	Davidsson, Johan/A-3229-2016; , Mattias/A-4442-2013	Davidsson, Johan/0000-0002-1717-1514; , Mattias/0000-0003-2372-6114; Mathiesen, Tiit/0000-0001-9463-1919	ALF Stockholms Lans Landsting; Swedish Defense	This study was funded by ALF Stockholms Lans Landsting and The Swedish Defense. We thank Dr. Glenn Goldstein of Sentient LifeSciences for gifting N-acetylcysteine amide to us for our experimental purposes.	Aitio ML, 2006, BRIT J CLIN PHARMACO, V61, P5, DOI 10.1111/j.1365-2125.2005.02523.x; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Ates B, 2008, FREE RADICAL RES, V42, P372, DOI 10.1080/10715760801998638; Bahat-Stroomza M, 2005, EUR J NEUROSCI, V21, P637, DOI 10.1111/j.1460-9568.2005.03889.x; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bartov O, 2006, BRAIN RES, V1069, P198, DOI 10.1016/j.brainres.2005.10.079; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; DEVRIES N, 1993, J CELL BIOCHEM, P270; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Drake J, 2002, J NEUROSCI RES, V68, P776, DOI 10.1002/jnr.10266; Gahm C, 2000, NEUROSURGERY, V46, P169; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Gong XZ, 2010, AM J NEPHROL, V31, P178, DOI 10.1159/000268161; Grinberg L, 2005, FREE RADICAL BIO MED, V38, P136, DOI 10.1016/j.freeradbiomed.2004.09.025; Gunther M, 2012, ACTA NEUROCHIR, V154, P689, DOI 10.1007/s00701-012-1297-1; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; ISSELS RD, 1988, BIOCHEM PHARMACOL, V37, P881, DOI 10.1016/0006-2952(88)90176-1; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Keller JN, 1998, J NEUROSCI, V18, P687; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Mathiesen T, 1995, ACTA NEUROCHIR, V137, P155, DOI 10.1007/BF02187188; MEYER K, 2008, J TRAUMA NURS, V15, P190; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; Miljkovic D, 2004, CYTOKINE GROWTH F R, V15, P21, DOI 10.1016/j.cytogfr.2003.10.003; Nakata K, 1996, MECH AGEING DEV, V90, P195, DOI 10.1016/0047-6374(96)01771-X; Noack H, 1998, GLIA, V23, P285, DOI 10.1002/(SICI)1098-1136(199808)23:4<285::AID-GLIA1>3.0.CO;2-2; Offen D, 2004, J NEUROCHEM, V89, P1241, DOI 10.1111/j.1471-4159.2004.02428.x; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Penugonda S, 2005, BRAIN RES, V1056, P132, DOI 10.1016/j.brainres.2005.07.032; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sunitha K, 2013, FREE RADICAL RES, V47, P357, DOI 10.3109/10715762.2013.781595; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	43	20	21	1	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2015	22	9					1477	1483		10.1016/j.jocn.2015.03.025			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CO4YU	WOS:000359167600020	26100161				2021-06-18	
J	Schyma, C; Lux, C; Madea, B; Courts, C				Schyma, Christian; Lux, Constantin; Madea, Burkhard; Courts, Cornelius			The 'triple contrast' method in experimental wound ballistics and backspatter analysis	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Gunshot wounds; Wound ballistics; Suicide; Firearms; Forensic medicine; Forensic genetics	BLOOD-SPATTER PATTERNS; CLOSE-RANGE SHOTS; BIOLOGICAL TRACES; GUN BARRELS; HEAD; GUNSHOTS; FIREARM; HAND; RECONSTRUCTION; PERSISTENCE	In practical forensic casework, backspatter recovered from shooters' hands can be an indicator of self-inflicted gunshot wounds to the head. In such cases, backspatter retrieved from inside the barrel indicates that the weapon found at the death scene was involved in causing the injury to the head. However, systematic research on the aspects conditioning presence, amount and specific patterns of backspatter is lacking so far. Herein, a new concept of backspatter investigation is presented, comprising staining technique, weapon and target medium: the 'triple contrast method' was developed, tested and is introduced for experimental backspatter analysis. First, mixtures of various proportions of acrylic paint for optical detection, barium sulphate for radiocontrast imaging in computed tomography and fresh human blood for PCR-based DNA profiling were generated (triple mixture) and tested for DNA quantification and short tandem repeat (STR) typing success. All tested mixtures yielded sufficient DNA that produced full STR profiles suitable for forensic identification. Then, for backspatter analysis, sealed foil bags containing the triple mixture were attached to plastic bottles filled with 10 % ballistic gelatine and covered by a 2-3-mm layer of silicone. To simulate backspatter, close contact shots were fired at these models. Endoscopy of the barrel inside revealed coloured backspatter containing typable DNA and radiographic imaging showed a contrasted bullet path in the gelatine. Cross sections of the gelatine core exhibited cracks and fissures stained by the acrylic paint facilitating wound ballistic analysis.	[Schyma, Christian] Univ Bern, Inst Forens Med, Bern, Switzerland; [Lux, Constantin; Madea, Burkhard; Courts, Cornelius] Univ Bonn, Inst Legal Med, Bonn, Germany	Schyma, C (corresponding author), Univ Bern, Inst Forens Med, Bern, Switzerland.	christian.schyma@irm.unibe.ch			SNF (Swiss National Science Foundation)Swiss National Science Foundation (SNSF); DFG (Deutsche Forschungsgemeinschaft)German Research Foundation (DFG)	This research work was funded by the SNF (Swiss National Science Foundation) and the DFG (Deutsche Forschungsgemeinschaft).	Betz P, 1995, FORENSIC SCI INT, V76, P47, DOI 10.1016/0379-0738(95)01793-3; Bruning A., 1934, DTSCH Z GESAMTE GERI, V23, P71, DOI [10.1007/BF01771912, DOI 10.1007/BF01771912]; Courts C, 2014, J FORENSIC SCI, V59, P1129, DOI 10.1111/1556-4029.12434; Courts C, 2012, INT J LEGAL MED, V126, P391, DOI 10.1007/s00414-011-0655-5; FACKLER ML, 1988, AM J FOREN MED PATH, V9, P218, DOI 10.1097/00000433-198809000-00008; Karger B, 1996, INT J LEGAL MED, V109, P66, DOI 10.1007/BF01355519; Karger B, 2002, AM J FOREN MED PATH, V23, P211, DOI 10.1097/00000433-200209000-00001; Karger B, 1997, INT J LEGAL MED, V110, P27; Kneubuehl BP, 2011, WOUND BALLISTICS: BASICS AND APPLICATIONS, P253; Kunz SN, 2013, FORENSIC SCI INT, V228, pE54, DOI 10.1016/j.forsciint.2013.02.012; Kunz SN, 2015, J FORENSIC SCI, V60, P166, DOI 10.1111/1556-4029.12572; Lux C, 2014, FORENSIC SCI INT, V237, P62, DOI 10.1016/j.forsciint.2014.01.016; Perdekamp MG, 2011, INT J LEGAL MED, V125, P479, DOI 10.1007/s00414-010-0517-6; Radford GE, 2009, THESIS OTAGO DUNEDIN; Regneri W, 2006, THESIS U SAARLANDES; Schyma C, 2000, J FORENSIC SCI, V45, P1303; Schyma C, 1999, J FORENSIC SCI, V44, P95; Schyma C, 2012, FORENSIC SCI INT, V214, P82, DOI 10.1016/j.forsciint.2011.07.021; Schyma C, 2010, RECHTSMEDIZIN, V20, P123, DOI 10.1007/s00194-009-0650-z; Schyma C, 2013, FORENSIC SCI INT-GEN, V7, P22, DOI 10.1016/j.fsigen.2012.05.008; Schyma C, 2012, INT J LEGAL MED, V126, P37, DOI 10.1007/s00414-010-0546-1; Schyma CWA, 2010, FORENSIC SCI INT, V197, P114, DOI 10.1016/j.forsciint.2010.01.002; Sellier K, 1969, SCHUSSWAFFEN SCHUSSW, P227; STONE IC, 1992, AM J FOREN MED PATH, V13, P275, DOI 10.1097/00000433-199212000-00001; STONE IC, 1987, J FORENSIC SCI, V32, P711; Taylor MC, 2011, INT J LEGAL MED, V125, P617, DOI 10.1007/s00414-010-0462-4; Verhoff MA, 2003, INT J LEGAL MED, V117, P229, DOI 10.1007/s00414-003-0383-6; Visser JM, 2003, THESIS U PRETORIA; Weimann W., 1931, Dtsch.Z.Gerichtl.Med., V17, P92; Yen K, 2003, AM J FOREN MED PATH, V24, P132, DOI 10.1097/01.paf.0000065164.92878.2f	30	20	20	0	50	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	SEP	2015	129	5					1027	1033		10.1007/s00414-015-1151-0			7	Medicine, Legal	Legal Medicine	CQ0VM	WOS:000360315900014	25616629				2021-06-18	
J	Smith, TA; Halstead, PD; McCalley, E; Kebschull, SA; Halstead, S; Killeffer, J				Smith, Terry A.; Halstead, P. David; McCalley, Elizabeth; Kebschull, Scott A.; Halstead, Scott; Killeffer, James			Angular head motion with and without head contact: implications for brain injury	SPORTS ENGINEERING			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; INTRACRANIAL-PRESSURE; PROFESSIONAL FOOTBALL; GAME IMPACTS; HIGH-SCHOOL; CONCUSSION; ACCELERATION; BIOMECHANICS; PERFORMANCE; HELMETS	Angular acceleration of the head has long been recognized as a biomechanical mechanism for traumatic brain injury. In sporting events as well as during bicycle and motorcycle accidents, this angular acceleration may occur with or without direct contact against a rigid surface. The objective of this research was to investigate the effect of combined indirect and direct loading on headform kinematic response and resulting brain injury predictors produced by finite element modeling. This was accomplished by conducting a series of guided free-fall tests that were designed to subject the headform to specific loading conditions-indirect loading (IL), direct loading (DL), and combined indirect/direct loading (IDL). Three different helmet types were selected for testing (bicycle, hockey and football). For the helmet types tested, the IDL condition resulted in significantly higher values of angular acceleration (6600-11,100 rad/s(2)), maximum principal strain (17.8-31.2), Von Mises stress (9.5-9.8 kPa), and cumulative strain damage measure at 15 % strain (2.7-7.7 %) than IL or DL alone. This trend was consistent across all helmet types and demonstrates the deleterious effects of combined loading on the brain tissue. These results also provide some insight into how seemingly similar impacts can produce substantial differences in brain injury outcome.	[Smith, Terry A.; Kebschull, Scott A.] Dynam Res Inc, Torrance, CA 90501 USA; [Halstead, P. David; McCalley, Elizabeth; Halstead, Scott] Southern Impact Res Ctr, Knoxville, TN USA; [Killeffer, James] Univ Tennessee, Med Ctr, Knoxville, TN USA	Smith, TA (corresponding author), Dynam Res Inc, Torrance, CA 90501 USA.	tas@dynres.com			National Operating Committee on Standards for Athletic Equipment (NOCSAE); Dynamic Research, Inc.	This work was supported in part by the National Operating Committee on Standards for Athletic Equipment (NOCSAE) and by Dynamic Research, Inc. The authors would like to acknowledge the contribution of Mr. Rob Roy for initial concept testing.	[Anonymous], 2013, VIRGINIA TECH HELMET; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Cantu R., 2000, NEUROLOGIC ATHLETIC; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Culver C, 1985, HYBRID, P147; Eppinger RH, 1995, STAPP CAR CRASH J, V38, P145; Fleisig GS, 1996, SPORTS MED, V21, P421, DOI 10.2165/00007256-199621060-00004; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1985, NEUROSURGERY, V2, P1531; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1961, SURG GYNECOL OBSTET, V113, P185; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; HURT HH, 1992, P ANN C ASS, P235; King A.I., 2003, IRCOBI C LISB PORT, P1; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mertz H., 1985, SAE PUBLICATION, VPT-44, P111; Mueller FO, 1977, ANN SURVEY CATASTROP; Nahum AM., 1977, P 21 STAPP CAR CRASH, P339, DOI [10.4271/770922., DOI 10.4271/770922]; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; NOCSAE, 2013, ND00111M13 NOCSAE; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 1967, P 11 STAPP CAR CRASH, P670906; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A., 2012, P IRCOBI C 2012 DUBL, P419; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Richards D, 2008, J ASTM INT, V5; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; SMITH TA, 1994, ACCIDENT ANAL PREV, V26, P795, DOI 10.1016/0001-4575(94)90055-8; Takhounts E., 2003, STAPP CAR CRASH J, V47, P107, DOI DOI 10.4271/2003-22-0007; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang L., 2003, IRCOBI C LISB PORT S, P27; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	48	20	20	0	15	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	SEP	2015	18	3					165	175		10.1007/s12283-015-0175-5			11	Sport Sciences	Sport Sciences	CY8RR	WOS:000366676500004					2021-06-18	
J	Jiang, L; Zhong, J; Dou, X; Cheng, C; Huang, Z; Sun, X				Jiang, L.; Zhong, J.; Dou, X.; Cheng, C.; Huang, Z.; Sun, X.			EFFECTS OF APOE ON INTRACELLULAR CALCIUM LEVELS AND APOPTOSIS OF NEURONS AFTER MECHANICAL INJURY	NEUROSCIENCE			English	Article						TBI; intracellular calcium level; APOE polymorphism; neuron; mechanical injury	TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E PROTECTS; THERAPEUTIC STRATEGIES; ALZHEIMERS-DISEASE; EEG ALTERATIONS; E-GENOTYPE; E4; RESPONSES; PATHOPHYSIOLOGY; ASSOCIATION	Objective: The current study aimed to explore the effects of apolipoprotein e (ApoE) on intracellular calcium ([Ca2+](i)) and apoptosis of neurons after mechanical injury in vitro. Methods: A neuron mechanical injury model was established after primary neurons obtained from APOE knockout and wild-type (WT) mice, and four experimental groups were generated: Group-ApoE4, Group-ApoE3, Group-ApoE(-) and Group-WT. Recombinant ApoE4 and ApoE3 were added to Group-ApoE4 and Group-ApoE3 respectively, and Group-ApoE(-) and Group-WT were control groups. Intracellular calcium was labeled by fluo-3/AM and examined using laser scanning confocal microscope and flow cytometry, and the apoptosis of neurons was also evaluated. Results: The intracellular calcium levels and apoptosis rates of mice neurons were significantly higher in Group-ApoE4 than in Group-ApoE3 and Group-WT after mechanical injury. However, without mechanical injury on neurons, no significant differences in intracellular calcium levels and apoptosis rates were found among all four experimental groups. The effects of ApoE4 on intracellular calcium levels and apoptosis rates of injured neurons were partly decreased by EGTA treatment. Conclusion: Compared with ApoE3-treatment and WT neurons, ApoE4 caused higher intracellular calcium levels and apoptosis rates of neurons after mechanical injury. This suggested APOE polymorphisms may affect neuron apoptosis after mechanical injury through different influences on intracellular calcium levels. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Jiang, L.; Zhong, J.; Cheng, C.; Huang, Z.; Sun, X.] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China; [Dou, X.] Chongqing Med Univ, Chongqing 400016, Peoples R China	Sun, X (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Youyi Rd, Chongqing 400016, Peoples R China.	sunxch1445@qq.com		Jiang, Li/0000-0002-2407-3672; sun, xiao chuan/0000-0001-6992-332X; Huang, Zhijian/0000-0002-8241-0761	National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30973087, 81371378]	The authors declare that they have no conflict of interest. The study was supported by National Science Foundation of China (approval number: 30973087 and 81371378).	Aono M, 2002, NEUROBIOL DIS, V11, P214, DOI 10.1006/nbdi.2002.0541; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26; Halliday MR, 2013, JAMA NEUROL, V70, P1198, DOI 10.1001/jamaneurol.2013.3841; Hiekkanen H, 2009, BRAIN INJURY, V23, P396, DOI 10.1080/02699050902926259; Houlden H, 2006, J NEUROL NEUROSUR PS, V77, P1106, DOI 10.1136/jnnp.2006.095513; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jiang L, 2011, NEUROSCI LETT, V505, P160, DOI 10.1016/j.neulet.2011.10.011; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Johnson JE, 2007, MOL VIS, V13, P887; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Ponomareva NV, 2008, NEUROBIOL AGING, V29, P819, DOI 10.1016/j.neurobiolaging.2006.12.019; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; Rice DS, 1998, DEVELOPMENT, V125, P3719; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Veinbergs I, 2002, J NEUROSCI RES, V67, P379, DOI 10.1002/jnr.10138; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; YASUDA T, 1993, PEDIATR NEUROSURG, V19, P21, DOI 10.1159/000120695; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zhou S, 2013, FEBS LETT, V587, P254, DOI 10.1016/j.febslet.2012.12.003; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152	34	20	22	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 20	2015	301						375	383		10.1016/j.neuroscience.2015.06.005			9	Neurosciences	Neurosciences & Neurology	CM7MO	WOS:000357877800033	26073697				2021-06-18	
J	Da Pozzo, E; Giacomelli, C; Barresi, E; Costa, B; Taliani, S; Passetti, FD; Martini, C				Da Pozzo, Eleonora; Giacomelli, Chiara; Barresi, Elisabetta; Costa, Barbara; Taliani, Sabrina; Passetti, Federico Da Settimo; Martini, Claudia			Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection	BIOCHEMICAL SOCIETY TRANSACTIONS			English	Article						central nervous system diseases; neurodegeneration; neuro-inflammation; neurotrauma; translocator protein; translocator protein (TSPO) ligand	18 KDA TSPO; BENZODIAZEPINE-RECEPTOR-LIGAND; POSITRON-EMISSION-TOMOGRAPHY; MICROGLIAL ACTIVATION; SUBCELLULAR LOCATIONS; THERAPEUTIC TARGET; BINDING-SITES; MOUSE MODEL; BRAIN; NEUROINFLAMMATION	The translocator protein (TSPO, 18 kDa), mainly localized in the outer mitochondrial membrane of steroidogenic tissues, is involved in several cellular functions. TSPO level alterations have been reported in a number of human disorders, particularly in cancer, psychiatric and neurological diseases. In the central nervous system (CNS), TSPO is usually expressed in glial cells, but also in some neuronal cell types. Interestingly, the expression of TSPO on glial cells rises after brain injury and increased TSPO expression is often observed in neurological disorders, gliomas, encephalitis and traumatic injury. Since TSPO is up-regulated in brain diseases, several structurally different classes of ligands targeting TSPO have been described as potential diagnostic or therapeutic agents. Recent researches have reported that TSPO ligands might be valuable in the treatment of brain diseases. This review focuses on currently available TSPO ligands, as useful tools for the treatment of neurodegeneration, neuro-inflammation and neurotrauma.	[Da Pozzo, Eleonora; Giacomelli, Chiara; Barresi, Elisabetta; Costa, Barbara; Taliani, Sabrina; Passetti, Federico Da Settimo; Martini, Claudia] Univ Pisa, Dept Pharm, I-56126 Pisa, Italy	Martini, C (corresponding author), Univ Pisa, Dept Pharm, Via Bonanno 6, I-56126 Pisa, Italy.	claudia.martini@unipi.it	TALIANI, SABRINA/AAO-7850-2020; Martini, Claudia/AAC-4089-2019; Giacomelli, Chiara/K-4954-2016; Da Pozzo, Eleonora/AAW-8186-2020; Da Pozzo, Eleonora/M-2215-2015; DA SETTIMO PASSETTI, FEDERICO/M-1451-2015	Martini, Claudia/0000-0001-9379-3027; Giacomelli, Chiara/0000-0002-6244-602X; Da Pozzo, Eleonora/0000-0003-4762-8949; Da Pozzo, Eleonora/0000-0003-4762-8949; Barresi, Elisabetta/0000-0002-9814-7195; TALIANI, SABRINA/0000-0001-8675-939X; DA SETTIMO PASSETTI, FEDERICO/0000-0002-7897-7917	Italian Ministry of University and Scientific ResearchMinistry of Education, Universities and Research (MIUR)	This research was supported by the Italian Ministry of University and Scientific Research (FIRB 2010, PRIN 2010-2011).	Bae KR, 2014, J NEUROIMMUNE PHARM, V9, P424, DOI 10.1007/s11481-014-9540-6; Bailey SL, 2006, CRIT REV IMMUNOL, V26, P149, DOI 10.1615/CritRevImmunol.v26.i2.40; Banati R. B., 2013, WO, Patent No. [2,014,138,791, 2014138791]; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Barron AM, 2013, J NEUROSCI, V33, P8891, DOI 10.1523/JNEUROSCI.1350-13.2013; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; BENAVIDES J, 1987, BRAIN RES, V421, P167, DOI 10.1016/0006-8993(87)91287-X; Bordet T, 2007, J PHARMACOL EXP THER, V322, P709, DOI 10.1124/jpet.107.123000; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x; Choi HB, 2002, J NEUROCHEM, V83, P546, DOI 10.1046/j.1471-4159.2002.01122.x; Choi J, 2011, GLIA, V59, P219, DOI 10.1002/glia.21091; Corbett D, 2008, EXP NEUROL, V214, P309, DOI 10.1016/j.expneurol.2008.08.018; Da Pozzo E, 2012, CURR MOL MED, V12, P426; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; Domazet-Loso T, 2008, MOL BIOL EVOL, V25, P2699, DOI 10.1093/molbev/msn214; Ferzaz B, 2002, J PHARMACOL EXP THER, V301, P1067, DOI 10.1124/jpet.301.3.1067; Girard C, 2012, J NEUROENDOCRINOL, V24, P71, DOI 10.1111/j.1365-2826.2011.02215.x; Girard C, 2008, P NATL ACAD SCI USA, V105, P20505, DOI 10.1073/pnas.0811201106; Hong SH, 2006, J NEUROSCI RES, V83, P1293, DOI 10.1002/jnr.20829; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Leaver KR, 2012, ACS CHEM NEUROSCI, V3, P114, DOI 10.1021/cn200099e; Lenglet T, 2014, EUR J NEUROL, V21, P529, DOI 10.1111/ene.12344; Morohaku K, 2014, ENDOCRINOLOGY, V155, P89, DOI 10.1210/en.2013-1556; Naseem Mehar, 2014, SCI WORLD J; OBEIRNE GB, 1990, EUR J BIOCHEM, V188, P131, DOI 10.1111/j.1432-1033.1990.tb15380.x; OLSON JMM, 1988, EUR J PHARMACOL, V152, P47, DOI 10.1016/0014-2999(88)90834-5; Owen DRJ, 2011, INT REV NEUROBIOL, V101, P19, DOI 10.1016/B978-0-12-387718-5.00002-X; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Ryu JK, 2005, NEUROBIOL DIS, V20, P550, DOI 10.1016/j.nbd.2005.04.010; Sarnowska A, 2009, NEUROCHEM INT, V55, P164, DOI 10.1016/j.neuint.2009.01.024; Sileikyte J, 2014, J BIOL CHEM, V289, P13769, DOI 10.1074/jbc.M114.549634; Soustiel JF, 2008, EXP NEUROL, V214, P201, DOI 10.1016/j.expneurol.2008.08.008; Stocco DM, 2014, ENDOCRINOLOGY, V155, P6, DOI 10.1210/en.2013-2041; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Sunyach C, 2012, NEUROPHARMACOLOGY, V62, P2346, DOI 10.1016/j.neuropharm.2012.02.013; Taliani S, 2011, CURR TOP MED CHEM, V11, P860, DOI 10.2174/156802611795165142; Tarnok K, 2008, NEUROCHEM INT, V53, P289, DOI 10.1016/j.neuint.2008.08.003; Trapani A, 2013, BIOCONJUGATE CHEM, V24, P1415, DOI 10.1021/bc300666f; Tu LN, 2014, J BIOL CHEM, V289, P27444, DOI 10.1074/jbc.M114.578286; Veiga S, 2005, J NEUROSCI RES, V80, P129, DOI 10.1002/jnr.20430; Veiga S, 2007, GLIA, V55, P1426, DOI 10.1002/glia.20558; Wilms H, 2003, NEUROBIOL DIS, V14, P417, DOI 10.1016/j.nbd.2003.07.002; Woods MJ, 1996, BIOCHEM PHARMACOL, V51, P1283, DOI 10.1016/0006-2952(96)00034-2; Zhao Yan-Yin, 2011, Neuron Glia Biol, V7, P187, DOI 10.1017/S1740925X12000129; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	50	20	20	0	12	PORTLAND PRESS LTD	LONDON	5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND	0300-5127	1470-8752		BIOCHEM SOC T	Biochem. Soc. Trans.	AUG	2015	43		4				559	565		10.1042/BST20150028			7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CO2QJ	WOS:000359001400005	26551693				2021-06-18	
J	Zhai, PP; Xu, LH; Yang, JJ; Jiang, ZL; Zhao, GW; Sun, L; Wang, GH; Li, X				Zhai, Pei-Pei; Xu, Li-Hua; Yang, Juan-Juan; Jiang, Zheng-Lin; Zhao, Guang-Wei; Sun, Li; Wang, Guo-Hua; Li, Xia			Reduction of inflammatory responses by L-serine treatment leads to neuroprotection in mice after traumatic brain injury	NEUROPHARMACOLOGY			English	Article						L-serine; Mouse; Traumatic brain injury; Neuroprotection; Inflammatory response; Glycine receptor	SENSITIVE GLYCINE RECEPTORS; GATED CHLORIDE CURRENT; CLOSED-HEAD INJURY; RAT-BRAIN; HYPOTHALAMIC NEURONS; NUCLEUS-ACCUMBENS; TRANSGENIC MICE; CEREBRAL-CORTEX; CELL-DEATH; EXPRESSION	This study was designed to evaluate the neuroprotective effect of L-serine and the underlying mechanisms in mice after traumatic brain injury (TBI) induced using a weight drop model. The mice were intraperitoneally injected with L-serine 3 h after TBI and then injected twice each day for 7 days or until the end of the experiment. The neurological severity score, brain water content, lesion volume, and neurone loss were determined. The levels of TNF-alpha, IL-1 beta, IL-6, and IL-10 and the number of GFAP- and Iba-1-positive cells and activated caspase-3-positive neurones in the brain tissue ipsilateral to TBI were also measured. Simultaneously, the influences of L-serine on these variables were observed. In addition, the expression of glycine receptors and L-serine-induced currents were measured. We found L-serine treatment: 1) decreased the neurological deficit score, brain water content, lesion volume, and neurone loss; 2) inhibited activated caspase-3; and 3) reduced the levels of TNF-alpha, IL-1 beta and IL-6 and the number of GFAP- and Iba-1-positive cells. The effects of L-serine were antagonised by the administration of strychnine, an antagonist of glycine receptors. In addition, we found that glycine receptors were expressed mainly in the cortical neurones but less in the astrocytes or microglial cells, and L-serine activated these receptors and induced strychnine-sensitive currents in these neurones. In conclusion, L-serine induces the activation of glycine receptors, which alleviates neuronal excitotoxicity, a secondary brain injury process, thereby reduces the activation of astrocytes and microglial cells and secretion of proinflammatory cytokines and inhibits neuronal apoptosis. Thus, L-serine treatment leads to neuroprotection of brain tissue through reducing inflammatory responses and improves recovery of the neurological functions in mice after traumatic brain injury. (C) 2015 Elsevier Ltd. All rights reserved.	[Jiang, Zheng-Lin] Nantong Univ, Inst Naut Med, Dept Neurophysiol & Neuropharmacol, Nantong 226001, Jiangsu, Peoples R China; Nantong Univ, Co Innovat Ctr Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China	Jiang, ZL (corresponding author), Nantong Univ, Inst Naut Med, Dept Neurophysiol & Neuropharmacol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	jiangzl@ntu.edu.cn		Jiang, Zheng-Lin/0000-0002-7134-5511	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000497, 81071614, 81372131]; Administration of Science and Technology of Nantong, Jiangsu, China [BK2012086]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Project for Innovation Development of Graduate Student of Nantong University	This work was supported partly by grants from the National Natural Science Foundation of China (81000497, 81071614 and 81372131) and from the Administration of Science and Technology of Nantong, Jiangsu, China (BK2012086), by project funding from the Priority Academic Program Development of Jiangsu Higher Education Institutions, and by the Project for Innovation Development of Graduate Student of Nantong University.	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; AKAIKE N, 1989, J NEUROPHYSIOL, V62, P1400; Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; BALDWIN HA, 1994, BRIT J PHARMACOL, V112, P188, DOI 10.1111/j.1476-5381.1994.tb13050.x; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; BETZ H, 1991, TRENDS NEUROSCI, V14, P458, DOI 10.1016/0166-2236(91)90045-V; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Chattipakorn SC, 2002, J NEUROPHYSIOL, V87, P1515, DOI 10.1152/jn.00365.2001; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; de Koning TJ, 2004, CURR OPIN NEUROL, V17, P197, DOI 10.1097/00019052-200404000-00019; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Freire MAM, 2012, W INDIAN MED J, V61, P751; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Jiang ZL, 2004, J NEUROPHYSIOL, V91, P248, DOI 10.1152/jn.00106.2003; KANTHAN R, 1995, STROKE, V26, P870, DOI 10.1161/01.STR.26.5.870; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kilb W, 2002, NEUROSCIENCE, V112, P299, DOI 10.1016/S0306-4522(02)00071-4; KRISHTAL OA, 1988, NEUROSCI LETT, V84, P271, DOI 10.1016/0304-3940(88)90519-8; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; Martin G, 2002, J PHARMACOL EXP THER, V302, P1135, DOI 10.1124/jpet.102.033399; McCool BA, 2000, BRAIN RES, V859, P341, DOI 10.1016/S0006-8993(00)02026-6; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mori M, 2002, J PHYSIOL-LONDON, V539, P191, DOI 10.1113/jphysiol.2001.013147; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rampon C, 1996, NEUROSCIENCE, V75, P737, DOI 10.1016/0306-4522(96)00278-3; Ren TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067044; Rubio-Perez Jose Miguel, 2012, ScientificWorldJournal, V2012, P756357, DOI 10.1100/2012/756357; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Sergeeva OA, 1998, NEUROSCI LETT, V243, P9, DOI 10.1016/S0304-3940(98)00072-X; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093405; TOKUTOMI N, 1989, BRIT J PHARMACOL, V97, P353, DOI 10.1111/j.1476-5381.1989.tb11961.x; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang GH, 2010, J NEUROSCI RES, V88, P2035, DOI 10.1002/jnr.22365; Xia L, 2012, J NEUROSCI RES, V90, P1424, DOI 10.1002/jnr.22811; Ye JH, 1996, BRAIN RES, V735, P20; Ye JH, 1999, J PHARMACOL EXP THER, V290, P104; Ye JH, 1998, BRAIN RES, V796, P53, DOI 10.1016/S0006-8993(98)00317-5; Zhang XJ, 2006, NEUROL INDIA, V54, P402; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	62	20	21	3	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	AUG	2015	95						1	11		10.1016/j.neuropharm.2015.02.026			11	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	CM0DR	WOS:000357349100001	25747604				2021-06-18	
J	Jimenez, N; Osorio, M; Ramos, JL; Apkon, S; Ebel, BE; Rivara, FP				Jimenez, Nathalia; Osorio, Marisa; Ramos, Jessica L.; Apkon, Susan; Ebel, Beth E.; Rivara, Frederick P.			Functional Independence After Inpatient Rehabilitation for Traumatic Brain Injury Among Minority Children and Adolescents	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Minority groups; Outcome; Rehabilitation	OUTCOMES; CARE; REGISTRY; QUALITY; TBI	Objective: To compare motor and cognitive functional independence scores between Hispanic, non-Hispanic black (NEB), and non-Hispanic white (NHW) children with traumatic brain injury (TBI) after discharge from inpatient rehabilitation. Design: Retrospective cohort study using the Uniform Data System for Medical Rehabilitation national dataset from the years 2002 to 2012. Setting: Inpatient rehabilitation units. Participants: Children (N=10,141) aged 6 months to 18 years who received inpatient rehabilitation for TBI. Interventions: Not applicable. Main Outcome Measures: Motor and cognitive functional independence after discharge from inpatient rehabilitation, adjusting for age, sex, admission function, length of stay, insurance, and region. Results: Inpatient rehabilitation therapy improved functional independence for all children. Younger age, lower admission functional independence scores, and Medicaid insurance were associated with lower functional independence at discharge. Hispanic and NHB children had lower discharge cognitive scores compared with NHW children; however, differences were small and were partially explained by insurance status and region. Children who received rehabilitation therapy at pediatric facilities had greater cognitive improvement. Conclusions: While racial/ethnic disparities are small, minority children are more likely to be younger, to have Medicaid, and to be cared for at nonpediatric facilities, factors that increase their risk for lower functional outcomes. (C) 2015 by the American Congress of Rehabilitation Medicine	[Jimenez, Nathalia] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Jimenez, Nathalia; Ebel, Beth E.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Osorio, Marisa; Apkon, Susan] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Ramos, Jessica L.; Ebel, Beth E.] Seattle Childrens Hosp, Ctr Divers & Hlth Equ, Seattle, WA USA; [Ebel, Beth E.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Ebel, Beth E.; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Jimenez, N (corresponding author), Dept Anesthesiol & Pain Med, Box 9824,4800 Sand Point Way NE, Seattle, WA 98105 USA.	nathalia.jimenez@seattlechildrens.org		Jimenez, Nathalia/0000-0002-6785-8330	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K23HDO7843-01]; National Center for Injury Prevention and Control, Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CE 001021]; Seattle Children's Hospital Center for Diversity and Health Equity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078453] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001021] Funding Source: NIH RePORTER	Supported by the National Institute of Child Health and Human Development (grant no. 1K23HDO7843-01), the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (grant no. R49 CE 001021), and Seattle Children's Hospital Center for Diversity and Health Equity.	Austin CA, 2013, BRAIN INJURY, V27, P1056, DOI 10.3109/02699052.2013.794964; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Stallion A, 2007, J TRAUMA, V62, P1262; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Swaine BR, 2000, AM J PHYS MED REHAB, V79, P412, DOI 10.1097/00002060-200009000-00002; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	13	20	20	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2015	96	7					1255	1261		10.1016/j.apmr.2015.02.019			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CM5XN	WOS:000357762400010	25747552	Green Accepted			2021-06-18	
J	MacDonald, J; Duerson, D				MacDonald, James; Duerson, Drew			Reliability of a Computerized Neurocognitive Test in Baseline Concussion Testing of High School Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						AxonSports; computerized cognitive assessment tool; intraclass correlation coefficient; psychometrics	SPORT-RELATED CONCUSSION; RETEST RELIABILITY; PERFORMANCE; MANAGEMENT; AGE; ADOLESCENTS; STATEMENT; CHILDREN; BATTERY	Objective:Baseline assessments using computerized neurocognitive tests are frequently used in the management of sport-related concussions. Such testing is often done on an annual basis in a community setting. Reliability is a fundamental test characteristic that should be established for such tests. Our study examined the test-retest reliability of a computerized neurocognitive test in high school athletes over 1 year.Design:Repeated measures design.Setting:Two American high schools.Participants:High school athletes (N = 117) participating in American football or soccer during the 2011-2012 and 2012-2013 academic years.Interventions:All study participants completed 2 baseline computerized neurocognitive tests taken 1 year apart at their respective schools. The test measures performance on 4 cognitive tasks: identification speed (Attention), detection speed (Processing Speed), one card learning accuracy (Learning), and one back speed (Working Memory).Main Outcome Measures:Reliability was assessed by measuring the intraclass correlation coefficient (ICC) between the repeated measures of the 4 cognitive tasks. Pearson and Spearman correlation coefficients were calculated as a secondary outcome measure.Results:The measure for identification speed performed best (ICC = 0.672; 95% confidence interval, 0.559-0.760) and the measure for one card learning accuracy performed worst (ICC = 0.401; 95% confidence interval, 0.237-0.542). All tests had marginal or low reliability.Conclusions:In a population of high school athletes, computerized neurocognitive testing performed in a community setting demonstrated low to marginal test-retest reliability on baseline assessments 1 year apart. Further investigation should focus on (1) improving the reliability of individual tasks tested, (2) controlling for external factors that might affect test performance, and (3) identifying the ideal time interval to repeat baseline testing in high school athletes.Clinical Relevance:Computerized neurocognitive tests are used frequently in high school athletes, often within a model of baseline testing of asymptomatic individuals before the start of a sporting season. This study adds to the evidence that suggests in this population such testing may lack sufficient reliability to support clinical decision making.	[MacDonald, James; Duerson, Drew] Nationwide Childrens Hosp, Dept Pediat, Div Sports Med, Columbus, OH USA; [MacDonald, James] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	MacDonald, J (corresponding author), Nationwide Childrens Hosp, Dept Pediat, Div Sports Med, 5680 Venture Dr, Dublin, OH 43017 USA.	james.macdonald@nationwidechildrens.org	Macdonald, James/C-4701-2012	MacDonald, James/0000-0002-0432-0808	American Medical Society for Sports Medicine	Dr. MacDonald is supported in his research through an American Medical Society for Sports Medicine "Young Investigator" Grant.	Anastasi A., 1998, PSYCHOL TESTING; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Centers for Disease Control and Prevention, FAQS BAS TEST YOUNG; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Darby D, VALIDITY AXON SPORTS; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; MacDonald J, 2012, CLIN J SPORT MED, V22, P187; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mc Dowell I., 2006, MEASURING HLTH GUIDE, V3rd; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	30	20	20	0	38	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2015	25	4					367	372		10.1097/JSM.0000000000000139			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	CM2EK	WOS:000357492400010	25061807				2021-06-18	
J	Tritos, NA; Yuen, KCJ; Kelly, DF				Tritos, Nicholas A.; Yuen, Kevin C. J.; Kelly, Daniel F.		AACE Neuroendocrine Pituitary Sci	AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: A NEUROENDOCRINE APPROACH TO PATIENTS WITH TRAUMATIC BRAIN INJURY	ENDOCRINE PRACTICE			English	Article							GROWTH-HORMONE REPLACEMENT; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY DYSFUNCTION; QUALITY-OF-LIFE; DIABETES-INSIPIDUS; UNITED-STATES; HYPOTHALAMOPITUITARY DYSFUNCTION; TESTOSTERONE THERAPY; LONG-TERM; HYPOPITUITARISM	Objective: Traumatic brain injury (TBI) is now recognized as a major public health concern in the United States and is associated with substantial morbidity and mortality in both children and adults. Several lines of evidence indicate that TBI-induced hypopituitarism is not infrequent in TBI survivors and may contribute to the burden of illness in this population. The goal of this article is to review the published data and propose an approach for the neuroendocrine evaluation and management of these patients. Methods: To identify pertinent articles, electronic literature searches were conducted using the following keywords: "traumatic brain injury," "pituitary," "hypopituitarism," "growth hormone deficiency," "hypogonadism," "hypoadrenalism," and "hypothyroidism." Relevant articles were identified and considered for inclusion in the present article. Results: TBI-induced hypopituitarism appears to be more common in patients with severe TBI. However, patients with mild TBI or those with repeated, sports-, or blast-related TBI are also at risk for hypopituitarism. Deficiencies of growth hormone and gonadotropins appear to be most common and have been associated with increased morbidity in this population. A systematic approach is advised in order to establish the presence of pituitary hormone deficiencies and implement appropriate replacement therapies. Conclusion: The presence of traumatic hypopituitarism should be considered during the acute phase as well as during the rehabilitation phase of patients with TBI. All patients with moderate to severe TBI require evaluation of pituitary function. In addition, symptomatic patients with mild TBI and impaired quality of life are at risk for hypopituitarism and should be offered neuroendocrine testing.	[Tritos, Nicholas A.] Massachusetts Gen Hosp, Neuroendocrine Unit, Zero Emerson Pl,Suite 112, Boston, MA 02114 USA; [Tritos, Nicholas A.] Harvard Univ, Sch Med, Boston, MA USA; [Yuen, Kevin C. J.] Swedish Neurosci Inst, Swedish Pituitary Ctr, Seattle, WA USA; [Kelly, Daniel F.] St Johns Brain Tumor Ctr, Santa Monica, CA USA; [Kelly, Daniel F.] Pituitary Disorders Program, Santa Monica, CA USA; [Kelly, Daniel F.] John Wayne Canc Inst, Santa Monica, CA USA	Tritos, NA (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, Zero Emerson Pl,Suite 112, Boston, MA 02114 USA.	ntritos@partners.org	Tritos, Nicholas/W-1594-2019	Tritos, Nicholas/0000-0001-8867-607X	IpsenIpsen; PfizerPfizer; Novo NordiskNovo Nordisk	Dr. Tritos has received research support from Ipsen, Pfizer, and Novo Nordisk. The other authors have no multiplicity of interest to disclose.	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Bhagia V, 2010, BRAIN INJURY, V24, P560, DOI 10.3109/02699051003601705; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Cegla J, 2013, CLIN ENDOCRINOL, V78, P738, DOI 10.1111/cen.12043; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cook DM, 2012, PITUITARY, V15, P301, DOI 10.1007/s11102-011-0372-6; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Devin JK, 2012, NEUROSURG CLIN N AM, V23, P679, DOI 10.1016/j.nec.2012.06.001; Dichtel LE, 2014, J CLIN ENDOCR METAB, V99, P4712, DOI 10.1210/jc.2014-2830; Dusick JR, 2012, PITUITARY, V15, P2, DOI 10.1007/s11102-008-0130-6; Estes Susie M, 2005, Pituitary, V8, P267, DOI 10.1007/s11102-006-6053-1; Farwell AP, 2013, CURR OPIN ENDOCRINOL, V20, P478, DOI 10.1097/01.med.0000433069.09294.e8; Fenske W, 2012, J CLIN ENDOCR METAB, V97, P3426, DOI 10.1210/jc.2012-1981; Fenske W, 2011, J CLIN ENDOCR METAB, V96, P1506, DOI 10.1210/jc.2010-2345; Fenske WK, 2014, J AM SOC NEPHROL, V25, P2376, DOI 10.1681/ASN.2013080895; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Garcia JM, 2013, J CLIN ENDOCR METAB, V98, P2422, DOI 10.1210/jc.2013-1157; Guerrero AF, 2010, MIL MED, V175, P574, DOI 10.7205/MILMED-D-09-00189; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; Hannon MJ, 2012, J CLIN ENDOCR METAB, V97, P1423, DOI 10.1210/jc.2011-3201; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2008, PITUITARY, V11, P255, DOI 10.1007/s11102-008-0102-x; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Lauzier F, 2014, CRIT CARE MED, V42, P712, DOI 10.1097/CCM.0000000000000046; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marko NF, 2010, PITUITARY, V13, P249, DOI 10.1007/s11102-010-0227-6; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Personnier C, 2014, J CLIN ENDOCR METAB, V99, P2052, DOI 10.1210/jc.2013-4129; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; SNOW K, 1992, MAYO CLIN PROC, V67, P1055, DOI 10.1016/S0025-6196(12)61120-3; Tanriverdi F, 2008, J NEUROTRAUM, V25, P1071, DOI 10.1089/neu.2007.0456; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Toogood AA, 2008, ENDOCRIN METAB CLIN, V37, P235, DOI 10.1016/j.ecl.2007.10.004; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Wilkinson Charles W, 2012, Front Neurol, V3, P11, DOI 10.3389/fneur.2012.00011; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	56	20	21	0	6	AMER ASSOC CLINICAL ENDOCRINOLOGISTS	JACKSONVILLE	245 RIVERSIDE AVENUE, STE 200, JACKSONVILLE, FL 32202 USA	1530-891X	1934-2403		ENDOCR PRACT	Endocr. Pract.	JUL	2015	21	7					823	831		10.4158/EP14567.DSCR			9	Endocrinology & Metabolism	Endocrinology & Metabolism	DO7LQ	WOS:000377964500014	26172127				2021-06-18	
J	Mwanga-Amumpaire, J; Carroll, RW; Baudin, E; Kemigisha, E; Nampijja, D; Mworozi, K; Santorino, D; Nyehangane, D; Nathan, DI; De Beaudrap, P; Etard, JF; Feelisch, M; Fernandez, BO; Berssenbrugge, A; Bangsberg, D; Bloch, KD; Boum, Y; Zapol, WM				Mwanga-Amumpaire, Juliet; Carroll, Ryan W.; Baudin, Elisabeth; Kemigisha, Elisabeth; Nampijja, Dorah; Mworozi, Kenneth; Santorino, Data; Nyehangane, Dan; Nathan, Daniel I.; De Beaudrap, Pierre; Etard, Jean-Franois; Feelisch, Martin; Fernandez, Bernadette O.; Berssenbrugge, Annie; Bangsberg, David; Bloch, Kenneth D.; Boum, Yap, II; Zapol, Warren M.			Inhaled Nitric Oxide as an Adjunctive Treatment for Cerebral Malaria in Children: A Phase II Randomized Open-Label Clinical Trial	OPEN FORUM INFECTIOUS DISEASES			English	Article						cerebral malaria; methemoglobin; nitric oxide; Plasmodium falciparum	TRAUMATIC BRAIN-INJURY; SEVERE FALCIPARUM-MALARIA; ENDOTHELIAL DYSFUNCTION; UNCOMPLICATED MALARIA; CEREBROSPINAL-FLUID; AFRICAN CHILDREN; KENYAN CHILDREN; INHALATION; MARKERS; HUMANS	Background. Children with cerebral malaria (CM) have high rates of mortality and neurologic sequelae. Nitric oxide (NO) metabolite levels in plasma and urine are reduced in CM. Methods. This randomized trial assessed the efficacy of inhaled NO versus nitrogen (N-2) as an adjunctive treatment for CM patients receiving intravenous artesunate. We hypothesized that patients treated with NO would have a greater increase of the malaria biomarker, plasma angiopoietin-1 (Ang-1) after 48 hours of treatment. Results. Ninety-two children with CM were randomized to receive either inhaled 80 part per million NO or N-2 for 48 or more hours. Plasma Ang-1 levels increased in both treatment groups, but there was no difference between the groups at 48 hours (P = not significant [NS]). Plasma Ang-2 and cytokine levels (tumor necrosis factor-alpha, interferon-., interleukin [IL]-1 beta, IL-6, IL-10, and monocyte chemoattractant protein-1) decreased between inclusion and 48 hours in both treatment groups, but there was no difference between the groups (P = NS). Nitric oxide metabolite levels-blood methemoglobin and plasma nitrate-increased in patients treated with NO (both P<.05). Seven patients in the N-2 group and 4 patients in the NO group died. Five patients in the N-2 group and 6 in the NO group had neurological sequelae at hospital discharge. Conclusions. Breathing NO as an adjunctive treatment for CM for a minimum of 48 hours was safe, increased blood methemoglobin and plasma nitrate levels, but did not result in a greater increase of plasma Ang-1 levels at 48 hours.	[Mwanga-Amumpaire, Juliet; Kemigisha, Elisabeth; Mworozi, Kenneth; Nyehangane, Dan; Boum, Yap, II] Epictr Mbarara Res Ctr, Mbarara, Uganda; [Mwanga-Amumpaire, Juliet; Nampijja, Dorah; Santorino, Data; Boum, Yap, II] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Carroll, Ryan W.; Nathan, Daniel I.; Bloch, Kenneth D.; Zapol, Warren M.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St,Thier Bldg,Floor 5, Boston, MA 02114 USA; [Carroll, Ryan W.; Bangsberg, David] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Dept Med, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Carroll, Ryan W.] MassGen Hosp Children, Pediat Crit Care Med, Boston, MA USA; [Baudin, Elisabeth; Etard, Jean-Franois] Epictr, Paris, France; [De Beaudrap, Pierre; Etard, Jean-Franois] Univ Montpellier I, Inst Rech Dev, UMI 233, F-34006 Montpellier, France; [Feelisch, Martin; Fernandez, Bernadette O.] Univ Southampton, Southampton SO9 5NH, Hants, England; [Berssenbrugge, Annie] Ikaria, Clinton, NJ USA; [Carroll, Ryan W.; Bangsberg, David; Bloch, Kenneth D.; Zapol, Warren M.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Carroll, RW (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St,Thier Bldg,Floor 5, Boston, MA 02114 USA.	rcarroll4@mgh.harvard.edu	De Beaudrap, Pierre/K-3113-2017; Etard, Jean Francois/A-9630-2008; Etard, Jean-Francois/V-4865-2019; Feelisch, Martin/C-3042-2008; Fernandez, Bernadette/AAG-7202-2020	De Beaudrap, Pierre/0000-0002-9037-6057; Etard, Jean Francois/0000-0002-4873-0788; Etard, Jean-Francois/0000-0002-4873-0788; Feelisch, Martin/0000-0003-2320-1158; Fernandez, Bernadette/0000-0001-6337-0381			Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; FROSTELL C, 1991, CIRCULATION, V83, P2038, DOI 10.1161/01.CIR.83.6.2038; Gianetti J, 2004, J THORAC CARDIOV SUR, V127, P44, DOI 10.1016/j.jtcvs.2002.08.001; Gladwin MT, 2011, JAMA-J AM MED ASSOC, V305, P893, DOI 10.1001/jama.2011.235; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P11482, DOI 10.1073/pnas.97.21.11482; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Gries A, 2000, THROMB HAEMOSTASIS, V83, P309; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Janka JJ, 2010, J INFECT DIS, V202, P791, DOI 10.1086/655225; Kinsella JR, 2006, CURR OPIN PEDIATR, V18, P107, DOI 10.1097/01.mop.0000193291.09894.6c; Kinsella JP, 1997, SEMIN PERINATOL, V21, P418, DOI 10.1016/S0146-0005(97)80007-9; Krishna S, 2012, CURR OPIN INFECT DIS, V25, P484, DOI 10.1097/QCO.0b013e3283567b20; Lang JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086053; Li YS, 2013, BRAIN RES, V1507, P134, DOI 10.1016/j.brainres.2013.02.031; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Mathru M, 2007, ANESTHESIOLOGY, V106, P275, DOI 10.1097/00000542-200702000-00015; Medana IM, 2005, T ROY SOC TROP MED H, V99, P610, DOI 10.1016/j.trstmh.2004.11.017; Medana IM, 2007, J NEUROL SCI, V258, P93, DOI 10.1016/j.jns.2007.03.005; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; MOLYNEUX ME, 1989, Q J MED, V71, P441; Nagasaka Y, 2008, ANESTHESIOLOGY, V109, P675, DOI 10.1097/ALN.0b013e318186316e; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Postels DG, 2012, NEUROLOGY, V79, P1268, DOI 10.1212/WNL.0b013e31826aacd4; Roberts JD, 1997, NEW ENGL J MED, V336, P605, DOI 10.1056/NEJM199702273360902; Serghides L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027714; Stammet P, 2013, J AM COLL CARDIOL, V62, P851, DOI 10.1016/j.jacc.2013.04.039; Stork E, 1997, NEW ENGL J MED, V336, P597; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2012, CIRC RES, V110, P727, DOI 10.1161/CIRCRESAHA.111.253419; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Wraight WM, 2001, BRIT J ANAESTH, V86, P267, DOI 10.1093/bja/86.2.267; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641	38	20	21	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2328-8957			OPEN FORUM INFECT DI	Open Forum Infect. Dis.	SUM	2015	2	3								10.1093/ofid/ofv111			9	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CX6BP	WOS:000365786500027	26309894	DOAJ Gold, Green Published			2021-06-18	
J	Boone, DR; Micci, MA; Taglialatela, IG; Hellmich, JL; Weisz, HA; Bi, M; Prough, DS; DeWitt, DS; Hellmich, HL				Boone, Deborah R.; Micci, Maria-Adelaide; Taglialatela, Isabella G.; Hellmich, Judy L.; Weisz, Harris A.; Bi, Min; Prough, Donald S.; DeWitt, Douglas S.; Hellmich, Helen L.			Pathway-Focused PCR Array Profiling of Enriched Populations of Laser Capture Microdissected Hippocampal Cells after Traumatic Brain Injury	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; FLUORO-JADE; ACTIVATION; NEUROPROTECTION; PROTEIN; DEATH; REPRODUCIBILITY; MODULATION; MECHANISMS	Cognitive deficits in survivors of traumatic brain injury (TBI) are associated with irreversible neurodegeneration in brain regions such as the hippocampus. Comparative gene expression analysis of dying and surviving neurons could provide insight into potential therapeutic targets. We used two pathway-specific PCR arrays (RT2 Profiler Apoptosis and Neurotrophins & Receptors PCR arrays) to identify and validate TBI-induced gene expression in dying (Fluoro-Jade-positive) or surviving (Fluoro-Jade-negative) pyramidal neurons obtained by laser capture microdissection (LCM). In the Apoptosis PCR array, dying neurons showed significant increases in expression of genes associated with cell death, inflammation, and endoplasmic reticulum (ER) stress compared with adjacent, surviving neurons. Pro-survival genes with pleiotropic functions were also significantly increased in dying neurons compared to surviving neurons, suggesting that even irreversibly injured neurons are able to mount a protective response. In the Neurotrophins & Receptors PCR array, which consists of genes that are normally expected to be expressed in both groups of hippocampal neurons, only a few genes were expressed at significantly different levels between dying and surviving neurons. Immunohistochemical analysis of selected, differentially expressed proteins supported the gene expression data. This is the first demonstration of pathway-focused PCR array profiling of identified populations of dying and surviving neurons in the brain after TBI. Combining precise laser microdissection of identifiable cells with pathway-focused PCR array analysis is a practical, low-cost alternative to microarrays that provided insight into neuroprotective signals that could be therapeutically targeted to ameliorate TBI-induced neurodegeneration.	[Boone, Deborah R.; Micci, Maria-Adelaide; Taglialatela, Isabella G.; Hellmich, Judy L.; Weisz, Harris A.; Bi, Min; Prough, Donald S.; DeWitt, Douglas S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	department of Anesthesiology (UTMB); Moody Foundation;  [RO1 NS052532]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052532] Funding Source: NIH RePORTER	This work was supported by RO1 NS052532 (HLH), and in part by the department of Anesthesiology (UTMB) and a Moody Foundation grant to DSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen Kristina E, 2011, BMC Res Notes, V4, P69, DOI 10.1186/1756-0500-4-69; Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Asztalos S, 2010, CANCER PREV RES, V3, P301, DOI 10.1158/1940-6207.CAPR-09-0069; Boone DR, 2013, JOVE-J VIS EXP, DOI 10.3791/50308; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Brain Trauma Foundation AAoNSCoNSJSoNaCC, 2003, GUID MAN SEV TRAUM B; Cao GD, 2002, J CEREBR BLOOD F MET, V22, P534, DOI 10.1097/00004647-200205000-00005; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Chen W, 2007, TOHOKU J EXP MED, V212, P319, DOI 10.1620/tjem.212.319; Choi HJ, 2011, BRIT J PHARMACOL, V162, P175, DOI 10.1111/j.1476-5381.2010.01041.x; Ciotti P, 2009, DIAGN MOL PATHOL, V18, P112, DOI 10.1097/PDM.0b013e3181831320; Clark RE, 2013, P NATL ACAD SCI USA, V110, P10365, DOI 10.1073/pnas.1301225110; d'Hellencourt CL, 2005, J NEUROCHEM, V93, P206, DOI 10.1111/j.1471-4159.2004.03017.x; Dai C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015008; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Elliott-Hunt CR, 2007, J NEUROCHEM, V100, P780, DOI 10.1111/j.1471-4159.2006.04239.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Haines B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031739; Hansel NN, 2008, ALLERGY, V63, P366, DOI 10.1111/j.1398-9995.2007.01540.x; Hellmich HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053230; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Hernandez-Baltazar D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070951; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Hou H, 2008, BIOCHEM BIOPH RES CO, V369, P641, DOI 10.1016/j.bbrc.2008.02.094; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Ikeda T, 2000, ACTA NEUROPATHOL, V100, P161, DOI 10.1007/s004019900162; Kendziorski CM, 2003, BIOSTATISTICS, V4, P465, DOI 10.1093/biostatistics/4.3.465; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Kuga D, 2008, NEURO-ONCOLOGY, V10, P995, DOI 10.1215/15228517-2008-064; Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Mori M, 2004, CELL DEATH DIFFER, V11, P1223, DOI 10.1038/sj.cdd.4401483; Murakami H, 2000, KIDNEY INT, V58, P1346, DOI 10.1046/j.1523-1755.2000.00295.x; Nogueira-Silva C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030517; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Pan CQ, 2012, FEBS LETT, V586, P2674, DOI 10.1016/j.febslet.2012.04.023; Petito CK, 2001, J NEUROPATH EXP NEUR, V60, P377, DOI 10.1093/jnen/60.4.377; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Ruan YL, 1997, J NEUROSCI RES, V50, P383, DOI 10.1002/(SICI)1097-4547(19971101)50:3<383::AID-JNR4>3.0.CO;2-E; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Salminen A, 1998, MOL BRAIN RES, V61, P203, DOI 10.1016/S0169-328X(98)00210-1; Satoh T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.169; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Slevin M, 2010, J VASC RES, V47, P323, DOI 10.1159/000265566; So T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00139; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; SUGIMOTO A, 1995, EMBO J, V14, P4434, DOI 10.1002/j.1460-2075.1995.tb00122.x; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Mena JET, 2014, ANAL BIOCHEM, V447, P126, DOI 10.1016/j.ab.2013.11.015; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wang GB, 2013, NEUROSCI LETT, V543, P72, DOI 10.1016/j.neulet.2013.02.067; Wang SY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-163; Williamson LL, 2013, BRAIN BEHAV IMMUN, V30, P186, DOI 10.1016/j.bbi.2013.01.077; Wu H, 2013, J MOL NEUROSCI, V49, P512, DOI 10.1007/s12031-012-9910-6; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zaheer S, 2013, NEUROCHEM RES, V38, P218, DOI 10.1007/s11064-012-0913-z; Zhang JH, 2004, DEV BRAIN RES, V152, P255, DOI 10.1016/j.devbrainres.2004.07.008	74	20	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127287	10.1371/journal.pone.0127287			20	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ0RO	WOS:000355185600078	26016641	DOAJ Gold, Green Published			2021-06-18	
J	Griesbach, GS; Kreber, LA; Harrington, D; Ashley, MJ				Griesbach, Grace S.; Kreber, Lisa A.; Harrington, David; Ashley, Mark J.			Post-Acute Traumatic Brain Injury Rehabilitation: Effects on Outcome Measures and Life Care Costs	JOURNAL OF NEUROTRAUMA			English	Article						vascular injury; traumatic brain injury; rehabilitation; therapeutic approaches for the treatment of CNS injury; outcome measures	RATING-SCALE; HEALTH; TBI	Rehabilitation is the predominant post-acute treatment for patients with traumatic brain injury (TBI). We retrospectively evaluated the effectiveness of post-acute TBI rehabilitation by comparing outcome measures and life care cost with that of patients with cerebrovascular accident (CVA) who underwent a multidisciplinary rehabilitation program within the same facility. To better assess the effects of rehabilitation, we only included patients with no benefit limitations from the insurance carrier. Functional effectiveness was determined by comparing outcome scales, which included the Disability Rating Scale, Mayo Portland Inventory, Occupational Status Scale, Living Status Scale, and the Centre for Neuro Skills Scale. Cost-effectiveness was determined by having certified life care planners create separate cost projections from the admission and discharge patient files. This allowed us to compare cost projections with and without rehabilitation for each patient. Significant decreases in the cost projections, i.e., rehabilitation savings (RS), were found after rehabilitation for TBI. These RS were equivalent to those of patients with CVA. Likewise, equivalent improvements were found on all of the outcome scales for both brain injury groups. We also evaluated if the latency from TBI to admission in the rehabilitation program had an influence on outcome. Cost and functional effectiveness was more marked when rehabilitation was initiated within the first year after TBI. The effects of age of TBI were also evaluated. Although RS were most marked in younger patients, improvements in outcome measures were observed in all age groups after post-acute rehabilitation.	[Griesbach, Grace S.; Kreber, Lisa A.; Harrington, David; Ashley, Mark J.] Ctr Neuro Skills, Bakersfield, CA USA; [Griesbach, Grace S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA	Griesbach, GS (corresponding author), Ctr Neuro Skills, 16542 Ventura Blvd,Suite 500, Encino, CA 91436 USA.	ggriesbach@neuroskills.com					Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Ashley M.J., 2012, CEREBRUM, V8; Ashley MJ, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P761, DOI 10.1201/9781439849828-c23; Ashley MJ, 1997, BRAIN INJURY, V11, P677; Bettger JAP, 2007, ARCH PHYS MED REHAB, V88, P1526, DOI 10.1016/j.apmr.2007.06.768; Blackwell DL, 2014, VITAL HLTH STAT, V10, P1; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Dahdah MN, 2014, J HEAD TRAUMA REHAB, V29, P451, DOI 10.1097/HTR.0b013e3182a61983; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Greenwood RJ, 2004, BRIT J NEUROSURG, V18, P462, DOI 10.1080/02688690400012327; Griesbach G.S., HDB CLIN NE IN PRESS; Lohse KR, 2014, STROKE, V45, P2053, DOI 10.1161/STROKEAHA.114.004695; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sander AM, 2008, J HEAD TRAUMA REHAB, V23, P271, DOI 10.1097/01.HTR.0000336839.68585.0f; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Tal G, 2013, PEDIATR NEUROL, V48, P424, DOI 10.1016/j.pediatrneurol.2012.11.008; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 2004, CLIN MED, V4, P61, DOI 10.7861/clinmedicine.4-1-61; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	28	20	20	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2015	32	10					704	711		10.1089/neu.2014.3754			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CH3ZP	WOS:000353970200005	25496475				2021-06-18	
J	Xu, LY; Ryu, J; Hiel, H; Menon, A; Aggarwal, A; Rha, E; Mahairaki, V; Cummings, BJ; Koliatsos, VE				Xu, Leyan; Ryu, Jiwon; Hiel, Hakim; Menon, Adarsh; Aggarwal, Ayushi; Rha, Elizabeth; Mahairaki, Vasiliki; Cummings, Brian J.; Koliatsos, Vassilis E.			Transplantation of human oligodendrocyte progenitor cells in an animal model of diffuse traumatic axonal injury: survival and differentiation	STEM CELL RESEARCH & THERAPY			English	Article							NEURAL STEM-CELLS; SPINAL-CORD-INJURY; AMYOTROPHIC-LATERAL-SCLEROSIS; SOD1 TRANSGENIC RATS; BRAIN-INJURY; HEAD-INJURY; MOUSE MODEL; FUNCTIONAL RECOVERY; MULTIPLE-SCLEROSIS; CORPUS-CALLOSUM	Introduction: Diffuse axonal injury is an extremely common type of traumatic brain injury encountered in motor vehicle crashes, sports injuries, and in combat. Although many cases of diffuse axonal injury result in chronic disability, there are no current treatments for this condition. Its basic lesion, traumatic axonal injury, has been aggressively modeled in primate and rodent animal models. The inexorable axonal and perikaryal degeneration and dysmyelination often encountered in traumatic axonal injury calls for regenerative therapies, including therapies based on stem cells and precursors. Here we explore the proof of concept that treatments based on transplants of human oligodendrocyte progenitor cells can replace or remodel myelin and, eventually, contribute to axonal regeneration in traumatic axonal injury. Methods: We derived human oligodendrocyte progenitor cells from the human embryonic stem cell line H9, purified and characterized them. We then transplanted these human oligodendrocyte progenitor cells into the deep sensorimotor cortex next to the corpus callosum of nude rats subjected to traumatic axonal injury based on the impact acceleration model of Marmarou. We explored the time course and spatial distribution of differentiation and structural integration of these cells in rat forebrain. Results: At the time of transplantation, over 90 % of human oligodendrocyte progenitor cells expressed A2B5, PDGFR, NG2, O4, Olig2 and Sox10, a profile consistent with their progenitor or early oligodendrocyte status. After transplantation, these cells survived well and migrated massively via the corpus callosum in both injured and uninjured brains. Human oligodendrocyte progenitor cells displayed a striking preference for white matter tracts and were contained almost exclusively in the corpus callosum and external capsule, the striatopallidal striae, and cortical layer 6. Over 3 months, human oligodendrocyte progenitor cells progressively matured into myelin basic protein(+) and adenomatous polyposis coli protein(+) oligodendrocytes. The injured environment in the corpus callosum of impact acceleration subjects tended to favor maturation of human oligodendrocyte progenitor cells. Electron microscopy revealed that mature transplant-derived oligodendrocytes ensheathed host axons with spiral wraps intimately associated with myelin sheaths. Conclusions: Our findings suggest that, instead of differentiating locally, human oligodendrocyte progenitor cells migrate massively along white matter tracts and differentiate extensively into ensheathing oligodendrocytes. These features make them appealing candidates for cellular therapies of diffuse axonal injury aiming at myelin remodeling and axonal protection or regeneration.	[Xu, Leyan; Ryu, Jiwon; Menon, Adarsh; Aggarwal, Ayushi; Rha, Elizabeth; Mahairaki, Vasiliki; Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Hiel, Hakim] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Cummings, Brian J.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Sue & Bill Gross Stem Cell Res Ctr, Dept Phys & Med Rehabil, Irvine, CA 92697 USA; [Cummings, Brian J.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Sue & Bill Gross Stem Cell Res Ctr, Dept Neurol Surg, Irvine, CA 92697 USA; [Cummings, Brian J.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Sue & Bill Gross Stem Cell Res Ctr, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Xu, LY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA.	lxu9@jhmi.edu	Cummings, Brian J/C-9180-2012	Cummings, Brian J/0000-0003-3628-5290; Aggarwal, Ayushi/0000-0003-0458-5619; Ryu, Jiwon/0000-0003-0251-7858	Maryland Technology Development Corporation (TEDCO) [TR2-01767]	This work was supported by a Maryland Technology Development Corporation (TEDCO) grant to VEK funded as companion to CIRM grant TR2-01767 to BJC. We would like to thank Ms Devon Hitt who offered great technical help with immunostaining and collection of some quantitative data.	ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; Alsanie WF, 2013, STEM CELLS DEV, V22, P2459, DOI 10.1089/scd.2012.0520; Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Boyd A, 2013, ACTA NEUROPATHOL, V125, P841, DOI 10.1007/s00401-013-1112-y; Brazzini A, 2010, J VASC INTERV RADIOL, V21, P443, DOI 10.1016/j.jvir.2010.01.008; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Chi LY, 2006, STEM CELLS, V24, P34, DOI 10.1634/stemcells.2005-0076; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Erlandsson A, 2004, EXP CELL RES, V301, P201, DOI 10.1016/j.yexcr.2004.08.009; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Fujimoto Y, 2012, STEM CELLS, V30, P1163, DOI 10.1002/stem.1083; GALLYAS F, 1971, ACTA MORPHOL HUNG, V19, P1; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Givogri MI, 2006, J NEUROSCI, V26, P3109, DOI 10.1523/JNEUROSCI.4366-05.2006; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hatch MN, 2009, J NEUROIMMUNOL, V212, P74, DOI 10.1016/j.jneuroim.2009.05.002; Hatch Maya N., 2009, V549, P59, DOI 10.1007/978-1-60327-931-4_5; Haus DL, 2014, STEM CELL RES, V13, P214, DOI 10.1016/j.scr.2014.06.008; Hess DC, 2014, INT J STROKE, V9, P381, DOI 10.1111/ijs.12065; Hooshmand MJ, 2014, MICROSCOPY ADV SCI R, V6, P59; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Kallakuri S, 2012, BRAIN RES, V1452, P29, DOI 10.1016/j.brainres.2012.02.065; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Koliatsos VE, 2008, EXPERT OPIN BIOL TH, V8, P137, DOI 10.1517/14712598.8.2.137 ; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; KOLIATSOS VE, 1994, J COMP NEUROL, V345, P510, DOI 10.1002/cne.903450404; Kwon BK, 2010, SPINE, V35, pS263, DOI 10.1097/BRS.0b013e3181f3286d; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Nasonkin I, 2009, STEM CELLS, V27, P2414, DOI 10.1002/stem.177; Nasonkin IO, 2006, EXP NEUROL, V201, P525, DOI 10.1016/j.expneurol.2006.05.002; Neirinckx V, 2014, STEM CELLS, V32, P829, DOI 10.1002/stem.1579; Nguyen HX, 2014, J COMP NEUROL, V522, P2767, DOI 10.1002/cne.23604; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Riley J, 2014, NEUROSURGERY, V74, P77, DOI 10.1227/NEU.0000000000000156; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; Sontag CJ, 2014, STEM CELL REP, V2, P620, DOI 10.1016/j.stemcr.2014.03.005; Suchet S., 1995, NEUROGLIA, P23; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057534; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tirotta E, 2010, J NEUROIMMUNOL, V224, P101, DOI 10.1016/j.jneuroim.2010.05.013; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Tripathi RB, 2008, J COMP NEUROL, V510, P129, DOI 10.1002/cne.21787; Vaquero J, 1999, J NEUROSURG, V91, P831, DOI 10.3171/jns.1999.91.5.0831; Vigano F, 2013, NAT NEUROSCI, V16, P1370, DOI 10.1038/nn.3503; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Weick JP, 2011, P NATL ACAD SCI USA, V108, P20189, DOI 10.1073/pnas.1108487108; Widera D, 2004, EUR J CELL BIOL, V83, P381, DOI 10.1078/0171-9335-00403; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Xu LY, 2012, REGEN MED, V7, P785, DOI [10.2217/rme.12.76, 10.2217/RME.12.76]; Xu LY, 2011, NEUROSCI LETT, V494, P222, DOI 10.1016/j.neulet.2011.03.017; Xu LY, 2009, J COMP NEUROL, V514, P297, DOI 10.1002/cne.22022; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yan J, 2004, J COMP NEUROL, V480, P101, DOI 10.1002/cne.20344; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Zakaria N, 2012, BRAIN RES, V1467, P81, DOI 10.1016/j.brainres.2012.05.046; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 1998, J NEUROSCI RES, V54, P181, DOI 10.1002/(SICI)1097-4547(19981015)54:2<181::AID-JNR6>3.0.CO;2-A	102	20	22	2	16	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-6512			STEM CELL RES THER	Stem Cell Res. Ther.	MAY 14	2015	6								93	10.1186/s13287-015-0087-0			18	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	CJ3VA	WOS:000355411000001	25971252	DOAJ Gold, Green Published			2021-06-18	
J	Boutis, K; Weerdenburg, K; Koo, E; Schneeweiss, S; Zemek, R				Boutis, Kathy; Weerdenburg, Kirstin; Koo, Ellen; Schneeweiss, Suzan; Zemek, Roger			The Diagnosis of Concussion in a Pediatric Emergency Department	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; CHILDREN; MANAGEMENT; SYMPTOMS; KNOWLEDGE; PHYSICIANS; STATEMENT; SPECTRUM	Objectives To compare the proportion of children diagnosed with a concussion by pediatric emergency physicians vs the proportion who met criteria for this injury as recommended by Zurich Fourth International Conference on Concussion consensus statement and to determine clinical variables associated with a physician diagnosis of a concussion. Study design This was a prospective, cross-sectional study conducted at a tertiary care pediatric emergency department. We enrolled children ages 5 through 17 who presented with a head injury and collected data on demographics, mechanism of injury, head injury-related symptoms/signs, physician diagnosis, and discharge advice. Results We identified 495 children whose mean age was 10.1 years (SD 3.4 years); 308 (62.2%) were male. Emergency physicians diagnosed concussion in 200 (40.4%; 95% CI 36.1, 44.7) children, and 443 (89.5%; 95% CI 86.8, 92.2) met criteria for concussion in accordance with the Zurich consensus statement (P < .0001). Age >= 10 years (OR 1.8), presentation >= 1 day after injury (OR 2.4), injury from collision sports (OR 5.6), and symptoms of headache (OR 2.2) or amnesia (OR 3.4) were the variables significantly associated with an emergency physician's diagnosis of concussion. Conclusions Pediatric emergency physicians diagnosed concussion less often relative to international consensus-based guidelines and used a limited number of variables to make this diagnosis compared with current recommendations. Thus, pediatric emergency physicians may be missing cases of concussion and the corresponding opportunity to provide critical advice for cognitive and physical management.	[Boutis, Kathy; Weerdenburg, Kirstin; Koo, Ellen; Schneeweiss, Suzan] Hosp Sick Children, Div Emergency Med, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Boutis, Kathy; Weerdenburg, Kirstin; Koo, Ellen; Schneeweiss, Suzan] Univ Toronto, Toronto, ON, Canada; [Zemek, Roger] Childrens Hosp Eastern Ontario, Dept Pediat, Div Emergency Med, Ottawa, ON K1H 8L1, Canada; [Zemek, Roger] Univ Ottawa, Ottawa, ON, Canada	Boutis, K (corresponding author), Hosp Sick Children, Div Emergency Med, Dept Pediat, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	kathy.boutis@sickkids.ca	Schneeweiss, Sebastian/C-2125-2013; Meijer, Anna/K-5118-2016; Zemek, Roger/H-1039-2018	Schneeweiss, Sebastian/0000-0003-2575-467X; 	Hospital for Sick Children, via the Pediatric Research Academic Initiative at SickKids Emergency (PRAISE); Canadian Hospitals Injury Reporting and Prevention Program	Funded by the Hospital for Sick Children, via the Pediatric Research Academic Initiative at SickKids Emergency (PRAISE), and the Canadian Hospitals Injury Reporting and Prevention Program. The authors declare no conflicts of interest.	[Anonymous], 2013, BR J SPORTS MED, V47, P259; Aubry M, 2002, BRIT J SPORT MED, V36, P6; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Buchanan K, 2011, ANN EMERG MED, V58, pS185, DOI 10.1016/j.annemergmed.2011.06.048; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Craton N, 2014, CLIN J SPORT MED, V24, P93; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Parachute Canada, 2014, RET PLAY GUID; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Purcell LK, 2014, PAED CHILD HEALT-CAN, V19, P153, DOI 10.1093/pch/19.3.153; Sarsfield MJ, 2013, PEDIATR EMERG CARE, V29, P884, DOI 10.1097/PEC.0b013e31829ec0d9; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Upchurch C, 2014, CLIN J SPORT MED; Zemek R., 2014, GUIDELINES DIAGNOSIN; Zemek R, 2014, CJEM IN PRESS; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	39	20	21	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	MAY	2015	166	5					1214	U436		10.1016/j.jpeds.2015.02.013			8	Pediatrics	Pediatrics	CG6DW	WOS:000353387100025	25919731				2021-06-18	
J	Bragin, DE; Statom, GL; Hagberg, S; Nemoto, EM				Bragin, Denis E.; Statom, Gloria L.; Hagberg, Sean; Nemoto, Edwin M.			Increases in microvascular perfusion and tissue oxygenation via pulsed electromagnetic fields in the healthy rat brain	JOURNAL OF NEUROSURGERY			English	Article						pulsed electromagnetic field; cerebrovascular flow; brain metabolism; two-photon laser scanning microscopy; NADH; vasodilation	FLUID SHEAR-STRESS; CEREBROCORTICAL CAPILLARY-FLOW; HIGH INTRACRANIAL-PRESSURE; NITRIC-OXIDE SYNTHASE; CEREBRAL-BLOOD-FLOW; DOUBLE-BLIND; POSTOPERATIVE PAIN; 1ST MESSENGER; SKIN; ISCHEMIA	OBJECT High-frequency pulsed electromagnetic field stimulation is an emerging noninvasive therapy being used clinically to facilitate bone and cutaneous wound healing. Although the mechanisms of action of pulsed electromagnetic fields (PEMF) are unknown, some studies suggest that its effects are mediated by increased nitric oxide (NO), a well-known vasodilator. The authors hypothesized that in the brain, PEMF increase NO, which induces vasodilation, enhances microvascular perfusion and tissue oxygenation, and may be a useful adjunct therapy in stroke and traumatic brain injury. To test this hypothesis, they studied the effect of PEMF on a healthy rat brain with and without NO synthase (NOS) inhibition. METHODS In vivo two-photon laser scanning microscopy (2PLSM) was used on the parietal cortex of rat brains to measure microvascular tone and red blood cell (RBC) flow velocity in microvessels with diameters ranging from 3 to 50 mu m, which includes capillaries, arterioles, and venules. Tissue oxygenation (reduced nicotinamide adenine dinucleotide [NADH] fluorescence) was also measured before and for 3 hours after PEMF treatment using the FDA-cleared Sof Pulse device (Ivivi Health Sciences, LLC). To test NO involvement, the NOS inhibitor N-G-nitro-L-arginine methyl ester (L-NAME) was intravenously injected (10 mg/kg). In a time control group, PEMF were not used. Doppler flux (0.8-mm probe diameter), brain and rectal temperatures, arterial blood pressure, blood gases, hematocrit, and electrolytes were monitored. RESULTS Pulsed electromagnetic field stimulation significantly dilated cerebral arterioles from a baseline average diameter of 26.4 +/- 0.84 mu m to 29.1 +/- 0.91 mu m (11 rats, p < 0.01). Increased blood volume flow through dilated arterioles enhanced capillary flow with an average increase in RBC flow velocity by 5.5% +/- 1.3% (p < 0.01). Enhanced microvascular flow increased tissue oxygenation as reflected by a decrease in NADH autofluorescence to 94.7% +/- 1.6% of baseline (p < 0.05). Nitric oxide synthase inhibition by L-NAME prevented PEMF-induced changes in arteriolar diameter, microvascular perfusion, and tissue oxygenation (7 rats). No changes in measured parameters were observed throughout the study in the untreated time controls (5 rats). CONCLUSIONS This is the first demonstration of the acute effects of PEMF on cerebral cortical microvascular perfusion and metabolism. Thirty minutes of PEMF treatment induced cerebral arteriolar dilation leading to an increase in microvascular blood flow and tissue oxygenation that persisted for at least 3 hours. The effects of PEMF were mediated by NO, as we have shown in NOS inhibition experiments. These results suggest that PEMF may be an effective treatment for patients after traumatic or ischemic brain injury. Studies on the effect of PEMF on the injured brain are in progress.	[Bragin, Denis E.; Statom, Gloria L.; Nemoto, Edwin M.] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Bragin, Denis E.] Univ New Mexico, Biomed Res & Integrat Neuroimaging Ctr, Albuquerque, NM 87131 USA; [Hagberg, Sean] Ivivi Hlth Sci, San Francisco, CA USA	Bragin, DE (corresponding author), 1 Univ New Mexico, Dept Neurosurg, MSC10 5615, Albuquerque, NM 87131 USA.	dbragin@salud.unm.edu	Bragin, Denis/E-5494-2016	Bragin, Denis/0000-0003-4894-0061	Ivivi Health Sciences, LLC; American Heart AssociationAmerican Heart Association [12BGIA11730011]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103400] Funding Source: NIH RePORTER	This research was supported by Ivivi Health Sciences, LLC, and American Heart Association grant 12BGIA11730011.	Aaron RK, 2004, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000118699.26862.41; Akai M, 2002, BIOELECTROMAGNETICS, V23, P132, DOI 10.1002/bem.106; Akdag MZ, 2007, ELECTROMAGN BIOL MED, V26, P99, DOI 10.1080/15368370701357866; Assiotis A, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-24; Baptista AF, 2009, J PERIPHER NERV SYST, V14, P285, DOI 10.1111/j.1529-8027.2009.00240.x; Bragin DE, 2013, STROKE, V44, P177, DOI 10.1161/STROKEAHA.112.668293; Bragin DE, 2011, J NEUROTRAUM, V28, P775, DOI 10.1089/neu.2010.1692; CHANCE B, 1962, SCIENCE, V137, P499, DOI 10.1126/science.137.3529.499; Diniz P, 2002, NITRIC OXIDE-BIOL CH, V7, P18, DOI 10.1016/S1089-8603(02)00004-6; Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a; Gilcreast Darlene M., 1998, Wound Repair and Regeneration, V6, P434, DOI 10.1046/j.1524-475X.1998.60505.x; GOSSLING HR, 1992, ORTHOPEDICS, V15, P711; Goudarzi I, 2010, BIOELECTROMAGNETICS, V31, P318, DOI 10.1002/bem.20567; GRANT G, 1994, BIOELECTROMAGNETICS, V15, P205, DOI 10.1002/bem.2250150305; Gupta A, 2009, NEUROL INDIA, V57, P622, DOI 10.4103/0028-3886.57820; Haarala C, 2003, NEUROREPORT, V14, P2019, DOI 10.1097/00001756-200311140-00003; Hauck EF, 2004, J CEREBR BLOOD F MET, V24, P383, DOI 10.1097/00004647-200404000-00003; Heden P, 2008, AESTHET PLAST SURG, V32, P660, DOI 10.1007/s00266-008-9169-z; Huber R, 2002, J SLEEP RES, V11, P289, DOI 10.1046/j.1365-2869.2002.00314.x; Hudetz AG, 1996, MICROVASC RES, V51, P131, DOI 10.1006/mvre.1996.0015; HUDETZ AG, 1995, AM J PHYSIOL-HEART C, V268, pH2202; ITO H, 1983, CLIN ORTHOP RELAT R, P283; KAMIYA A, 1980, AM J PHYSIOL, V239, pH14; Kim SS, 2002, EXP MOL MED, V34, P53, DOI 10.1038/emm.2002.8; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; MAYROVITZ HN, 1992, WOUNDS, V4, P197; MAYROVITZ HN, 1995, WOUNDS, V7, P90; Mckay JC, 2007, BIOELECTROMAGNETICS, V28, P81, DOI 10.1002/bem.20284; McKay JC, 2010, BIOELECTROMAGNETICS, V31, P64, DOI 10.1002/bem.20533; Midura RJ, 2005, J ORTHOP RES, V23, P1035, DOI 10.1016/j.orthres.2005.03.015; MIURA M, 1991, J PHYSIOL-LONDON, V435, P257, DOI 10.1113/jphysiol.1991.sp018509; MIURA M, 1993, J PHYSIOL-LONDON, V461, P513, DOI 10.1113/jphysiol.1993.sp019526; MOTTI EDF, 1986, J NEUROSURG, V65, P834, DOI 10.3171/jns.1986.65.6.0834; Nelson FR, 2013, RHEUMATOL INT, V33, P2169, DOI 10.1007/s00296-012-2366-8; Noda, 2000, Pathophysiology, V7, P127, DOI 10.1016/S0928-4680(00)00039-0; Pan YH, 2013, BIOELECTROMAGNETICS, V34, P180, DOI 10.1002/bem.21755; Patruno A, 2010, BRIT J DERMATOL, V162, P258, DOI 10.1111/j.1365-2133.2009.09527.x; Pena-Philippides JC, 2014, TRANSL STROKE RES, V5, P491, DOI 10.1007/s12975-014-0334-1; PENNINGTON GM, 1993, MIL MED, V158, P101; Pilla A., 2006, HDB BIOL EFFECTS ELE, P351; Pilla A, 2011, BBA-GEN SUBJECTS, V1810, P1236, DOI 10.1016/j.bbagen.2011.10.001; Pilla AA, 2013, ELECTROMAGN BIOL MED, V32, P123, DOI 10.3109/15368378.2013.776335; Pilla AA, 2012, BIOCHEM BIOPH RES CO, V426, P330, DOI 10.1016/j.bbrc.2012.08.078; Rasouli J, 2012, NEUROSCI LETT, V519, P4, DOI 10.1016/j.neulet.2012.03.089; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Rohde C, 2010, PLAST RECONSTR SURG, V125, P1620, DOI 10.1097/PRS.0b013e3181c9f6d3; Sandyk R, 1994, Int J Neurosci, V76, P185; Sandyk R, 1996, INT J NEUROSCI, V87, P209, DOI 10.3109/00207459609070839; Schuhfried O, 2005, INT J SPORTS MED, V26, P886, DOI 10.1055/s-2005-837451; Seylaz J, 1999, J CEREBR BLOOD F MET, V19, P863, DOI 10.1097/00004647-199908000-00005; Sisken B F, 1990, Restor Neurol Neurosci, V1, P303, DOI 10.3233/RNN-1990-13419; Smith TL, 2004, J ORTHOPAED RES, V22, P80, DOI 10.1016/S0736-0266(03)00157-8; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Tepper OM, 2004, FASEB J, V18, P1231, DOI 10.1096/fj.03-0847fje; Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0; UENO S, 1986, MED BIOL ENG COMPUT, V24, P57, DOI 10.1007/BF02441606; World Cameron J, 2006, Curr Atheroscler Rep, V8, P240, DOI 10.1007/s11883-006-0079-8; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Yuan YA, 2010, CARDIOLOGY, V117, P57, DOI 10.1159/000321459	59	20	20	0	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2015	122	5					1239	1247		10.3171/2014.8.JNS132083			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG5XP	WOS:000353369500038	25343187	Green Accepted, Bronze			2021-06-18	
J	Lee, JC; Rittenhouse, K; Bupp, K; Gross, B; Rogers, A; Rogers, FB; Horst, M; Estrella, L; Thurmond, J				Lee, John C.; Rittenhouse, Katelyn; Bupp, Katherine; Gross, Brian; Rogers, Amelia; Rogers, Frederick B.; Horst, Michael; Estrella, Lisa; Thurmond, James			An analysis of Brain Trauma Foundation traumatic brain injury guideline compliance and patient outcome	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Mortality; Compliance; Guidelines	CARE	Introduction: Evidence-based guidelines for the care of severe traumatic brain injury have been available from the Brain Trauma Foundation (BTF) since 1995. A total of 15 recommendations compose the current guidelines. Although each individual guideline has been validated in isolation, to date, little research has examined the guidelines in composite. We examined the relationship between compliance with the BTF severe TBI guidelines and mortality. Materials and methods: In a Pennsylvania-verified, mature Level II trauma centre, patients with an admission Glasgow Coma Scale (GCS) <= 8 and an abnormal head CT from 2007 to 2012 were queried from the trauma registry. Exclusion criteria included: patients who sustained a non-survivable injury (AIS head 6), died <= 24 h, and/or were transferred to a paediatric trauma centre. Strict adherence to the BTF guidelines was determined in a binary fashion (yes/no). We then calculated each patient's percent compliance with total number of guidelines. Bivariate analysis was used to find significant predictors of mortality (p < 0.05), including percent BTF guidelines compliance. Significant factors were added to a multivariable logistic regression model to look at mortality rates across the percent compliance spectrum. Results: 185 Patients met inclusion criteria. Percent compliance ranged from 28.6% to 94.4%, (median = 71.4%). Following adjustment for age, AIS head, and GCS motor, patients with 55-75% compliance (AOR: 0.20; 95% CI: 0.06-0.70) and >75% compliance (AOR: 0.27; 95% CI: 0.08-0.94) had reduced odds of mortality, as compared to <55% compliance to the BTF guidelines. When the unadjusted rate of mortality was compared across the compliance spectrum, the odds of mortality decreased as compliance increased until 75%, and then reversed. Conclusion: Our data indicate that full compliance with all 15 severe TBI guidelines is difficult to achieve and may not be necessary to optimally care for patients. (C) 2015 Elsevier Ltd. All rights reserved.	[Lee, John C.; Rittenhouse, Katelyn; Bupp, Katherine; Gross, Brian; Rogers, Amelia; Rogers, Frederick B.; Horst, Michael; Estrella, Lisa; Thurmond, James] Lancaster Gen Hlth, Trauma Serv, Lancaster, PA 17601 USA	Lee, JC (corresponding author), Lancaster Gen Hlth, Trauma Serv, 555 N,Duke St, Lancaster, PA 17601 USA.	jclee@lghealth.org; kr061@lghealth.org; kbupp2@lghealth.org; bg029@lghealth.org; atrogers89@gmail.com; frogers2@lghealth.org; mahorst@lghealth.org; lestrella2@lghealth.org; jthurmond2@lghealth.org					Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Injury Association of America, 2014, BRAIN INJ; Brain Trauma Foundation, 2014, HIST BTF; Bulger EM, 2002, NEUROL CRIT CARE, V52, P1202; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Centers for Disease Control and Prevention, 2014, SEV TRAUM BRAIN INJ; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255	16	20	21	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2015	46	5					854	858		10.1016/j.injury.2014.12.023			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CG2ZJ	WOS:000353144900016	25661105				2021-06-18	
J	Tao, X; Chen, X; Hao, S; Hou, Z; Lu, T; Sun, M; Liu, B				Tao, X.; Chen, X.; Hao, S.; Hou, Z.; Lu, T.; Sun, M.; Liu, B.			PROTECTIVE ACTIONS OF PJ34, A POLY(ADP-RIBOSE)POLYMERASE INHIBITOR, ON THE BLOOD-BRAIN BARRIER AFTER TRAUMATIC BRAIN INJURY IN MICE	NEUROSCIENCE			English	Article						poly(ADP-ribose) polymerase; blood-brain barrier; brain edema; traumatic brain injury; NF-kappa B	FOCAL CEREBRAL-ISCHEMIA; NF-KAPPA-B; CLOSED-HEAD INJURY; CELL-DEATH; SUBARACHNOID HEMORRHAGE; POLYMERASE INHIBITION; EDEMA FORMATION; WHITE-MATTER; RAT-BRAIN; MATRIX-METALLOPROTEINASE-9	Poly(ADP-ribose) polymerase (PARP) is activated by oxidative stress and plays an important role in traumatic brain injury (TBI). The objective of this study was to investigate whether PARP activation participated in the blood-brain barrier (BBB) disruption and edema formation in a mouse model of controlled cortical impact (CCI). N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide (PJ34) (10 mg/kg), a selective PARP inhibitor, was administered intraperitoneally at 5 min and 8 h after experimental CCI. After 6 h and 24 h of CCI, the permeability of the cortical BBB was determined after Evans Blue administration. The water content of the brain was also measured. Treatment with PJ34 markedly attenuated the permeability of the BBB and decreased the brain edema at 6 h and 24 h after CCI. Our data showed the up-regulation of nuclear factor-kappa B in cytosolic fractions and nuclear fractions in the injured cortex, and these changes were reversed by PJ34. Moreover, PJ34 significantly lessened the activities of myeloperoxidase and the levels of matrix metalloproteinase-9, enhanced the levels of occludin, laminin, collagen IV and integrin beta 1, reduced neurological deficits, decreased the contusion volume, and attenuated the necrotic and apoptotic neuronal cell death. These data suggest the protective effects of PJ34 on BBB integrity and cell death during acute TBI. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.	[Tao, X.; Chen, X.; Hao, S.; Hou, Z.; Lu, T.; Liu, B.] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Liu, B.] Capital Med Univ, Dept Neurotrauma, Beijing Neurosurg Inst, Beijing 100050, Peoples R China; [Sun, M.] Capital Med Univ, Dept Neuropharmacol, Beijing Neurosurg Inst, Beijing 100050, Peoples R China; [Liu, B.] Nerve Injury & Repair Ctr Beijing Inst Brain Diso, Beijing 100050, Peoples R China; [Liu, B.] Gen Hosp Armed Police Forces, Dept Neurotrauma, Beijing 100039, Peoples R China; [Liu, B.] China Natl Clin Res Ctr Neurol Dis Beijing, Beijing 100050, Peoples R China; [Liu, B.] Beijing Key Lab Cent Nervous Syst Injury, Beijing 100050, Peoples R China	Sun, M (corresponding author), Capital Med Univ, Dept Neuropharmacol, Beijing Neurosurg Inst, 6 Tiantan Xili, Beijing 100050, Peoples R China.	sunming999@yahoo.com; liubaiyun1963@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171144]	This work was supported by research grants from the National Natural Science Foundation of China (No. 81171144).	Akamatsu Y, 2011, NEUROSCI LETT, V503, P110, DOI 10.1016/j.neulet.2011.08.018; Asahi M, 2001, J NEUROSCI, V21, P7724; Biber N, 2009, BRAIN INJURY, V23, P577, DOI 10.1080/02699050902926317; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; Haddad M, 2006, BRIT J PHARMACOL, V149, P23, DOI 10.1038/sj.bjp.0706837; Haddad M, 2008, EUR J PHARMACOL, V588, P52, DOI 10.1016/j.ejphar.2008.04.013; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hosomi N, 2005, J CEREBR BLOOD F MET, V25, P959, DOI 10.1038/sj.jcbfm.9600086; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Koedel U, 2002, J CEREBR BLOOD F MET, V22, P39, DOI 10.1097/00004647-200201000-00005; Koh SH, 2004, EUR J NEUROSCI, V20, P1461, DOI 10.1111/j.1460-9568.2004.03632.x; Komjati K, 2004, INT J MOL MED, V13, P373; Krizbai IA, 2005, SHOCK, V24, P428, DOI 10.1097/01.shk.0000183389.98519.d3; Lenzser G, 2007, J CEREBR BLOOD F MET, V27, P1318, DOI 10.1038/sj.jcbfm.9600437; Lescot T, 2010, J NEUROTRAUM, V27, P1069, DOI 10.1089/neu.2009.1188; Li PY, 2014, STROKE, V45, P857, DOI 10.1161/STROKEAHA.113.004100; Lian H, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-47; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Moroni F, 2008, CURR OPIN PHARMACOL, V8, P96, DOI 10.1016/j.coph.2007.10.005; Pacher P, 2005, ANTIOXID REDOX SIGN, V7, P1568, DOI 10.1089/ars.2005.7.1568; Park EM, 2004, STROKE, V35, P2896, DOI 10.1161/01.STR.0000147042.53659.6c; Romero IA, 2003, NEUROSCI LETT, V344, P112, DOI 10.1016/S0304-3940(03)00348-3; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Sehba FA, 2004, J NEUROSURG, V101, P633, DOI 10.3171/jns.2004.101.4.0633; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Sun M, 2008, CELL MOL NEUROBIOL, V28, P593, DOI 10.1007/s10571-007-9183-8; Switzer JA, 2011, STROKE, V42, P2633, DOI 10.1161/STROKEAHA.111.618215; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375	52	20	22	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 16	2015	291						26	36		10.1016/j.neuroscience.2015.01.070			11	Neurosciences	Neurosciences & Neurology	CD7VN	WOS:000351303100003	25668593				2021-06-18	
J	Hu, JZ; Long, H; Wu, TD; Zhou, Y; Lu, HB				Hu, J. Z.; Long, H.; Wu, T. -D.; Zhou, Y.; Lu, H. -B.			THE EFFECT OF ESTROGEN-RELATED RECEPTOR alpha ON THE REGULATION OF ANGIOGENESIS AFTER SPINAL CORD INJURY	NEUROSCIENCE			English	Article						spinal cord injury; angiogenesis; estrogen receptor-related; receptor-alpha; XCT790.	PROLIFERATOR-ACTIVATED RECEPTOR; ENDOTHELIAL GROWTH-FACTOR; GAMMA COACTIVATOR-1-ALPHA PGC-1-ALPHA; ERR-ALPHA; VASCULAR DISRUPTION; CONTUSION INJURY; VEGF RECEPTORS; BREAST-CANCER; RAT-BRAIN; EXPRESSION	Estrogen receptor-related receptor-alpha (ERR alpha) is an orphan member of the nuclear receptor superfamily that interacts with peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) to stimulate vascular endothelial growth factor (VEGF) expression and angiogenesis in a hypoxia-inducible factor-1 alpha-independent pathway. Although it is not regulated by any natural ligand, the action of ERR alpha can be blocked by the synthetic molecule XCT790. In the present study, Sprague-Dawley rats were randomly allocated to a sham group, injury-saline group or injury-XCT90 group. A modified Allen's weight-drop method was applied to induce the acute traumatic spinal cord injury (SCI) model in these rats, and an injection of XCT790 was administered every 24 h, starting half an hour after the SCI contusion. Histological analyses revealed that XCT790 significantly aggravated tissue damage and decreased the number of ERR alpha-positive cells at 1, 3 and 7 days after SCI. Western blot and quantitative real-time polymerase chain reaction (qRT-PCR) analyses also indicated that XCT790 dramatically repressed the expression of ERR alpha, thus reducing the expression of VEGF and angiopoietin-2 (Ang-2) throughout the duration of the experiment, but the expression of PGC-1 alpha was not affected. Immunofluorescence analyses indicated that vascular density and endothelial cell proliferation were decreased in the injury-XCT90 group compared with the injury-saline group. These results suggest that ERR alpha is involved in mediating angiogenesis after SCI in the rat traumatic SCI model. (C) 2015 The Authors. Published by Elsevier Ltd. on behalf of IBRO.	[Hu, J. Z.; Long, H.; Wu, T. -D.; Zhou, Y.] Cent S Univ, Xiangya Hosp, Dept Spine Surg, Changsha 410008, Hunan, Peoples R China; [Lu, H. -B.] Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China	Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, Changsha 410008, Hunan, Peoples R China.	hongbinlu@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171698, 81371956]; Specialized Research Fund for the Doctoral Program of Higher EducationSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20130162110078]	This work was supported by grants from the National Natural Science Foundation of China (No. 81171698 and No. 81371956), and from Specialized Research Fund for the Doctoral Program of Higher Education (No. 20130162110078).	Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bazley FA, 2012, J NEUROSURG-SPINE, V16, P414, DOI 10.3171/2012.1.SPINE11684; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bonnelye E, 2007, ENDOCRINOLOGY, V148, P1195, DOI 10.1210/en.2006-0962; Casella GTB, 2006, EXP NEUROL, V202, P8, DOI 10.1016/j.expneurol.2006.05.028; Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827; Chen CW, 2010, NEUROCHEM RES, V35, P1111, DOI 10.1007/s11064-010-0162-y; Choi JS, 2007, J HISTOCHEM CYTOCHEM, V55, P821, DOI 10.1369/jhc.6A7139.2007; Distler JHW, 2003, Q J NUCL MED, V47, P149; Dore-Duffy P, 2007, ANTIOXID REDOX SIGN, V9, P1363, DOI 10.1089/ars.2007.1713; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Durham-Lee JC, 2012, NEUROSCIENCE, V202, P454, DOI 10.1016/j.neuroscience.2011.09.058; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Fong GH, 2008, ANGIOGENESIS, V11, P121, DOI 10.1007/s10456-008-9107-3; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Krum JM, 2008, EXP NEUROL, V212, P108, DOI 10.1016/j.expneurol.2008.03.019; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Liu XH, 2014, SPINE J, V14, P119, DOI 10.1016/j.spinee.2013.06.084; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Long HQ, 2012, MED HYPOTHESES, V79, P82, DOI 10.1016/j.mehy.2012.04.006; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Lutton C, 2012, J NEUROTRAUM, V29, P957, DOI 10.1089/neu.2010.1423; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Ndubuizu OI, 2010, BRAIN RES, V1366, P101, DOI 10.1016/j.brainres.2010.09.064; Ng MTL, 2011, TRANSL STROKE RES, V2, P474, DOI 10.1007/s12975-011-0109-x; Ning GZ, 2013, REGEN MED, V8, P271, DOI [10.2217/RME.13.26, 10.2217/rme.13.26]; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Pichiule P, 2002, J APPL PHYSIOL, V93, P1131, DOI 10.1152/japplphysiol.00318.2002; Ritz MF, 2010, CURR NEUROVASC RES, V7, P301, DOI 10.2174/156720210793180756; Sapieha P, 2012, BLOOD, V120, P2182, DOI 10.1182/blood-2012-04-396846; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Shoag J, 2010, ARTERIOSCL THROM VAS, V30, P662, DOI 10.1161/ATVBAHA.108.181636; Skold M, 2000, EUR J NEUROSCI, V12, P3675, DOI 10.1046/j.1460-9568.2000.00263.x; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Stein RA, 2009, J STEROID BIOCHEM, V114, P106, DOI 10.1016/j.jsbmb.2009.02.010; Teyssier C, 2008, NUCLEIC ACIDS RES, V36, P5350, DOI 10.1093/nar/gkn520; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wang J, 2010, CELL PROLIFERAT, V43, P103, DOI 10.1111/j.1365-2184.2009.00659.x; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Yamazaki S., 2014, JAALD, Bulletin of the Japan Association of Agricultural Librarians and Information Specialists, P1; Zhang KQ, 2011, CARDIOVASC RES, V89, P426, DOI 10.1093/cvr/cvq296; Zheng Z, 2010, DIABETES, V59, P2315, DOI 10.2337/db10-0638; Zhou Y, 2013, CHINESE MED J-PEKING, V126, P3897, DOI 10.3760/cma.j.issn.0366-6999.20130571	50	20	22	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 2	2015	290						570	580		10.1016/j.neuroscience.2015.01.067			11	Neurosciences	Neurosciences & Neurology	CD3LG	WOS:000350979300051	25665753	Other Gold			2021-06-18	
J	Covassin, T; Beidler, E; Ostrowski, J; Wallace, J				Covassin, Tracey; Beidler, Erica; Ostrowski, Jennifer; Wallace, Jessica			Psychosocial Aspects of Rehabilitation in Sports	CLINICS IN SPORTS MEDICINE			English	Article						Psychosocial skills; Rehabilitation; Injury; Psychological recovery	CRUCIATE LIGAMENT RECONSTRUCTION; EMOTIONAL RESPONSES; SERIOUS INJURY; RETURN; CONCUSSION; FEAR; COMMUNICATION; RECOVERY; OUTCOMES; STRESS	When an athlete is injured, the primary focus of the sports medicine team is to treat the physical effects of the injury. However, many injured athletes experience negative psychological responses that should also be addressed throughout the rehabilitation process. Sports medicine professions should use psychosocial skills to help decrease the negative consequences of the injury, such as fear of reinjury, anxiety, depression, and adherence to rehabilitation. These psychosocial skills include goal setting, imagery, relaxation techniques, motivation, and self-talk. This article addresses the negative consequences of injury, psychosocial skills used to aid in the rehabilitation process, and clinical implications of the psychological aspects of rehabilitation in sport.	[Covassin, Tracey; Beidler, Erica; Wallace, Jessica] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Ostrowski, Jennifer] Weber State Univ, Dept Hlth Promot & Human Performance, Ogden, UT 84408 USA	Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, 308 West Circle Dr, E Lansing, MI 48824 USA.	covassin@msu.edu					Ardern CL, 2011, BRIT J SPORT MED, V45, P596, DOI 10.1136/bjsm.2010.076364; Arvinen-Barrow M, 2008, SPORT EXERC MED, V37, P15; Bianco T, 2001, RES Q EXERCISE SPORT, V72, P376, DOI 10.1080/02701367.2001.10608974; Burton D., 2001, HDB SPORT PSYCHOL, P497; Cassidy CM, 2006, ATHLET THER TODAY, V11, P57; Chmielewski TL, 2008, J ORTHOP SPORT PHYS, V38, P746, DOI 10.2519/jospt.2008.2887; Clement D, 2013, J ATHL TRAINING, V48, P512, DOI 10.4085/1062-6050-48.3.21; Danish S, 1986, PSYCHOL ASPECTS CARE; Dawson MA, 2014, J ATHL TRAINING, V49, P331, DOI 10.4085/1062-6050-49.1.09; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Evans L, 2000, SPORT PSYCHOL, V14, P188, DOI 10.1123/tsp.14.2.188; Feltz D, 1986, SPORT INJURIES UNTHW, P336; Fisher A. Craig, 1993, Journal of Athletic Training, V28, P43; Flanigan DC, 2013, ARTHROSCOPY, V29, P1322, DOI 10.1016/j.arthro.2013.05.015; Gould D, 1997, SPORT PSYCHOL, V11, P361, DOI 10.1123/tsp.11.4.361; Granquist M. D, 2014, PSYCHOSOCIAL STRATEG; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hagger MS, 2005, J APPL SOC PSYCHOL, V35, P2345, DOI 10.1111/j.1559-1816.2005.tb02106.x; Hall CR, 1998, INT J SPORT PSYCHOL, V29, P73; Hanrahan SJ, 2010, ROUT INT HANDB, P460; HARDY L, 1996, UNDERSTANDING PSYCHO; HIRD JS, 1991, J SPORT EXERCISE PSY, V13, P281, DOI 10.1123/jsep.13.3.281; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Ievleva L., 1991, SPORT PSYCHOL, V5, P25, DOI DOI 10.1123/TSP.5.1.25; Issac A, 1992, SPORT PSYCHOL, V6, P192; JACOBSON E, 1987, AM J PSYCHOL, V100, P522, DOI 10.2307/1422693; Johnston LH, 2000, BRIT J SPORT MED, V34, P436, DOI 10.1136/bjsm.34.6.436; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kvist J, 2005, KNEE SURG SPORT TR A, V13, P393, DOI 10.1007/s00167-004-0591-8; Larson G, 1996, SPORT PSYCHOL, V10, P15; LEDDY MH, 1994, RES Q EXERCISE SPORT, V65, P347, DOI 10.1080/02701367.1994.10607639; Mainwaring L, 1999, CAN J REHABIL, V12, P145; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; McCullough KA, 2012, AM J SPORT MED, V40, P2523, DOI 10.1177/0363546512456836; Mortiz S, 1996, SPORT PSYCHOL, V10, P171; Pargman D, 2007, USE IMAGERY REHABILI; Pavio A, 1985, CAN J APPL SPORT SCI, V10, P22; Podlog L, 2006, J APPL SPORT PSYCHOL, V18, P44, DOI 10.1080/10413200500471319; Podlog L, 2007, PSYCHOL SPORT EXERC, V8, P535, DOI 10.1016/j.psychsport.2006.07.008; Podlog L, 2011, PHYS THER SPORT, V12, P36, DOI 10.1016/j.ptsp.2010.07.005; Potter M, 1999, NZ J PHYSIOTHERAPY, V28, P24; Prentice WE, 2013, ARNHEIMS PRINCIPLES; Rodgers W., 1991, J APPL SPORT PSYCHOL, V3, P109, DOI DOI 10.1080/10413209108406438; Ross MJ, 1996, J CONSULT CLIN PSYCH, V64, P406, DOI 10.1037/0022-006X.64.2.406; Sage G., 1977, INTRO MOTOR BEHAV NE, V2; SMITH AM, 1990, MAYO CLIN PROC, V65, P38, DOI 10.1016/S0025-6196(12)62108-9; Sordoni C, 2002, PHYSIOTHER CAN, V54, P177; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; te Wierike SCM, 2013, SCAND J MED SCI SPOR, V23, P527, DOI 10.1111/sms.12010; Tongue JR, 2005, J BONE JOINT SURG AM, V87A, P652, DOI 10.2106/00004623-200503000-00027; Tracey J, 2003, J APPL SPORT PSYCHOL, V15, P279, DOI 10.1080/714044197; Tripp DA, 2007, REHABIL PSYCHOL, V52, P74, DOI 10.1037/0090-5550.52.1.74; Udry E, 1997, J SPORT EXERCISE PSY, V19, P229, DOI 10.1123/jsep.19.3.229; Vealey R, 2006, SEEING IS BELIEVING; Walker N, 2004, COPING AND EMOTION IN SPORT, P91; Walker N, 2007, J R SOC PROMO HEALTH, V127, P174, DOI 10.1177/1466424007079494; Watt A. P., 2004, J MENT IMAGERY, V28, P149; Weinberg R., 2011, FDN SPORT EXERCISE P; Weiss M. R., 1986, J NATL ATHLETIC TRAI, P104; Wiese-Bjornstal DM, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2010.01195.x; Wiese-Bjornstal DM, 1998, J APPL SPORT PSYCHOL, V10, P46, DOI 10.1080/10413209808406377; Williams J, 2006, APPL SPORT PSYCHOL P, P285; Williams JM, 1998, J APPL SPORT PSYCHOL, V10, P5, DOI 10.1080/10413209808406375; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b	64	20	23	3	81	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	APR	2015	34	2					199	+		10.1016/j.csm.2014.12.004			15	Sport Sciences	Sport Sciences	CG6RM	WOS:000353430100003	25818709				2021-06-18	
J	Nielson, DM; McKnight, CA; Patel, RN; Kalnin, AJ; Mysiw, WJ				Nielson, Dylan M.; McKnight, Curtis A.; Patel, Riddhi N.; Kalnin, Andrew J.; Mysiw, Walter J.			Preliminary Guidelines for Safe and Effective Use of Repetitive Transcraniat Magnetic Stimulation in Moderate to Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Case report; Depression; Rehabilitation; Transcranial magnetic stimulation	TREATMENT-RESISTANT DEPRESSION; RANDOMIZED CONTROLLED-TRIAL; SKULL PLATES; HEAD-INJURY; EFFICACY; SCALE; DISORDER; EXCITABILITY; SEIZURE; STATE	Transcranial magnetic stimulation has generated extensive interest within the traumatic brain injury (TBI) rehabilitation community, but little work has been done with repetitive protocols, which can produce prolonged changes in behavior. This is partly because of concerns about the safety of repetitive transcranial magnetic stimulation (rTMS) in subjects with TBI, particularly the risk of seizures. These risks can be minimized by careful selection of the rTMS protocol and exclusion criteria. In this article, we identify guidelines for safe use of rTMS in subjects with TBI based on a review of the literature and illustrate their application with a case study. Our subject is a 48-year-old man who sustained a severe TBI 5 years prior to beginning rTMS for the treatment of post-TBI depression. After a 4-week baseline period, we administered daily sessions of low-frequency stimulation to the right dorsolateral prefrontal cortex for 6 weeks. After stimulation, we performed monthly assessments for 3 months. The Hamilton Depression Rating Scale (HAMD) was our primary outcome measure. The stimulation was well tolerated and the patient reported no side effects. After 6 weeks of stimulation, the patient's depression was slightly improved, and these improvements continued through followup. At the end of follow-up, the patient's HAMD score was 49% of the average baseline score. (C) 2015 by the American Congress of Rehabilitation Medicine	[Nielson, Dylan M.; Patel, Riddhi N.; Mysiw, Walter J.] Ohio State Univ, Dept Phys Med & Rehabil, Wexner Med Ctr, Columbus, OH 43210 USA; [McKnight, Curtis A.] Ohio State Univ, Dept Psychiat, Wexner Med Ctr, Columbus, OH 43210 USA; [Kalnin, Andrew J.] Ohio State Univ, Dept Radiol, Wexner Med Ctr, Columbus, OH 43210 USA	Mysiw, WJ (corresponding author), 1818 Dodd Hall,480 Med Ctr Dr, Columbus, OH 43210 USA.	w.mysiw@osumc.edu		Nielson, Dylan/0000-0003-4613-6643	Department of Physical Medicine and Rehabilitation, Wexner Medical Center, The Ohio State University	Supported by the Department of Physical Medicine and Rehabilitation, Wexner Medical Center, The Ohio State University.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersson J.L.R., 2007, NONLINEAR REGISTRATI; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Chistyakov AV, 1999, CLIN NEUROPHYSIOL, V110, P1080, DOI 10.1016/S1388-2457(99)00029-2; Datta A, 2010, NEUROIMAGE, V52, P1268, DOI 10.1016/j.neuroimage.2010.04.252; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Epstein CM, 2006, CLIN NEUROPHYSIOL, V117, P2566, DOI 10.1016/j.clinph.2006.07.262; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fitzgerald PB, 2011, J ECT, V27, P38, DOI 10.1097/YCT.0b013e3181eb30c6; Fitzgerald PB, 2009, NEUROPSYCHOPHARMACOL, V34, P1255, DOI 10.1038/npp.2008.233; Fitzgerald PB, 2013, SIDE EFFECTS RTMS TR; Fox MD, 2012, BIOL PSYCHIAT, V72, P595, DOI 10.1016/j.biopsych.2012.04.028; George MS, 2010, ARCH GEN PSYCHIAT, V67, P507, DOI 10.1001/archgenpsychiatry.2010.46; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Hedlung J. L., 1979, J OPERATIONAL PSYCHI, V10, P149, DOI DOI 10.1192/BJP.BP.106.032532; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hsu WY, 2011, EPILEPSY RES, V96, P231, DOI 10.1016/j.eplepsyres.2011.06.002; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jorge RE, 2004, BIOL PSYCHIAT, V55, P398, DOI 10.1016/j.biopsych.2003.08.017; Jorge RE, 2008, ARCH GEN PSYCHIAT, V65, P268, DOI 10.1001/archgenpsychiatry.2007.45; Kim L, 2011, ANN REHABIL MED-ARM, V35, P765, DOI 10.5535/arm.2011.35.6.765; Kito S, 2011, PSYCHIAT CLIN NEUROS, V65, P175, DOI 10.1111/j.1440-1819.2010.02183.x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Manganotti P, 2013, BRAIN STIMUL, V6, P913, DOI 10.1016/j.brs.2013.06.006; McDonald WM, 2011, DEPRESS ANXIETY, V28, P973, DOI 10.1002/da.20885; Nowak DA, 2006, CLIN NEUROPHYSIOL, V117, P1631, DOI 10.1016/j.clinph.2006.03.017; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rotenberg A, 2007, CLIN NEUROPHYSIOL, V118, P2536, DOI 10.1016/j.clinph.2007.08.003; Rotenberg A, 2009, CLIN NEUROPHYSIOL, V120, P1417, DOI 10.1016/j.clinph.2009.05.004; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xia GH, 2008, INT J NEUROPSYCHOPH, V11, P119, DOI 10.1017/S1461145707007699	43	20	20	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2015	96	4		2			S138	S144		10.1016/j.apmr.2014.09.010			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CE9RA	WOS:000352179900007	25281871				2021-06-18	
J	Wolfe, KR; Bigler, ED; Dennis, M; Gerhardt, CA; Rubin, K; Taylor, HG; Vannatta, K; Yeates, KO				Wolfe, Kelly R.; Bigler, Erin D.; Dennis, Maureen; Gerhardt, Cynthia A.; Rubin, Kenneth; Taylor, H. Gerry; Vannatta, Kathryn; Yeates, Keith Owen			Self-Awareness of Peer-Rated Social Attributes in Children With Traumatic Brain Injury	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						neurological disorders; neuropsychology; peers; psychosocial functioning	QUALITY-OF-LIFE; EVERYDAY ATTENTION; TEA-CH; ADOLESCENTS; COMPETENCE; PATTERNS; RATINGS; ADHD	Objective This study investigated self-awareness of peer-rated social attributes and its relations to executive function (EF), theory of mind (TOM), and psychosocial adjustment in children with traumatic brain injury (TBI). Methods Self-and peer perceptions of classroom social behavior were assessed for 87 children 8-13 years of age: 15 with severe TBI, 40 with complicated mild/moderate TBI, and 32 with orthopedic injury. Participants completed measures of EF and TOM, and parents rated children's psychosocial adjustment. Results Self-ratings of classroom social behavior did not differ between injury groups. Self-and peer ratings generally agreed, although children with severe TBI rated themselves as less rejected/victimized than did their peers. Higher EF predicted better self-and peer ratings and smaller self-peer discrepancies, which in turn predicted better adjustment. Conclusions Children with TBI show variable social self-awareness, which relates to EF and adjustment. Future studies should identify additional factors that contribute to limited insight.	[Wolfe, Kelly R.; Yeates, Keith Owen] Nationwide Childrens Hosp, Dept Psychol, Columbus, OH 43205 USA; [Wolfe, Kelly R.; Gerhardt, Cynthia A.; Vannatta, Kathryn; Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Wolfe, Kelly R.; Gerhardt, Cynthia A.; Vannatta, Kathryn; Yeates, Keith Owen] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON M5S 1A1, Canada; [Gerhardt, Cynthia A.; Vannatta, Kathryn] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH 43205 USA; [Rubin, Kenneth] Univ Maryland, Dept Human Dev & Quantitat Methodol, College Pk, MD 20742 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH USA	Wolfe, KR (corresponding author), Nationwide Childrens Hosp, Dept Psychol, 700 Childrens Dr, Columbus, OH 43205 USA.	Kelly.Wolfe@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020; Rubin, Kenneth H/M-5276-2018	Rubin, Kenneth H/0000-0002-2608-2484; Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human Development at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5 R01 HD048946]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048946] Funding Source: NIH RePORTER	This work was supported by the National Institute of Child Health and Human Development at the National Institutes of Health (grant number 5 R01 HD048946 to K.O.Y.).	Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BOIVIN M, 1994, DEV PSYCHOPATHOL, V6, P483, DOI 10.1017/S0954579400006064; Bowker JCW, 2006, MERRILL PALMER QUART, V52, P671, DOI 10.1353/mpq.2006.0000; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; de Castro BO, 2007, J ABNORM CHILD PSYCH, V35, P165, DOI 10.1007/s10802-006-9063-6; De Los Reyes A, 2013, ANNU REV CLIN PSYCHO, V9, P123, DOI 10.1146/annurev-clinpsy-050212-185617; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fleming J., 1995, BRIT J OCCUP THER, V58, P55, DOI DOI 10.1177/030802269505800204; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Gresham FM, 2000, J SCHOOL PSYCHOL, V38, P151, DOI 10.1016/S0022-4405(99)00042-4; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hayes A.F., 2018, INTRO MEDIATION MODE, V2nd ed.; Heaton SC, 2001, CHILD NEUROPSYCHOL, V7, P251, DOI 10.1076/chin.7.4.251.8736; Howard I, 2005, ETHNIC DIS, V15, pS51; Krueger CE, 2011, CLIN NEUROPSYCHOL, V25, P741, DOI 10.1080/13854046.2011.569759; Laird RD, 2013, J ABNORM CHILD PSYCH, V41, P1, DOI 10.1007/s10802-012-9659-y; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; MASTEN AS, 1985, DEV PSYCHOL, V21, P523, DOI 10.1037/0012-1649.21.3.523; Mikami AY, 2010, J CLIN CHILD ADOLESC, V39, P373, DOI 10.1080/15374411003691735; Oakland, 2003, ABAS 2 ADAPTIVE BEHA; Reynolds CR., 2004, BEHAV ASSESSMENT SYS, V2nd; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rubin KH, 2006, J ABNORM CHILD PSYCH, V34, P143, DOI 10.1007/s10802-005-9017-4; Salley CG, 2010, SELF IDENTITY, V9, P209, DOI 10.1080/15298860902979224; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHLSER ABBREVIATED; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Zakriski AL, 1996, CHILD DEV, V67, P1048, DOI 10.2307/1131879	45	20	20	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	APR	2015	40	3			SI		272	284		10.1093/jpepsy/jsu060			13	Psychology, Developmental	Psychology	CF3YT	WOS:000352485700002	25080604	Bronze, Green Published			2021-06-18	
J	Fedor, A; Gunstad, J				Fedor, Andrew; Gunstad, John			Limited Knowledge of Concussion Symptoms in College Athletes	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						concussion; knowledge; college; athletes; amnesia	SPORT-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; POSTCONCUSSION SYNDROME; HEAD-INJURY; EPIDEMIOLOGY	Concussions are common in athletes and often go unreported. A likely contributor to underreporting of concussions in athletes is lack of knowledge of concussion-related symptoms. The current study assessed concussion symptom knowledge in 382 Division I athletes and 230 nonathletes. Participants were asked to identify potential symptoms following a concussion from a list of both real symptoms and distractors. Student-athletes expected significantly more total symptoms following a concussion than did nonathletes, and they correctly identified symptoms such as nausea and/or vomiting and being easily upset by loud noises more frequently than controls. However, many student-athletes failed to identify possible emotional symptoms resulting from a concussion, and approximately 70% of student-athletes endorsed the distracter item "forgetting names or faces of people you know well" as being a symptom of concussion. These current findings suggest that student-athletes may have an incomplete understanding of concussion-related symptoms, and future studies are needed to determine whether formal education sessions can improve knowledge for this high-risk population.	[Fedor, Andrew; Gunstad, John] Kent State Univ, Dept Psychol, Kent, OH 44242 USA	Gunstad, J (corresponding author), Kent State Univ, Dept Psychol, 221 Kent Hall, Kent, OH 44242 USA.	jgunstad@kent.edu					American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Covassin T, 2003, J ATHL TRAINING, V38, P238; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Edmed SL, 2012, APPL NEUROPSYCH-ADUL, V19, P164, DOI 10.1080/09084282.2011.643961; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LIVINGSTON SC, 2004, J ATHL TRAINING, V39, pS17; Lovell MR, 2007, IMPACT VERSION 6 0 C; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Pardini D., 2004, BR J SPORTS MED, V38, P661; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Simonds C.B., 2004, DISS ABSTR INT B, V65, P3724; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039	25	20	20	0	38	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 4	2015	22	2					108	113		10.1080/23279095.2013.860604			6	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	CC5DR	WOS:000350379400005	25072295				2021-06-18	
J	Dayan, PS; Holmes, JF; Hoyle, J; Atabaki, S; Tunik, MG; Lichenstein, R; Miskin, M; Kuppermann, N				Dayan, Peter S.; Holmes, James F.; Hoyle, John, Jr.; Atabaki, Shireen; Tunik, Michael G.; Lichenstein, Richard; Miskin, Michelle; Kuppermann, Nathan		PECARN	Headache in Traumatic Brain Injuries From Blunt Head Trauma	PEDIATRICS			English	Article							DECISION RULE; INTRACRANIAL INJURY; COMPUTED-TOMOGRAPHY; CHILDREN; PREDICTION; VARIABLES	OBJECTIVE: To determine the risk of traumatic brain injuries (TBIs) in children with headaches after minor blunt head trauma, particularly when the headaches occur without other findings suggestive of TBIs (ie, isolated headaches). METHODS: This was a secondary analysis of a prospective observational study of children 2 to 18 years with minor blunt head trauma (ie, Glasgow Coma Scale scores of 14-15). Clinicians assessed the history and characteristics of headaches at the time of initial evaluation, and documented findings onto case report forms. Our outcome measures were (1) clinically important TBI (ciTBI) and (2) TBI visible on computed tomography (CT). RESULTS: Of 27 495 eligible patients, 12 675 (46.1%) had headaches. Of the 12 567 patients who had complete data, 2462 (19.6%) had isolated headaches. ciTBIs occurred in 0 of 2462 patients (0%; 95% confidence interval [CI]: 0%-0.1%) in the isolated headache group versus 162 of 10 105 patients (1.6%; 95% CI: 1.4%-1.9%) in the nonisolated headache group (risk difference, 1.6%; 95% CI: 1.3%-1.9%). TBIs on CT occurred in 3 of 456 patients (0.7%; 95% CI: 0.1%-1.9%) in the isolated headache group versus 271 of 6089 patients (4.5%; 95% CI: 3.9%-5.0%) in the nonisolated headache group (risk difference, 3.8%; 95% CI: 2.3%-4.5%). We found no significant independent associations between the risk of ciTBI or TBI on CT with either headache severity or location. CONCLUSIONS: ciTBIs are rare and TBIs on CT are very uncommon in children with minor blunt head trauma when headaches are their only sign or symptom.	[Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Div Pediat Emergency Med, Morgan Stanley Childrens Hosp, New York, NY 10032 USA; [Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA; [Hoyle, John, Jr.] Helen DeVos Childrens Hosp, Div Emergency Med, Grand Rapids, MI USA; [Hoyle, John, Jr.] Michigan State Univ, Dept Emergency Med, E Lansing, MI 48824 USA; [Hoyle, John, Jr.] Western Michigan Univ, Dept Emergency Med, Sch Med, Kalamazoo, MI 49008 USA; [Hoyle, John, Jr.] Western Michigan Univ, Dept Pediat, Sch Med, Kalamazoo, MI 49008 USA; [Atabaki, Shireen] George Washington Univ, Sch Med, Dept Pediat, Childrens Natl Med Ctr, Washington, DC 20052 USA; [Atabaki, Shireen] George Washington Univ, Childrens Natl Med Ctr, Dept Emergency Med, Sch Med, Washington, DC 20052 USA; [Tunik, Michael G.] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Tunik, Michael G.] NYU, Sch Med, Dept Emergency Med, New York, NY USA; [Lichenstein, Richard] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Miskin, Michelle] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA	Dayan, PS (corresponding author), New York Presbyterian Morgan Stanley Childrens Ho, 3959 Broadway,CHN-1-116, New York, NY 10032 USA.	psd6@columbia.edu		Tunik, Michael/0000-0002-2368-5933; Holubkov, Richard/0000-0003-0431-3381; Tsung, James/0000-0002-4718-8325	Health Resources and Services Administration (HRSA)/Maternal and Child Health Bureau (MCHB), Division of Research, Education, and Training; Emergency Medical Services of Children (EMSC) [R40MC02461]; EMSC program of the MCHB/HRSA [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, U03MC22685]	Supported by a grant from the Health Resources and Services Administration (HRSA)/Maternal and Child Health Bureau (MCHB), Division of Research, Education, and Training, and the Emergency Medical Services of Children (EMSC) program (R40MC02461). The Pediatric Emergency Care Applied Research Network is supported by cooperative agreements U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, and U03MC22685 from the EMSC program of the MCHB/HRSA.	Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Da Dalt L, 2006, EUR J PEDIATR, V165, P142, DOI 10.1007/s00431-005-0019-6; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Frush DP, 2008, PEDIATR RADIOL, V38, pS629, DOI 10.1007/s00247-008-1006-7; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; National Center for Injury Prevention and Control, TRAUM BRAIN INJ US; Newgard CD, 2007, ACAD EMERG MED, V14, P669, DOI 10.1197/j.aem.2006.11.038; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Raghunathan TL., 2001, SURV METHODOL, V27, P85; Rubin DB., 1987, MULTIPLE IMPUTATION; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Sun BCH, 2007, ANN EMERG MED, V49, pe1; Sun BC, 2007, ANN EMERG MED, V49, P325, DOI 10.1016/j.annemergmed.2006.08.032	24	20	21	0	1	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	MAR	2015	135	3					504	512		10.1542/peds.2014-2695			9	Pediatrics	Pediatrics	CF0BD	WOS:000352206600050	25647678				2021-06-18	
J	Ramski, DE; Hennrikus, WP; Bae, DS; Baldwin, KD; Patel, NM; Waters, PM; Flynn, JM				Ramski, David E.; Hennrikus, William P.; Bae, Donald S.; Baldwin, Keith D.; Patel, Neeraj M.; Waters, Peter M.; Flynn, John M.			Pediatric Monteggia Fractures: A Multicenter Examination of Treatment Strategy and Early Clinical and Radiographic Results	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						Monteggia; internal fixation; outcomes; pediatric	OPEN REDUCTION; ANNULAR LIGAMENT; RADIAL HEAD; CHILDREN; DISLOCATIONS; LESIONS; RECONSTRUCTION; INJURIES	Background: Monteggia fractures remain challenging pediatric injuries because of difficulties in diagnosis, propensity for instability, and complexity of late reconstruction. The objective of this investigation was to assess the efficacy of the following treatment strategy based upon ulnar fracture pattern: closed reduction (CR) for plastic/greenstick fractures, intramedullary (IM) pin fixation for transverse/short oblique fractures, and open reduction and internal fixation for long oblique/comminuted fractures. Methods: A total of 112 acute Monteggia fracture patients were retrospectively analyzed at two level 1 pediatric trauma centers from 2000 to 2011. Mean age was 6.9 +/- 2.9 years (range, 0.6 to 16.7 y); 54% were male. Mean clinical follow-up was 19.8 weeks. Fracture patterns were classified and patients were separated into 3 groups: treatment according to the strategy versus more rigorous versus less rigorous intervention. The Fisher exact test was used to compare the rates of failure between the groups. "Failure" was defined as failure to obtain and maintain an anatomic reduction of the radial head and/or loss of ulnar reduction during follow-up. Results: None of the 57 patients treated according to the strategy experienced failure, nor did any of the 23 patients treated more rigorously. In contrast, 6 of 32 patients (19%) who were treated less rigorously compared with the recommended strategy demonstrated recurrent radiocapitellar instability (n = 3), loss of ulnar fracture reduction requiring revision surgery (n = 2), or both events together (n = 1) (P < 0.001). Specifically, all treatment failures occurred in complete fractures treated nonoperatively-there were 6/18 failures (33% failure rate) of complete fractures treated nonoperatively compared with 0/52 failures of complete fractures treated operatively (P < 0.001). Other complications were similarly distributed between the treatment groups and consisted of 1 ulnar nonunion, 2 compartment syndromes, and 3 transient nerve palsies/neuropraxias. Comminuted fractures required open reduction of the radiocapitellar joint more than other fracture types (P < 0.001). Conclusions: In this pediatric Monteggia series, recurrent instability only occurred in patients who were not treated according to the ulnar-based strategy. Complete ulnar fracture patterns are at risk of failure without initial operative treatment.	[Ramski, David E.; Baldwin, Keith D.; Patel, Neeraj M.; Flynn, John M.] Childrens Hosp Philadelphia, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Hennrikus, William P.; Bae, Donald S.; Waters, Peter M.] Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA	Waters, PM (corresponding author), Boston Childrens Hosp, 300 Longwood Ave,Hunnewell 2, Boston, MA 02115 USA.	peter.waters@childrens.harvard.edu		Patel, Neeraj/0000-0002-0255-8783			Bado J L, 1967, Clin Orthop Relat Res, V50, P71; Beutel BG, 2012, ORTHOPEDICS, V35, P138, DOI 10.3928/01477447-20120123-32; David-West KS, 2005, INJURY, V36, P1206, DOI 10.1016/j.injury.2004.12.033; Degreff I, 2004, J ORTHOP TRAUMA, V18, P375, DOI 10.1097/00005131-200407000-00008; DORMANS JP, 1990, ORTHOP CLIN N AM, V21, P251; FOWLES JV, 1983, J BONE JOINT SURG AM, V65, P1276, DOI 10.2106/00004623-198365090-00008; Hui JHP, 2005, J PEDIATR ORTHOPED, V25, P501, DOI 10.1097/01.bpo.0000158812.37225.b3; Kunkel S, 2011, J PEDIATR ORTHOPED, V31, P628, DOI 10.1097/BPO.0b013e3182210988; Leonidou A, 2012, J PEDIATR ORTHOPED, V32, P352, DOI 10.1097/BPO.0b013e31825611fc; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724; Monteggia GB, 1914, I CHIRURG, P1813; Nakamura K, 2009, J BONE JOINT SURG AM, V91A, P1394, DOI 10.2106/JBJS.H.00644; Nanno Mitsuhiko, 2007, Am J Orthop (Belle Mead NJ), V36, pE80; OLNEY BW, 1989, J PEDIATR ORTHOPED, V9, P219; Ring D, 1996, J BONE JOINT SURG BR, V78B, P734; Rodgers WB, 1996, J BONE JOINT SURG AM, V78A, P1322, DOI 10.2106/00004623-199609000-00005; Tan JW, 2008, INJURY, V39, P451, DOI 10.1016/j.injury.2007.07.010; WILEY JJ, 1985, J BONE JOINT SURG BR, V67, P728	18	20	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	MAR	2015	35	2					115	120		10.1097/BPO.0000000000000213			6	Orthopedics; Pediatrics	Orthopedics; Pediatrics	CB9UM	WOS:000349978700005	24978320				2021-06-18	
J	Richardson, C; McKay, A; Ponsford, JL				Richardson, Cally; McKay, Adam; Ponsford, Jennie L.			Factors Influencing Self-Awareness Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						close other; depression; injury severity; self-awareness; traumatic brain injury	IMPAIRED AWARENESS; EXECUTIVE FUNCTION; POSTTRAUMATIC AMNESIA; PSYCHIATRIC-DISORDERS; DEPRESSION SCALE; HOSPITAL ANXIETY; EMOTIONAL STATUS; HEAD-INJURY; REHABILITATION; DEFICITS	Objective: To examine self-awareness and injury-related, emotional and demographic factors across acute/subacute (3-12 months), medium-term (24-60 months), and long-term (120-240 months) time periods after traumatic brain injury (TBI), because unawareness of injury-related changes can affect engagement in rehabilitation and functional outcomes. Participants: A total of 168 individuals with mild to severe TBI and 105 of their close others. Main Outcomes Measures: Awareness Questionnaire (AQ) and Hospital Anxiety and Depression Scale. Design: Cross-sectional study. Results: There were no significant differences in awareness as a function of time postinjury, except for the AQ motor/sensory domain wherein individuals with TBI at longer time periods displayed increased awareness of deficits than those at earlier time periods. Greater patient-other AQ discrepancy scores (interpreted as lower patient awareness) were associated with longer posttraumatic amnesia duration in the individual with TBI and also with increased self-reported depressive symptoms in the close others. Conversely, smaller AQ discrepancy scores (interpreted as better awareness) were associated with increased self-reported depressive symptoms by the individuals with TBI. Conclusion: This study highlights the limitations of using discrepancy scores to measure awareness, as ratings of injury-related changes are influenced by the mood of the individual with TBI and the close other, as well as by injury severity.	[Richardson, Cally; McKay, Adam; Ponsford, Jennie L.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3800, Australia; [Richardson, Cally; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [McKay, Adam] Epworth Rehabil, Melbourne, Vic, Australia	Richardson, C (corresponding author), Monash Univ, Sch Psychol & Psychiat, Wellington Rd, Melbourne, Vic 3800, Australia.	cally.richardson@monash.edu	McKay, Adam JD/M-6003-2017	McKay, Adam JD/0000-0002-0479-7681			Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [10.1097/00001199-198909000-00008, DOI 10.1097/00001199-198909000-00008]; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Dirette DK, 2007, BRAIN INJURY, V21, P1131, DOI 10.1080/02699050701687326; Dirette DK., 2008, BRIT J OCCUPATIONAL, V71, P44, DOI DOI 10.1177/030802260807100202; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kreutzer JS., 1999, NEUROBEHAVIORAL FUNC; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Newman AC, 2000, BRAIN INJURY, V14, P333; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P1; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Snaith R.P., 1994, HOSP ANXIETY DEPRESS; Tabachnick BG, 2007, USING MULTIVARIATE S; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Wallace CA, 2000, BRAIN INJURY, V14, P549; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007	65	20	21	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					E43	E54		10.1097/HTR.0000000000000048			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300005	24721809				2021-06-18	
J	Robertson, CL; Fidan, E; Stanley, RM; Noje, C; Bayir, H				Robertson, Courtney L.; Fidan, Emin; Stanley, Rachel M.; Noje, Corina; Bayir, Huelya			Progesterone for Neuroprotection in Pediatric Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						children; developmental brain injury; infant; neurosteroid; trauma	SEX STEROID-HORMONES; CORTICAL CONTUSION INJURY; EXTREMELY PRETERM INFANTS; CENTRAL-NERVOUS-SYSTEM; METHYL-D-ASPARTATE; RAT-BRAIN; IMMATURE RATS; CELL-DEATH; INFLAMMATORY RESPONSE; GABA(A) RECEPTORS	Objective: To provide an overview of the preclinical literature on progesterone for neuroprotection after traumatic brain injury and to describe unique features of developmental brain injury that should be considered when evaluating the therapeutic potential for progesterone treatment after pediatric traumatic brain injury. Data Sources: National Library of Medicine PubMed literature review. Study Selection: The mechanisms of neuroprotection by progesterone are reviewed, and the preclinical literature using progesterone treatment in adult animal models of traumatic brain injury is summarized. Unique features of the developing brain that could either enhance or limit the efficacy of neuroprotection by progesterone are discussed, and the limited preclinical literature using progesterone after acute injury to the developing brain is described. Finally, the current status of clinical trials of progesterone for adult traumatic brain injury is reviewed. Data Extraction and Data Synthesis: Progesterone is a pleiotropic agent with beneficial effects on secondary injury cascades that occur after traumatic brain injury, including cerebral edema, 40 studies have used progesterone for treatment after traumatic brain injury in adult animal models, with results summarized in tabular form. However, very few studies have evaluated progesterone in pediatric animal models of brain injury. To date, two human phase II trials of progesterone for adult traumatic brain injury have been published, and two multicenter phase III trials are underway. Conclusions: The unique features of the developing brain from that of a mature adult brain make it necessary to independently study progesterone in clinically relevant, immature animal models of traumatic brain injury. Additional preclinical studies could lead to the development of a novel neuroprotective therapy that could reduce the long-term disability in head-injured children and could potentially provide benefit in other forms of pediatric brain injury (global ischemia, stroke, and statue epilepticus).	[Robertson, Courtney L.; Noje, Corina] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Robertson, Courtney L.; Noje, Corina] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Fidan, Emin; Bayir, Huelya] Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Stanley, Rachel M.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Stanley, Rachel M.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Bayir, Huelya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA USA	Robertson, CL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	crober48@jhmi.edu; bayihx@upmc.edu			Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [1H34MC193530100]; Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS061817, NS076511]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061817, R01NS076511] Funding Source: NIH RePORTER	Dr. Stanley received support from the Health Resources and Services Administration (1H34MC193530100). Her institution received grant support from the Health Resources and Services Administration (planning grant to plan a trial of progesterone for pediatric traumatic brain injury). Dr. Noje is employed by Johns Hopkins School of Medicine. Dr. Bayir received support for article research from the National Institutes of Health (NS061817 and NS076511). Her institution received grant support from NINDS. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Ardeshiri A, 2006, EUR J NEUROSCI, V24, P2567, DOI 10.1111/j.1460-9568.2006.05142.x; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Baykara B, 2013, BIOTECH HISTOCHEM, V88, P250, DOI 10.3109/10520295.2013.769630; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Beyenburg S, 2001, EPILEPSY RES, V44, P141, DOI 10.1016/S0920-1211(01)00194-2; BHR Pharma LLC, SYNAPSE GLOB PHAS 3; Billiards SS, 2006, J COMP NEUROL, V497, P199, DOI 10.1002/cne.20991; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Carre JL, 2001, J STEROID BIOCHEM, V78, P89, DOI 10.1016/S0960-0760(01)00079-6; Cekic M, 2012, RESTOR NEUROL NEUROS, V30, P115, DOI 10.3233/RNN-2011-0628; Cekic M, 2011, NEUROBIOL AGING, V32, P864, DOI 10.1016/j.neurobiolaging.2009.04.017; Chan JR, 1998, P NATL ACAD SCI USA, V95, P10459, DOI 10.1073/pnas.95.18.10459; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; DALTON K, 1976, BRIT J PSYCHIAT, V129, P438, DOI 10.1192/bjp.129.5.438; DALTON K, 1979, J ROY SOC MED, V72, P397; Dazert P, 2006, NEUROSCIENCE, V142, P1071, DOI 10.1016/j.neuroscience.2006.07.056; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; Ezquer ME, 2008, BRAIN RES, V1214, P73, DOI 10.1016/j.brainres.2008.03.029; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Ferrazzano P, 2013, CNS NEUROL DISORD-DR, V12, P338, DOI 10.2174/1871527311312030007; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; Gonzalez-Ramirez M, 2010, PHARMACOL BIOCHEM BE, V97, P267, DOI 10.1016/j.pbb.2010.08.009; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2011, BEHAV BRAIN RES, V217, P202, DOI 10.1016/j.bbr.2010.09.029; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Grosso S, 2003, EPILEPSY RES, V54, P29, DOI 10.1016/S0920-1211(03)00042-1; GUENNOUN R, 1995, MOL BRAIN RES, V30, P287, DOI 10.1016/0169-328X(95)00016-L; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Hoffman GE, 2006, ENDOCRINE, V29, P217, DOI 10.1385/ENDO:29:2:217; HOLMES GL, 1984, DEV BRAIN RES, V16, P45, DOI 10.1016/0165-3806(84)90061-0; Hua F, 2012, HORM BEHAV, V61, P642, DOI 10.1016/j.yhbeh.2012.02.017; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Ibanez C, 2004, NEUROPATH APPL NEURO, V30, P80, DOI 10.1046/j.0305-1846.2003.00515.x; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; JungTestas I, 1996, CELL MOL NEUROBIOL, V16, P439, DOI 10.1007/BF02088110; Kasturi BS, 2009, RESTOR NEUROL NEUROS, V27, P265, DOI [10.3233/RNN-2009-0475, 10.3233/RNN-2009-0476]; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI 10.1139/y10-103; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Kohchi C, 1998, BRAIN RES, V801, P233, DOI 10.1016/S0006-8993(98)00585-X; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Luoma JI, 2012, J STEROID BIOCHEM, V131, P30, DOI 10.1016/j.jsbmb.2011.11.002; MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A; MCDONALD JW, 1992, BRAIN RES, V583, P54, DOI 10.1016/S0006-8993(10)80009-5; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Mellon SH, 2007, PHARMACOL THERAPEUT, V116, P107, DOI 10.1016/j.pharmthera.2007.04.011; Miller L, 1998, J IMMUNOL, V160, P5098; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Moorthy K, 2005, EXP GERONTOL, V40, P295, DOI 10.1016/j.exger.2005.01.004; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Nunez JL, 2007, DEV NEUROBIOL, V67, P1879, DOI 10.1002/dneu.20567; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Perrot-Sinal TS, 2003, NEUROSCIENCE, V116, P995, DOI 10.1016/S0306-4522(02)00794-7; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Quadros PS, 2008, ENDOCRINOLOGY, V149, P3054, DOI 10.1210/en.2007-1133; Quadros PS, 2007, J COMP NEUROL, V504, P42, DOI 10.1002/cne.21427; Rhodes ME, 2005, EPILEPSY BEHAV, V6, P320, DOI 10.1016/j.yebeh.2005.02.006; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Trotter A, 2001, J CLIN ENDOCR METAB, V86, P601, DOI 10.1210/jc.86.2.601; Trotter A, 1999, J CLIN ENDOCR METAB, V84, P4531, DOI 10.1210/jc.84.12.4531; Trotter A, 2012, J CLIN ENDOCR METAB, V97, P1041, DOI 10.1210/jc.2011-2612; Tsuji M, 2012, EXP NEUROL, V233, P214, DOI 10.1016/j.expneurol.2011.10.004; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; VanLandingham JW, 2008, J CEREBR BLOOD F MET, V28, P1786, DOI 10.1038/jcbfm.2008.73; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Wagner CK, 2008, ENDOCRINOLOGY, V149, P2743, DOI 10.1210/en.2008-0049; Wagner CK, 2006, FRONT NEUROENDOCRIN, V27, P340, DOI 10.1016/j.yfrne.2006.07.003; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Wechsler B, 2005, J TRAUMA, V58, P940, DOI 10.1097/01.TA.0000162630.78386.98; Wright D, PROGESTERONE TRAUMAT; Wright DW, 2008, BRAIN INJURY, V22, P107, DOI 10.1080/02699050701867399; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	124	20	25	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2015	16	3					236	244		10.1097/PCC.0000000000000323			9	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	CD1AZ	WOS:000350807300008	25581631	Green Accepted			2021-06-18	
J	Roiger, T; Weidauer, L; Kern, B				Roiger, Trevor; Weidauer, Lee; Kern, Bryce			A Longitudinal Pilot Study of Depressive Symptoms in Concussed and Injured/Nonconcussed National Collegiate Athletic Association Division I Student-Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						psychology; Center for Epidemiologic Studies Depression Scale; athletic injuries	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; PROFESSIONAL FOOTBALL PLAYERS; CLINICAL-OUTCOMES ASSESSMENT; SPORT-RELATED CONCUSSION; SOCIAL SUPPORT; RISK-FACTORS; POSTINJURY DEPRESSION; HEAD-INJURY; FOLLOW-UP	Context: Depression, which affects millions of Americans each year, among them collegiate student-athletes, can be caused by a wide range of circumstances, including sport-related injuries. Objective: To longitudinally examine the extent to which National Collegiate Athletic Association Division I student-athletes demonstrated postinjury depressive symptoms. Design: Descriptive epidemiologic study. Setting: National Collegiate Athletic Association Division I collegiate athletics. Patients or Other Participants: Concussed, injured/nonconcussed, and healthy Division I collegiate student-athletes (aged 18-22 years) competing in men's basketball, football, and wrestling and women's basketball, soccer, and volleyball. Main Outcome Measure(s): Participants completed the Center for Epidemiologic Studies Depression Scale at baseline and at 1 week, 1 month, and 3 months postinjury. We measured differences in depressive scores among concussed, injured/nonconcussed, and healthy participants. Longitudinal changes in postconcussion depressive symptoms were also examined. Results: No differences in baseline depressive symptoms among subgroups were noted. After an increase between baseline and 1 week (4.3, 95% confidence interval [CI] = 0.41, 8.16, P = .02), depressive symptoms in the concussion group decreased between 1 week and 1 month (-2.7, 95% CI = -4.96, -0.47, P = .01) and between 1 week and 3 months (-4.0, 95% CI = -6.50, -1.49, P = .004). The injured/nonconcussed group showed differences between baseline and 1 week (4.6, 95% CI -1.08, 8.17, P = .009) and between baseline and 1 month (3.2, 95% CI = -0.05, 6.30, P = .03). No significant differences were present in depressive symptoms between concussed participants and injured/nonconcussed participants at any of the postinjury time points. Conclusions: Depression may present as a postinjury sequela in Division I collegiate athletes. Athletes who sustain a concussion or other injury resulting in time lost from practice or competition need to be observed carefully for signs and symptoms that may indicate depression. Tools such as the Center for Epidemiologic Studies Depression Scale can be valuable in helping clinicians to recognize and manage depressive symptoms in these individuals.	[Roiger, Trevor; Weidauer, Lee] S Dakota State Univ, Brookings, SD 57007 USA; [Kern, Bryce] Sport & Spine Phys Therapy, Wausau, WI USA	Roiger, T (corresponding author), S Dakota State Univ, Box 2203 SIM 116, Brookings, SD 57007 USA.	trevor.roiger@sdstate.edu					Appaneal RN, 2009, J SPORT EXERCISE PSY, V31, P60, DOI 10.1123/jsep.31.1.60; Armstrong S, 2009, J AM COLL HEALTH, V57, P521, DOI 10.3200/JACH.57.5.521-526; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; CHAN CS, 1988, PERCEPT MOTOR SKILL, V66, P875, DOI 10.2466/pms.1988.66.3.875; Eisenberg D, 2007, AM J ORTHOPSYCHIAT, V77, P534, DOI 10.1037/0002-9432.77.4.534; Giza CC, 2001, J ATHL TRAINING, V36, P228; Green SL, 2001, J APPL SPORT PSYCHOL, V13, P40, DOI 10.1080/10413200109339003; GROVE JR, 1992, INT J SPORT PSYCHOL, V23, P93; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Kelly W. E., 1999, COLL STUDENT J, V33, P72; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McDonald SA, 1990, SPORT PSYCHOL, V4, P261; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; Morgan C, 2003, CYBERPSYCHOL BEHAV, V6, P133, DOI 10.1089/109493103321640329; National Collegiate Athletic Association, 2012, 2012 13 NCAA SPORTS, P121; Parsons JT, 2011, J SPORT REHABIL, V20, P17, DOI 10.1123/jsr.20.1.17; Peden AR, 2001, J AM COLL HEALTH, V49, P299, DOI 10.1080/07448480109596316; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richmond TS, 2009, PSYCHOL MED, V39, P1709, DOI 10.1017/S0033291709005376; Roh YH, 2012, ARCH ORTHOP TRAUM SU, V132, P1251, DOI 10.1007/s00402-012-1545-0; Shean G, 2008, J GENET PSYCHOL, V169, P281, DOI 10.3200/GNTP.169.3.281-292; Smarr KL., 2003, ARTHRITIS CARE RES, V49, pS134, DOI [10.1002/art.11410, DOI 10.1002/ART.11410]; Snyder AR, 2008, J ATHL TRAINING, V43, P428, DOI 10.4085/1062-6050-43.4.428; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; STEIN PJ, 1978, J SOC ISSUES, V34, P136, DOI 10.1111/j.1540-4560.1978.tb02545.x; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Valovich McLeod TC, 2008, J ATHL TRAINING, V43, P437, DOI DOI 10.404/1062-6050-43.4.437; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b	40	20	20	0	21	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2015	50	3					256	261		10.4085/1062-6050-49.3.83			6	Sport Sciences	Sport Sciences	CQ8AM	WOS:000360828300004	25562455	Green Published, Bronze			2021-06-18	
J	Ryan, NP; Hughes, N; Godfrey, C; Rosema, S; Catroppa, C; Anderson, VA				Ryan, Nicholas P.; Hughes, Nathan; Godfrey, Celia; Rosema, Stefanie; Catroppa, Cathy; Anderson, Vicki A.			Prevalence and Predictors of Externalizing Behavior in Young Adult Survivors of Pediatric Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						antisocial behavior; crime; externalizing behavior (EB); traumatic brain injury; young adulthood	ANTISOCIAL-BEHAVIOR; NEUROPSYCHOLOGICAL MEASURES; EXECUTIVE DYSFUNCTION; EMOTION PERCEPTION; SUBSTANCE USE; CHILDHOOD; OUTCOMES; CHILDREN; SKILLS; VULNERABILITY	Objectives: To investigate rates of clinically significant externalizing behavior (EB) in young adult survivors of pediatric traumatic brain injury (TBI) and evaluate the contribution of pre- and postinjury risk and resilience factors to EB outcomes 16 years after injury. Setting: Melbourne, Australia. Participants: Fifty-five young adults (mean age = 23.85 years; injury age: 1.0-12 years) admitted to an emergency department following TBI between 1993 and 1997. Design: Longitudinal prospective study with data collected at the acute, 10-year, and 16-year postinjury time points. Main Measures: Severity of TBI, adaptive functioning, family functioning, full-scale IQ, executive functioning, social communication, and symptoms of EB. Results: One of every 4 young people with a history of pediatric TBI demonstrated clinical or subthreshold levels of EB in young adulthood. More frequent EB was associated with poorer preinjury adaptive functioning, lower full-scale IQ, and more frequent pragmatic communication difficulty. Conclusion: Pediatric TBI is associated with an elevated risk for externalizing disorders in the transition to adulthood. Results underscore the need for screening and assessment of TBI among young offenders and suggest that early and long-term targeted interventions may be required to address risk factors for EB in children and young people with TBI.	[Ryan, Nicholas P.; Hughes, Nathan; Godfrey, Celia; Rosema, Stefanie; Catroppa, Cathy; Anderson, Vicki A.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Ryan, Nicholas P.; Hughes, Nathan; Godfrey, Celia; Catroppa, Cathy; Anderson, Vicki A.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Hughes, Nathan] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Rosema, Stefanie; Catroppa, Cathy; Anderson, Vicki A.] Royal Childrens Hosp Melbourne, Melbourne, Vic 3052, Australia	Ryan, NP (corresponding author), Royal Childrens Hosp Melbourne, Murdoch Childrens Res Inst, Level 4 West,Flemington Rd, Melbourne, Vic 3052, Australia.	nicholas.ryan@mcri.edu.au	Ryan, Nicholas/K-5445-2019	Ryan, Nicholas/0000-0002-0878-8889	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Victorian Neurotrauma initiative; Murdoch Children's Research Institute, Clinical Sciences; Victorian Government's Operational Infrastructure Scheme	This work was funded through research grants awarded by the National Health and Medical Research Council, the Victorian Neurotrauma initiative and the Murdoch Children's Research Institute, Clinical Sciences, and supported by the Victorian Government's Operational Infrastructure Scheme.	Achenbach T. M., 2009, ACHENBACH SYSTEM EMP; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Bayley N., 1969, BAYLEY SCALES INFANT; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beitchman JH, 1999, J CLIN CHILD PSYCHOL, V28, P312, DOI 10.1207/S15374424jccp280303; Bor W, 2007, YOUNG ADULT OUTCOMES; Bottoms A, 2011, ESCAPE ROUTES: CONTEMPORARY PERSPECTIVES ON LIFE AFTER PUNISHMENT, P43; BRESLAU N, 1990, ARCH GEN PSYCHIAT, V47, P15; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Brownlie EB, 2004, J ABNORM CHILD PSYCH, V32, P453, DOI 10.1023/B:JACP.0000030297.91759.74; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Daniel A. E., 1983, POWER PRIVILEGE PRES; Davies RC, 2012, J HEAD TRAUMA REHAB, V27, pE21, DOI 10.1097/HTR.0b013e31825360da; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Dockrell J, 2007, RAISING ACHIEVEMENTS; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; FARRINGTON DP, 1995, J CHILD PSYCHOL PSYC, V36, P929, DOI 10.1111/j.1469-7610.1995.tb01342.x; Farrington DP, 1992, THE SCH YEARS, V2, P123; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gioia G.A., 2000, BEHAV RATING INVENTO; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Henry B., 1997, HDB ANTISOCIAL BEHAV, P280; Hines PJ, 2010, SCIENCE, V328, P447, DOI 10.1126/science.328.5977.447; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kenny DT, 2007, COMTEMPORARY ISSUES, V107, P1; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lowe K, 2007, J INTELL DISABIL RES, V51, P625, DOI 10.1111/j.1365-2788.2006.00948.x; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Mulvey Edward P, 2004, Youth Violence Juv Justice, V2, P213, DOI 10.1177/1541204004265864; Office of the Surgeon General (US); National Center for Injury Prevention and Control (US); National Institute of Mental Health (US); Center for Mental Health Services (US), 2001, YOUTH VIOL REP SURG; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Pearson, 2009, ADV CLIN SOLUTIONS W; Prior D, 2004, PREVENTING CHILDRENS; Raine A, 2005, J ABNORM PSYCHOL, V114, P38, DOI 10.1037/0021-843X.114.1.38; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Snow P, 2012, TRENDS ISSUES CR APR; Snow PC, 2011, INT J SPEECH-LANG PA, V13, P480, DOI 10.3109/17549507.2011.578661; Sparrow S., 1984, VINELAND ADAPTIVE BE; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; TEASDALE G, 1974, LANCET, V2, P81; Tenneij NH, 2007, J APPL RES INTELLECT, V20, P391, DOI 10.1111/j.1468-3148.2007.00383.x; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wechsler D, 1991, MANUAL WECHSLER SCAL; Wechsler D, 1989, MANUAL PRESCHOOL PRI; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Woods DT, 2011, DEV NEUROREHABIL, V14, P274, DOI 10.3109/17518423.2011.586371; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	72	20	20	0	30	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					75	85		10.1097/HTR.0000000000000123			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300010	25734838	Green Published			2021-06-18	
J	Miller, AP; Shah, AS; Aperi, BV; Budde, MD; Pintar, FA; Tarima, S; Kurpad, SN; Stemper, BD; Glavaski-Joksimovic, A				Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Budde, Matthew D.; Pintar, Frank A.; Tarima, Sergey; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra			Effects of blast overpressure on neurons and glial cells in rat organotypic hippocampal slice cultures	FRONTIERS IN NEUROLOGY			English	Article						blast injury; traumatic brain injury; in vitro model; organotypic slice culture; hippocampus; cell death	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; CENTRAL-NERVOUS-SYSTEM; REACTIVE ASTROCYTES; SELECTIVE VULNERABILITY; MICROGLIA ACTIVATION; MOLECULAR-MECHANISMS; INDUCED NEUROTRAUMA; NEURITE OUTGROWTH; OXIDATIVE STRESS	Due to recent involvement in military conflicts, and an increase in the use of explosives, there has been an escalation in the incidence of blast-induced traumatic brain injury (bTBI) among US military personnel. Having a better understanding of the cellular and molecular cascade of events in bTB I is prerequisite for the development of an effective therapy that currently is unavailable. The present study utilized organotypic hippocampal slice cultures (OHCs) exposed to blast overpressures of 150 kPa (low) and 280 kPa (high) as an in vitro bTBI model. Using this model, we further characterized the cellular effects of the blast injury. Blast-evoked cell death was visualized by a propidium iodide (PI) uptake assay as early as 2 h post-injury. Quantification of PI staining in the cornu Ammonis 1 and 3 (CA1 and CA3) and the dentate gyrus regions of the hippocampus at 2, 24, 48, and 72 h following blast exposure revealed significant time dependent effects. OHCs exposed to 150 kPa demonstrated a slow increase in cell death plateauing between 24 and 48 h, while OHCs from the high-blast group exhibited a rapid increase in cell death already at 2 h, peaking at 24 h post-injury. Measurements of lactate dehydrogenase release into the culture medium also revealed a significant increase in cell lysis in both low- and high-blast groups compared to sham controls. OHCs were fixed at 72 h post-injury and immunostained for markers against neurons, astrocytes, and microglia. Labeling OHCs with PI, neuronal, and glial markers revealed that the blast-evoked extensive neuronal death and to a lesser extent loss of glial cells. Furthermore, our data demonstrated activation of astrocytes and microglial cells in low- and high-blasted OHCs, which reached a statistically significant difference in the high-blast group. These data confirmed that our in vitro bTBI model is a useful tool for studying cellular and molecular changes after blast exposure.	[Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Budde, Matthew D.; Pintar, Frank A.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53295 USA; [Miller, Anna P.; Pintar, Frank A.; Kurpad, Shekar N.; Glavaski-Joksimovic, Aleksandra] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53295 USA; [Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Budde, Matthew D.; Pintar, Frank A.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA; [Tarima, Sergey] Med Coll Wisconsin, Div Biostat, Inst Hlth & Soc, Milwaukee, WI 53295 USA	Glavaski-Joksimovic, A (corresponding author), Med Coll Wisconsin, Zablocki VA Med Ctr, Dept Neurosurg, Neurosci Res Labs 151, 5000 West Natl Ave, Milwaukee, WI 53295 USA.	aglavaski@mcw.edu	Stemper, Brian/AAX-7611-2020; Kurpad, Shekar/V-2188-2019	Miller, Anna/0000-0002-6823-0852	Department of Neurosurgery, Medical College of Wisconsin; VA Medical ResearchUS Department of Veterans Affairs	This work was supported by the Department of Neurosurgery, Medical College of Wisconsin and the VA Medical Research. Authors acknowledge Christy Stadig, Natasha Wilkins, Rachel Chiariello, Ronald Chmill, Eric Inglin, Corey Hopp, Richard Pahapill, and Kyle Stehlik for their excellent technical assistance.	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Arun P, 2012, NEUROREPORT, V23, P342, DOI 10.1097/WNR.0b013e328351b58d; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Billingham C, 2013, NEUROPATH APPL NEURO, V39, P243, DOI 10.1111/j.1365-2990.2012.01283.x; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chechneva O, 2005, NEUROSCIENCE, V136, P343, DOI 10.1016/j.neuroscience.2005.07.058; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cho ES, 2007, J VET SCI, V8, P15, DOI 10.4142/jvs.2007.8.1.15; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Coltman BW, 1996, INT J DEV NEUROSCI, V14, P707, DOI 10.1016/S0736-5748(96)00071-8; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.3.CO;2-0; Dailey ME, 1999, METHODS, V18, P222, DOI 10.1006/meth.1999.0775; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Deweer B, 2001, BEHAV BRAIN RES, V127, P209, DOI 10.1016/S0166-4328(01)00366-7; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Foraker JE, 2011, J NEUROCHEM, V119, P1052, DOI 10.1111/j.1471-4159.2011.07511.x; Friend DM, 2013, J NEUROCHEM, V125, P566, DOI 10.1111/jnc.12201; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gao HM, 2002, J NEUROSCI, V22, P782, DOI 10.1523/JNEUROSCI.22-03-00782.2002; Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867; GIULIAN D, 1995, J NEUROSCI, V15, P7712; Glavaski-Joksimovic A, 2009, NEUROSCIENCE, V162, P472, DOI 10.1016/j.neuroscience.2009.04.070; Glavaski-Joksimovic A, 2008, CLONING STEM CELLS, V10, P75, DOI 10.1089/clo.2007.0065; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; Heppner FL, 1998, EUR J NEUROSCI, V10, P3284, DOI 10.1046/j.1460-9568.1998.00379.x; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Holopainen IE, 2005, NEUROCHEM RES, V30, P1521, DOI 10.1007/s11064-005-8829-5; Huuskonen J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-25; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; LEBLOND J, 1989, J NEUROPHYSIOL, V62, P1; Lein PJ, 2011, METHODS MOL BIOL, V758, P115, DOI 10.1007/978-1-61779-170-3_8; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.00216.x; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Lucci EB, 2006, SURG CLIN N AM, V86, P579, DOI 10.1016/j.suc.2006.03.001; Luo XG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-12; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; McGeer PL, 1998, J NEURAL TRANSM-SUPP, P159; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Mewes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045017; MILLER LDP, 1994, NEUROSCIENCE, V63, P471, DOI 10.1016/0306-4522(94)90544-4; Mitrasinovic OM, 2005, J NEUROSCI, V25, P4442, DOI 10.1523/JNEUROSCI.0514-05.2005; More SV, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/952375; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nakajima K, 2001, NEUROSCI LETT, V307, P171, DOI 10.1016/S0304-3940(01)01943-7; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Norris JN, 2014, BRAIN INJURY, V28, P1052, DOI 10.3109/02699052.2014.891761; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Panzer MB, 2012, J TRAUMA ACUTE CARE, V72, P454, DOI 10.1097/TA.0b013e31821e8270; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Raineteau O, 2004, MOL CELL NEUROSCI, V26, P241, DOI 10.1016/j.mcn.2004.01.003; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; RIESKE E, 1989, BRAIN RES, V492, P1, DOI 10.1016/0006-8993(89)90883-4; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Sarnowska A, 2009, STEM CELLS DEV, V18, P1191, DOI 10.1089/scd.2008.0096; Sarnowska A, 2009, EXP NEUROL, V215, P317, DOI 10.1016/j.expneurol.2008.10.023; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shah AS, 2011, ASME 2011 INT MECH E; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Skibo GG, 2000, NEUROSCIENCE, V96, P427, DOI 10.1016/S0306-4522(99)00562-X; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Streit WJ, 2000, J NEUROSCI RES, V61, P10, DOI 10.1002/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E; Stuchlik A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00106; Su T, 2011, BRAIN RES, V1385, P68, DOI 10.1016/j.brainres.2011.01.115; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; SUNESON A, 1989, J TRAUMA, V29, P10, DOI 10.1097/00005373-198901000-00003; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Taylor PA, 2009, LY TIME, V131, DOI [10.1115/1.3118765, DOI 10.1115/1.3118765]; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Pinto MCX, 2012, NEUROCHEM INT, V61, P713, DOI 10.1016/j.neuint.2012.06.018; Xie K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064907; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhou SD, 2011, BIOTECHNOL J, V6, P513, DOI 10.1002/biot.201000254; Ziemka-Nalecz M, 2013, ACTA NEUROBIOL EXP, V73, P130; Zou J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00077	149	20	20	0	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 12	2015	6								20	10.3389/fneur.2015.00020			16	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CU7YM	WOS:000363757800001	25729377	DOAJ Gold, Green Published			2021-06-18	
J	Brucken, A; Kurnaz, P; Bleilevens, C; Derwall, M; Weis, J; Nolte, K; Rossaint, R; Fries, M				Bruecken, Anne; Kurnaz, Pinar; Bleilevens, Christian; Derwall, Matthias; Weis, Joachim; Nolte, Kay; Rossaint, Rolf; Fries, Michael			Delayed Argon Administration Provides Robust Protection Against Cardiac Arrest-Induced Neurological Damage	NEUROCRITICAL CARE			English	Article						Cardiopulmonary resuscitation; Hypoxia-ischemia, Brain; Reperfusion injury; Noble gases; Argon; Neuroprotective agents	TRAUMATIC BRAIN-INJURY; NOBLE-GAS ARGON; REDUCES NEUROHISTOPATHOLOGICAL DAMAGE; IN-VITRO MODEL; NEONATAL ASPHYXIA; XENON; RATS; NEUROPROTECTION; ISCHEMIA; PIGS	Argon at a dosage of 70 % is neuroprotective, when given 1 h after cardiac arrest (CA) in rats. We investigated if a neuroprotective effect of argon would also be observed, when administration was delayed. Twenty-four male Sprague-Dawley rats, weighing between 400 and 500 g were subjected to 7 min of CA and 3 min of cardiopulmonary resuscitation. Animals were randomized to receive either 1 h of 70 % argon ventilation 1 h (n = 8) or 3 h (n = 8) after return of spontaneous circulation or no argon treatment (n = 8). For all animals, a neurological deficit score (NDS) was calculated daily for 7 days following the experiment. On day 8, rats were re-anesthetized and transcardially perfused before brains were harvested for histopathological analyses. All animals survived. Control animals exhibited severe neurologic dysfunction at all time points as measured with the NDS. Argon-treated animals showed significant improvements in the NDS through all postoperative days, even when argon administration was delayed for 3 h. This was paralleled by a significant reduction in the neuronal damage index in the neocortex and the hippocampal CA 3/4 region in argon-treated animals, regardless of the timing of argon administration. However, animals of the delayed argon administration group additionally showed significant reductions in the basal ganglia in comparison with control animals. Our study demonstrates that a 1-h application of argon provided a significant reduction in histopathological damage, associated with a marked improvement in functional neurologic recovery even when treatment was delayed for 3 h. This is highly significant with regard to clinical situations, where argon treatment cannot be provided timely.	[Bruecken, Anne; Kurnaz, Pinar; Bleilevens, Christian; Derwall, Matthias; Rossaint, Rolf; Fries, Michael] Univ Hosp RWTH Aachen, Dept Anesthesiol, D-52074 Aachen, Germany; [Weis, Joachim; Nolte, Kay] Univ Hosp RWTH Aachen, Inst Neuropathol, D-52074 Aachen, Germany	Brucken, A (corresponding author), Univ Hosp RWTH Aachen, Dept Anesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany.	abruecken@ukaachen.de	Weis, Joachim/G-1984-2014; Bleilevens, Christian/AAG-8034-2020	Weis, Joachim/0000-0003-3280-6773; Bleilevens, Christian/0000-0002-2104-1843			Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Antonov A A, 2009, Aviakosm Ekolog Med, V43, P27; Arola OJ, 2013, CRIT CARE MED, V41, P2116, DOI 10.1097/CCM.0b013e31828a4337; Brucken A, 2013, BRIT J ANAESTH, V110, P106, DOI 10.1093/bja/aes509; Brucken A, 2014, RESUSCITATION, V85, P826, DOI 10.1016/j.resuscitation.2014.02.014; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; David HN, 2013, N-S ARCH PHARMACOL, V386, P91, DOI 10.1007/s00210-012-0809-0; David HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030934; Derwall M, 2009, MINERVA ANESTESIOL, V75, P37; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Fries M, 2008, CRIT CARE MED, V36, P2420, DOI 10.1097/CCM.0b013e3181802874; Fries M, 2012, CRIT CARE MED, V40, P1297, DOI 10.1097/CCM.0b013e31823c8ce7; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Idris AH, 1996, RESUSCITATION, V33, P69, DOI 10.1016/S0300-9572(96)01055-6; Jawad N, 2009, NEUROSCI LETT, V460, P232, DOI 10.1016/j.neulet.2009.05.069; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Luo Y, 2008, ANESTHESIOLOGY, V109, P782, DOI 10.1097/ALN.0b013e3181895f88; Ma D, 2002, BRIT J ANAESTH, V89, P739, DOI 10.1093/bja/aef258; NEUMAR RW, 1995, RESUSCITATION, V29, P249, DOI 10.1016/0300-9572(94)00827-3; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ristagno G, 2014, SHOCK, V41, P72, DOI 10.1097/SHK.0000000000000049; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Schmidt M, 2005, ANESTHESIOLOGY, V102, P929, DOI 10.1097/00000542-200505000-00011; Soldatov P E, 1998, Aviakosm Ekolog Med, V32, P33; STARK RA, 1981, J APPL PHYSIOL, V51, P1355; Yarin YM, 2005, HEARING RES, V201, P1, DOI 10.1016/j.heares.2004.09.015; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	30	20	21	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2015	22	1					112	120		10.1007/s12028-014-0029-1			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	CA3FH	WOS:000348791300015	25081369				2021-06-18	
J	Budohoski, KP; Czosnyka, M; Kirkpatrick, PJ; Reinhard, M; Varsos, GV; Kasprowicz, M; Zabek, M; Pickard, JD; Smielewski, P				Budohoski, Karol P.; Czosnyka, Marek; Kirkpatrick, Peter J.; Reinhard, Matthias; Varsos, Georgios V.; Kasprowicz, Magdalena; Zabek, Miroslaw; Pickard, John D.; Smielewski, Peter			Bilateral Failure of Cerebral Autoregulation is Related to Unfavorable Outcome After Subarachnoid Hemorrhage	NEUROCRITICAL CARE			English	Article						Cerebral autoregulation; Delayed cerebral ischemia; Subarachnoid hemorrhage; Transcranial Doppler	TRAUMATIC BRAIN-INJURY; PRESSURE-AUTOREGULATION; BLOOD-FLOW; CEREBROVASCULAR AUTOREGULATION; TRANSCRANIAL DOPPLER; ASYMMETRY; ISCHEMIA; REACTIVITY; IMPAIRMENT; PREDICTION	The extent of hemodynamic disturbances following subarachnoid hemorrhage (SAH) varies. We aim to determine the prognostic implications of unilateral and bilateral autoregulatory failure on delayed cerebral ischemia (DCI) and outcome. Ninety-eight patients with aneurysmal SAH were recruited. Autoregulation was assessed using systolic flow index-Sxa. Interhemispheric difference in autoregulation was calculated to assess the spatial distribution and symmetry of autoregulatory changes. Assessment of interhemispheric difference in autoregulation in combination with overall autoregulation was used to measure the extent of autoregulatory impairment. Patients were dichotomized by the presence of DCI and 3-month mRS. Higher flow velocity and worse autoregulation (p < 0.0000001, 95 % CI 10.7-21.3 and p = 0.00001, 95 % CI 0.03-0.07 for difference in FV and Sxa, respectively) were found ipsilateral to the ischemic hemisphere or location of aneurysm (if no ischemia detected). DCI group had a higher interhemispheric difference of autoregulation than non-DCI group (p = 0.035, 95 % CI 0.003-0.08). 16/18 patients with unfavorable outcome vs. 17/72 with favorable outcome had overall poor autoregulation with low interhemispheric differences (p = 0.0013, chi (2)). Unilateral autoregulatory failure was seen on a median day 3, bilateral on day 4, and vasospasm was detected on day 6. Unilateral autoregulation failure was seen in patients who developed DCI (worse ipsilateral to the ischemic hemisphere). Bilateral autoregulation failure was seen more frequently in patients with unfavorable outcome. Analysis of the temporal profile showed unilateral dysautoregulation as the primary event predisposing to DCI, which in selected cases led to bilateral failure and unfavorable outcomes.	[Budohoski, Karol P.; Czosnyka, Marek; Kirkpatrick, Peter J.; Varsos, Georgios V.; Kasprowicz, Magdalena; Pickard, John D.; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [Reinhard, Matthias] Univ Freiburg, Dept Neurol, Freiburg, Germany; [Kasprowicz, Magdalena] Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland; [Zabek, Miroslaw] Mazovia Brodno Hosp, Dept Neurosurg, Postgrad Med Ctr, Warsaw, Poland	Budohoski, KP (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Hills Rd, Cambridge CB2 0QQ, England.	karol.budohoski@gmail.com		Zabek, Miroslaw/0000-0001-6847-2424; czosnyka, marek/0000-0003-2446-8006; Kasprowicz, Magdalena/0000-0002-2271-7737; Smielewski, Peter/0000-0001-5096-3938	St Catherine's College, University of Cambridge; Polish Ministry of Science and Higher EducationMinistry of Science and Higher Education, Poland; National Institute of Health Research Senior Investigator Awards; National Institute of Health Research Senior Investigator Award - CSF dynamics; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G9439390, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	KPB received a grant from St Catherine's College, University of Cambridge. MK was supported by Polish Ministry of Science and Higher Education. JDP is a recipient of National Institute of Health Research Senior Investigator Awards. MC is a recipient of National Institute of Health Research Senior Investigator Award - CSF dynamics.	Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; CZOSNYKA M, 1994, NEUROSURGERY, V35, P287, DOI 10.1227/00006123-199408000-00015; Gooskens I, 2003, ACTA NEUROCHIR, V145, P527, DOI 10.1007/s00701-003-0045-y; HARPER AM, 1972, NEURORADIOLOGY, V3, P134, DOI 10.1007/BF00341495; HEILBRUN MP, 1972, J NEUROSURG, V37, P36, DOI 10.3171/jns.1972.37.1.0036; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Hu K, 2009, J NEUROTRAUM, V26, P227, DOI 10.1089/neu.2008.0643; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Komotar RJ, 2009, NEUROSURGERY, V64, P397, DOI 10.1227/01.NEU.0000338946.42939.C7; Lam JMK, 2000, NEUROSURGERY, V47, P819, DOI 10.1097/00006123-200010000-00004; Lang EW, 2003, J CLIN NEUROSCI, V10, P670, DOI 10.1016/S0967-5868(03)00197-8; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; PICKARD JD, 1980, J NEUROSURG, V53, P305, DOI 10.3171/jns.1980.53.3.0305; Piechnik SK, 2001, J CEREBR BLOOD F MET, V21, P182, DOI 10.1097/00004647-200102000-00010; Ratsep T, 2001, J NEUROSURG, V95, P393, DOI 10.3171/jns.2001.95.3.0393; Reinhard M, 2003, STROKE, V34, P2138, DOI 10.1161/01.STR.0000087788.65566.AC; Rinne J, 1996, NEUROSURGERY, V38, P2, DOI 10.1097/00006123-199601000-00002; Schmidt EA, 2003, J NEUROIMAGING, V13, P248, DOI 10.1177/1051228403013003008; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Telman G, 2006, EUR J VASC ENDOVASC, V32, P375, DOI 10.1016/j.ejvs.2006.04.031; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320	33	20	20	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2015	22	1					65	73		10.1007/s12028-014-0032-6			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	CA3FH	WOS:000348791300009	25056137				2021-06-18	
J	Epstein, DS; Mitra, B; Cameron, PA; Fitzgerald, M; Rosenfeld, JV				Epstein, Daniel S.; Mitra, Biswadev; Cameron, Peter A.; Fitzgerald, Mark; Rosenfeld, Jeffrey V.			Acute traumatic coagulopathy in the setting of isolated traumatic brain injury: Definition, incidence and outcomes	BRITISH JOURNAL OF NEUROSURGERY			English	Article						blood coagulation; brain injuries; coagulopathy; craniocerebral trauma; isolated head trauma; traumatic brain injury; wound and injuries	MASSIVE BLOOD-TRANSFUSION; FRESH-FROZEN PLASMA; TRANEXAMIC ACID; COAGULATION; PATHOGENESIS; EFFICACY; TRIAL	Background and objectives. Acute traumatic coagulopathy (ATC) has been reported in the setting of isolated traumatic brain injury (iTBI) and associated with poor outcomes. Among patients with iTBI, we aimed to select an appropriate definition of ATC, outline the incidence of ATC and examine clinical variables associated with ATC. Methods. A retrospective review of The Alfred Trauma Registry was conducted and patients with iTBI (head AIS [Abbreviated Injury Score] 3 and all other body regions AIS <3) were selected for analysis. The association of the international normalised ratio (INR) on arrival at hospital with the mortality on hospital discharge was explored, to select an appropriate clinical horizon to define ATC. The incidence of ATC was calculated using this definition. Injury and clinical variables measurable pre-hospital and immediately on arrival at the hospital were analysed to determine independent associations with ATC. Results. There were 1718 patients with iTBI included in the study. The overall mortality was 12%, but significantly greater when initial INR was measured at >= 1.3 (45.1%; p < 0.01). The proportion of patients with ATC, using this definition, was 7.7% (95% CI: 6.5-9.0). The pre-hospital variables independently associated with ATC in the setting of iTBI were age (OR 1.02,95% CI 1.01-1.03), shock index (SI) of >= 1 (OR 1.68,95% CI 1.01-2.79) and abnormal pupils (OR 8.33, 95% CI 4.50-15.89). The presence of at least two factors, of age >50 yrs, SI >= 1, or abnormal pupils, was 97.54% (95% Cl: 96.6-98.2) specific for ATC. Conclusions. An abnormal initial INR in the setting of iTBI was associated with poor outcomes, regardless of magnitude. The incidence of ATC appears too low to recommend empiric pro-coagulant management for all patients with iTBI. The subgroup of patients older than 50 yrs., with shock or abnormal size of pupils, may be considered for interventional trials of early treatment against ATC.	[Epstein, Daniel S.; Mitra, Biswadev; Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic 3004, Australia; [Epstein, Daniel S.; Mitra, Biswadev; Cameron, Peter A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Cameron, Peter A.] Hamad Med Corp, Emergency Med, Doha, Qatar; [Fitzgerald, Mark] Alfred Hosp, Trauma Serv, Melbourne, Vic 3004, Australia; [Fitzgerald, Mark; Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] USUHS, F Edward Hebert Sch Med, Dept Surg, Bethesda, MD USA	Mitra, B (corresponding author), Alfred Hosp, Emergency & Trauma Ctr, Commercial Rd, Melbourne, Vic 3004, Australia.	b.mitra@alfred.org.au	Epstein, Daniel/AAQ-4181-2020; Mitra, Biswadev/AAC-3724-2019	Epstein, Daniel/0000-0003-2215-7749; Mitra, Biswadev/0000-0002-0508-2450; Fitzgerald, Mark/0000-0003-0183-7761; Cameron, Peter/0000-0002-1443-557X			Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Gajic O, 2006, CRIT CARE MED, V34, pS170, DOI 10.1097/01.CCM.0000214288.88308.26; Gennarelli T.A., 2008, ABBREVIATED INJURY S; Gruen RL, 2011, LANCET, V377, P1052, DOI 10.1016/S0140-6736(11)60396-6; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mitra B, 2012, VOX SANG, V102, P324, DOI 10.1111/j.1423-0410.2011.01564.x; Mitra B, 2013, INJURY; Mitra B, 2012, INJURY, V43, P33, DOI 10.1016/j.injury.2011.10.011; Mitra B, 2011, RESUSCITATION, V82, P1208, DOI 10.1016/j.resuscitation.2011.04.007; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schierhout G, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000566, 10.1002/14651858. CD000566]; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567; Yuan S, 2007, THROMB RES, V120, P29, DOI 10.1016/j.thromres.2006.07.002; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	28	20	22	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2015	29	1					118	122		10.3109/02688697.2014.950632			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CE2KQ	WOS:000351644900033	25153987				2021-06-18	
J	Griesdale, DEG; Ortenwall, V; Norena, M; Wong, H; Sekhon, MS; Kolmodin, L; Henderson, WR; Dodek, P				Griesdale, Donald E. G.; Ortenwall, Victoria; Norena, Monica; Wong, Hubert; Sekhon, Mypinder S.; Kolmodin, Leif; Henderson, William R.; Dodek, Peter			Adherence to guidelines for management of cerebral perfusion pressure and outcome in patients who have severe traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Brain injuries; Traumatic; Cerebral perfusion pressure; Intracranial pressure; Neurocritical care; Area under curve	SECONDARY INSULTS; PROGNOSTIC VALUE; HEAD-INJURY; AUTOREGULATION; EPIDEMIOLOGY; PREDICTION; REACTIVITY; PROTOCOL	Purpose: The aims of this study are to assess adherence to the Brain Trauma Foundation (BTF) cerebral perfusion pressure (CPP) guidelines and to determine if adherence is associated with mortality in patients who have a severe traumatic brain injury. Materials and methods: Retrospective cohort study of 127 patients admitted to one intensive care unit between 2006 and 2012. Adherence to BTF guidelines was measured as the time that the CPP was within 50 to 70 mm Hg divided by the total time of CPP monitoring (CPP time index). Results: The percentage of time that the CPP was within the recommended range was 31.6% (SD, 22.2); CPP was greater than 70 mm Hg for 63.9% (SD, 26.2) of the time and less than 50 mm Hg for 4.5% of the time (SD, 16.3). After adjustment for covariates, CPP time index (between 50 and 70 mm Hg) was not associated with hospital mortality (odds ratio [OR], 1.2; 95% confidence interval [CI], 0.98-1.6; P=.079). The time indices for CPP >= 70 and <50 mm Hg were associated with decreased (OR, 0.66; 95% CI, 0.52-0.82; P<.0001) and increased (OR, 9.9; 95% CI, 1.4-69.6; P=.021) mortality, respectively. Conclusion: Cerebral perfusion pressure was greater than 70 mm Hg for most of the time. This level of CPP was associated with decreased hospital mortality. (C) 2014 Elsevier Inc. All rights reserved.	[Griesdale, Donald E. G.; Sekhon, Mypinder S.; Kolmodin, Leif; Henderson, William R.; Dodek, Peter] Univ British Columbia, Dept Med, Div Crit Care Med, Vancouver, BC, Canada; [Griesdale, Donald E. G.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Griesdale, Donald E. G.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Ortenwall, Victoria] Lund Univ, Dept Anaesthesiol & Crit Care Med, Lund, Sweden; [Norena, Monica; Wong, Hubert; Dodek, Peter] Providence Hlth Care, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Norena, Monica; Wong, Hubert; Dodek, Peter] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Wong, Hubert] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada	Griesdale, DEG (corresponding author), Vancouver Gen Hosp, Room 2438,2nd Floor,855 West 12th Ave, Vancouver, BC V5Z 1M9, Canada.	donald.griesdale@vch.ca		Griesdale, Donald/0000-0001-5985-8624	Vancouver Coastal Health Research Institute's "VGH & UBC Hospital Foundation Best of Health Fund"; Department of Anesthesiology, Pharmacology & Therapeutics at the University of British Columbia; Department of Anesthesiology & Perioperative Care at Vancouver General Hospital	Dr Griesdale is supported in part through the Vancouver Coastal Health Research Institute's "VGH & UBC Hospital Foundation Best of Health Fund" and the Department of Anesthesiology, Pharmacology & Therapeutics at the University of British Columbia and The Department of Anesthesiology & Perioperative Care at Vancouver General Hospital.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 2007, NEUROL RES, V29, P672, DOI 10.1179/016164107X240053; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Grande P O, 1997, Acta Anaesthesiol Scand Suppl, V110, P36; Griesdale DEG, 2010, CAN J NEUROL SCI, V37, P43, DOI 10.1017/S031716710000963X; Hameed SM, 2010, J TRAUMA, V69, P1350, DOI 10.1097/TA.0b013e3181e751f7; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; LASSEN NA, 1974, CIRC RES, V34, P749, DOI 10.1161/01.RES.34.6.749; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mackenzie IMJ, 2011, INTENS CARE MED, V37, P435, DOI 10.1007/s00134-010-2103-2; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Statistics Canada, 2011, LEAD CAUS DEATH TOT; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297; Vespa Paul, 2003, Neurosurg Focus, V15, pE4; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wenner JB, 2009, J CRIT CARE, V24, P401, DOI 10.1016/j.jcrc.2009.03.008	39	20	24	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2015	30	1					111	115		10.1016/j.jcrc.2014.07.026			5	Critical Care Medicine	General & Internal Medicine	AW4GJ	WOS:000346238900019	25179411				2021-06-18	
J	Isaac, L; Main, KL; Soman, S; Gotlib, IH; Furst, AJ; Kinoshita, LM; Fairchild, JK; Yesavage, JA; Ashford, JW; Bayley, PJ; Adamson, MM				Isaac, Linda; Main, Keith L.; Soman, Salil; Gotlib, Ian H.; Furst, Ansgar J.; Kinoshita, Lisa M.; Fairchild, J. Kaci; Yesavage, Jerome A.; Ashford, J. Wesson; Bayley, Peter J.; Adamson, Maheen M.			The impact of depression on Veterans with PTSD and traumatic brain injury: A diffusion tensor imaging study	BIOLOGICAL PSYCHOLOGY			English	Article						Depression; PTSD; TBI; Emotion; DTI; Veterans	WHITE-MATTER ABNORMALITIES; ANTERIOR CINGULATE CORTEX; LATE-LIFE DEPRESSION; MAJOR DEPRESSION; PREFRONTAL CORTEX; EMOTION REGULATION; WORKING-MEMORY; DISORDER; STRESS; TRACTOGRAPHY	A significant proportion of military personnel deployed in support of Operation Enduring Freedom and Operation Iraqi Freedom were exposed to war-zone events associated with traumatic brain injury (TBI), depression (DEP) and posttraumatic stress disorder (PTSD). The co-occurrence of TBI, PTSD and DEP in returning Veterans has recently increased research and clinical interest. This study tested the hypothesis that white matter abnormalities are further impacted by depression. Of particular relevance is the uncinate fasciculus (UF), which is a key fronto-temporal tract involved in mood regulation, and the cingulum; a tract that connects to the hippocampus involved in memory integration. Diffusion tensor imaging (DTI) was performed on 25 patients with a combination of PTSD, TBI and DEP and 20 patients with PTSD and TBI (no DEP). Microstructural changes of white matter were found in the cingulum and UF. Fractional anisotropy (FA) was lower in Veterans with DEP compared to those without DEP. Published by Elsevier B.V.	[Isaac, Linda; Main, Keith L.; Soman, Salil; Furst, Ansgar J.; Ashford, J. Wesson; Bayley, Peter J.; Adamson, Maheen M.] Vet Affairs Palo Alto HealthCare Syst, War Related Illness & Injury Study Ctr, Palo Alto, CA 94304 USA; [Isaac, Linda; Main, Keith L.; Furst, Ansgar J.; Fairchild, J. Kaci; Yesavage, Jerome A.; Ashford, J. Wesson; Bayley, Peter J.; Adamson, Maheen M.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Furst, Ansgar J.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Soman, Salil] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Gotlib, Ian H.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Kinoshita, Lisa M.; Fairchild, J. Kaci; Yesavage, Jerome A.] Vet Affairs Palo Alto HealthCare Syst, Palo Alto, CA USA	Isaac, L (corresponding author), Vet Affairs Palo Alto HealthCare Syst, War Related Illness & Injury Study Ctr, Palo Alto, CA 94304 USA.	lisaac@stanford.edu	Ashford, J. Wesson/D-3929-2009	Adamson, Maheen/0000-0002-1534-4063; Soman, Salil/0000-0002-5887-0717			Abe O, 2010, NEURORADIOLOGY, V52, P699, DOI 10.1007/s00234-010-0716-3; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; BAXTER LR, 1989, ARCH GEN PSYCHIAT, V46, P243; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beck AT., 1996, BECK DEPRESSION INVE, V2; Benotsch EG, 2000, J ABNORM PSYCHOL, V109, P205, DOI 10.1037//0021-843X.109.2.205; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Brewin C. R., 2012, J ABNORM PSYCHOL, V118, P767; Brown ES, 2000, COMPR PSYCHIAT, V41, P19, DOI 10.1016/S0010-440X(00)90126-3; Canli T, 2004, NEUROREPORT, V15, P2585, DOI 10.1097/00001756-200412030-00005; Colloby SJ, 2011, J AFFECT DISORDERS, V135, P216, DOI 10.1016/j.jad.2011.07.025; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Demeyer I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065429; Donaldson C, 2007, BEHAV RES THER, V45, P2664, DOI 10.1016/j.brat.2007.07.002; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Gross J.J., 2008, HDB EMOTIONS, P497; Gross JJ, 2013, EMOTION, V13, P359, DOI 10.1037/a0032135; Hamilton JP, 2013, NEUROBIOL DIS, V52, P4, DOI 10.1016/j.nbd.2012.01.015; Hedges DW, 2007, NEUROCASE, V13, P402, DOI 10.1080/13554790701851551; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Horesh D, 2013, PSYCHIAT RES, V208, P265, DOI 10.1016/j.psychres.2012.12.004; Horn DI, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00033; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Joormann J, 2008, J ABNORM PSYCHOL, V117, P182, DOI 10.1037/0021-843X.117.1.182; Joormann J, 2010, COGNITION EMOTION, V24, P281, DOI 10.1080/02699930903407948; Kieseppa T, 2010, J AFFECT DISORDERS, V120, P240, DOI 10.1016/j.jad.2009.04.023; Kircanski K, 2012, WIRES COGN SCI, V3, P301, DOI 10.1002/wcs.1177; Lange G, 2013, MIL MED, V178, P705, DOI 10.7205/MILMED-D-13-00053; Li LJ, 2007, BRAIN RES, V1168, P124, DOI 10.1016/j.brainres.2007.06.094; Liao Y, 2013, J PSYCHIATR NEUROSCI, V38, P49, DOI 10.1503/jpn.110180; Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Nobuhara K, 2006, J NEUROL NEUROSUR PS, V77, P120, DOI 10.1136/jnnp.2004.055129; Oishi K., 2011, MRI ATLAS HUMAN WHIT; Paelecke-Habermann Y, 2005, J AFFECT DISORDERS, V89, P125, DOI 10.1016/j.jad.2005.09.006; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Runnals JJ, 2013, PAIN MED; Schecklmann M, 2011, PSYCHIAT RES-NEUROIM, V194, P378, DOI 10.1016/j.pscychresns.2011.01.016; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shimony JS, 2009, BIOL PSYCHIAT, V66, P245, DOI 10.1016/j.biopsych.2009.02.032; Sutker PB, 1996, PSYCHOL ASSESSMENT, V8, P18, DOI 10.1037/1040-3590.8.1.18; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Taylor Warren D, 2007, Neuropsychiatr Dis Treat, V3, P669; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler D., 1939, MEASUREMENT ADULT IN; Wu F, 2011, PSYCHIAT RES-NEUROIM, V191, P80, DOI 10.1016/j.pscychresns.2010.09.002; Zhang AF, 2013, NEUROPSYCHOPHARMACOL, V38, P1451, DOI 10.1038/npp.2013.41; Zhang WH, 2008, NEUROIMAGE, V42, P771, DOI 10.1016/j.neuroimage.2008.04.241; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049; Zivin K., 2007, PSYCHIAT SERV, V63, P823	64	20	24	0	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0301-0511	1873-6246		BIOL PSYCHOL	Biol. Psychol.	FEB	2015	105						20	28		10.1016/j.biopsycho.2014.12.011			9	Psychology, Biological; Behavioral Sciences; Psychology; Psychology, Experimental	Psychology; Behavioral Sciences	CB8WH	WOS:000349912100002	25559772				2021-06-18	
J	Jonker, FA; Jonker, C; Scheltens, P; Scherder, EJA				Jonker, Frank A.; Jonker, Cees; Scheltens, Philip; Scherder, Erik J. A.			The role of the orbitofrontal cortex in cognition and behavior	REVIEWS IN THE NEUROSCIENCES			English	Article						behavior disorders; gambling task; orbitofrontal cortex damage; reversal learning; theory of mind (ToM)	VENTROMEDIAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE DAMAGE; DECISION-MAKING; RHESUS-MONKEYS; LESIONS; MIND; EMOTION; PSYCHOPATHY; REWARD	The orbitofrontal cortex (OFC) plays a crucial role in behavior and is a common site for damage due to different types of injuries, e.g., closed head injuries, cerebrovascular accidents, tumors, neurosurgical interventions. Despite the (severe) behavioral changes following OFC lesions, persons with damage to the OFC appear to be cognitively intact, i.e., at least when assessed by means of standard neuropsychological tests. Meanwhile, neuropsychological tests addressing reversal learning, gambling, and social cognition show a decline in these patients. The goal of the present review is to link the performance of these latter neuropsychological tests to behavior. The results suggest that in patients with orbitofrontal lesions, reversal learning is more associated with behavioral disinhibition and that impairment in recognition of expressed emotion is more associated with social inappropriate behavior. The faux pas test (theory of mind) appears not to be sensitive to orbitofrontal lesions. Future studies should involve a larger numbers of patients with well-defined locations in the OFC and should integrate specific neuropsychological tests and quantitative behavioral measures to better understand the contribution of the OFC to cognition and behavior.	[Jonker, Frank A.] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Vesalius Ctr Neuropsychiatry Woerden, GGZ Altrecht, NL-3447 GN Woerden, Netherlands; [Jonker, Cees] Vrije Univ Amsterdam Med Ctr, Inst Hlth & Care Res, Dept EMGO, NL-1081 BT Amsterdam, Netherlands; [Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Alzheimer Ctr, NL-1007 MB Amsterdam, Netherlands; [Scheltens, Philip] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands; [Scherder, Erik J. A.] Vrije Univ Amsterdam, Dept Clin Neuropsychol, NL-1081 BT Amsterdam, Netherlands	Jonker, FA (corresponding author), Vrije Univ Amsterdam, Dept Clin Neuropsychol, Vesalius Ctr Neuropsychiatry Woerden, GGZ Altrecht, Polanerbaan 2, NL-3447 GN Woerden, Netherlands.	fr.jonker@altrecht.nl	Scheltens, Philip/AAL-9631-2020	Scheltens, Philip/0000-0002-1046-6408; Jonker, Frank/0000-0002-6786-5573	GGZ Altrecht, Vesalius Centre for Neuropsychiatry; Department of Clinical Neuropsychology, VU University; Alzheimer Centre and Department of Neurology, VU University Medical Center	F.A.J. would like to express his deep gratitude to E.J.A. Scherder, C. Jonker, and P. Scheltens, his research supervisors, for their patient guidance, enthusiastic encouragement, and critical revision of the manuscript for important intellectual content. He would also like to thank GGZ Altrecht, Vesalius Centre for Neuropsychiatry; Department of Clinical Neuropsychology, VU University; Alzheimer Centre and Department of Neurology, VU University Medical Center for their financial supporter on this research project.	Anderson SW, 2006, J INT NEUROPSYCH SOC, V12, P224, DOI 10.1017/S1355617706060346; Bachevalier J, 2011, ANN NY ACAD SCI, V1239, P71, DOI 10.1111/j.1749-6632.2011.06211.x; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Berlin HA, 2005, AM J PSYCHIAT, V162, P2360, DOI 10.1176/appi.ajp.162.12.2360; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Blair RJR, 2007, ANN NY ACAD SCI, V1121, P461, DOI 10.1196/annals.1401.017; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Busemeyer JR, 2002, PSYCHOL ASSESSMENT, V14, P253, DOI 10.1037//1040-3590.14.3.253; Cohen L, 1999, LANCET, V353, P34, DOI 10.1016/S0140-6736(98)09047-3; Cummings JL, 1995, ANN NY ACAD SCI, V769, P1, DOI 10.1111/j.1749-6632.1995.tb38127.x; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; Fellows LK, 2007, ANN NY ACAD SCI, V1121, P421, DOI 10.1196/annals.1401.023; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Floris G, 2008, NEUROCASE, V14, P385, DOI 10.1080/13554790802385418; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Funayama M, 2010, COGN BEHAV NEUROL, V23, P135, DOI 10.1097/WNN.0b013e3181d746ba; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Hahm DS, 2001, NEUROLOGY, V56, P398, DOI 10.1212/WNL.56.3.398; Hanna-Pladdy B, 2007, J Neurol Phys Ther, V31, P119; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Kazama A, 2009, J NEUROSCI, V29, P2794, DOI 10.1523/JNEUROSCI.4655-08.2009; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Mitchell DGV, 2006, NEUROPSYCHOLOGY, V20, P280, DOI 10.1037/0894-4105.20.3.280; Mitchell DGV, 2006, NEUROCASE, V12, P164, DOI 10.1080/13554790600611288; Moll J, 2008, ANN NY ACAD SCI, V1124, P161, DOI 10.1196/annals.1440.005; Namiki C, 2008, NEUROCASE, V14, P474, DOI 10.1080/13554790802459494; Ogai M, 2005, ACTA PSYCHIAT SCAND, V111, P74, DOI 10.1111/j.1600-0447.2004.00395.x; Ohtake H, 2005, J NEUROL NEUROSUR PS, V76, P1309, DOI 10.1136/jnnp.2004.061846; Poletti M, 2010, J NEUROPSYCH CLIN N, V22, pE7, DOI 10.1176/appi.neuropsych.22.2.247-d.e7; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rudebeck PH, 2013, NAT NEUROSCI, V16, P1140, DOI 10.1038/nn.3440; Rudebeck PH, 2011, ANN NY ACAD SCI, V1239, P1, DOI 10.1111/j.1749-6632.2011.06267.x; Rudebeck PH, 2011, J NEUROSCI, V31, P10569, DOI 10.1523/JNEUROSCI.0091-11.2011; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Slachevsky A, 2006, BIOL RES, V39, P237, DOI 10.4067/S0716-97602006000200006; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Umeda S, 2010, SOC NEUROSCI-UK, V5, P19, DOI 10.1080/17470910902990584; Volle E, 2002, NEUROLOGY, V58, P488, DOI 10.1212/WNL.58.3.488; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Walton ME, 2011, ANN NY ACAD SCI, V1239, P14, DOI 10.1111/j.1749-6632.2011.06257.x; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012	54	20	22	0	43	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	FEB	2015	26	1					1	11		10.1515/revneuro-2014-0043			11	Neurosciences	Neurosciences & Neurology	CC5KE	WOS:000350396700001	25252749				2021-06-18	
J	Khodaie, B; Lotfinia, AA; Ahmadi, M; Lotfinia, M; Jafarian, M; Karimzadeh, F; Coulon, P; Gorji, A				Khodaie, Babak; Lotfinia, Ahmad Ali; Ahmadi, Milad; Lotfinia, Mahmoud; Jafarian, Maryam; Karimzadeh, Fariba; Coulon, Philippe; Gorji, Ali			Structural and functional effects of social isolation on the hippocampus of rats with traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Memory impairment; Brain trauma; Cell death; Neuronal damage; Cognition	SPREADING DEPRESSION; PHYSICAL-ACTIVITY; NEURONAL DEATH; HEART-DISEASE; CELL-DEATH; OPEN-FIELD; STROKE; MICE; STRESS; PARVALBUMIN	Social isolation has significant long-term psychological and physiological consequences. Both social isolation and traumatic brain injury (TBI) alter normal brain function and structure. However, the influence of social isolation on recovery from TBI is unclear. This study aims to evaluate if social isolation exacerbates the anatomical and functional deficits after TBI in young rats. juvenile male rats were divided into four groups; sham operated control with social contacts, sham control with social isolation, TBI with social contacts, and TBI with social isolation. During four weeks after brain injury in juvenile rats, we evaluated the animal behaviors by T-maze and open-field tests, recorded brain activity with electrocorticograms and assessed structural changes by histological procedures in the hippocampal dentate gyrus, CA1, and CA3 areas. Our findings revealed significant memory impairments and hyperactivity conditions in rats with TBI and social isolation compared to the other groups. Histological assessments showed an increase of the mean number of dark neurons, apoptotic cells, and caspase-3 positive cells in all tested areas of the hippocampus in TBI rats with and without social isolation compared to sham rats. Furthermore, social isolation significantly increased the number of dark cells, apoptotic neurons, and caspase-3 positive cells in the hippocampal CA3 region in rats with TBI. This study indicates the harmful effect of social isolation on anatomical and functional deficits induced by TBI in juvenile rats. Prevention of social isolation may improve the outcome of TBI. (C) 2014 Elsevier B.V. All rights reserved.	[Khodaie, Babak; Lotfinia, Ahmad Ali; Ahmadi, Milad; Lotfinia, Mahmoud; Jafarian, Maryam; Karimzadeh, Fariba; Gorji, Ali] Khatam Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Khodaie, Babak; Lotfinia, Ahmad Ali; Ahmadi, Milad] Islamic Azad Univ, Karaj Branch, Fac Vet Med, Karaj, Iran; [Lotfinia, Mahmoud] Shahid Beheshti Med Univ, Sch Med, Tehran, Iran; [Coulon, Philippe; Gorji, Ali] Univ Munster, Epilepsy Res Ctr, D-48149 Munster, Germany; [Gorji, Ali] Univ Munster, Klin & Poliklin Neurochirurg, D-48149 Munster, Germany; [Gorji, Ali] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Gorji, Ali] Univ Munster, Inst Neurophysiol, D-48149 Munster, Germany	Gorji, A (corresponding author), Univ Munster, Epilepsy Res Ctr, Robert Koch Str 27a, D-48149 Munster, Germany.	gorjial@uni-muenster.de	Coulon, Philippe/I-9214-2016; Meijer, Anna/K-5118-2016; Karimzadeh, Fariba/O-3897-2015	Coulon, Philippe/0000-0001-8350-5837; Gorji, Ali/0000-0002-4557-3270; Karimzadeh, Fariba/0000-0002-8805-3486; karimzadeh, F./0000-0002-7561-5021	Shefa Neuroscience Center [25609]	This work was funded by the Shefa Neuroscience Center grant related to Dr-Thesis 25609.	Arranz Lorena, 2009, Rev Esp Geriatr Gerontol, V44, P137, DOI 10.1016/j.regg.2008.12.001; Barratt RL, 2011, CONTEMP NURSE, V39, P180, DOI 10.5172/conu.2011.180; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Boden-Albala B, 2005, NEUROLOGY, V64, P1888, DOI 10.1212/01.WNL.0000163510.79351.AF; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Charbonnier F, 2007, MOL NEUROBIOL, V35, P217, DOI 10.1007/s12035-007-0027-9; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Conrad Cheryl D, 2006, Behav Cogn Neurosci Rev, V5, P41, DOI 10.1177/1534582306289043; Cotman CW, 2007, ALZHEIMERS DEMENT, V3, pS30, DOI 10.1016/j.jalz.2007.01.013; Filipovic D, 2013, NEUROSCIENCE, V236, P47, DOI 10.1016/j.neuroscience.2013.01.033; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Garrido P, 2013, J NEURAL TRANSM, V120, P829, DOI 10.1007/s00702-012-0935-3; Gaskin PL, 2014, PSYCHOPHARMACOLOGY B; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Grant N, 2009, ANN BEHAV MED, V37, P29, DOI 10.1007/s12160-009-9081-z; Grippo AJ, 2007, PSYCHONEUROENDOCRINO, V32, P966, DOI 10.1016/j.psyneuen.2007.07.004; Hawkley LC, 2009, HEALTH PSYCHOL, V28, P354, DOI 10.1037/a0014400; Hu W, 2010, NEUROPSYCHOPHARMACOL, V35, P1693, DOI 10.1038/npp.2010.31; Huang E, 2013, BRAIN RES, V1529, P125, DOI 10.1016/j.brainres.2013.06.042; Huang HJ, 2011, BRAIN RES, V1371, P150, DOI 10.1016/j.brainres.2010.11.043; Ikeda A, 2008, STROKE, V39, P768, DOI 10.1161/STROKEAHA.107.496695; Inta D, 2013, J NEURAL TRANSM, V120, P1605, DOI 10.1007/s00702-013-1049-2; Jafarian M, 2010, NEUROSCIENCE, V169, P388, DOI 10.1016/j.neuroscience.2010.04.062; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Jones CA, 2011, PSYCHOPHARMACOLOGY, V214, P269, DOI 10.1007/s00213-010-1931-7; Karimzadeh F, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-76; Kherani ZS, 2008, ACTA NEUROPATHOL, V116, P447, DOI 10.1007/s00401-008-0386-y; Kurina LM, 2011, SLEEP, V34, P1519, DOI 10.5665/sleep.1390; Lapiz M D S, 2003, Neurosci Behav Physiol, V33, P13, DOI 10.1023/A:1021171129766; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Moragrega I, 2003, BEHAV BRAIN RES, V147, P1, DOI 10.1016/S0166-4328(03)00112-8; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; O'Keefe LM, 2014, BEHAV BRAIN RES, V260, P162, DOI 10.1016/j.bbr.2013.10.047; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Purushothuman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059740; Reboucas RCR, 1997, PHYSIOL BEHAV, V62, P1159, DOI 10.1016/S0031-9384(97)00312-0; RINK A, 1995, AM J PATHOL, V147, P1575; ROBINSON N, 1969, J NEUROL NEUROSUR PS, V32, P317, DOI 10.1136/jnnp.32.4.317; Sachs M, 2007, NEUROBIOL DIS, V25, P27, DOI 10.1016/j.nbd.2006.08.013; Sadeghian H, 2012, EXP NEUROL, V233, P438, DOI 10.1016/j.expneurol.2011.11.017; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Spalletta G, 2006, MOL PSYCHIATR, V11, P984, DOI 10.1038/sj.mp.4001879; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Venna VR, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.128; Weil ZM, 2008, MOL PSYCHIATR, V13, P913, DOI 10.1038/mp.2008.70; Whitaker LR, 2013, NEURON, V77, P335, DOI 10.1016/j.neuron.2012.11.022; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	50	20	22	0	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	FEB 1	2015	278						55	65		10.1016/j.bbr.2014.09.034			11	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AY5AQ	WOS:000347586300007	25264185				2021-06-18	
J	Kiernan, PT; Montenigro, PH; Solomon, TM; McKee, AC				Kiernan, Patrick T.; Montenigro, Philip H.; Solomon, Todd M.; McKee, Ann C.			Chronic Traumatic Encephalopathy: A Neurodegenerative Consequence of Repetitive Traumatic Brain Injury	SEMINARS IN NEUROLOGY			English	Article						chronic traumatic encephalopathy; traumatic brain injury; tauopathy; TDP-43; Alzheimer disease	CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; AXONAL INJURY; AMYLOID-BETA; MOUSE MODEL; TAU PATHOLOGY; NEUROFIBRILLARY TANGLES; COGNITIVE IMPAIRMENT; DOCOSAHEXAENOIC ACID; MULTIPLE EPISODES	Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease that develops as a result of repetitive mild traumatic brain injury. Chronic traumatic encephalopathy is characterized by a unique pattern of accumulation of hyperphosphorylated tau in neurons and astrocytes. The tau abnormalities begin focally and perivascularly at the depths of the cerebral sulci, spread to the superficial layers of the adjacent cortex, and eventually become widespread throughout the medial temporal lobes, diencephalon, and brainstem. Abnormalities in 43 kDa TAR DNA-binding protein are also found in most cases of CTE. To date, CTE can only be diagnosed by postmortem neuropathological examination, although there are many ongoing research studies examining imaging techniques and biomarkers that might prove to have diagnostic utility. Currently, the incidence and prevalence of CTE are unknown, although great strides are being made to better understand the clinical symptoms and signs of CTE. Further research is critically needed to better identify the genetic and environmental risk factors for CTE as well as potential rehabilitation and therapeutic strategies.	[Kiernan, Patrick T.; Montenigro, Philip H.; Solomon, Todd M.; McKee, Ann C.] Boston Univ, Chron Traumat Encephalopathy Ctr, Boston, MA 02215 USA; [Montenigro, Philip H.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Solomon, Todd M.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Solomon, Todd M.; McKee, Ann C.] Boston Univ, Alzheimers Dis Ctr, Boston, MA 02215 USA; [McKee, Ann C.] VA Boston Healthcare Syst, Jamaica Plain, MA USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol & Lab Sci, Boston, MA 02118 USA	McKee, AC (corresponding author), VA Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA.	amckee@bu.edu		Montenigro, Philip/0000-0003-4442-9207	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01N5086659-01]; Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Affairs Biorepository [CSP 501]; Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS); Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, 0572063345-5]; National Institute of Aging Boston University Framingham Heart Study [R01 (AG1649)]; National Operating Committee on Standards for Athletic Equipment (NOCSAE); Sports Legacy Institute; Andlinger Foundation; WWE (World Wrestling Entertainment); National Football League (NFL); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	The authors gratefully acknowledge the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA). We also gratefully acknowledge the help of all members of the Chronic Traumatic Encephalopathy Center at Boston University, the Boston VA, as well as the individuals and families whose participation and contributions made this work possible. This work was supported by the National Institute of Neurological Disorders and Stroke (1U01N5086659-01), Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), the Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS), Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C), the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5), the National Institute of Aging Boston University Framingham Heart Study R01 (AG1649), the National Operating Committee on Standards for Athletic Equipment (NOCSAE), and the Sports Legacy Institute. This work was also supported by unrestricted gifts from the Andlinger Foundation, the WWE (World Wrestling Entertainment), and the National Football League (NFL).	Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; [Anonymous], 2006, MED SCI SPORT EXER, V38, P395, DOI 10.1249/01.mss.0000202025.48774.31; Anthony IC, 2010, BRAIN, V133, P3685, DOI 10.1093/brain/awq263; Au R, 2012, CURR ALZHEIMER RES, V9, P673; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Biros MH, 1999, ACAD EMERG MED, V6, P1088, DOI 10.1111/j.1553-2712.1999.tb00109.x; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Constantinidis J, 1967, Schweiz Arch Neurol Neurochir Psychiatr, V100, P117; Conte V, 2004, J NEUROCHEM, V90, P758, DOI 10.1111/j.1471-4159.2004.02560.x; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Critchley M., 1949, NEUROCHIRURG HOMMAGE, P131; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1111/j.1365-2990.1996.tb00840.x; Genis L, 2000, J NEUROSCI RES, V60, P559, DOI 10.1002/(SICI)1097-4547(20000515)60:4<559::AID-JNR15>3.0.CO;2-K; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GORELL JM, 1994, NEUROLOGY, V44, P1865, DOI 10.1212/WNL.44.10.1865; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Harada R, 2013, EUR J NUCL MED MOL I, V40, P125, DOI 10.1007/s00259-012-2261-2; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jicha GA, 2010, J ALZHEIMERS DIS, V19, P253, DOI 10.3233/JAD-2010-1237; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lado WE, 2003, PERCEPT MOTOR SKILL, V97, P1115, DOI 10.2466/PMS.97.7.1115-1127; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; MCCOWN IA, 1959, JAMA-J AM MED ASSOC, V169, P1409, DOI 10.1001/jama.1959.03000300005002; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Millspaugh J., 1937, US NAVAL MED B, V35, P297; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Moisse K, 2009, BRAIN RES, V1296, P176, DOI 10.1016/j.brainres.2009.07.023; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Morales R, 2009, CNS NEUROL DISORD-DR, V8, P363, DOI 10.2174/187152709789541998; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nakajima Y, 2010, TOHOKU J EXP MED, V221, P229, DOI 10.1620/tjem.221.229; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Okawa Y, 2003, FEBS LETT, V535, P183, DOI 10.1016/S0014-5793(02)03883-8; OLSSON Y, 1971, ACTA NEUROPATHOL, V19, P225, DOI 10.1007/BF00684599; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Sato T, 2009, NEUROSCIENCE, V164, P1565, DOI 10.1016/j.neuroscience.2009.09.050; Sephton CF, 2012, BIOL CHEM, V393, P589, DOI 10.1515/hsz-2012-0115; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; Sotiropoulos I, 2008, J NEUROCHEM, V107, P385, DOI 10.1111/j.1471-4159.2008.05613.x; Sotiropoulos I, 2011, J NEUROSCI, V31, P7840, DOI 10.1523/JNEUROSCI.0730-11.2011; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strong MJ, 2011, J MOL NEUROSCI, V45, P648, DOI 10.1007/s12031-011-9609-0; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Waite LM, 1997, MED J AUSTRALIA, V167, P429, DOI 10.5694/j.1326-5377.1997.tb126655.x; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	113	20	20	0	21	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					20	28		10.1055/s-0035-1545080			9	Clinical Neurology	Neurosciences & Neurology	CC4AP	WOS:000350293300005	25714864				2021-06-18	
J	Vernau, BT; Grady, MF; Goodman, A; Wiebe, DJ; Basta, L; Park, Y; Arbogast, KB; Master, CL				Vernau, Brian T.; Grady, Matthew F.; Goodman, Arlene; Wiebe, Douglas J.; Basta, Luke; Park, Yong; Arbogast, Kristy B.; Master, Christina L.			Oculomotor and Neurocognitive Assessment of Youth Ice Hockey Players: Baseline Associations and Observations After Concussion	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							CONVERGENCE INSUFFICIENCY; NEARPOINT; CHILDREN; MEMORY	Baseline scores on the King-Devick (K-D) Test, Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), Sport Concussion Assessment Tool 3 (SCAT3), and convergence were evaluated in youth hockey players. Worse K-D times were associated with worse ImPACT visual motor speed and reaction time. Eleven concussed athletes were retested, and there was a trend toward improved ImPACT and K-D times compared to baseline.	[Vernau, Brian T.; Grady, Matthew F.; Master, Christina L.] Childrens Hosp Philadelphia, Dept Surg, Div Orthoped, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Grady, Matthew F.] Univ Penn, Perelman Sch Med, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA; [Goodman, Arlene] St Peters Sports Med Inst, Somerset, NJ USA; [Wiebe, Douglas J.; Basta, Luke] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Park, Yong] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Arbogast, Kristy B.] Univ Penn, Perelman Sch Med, Dept Pediat, Ctr Injury Res & Prevent,Div Emergency Med, Philadelphia, PA 19104 USA; [Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Master, CL (corresponding author), Childrens Hosp Philadelphia, Div Gen Pediat, Div Orthoped, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	masterc@email.chop.edu	Wiebe, Douglas J/Q-1168-2017	Master, Christina/0000-0002-6717-4270; Arbogast, Kristy/0000-0002-1694-4562			Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Hayes GJ, 1998, OPTOMETRY VISION SCI, V75, P506, DOI 10.1097/00006324-199807000-00019; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Rouse MW, 1998, OPTOMETRY VISION SCI, V75, P88, DOI 10.1097/00006324-199802000-00012; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Scheiman M, 2008, OPHTHAL EPIDEMIOL, V15, P24, DOI 10.1080/09286580701772037; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x	10	20	20	0	21	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	JAN 2	2015	40	1			SI		7	11		10.1080/87565641.2014.971955			5	Psychology, Developmental; Psychology; Psychology, Experimental	Psychology	CA6IR	WOS:000349015800002	25649773				2021-06-18	
J	Walsh, KS; Paltin, I; Gioia, GA; Isquith, P; Kadan-Lottick, NS; Neglia, JP; Brouwers, P				Walsh, Karin S.; Paltin, Iris; Gioia, Gerard A.; Isquith, Peter; Kadan-Lottick, Nina S.; Neglia, Joseph P.; Brouwers, Pim			Everyday executive function in standard-risk acute lymphoblastic leukemia survivors	CHILD NEUROPSYCHOLOGY			English	Article						Central nervous system; Neuropsychology; Leukemia; Neurobehavioral manifestations; Survivors	TRAUMATIC BRAIN-INJURY; ACUTE LYMPHOCYTIC-LEUKEMIA; LONG-TERM SURVIVORS; CHILDHOOD LEUKEMIA; COGNITIVE IMPAIRMENT; CRANIAL IRRADIATION; CHILDREN; CHEMOTHERAPY; PERFORMANCE; ATTENTION	We aimed to evaluate parent-rated executive function (EF) in pediatric standard risk acute lymphoblastic leukemia (SR-ALL) survivors compared to a healthy comparison (HC) group. We hypothesized that SR-ALL survivors would have greater reported executive dysfunction compared to HC, and that those younger at the time of treatment would demonstrate greater EF difficulties. A sample of 256 SR-ALL survivors evaluated an average nine years after treatment were compared to HC matched for gender, assessment age, and maternal education. Profile analysis was used to compare the groups across EF scales on the BRIEF. The prevalence of clinical elevations in the groups was compared via chi square, and odds ratios were calculated. Regression models were applied to examine the role of age at diagnosis and age at assessment in reported EF. Results indicated that SR-ALL survivors' mean scores of EF are similar to HC, except for flexibility and initiation. Survivors were rated as having clinical impairments with flexibility, initiation, working memory, and emotional control at rates two to three times that of HC. The risk of working memory and self-monitoring deficits was greater in survivors who were older when assessed. There was no relationship between age at diagnosis or treatment regimen on EF. These findings suggest sparing of extensive and severe EF deficits in SR-ALL survivors overall. However, a subset of survivors displays clinically significant executive dysfunction. There appears to be a heightened susceptibility to disrupted metacognitive functions as survivors age. This has implications for how we monitor neurocognitive development and functioning of SR-ALL survivors, and highlights opportunities for cognitive interventions.	[Walsh, Karin S.; Gioia, Gerard A.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Walsh, Karin S.; Gioia, Gerard A.] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Paltin, Iris] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Paltin, Iris] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Isquith, Peter] Geisel Sch Med Dartmouth, Norwich, VT USA; [Kadan-Lottick, Nina S.] Yale Univ, Sch Med, New Haven, CT USA; [Kadan-Lottick, Nina S.] Yale Sect Pediat Hematol Oncol, New Haven, CT USA; [Neglia, Joseph P.] Univ Minnesota, Amplatz Childrens Hosp, Minneapolis, MN USA; [Brouwers, Pim] Baylor Coll Med, Houston, TX 77030 USA; [Brouwers, Pim] NIMH, Div AIDS Res, NIH, Rockville, MD 20857 USA	Walsh, KS (corresponding author), Childrens Natl Med Ctr, 111 Michigan Ave, Washington, DC 20010 USA.	kwalsh@childrensnational.org	Isquith, Peter/AAY-4851-2020	Kadan-Lottick, Nina/0000-0002-6857-396X; Walsh, Karin/0000-0001-9637-2164; Neglia, Joseph/0000-0002-5525-0598	American Cancer SocietyAmerican Cancer Society; St. Baldrick's Foundation	This study was supported by research funding by the American Cancer Society to Joseph Neglia and Nina Kadan-Lottick. Dr. Kadan-Lottick's effort was additionally funded as a St. Baldrick's Foundation Scholar.	Anderson VA, 2002, CHILD NEUROPSYCHOL, V8, P231, DOI 10.1076/chin.8.4.231.13509; Andrews K, 2001, J PEDIATR PSYCHOL, V26, P1, DOI 10.1093/jpepsy/26.1.1; Buizer AI, 2006, CANCER, V106, P2067, DOI 10.1002/cncr.21820; Buizer AI, 2009, PEDIATR BLOOD CANCER, V52, P447, DOI 10.1002/pbc.21869; Campbell LK, 2007, PEDIATR BLOOD CANCER, V49, P65, DOI 10.1002/pbc.20860; Campbell LK, 2009, J PEDIATR PSYCHOL, V34, P317, DOI 10.1093/jpepsy/jsn080; Carey ME, 2008, AM J NEURORADIOL, V29, P792, DOI 10.3174/ajnr.A0904; Caron JE, 2009, PEDIATR BLOOD CANCER, V53, P551, DOI 10.1002/pbc.22128; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; de Vries MAG, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-103; Dennis M, 2000, SCI PRACT NEUROPSYCH, P3; Gioia G. A., 2000, BRIEF BEHAV RATING I; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Jacobson LA, 2011, CHILD NEUROPSYCHOL, V17, P255, DOI 10.1080/09297049.2010.535654; Jain N, 2009, CANCER-AM CANCER SOC, V115, P4238, DOI 10.1002/cncr.24464; Kadan-Lottick NS, 2009, J CLIN ONCOL, V27, P5986, DOI 10.1200/JCO.2009.23.5408; Kadan-Lottick NS, 2009, BLOOD, V114, P1746, DOI 10.1182/blood-2008-12-186502; Kingma A, 2002, J PEDIAT HEMATOL ONC, V24, P106, DOI 10.1097/00043426-200202000-00010; Kolb B., 1995, BRAIN PLASTICITY BEH; Krappmann P, 2007, PEDIATR HEMAT ONCOL, V24, P101, DOI 10.1080/08880010601123281; Krull KR, 2008, J PEDIATR-US, V152, P101, DOI 10.1016/j.jpeds.2007.05.047; MAUTZ W, 2002, J INT NEUROPSYCH SOC, V8, P292; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Molfese VJ, 2010, CONTEMP EDUC PSYCHOL, V35, P116, DOI 10.1016/j.cedpsych.2010.03.004; MOORE IMK, 1991, CANCER, V68, P1913; Payne JM, 2011, CHILD NEUROPSYCHOL, V17, P313, DOI 10.1080/09297049.2010.542746; Peterson CC, 2008, PEDIATR BLOOD CANCER, V51, P99, DOI 10.1002/pbc.21544; Precourt S, 2002, DEV NEUROPSYCHOL, V21, P173, DOI 10.1207/S15326942DN2102_4; RUBENSTEIN CL, 1990, J DEV BEHAV PEDIATR, V11, P301; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Stork LC, 2010, BLOOD, V115, P2740, DOI 10.1182/blood-2009-07-230656; Tolar J, 2005, PEDIATR BLOOD CANCER, V45, P5, DOI 10.1002/pbc.20239; Voigt RG, 2007, CLIN PEDIATR, V46, P523, DOI 10.1177/0009922806299100; von der Weid N, 2003, EUR J CANCER, V39, P359, DOI 10.1016/S0959-8049(02)00260-5; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Waber DP, 2006, DEV NEUROPSYCHOL, V29, P459, DOI 10.1207/s15326942dn2903_5; Waber DP, 2000, J PEDIAT HEMATOL ONC, V22, P206, DOI 10.1097/00043426-200005000-00004; Willoughby MT, 2012, CHILD NEUROPSYCHOL, V18, P79, DOI 10.1080/09297049.2011.578572	38	20	21	0	27	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JAN 2	2015	21	1					78	89		10.1080/09297049.2013.876491			12	Clinical Neurology	Neurosciences & Neurology	AS6TC	WOS:000344394100005	24428397				2021-06-18	
J	Bodanapally, UK; Saksobhavivat, N; Shanmuganathan, K; Aarabi, B; Roy, AK				Bodanapally, Uttam K.; Saksobhavivat, Nitima; Shanmuganathan, Kathirkamanathan; Aarabi, Bizhan; Roy, Ashis K.			Arterial injuries after penetrating brain injury in civilians: risk factors on admission head computed tomography	JOURNAL OF NEUROSURGERY			English	Article						intracranial arterial injuries; penetrating traumatic brain injury; traumatic intracranial pseudoaneurysms; trauma	TRAUMATIC ANEURYSMS; SUBARACHNOID HEMORRHAGE; DIAGNOSIS; ANGIOGRAPHY; MANAGEMENT; WOUNDS	OBJECT The object of this study was to determine the specific CT findings of the injury profile in penetrating brain injury (PBI) that are risk factors related to intracranial arterial injuries. METHODS The authors retrospectively evaluated admission head CTs and accompanying digital subtraction angiography (DSA) studies from patients with penetrating trauma to the head in the period between January 2005 and December 2012. Two authors reviewed the CT images to determine the presence or absence of 30 injury profile variables and quantified selected variables. The CT characteristics in patients with and without arterial injuries were compared using univariate analysis, multivariate analysis, and receiver operating characteristic (ROC) curve analysis to determine the respective risk factors, independent predictors, and optimal threshold values for the continuous variables. RESULTS Fifty:five patients were eligible for study inclusion. The risk factors for an intracranial arterial injury on univariate analysis were an entry wound over the frontobasal-temporal regions, a bihemispheric wound trajectory, a wound trajectory in proximity to the circle of Willis (COW), a subarachnoid hemorrhage (SAH), a higher SAH score, an intraventricular hemorrhage (IVH), and a higher IVH score. A trajectory in proximity to the COW was the best predictor of injury (OR 6.8 and p = 0.005 for all penetrating brain injuries [PBIs]; OR 13.3 and p = 0.001 for gunshot wounds [GSWs]). Significant quantitative variables were higher SAH and IVH scores. An SAH score of 3 (area under the ROC curve [AUC] for all PBIs 0.72; AUC for GSWs 0.71) and an IVH score of 3 (AUC for all PBIs 0.65; AUC for GSWs 0.65) could be used as threshold values to suggest an arterial injury. CONCLUSIONS The risk factors identified may help radiologists suggest the possibility of arterial injury and prioritize neurointerventional consultation and potential DSA studies.	[Bodanapally, Uttam K.; Shanmuganathan, Kathirkamanathan; Roy, Ashis K.] Univ Maryland, Med Ctr, Dept Radiol, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Aarabi, Bizhan] Univ Maryland, Med Ctr, Dept Neurosurg, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Saksobhavivat, Nitima] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Radiol, Bangkok 10700, Thailand	Bodanapally, UK (corresponding author), Univ Maryland, Med Ctr, Dept Radiol, 22S Greene St, Baltimore, MD 21201 USA.	ubodanapally@umm.edu					AARABI B, 1995, NEUROSURG CLIN N AM, V6, P775; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Aarabi B, 2001, J TRAUMA S, V51, pS26; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; GRAEB DA, 1982, RADIOLOGY, V143, P91, DOI 10.1148/radiology.143.1.6977795; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; Sliker CW, 2008, AM J ROENTGENOL, V190, P790, DOI 10.2214/AJR.07.2378; Steenburg SD, 2010, RADIOGRAPHICS, V30, P869, DOI 10.1148/rg.304105022	13	20	20	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2015	122	1					219	226		10.3171/2014.9.JNS14679			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX5DQ	WOS:000346947600031	25361486	Bronze			2021-06-18	
J	Bor, N; Rubin, G; Rozen, N; Herzenberg, JE				Bor, Noam; Rubin, Guy; Rozen, Nimrod; Herzenberg, John E.			Chronic Anterior Monteggia Lesions in Children: Report of 4 Cases Treated With Closed Reduction by Ulnar Osteotomy and External Fixation	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						Monteggia fracture dislocation; external fixation; radial head dislocation; ulnar fracture	RADIAL-HEAD DISLOCATION; FRACTURE-DISLOCATIONS; MANAGEMENT; RECONSTRUCTION; ELBOW	Background: Chronic, subacute, and chronic Monteggia fracture dislocations of the elbow are challenging problems. The literature generally recommends complex open reconstructive procedures. We present an alternative, minimally invasive, percutaneous method with external fixation. Methods: This was a retrospective review of 4 cases presenting with chronic Monteggia lesions with anterior dislocation of the radial head. Results: Reduction of the radiocapitellar joint was successfully achieved in all patients after ulnar osteotomy and gradual correction using the Ilizarov external fixation. Open reduction or reconstruction of the radio-ulnar-capitellar joint and/or ligament was not undertaken. The patients were between 9 and 11 years of age at the time of injury. The time from injury to treatment was between 3 and 56 months. At follow-up of an average of 3.5 years (range, 2 to 6 y), all patients had full movement of the elbow and normal function of the forearm. Radiographically, all radial heads were well reduced and the ulnar osteotomy showed remodeling. Conclusions: The technique is relatively simple and avoids the risks and technical challenges of open osteotomies, open reduction, and ligament reconstruction. Gradual reduction of the radial head with the aid of an external fixation is a safe and effective method of treatment for chronic Monteggia lesions.	[Bor, Noam; Rubin, Guy; Rozen, Nimrod] Haemek Med Ctr, Dept Orthopaed Surg, Pediat Orthopaed Unit, Afula, Israel; [Bor, Noam; Rubin, Guy; Rozen, Nimrod] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Herzenberg, John E.] Sinai Hosp, Rubin Inst Adv Orthoped, Int Ctr Limb Lengthening, Baltimore, MD 21215 USA	Bor, N (corresponding author), 1 Saknai St, IL-18753 Afula, Israel.	noambor@yahoo.com	Rubin, Guy/AAN-8891-2020	Rubin, Guy/0000-0002-1032-7280			Bado J L, 1967, Clin Orthop Relat Res, V50, P71; Belangero WD, 2007, INT ORTHOP, V31, P151, DOI 10.1007/s00264-006-0153-4; Bell Tawse AJ, 1965, J BONE JOINT SURG BR, V47, P718; BEST TN, 1994, J PEDIATR ORTHOPED, V14, P193, DOI 10.1097/01241398-199403000-00012; De Boeck H, 2000, CLIN ORTHOP RELAT R, P215; DeBoeck H, 1997, CLIN ORTHOP RELAT R, P94; Devnani AS, 1997, INJURY, V28, P131, DOI 10.1016/S0020-1383(96)00160-X; Exner GU, 2001, J BONE JOINT SURG BR, V83B, P547, DOI 10.1302/0301-620X.83B4.11103; Hasler CC, 2005, J BONE JOINT SURG BR, V87B, P88; HIRAYAMA T, 1987, J BONE JOINT SURG BR, V69, P639; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P583, DOI 10.1097/00004694-200209000-00004; Ladermann A, 2007, J CHILD ORTHOP, V1, P237, DOI 10.1007/s11832-007-0039-z; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724; LINCOLN TL, 1994, J PEDIATR ORTHOPED, V14, P454, DOI 10.1097/01241398-199407000-00006; Lu XM, 2013, J PEDIATR ORTHOPED, V33, P398, DOI 10.1097/BPO.0b013e3182812762; MONTEGGIA GB, 1814, INSTITUZIONI CHIRURG; Papandrea R, 2000, CLIN ORTHOP RELAT R, P115; Ring D, 1996, J BONE JOINT SURG BR, V78B, P734; Rodriguez-Merchan EC, 2005, CLIN ORTHOP RELAT R, P65, DOI 10.1097/01.blo.0000156480.76450.04; Song KS, 2012, J ORTHOP TRAUMA, V26, P597, DOI 10.1097/BOT.0b013e3182548981; Wilkins KE, 2002, J PEDIATR ORTHOPED, V22, P548, DOI 10.1097/01.BPO.0000019211.02000.60	21	20	24	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JAN	2015	35	1					7	10		10.1097/BPO.0000000000000203			4	Orthopedics; Pediatrics	Orthopedics; Pediatrics	AW3MC	WOS:000346189800003	24787311				2021-06-18	
J	Costine, BA; Missios, S; Taylor, SR; McGuone, D; Smith, CM; Dodge, CP; Harris, BT; Duhaime, AC				Costine, Beth A.; Missios, Symeon; Taylor, Sabrina R.; McGuone, Declan; Smith, Colin M.; Dodge, Carter P.; Harris, Brent T.; Duhaime, Ann-Christine			The Subventricular Zone in the Immature Piglet Brain: Anatomy and Exodus of Neuroblasts into White Matter after Traumatic Brain Injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; Subventricular zone; Neurogenesis; Neuroblasts	MATURATION-DEPENDENT RESPONSE; CENTRAL-NERVOUS-SYSTEM; CELL-PROLIFERATION; POSTNATAL NEUROGENESIS; OLFACTORY-BULB; DENTATE GYRUS; IN-VITRO; FOREBRAIN; MIGRATION; MICE	Stimulation of postnatal neurogenesis in the subventricular zone (SVZ) and robust migration of neuroblasts to the lesion site in response to traumatic brain injury (TBI) is well established in rodent species; however, it is not yet known whether postnatal neurogenesis plays a role in repair after TBI in gyrencephalic species. Here we describe the anatomy of the SVZ in the piglet for the first time and initiate an investigation into the effect of TBI on the SVZ architecture and the number of neuroblasts in the white matter. Among all ages of immaturity examined the SVZ contained a dense mesh network of neurogenic precursor cells (doublecortin+) positioned directly adjacent to the ependymal cells (ventricular SVZ, Vsvz) and neuroblasts organized into chains that were distinct from the Vsvz (abventricular SVZ, Asvz). Though the architecture of the SVZ was similar among ages, the areas of Vsvz and Asvz neuroblast chains declined with age. At postnatal day (PND) 14 the white matter tracts have a tremendous number of individual neuroblasts. In our scaled corticalimpact model, lesion size increased with age. Similarly, the response of the SVZ to injury was also age dependent. The younger age groups that sustained the proportionately smallest lesions had the largest SVZ areas, which further increased in response to injury. In piglets that were injured at 4 months of age and had the largest lesions, the SVZ did not increase in response to injury. Similar to humans, swine have abundant gyri and gyral white matter, providing a unique platform to study neuroblasts potentially migrating from the SVZ to the lesioned cortex along these white matter tracts. In piglets injured at PND 7, TBI did not increase the total number of neuroblasts in the white matter compared to uninjured piglets, but redistribution occurred with a greater number of neuroblasts in the white matter of the hemisphere ipsilateral to the injury compared to the contralateral hemisphere. At 7 days after injury, less than 1% of neuroblasts in the white matter were born in the 2 days following injury. These data show that the SVZ in the piglet shares many anatomical similarities with the SVZ in the human infant, and that TBI had only modest effects on the SVZ and the number of neuroblasts in the white matter. Piglets at an equivalent developmental stage to human infants were equipped with the largest SVZ and a tremendous number of neuroblasts in the white matter, which may be sufficient in lesion repair without the dramatic stimulation of neurogenic machinery. It has yet to be determined whether neurogenesis and migrating neuroblasts play a role in repair after TBI and/or whether an alteration of normal migration during active postnatal population of brain regions is beneficial in species with gyrencephalic brains. (C) 2015 S. Karger AG, Basel	[Costine, Beth A.; Smith, Colin M.; Duhaime, Ann-Christine] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurosurg, Charlestown, MA 02114 USA; [McGuone, Declan] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02114 USA; [Costine, Beth A.; Duhaime, Ann-Christine] Harvard Univ, Sch Med, Dept Neurosurg, Charlestown, MA 02114 USA; [Missios, Symeon] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA; [Taylor, Sabrina R.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Dodge, Carter P.] Childrens Hosp Dartmouth, Dartmouth Med Sch, Dept Anesthesiol, Lebanon, NH USA; [Harris, Brent T.] Georgetown Med Sch, Dept Neurol, Washington, DC USA; [Harris, Brent T.] Georgetown Med Sch, Dept Pathol, Washington, DC USA	Costine, BA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Bldg 149,13th St,Room 3-405, Charlestown, MA 02114 USA.	bcostine@mgh.harvard.edu		Costine-Bartell, Beth/0000-0001-7559-9378	NIH National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD45364-5]; Pediatric Neuroscience Fund of the Children's Hospital at Dartmouth; Nicholas T. Zervas Chair of Harvard Medical School; Joel Alan Viktor Research Fund at Massachusetts General Hospital; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5P30NS045776]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS045776] Funding Source: NIH RePORTER	This work was supported by R01 HD45364-5 from the NIH National Institute of Child Health and Human Development, the Pediatric Neuroscience Fund of the Children's Hospital at Dartmouth, the Nicholas T. Zervas Chair of Harvard Medical School, and the Joel Alan Viktor Research Fund at Massachusetts General Hospital. The authors express their gratitude to Leslie Adams, Kate Hillier, Ijeoma Chinwuba, Michael Simoni, and Kristen Saliga for their assistance with animal handling, immunohistochemistry and quantification. The authors also wish to thank Kenneth Orndorff (Dartmouth Optical Cellular Imaging Shared Resource Center) and Igor Bagayev (MGH Neuroscience Center Imaging Core supported by NINDS grant 5P30NS045776) for their assistance with confocal microscopy and Emily Belli for proofreading the manuscript.	ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; BLAKEMORE WF, 1972, J NEUROCYTOL, V1, P69, DOI 10.1007/BF01098647; Boer K, 2009, EPILEPSIA, V50, P2629, DOI 10.1111/j.1528-1167.2009.02191.x; Breunig JJ, 2007, CELL STEM CELL, V1, P612, DOI 10.1016/j.stem.2007.11.008; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; De Marchis S, 2004, J COMP NEUROL, V476, P290, DOI 10.1002/cne.20217; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Doetsch F, 1997, J NEUROSCI, V17, P5046; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2006, DEV NEUROSCI, V28, P230; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Francis HW, 2006, J NEUROSCI METH, V150, P150, DOI 10.1016/j.jneumeth.2005.06.020; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gleason D, 2008, NEUROSCIENCE, V156, P81, DOI 10.1016/j.neuroscience.2008.06.065; Gordon RJ, 2007, NEUROSCIENCE, V146, P1704, DOI 10.1016/j.neuroscience.2007.03.011; Grate LL, 2003, J NEUROSCI METH, V123, P201, DOI 10.1016/S0165-0270(02)00361-8; Guidi S, 2011, BRAIN RES BULL, V85, P169, DOI 10.1016/j.brainresbull.2011.03.028; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Jankovski A, 1996, J COMP NEUROL, V371, P376; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Koob AO, 2008, INT J DEV NEUROSCI, V26, P641, DOI 10.1016/j.ijdevneu.2008.04.001; Liard O, 2009, J NEUROSCI METH, V182, P172, DOI 10.1016/j.jneumeth.2009.06.008; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/0897715042664876; Malik SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036016; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Masuda T, 2007, NEUROSCI LETT, V425, P114, DOI 10.1016/j.neulet.2007.08.039; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Nixon K, 2008, NEUROBIOL DIS, V31, P218, DOI 10.1016/j.nbd.2008.04.009; Peretto P, 2005, J COMP NEUROL, V487, P407, DOI 10.1002/cne.20576; Ponti G, 2006, J COMP NEUROL, V498, P491, DOI 10.1002/cne.21043; Qiu L, 2007, J CEREBR BLOOD F MET, V27, P785, DOI 10.1038/sj.jcbfm.9600385; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sundholm-Peters NL, 2004, J NEUROCYTOL, V33, P153, DOI 10.1023/B:NEUR.0000029654.70632.3a; Taylor SR, 2013, J NEUROSURG-PEDIATR, V12, P545, DOI 10.3171/2013.8.PEDS13154; Thomsen GM, 2014, STEM CELL RES, V13, P48, DOI 10.1016/j.scr.2014.04.013; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Walton RM, 2013, HISTOCHEM CELL BIOL, V139, P415, DOI 10.1007/s00418-012-1053-x; Yin F, 2011, CYTOTECHNOLOGY, V63, P363, DOI 10.1007/s10616-011-9353-x; Zhang C, 2005, J NEUROTRAUM, V22, P1456, DOI 10.1089/neu.2005.22.1456	43	20	20	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2015	37	2					115	130		10.1159/000369091			16	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	CG8LB	WOS:000353558000003	25678047	Green Accepted, Bronze			2021-06-18	
J	Dorman, JC; Valentine, VD; Munce, TA; Tjarks, BJ; Thompson, PA; Bergeron, MF				Dorman, Jason C.; Valentine, Verle D.; Munce, Thayne A.; Tjarks, B. Joel; Thompson, Paul A.; Bergeron, Michael F.			Tracking postural stability of young concussion patients using dual-task interference	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Balance; Brain injury; Clinical assessment; Cognitive function; Injury management	MILD HEAD-INJURY; BALANCE PERFORMANCE; FOOTBALL PLAYERS; SEX-DIFFERENCES; COGNITIVE TASK; BRAIN; STATEMENT; RECOVERY; SYMPTOMS; DEFICITS	Objectives: This study examined the diagnostic benefit of using dual-task interference balance testing in young concussion patients and the longitudinal changes in postural stability that occur relative to other standard clinical assessments of concussion injury. Design: Longitudinal, case-control. Methods: Eighteen patients (16.6 (1.6)y) diagnosed with a concussion provided 22 separate ratings to characterize the severity of their current concussion-related symptoms and were evaluated for postural stability at each of four clinical visits. Twenty-six injury-free adolescents (17 (2.8) y) performed balance testing on two occasions, separated by 1 week. Results: There was a progressive decrease in self-reported symptoms from visit 1 to visit 4 (P<0.0001-0.001). A similar improvement occurred in postural stability, indicated by 95% ellipse area and velocity. However, the differences in ellipse area and velocity were significant only between visit 1 and the rest of the visits as a whole (P<0.0001-0.05). There was a significant difference between concussion patients and healthy, injury-free participants in ellipse area and velocity during visit 1. A group difference was also observed in ellipse area on visit 2, but only during the two balance tests that involved a concomitant secondary cognitive task. Conclusions: Improvements in postural stability coincide with reductions in reported symptoms, though apparent recovery of these selected measures of postural stability seemingly occurs sooner. Because of the distinguishing time course of recovery indicated by dual-task interference balance testing, this type of balance testing assessment may be particularly valuable in evaluating integrated functional impairment and recovery in young concussion patients. (C) 2013 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Dorman, Jason C.; Munce, Thayne A.; Bergeron, Michael F.] Sanford USD Med Ctr, Natl Inst Athlet Hlth & Performance, Sioux Falls, SD 57117 USA; [Valentine, Verle D.] Sanford USD Med Ctr, Sanford Orthoped & Sports Med, Sioux Falls, SD USA; [Valentine, Verle D.; Munce, Thayne A.; Tjarks, B. Joel; Thompson, Paul A.; Bergeron, Michael F.] Univ S Dakota, Sanford Sch Med, Vermillion, SD 57069 USA; [Thompson, Paul A.] Sanford Res, Methodol & Data Anal Ctr, Sioux Falls, SD USA	Dorman, JC (corresponding author), Sanford USD Med Ctr, Natl Inst Athlet Hlth & Performance, Sioux Falls, SD 57117 USA.	jason.dorman@sanfordhealth.org	Meijer, Anna/K-5118-2016	Thompson, Paul/0000-0002-8612-165X			Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brauer SG, 2004, HUM MOVEMENT SCI, V23, P489, DOI 10.1016/j.humov.2004.08.020; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Giza CC, 2013, NEUROLOGY, P1; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hallet M, 2009, EUR NEUROL REV, V4, P34; Holmes JD, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/696492; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Morris M, 2000, GAIT POSTURE, V12, P205, DOI 10.1016/S0966-6362(00)00076-X; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ross LM, 2011, J SPORT REHABIL, V20, P296, DOI 10.1123/jsr.20.3.296; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	26	20	20	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JAN	2015	18	1					2	7		10.1016/j.jsams.2013.11.010			6	Sport Sciences	Sport Sciences	AY7UK	WOS:000347764000002	24380848				2021-06-18	
J	Normoyle, KP; Kim, M; Farahvar, A; Llano, D; Jackson, K; Wang, H				Normoyle, Kieran P.; Kim, Miri; Farahvar, Arash; Llano, Daniel; Jackson, Kevin; Wang, Huan			THE EMERGING NEUROPROTECTIVE ROLE OF MITOCHONDRIAL UNCOUPLING PROTEIN-2 IN TRAUMATIC BRAIN INJURY	TRANSLATIONAL NEUROSCIENCE			English	Article						Neuronal injury; Mitochondria; Traumatic brain injury; Ischemia; Neuronal cell death	PREVENTS NEURONAL DEATH; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; TEMPERATURE MANAGEMENT; MILD HYPOTHERMIA; CARDIAC-ARREST; RAT-BRAIN; OXYGEN; UCP2; DISRUPTION	Traumatic brain injury (TBI) is a multifaceted disease with intrinsically complex heterogeneity and remains a significant clinical challenge to manage. TBI model systems have demonstrated many mechanisms that contribute to brain parenchymal cell death, including glutamate and calcium toxicity, oxidative stress, inflammation, and mitochondrial dysfunction. Mitochondria are critically regulated by uncoupling proteins (UCP), which allow protons to leak back into the matrix and thus reduce the mitochondrial membrane potential by dissipating the proton motive force. This uncoupling of oxidative phosphorylation from adenosine triphosphate (ATP) synthesis is potentially critical for protection against cellular injury as a result of TBI and stroke. A greater understanding of the underlying mechanism or mechanisms by which uncoupling protein-2 (UCP2) functions to maintain or optimize mitochondrial function, and the conditions which precipitate the failure of these mechanisms, would inform future research and treatment strategies. We posit that UCP2-mediated function underlies the physiological response to neuronal stress associated with traumatic and ischemic injury and that clinical development of UCP2-targeted treatment would significantly impact these patient populations. With a focus on clinical relevance in TBI, we synthesize current knowledge concerning UCP2 and its potential neuroprotective role and apply this body of knowledge to current and potential treatment modalities.	[Normoyle, Kieran P.; Llano, Daniel] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Normoyle, Kieran P.; Kim, Miri] Univ Illinois, Coll Med, Urbana, IL 61801 USA; [Normoyle, Kieran P.] Massachusetts Gen Hosp, Dept Child Neurol, Boston, MA 02114 USA; [Kim, Miri] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Farahvar, Arash] Carle Fdn Hosp, Dept Neurosurg, Urbana, IL USA; [Llano, Daniel; Wang, Huan] Carle Fdn Hosp, Dept Neurol, Urbana, IL 61801 USA; [Llano, Daniel; Jackson, Kevin] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Jackson, Kevin; Wang, Huan] Univ Illinois, Beckman Inst, TNL, Urbana, IL 61801 USA	Wang, H (corresponding author), Carle Fdn Hosp, Dept Neurol, Urbana, IL 61801 USA.	huanwang@illinois.edu	Llano, Daniel/X-8184-2019	Llano, Daniel/0000-0003-0933-1837; , Miri/0000-0002-5227-9803			Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Boucher J, 2010, BRAIN STRUCT FUNCT, V215, P49, DOI 10.1007/s00429-010-0273-x; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; Ciccarelli O, 2010, NEUROLOGY, V74, P721, DOI 10.1212/WNL.0b013e3181d26968; Crouser E, 2013, AM J RESP CRIT CARE, V187, P460, DOI 10.1164/rccm.201301-0107ED; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Diano S, 2000, ENDOCRINOLOGY, V141, P4226, DOI 10.1210/en.141.11.4226; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dzbek J, 2008, J BIOL CHEM, V283, P33232, DOI 10.1074/jbc.M802404200; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Fuxe K, 2005, J NEURAL TRANSM, V112, P65, DOI 10.1007/s00702-004-0158-3; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; Graw JA, 2013, ALCOHOL CLIN EXP RES, V37, P1650, DOI 10.1111/acer.12144; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Henry BA, 2011, ENDOCRINOLOGY, V152, P2609, DOI 10.1210/en.2011-0143; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Horvath TL, 1999, J NEUROSCI, V19, P10417; Horvath TL, 2003, ENDOCRINOLOGY, V144, P2757, DOI 10.1210/en.2003-0163; Hosler JP, 2006, ANNU REV BIOCHEM, V75, P165, DOI 10.1146/annurev.biochem.75.062003.101730; Huang YZ, 2012, J NEUROSCI, V32, P15521, DOI 10.1523/JNEUROSCI.0755-12.2012; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Kinnally K. W., 2006, CURR PROTOC TOXICOL, V2, P12; Kinnally KW, 2011, BBA-MOL CELL RES, V1813, P616, DOI 10.1016/j.bbamcr.2010.09.013; Kleinridders A, 2013, J CLIN INVEST, V123, P4667, DOI 10.1172/JCI67615; Klingenberg M, 2010, BBA-BIOENERGETICS, V1797, P579, DOI 10.1016/j.bbabio.2010.02.012; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Li N, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/740849; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liu Yajun, 2009, BMC Physiology, V9, P17, DOI 10.1186/1472-6793-9-17; Lopez NE, 2012, BRAIN RES, V1489, P140, DOI 10.1016/j.brainres.2012.10.031; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; Mizuno T, 2000, BIOCHEM BIOPH RES CO, V278, P691, DOI 10.1006/bbrc.2000.3859; Mortiboys H, 2013, BRAIN, V136, P3038, DOI 10.1093/brain/awt224; Nagley P, 2010, BBA-MOL BASIS DIS, V1802, P167, DOI 10.1016/j.bbadis.2009.09.004; NegreSalvayre A, 1997, FASEB J, V11, P809; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Niethammer P, 2008, CURR BIOL, V18, P586, DOI 10.1016/j.cub.2008.03.038; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Olsen RKJ, 2013, MOL GENET METAB, V110, pS31, DOI 10.1016/j.ymgme.2013.10.007; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Paradis E, 2003, TRENDS MOL MED, V9, P522, DOI 10.1016/j.molmed.2003.10.009; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Qi L, 2012, MOL MED, V18, P186, DOI 10.2119/molmed.2011.00390; Reeve AK, 2012, ARCH NEUROL-CHICAGO, V69, P385, DOI 10.1001/archneurol.2011.2675; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Richard D, 1998, J COMP NEUROL, V397, P549; Richard D, 2011, FRONT BIOSCI-LANDMRK, V16, P1233, DOI 10.2741/3786; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Rittenberger JC, 2013, NEW ENGL J MED, V369, P2262, DOI 10.1056/NEJMe1312700; Robinson AD, 2011, AM J MED SCI, V342, P129, DOI 10.1097/MAJ.0b013e3182231ee3; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00091; Rousset S, 2007, FEBS LETT, V581, P479, DOI 10.1016/j.febslet.2007.01.010; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Steer JH, 2013, INHAL TOXICOL, V25, P544, DOI 10.3109/08958378.2013.810679; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Van Vleet TM, 2015, NEUROCASE, V21, P489, DOI 10.1080/13554794.2014.928329; Veal E, 2011, ANTIOXID REDOX SIGN, V15, P147, DOI 10.1089/ars.2011.3968; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Yamada S, 2003, J NEUROCHEM, V87, P461, DOI 10.1046/j.1471-4159.2003.02005.x; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014	107	20	23	0	1	SCIENDO	WARSAW	DE GRUYTER POLAND SP Z O O, BOGUMILA ZUGA 32A STR, 01-811 WARSAW, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	JAN	2015	6	1					179	186		10.1515/tnsci-2015-0019			8	Neurosciences	Neurosciences & Neurology	CQ6GJ	WOS:000360702200012	28123803	DOAJ Gold, Green Published			2021-06-18	
J	Snell, DL; Surgenor, LJ; Hay-Smith, EJC; Williman, J; Siegert, RJ				Snell, Deborah L.; Surgenor, Lois J.; Hay-Smith, E. Jean C.; Williman, Jonathan; Siegert, Richard J.			The contribution of psychological factors to recovery after mild traumatic brain injury: Is cluster analysis a useful approach?	BRAIN INJURY			English	Article						Cluster analysis; illness beliefs; mild traumatic brain injury; MTBI; post-concussion symptoms	POST-CONCUSSION SYMPTOMS; LOW-BACK-PAIN; ILLNESS PERCEPTIONS; HEAD-INJURY; POSTCONCUSSION SYNDROME; MYOCARDIAL-INFARCTION; RISK-FACTORS; BASE RATES; QUESTIONNAIRE; BELIEFS	Objectives: Outcomes after mild traumatic brain injury (MTBI) vary, with slow or incomplete recovery for a significant minority. This study examines whether groups of cases with shared psychological factors but with different injury outcomes could be identified using cluster analysis. Method: This is a prospective observational study following 147 adults presenting to a hospital-based emergency department or concussion services in Christchurch, New Zealand. This study examined associations between baseline demographic, clinical, psychological variables (distress, injury beliefs and symptom burden) and outcome 6 months later. A two-step approach to cluster analysis was applied (Ward's method to identify clusters, K-means to refine results). Results: Three meaningful clusters emerged (high-adapters, medium-adapters, low-adapters). Baseline cluster-group membership was significantly associated with outcomes over time. High-adapters appeared recovered by 6-weeks and medium-adapters revealed improvements by 6-months. The low-adapters continued to endorse many symptoms, negative recovery expectations and distress, being significantly at risk for poor outcome more than 6-months after injury (OR (good outcome) = 0.12; CI = 0.03-0.53; p<0.01). Conclusions: Cluster analysis supported the notion that groups could be identified early post-injury based on psychological factors, with group membership associated with differing outcomes over time. Implications for clinical care providers regarding therapy targets and cases that may benefit from different intensities of intervention are discussed.	[Snell, Deborah L.] Burwood Hosp, Concuss Clin, Christchurch, New Zealand; [Snell, Deborah L.] Univ Otago, Dept Orthopaed Surg & Musculoskeletal Med, Christchurch 8140, New Zealand; [Surgenor, Lois J.] Univ Otago, Dept Psychol Med, Christchurch 8140, New Zealand; [Hay-Smith, E. Jean C.] Univ Otago, Rehabil Teaching & Res Unit, Wellington, New Zealand; [Williman, Jonathan] Univ Otago, Sch Med, Wellington, New Zealand; [Siegert, Richard J.] AUT Univ, Fac Hlth & Environm Studies, Auckland, New Zealand	Snell, DL (corresponding author), Univ Otago, Dept Orthopaed Surg & Musculoskeletal Med, POB 4345, Christchurch 8140, New Zealand.	debbie.snell@burwood.org.nz	Williman, Jonathan/E-8206-2016; Siegert, Richard J./K-2030-2019	Williman, Jonathan/0000-0001-5080-4435; Siegert, Richard/0000-0002-3074-0929	Neurological Foundation of New Zealand [0728-SPG]	The authors report no conflicts of interest. This research has been support by a Small Project Grant from the Neurological Foundation of New Zealand (Grant no: 0728-SPG).	Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Broadbent E, 2009, J PSYCHOSOM RES, V67, P17, DOI 10.1016/j.jpsychores.2008.12.001; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll L, 2004, J REHABILITATION M S, V43, P113; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Clatworthy J, 2005, BRIT J HEALTH PSYCH, V10, P329, DOI 10.1348/135910705X25697; Clatworthy J, 2007, PSYCHOL HEALTH, V22, P123, DOI 10.1080/14768320600774496; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Foster NE, 2008, PAIN, V136, P177, DOI 10.1016/j.pain.2007.12.007; French DP, 2006, J PSYCHOSOM RES, V61, P757, DOI 10.1016/j.jpsychores.2006.07.029; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Goulding L, 2010, J ADV NURS, V66, P946, DOI 10.1111/j.1365-2648.2010.05306.x; Hobro N, 2004, PAIN, V108, P276, DOI 10.1016/j.pain.2003.12.027; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Jonsbu E, 2013, BEHAV COGN PSYCHOTH, V41, P398, DOI 10.1017/S1352465813000179; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Leventhal H, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P19; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Llewellyn CD, 2007, J PSYCHOSOM RES, V63, P17, DOI 10.1016/j.jpsychores.2007.01.013; Macleod AD, 2010, MED HYPOTHESES, V74, P1033, DOI 10.1016/j.mehy.2010.01.002; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P899, DOI 10.1080/09602011.2010.517688; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V41, P611; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; MossMorris R, 1996, BRIT J HEALTH PSYCH, V1, P15, DOI 10.1111/j.2044-8287.1996.tb00488.x; Munro BH, 2005, STAT METHODS HLTH CA; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; NZGG, 2006, TRAUM BRAIN INJ DIAG; Ontario Neurotrauma Foundation, 2013, GUID CONC MILD TRAUM; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; PETRIE K, 1995, J PSYCHOSOM RES, V39, P31, DOI 10.1016/0022-3999(94)00071-C; Powell GE, 2008, J NEUROL NEUROSUR PS, V79, P237, DOI 10.1136/jnnp.2007.131722; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Siemonsma PC, 2013, PHYS THER, V93, P435, DOI 10.2522/ptj.20110150; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Snell D, 2006, NEW ZEAL MED J, V119, P66; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Stuifbergen AK, 2006, WOMEN HEALTH ISS, V16, P353, DOI 10.1016/j.whi.2006.05.003; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; TEASDALE G, 1974, LANCET, V2, P81; Van Ittersum MW, 2009, PATIENT EDUC COUNS, V74, P53, DOI 10.1016/j.pec.2008.07.041; Weinman J, 2010, COMMUNICATION; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Yan J, 2014, INT J NURS STUD, V51, P844, DOI 10.1016/j.ijnurstu.2013.10.011	60	20	20	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					291	299		10.3109/02699052.2014.976594			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000002	25409487				2021-06-18	
J	Stevens, LF; Pickett, TC; Schaaf, KPW; Taylor, BC; Gravely, A; Van Houtven, CH; Friedemann-Sanchez, G; Griffin, JM				Stevens, Lillian Flores; Pickett, Treven C.; Schaaf, Kathryn P. Wilder; Taylor, Brent C.; Gravely, Amy; Van Houtven, Courtney Harold; Friedemann-Sanchez, Greta; Griffin, Joan M.			The Relationship between Training and Mental Health among Caregivers of Individuals with Polytrauma	BEHAVIOURAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ZARIT BURDEN INTERVIEW; FAMILIES; REHABILITATION; WAR; DISTRESS; VETERANS; NEEDS; CARE; INFORMATION	This was a hypothesis-generating exploration of relationships between caregiver training during TBI/polytrauma rehabilitation and caregiver mental health. In this cross-sectional study, 507 informal caregivers to US service members with TBI who received inpatient rehabilitation care in a Veterans Affairs' Polytrauma Rehabilitation Center from 2001 to 2009 completed a retrospective, self-report survey. Embedded in the survey were measures of caregiver mental health, including the National Institutes of Health's Patient Reported Outcome Measurement Information System (PROMIS) Anxiety and Depression Short Forms, the Rosenberg Self-Esteem scale, and the Zarit Burden Short Form. Though no groups endorsed clinical levels, mental health symptoms varied by caregiver training category (Trained, Not Trained, and Did Not Need Training). Caregivers who did not receive training on how to navigate healthcare systems endorsed higher depression and burden and lower self-esteem than those who did. Caregivers who did not receive training in supporting their care recipients' emotions endorsed higher anxiety, depression, and burden and lower self-esteem than those who did. Analyses also suggested a different association between training and mental health based on caregivers' relationship to the care recipient and the intensity of care recipient needs. Potential hypotheses for testing in future studies raised by these findings are discussed.	[Stevens, Lillian Flores; Pickett, Treven C.; Schaaf, Kathryn P. Wilder] Hunter Holmes McGuire VAMC, Psychol Sect 116B, Richmond, VA 23249 USA; [Stevens, Lillian Flores; Pickett, Treven C.; Schaaf, Kathryn P. Wilder] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Stevens, Lillian Flores; Pickett, Treven C.; Schaaf, Kathryn P. Wilder] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA; [Pickett, Treven C.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23284 USA; [Taylor, Brent C.; Gravely, Amy; Griffin, Joan M.] Minneapolis VA Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA; [Van Houtven, Courtney Harold] Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; [Friedemann-Sanchez, Greta] Univ Minnesota, Humphrey Sch Publ Affairs, Humphrey Ctr 267, Minneapolis, MN 55455 USA; [Griffin, Joan M.] Kern Ctr Sci Hlth Care Delivery, Mayo Clin, Div Hlth Care Policy & Res, Dept Hlth Sci Res, Rochester, MN 55905 USA	Stevens, LF (corresponding author), Hunter Holmes McGuire VAMC, Psychol Sect 116B, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.	lillian.stevens@va.gov	Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377; Van Houtven, Courtney/0000-0002-0783-1611; Friedemann-Sanchez, Greta/0000-0002-0493-7218	Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment; Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical CenterUS Department of Veterans Affairs; Hunter Holmes McGuire VA Medical Center; Department of Veterans Affairs, Veterans Health Administration, Office of Research and DevelopmentUS Department of Veterans Affairs; Health Services Research and Development (HSRD) service [SDR-07-044]	The writing of this paper was supported by the Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment; the Department of Veterans Affairs Mid-Atlantic Mental Illness Research, Education and Clinical Center; and the Hunter Holmes McGuire VA Medical Center (Lillian Flores Stevens). The material is based on work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, and a grant from the Health Services Research and Development (HSR&D) service (SDR-07-044; Joan M. Griffin).	Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Arean P. A., 2013, HIGH QUALITY PSYCHOT; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Calhoun PS, 2002, J TRAUMA STRESS, V15, P205, DOI 10.1023/A:1015251210928; Cavallo M.M., 2011, TXB TRAUMATIC BRAIN, P483; Chiu YL, 2004, J CLIN NURS, V13, P655, DOI 10.1111/j.1365-2702.2004.00844.x; Choi SW, 2010, QUAL LIFE RES, V19, P125, DOI 10.1007/s11136-009-9560-5; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Coon DW, 2004, AGING MENT HEALTH, V8, P330, DOI 10.1080/13607860410001709683; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Defense and Veterans Brain Injury Center, DOD TBI WORLD WID NU; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Department of Veterans Affairs, 2013, VHA HDB, V1172; Ford JH, 2014, J REHABIL RES DEV, V51, P1311, DOI 10.1682/JRRD.2014.03.0066; Friedemann-Sanchez G, 2008, REHABIL NURS, V33, P206, DOI 10.1002/j.2048-7940.2008.tb00229.x; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gottlieb BH, 2004, AGING MENT HEALTH, V8, P364, DOI 10.1080/13607860410001709719; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hall C, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1125-3; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Moules S, 1999, BRAIN INJURY, V13, P983; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Perrin PB, 2010, J REHABIL RES DEV, V47, P605, DOI 10.1682/JRRD.2009.10.0170; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1126/science.148.3671.804; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schaaf KPW, 2013, REHABIL PSYCHOL, V58, P106, DOI 10.1037/a0031693; Siegert RJ, 2010, J REHABIL MED, V42, P302, DOI 10.2340/16501977-0511; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x	42	20	20	0	10	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								185941	10.1155/2015/185941			13	Clinical Neurology	Neurosciences & Neurology	CZ1EY	WOS:000366849900001	26770015	DOAJ Gold, Green Published			2021-06-18	
J	Li, W; Long, JA; Watts, LT; Jiang, Z; Shen, Q; Li, YX; Duong, TQ				Li, Wei; Long, Justin Alexander; Watts, Lora Talley; Jiang, Zhao; Shen, Qiang; Li, Yunxia; Duong, Timothy Q.			A Quantitative MRI Method for Imaging Blood-Brain Barrier Leakage in Experimental Traumatic Brain Injury	PLOS ONE			English	Article							REPERFUSION INJURY; MODEL SELECTION; PATLAK PLOTS; RAT MODEL; GD-DTPA; PERMEABILITY; STROKE; PARAMETERS; DIFFUSION; BREAKDOWN	Blood-brain barrier (BBB) disruption is common following traumatic brain injury (TBI). Dynamic contrast enhanced (DCE) MRI can longitudinally measure the transport coefficient K-trans which reflects BBB permeability. K-trans measurements however are not widely used in TBI research because it is generally considered to be noisy and possesses low spatial resolution. We improved spatiotemporal resolution and signal sensitivity of K-trans MRI in rats by using a high-sensitivity surface transceiver coil. To overcome the signal drop off profile of the surface coil, a pre-scan module was used to map the flip angle (B-1 field) and magnetization (M-0) distributions. A series of T-1-weighted gradient echo images were acquired and fitted to the extended Kety model with reversible or irreversible leakage, and the best model was selected using F-statistics. We applied this method to study the rat brain one hour following controlled cortical impact (mild to moderate TBI), and observed clear depiction of the BBB damage around the impact regions, which matched that outlined by Evans Blue extravasation. Unlike the relatively uniform T-2 contrast showing cerebral edema, K-trans shows a pronounced heterogeneous spatial profile in and around the impact regions, displaying a nonlinear relationship with T-2. This improved K-trans MRI method is also compatible with the use of high-sensitivity surface coil and the high-contrast two-coil arterial spin-labeling method for cerebral blood flow measurement, enabling more comprehensive investigation of the pathophysiology in TBI.	[Li, Wei; Long, Justin Alexander; Watts, Lora Talley; Jiang, Zhao; Shen, Qiang; Li, Yunxia; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Li, Wei; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Watts, Lora Talley; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Duong, Timothy Q.] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX USA	Li, W (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA.	liw5@uthscsa.edu; duongt@uthscsa.edu	Duong, Tim/AAL-8357-2021; Shen, Qiang/B-8784-2008; Watts, Lora Talley/A-2724-2012	Duong, Tim/0000-0001-6403-2827; Shen, Qiang/0000-0002-4287-3403; Watts, Lora Talley/0000-0002-2337-1504	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS45879, UL1 TR001119, TL1TR001119, KL2 TR001118]; NIH/NINDS via the Clinical Translational Science Awards (CTSA) [TL1TR001119, UL1TR001119, 8UL1TR000149]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001118, TL1TR001119, UL1TR001120, UL1TR000149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045879] Funding Source: NIH RePORTER	The study was supported in part by grants from NIH/NINDS R01 NS45879 (TQD), UL1 TR001119 (WL), TL1TR001119 (JAL), and KL2 TR001118 (LTW) via the Clinical Translational Science Awards (CTSA, parent grant UL1TR001119, 8UL1TR000149, and TL1TR001119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1998, ACT NEUR S, V71, P104; Aryal MP, 2014, MAGN RESON MED, V71, P2206, DOI 10.1002/mrm.24873; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Ding GL, 2008, STROKE, V39, P1563, DOI 10.1161/STROKEAHA.107.502146; Duong TQ, 2007, BRAIN RES, V1135, P186, DOI 10.1016/j.brainres.2006.11.097; Durukan A, 2009, BRAIN RES, V1280, P158, DOI 10.1016/j.brainres.2009.05.025; Ewing JR, 2013, NMR BIOMED, V26, P1028, DOI 10.1002/nbm.2996; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; Gursoy-Ozdemir Y, 2000, STROKE, V31, P1974, DOI 10.1161/01.STR.31.8.1974; Jiang Z, 2014, NEUROSCI LETT, V566, P298, DOI 10.1016/j.neulet.2014.02.066; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Nagaraja TN, 2010, MAGN RESON MED, V63, P1502, DOI 10.1002/mrm.22339; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Pike MM, 2009, MAGN RESON MED, V61, P615, DOI 10.1002/mrm.21931; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P280, DOI 10.1097/01.WCB.0000110048.43905.E5; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Tofts PS, 2010, SIGNAL, V500, P400; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Yankeelov TE, 2007, MAGN RESON MED, V57, P353, DOI 10.1002/mrm.21131	26	20	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e114173	10.1371/journal.pone.0114173			16	Multidisciplinary Sciences	Science & Technology - Other Topics	AX4MS	WOS:000346907200050	25478693	DOAJ Gold, Green Published			2021-06-18	
J	Hochstadter, E; Stewart, TC; Alharfi, IM; Ranger, A; Fraser, DD				Hochstadter, Elana; Stewart, Tanya Charyk; Alharfi, Ibrahim M.; Ranger, Adrianna; Fraser, Douglas D.			Subarachnoid Hemorrhage Prevalence and Its Association with Short-Term Outcome in Pediatric Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Children; Severe traumatic brain injury; Subarachnoid hemorrhage; Mortality	SEVERE HEAD-INJURY; COMPUTERIZED-TOMOGRAPHY; POSTTRAUMATIC VASOSPASM; PROGRESSIVE HEMORRHAGE; CEREBRAL VASOSPASM; PROGNOSTIC FACTORS; RISK-FACTORS; TIME-COURSE; CHILDREN; COAGULOPATHY	Subarachnoid hemorrhage (SAH) is an independent prognostic indicator of outcome in adult severe traumatic brain injury (sTBI). There is a paucity of investigations on SAH in pediatric sTBI. The goal of this study was to determine in pediatric sTBI patients SAH prevalence, associated factors, and its relationship to short-term outcome. We retrospectively analyzed 171 sTBI patients (pre-sedation GCS a parts per thousand currency sign8 and head MAIS a parts per thousand yen4) who underwent CT head imaging within the first 24 h of hospital admission. Data were analyzed with both univariate and multivariate techniques. SAH was found in 42 % of sTBI patients (n = 71/171), and it was more frequently associated with skull fractures, cerebral edema, diffuse axonal injury, contusion, and intraventricular hemorrhage (p < 0.05). Patients with SAH had higher Injury Severity Scores (p = 0.032) and a greater frequency of fixed pupil(s) on admission (p = 0.001). There were no significant differences in etiologies between sTBI patients with and without SAH. Worse disposition occurred in sTBI patients with SAH, including increased mortality (p = 0.009), increased episodes of central diabetes insipidus (p = 0.002), greater infection rates (p = 0.002), and fewer ventilator-free days (p = 0.001). In sTBI survivors, SAH was associated with increased lengths of stay (p < 0.001) and a higher level of care required on discharge (p = 0.004). Despite evidence that SAH is linked to poorer outcomes on univariate analyses, multivariate analysis failed to demonstrate an independent association between SAH and mortality (p = 0.969). SAH was present in almost half of pediatric sTBI patients, and it was indicative of TBI severity and a higher level of care on discharge. SAH in pediatric patients was not independently associated with increased risk of mortality.	[Hochstadter, Elana; Alharfi, Ibrahim M.; Fraser, Douglas D.] Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada; [Stewart, Tanya Charyk] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [Stewart, Tanya Charyk] London Hlth Sci Ctr, Trauma Program, London, ON, Canada; [Alharfi, Ibrahim M.] King Fahad Med City, Childrens Hosp, Pediat Crit Care, Riyadh, Saudi Arabia; [Ranger, Adrianna; Fraser, Douglas D.] Univ Western Ontario, London, ON, Canada; [Ranger, Adrianna; Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, Douglas D.] Translat Res Ctr, London, ON, Canada; [Fraser, Douglas D.] LHSC, Childrens Hosp, London, ON N6A 5W9, Canada	Fraser, DD (corresponding author), LHSC, Childrens Hosp, Room C2-C82,800 Commissioners Rd E, London, ON N6A 5W9, Canada.	douglas.fraser@lhsc.on.ca					Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/NEU.2013.2904, 10.1089/neu.2013.2904]; Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; Alharfi IM, 2013, PEDIATR CRIT CARE ME, V14, P203, DOI 10.1097/PCC.0b013e31827127b5; American College of Surgeons. Committe on Trauma, 2008, ADV TRAUM LIF SUPP D; Aminmansour B, 2009, J RES MED SCI, V14, P343; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Compton J S, 1987, Br J Neurosurg, V1, P435, DOI 10.3109/02688698708999633; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hirsch W, 2002, PAEDIATR ANAESTH, V12, P337, DOI 10.1046/j.1460-9592.2002.00837.x; Hosmer D, 1989, APPL LOGISTIC REGRES; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; KALFF R, 1989, CHILD NERV SYST, V5, P156, DOI 10.1007/BF00272118; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Morrison Gavin, 2013, Pathophysiology, V20, P49, DOI 10.1016/j.pathophys.2012.02.006; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; O'Brien NF, 2010, INTENS CARE MED, V36, P680, DOI 10.1007/s00134-009-1747-2; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Servadei F, 2002, NEUROSURGERY, V50, P7; Shahlaie K, 2011, J NEUROSURG, V115, P602, DOI 10.3171/2011.5.JNS101667; Sigurta A, 2013, INTENS CARE MED, V39, P129, DOI 10.1007/s00134-012-2748-0; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Tomberg T, 1996, ACTA NEUROCHIR, V138, P543, DOI 10.1007/BF01411174; Tu CJ, 2011, J INT MED RES, V39, P1757, DOI 10.1177/147323001103900518; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wong M. F. M., 1998, Annals Academy of Medicine Singapore, V27, P340	54	20	20	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2014	21	3					505	513		10.1007/s12028-014-9986-7			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	AT2TY	WOS:000344790100017	24798696				2021-06-18	
J	Miller, TR; Steinbeigle, R; Wicks, A; Lawrence, BA; Barr, M; Barr, RG				Miller, Ted R.; Steinbeigle, Ryan; Wicks, Amy; Lawrence, Bruce A.; Barr, Marilyn; Barr, Ronald G.			Disability-Adjusted Life-Year Burden of Abusive Head Trauma at Ages 0-4	PEDIATRICS			English	Article						child abuse; DALY; Health Utilities Index; maltreatment; shaken baby syndrome; traumatic brain injury	QUALITY-OF-LIFE; OPERATIONAL CASE-DEFINITION; BRAIN-INJURY; CHILD MALTREATMENT; GLOBAL BURDEN; UNITED-STATES; HEALTH; CLASSIFICATION; ADOLESCENTS; DISEASES	OBJECTIVE: We estimated the disability-adjusted life-year (DALY) burden of abusive head trauma (AHT) at ages 0 to 4 years in the United States. METHODS: DALYs are computed by summing years of productive life that survivors lost to disability plus life-years lost to premature death. Surveying a convenience sample of 170 caregivers and pediatricians yielded health-related disability over time according to severity of AHT (measured with the Health Utilities Index, Mark 2). Incidence estimates for 2009 came from Vital Statistics for Mortality, Healthcare Cost and Utilization Program Kids' Inpatient Database for hospitalized survivors, and published ratios of 0.894 case treated and released and 0.340 case not diagnosed/treated while in the acute phase per survivor admitted. Survival probability over time after discharge came from published sources. RESULTS: An estimated 4824 AHT cases in 2009 included 334 fatalities within 30 days. DALYs per surviving child averaged 0.555 annually for severe AHT (95% confidence interval: 0.512-0.598) and 0.155 (95% confidence interval: 0.120-0.190) for other cases. Including life-years lost to premature mortality, estimated lifetime burden averaged 4.7 DALYs for mild AHT, 5.4 for moderate AHT, 24.1 for severe AHT, and 29.8 for deaths. On average, DALY loss per 30-day survivor included 7.6 years of lost life expectancy and 5.7 years lived with disability. Estimated burden of AHT incidents in 2009 was 69 925 DALYs or 0.017 DALYs per US live birth. CONCLUSIONS: AHT is extremely serious, often resulting in severe physical damage or death. The annual DALY burden several years after mild AHT exceeds the DALY burden of a severe burn.	[Miller, Ted R.; Lawrence, Bruce A.] Pacific Inst Res & Evaluat, Calverton, MD 20705 USA; [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth Res, Perth, WA 6845, Australia; [Steinbeigle, Ryan; Wicks, Amy; Barr, Marilyn] Natl Ctr Shaken Baby Syndrome, Farmington, UT USA; [Barr, Ronald G.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada	Miller, TR (corresponding author), Pacific Inst Res & Evaluat, 11720 Beltsville Dr,Suite 900, Calverton, MD 20705 USA.	miller@pire.org		Miller, Ted/0000-0002-0958-2639	Annie Casey Foundation; Canada Research Chair in Community Child Health Research	The authors' work was supported by grants from the Annie Casey Foundation (Drs Miller, Wicks, Steinbeigle, Lawrence, and Barr) and a Canada Research Chair in Community Child Health Research (Dr Barr). Neither funder was involved in decisions regarding design, analysis, or interpretation of study results. The findings and conclusions in this report are those of the authors and do not necessarily represent the official positions of the funders.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arias E., 2014, NATL VITAL STAT REPO, V62; Bourgeois FT, 2014, PEDIATRICS, V133, P78, DOI 10.1542/peds.2013-2567; Corso PS, 2011, AM J PUBLIC HEALTH, V101, P487, DOI 10.2105/AJPH.2010.196584; Drummond MF., 2007, METHODS EC EVALUATIO; Gold M., 1996, Cost-Effectiveness in Health and Medicine.; Maguire SA, 2013, EYE, V27, P28, DOI 10.1038/eye.2012.213; Miller T, 2013, QUAL LIFE RES, V22, P2293, DOI 10.1007/s11136-012-0321-5; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Parks S, 2012, INJURY PREV, V18, P392, DOI 10.1136/injuryprev-2011-040234; Parks SE, 2012, INJURY PREV, V18, P193, DOI 10.1136/injuryprev-2011-040128; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Peterson C, 2014, PEDIATRICS, V134, P91, DOI 10.1542/peds.2014-0117; Prosser LA, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-42; Roberts G, 2013, J PEDIATR-US, V163, P1008, DOI 10.1016/j.jpeds.2013.05.048; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Wolke D, 2013, J PEDIATR-US, V163, P1020, DOI 10.1016/j.jpeds.2013.04.030; Xiang J, 2013, BRAIN INJURY, V27, P1555, DOI 10.3109/02699052.2013.831126	21	20	20	0	9	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	DEC	2014	134	6					E1545	E1550		10.1542/peds.2014-1385			6	Pediatrics	Pediatrics	AU8KB	WOS:000345844200005	25404725				2021-06-18	
J	Baker, JG; Rieger, BP; McAvoy, K; Leddy, JJ; Master, CL; Lana, SJ; Willer, BS				Baker, J. G.; Rieger, B. P.; McAvoy, K.; Leddy, J. J.; Master, C. L.; Lana, S. J.; Willer, B. S.			Principles for return to learn after concussion	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE			English	Article							HEAD-INJURY; CHILDREN; SPORT; ADOLESCENTS		[Baker, J. G.] SUNY Buffalo, Sch Social Work Nucl Med Orthopaed & Sports Med, Buffalo, NY 14214 USA; [Rieger, B. P.] SUNY Upstate Med Univ, Upstate Concuss Ctr, Syracuse, NY 13210 USA; [McAvoy, K.] Rocky Mt Youth Hosp Children, Ctr Concuss, Denver, CO USA; [Leddy, J. J.] SUNY Buffalo, Buffalo, NY 14214 USA; [Master, C. L.] Childrens Hosp Philadelphia, Dept Surg & Pediat, Philadelphia, PA 19104 USA; [Lana, S. J.] SUNY Buffalo, Dept Pediat, Buffalo, NY 14214 USA; [Willer, B. S.] SUNY Buffalo, Dept Psychiat, Buffalo, NY 14214 USA	Baker, JG (corresponding author), SUNY Buffalo, Sch Social Work, 219 Parker Hall, Buffalo, NY 14214 USA.	jgbaker@buffalo.edu		Master, Christina/0000-0002-6717-4270	Robert Rich Family Foundation; Program for Understanding Childhood Concussion and Stroke; Buffalo Bills Team Physician Fund; Buffalo Sabres Foundation	We thank the following organisations for financial support: The Robert Rich Family Foundation, Program for Understanding Childhood Concussion and Stroke, Buffalo Bills (Ralph Wilson) Team Physician Fund and the Buffalo Sabres Foundation.	Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gioia GA, 2010, J INT NEUROPSYCH SOC, V16, P178; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McAvoy K, 2009, REAP BENEFITS GOOD C; McAvoy K, 2012, BRAIN INJ PROF, V9, P26; McAvoy K, 2012, COMMUNIQUE, V40; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Oregon Center for Applied Science I, CONC MAN POL RES HDB; Rieger BP, 2012, BRAIN INJ PROF, V9, P22; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107	18	20	20	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-5031	1742-1241		INT J CLIN PRACT	Int. J. Clin. Pract.	NOV	2014	68	11					1286	1288		10.1111/ijcp.12517			3	Medicine, General & Internal; Pharmacology & Pharmacy	General & Internal Medicine; Pharmacology & Pharmacy	AS8BN	WOS:000344475500003	25348379	Bronze			2021-06-18	
J	Bodanapally, UK; Shanmuganathan, K; Boscak, AR; Jaffray, PM; Van der Byl, G; Roy, AK; Dreizin, D; Fleiter, TR; Mirvis, SE; Krejza, J; Aarabi, B				Bodanapally, Uttam K.; Shanmuganathan, Kathirkamanathan; Boscak, Alexis R.; Jaffray, Paul M.; Van der Byl, Giulia; Roy, Ashis K.; Dreizin, David; Fleiter, Thorsten R.; Mirvis, Stuart E.; Krejza, Jaroslaw; Aarabi, Bizhan			Vascular complications of penetrating brain injury: comparison of helical CT angiography and conventional angiography	JOURNAL OF NEUROSURGERY			English	Article						intracranial arterial injuries; penetrating traumatic brain injury; traumatic intracranial pseudoaneurysms; CT angiography; digital subtraction angiography; vascular disorders	MISSILE HEAD WOUNDS; TRAUMATIC ANEURYSMS; NECK INJURIES; INITIAL EVALUATION; ARTERIAL INJURIES; GUNSHOT WOUNDS; DIAGNOSIS; MANAGEMENT	Object. The authors conducted a study to compare the sensitivity and specificity of helical CT angiography (CTA) and digital subtraction angiography (DSA) in detecting intracranial arterial injuries after penetrating traumatic brain injury (PTBI). Methods. In a retrospective evaluation of 48 sets of angiograms from 45 consecutive patients with PTBI, 3 readers unaware of the DSA findings reviewed the CTA images to determine the presence or absence of arterial injuries. A fourth reader reviewed all the disagreements and decided among the 3 interpretations. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of CTA were calculated on a per-injury basis and in a subpopulation of patients with traumatic intracranial aneurysms (TICAs). Results. Sensitivity of CTA for detecting arterial injuries was 72.7% (95% CI 49.8%-89.3%); specificity, 93.5% (95% CI 78.6%-99.2%); PPV, 88.9% (95% CI 65.3%-98.6%); and NPV, 82.9% (95% CI 66.4%-93.4%). All 7 TICAs were correctly identified by CTA. Sensitivity, specificity, PPV, and NPV of CTA in detecting TICAs were 100%. To compare agreement with DSA, the standard of reference, confidence scores categorized as low, intermediate, and high probability yielded an overall effectiveness of 77.8% (95% CI 71.8%-82.9%). Conclusions. Computed tomography angiography had limited overall sensitivity in detecting arterial injuries in patients with PTBI. However, it was accurate in identifying TICAs, a subgroup of injuries usually managed by either surgical or endovascular approaches, and non-TICA injuries involving the first-order branches of intracranial arteries.	[Bodanapally, Uttam K.; Shanmuganathan, Kathirkamanathan; Boscak, Alexis R.; Jaffray, Paul M.; Roy, Ashis K.; Dreizin, David; Fleiter, Thorsten R.; Mirvis, Stuart E.; Krejza, Jaroslaw] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Radiol, Baltimore, MD 21201 USA; [Aarabi, Bizhan] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Neurosurg, Baltimore, MD 21201 USA; [Van der Byl, Giulia] Univ Pavia, San Matteo Med Ctr, IRCCS Fdn, Dept Radiol, I-27100 Pavia, Italy	Bodanapally, UK (corresponding author), Univ Maryland, Med Ctr, Dept Radiol, 22 S Greene St, Baltimore, MD 21201 USA.	ubodanapally@umm.edu	Krejza, Jaroslaw/A-1355-2009				AARABI B, 1995, NEUROSURG CLIN N AM, V6, P775; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Aarabi B, 2001, J TRAUMA S, V51, pS26; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; [Anonymous], 2001, J TRAUMA S, V51, pS7; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HOLLERMAN JJ, 1990, AM J ROENTGENOL, V155, P685, DOI 10.2214/ajr.155.4.2119095; Inaba K, 2006, J TRAUMA, V61, P144, DOI 10.1097/01.ta.0000222711.01410.bc; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; Munera F, 2002, RADIOLOGY, V224, P366, DOI 10.1148/radiol.2242010973; Munera F, 2000, RADIOLOGY, V216, P356, DOI 10.1148/radiology.216.2.r00jl25356; Sliker CW, 2008, AM J ROENTGENOL, V190, P790, DOI 10.2214/AJR.07.2378; Steenburg SD, 2010, RADIOGRAPHICS, V30, P869, DOI 10.1148/rg.304105022	15	20	21	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2014	121	5					1275	1283		10.3171/2014.7.JNS132688			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AR4AM	WOS:000343530400037	25170662				2021-06-18	
J	Chan, WP; Narducci, M; Gao, Y; Cheng, MY; Cheong, JH; George, AK; Cheam, DD; Leong, SC; Damalerio, MRB; Lim, RQ; Tsai, ML; Rahman, ARA; Park, MK; Kong, ZH; Prashanth, RJ; Je, M				Chan, Wai Pan; Narducci, Margarita; Gao, Yuan; Cheng, Ming-Yuan; Cheong, Jia Hao; George, Arup K.; Cheam, Daw Don; Leong, Siew Chong; Damalerio, Maria Ramona B.; Lim, Ruiqi; Tsai, Ming-Ling; Rahman, Abdur R. A.; Park, Mi Kyoung; Kong, Zhi Hui; Prashanth, Rao Jai; Je, Minkyu			A Monolithically Integrated Pressure/Oxygen/Temperature Sensing SoC for Multimodality Intracranial Neuromonitoring	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article; Proceedings Paper	9th IEEE Asian Solid-State Circuits Conference (A-SSCC)	NOV 11-13, 2013	Singapore, SINGAPORE	IEEE, IEEE SSCS Singapore, Singapore Semicond Ind Assoc		Capacitance to voltage converter (CVC); capacitive pressure sensor; electrochemical oxygen sensor; intracranial pressure (ICP); temperature sensor; traumatic brain injury (TBI)	SMART TEMPERATURE SENSOR; 3-SIGMA INACCURACY; DISSOLVED-OXYGEN; PRESSURE SENSOR; CMOS; COMPENSATION; MICROSYSTEM; WIRELESS; 10-BIT; INJURY	A fully integrated SoC for multimodality intracranial neuromonitoring is presented in this paper. Three sensors including a capacitive MEMS pressure sensor, an electrochemical oxygen sensor and a solid-state temperature sensor are integrated together in a single chip with their respective interface circuits. Chopper stabilization and dynamic element matching techniques are applied in sensor interface circuits to reduce circuit noise and offset. On-chip calibration is implemented for each sensor to compensate process variations. Measured sensitivity of the pressure, oxygen, and temperature sensors are 18.6 aF/mmHg, 194 pA/mmHg, and 2 mV/degrees C, respectively. Implemented in 0.18 mu m CMOS, the SoC occupies an area of 1.4 mm x 4 mm and consumes 166 W DC power. A prototype catheter for intracranial pressure (ICP) monitoring has been implemented and the performance has been verified with ex vivo experiment.	[Chan, Wai Pan; Narducci, Margarita; Gao, Yuan; Cheng, Ming-Yuan; Cheong, Jia Hao; Cheam, Daw Don; Leong, Siew Chong; Damalerio, Maria Ramona B.; Lim, Ruiqi; Tsai, Ming-Ling; Rahman, Abdur R. A.; Park, Mi Kyoung] ASTAR, Inst Microelect, Singapore 117685, Singapore; [George, Arup K.; Kong, Zhi Hui] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Prashanth, Rao Jai] Natl Inst Neurosci, Dept Neurosurg, Singapore 308433, Singapore; [Je, Minkyu] Daegu Gyeongbuk Inst Sci & Technol, Dept Informat & Commun Engn, Taegu 711873, South Korea	Chan, WP (corresponding author), ASTAR, Inst Microelect, Singapore 117685, Singapore.	gaoy@ime.a-star.edu.sg; zhkong@ntu.edu.sg; rao_jai@nni.com.sg; minkyu.je@dgist.ac.kr	Gao, Yuan/E-4502-2011; Je, Minkyu/P-5960-2019; Je, Minkyu/G-3056-2016; Je, Minkyu/Q-9864-2018	Gao, Yuan/0000-0002-0832-2982; Je, Minkyu/0000-0003-4580-2771; narducci, margarita/0000-0002-2639-8745	Science and Engineering Research Council of Agency for Science, Technology and Research (A*STAR), SingaporeAgency for Science Technology & Research (ASTAR) [102 148 0002]	This paper was approved by Guest Editor Zhihua Wang. This work was supported by the Science and Engineering Research Council of Agency for Science, Technology and Research (A*STAR), Singapore, under Grant 102 148 0002.	Abo AM, 1999, IEEE J SOLID-ST CIRC, V34, P599, DOI 10.1109/4.760369; Assaad RS, 2009, IEEE J SOLID-ST CIRC, V44, P2535, DOI 10.1109/JSSC.2009.2024819; Chai K. T. C., 2010, 2010 IEEE AS SOILD S, P1; CHAN WP, 2013, 2013 IEEE AS SOL STA, P89; Chen P, 2010, IEEE J SOLID-ST CIRC, V45, P600, DOI 10.1109/JSSC.2010.2040658; Cheong JH, 2011, IEEE T CIRCUITS-II, V58, P407, DOI 10.1109/TCSII.2011.2158255; Chitnis G, 2013, IEEE T BIO-MED ENG, V60, P250, DOI 10.1109/TBME.2012.2205248; Clark LC, 1959, US Patent, Patent No. 2913386; Cong P, 2009, IEEE J SOLID-ST CIRC, V44, P3631, DOI 10.1109/JSSC.2009.2035551; Cong P, 2008, SENSOR MATER, V20, P327; Faul M., 2010, CTR DIS CONTROL PREV; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hasan SMR, 2007, IEEE SENS J, V7, P814, DOI 10.1109/JSEN.2007.893236; Hong HC, 2007, IEEE J SOLID-ST CIRC, V42, P2161, DOI 10.1109/JSSC.2007.905237; KARAGOUNIS V, 1986, IEEE T BIO-MED ENG, V33, P108, DOI 10.1109/TBME.1986.325884; Lambrechts M., 1992, BIOSENSORS MICROELEC; Leung KN, 2003, IEEE J SOLID-ST CIRC, V38, P1691, DOI 10.1109/JSSC.2003.817256; Liao YT, 2012, IEEE J SOLID-ST CIRC, V47, P335, DOI 10.1109/JSSC.2011.2170633; Lou L., 2012, J MICROMECH MICROENG, V22, P1; Martin CS, 2012, SENSOR ACTUAT B-CHEM, V175, P111, DOI 10.1016/j.snb.2011.12.098; Melgaard J, 2011, IEEE T NEUR SYS REH, V19, P700, DOI 10.1109/TNSRE.2011.2171368; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Narducci M, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/5/055007; Pertijs MAP, 2005, IEEE J SOLID-ST CIRC, V40, P2805, DOI 10.1109/JSSC.2005.858476; Sebastiano F, 2010, IEEE J SOLID-ST CIRC, V45, P2591, DOI 10.1109/JSSC.2010.2076610; Stangel K, 2001, IEEE J SOLID-ST CIRC, V36, P1094, DOI 10.1109/4.933466; Wang P, 2011, SENSOR ACTUAT B-CHEM, V153, P145, DOI 10.1016/j.snb.2010.09.075	27	20	20	1	25	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9200	1558-173X		IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	NOV	2014	49	11					2449	2461		10.1109/JSSC.2014.2345754			13	Engineering, Electrical & Electronic	Engineering	AS6YD	WOS:000344404200008					2021-06-18	
J	Surgucheva, I; He, S; Rich, MC; Sharma, R; Ninkina, NN; Stahel, PF; Surguchov, A				Surgucheva, Irina; He, Shuangteng; Rich, Megan C.; Sharma, Ram; Ninkina, Natalia N.; Stahel, Philip F.; Surguchov, Andrei			Role of synucleins in traumatic brain injury - An experimental in vitro and in vivo study in mice	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Traumatic brain injury; In vitro scratch injury model; Protein aggregation; Synucleins; Cofilin-actin rods	GLIAL CYTOPLASMIC INCLUSIONS; ALPHA-SYNUCLEIN; GAMMA-SYNUCLEIN; AXONAL-TRANSPORT; HEAD-INJURY; PARKINSON-DISEASE; CELL-DEATH; PROTEINS; SYSTEM; OVEREXPRESSION	Synucleins are small prone to aggregate proteins associated with several neurodegenerative diseases (NDDs), however their role in traumatic brain injury (TBI) is an emerging area of investigation. Using in vitro scratch injury model and in vivo mouse weight-drop model we have found that the injury causes alterations in the expression and localization of synucleins near the damaged area. Before injury, alpha-synuclein is diffused in the cytoplasm of neurons and gamma-synuclein is both in the cytoplasm and nucleus of oligodendrocytes. After the scratch injury of the mixed neuronal and glial culture, alpha-synuclein forms punctate structures in the cytoplasm of neurons and gamma-synuclein is almost completely localized to the nucleus of the oligodendrocytes. Furthermore, the amount of post-translationally modified Met(38)-oxidized gamma-synuclein is increased 3.8 fold 24 h after the scratch. alpha- and gamma-synuclein containing cells increased in the initially cell free scratch zone up to 24 h after the scratch. Intracellular expression and localization of synucleins are also changed in a mouse model of focal closed head injury, using a standardized weight drop device. gamma-Synuclein goes from diffuse to punctate staining in a piriform cortex near the amygdala, which may reflect the first steps in the formation of deposits/inclusions. Surprisingly, oxidized gamma-synuclein co-localizes with cofilin-actin rods in the thalamus, which are absent in all other regions of the brain. These structures reach their peak amounts 7 days after injury. The changes in gamma-synuclein localization are accompanied by injury-induced alterations in the morphology of both astrocytes and neurons. Published by Elsevier Inc.	[Surgucheva, Irina; Surguchov, Andrei] VA Med Ctr, Retinal Biol Res Lab, Kansas City, MO 64128 USA; [Surgucheva, Irina; Surguchov, Andrei] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA; [He, Shuangteng] Kansas City Dept Vet Affairs Med Ctr, Stroke Res Lab, Kansas City, MO 64128 USA; [Rich, Megan C.; Stahel, Philip F.] Univ Colorado, Denver Hlth Med Ctr, Sch Med, Dept Orthopaed, Denver, CO 80204 USA; [Rich, Megan C.; Stahel, Philip F.] Univ Colorado, Denver Hlth Med Ctr, Sch Med, Dept Neurosurg, Denver, CO 80204 USA; [Sharma, Ram] VA Med Ctr, Res Serv, Kansas City, MO 64128 USA; [Ninkina, Natalia N.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Surguchov, A (corresponding author), VA Med Ctr, Retinal Biol Res Lab, 4801 East Linwood, Kansas City, MO 64128 USA.	asurguchov@kumc.edu	Ninkina, Natalia N/A-1732-2011	Sharma, Ram/0000-0002-7485-1356	VA Merit review grantUS Department of Veterans Affairs [1I01BX000361]; Glaucoma Foundation [QB42308]	This work was supported by VA Merit review grant 1I01BX000361 and the Glaucoma Foundation grant QB42308. We thank Dr. James R Bamburg from the Department of Biochemistry and Molecular Biology, Colorado State University for a generous gift of cofilin antibodies and many helpful suggestions.	Albani D, 2004, FASEB J, V18, P1713, DOI 10.1096/fj.04-1621fje; Bachurin SO, 2012, NEUROTOX RES, V22, P33, DOI 10.1007/s12640-011-9299-y; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Benedict JW, 2007, J NEUROSCI RES, V85, P2882, DOI 10.1002/jnr.21416; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Beyer K, 2013, MOL NEUROBIOL, V47, P509, DOI 10.1007/s12035-012-8330-5; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Braak H., 2002, J NEUROL, V249, pIII/1, DOI DOI 10.1007/S00415-002-1301-4; Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Busch DJ, 2012, J COMP NEUROL, V520, P1751, DOI 10.1002/cne.23011; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chiba Y, 2012, NEUROPATH APPL NEURO, V38, P559, DOI 10.1111/j.1365-2990.2011.01229.x; Ding HP, 2013, J MOL NEUROSCI, V51, P1000, DOI 10.1007/s12031-013-0086-5; Ducas VC, 2012, J MOL BIOL, V423, P528, DOI 10.1016/j.jmb.2012.08.008; Dunning CJR, 2013, PRION, V7, P92, DOI 10.4161/pri.23806; Esposito A, 2007, NEUROBIOL DIS, V26, P521, DOI 10.1016/j.nbd.2007.01.014; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Galvin JE, 2000, AM J PATHOL, V157, P361, DOI 10.1016/S0002-9440(10)64548-8; Garland P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047552; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Guo YJ, 2012, CELL SIGNAL, V24, P1109, DOI 10.1016/j.cellsig.2012.01.007; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Higuchi M, 2002, NEUROMOL MED, V2, P131, DOI 10.1385/NMM:2:2:131; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jin HJ, 2011, J NEUROSCI, V31, P2035, DOI 10.1523/JNEUROSCI.5634-10.2011; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Manning-Bog AB, 2003, J NEUROSCI, V23, P3095; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Morfini G, 2002, NEUROMOL MED, V2, P89, DOI 10.1385/NMM:2:2:089; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nakamura T, 2012, EXP NEUROL, V238, P12, DOI 10.1016/j.expneurol.2012.06.032; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Roy S, 2008, J NEUROSCI, V28, P5248, DOI 10.1523/JNEUROSCI.0309-08.2008; Sakurai M, 2009, J CEREBR BLOOD F MET, V29, P752, DOI 10.1038/jcbfm.2008.167; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Sousa VL, 2009, MOL BIOL CELL, V20, P3725, DOI 10.1091/mbc.E08-03-0302; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun CY, 2013, MOL CELLS, V36, P47, DOI 10.1007/s10059-013-0014-0; Surgucheva I, 2002, J NEUROSCI RES, V68, P97, DOI 10.1002/jnr.10198; Surgucheva IG, 2003, ARCH BIOCHEM BIOPHYS, V410, P167, DOI 10.1016/S0003-9861(02)00664-1; Surgucheva I, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0132-8; Surgucheva I, 2012, BIOCHEMISTRY-US, V51, P4743, DOI 10.1021/bi300478w; Surgucheva I, 2008, J BIOL CHEM, V283, P36377, DOI 10.1074/jbc.M806660200; Surguchov A, 2001, CELL MOTIL CYTOSKEL, V49, P218, DOI 10.1002/cm.1035; Surguchov A, 2008, INT REV CEL MOL BIO, V270, P225, DOI 10.1016/S1937-6448(08)01406-8; Surguchov A, 2013, J NEUROSCI RES, V91, P161, DOI 10.1002/jnr.23149; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Zhou Y, 2004, J BIOL CHEM, V279, P39155, DOI 10.1074/jbc.M405456200	76	20	21	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	NOV	2014	63						114	123		10.1016/j.mcn.2014.10.005			10	Neurosciences	Neurosciences & Neurology	AW4BT	WOS:000346227200012	25447944				2021-06-18	
J	Dunham, CM; Hoffman, DA; Huang, GS; Omert, LA; Gemmel, DJ; Merrell, R				Dunham, C. Michael; Hoffman, David A.; Huang, Gregory S.; Omert, Laurel A.; Gemmel, David J.; Merrell, Renee			Traumatic Intracranial Hemorrhage Correlates with Preinjury Brain Atrophy, but Not with Antithrombotic Agent Use: A Retrospective Study	PLOS ONE			English	Article							BLUNT HEAD TRAUMA; LOW-DOSE ASPIRIN; WARFARIN USE; ANTIPLATELET AGENTS; PREOPERATIVE ASPIRIN; CORONARY-ANGIOGRAPHY; ATRIAL-FIBRILLATION; CEREBRAL ATROPHY; PATIENTS OLDER; INJURY	Background: The impact of antithrombotic agents (warfarin, clopidogrel, ASA) on traumatic brain injury outcomes is highly controversial. Although cerebral atrophy is speculated as a risk for acute intracranial hemorrhage, there is no objective literature evidence. Materials and Methods: This is a retrospective, consecutive investigation of patients with signs of external head trauma and age >= 60 years. Outcomes were correlated with antithrombotic-agent status, coagulation test results, admission neurologic function, and CT-based cerebral atrophy dimensions. Results: Of 198 consecutive patients, 36% were antithrombotic-negative and 64% antithrombotic-positive. ASA patients had higher arachidonic acid inhibition (p = 0.04) and warfarin patients had higher INR (p < 0.001), compared to antithrombotic-negative patients. Antithrombotic-positive intracranial hemorrhage rate (38.9%) was similar to the antithrombotic-negative rate (31.9%; p = 0.3285). Coagulopathy was not present on the ten standard coagulation, thromboelastography, and platelet mapping tests with intracranial hemorrhage and results were similar to those without hemorrhage (p >= 0.1354). Hemorrhagic-neurologic complication (intracranial hemorrhage progression, need for craniotomy, neurologic deterioration, or death) rates were similar for antithrombotic-negative (6.9%) and antithrombotic-positive (8.7%; p = 0.6574) patients. The hemorrhagic-neurologic complication rate was increased when admission major neurologic dysfunction was present (63.2% versus 2.2%; RR = 28.3; p < 0.001). Age correlated inversely with brain parenchymal width (p < 0.001) and positively with lateral ventricular width (p = 0.047) and cortical atrophy (p < 0.001). Intracranial hemorrhage correlated with cortical atrophy (p < 0.001) and ventricular width (p < 0.001). Conclusions: Intracranial hemorrhage is not associated with antithrombotic agent use. Intracranial hemorrhage patients have no demonstrable coagulopathy. The association of preinjury brain atrophy with acute intracranial hemorrhage is a novel finding. Contrary to antithrombotic agent status, admission neurologic abnormality is a predictor of adverse post-admission outcomes. Study findings indicate that effective hemostasis is maintained with antithrombotic therapy.	[Dunham, C. Michael; Huang, Gregory S.; Merrell, Renee] St Elizabeth Hlth Ctr, Trauma Crit Care Serv, Youngstown, OH 44501 USA; [Hoffman, David A.] St Elizabeth Hlth Ctr, Div Cardiol, Youngstown, OH USA; [Omert, Laurel A.] CSL Behring, King Of Prussia, PA USA; [Gemmel, David J.] St Elizabeth Hlth Ctr, Youngstown, OH USA	Dunham, CM (corresponding author), St Elizabeth Hlth Ctr, Trauma Crit Care Serv, Youngstown, OH 44501 USA.	dunham.michael@sbcglobal.net		Huang, Gregory/0000-0001-6355-6012			Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; Akdogan I, 2010, FOLIA MORPHOL, V69, P193; Alghamdi AA, 2007, J CARDIAC SURG, V22, P247, DOI 10.1111/j.1540-8191.2007.00402.x; Annala AP, 2008, AM J CARDIOL, V102, P386, DOI 10.1016/j.amjcard.2008.04.003; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Birnie DH, 2013, NEW ENGL J MED, V368, P2084, DOI 10.1056/NEJMoa1302946; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Burger W, 2005, J INTERN MED, V257, P399, DOI 10.1111/j.1365-2796.2005.01477.x; DIETRICH W, 1995, J CARDIOTHOR VASC AN, V9, P250, DOI 10.1016/S1053-0770(05)80316-7; DOHERTY DL, 1988, ARCH PHYS MED REHAB, V69, P542; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Downey DM, 2009, AM SURGEON, V75, P1100; El-Jack SS, 2006, AM J CARDIOL, V97, P485, DOI 10.1016/j.amjcard.2005.09.079; ELLIS G L, 1990, Emergency Medicine Clinics of North America, V8, P281; Fjell AM, 2013, J NEUROSCI, V33, P8237, DOI 10.1523/JNEUROSCI.5506-12.2013; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Furie KL, 2012, STROKE, V43, P3442, DOI 10.1161/STR.0b013e318266722a; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Gage BF, 2005, AM J MED, V118, P612, DOI 10.1016/j.amjmed.2005.02.022; Gangavati AS, 2009, J AM GERIATR SOC, V57, P1470, DOI 10.1111/j.1532-5415.2009.02344.x; GUR RC, 1991, P NATL ACAD SCI USA, V88, P2845, DOI 10.1073/pnas.88.7.2845; Hanif S, 2009, Ir Med J, V102, P255; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jamula E, 2009, THROMB RES, V124, P292, DOI 10.1016/j.thromres.2009.01.007; Jennett B, 1981, MANAGEMENT HEAD INJU, P184; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Lippe CM, 2014, CATHETER CARDIOVASC; Manchikanti Laxmaiah, 2013, Pain Physician, V16, pSE261; Matsumae M, 1996, J NEUROSURG, V84, P982, DOI 10.3171/jns.1996.84.6.0982; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Nelson RS, 2008, AM J SURG, V196, P994, DOI 10.1016/j.amjsurg.2008.07.036; Nematullah A, 2009, J CAN DENT ASSOC, V75, P41; Onal IK, 2013, CLIN RES HEPATOL GAS, V37, P171, DOI 10.1016/j.clinre.2012.04.010; Ortel TL, 2012, BLOOD, V120, P4699, DOI 10.1182/blood-2012-05-423228; Otley CC, 2003, MAYO CLIN PROC, V78, P1392, DOI 10.4065/78.11.1392; Ott MM, 2010, J TRAUMA, V68, P560, DOI 10.1097/TA.0b013e3181ad6600; Pasquier F, 1996, EUR NEUROL, V36, P268, DOI 10.1159/000117270; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Poyry T, 2013, J HEAD TRAUMA REHAB, V28, P89, DOI 10.1097/HTR.0b013e318250eadd; Resnick SM, 2003, J NEUROSCI, V23, P3295; Richmond R, 2011, J TRAUMA, V71, pE8, DOI 10.1097/TA.0b013e3181fbaa46; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Sun JCJ, 2008, EUR HEART J, V29, P1057, DOI 10.1093/eurheartj/ehn104; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wallace DL, 2004, J HAND SURG-BRIT EUR, V29B, P203, DOI 10.1016/j.jhsb.2003.12.008; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Yelon J, 2013, TRAUMA, P874	56	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2014	9	10							e109473	10.1371/journal.pone.0109473			9	Multidisciplinary Sciences	Science & Technology - Other Topics	AQ3DZ	WOS:000342670800085	25279785	DOAJ Gold, Green Published			2021-06-18	
J	Wang, JW; Zou, DH; Li, ZD; Huang, P; Li, DR; Shao, Y; Wang, HJ; Chen, YJ				Wang, Jiawen; Zou, Donghua; Li, Zhengdong; Huang, Ping; Li, Dongri; Shao, Yu; Wang, Huijun; Chen, Yijiu			Mechanical Properties of Cranial Bones and Sutures in 1-2-Year-Old Infants	MEDICAL SCIENCE MONITOR			English	Article						Cranial Sutures; Fractures, Bone; Head Injuries, Closed; Infant	FINITE-ELEMENT MODEL; CRANIOFACIAL SUTURES; BRAIN-INJURY; HEAD-INJURY; SKULL; VALIDATION; SIMULATION; IMPACT; FALLS	Background: The mechanical properties of 1-2-year-old pediatric cranial bones and sutures and their influential factors were studied to better understand how the pediatric calvarium reacts to loading. Material/Methods: Cranial bone and suture specimens were extracted from seven fresh-frozen human infant cadavers (1.5 +/- 0.5 years old). Eight specimens were obtained from each subject: two frontal bones, two parietal bones, two sagittal suture samples, and two coronal suture samples. The specimens were tested in a three-point bend setup at 1.5 mm/s. The mechanical properties, such as ultimate stress, elastic modulus, and ultimate strain, were calculated for each specimen. Results: The ultimate stress and elastic modulus of the frontal bone were higher than those of the parietal bone (P<0.05). No differences were found between the coronal and sagittal sutures in ultimate stress, elastic modulus, or ultimate strain (P>0.05). The ultimate stress and elastic modulus of the frontal and parietal bones were higher than those of the sagittal and coronal sutures (P<0.05), whereas the opposite ultimate strain findings were revealed (P<0.05). Conclusions: There was no significant difference in ultimate stress, elastic modulus, or ultimate strain between the sagittal and coronal sutures. However, there were significant differences in ultimate stress, elastic modulus, and ultimate strain between the frontal and parietal bones as well as between the cranial bones and sutures.	[Wang, Jiawen; Li, Dongri; Wang, Huijun; Chen, Yijiu] Southern Med Univ, Coll Med, Dept Forens Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Jiawen; Zou, Donghua; Li, Zhengdong; Huang, Ping; Shao, Yu; Chen, Yijiu] Minist Justice, Inst Forens Sci, Shanghai Key Lab Forens Med, Shanghai, Peoples R China; [Wang, Jiawen] Foshan Univ, Basic Med Coll, Dept Pathol Teaching, Foshan, Peoples R China; [Wang, Jiawen] Foshan Univ, Basic Med Coll, Res Sect, Foshan, Peoples R China	Chen, YJ (corresponding author), Southern Med Univ, Coll Med, Dept Forens Sci, Guangzhou, Guangdong, Peoples R China.	hjwang@smu.edu.cn; yijiuchen@aliyun.com	Huang, Ping/L-1193-2019		12th Five-year National Plan for Science and Technology [2012BAK16B02]; Council of National Science Foundation of China [81273338-81102300]; Scientific and Technological Key Project of Shanghai Municipality [14231202500-14DZ2271500]; Shanghai Postdoctoral Scientific Program [14R21423000]	The 12th Five-year National Plan for Science and Technology (No. 2012BAK16B02), the Council of National Science Foundation of China (No. 81273338-81102300), the Scientific and Technological Key Project of Shanghai Municipality (No. 14231202500-14DZ2271500), the Shanghai Postdoctoral Scientific Program (No. 14R21423000)	Baumer TG, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000081; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Davis C, 2010, PLAST RECONSTR SURG, V125, P1111, DOI 10.1097/PRS.0b013e3181d0abcf; Davis MT, 2012, J BIOMECH, V45, P2493, DOI 10.1016/j.jbiomech.2012.07.001; Delille R, 2007, INT J CRASHWORTHINES, V12, P101, DOI 10.1080/13588260701433081; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Herring S W, 2005, Orthod Craniofac Res, V8, P174, DOI 10.1111/j.1601-6343.2005.00328.x; Jasinoski SC, 2012, J BIOMECH, V45, P2050, DOI 10.1016/j.jbiomech.2012.05.007; Jasinoski SC, 2010, J BIOMECH, V43, P3104, DOI 10.1016/j.jbiomech.2010.08.007; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; Lapeer RJ, 2001, J BIOMECH, V34, P1125, DOI 10.1016/S0021-9290(01)00070-7; Li ZG, 2013, COMPUT METH PROG BIO, V112, P309, DOI 10.1016/j.cmpb.2013.05.008; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; Maloul A, 2014, J BIOMECH, V47, P245, DOI 10.1016/j.jbiomech.2013.09.009; Maloul A, 2013, J BIOMECH, V46, P912, DOI 10.1016/j.jbiomech.2012.12.016; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; McLaughlin E, 2000, CLEFT PALATE-CRAN J, V37, P590, DOI 10.1597/1545-1569(2000)037<0590:TLDCON>2.0.CO;2; Moazen M, 2013, ANAT REC, V296, P198, DOI 10.1002/ar.22629; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Motherway J, 2009, Leg Med (Tokyo), V11 Suppl 1, pS220, DOI 10.1016/j.legalmed.2009.01.072; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; Peterson J, 2003, ANAT REC PART A, V274A, P785, DOI 10.1002/ar.a.10096; Peterson J, 2002, ANAT REC, V268, P7, DOI 10.1002/ar.10131; Pierce MC, 2008, ANNU REV BIOMED ENG, V10, P85, DOI 10.1146/annurev.bioeng.9.060906.151907; Rafferty KL, 1999, J MORPHOL, V242, P167, DOI 10.1002/(SICI)1097-4687(199911)242:2<167::AID-JMOR8>3.0.CO;2-1; Roark R.J., 1986, FORMULAS STRESS STRA; Roth S, 2010, COMPUT METH PROG BIO, V99, P25, DOI 10.1016/j.cmpb.2009.10.004; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Timoshenko S.P., 1970, THEORY ELASTICITY, V3rd ed.; Wang Q, 2012, ANAT REC, V295, P278, DOI 10.1002/ar.21532; Wang QA, 2010, ANAT REC, V293, P1477, DOI 10.1002/ar.21203	33	20	26	1	16	INT SCIENTIFIC LITERATURE, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	OCT 3	2014	20						1808	1813					6	Medicine, Research & Experimental	Research & Experimental Medicine	AQ3ET	WOS:000342673100002	25279966	Green Published			2021-06-18	
J	Con, J; Friese, RS; Long, DM; Zangbar, B; O'Keeffe, T; Joseph, B; Rhee, P; Tang, AL				Con, Jorge; Friese, Randall S.; Long, Dustin M.; Zangbar, Bardiya; O'Keeffe, Terence; Joseph, Bellal; Rhee, Peter; Tang, Andrew L.			Falls from ladders: age matters more than height	JOURNAL OF SURGICAL RESEARCH			English	Article						Fall from ladder; Head injuries; Truncal injuries; Extremity fractures; Geriatric trauma	INJURIES; SEVERITY; PATTERNS	Background: Falls from ladders account for a significant number of hospital visits. However, the epidemiology, injury pattern, and how age affects such falls are poorly described in the literature. Materials and methods: Patients >= 18 y who suffered falls from ladders over a 51/2-y period were identified in our trauma registry. Dividing patients into three age groups (18-45, 46-65, and >66 y), we compared demographic characteristics, clinical data, and outcomes including injury pattern and mortality. The odds ratios (ORs) were calculated with the group 18-45 y as reference; group means were compared with one-way analysis of variance. Results: Of 27,155 trauma patients, 340 (1.3%) had suffered falls from ladders. The average age was 55 y, with a male predominance of 89.3%. Average fall height was 9.8 ft, and mean Injury Severity Score was 10.6. Increasing age was associated with a decrease in the mean fall height (P < 0.001), an increase in the mean Injury Severity Score (P < 0.05), and higher likelihood of admission (>66 y: OR, 5.3; confidence interval [CI], 2.5-11.5). In univariate analysis, patients in the >66-y age group were more likely to sustain traumatic brain injuries (OR, 3.4; CI, 1.5-7.8) and truncal injuries (OR, 3.6; CI, 1.9-7.0) and less likely to sustain hand and/or forearm fractures (OR, 0.3; CI, 0.1-0.9). Conclusions: Older people are particularly vulnerable after falling from ladders. Although they fell from lower heights, the elderly sustained different and more severe injury patterns. Ladder safety education should be particularly tailored at the elderly. (C) 2014 Elsevier Inc. All rights reserved.	[Con, Jorge] W Virginia Univ, Dept Surg, Morgantown, WV 26506 USA; [Friese, Randall S.; Zangbar, Bardiya; O'Keeffe, Terence; Joseph, Bellal; Rhee, Peter; Tang, Andrew L.] Univ Arizona, Dept Surg, Tucson, AZ USA; [Long, Dustin M.] W Virginia Univ, Dept Biostat, Morgantown, WV 26506 USA	Con, J (corresponding author), W Virginia Univ, Hlth Sci Ctr, Dept Surg, POB 9238, Morgantown, WV 26506 USA.	jocon@hsc.wvu.edu	Long, Dustin/AAA-5006-2019; Zangbar, Bardiya/K-7147-2014	Long, Dustin/0000-0002-5423-4481; Zangbar, Bardiya/0000-0003-1215-1693	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54 GM104942] Funding Source: Medline		American College of Surgeons. Committe on Trauma, 2008, ADV TRAUM LIF SUPP D; Brown A., 2013, GALLUP EC; D'Souza AL, 2007, AM J PREV MED, V32, P413, DOI 10.1016/j.amepre.2007.01.012; Demetriades D, 2005, J TRAUMA, V58, P342, DOI 10.1097/01.TA.0000135161.44100.D8; Diggs BS, 2005, ACAD EMERG MED, V12, P267, DOI 10.1197/j.aem.2004.10.028; Lapostolle F, 2005, CRIT CARE MED, V33, P1239, DOI 10.1097/01.CCM.0000164564.11989.C3; O'Sullivan J, 2004, INJURY, V35, P429, DOI 10.1016/S0020-1383(03)00265-1; Office of Statistics and Programming NCfIPaC CDC, 2010, 10 LEAD CAUS INJ DEA; Partridge RA, 1998, ACAD EMERG MED, V5, P31, DOI 10.1111/j.1553-2712.1998.tb02571.x; Richter D, 1996, INJURY, V27; ROZYCKI GS, 1991, ARCH EMERG MED, V8, P245; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021	12	20	21	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2014	191	2					262	267		10.1016/j.jss.2014.05.072			6	Surgery	Surgery	AO5CB	WOS:000341358100003	25066188	Green Accepted			2021-06-18	
J	Jullienne, A; Roberts, JM; Pop, V; Murphy, MP; Head, E; Bix, GJ; Badaut, J				Jullienne, Amandine; Roberts, Jill M.; Pop, Viorela; Murphy, M. Paul; Head, Elizabeth; Bix, Gregory J.; Badaut, Jerome			Juvenile traumatic brain injury induces long-term perivascular matrix changes alongside amyloid-beta accumulation	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						amyloid; fibronectin; juvenile; P-glycoprotein; perlecan domain V; traumatic brain injury	PERLECAN DOMAIN V; FOCAL CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; FIBRIL FORMATION; FIBRONECTIN; BARRIER; EXPRESSION; PEPTIDE; GROWTH; ALPHA-5-BETA-1	In our juvenile traumatic brain injury (jTBI) model, emergence of cognitive dysfunctions was observed up to 6 months after trauma. Here we hypothesize that early brain injury induces changes in the neurovascular unit (NVU) that would be associated with amyloid-beta (A beta) accumulation. We investigated NVU changes for up to 6 months in a rat jTBI model, with a focus on the efflux protein P-glycoprotein (P-gp) and on the basement membrane proteins perlecan and fibronectin, all known to be involved in A beta clearance. Rodent-A beta staining is present and increased after jTBI around cerebral blood microvessels, and the diameter of those is decreased by 25% and 34% at 2 and 6 months, respectively, without significant angiogenesis. P-glycoprotein staining in endothelium is decreased by 22% and parallels an increase of perlecan and fibronectin staining around cerebral blood vessels. Altogether, these results strongly suggest that the emergence of long-term behavioral dysfunctions observed in rodent jTBI may be related to endothelial remodeling at the blood-brain barrier alongside vascular dysfunction and altered A beta trafficking. This study shows that it is important to consider jTBI as a vascular disorder with long-term consequences on cognitive functions.	[Jullienne, Amandine; Pop, Viorela; Badaut, Jerome] Loma Linda Univ, Dept Pediat, Loma Linda, CA 92350 USA; [Roberts, Jill M.; Murphy, M. Paul; Head, Elizabeth; Bix, Gregory J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Badaut, Jerome] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92350 USA; [Badaut, Jerome] Bordeaux Univ, CNRS, UMR 5287, Bordeaux, France	Bix, GJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.	gregorybix@uky.edu; jerome.badaut@u-bordeaux1.fr	Jullienne, Amandine/H-3081-2019	Jullienne, Amandine/0000-0001-9458-055X	NSFNational Science Foundation (NSF) [MRI-DBI 0923559]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065842] Funding Source: NIH RePORTER	We thank Germaine Paris for the technical help, Jacqueline S Coats for surgeries and Monica Romero for a portion of imaging performed at the Loma Linda University School of Medicine Advanced Imaging and Microscopy Core (LLUSM AIM) Facility supported by NSF grant, MRI-DBI 0923559 (to SM Wilson).	Al-Ahmad AJ, 2011, GLIA, V59, P1822, DOI 10.1002/glia.21227; Alhaddad H, 2012, CRIT CARE MED, V40, P3215, DOI 10.1097/CCM.0b013e318265680a; Alosco ML, 2014, INT J GERIATR PSYCH, V29, P428, DOI 10.1002/gps.4023; Burke MC, 2013, NEUROPATHOL APPL NEU, V40, P284; Castillo GM, 1997, J NEUROCHEM, V69, P2452; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Clarke DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045257; Cotman SL, 2000, MOL CELL NEUROSCI, V15, P183, DOI 10.1006/mcne.1999.0816; De-Carvalho MCA, 1999, BRAZ J MED BIOL RES, V32, P583, DOI 10.1590/S0100-879X1999000500012; Deb S, 2003, BRAIN RES, V970, P205, DOI 10.1016/S0006-8993(03)02344-8; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fukuda S, 2004, STROKE, V35, P998, DOI 10.1161/01.STR.0000119383.76447.05; Hawkes CA, 2013, AGING CELL, V12, P224, DOI 10.1111/acel.12045; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; HOMANDBERG GA, 1986, BIOCHIM BIOPHYS ACTA, V874, P61, DOI 10.1016/0167-4838(86)90102-0; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; King VR, 2010, NEUROSCIENCE, V168, P523, DOI 10.1016/j.neuroscience.2010.03.040; Kiuchi Y, 2002, LIFE SCI, V70, P2421, DOI 10.1016/S0024-3205(02)01501-1; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Lee B, 2011, J CLIN INVEST, V121, P3005, DOI 10.1172/JCI46358; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; Milner R, 2002, MOL CELL NEUROSCI, V20, P616, DOI 10.1006/mcne.2002.1151; Milner R, 2008, MOL CELL NEUROSCI, V38, P43, DOI 10.1016/j.mcn.2008.01.013; MUIR D, 1992, J CELL BIOL, V116, P177, DOI 10.1083/jcb.116.1.177; Parham C, 2014, J ALZHEIMERS DIS, V38, P415, DOI 10.3233/JAD-130683; Park L, 2008, P NATL ACAD SCI USA, V105, P1347, DOI 10.1073/pnas.0711568105; Patel NS, 2010, J NEUROCHEM, V112, P66, DOI 10.1111/j.1471-4159.2009.06426.x; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Pop V, 2013, J CEREBR BLOOD F MET, V33, P205, DOI 10.1038/jcbfm.2012.154; Popa-Wagner A, 2015, J NEURAL TRANSM, V122, P47, DOI 10.1007/s00702-013-1129-3; Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P1034, DOI 10.1097/NEN.0b013e3181f46e25; van Horssen J, 2001, ACTA NEUROPATHOL, V102, P604; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; Wright S, 2012, NEUROBIOL AGING, V33, P1379, DOI 10.1016/j.neurobiolaging.2010.10.018; Xiong HQ, 2009, J NEUROSCI, V29, P5463, DOI 10.1523/JNEUROSCI.5103-08.2009; Zhao LR, 2005, BRAIN RES, V1054, P1, DOI 10.1016/j.brainres.2005.04.056	40	20	20	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2014	34	10					1637	1645		10.1038/jcbfm.2014.124			9	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	AQ1IV	WOS:000342536000008	25052558	Green Published, Bronze			2021-06-18	
J	Picetti, E; De Angelis, A; Villani, F; Antonini, MV; Rossi, I; Servadei, F; Caspani, ML				Picetti, Edoardo; De Angelis, Antonino; Villani, Fabio; Antonini, Marta Velia; Rossi, Ilaria; Servadei, Franco; Caspani, Maria Luisa			Intravenous paracetamol for fever control in acute brain injury patients: cerebral and hemodynamic effects	ACTA NEUROCHIRURGICA			English	Article						Brain injury; Fever; Management; Paracetamol	ACUTE ISCHEMIC STROKE; INTENSIVE-CARE-UNIT; BODY-TEMPERATURE; INDUCED HYPOTENSION; CLINICAL-TRIAL; ACETAMINOPHEN; HYPERTHERMIA; IMPACT; MANAGEMENT; PROTOCOLS	Fever occurs frequently in acute brain injury patients, and its occurrence is associated with poorer outcomes. Paracetamol, an antipyretic frequently employed in patients with cerebral damage, may cause hypotension. We evaluated the cerebral and hemodynamic effects of intravenous (IV) paracetamol for the control of fever in Neuro-Intensive Care Unit (NICU) patients. This is a prospective observational study in which we enrolled 32 NICU patients: Subarachnoid Hemorrhage (SAH, n = 18), Traumatic Brain Injury (TBI, n = 10), Intracerebral Hemorrhage (ICH, n = 2) and Acute Ischemic Stroke (AIS, n = 2). The administration of paracetamol resulted in a decrease of core body temperature (Tc) (p = 0,0001), mean arterial pressure (MAP) (p = 0,0006), cerebral perfusion pressure (CPP) (p = 0,0033), and jugular venous oxygen saturation (SjVO2) (p = 0.0193), and in an increase of arteriojugular venous differences of oxygen (AVDO2) (p = 0.0012). The proportion of patients who had an infusion of norepinephrine increased from 47 % to 75 % (p = 0.0039 McNemar Test). When intracranial pressure (ICP) at the start of paracetamol infusion (t-0) was compared with the measurement of ICP after 2 h, a significant correlation was observed (r = 0.669, p = 0.0002). This marked and significant correlation can be explained by the fact that for the higher levels of ICP assessed at t-0 (greater than 15 mmHg), we observed a marked reduction of ICP concomitant with the decrease of Tc. No problems related to norepinephrine administration and/or increase in dosage were observed. Paracetamol administration is effective but exposes patients to hypotensive episodes that must be recognized and treated expeditiously to prevent further damage to the injured brain.	[Picetti, Edoardo; Antonini, Marta Velia; Rossi, Ilaria; Caspani, Maria Luisa] Azienda Osped Univ Parma, Serv Anestesia & Rianimaz 1, I-43100 Parma, Italy; [De Angelis, Antonino; Villani, Fabio] Univ Parma, Scuola Specializzaz Anestesia & Rianimaz, I-43100 Parma, Italy; [Servadei, Franco] Azienda Osped Univ Parma, I-43100 Parma, Italy	Picetti, E (corresponding author), Azienda Osped Univ Parma, Serv Anestesia & Rianimaz 1, Via Gramsci 14, I-43100 Parma, Italy.	edoardopicetti@hotmail.com	Viani, Rafael/V-1196-2018	Servadei, Franco/0000-0002-3595-3464			Boyle M, 1997, Aust Crit Care, V10, P120, DOI 10.1016/S1036-7314(97)70414-4; Brown G, 1996, HEART LUNG, V25, P137, DOI 10.1016/S0147-9563(96)80116-6; Cormio M, 2000, INTENS CARE MED, V26, P552, DOI 10.1007/s001340051203; de Maat MM, 2010, EUR J CLIN PHARMACOL, V66, P713, DOI 10.1007/s00228-010-0806-5; den Hertog HM, 2012, ACTA NEUROL SCAND, V125, P265, DOI 10.1111/j.1600-0404.2011.01529.x; den Hertog HM, 2009, LANCET NEUROL, V8, P434, DOI 10.1016/S1474-4422(09)70051-1; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Dippel DWJ, 2001, STROKE, V32, P1607, DOI 10.1161/01.STR.32.7.1607; Duggan ST, 2009, DRUGS, V69, P101, DOI 10.2165/00003495-200969010-00007; Graham GG, 2013, INFLAMMOPHARMACOLOGY, V21, P201, DOI 10.1007/s10787-013-0172-x; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hersch M, 2008, PHARMACOTHERAPY, V28, P1205, DOI 10.1592/phco.28.10.1205; Johnston NJ, 2006, RESUSCITATION, V70, P254, DOI 10.1016/j.resuscitation.2006.02.010; Kasner SE, 2002, STROKE, V33, P130, DOI 10.1161/hs0102.101477; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Koennecke HC, 2001, NEUROLOGY, V57, P2301, DOI 10.1212/WNL.57.12.2301; Mackenzie I, 2000, INTENS CARE MED, V26, P1408, DOI 10.1007/s001340000614; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Middleton S, 2011, LANCET, V378, P1699, DOI 10.1016/S0140-6736(11)61485-2; Mrozek S, 2009, ANN FR ANESTH, V28, P448, DOI 10.1016/j.annfar.2009.01.018; Peacock WF, 2011, ACAD EMERG MED, V18, P360, DOI 10.1111/j.1553-2712.2011.01043.x; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Stocchetti N, 2005, J NEUROL NEUROSUR PS, V76, P1135, DOI 10.1136/jnnp.2004.041269; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Tu YK, 2005, EUR J ORAL SCI, V113, P279, DOI 10.1111/j.1600-0722.2005.00229.x; Tu YK, 2007, STAT MED, V26, P443, DOI 10.1002/sim.2538	28	20	20	0	10	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2014	156	10					1953	1959		10.1007/s00701-014-2129-2			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AP6SX	WOS:000342209100020	24838770				2021-06-18	
J	Unsworth, CA; Baker, A				Unsworth, Carolyn A.; Baker, Anne			Driver rehabilitation: A systematic review of the types and effectiveness of interventions used by occupational therapists to improve on-road fitness-to-drive	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Driver intervention; Driver rehabilitation; Fitness-to-drive; On-road; Systematic review	TRAUMATIC BRAIN-INJURY; HEALTH-CARE INTERVENTIONS; PERFORMANCE; FEASIBILITY; SIMULATION; ABILITIES; PROGRAM; CLIENTS; STROKE	Objective: Driver rehabilitation has the potential to improve on-road safety and is commonly recommended to clients. The aim of this systematic review was to identify what intervention approaches are used by occupational therapists as part of driver rehabilitation programmes, and to determine the effectiveness of these interventions. Method: Six electronic databases (MEDLINE, CINAHL, Psycinfo, Embase, The Cochrane Library, and OTD-Base) were searched. Two authors independently reviewed studies reporting all types of research designs and for all patient populations, provided the interventions could be administered by occupational therapists. The methodological quality of studies was assessed using the 'Downs and Black Instrument', and the level of evidence for each intervention approach was established using 'Centre for Evidence Based Medicine' criteria. Results: Sixteen studies were included in the review. The most common type of intervention approach used was computer-based driving simulator training (n=8), followed by off-road skill-specific training (n=4), and off-road education programmes (n=3). Car adaptations/modifications were used in one of the included studies. There was significant variability between studies with regards to frequency, duration, and total number of intervention sessions, and the diagnoses of the participants. Of the four intervention approaches, there is evidence to support the effectiveness of off-road skill-specific training (with older clients), and computer-based driving simulator training (with both older clients and participants with acquired brain injury). Conclusion: Three types of intervention approaches are commonly reported, however, there is limited evidence to determine to effectiveness of these in improving fitness-to-drive. Further research is required, with clients from a range of diagnostic groups to establish evidence-based interventions and determine their effectiveness in improving these clients' on-road fitness-to-drive. Crown Copyright (C) 2014 Published by Elsevier Ltd. All rights reserved.	[Unsworth, Carolyn A.; Baker, Anne] La Trobe Univ, Fac Hlth Sci, Melbourne, Vic 3086, Australia; [Unsworth, Carolyn A.] Jonkoping Univ, Dept Rehabil, Sch Hlth Sci, Jonkoping, Sweden	Unsworth, CA (corresponding author), La Trobe Univ, Kingsbury Dr, Bundoora, Vic 3086, Australia.	c.unsworth@latrobe.edu.au		Unsworth, Carolyn/0000-0001-6430-2823; Baker, Anne/0000-0002-3779-5463			Adler G, 2006, J AGING STUD, V20, P227, DOI 10.1016/j.jaging.2005.09.003; Anschutz JR, 2010, TOP STROKE REHABIL, V17, P337, DOI 10.1310/tsr1705-337; Bauer MaryJ., 2003, QUAL SOC WORK, V2, P309, DOI [DOI 10.1177/14733250030023006, 10.1177/14733250030023006]; Bedard M, 2004, CAN J PUBLIC HEALTH, V95, P295, DOI 10.1007/BF03405135; Classen S, 2009, AM J OCCUP THER, V63, P580, DOI 10.5014/ajot.63.5.580; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Eby DW, 2003, J SAFETY RES, V34, P371, DOI 10.1016/j.jsr.2003.09.006; Fricke J., 2001, AUST OCCUP THER J, V48, P118, DOI [10.1046/j.0045-0766.2001.00246.x, DOI 10.1046/J.0045-0766.2001.00246.X]; Gamache PL, 2011, BRAIN INJURY, V25, P416, DOI 10.3109/02699052.2011.558039; George S., 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008357, DOI 10.1002/14651858.CD008357]; Hitosugi M, 2011, INT J GEN MED, V4, P191, DOI 10.2147/IJGM.S17475; Hopewell CA, 2002, J HEAD TRAUMA REHAB, V17, P48, DOI 10.1097/00001199-200202000-00007; Huchler S., 2001, EURA MEDICOPHYS, V37, P283; Hunt LA, 2008, AM J OCCUP THER, V62, P136, DOI 10.5014/ajot.62.2.136; Jacobs K, 1997, Work, V8, P281, DOI 10.3233/WOR-1997-8308; Keskinen E., 1996, REPORTS FEDERAL I RO; KEWMAN DG, 1985, REHABIL PSYCHOL, V30, P11; KLAVORA P, 1995, AM J OCCUP THER, V49, P534, DOI 10.5014/ajot.49.6.534; Klonoff PS, 2010, BRAIN INJURY, V24, P63, DOI 10.3109/02699050903512863; Korner-Bitensky N, 2009, J SAFETY RES, V40, P105, DOI 10.1016/j.jsr.2009.02.002; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.7326/0003-4819-151-4-200908180-00136]; Liddle J., 2003, BRIT J OCCUP THER, V66, DOI [https://doi.org/10.1177/030802260306600307, DOI 10.1177/030802260306600307]; MATCH E, 1969, EXCEPT CHILDREN, V35, P563; Mazer BL, 2003, ARCH PHYS MED REHAB, V84, P541, DOI 10.1053/apmr.2003.50085; Michon J.A., 1985, HUMAN BEHAV TRAFFIC, P485; OT Australia-Victoria, 1998, COMP STAND OCC THER; Pellerito J. M., 2006, DRIVER REHABILITATIO; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Redepenning S, 2006, DRIVER REHABILITATIO; Reger S I, 1981, Bull Prosthet Res, V10-36, P35; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Stay W. B., 2006, OCCUPATIONAL THERAPY; Sung WH, 2012, J CHIN MED ASSOC, V75, P600, DOI 10.1016/j.jcma.2012.08.004; The Centre for Evidence-Based Medicine, 2009, LEV EV; Unsworth CA, 2011, OT DORA BATTERY OCCU; Unsworth CA, 2007, AUST OCCUP THER J, V54, P153, DOI 10.1111/j.1440-1630.2006.00617.x; World Health Organization, 2001, INT CLASS FUNCT DIS	38	20	22	0	29	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	OCT	2014	71						106	114		10.1016/j.aap.2014.04.017			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	AN0WF	WOS:000340304000012	24906164				2021-06-18	
J	Mencl, S; Hennig, N; Hopp, S; Schuhmann, MK; Albert-Weissenberger, C; Siren, AL; Kleinschnitz, C				Mencl, Stine; Hennig, Nelli; Hopp, Sarah; Schuhmann, Michael K.; Albert-Weissenberger, Christiane; Siren, Anna-Leena; Kleinschnitz, Christoph			FTY720 does not protect from traumatic brain injury in mice despite reducing posttraumatic inflammation	JOURNAL OF NEUROIMMUNOLOGY			English	Article						FTY720; Traumatic brain injury; Inflammation; Blood-brain barrier; Lymphocytes; Edema	CLOSED-HEAD INJURY; SPHINGOSINE 1-PHOSPHATE RECEPTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CONTROLLED CORTICAL IMPACT; MULTIPLE-SCLEROSIS; ISCHEMIC-STROKE; WEIGHT-DROP; B1 PROTECTS; FINGOLIMOD; BARRIER	Inflammation is a pathological hallmark of traumatic brain injury (TBI). Recent evidence suggests that immune cells such as lymphocytes are of particular relevance for lesion development after TBI. FTY720, a sphingosine-1-phosphate (SIP) receptor modulator, sequesters T lymphocytes in lymphoid organs and has been shown to improve outcome in a variety of neurological disease models. We investigated the mode of FTY720 action in models of TBI. Focal cortical cryolesion was induced in C57BL/6 mice treated with FTY720 (1 mg/kg) or vehicle immediately before injury. Lesion size was assessed 24 h later. Immune cells in the blood and brain were counted by flow cytometry and immunocytochemistry. The integrity of the blood-brain barrier was analyzed using Evans Blue dye. To validate the findings in a diffuse brain trauma model, FTY720-treated mice and controls were subjected to weight drop contusion injury and neurological deficits were assessed until day 7. As expected FTY720 significantly lowered the numbers of circulating lymphocytes and attenuated the invasion of immune cells into the damaged brain parenchyma. However, FTY720 was unable to improve lesion size or functional outcome in both trauma models at either stage, i.e. acute vs chronic. Accordingly, the extent of blood-brain barrier disruption and neuronal apoptosis was similar between FTY720-treated mice and controls. We conclude that pharmacological SIP receptor modulation is an unfavorable strategy to combat TBI. Moreover, our findings put into perspective the pathophysiological relevance of inflammatory cells in traumatic neurodegeneration. (C) 2014 The Authors. Published by Elsevier B.V.	[Mencl, Stine; Hopp, Sarah; Schuhmann, Michael K.; Albert-Weissenberger, Christiane; Kleinschnitz, Christoph] Univ Hosp Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; [Hennig, Nelli; Siren, Anna-Leena] Univ Hosp Wurzburg, Dept Neurosurg, D-97080 Wurzburg, Germany	Kleinschnitz, C (corresponding author), Univ Hosp Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	christoph.kleinschnitz@uni-wuerzburg.de	Siren, Anna-Leena/AAE-1374-2019	Siren, Anna-Leena/0000-0002-2217-0081; Kleinschnitz, Christoph/0000-0002-1650-8875	Interdisciplinary Center for Clinical Research (IZKF) Wurzburg [A226]; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [SFB 688 TP13]; Novartis Pharma GmbH, Nurnberg, Germany	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) Wurzburg (Project A226 to ALS and CK), the Deutsche Forschungsgemeinschaft (DFG, SFB 688 TP13 to CK) and the Novartis Pharma GmbH, Nurnberg, Germany (unrestricted grant to ALS and CK).	Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Albert-Weissenberger C, 2012, J CEREBR BLOOD F MET, V32, P1747, DOI 10.1038/jcbfm.2012.62; Balatoni B, 2007, BRAIN RES BULL, V74, P307, DOI 10.1016/j.brainresbull.2007.06.023; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Campos F, 2013, STROKE, V44, P505, DOI 10.1161/STROKEAHA.112.679043; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Czigner A, 2007, ACTA NEUROCHIR, V149, P281, DOI 10.1007/s00701-006-1095-8; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Dev KK, 2008, PHARMACOL THERAPEUT, V117, P77, DOI 10.1016/j.pharmthera.2007.08.005; Engel S, 1996, Acta Neurochir Suppl, V66, P89; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gillingwater TH, 2012, BRIT J PHARMACOL, V165, P858, DOI 10.1111/j.1476-5381.2011.01612.x; Hartl R, 1997, ACT NEUR S, V70, P240; Hartl R, 1997, J CEREBR BLOOD F MET, V17, P1210; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Jin XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041892; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kraft P, 2013, STROKE, V44, P3202, DOI 10.1161/STROKEAHA.113.002880; Langhauser F, 2012, BLOOD, V120, P4082, DOI 10.1182/blood-2012-06-440057; Liesz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021312; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miron VE, 2008, J NEUROL SCI, V274, P13, DOI 10.1016/j.jns.2008.06.031; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Norimatsu Y, 2012, AM J PATHOL, V180, P1625, DOI 10.1016/j.ajpath.2011.12.012; Pfeilschifter W, 2010, STROKE, V41, pE193, DOI 10.1161/STROKEAHA.110.578278; Raslan Furat, 2012, Exp Transl Stroke Med, V4, P6, DOI 10.1186/2040-7378-4-6; Raslan F, 2010, J CEREBR BLOOD F MET, V30, P1477, DOI 10.1038/jcbfm.2010.28; Rolland WB, 2013, EXP NEUROL, V241, P45, DOI 10.1016/j.expneurol.2012.12.009; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Soares HD, 1995, J NEUROSCI, V15, P8223; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; van Doom R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-133; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zhang Z, 2008, NEUROPATH APPL NEURO, V34, P330, DOI 10.1111/j.1365-2990.2007.00893.x; Zhang ZY, 2007, J CELL MOL MED, V11, P307, DOI 10.1111/j.1582-4934.2007.00019.x; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386	48	20	20	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	SEP 15	2014	274	1-2					125	131		10.1016/j.jneuroim.2014.07.010			7	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	AQ5TN	WOS:000342871600015	25081505	Other Gold			2021-06-18	
J	Schonberger, M; Herrberg, M; Ponsford, J				Schoenberger, Michael; Herrberg, Marlene; Ponsford, Jennie			Fatigue as a Cause, Not a Consequence of Depression and Daytime Sleepiness: A Cross-Lagged Analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cross-lagged analysis; daytime sleepiness; depression; fatigue; head injury; longitudinal study; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SCALE	Objectives: To examine the temporal relation between fatigue, depression, and daytime sleepiness after traumatic brain injury. Fatigue is a frequent and disabling consequence of traumatic brain injury (TBI). However, it is unclear whether fatigue is a primary consequence of the structural brain injury or a secondary consequence of injury-related sequelae such as depression and daytime sleepiness. Participants: Eighty-eight adults with complicated mild-severe TBI (69% male). Main Measures: Fatigue Severity Scale; depression subscale of the Hospital Anxiety and Depression Scale; Epworth Sleepiness scale at baseline and 6-month follow-up. Results: A cross-lagged path analysis computed within a structural equation modeling framework revealed that fatigue was predictive of depression (beta = .20, P < .05) and sleepiness (beta = .25, P < .05). However, depression and sleepiness did not predict fatigue (P > .05). Conclusions: The results support the view of fatigue after TBI as "primary fatigue"-that is, a consequence of the structural brain injury rather than a secondary consequence of depression or daytime sleepiness. A rehabilitation approach that assists individuals with brain injury in learning to cope with their neuropsychological and physical limitations in everyday life might attenuate their experience with fatigue.	[Schoenberger, Michael; Herrberg, Marlene] Univ Freiburg, Dept Rehabil Psychol & Psychotherapy, Inst Psychol, D-79106 Freiburg, Germany; [Schoenberger, Michael; Ponsford, Jennie] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Schoenberger, Michael; Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia	Schonberger, M (corresponding author), Univ Freiburg, Dept Rehabil Psychol & Psychotherapy, Inst Psychol, Engelberger Str 41, D-79106 Freiburg, Germany.	schoenberger@psychologie.uni-freiburg.de			National Health and Medical Research Council (Australia)National Health and Medical Research Council of Australia [334002]; Monash University, MelbourneMonash University	This study was funded by National Health and Medical Research Council (Australia) grant no. 334002 and Monash University, Melbourne.	Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2012, J HEAD TRAUMA REHAB, V6, P1; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Chaumet G, 2008, NEUROLOGY, V71, P1609, DOI 10.1212/01.wnl.0000334753.49193.48; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johns MW, 2000, J SLEEP RES, V9, P5, DOI 10.1046/j.1365-2869.2000.00177.x; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Martin JL, 2013, ENCY SLEEP, P254; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Parkes JD, 1998, J SLEEP RES, V7, P41, DOI 10.1046/j.1365-2869.1998.00093.x; PELZ DC, 1964, AM SOCIOL REV, V29, P836, DOI 10.2307/2090866; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Snaith R.P., 1994, HOSP ANXIETY DEPRESS; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	34	20	20	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					427	431		10.1097/HTR.0b013e31829ddd08			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700011	23867997				2021-06-18	
J	Willmott, C; Withiel, T; Ponsford, J; Burke, R				Willmott, Catherine; Withiel, Toni; Ponsford, Jennie; Burke, Richard			COMT Val(158)Met and Cognitive and Functional Outcomes after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognition; COMT Val(158)Met; genetics; outcomes; traumatic brain injury	CATECHOL-O-METHYLTRANSFERASE; RAT FRONTAL-CORTEX; HEAD-INJURY; WORKING-MEMORY; PREFRONTAL CORTEX; GENETIC-VARIATION; VAL158MET GENOTYPE; HOMOVANILLIC-ACID; DOPAMINE; ASSOCIATION	There is significant variability in long-term outcomes after traumatic brain injury (TBI), making accurate prognosis difficult. In seeking to enhance understanding of outcomes, this study aimed to investigate whether COMT Val(158)Met allele status was associated with performance on neuropsychological measures of attention and working memory, executive functioning, learning and memory, and speed of information processing in the early rehabilitation phase. The study also aimed to examine whether the COMT polymorphism was associated with longer-term functional outcomes. A total of 223 participants (71.3% male) with moderate-to-severe TBI were recruited as rehabilitation inpatients to participate in a prospective, longitudinal head injury outcome study. The three COMT genotype groups (Val/Val, Val/Met, and Met/Met) were well matched for estimated full-scale IQ, years of education, age at injury, and injury severity. Results showed no significant difference between genotypes on neuropsychological measures (all p>0.05) or functional outcome, as measured by the Glasgow Outcome Scale-Extended (GOS-E), after controlling for age, education, and severity of injury. The presence of frontal lobe pathology was also not associated with cognitive performance. Those with greater injury severity (i.e., longer duration of post-traumatic amnesia) performed more poorly on measures of processing speed and verbal new learning and recall. It was concluded that there was little support for the influence of COMT Val(158)Met on cognitive function, or functional outcome measures, in the acute rehabilitation phase after TBI.	[Willmott, Catherine; Withiel, Toni; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Willmott, Catherine; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Burke, Richard] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Willmott, C (corresponding author), Monash Univ, Sch Psychol Sci, Monash Psychol Ctr, Bldg 1,270 Ferntree Gully Rd, Notting Hill, Vic 3168, Australia.	catherine.willmott@monash.edu	Willmott, Catherine/AAA-5105-2019	Willmott, Catherine/0000-0001-8517-9035; Burke, Richard/0000-0003-0086-0767	Victorian Government Transport Accident Commission; Institute for Safety Compensation and Recovery Research	This project was supported by the Victorian Government Transport Accident Commission and the Institute for Safety Compensation and Recovery Research. The authors thank Drs. Katrina Simpson Gershon Spitz for their advice regarding statistical analysis as well as the participants who gave so generously of their time.	Aguilera M, 2008, AM J MED GENET B, V147B, P898, DOI 10.1002/ajmg.b.30705; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; BAREGGI SR, 1975, EUR NEUROL, V13, P528, DOI 10.1159/000114709; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; Bigler ED, 2005, TXB TRAUMATIC BRAIN; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Flashman L.A., 2004, J NEUROPSYCHIATRY CL, V16, P238; Glatt SJ, 2003, MOL PSYCHIATR, V8, P911, DOI 10.1038/sj.mp.4001321; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; GROSSMAN MH, 1992, LIFE SCI, V50, P473, DOI 10.1016/0024-3205(92)90386-4; GROSSMAN MH, 1992, GENOMICS, V12, P822, DOI 10.1016/0888-7543(92)90316-K; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Kinsella G., 2008, INFORM PROCESSING SP, P173; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Markianos M, 1996, ACTA NEUROCHIR, V138, P57, DOI 10.1007/BF01411725; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Meyers J., 1995, REY COMPLEX FIGURE T; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Millis S.R., 2001, BRAIN INJURY, V15, P401; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; NAYAK AK, 1980, J NEUROL SCI, V47, P211, DOI 10.1016/0022-510X(80)90005-2; Newman LA, 2008, PSYCHOPHARMACOLOGY, V200, P39, DOI 10.1007/s00213-008-1097-8; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Schmidt M., 1996, REY AUDITORY VERBAL; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Sengupta S, 2008, NEUROPSYCHOPHARMACOL, V33, P3069, DOI 10.1038/npp.2008.85; Sheldrick AJ, 2008, EUR PSYCHIAT, V23, P385, DOI 10.1016/j.eurpsy.2008.05.002; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sloan S., 2012, TRAUMATIC BRAIN INJU; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; VECHT CJ, 1975, ARCH NEUROL-CHICAGO, V32, P792, DOI 10.1001/archneur.1975.00490540036004; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Willmott C, 2013, BRAIN INJURY, V27, P1281, DOI 10.3109/02699052.2013.809553; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009	65	20	20	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2014	31	17					1507	1514		10.1089/neu.2013.3308			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AO7GO	WOS:000341520700005	24786534				2021-06-18	
J	Mei, C; Reilly, S; Reddihough, D; Mensah, F; Morgan, A				Mei, Cristina; Reilly, Sheena; Reddihough, Dinah; Mensah, Fiona; Morgan, Angela			Motor speech impairment, activity, and participation in children with cerebral palsy	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						Cerebral palsy; motor speech disorders; activity and participation	COMPLEX COMMUNICATION NEEDS; TRAUMATIC BRAIN-INJURY; CLASSIFICATION-SYSTEM; DYSARTHRIA; INTELLIGIBILITY; DISABILITIES; INDIVIDUALS; RELIABILITY; PERSPECTIVE; ENVIRONMENT	The present study used a population-based sample of children with cerebral palsy (CP) to estimate the prevalence of motor speech impairment and its association with activity and participation. A sample of 79 Victorian children aged 4 years 11 months to 6 years 5 months was recruited through the Victorian CP Register. The presence of motor speech impairment was recorded using the Viking Speech Scale (VSS). Activity and participation outcomes included speech intelligibility (the National Technical Institute for the Deaf rating scale, NTID), the Functional Communication Classification System (FCCS) and Communication Function Classification System (CFCS). A parent completed rating scale was used to examine the association between motor speech impairment and participation. Ninety per cent (71/79) of children demonstrated a motor speech impairment. Strong associations were found between the VSS and NTID (<.001), CFCS (<.001), and FCCS levels (<.001). VSS levels III-IV were significantly associated with restrictions in home, school, and community-based participation as perceived by parents. Although some diversity in activity and participation outcomes was observed within specific VSS levels, the results of this study suggested that children with mild motor speech impairments are more likely to demonstrate superior activity and participation outcomes compared to children with moderate or severe deficits.	[Mei, Cristina; Reilly, Sheena; Reddihough, Dinah; Mensah, Fiona; Morgan, Angela] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Mei, Cristina; Reilly, Sheena; Reddihough, Dinah; Mensah, Fiona; Morgan, Angela] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Reilly, Sheena; Reddihough, Dinah; Mensah, Fiona; Morgan, Angela] Royal Childrens Hosp, Melbourne, Vic, Australia	Mei, C (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	cristina.mei@mcri.edu.au	Mensah, Fiona K/G-3382-2018; Reilly, Sheena/A-7035-2016; Morgan, Angela/J-5235-2017	Mensah, Fiona K/0000-0002-6951-9949; Reilly, Sheena/0000-0001-6506-4767; Morgan, Angela/0000-0003-1147-7405; Mei, Cristina/0000-0002-6765-8064	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [607448]; Speech Pathology Australia; NHMRCNational Health and Medical Research Council of Australia [607315, 1041892, 436914, 1037449]; Victorian Government	We are grateful to all the families who participated in this study. We kindly thank Sue Reid (Manager of the VCPR) and the following departments at the Royal Children's Hospital, Melbourne, for their generous assistance in recruiting families: Developmental Medicine, Orthopaedics, and the Victorian Paediatric Rehabilitation Service. This project was funded by a National Health and Medical Research Council (NHMRC) Postgraduate Scholarship (#607448) and a Speech Pathology Australia Nadia Verrall Research Grant. The following authors were funded by NHMRC: AM (Career Development Award #607315); SR (Practitioner Fellowship #1041892); and FM (Population Health Capacity Building Grant #436914 and Early Career Fellowship #1037449). Support was also received from the Victorian Government's Operational Infrastructure Support Program.	Barty E, 2009, 3 INT CER PALS C SYD; Clarke MT, 2011, RES DEV DISABIL, V32, P774, DOI 10.1016/j.ridd.2010.11.002; Clarke M, 2012, AUGMENT ALTERN COMM, V28, P44, DOI 10.3109/07434618.2011.653605; Cockerill H, 2014, CHILD CARE HLTH DEV, V40, P149, DOI 10.1111/cch.12066; Colver A, 2012, ARCH PHYS MED REHAB, V93, P2154, DOI 10.1016/j.apmr.2012.07.011; Dickinson HO, 2007, LANCET, V369, P2171, DOI 10.1016/S0140-6736(07)61013-7; Eadie TL, 2006, AM J SPEECH-LANG PAT, V15, P307, DOI 10.1044/1058-0360(2006/030); Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162; FLIPSEN P, 1995, J COMMUN DISORD, V28, P3, DOI 10.1016/0021-9924(94)00015-R; Forsyth R, 2007, DEV MED CHILD NEUROL, V49, P345, DOI 10.1111/j.1469-8749.2007.00345.x; Guro A, 2010, PERSPECT AUGMENT ALT, V19, P12, DOI DOI 10.1044/AAC19.1.12; Hammal D, 2004, DEV MED CHILD NEUROL, V46, P292, DOI 10.1017/S0012162204000489; Hartelius L, 2008, FOLIA PHONIATR LOGO, V60, P11, DOI 10.1159/000111799; Hidecker MJC, 2011, DEV MED CHILD NEUROL, V53, P704, DOI 10.1111/j.1469-8749.2011.03996.x; Johnson DD., 1975, J ACAD REHABIL AUDIO, V8, P17; Kent Ray D. Giuliana, 1994, AM J SPEECH-LANG PAT, V3, P81; Lawlor K, 2006, DEV NEUROREHABIL, V9, P219; Liegeois F, 2010, BRAIN LANG, V114, P126, DOI 10.1016/j.bandl.2009.12.004; Liegeois FJ, 2013, BRAIN LANG, V127, P388, DOI 10.1016/j.bandl.2013.05.003; McAuliffe MJ, 2010, BRAIN INJURY, V24, P1408, DOI 10.3109/02699052.2010.511590; McFadd E, 2013, DEV NEUROREHABIL, V16, P102, DOI 10.3109/17518423.2012.723762; Mei C., 2012, DEV MED CHILD NEU S5, V54, P84; Michelsen SI, 2013, DEV MED CHILD NEUROL, V55, P684, DOI 10.1111/dmcn.12186; Nordberg A, 2013, ACTA PAEDIATR, V102, P161, DOI 10.1111/apa.12076; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Parkes J, 2010, DEV MED CHILD NEUROL, V52, P1113, DOI 10.1111/j.1469-8749.2010.03765.x; Pennington L, 2001, DEV MED CHILD NEUROL, V43, P83, DOI 10.1017/S0012162201000147; Pennington L, 2013, RES DEV DISABIL, V34, P3202, DOI 10.1016/j.ridd.2013.06.035; Pennington L, 2013, DEV MED CHILD NEUROL, V55, P464, DOI 10.1111/dmcn.12098; Raghavendra P, 2011, DEV NEUROREHABIL, V14, P145, DOI 10.3109/17518423.2011.568994; Reid SM, 2011, RES DEV DISABIL, V32, P2909, DOI 10.1016/j.ridd.2011.05.012; Thirumanickam A, 2011, AUGMENT ALTERN COMM, V27, P195, DOI 10.3109/07434618.2011.610818; Virella D., 2012, 4 INT CER PALS C PIS; World Health Organization, 2001, INT CLASS FUNCT DIS; Yorkston KM, 2001, AM J SPEECH-LANG PAT, V10, P126, DOI 10.1044/1058-0360(2001/013); Zimmerman I. L., 2002, PRESCHOOL LANGUAGE S	36	20	21	1	21	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	AUG	2014	16	4					427	435		10.3109/17549507.2014.917439			9	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AM4DT	WOS:000339803700010	24910254				2021-06-18	
J	Nalliah, RP; Anderson, IM; Lee, MK; Rampa, S; Allareddy, V; Allareddy, V				Nalliah, Romesh P.; Anderson, Ingrid M.; Lee, Min Kyeong; Rampa, Sankeerth; Allareddy, Veerasathpurush; Allareddy, Veerajalandhar			Epidemiology of Hospital-Based Emergency Department Visits Due to Sports Injuries	PEDIATRIC EMERGENCY CARE			English	Article						sports injury; epidemiology; hospital charge	UNITED-STATES; BRITISH-COLUMBIA; CONCUSSIONS	Background: Sports-related injuries in adolescents incur a significant amount of hospital resources. Sports-related injuries are not an uncommon cause of ED visit; however, national estimates of such injuries in teenagers are unknown. Objectives: The aim of this study was to identify and characterize emergency department (ED) visits that result from sports-related injuries among teenagers across the United States. This study describes the outcomes associated with sports-related injuries necessitating ED visits among teenagers at a national level. Study Design: This is a descriptive epidemiology study. Methods: The 2008 Nationwide Emergency Department Sample data set, the largest all-payer health care database in the United States, was used to identify ED visits with external cause of injury related to sports occurring in patients aged 13 through 19 years. Outcomes examined included discharge status after the ED visit and presence of concomitant injuries. Descriptive statistics was used to summarize the estimates. Nationwide representative estimates were computed using the discharge weight variable. Results: There were 432,609 ED visits by those between the ages of 13 and 19 years who experienced sports-related injuries, with total charges close to $447.4 million, with a mean total per-visit charge of $1205. The male patients accounted for 76.8% of the total ED visits. The most frequently occurring injuries were superficial injury or contusion (n = 118,250 ED visits); sprains and strains (n = 105,476); fracture of the upper limb (n = 63,151); open wounds of the head, the neck, and the trunk (n = 46,176); as well as intracranial injury (n = 30,726). Close to 29% of all ED visits occurred among those residing in geographical areas with median household income levels of greater than $64,000. After the ED visit, 1.6% were admitted to the same hospital, with a mean length of stay of 2.4 days and a mean hospital charge for ED visit and inpatient services of $22,703. The male patients composed 87.5% of the hospitalizations. The total of hospitalization charges across the entire United States was $154.8 million. Conclusions: Sports injuries account for a substantial number of 2008 teenage ED visits in the United States. Patient-and hospital-level characteristics were analyzed and highlighted.	[Nalliah, Romesh P.] Harvard Univ, Sch Dent Med, Off Dent Educ, Boston, MA 02115 USA; [Anderson, Ingrid M.; Allareddy, Veerajalandhar] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Lee, Min Kyeong] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Rampa, Sankeerth] Texas A&M Univ, Coll Publ Hlth, College Stn, TX USA; [Allareddy, Veerasathpurush] Univ Iowa, Coll Dent, Dept Orthodont, Iowa City, IA 52242 USA	Allareddy, V (corresponding author), Rainbow Babies & Childrens Hosp, Dept Pediat Crit Care, 11100 Euclid Ave, Cleveland, OH 44107 USA.	Veerajalandhar.Allareddy@UHhospitals.org	Nalliah, Romesh/AAV-2016-2020	Nalliah, Romesh/0000-0002-6287-0656			Chew EM, 2012, J HAND SURG-AM, V37A, P1684, DOI 10.1016/j.jhsa.2012.05.010; Collard DCM, 2011, BRIT J SPORT MED, V45, P1058, DOI 10.1136/bjsm.2010.082545; Gage BE, 2012, ACAD EMERG MED, V19, P378, DOI 10.1111/j.1553-2712.2012.01315.x; Habelt S, 2011, ORTHOP REV PAVIA, V3, pe18, DOI [10.4081/or.2011.e18, DOI 10.4081/OR.2011.E18]; Knowles SB, 2007, INJURY PREV, V13, P416, DOI 10.1136/ip.2006.014720; Leadbeater B, 2010, INT J INJ CONTROL SA, V17, P119, DOI 10.1080/17457300903564561; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Nalliah RP, 2013, DENT TRAUMATOL, V29, P115, DOI 10.1111/j.1600-9657.2012.01137.x; Nationwide Emergency Department Sample, HEALTHC COST UT PROJ; Pakzad-Vaezi K, 2011, PAED CHILD HEALT-CAN, V16, P217, DOI 10.1093/pch/16.4.217; Shah SS, 2012, J TRAUMA ACUTE CARE, V72, P1688, DOI 10.1097/TA.0b013e31824a4c5b; Steptoe A, 1996, LANCET, V347, P1789, DOI 10.1016/S0140-6736(96)91616-5; Veleminsky M, 2012, MED SCI MONITOR, V18, pPH19, DOI 10.12659/MSM.882508; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923	14	20	22	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	AUG	2014	30	8					511	515		10.1097/PEC.0000000000000180			5	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	AN7LG	WOS:000340781000001	25062295				2021-06-18	
J	Joseph, B; Aziz, H; Pandit, V; Kulvatunyou, N; Hashmi, A; Tang, A; Sadoun, M; O'Keeffe, T; Vercruysse, G; Green, DJ; Friese, RS; Rhee, P				Joseph, Bellal; Aziz, Hassan; Pandit, Viraj; Kulvatunyou, Narong; Hashmi, Ammar; Tang, Andrew; Sadoun, Moutamn; O'Keeffe, Terence; Vercruysse, Gary; Green, Donald J.; Friese, Randall S.; Rhee, Peter			A Three-Year Prospective Study of Repeat Head Computed Tomography in Patients with Traumatic Brain Injury	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							CT; MILD	BACKGROUND: A definitive consensus on the standardization of practice of a routine repeat head CT (RHCT) scan in patients with traumatic intracranial hemorrhage is lacking. We hypothesized that in examinable patients without neurologic deterioration, RHCT scan does not lead to neurosurgical intervention (craniotomy/craniectomy). STUDY DESIGN: This was a 3-year prospective cohort analysis of patients aged 18 years and older, without antiplatelet or anticoagulation therapy, presenting to our level 1 trauma center with intracranial hemorrhage on initial head CT and a follow-up RHCT. Neurosurgical intervention was defined by craniotomy/craniectomy. Neurologic deterioration was defined as altered mental status, focal neurologic deficits, and/or pupillary changes. RESULTS: A total of 1,129 patients were included. Routine RHCT was performed in 1,099 patients. The progression rate was 19.7% (216 of 1,099), with subsequent neurosurgical intervention in 4 patients. Four patients had an abnormal neurologic examination, with a Glasgow Coma Scale (GCS) of <= 8 requiring intubation. Thirty patients had an RHCT secondary to neurologic deterioration; 53% (16 of 30) had progression on RHCT, of which 75% (12 of 16) required neurosurgical intervention. There was an association between deterioration in neurologic examination and need for neurosurgical intervention (odds ratio 3.98; 95% CI 1.7 to 9.1). The negative predictive value of a deteriorating neurologic examination in predicting the need for neurosurgical intervention was 100% in patients with GCS > 8. CONCLUSIONS: Routine repeat head CT scan is not warranted in patients with normal neurologic examination. Routine repeat head CT scan does not supplement the need for neurologic examination for determining management in patients with traumatic brain injury. (C) 2014 by the American College of Surgeons	[Joseph, Bellal; Aziz, Hassan; Pandit, Viraj; Kulvatunyou, Narong; Hashmi, Ammar; Tang, Andrew; Sadoun, Moutamn; O'Keeffe, Terence; Vercruysse, Gary; Green, Donald J.; Friese, Randall S.; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ 85724 USA	Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu					Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; CDC IPaC, TRAUMATIC BRAIN INJU; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; COPE DN, 1988, ARCH PHYS MED REHAB, V69, P483; Harbrecht BG, 2010, J TRAUMA, V68, P1367, DOI 10.1097/TA.0b013e3181d990da; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Joseph B, 2014, AM SURGEON, V80, P43; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Laack TA, 2011, J TRAUMA, V70, P1362, DOI 10.1097/TA.0b013e3181e1707f; Roudsari B, 2010, J AM COLL RADIOL, V7, P796, DOI 10.1016/j.jacr.2010.05.006; Salim A, 2013, J TRAUMA ACUTE CARE, V74, P973; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Shackford SR, 2004, J TRAUMA, V56, P480; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Sinson G, 2001, J TRAUMA, V51, P875; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Thorson CM, 2013, J TRAUMA ACUTE CARE, V74, P967, DOI 10.1097/TA.0b013e3182877fed; Valadka A, 2002, TRAUMA, P385; Valadka AB, 2010, J TRAUMA, V68, P1372	26	20	20	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	JUL	2014	219	1					45	51		10.1016/j.jamcollsurg.2013.12.062			7	Surgery	Surgery	AL7NI	WOS:000339320300008	24745622				2021-06-18	
J	Lee, TH; Hampton, DA; Diggs, BS; McCully, SP; Kutcher, M; Redick, BJ; Podbielski, J; Cotton, BA; Cohen, M; Schreiber, MA				Lee, Tim H.; Hampton, David A.; Diggs, Brian S.; McCully, Sean P.; Kutcher, Matt; Redick, Britt J.; Podbielski, Jeannette; Cotton, Bryan A.; Cohen, Mitchell; Schreiber, Martin A.			Traumatic brain injury is not associated with coagulopathy out of proportion to injury in other body regions	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Trauma; coagulopathy; traumatic brain injury	HEAD-INJURY; MECHANISMS; DEATHS; RISK	BACKGROUND: Coagulopathy following trauma is associated with poor outcomes. Traumatic brain injury has been associated with coagulopathy out of proportion to other body regions. We hypothesized that injury severity and shock determine coagulopathy independent of body region injured. METHODS: We performed a prospective, multicenter observational study at three Level 1 trauma centers. Conventional coagulation tests (CCTs) and rapid thrombelastography (r-TEG) were used. Admission vital signs, base deficit (BD), CCTs, and r-TEG data were collected. The Abbreviated Injury Scale (MS) score and Injury Severity Score (ISS) were obtained. Severe injury was defined as AIS score greater than or equal to 3 for each body region. Patients were grouped according to their dominant AIS region of injury. Dominant region of injury was defined as the single region with the highest AIS score. Patients with two or more regions with the same greatest AIS score and patients without a region with an AIS score greater than or equal to 3 were excluded. Coagulation parameters were compared between the dominant AIS region. Significant hypoperfusion was defined as BD greater than or equal to 6. RESULTS: Of the 795 patients enrolled, 462 met criteria for grouping by dominant AIS region. Patients were predominantly white (59%), were male (75%), experienced blunt trauma (71%), and had a median ISS of 25 (interquartile range, 14-29). Patients with BD greater than or equal to 6 (n = 110) were hypocoagulable by CCT and r-TEG compared with patients with BD less than 6 (n = 223). Patients grouped by dominant MS region showed no significant differences for any r-TEG or CCT parameter. Patients with BD greater than or equal to 6 demonstrated no difference in any r-TEG or CCT parameter between dominant MS regions. CONCLUSION: Coagulopathy results from a combination of tissue injury and shock independent of the dominant region of injury. With the use of MS as a measure of injury severity, traumatic brain injury was not independently associated with more profound coagulopathy. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Lee, Tim H.; Hampton, David A.; Diggs, Brian S.; McCully, Sean P.; Kutcher, Matt; Redick, Britt J.; Podbielski, Jeannette; Cotton, Bryan A.; Cohen, Mitchell; Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Surg, Div Trauma Crit Care & Acute Care Surg, Portland, OR 97239 USA	Schreiber, MA (corresponding author), Oregon Hlth & Sci Univ, Dept Surg, Div Trauma Crit Care & Acute Care Surg, 3181 SW Sam Jackson Pk Rd,Mail Code L-611, Portland, OR 97239 USA.	schreibm@ohsu.edu		Kutcher, Matthew/0000-0003-4566-5359			Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Davenport R, 2013, TRANSFUSION, V53, p23S, DOI 10.1111/trf.12032; Davenport R, 2011, BRIT J HAEMATOL, V155, P537, DOI 10.1111/j.1365-2141.2011.08885.x; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2012, SHOCK, V38, P450, DOI 10.1097/SHK.0b013e31826dbd23; Mattox K, 2012, TRAUMA; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schreiber MA, 2005, CURR OPIN CRIT CARE, V11, P590, DOI 10.1097/01.ccx.0000186374.49320.ab; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	21	20	23	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2014	77	1					67	72		10.1097/TA.0000000000000255			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	AK4IY	WOS:000338389600018	24977757				2021-06-18	
J	Luo, BE; Huang, JH; Lu, L; Hu, XY; Luo, ZJ; Li, M				Luo, Beier; Huang, Jinghui; Lu, Lei; Hu, Xueyu; Luo, Zhuojing; Li, Ming			Electrically induced brain-derived neurotrophic factor release from schwann cells	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						calcium; brain-derived neurotrophic factor; mitogen-activated protein kinase; electrical stimulation; calcium-calmodulin dependent protein kinase	CONDUCTIVE POLYPYRROLE/CHITOSAN POLYMERS; OLFACTORY ENSHEATHING CELLS; PERIPHERAL-NERVE; SPINAL-CORD; HIPPOCAMPAL-NEURONS; DEPENDENT RELEASE; REGENERATION; BDNF; FIELDS; NGF	Regulating the production of brain-derived neurotrophic factor (BDNF) in Schwann cells (SCs) is critical for their application in traumatic nerve injury, neurodegenerative disorders, and demyelination disease in both central and peripheral nervous systems. The present study investigated the possibility of using electrical stimulation (ES) to activate SCs to release BDNF. We found that short-term ES was capable of promoting BDNF production from SCs, and the maximal BDNF release was achieved by ES at 6 V (3 Hz, 30 min). We further examined the involvement of intracellular calcium ions ([Ca2+](i)) in the ES-induced BDNF production in SCs by pharmacological studies. We found that the ES-induced BDNF release required calcium influx through T-type voltage-gated calcium channel (VGCC) and calcium mobilization from internal calcium stores, including inositol triphosphate-sensitive stores and caffeine/ryanodine-sensitive stores. In addition, calcium-calmodulin dependent protein kinase IV (CaMK IV), mitogen-activated protein kinase (MAPK), and cAMP response element-binding protein (CREB) were found to play important roles in the ES-induced BDNF release from SCs. In conclusion, ES is capable of activating SCs to secrete BDNF, which requires the involvement of calcium influx through T-type VGCC and calcium mobilization from internal calcium stores. In addition, activation of CaMK IV, MAPK, and CREB were also involved in the ES-induced BDNF release. The findings indicate that ES can improve the neurotrophic ability in SCs and raise the possibility of developing electrically stimulated SCs as a source of cell therapy for nerve injury in both peripheral and central nervous systems. (c) 2014 Wiley Periodicals, Inc.	[Luo, Beier; Li, Ming] Second Mil Med Univ, Inst Orthopaed, Changhai Hosp, Shanghai, Peoples R China; [Huang, Jinghui; Hu, Xueyu; Luo, Zhuojing] Fourth Mil Med Univ, Inst Orthopaed, Xijing Hosp, Xian 710032, Peoples R China; [Lu, Lei] Fourth Mil Med Univ, Dept Oral Anat & Physiol, Sch Stomatol, Xian 710032, Peoples R China	Luo, ZJ (corresponding author), Fourth Mil Med Univ, Inst Orthopaed, Xijing Hosp, Xian 710032, Peoples R China.	zhuojingl@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201389, 30973052, 30872870]; National Basic Research Program of China (973 Program)National Basic Research Program of China [2014CB542206]; Program for Changjiang Scholar and Innovative Research Team in UniversityProgram for Changjiang Scholars & Innovative Research Team in University (PCSIRT) [IRT1053]	Contract grant sponsor: National Natural Science Foundation of China; Contract grant numbers: 81201389; 30973052; 30872870; Contract grant sponsor: National Basic Research Program of China (973 Program); Contract grant number: 2014CB542206; Contract grant sponsor: Program for Changjiang Scholar and Innovative Research Team in University; Contract grant number: IRT1053.	Balkowiec A, 2002, J NEUROSCI, V22, P10399; Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Brighton CT, 2008, J BONE JOINT SURG AM, V90A, P833, DOI 10.2106/JBJS.F.01437; BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235; Canossa M, 2001, EMBO J, V20, P1640, DOI 10.1093/emboj/20.7.1640; Cho MR, 2002, FRONT BIOSCI, V7, pA1, DOI 10.2741/cho; COLLIER TJ, 1993, EXP NEUROL, V124, P129, DOI 10.1006/exnr.1993.1183; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Fang YA, 2010, J TISSUE ENG REGEN M, V4, P581, DOI 10.1002/term.264; Geremia NM, 2010, EXP NEUROL, V223, P128, DOI 10.1016/j.expneurol.2009.07.022; Ghosh M, 2012, GLIA, V60, P979, DOI 10.1002/glia.22330; Gravel C, 1997, NAT MED, V3, P765, DOI 10.1038/nm0797-765; Griesbeck O, 1999, MICROSC RES TECHNIQ, V45, P262, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K; He J, 2009, CHEM-BIOL INTERACT, V177, P34, DOI 10.1016/j.cbi.2008.08.012; Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511; Huang JH, 2010, GLIA, V58, P622, DOI 10.1002/glia.20951; Kobayashi M, 2012, J NEUROPATH EXP NEUR, V71, P511, DOI 10.1097/NEN.0b013e318257fe7b; Kwon YW, 1996, J NEUROBIOL, V29, P503; Liang W, 2010, BRAIN RES, V1357, P19, DOI 10.1016/j.brainres.2010.07.091; McGrath AM, 2010, BRAIN RES BULL, V83, P207, DOI 10.1016/j.brainresbull.2010.07.001; McKasson MJ, 2008, EXP NEUROL, V211, P585, DOI 10.1016/j.expneurol.2008.02.015; MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45; MONTEROMENEI CN, 1992, BRAIN RES, V570, P198, DOI 10.1016/0006-8993(92)90582-T; Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453; OZAWA H, 1989, J CELL PHYSIOL, V138, P477, DOI 10.1002/jcp.1041380306; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Penna V, 2012, CELLS TISSUES ORGANS, V196, P534, DOI 10.1159/000338059; Qi FY, 2013, BIOMATERIALS, V34, P1799, DOI 10.1016/j.biomaterials.2012.11.042; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi GX, 2008, BIOMATERIALS, V29, P3792, DOI 10.1016/j.biomaterials.2008.06.010; Song GB, 2008, ANTICANCER RES, V28, P2245; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Tep C, 2012, J BIOL CHEM, V287, P1600, DOI 10.1074/jbc.M111.312736; Wang T, 2011, CELL MOL NEUROBIOL, V31, P357, DOI 10.1007/s10571-010-9626-5; Ward NL, 2000, EXP NEUROL, V162, P297, DOI 10.1006/exnr.1999.7346; ZHANG WC, 1994, CHINESE MED J-PEKING, V107, P583; Zhao ZQ, 2012, STEM CELL RES, V8, P38, DOI 10.1016/j.scr.2011.08.001	38	20	21	0	18	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUL	2014	92	7					893	903		10.1002/jnr.23365			11	Neurosciences	Neurosciences & Neurology	AG8YL	WOS:000335704400008	24753179				2021-06-18	
J	Krewer, C; Hartl, S; Muller, F; Koenig, E				Krewer, Carmen; Hartl, Sandra; Mueller, Friedemann; Koenig, Eberhard			Effects of Repetitive Peripheral Magnetic Stimulation on Upper-Limb Spasticity and Impairment in Patients With Spastic Hemiparesis: A Randomized, Double-Blind, Sham-Controlled Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Hemiparesis; Magnetic stimulation therapy; Movement; Rehabilitation; Spastic paraparesis; Stroke; Traumatic brain injury	NEUROMUSCULAR ELECTRICAL-STIMULATION; TARDIEU SCALE; ASHWORTH SCALE; STROKE; DEPRESSION; RECOVERY; INJURY; WRIST; TONE; RPMS	Objective: To investigate short-term and long-term effects of repetitive peripheral magnetic stimulation (rpMS) on spasticity and motor function. Design: Monocentric, randomized, double-blind, sham-controlled trial. Setting: Neurologic rehabilitation hospital. Participants: Patients (N=66) with severe hemiparesis and mild to moderate spasticity resulting from a stroke or a traumatic brain injury. The average time +/- SD since injury for the intervention groups was 26 +/- 71 weeks or 37 +/- 82 weeks. Interventions: rpMS for 20 minutes or sham stimulation with subsequent occupational therapy for 20 minutes, 2 times a day, over a 2-week period. Main Outcome Measures: Modified Tardieu Scale and Fugl-Meyer Assessment (arm score), assessed before therapy, at the end of the 2-week treatment period, and 2 weeks after study treatment. Additionally, the Tardieu Scale was assessed after the first and before the third therapy session to determine any short-term effects. Results: Spasticity (Tardieu >0) was present in 83% of wrist flexors, 62% of elbow flexors, 44% of elbow extensors, and 10% of wrist extensors. Compared with the sham stimulation group, the rpMS group showed short-term effects on spasticity for wrist flexors (P=.048), and long-term effects for elbow extensors (P<.045). Arm motor function (rpMS group: median 5 [4-27]; sham group: median 4 [4-9]) did not significantly change over the study period in either group, whereas rpMS had a positive effect on sensory function. Conclusions: Therapy with rpMS increases sensory function in patients with severe limb paresis. The magnetic stimulation, however, has limited effect on spasticity and no effect on motor function. (C) 2014 by the American Congress of Rehabilitation Medicine	[Krewer, Carmen; Hartl, Sandra; Mueller, Friedemann; Koenig, Eberhard] Schoen Klin Bad Aibling, Motor Res Dept, D-83043 Bad Aibling, Germany	Krewer, C (corresponding author), Schoen Klin Bad Aibling, Kolbermoorer Str 72, D-83043 Bad Aibling, Germany.	CKrewer@schoen-kliniken.de	Krewer, Carmen/H-2845-2019	Krewer, Carmen/0000-0002-4153-0791			Burridge JH, 2005, DISABIL REHABIL, V27, P69, DOI 10.1080/09638280400014592; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Haugh AB, 2006, DISABIL REHABIL, V28, P899, DOI 10.1080/09638280500404305; Heldmann B, 2000, NEUROREPORT, V11, P3193, DOI 10.1097/00001756-200009280-00029; Krause P, 2003, SUPPL CLIN NEUROPHYS, V56, P220; MAHONEY F I, 1965, Md State Med J, V14, P61; Malhotra S, 2013, CLIN REHABIL, V27, P579, DOI 10.1177/0269215512464502; McIntyre RS, 2005, CAN MED ASSOC J, V173, P1327, DOI 10.1503/cmaj.050786; Mehrholz J, 2005, CLIN REHABIL, V19, P751, DOI 10.1191/0269215505cr889oa; Muller MM, 2008, THESIS TECHNISCHE U; Nielsen J F, 1996, Mult Scler, V2, P227; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Paolucci S, 1999, ARCH PHYS MED REHAB, V80, P985, DOI 10.1016/S0003-9993(99)90048-5; Patrick E, 2006, CLIN REHABIL, V20, P173, DOI 10.1191/0269215506cr922oa; Rosewilliam S, 2012, ARCH PHYS MED REHAB, V93, P1715, DOI 10.1016/j.apmr.2012.05.017; Struppler A, 2003, SUPPL CLIN NEUROPHYS, V56, P358; Struppler A, 2004, EXP BRAIN RES, V157, P59, DOI 10.1007/s00221-003-1817-6; Struppler A, 2003, NEUROREHABILITATION, V18, P69; Sunnerhagen KS, 2013, NEUROLOGY, V80, pS35, DOI 10.1212/WNL.0b013e3182764aa2; Thibaut A, 2013, BRAIN INJURY, V27, P1093, DOI 10.3109/02699052.2013.804202; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wissel J, 2010, J NEUROL, V257, P1067, DOI 10.1007/s00415-010-5463-1; Woollacott, 2001, MOTOR CONTROL THEORY	24	20	26	1	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2014	95	6					1039	1047		10.1016/j.apmr.2014.02.003			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AI3OY	WOS:000336773000006	24561057				2021-06-18	
J	Lewandowski-Belfer, JJ; Patel, AV; Darracott, RM; Jackson, DA; Nordeen, JD; Freeman, WD				Lewandowski-Belfer, Julie J.; Patel, Alden V.; Darracott, Robert M.; Jackson, Daniel A.; Nordeen, Jerah D.; Freeman, W. David			Safety and Efficacy of Repeated Doses of 14.6 or 23.4 % Hypertonic Saline for Refractory Intracranial Hypertension	NEUROCRITICAL CARE			English	Article						Hypertonic saline; Hyperosmolar agents; Intracranial pressure; Osmotherapy; Intracranial hypertension; Serum sodium	TRAUMATIC BRAIN-INJURY; PRESSURE; MANAGEMENT; THERAPY	The efficacy of administering single bolus doses of 14.6 or 23.4 % hypertonic saline (HTS) to treat refractory intracranial hypertension has been demonstrated in the literature and has emerged as an important therapeutic option in treating these patients. However, many institutions lack experience with this therapy and there are few published studies evaluating the safety of repeated bolus dosing of HTS. A retrospective review of patients admitted between January 2008 and July 2012 was conducted to evaluate the use of repeated dosing of HTS in patients with refractory intracranial hypertension. The primary objective was to evaluate the safety of repeated dosing of HTS assessed by documented adverse effects such as central pontine myelinolysis (CPM) and severe fluctuations in serum sodium concentrations. Secondary objectives were to evaluate the efficacy of repeated dosing HTS in reducing intracranial pressure (ICP) and to compare the dose-response relationship of 14.6 and 23.4 % doses. Fifty-five patients were included for evaluation, each receiving an average of 8.9 (range 2-61) doses of HTS. A statistically significant increase in mean serum sodium concentration occurred with the administration of HTS (p < 0.0001). No cases of CPM were identified. The use of HTS was found to be effective based on decreases in ICP after administration (p < 0.0001, mean ICP reduction: 10.1 mmHg, range 3-23.6 mmHg). The efficacy of 23.4 % saline in decreasing ICP was not found to be significantly different than 14.6 % saline (p = 0.23). Repeat bolus dosing of 14.6 or 23.4 % HTS appears to be relatively safe and effective for treating refractory intracranial hypertension assuming there is frequent electrolyte monitoring and concomitant fluid management.	[Lewandowski-Belfer, Julie J.] Spectrum Hlth Butterworth, Dept Pharm, Grand Rapids, MI 49503 USA; [Lewandowski-Belfer, Julie J.; Patel, Alden V.; Darracott, Robert M.; Jackson, Daniel A.; Nordeen, Jerah D.] Mayo Clin, Dept Pharm, Jacksonville, FL 32224 USA; [Freeman, W. David] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Freeman, W. David] Mayo Clin, Dept Neurosurg, Jacksonville, FL 32224 USA; [Freeman, W. David] Mayo Clin, Dept Crit Care, Jacksonville, FL 32224 USA	Lewandowski-Belfer, JJ (corresponding author), Spectrum Hlth Butterworth, Dept Pharm, 100 Michigan NE, Grand Rapids, MI 49503 USA.	lewanjj@gmail.com; Patel.Alden@mayo.edu; Darracott.Robert@mayo.edu; Jackson.Daniel1@mayo.edu; Nordeen.Jerah@mayo.edu; freeman.william1@mayo.edu	Belfer, Julie/AAY-7497-2020	Freeman, M.D., William D./0000-0003-2326-0633			Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Eskandari R, 2013, J NEUROSURG, V119, P338, DOI 10.3171/2013.4.JNS121541; Forsyth LL, 2008, PHARMACOTHERAPY, V28, P469, DOI 10.1592/phco.28.4.469; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Paredes-Andrade E, 2012, NEUROCRIT CARE, V17, P204, DOI 10.1007/s12028-011-9574-z; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Torre-Healy A, 2012, NEUROCRIT CARE, V17, P117, DOI 10.1007/s12028-011-9649-x; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; Valentino Alden K, 2008, J Vasc Interv Neurol, V1, P113; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56	17	20	21	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2014	20	3					436	442		10.1007/s12028-013-9907-1			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	AI7RH	WOS:000337092900012	24026522				2021-06-18	
J	Personnier, C; Crosnier, H; Meyer, P; Chevignard, M; Flechtner, I; Boddaert, N; Breton, S; Mignot, C; Dassa, Y; Souberbielle, JC; Piketty, M; Laborde, K; Jais, JP; Viaud, M; Puget, S; Sainte-Rose, C; Polak, M				Personnier, Claire; Crosnier, Helene; Meyer, Philippe; Chevignard, Mathilde; Flechtner, Isabelle; Boddaert, Nathalie; Breton, Sylvain; Mignot, Caroline; Dassa, Yamina; Souberbielle, Jean-Claude; Piketty, Marie; Laborde, Kathleen; Jais, Jean-Philipe; Viaud, Magali; Puget, Stephanie; Sainte-Rose, Christian; Polak, Michel			Prevalence of Pituitary Dysfunction After Severe Traumatic Brain Injury in Children and Adolescents: A Large Prospective Study	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							GROWTH-HORMONE DEFICIENCY; QUALITY-OF-LIFE; GH REPLACEMENT; HYPOPITUITARISM; EPIDEMIOLOGY; PREDICTORS; BIRTH	Context: Traumatic brain injury (TBI) in childhood is a major public health issue. Objective: We sought to determine the prevalence of pituitary dysfunction in children and adolescents after severe TBI and to identify any potential predictive factors. Design: This was a prospective longitudinal study. Setting: The study was conducted at a university hospital. Patients: Patients, hospitalized for severe accidental or inflicted TBI, were included. The endocrine assessment was performed between 6 and 18 months after the injury. Main Outcome Measures: Basal and dynamic tests of pituitary function were performed in all patients and GH dynamic testing was repeated in patients with low stimulated GH peak (<7 ng/mL). The diagnosis of proven severe GH deficiency (GHD) was based on the association of two GH peaks less than 5 ng/mL on both occasions of testing and IGF-I levels below -2 SD score. Initial cranial tomography or magnetic resonance imaging was analyzed retrospectively. Results: We studied 87 children and adolescents [60 males, median age 6.7 y (range 0.8-15.2)] 9.5 +/- 3.4 months after the TBI (73 accidental, 14 inflicted). The second GH peak, assessed 4.9 +/- 0.1 months after the first evaluation, remained low in 27 children and adolescents. Fifteen patients had a GH peak less than 5 ng/mL (mean IGF-ISD score -1.3 +/- 1.5) and five (5.7%) strict criteria for severe GHD. Two children had mild central hypothyroidism and one had ACTH deficiency. We did not find any predictive factors associated with existence of GHD (demographic characteristics, growth velocity, trauma severity, and radiological parameters). Conclusion: At 1 year after the severe TBI, pituitary dysfunction was found in 8% of our study sample. We recommend systematic hormonal assessment in children and adolescents 12 months after a severe TBI and prolonged clinical endocrine follow-up.	[Personnier, Claire; Crosnier, Helene; Dassa, Yamina; Viaud, Magali; Polak, Michel] Hop Univ Necker Enfants Malades, AP HP, Pediat Endocrinol Gynecol & Diabetol Unit, F-75015 Paris, France; [Meyer, Philippe] Hop Univ Necker Enfants Malades, AP HP, Pediat Anesthesiol Unit, F-75015 Paris, France; [Boddaert, Nathalie; Breton, Sylvain] Hop Univ Necker Enfants Malades, AP HP, Radiol Unit, F-75015 Paris, France; [Mignot, Caroline; Puget, Stephanie; Sainte-Rose, Christian] Hop Univ Necker Enfants Malades, AP HP, Pediat Neurosurg Unit, F-75015 Paris, France; [Souberbielle, Jean-Claude; Piketty, Marie; Laborde, Kathleen] Hop Univ Necker Enfants Malades, AP HP, Funct Explorat Unit, F-75015 Paris, France; [Jais, Jean-Philipe] Hop Univ Necker Enfants Malades, AP HP, Dept Biostat, F-75015 Paris, France; [Chevignard, Mathilde] Hop St Maurice, Rehabil Dept Children Acquired Neurol Injury, F-94410 St Maurice, France; [Boddaert, Nathalie; Breton, Sylvain; Puget, Stephanie; Sainte-Rose, Christian; Polak, Michel] Univ Paris 05, F-75014 Paris, France; [Chevignard, Mathilde] Univ Paris 06, ER6, F-75252 Paris, France; [Boddaert, Nathalie; Polak, Michel] IMAGINE Affiliate, F-75015 Paris, France	Crosnier, H (corresponding author), Hop Univ Necker Enfants Malades, Serv Endocrinol Gynecol & Diabetol Pediatr, 149 Rue Sevres, F-75015 Paris, France.	h.savajol-crosnier@orange.fr; michel.polak@nck.aphp.fr	Meyer, Philippe/ABE-4242-2020	Meyer, Philippe/0000-0002-3829-6631; boddaert, nathalie/0000-0003-0991-7774	Pfizer SAS	This work was supported by through an educational grant from Pfizer SAS. The sponsor was not involved in the data collection, manuscript preparation, or publishing decisions.	Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; ALBERTSSONWIKLAND K, 1994, J CLIN ENDOCR METAB, V78, P1195, DOI 10.1210/jc.78.5.1195; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Cansu A, 2006, EPILEPSIA, V47, P1855, DOI 10.1111/j.1528-1167.2006.00821.x; Carel JC, 1997, J CLIN ENDOCR METAB, V82, P2117, DOI 10.1210/jc.82.7.2117; Casano-Sancho P, 2013, CLIN ENDOCRINOL OXF; Czernichow P, 2011, DIAGNOSIS ENDOCRINE; Devesa J, 2011, THER CLIN RISK MANAG, V7, P199, DOI 10.2147/TCRM.S21403; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FOLEY TP, 1972, J CLIN INVEST, V51, P431, DOI 10.1172/JCI106829; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Jourdan C, 2012, DEV MED CHILD NEUROL, V54, P624, DOI 10.1111/j.1469-8749.2012.04291.x; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; LOCHE S, 1987, CLIN ENDOCRINOL, V27, P145, DOI 10.1111/j.1365-2265.1987.tb01139.x; Masson F, 1996, ARCH PEDIATRIE, V3, P651, DOI 10.1016/0929-693X(96)87085-0; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Moon RJ, 2009, ARCH DIS CHILD, V94, P699, DOI 10.1136/adc.2008.145235; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Polak M, 2013, J CLIN ENDOCR METAB, V98, P2682, DOI 10.1210/jc.2013-2236; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Ranke MB, 2011, DIAGNOSTICS OF ENDOCRINE FUNCTION IN CHILDREN AND ADOLESCENTS, 4TH EDITION, P102; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Sempe M, 1979, AUXOLOGIE METHODES S; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; TEASDALE G, 1974, LANCET, V2, P81; Wamstad JB, 2013, BRAIN INJURY, V27, P200, DOI 10.3109/02699052.2012.672786; World Health Organization, 2006, NEUR DIS PUBL HLTH C	45	20	21	0	4	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	JUN	2014	99	6					2052	2060		10.1210/jc.2013-4129			9	Endocrinology & Metabolism	Endocrinology & Metabolism	AP8PI	WOS:000342340500046	24635130	Bronze			2021-06-18	
J	Puschmann, TB; de Pablo, Y; Zanden, C; Liu, J; Pekny, M				Puschmann, Till B.; de Pablo, Yolanda; Zanden, Carl; Liu, Johan; Pekny, Milos			A Novel Method for Three-Dimensional Culture of Central Nervous System Neurons	TISSUE ENGINEERING PART C-METHODS			English	Article							IN-VITRO; REACTIVE ASTROCYTES; CNS SYNAPTOGENESIS; NEURITE OUTGROWTH; PORE-SIZE; SCAFFOLDS; CELLS; DIFFERENTIATION; CHOLESTEROL; MATRIX	Neuronal signal transduction and communication in vivo is based on highly complex and dynamic networks among neurons expanding in a three-dimensional (3D) manner. Studies of cell-cell communication, synaptogenesis, and neural network plasticity constitute major research areas for understanding the involvement of neurons in neurodegenerative diseases, such as Huntington's, Alzheimer's, and Parkinson's disease, and in regenerative neural plasticity responses in situations, such as neurotrauma or stroke. Various cell culture systems constitute important experimental platforms to study neuronal functions in health and disease. A major downside of the existing cell culture systems is that the alienating planar cell environment leads to aberrant cell-cell contacts and network formation and increased reactivity of cell culture-contaminating glial cells. To mimic a suitable 3D environment for the growth and investigation of neuronal networks in vitro has posed an insurmountable challenge. Here, we report the development of a novel electrospun, polyurethane nanofiber-based 3D cell culture system for the in vitro support of neuronal networks, in which neurons can grow freely in all directions and form network structures more complex than any culture system has so far been able to support. In this 3D system, neurons extend processes from their cell bodies as a function of the nanofiber diameter. The nanofiber scaffold also minimizes the reactive state of contaminating glial cells.	[Puschmann, Till B.; de Pablo, Yolanda; Pekny, Milos] Univ Gothenburg, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil,Sahlgrenska Acad, SE-40530 Gothenburg, Sweden; [Zanden, Carl; Liu, Johan] Chalmers, SMIT Ctr, S-41296 Gothenburg, Sweden; [Zanden, Carl; Liu, Johan] Chalmers, Bionano Syst Lab, Dept Microtechnol & Nanosci MC2, S-41296 Gothenburg, Sweden; [Pekny, Milos] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia	Puschmann, TB (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil,Sahlgrenska Acad, Box 440, SE-40530 Gothenburg, Sweden.	till.puschmann@neuro.gu.se; milos.pekny@neuro.gu.se	de Pablo, Yolanda/AAD-1642-2019; Puschmann, Till/H-2901-2013; Liu, Johan/O-3375-2019	de Pablo, Yolanda/0000-0001-5208-2114; Puschmann, Till/0000-0003-4859-2482; 	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [11548]; ALF Gothenburg [11392]; AFA Research Foundation; Soderbergs Foundations; Sten A. Olsson Foundation for Research and Culture; Hjarnfonden; Hagstromer's Foundation Millennium; Amlov's Foundation; E. Jacobson's Donation Fund; VINNOVA Health ProgramVinnova; Swedish Stroke Foundation; Swedish Society of Medicine; Free Mason Foundation; Chalmers University of Technology; NanoNet COST ActionEuropean Cooperation in Science and Technology (COST) [BM1002]; EUEuropean Commission [237956, 279017]	This work was supported by the Swedish Medical Research Council (11548), ALF Gothenburg (11392), AFA Research Foundation, Soderbergs Foundations, Sten A. Olsson Foundation for Research and Culture, Hjarnfonden, Hagstromer's Foundation Millennium, Amlov's Foundation, E. Jacobson's Donation Fund, VINNOVA Health Program, the Swedish Stroke Foundation, the Swedish Society of Medicine, the Free Mason Foundation, Chalmers University of Technology, NanoNet COST Action (BM1002), EU FP 7 Program Edu-Glia (237956), EU FP 7 Program TargetBraIn (279017).	Asefnejad A, 2011, INT J NANOMED, V6, P2375, DOI 10.2147/IJN.S15586; Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Currais A, 2009, AGING-US, V1, P363, DOI 10.18632/aging.100045; East E, 2009, J TISSUE ENG REGEN M, V3, P634, DOI 10.1002/term.209; Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Hu R, 2007, NEUROSCIENCE, V144, P1229, DOI 10.1016/j.neuroscience.2006.09.056; Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Jones EV, 2012, METHODS MOL BIOL, V814, P341, DOI 10.1007/978-1-61779-452-0_22; Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048824; Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X; O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052; O'Callaghan James P, 2005, Expert Opin Drug Saf, V4, P433, DOI 10.1517/14740338.4.3.433; Pekna M, 2012, STROKE, V43, P2819, DOI 10.1161/STROKEAHA.112.654228; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pfrieger FW, 2010, BRAIN RES REV, V63, P39, DOI 10.1016/j.brainresrev.2009.11.002; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Puschmann TB, 2014, J NEUROCHEM, V128, P878, DOI 10.1111/jnc.12519; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Qu J, 2013, J BIOMED MATER RES A, V101, P2667, DOI 10.1002/jbm.a.34551; Smeal RM, 2008, EXP NEUROL, V213, P281, DOI 10.1016/j.expneurol.2008.05.026; Steinmetz CC, 2006, J PHYSIOL-LONDON, V577, P249, DOI 10.1113/jphysiol.2006.117358; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Yu PP, 2012, METHODS MOL BIOL, V814, P327, DOI 10.1007/978-1-61779-452-0_21	32	20	20	0	38	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	JUN 1	2014	20	6					485	492		10.1089/ten.tec.2013.0445			8	Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical; Materials Science, Biomaterials	Cell Biology; Engineering; Materials Science	AH2YE	WOS:000335987200004	24102451				2021-06-18	
J	Skoglund, K; Hillered, L; Purins, K; Tsitsopoulos, PP; Flygt, J; Engquist, H; Lewen, A; Enblad, P; Marklund, N				Skoglund, Karin; Hillered, Lars; Purins, Karlis; Tsitsopoulos, Parmenion P.; Flygt, Johanna; Engquist, Henrik; Lewen, Anders; Enblad, Per; Marklund, Niklas			The Neurological Wake-up Test Does not Alter Cerebral Energy Metabolism and Oxygenation in Patients with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Cerebral microdialysis; Brain tissue oxygenation; Jugular venous oxygenation; Neurological wake-up test; Brain energy metabolism; Interruption of sedation	RANDOMIZED CONTROLLED-TRIAL; INTENSIVE-CARE-UNIT; SEVERE HEAD-INJURY; MECHANICALLY VENTILATED PATIENTS; POSITRON-EMISSION-TOMOGRAPHY; DAILY SEDATION INTERRUPTION; CRITICALLY-ILL PATIENTS; INTRACEREBRAL MICRODIALYSIS; NEUROCRITICAL CARE; PERFUSION-PRESSURE	The neurological wake-up test (NWT) is used to monitor the level of consciousness in patients with traumatic brain injury (TBI). However, it requires interruption of sedation and may elicit a stress response. We evaluated the effects of the NWT using cerebral microdialysis (MD), brain tissue oxygenation (PbtiO2), jugular venous oxygen saturation (SjvO(2)), and/or arterial-venous difference (AVD) for glucose, lactate, and oxygen in patients with severe TBI. Seventeen intubated TBI patients (age 16-74 years) were sedated using continuous propofol infusion. All patients received intracranial pressure (ICP) and cerebral perfusion pressure (CPP) monitoring in addition to MD, PbtiO2 and/or SjvO(2). Up to 10 days post-injury, ICP, CPP, PbtiO2 (51 NWTs), MD (49 NWTs), and/or SjvO(2) (18 NWTs) levels during propofol sedation (baseline) and NWT were compared. MD was evaluated at a flow rate of 1.0 mu L/min (28 NWTs) or the routine 0.3 mu L/min rate (21 NWTs). The NWT increased ICP and CPP levels (p < 0.05). Compared to baseline, interstitial levels of glucose, lactate, pyruvate, glutamate, glycerol, and the lactate/pyruvate ratio were unaltered by the NWT. Pathological SjvO(2) (< 50 % or > 71 %; n = 2 NWTs) and PbtiO2 (< 10 mmHg; n = 3 NWTs) values were rare at baseline and did not change following NWT. Finally, the NWT did not alter the AVD of glucose, lactate, or oxygen. The NWT-induced stress response resulted in increased ICP and CPP levels although it did not negatively alter focal neurochemistry or cerebral oxygenation in TBI patients.	[Skoglund, Karin; Hillered, Lars; Purins, Karlis; Tsitsopoulos, Parmenion P.; Flygt, Johanna; Engquist, Henrik; Lewen, Anders; Enblad, Per; Marklund, Niklas] Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, S-75185 Uppsala, Sweden	Marklund, N (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, S-75185 Uppsala, Sweden.	niklas.marklund@neuro.uu.se	Lewen, Anders/A-5156-2013; Engquist, Henrik/S-1890-2016	Lewen, Anders/0000-0003-4925-1348; Engquist, Henrik/0000-0002-9826-1422; Hillered, Lars/0000-0002-2808-9292; Marklund, Niklas/0000-0002-9797-5626	Medical Faculty, Uppsala University, Uppsala, Sweden; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; Ahlen Foundation; Selander Foundation; Uppsala University Hospital (ALF Funds)	We are grateful for the support of the neurocritical care unit staff at Uppsala University Hospital and Inger Stahl-Myllyaho and Dr. Tim Howells for their technical support. This study was supported by Grants from the Medical Faculty, Uppsala University, Uppsala, Sweden and the Swedish Research Council, The Swedish Brain Foundation, The Ahlen Foundation, The Selander Foundation, and the Uppsala University Hospital (ALF Funds).	Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Anifantaki S, 2009, J ADV NURS, V65, P1054, DOI 10.1111/j.1365-2648.2009.04967.x; Augustes R, 2011, ANAESTH INTENS CARE, V39, P401, DOI 10.1177/0310057X1103900310; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Bucknall TK, 2008, CRIT CARE MED, V36, P1444, DOI 10.1097/CCM.0b013e318168f82d; Chesnut R M, 1995, New Horiz, V3, P366; Chieregato A, 2003, J NEUROL NEUROSUR PS, V74, P784, DOI 10.1136/jnnp.74.6.784; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Grande PO, 2007, ACTA ANAESTH SCAND, V51, P1294, DOI 10.1111/j.1399-6576.2007.01475.x; Haitsma IK, 2007, PROG BRAIN RES, V161, P207, DOI 10.1016/S0079-6123(06)61014-5; Helbok R, 2012, CRIT CARE, V16, DOI 10.1186/cc11880; Helbok R, 2009, NEUROCRIT CARE, V11, P133, DOI 10.1007/s12028-009-9262-4; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hutchinson PJ, 2005, ACTA NEUROCHIR SUPPL, V95, P441; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Kett-White R, 2002, ACT NEUR S, V81, P363; Koizumi H, 2008, ACT NEUR S, V102, P193, DOI 10.1007/978-3-211-85578-2_38; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Mehta S, 2012, JAMA-J AM MED ASSOC, V308, P1985, DOI 10.1001/jama.2012.13872; Meierhans R, 2012, MINERVA ANESTESIOL, V78, P185; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Perez Augusto, 2003, Pediatr Crit Care Med, V4, P33; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Poca MA, 2007, J NEUROSURG, V106, P530, DOI 10.3171/jns.2007.106.4.530; Prisco L, 2012, CRIT CARE, V16, DOI 10.1186/cc11891; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Purins K, 2011, CRIT CARE MED, V39, P512, DOI 10.1097/CCM.0b013e318206b824; Purins K, 2010, ACTA NEUROCHIR, V152, P681, DOI 10.1007/s00701-009-0532-x; Rao GSU, 2011, CURR OPIN ANESTHESIO, V24, P487, DOI 10.1097/ACO.0b013e32834a8965; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Schweickert WD, 2004, CRIT CARE MED, V32, P1272, DOI 10.1097/01.CCM.0000127263.54807.79; Skoglund K, 2009, NEUROCRIT CARE; Skoglund K, 2012, CRIT CARE MED, V40, P216, DOI 10.1097/CCM.0b013e31822d7dbd; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stover JF, 2012, CRIT CARE MED, V40, P338, DOI 10.1097/CCM.0b013e31823291bf; Stover JF, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13245; Stuart RM, 2010, NEUROCRIT CARE, V12, P188, DOI 10.1007/s12028-010-9330-9; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wittbrodt ET, 2005, PHARMACOTHERAPY, V25, p3S, DOI 10.1592/phco.2005.25.5_Part_2.3S	70	20	22	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2014	20	3					413	426		10.1007/s12028-013-9876-4			14	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	AI7RH	WOS:000337092900010	23934408				2021-06-18	
J	Gregorio, GW; Gould, KR; Spitz, G; van Heugten, CM; Ponsford, JL				Gregorio, Gisela Wolters; Gould, Kate R.; Spitz, Gershon; van Heugten, Caroline M.; Ponsford, Jennie L.			Changes in Self-Reported Pre- to Postinjury Coping Styles in the First 3 Years After Traumatic Brain Injury and the Effects on Psychosocial and Emotional Functioning and Quality of Life	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						TBI; quality of life; depression; psychological; anxiety; adaptation	PSYCHIATRIC-DISORDERS; DEPRESSION SCALE; HOSPITAL ANXIETY; HEAD-INJURY; RECOVERY; REHABILITATION; ADJUSTMENT; HEALTH; STRATEGIES; PROGRAM	Objective: To examine the influence of self-reported preinjury coping on postinjury coping, psychosocial functioning, emotional functioning, and quality of life at 1 year following traumatic brain injury (TBI). Setting: Inpatient hospital and community. Participants: One hundred seventy-four participants with TBI. Design: Prospective, longitudinal design. Participants were assessed at 5 time points: after emerging from posttraumatic amnesia, and at 6, 12, 24, and 36 months postinjury. Main Measures: Coping Scale for Adults-Short Version; Quality of Life Inventory; Sydney Psychosocial Reintegration Scale; Hospital Anxiety and Depression Scale. Results: High preinjury use of nonproductive coping style predicted high use of nonproductive coping, more anxiety, and lower psychosocial functioning at 1 year postinjury. Increased use of nonproductive coping and decreased use of productive coping predicted poorer psychosocial outcome at 1 year post-TBI. Use of both productive and nonproductive coping decreased in the first 6 to 12 months post-TBI relative to preinjury. Unlike productive coping, nonproductive coping reached preinjury levels within 3 years postinjury. Conclusion: The findings support identification of individuals at risk of relying on nonproductive coping and poorer psychosocial outcome following TBI. In addition, the results emphasize the need to implement timely interventions to facilitate productive coping and reduce the use of nonproductive coping in order to maximize favorable long-term psychosocial outcome.	[Gregorio, Gisela Wolters; van Heugten, Caroline M.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Gould, Kate R.; Spitz, Gershon; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Gould, Kate R.; Spitz, Gershon; Ponsford, Jennie L.] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Gould, Kate R.; Ponsford, Jennie L.] Alfred Hosp, Ctr Excellence Traumat Brain Injury Res, Natl Trauma Res Inst, Melbourne, Vic, Australia	Ponsford, JL (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton Campus, Clayton, Vic 3800, Australia.	Jennie.Ponsford@monash.edu	Spitz, Gershon/H-7755-2014; Gould, Kate/AAA-5511-2020	Spitz, Gershon/0000-0002-7810-1480; Gould, Kate/0000-0002-3564-7408			Access Economics Pty Ltd, 2009, EC COST SPIN CORD IN; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571; Frisch M. B, 1994, QUALITY LIFE INVENTO; Frisch M.B., 1992, PSYCHOL ASSESSMENT, V4, P92, DOI [DOI 10.1037/1040-3590.4.1.92, 10.1037/1040-3590.4.1.92]; Frydenberg E., 1997, COPING SCALE ADULTS; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Helps Y., 2008, INJURY RES STAT SERI, V45; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Martz E., 2007, COPING CHRONIC ILLNE; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P899, DOI 10.1080/09602011.2010.517688; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Riley GA, 2010, NEUROPSYCHOL REHABIL, V20, P869, DOI 10.1080/09602011.2010.503041; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Singer J.D., 2003, APPL LONGITUDINAL DA; Snaith R.P., 1994, HADS HOSP ANXIETY DE; Tan FES, 2008, BEST PRACTICES QUANT, P451, DOI DOI 10.4135/9781412995627.D36; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	20	20	0	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2014	29	3					E43	E53		10.1097/HTR.0b013e318292fb00			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AG9SE	WOS:000335759100005	23835873				2021-06-18	
J	Itzekson, Z; Maggio, N; Milman, A; Shavit, E; Pick, CG; Chapman, J				Itzekson, Zeev; Maggio, Nicola; Milman, Anat; Shavit, Efrat; Pick, Chaim G.; Chapman, Joab			Reversal of Trauma-Induced Amnesia in Mice by a Thrombin Receptor Antagonist	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						mTBI; Amnesia; Thrombin; PAR1; Hippocampus; Long term potentiation	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LONG-TERM POTENTIATION; BRAIN-INJURY; COGNITIVE DEFICITS; SEIZURES; MODEL; NEUROPROTECTION; CONSEQUENCES; EXCITABILITY; HIPPOCAMPUS	Minimal traumatic brain injury (mTBI) is associated with the existence of retrograde amnesia and microscopic bleeds containing activated coagulation factors. In an mTBI model, we report that thrombin induces amnesia through its receptor protease-activated receptor 1 (PAR-1). Thrombin activity was significantly elevated (32 %, p < 0.05) 5 min following mTBI compared to controls. Amnesia was assessed by the novel object recognition test in mTBI animals and in animals injected intracerebroventricularly (ICV) with either thrombin or a PAR-1 agonist 1 h after the acquisition phase. Saline-injected controls had a preference index of over 0.3 while mTBI animals and those injected with thrombin or the PAR-1 agonist spent equal time with both objects indicating no recall of the object presented to them 24 h previously (p < 0.05). Co-injecting a PAR-1 antagonist (SCH79797) completely blocked the amnestic effects of mTBI, thrombin, and the PAR-1 agonist. Long-term potentiation, measured in hippocampal slices 24 h after mTBI, ICV thrombin or the PAR-1 agonist, was significantly impaired and this effect was completely reversed by the PAR-1 antagonist. The results support a crucial role for PAR-1 in the generation of amnesia following mTBI, revealing a novel therapeutic target for the cognitive effects of brain trauma.	[Itzekson, Zeev; Shavit, Efrat; Chapman, Joab] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Itzekson, Zeev; Maggio, Nicola; Shavit, Efrat; Chapman, Joab] Chaim Sheba Med Ctr, Dept Neurol, IL-52621 Tel Hashomer, Israel; [Maggio, Nicola] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel; [Milman, Anat; Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-6997801 Tel Aviv, Israel; [Milman, Anat] Tel Aviv Sourasky Med Ctr, Internal Med Dept B, IL-64239 Tel Aviv, Israel	Chapman, J (corresponding author), Chaim Sheba Med Ctr, Dept Neurol, IL-52621 Tel Hashomer, Israel.	jchapman@post.tau.ac.il	Chapman, Joab/E-4598-2010	Milman, Anat/0000-0002-8551-4101; Maggio, Nicola/0000-0001-5041-2108			Aronovich R, 2005, IMMUNOBIOLOGY, V210, P781, DOI 10.1016/j.imbio.2005.10.010; Beilin O, 2005, J NEUROSCI RES, V79, P351, DOI 10.1002/jnr.20270; Beilin O, 2001, NEUROREPORT, V12, P2347, DOI 10.1097/00001756-200108080-00013; Beilin O, 2007, NEUROREPORT, V18, P581, DOI 10.1097/WNR.0b013e328091c1e6; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Chapman J, 2006, AUTOIMMUN REV, V5, P528, DOI 10.1016/j.autrev.2006.02.011; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; Feinsod M, 2012, WORLD NEUROSURG, V78, P371, DOI 10.1016/j.wneu.2011.12.007; Friedmann I, 2001, J NEUROIMMUNOL, V121, P12, DOI 10.1016/S0165-5728(01)00397-6; Friedmann I, 2001, J NEUROCHEM, V76, P641, DOI 10.1046/j.1471-4159.2001.00001.x; Friedmann I, 1999, FASEB J, V13, P533; Han KS, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-32; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee KR, 1997, J NEUROSURG, V87, P73, DOI 10.3171/jns.1997.87.1.0073; Luo W, 2007, BRAIN RES REV, V56, P331, DOI 10.1016/j.brainresrev.2007.08.002; Maggio N, 2008, J NEUROSCI, V28, P732, DOI 10.1523/JNEUROSCI.3665-07.2008; Maggio N, 2013, EXP NEUROL, V247, P595, DOI 10.1016/j.expneurol.2013.02.011; Maggio N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00019; Maggio N, 2013, NEUROBIOL DIS, V50, P171, DOI 10.1016/j.nbd.2012.10.017; Maggio N, 2012, HIPPOCAMPUS, V22, P267, DOI 10.1002/hipo.20893; Mhatre M, 2004, NEUROBIOL AGING, V25, P783, DOI 10.1016/j.neurobiolaging.2003.07.007; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Movsesyan VA, 2001, EXP NEUROL, V167, P366, DOI 10.1006/exnr.2000.7567; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Shavit E, 2008, BRAIN, V131, P1113, DOI 10.1093/brain/awn005; Shavit E, 2011, J NEUROCHEM, V119, P460, DOI 10.1111/j.1471-4159.2011.07436.x; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	43	20	20	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAY	2014	53	1					87	95		10.1007/s12031-013-0200-8			9	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AG2JN	WOS:000335242500010	24352712				2021-06-18	
J	Selassie, AW; Cao, Y; Church, EC; Saunders, LL; Krause, J				Selassie, Anbesaw W.; Cao, Yue; Church, Elizabeth C.; Saunders, Lee L.; Krause, James			Accelerated Death Rate in Population-Based Cohort of Persons With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						preexisting diseases; traumatic brain injury; postdischarge mortality; cumulative probability of death; low socioeconomic status	SPINAL-CORD-INJURY; LONG-TERM SURVIVAL; RISK-FACTORS; ALLOSTATIC LOAD; LATE MORTALITY; UNITED-STATES; HEAD-INJURY; OUTCOMES; TRENDS; CARE	Objectives: To determine the influence of preexisting heart, liver, kidney, cancer, stroke, and mental health problems and examine the influence of low socioeconomic status on mortality after discharge from acute care facilities for individuals with traumatic brain injury. Participants: Population-based retrospective cohort study of 33695 persons discharged from acute care hospital with traumatic brain injury in South Carolina, 1999-2010. Main Measures: Days elapsing from the dates of injury to death established the survival time (T). Data were censored at the 145th month. Multivariable Cox regression was used to examine the independent effect of the variables on death. Age-adjusted cumulative probability of death for each chronic disease of interest was plotted. Results: By the 70th month of follow-up, rate of death was accelerated from 10-fold for heart diseases to 2.5-fold for mental health problems. Adjusted hazard ratios for diseases of the heart (2.13), liver-renal (3.25), cancer (2.64), neurological diseases and stroke (2.07), diabetes (1.89), hypertension (1.43), and mental health problems (1.59) were highly significant (each with P < .001). Compared with persons with private insurance, the hazard ratio was significantly elevated with Medicaid (1.67), Medicare (1.54), and uninsured (1.27) (each with P < .001). Conclusion: Specific chronic diseases strongly influenced postdischarge mortality after traumatic brain injury. Low socioeconomic status as measured by the type of insurance elevated the risk of death.	[Selassie, Anbesaw W.] Med Univ S Carolina, Div Epidemiol & Biostat, Dept Publ Hlth Sci, Charleston, SC 29466 USA; [Cao, Yue; Saunders, Lee L.; Krause, James] Med Univ S Carolina, Coll Hlth Profess, Dept Hlth Sci & Res, Charleston, SC 29466 USA; [Church, Elizabeth C.] Med Univ S Carolina, Coll Med, Charleston, SC 29466 USA	Selassie, AW (corresponding author), Med Univ S Carolina, Div Epidemiol & Biostat, Dept Publ Hlth Sci, 135 Cannon St,Ste 303,MSC 835, Charleston, SC 29466 USA.	selassie@musc.edu		Church, Chandler/0000-0002-3614-5311	Department of Education, NIDRR grant [H133B090005]	This study is supported by a grant from the Department of Education, NIDRR grant number H133B090005 (PI: James Krause, PhD). The contents do not necessarily represent the policy of the Department of Education and should not be assumed as endorsement by the federal government. The authors recognize Mss Georgette Demian and Nicole Spivey from the South Carolina Department of Health and Environmental Control for their coordination of the abstraction process and for validating the accuracy of the medical record review report. Dr Linda Veldheer, Director of the Head and Spinal Cord Injury, Division of the South Carolina Department of Disabilities and Special Needs, assisted with data oversight for the project.	Allgulander C, 2000, AM J PSYCHIAT, V157, P244, DOI 10.1176/appi.ajp.157.2.244; Allison PD, 1995, SURVIVAL ANAL USING, V1, P29; American Medical Association, 2009, INT CLASS DIS; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Bajaj JS, 2008, AM J GASTROENTEROL, V103, P1674, DOI 10.1111/j.1572-0241.2008.01814.x; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brown AW, 2004, NEUROREHABILITATION, V19, P37; BURSTIN HR, 1992, JAMA-J AM MED ASSOC, V268, P2383, DOI 10.1001/jama.268.17.2383; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; [Centers for Disease Control and Prevention National Center for Health Statistics], 2012, COMPR MORT FIL 1999; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2; Darlington GA, 1998, COLLINEARITY ENCY BI, P788; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Ferraris VA, 2010, J TRAUMA, V69, P645, DOI 10.1097/TA.0b013e3181d8941d; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Gebhard F, 1998, SHOCK, V10, P237, DOI 10.1097/00024382-199810000-00002; Georgiou C, 2009, WORLD J SURG, V33, P1087, DOI 10.1007/s00268-009-9923-7; Grunau GL, 2006, J CLIN EPIDEMIOL, V59, P274, DOI 10.1016/j.jclinepi.2005.08.007; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Kleinbaum DG, 1996, EVALUATING PROPORTIO, P130; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Krause JS, 2012, SPINAL CORD, V50, P784, DOI 10.1038/sc.2012.49; Krause JS, 2011, ARCH PHYS MED REHAB, V92, P339, DOI 10.1016/j.apmr.2010.09.032; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Leahy R, 2012, COLLEGIUM ANTROPOL, V36, P11; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lorelli DR, 2001, AM SURGEON, V67, P693; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Mullins RJ, 1999, J TRAUMA, V47, pS59, DOI 10.1097/00005373-199909001-00013; Murphy SL, 2012, DEATHS PRELIMINARY D; Penman AD, 2008, COMPUT METH PROG BIO, V89, P50, DOI 10.1016/j.cmpb.2007.10.004; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Phillips LH, 2009, MUSCLE NERVE, V39, P1, DOI 10.1002/mus.21243; Prada SI, 2012, EVALUATION REV, V36, P133, DOI 10.1177/0193841X12442674; Qi L, 2012, MOL MED, V18, P186, DOI 10.2119/molmed.2011.00390; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; SAS, 2009, STAT AN SOFTW VERS 9; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Seamon MJ, 2010, J TRAUMA, V69, P568, DOI 10.1097/TA.0b013e3181ec0867; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Selassie A, 2003, S CAROLINA TRAUMATIC; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selassie AW, 2011, ARCH PHYS MED REHAB, V92, P1534, DOI 10.1016/j.apmr.2011.04.018; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Shoko T, 2010, J AM COLL SURGEONS, V211, P338, DOI 10.1016/j.jamcollsurg.2010.04.010; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Smedley BD, 2010, UNEQUAL TREATMENT, P125; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; The Economist Intelligence Unit, 2009, BREAK GLOB BURD CANC; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ., 1995, GUIDELINES SURVEILLA; Varma A, 2010, SPINE, V35, P778, DOI 10.1097/BRS.0b013e3181ba1359; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107	73	20	20	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2014	29	3					E8	E19		10.1097/HTR.0b013e3182976ad3			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AG9SE	WOS:000335759100002	23835874				2021-06-18	
J	Crenn, P; Hamchaoui, S; Bourget-Massari, A; Hanachi, M; Melchior, JC; Azouvi, P				Crenn, Pascal; Hamchaoui, Sabrina; Bourget-Massari, Aliette; Hanachi, Mouna; Melchior, Jean-Claude; Azouvi, Philippe			Changes in weight after traumatic brain injury in adult patients: A longitudinal study	CLINICAL NUTRITION			English	Article						Traumatic brain injury; Weight change; Behavioral dysexecutive syndrome; Eating disorders	HEAD-INJURY; FOOD-INTAKE; HYPOPITUITARISM; OBESITY; GAIN	Background & aims: Although changes in weight have been reported after traumatic brain injury (TBI), their frequency and underlying factors are little known. Our aim was to determine the prevalence of weight changes and the associated factors during the recovery phase after TBI. Methods: Longitudinal follow-up of adults with TBI. Multivariate analysis was carried out on weight change, demographic data, dysexecutive syndrome, eating behavior, physical activity, therapeutic classes and metabolic complications. Results: 107 patients (81 males/26 females), age 36 +/- 13 yrs, baseline BMI 23.3 +/- 3.9, followed for 38 (8-66) months, were included. In intensive care, patients lost a mean 11 +/- 6 kg. End of follow-up, mean BMI was not different to pre-TBI BMI, but patients could be categorized in 3 groups: stable (30%), loss (28%, -8 +/- 7 kg) and gain (42%, +9 +/- 6 kg). Sex, age, severity of TBI, intensive care weight loss, physical activity, therapeutic classes and the occurrence of metabolic syndrome did not differ between the groups. Factors related to weight gain were hyperphagia, OR 4.5 (IC95%, 1.6-12.1) and presence of a dysexecutive syndrome, OR 2.5 (IC95%, 1.03-6.3). Factors related to weight loss were hypophagia, OR 4.1 (IC95%, 1.5-10.9) and higher pre-TBI BMI, OR 4.9 (IC95%, 1.7-14.0). Conclusions: Over a median period of 38 months, 42% of TBI patients gained and 28% lost weight. Factors associated with these changes were the presence of a behavioral dysexecutive syndrome for weight gain, oral food intake and initial BMI, which were inversely associated with weight at end of follow-up. These findings highlight the importance of evaluating the time course of weight changes and providing specific nutritional care. (C) 2013 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.	[Crenn, Pascal; Hanachi, Mouna; Melchior, Jean-Claude; Azouvi, Philippe] Univ Versailles St Quentin En Yvelines, EA 4497, Versailles, France; [Crenn, Pascal; Hamchaoui, Sabrina; Bourget-Massari, Aliette; Hanachi, Mouna; Melchior, Jean-Claude; Azouvi, Philippe] Hop Raymond Poincare, AP HP, F-92380 Garches, France	Crenn, P (corresponding author), Hop Raymond Poincare, Dept Med Aigue Specialisee, 104 Blvd Raymond Poincare, F-92380 Garches, France.	pascal.crenn@rpc.aphp.fr		CRENN, Pascal/0000-0002-8213-2319			Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Brooke M, 1989, NEUROREHAB NEURAL RE, V3, P27; Castano B, 2010, NEUROREHABILITATION, V27, P113, DOI 10.3233/NRE-2010-0586; Denes Z, 2004, DISABIL REHABIL, V26, P1163, DOI 10.1080/09638280412331270380; Dolberg OT, 2005, PSYCHOPHARMACOLOGY, V179, P838, DOI 10.1007/s00213-004-2117-y; Fujii M, 1998, BRAIN INJURY, V12, P709, DOI 10.1080/026990598122278; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Henson Martha B., 1993, Brain Injury, V7, P169, DOI 10.3109/02699059309008170; Jourdan C, 2012, DEV MED CHILD NEUROL, V54, P624, DOI 10.1111/j.1469-8749.2012.04291.x; Klose M, 2007, CLIN ENDOCRINOL OXF, V67; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; LEWIN J, 1992, Brain Injury, V6, P199, DOI 10.3109/02699059209029660; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MIYASAKI K, 1972, ACTA PATHOL JAPON, V22, P779; Ogura K, 2008, BRAIN DEV-JPN, V30, P469, DOI 10.1016/j.braindev.2007.12.011; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; Schwartz MW, 2000, NATURE, V404, P661; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; *WHO, 2002, MOV HLTH; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	26	20	20	0	12	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	APR	2014	33	2					348	353		10.1016/j.clnu.2013.06.003			6	Nutrition & Dietetics	Nutrition & Dietetics	AF8SI	WOS:000334985500026	23810396				2021-06-18	
J	Harris, DA; Lam, S				Harris, Dominic A.; Lam, Sandi			Venous thromboembolism in the setting of pediatric traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; deep vein thrombosis; trauma; venous thromboembolism; pediatric; children	DEEP-VEIN THROMBOSIS; RISK-FACTORS; HOSPITALIZED CHILDREN; COAGULATION SYSTEM; POPULATION; COAGULOPATHY; MORTALITY; PATTERNS; OUTCOMES	Object. The risk of venous thromboembolism (VTE) in children with traumatic brain injury (TBI) has not been well characterized given its rarity in the pediatric population. Investigation of risk factors for VTE in this group requires the use of a large sample size. Using nationally representative hospital discharge data for 2009, the authors of this study characterize the incidence and risk factors for VTE in children hospitalized for TBI. Methods. The authors conducted a cross-sectional study using data from the Healthcare Cost and Utilization Project Kids' Inpatient Database to examine VTE in TBI-associated hospitalizations for patients 20 years of age or younger during the year 2009. Results. There were 58,529 children with TBI-related admissions, including 267 with VTE diagnoses. Venous thromboembolisms occurred in 4.6 per 1000 TBI-associated hospitalizations compared with 1.2 per 1000 pediatric hospitalizations overall. By adjusted logistic regression, patients significantly more likely to be diagnosed with VTE had the following: older age of 15-20 years (adjusted odds ratio [aOR] 3.7, 95% CI 1.8-8.0), venous catheterization (aOR 3.0, 95% CI 2.0-4.6), mechanical ventilation (aOR 1.9, 95% CI 1.2-2.9), tracheostomy (aOR 2,3, 95% CI 1.3-4.0), nonaccidental trauma (aOR 2.8,95% CI 1.1-6.9), increased length of stay (aOR 1.02, 95% CI 1.01-1.03), orthopedic surgery (aOR 2.4,95% CI 1.8-3.4), and cranial surgery (aOR 1.8, 95% CI 1.1-2.8). Conclusions. Using the Kids' Inpatient Database, the authors found that risk factors for VTE in the setting of TBI in the pediatric population include older age, venous catheterization, nonaccidental trauma, increased length of hospital stay, orthopedic surgery, and cranial surgery.	[Harris, Dominic A.; Lam, Sandi] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	Lam, S (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Neurosurg, 6701 Fannin St,Ste 1230-01, Houston, TX 77030 USA.	sandilam@gmail.com		Lam, Sandi/0000-0003-3294-6637			ANDREW M, 1994, BLOOD, V83, P1251, DOI 10.1182/blood.V83.5.1251.1251; [Anonymous], 2013, INTR HCUP KIDS INP D; Barnato AE, 2009, MED CARE, V47, P1098, DOI 10.1097/MLR.0b013e3181993191; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Grandas OH, 2000, AM SURGEON, V66, P273; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Hanson SJ, 2010, J TRAUMA, V68, P52, DOI 10.1097/TA.0b013e3181a74652; Higgerson RA, 2011, PEDIATR CRIT CARE ME, V12, P628, DOI 10.1097/PCC.0b013e318207124a; Ignjatovic V, 2011, SEMIN THROMB HEMOST, V37, P723, DOI 10.1055/s-0031-1297162; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Lapidus LJ, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-177; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Miller BE, 1997, ANESTH ANALG, V84, P745, DOI 10.1097/00000539-199704000-00008; Patel AP, 2013, J NEUROSURG, V118, P505, DOI 10.3171/2012.11.JNS121243; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Roaten JB, 2006, J PEDIATR SURG, V41, P2013, DOI 10.1016/j.jpedsurg.2006.08.028; Sandoval JA, 2008, J VASC SURG, V47, P837, DOI 10.1016/j.jvs.2007.11.054; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Vavilala MS, 2002, J TRAUMA, V52, P922, DOI 10.1097/00005373-200205000-00017; Vu LT, 2008, J PEDIATR SURG, V43, P1095, DOI 10.1016/j.jpedsurg.2008.02.036; Walkey AJ, 2013, CRIT CARE MED, V41, P1450, DOI 10.1097/CCM.0b013e31827caa89	28	20	20	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2014	13	4					448	455		10.3171/2014.1.PEDS13479			8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AD7IY	WOS:000333438700015	24559280				2021-06-18	
J	Krellman, JW; Kolakowsky-Hayner, SA; Spielman, L; Dijkers, M; Hammond, FM; Bogner, J; Hart, T; Cantor, JB; Tsaousides, T				Krellman, Jason W.; Kolakowsky-Hayner, Stephanie A.; Spielman, Lisa; Dijkers, Marcel; Hammond, Flora M.; Bogner, Jennifer; Hart, Tessa; Cantor, Joshua B.; Tsaousides, Theodore			Predictors of Follow-Up Completeness in Longitudinal Research on Traumatic Brain Injury: Findings From the National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model Systems Program	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Bias (epidemiology); Follow-up studies; Lost to follow-up; Outcome assessment (health care); Rehabilitation	ATTRITION; BIAS; OUTCOMES; COHORT; IMPACT; RATES	Objective: To identify baseline participant variables in the domains of demographics, medical/psychosocial history, injury characteristics, and postinjury functional status associated with longitudinal follow-up completeness in persons with traumatic brain injury (TBI) using the TBI Model Systems (TBIMS) National Database (NDB). Design: Exhaustive chi-square automatic interaction detection was used to identify factors that classified participants according to level of follow-up completeness. Setting: Retrospective analysis of a multi-center longitudinal database. Participants: Individuals (N=8249) enrolled in the TBIMS NDB between 1989 and 2009 who were eligible for at least the first (year 1) follow-up up to the fifth (year 15) follow-up. Interventions: None. Main Outcome Measures: Follow-up completeness as defined by 6 different longitudinal response patterns (LRPs): completing all follow-ups, wave nonresponse, dropping out, completing no follow-ups without formally withdrawing, formally withdrawing before completing any follow-ups, and formally withdrawing after completing some. follow-ups. Results: Completing all follow-ups was associated with higher levels of education, living with parents or others, and having acute care payer data entered in the NDB. Subgroups more vulnerable to loss to follow-up (LTFU) included those with less education, racial/ethnic minority backgrounds, those with better motor functioning on rehabilitation discharge, and those for whom baseline data on education, employment, and acute care payer were not collected. No subgroups were found to be more likely to have the LRPs of dropping out or formal withdrawal. Conclusions: These data identify subgroups in which retention strategies beyond those most commonly used might reduce LTFU in longitudinal studies of persons with TBI, such as the TBIMS, and suggest future investigations into factors associated with missing baseline data. (C) 2014 by the American Congress of Rehabilitation Medicine	[Krellman, Jason W.; Spielman, Lisa; Dijkers, Marcel; Cantor, Joshua B.; Tsaousides, Theodore] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Kolakowsky-Hayner, Stephanie A.] Rehabil Res Ctr, Santa Clara Valley Med Ctr, San Jose, CA USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA	Krellman, JW (corresponding author), Icahn Sch Med Mt Sinai, 1 Gustave L Levy Pl,Box 1163, New York, NY 10029 USA.	jason.krellman@mountsinai.org	Bogner, Jennifer/E-2773-2011; Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Dijkers, Marcel/0000-0002-8362-5596	National Institute on Disability and Rehabilitation Research, U.S. Department of EducationUS Department of Education [H133P050004, H133B980013, H133A070038, H133A120035, H133A070042, H133A070029, H133A120086, H133A070040, H133A120037]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [1R49CE001171-01]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001171] Funding Source: NIH RePORTER	Supported by the National Institute on Disability and Rehabilitation Research, U.S. Department of Education (grants nos. H133P050004, H133B980013, and H133A070038 [Mt. Sinai]; H133A070038 [Santa Clara]; H133A120035 and H133A070042 [Indiana University]; H133A070029 and H133A120086 [Ohio State], and H133A070040 and H133A120037 [Moss]) and the Centers for Disease Control and Prevention (grant no. 1R49CE001171-01 [Mt. Sinai]).	Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Bell KR, 2008, AM J PHYS MED REHAB, V87, P330, DOI 10.1097/PHM.0b013e318168d092; Bergman P, 2010, INT J SOC PSYCHIATR, V56, P119, DOI 10.1177/0020764008098838; Biggs D, 1991, THE J, V18, P49, DOI DOI 10.1080/02664769100000005; Brilleman SL, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-71; Brown DM, 2006, AIDS CARE, V18, P821, DOI 10.1080/09540120500466747; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Claus RE, 2002, J PSYCHOACTIVE DRUGS, V34, P69, DOI 10.1080/02791072.2002.10399938; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; de Groot S, 2009, J REHABIL MED, V41, P382, DOI 10.2340/16501977-0346; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; GREENLAND S, 1977, AM J EPIDEMIOL, V106, P184, DOI 10.1093/oxfordjournals.aje.a112451; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Harrison-Felix C, 1998, PREDICTORS LOSS FOLL; Holavanahalli RK, 2006, J BURN CARE RES, V27, P703, DOI 10.1097/01.BCR.0000238085.87863.81; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Hunt JR, 1998, EPIDEMIOL REV, V20, P57, DOI 10.1093/oxfordjournals.epirev.a017972; Kass G., 1980, J R STAT SOC C-APPL, V29, P119, DOI DOI 10.2307/2986296; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kleschinsky JH, 2009, J STUD ALCOHOL DRUGS, V70, P751, DOI 10.15288/jsad.2009.70.751; Kristman VL, 2005, EUR J EPIDEMIOL, V20, P657, DOI 10.1007/s10654-005-7919-7; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Scott CK, 2006, J TRAUMA STRESS, V19, P757, DOI 10.1002/jts.20186; Scott CK, 2004, DRUG ALCOHOL DEPEN, V74, P21, DOI 10.1016/j.drugalcdep.2003.11.007; Touloumi G, 2001, STAT MED, V20, P3715, DOI 10.1002/sim.1114; Traumatic Brain Injury Model Systems National Data and Statistical Center, GUID STRAT MAX FOLL; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2012, TBI MOD SYST PRES	30	20	21	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2014	95	4					633	641		10.1016/j.apmr.2013.10.016			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AF3YJ	WOS:000334648300008	24211496				2021-06-18	
J	Poltavski, DV; Biberdorf, D				Poltavski, Dmitri V.; Biberdorf, David			Screening for lifetime concussion in athletes: Importance of oculomotor measures	BRAIN INJURY			English	Article						Concussion; hockey; ImPACT; NPFD; oculomotor measures; Visagraph	METABOLIC BRAIN VULNERABILITY; STATES HIGH-SCHOOL; TEMPORAL WINDOW; NEUROPSYCHOLOGICAL PERFORMANCE; SPORTS CONCUSSION; VISUAL FUNCTION; SYMPTOM SURVEY; HISTORY; INJURY; REHABILITATION	Hypothesis/objective: The purpose of the present study was to determine the utility of oculomotor-based evaluation protocols in screening for lifetime concussion incidence in elite hockey players. Methods: Forty-two Division I collegiate male and female hockey players were evaluated using the guidelines of an overall oculomotor-based diagnostic clinical test protocol for the mTBI population. The sensitivity of the collected measures to lifetime concussion was then compared with the corresponding sensitivity of measures of neuropsychological functioning (ImPACT) often used with athletes for acute concussion diagnosis. Results: This model showed that a hockey player with a Near Point of Fixation Disparity (NPFD) equal to or greater than 15 cm, Visagraph comprehension rate less than 85% and the total score on part A of an ADHD questionnaire equal to or greater than 11 was on average 10.72-times more likely to have previously suffered a concussion than an athlete with lower values on the NPFD and ADHD questionnaire and a higher comprehension rate on the Visagraph. None of the IMPACT baseline assessment measures were significantly predictive of the individual's concussion history. Conclusion: The study provides a relatively sensitive screening tool to assess the probability of previous concussion(s) in an athlete. This model may allow athletic personnel to address in a timely manner the risks associated with repeat concussions and to develop individualized concussion management protocols.	[Poltavski, Dmitri V.] Univ N Dakota, Dept Psychol, Grand Forks, ND 58202 USA; [Biberdorf, David] Valley Vis Clin, Grand Forks, ND USA	Poltavski, DV (corresponding author), Univ N Dakota, Dept Psychol, 319 Harvard St,Stop 8380, Grand Forks, ND 58202 USA.	dmitri.poltavski@email.und.edu					Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Chen AH, 2000, OPHTHAL PHYSL OPT, V20, P185; Ciuffreda K. J., 2005, BRAIN INJURY PROFESS, V2, P16; Ciuffreda K. J., 2012, VISUAL DIAGNOSIS CAR, P95; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Cooper J, 2012, OPTOMETRY, V83, P20; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Esposito G, 1996, J NUCL MED, V37, P559; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; HOSMER DW, 2000, WILEY PS TX, P1; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; KROHEL GB, 1986, ANN OPHTHALMOL, V18, P101; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lederer PJ, 2010, 40 ANN COVD M PUERT; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Nolin P, 2012, BRAIN INJURY, V26, P1564, DOI 10.3109/02699052.2012.698359; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Reid R., 1998, ADHD RATING SCALE 4; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Shuttleworth-Edwards AB, 2008, J CLIN EXP NEUROPSYC, V30, P870, DOI 10.1080/13803390701846914; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Tannen B. M., 2007, J BEHAV OPTOMETRY, V18, P143; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	58	20	20	0	30	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					475	485		10.3109/02699052.2014.888771			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900012	24702485				2021-06-18	
J	Aarabi, B; Mirvis, S; Shanmuganathan, K; Vaccaro, AR; Holmes, CJ; Akhtar-Danesh, N; Fehlings, MG; Dvorak, MF				Aarabi, Bizhan; Mirvis, Stuart; Shanmuganathan, Kathirkamanthan; Vaccaro, Alexander R.; Holmes, Cassandra J.; Akhtar-Danesh, Noori; Fehlings, Michael G.; Dvorak, Marcel F.			Comparative effectiveness of surgical versus nonoperative management of unilateral, nondisplaced, subaxial cervical spine facet fractures without evidence of spinal cord injury	JOURNAL OF NEUROSURGERY-SPINE			English	Article						trauma; spinal cord injury; MRI; ASIA scale; cervical facet fracture; nondisplaced fracture; traumatic brain injury	ANTERIOR FUSION; CLASSIFICATION; DISLOCATIONS; FACETECTOMY; INSTABILITY	Object. Facet joints are major stabilizers of cervical motion allowing for effortless and pain-free multidimensional cervical spine movements without significant linear or rotational translation, thus minimizing any chance for spinal cord or nerve root impingement. Unilateral, nondisplaced subaxial facet fractures do not meet the conventional criteria for spinal instability under physiological loads. Limited evidence indicates that even with no or minimal displacement, 20%-80% of these fractures fail nonoperative management. The risk factors for instability in isolated nondisplaced subaxial facet fractures remain uncertain. In this retrospective study of prospectively collected data, the authors attempted to identify the predictors of failure in the management of isolated, nondisplaced subaxial facet fractures admitted to their Level I trauma center over a 10-year period. Methods. Demographic, clinical, imaging, and follow-up data for 25 patients with unilateral nondisplaced subaxial facet fractures who were managed surgically (n = 10) or nonoperatively (n = 15) were statistically analyzed. Results. The mean age of the patients was 38 years, 19 were male, and 21 of the fractures were the result of either motor vehicle acciderits or falls. The mean motorscore on the American Spinal Injury Association scale was 99.2, and the mean Subaxial Injury Classification (SLIC) severity score was 3 (operated 3.5, nonoperated 2.3). Allen mechanistic classification included 22 compressive-extension Stage 1 and 2 distractive-extension Stage 1 fractures. Subaxial facet fractures involved C-7 in 17 patients (68%), C-6 in 7 (28%), and C-3 in 1 (4%). The anatomical plane of fracture through the lateral mass was sagittal in 12 patients, axial in 8, and coronal in 3 patients. Nondisplaced floating lateral mass injuries were noted in 2 patients. The mean instability score, considering 7 components of the discoligamentous complex on MRI, was 3.2 (operated 3.6, nonoperated 3.0). Ten (40%) of 25 patients in this investigation did not have successful management, 9 in the nonoperated and 1 in the operated group (p = 0.018). Unsuccessful management was significantly greater in younger patients (p = 0.0008), possibly indicating selection bias (p = 0.07, Wilcoxon ranksum test). Fracture plane, instability, and SLIC scores did not play a significant role in treatment failure in this study. Conclusions. In this study, surgery was superior to nonoperative management of isolated, nondisplaced, or minimally displaced subaxial cervical spine facet fractures.	[Aarabi, Bizhan] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Mirvis, Stuart; Shanmuganathan, Kathirkamanthan] Univ Maryland, Sch Med, Dept Radiol, Baltimore, MD 21201 USA; [Vaccaro, Alexander R.] Thomas Jefferson Univ, Dept Orthoped Surg, Philadelphia, PA 19107 USA; [Holmes, Cassandra J.] Coll William & Mary, Williamsburg, VA USA; [Akhtar-Danesh, Noori] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Akhtar-Danesh, Noori] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Neurosurg, Toronto, ON M5S 1A1, Canada; [Dvorak, Marcel F.] Univ British Columbia, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada	Aarabi, B (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, 22 S Greene St,Ste S-12-D, Baltimore, MD 21201 USA.	baarabi@smail.umaryland.edu		Fehlings, Michael/0000-0002-5722-6364; Dvorak, Marcel/0000-0002-9404-8448	Cerapedics; NuVasive; Stryker Spine	Dr. Vaccaro has direct stock ownership in Advanced Spinal Intellectual Properties, Bonovo Orthopaedics, Computational Biodynamics, Cross Current, Cytonics, Electrocore, Flagship Surgical, FlowPharma, Gamma Spine, Globus, In Vivo, Innovative Surgical Design, K-2 Medical, Location Based Intelligence, NeuCore, Paradigm Spine, Progressive Spinal Technologies, R.S.I., Replication Medica, Rothman Institute and Related Properties, Small Bone Innovations, Spine Medica, Spinicity, Spinology, Stout Medical, and Syndicom; is an employee of the Rothman Institute; serves as a consultant to the Gerson Lehrman Group, Guidepoint Global, Innovative Surgical Design, Medacorp, and Stout Medical; has received royalties from Aesculap, Biomet Spine, DePuy, Globus, Medtronics, NuVasive, and Stryker Spine; serves on Boards and Committees for AO Spine, Association of Collaborative Spine Research, Innovative Surgical Design, and Spinicity; and has received grants from Cerapedics, NuVasive, and Stryker Spine.	ALLEN BL, 1982, SPINE, V7, P1, DOI 10.1097/00007632-198200710-00001; Anderson PA, 2007, J BONE JOINT SURG AM, V89A, P1057, DOI 10.2106/JBJS.F.00684; BEYER CA, 1991, J BONE JOINT SURG BR, V73, P977; BUCHOLZ RD, 1989, J NEUROSURG, V70, P884, DOI 10.3171/jns.1989.70.6.0884; CUSICK JF, 1988, SPINE, V13, P808, DOI 10.1097/00007632-198807000-00017; DENIS F, 1983, SPINE, V8, P817, DOI 10.1097/00007632-198311000-00003; Dvorak MF, 2007, SPINE, V32, P3007, DOI 10.1097/BRS.0b013e31815cd439; Halliday AL, 1997, SPINE, V22, P2614, DOI 10.1097/00007632-199711150-00007; HARRIS JH, 1986, ORTHOP CLIN N AM, V17, P15; HOLDSWORTH FW, 1963, J BONE JOINT SURG BR, V45, P6; Kwon BK, 2007, J NEUROSURG-SPINE, V7, P1, DOI 10.3171/SPI-07/07/001; Lee SH, 2009, J TRAUMA, V66, P758, DOI 10.1097/TA.0b013e31818cc32a; Lifeso RM, 2000, SPINE, V25, P2028, DOI 10.1097/00007632-200008150-00005; NICOLL EA, 1949, J BONE JOINT SURG BR, V31, P376; Rabb CH, 2007, J SPINAL DISORD TECH, V20, P416, DOI 10.1097/BSD.0b013e318030d32a; RAYNOR RB, 1985, J NEUROSURG, V63, P278, DOI 10.3171/jns.1985.63.2.0278; SCHAEFER DM, 1992, J NEUROSURG, V76, P218, DOI 10.3171/jns.1992.76.2.0218; SHAPIRO SA, 1993, NEUROSURGERY, V33, P832; Spector LR, 2006, SPINE, V31, P2827, DOI 10.1097/01.brs.0000245864.72372.8f; Vaccaro AR, 2007, SPINE, V32, P2365, DOI 10.1097/BRS.0b013e3181557b92; WHITE A A, 1976, Spine, V1, P15, DOI 10.1097/00007632-197603000-00003; White AA, 1990, CLIN BIOMECHANICS SP, P1; ZDEBLICK TA, 1993, SPINE, V18, P2005, DOI 10.1097/00007632-199310001-00013	23	20	21	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	MAR	2014	20	3					270	277		10.3171/2013.11.SPINE13733			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AB8OD	WOS:000332049000004	24405465				2021-06-18	
J	Sarkar, K; Keachie, K; Nguyen, U; Muizelaar, JP; Zwienenberg-Lee, M; Shahlaie, K				Sarkar, Korak; Keachie, Krista; Nguyen, UyenThao; Muizelaar, J. Paul; Zwienenberg-Lee, Marike; Shahlaie, Kiarash			Computed tomography characteristics in pediatric versus adult traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; computed tomography; pediatric; adult; trauma	GLASGOW COMA SCALE; HEAD-INJURY; UNIQUE FEATURES; CLINICAL-TRIALS; CHILDREN; PREDICTION; CLASSIFICATION; BIOMECHANICS; VALIDATION; MANAGEMENT	Object. Traumatic brain injury (TBI) is a leading cause of injury, hospitalization, and death among pediatric patients. Admission CT scans play an important role in classifying TBI and directing clinical care, but little is known about the differences in CT findings between pediatric and adult patients. The aim of this study was to determine if radiographic differences exist between adult and pediatric TBI. Methods. The authors retrospectively analyzed TBI registry data from 1206 consecutive patients with nonpenetrating TBI treated at a Level 1 adult and pediatric trauma center over a 30-month period. Results. The distribution of sex, race, and Glasgow Coma Scale (GCS) score was not significantly different between the adult and pediatric populations; however, the distribution of CT findings was significantly different. Pediatric patients with TBI were more likely to have skull fractures (OR 3.21, p < 0.01) and epidural hematomas (OR 1.96, p < 0.01). Pediatric TBI was less likely to be associated with contusion, subdural hematoma, subarachnoid hemorrhage, or compression of the basal cisterns (p < 0.05). Rotterdam CT scores were significantly lower in the pediatric population (2.3 vs 2.6, p < 0.001). Conclusions. There are significant differences in the CT findings in pediatric versus adult TBI, despite statistical similarities with regard to clinical severity of injury as measured by the GCS. These differences may be due to anatomical characteristics, the biomechanics of injury, and/or differences in injury mechanisms between pediatric and adult patients. The unique characteristics of pediatric TBI warrant consideration when formulating a clinical trial design or predicting functional outcome using prognostic models developed from adult TBI data.	[Sarkar, Korak] Univ Calif Davis, Sch Med, Dept Neurol, Sacramento, CA 95817 USA; [Keachie, Krista; Muizelaar, J. Paul; Zwienenberg-Lee, Marike; Shahlaie, Kiarash] Univ Calif Davis, Sch Med, Dept Neurol Surg, Sacramento, CA 95817 USA; [Nguyen, UyenThao] Univ Calif Davis, Sch Med, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA	Shahlaie, K (corresponding author), Univ Calif Davis, Sch Med, Dept Neurol Surg, 4860 St,Ste 3740, Sacramento, CA 95817 USA.	kiarash.shahlaie@ucdmc.ucdavis.edu			National Center for Advancing Translational Sciences (NIH) [TR000002]	This project was supported by the National Center for Advancing Translational Sciences (NIH Grant No. TR000002).	Acosta CD, 2010, ACAD EMERG MED, V17, P1364, DOI 10.1111/j.1553-2712.2010.00926.x; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 2007, J NEUROTRAUM, V24, pvii; Cadena G, 2012, J NEUROTRAUM, V29, pA41; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; Huh Jimmy W, 2009, Anesthesiol Clin, V27, P213, DOI 10.1016/j.anclin.2009.05.006; Katsnelson M, 2012, NEUROSURGERY, V70, P1095, DOI 10.1227/NEU.0b013e318240c1ed; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Litvack ZN, 2008, ACUTE BRAIN SPINAL C, P93; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; RAPHAELY RC, 1980, PEDIATR CLIN N AM, V27, P715; Reece RM, 2008, AM J PREV MED, V34, pS116, DOI 10.1016/j.amepre.2007.11.005; Roeder RA, 2011, J CRANIOFAC SURG, V22, P392, DOI 10.1097/SCS.0b013e318208ba30; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Wang NE, 2008, ANN EMERG MED, V52, P607, DOI 10.1016/j.annemergmed.2008.05.011; Wymann NME, 2008, J ORAL MAXIL SURG, V66, P58, DOI 10.1016/j.joms.2007.04.023	34	20	21	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2014	13	3					307	314		10.3171/2013.12.PEDS13223			8	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AB8OC	WOS:000332048900013	24410128				2021-06-18	
J	Limond, J; Adlam, ALR; Cormack, M				Limond, J.; Adlam, A-L. R.; Cormack, M.			A Model for Pediatric Neurocognitive Interventions: Considering the Role of Development and Maturation in Rehabilitation Planning	CLINICAL NEUROPSYCHOLOGIST			English	Article						Children; Brain injury; Cognitive rehabilitation	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; WORKING-MEMORY; COGNITIVE REHABILITATION; UTILIZATION DEFICIENCIES; FAMILY INTERVENTION; FLUID INTELLIGENCE; EXECUTIVE FUNCTION; CLINICAL-PRACTICE; GOAL MANAGEMENT	The need for post-acute neurorehabilitation after childhood acquired brain injury is increasingly recognized but recent reviews highlight the limited evidence-base and lack of a neuropsychological treatment model. Evidence from different fields was reviewed to inform the development of a pediatric neurocognitive interventions (PNI) model. The review included literature from child neuropsychology, adult neuropsychology, cognitive neuroscience, learning disabilities, education, and mental health. The resulting PNI model provides a systematic approach to delivering and evaluating appropriate care while minimizing the obstacles to successful outcomes. The model emphasizes the role of development and cognitive maturation in the planning of rehabilitation. Areas that represent significant gaps in our knowledge are discussed and future research directions are suggested based on predictions generated by the proposed model.	[Limond, J.] CoRaL Psychol Ltd, Glasgow G1 3DX, Lanark, Scotland; [Limond, J.] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [Adlam, A-L. R.] Univ Exeter, Ctr Clin Neuropsychol Res, Sch Psychol, Exeter EX4 4QJ, Devon, England; [Cormack, M.] NHS Lanarkshire, Motherwell, Lanark, Scotland	Limond, J (corresponding author), CoRaL Psychol Ltd, 38 Queen St, Glasgow G1 3DX, Lanark, Scotland.	jenny@coralpsychology.co.uk		Adlam, Anna/0000-0001-7212-4051			Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Bedard AC, 2002, DEV NEUROPSYCHOL, V21, P93, DOI 10.1207/S15326942DN2101_5; Bernstein J. H., 2010, PRINCIPLES PRACTICE, P17; Bjorklund DF, 1997, DEV REV, V17, P411, DOI 10.1006/drev.1997.0440; Bjorklund DF., 2012, CHILDRENS THINKING C; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Byard Katie, 2011, Clin Child Psychol Psychiatry, V16, P165, DOI 10.1177/1359104511403582; Carli P, 2004, LANCET, V363, P584, DOI 10.1016/S0140-6736(04)15626-2; Case R., 1995, MEMORY PERFORMANCE C; Catroppa C, 2009, DEV NEUROREHABIL, V12, P53, DOI 10.1080/17518420802634476; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; CRONE EA, 2011, DEV COGN NEUROS-NETH, V1, P101, DOI DOI 10.1016/J.DCN.2010.12.001; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DeMarie D, 2004, J COGN DEV, V5, P461, DOI 10.1207/s15327647jcd0504_4; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feeney TJ, 2010, J HEAD TRAUMA REHAB, V25, P416, DOI 10.1097/HTR.0b013e3181fbc0a2; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Franzen KM, 1996, CHILD NEUROPSYCHOL, V2, P176, DOI 10.1080/09297049608402250; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Goswami U., 2008, COGNITIVE DEV LEARNI; Harris JR, 1996, J COMMUN DISORD, V29, P79, DOI 10.1016/0021-9924(94)00035-2; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Haywood HC, 2007, DYNAMIC ASSESSMENT IN PRACTICE: CLINICAL AND EDUCATIONAL APPLICATIONS, P1; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Johnson MH, 2002, DEV PSYCHOPATHOL, V14, P521, DOI 10.1017/S0954579402003073; Karmiloff-Smith A, 1998, TRENDS COGN SCI, V2, P389, DOI 10.1016/S1364-6613(98)01230-3; Krasny-Pacini A., J HEAD TRAU IN PRESS; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Lohaugen GCC, 2011, J PEDIATR-US, V158, P555, DOI 10.1016/j.jpeds.2010.09.060; Mackey AP, 2011, DEVELOPMENTAL SCI, V14, P582, DOI 10.1111/j.1467-7687.2010.01005.x; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; McDougall J, 2011, DEV NEUROREHABIL, V14, P41, DOI 10.3109/17518423.2010.521795; McDougall J, 2010, DEV NEUROREHABIL, V13, P204, DOI 10.3109/17518421003620525; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mechelli A, 2002, NEUROIMAGE, V17, P1459, DOI 10.1006/nimg.2002.1231; Medical Research Council, 2008, DEV EVALUATING COMPL; Mueller MM, 2007, PSYCHOL SCHOOLS, V44, P691, DOI 10.1002/pits.20258; Oatman-Stanford D., 2013, THESIS U EDINBURGH; Oberg L, 1998, J HEAD TRAUMA REHAB, V13, P44, DOI 10.1097/00001199-199806000-00005; ONeill ME, 1996, J PEDIATR PSYCHOL, V21, P73, DOI 10.1093/jpepsy/21.1.73; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; Rankin Peter M, 2005, Pediatr Rehabil, V8, P283, DOI 10.1080/13638490400022436; Reid R, 2005, EXCEPT CHILDREN, V71, P361; Reis J. K., 2007, PEDIAT NEUROPSYCHOLO; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Rous R., 2012, BRAIN IMPAIR, V13, P147; Scherf KS, 2006, J COGNITIVE NEUROSCI, V18, P1045, DOI 10.1162/jocn.2006.18.7.1045; Schwenck C, 2007, CHILD DEV, V78, P1771, DOI 10.1111/j.1467-8624.2007.01090.x; Shallice T., 2011, ORG MIND; Siegler RS, 1996, EMERGING MINDS PROCE; Sjo NM, 2010, ACTA PAEDIATR, V99, P230, DOI 10.1111/j.1651-2227.2009.01587.x; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Spevack TV, 2007, PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE, P6; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Tate RL, 2008, BRAIN IMPAIR, V9, P282, DOI 10.1375/brim.9.3.282; Tomlin AM, 2003, PROF PSYCHOL-RES PR, V34, P617, DOI 10.1037/0735-7028.34.6.617; Trickey D., 2008, CHILDRENS ANXIETY CO; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2010, NEUROREHABILITATION, V27, P63, DOI 10.3233/NRE-2010-0581; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wilson BA, 2009, DEV NEUROREHABIL, V12, P421, DOI 10.3109/17518420903200573; World Health Organization, 2001, INT CLASS FUNCT DIS; World Health Organization [WHO], 2007, INT CLASS FUNCT DIS; Wright Ingram, 2004, Pediatr Rehabil, V7, P85, DOI 10.1080/13638490410001668758; Ylvisaker M., 2003, TECHNICAL REPORT; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891	86	20	20	2	30	TAYLOR & FRANCIS INC	PHILADELPHIA	520 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB 17	2014	28	2					181	198		10.1080/13854046.2013.873083			18	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	AB7TU	WOS:000331994400002	24498935	Green Accepted			2021-06-18	
J	Goh, CP; Putz, U; Howitt, J; Low, LH; Gunnersen, J; Bye, N; Morganti-Kossmann, C; Tan, SS				Goh, Choo-Peng; Putz, Ulrich; Howitt, Jason; Low, Ley-Hian; Gunnersen, Jenny; Bye, Nicole; Morganti-Kossmann, Cristina; Tan, Seong-Seng			Nuclear trafficking of Pten after brain injury leads to neuron survival not death	EXPERIMENTAL NEUROLOGY			English	Article						Nclfip1; Neuroprotection; Nedd4; Pten; Traumatic brain injury; Ubiquitination	CEREBRAL-ISCHEMIA; UBIQUITIN LIGASE; COGNITIVE DEFICITS; TUMOR SUPPRESSION; NEDD4 FAMILY; IN-VIVO; PROTEIN; NDFIP1; STROKE; PHOSPHORYLATION	There is controversy whether accumulation of the tumor suppressor PTEN protein in the cell nucleus under stress conditions such as trauma and stroke causes cell death. A number of in vitro studies have reported enhanced apoptosis in neurons possessing nuclear PTEN, with the interpretation that its nuclear phosphatase activity leads to reduction of the survival protein phospho-Akt. However, there have been no in vivo studies to show that nuclear PTEN in neurons under stress is detrimental. Using a mouse model of injury, we demonstrate here that brain trauma altered the nucleo-cytoplasmic distribution of Pten, resulting in increased nuclear Pten but only in surviving neurons near the lesion. This event was driven by Ndfip1, an adaptor and activator of protein ubiquitination by Nedd4 E3 ligases. Neurons next to the lesion with nuclear PTEN were invariably negative for TUNEL, a marker for cell death. These neurons also showed increased Ndfip1 which we previously showed to be associated with neuron survival. Biochemical assays revealed that overall levels of Pten in the affected cortex were unchanged after trauma, suggesting that Pten abundance globally had not increased but rather Pten subcellular location in affected neurons had changed. Following experimental injury, the number of neurons with nuclear Pten was reduced in heterozygous mice (Ndfip1(+/-)) although lesion volumes were increased. We conclude that nuclear trafficking of Pten following injury leads to neuron survival not death. (C) 2013 Elsevier Inc. All rights reserved.	[Goh, Choo-Peng; Putz, Ulrich; Howitt, Jason; Low, Ley-Hian; Gunnersen, Jenny; Tan, Seong-Seng] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Brain Dev & Regenerat Lab, Parkville, Vic 3010, Australia; [Bye, Nicole; Morganti-Kossmann, Cristina] Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Clayton, Vic 3800, Australia	Tan, SS (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Brain Dev & Regenerat Lab, Parkville, Vic 3010, Australia.	stan@florey.edu.au		Howitt, Jason/0000-0001-9922-7931; Gunnersen, Jenny/0000-0002-6310-7724; Morganti-Kossmann, Cristina/0000-0002-0807-2063	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; Victorian Government through the Operational Infrastructure Scheme	This work was supported by the National Health and Medical Research Council (NH&MRC) and the Victorian Government through the Operational Infrastructure Scheme.	Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Chang N, 2007, TRENDS NEUROSCI, V30, P581, DOI 10.1016/j.tins.2007.08.006; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Deleris P, 2003, J BIOL CHEM, V278, P38884, DOI 10.1074/jbc.M300816200; Ehrnhoefer DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027680; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Howitt J, 2012, J CELL BIOL, V196, P29, DOI 10.1083/jcb.201105009; Howitt J, 2009, P NATL ACAD SCI USA, V106, P15489, DOI 10.1073/pnas.0904880106; Lackovic J, 2012, EXP NEUROL, V235, P326, DOI 10.1016/j.expneurol.2012.02.014; Lee SM, 2009, J CEREBR BLOOD F MET, V29, P1589, DOI 10.1038/jcbfm.2009.81; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu BS, 2010, STROKE, V41, P1018, DOI 10.1161/STROKEAHA.110.579011; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mao L, 2013, NEUROSCIENCE, V231, P272, DOI 10.1016/j.neuroscience.2012.11.050; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Mund T, 2010, P NATL ACAD SCI USA, V107, P11429, DOI 10.1073/pnas.0911714107; Namura S, 1998, J NEUROSCI, V18, P3659; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Omori N, 2002, BRAIN RES, V954, P317, DOI 10.1016/S0006-8993(02)03366-8; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shi GD, 2011, BIOCHEM BIOPH RES CO, V404, P941, DOI 10.1016/j.bbrc.2010.12.085; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stadler K, 2008, AM J PHYSIOL-ENDOC M, V295, pE456, DOI 10.1152/ajpendo.00015.2008; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Zhang S, 2013, J NEUROSCI, V33, P7997, DOI 10.1523/JNEUROSCI.5661-12.2013; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zheng M, 2012, J CELL SCI, V125, P1556, DOI 10.1242/jcs.095729; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	40	20	21	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2014	252						37	46		10.1016/j.expneurol.2013.11.017			10	Neurosciences	Neurosciences & Neurology	299TW	WOS:000330419600005	24275527				2021-06-18	
J	Hu, YC; Sun, Q; Li, W; Zhang, DD; Ma, B; Li, S; Li, WD; Zhou, ML; Hang, CH				Hu, Yang-Chun; Sun, Qing; Li, Wei; Zhang, Ding-Ding; Ma, Biao; Li, Song; Li, Wei-De; Zhou, Meng-Liang; Hang, Chun-Hua			Biphasic activation of nuclear factor kappa B and expression of p65 and c-Rel after traumatic brain injury in rats	INFLAMMATION RESEARCH			English	Article						Inflammatory response; Traumatic brain injury; Nuclear factor kappa B (NF-kappa B); Biphasic activation	CEREBRAL-ISCHEMIA; INDUCED APOPTOSIS; OXIDATIVE STRESS; NEURON SURVIVAL; DNA-BINDING; ROLES; ALPHA; OPPORTUNITIES; INDUCTION; PROTEINS	Nuclear factor kappa B (NF-kappa B) functions as a key regulator in the central nervous system and regulates the inflammatory pathway. There are two peaks of cerebral NF-kappa B activation after neonatal hypoxia-ischemia and subarachnoid hemorrhage. Our previous studies found that NF-kappa B activity was up-regulated at an early stage and remained elevated at day 7 after traumatic brain injury (TBI). However, data are lacking regarding an overview of NF-kappa B activity and expression of NF-kappa B subunits after TBI. Hence, the current study was designed to detect the time course of NF-kappa B activation and expression of NF-kappa B p65 and c-Rel subunits around the contused cortex following TBI. Adult Sprague-Dawley rats were randomly divided into sham and TBI groups at different time points. A TBI model was induced, and then the NF-kappa B DNA-binding activity in the surrounding areas of injured brain was detected by electrophoretic mobility shift assay. Western blotting was used to measure the protein levels of p65 and c-Rel in the nucleus. The concentrations of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) were detected by enzyme-linked immunosorbent assay. Moreover, the distribution of c-Rel and p65 was examined by immunohistochemical studies. There were double peaks of cerebral cortical NF-kappa B activity, at 3 and 10 days post-injury. Additionally, protein levels of p65 were found to be elevated and peaked at 3 days after TBI, while levels of c-Rel were elevated significantly during the later phase of injury. Furthermore, TNF-alpha and IL-1 beta concentrations also showed a biphasic increase. Biphasic activation of NF-kappa B could be induced after experimental TBI in rats. NF-kappa B p65 and c-Rel subunits were elevated at different post-TBI time periods, leading to a hypothesis that different NF-kappa B subunits might be involved in different pathophysiological processes after TBI.	[Hu, Yang-Chun; Sun, Qing; Li, Wei; Zhang, Ding-Ding; Ma, Biao; Zhou, Meng-Liang; Hang, Chun-Hua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Li, Song; Li, Wei-De] Southern Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Hang, CH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation, ChinaNational Natural Science Foundation of China (NSFC) [81171170, 81371294]; Nature Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK2010459]; Military Medical Scientific and Technological Innovation Project [10Z024]	We gratefully acknowledge the generous assistance from Dr. Gen-Bao Feng. This study was supported by the National Natural Science Foundation, China (NO. 81171170, 81371294), Nature Science Foundation of Jiangsu Province, China (BK2010459) and Military Medical Scientific and Technological Innovation Project (10Z024).	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Clemens JA, 1997, MOL BRAIN RES, V48, P187, DOI 10.1016/S0169-328X(97)00092-2; ERNST MK, 1995, MOL CELL BIOL, V15, P872; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lescot T, 2007, PRESSE MED, V36, P1117, DOI 10.1016/j.lpm.2007.01.017; Lezoualc'h F, 1998, J NEUROSCI, V18, P3224; Lin SC, 1998, MOL CELL BIOL, V18, P5523, DOI 10.1128/MCB.18.9.5523; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nijboer CH, 2008, STROKE, V39, P2578, DOI 10.1161/STROKEAHA.108.516401; Perkins ND, 1997, INT J BIOCHEM CELL B, V29, P1433, DOI 10.1016/S1357-2725(97)00088-5; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; PRASAD AV, 1994, NEUROSCI LETT, V170, P145, DOI 10.1016/0304-3940(94)90260-7; PRASAD AV, 1994, RADIAT RES, V138, P367, DOI 10.2307/3578685; Qin ZH, 1998, MOL PHARMACOL, V53, P33; RODRIGUEZ MS, 1995, MOL CELL BIOL, V15, P2413; Roshak AK, 1996, J BIOL CHEM, V271, P31496, DOI 10.1074/jbc.271.49.31496; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; You WC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/786242; Youssef S, 2006, NAT IMMUNOL, V7, P901, DOI 10.1038/ni0906-901	33	20	23	0	8	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	FEB	2014	63	2					109	115		10.1007/s00011-013-0677-1			7	Cell Biology; Immunology	Cell Biology; Immunology	293JU	WOS:000329968000003	24146067				2021-06-18	
J	Karamanos, E; Talving, P; Skiada, D; Osby, M; Inaba, K; Lam, L; Albuz, O; Demetriades, D				Karamanos, Efstathios; Talving, Peep; Skiada, Dimitra; Osby, Melanie; Inaba, Kenji; Lam, Lydia; Albuz, Ozgur; Demetriades, Demetrios			Is Prehospital Endotracheal Intubation Associated with Improved Outcomes in Isolated Severe Head Injury? A Matched Cohort Analysis	PREHOSPITAL AND DISASTER MEDICINE			English	Article						blood gas; endotracheal intubation; head injury; isolated; prehospital		Introduction: Prehospital endotracheal intubation (ETI) following traumatic brain injury in urban settings is controversial. Studies investigating admission arterial blood gas (ABG) patterns in these instances are scant. Hypothesis: Outcomes in patients subjected to divergent prehospital airway management options following severe head injury were studied. Methods: This was a retrospective propensity-matched study in patients with isolated TBI (head Abbreviated Injury Scale (AIS) >= 3) and Glasgow Coma Scale (GCS) score of <= 8 admitted to a Level 1 urban trauma center from January 1, 2003 through October 31, 2011. Cases that had prehospital ETI were compared to controls subjected to oxygen by mask in a one to three ratio for demographics, mechanism of injury, tachycardia/hypotension, Injury Severity Score, type of intracranial lesion, and all major surgical interventions. Primary outcome was mortality and secondary outcomes included admission gas profile, in-hospital morbidity, ICU length of stay (ICU LOS) and hospital length of stay (HLOS). Results: Cases (n = 55) and controls (n = 165) had statistically similar prehospital and in-hospital variables after propensity matching. Mortality was significantly higher for the ETI group (69.1% vs 55.2% respectively, P = .011). There was no difference in pH, base deficit, and pCO2 on admission blood gases; however the ETI group had significantly lower pO2 (187 (SD = 14) vs 213 (SD = 13), P = .034). There was a significantly increased incidence of septic shock in the ETI group. Patients subjected to prehospital ETI had a longer HLOS and ICU LOS. Conclusion: In isolated severe traumatic brain injury, prehospital endotracheal intubation was associated with significantly higher adjusted mortality rate and worsened admission oxygenation. Further prospective validation of these findings is warranted.	[Karamanos, Efstathios; Talving, Peep; Skiada, Dimitra; Osby, Melanie; Inaba, Kenji; Lam, Lydia; Albuz, Ozgur; Demetriades, Demetrios] Univ Southern Calif, Div Acute Care Surg Trauma Emergency Surg & Surg, Keck Sch Med, Los Angeles, CA 90033 USA	Karamanos, E (corresponding author), Univ Southern Calif, Dept Surg, Keck Sch Med, LAC USC Med Ctr,Div Acute Care Surg, 1200 North State St,Room 6341, Los Angeles, CA 90033 USA.	ef.karamanos@gmail.com	INABA, KENJI/AAC-8532-2020; Karamanos, Efstathios/AAU-8082-2020; Albuz, Ozgur/G-1480-2015; Talving, Peep/E-6015-2013	Karamanos, Efstathios/0000-0002-5118-4642; 			Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bauer K, 2012, CRIT CARE NURS Q, V35, P281, DOI 10.1097/CNQ.0b013e3182542eb5; Bochicchio Grant V, 2003, Curr Opin Crit Care, V9, P524, DOI 10.1097/00075198-200312000-00010; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Dupanovic M, 2010, CURR OPIN ANESTHESIO, V23, P276, DOI 10.1097/ACO.0b013e3283360b4f; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; GRAHAM DI, 1971, LANCET, V1, P265; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Lossius HM, 2011, CRIT CARE, V15, DOI 10.1186/cc9973; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008	19	20	20	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1049-023X	1945-1938		PREHOSP DISASTER MED	Prehospital Disaster Med.	FEB	2014	29	1					32	36		10.1017/S1049023X13008947			5	Emergency Medicine	Emergency Medicine	VG1BE	WOS:000445148900007	24330753				2021-06-18	
J	Lin, TP; Adler, CH; Hentz, JG; Balcer, LJ; Galetta, SL; Devick, S				Lin, Tanya P.; Adler, Charles H.; Hentz, Joseph G.; Balcer, Laura J.; Galetta, Steven L.; Devick, Steve			Slowing of number naming speed by King-Devick Test in Parkinson's disease	PARKINSONISM & RELATED DISORDERS			English	Article						Parkinson's disease; Eye movements; Cognitive function	VISUALLY-GUIDED SACCADES; EYE-MOVEMENT CONTROL	Background: The King Devick (MD) test measures the speed of rapid number naming, and is postulated to require fast eye movements, attention, language, and possibly other aspects of cognitive functions. While used in multiple sports concussion studies, it has not been applied to the field of movement disorders. Methods: Forty-five Parkinson's disease (PD), 23 essential tremor (ET), and 65 control subjects were studied. Subjects performed two trials of reading out loud single-digit numbers separated by varying spacing on three test cards that were of different formats. The sum time of the faster trial was designated the MD score and compared across the three groups. Results: PD patients had higher (worse) MD scores, with longer reading times compared to ET and control subjects (66 s vs. 49 s vs. 52 s, p < 0.001, adjusting for age and gender). No significant difference was found between ET and control (Delta = -3 s, 95% CI: -10 to 4). Conclusions: This is the first study of the Ming Devick Test in Parkinson's disease. PD patients were found to have a slower rapid number naming speed compared to controls. This test may be a simple and rapid bedside tool for quantifying correlates of visual and cognitive function in Parkinson's disease. (C) 2013 Elsevier Ltd. All rights reserved.	[Lin, Tanya P.; Adler, Charles H.] Mayo Clin, Coll Med, Dept Neurol, Scottsdale, AZ 85259 USA; [Hentz, Joseph G.] Mayo Clin, Coll Med, Dept Biostat, Scottsdale, AZ USA; [Balcer, Laura J.; Galetta, Steven L.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Devick, Steve] King Devick Test LLC, Oak Brook Terrace, IL USA	Adler, CH (corresponding author), Mayo Clin, Coll Med, Dept Neurol, Scottsdale, AZ 85259 USA.	cadler@mayo.edu			National Institute of Neurological Disorders and Stroke (National Brain and Tissue Resource for Parkinson's Disease and Related Disorders) [U24 NS072026]; National Institute on Aging (Arizona Alzheimer's Disease Core Center)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG19610]; Arizona Department of Health Services (Arizona Alzheimer's Research Center) [211002]; Arizona Biomedical Research Commission [4001, 0011, 05901, 1001]; Mayo Clinic Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U24NS072026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG019610] Funding Source: NIH RePORTER	The Arizona Parkinson's Disease Consortium and the Brain and Body Donation Program are supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05901 and 1001 to the Arizona Parkinson's Disease Consortium), and Mayo Clinic Foundation.	Anderson TJ, 2013, NAT REV NEUROL, V9, P74, DOI 10.1038/nrneurol.2012.273; Archibald NK, 2013, BRAIN, V136, P739, DOI 10.1093/brain/awt005; Chambers JM, 2010, NEUROPSYCHOLOGIA, V48, P887, DOI 10.1016/j.neuropsychologia.2009.11.006; Chan F, 2005, NEUROPSYCHOLOGIA, V43, P784, DOI 10.1016/j.neuropsychologia.2004.06.026; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Helmchen C, 2012, MOVEMENT DISORD, V27, P1012, DOI 10.1002/mds.25042; MacAskill MR, 2012, NEUROPSYCHOLOGIA, V50, P3338, DOI 10.1016/j.neuropsychologia.2012.09.025; Marino S, 2010, NEUROL SCI, V31, P381, DOI 10.1007/s10072-009-0180-1; Matsumoto H, 2011, MOVEMENT DISORD, V26, P1619, DOI 10.1002/mds.23683; Perneczky R, 2011, NEUROBIOL DIS, V43, P79, DOI 10.1016/j.nbd.2011.01.032; Terao Y, 2011, NEUROPSYCHOLOGIA, V49, P1794, DOI 10.1016/j.neuropsychologia.2011.03.002	12	20	20	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	FEB	2014	20	2					226	229		10.1016/j.parkreldis.2013.10.009			4	Clinical Neurology	Neurosciences & Neurology	AB3IW	WOS:000331685500018	24269283	Green Accepted			2021-06-18	
J	Powers, KC; Kalmar, JM; Cinelli, ME				Powers, Kaley C.; Kalmar, Jayne M.; Cinelli, Michael E.			Dynamic stability and steering control following a sport-induced concussion	GAIT & POSTURE			English	Article						Concussion; Dynamic balance control; Steering; Temporal variability	TRAUMATIC BRAIN-INJURY; CENTER-OF-MASS; GAIT VARIABILITY; BALANCE CONTROL; OLDER-ADULTS; FALL RISK; HEAD; COORDINATION; DIRECTION; STRATEGIES	Loss of balance control is one of the cardinal symptoms following a concussion; however, the ability to detect the duration of these balance impairments seems to largely depend on task type and complexity. Typical balance assessment tools are simplistic and do not challenge dynamic balance control. Changing direction represents an internal perturbation that challenges the balance control system. The purpose of this study was to examine the effects of a concussion on dynamic stability and steering control. Nine male intercollegiate North American football players who experienced a concussion (CONC) were tested during the symptomatic phase (acute) and again once they had been cleared to return to play (RTP) while the controls (age-and position-matched teammates) were tested at a single time point coinciding with the acute phase testing of their matched injured player. All participants performed a steering task, requiring them to walk straight or turn in the direction of a visual cue located either 60 degrees or 45 degrees to the left or right of the centre line. CONC demonstrated increased swing time variability, segmental re-orientation variability, and the amount of time it took the centre of mass to reach the minimum lateral dynamic stability margin. These results suggest that CONC were more unstable and adopted a conservative gait strategy. Differences in the variability measures persisted even after the athlete was cleared to RTP. Overall, the findings reveal that intercollegiate football players with concussions have difficulty controlling temporal characteristics of gait, which cause dynamic instability to persist even at RTP. (C) 2013 Elsevier B.V. All rights reserved.	[Powers, Kaley C.; Kalmar, Jayne M.; Cinelli, Michael E.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON N2L 3C5, Canada	Cinelli, ME (corresponding author), Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, 75 Univ Ave,W Rm 501, Waterloo, ON N2L 3C5, Canada.	mcinelli@wlu.ca	Cinelli, Michael/ABE-7625-2020	Cinelli, Michael/0000-0002-5802-2590			Aruin AS, 2002, J AUTOMATIC CONTROL, V12, P31, DOI [DOI 10.2298/JAC0201031A, 10.2298/ JAC0201031A.]; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Franconeri SL, 2005, PSYCHOL SCI, V16, P275, DOI 10.1111/j.0956-7976.2005.01528.x; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Grasso R, 1996, NEUROREPORT, V7, P1170, DOI 10.1097/00001756-199604260-00015; Grasso R, 1998, NEUROSCI LETT, V253, P115, DOI 10.1016/S0304-3940(98)00625-9; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hollands MA, 2004, EXP BRAIN RES, V154, P261, DOI 10.1007/s00221-003-1718-8; Hollands MA, 2001, EXP BRAIN RES, V140, P223, DOI 10.1007/s002210100811; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maki BE, 2008, J ELECTROMYOGR KINES, V18, P243, DOI 10.1016/j.jelekin.2007.06.005; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; RIETDYK S, 1994, HUM MOVEMENT SCI, V13, P109, DOI 10.1016/0167-9457(94)90031-0; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Winter D.A., 2004, BIOMECHANICS MOTOR C; Xu DL, 2004, J MOTOR BEHAV, V36, P316, DOI 10.3200/JMBR.36.3.316-326	29	20	20	0	19	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	FEB	2014	39	2					728	732		10.1016/j.gaitpost.2013.10.005			5	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	293NQ	WOS:000329979300011	24231441				2021-06-18	
J	Espinosa-Garcia, C; Aguilar-Hernandez, A; Ceruantes, M; Morali, G				Espinosa-Garcia, Claudia; Aguilar-Hernandez, Alejandra; Ceruantes, Miguel; Morali, Gabriela			Effects of progesterone on neurite growth inhibitors in the hippocampus following global cerebral ischemia	BRAIN RESEARCH			English	Article						Global cerebral ischemia; Progesterone; Neuroprotection; Nogo-A; Neurite growth inhibitors	TRAUMATIC BRAIN-INJURY; CA1 PYRAMIDAL NEURONS; SPINAL-CORD-INJURY; TRANSIENT FOREBRAIN ISCHEMIA; NOGO-A EXPRESSION; FUNCTIONAL RECOVERY; ADULT-RAT; CELL-DEATH; NEUROPROTECTIVE FACTOR; DENDRITIC PLASTICITY	In this study, the effects of progesterone (P-4) on the immunoreactivity to the neurite growth inhibitor Nogo-A, its receptor (Ng-R), and its effector Rho-A in the rat hippocampus, in association with parameters of spatial learning and memory following global cerebral ischemia, were assessed. Adult male rats were subjected to global cerebral ischemia (15 min), and treated with P-4 or its vehicle at 15 min, 2, 6, 24,48 and 72 h of reperfusion. Immunoreactivity to Nogo-A, Ng-R, and Rho-A was evaluated at 24 h, 72 h or 7 d, or at 14 d of reperfusion after rats were tested in the Morris Water Maze (MWM). Global cerebral ischemia induced an increase in Nogo-A, Ng-R, and Rho-A immunoreactivities in the cell bodies of CA1 pyramidal neurons at 24 h after global cerebral ischemia, peaking at 72 h, and persisting 14 d later. In addition, at 72 h, a strong immunoreactivity was observed in the hippocampal layers where dendritic arborizations of C.A1 pyramidal neurons are located. Treatment with P-4 reduced Nogo-A, Ng-R, and Rho-A immunoreactivities in CA1, particularly at 72 h of reperfusion. These effects of P-4 were consistent with the parameters of a more efficient spatial learning and memory in the MWM, as compared to vehicle-treated rats. Overall results suggest the reduction of neurite growth inhibitory molecules Nogo-A, Ng-R, and Rho-A, as a part of the restorative effects of progesterone possibly allowing the plastic phenomena to occur, able to support the functional preservation of the hippocampus following global cerebral ischemia. (C) 2013 Elsevier B.V. All rights reserved.	[Espinosa-Garcia, Claudia; Aguilar-Hernandez, Alejandra; Morali, Gabriela] UMAE Hosp Especialidades, CMN Siglo XXI, IMSS, Unidad Invest Med Farmacol, Mexico City 03100, DF, Mexico; [Ceruantes, Miguel] Univ Michoacana SNH, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia, Michoacan, Mexico	Morali, G (corresponding author), UMAE Hosp Especialidades, CMN Siglo XXI, IMSS, Unidad Invest Med Farmacol, Eugenia 626 Girasol 302, Mexico City 03100, DF, Mexico.	gmorali@hotmail.com	Morali, Gabriela/AAH-8014-2020	Espinosa-Garcia, Claudia/0000-0002-9909-9092	Instituto Mexicano del Seguro Social [FIS/IMSS/PROT/G10/827, 2010020]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [CB-2009-01/134199, 229241]	This paper constitutes a partial fulfillment of the requirements for the Ph.D. of CEG at the Programa de Doctorado en Ciencias Biomedicas, UNAM. This study was partially supported by Instituto Mexicano del Seguro Social (Grant no. FIS/IMSS/PROT/G10/827; CEG fellowship 2010020), and CONACYT (Grant no. CB-2009-01/134199; CEG fellowship 229241). The authors thank Ms. Maria del Carmen Baltazar for her skillful technical assistance.	Aggarwal R, 2008, J PHARM PHARMACOL, V60, P731, DOI 10.1211/jpp.60.6.0008; Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Barone FC, 2006, CLIN NEUROSCI RES, V6, P329, DOI 10.1016/j.cnr.2006.09.010; Block F, 1999, PROG NEUROBIOL, V58, P279, DOI 10.1016/S0301-0082(98)00085-9; Briones TL, 2006, EXP NEUROL, V198, P530, DOI 10.1016/j.expneurol.2005.12.032; Cekic M, 2012, RESTOR NEUROL NEUROS, V30, P115, DOI 10.3233/RNN-2011-0628; Cervantes M, 2012, ADV PRECLINICAL STUD; Chao PK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-121; Cheatwood JL, 2008, TOP STROKE REHABIL, V15, P42, DOI 10.1310/tsr1501-42; Chen SY, 2009, NEUROSCI LETT, V465, P171, DOI 10.1016/j.neulet.2009.09.011; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Espinosa-Garcia C, 2013, NEUROSCI LETT, V550, P98, DOI 10.1016/j.neulet.2013.06.023; Fang PC, 2010, STROKE, V41, P544, DOI 10.1161/STROKEAHA.109.572073; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hamill Cecily E, 2005, Clin Neurosurg, V52, P29; Hartman RE, 2005, BRAIN RES, V1043, P48, DOI 10.1016/j.brainres.2005.02.030; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Himeda T, 2007, CELL MOL NEUROBIOL, V27, P229, DOI 10.1007/s10571-006-9104-2; Huber AB, 2002, J NEUROSCI, V22, P3553; Hunt D, 2003, MOL CELL NEUROSCI, V24, P1083, DOI 10.1016/j.mcn.2003.09.002; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Jiang C, 2011, INT IMMUNOPHARMACOL, V11, P1925, DOI 10.1016/j.intimp.2011.08.001; Jiang W, 2009, TRANSL RES, V154, P40, DOI 10.1016/j.trsl.2009.04.005; Karanjia N, 2011, CURR TREAT OPTION NE, V13, P191, DOI 10.1007/s11940-011-0112-2; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kovalenko T, 2006, HIPPOCAMPUS, V16, P814, DOI 10.1002/hipo.20211; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Mingorance A, 2004, MOL CELL NEUROSCI, V26, P34, DOI 10.1016/j.mcn.2004.01.001; Miyazaki H, 2001, BRAIN RES, V922, P165, DOI 10.1016/S0006-8993(01)03013-X; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; Morali G, 2012, RESTOR NEUROL NEUROS, V30, P1, DOI 10.3233/RNN-2011-0605; Morali G, 2011, RESTOR NEUROL NEUROS, V29, P1, DOI 10.3233/RNN-2011-0571; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MUDRICK LA, 1989, BRAIN RES, V493, P179, DOI 10.1016/0006-8993(89)91014-7; Mukaino M, 2010, EXP NEUROL, V224, P403, DOI 10.1016/j.expneurol.2010.04.020; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; O'Kane EM, 2003, MOL BRAIN RES, V114, P1, DOI 10.1016/S0169-328X(03)00121-9; ONODERA H, 1990, NEUROSCIENCE, V38, P125, DOI 10.1016/0306-4522(90)90379-I; Orzylowska O, 1999, NEUROSCI LETT, V263, P72, DOI 10.1016/S0304-3940(99)00043-9; Overman JJ, 2014, NEUROSCIENTIST, V20, P15, DOI 10.1177/1073858413491146; Ozacmak VH, 2009, PHYSIOL RES, V58, P909, DOI 10.33549/physiolres.931647; Papadopoulos CM, 2006, CEREB CORTEX, V16, P529, DOI 10.1093/cercor/bhi132; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; PULSINELLI WA, 1988, STROKE, V19, P913, DOI 10.1161/01.STR.19.7.913; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Roine R.O., 1997, CURRENT REV CEREBROV, P159; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Ruan YW, 2006, NEUROSCIENCE, V140, P191, DOI 10.1016/j.neuroscience.2006.01.039; Ruan YW, 2012, NEUROSCIENCE, V218, P268, DOI 10.1016/j.neuroscience.2012.05.035; Ruan YW, 2009, J NEUROSCI RES, V87, P61, DOI 10.1002/jnr.21816; Sairanen TR, 1997, J CEREBR BLOOD F MET, V17, P1107, DOI 10.1097/00004647-199710000-00013; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Schneider A, 2009, ANESTH ANALG, V108, P971, DOI 10.1213/ane.0b013e318193ca99; Schumacher M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00010; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Skibo GG, 2010, VITAM HORM, V82, P107, DOI 10.1016/S0083-6729(10)82006-0; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Tang HL, 2013, HORM BEHAV, V64, P527, DOI 10.1016/j.yhbeh.2013.06.009; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083; VanGuilder HD, 2012, J NEUROCHEM, V121, P77, DOI 10.1111/j.1471-4159.2012.07671.x; Wang TZ, 2010, BRAIN RES, V1360, P147, DOI 10.1016/j.brainres.2010.08.101; Wang XX, 2002, J NEUROSCI, V22, P5505; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yang JF, 2013, J SURG RES, V182, pE69, DOI 10.1016/j.jss.2012.11.010; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yasuda Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-70; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010; Zhang Z, 2010, HIPPOCAMPUS, V20, P402, DOI 10.1002/hipo.20642; Zhao YZ, 2011, SYNAPSE, V65, P880, DOI 10.1002/syn.20915; Zhou CM, 2003, BIOCHEM BIOPH RES CO, V309, P368, DOI 10.1016/j.bbrc.2003.08.006; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	91	20	23	1	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 30	2014	1545						23	34		10.1016/j.brainres.2013.11.030			12	Neurosciences	Neurosciences & Neurology	AA3XC	WOS:000331027500003	24316245				2021-06-18	
J	Wong, JYH; Choi, AWM; Fong, DYT; Wong, JKS; Lau, CL; Kam, CW				Wong, Janet Yuen-Ha; Choi, Anna Wai-Man; Fong, Daniel Yee-Tak; Wong, John Kit-Shing; Lau, Chu-Leung; Kam, Chak-Wah			Patterns, aetiology and risk factors of intimate partner violence-related injuries to head, neck and face in Chinese women	BMC WOMENS HEALTH			English	Article						Head injuries; Maxillofacial injuries; Intimate partner violence; Abused Chinese women	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; BATTERED WOMEN; EMERGENCY-DEPARTMENT; SEVERITY SCORE; VICTIMS; POPULATION; MARRIAGES; ABUSE; STAY	Background: Intimate partner violence (IPV) related injuries have been recognized among health care professionals. However, few studies have provided detailed information on injuries to the head, neck and face regions in Chinese women. As abused Chinese women are generally unwilling to disclose IPV and there are differences in socio-demographic characteristics, societal norms and behaviours, the women may exhibit different patterns, aetiology and risk factors of IPV-related HNF injuries. This study aims to examine the patterns of head, neck and face injuries presenting to Accident and Emergency departments, including the anatomical regions, types, severity, aetiology and demographic and non-demographic risk factors of injuries inflicted by intimate partners in Chinese context. Methods: Medical charts of 223 women presented to the Accident and Emergency departments of two regional hospitals in Hong Kong between January 2010 and December 2011 were reviewed independently by two reviewers. Results: Head, neck and face injuries remained the most common injuries found in abused Chinese women (77.6%), and punching with a fist was the most common aetiology (60.2%). In particular, punching with a fist was significantly associated on the upper third of the maxillofacial region (p = .01) and the back part of the head (p = .03). Moreover, cohabiting and separated women were more likely to have multiple injuries than those who were married (OR = 3.3, 95% CI = 1.4, 7.8; OR = 2.1, 95% CI = .4, 11.9). Conclusions: The findings enhance the understanding of head, neck and face injuries and inform clinicians about the linkage among injuries and risks in abused Chinese women.	[Wong, Janet Yuen-Ha; Fong, Daniel Yee-Tak] Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, Pokfulam, Hong Kong, Peoples R China; [Choi, Anna Wai-Man] Univ Hong Kong, Fac Social Sci, Dept Social Work & Social Adm, Pokfulam, Hong Kong, Peoples R China; [Wong, John Kit-Shing; Kam, Chak-Wah] Tuen Mun Hosp, Dept Accid & Emergency Med, Tuen Mun, Hong Kong, Peoples R China; [Lau, Chu-Leung] Pok Oi Hosp, Dept Accid & Emergency Med, Yuen Long, Hong Kong, Peoples R China	Wong, JYH (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, 4-F,William MW Mong Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	janetyh@hku.hk	Wong, Janet Yuen Ha/F-4433-2011; Choi, Wai Man/F-9776-2012; Fong, Daniel/C-4269-2009	Wong, Janet Yuen Ha/0000-0002-3000-4577; Choi, Wai Man/0000-0002-9341-8515; Fong, Daniel/0000-0001-7365-9146			Amon M, 2006, J TRAUMA, V61, P924, DOI 10.1097/01.ta.0000195979.25659.fe; [Anonymous], 2011, STAT NEWL REP CHILD; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BEVERLAND DE, 1983, INJURY, V15, P19, DOI 10.1016/0020-1383(83)90156-0; Bhandari M, 2006, J TRAUMA, V61, P1473, DOI 10.1097/01.ta.0000196419.36019.5a; Campbell JC, 2004, J INTERPERS VIOLENCE, V19, P1464, DOI 10.1177/0886260504269698; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; CDC, 2003, HEADS FACTS PHYS MIL; *CDCP, 2003, HEADS BRAIN INJ YOUR; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Dolezal T., 2009, HIDDEN COSTS HLTH CA; Hedlund GL, 2009, FORENSIC SCI MED PAT, V5, P280, DOI 10.1007/s12024-009-9132-6; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kenney CT, 2006, DEMOGRAPHY, V43, P127, DOI 10.1353/dem.2006.0007; Kim J, 2008, J INTERPERS VIOLENCE, V23, P1465, DOI 10.1177/0886260508314307; Kothari CL, 2006, ANN EMERG MED, V47, P190, DOI 10.1016/j.annemergmed.2005.10.016; Krug E.G., 2002, WORLD REPORT VIOLENC; Lam CLK, 2002, SOC SCI MED, V55, P1635, DOI 10.1016/S0277-9536(01)00296-9; Lau C. L., 2008, Hong Kong Medical Journal, V14, P451; Le BT, 2001, J ORAL MAXIL SURG, V59, P1277, DOI 10.1053/joms.2001.27490; Logan TK, 2004, J INTERPERS VIOLENCE, V19, P1478, DOI 10.1177/0886260504269699; Meyer S, 2012, AUST NZ J CRIMINOL, V45, P179, DOI 10.1177/0004865812443677; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Moyer VA, 2013, ANN INTERN MED, V158, P478, DOI 10.7326/0003-4819-158-6-201303190-00588; Muelleman RL, 1996, ANN EMERG MED, V28, P486, DOI 10.1016/S0196-0644(96)70110-5; Osborne JW., 2004, PRACTICAL ASSESSMENT, V9; Roberts A.C., 1998, PREFRONTAL CORTEX EX; Romans S, 2007, J INTERPERS VIOLENCE, V22, P1495, DOI 10.1177/0886260507306566; Saddki N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-268; Saltzman L.E., 2002, INTIMATE PARTNER VIO; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Thompson RS, 2006, AM J PREV MED, V30, P447, DOI 10.1016/j.amepre.2006.01.016; Tiwari A, 2001, Can J Nurs Res, V33, P63; Tiwari A., 2009, OPEN SOCIAL SCI J, V2, P32, DOI DOI 10.2174/1874945300902010032; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Ulrich YC, 2003, AM J PREV MED, V24, P9, DOI 10.1016/S0749-3797(02)00577-9; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Wilbur L, 2001, J EMERG MED, V21, P297, DOI 10.1016/S0736-4679(01)00398-5; World Health Organization, 2013, RESP INT PARTN VIOL; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503; Yuen-Tsang A, 2005, AFFILIA J WOM SOC WO, V20, P284, DOI 10.1177/0886109905277614	44	20	22	1	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6874			BMC WOMENS HEALTH	BMC Womens Health	JAN 10	2014	14								6	10.1186/1472-6874-14-6			9	Public, Environmental & Occupational Health; Obstetrics & Gynecology	Public, Environmental & Occupational Health; Obstetrics & Gynecology	AB7NI	WOS:000331976800001	24410868	DOAJ Gold, Green Published			2021-06-18	
J	Araujo, GC; Antonini, TN; Monahan, K; Gelfius, C; Klamar, K; Potts, M; Yeates, KO; Bodin, D				Araujo, Gabriel C.; Antonini, Tanya N.; Monahan, Kerry; Gelfius, Carl; Klamar, Karl; Potts, Michelle; Yeates, Keith O.; Bodin, Doug			The Relationship Between Suboptimal Effort and Post-Concussion Symptoms in Children and Adolescents With Mild Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Effort; Post-concussion symptoms; Mild traumatic brain injury; Children; Neuropsychology	ADULT INTELLIGENCE SCALE; DIGIT SPAN SUBTEST; HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; TEST-PERFORMANCE; POOR EFFORT; TASK-FORCE; OUTCOMES; BIAS; RECOVERY	This retrospective chart review study explored the relationship between suboptimal effort and post-concussion symptoms in pediatric mild traumatic brain injury (mTBI). Participants were 382 clinically referred children and adolescents between 8 and 16 years of age who sustained an mTBI. Suboptimal effort was identified using reliable digit span and age-corrected scaled scores from the Numbers subtest of the Children's Memory Scale (CMS); 20% of the sample were classified as non-credible performers. Chi-square analyses and t-tests were used to examine differences in post-concussion symptoms and neuropsychological test performance between credible and non-credible performers. Linear regression was used to examine whether CMS Numbers performance predicted post-concussion symptoms after controlling for baseline symptoms and other relevant demographic-and injury-related factors. We found that non-credible performers presented with a greater number of post-concussion symptoms as compared with credible performers. Additionally, non-credible performers demonstrated comparatively poorer performance on neuropsychological tests of focused attention and processing speed. These results suggest that children and adolescents with mTBI who fail effort testing might have a greater tendency to exaggerate post-concussion symptoms and cognitive impairment. The clinical implications of these findings are discussed.	[Araujo, Gabriel C.; Antonini, Tanya N.; Monahan, Kerry; Yeates, Keith O.; Bodin, Doug] Nationwide Childrens Hosp, Dept Psychol & Neuropsychol, Columbus, OH 43205 USA; [Araujo, Gabriel C.; Antonini, Tanya N.; Monahan, Kerry; Gelfius, Carl; Klamar, Karl; Potts, Michelle; Yeates, Keith O.; Bodin, Doug] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Gelfius, Carl; Klamar, Karl; Potts, Michelle] Nationwide Childrens Hosp, Dept Phys Med & Rehabil, Columbus, OH 43205 USA	Bodin, D (corresponding author), Nationwide Childrens Hosp, Dept Psychol & Neuropsychol, 700 Childrens Dr, Columbus, OH 43205 USA.	Doug.Bodin@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892			American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chafetz MD, 2007, ARCH CLIN NEUROPSYCH, V22, P1, DOI 10.1016/j.acn.2006.10.003; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; FROMMAUCH D, 1983, J CLIN NEUROPSYCHOL, V5, P221, DOI 10.1080/01688638308401171; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Janusz J.A., 2012, MILD TRAUMATIC BRAIN; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; KNIGHTS R, 1966, RES B, V20; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; McCrea M, 2008, MILD TRAUMATIC BRAIN; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Pennington BF., 2010, PEDIAT NEUROPSYCHOLO; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Reitan RM., 1985, HALSTEAD REITAN NEUR; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Sosin DM, 1996, BRAIN INJURY, V10, P47; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Tombaugh TN, 1996, TEST MEMORY MALINGER; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063; World Health Organization, 1992, INT CLASS DIS; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	56	20	20	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2014	28	5					786	801		10.1080/13854046.2014.896415			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	AP4MM	WOS:000342051100007	24646066				2021-06-18	
J	Curtis, K; Lam, M; Mitchell, R; Black, D; Taylor, C; Dickson, C; Jan, S; Palmer, CS; Langcake, M; Myburgh, J				Curtis, Kate; Lam, Mary; Mitchell, Rebecca; Black, Deborah; Taylor, Colman; Dickson, Cara; Jan, Stephen; Palmer, Cameron S.; Langcake, Mary; Myburgh, John			Acute costs and predictors of higher treatment costs of trauma in New South Wales, Australia	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Health economics; Cost; Outcomes; Injury	HOSPITAL COSTS; INJURY; SYSTEM; MORTALITY; VICTORIA	Background: Accurate economic data are fundamental for improving current funding models and ultimately in promoting the efficient delivery of services. The financial burden of a high trauma casemix to designated trauma centres in Australia has not been previously determined, and there is some evidence that the episode funding model used in Australia results in the underfunding of trauma. Aim: To describe the costs of acute trauma admissions in trauma centres, identify predictors of higher treatment costs and cost variance in New South Wales (NSW), Australia. Materials and methods: Data linkage of admitted trauma patient and financial data provided by 12 Level 1 NSW trauma centres for the 08/09 financial year was performed. Demographic, injury details and injury scores were obtained from trauma registries. Individual patient general ledger costs (actual trauma patient costs), Australian Refined Diagnostic Related Groups (AR-DRG) and state-wide average costs (which form the basis of funding) were obtained. The actual costs incurred by the hospital were then compared with the state-wide AR-DRG average costs. Multivariable multiple linear regression was used for identifying predictors of costs. Results: There were 17,522 patients, the average per patient cost was $10,603 and the median was $4628 (interquartile range: $2179-10,148). The actual costs incurred by trauma centres were on average $134 per bed day above AR-DRG costs-determined costs. Falls, road trauma and violence were the highest causes of total cost. Motor cyclists and pedestrians had higher median costs than motor vehicle occupants. As a result of greater numbers, patients with minor injury had comparable total costs with those generated by patients with severe injury. However the median cost of severely injured patients was nearly four times greater. The count of body regions injured, sex, length of stay, serious traumatic brain injury and admission to the Intensive Care Unit were significantly associated with increased costs (p < 0.001). Conclusion: This multicentre trauma costing study demonstrated the feasibility of trauma registry and financial data linkage. Discrepancies between the observed costs of care in these 12 trauma centres and the NSW average AR-DRG costs suggest that trauma care is currently underfunded in NSW. Crown Copyright (C) 2012 Published by Elsevier Ltd. All rights reserved.	[Curtis, Kate] Univ Sydney, Sydney Nursing Sch, Sydney, NSW 2006, Australia; [Curtis, Kate; Dickson, Cara; Langcake, Mary; Myburgh, John] St George Hosp, Sydney, NSW, Australia; [Mitchell, Rebecca] Univ New S Wales, Sydney, NSW 2052, Australia; [Curtis, Kate; Myburgh, John] Univ NSW, Fac Med, St George Clin Sch, Sydney, NSW, Australia; [Lam, Mary; Black, Deborah] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Taylor, Colman] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Palmer, Cameron S.] Royal Childrens Hosp, Trauma Serv, Melbourne, Vic, Australia; [Palmer, Cameron S.] Monash Univ, Dept Epidemiol & Preventat Med, Clayton, Vic 3800, Australia	Curtis, K (corresponding author), St George Publ Hosp, Trauma Serv, Gray St, Kogarah, NSW 2217, Australia.	Kate.Curtis@sesiahs.health.nsw.gov.au	Jan, Stephen/AAG-3333-2021; black, deborah/C-2829-2017; Mitchell, Rebecca/Z-5476-2019	black, deborah/0000-0001-9174-1565; Mitchell, Rebecca/0000-0003-1939-1761; Jan, Stephen/0000-0003-2839-1405	Sydney Nursing School/Sydney University Post-doctoral Fellowship; ARC-linkage Post-doctoral FellowshipAustralian Research Council [LP0990057]; NHMRC Senior Research FellowshipNational Health and Medical Research Council of Australia [1020430]; NSW Institute of Injury and Trauma Management; The St George, Sutherland Medical Research Foundation	K. Curtis was supported by a Sydney Nursing School/Sydney University Post-doctoral Fellowship. R. Mitchell was supported by an ARC-linkage Post-doctoral Fellowship (LP0990057). Stephen Jan is a recipient of an NHMRC Senior Research Fellowship (1020430). Funding support was provided by the NSW Institute of Injury and Trauma Management and The St George, Sutherland Medical Research Foundation. The study sponsors had no involvement in the study design, collection, analysis and interpretation of data or the writing of the manuscript.	Association for the Advancement of Automotive Medicine, 1998, ABBR INJ SCAL 1998 R; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005 2; Australian Institute of Health and Welfare, 2010, AUSTR HLTH 2010; Australian Institute of Health and Welfare (AIHW), 2010, AUSTR I HLTH WELF AI, V17; Australian Institute of Health and Welfare (AIHW), 2010, AUSTR I HLTH WELF AI, V42; Australian Tax Office, 2010, FIN YEAR END 30 JUN; Branch I-GFS, 2008, EPISODE FUNDING POLI, P1; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Christensen MC, 2008, INJURY, V39, P1013, DOI 10.1016/j.injury.2008.01.012; Christensen MC, 2008, CRIT CARE, V12, DOI 10.1186/cc6797; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Curtis Kate, 2002, Aust Health Rev, V25, P73; Curtis K, 2011, HEALTH INF MANAG J, V40, P7, DOI 10.1177/183335831104000102; Curtis K, 2009, AUST HEALTH REV, V33, P84, DOI 10.1071/AH090084; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Grotz M, 2004, UNFALLCHIRURG, V107, P68, DOI 10.1007/s00113-003-0715-5; Health NSW, 2009, SEL SPEC STAT SERV P; International Business Machines Corporation (IBM), 2008, STAT PACK SOC SCI SP; Ivers R, 2006, INJURY PREV, V12, P351, DOI 10.1136/ip.2006.013813; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Lyons RA, 2010, INT J INJ CONTROL SA, V17, P145, DOI 10.1080/17457300903453104; MACKENZIE EJ, 1990, J TRAUMA, V30, P1096, DOI 10.1097/00005373-199009000-00005; Mitchell RJ, 2008, MED J AUSTRALIA, V188, P405, DOI 10.5694/j.1326-5377.2008.tb01685.x; NSW Health Department, 2006, 2006 2007 NSW PROGR; NSW Health Department, 2010, NSW HLTH EP FUND POL; Palmer CS, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-1; Pape HC, 2009, EUR J TRAUMA EMERG S, V35, P61, DOI 10.1007/s00068-008-8013-0; Peden M., 2002, INJURY LEADING CAUSE; PowerHealth Solutions, 2006, POWERPERFORMANCE MAN; Probst C, 2009, UNFALLCHIRURG, V112, P975, DOI 10.1007/s00113-009-1684-0; Rotondo MF, 2009, J TRAUMA, V67, P915, DOI 10.1097/TA.0b013e3181b848e7; Rowell D, 2011, J TRAUMA, V70, P1086, DOI 10.1097/TA.0b013e3181ed4d29; Twijnstra MJ, 2010, ANN SURG, V251, P339, DOI 10.1097/SLA.0b013e3181c0e910; Willensberg L, 2011, ROADS REC SUCC SYST; World Health Organization, 2012, INT CLASS DIS ICD; World Health Organization, 2009, GLOB STAT REP ROAD S	37	20	20	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2014	45	1					279	284		10.1016/j.injury.2012.10.002			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	264OJ	WOS:000327887800051	23092784				2021-06-18	
J	Decloe, MD; Meeuwisse, WH; Hagel, BE; Emery, CA				Decloe, Melissa D.; Meeuwisse, Willem H.; Hagel, Brent E.; Emery, Carolyn A.			Injury rates, types, mechanisms and risk factors in female youth ice hockey	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Ice hockey; Children's injuries; Epidemiology; Injury Prevention; Concussion	OF-THE-LITERATURE; BODY CHECKING; PLAYERS; EPIDEMIOLOGY; SPORT	Background The objectives of this cohort study were to examine the rate, types, mechanisms and risk factors for injury in female youth (ages 9-17) ice hockey players in the Girls Hockey Calgary Association. Methods The main outcome was ice hockey injury, defined as any injury occurring during the 2008/2009 season that required medical attention, and/or removal from a session and/or missing a subsequent session. Potential risk factors included age group, level of play, previous injury, ice hockey experience, physical activity level, weight, height, position of play and menarche. Incidence rate ratios (IRR) were estimated with Poisson Regression adjusted for cluster (team). Exposure data were collected for every session for each participating player. Results Twenty-eight teams (n=324) from Atom (ages 9-10), PeeWee (11-12), Bantam (13-14) and Midget (15-17) participated with 53 reported injuries. The overall injury rate was 1.9 injuries/1000 player-hours (95% CI 1.4 to 2.7). Previous injury (IRR=2.7, 95% CI 1.7 to 4.3), games (IRR=2.1, 95% CI 1.1 to 4.2), menarche (PeeWee) (IRR=4.1, 95% CI 1.0 to 16.8) were significant risk factors. In Midget, the more elite divisions were associated with a lower injury risk (A-IRR=0.2, 95% CI 0.1 to 0.5) (AAA-IRR=0.5, 95% CI 0.2 to 0.9). Conclusions Injury rates were lower in this study than previously found in male youth and women's ice hockey populations. Previous injury and game play as risk factors are consistent with the literature. Menarche as a risk factor is a new finding in this study. This research will inform future studies of the development of injury prevention strategies in this population.	[Decloe, Melissa D.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada; [Meeuwisse, Willem H.; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB T2N 1N4, Canada; [Hagel, Brent E.; Emery, Carolyn A.] Alberta Childrens Prov Gen Hosp, Dept Pediat, Fac Med, Calgary, AB, Canada; [Hagel, Brent E.; Emery, Carolyn A.] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada	Emery, CA (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada.	caemery@ucalgary.ca	Hagel, Brent/AAK-3319-2020; Emery, Carolyn/AAI-2761-2020		Alberta Centre for Child, Family and Community Research [08SM-EMERY]	This research project was funded through an Investigator-driven grant from the Alberta Centre for Child, Family and Community Research (grant number 08SM-EMERY).	Agel J, 2007, J ATHL TRAINING, V42, P249; Benson Brian W, 2005, Med Sport Sci, V49, P86, DOI 10.1159/000085393; BERNARD D, 1993, ASTM STP, V1212, P44; Bracko MR, 2001, PEDIATR EXERC SCI, V13, P26, DOI 10.1123/pes.13.1.26; Brunelle JP, 2005, J SCI MED SPORT, V8, P294, DOI 10.1016/S1440-2440(05)80040-4; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Dryden D M, 2000, J Sci Med Sport, V3, P140, DOI 10.1016/S1440-2440(00)80076-6; Dryden DM, 2000, MED SCI SPORT EXER, V32, P1378, DOI 10.1097/00005768-200008000-00004; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; Emery CA, 2008, BRIT J SPORT MED, V42, P491; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Emery CA, 2009, CLIN J SPORT MED, V19, P207, DOI 10.1097/JSM.0b013e31819d658e; FINKE R C, 1988, Journal of Orthopaedic and Sports Physical Therapy, V10, P54; FROME EL, 1985, AM J EPIDEMIOL, V121, P309, DOI 10.1093/oxfordjournals.aje.a114001; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Hanson SL, 1999, SOCIOL SPORT J, V16, P92, DOI 10.1123/ssj.16.2.92; Hewett TE, 2007, AM J SPORT MED, V35, P659, DOI 10.1177/0363546506295699; *HOCK CAN, HOCK CAN ANN REP 200; LYSENS RJ, 1991, SPORTS MED, V12, P281, DOI 10.2165/00007256-199112050-00001; Molsa J, 2003, AM J SPORT MED, V31, P751; Montelpare WJ, 2004, ASTM INT, V1, P70; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; ROY MA, 1989, PHYSICIAN SPORTSMED, V17, P119, DOI 10.1080/00913847.1989.11709735; Roy MA, 1989, PHYS SP MED, V17, P125; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; Smith AM, 1997, AM J SPORT MED, V25, P500, DOI 10.1177/036354659702500413; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Theberge N, 2003, YOUTH SOC, V34, P497, DOI 10.1177/0044118X03034004005; Voaklander DC, 1998, SPORTS MED TRAINING, V8, P239, DOI 10.1080/15438629809512530; Wattie N, 2007, PEDIATRICS, V120, P142, DOI 10.1542/peds.2006-2672; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06	33	20	20	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2014	48	1					51	+		10.1136/bjsports-2012-091653			7	Sport Sciences	Sport Sciences	272YX	WOS:000328500500011	23446642				2021-06-18	
J	Di Pietro, V; Amorini, AM; Tavazzi, B; Vagnozzi, R; Logan, A; Lazzarino, G; Signoretti, S; Lazzarino, G; Belli, A				Di Pietro, Valentina; Amorini, Angela Maria; Tavazzi, Barbara; Vagnozzi, Roberto; Logan, Ann; Lazzarino, Giacomo; Signoretti, Stefano; Lazzarino, Giuseppe; Belli, Antonio			The Molecular Mechanisms Affecting N-Acetylaspartate Homeostasis Following Experimental Graded Traumatic Brain Injury	MOLECULAR MEDICINE			English	Article							ACETYL-L-ASPARTATE; CENTRAL-NERVOUS-SYSTEM; TEMPORAL WINDOW; MITOCHONDRIAL; ASPARTOACYLASE; VULNERABILITY; CONCUSSIONS; DAMAGE; MODEL; NAA	To characterize the molecular mechanisms of N-acetylaspartate (NAA) metabolism following traumatic brain injury (TBI), we measured the NAA, adenosine triphosphate (ATP) and adenosine diphosphate (ADP) concentrations and calculated the ATP/ADP ratio at different times from impact, concomitantly evaluating the gene and protein expressions controlling NAA homeostasis (the NAA synthesizing and degrading enzymes N-acetyltransferase 8-like and aspartoacylase, respectively) in rats receiving either mild or severe TBI. The reversible changes in NAA induced by mild TBI were due to a combination of transient mitochondrial malfunctioning with energy crisis (decrease in ATP and in the ATP/ADP ratio) and modulation in the gene and protein levels of N-acetyltransferase 8-like and increase of aspartoacylase levels. The irreversible decrease in NAA following severe TBI, was instead characterized by profound mitochondrial malfunctioning (constant 65% decrease of the ATP/ADP indicating permanent impairment of the mitochondrial phosphorylating capacity), dramatic repression of the N-acetyltransferase 8-like gene and concomitant remarkable increase in the aspartoacylase gene and protein levels. The mechanisms underlying changes in NAA homeostasis following graded TBI might be of note for possible new therapeutic approaches and will help in understanding the effects of repeat concussions occurring during particular periods of the complex NAA recovery process, coincident with the so called window of brain vulnerability.	[Di Pietro, Valentina; Logan, Ann; Belli, Antonio] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Neuropharmacol & Neurobiol Sect, Birmingham, W Midlands, England; [Amorini, Angela Maria; Tavazzi, Barbara; Lazzarino, Giacomo] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, I-00168 Rome, Italy; [Vagnozzi, Roberto] Univ Roma Tor Vergata, Dept Biomed & Prevent, Neurosurg Sect, Rome, Italy; [Signoretti, Stefano] San Camillo Hosp, Dept Neurosci Head & Neck Surg, Div Neurosurg, Rome, Italy; [Lazzarino, Giuseppe] Univ Catania, Dept Biol Geol & Environm Sci, Div Biochem & Mol Biol, Catania, Italy	Tavazzi, B (corresponding author), Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Largo F Vito 1, I-00168 Rome, Italy.	btavazzi@rm.unicatt.it	TAVAZZI, BARBARA/AAB-9830-2019; Signoretti, stefano/AAL-5631-2020; Belli, Antonio/I-3799-2015; lazzarino, giuseppe/K-2277-2015	TAVAZZI, BARBARA/0000-0001-8743-0895; Signoretti, stefano/0000-0002-8086-1622; Belli, Antonio/0000-0002-3211-9933; AMORINI, Angela Maria/0000-0003-3525-9955; Logan, Ann/0000-0003-3215-5042; Di Pietro, Valentina/0000-0001-9430-4723; Lazzarino, Giacomo/0000-0003-1639-0966; lazzarino, giuseppe/0000-0002-5917-7279	University of Catania; University of Rome Tor Vergata; Catholic University of Rome	This work was done at The Institute of Biochemistry and Clinical Biochemistry, Catholic University of Rome, Rome, Italy and The Neuropharmacology and Neurobiology Section, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom. This work was supported in part by research funds of the University of Catania, University of Rome Tor Vergata and Catholic University of Rome.	Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Amaral Ana I, 2013, Front Endocrinol (Lausanne), V4, P54, DOI 10.3389/fendo.2013.00054; Ariyannur PS, 2010, BRAIN RES, V1335, P1, DOI 10.1016/j.brainres.2010.04.008; Arun P, 2009, NEUROCHEM INT, V55, P219, DOI 10.1016/j.neuint.2009.03.003; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; Benarroch EE, 2008, NEUROLOGY, V70, P1353, DOI 10.1212/01.wnl.0000311267.63292.6c; Bitto E, 2007, P NATL ACAD SCI USA, V104, P456, DOI 10.1073/pnas.0607817104; Clark JF, 2006, MED HYPOTHESES, V67, P506, DOI 10.1016/j.mehy.2006.02.047; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; Jessen F, 2011, J ALZHEIMERS DIS, V27, P393, DOI 10.3233/JAD-2011-110398; Kamada Kyousuke, 1995, Neurologia Medico-Chirurgica, V35, P1, DOI 10.2176/nmc.35.1; LAZZARINO G, 1989, ANAL BIOCHEM, V181, P239, DOI 10.1016/0003-2697(89)90236-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Maniega SM, 2008, NEUROLOGY, V71, P1993, DOI 10.1212/01.wnl.0000336970.85817.4a; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MATALON R, 1988, AM J MED GENET, V29, P463, DOI 10.1002/ajmg.1320290234; Moreno A, 2001, J NEUROCHEM, V77, P347, DOI 10.1046/j.1471-4159.2001.00282.x; Qian JC, 2013, NEUROCHEM RES, V38, P208, DOI 10.1007/s11064-012-0910-2; Rae C, 2012, NEUROCHEM RES, V37, P2541, DOI 10.1007/s11064-012-0847-5; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; Rigotti DJ, 2012, NEUROLOGY, V78, P1383, DOI 10.1212/WNL.0b013e318253d609; Rubin Y, 1997, J NEUROTRAUM, V14, P441, DOI 10.1089/neu.1997.14.441; Satrustegui J, 2007, J NEUROSCI RES, V85, P3359, DOI 10.1002/jnr.21299; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Signoretti S, 2002, ACT NEUR S, V81, P373; Tahay G, 2012, BIOCHEM J, V441, P105, DOI 10.1042/BJ20111179; Tallan HH., 1957, J BIOL CHEM, P22441; Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Vagnozzi R, 2012, BRAIN INJURY PATHOGE, P501; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263	40	20	23	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1076-1551	1528-3658		MOL MED	Mol. Med.	JAN-JUN	2014	20						147	157		10.2119/molmed.2013.00153			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9QL	WOS:000334343100003	24515258	DOAJ Gold, Green Published			2021-06-18	
J	Goodrich, GL; Martinsen, GL; Flyg, HM; Kirby, J; Garvert, DW; Tyler, CW				Goodrich, Gregory L.; Martinsen, Gary L.; Flyg, Heidi M.; Kirby, Jennine; Garvert, Donn W.; Tyler, Christopher W.			Visual function, traumatic brain injury, and posttraumatic stress disorder	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						binocular vision; blast-related; medication side effects; non-blast-related; oculomotor function; posttraumatic stress disorder; traumatic brain injury; vision function; vision loss; visual symptoms	CONVERGENCE INSUFFICIENCY; MILITARY; VETERANS; BLAST; AFGHANISTAN; DYSFUNCTION; DEPRESSION; IMPAIRMENT; OUTCOMES; IRAQI	Traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) are signature injuries of the Iraq and Afghanistan conflicts. The conditions can be comorbid and have overlapping signs and symptoms, making it difficult to diagnose and treat each. TBI is associated with numerous changes in vision function, but vision problems secondary to PTSD have not been documented. To address this shortcoming, we reviewed the medical records of 100 patients with a history of TBI, noting PTSD diagnoses, visual symptoms, vision function abnormalities, and medications with visual side effects. Forty-one patients had PTSD and 59 did not. High rates of binocular vision and oculomotor function deficits were measured in patients with a history of TBI, but no significant differences between patients with or without PTSD were evident. However, compared to patients without PTSD, patients with PTSD had more self-reported visual symptoms in all four assessments and the complaint rates were significantly higher for light sensitivity and reading problems. Together, these findings may be beneficial in understanding vision problems in patients with TBI and PTSD as comorbid conditions compared with those with TBI alone.	[Goodrich, Gregory L.; Martinsen, Gary L.; Flyg, Heidi M.; Kirby, Jennine; Garvert, Donn W.] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Tyler, Christopher W.] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	Goodrich, GL (corresponding author), Dept Vet Affairs Palo Alto Hlth Care Syst, 795 Willow Rd,Bldg T-365, Menlo Pk, CA 94025 USA.	Gregory.Goodrich@va.gov	Goodrich, Gregory L./AAF-7184-2019		Department of Veterans Affairs Quality Enhancement Research InitiativeUS Department of Veterans Affairs [RRP 11-008]; Department of DefenseUnited States Department of Defense [W81XWH-11-2-0066]	This material was based on work supported in part by the Department of Veterans Affairs Quality Enhancement Research Initiative (grant RRP 11-008) and by a subcontract to Dr. Goodrich of Department of Defense grant W81XWH-11-2-0066 to Dr. Tyler.	[Anonymous], DSM CRITERIA FOR PTS; Bahraini N, 2012, FRONT NEUROL, V3; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bentley S., 2005, SHORT HIST PTSD THER; Borsting E, 1999, OPTOMETRY VISION SCI, V76, P221, DOI 10.1097/00006324-199904000-00025; Bower K.M., 2003, 6 SIGMA FORUM MAGAZI, VVolume 2, P35, DOI DOI 10.1080/01621459.1974.10482955; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Burgess Paula, 2010, J Emerg Trauma Shock, V3, P164, DOI 10.4103/0974-2700.62120; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Drugs.com, 2014, TRAZODONE; Gellis LA, 2010, PRIM CARE COMPANION, V12; GERSONS BPR, 1992, BRIT J PSYCHIAT, V161, P742, DOI 10.1192/bjp.161.6.742; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Han M H Esther, 2008, Optometry, V79, P252, DOI 10.1016/j.optm.2008.01.001; Hofstetter HW., 1944, AM J OPTOM ARCH AM A, V21, P345, DOI [10.1097/00006324-194409000-00001, DOI 10.1097/00006324-194409000-00001]; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Kendall-Tackett KA, 2000, CHILD ABUSE NEGLECT, V24, P799, DOI 10.1016/S0145-2134(00)00136-8; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Litz B. T., 2009, PTSD RES Q, V20, P1; Liu DJ, 2013, J MOL NEUROSCI, V49, P360, DOI 10.1007/s12031-012-9874-6; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Maples WC, 1992, J BEHAV OPTOM, V3, P143; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; PubMed Health, DRUGS A Z; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; SUMMERALL EL, TRAUMATIC BRAIN INJU; Tanielian T., 2008, INVISIBLE WOUNDS OF; Trachtman JN, 2010, OPTOMETRY, V81, P240, DOI 10.1016/j.optm.2009.07.017; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033	46	20	20	1	18	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	4					547	558		10.1682/JRRD.2013.02.0049			12	Rehabilitation	Rehabilitation	AN8ZR	WOS:000340895400004	25144168	Bronze, Green Accepted			2021-06-18	
J	Joseph, B; Aziz, H; Pandit, V; Kulvatunyou, N; O'Keeffe, T; Tang, A; Wynne, J; Hashmi, A; Vercruysse, G; Friese, RS; Rhee, P				Joseph, Bellal; Aziz, Hassan; Pandit, Viraj; Kulvatunyou, Narong; O'Keeffe, Terence; Tang, Andrew; Wynne, Julie; Hashmi, Ammar; Vercruysse, Gary; Friese, Randall S.; Rhee, Peter			Low-dose aspirin therapy is not a reason for repeating head computed tomographic scans in traumatic brain injury: a prospective study	JOURNAL OF SURGICAL RESEARCH			English	Article							INTRACRANIAL HEMORRHAGE; ELDERLY-PATIENTS; OUTCOMES; ANTIPLATELET	Background: Most studies have categorized all antiplatelet drugs into one category. The aim of our study was to evaluate the utility of repeat head computed tomography (RHCT) and outcomes in patients on low-dose aspirin (acetylsalicylic acid; ASA) therapy. Methods: Patients with traumatic brain injury with intracranial hemorrhage on initial head computed tomography (CT) were prospectively enrolled. Patients on prehospital low-dose (81 mg) aspirin therapy were matched with patients exclusive of antiplatelet and anticoagulation therapy using propensity score matching in a 1:1 ratio for age, Glasgow Coma Scale, head Abbreviated Injury Scale score, Injury Severity Score, and neurological examination. Outcome measures were progression on RHCT and subsequent neurosurgical intervention. Results: A total of 144 patients who had intracranial hemorrhage on initial CT scan (ASA group: 72; No-ASA group: 72) were enrolled. The mean age was 72.8 +/- 11.7 years, 59.7% were male, and median head Abbreviated Injury Scale was 3 (2-3). There was no difference in progression on RHCT (25% in ASA versus 16.6% in no-ASA), change in management as a result of RHCT (1.4% versus 1.4%), RHCT as a result of neurological decline (0 versus 1.4%), discharge Glasgow Coma Scale (15 [14-15] versus 15 [14-15]), and mortality (0 versus 1.4%) between the two groups. Conclusions: Low-dose aspirin therapy is not associated with progression of initial insult on RHCT or clinical deterioration. Prehospital low-dose aspirin therapy as a sole criterion should not warrant a routine repeat head CT in traumatic brain injury. Published by Elsevier Inc.	[Joseph, Bellal; Aziz, Hassan; Pandit, Viraj; Kulvatunyou, Narong; O'Keeffe, Terence; Tang, Andrew; Wynne, Julie; Hashmi, Ammar; Vercruysse, Gary; Friese, Randall S.; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ 85724 USA	Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu					Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; DOUTREMEPUICH C, 1990, HAEMOSTASIS, V20, P99; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; HIRSH J, 1995, CHEST, V108, pS231, DOI 10.1378/chest.108.4_Supplement.231S; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Joseph B, 2013, AM SURG IN PRESS; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Mattox K, 2012, TRAUMA; MERRIMAN E, 1979, J NEUROSURG, V50, P682, DOI 10.3171/jns.1979.50.5.0682; MINAR E, 1995, CIRCULATION, V91, P2167, DOI 10.1161/01.CIR.91.8.2167; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; REYMOND MA, 1992, NEUROSURG REV, V15, P21, DOI 10.1007/BF02352062; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; SPEKTOR S, 1995, ACTA NEUROCHIR, V134, P51, DOI 10.1007/BF01428502; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Yu J, 2012, JACC-CARDIOVASC INTE, V5, P1231, DOI 10.1016/j.jcin.2012.07.016	17	20	21	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2014	186	1					287	291		10.1016/j.jss.2013.08.009			5	Surgery	Surgery	274TJ	WOS:000328628800051	24011918				2021-06-18	
J	Kamal, MA; Priyamvada, S; Anbazhagan, AN; Jabir, NR; Tabrez, S; Greig, NH				Kamal, Mohammad A.; Priyamvada, Shubha; Anbazhagan, Arivarasu N.; Jabir, Nasimudeen R.; Tabrez, Shams; Greig, Nigel H.			Linking Alzheimer's Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Alzheimer's disease; Anti-cholinesterase; Butyrylcholinesterase; Inflammation; Type 2 diabetes mellitus	GLYCATION END-PRODUCTS; GLUCAGON-LIKE PEPTIDE-1; NECROSIS-FACTOR-ALPHA; HUMAN SERUM BUTYRYLCHOLINESTERASE; AMYLOID PRECURSOR PROTEIN; GROWTH-FACTOR EXPRESSION; A-BETA LEVELS; MOUSE MODEL; METABOLIC SYNDROME; ANIMAL-MODELS	Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are two progressive and devastating health disorders afflicting millions of people worldwide. The probability and incidence of both have increased considerably in recent years consequent to increased longevity and population growth. Progressively more links are being continuously found between inflammation and central nervous system disorders like AD, Parkinson's disease, Huntington's disease, motor neuron disease, multiple sclerosis, stroke, traumatic brain injury and even cancers of the nervous tissue. The depth of the relationship depends on the timing and extent of anti- or pro-inflammatory gene expression. Inflammation has also been implicated in T2DM. Misfolding and fibrillization (of tissue specific and/or non-specific proteins) are features common to both AD and T2DM and are induced by as well as contribute to inflammation and stress (oxidative/glycation). This review appraises the roles of inflammation and abnormalities in the insulin signaling system as important shared features of T2DM and AD. The capacity of anti-cholinesterases in reducing the level of certain common inflammatory markers in particular if they may provide therapeutic potential to mitigate awry mechanisms leading to AD.	[Kamal, Mohammad A.; Jabir, Nasimudeen R.; Tabrez, Shams] King Abdulaziz Univ, King Fahd Med Res Ctr, Fundamental & Appl Biol Grp, Metabol & Enzymol Unit, Jeddah 21589, Saudi Arabia; [Priyamvada, Shubha; Anbazhagan, Arivarasu N.] Univ Illinois, Dept Med, Sect Digest Dis & Nutr, Chicago, IL 60612 USA; [Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH,Biomed Res Ctr, Baltimore, MD 21224 USA	Kamal, MA (corresponding author), King Abdulaziz Univ, King Fahd Med Res Ctr, Fundamental & Appl Biol Grp, Metabol & Enzymol Unit, POB 80216, Jeddah 21589, Saudi Arabia.	meu.fabg@hotmail.com	Rehumathbeevi, Jabir Nasimudeen/H-9483-2012; Kamal, Mohammad Amjad/J-2918-2014; Tabrez, Shams/H-9476-2012; Tabrez, Shams/H-7315-2019	Rehumathbeevi, Jabir Nasimudeen/0000-0001-8548-7986; Kamal, Mohammad Amjad/0000-0003-0088-0565; Tabrez, Shams/0000-0003-4550-415X; Tabrez, Shams/0000-0003-4550-415X; Priyamvada, Shubha/0000-0002-7241-569X	Intramural Research Program of the National Institute on Aging, National Institutes of Health, Baltimore, MD, USA; Section of Digestive Diseases and Nutrition, Department of Medicine, University of Illinois, Chicago, USA; deanship of scientific research at KSU [RGP-VPP-215]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000311] Funding Source: NIH RePORTER	N.G. is supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Baltimore, MD, USA. SP and NAA are grateful for support by the Section of Digestive Diseases and Nutrition, Department of Medicine, University of Illinois, Chicago, USA. MAK, JNR and ST also extend their appreciation to the deanship of scientific research at KSU for funding the work through the research group project No- RGP-VPP-215.	ABBOTT CA, 1993, CLIN SCI, V85, P77, DOI 10.1042/cs0850077; Ahmed I, 2006, MT SINAI J MED, V73, P759; Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x; Aleong R, 2008, CURR ALZHEIMER RES, V5, P33; Allam AR, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-28; Ando K, 1999, J NEUROSCI, V19, P4421; ARENDT T, 1984, LANCET, V1, P173; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Banks WA, 1997, PEPTIDES, V18, P1577, DOI 10.1016/S0196-9781(97)00238-6; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; BASKIN DG, 1985, LIFE SCI, V36, P627, DOI 10.1016/0024-3205(85)90166-3; Becker RE, 2010, CURR ALZHEIMER RES, V7, P642; Becker RE, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000446; Beeler N, 2009, BRAIN RES BULL, V80, P274, DOI 10.1016/j.brainresbull.2009.07.006; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Biessels GJ, 2004, EUR J PHARMACOL, V490, P1, DOI 10.1016/j.ejphar.2004.02.057; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Borovikova LV, 2000, NATURE, V405, P458; CACABELOS R, 1991, METHOD FIND EXP CLIN, V13, P455; Capsoni S, 2011, CNS NEUROL DISORD-DR, V10, P635, DOI 10.2174/187152711796235032; Chaney MO, 2005, BBA-MOL BASIS DIS, V1741, P199, DOI 10.1016/j.bbadis.2005.03.014; Chen GJ, 2003, J ALZHEIMERS DIS, V5, P209, DOI 10.3233/JAD-2003-5305; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Chiang HC, 2010, P NATL ACAD SCI USA, V107, P7060, DOI 10.1073/pnas.0909314107; Cholerton B, 2011, DIABETIC MED, V28, P1463, DOI 10.1111/j.1464-5491.2011.03464.x; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Das UN, 2007, MED SCI MONITOR, V13, pRA214; Das UN, 2007, J NUTR BIOCHEM, V18, P701, DOI 10.1016/j.jnutbio.2007.01.002; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Eldor R, 2006, DIABETES RES CLIN PR, V74, pS3, DOI 10.1016/j.diabres.2006.06.004; Fang F, 2010, FASEB J, V24, P1043, DOI 10.1096/fj.09-139634; Ferrucci L, 2002, J AM GERIATR SOC, V50, P1947, DOI 10.1046/j.1532-5415.2002.50605.x; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Gautam S, 2011, MOL GENET METAB, V102, P389, DOI 10.1016/j.ymgme.2010.12.012; Greig NH, 2005, P NATL ACAD SCI USA, V102, P17213, DOI 10.1073/pnas.0508575102; Guo JT, 2002, J NEUROSCI, V22, P5900; Gupta A, 2003, INT J CLIN PRACT, V57, P36; Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170; Hamer M, 2009, AGE, V31, P171, DOI 10.1007/s11357-009-9097-0; Hashim Y, 2001, DIABETOLOGIA, V44, P2227, DOI 10.1007/s001250100033; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Janelsins MC, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-23; Jellinger KA, 2006, J NEURAL TRANSM, V113, P1603, DOI 10.1007/s00702-006-0578-3; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Kaiyala KJ, 2000, DIABETES, V49, P1525, DOI 10.2337/diabetes.49.9.1525; Kamal MA, 2006, BBA-GEN SUBJECTS, V1760, P200, DOI 10.1016/j.bbagen.2005.10.003; Kamal MA, 2008, J NEURAL TRANSM, V115, P889, DOI 10.1007/s00702-008-0022-y; Kamal MA, 2008, NEUROCHEM RES, V33, P745, DOI 10.1007/s11064-007-9490-y; Kamal MA, 2006, J ALZHEIMERS DIS, V10, P43; Kaneto H, 2007, CURR MOL MED, V7, P674, DOI 10.2174/156652407782564408; Kelley KW, 2013, BRAIN BEHAV IMMUN; Kennedy DJ, 2011, METAB SYNDR RELAT D, V9, P239, DOI 10.1089/met.2011.0003; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Kloppenborg RP, 2008, EUR J PHARMACOL, V585, P97, DOI 10.1016/j.ejphar.2008.02.049; Koivisto AM, 2005, J NEUROGENET, V19, P155, DOI 10.1080/01677060600569721; Kumar S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-9; LAM K, 1994, J BIOL CHEM, V269, P20648; Laws SM, 2005, HUM MUTAT, V26, P29, DOI 10.1002/humu.20180; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Li L, 2007, BRAIN RES REV, V56, P384, DOI 10.1016/j.brainresrev.2007.09.001; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Lue Lih-Fen, 2012, Int J Alzheimers Dis, V2012, P918680, DOI 10.1155/2012/918680; Lue LF, 2010, MOL NEUROBIOL, V41, P115, DOI 10.1007/s12035-010-8106-8; Luo WM, 2006, J MED CHEM, V49, P2174, DOI 10.1021/JM050578P; Luo WM, 2005, J ORG CHEM, V70, P6171, DOI 10.1021/jo0503052; Luo WM, 2005, J MED CHEM, V48, P986, DOI 10.1021/jm049309+; MARKS JL, 1991, ADV EXP MED BIOL, V293, P459; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Milionis HJ, 2008, CNS SPECTRUMS, V13, P606, DOI 10.1017/S1092852900016886; Miyamoto Y, 2005, J NEUROSCI, V25, P1826, DOI 10.1523/jneurosci.3030-04.2005; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Nizri E, 2007, PHARMACOLOGY, V79, P42, DOI 10.1159/000097628; Nunomura A, 2012, NEUROTOX RES, V22, P231, DOI 10.1007/s12640-012-9331-x; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; PALMER JP, 1989, DIABETES, V38, P1211, DOI 10.2337/diabetes.38.10.1211; Pangalos MN, 2007, NAT REV DRUG DISCOV, V6, P521, DOI 10.1038/nrd2094; PERRY EK, 1986, BRIT MED BULL, V42, P63, DOI 10.1093/oxfordjournals.bmb.a072100; Perry RT, 2001, NEUROBIOL AGING, V22, P873, DOI 10.1016/S0197-4580(01)00291-3; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Perry Tracy Ann, 2005, Current Alzheimer Research, V2, P377, DOI 10.2174/1567205054367892; Priyadarshini M, 2012, CNS NEUROL DISORD-DR, V11, P482, DOI 10.2174/187152712800792767; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; RADA P, 1991, BRAIN RES, V550, P287, DOI 10.1016/0006-8993(91)91330-4; Rao AA, 2007, MED HYPOTHESES, V69, P1272, DOI 10.1016/j.mehy.2007.03.032; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Reale M, 2012, CURR ALZHEIMER RES, V9, P447, DOI 10.2174/156720512800492549; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Roriz JS, 2009, BBA-MOL BASIS DIS, V1792, P432, DOI 10.1016/j.bbadis.2008.12.003; Rosenberg Paul B, 2006, MedGenMed, V8, P24; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Sasaki N, 2001, BRAIN RES, V888, P256, DOI 10.1016/S0006-8993(00)03075-4; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Smith U, 2007, J INTERN MED, V262, P142, DOI 10.1111/j.1365-2796.2007.01827.x; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Taepavarapruk P, 2010, J NEUROCHEM, V112, P1054, DOI 10.1111/j.1471-4159.2009.06524.x; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tam XHL, 2011, CLIN SCI, V120, P81, DOI 10.1042/CS20100256; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Thakur A, 2007, J NEUROSCI RES, V85, P1668, DOI 10.1002/jnr.21298; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tobinick E, 2012, CURR ALZHEIMER RES, V9, P99, DOI 10.2174/156720512799015073; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Vasto S, 2009, MECH AGEING DEV, V130, P40, DOI 10.1016/j.mad.2008.06.003; Vetter SW, 2011, CLIN CHIM ACTA, V412, P2105, DOI 10.1016/j.cca.2011.07.022; Vidal CJ, 2005, CHEM-BIOL INTERACT, V157, P227, DOI 10.1016/j.cbi.2005.10.035; Watson GS, 2003, NEUROLOGY, V60, P1899, DOI 10.1212/01.WNL.0000065916.25128.25; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Win MTT, 2012, EXP DIABETES RES, DOI 10.1155/2012/894605; Wortwein G, 1997, INT J DEV NEUROSCI, V15, P147, DOI 10.1016/S0736-5748(97)00002-6; Yamagishi S, 2005, MED HYPOTHESES, V64, P1205, DOI 10.1016/j.mehy.2005.01.016; Yamagishi S, 2003, INT J CLIN PHARM RES, V23, P129; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Yu QS, 1999, J MED CHEM, V42, P1855, DOI 10.1021/jm980459s; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	139	20	21	0	18	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2014	13	2					338	346		10.2174/18715273113126660137			9	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	AN8EL	WOS:000340835800018	24074448	Green Accepted			2021-06-18	
J	Ness, BM; Vroman, K				Ness, Bryan M.; Vroman, Kerryellen			Preliminary Examination of the Impact of Traumatic Brain Injury and Posttraumatic Stress Disorder on Self-Regulated Learning and Academic Achievement Among Military Service Members Enrolled in Postsecondary Education	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						posttraumatic stress disorder; service member; self-regulated learning; military; academic achievement; traumatic brain injury	PERFORMANCE-APPROACH; COLLEGE-STUDENTS; VETERANS; EFFICACY; IRAQ; AFGHANISTAN; MOTIVATION; COMMUNITY; GOALS; PTSD	Objective: Delineate the effects of self-reported traumatic brain injury (TBI) or posttraumatic stress disorder (PTSD) on self-regulated learning and academic achievement for university-enrolled military Service members. Participants: Students (N = 192) from 8 regionally diverse universities, representing an estimated 6% of Service members enrolled across schools. Setting: Public universities that are members of the Servicemember Opportunity College consortium. Design: Cross-sectional study evaluating the relationships between self-reported TBI, PTSD, and self-regulated learning variables and their contribution to academic achievement. Main Measures: Self-report of military service; symptoms of TBI and PTSD; self-regulation strategies including effort, time/environment regulation, and academic self-efficacy; and grade point average (GPA). Results: There was no effect of self-reported TBI or PTSD on GPA, effort regulation, or time/environment regulation strategies; however, participants with TBI or PTSD reported significantly lower academic self-efficacy. Multiple regression analysis revealed self-efficacy was the strongest predictor of GPA among all participants, followed by military rank. Conclusion: The sample consisted of high achieving students responsive to a university administrator, which raises the possibility of sampling bias. Because of the low recruitment rate for this study and lack of published research on this subject, replicating the results is necessary before drawing generalizable conclusions about the population.	[Ness, Bryan M.] Univ New Hampshire, Dept Commun Sci & Disorders, Durham, NH 03824 USA; [Vroman, Kerryellen] Univ New Hampshire, Dept Occupat Therapy, Durham, NH 03824 USA	Ness, BM (corresponding author), Univ New Hampshire, Dept Commun Sci & Disorders, 4 Lib Way,151 Hewitt Hall, Durham, NH 03824 USA.	Bryan.Ness@unh.edu					Bandura A, 1996, CHILD DEV, V67, P1206, DOI 10.1111/j.1467-8624.1996.tb01791.x; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bragin M, 2010, CLIN SOC WORK J, V38, P316, DOI 10.1007/s10615-010-0267-4; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Britton PC, 2012, AM J PUBLIC HEALTH, V102, pS125, DOI 10.2105/AJPH.2011.300415; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cleary TJ, 2004, PSYCHOL SCHOOLS, V41, P537, DOI 10.1002/pits.10177; Crede M, 2011, LEARN INDIVID DIFFER, V21, P337, DOI 10.1016/j.lindif.2011.03.002; Demers A, 2011, J LOSS TRAUMA, V16, P160, DOI 10.1080/15325024.2010.519281; DiRamio D., 2011, ASHE HIGHER ED REPOR, V37, P1, DOI DOI 10.1002/AEHE.3703; DiRamio D, 2008, J STUD AFF RES PRACT, V45, P73; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; Ellison ML, 2012, PSYCHIATR REHABIL J, V35, P209, DOI 10.2975/35.3.2012.209.217; Field K., 2008, CHRON HIGHER EDUC, V54, pA1; Galor S, 2012, J LOSS TRAUMA, V17, P522, DOI 10.1080/15325024.2012.674440; Gore PA, 2006, J CAREER ASSESSMENT, V14, P92, DOI 10.1177/1069072705281367; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Kitsantas A, 2008, J ADV ACAD, V20, P42, DOI 10.4219/jaa-2008-867; Linnenbrink EA, 2002, SCHOOL PSYCHOL REV, V31, P313; Linnenbrink EA, 2005, J EDUC PSYCHOL, V97, P197, DOI 10.1037/0022-0663.97.2.197; Livingston WG, 2011, J STUD AFF RES PRACT, V48, P315, DOI 10.2202/1949-6605.6292; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; Nandagopal K, 2012, LEARN INDIVID DIFFER, V22, P597, DOI 10.1016/j.lindif.2011.11.018; National Center for PTSD, US PTSD CHECKL; O'Herrin E., 2011, PEER REV, V13, P15; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Patrick H, 1997, J EARLY ADOLESCENCE, V17, P109, DOI 10.1177/0272431697017002001; Persky KR, 2010, COMMUNITY COLL J RES, V35, P111, DOI 10.1080/10668926.2011.525184; Pintrich P., 1991, MANUAL MOTIVATED STR; PINTRICH PR, 1990, J EDUC PSYCHOL, V82, P33, DOI 10.1037/0022-0663.82.1.33; Pintrich PR, 2004, EDUC PSYCHOL REV, V16, P385, DOI 10.1007/s10648-004-0006-x; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Rotgans J, 2009, EDUC STUD-UK, V35, P239, DOI 10.1080/03055690802648051; Ruban LM, 2003, J LEARN DISABIL-US, V36, P270, DOI 10.1177/002221940303600306; Rumann CB, 2010, J HIGH EDUC, V81, P431, DOI 10.1353/jhe.0.0103; Ryan AM, 2006, PERS SOC PSYCHOL B, V32, P1246, DOI 10.1177/0146167206289345; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schunk DH, 1997, EDUC PSYCHOL-US, V32, P195, DOI 10.1207/s15326985ep3204_1; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Service Opportunity College Consortium, PROV ED OPP SERV MEM; Smith Mark W, 2005, Ment Health Serv Res, V7, P89, DOI 10.1007/s11020-005-3780-2; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Steele J. L., 2010, MILITARY VETERANS EX; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Trainin G, 2005, LEARN DISABILITY Q, V28, P261, DOI 10.2307/4126965; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; U.S. Department of Education, 2003 04 2007 08 NAT; US Census Bureau, 2011, AM FACT FIND VET STA; US Department of Veterans Affairs, 2011, ED ATT VET 2000 2009; Vance ML, 2009, J POSTSECOND EDUC DI, V22, P18; Vollmeyer R, 2006, EDUC PSYCHOL REV, V18, P239, DOI 10.1007/s10648-006-9017-0; Weathers F, PTSD CHECKLIST MILIT; Widome R, 2011, AM J HEALTH BEHAV, V35, P387, DOI 10.5993/AJHB.35.4.1; Zimmerman BJ, 2008, AM EDUC RES J, V45, P166, DOI 10.3102/0002831207312909; Zimmerman BJ, 1990, EDUC PSYCHOL REV, V2, P173, DOI 10.1007/BF01322178	62	20	20	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2014	29	1					33	43		10.1097/HTR.0b013e3182a1cd4e			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AH1OC	WOS:000335889400008	23982790				2021-06-18	
J	Pekny, T; Faiz, M; Wilhelmsson, U; Curtis, MA; Matej, R; Skalli, O; Pekny, M				Pekny, Tulen; Faiz, Maryam; Wilhelmsson, Ulrika; Curtis, Maurice A.; Matej, Radoslav; Skalli, Omar; Pekny, Milos			Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease	APMIS			English	Article						Astrocytes; GFAP; intermediate filaments; Alexander disease; neurodegenerative diseases	FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE-FILAMENTS; MICE DEFICIENT; VIMENTIN; GFAP; ACTIVATION; REGENERATION; ABSENCE; STRESS; CELLS	Alexander disease (AxD) is a neurodegenerative disorder with prominent white matter degeneration and the presence of Rosenthal fibers containing aggregates of glial fibrillary acidic protein (GFAP), and small stress proteins HSP27 and B-crystallin, and widespread reactive gliosis. AxD is caused by mutations in GFAP, the main astrocyte intermediate filament protein. We previously showed that intermediate filament protein synemin is upregulated in reactive astrocytes after neurotrauma. Here, we examined immunohistochemically the presence of synemin in reactive astrocytes and Rosenthal fibers in two patients with AxD. There was an abundance of GFAP-positive Rosenthal fibers and widespread reactive gliosis in the white matter and subpial regions. Many of the GFAP-positive reactive astrocytes were positive for synemin, and synemin was also present in Rosenthal fibers. We show that synemin is expressed in reactive astrocytes in AxD, and is also present in Rosenthal fibers. The potential role of synemin in AxD pathogenesis remains to be investigated.	[Pekny, Tulen; Faiz, Maryam; Wilhelmsson, Ulrika; Curtis, Maurice A.; Pekny, Milos] Univ Gothenburg, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol,Sahlgrenska Acad, SE-41390 Gothenburg, Sweden; [Skalli, Omar] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Matej, Radoslav] Thomayers Hosp, Dept Pathol & Mol Med, Prague, Czech Republic	Pekny, M (corresponding author), Univ Gothenburg, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol,Sahlgrenska Acad, Medicinaregatan 9A, SE-41390 Gothenburg, Sweden.	Milos.Pekny@neuro.gu.se		Curtis, Maurice/0000-0003-4496-0233	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [11548]; AFA Insurance; Swedish Stroke Foundation; Torsten Foundation; Ragnar Soderberg Foundation; Swedish Society for Medicine; Region of Vastra Gotaland; Frimurare Foundation; Amlov's Foundation; Sten A. Olsson Foundation for Research and Culture; Foundation Edit Jacobson's Donation Fund; Trygg-Hansa; Hjarnfonden; ALF Goteborg [11392]; EUEuropean Commission [237956]; TargetBraIn [279017]; NanoNet COST ActionEuropean Cooperation in Science and Technology (COST) [BM1002]	We would like to thank the late Prof. Milan Elleder for his involvement in this project. Rita Grander, Ann-Marie Alborn, and Prof. Klas Blomgren are acknowledged for technical help. This work was supported by grants from the Swedish Medical Research Council (11548), AFA Insurance, Swedish Stroke Foundation, Torsten and Ragnar Soderberg Foundations, the Swedish Society for Medicine, the Region of Vastra Gotaland (RUN), Frimurare Foundation, Amlov's Foundation, Sten A. Olsson Foundation for Research and Culture, Foundation Edit Jacobson's Donation Fund, Trygg-Hansa, Hjarnfonden, ALF Goteborg (11392), the EU FP7 Programs EduGlia (237956) and TargetBraIn (279017), and NanoNet COST Action (BM1002).	Brenner M, 2001, NAT GENET, V27, P117; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Matej R, 2008, CLIN NEUROPATHOL, V27, P64; Messing A, 2010, NEUROTHERAPEUTICS, V7, P507, DOI 10.1016/j.nurt.2010.05.013; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2004, TRENDS NEUROSCI, V27, P243, DOI 10.1016/j.tins.2004.01.012; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Tang GM, 2008, AUTOPHAGY, V4, P701, DOI 10.4161/auto.6028; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; TOMOKANE N, 1991, AM J PATHOL, V138, P875; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Yoshida T, 2011, J NEUROL, V258, P1998, DOI 10.1007/s00415-011-6056-3	25	20	20	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0903-4641	1600-0463		APMIS	APMIS	JAN	2014	122	1					76	80		10.1111/apm.12088			5	Immunology; Microbiology; Pathology	Immunology; Microbiology; Pathology	278SD	WOS:000328909100010	23594359				2021-06-18	
J	Steenstrup, SE; Bere, T; Bahr, R				Steenstrup, Sophie E.; Bere, Tone; Bahr, Roald			Head injuries among FIS World Cup alpine and freestyle skiers and snowboarders: a 7-year cohort study	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Concussion; Sporting Injuries; Epidemiology; Head Injuries; Ski Injuries	SYSTEMATIC VIDEO ANALYSIS; CRUCIATE LIGAMENT INJURY; CONSENSUS STATEMENT; INTERNATIONAL-CONFERENCE; CONCUSSION INCIDENCE; MECHANISMS; SPORTS; ZURICH; CROSS	Background Traumatic brain injury is the leading cause of death for skiers and snowboarders. Fatal head injuries have also occurred at the International Ski Federation (FIS) World Cup (WC) level. We therefore wanted to describe the risk of head injuries across disciplines and sex among WC skiers and snowboarders. Method We conducted retrospective interviews with FIS WC athletes at the end of seven consecutive seasons (2006-2013) to register injuries sustained during the competitive season. Head injuries were classified as head/face' injuries and did not include neck or cervical spine injuries. To calculate the exposure, we extracted data from the official FIS website for all WC competitions for each of the athletes interviewed. Results A total of 2080 injuries were reported during seven WC seasons. Of these, 245 (11.8%) were head/face injuries. Of the 245 head/face injuries reported, nervous system injuries/concussions were the most common (81.6%) and 58 of these were severe (23.7%). The injury incidence per 1000 competition runs was higher in freestyle (1.8, 95% CI 1.2 to 2.4) than in alpine skiing (0.9, 95% CI 0.6 to 1.2; risk ratio (RR) 2.05, 95% CI 1.25 to 3.46) and snowboard (1.0, 95% CI 0.6 to 1.3; RR 1.85, 95% CI 1.15 to 2.99). Women had a higher injury incidence (5.8, 95% CI 4.8 to 6.9) versus men (3.9, 95% CI 3.2 to 4.6; RR 1.48, 95% CI 1.15 to 1.90) throughout the season (per 100 athletes). Conclusions The majority of head/face injuries were nervous system injuries/concussions and one in four injuries was severe. Freestyle skiers had the highest overall head injury incidence. Across all disciplines, the injury incidence was higher in women than in men.	[Steenstrup, Sophie E.; Bere, Tone; Bahr, Roald] Norwegian Sch Sports Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, N-0806 Oslo, Norway; [Bere, Tone] Aspetar, Doha, Qatar	Steenstrup, SE (corresponding author), Norwegian Sch Sports Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, PB 4014 Ulleval Stad, N-0806 Oslo, Norway.	s.e.steenstrup@nih.no	Bahr, Roald/B-6964-2014	Bahr, Roald/0000-0001-5725-4237	Royal Norwegian Ministry of Culture; South-Eastern Norway Regional Health Authority; International Olympic Committee; Norwegian Olympic Committee & Confederation of Sport; Norsk Tipping AS; International Ski Federation; Don Joy Orthotics (DJO)	The Oslo Sports Trauma Research Center has been established at the Norwegian School of Sports Sciences through generous grants from the Royal Norwegian Ministry of Culture, the South-Eastern Norway Regional Health Authority, the International Olympic Committee, the Norwegian Olympic Committee & Confederation of Sport and Norsk Tipping AS. The FIS Injury Surveillance System is supported by the International Ski Federation and has been established through a generous grant from Don Joy Orthotics (DJO).	Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Bakken A, 2011, BRIT J SPORT MED, V45, P1315, DOI 10.1136/bjsports-2011-090527; Bere T, 2013, SCAND J MED SCI SPOR, DOI [10.1111/sms.12038, DOI 10.1111/SMS.12038.PUBLISHED]; Bere T, 2014, BRIT J SPORT MED, V48, P40; Bere T, 2013, AM J SPORT MED, V41, P1067, DOI 10.1177/0363546513479341; Bere T, 2011, BRIT J SPORT MED, V45, P1294, DOI 10.1136/bjsports-2011-090517; Bere T, 2011, AM J SPORT MED, V39, P1421, DOI 10.1177/0363546511405147; Brooks MA, 2010, INJURY PREV, V16, P119, DOI 10.1136/ip.2009.022608; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Florenes TW, 2011, SCAND J MED SCI SPOR, V21, P196, DOI 10.1111/j.1600-0838.2009.01048.x; Florenes TW, 2010, BRIT J SPORT MED, V44, P803, DOI 10.1136/bjsm.2009.071159; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Fuller CW, 2006, SCAND J MED SCI SPOR, V16, P83, DOI 10.1111/j.1600-0838.2006.00528.x; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Hagel BE, 2004, EPIDEMIOLOGY, V15, P279, DOI 10.1097/01.ede.0000120044.62029.b4; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Levy AS, 2000, SEMIN NEUROL, V20, P233, DOI 10.1055/s-2000-9833; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Major DH, 2014, BRIT J SPORT MED, V48, P18, DOI 10.1136/bjsports-2013-092573; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Mecham MD, 1999, J APPL BIOMECH, V15, P27, DOI 10.1123/jab.15.1.27; Randjelovic S, 2014, BRIT J SPORT MED, V48, P31; Ruedl G, 2011, WILD ENVIRON MED, V22, P326, DOI 10.1016/j.wem.2011.06.008; Russell K, 2013, CLIN J SPORT MED, V23, P172, DOI 10.1097/JSM.0b013e31827bd918; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Steenstrup SE, 2011, BRIT J SPORT MED, V45, P1310, DOI 10.1136/bjsports-2011-090528; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	32	20	24	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2014	48	1					41	+		10.1136/bjsports-2013-093145			6	Sport Sciences	Sport Sciences	272YX	WOS:000328500500009	24334504				2021-06-18	
J	Thiagarajan, P; Ciuffreda, KJ				Thiagarajan, Preethi; Ciuffreda, Kenneth J.			Effect of oculomotor rehabilitation on accommodative responsivity in mild traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						accommodation; accommodative dysfunction; accommodative training; acquired brain injury; mild traumatic brain injury; neuroplasticity; oculomotor learning; oculomotor rehabilitation; traumatic brain injury; vision rehabilitation	CONVERGENCE INSUFFICIENCY; OBJECTIVE ASSESSMENT; NEURAL PLASTICITY; VERGENCE; DYNAMICS; SPASM; MODEL; VALIDITY; PROTOCOL; BEHAVIOR	Accommodative dysfunction is a common oculomotor sequelae of mild traumatic brain injury (mTBI). This study evaluated a range of dynamic (objective) and static (subjective) measures of accommodation in 12 nonstrabismic individuals with mTBI and near vision-related symptoms before and after oculomotor training (OMT) and placebo (P) training (6 wk, two sessions per week, 3 h of training each). Following OMT, the dynamics of accommodation improved markedly. Clinically, there was a significant increase in the maximum accommodative amplitude both monocularly and binocularly. In addition, the near vision symptoms reduced along with improved visual attention. None of the measures were found to change significantly following P training. These results provide evidence for a significant positive effect of the accommodatively based OMT on accommodative responsivity. Such improvement is suggestive of oculomotor learning, demonstrating considerable residual brain-visual system plasticity in the adult compromised brain.	[Thiagarajan, Preethi; Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA	Thiagarajan, P (corresponding author), Retina Fdn Southwest, 9600 N Cent Expy,Ste 200, Dallas, TX 75231 USA.	pthiagarajan@retinafoundation.org			U.S. Department of Defense (DoD)United States Department of Defense [W81XWH-10-1-1041, W81XWH-12-1-0240]; College of Optometrists in Vision Development; SUNY graduate program	This material was based on work supported by the U.S. Department of Defense (DoD) (grant W81XWH-10-1-1041 and W81XWH-12-1-0240), College of Optometrists in Vision Development, and SUNY graduate program.	ALQURAINY IA, 1995, BRIT J ORAL MAX SURG, V33, P71, DOI 10.1016/0266-4356(95)90203-1; Alvarez TL, 2010, OPTOMETRY VISION SCI, V87, P985, DOI 10.1097/OPX.0b013e3181fef1aa; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; BALSAM M H, 1959, Am J Optom Arch Am Acad Optom, V36, P567; Benjamin WJ, 2006, BORISHS CLIN REFRACT; BOHLMANN BJ, 1987, J CLIN NEURO-OPHTHAL, V7, P129; Chan RVP, 2002, J NEURO-OPHTHALMOL, V22, P15, DOI 10.1097/00041327-200203000-00005; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2012, PRESBYOPIA: ORIGIN, EFFECTS, AND TREATMENT, P103; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; CIUFFREDA KJ, 1984, DOC OPHTHALMOL, V56, P303, DOI 10.1007/BF00155676; CIUFFREDA KJ, 1988, AM J OPTOM PHYS OPT, V65, P365; Ciuffreda KJ., 2006, ACCOMMODATION PUPIL, V6th ed, P93, DOI DOI 10.1016/B978-0-7506-7524-6.50009-0; Cuiffreda K., 1992, J BEHAV OPTOM, V3, P3; Duane A, 1922, Trans Am Ophthalmol Soc, V20, P132; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Filoteo JV, 1997, ARCH CLIN NEUROPSYCH, V12, P621; GAMLIN PDR, 1995, J NEUROPHYSIOL, V73, P2115; GIANUTSOS R, 1988, ARCH PHYS MED REHAB, V69, P573; GILMARTIN B, 1986, OPHTHAL PHYSL OPT, V6, P23, DOI 10.1111/j.1475-1313.1986.tb00697.x; Green W, 2010, OPTOMETRY, V81, P129, DOI 10.1016/j.optm.2009.07.015; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Harrison RJ, 1987, BINOC VIS, V2, P93; HEATH G G, 1956, Am J Optom Arch Am Acad Optom, V33, P569; Hebb DO., 1949, ORG BEHAV NEUROPSYCH; Hung GK, 1996, OPHTHAL PHYSL OPT, V16, P31, DOI 10.1016/0275-5408(95)00110-7; HUNG GK, 1980, IEEE T BIO-MED ENG, V27, P439, DOI 10.1109/TBME.1980.326752; HUNG GK, 1983, IEEE T BIO-MED ENG, V30, P665, DOI 10.1109/TBME.1983.325069; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915; Khan AA, 2005, DIGITAL SIGNAL PROCE; KOWAL L, 1992, AUST NZ J OPHTHALMOL, V20, P35, DOI 10.1111/j.1442-9071.1992.tb00701.x; KRAN BS, 1988, AM J OPTOM PHYS OPT, V65, P703; Leslie S, 2001, VISUAL VESTIBULAR CO; LIU JS, 1979, AM J OPTOM PHYS OPT, V56, P285; Monteiro MLR, 2003, BRIT J OPHTHALMOL, V87, P243, DOI 10.1136/bjo.87.2.243; ODONNELL JP, 1994, J CLIN PSYCHOL, V50, P596, DOI 10.1002/1097-4679(199407)50:4<596::AID-JCLP2270500416>3.0.CO;2-S; Ohtsuka K, 2002, AM J OPHTHALMOL, V133, P425, DOI 10.1016/S0002-9394(01)01356-3; Ohtsuka K, 1997, BRIT J OPHTHALMOL, V81, P476, DOI 10.1136/bjo.81.6.476; ROSENFIELD M, 1991, INVEST OPHTH VIS SCI, V32, P2985; ROSENFIELD M, 1994, OPHTHAL PHYSL OPT, V14, P265, DOI 10.1111/j.1475-1313.1994.tb00007.x; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Scheiman M., 2008, CLIN MANAGEMENT BINO, V3rd; Scheiman M, 2001, VISUAL VESTIBULAR CO; SCHNIDER CM, 1984, INVEST OPHTH VIS SCI, V25, P414; Schor CM, 2006, VISION RES, V46, P242, DOI 10.1016/j.visres.2005.09.030; Schor CM, 2005, VISION RES, V45, P1237, DOI 10.1016/j.visres.2004.11.011; Snell RS, 1998, CLIN ANATOMY EYE, P1998; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Thiagarajan P., 2012, THESIS STATE U NEW Y; Trenerry MR, 1990, VISUAL SERACH ATTENT; Warraich Z, 2010, PM&R, V2, pS208, DOI 10.1016/j.pmrj.2010.10.016; Willeford KT, 2013, DOC OPHTHALMOL, V126, P29, DOI 10.1007/s10633-012-9357-7; Yuan WH, 1999, IEEE T BIO-MED ENG, V46, P1191, DOI 10.1109/10.790495; Zellers J A, 1984, J Am Optom Assoc, V55, P31; Zost MG, 2001, DIAGNOSIS MANAGEMENT, P75	62	20	20	0	17	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	2					175	191		10.1682/JRRD.2013.01.0027			17	Rehabilitation	Rehabilitation	AI3ZM	WOS:000336804700004	24933717	Bronze			2021-06-18	
J	Robertson, CL; Saraswati, M; Scafidi, S; Fiskum, G; Casey, P; McKenna, MC				Robertson, Courtney L.; Saraswati, Manda; Scafidi, Susanna; Fiskum, Gary; Casey, Paula; McKenna, Mary C.			Cerebral Glucose Metabolism in an Immature Rat Model of Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						developmental brain injury; metabolism; mitochondria; NMR spectroscopy; trauma	MAGNETIC-RESONANCE-SPECTROSCOPY; CONTROLLED CORTICAL IMPACT; C-13 NMR; GLIAL METABOLISM; GLUTAMINE CYCLE; AMINO-ACIDS; IN-VIVO; ASTROCYTES; DYSFUNCTION; TRAFFICKING	Altered cerebral metabolism and mitochondrial function have been identified in experimental and clinical studies of pediatric traumatic brain injury (TBI). Metabolic changes detected using H-1 (proton) magnetic resonance spectroscopy correlate with long-term outcomes in children after severe TBI. We previously identified early (4-h) and sustained (24-h and 7-day) abnormalities in brain metabolites after controlled cortical impact (CCI) in immature rats. The current study aimed to identify specific alterations of cerebral glucose metabolism at 24h after TBI in immature rats. Rats (postnatal days 16-18) underwent CCI to the left parietal cortex. Sham rats underwent craniotomy only. Twenty-four hours after CCI, rats were injected (intraperitoneally) with [1,6-C-13]glucose. Brains were removed, separated into hemispheres, and frozen. Metabolites were extracted with perchloric acid and analyzed using H-1 and C-13-nuclear magnetic resonance spectroscopy. TBI resulted in decreases in N-acetylaspartate in both hemispheres, compared to sham contralateral. At 24h after TBI, there was significant decrease in the incorporation of C-13 label into [3-C-13]glutamate and [2-C-13]glutamate in the injured brain. There were no differences in percent enrichment of [3-C-13]glutamate, [4-C-13]glutamate, [3-C-13]glutamine, or [4-C-13]glutamine. There was significantly lower percent enrichment of [2-C-13]glutamate in both TBI sides and the sham craniotomy side, compared to sham contralateral. No differences were detected in enrichment of C-13 glucose label in [2-C-13]glutamine, [2-C-13]GABA (gamma-aminobutyric acid), [3-C-13]GABA, or [4-C-13]GABA, [3-C-13]lactate, or [3-C-13]alanine between groups. Results suggest that overall oxidative glucose metabolism in the immature brain recovers at 24h after TBI. Specific reductions in [2-C-13]glutamate could be the result of impairments in either neuronal or astrocytic metabolism. Future studies should aim to identify pathways leading to decreased metabolism and develop cell-selective metabolic rescue.	[Robertson, Courtney L.; Saraswati, Manda; Scafidi, Susanna] Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Robertson, Courtney L.; Scafidi, Susanna] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD 21287 USA; [Casey, Paula; McKenna, Mary C.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [McKenna, Mary C.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA	Robertson, CL (corresponding author), Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, 1800 Orleans St,Bloomberg Childrens Room 6321, Baltimore, MD 21287 USA.	crober48@jhmi.edu		Scafidi, Susanna/0000-0002-1229-8778	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08 NS42805, 5P01 HD016596, K08 NS069815]; University of Maryland Department of Pediatrics (SRIS grant); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P01HD016596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS069815, K08NS042805] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (grants K08 NS42805, 5P01 HD016596, and K08 NS069815) and the the University of Maryland Department of Pediatrics (SRIS grant).	Aaen GS, 2010, PEDIATRICS, V125, P295, DOI 10.1542/peds.2008-3312; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik-Olson BL, 2010, J NEUROTRAUM, V27, P2191, DOI 10.1089/neu.2010.1508; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cremer J E, 1974, Biochem J, V142, P527; DEVIVO DC, 1975, J NEUROCHEM, V25, P161, DOI 10.1111/j.1471-4159.1975.tb12244.x; Eid T, 2012, NEUROCHEM RES, V37, P2339, DOI 10.1007/s11064-012-0766-5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Haberg A, 1998, J CEREBR BLOOD F MET, V18, P1223, DOI 10.1097/00004647-199811000-00008; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hassel B, 1997, J CEREBR BLOOD F MET, V17, P1230, DOI 10.1097/00004647-199711000-00012; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.3.CO;2-E; HOLTZMAN D, 1975, J NEUROCHEM, V24, P1011, DOI 10.1111/j.1471-4159.1975.tb03670.x; HOLTZMAN D, 1973, BIOL NEONATE, V22, P230; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marin-Valencia I, 2012, NEUROCHEM INT, V61, P1036, DOI 10.1016/j.neuint.2012.07.020; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; McKenna MC, 1996, J NEUROCHEM, V66, P386; Melo TM, 2005, J CEREBR BLOOD F MET, V25, P1254, DOI 10.1038/sj.jcbfm.9600128; Melo TM, 2006, J CEREBR BLOOD F MET, V26, P1496, DOI 10.1038/sj.jcbfm.9600300; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Qu H, 2003, NEUROCHEM INT, V42, P101, DOI 10.1016/S0197-0186(02)00051-7; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Richards EM, 2007, STROKE, V38, P1578, DOI 10.1161/STROKEAHA.106.473967; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; SONNEWALD U, 1993, NEUROCHEM INT, V22, P19, DOI 10.1016/0197-0186(93)90064-C; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; van der Hel WS, 2005, NEUROLOGY, V64, P326, DOI 10.1212/01.WNL.0000149636.44660.99; Walls AB, 2011, J CEREBR BLOOD F MET, V31, P494, DOI 10.1038/jcbfm.2010.115; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Wong KP, 2011, J NUCL MED, V52, P800, DOI 10.2967/jnumed.110.085092; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zwingmann C, 2003, NMR BIOMED, V16, P370, DOI 10.1002/nbm.850	51	20	20	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 15	2013	30	24					2066	2072		10.1089/neu.2013.3007			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	271QK	WOS:000328406500008	24032394	Green Published			2021-06-18	
J	Di Ieva, A; Schmitz, EM; Cusimano, MD				Di Ieva, Antonio; Schmitz, Erika M.; Cusimano, Michael D.			Analysis of Intracranial Pressure: Past, Present, and Future	NEUROSCIENTIST			English	Article						fractal analysis; intracranial pressure; neuromonitoring; nonlinear analysis; time series; traumatic brain injury	ARTIFICIAL NEURAL-NETWORKS; DETRENDED FLUCTUATION ANALYSIS; HEART-RATE-VARIABILITY; LEMPEL-ZIV COMPLEXITY; WAVE-FORM; FRACTAL CHARACTERIZATION; STATISTICAL PHYSICS; APPROXIMATE ENTROPY; TIME-SERIES; HYPERTENSION	The monitoring of intracranial pressure (ICP) is an important tool in medicine for its ability to portray the brain's compliance status. The bedside monitor displays the ICP waveform and intermittent mean values to guide physicians in the management of patients, particularly those having sustained a traumatic brain injury. Researchers in the fields of engineering and physics have investigated various mathematical analysis techniques applicable to the waveform in order to extract additional diagnostic and prognostic information, although they largely remain limited to research applications. The purpose of this review is to present the current techniques used to monitor and interpret ICP and explore the potential of using advanced mathematical techniques to provide information about system perturbations from states of homeostasis. We discuss the limits of each proposed technique and we propose that nonlinear analysis could be a reliable approach to describe ICP signals over time, with the fractal dimension as a potential predictive clinically meaningful biomarker. Our goal is to stimulate translational research that can move modern analysis of ICP using these techniques into widespread practical use, and to investigate to the clinical utility of a tool capable of simplifying multiple variables obtained from various sensors.	[Di Ieva, Antonio; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Di Ieva, Antonio; Schmitz, Erika M.; Cusimano, Michael D.] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada	Di Ieva, A (corresponding author), St Michaels Hosp, Dept Surg, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	diieva@hotmail.com	Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650; Di Ieva, Antonio/0000-0002-5341-5416			Aboy M, 2001, P ANN INT IEEE EMBS, V23, P2231, DOI 10.1109/IEMBS.2001.1017216; Aboy M, 2006, IEEE T BIO-MED ENG, V53, P2282, DOI 10.1109/TBME.2006.883696; Anderson JL, 1997, J AM COLL CARDIOL, V30, P226, DOI 10.1016/S0735-1097(97)00108-3; Andrews PJD, 2004, INTENS CARE MED, V30, P1730, DOI 10.1007/s00134-004-2376-4; Ang B.T., 2010, P 10 IEEE INT C INF, P1; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Barth M, 2010, NEUROCRIT CARE, V12, P234, DOI 10.1007/s12028-009-9287-8; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; Bellotti A, 2001, CLIN NEUROL NEUROSUR, V103, P223, DOI 10.1016/S0303-8467(01)00154-8; Bravi A, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-90; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burr RL, 2008, IEEE T BIO-MED ENG, V55, P2509, DOI 10.1109/TBME.2008.2001286; Caccia DC, 1997, PHYSICA A, V246, P609, DOI 10.1016/S0378-4371(97)00363-4; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Cecil S, 2011, CRIT CARE NURSE, V31, P25, DOI 10.4037/ccn2010226; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Di Ieva A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00429; DILEVA A, 2012, NEURORADIOLOGY; Eide PK, 2007, NEUROL RES, V29, P578, DOI 10.1179/016164107X172167; Eide PK, 2010, ACTA NEUROL SCAND, V122, P262, DOI 10.1111/j.1600-0404.2009.01304.x; Eide PK, 2006, MED ENG PHYS, V28, P579, DOI 10.1016/j.medengphy.2005.09.008; Eide PK, 2012, J NEUROSURG, V116, P961, DOI 10.3171/2012.1.JNS111313; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Fan JY, 2010, BIOL RES NURS, V11, P317, DOI 10.1177/1099800409349164; Fausett L., 1994, FUNDAMENTALS NEURAL; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GREENBERG MS, 2006, HDB NEUROSURGERY, P866; Hamilton R, 2009, IEEE ENG MED BIO, P4331, DOI 10.1109/IEMBS.2009.5332749; Havlin S, 1999, PHYSICA A, V274, P99, DOI 10.1016/S0378-4371(99)00333-7; Heissler Hans E, 2012, Acta Neurochir Suppl, V114, P87, DOI 10.1007/978-3-7091-0956-4_15; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Holm S, 2008, MED ENG PHYS, V30, P164, DOI 10.1016/j.medengphy.2007.03.003; Hornero R, 2006, CRIT CARE MED, V34, P87, DOI 10.1097/01.CCM.0000190426.44782.F0; Hornero R, 2005, IEEE T BIO-MED ENG, V52, P1671, DOI 10.1109/TBME.2005.855722; Hornero R, 2007, MED BIOL ENG COMPUT, V45, P617, DOI 10.1007/s11517-007-0194-x; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; IYENGAR N, 1996, AM J PHYSL 2, V271, pR1028; Jospin M, 2007, IEEE T BIO-MED ENG, V54, P840, DOI 10.1109/TBME.2007.893453; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kenkel N., 1996, COENOSES, V11, P77, DOI DOI 10.1002/PBC; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; Losa GA, 2009, RIV BIOL-BIOL FORUM, V102, P29; Low D, 2009, J NEUROTRAUM, V26, P1177, DOI [10.1089/neu.2008.0841, 10.1089/neu.2008-0841]; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Makikallio TH, 2001, J AM COLL CARDIOL, V37, P1395, DOI 10.1016/S0735-1097(01)01171-8; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Mariak Z, 2000, ACTA NEUROCHIR, V142, P407, DOI 10.1007/s007010050450; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mayer SA, 2002, J INTENSIVE CARE MED, V17, P55, DOI 10.1046/j.1525-1489.2002.17201.x; Morgalla MH, 1999, J NEUROL SCI, V168, P90, DOI 10.1016/S0022-510X(99)00137-9; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Perkiomaki JS, 2005, CLIN EXP HYPERTENS, V27, P149, DOI 10.1081/CEH-200048742; Perkiomaki JS, 2001, AM J CARDIOL, V88, P17, DOI 10.1016/S0002-9149(01)01578-8; PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; Santamarta D, 2010, CHILD NERV SYST, V26, P1683, DOI 10.1007/s00381-010-1244-5; Scalzo F, 2012, IEEE PULSE, V3, P49, DOI 10.1109/MPUL.2011.2181024; SCHEPERS HE, 1992, IEEE ENG MED BIOL, V11, P57, DOI 10.1109/51.139038; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Shaw M, 2008, ACT NEUR S, V102, P229, DOI 10.1007/978-3-211-85578-2_44; Shieh JS, 2004, NEUROCOMPUTING, V57, P239, DOI 10.1016/j.neucom.2003.10.006; SHIELDS CB, 1984, NEUROSURGERY, V14, P592, DOI 10.1227/00006123-198405000-00014; Stadnitski T, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00127; Stanley HE, 1999, PHYSICA A, V270, P309, DOI 10.1016/S0378-4371(99)00230-7; STANLEY HE, 1988, NATURE, V335, P405, DOI 10.1038/335405a0; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Swiercz M, 2000, ACTA NEUROCHIR, V142, P401, DOI 10.1007/s007010050449; SZEWCZYKOWSKI J, 1977, J NEUROSURG, V47, P19, DOI 10.3171/jns.1977.47.1.0019; SZEWCZYKOWSKI J, 1976, J NEUROSURG, V45, P155, DOI 10.3171/jns.1976.45.2.0155; Tapanainen JM, 2002, AM J CARDIOL, V90, P347, DOI 10.1016/S0002-9149(02)02488-8; Varela M, 2003, EUR J APPL PHYSIOL, V89, P230, DOI 10.1007/s00421-002-0790-2; Weiss B, 2009, J NEUROSCI METH, V185, P116, DOI 10.1016/j.jneumeth.2009.07.027; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; West BJ, 2010, FRONT PHYSIOL, V1, DOI [10.3389/fphys.2010.00012, 10.3389/fphys.2010.00001]; Westhout FD, 2008, SURG NEUROL, V70, P70, DOI 10.1016/j.surneu.2007.04.020; Zhang F, 2011, IEEE ENG MED BIO, P7111, DOI 10.1109/IEMBS.2011.6091797; Zhang XS, 1999, IEEE T BIO-MED ENG, V46, P548, DOI 10.1109/10.759055; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	89	20	21	0	32	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-8584	1089-4098		NEUROSCIENTIST	Neuroscientist	DEC	2013	19	6					592	603		10.1177/1073858412474845			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	247WG	WOS:000326653000010	23389057				2021-06-18	
J	Wong, GKC; Teoh, J; Yeung, J; Chan, E; Siu, E; Woo, P; Rainer, T; Poon, WS				Wong, George Kwok Chu; Teoh, Jeremy; Yeung, Janice; Chan, Emily; Siu, Eva; Woo, Peter; Rainer, Timothy; Poon, Wai Sang			Outcomes of traumatic brain injury in Hong Kong: Validation with the TRISS, CRASH, and IMPACT models	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Mortality; Outcome; Prediction; Traumatic brain injury	PROGNOSTIC MODELS; EMERGENCY CARE; PREDICTION; SCORE; MORTALITY; MODERATE	We aimed to test prognostic models (the Trauma Injury Severity Score, International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury, and Corticosteroid Randomisation After Significant Head Injury models) for 14-day mortality, 6-month mortality, and 6-month unfavorable outcome in a cohort of trauma patients with traumatic brain injury (TBI) in Hong Kong. We analyzed 661 patients with significant TBI treated in a regional trauma centre in Hong Kong over a 3-year period. The discriminatory power of the models was assessed as the area under the receiver operating characteristic curve. One-sample t-tests were used to compare actual outcomes in the cohort against predicted outcomes. All three prognostic models were shown to have good discriminatory power and no significant systemic over-estimation or under-estimation. In conclusion, all three predictive models are applicable to eligible TBI patients in Hong Kong. These predictive models can be utilized to audit TBI management outcomes for trauma service development in the future. (C) 2013 Elsevier Ltd. All rights reserved.	[Wong, George Kwok Chu; Teoh, Jeremy; Chan, Emily; Siu, Eva; Woo, Peter; Poon, Wai Sang] Chinese Univ Hong Kong, Prince Wales Hosp, Div Neurosurg, Shatin, Hong Kong, Peoples R China; [Yeung, Janice; Rainer, Timothy] Chinese Univ Hong Kong, Prince Wales Hosp, Accid & Emergency Acad Unit, Hong Kong, Hong Kong, Peoples R China	Wong, GKC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Div Neurosurg, Shatin, Hong Kong, Peoples R China.	georgewong@surgery.cuhk.edu.hk	Rainer, Timothy H/I-2591-2013; Wong, George KC/A-6378-2011; Wong, George Kwok Chu/L-4344-2016; Teoh, Jeremy Yuen Chun/H-5184-2016; Poon, Wai Sang/F-1558-2011	Rainer, Timothy H/0000-0003-3355-3237; Wong, George KC/0000-0002-6078-2548; Teoh, Jeremy Yuen Chun/0000-0002-9361-2342; 			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Cheng CH, 2008, ANN SURG, V247, P335, DOI 10.1097/SLA.0b013e31815ccc2e; de Jongh MAC, 2010, BRIT J SURG, V97, P1805, DOI 10.1002/bjs.7216; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rogers FB, 2012, J TRAUMA ACUTE CARE, V73, P326, DOI 10.1097/TA.0b013e31825a7758; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	18	20	21	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2013	20	12					1693	1696		10.1016/j.jocn.2012.12.032			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	261UO	WOS:000327690300010	23993210				2021-06-18	
J	Rao, V; Klepstad, P; Losvik, OK; Solheim, O				Rao, Vidar; Klepstad, Pal; Losvik, Ole Kristian; Solheim, Ole			Confusion with cerebral perfusion pressure in a literature review of current guidelines and survey of clinical practise	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							SEVERE HEAD-INJURY; TRAUMATIC BRAIN INJURY; MANAGEMENT; HYPERTENSION; REACTIVITY	Background: Cerebral perfusion pressure (CPP) is defined as the difference between the mean arterial pressure (MAP) and the intracranial pressure (ICP). However, since patients with traumatic brain injury (TBI) are usually treated with head elevation, the recorded CPP values depends on the zero level used for calibration of the arterial blood pressure. Although international guidelines suggest that target values of optimal CPP are within the range of 50 - 70 mmHg in patients with TBI, the calibration of blood pressure, which directly influences CPP, is not described in the guidelines. The aim of this study was to review the literature used to support the CPP recommendations from the Brain Trauma Foundation, and to survey common clinical practice with respect to MAP, CPP targets and head elevation in European centres treating TBI patients. Methods: A review of the literature behind CPP threshold recommendations was performed. Authors were contacted if the publications did not report how MAP or CPP was measured. A short questionnaire related to measurement and treatment targets of MAP and CPP was sent to European neurosurgical centres treating patients with TBI. Results: Assessment methods for CPP measurement were only retrieved from 6 of the 11 studies cited in the TBI guidelines. Routines for assessment of CPP varied between these 6 publications. The 58 neurosurgical centres that answered our survey reported diverging routines on how to measure MAP and target CPP values. Higher CPP threshold were not observed if blood pressure was calibrated at the heart level (p = 0.51). Conclusions: The evidence behind the recommended CPP thresholds shows no consistency on how blood pressure is calibrated and clinical practice for MAP measurements and CPP target values seems to be highly variable. Until a consensus is reached on how to measure CPP, confusion will prevail.	[Rao, Vidar; Solheim, Ole] St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Rao, Vidar; Solheim, Ole] Norwegian Univ Sci & Technol, Fac Med, Dept Neurosci, N-7034 Trondheim, Norway; [Klepstad, Pal] St Olavs Hosp, Dept Anaesthesiol & Intens Care Med, Trondheim, Norway; [Klepstad, Pal] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Losvik, Ole Kristian] Univ Tromso, Fac Hlth Sci, Dept Clin Med, Tromso, Norway	Rao, V (corresponding author), St Olavs Hosp, Dept Neurosurg, Trondheim, Norway.	vidarrao@gmail.com		Solheim, Ole/0000-0002-5954-4817; Losvik, Ole Kristian/0000-0001-8846-3277			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; McGraw CP, 1989, ICPVII, P839; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Weber C, 2013, ACTA NEUROCHIR, V155, P747, DOI 10.1007/s00701-013-1640-1	13	20	21	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV 21	2013	21								78	10.1186/1757-7241-21-78			5	Emergency Medicine	Emergency Medicine	266SB	WOS:000328042900002	24262017	DOAJ Gold, Green Published			2021-06-18	
J	McCully, SP; Schreiber, MA				McCully, Sean P.; Schreiber, Martin A.			Traumatic Brain Injury and Its Effect on Coagulopathy	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						trauma; hemostasis; coagulopathy; traumatic brain injury	HEAD TRAUMA; COAGULATION; ABNORMALITIES; HEMORRHAGE; MILD	Polytraumatic injury results in tissue factor (TF) release from damaged cells. The acute coagulopathy of trauma (ACT) occurs early and results from significant tissue injury and tissue hypoperfusion. ACT is augmented by therapies resulting in acidemia, hypothermia, and hemodilution contributing to trauma-induced coagulopathy. Coagulopathy associated with traumatic brain injury (TBI) results from the interplay of numerous variables. Because of the high concentration of TF in brain tissue, TBI has been believed to be associated with a greater degree of coagulopathy compared with injury in other body systems. TBI has also recently been shown to cause platelet dysfunction. Platelet receptor inhibition prevents cellular initiation and amplification of the clotting cascade, limiting thrombin incorporation, and stabilization of clot to stop hemorrhage. Therefore, head injury in the presence of polytrauma does appear to augment ACT and warrants close monitoring and appropriate intervention.	[McCully, Sean P.; Schreiber, Martin A.] Oregon Hlth & Sci Univ, TRIO, Portland, OR 97239 USA	McCully, SP (corresponding author), Oregon Hlth & Sci Univ, Dept Surg, 3181 SW Sam Jackson Pk Rd,Mail Code L223, Portland, OR 97239 USA.	mccully@ohsu.edu					Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chu AJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/367284; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Franschman G, 2012, BRAIN INJURY, V26, P1464, DOI 10.3109/02699052.2012.694566; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Goodnight S H Jr, 1977, Compr Ther, V3, P25; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; MACGEE EE, 1970, J NEUROSURG, V32, P578, DOI 10.3171/jns.1970.32.5.0578; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MCNICOL PL, 1994, ANAESTH INTENS CARE, V22, P659, DOI 10.1177/0310057X9402200603; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; PENICK G D, 1960, Int Rec Med, V173, P491; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schrieber M, 2007, J TRAUMA, V63, P1261; Shore-Lesserson L, 1999, ANESTH ANALG, V88, P312, DOI 10.1097/00000539-199902000-00016; Silver J, 2005, TXB TRAUMATIC BRAIN, P27; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 1995, PEDIATR NEUROSURG, V23, P299, DOI 10.1159/000120975; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Sugawara T, 2009, STROKE, V40, P1530, DOI 10.1161/STROKEAHA.108.531699; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1	45	20	24	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	NOV	2013	39	8					896	901		10.1055/s-0033-1357484			6	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	242ID	WOS:000326231500006	24114009				2021-06-18	
J	Wong, D; Dahm, J; Ponsford, J				Wong, Dana; Dahm, Jane; Ponsford, Jennie			Factor structure of the Depression Anxiety Stress Scales in individuals with traumatic brain injury	BRAIN INJURY			English	Article						Anxiety; depression; Depression Anxiety Stress Scales; factor analysis; traumatic brain injury	PSYCHOMETRIC PROPERTIES; PSYCHIATRIC-DISORDERS; HOSPITAL ANXIETY; CLINICAL-SAMPLES; DASS	Primary objective: The Depression Anxiety Stress Scales (DASS) and its shorter version, the DASS21, demonstrate a consistent factor structure. However, when these scales are used with people with traumatic brain injury (TBI), it is possible that TBI symptoms that overlap with anxiety and depression (e. g. irritability, inertia, emotional lability) result in changes to the underlying structure. This study aimed to establish whether the factor structure of the DASS and DASS21 when used with individuals with TBI is consistent with the three scales designated in the manual. Methods and procedures: One hundred and twenty-three participants with mild-to-severe TBI completed the DASS. Main outcomes and results: The factor structure of the DASS was found to be consistent with the designated scales, with the exception of four items that cross-loaded weakly on multiple factors. However, the factor structure of the DASS21 did not correspond as closely to the designated depression, anxiety and stress scales, which appeared to be due to the fact that many of the highest loading items on the DASS were not included items in the DASS21. Conclusions: These results indicate that it may be preferable to use the full DASS, rather than the DASS21, with individuals with TBI.	[Wong, Dana; Dahm, Jane; Ponsford, Jennie] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia	Wong, D (corresponding author), Monash Univ, Sch Psychol & Psychiat, Bldg 17,Wellington Rd, Clayton, Vic 3800, Australia.	dana.wong@monash.edu		Wong, Dana/0000-0001-9619-1929	Monash UniversityMonash University; Transport Accident Commission (Victoria); National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	The data reported in this study was collected as part of studies funded by Monash University, the Transport Accident Commission (Victoria) and the National Health and Medical Research Council. The funding sources had no role in study design or data analysis. The authors alone were responsible for the content and writing of the paper.	Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Clara IP, 2001, J PSYCHOPATHOL BEHAV, V23, P61, DOI 10.1023/A:1011095624717; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Dahm J, J AFFECTIVE IN PRESS; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Gloster AT, 2008, J AFFECT DISORDERS, V110, P248, DOI 10.1016/j.jad.2008.01.023; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Page AC, 2007, BRIT J CLIN PSYCHOL, V46, P283, DOI 10.1348/014466506X158996; Skilbeck C, 2011, BRAIN IMPAIR, V12, P22, DOI 10.1375/brim.12.1.22	17	20	20	2	20	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1377	1382		10.3109/02699052.2013.823662			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500006	23924030				2021-06-18	
J	Luo, Q; Xu, D; Roskos, T; Stout, J; Kull, L; Cheng, X; Whitson, D; Boomgarden, E; Gfeller, J; Bucholz, RD				Luo, Qian; Xu, Duo; Roskos, Tyler; Stout, Jeff; Kull, Lynda; Cheng, Xi; Whitson, Diane; Boomgarden, Erich; Gfeller, Jeffrey; Bucholz, Richard D.			Complexity Analysis of Resting State Magnetoencephalography Activity in Traumatic Brain Injury Patients	JOURNAL OF NEUROTRAUMA			English	Article						LZC; MEG; resting state; TBI	IMAGING APPROACH; TIME-SERIES; MILD; EEG; DYNAMICS; MEG	Diagnosis of mild traumatic brain injuries (TBIs) has been difficult because of the absence of obvious focal brain lesions, using conventional computed tomography (CT) or magnetic resonance imaging (MRI) scans, in a large percentage of TBIs. One useful measure that can characterize potential tissue and neural network damage objectively is Lempel-Ziv complexity (LZC) applied to magnetoencephalography (MEG) signals. LZC is a model-independent estimator of system complexity that estimates the number of different patterns in a sequence. We hypothesized that because of the potential network damage, TBIs would show a reduced level of complexity in regions that are impaired. We included 18 healthy controls and 18 military veterans with TBI in the study. Resting state MEG data were acquired, and the LZCs were analyzed across the whole brain. Our results indicated reduced complexity in multiple brain areas in TBI patients relative to the healthy controls. In addition, we detected several neuropsychological measures associated with motor responses, visual perception, and memory, correlated with LZC, which likely explains some of the cognitive deficits in TBI patients.	[Luo, Qian; Xu, Duo; Roskos, Tyler; Stout, Jeff; Kull, Lynda; Whitson, Diane; Boomgarden, Erich; Bucholz, Richard D.] St Louis Univ, Sch Med, Dept Neurosurg, St Louis, MO 63104 USA; [Cheng, Xi] Johns Hopkins Univ, Lieber Inst Brain Dev, Baltimore, MD USA; [Gfeller, Jeffrey] St Louis Univ, Dept Psychol, St Louis, MO 63104 USA	Luo, Q (corresponding author), St Louis Univ, Sch Med, Dept Neurosurg, 1320 South Grand Blvd,1st Floor,ODonnell Hall, St Louis, MO 63104 USA.	qluo2@slu.edu			Department of DefenseUnited States Department of Defense [W81XWH-08-2-0191]	The study is supported by the Department of Defense grant W81XWH-08-2-0191 granted to Dr R. Bucholz.	Abasolo D, 2006, PHYSIOL MEAS, V27, P241, DOI 10.1088/0967-3334/27/3/003; Mendez MA, 2012, J PSYCHOPHARMACOL, V26, P636, DOI 10.1177/0269881111408966; Anokhin AP, 2000, DEV PSYCHOBIOL, V36, P9, DOI 10.1002/(SICI)1098-2302(200001)36:1<9::AID-DEV2>3.3.CO;2-X; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI 10.1089/neu.2009-0885; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Fernandez A, 2011, CLIN NEUROPHYSIOL, V122, P2227, DOI 10.1016/j.clinph.2011.04.011; Fernandez A, 2009, BIOL PSYCHIAT, V65, P571, DOI 10.1016/j.biopsych.2008.10.046; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jelles B, 1999, CLIN NEUROPHYSIOL, V110, P1159, DOI 10.1016/S1388-2457(99)00013-9; Jeong J, 1998, MED ENG PHYS, V20, P669, DOI 10.1016/S1350-4533(98)00078-2; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; LUTZENBERGER W, 1995, BIOL CYBERN, V73, P477, DOI 10.1007/BF00201482; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; MeyerLindenberg A, 1996, ELECTROEN CLIN NEURO, V99, P405, DOI 10.1016/S0013-4694(96)95699-0; Radhakrishnan N, 1998, IEEE ENG MED BIOL, V17, P89, DOI 10.1109/51.677174; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Management of Substance Use Disorders Working Group, 2009, VA DOD CLIN PRACT GU; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Weathers F.W., 1993, 9 ANN C ISTSS SAN AN; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601	30	20	20	1	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2013	30	20					1702	1709		10.1089/neu.2012.2679			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	232JW	WOS:000325491000002	23692211	Green Published			2021-06-18	
J	Cousar, JL; Conley, YP; Willyerd, FA; Sarnaik, AA; Puccio, AM; Empey, PE; Kochanek, PM; Bell, MJ; Okonkwo, DO; Clark, RSB				Cousar, J'mir L.; Conley, Yvette P.; Willyerd, F. Anthony; Sarnaik, Ajit A.; Puccio, Ava M.; Empey, Philip E.; Kochanek, Patrick M.; Bell, Michael J.; Okonkwo, David O.; Clark, Robert S. B.			Influence of ATP-Binding Cassette Polymorphisms on Neurological Outcome After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Blood-brain barrier; Head trauma; Membrane transporter; Multidrug resistance protein; Multidrug resistance-associated protein; P-Glycoprotein	P-GLYCOPROTEIN EXPRESSION; MULTIDRUG-RESISTANCE; C3435T POLYMORPHISM; DRUG-TRANSPORTER; ABC TRANSPORTERS; GENETIC-FACTORS; MDR1 GENE; EPILEPSY; ASSOCIATION; BARRIER	As important mediators of solute transport at the blood-brain and blood-cerebrospinal fluid barriers, ATP-binding cassette (ABC) transporters (including ABCB1, ABCC1, and ABCC2), impact the bioavailability of drugs and endogenous substrates in the brain. While several ABCB1, ABCC1, and ABCC2 single nucleotide polymorphisms (SNPs) have been identified, their impact on outcome after traumatic brain injury (TBI) is unknown. ABCB1, ABCC1, and ABCC2 SNPs are associated with Glasgow Outcome Scale (GOS) score after TBI. DNA samples from 305 adult patients with severe TBI (Glasgow Coma Scale, GCS score a parts per thousand currency sign 8) were genotyped for tagging SNPs of ABCB1 (rs1045642; rs1128503), ABCC1 (rs212093; rs35621; rs4148382), and ABCC2 (rs2273697). For each SNP, patients were dichotomized based on presence of variant allele for multivariate analysis to determine associations with GOS assigned at 6 months adjusting for GCS, Injury Severity score, age, and patient sex. For ABCB1 rs1045642, patients homozygous for the T allele were less likely to be assigned poor outcome versus those possessing the C allele [CT/CC; odds of unfavorable GOS = 0.71(0.55-0.92)]. For ABCC1 rs4148382, patients homozygous for the G allele were less likely to be assigned poor outcome versus those possessing the A allele [AG/AA; odds of unfavorable GOS = 0.73(0.55-0.98)]. In this single-center study, patients homozygous for the T allele of ABCB1 rs1045642 or the G allele of ABCC1 rs4148382 were found to have better outcome after severe TBI. Further study is necessary to replicate these very preliminary findings and to determine whether these associations are due to central nervous system bioavailability of ABC transporter drug substrates commonly used in the management of TBI, brain efflux of endogenous solutes, or both.	[Cousar, J'mir L.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45267 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15260 USA; [Willyerd, F. Anthony] Childrens Hosp Pittsburgh, UPMC Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Sarnaik, Ajit A.] Univ Pediatricians, Detroit, MI 48201 USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Empey, Philip E.] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.] Safar Ctr Resuscitat Res, Dept Pediat, Pittsburgh, PA 15260 USA; [Kochanek, Patrick M.] Safar Ctr Resuscitat Res, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15224 USA; [Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15224 USA; [Clark, Robert S. B.] Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA	Clark, RSB (corresponding author), Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	cousarjr@uc.edu; yconley@pitt.edu; anthony.willyerd@chp.edu; asarnai@med.wayne.edu; puccioam@upmc.edu; pempey@pitt.edu; kochanekpm@ccm.upmc.edu; bellmj4@upmc.edu; okonkwodo@upmc.edu; clarkrs@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015; Empey, Philip/L-9604-2019	Kochanek, Patrick M/0000-0002-2627-913X; Empey, Philip/0000-0001-7474-2339; Conley, Yvette/0000-0002-1784-6067	University of Pittsburgh School of Medicine Clinical Scientist Training Program; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS069247, P50 NS30318]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD40686]; NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR000146]; NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR008424]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, R01NS069247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	The authors would like to thank Sandra Deslouches for expert technical assistance. This work is supported by University of Pittsburgh School of Medicine Clinical Scientist Training Program (JLC); NINDS R01 NS069247 (RSBC, PEE), P50 NS30318 (DOO, AMP, YPC, PMK, RSBC); NICHD T32 HD40686 (AAS); NCATS KL2 TR000146 (PEE); and NINR R01 NR008424 (YPC).	Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Basic S, 2008, SEIZURE-EUR J EPILEP, V17, P524, DOI 10.1016/j.seizure.2008.01.003; Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844; Bournissen FG, 2009, EPILEPSIA, V50, P898, DOI 10.1111/j.1528-1167.2008.01858.x; Budulac SE, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-60; Cascorbi I, 2011, HANDB EXP PHARMACOL, V201, P261, DOI 10.1007/978-3-642-14541-4_6; Cotte S, 2009, BRAIN, V132, P2517, DOI 10.1093/brain/awp164; Dardiotis E, 2012, CURR OPIN PSYCHIATR, V25, P231, DOI 10.1097/YCO.0b013e3283523c0e; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Deeley RG, 2006, FEBS LETT, V580, P1103, DOI 10.1016/j.febslet.2005.12.036; Dey S, 2003, EXPERT OPIN BIOL TH, V3, P23, DOI 10.1517/eobt.3.1.23.20957; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Haerian BS, 2011, PHARMACOGENOMICS, V12, P713, DOI 10.2217/PGS.10.212; Hartz AMS, 2011, CURR PHARM BIOTECHNO, V12, P656; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hodges LM, 2011, PHARMACOGENET GENOM, V21, P152, DOI 10.1097/FPC.0b013e3283385a1c; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Howie BN, 2006, HUM GENET, V120, P58, DOI 10.1007/s00439-006-0182-5; Hung CC, 2007, PHARMACOGENOMICS, V8, P1151, DOI 10.2217/14622416.8.9.1151; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Jedlitschky G, 2014, CURR PHARM DESIGN, V20, P1523, DOI 10.2174/13816128113199990460; JENNETT B, 1975, LANCET, V1, P480; Kim WJ, 2010, PHARMACOGENET GENOM, V20, P249, DOI 10.1097/FPC.0b013e328338073a; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kwan P, 2007, EPILEPSY BEHAV, V11, P112, DOI 10.1016/j.yebeh.2007.04.013; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ebid AHI, 2007, THER DRUG MONIT, V29, P305; Owen A, 2005, BRIT J CLIN PHARMACO, V59, P365, DOI 10.1111/j.1365-2125.2005.02229.x; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Siedlinski M, 2009, PHARMACOGENET GENOM, V19, P675, DOI 10.1097/FPC.0b013e32832f5eff; Spudich A, 2006, NAT NEUROSCI, V9, P487, DOI 10.1038/nn1676; Ufer M, 2009, PHARMACOGENET GENOM, V19, P353, DOI 10.1097/FPC.0b013e328329940b; van Assema DME, 2012, BRAIN, V135, P181, DOI 10.1093/brain/awr298	38	20	20	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	OCT	2013	19	2					192	198		10.1007/s12028-013-9881-7			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	221GB	WOS:000324644800009	23896815	Green Accepted			2021-06-18	
J	Gupta, RK; Prasad, S				Gupta, R. K.; Prasad, S.			Early down regulation of the glial Kir4.1 and GLT-1 expression in pericontusional cortex of the old male mice subjected to traumatic brain injury	BIOGERONTOLOGY			English	Article						Glia; Aging; Traumatic brain injury (TBI); Glutamate and K+ homeostasis; GLT-1/EAAT2; Kir4.1	GLUTAMATE TRANSPORTER GLT-1; FLUID PERCUSSION; HEAD-INJURY; EXTRACELLULAR POTASSIUM; RAT-BRAIN; PROTEINS; ESTROGEN; ACCUMULATION; MECHANISMS; ASTROCYTES	Astroglia play multiple roles in brain function by providing matrix to neurons, secreting neurotrophic factors, maintaining K+ and glutamate homeostasis and thereby controlling synaptic plasticity which undergoes alterations during aging. K+ and glutamate homeostasis is maintained by astrocytes membrane bound inwardly rectifying K+ channel (Kir4.1) and glutamate transporter-1 (GLT-1 or EAAT-2) proteins, respectively in the synapse and their expression may be altered due to traumatic brain injury (TBI). Also, it is not well understood whether this change is age dependent. To find out this, TBI was experimentally induced in adult and old male AKR strain mice using CHI technique, and expression of the Kir4.1 and GLT-1 in the pericontusional cortex at various time intervals was studied by Western blotting and semi quantitative RT-PCR techniques. Here, we report that expression of both Kir4.1 and GLT-1 genes at transcript and protein levels is significantly down regulated in the pericontusional ipsi-lateral cortex of old TBI mice as compared to that in the adult TBI mice as function of time after injury. Further, expression of both the genes starts decreasing early in old mice i.e., from the first hour after TBI as compared to that starts from fourth hour in adult TBI mice. Thus TBI affects expression of Kir4.1 and GLT-1 genes in age- and time dependent manner and it may lead to accumulations of more K+ and glutamate early in the synapse of old mice as compared to adult. This may be implicated in the TBI induced early and severe neuronal depolarization and excito-neurotoxicity in old age.	[Gupta, R. K.; Prasad, S.] Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India	Prasad, S (corresponding author), Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.	s.sprasadbhu@gmail.com	Gupta, Rajaneesh/AAD-5893-2019	Gupta, Rajaneesh/0000-0003-0212-6478	Council of Scientific and Industrial Research (CSIR), Govt. of India (CSIR) [09/013 (0111) 2007-EMR I]; CSIRCouncil of Scientific & Industrial Research (CSIR) - India [37/1389/09/EMR-II]; BRNS, Govt. of IndiaDepartment of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS) [2009/37/55/3298]	R.K. Gupta acknowledges the Council of Scientific and Industrial Research (CSIR), Govt. of India for a Junior and Senior Research Fellowship (CSIR Award No. File No: 09/013 (0111) 2007-EMR I). S. Prasad acknowledges the research grants support from CSIR (37/1389/09/EMR-II) and BRNS (2009/37/55/3298), Govt. of India.	Anderson J, 2009, J NEUROTRAUM, V26, P1557, DOI [10.1089/neu.2008.0765, 10.1089/neu.2008-0765]; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Bordey A, 1998, EPILEPSY RES, V32, P286, DOI 10.1016/S0920-1211(98)00059-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buga AM, 2008, ROM J MORPHOL EMBRYO, V49, P279; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Francke M, 1997, GLIA, V20, P210, DOI 10.1002/(SICI)1098-1136(199707)20:3<210::AID-GLIA5>3.0.CO;2-B; Gershkoff A M, 1993, Arch Phys Med Rehabil, V74, pS402; GIFFARD RG, 1990, BRAIN RES, V530, P138, DOI 10.1016/0006-8993(90)90670-7; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Goleburn C., 2001, J CLIN GEROPSYCHOLOG, V7, DOI [https://doi.org/10.1023/A:1011335027445, DOI 10.1023/A:1011335027445]; Gordon MN, 1997, J COMP NEUROL, V388, P106; Gupta RK, 2013, AGE, V35, P59, DOI 10.1007/s11357-011-9330-5; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Homayoun P, 1997, J NEUROCHEM, V69, P199; Itoh T, 2013, BRAIN STRUCT FUNCT, V218, P209, DOI 10.1007/s00429-012-0394-5; Joh HD, 2006, J CEREBR BLOOD F MET, V26, P518, DOI 10.1038/sj.jcbfm.9600211; KANUNGO MS, 1994, GENES AGING, P167; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Lyeth BG, 1996, BRAIN RES, V742, P63, DOI 10.1016/S0006-8993(96)01002-5; MacFarlane SN, 1997, J NEUROSCI, V17, P7316; MALENKA RC, 1981, SCIENCE, V214, P339, DOI 10.1126/science.7280695; Marcaggi P, 2004, GLIA, V47, P217, DOI 10.1002/glia.20027; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; Mitani A, 2003, J NEUROSCI, V23, P7176, DOI 10.1523/JNEUROSCI.23-18-07176.2003; Modi PK, 2010, CELL MOL NEUROBIOL, V30, P709, DOI 10.1007/s10571-009-9495-y; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; POLLEN D A, 1970, Science (Washington D C), V167, P1252, DOI 10.1126/science.167.3922.1252; Prasad S, 2011, RECENT TRENDS BIOTEC, V2, P1; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Rusa R, 1999, STROKE, V30, P1665, DOI 10.1161/01.STR.30.8.1665; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; SWANSON RA, 1995, J CEREBR BLOOD F MET, V15, P417, DOI 10.1038/jcbfm.1995.52; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; TOPP KS, 1989, GLIA, V2, P201, DOI 10.1002/glia.440020309; Trotti D, 1997, EUR J NEUROSCI, V9, P1236, DOI 10.1111/j.1460-9568.1997.tb01478.x; Vemuganti LRR, 1998, J NEUROCHEM, V70, P2020; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	56	20	20	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1389-5729	1573-6768		BIOGERONTOLOGY	Biogerontology	OCT	2013	14	5					531	541		10.1007/s10522-013-9459-y			11	Geriatrics & Gerontology	Geriatrics & Gerontology	234CM	WOS:000325617400006	24026668				2021-06-18	
J	Luo, J; Lee, S; Wu, D; Yeh, J; Ellamushi, H; Wheeler, AP; Warnes, G; Zhang, Y; Bo, X				Luo, J.; Lee, S.; Wu, D.; Yeh, J.; Ellamushi, H.; Wheeler, A. P.; Warnes, G.; Zhang, Y.; Bo, X.			P2X7 purinoceptors contribute to the death of Schwann cells transplanted into the spinal cord	CELL DEATH & DISEASE			English	Article						purinoceptor; ATP receptor; Schwann cell; cell death; cell transplantation; spinal cord injury	P2X(7) RECEPTOR EXPRESSION; EXTRACELLULAR ATP; PURINERGIC RECEPTORS; IMPROVES RECOVERY; HUMAN ASTROCYTES; P-2Z RECEPTOR; OXIDIZED ATP; STRATEGIES; SURVIVAL; CALCIUM	The potential to use Schwann cells (SCs) in neural repair for patients suffering from neurotrauma and neurodegenerative diseases is well recognized. However, significant cell death after transplantation hinders the clinical translation of SC-based therapies. Various factors may contribute to the death of transplanted cells. It is known that prolonged activation of P2X7 purinoceptors (P2X7R) can lead to death of certain types of cells. In this study, we show that rat SCs express P2X7R and exposure of cultured SCs to high concentrations of ATP (3-5mM) or a P2X7R agonist, 2'(3')-O-(4-benzoylbenzoyl)ATP (BzATP) induced significant cell death rapidly. High concentrations of ATP and BzATP increased ethidium uptake by SCs, indicating increased membrane permeability to large molecules, a typical feature of prolonged P2X7R activation. SC death, as well as ethidium uptake, induced by ATP was blocked by an irreversible P2X7R antagonist oxidized ATP (oxATP) or a reversible P2X7R antagonist A438079. oxATP also significantly inhibits the increase of intracellular free calcium induced by minimolar ATP concentrations. Furthermore, ATP did not cause death of SCs isolated from P2X7R-knockout mice. All these results suggest that P2X7R is responsible for ATP-induced SC death in vitro. When rat SCs were treated with oxATP before transplantation into uninjured rat spinal cord, 35% more SCs survived than untreated SCs 1 week after transplantation. Moreover, 58% more SCs isolated from P2X7R-knockout mice survived after being transplanted into rat spinal cord than SCs from wild-type mice. This further confirms that P2X7R is involved in the death of transplanted SCs. These results indicate that targeting P2X7R on SCs could be a potential strategy to improve the survival of transplanted cells. As many other types of cells, including neural stem cells, also express P2X7R, deactivating P2X7R may improve the survival of other types of transplanted cells.	[Luo, J.; Lee, S.; Wu, D.; Yeh, J.; Ellamushi, H.; Zhang, Y.; Bo, X.] Queen Mary Univ London, Blizard Inst, Ctr Neurosci & Trauma, London E1 2AT, England; [Luo, J.] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Physiol, Wuhan 430030, Peoples R China; [Lee, S.] Semyung Univ, Coll Korean Med, Jechon 390711, South Korea; [Yeh, J.; Ellamushi, H.] Dept Neurosurg, London E1 2AT, England; [Wheeler, A. P.] Blizard Adv Light Microscopy Core Facil, London E1 2AT, England; [Warnes, G.] Queen Mary Univ London, Flow Cytometry Core Facil, Blizard Inst, Barts & London Sch Med & Dent, London E1 2AT, England	Bo, X (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Neurosci & Trauma, 4 Newark St, London E1 2AT, England.	x.bo@qmul.ac.uk	Warnes, Gary/I-1110-2019; Bo, Xuenong/E-9845-2012	Warnes, Gary/0000-0001-7614-6266; Bo, Xuenong/0000-0002-9202-3562; Wheeler, Ann/0000-0001-8617-827X	International Spinal Research Trust [NRB094]; Wellcome TrustWellcome TrustEuropean Commission [084688/Z/08/Z]; Medtronic UKMedtronic; Semyung University	We are very grateful to GlaxoSmithKline UK for providing the P2X7R KO mice. We thank JV Priestley, G Burnstock, and G Knight for critical reading of the manuscript. This work was supported by a Nathalie Rose Barr PhD Studentship from International Spinal Research Trust (NRB094) (to YZ and XB) and a Wellcome Trust grant (084688/Z/08/Z) to XB and YZ). YZ was supported by a grant from Medtronic UK (to JY and HE). SL was supported by studentship from Semyung University (to XB and JY).	Beigi RD, 2003, BRIT J PHARMACOL, V140, P507, DOI 10.1038/sj.bjp.0705470; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Colomar A, 2001, EUR J NEUROSCI, V14, P927, DOI 10.1046/j.0953-816x.2001.01714.x; Coutinho-Silva R, 1999, AM J PHYSIOL-CELL PH, V276, pC1139; Craighead MW, 2001, NEUROSCI LETT, V311, P77, DOI 10.1016/S0304-3940(01)02110-3; Delarasse C, 2009, J NEUROCHEM, V109, P846, DOI 10.1111/j.1471-4159.2009.06008.x; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Di Virgilio F, 2003, BRIT J PHARMACOL, V140, P441, DOI 10.1038/sj.bjp.0705469; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10; EASTERBROOKSMITH SB, 1976, EUR J BIOCHEM, V62, P125, DOI 10.1111/j.1432-1033.1976.tb10105.x; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; Ferrari D, 1997, NEUROPHARMACOLOGY, V36, P1295, DOI 10.1016/S0028-3908(97)00137-8; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Fortun J, 2009, NEUROSCI LETT, V456, P124, DOI 10.1016/j.neulet.2008.08.092; Franke H, 2004, J NEUROPATH EXP NEUR, V63, P686, DOI 10.1093/jnen/63.7.686; Grafe P, 1999, J PHYSIOL-LONDON, V515, P377, DOI 10.1111/j.1469-7793.1999.377ac.x; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287; John GR, 2001, J NEUROSCI, V21, P4134, DOI 10.1523/JNEUROSCI.21-12-04134.2001; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Le Feuvre R, 2002, EUR J PHARMACOL, V447, P261, DOI 10.1016/S0014-2999(02)01848-4; Luo JA, 2011, GLIA, V59, P424, DOI 10.1002/glia.21111; LYONS SA, 1994, J NEUROCHEM, V63, P552; Matute C, 2008, MOL NEUROBIOL, V38, P123, DOI 10.1007/s12035-008-8028-x; Narcisse L, 2005, GLIA, V49, P245, DOI 10.1002/glia.20110; Nelson DW, 2006, J MED CHEM, V49, P3659, DOI 10.1021/jm051202e; Newman EA, 2001, J NEUROSCI, V21, P2215; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Notomi S, 2011, AM J PATHOL, V179, P2798, DOI 10.1016/j.ajpath.2011.08.035; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Schneider EM, 2006, ANN NY ACAD SCI, V1090, P245, DOI 10.1196/annals.1378.027; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Zhang Y, 2007, EUR J NEUROSCI, V25, P351, DOI 10.1111/j.1460-9568.2007.05311.x	44	20	20	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	OCT	2013	4								e829	10.1038/cddis.2013.343			10	Cell Biology	Cell Biology	251XK	WOS:000326967100015	24091672	DOAJ Gold, Green Published			2021-06-18	
J	Lyttle, MD; Cheek, JA; Blackburn, C; Oakley, E; Ward, B; Fry, A; Jachno, K; Babl, FE				Lyttle, Mark D.; Cheek, John A.; Blackburn, Carol; Oakley, Ed; Ward, Brenton; Fry, Amanda; Jachno, Kim; Babl, Franz E.			Applicability of the CATCH, CHALICE and PECARN paediatric head injury clinical decision rules: pilot data from a single Australian centre	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; PREDICTION RULES; REFERRAL CENTER; CHILDREN; CT; ADOLESCENTS; VICTORIA; RISK	Background Clinical decision rules (CDRs) for paediatric head injury (HI) exist to identify children at risk of traumatic brain injury. Those of the highest quality are the Canadian assessment of tomography for childhood head injury (CATCH), Children's head injury algorithm for the prediction of important clinical events (CHALICE) and Pediatric Emergency Care Applied Research Network (PECARN) CDRs. They target different cohorts of children with HI and have not been compared in the same setting. We set out to quantify the proportion of children with HI to which each CDR was applicable. Methods Consecutive children presenting to an Australian paediatric Emergency Department with HIs were enrolled. Published inclusion/exclusion criteria and predictor variables from the CDRs were collected prospectively. Using these we determined the frequency with which each CDR was applicable. Results 1012 patients (69.9%) were enrolled with 949 available for analysis. Mean age was 6.8 years (21% < 2 years). 95% had initial Glasgow Coma Scale 15. CT rate was 12.8% and neurosurgery rate was 0.7%. No CDR was applicable to all patients. CHALICE was applicable to the most (97%, 95% CI 96% to 98%) and CATCH to the fewest (26%, 95% CI 24% to 29%). PECARN was applicable to 76% (95% CI 70% to 82%) aged < 2 years, and 74% (95% CI 71% to 77%) aged 2-< 18 years. Conclusions Each CDR is applicable to a different proportion of children with HI. This makes a direct comparison of the CDRs difficult. Prior to selection of any for implementation they should undergo validation outside the derivation setting coupled with an analysis of their performance accuracy, usability and cost effectiveness.	[Lyttle, Mark D.; Cheek, John A.; Blackburn, Carol; Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Lyttle, Mark D.] Bristol Royal Hosp Children, Emergency Dept, Bristol, Avon, England; [Oakley, Ed; Ward, Brenton; Fry, Amanda; Jachno, Kim; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Oakley, Ed] Monash Med Ctr, Emergency Dept, Clayton, Vic 3168, Australia; [Oakley, Ed] Monash Univ, Clayton, Vic, Australia; [Babl, Franz E.] Univ Melbourne, Melbourne, Vic, Australia	Babl, FE (corresponding author), Univ Melbourne, Royal Childrens Hosp, Emergency Dept, Parkville, Vic 3055, Australia.	franz.babl@rch.org.au		Lyttle, Mark/0000-0002-8634-7210; Jachno, Kim/0000-0003-2550-9674	Murdoch Children's Research Institute (MCRI), Melbourne, Australia	The study was supported in part by grant funding from the Murdoch Children's Research Institute (MCRI), Melbourne, Australia. MCRI is a non-governmental paediatric research institute. There was no influence from the part funder on design or conduct of the study.	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DI, 2002, PEDIATR RADIOL, V32, P42; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Canadian Institute for Health Information, HEAD INJ CAN DEC CHA; Conners GP, 1999, PEDIATR EMERG CARE, V15, P241; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2010, EMERG MED AUSTRALAS, V22, P56, DOI 10.1111/j.1742-6723.2009.01249.x; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; FAULKNER K, 1987, ACTA RADIOL, V28, P483; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lockie F, INT NEUR SOC M 10 IN; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Osmond MH, 2006, ACAD EMERG MED, P13; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Peden M., 2008, WORLD REPORT CHILD I; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Royal Children's Hospital, CLIN PRACT GUID HEAD; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Sun BC, 2007, ANN EMERG MED, V49, P325, DOI 10.1016/j.annemergmed.2006.08.032; VADE A, 1995, AM J ROENTGENOL, V165, P905, DOI 10.2214/ajr.165.4.7676990	28	20	23	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	OCT	2013	30	10					790	794		10.1136/emermed-2012-201887			5	Emergency Medicine	Emergency Medicine	267XI	WOS:000328131300004	23015114				2021-06-18	
J	Sansonetti, D; Hoffmann, T				Sansonetti, Danielle; Hoffmann, Tammy			Cognitive assessment across the continuum of care: The importance of occupational performance-based assessment for individuals post-stroke and traumatic brain injury	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						assessment outcomes; brain injury; cognition	STROKE REHABILITATION; TASK-ANALYSIS; IMPAIRMENTS; MANAGEMENT; THERAPISTS; DEMENTIA; PERCEIVE; RECALL; SYSTEM; PLAN	Background/aimWhen working with individuals following stroke or traumatic brain injury, an important role of the occupational therapist is to assess the impact of cognitive impairment on their ability to engage in occupations and resume important life roles. The aim of this study was to survey therapists' reasons for selection of and challenges with using various cognitive assessment approaches, across the continuum of care, when working with individuals following stroke and traumatic brain injury. MethodsA cross-sectional survey, completed via post or online, with responses from 209 Australian occupational therapists was conducted. Participants included clinicians working in acute, inpatient rehabilitation and community settings. ResultsOccupational performance-based assessments were ranked as the most important assessment method, with 69% of participants reporting using these assessments for more than 75% of their clients with cognitive impairment. Participants identified the lack of quantitative data provided by these assessments as a frequent challenge. The identification of cognitive deficits was the highest ranked reason for using cognitive screens and batteries. Challenges identified with using cognitive screens and batteries included difficulty linking assessment results to occupational performance, and difficulty using results to generate intervention strategies. The majority of participants reported using a combined approach to assessment, and used screens and batteries to support findings of occupational performance-based assessments. ConclusionsTargeted efforts to further incorporate standardised occupational performance-based methods into clinical practice, research, and ongoing professional development is required to enhance occupational therapy services when working with individuals with cognitive impairment.	[Sansonetti, Danielle] St Vincents Hosp, Occupat Therapy Dept, Melbourne, Vic 3101, Australia; [Sansonetti, Danielle] Eastern Hlth, Melbourne, Vic, Australia; [Hoffmann, Tammy] Bond Univ, Ctr Res Evidence Based Practice, Fac Hlth Sci & Med, Gold Coast, Qld, Australia; [Hoffmann, Tammy] Univ Queensland, Div Occupat Therapy, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia	Sansonetti, D (corresponding author), St Vincents Hosp, Occupat Therapy Dept, St Georges Hosp Campus,283 Cotham Rd, Melbourne, Vic 3101, Australia.	Danielle.Sansonetti@easternhealth.org.au	Hoffmann, Tammy/E-8029-2010	Hoffmann, Tammy/0000-0001-5210-8548			*AIHW, 2006, WE MAN STROK AUSTR; AIHW (Australian Institute of Health & Welfare), 2007, HOSP SEP DUE TRAUM B; Alotaibi NM, 2009, OCCUP THER HEALTH CA, V23, P302, DOI 10.3109/07380570903222583; Arthanat S, 2004, DISABIL REHABIL, V26, P235, DOI 10.1080/09638280310001644889; Aubin G, 2009, AUST OCCUP THER J, V56, P189, DOI 10.1111/j.1440-1630.2007.00725.x; BAUM C, 1993, AM J OCCUP THER, V47, P431, DOI 10.5014/ajot.47.5.431; Baum CM, 2010, NEUROPSYCHOLOGY EVER, P62; Douglas A, 2008, PHYS OCCUP THER GERI, V26, P13, DOI 10.1080/02703180801963758; Douglas Alison, 2007, Can J Occup Ther, V74, P370; Fry K, 2002, AUSTR OCCUPATIONAL T, V49, P182, DOI 10.1046/j.1440-1630.2002.00337.x; Gauggel S, 2000, J HEAD TRAUMA REHAB, V15, P710, DOI 10.1097/00001199-200002000-00009; Giles GM, 1998, COGNITION AND OCCUPATION IN REHABILITATION, P125; Groves D., 2010, OCCUPATIONAL THERAPY, V12, P20; Hartman-Maeir A, 2009, OCCUP THER HEALTH CA, V23, P1, DOI 10.1080/07380570802455516; Hartman-Maeir A, 2009, AM J OCCUP THER, V63, P592, DOI 10.5014/ajot.63.5.592; Koh CL, 2009, AUST OCCUP THER J, V56, P324, DOI 10.1111/j.1440-1630.2008.00764.x; Korner-Bitensky N, 2011, AUST OCCUP THER J, V58, P241, DOI 10.1111/j.1440-1630.2011.00943.x; Lee S S, 2001, Can J Occup Ther, V68, P41; Lewis MW, 2011, NEUROPSYCHOL REHABIL, V21, P145, DOI 10.1080/09602011.2010.543867; National Stroke Foundation, 2009, NAT STROK AUD AC SER; Nott MT, 2008, AUST OCCUP THER J, V55, P188, DOI 10.1111/j.1440-1630.2007.00685.x; NYGARD L, 1994, AM J OCCUP THER, V48, P689, DOI 10.5014/ajot.48.8.689; Ozdemir F, 2001, AM J PHYS MED REHAB, V80, P410, DOI 10.1097/00002060-200106000-00003; POOLE J, 1991, AM J OCCUP THER, V45, P1067; Salter K, 2005, DISABIL REHABIL, V27, P191, DOI 10.1080/09638280400008537; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Toglia J., 2009, WILLARD SPACKMANS OC, P739; Vining-Radomski M., 2008, OCCUPATIONAL THERAPY, P260; WHEATLEY CJ, 1994, AM J OCCUP THER, V48, P163, DOI 10.5014/ajot.48.2.163; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P37, DOI 10.1017/CBO9780511581083.005; Woodford HJ, 2007, QJM-INT J MED, V100, P469, DOI 10.1093/qjmed/hcm051; World Health Organization, 2001, INT CLASS FUNCT DIS; Zwecker M, 2002, ARCH PHYS MED REHAB, V83, P342, DOI 10.1053/apmr.2002.29641	33	20	21	0	27	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766			AUST OCCUP THER J	Aust. Occup. Ther. J.	OCT	2013	60	5					334	342		10.1111/1440-1630.12069			9	Rehabilitation	Rehabilitation	228AM	WOS:000325157200005	24089985				2021-06-18	
J	Tang, HL; Sha, HY; Sun, HP; Wu, X; Xie, LQ; Wang, P; Xu, CS; Larsen, C; Zhang, HL; Gong, Y; Mao, Y; Chen, XC; Zhou, LF; Feng, XY; Zhu, JH				Tang, Hailiang; Sha, Hongying; Sun, Huaping; Wu, Xing; Xie, Liqian; Wang, Pu; Xu, Chengshi; Larsen, Christian; Zhang, Helen L.; Gong, Ye; Mao, Ying; Chen, Xiancheng; Zhou, Liangfu; Feng, Xiaoyuan; Zhu, Jianhong			Tracking Induced Pluripotent Stem Cells-Derived Neural Stem Cells in the Central Nervous System of Rats and Monkeys	CELLULAR REPROGRAMMING			English	Article							BRAIN; FIBROBLASTS; PARTICLES; INDUCTION; INJURY	Despite of the immense breakthroughs of induced pluripotent stem cells (iPSCs), clinical application of iPSCs and their derivates remains hampered by a lack of definitive in vivo studies. Here, we attempted to track iPSCs-derived neural stem cells (NSCs) in the rodent and primate central nervous system (CNS) and explore their therapeutic viability for stem cell replacement in traumatic brain injury (TBI) rats and monkeys with spinal cord injury (SCI). Superparamagnetic iron oxide (SPIO) particles were used to label iPSCs-derived NSCs in vitro. Labeled NSCs were implanted into TBI rats and SCI monkeys 1 week after injury, and then imaged using gradient reflection echo (GRE) sequence by 3.0T magnetic resonance imaging (MRI) scanner. MRI analysis was performed at 1, 7, 14, 21, and 30 days, respectively, following cell transplantation. Pronounced hypointense signals were initially detected at the cell injection sites in rats and monkeys and were later found to extend progressively to the lesion regions, demonstrating that iPSCs-derived NSCs could migrate to the lesion area from the primary sites. The therapeutic efficacy of iPSCs-derived NSCs was examined concomitantly through functional recovery tests of the animals. In this study, we tracked iPSCs-derived NSCs migration in the CNS of TBI rats and SCI monkeys in vivo for the first time. Functional recovery tests showed obvious motor function improvement in transplanted animals. These data provide the necessary foundation for future clinical application of iPSCs for CNS injury.	[Tang, Hailiang; Wu, Xing; Xie, Liqian; Wang, Pu; Xu, Chengshi; Larsen, Christian; Zhang, Helen L.; Gong, Ye; Mao, Ying; Chen, Xiancheng; Zhou, Liangfu; Zhu, Jianhong] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200040, Peoples R China; [Sha, Hongying] Fudan Univ, Natl Key Lab Med Neurobiol, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Sun, Huaping; Feng, Xiaoyuan] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200040, Peoples R China; [Zhu, Jianhong] Fudan Univ, Natl Key Lab Med Neurobiol, Inst Brain Sci, Shanghai Med Coll, Shanghai 200032, Peoples R China	Feng, XY (corresponding author), HuaShan Hosp, Dept Radiol, Shanghai, Peoples R China.	xyfeng@fudan.edu.cn; jzhu@fudan.edu.cn			National Nature Science FoundationNational Natural Science Foundation of China (NSFC) [81200936, 2010CB945500, 2012CB966300, 11JC1401000, 2009CB941100]; Ministry of Science and Technology of China and Shanghai City Science Foundation; Shanghai Medical College Young Scientist Fund of Fudan University [11L-24]	We are grateful to the technicians (Luping Chen, Yiwen Shen, and Qisheng Tang) in the stem cell lab for their assistance in animal preparation and advice on experiments. This work was supported by grants (81200936, 2010CB945500, 2012CB966300, 11JC1401000, 2009CB941100) from National Nature Science Foundation, Ministry of Science and Technology of China and Shanghai City Science Foundation, and 2011 Shanghai Medical College Young Scientist Fund of Fudan University (11L-24).	Allen A. R., 1991, PHARM BIOCH BEHAV, V57, P878; Breunig JJ, 2011, NEURON, V70, P614, DOI 10.1016/j.neuron.2011.05.005; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Dixon E.C., 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Henrich C., 1996, SCIENCE, V273, P510; Hoehn M, 2007, J PHYSIOL-LONDON, V584, P25, DOI 10.1113/jphysiol.2007.139451; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Neri M, 2008, STEM CELLS, V26, P505, DOI 10.1634/stemcells.2007-0251; Postmantur R., 1997, NEUROSCIENCE, V77, P765; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Shapiro EM, 2006, NEUROIMAGE, V32, P1150, DOI 10.1016/j.neuroimage.2006.04.219; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VILLEGAS J, 2005, CURR PROTOC MOL BIOL, pCH28, DOI DOI 10.1002/0471142727.MB2803S71; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	20	20	21	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2152-4971	2152-4998		CELL REPROGRAM	Cell. Reprogramm.	OCT 1	2013	15	5					435	442		10.1089/cell.2012.0081			8	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Genetics & Heredity	Cell Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	293RO	WOS:000329991600016	24020696	Green Published			2021-06-18	
J	Farrell-Carnahan, L; Franke, L; Graham, C; McNamee, S				Farrell-Carnahan, Leah; Franke, Laura; Graham, Carolyn; McNamee, Shane			Subjective Sleep Disturbance in Veterans Receiving Care in the Veterans Affairs Polytrauma System Following Blast-Related Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INSOMNIA; PREDICTORS; IMPACT; IRAQ; AFGHANISTAN; MECHANISMS; DEPRESSION; SEVERITY; BEHAVIOR	Objectives: This investigation sought to characterize prevalence and factors associated with subjective sleep disturbance (SSD) in a clinical sample of veterans with blast-related mild traumatic brain injury (mTBI). Methods: Adult veterans with history of blast-related mTBI were enrolled in a cross-sectional study. Data on demographics, injury, and current symptoms, including SSD, were obtained. Descriptive and univariate analyses investigated prevalence of SSD and associated factors. Results: Participants were 114 veterans with blast-related mTBI (96% male; mean age = 31 years, SD = 8; mean number of days since injury = 1,044, SD = 538). 78% screened positive for post-traumatic stress disorder and 77% reported SSD. Loss of consciousness at time of injury, current nightmares, depression, headache, fatigue, and positive screen for post-traumatic stress disorder were significantly associated with SSD (p < 0.05). Conclusions: SSD was pervasive in this clinical sample and was significantly associated with multiple modifiable emotional symptoms as well as headache and fatigue; this is consistent with previous literature including samples with history of nonblast-related mTBI. Future research incorporating objective measurement of SSD and associated symptoms is needed to inform evidence-based screening, assessment, and treatment efforts for veterans with history of mTBI.	[Farrell-Carnahan, Leah; McNamee, Shane] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA 23249 USA; [Franke, Laura] Def & Vet Brain Injury Ctr, Richmond, VA 23249 USA; [Farrell-Carnahan, Leah; Franke, Laura; Graham, Carolyn; McNamee, Shane] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Dept Phys Med & Rehabil, Richmond, VA 23223 USA	Farrell-Carnahan, L (corresponding author), Hunter Holmes McGuire Vet Affairs Med Ctr, 1201 Broad Rock Blvd, Richmond, VA 23249 USA.				Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	We thank William C. Walker, MD, principal investigator; Michelle Nichols, MSN, RN, research nurse manager/coinvestigator; and Tiffany Lewis, MA, study coordinator and research assistant. We also thank research assistants: Angela Satariano, COTA; Tiffany Amos, BS; Emily Lynn, BS; April Dean, BS; Jordan Stinson, BS; Nichole Kelly, MS; Jasmine Smith, BS; and William Came, PhD, psychologist/consultant. The parent study, Prospective Traumatic Brain Injury Tracking Protocol, is funded by Defense and Veterans Brain Injury Center.	Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bryan CJ, 2011, HEADACHE, V51, P945, DOI 10.1111/j.1526-4610.2011.01887.x; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; COUCH JR, 1995, J NEUROL REHABIL, V9, P83; Defense and Veterans Brain Injury Center, 2013, DEF VET BRAIN INJ CT; Department of Veterans Affairs, 2010, DEP VET AFF VA DOD C; Department of Veterans Affairs, 2009, DEP VET AFF MAN MAJ; Department of Veterans Affairs, 2009, DEP VET AFF MAN CONC; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Evans RW., 2006, NEUROLOGY TRAUMA, P95; Foley D, 2004, J PSYCHOSOM RES, V56, P497, DOI 10.1016/j.jpsychores.2004.02.010; Graham CA, 2003, J SEX RES, V40, P325, DOI 10.1080/00224490209552198; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Hatoum HT, 1998, PHARMACOECONOMICS, V14, P629, DOI 10.2165/00019053-199814060-00004; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P2179; JENNETT B, 1975, LANCET, V1, P480; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Leger D, 2006, SLEEP, V29, P171; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Manber R, 2012, J CLIN SLEEP MED, V8, P209, DOI 10.5664/jcsm.1786; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; National Center for PTSD, 2012, US PTSD CHECKL; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Paulhus D.L., 1991, MEASURES PERSONALITY, P17, DOI [DOI 10.1016/B978-0-12-590241-0.50006-X, 10.1016/B978-0-12-590241-0.50006-X, DOI 10.1016/b978-0-12-590241-0.50006-x]; Ribeiro JD, 2012, J AFFECT DISORDERS, V136, P743, DOI 10.1016/j.jad.2011.09.049; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845	42	20	20	1	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	SEP	2013	178	9					951	956		10.7205/MILMED-D-13-00037			6	Medicine, General & Internal	General & Internal Medicine	AN7UC	WOS:000340805500009	24005542	Bronze			2021-06-18	
J	Yoshida, S; Kato, T; Higuchi, M; Yako, H; Chen, M; Kanno, N; Ueharu, H; Kato, Y				Yoshida, S.; Kato, T.; Higuchi, M.; Yako, H.; Chen, M.; Kanno, N.; Ueharu, H.; Kato, Y.			Rapid Transition of NESTIN-Expressing Dividing Cells from PROP1-Positive to PIT1-Positive Advances Prenatal Pituitary Development	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						NESTIN; PROP1; PIT1; pituitary; stem/progenitor cell	TRAUMATIC BRAIN-INJURY; STEM/PROGENITOR CELL; RAT PITUITARY; STEM-CELLS; POPULATION; PRX2	We recently reported that the quantitative and qualitative transition of stem/progenitor cells occurs by the acquisition of a novel mechanism in the terminal differentiation during postnatal development of the anterior pituitary. We hypothesised that this novel mechanism is an alteration of a cell supply system accompanying proliferation of the progenitor cells. In the present study, we examined the proliferation activities of progenitor cells by indication of the expression of Nestin, a marker of rapidly dividing progenitor cells, aiming to verify our hypothesis and to resolve another outstanding issue regarding whether the Nestin gene is expressed in the pituitary. We found that NESTIN-positive dividing cells certainly exist in the pituitary through all stages of development. Almost all of the PROP1-positive progenitor cells express Nestin in early embryonic pituitary development. Thereafter, Nestin-expressing dividing cells involved in the cell supply system transfer from PROP1-positive progenitor cells to committed progenitor cells, such as PIT1-positive cells, on neonatal pituitary development. Furthermore, our data, together with the findings of previous studies on cell lineage tracing analyses using Nestin-Cre mice derived by the central nervous system (CNS)-specific Nestin promoter, suggest that at least two regulation systems for Nestin-expression exist in the pituitary, with the majority of these not being CNS-specific.	[Yoshida, S.; Yako, H.; Chen, M.; Kanno, N.; Ueharu, H.; Kato, Y.] Meiji Univ, Grad Sch Agr, Div Life Sci, Tokyo, Kanagawa, Japan; [Kato, T.; Higuchi, M.; Kato, Y.] Meiji Univ, Inst Reprod & Endocrinol, Tokyo, Kanagawa, Japan; [Kato, Y.] Meiji Univ, Sch Agr, Dept Life Sci, Tokyo, Kanagawa, Japan	Kato, Y (corresponding author), Sch Agr, Dept Life Sci, Kanagawa, Japan.	yukato@isc.meiji.ac.jp		Higuchi, Masashi/0000-0003-2129-1065	MEXT of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [06454019, 21380184]; Institute of Science and Technology, Meiji University; Meiji University International Institute for BioResource Research (MUIIR)	We wish to thank Dr A. F. Parlow and the NIDDK for supplying us with the antibodies to the pituitary hormones. We also thank Dr S. Tanaka of Shizuoka University for providing the antibodies to human GH and ACTH. The present study was partially supported by Grants-in-Aid for Scientific Research (B) Numbers 06454019 and 21380184 and by the 'High-Tech Research Center' Project for Private Universities, a matching fund subsidy from the MEXT of Japan, and a Research Grant (A) to Y. Kato from the Institute of Science and Technology, Meiji University. This study was partly supported by Meiji University International Institute for BioResource Research (MUIIR).	Aihara M, 2004, LAB INVEST, V84, P1581, DOI 10.1038/labinvest.3700186; Allaerts W, 2005, EUR J ENDOCRINOL, V153, P1, DOI 10.1530/eje.1.01949; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Chen JH, 2009, STEM CELLS, V27, P1182, DOI 10.1002/stem.51; Chen M, 2013, CELL TISSUE RES, DOI 10.1007/s00441-013-1713-8; DAIKOKU S, 1981, ARCH HISTOL JAPON, V44, P103, DOI 10.1679/aohc1950.44.103; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; Devnath S, 2008, J NEUROENDOCRINOL, V20, P687, DOI 10.1111/j.1365-2826.2008.01716.x; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Galichet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011443; Gautron L, 2009, NEUROENDOCRINOLOGY, V90, P19, DOI 10.1159/000220994; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Gremeaux L, 2012, STEM CELLS DEV, V21, P801, DOI 10.1089/scd.2011.0496; Hendrickson ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018535; Higuchi M, 2013, CELL TISSUE RES, V353, P27, DOI 10.1007/s00441-013-1632-8; Hunziker E, 2000, BIOCHEM BIOPH RES CO, V271, P116, DOI 10.1006/bbrc.2000.2611; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Krylyshkina O, 2005, ENDOCRINOLOGY, V146, P2376, DOI 10.1210/en.2004-1209; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Mitsuishi H, 2013, CELL TISSUE RES, DOI 10.1007/s00441-013-1686-7; Salehi F, 2008, J NEUROSURG, V108, P118, DOI 10.3171/JNS/2008/108/01/0118; Shih CC, 2001, BLOOD, V98, P2412, DOI 10.1182/blood.V98.8.2412; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; Susa T, 2012, J NEUROENDOCRINOL, V24, P1201, DOI 10.1111/j.1365-2826.2012.02336.x; Vankelecom H, 2010, GEN COMP ENDOCR, V166, P478, DOI 10.1016/j.ygcen.2009.11.007; VILAPORCILE E, 1972, Z ZELLFORSCH MIK ANA, V129, P328, DOI 10.1007/BF00307293; Weiss S, 2009, CLIN NEUROPATHOL, V28, P309; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yako H, 2013, CELL TISSUE RES CELL, DOI 10.1007/s00441-013-1717-4; Yoshida S, 2011, J NEUROENDOCRINOL, V23, P933, DOI 10.1111/j.1365-2826.2011.02198.x; Yoshida S, 2009, BIOCHEM BIOPH RES CO, V385, P11, DOI 10.1016/j.bbrc.2009.05.027; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	37	20	20	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	SEP	2013	25	9					779	791		10.1111/jne.12077			13	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	202WD	WOS:000323250300002	23855824				2021-06-18	
J	King, EG; Kretzmer, TS; Vanderploeg, RD; Asmussen, SB; Clement, VL; Belanger, HG				King, Emily G.; Kretzmer, Tracy S.; Vanderploeg, Rodney D.; Asmussen, Sarah B.; Clement, Veronica L.; Belanger, Heather G.			Pilot of a Novel Intervention for Postconcussive Symptoms in Active Duty, Veterans, and Civilians	REHABILITATION PSYCHOLOGY			English	Article						mild TBI; postconcussive symptoms; psychoeducational intervention; computer intervention	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MINOR HEAD-INJURY; RANDOMIZED-TRIAL; MILITARY; CONCUSSION; IMPACT; REHABILITATION; PSYCHOTHERAPY; METAANALYSIS	Purpose/Objective: The authors present a study aimed at pilot testing a novel delivery method, namely a computer intervention, for postconcussive symptom reduction in active duty, veteran, and civilian patients with acute and chronic complaints. Following a concussion/mild traumatic brain injury (MTBI), most individuals recover completely, but a significant proportion report postconcussive symptoms months to years following the injury. Psychoeducational intervention has shown to be effective in reducing postconcussive symptoms in studies done with acute civilian samples, but the efficacy of psychoeducational interventions with individuals who served in combat or have chronic complaints remains unclear. Research Method/Design: Twenty-five active duty, veteran, and civilian participants took part in this study. At baseline, each participant completed a self-run psychoeducational computer-based treatment. Participants were reassessed 1-month postintervention via phone to evaluate postconconcussive symptom severity. Results: Participants reported significantly fewer postconcussive symptoms at follow-up than baseline (d = .99). Intervention satisfaction was reported, with feedback related to ease of use and quality. Conclusions/Implications: Extending previous studies, current findings demonstrated that psychoeducational intervention following MTBI was associated with postconcussive symptom complaint reduction in both acute and chronic patients. These data also confirm the feasibility of using computerized psychoeducation and speak to the importance of providing education to both acute and chronic patients across settings. Feedback from participants was generally positive. Further investigation with a control group is warranted.	[King, Emily G.; Kretzmer, Tracy S.; Vanderploeg, Rodney D.; Clement, Veronica L.; Belanger, Heather G.] James A Haley VA, Dept Mental Hlth & Behav Sci, Tampa, FL USA; [Kretzmer, Tracy S.; Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.; Asmussen, Sarah B.; Belanger, Heather G.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Asmussen, Sarah B.] DVBIC Concuss Clin Camp Pendleton & Navy Med Ctr, San Diego, CA USA	King, EG (corresponding author), Bay Pines VA Healthcare Syst, Mental Hlth & Behav Sci, St Petersburg, FL USA.	Emily.King@va.gov					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Barak A, 2008, J TECHNOL HUMAN SERV, V26, P109, DOI 10.1080/15228830802094429; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Department of Veterans Affairs and Department of Defense, CLIN PRACT GUID MAN; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; French LM, 2012, J HEAD TRAUMA REHAB, V27, P63, DOI 10.1097/HTR.0b013e3182248344; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Girard P, 2007, J REHABIL RES DEV, V44, P1017, DOI 10.1682/JRRD.2006.12.0174; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; Hodgson J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kazdin AE, 2011, PERSPECT PSYCHOL SCI, V6, P21, DOI 10.1177/1745691610393527; Keane, 1991, PCL C DSM 4; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, OXFORD WORKSHOP SERI; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rizzo A, 2011, J CLIN PSYCHOL MED S, V18, P176, DOI 10.1007/s10880-011-9247-2; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Strachan M, 2012, CONTEMP CLIN TRIALS, V33, P402, DOI 10.1016/j.cct.2011.11.007; Sullivan KA, 2012, J HEAD TRAUMA REHAB, V27, P293, DOI 10.1097/HTR.0b013e31822123ce; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; TYLER GS, 1980, HEADACHE, V20, P213, DOI 10.1111/j.1526-4610.1980.hed2004213.x; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023	55	20	20	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2013	58	3					272	279		10.1037/a0033116			8	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	204ZB	WOS:000323408700006	23815304				2021-06-18	
J	Kutsogiannis, DJ; Asthana, S; Townsend, DR; Singh, G; Karvellas, CJ				Kutsogiannis, Demetrios J.; Asthana, Sonal; Townsend, Derek R.; Singh, Gurmeet; Karvellas, Constantine J.			The incidence of potential missed organ donors in intensive care units and emergency rooms: a retrospective cohort	INTENSIVE CARE MEDICINE			English	Article						Organ donation; Donation after circulatory death; Brain death; Collaborative requesting	TRAUMATIC BRAIN-INJURY; CARDIAC DEATH; LUNG TRANSPLANTATION; LIFE-SUPPORT; DONATION; WITHDRAWAL; HEMORRHAGE; MORTALITY; DECISION; CRITERIA	There is a shortage of organ donors in Canada. The number of potential organ donors that are not referred to organ procurement organizations in Canada is unknown. We conducted a retrospective cohort study of all deaths in ICUs and emergency rooms not referred to the Human Organ Procurement and Exchange Program in four hospitals between 1 January 2008 and 31 December 2010. The primary outcome was the number of normal and expanded criteria heart-beating donors and circulatory death (DCD) donors. Of 2,931 deaths, 64 patients were identified as having a high probability for progression to heart-beating donation (Glasgow Coma Score of 3 and three or more absent brainstem reflexes) and 130 patients were assessed for possible DCD donation. The number of potential abdominal and lung heart-beating donors ranged from 3.2 to 7.5 and 0.5 to 2.7 per million population. The number of potential DCD abdominal and lung donors ranged from 3.9 to 6.5 and 2.7 to 4.3 per million population. Potential heart-beating abdominal (p = 0.04) and lung (p = 0.06) donors increased after legislation mandating donation discussion. Non-pupillary brainstem reflexes were documented in fewer than 60 % of records. Life-sustaining treatment was withdrawn in 19 of 46 (41.3 %) cardiac arrest patients not requiring high doses of vasoactive drugs within 24 h. The number of heart-beating or DCD organ donors represented by missed referrals may represent up to 7.5 donors per million population. Improved documentation of brainstem reflexes and encouraging referral of patients suffering cardiac arrest to ICU specialists may improve donor numbers.	[Kutsogiannis, Demetrios J.; Townsend, Derek R.; Singh, Gurmeet; Karvellas, Constantine J.] Univ Alberta, Fac Med & Dent, Div Crit Care Med, Edmonton, AB, Canada; [Asthana, Sonal] BGS Global Hosp, Div Transplantat, Bangalore, Karnataka, India; [Kutsogiannis, Demetrios J.] Royal Alexandra Hosp, Edmonton, AB T5H 3V9, Canada	Kutsogiannis, DJ (corresponding author), Royal Alexandra Hosp, 616 CSC,10240 Kingsway Ave, Edmonton, AB T5H 3V9, Canada.	jim.kutsogiannis@ualberta.ca		Karvellas, Constantine/0000-0002-1555-1089			Abadie A, 2006, J HEALTH ECON, V25, P599, DOI 10.1016/j.jhealeco.2006.01.003; Antonelli M, 2012, INTENS CARE MED, V38, P192, DOI 10.1007/s00134-011-2447-2; Barber K, 2006, BMJ-BRIT MED J, V332, P1124, DOI 10.1136/bmj.38804.658183.55; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Botha P, 2009, CURR OPIN ORGAN TRAN, V14, P206, DOI 10.1097/MOT.0b013e328326c834; Canadian Institute for Health Information, 2010, E STAT REP TRANSPL W; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; de Groot YJ, 2012, CRIT CARE MED, V40, P233, DOI 10.1097/CCM.0b013e31822f0633; de Groot YJ, 2011, INTENS CARE MED, V37, P665, DOI 10.1007/s00134-011-2131-6; de Groot YJ, 2010, INTENS CARE MED, V36, P1488, DOI 10.1007/s00134-010-1848-y; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Hemphill JC, 2004, STROKE, V35, P1130, DOI 10.1161/01.STR.0000125858.71051.ca; Kohn R, 2011, INTENS CARE MED, V37, P1210, DOI 10.1007/s00134-011-2257-6; Kompanje EJO, 2006, INTENS CARE MED, V32, P217, DOI 10.1007/s00134-005-0001-9; Morgan SE, 2008, J HEALTH PSYCHOL, V13, P644, DOI 10.1177/1359105308090936; Ojo AO, 2005, SEMIN DIALYSIS, V18, P463, DOI 10.1111/j.1525-139X.2005.00090.x; Opdam HI, 2004, INTENS CARE MED, V30, P1390, DOI 10.1007/s00134-004-2185-9; Oto T, 2008, GEN THORAC CARDIOVAS, V56, P533, DOI 10.1007/s11748-008-0315-y; Oz MC, 2003, J HEART LUNG TRANSPL, V22, P389, DOI 10.1016/S1053-2498(03)00074-3; Rabinstein AA, 2012, LANCET NEUROL, V11, P414, DOI 10.1016/S1474-4422(12)70060-1; Rosner B., 1995, FUNDAMENTALS BIOSTAT, V4th ed; Rull R, 2003, LIVER TRANSPLANT, V9, P389, DOI 10.1053/jlts.2003.50050; Salim A, 2010, J TRAUMA, V69, P451, DOI 10.1097/TA.0b013e3181e7847a; Shemie SD, 2006, CAN MED ASSOC J, V175, pS1, DOI 10.1503/cmaj.060895; Simpkin AL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b991; Snell GI, 2008, AM J TRANSPLANT, V8, P1282, DOI 10.1111/j.1600-6143.2008.02231.x; Tu JV, 2009, CAN MED ASSOC J, V180, pE118, DOI 10.1503/cmaj.081197; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Weng L, 2011, INTENS CARE MED, V37, P655, DOI 10.1007/s00134-010-2124-x; Yee AH, 2010, NEUROLOGY, V74, P1380, DOI 10.1212/WNL.0b013e3181dad5f0; Yeung Jonathan C, 2009, Thorac Surg Clin, V19, P261, DOI 10.1016/j.thorsurg.2009.02.006; Young D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3911; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72	33	20	22	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	AUG	2013	39	8					1452	1459		10.1007/s00134-013-2952-6			8	Critical Care Medicine	General & Internal Medicine	182UC	WOS:000321769100013	23702637				2021-06-18	
J	McLellan, T; McKinlay, A				McLellan, T.; McKinlay, A.			Sensitivity to emotion, empathy and theory of mind: Adult performance following childhood TBI	BRAIN INJURY			English	Article						Brain injury; facial expression; paediatric injury; social perception	TRAUMATIC BRAIN-INJURY; PERCEPTION DEFICITS; FACIAL EXPRESSION; RECOGNITION; CHILDREN; ABILITY	Primary objective: To examine deficits in emotion perception for adults who had experienced a traumatic brain injury (TBI) during childhood and investigate relationships between emotion perception skills, empathy and Theory of Mind (ToM). Design: Participants consisted of a random selection of individuals (n - 52) who had previously been recruited for a larger study. All participants had experienced an injury event as a child (0-17 years) (mild TBI, moderate/severe TBI or fractured limb) and were now aged between 18-30 years, with a minimum of 5 years post-injury. Methods and procedure: Each participant completed an emotion-sensitivity task, facial expression recognition task, the faux pas test (ToM) and the Interpersonal Reactivity Inventory (IRI: Empathy). Main outcomes: Individuals with moderate/severe TBI were less sensitivite to emotion and less accurate at facial expression recognition than those with mild TBI and orthopaedic controls. Difficulty with affective ToM but not empathy was also found. The emotion-sensitivity and the facial expression recognition tasks were unrelated, with only emotion sensitivity but not expression recognition related to ToM and IRI empathy. Conclusions: The current findings indicated that deficits in social skills are long lasting and raises the issue of whether intervention to improve sensitivity to genuine emotion can influence more complex social skills and improve quality of social interactions for individuals following TBI.	[McLellan, T.; McKinlay, A.] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [McKinlay, A.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia	McLellan, T (corresponding author), Univ Canterbury, Private Bag 4800, Christchurch 1, New Zealand.	traceylmclellan@gmail.com		McKinlay, Audrey/0000-0001-9846-8514	Department of Psychology, University of Canterbury, New Zealand	This research received ethical approval from the Upper South B Regional Ethics Committee, New Zealand. We acknowledge that the information in this manuscript and the manuscript itself has never been published either electronically or in print. The authors have no conflict of interest in the production of this manuscript. The current study was funded by the Department of Psychology, University of Canterbury, New Zealand.	Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Johnston L, 2008, AUST J PSYCHOL, V60, P135, DOI 10.1080/00049530701449521; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Matsumoto D., 1988, JAPANESE CAUCASIAN F; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McLellan T, 2010, COGNITION EMOTION, V24, P1277, DOI 10.1080/02699930903306181; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Miles L, 2007, J NONVERBAL BEHAV, V31, P259, DOI 10.1007/s10919-007-0036-4; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543	23	20	20	0	37	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2013	27	9					1032	1037		10.3109/02699052.2013.794965			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	180HZ	WOS:000321586100007	23781878				2021-06-18	
J	Tian, Y; Wang, ZG; Jia, Y; Li, SJ; Wang, B; Wang, SZ; Sun, L; Zhang, JN; Chen, JL; Jiang, RC				Tian, Ye; Wang, Zengguang; Jia, Ying; Li, Shengjie; Wang, Bin; Wang, Shizhao; Sun, Lin; Zhang, Jianning; Chen, Jieli; Jiang, Rongcai			Intracranial pressure variability predicts short-term outcome after intracerebral hemorrhage: A retrospective study	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Intracranial pressure; Successive variation; Short-term outcome; Intracerebral hemorrhage; Mannitol; Cerebral perfusion pressure	TRAUMATIC BRAIN-INJURY; BLOOD-PRESSURE; STROKE; MANAGEMENT; MULTICENTER; CHINA	Introduction: Elevated intracranial pressure (ICP) is generally observed in brain injury and intracerebral hemorrhage (ICH) patients and is consistently associated with poor neurological outcome. Intracranial pressure variability (IPV) is a better predictor of long-term neurological outcome than mean ICP in traumatic brain injury patients. However, whether IPV regulates functional outcome in ICH patients has not been investigated. In the present study, we investigated the relationship between IPV and functional outcome in ICH patients and determined whether IPV is a valid predictor of neurological outcome in ICH patients. Methods: A consecutive series of 56 patients with ICH were enrolled in this study. These patients underwent surgical treatments and were planted with an ICP monitor. The ICP was continuously recorded for 7 days at one-hour intervals. The mean arterial blood pressure (MAP) and cerebral perfusion pressure (CPP) were also calculated. We used successive variation (SV) to represent IPV, which was calculated by averaging the difference in ICP between successive parameters. The short-term outcome was dichotomized into improved and deteriorated groups based on the changes in their Glasgow Coma Scale (GCS) score between admission and 30 days after admission. The long-term outcome was evaluated by Glasgow Outcome Scale (GOS) at 12 months after discharge from the hospital, and the patients were dichotomized into independent and dependent groups. Results: The results showed that IPV was lower in the improved patient group and higher in patients with poorer outcome at 30 days after ICH. There was a significant positive correlation between SV and short-term neurological outcome. We also found the in-patient mortality was significantly increased in the high IPV patient group (P = 0.02), which was divided by the cutoff point using receiver operating characteristic (ROC) curve analysis. The univariate correlation analysis demonstrated that the IPV levels were positively correlated with mean ICP (R-2 = 0.652, P = 0.000), while were negatively correlated with CPP (R-2 = 0.426, P = 0.000). Increases in SV of ICP were a predictor of 30-day poor short-term outcome, but not for 12-month long-term outcome after adjusting for the potential confounders in a multivariable logistic regression model. Conclusions: The results suggest that high IPV is correlated with poorer outcome in ICH patients. Managing the ICP at an appropriate level during the early phase after ICH may improve functional outcome in ICH patients. (C) 2013 Elsevier B.V. All rights reserved.	[Tian, Ye; Wang, Zengguang; Jia, Ying; Li, Shengjie; Wang, Bin; Wang, Shizhao; Sun, Lin; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Tian, Ye; Wang, Zengguang; Jia, Ying; Li, Shengjie; Wang, Bin; Wang, Shizhao; Sun, Lin; Zhang, Jianning; Jiang, Rongcai] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Tian, Ye; Wang, Zengguang; Jia, Ying; Li, Shengjie; Wang, Bin; Wang, Shizhao; Sun, Lin; Zhang, Jianning; Jiang, Rongcai] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Tian, Ye; Wang, Zengguang; Jia, Ying; Li, Shengjie; Wang, Bin; Wang, Shizhao; Sun, Lin; Zhang, Jianning; Jiang, Rongcai] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Chen, Jieli] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA	Chen, JL (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	yetian1986@gmail.com; wzgforrest@sina.com; jynlgz@sina.com; lishengjie870707@sina.com; tianjinwangb@163.com; wsz1987315@163.com; tjsl2010@163.com; jianningzhang@hotmail.com; jieli@neuro.hfh.edu; jianghope@gmail.com					Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Burr RL, 2008, IEEE T BIO-MED ENG, V55, P2509, DOI 10.1109/TBME.2008.2001286; Czosnyka Marek, 2007, Neurosurg Focus, V22, pE10; Fan JY, 2010, BIOL RES NURS, V11, P317, DOI 10.1177/1099800409349164; Herrington WG, 2011, NEUROLOGY, V77, P2073, DOI 10.1212/WNL.0b013e318239be24; JENNETT B, 1975, LANCET, V1, P480; Kalita J, 2009, ACTA NEUROL SCAND, V119, P254, DOI 10.1111/j.1600-0404.2008.01095.x; Kirkness CJ, 2008, ACTA NEUROCHIR SUPPL, V102, P105, DOI 10.1007/978-3-211-85578-2_21; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Ko Y, 2010, STROKE, V41, P2512, DOI 10.1161/STROKEAHA.110.595561; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Messe S, 2009, NEUROCRIT CARE, V11, P38, DOI 10.1007/s12028-009-9207-y; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; SCHACHINGER H, 1989, J HYPERTENS, V7, pS81; Spruit-van Eijk M, 2012, AGE AGEING, V41, P746, DOI 10.1093/ageing/afs105; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wagle J, 2011, DEMENT GERIATR COGN, V31, P379, DOI 10.1159/000328970; Wei JW, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-16; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C	23	20	22	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	JUL 15	2013	330	1-2					38	44		10.1016/j.jns.2013.04.001			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	170GA	WOS:000320837200009	23628469				2021-06-18	
J	Olivecrona, M; Olivecrona, Z				Olivecrona, Magnus; Olivecrona, Zandra			Use of the CRASH study prognosis calculator in patients with severe traumatic brain injury treated with an intracranial pressure-targeted therapy	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						CRASH calculator; Intracranial pressure targeted therapy; Lund concept; Prognosis; Severe traumatic brain injury	PLACEBO-CONTROLLED TRIAL; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; VOLUME REGULATION; MRC CRASH; PROSTACYCLIN; PRINCIPLES; ADULTS; SCALE; EDEMA	Based on the Corticosteroid Randomisation after Significant Head Injury (CRASH) trial database, a prognosis calculator has been developed for the prediction of outcome in an individual patient with a head injury. In 47 patients with severe traumatic brain injury (sTBI) prospectively treated using an intracranial pressure (ICP) targeted therapy, the individual prognosis for mortality at 14 days and unfavourable outcome at 6 months was calculated and compared with the actual outcome. An overestimation of the risk of mortality and unfavourable outcome was found. The mean risk for mortality and unfavourable outcome were estimated to be 44.6 +/- 32.5% (95% confidence interval [CI], 35.1-54.2%) and 69.3 +/- 23.7% (95% CI, 62.3-76.2%). The actual outcome was 4.3% and 42.6% respectively. The absolute risk reduction (ARR) for mortality was 33.1% and for unfavourable outcome 29.8%. A logistic fit for outcome at 6 months shows a statistically significant difference (p < 0.01). A receiver operating characteristic (ROC) curve analysis shows an area under the curve (AUC) of 0.691. The CRASH prognosis calculator overestimates the risk of mortality and unfavourable outcome in patients with sTBI treated with an ICP-targeted therapy based on the Lund concept. We do not advocate the use of the calculator for treatment decisions in individual patients. We further conclude that patients with blunt sTBI admitted within 8 hours of trauma should be treated regardless of their clinical status as long as the initial cerebral perfusion pressure is > 10 mmHg. (C) 2012 Elsevier Ltd. All rights reserved.	[Olivecrona, Magnus; Olivecrona, Zandra] Umea Univ, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden	Olivecrona, M (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden.	Magnus.olivecrona@neuro.umu.se			Foundation for Clinical Neurosciences at Umea University; Umea University Hospital; Tore Nilsson Fund; Kempe Fund; Capio Research Fund	This study was financially supported by the Foundation for Clinical Neurosciences at Umea University, Umea University Hospital, the Tore Nilsson Fund, the Kempe Fund, and the Capio Research Fund.	ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bobinski L, 2012, ACTA NEUROCHIR, V154, P1069, DOI 10.1007/s00701-012-1345-x; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dizdarevic K, 2012, CLIN NEUROL NEUROSUR, V114, P142, DOI 10.1016/j.clineuro.2011.10.005; Edwards P, 2005, LANCET, V365, P1957; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2010, ACTA NEUROCHIR, V152, P959, DOI 10.1007/s00701-010-0626-5; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; JENNETT B, 1975, LANCET, V1, P480; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2012, ACTA NEUROCHIR, V154, P1567, DOI 10.1007/s00701-012-1351-z; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; SCHERER W, 2008, EUROPEAN J ANAES S43, V25, P7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	22	20	20	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2013	20	7					996	1001		10.1016/j.jocn.2012.09.015			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	178QX	WOS:000321463600017	23702375				2021-06-18	
J	Tallus, J; Lioumis, P; Hamalainen, H; Kahkonen, S; Tenovuo, O				Tallus, Jussi; Lioumis, Pantelis; Hamalainen, Heikki; Kahkonen, Seppo; Tenovuo, Olli			Transcranial Magnetic Stimulation-Electroencephalography Responses in Recovered and Symptomatic Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; electroencephalography; transcranial magnetic stimulation	PRIMARY MOTOR CORTEX; HEAD-INJURY; LONG-TERM; FUNCTIONAL CONNECTIVITY; CORTICAL EXCITABILITY; SPORTS CONCUSSION; NEURONAL-ACTIVITY; CORPUS-CALLOSUM; EEG RESPONSES; COMBINED TMS	Mild traumatic brain injury (mTBI) may cause diffuse damage to the brain, especially to the frontal areas, that may lead to persistent symptoms. We studied participants with past mTBI by means of navigated transcranial magnetic stimulation (nTMS) combined with electroencephalography (EEG). Eleven symptomatic and 8 recovered participants with a history of single mTBI and 9 healthy controls participated. Average time from injury to testing was 5 years. The participants did not have abnormalities or signs of injury on brain magnetic resonance imaging, and they did not use any centrally acting medication. Left primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC) were stimulated with nTMS and evoked potentials measured from the corresponding areas of both hemispheres. Delayed ipsilateral P30 and contralateral N45 peak latencies to left DLPFC nTMS were found in the symptomatic group, along with higher DLPFC N100 amplitudes compared with the control or recovered group. The recovered group had shorter P200 latencies in left DLPFC nTMS compared with the other groups. Both mTBI groups had higher motor thresholds compared with the control group. In left M1 nTMS, the mTBI groups showed less P30 amplitude increase, and the symptomatic group showed longer P60 interhemispheric latency difference with higher stimulation intensities. The results suggest altered brain reactivity and connectivity in mTBI. Some of the observed differences may be related to compensatory mechanisms of recovery. nTMS-EEG is a potentially useful tool for studying the effects of mTBI.	[Tallus, Jussi; Hamalainen, Heikki] Univ Turku, Ctr Cognit Neurosci, Dept Psychol, Turku 20014, Finland; [Lioumis, Pantelis; Kahkonen, Seppo] Univ Helsinki, Cent Hosp, HUSLAB, BioMag Lab, Helsinki, Finland; [Tenovuo, Olli] Univ Turku, Turku Univ Hosp, Dept Neurol, Turku 20014, Finland	Tallus, J (corresponding author), Univ Turku, Ctr Cognit Neurosci, Dept Psychol, Assistentinkatu 7, Turku 20014, Finland.	jptall@utu.fi	Lioumis, Pantelis/A-3801-2019	Lioumis, Pantelis/0000-0003-2016-9199	Helsinki University Central Hospital (EVO-funding); SalWe Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation) [1104/10]; University of Turku; Tekes - the Finnish Funding Agency for Technology and InnovationFinnish Funding Agency for Technology & Innovation (TEKES)	Pantelis Lioumis was supported by Helsinki University Central Hospital (EVO-funding) and the SalWe Research Program for Mind and Body (Tekes - the Finnish Funding Agency for Technology and Innovation grant 1104/10).; Heikki Hamalainen was supported by the University of Turku (professorship) and Tekes - the Finnish Funding Agency for Technology and Innovation.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BARKER AT, 1985, LANCET, V1, P1106; Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Bikmullina R, 2009, EXP BRAIN RES, V194, P517, DOI 10.1007/s00221-009-1723-7; Bonato C, 2006, CLIN NEUROPHYSIOL, V117, P1699, DOI 10.1016/j.clinph.2006.05.006; Bonnard M, 2009, EUR J NEUROSCI, V30, P913, DOI 10.1111/j.1460-9568.2009.06864.x; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Bruckmann S, 2012, BRAIN, V135, P2215, DOI 10.1093/brain/aws071; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Del Felice A, 2011, EPILEPSY RES, V96, P123, DOI 10.1016/j.eplepsyres.2011.05.015; Edgley SA, 1997, BRAIN, V120, P839, DOI 10.1093/brain/120.5.839; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Esser SK, 2005, J NEUROPHYSIOL, V94, P622, DOI 10.1152/jn.01230.2004; Ferreri F, 2011, NEUROIMAGE, V54, P90, DOI 10.1016/j.neuroimage.2010.07.056; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Julkunen P, 2008, J NEUROSCI METH, V172, P270, DOI 10.1016/j.jneumeth.2008.04.021; Kahkonen S, 2005, NEUROIMAGE, V24, P955, DOI 10.1016/j.neuroimage.2004.09.048; Kahkonen S, 2003, NEUROPSYCHOPHARMACOL, V28, P747, DOI 10.1038/sj.npp.1300099; Komssi S, 2004, HUM BRAIN MAPP, V21, P154, DOI 10.1002/hbm.10159; Komssi S, 2002, CLIN NEUROPHYSIOL, V113, P175, DOI 10.1016/S1388-2457(01)00721-0; Komssi S, 2006, BRAIN RES REV, V52, P183, DOI 10.1016/j.brainresrev.2006.01.008; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lioumis P, 2009, HUM BRAIN MAPP, V30, P1387, DOI 10.1002/hbm.20608; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Nikulin VV, 2003, EUR J NEUROSCI, V18, P1206, DOI 10.1046/j.1460-9568.2003.02858.x; Paus T, 2001, J NEUROPHYSIOL, V86, P1983; ROSENTHAL J, 1967, J NEUROPHYSIOL, V30, P844; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; Saisanen L, 2008, J CLIN NEUROPHYSIOL, V25, P367, DOI 10.1097/WNP.0b013e31818e7944; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Siebner HR, 2009, CORTEX, V45, P1035, DOI 10.1016/j.cortex.2009.02.007; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Van Der Werf YD, 2006, EXP BRAIN RES, V175, P246, DOI 10.1007/s00221-006-0548-x; Van der Werf YD, 2006, EXP BRAIN RES, V175, P231, DOI 10.1007/s00221-006-0551-2; Virtanen J, 1999, MED BIOL ENG COMPUT, V37, P322, DOI 10.1007/BF02513307; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333	52	20	21	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	14					1270	1277		10.1089/neu.2012.2760			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	183MV	WOS:000321821100007	23384582	Green Published			2021-06-18	
J	Bertens, D; Fasotti, L; Boelen, DHE; Kessels, RPC				Bertens, Dirk; Fasotti, Luciano; Boelen, Danielle H. E.; Kessels, Roy P. C.			A randomized controlled trial on errorless learning in goal management training: study rationale and protocol	BMC NEUROLOGY			English	Article						Goal management training; Errorless learning; Executive deficits; Acquired brain injury	TRAUMATIC BRAIN-INJURY; EXECUTIVE DYSFUNCTION; PRACTICAL GUIDE; FRONTAL-LOBE; OLDER-ADULTS; REHABILITATION; MEMORY; DEMENTIA; IMPLICIT; INDIVIDUALS	Background: Many brain-injured patients referred for outpatient rehabilitation have executive deficits, notably difficulties with planning, problem-solving and goal directed behaviour. Goal Management Training (GMT) has proven to be an efficacious cognitive treatment for these problems. GMT entails learning and applying an algorithm, in which daily tasks are subdivided into multiple steps. Main aim of the present study is to examine whether using an errorless learning approach (preventing the occurrence of errors during the acquisition phase of learning) contributes to the efficacy of Goal Management Training in the performance of complex daily tasks. Methods/Design: The study is a double blind randomized controlled trial, in which the efficacy of Goal Management Training with an errorless learning approach will be compared with conventional Goal Management Training, based on trial and error learning. In both conditions 32 patients with acquired brain injury of mixed etiology will be examined. Main outcome measure will be the performance on two individually chosen everyday-tasks before and after treatment, using a standardized observation scale and goal attainment scaling. Discussion: This is the first study that introduces errorless learning in Goal Management Training. It is expected that the GMT-errorless learning approach will improve the execution of complex daily tasks in brain-injured patients with executive deficits. The study can contribute to a better treatment of executive deficits in cognitive rehabilitation.	[Bertens, Dirk; Fasotti, Luciano; Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Fasotti, Luciano] Rehabil Med Ctr Groot Klimmendaal SIZA Support &, Arnhem, Netherlands; [Boelen, Danielle H. E.; Kessels, Roy P. C.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands	Bertens, D (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	d.bertens@donders.ru.nl	Kessels, Roy P.C./D-1902-2010; Bertens, Dirk/X-4633-2018	Kessels, Roy P.C./0000-0001-9500-9793; 	National Initiative Brain and Cognition (NIHC) [056-11-011]	The study is funded by the National Initiative Brain and Cognition (NIHC, grant # 056-11-011). This quick-result project is embedded in the pillar "The Healthy Brain, Program Cognitive Rehabilitation".	Baddeley A, 1988, Psychopharmacol Ser, V6, P12; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; BADDELEY AD, 1992, NEUROPSYCHOLOGY MEMO, P309; Bettcher BM, 2008, J INT NEUROPSYCH SOC, V14, P199, DOI 10.1017/S1355617708080193; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess Kenneth L, 2002, Provider, V28, P43; Burgess P. W., 1996, BADS BEHAV ASSESSMEN; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; Damasio AR, 1995, ANN NY ACAD SCI, V769, P241, DOI 10.1111/j.1749-6632.1995.tb38142.x; Dechamps A, 2011, AM J ALZHEIMERS DIS, V26, P273, DOI 10.1177/1533317511404394; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Fillingham JK, 2005, INT J LANG COMM DIS, V40, P505, DOI 10.1080/13682820500138572; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Haslam C, 2011, J CLIN EXP NEUROPSYC, V33, P432, DOI 10.1080/13803395.2010.533155; Hebb D. O, 1961, BRAIN MECH LEARNING, P37, DOI DOI 10.5962/BHL.TITLE.7220; Hunkin NM, 1998, NEUROPSYCHOLOGIA, V36, P25, DOI 10.1016/S0028-3932(97)00106-1; Kern RS, 2009, SCHIZOPHRENIA BULL, V35, P807, DOI 10.1093/schbul/sbn010; Kessels RPC, 2009, NEUROREHABILITATION, V25, P307, DOI 10.3233/NRE-2009-0529; Kessels RPC, 2005, J INT NEUROPSYCH SOC, V11, P144; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Kuzis G, 1999, NEUROPSY NEUROPSY BE, V12, P265; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI [10.1097/00001199-198709000-00009, DOI 10.1097/00001199-198709000-00009]; McClelland J L, 1999, Prog Brain Res, V121, P75; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Mount J, 2007, NEUROREHABILITATION, V22, P123; POLLENS RD, 1988, J COGNITIVE REHABILI, V6, P26; Robertson IH, 1996, GOAL MANAGEMENT TRAI; Shallice, 1997, HAYLING BRIXTON TEST; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spinella M, 2005, INT J NEUROSCI, V115, P649, DOI 10.1080/00207450590524304; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; van Hooren SAH, 2007, PATIENT EDUC COUNS, V65, P205, DOI 10.1016/j.pec.2006.07.010; Voigt-Radloff S, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-44; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wilson B.A., 2008, RIVERMEAD BEHAV MEMO; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Yochim BP, 2009, J CLIN EXP NEUROPSYC, V31, P658, DOI 10.1080/13803390802448669; Zimmermann P, 2007, TEST ATTENTIONAL PER	54	20	21	0	29	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	JUN 20	2013	13								64	10.1186/1471-2377-13-64			9	Clinical Neurology	Neurosciences & Neurology	171OS	WOS:000320939400001	23786651	DOAJ Gold, Green Published			2021-06-18	
J	Perlick, DA; Straits-Troster, K; Strauss, JL; Norell, D; Tupler, LA; Levine, B; Luo, XD; Holman, C; Marcus, T; Dixon, LB; Dyck, DG				Perlick, Deborah A.; Straits-Troster, Kristy; Strauss, Jennifer L.; Norell, Diane; Tupler, Larry A.; Levine, Bruce; Luo, Xiaodong; Holman, Caroline; Marcus, Tara; Dixon, Lisa B.; Dyck, Dennis G.			Implementation of Multifamily Group Treatment for Veterans With Traumatic Brain Injury	PSYCHIATRIC SERVICES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; PSYCHOMETRIC PROPERTIES; SERVICE MEMBERS; FAMILIES; IRAQ; AFGHANISTAN; THERAPY; SCHIZOPHRENIA; INTERVENTION	Objective: This study evaluated the initial efficacy and feasibility of implementing multifamily group treatment for veterans with traumatic brain injury (TBI). Methods: Veterans at two Veterans Affairs medical centers were prescreened by their providers for participation in an open trial of multifamily group treatment for TBI. Enrollment was limited to consenting veterans with a clinical diagnosis of TBI sustained during the Operation Enduring Freedom-Operation Iraqi Freedom era, a family member or partner consenting to participate, and a score >= 20 on the Mini-Mental State Examination. The nine-month (April 2010-March 2011) trial consisted of individual family sessions, an educational workshop, and bimonthly multifamily problem-solving sessions. Interpersonal functioning and symptomatic distress among veterans and family burden, empowerment, and symptomatic distress among families were assessed before and after treatment. Results: Providers referred 34 (58%) of 59 veterans screened for the study; of those, 14 (41%) met criteria and consented to participate, and 11 (32%) completed the study. Severity of TBI, insufficient knowledge about the benefits of family involvement, and access problems influenced decisions to exclude veterans or refuse to participate. Treatment was associated with decreased veteran anger expression (p <=.01) and increased social support and occupational activity (p <=.05), with effect sizes ranging from .6 to 1.0. Caregivers reported decreased burden (p <=.05) and increased empowerment (p <=.01). Conclusions: The results supported implementation of a randomized controlled trial, building in education at the provider and family level.	[Perlick, Deborah A.; Luo, Xiaodong] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Perlick, Deborah A.; Levine, Bruce; Holman, Caroline; Marcus, Tara] MIRECC, US Dept Vet Affairs VA, Bronx, NY USA; [Straits-Troster, Kristy; Tupler, Larry A.] Durham VA Med Ctr, Midatlantic Reg MIRECC, Durham, NC USA; [Strauss, Jennifer L.] Durham VA Med Ctr, Hlth Serv Res & Dev Serv, Durham, NC USA; [Strauss, Jennifer L.] Duke Univ, Dept Psychiat, Durham, NC 27706 USA; [Norell, Diane] Eastern Washington Univ, Dept Occupat Therapy, Cheney, WA 99004 USA; [Dixon, Lisa B.] Columbia Univ, Dept Psychiat, New York, NY USA; [Dixon, Lisa B.] New York State Psychiat Inst & Hosp, Ctr Practice Innovat, New York, NY 10032 USA; [Dyck, Dennis G.] Washington State Univ, Dept Psychol, Spokane, WA USA	Perlick, DA (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, 1 Gustave L Levy Pl, New York, NY 10029 USA.	deborah.perlick@va.gov			Department of DefenseUnited States Department of Defense [W81XWH-08-2-0054]; Veterans Affairs Research Career Development AwardUS Department of Veterans Affairs [RCD 06-020]; Mental Illness, Research, Education and Clinical Centers; Veterans Integrated Service Networks 3 and 6	This study was supported by a Department of Defense award (W81XWH-08-2-0054) to Dr. Perlick, by a Veterans Affairs Research Career Development Award (RCD 06-020) to Dr. Strauss, and by the Mental Illness, Research, Education and Clinical Centers associated with Veterans Integrated Service Networks 3 and 6. The authors acknowledge the support and guidance of Claire Henderson, M. D., Katherine Taber, Ph.D., Robin Hurley, M. D., and Adrian Cristian, M.D.	Albright G, 2011, GAMES HLTH, V1, P9; [Anonymous], 1998, REH PERS TRAUM BRAIN; Batten SV, 2008, J CLIN PSYCHOL, V64, P928, DOI 10.1002/jclp.20513; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Bowling UB, 2008, PROF PSYCHOL-RES PR, V39, P451, DOI 10.1037/0735-7028.39.4.451; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Cozza SJ, 2010, J TRAUMA STRESS, V23, P112, DOI 10.1002/jts.20488; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dausch BM, 2012, AM J PSYCHIATR REHAB, V15, P5, DOI 10.1080/15487768.2012.655223; Dausch BM, 2009, J TELEMED TELECARE, V15, P211, DOI 10.1258/jtt.2009.081216; Deckersbach T, 2010, CNS NEUROSCI THER, V16, P298, DOI 10.1111/j.1755-5949.2009.00110.x; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Gewirtz AH, 2010, J CONSULT CLIN PSYCH, V78, P599, DOI 10.1037/a0020571; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; KNIGHT RG, 1988, BRIT J CLIN PSYCHOL, V27, P279, DOI 10.1111/j.2044-8260.1988.tb00792.x; KOENIG HG, 1993, PSYCHOSOMATICS, V34, P61, DOI 10.1016/S0033-3182(93)71928-3; KOREN PE, 1992, REHABIL PSYCHOL, V37, P305, DOI 10.1037/h0079106; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; McDonell MG, 2007, COGNITIVE THER RES, V31, P785, DOI 10.1007/s10608-006-9098-6; McFarlane W.R., 2002, MULTIFAMILY GROUPS T; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Mueser KT, 1999, BEHAV FAMILY THERAPY; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Perlick DA, 2011, PROF PSYCHOL-RES PR, V42, P70, DOI 10.1037/a0022319; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rodgers ML, 2007, AM J PHYS MED REHAB, V86, P482, DOI 10.1097/PHM.0b013e31805c00a1; Rotondi AJ, 2010, PSYCHIAT SERV, V61, P1099, DOI 10.1176/ps.2010.61.11.1099; Sautter FJ, 2011, PROF PSYCHOL-RES PR, V42, P63, DOI 10.1037/a0022323; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schmitter-Edgecombe M, 2012, ALZH ASS INT C VANC; Schumm JA, AM J FAMILY IN PRESS; Sherman MD, 2009, PROF PSYCHOL-RES PR, V40, P593, DOI 10.1037/a0016333; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Straits-Troster KA, 2011, PSYCHOL TRAUMA-US, V3, P283, DOI 10.1037/a0024645; Straits-Troster K, 2013, PSYCHIAT SERVICES; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	41	20	21	0	17	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	JUN	2013	64	6					534	540		10.1176/appi.ps.001622012			7	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	255XF	WOS:000327272700007	23450320				2021-06-18	
J	Metting, Z; Cerliani, L; Rodiger, LA; van der Naalt, J				Metting, Zwany; Cerliani, Leonardo; Rodiger, Lars A.; van der Naalt, Joukje			Pathophysiological Concepts in Mild Traumatic Brain Injury: Diffusion Tensor Imaging Related to Acute Perfusion CT Imaging	PLOS ONE			English	Article							HEAD-INJURY; DAMAGE; DYSFUNCTION; IMPAIRMENT	Background: A subgroup of patients with mild traumatic brain injury (TBI) experiences residual symptoms interfering with their return to work. The pathophysiological substrate of the suboptimal outcome in these patients is a source of debate. Objective: To provide greater insight into the pathophysiological mechanisms of mild TBI. Methods: Diffusion tensor imaging (DTI) was performed during follow-up of 18 patients with mild TBI and compared with healthy control subjects. DTI data of the patient group were also compared with perfusion CT imaging in the acute phase of injury. Results: In patients with mild TBI, a trend was observed for a decreased fractional anisotropy (FA) in widespread bilateral frontal white matter areas with increased mean diffusivity (MD) in the parieto-temporal regions, compared to healthy control subjects. Cerebral blood volume (CBV) correlated significantly with FA in several white matter tracts including the corpus callosum, the internal capsule, the inferior fronto-occipital fascicle, the corticospinal tract, the superior and the inferior longitudinal fascicle. Conclusion: In mild TBI with normal conventional imaging significant associations between cerebral perfusion in the acute phase of injury and DTI analyses in the chronic phase of injury were discerned. The pathophysiological concept of these findings is being outlined.	[Metting, Zwany; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands; [Cerliani, Leonardo] Univ Groningen, NeuroImaging Ctr, Groningen, Netherlands; [Cerliani, Leonardo] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Rodiger, Lars A.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands	Metting, Z (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands.	z.metting@umcg.nl		cerliani, leonardo/0000-0002-2655-6133	ZonMw, Den Haag, The NetherlandsNetherlands Organization for Health Research and DevelopmentNetherlands Government [39200002]; NWO MaGW Open competition grant [400-08-089]; NIHC grant [056-13-017]	This study was funded by ZonMw, Den Haag, The Netherlands (grant number 39200002). In addition, L. Cerliani is supported by an NWO MaGW Open competition grant (grant number 400-08-089) and by an NIHC grant (grant number 056-13-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Ueda Y, 2006, ACTA NEUROPATHOL, V112, P85, DOI 10.1007/s00401-005-0029-5; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	20	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64461	10.1371/journal.pone.0064461			6	Multidisciplinary Sciences	Science & Technology - Other Topics	149OK	WOS:000319330200139	23704986	DOAJ Gold, Green Published			2021-06-18	
J	Wu, P; Zhao, YX; Haidacher, SJ; Wang, EY; Parsley, MO; Gao, JL; Sadygov, RG; Starkey, JM; Luxon, BA; Spratt, H; DeWitt, DS; Prough, DS; Denner, L				Wu, Ping; Zhao, Yingxin; Haidacher, Sigmund J.; Wang, Enyin; Parsley, Margaret O.; Gao, Junling; Sadygov, Rovshan G.; Starkey, Jonathan M.; Luxon, Bruce A.; Spratt, Heidi; DeWitt, Douglas S.; Prough, Donald S.; Denner, Larry			Detection of Structural and Metabolic Changes in Traumatically Injured Hippocampus by Quantitative Differential Proteomics	JOURNAL OF NEUROTRAUMA			English	Article						animal models; bioinformatics; mass spectrometry; proteomics; traumatic brain injury	TANDEM MASS-SPECTROMETRY; 2-DIMENSIONAL GEL-ELECTROPHORESIS; CONTROLLED CORTICAL IMPACT; HUMAN CEREBROSPINAL-FLUID; NEURAL STEM-CELLS; PROTEIN-KINASE-C; BRAIN-INJURY; GLUTAMATE RECEPTORS; CALCINEURIN SUBUNIT; NEUROTROPHIC FACTOR	Traumatic brain injury (TBI) is a complex and common problem resulting in the loss of cognitive function. In order to build a comprehensive knowledge base of the proteins that underlie these cognitive deficits, we employed unbiased quantitative mass spectrometry, proteomics, and bioinformatics to identify and quantify dysregulated proteins in the CA3 subregion of the hippocampus in the fluid percussion model of TBI in rats. Using stable isotope O-18-water differential labeling and multidimensional tandem liquid chromatography (LC)-MS/MS with high stringency statistical analyses and filtering, we identified and quantified 1002 common proteins, with 124 increased and 76 decreased. The Ingenuity Pathway Analysis (IPA) bioinformatics tool identified that TBI had profound effects on downregulating global energy metabolism, including glycolysis, the Krebs cycle, and oxidative phosphorylation, as well as cellular structure and function. Widespread upregulation of actin-related cytoskeletal dynamics was also found. IPA indicated a common integrative signaling node, calcineurin B1 (CANB1, CaNB alpha, or PPP3R1), which was downregulated by TBI. Western blotting confirmed that the calcineurin regulatory subunit, CANB1, and its catalytic binding partner PP2BA, were decreased without changes in other calcineurin subunits. CANB1 plays a critical role in downregulated networks of calcium signaling and homeostasis through calmodulin and calmodulin-dependent kinase II to highly interconnected structural networks dominated by tubulins. This large-scale knowledge base lays the foundation for the identification of novel therapeutic targets for cognitive rescue in TBI.	[Wu, Ping; Wang, Enyin; Gao, Junling] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Zhao, Yingxin; Haidacher, Sigmund J.; Denner, Larry] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Parsley, Margaret O.; DeWitt, Douglas S.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Sadygov, Rovshan G.; Starkey, Jonathan M.; Luxon, Bruce A.; Spratt, Heidi] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Haidacher, Sigmund J.; Denner, Larry] Univ Texas Med Branch, Stark Diabet Ctr, Galveston, TX 77555 USA; [Zhao, Yingxin; Haidacher, Sigmund J.; Denner, Larry] Univ Texas Med Branch, McCoy Stem Cells & Diabet Mass Spectrometry Res L, Galveston, TX 77555 USA; [Zhao, Yingxin; Sadygov, Rovshan G.; Luxon, Bruce A.; Spratt, Heidi; Denner, Larry] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Zhao, Yingxin; Sadygov, Rovshan G.; Luxon, Bruce A.; Spratt, Heidi; Denner, Larry] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA	Denner, L (corresponding author), Univ Texas Med Branch, Div Endocrinol, 8-138 Med Res Bldg, Galveston, TX 77555 USA.	ladenner@utmb.edu	Luxon, Bruce A/C-9140-2012; Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X; Starkey, Jonathan/0000-0002-9083-6455	Department of the Army via the U.S. Army Medical Research Acquisition Activity, Fort Detrick, Maryland [W81XWH-08-2-0137]; Miriam and Emmett McCoy Foundation; Coalition for Brain Injury Research; Moody Foundation; TIRR Foundation; John S. Dunn Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000071] Funding Source: NIH RePORTER	This work was supported by the Department of the Army (W81XWH-08-2-0137 to P.W .), via the U.S. Army Medical Research Acquisition Activity, Fort Detrick, Maryland. The content of this work does not necessarily reflect the position or the policy of the U.S. government, and no official endorsement should be inferred. Other support for this study came from the Miriam and Emmett McCoy Foundation (L.D.), the Coalition for Brain Injury Research (P.W.), the Moody Foundation (P.W.), the TIRR Foundation (P.W.), and the John S. Dunn Research Foundation (P.W.).	Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Bales JW, 2010, BRAIN RES, V1358, P211, DOI 10.1016/j.brainres.2010.08.029; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Bedell EA, 2004, J NEUROTRAUM, V21, P1212; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; Burgess JA, 2006, J PROTEOME RES, V5, P1674, DOI 10.1021/pr060160v; Chaichana KL, 2010, WORLD NEUROSURG, V73, P22, DOI 10.1016/j.surneu.2009.05.027; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Consales C, 2007, BRAIN RES, V1159, P28, DOI 10.1016/j.brainres.2007.04.071; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Fukura H, 1996, J NEUROCHEM, V67, P1426; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Goshe MB, 2003, CURR OPIN BIOTECH, V14, P101, DOI 10.1016/S0958-1669(02)00014-9; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Haskins WE, 2005, J NEUROTRAUM, V22, P629, DOI 10.1089/neu.2005.22.629; Heller M, 2003, J AM SOC MASS SPECTR, V14, P704, DOI 10.1016/S1044-0305(03)00207-1; Hoffrogge R, 2007, PROTEOMICS, V7, P33, DOI 10.1002/pmic.200600614; Hong Z, 2009, PROTEOM CLIN APPL, V3, P1072, DOI 10.1002/prca.200800234; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Huang RQ, 1998, J PHARMACOL EXP THER, V286, P243; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kochanek P M, 1993, Crit Care Med, V21, pS333, DOI 10.1097/00003246-199309001-00016; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lehninger AL, 1970, BIOCH MOL BASIS CELL; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McNamara RK, 2005, HIPPOCAMPUS, V15, P675, DOI 10.1002/hipo.20089; Ohmitsu M, 1999, J BIOL CHEM, V274, P408, DOI 10.1074/jbc.274.1.408; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Oshima T, 2009, BRAIN RES, V1290, P102, DOI 10.1016/j.brainres.2009.07.022; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Palop JJ, 2011, METHODS MOL BIOL, V670, P245, DOI 10.1007/978-1-60761-744-0_17; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rusnak F, 2000, PHYSIOL REV, V80, P1483; Sadygov RG, 2010, J PROTEOME RES, V9, P4306, DOI 10.1021/pr100642q; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SHAPIRA Y, 1989, Neurological Research, V11, P169; Soares HD, 1995, J NEUROSCI, V15, P8223; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Starkey JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011095; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; TAN SE, 1994, J NEUROSCI, V14, P1123; Tao WA, 2003, CURR OPIN BIOTECH, V14, P110, DOI 10.1016/S0958-1669(02)00018-6; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; VENKATARAMANAN R, 1987, TRANSPLANT P, V19, P30; Wang EY, 2012, J NEUROTRAUM, V29, P295, DOI 10.1089/neu.2011.2043; Wang KKW, 2004, INT REV NEUROBIOL, V61, P215; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yang SA, 2000, BIOCHEMISTRY-US, V39, P16147, DOI 10.1021/bi001321q; Yang XY, 2009, BRAIN INJURY, V23, P830, DOI 10.1080/02699050903196670; Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yoong LF, 2009, MOL CELL NEUROSCI, V41, P464, DOI 10.1016/j.mcn.2009.05.002; Zhao YX, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-15; Zhu WL, 2011, J NEUROCHEM, V117, P1075, DOI 10.1111/j.1471-4159.2011.07285.x; Zuberovic A, 2009, ELECTROPHORESIS, V30, P1836, DOI 10.1002/elps.200800714	83	20	20	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2013	30	9			SI		775	788		10.1089/neu.2012.2391			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	145BJ	WOS:000318987600009	22757692	Green Published			2021-06-18	
J	Esquenazi, A; Lee, S; Packel, AT; Braitman, L				Esquenazi, Alberto; Lee, Stella; Packel, Andrew T.; Braitman, Leonard			A Randomized Comparative Study of Manually Assisted Versus Robotic-Assisted Body Weight Supported Treadmill Training in Persons With a Traumatic Brain Injury	PM&R			English	Article							DRIVEN GAIT ORTHOSIS; STROKE REHABILITATION; PHYSICAL-THERAPY; MUSCLE STRENGTH; BOBATH CONCEPT; WALKING SPEED; SPINAL-CORD; IMPACT; PHYSIOTHERAPY; IMPROVEMENT	Objectives: (1) To compare the effects of robotic-assisted treadmill training (RATT) and manually assisted treadmill training (MATT) in participants with traumatic brain injury (TBI) and (2) to determine the potential impact on the symmetry of temporal walking parameters, 6-minute walk test, and the mobility domain of the Stroke Impact Scale, version 3.0 (SIS). Design: Randomized prospective study. Subjects: A total of 16 participants with TBI and a baseline over ground walking self-selected velocity (SSV) of >= 0.2 m/s to 0.6 m/s randomly assigned to either the RATT or MATT group. Intervention: Gait training for 45 minutes, 3 times a week with either RATT or MATT for a total of 18 training sessions. Outcome Measures: Primary: Overground walking SSV, maximal velocity. Secondary: Spatiotemporal symmetry, 6-minute walk test, and SIS. Results: Between-group differences were not statistically significant for any measure. However, from pretraining to post-training, the average SSV increased by 49.8% for the RATT group (P = .01) and by 31% for MATT group (P = .06). The average maximal velocity increased by 14.9% for the RATT group (P = .06) and by 30.8% for the MATT group (P = .01). Less staffing and effort was needed for RATT in this study. Step-length asymmetry ratio improved during SSV by 33.1% for the RATT group (P = .01) and by 9.1% for the MATT group (P = .73). The distance walked increased by 11.7% for the robotic group (P = .21) and by 19.3% for manual group (P = .03). A statistically significant improvement in the mobility domain of the SIS was found for both groups (P <= .03). Conclusions: The results of this study demonstrate greater improvement in symmetry of gait (step length) for RATT and no significant differences between RATT and MATT with regard to improvement in gait velocity, endurance, and SIS. Our study provides evidence that participants with a chronic TBI can experience improvements in gait parameters with gait training with either MATT or RATT.	[Esquenazi, Alberto] MossRehab, Dept Phys Med & Rehabil, Gait & Mot Anal Lab, Elkins Pk, PA 19027 USA; [Lee, Stella] MossRehab, Gait & Mot Anal Lab, Elkins Pk, PA 19027 USA; [Packel, Andrew T.] MossRehab, Dept Phys Therapy, Gait & Mot Anal Lab, Elkins Pk, PA 19027 USA; [Braitman, Leonard] Albert Einstein Healthcare Network, Res & Technol Dev, Philadelphia, PA USA	Esquenazi, A (corresponding author), MossRehab, Dept Phys Med & Rehabil, Gait & Mot Anal Lab, 60 Township Line Rd, Elkins Pk, PA 19027 USA.	aesquena@einstein.edu	Packel, Andrew/AAJ-4840-2021	Packel, Andrew/0000-0002-5048-1661	MossRehab Research Fund; Department of Defense, CDC	Disclosure related to this publication: grant, MossRehab Research Fund; Disclosure outside this publication: grants, Department of Defense, CDC	Adolph KE, 2003, CHILD DEV, V74, P475, DOI 10.1111/1467-8624.7402011; Bohannon RW, 2007, J REHABIL MED, V39, P14, DOI 10.2340/16501977-0018; Brunham Sandra, 1992, Physiotherapy Theory and Practice, V8, P215, DOI 10.3109/09593989209108105; Carr J. H., 1998, NEUROLOGICAL REHABIL; Chen G, 2005, GAIT POSTURE, V22, P57, DOI 10.1016/j.gaitpost.2004.06.008; Cherng RJ, 2007, AM J PHYS MED REHAB, V86, P548, DOI 10.1097/PHM.0b013e31806dc302; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colombo G, 2000, J REHABIL RES DEV, V37, P693; Colombo G, 2001, SPINAL CORD, V39, P252, DOI 10.1038/sj.sc.3101154; Combs Stephanie A., 2011, Physiotherapy Theory and Practice, V27, P223, DOI 10.3109/09593985.2010.485628; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; da Cunha IT, 2002, ARCH PHYS MED REHAB, V83, P1258, DOI 10.1053/apmr.2002.34267; DeJong G, 2005, ARCH PHYS MED REHAB, V86, pS1, DOI 10.1016/j.apmr.2005.09.003; DICKSTEIN R, 1986, PHYS THER, V66, P1233, DOI 10.1093/ptj/66.8.1233; Dobkin B, 2006, NEUROLOGY, V66, P484, DOI 10.1212/01.wnl.0000202600.72018.39; Dromerick Alexander W, 2006, NeuroRx, V3, P428, DOI 10.1016/j.nurx.2006.07.004; Duncan PW, 2011, NEW ENGL J MED, V364, P2026, DOI 10.1056/NEJMoa1010790; Duncan PW, 2003, NEUROLOGY, V60, P291, DOI 10.1212/01.WNL.0000041493.65665.D6; Elovic E, 1996, MED REHABILITATION T; Esquenazi A, 2011, PHYS MED REHABILITAT, P99; Fait PE, 2011, PERCEPT MOTOR SKILL, V112, P29, DOI 10.2466/05.10.23.25.PMS.112.1.29-43; Flansbjer UB, 2006, ARCH PHYS MED REHAB, V87, P974, DOI 10.1016/j.apmr.2006.03.008; Freivogel S, 2008, BRAIN INJURY, V22, P625, DOI 10.1080/02699050801941771; Hafsteinsdottir TB, 2005, J NEUROL NEUROSUR PS, V76, P788, DOI 10.1136/jnnp.2004.042267; Harris-Love ML, 2001, NEUROREHAB NEURAL RE, V15, P105, DOI 10.1177/154596830101500204; HESSE S, 1995, STROKE, V26, P976, DOI 10.1161/01.STR.26.6.976; Hesse S, 2001, ARCH PHYS MED REHAB, V82, P1547, DOI 10.1053/apmr.2001.26607; Hidler J, 2009, NEUROREHAB NEURAL RE, V23, P5, DOI 10.1177/1545968308326632; Hornby TG, 2008, STROKE, V39, P1786, DOI 10.1161/STROKEAHA.107.504779; Husemann B, 2007, STROKE, V38, P349, DOI 10.1161/01.STR.0000254607.48765.cb; International Classification of Functioning Disability and Health, WHO MEMB STAT 54 WOR; Jezernik S, 2003, SPINAL CORD, V41, P657, DOI 10.1038/sj.sc.3101518; KARNI A, 1995, NATURE, V377, P155; Kollen BJ, 2009, STROKE, V40, pE89, DOI 10.1161/STROKEAHA.108.533828; KOTTKE FJ, 1978, ARCH PHYS MED REHAB, V59, P567; Kwakkel G, 2006, DISABIL REHABIL, V28, P823, DOI 10.1080/09638280500534861; Lai SM, 2003, STROKE, V34, P488, DOI 10.1161/01.STR.0000054162.94998.C0; Lamontagne A, 2004, STROKE, V35, P2543, DOI 10.1161/01.STR.0000144685.88760.d7; Laufer Y, 2001, J REHABIL RES DEV, V38, P69; Lennon S, 2006, DISABIL REHABIL, V28, P873, DOI 10.1080/09638280500535132; Lin KC, 2010, NEUROREHAB NEURAL RE, V24, P486, DOI 10.1177/1545968309356295; Lin PY, 2006, ARCH PHYS MED REHAB, V87, P562, DOI 10.1016/j.apmr.2005.12.042; Macko R F, 2005, Top Stroke Rehabil, V12, P45; Mayr A, 2007, NEUROREHAB NEURAL RE, V21, P307, DOI 10.1177/1545968307300697; McCain KJ, 2008, ARCH PHYS MED REHAB, V89, P684, DOI 10.1016/j.apmr.2007.09.050; Mehrholz J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub2; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Partridge C, 1996, Physiother Res Int, V1, P205, DOI 10.1002/pri.59; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Patterson SL, 2008, J REHABIL RES DEV, V45, P221, DOI 10.1682/JRRD.2007.02.0024; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Pohl M, 2002, STROKE, V33, P553, DOI 10.1161/hs0202.102365; RICHARDS CL, 1993, ARCH PHYS MED REHAB, V74, P612, DOI 10.1016/0003-9993(93)90159-8; Sacco K, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00146; Schwartz I, 2009, PM&R, V1, P516, DOI 10.1016/j.pmrj.2009.03.009; Smith GV, 1999, STROKE, V30, P2112, DOI 10.1161/01.STR.30.10.2112; Smith PS, 2008, CLIN REHABIL, V22, P997, DOI 10.1177/0269215508088988; Sullivan KJ, 2002, ARCH PHYS MED REHAB, V83, P683, DOI 10.1053/apmr.2002.32488; Taylor A, 1980, P INT C REH ENG TOR; Torres-Oviedo G, 2011, PROG BRAIN RES, V191, P65, DOI 10.1016/B978-0-444-53752-2.00013-8; Tucker JA, 2008, REHABIL PSYCHOL, V53, P279, DOI 10.1037/a0012963; Tyrell CM, 2011, PHYS THER, V91, P392, DOI 10.2522/ptj.20090425; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; Wada Y, 2010, AM J PHYS MED REHAB, V89, P683, DOI 10.1097/PHM.0b013e3181e29d27; Ware JE., 1993, SF 36 HLTH SURVEY MA; Westlake KP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-18; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wirz M, 2005, ARCH PHYS MED REHAB, V86, P672, DOI 10.1016/j.apmr.2004.08.004	70	20	20	2	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	APR	2013	5	4					280	290		10.1016/j.pmrj.2012.10.009			11	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	137VI	WOS:000318465900003	23200117				2021-06-18	
J	Giacino, JT; Katz, DI; Whyte, J				Giacino, Joseph T.; Katz, Douglas I.; Whyte, John			Neurorehabilitation in Disorders of Consciousness	SEMINARS IN NEUROLOGY			English	Article						disorders of consciousness; vegetative state; minimally conscious state; rehabilitation; outcome	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; VEGETATIVE STATE; INTRATHECAL BACLOFEN; SENSORY STIMULATION; RECOVERY; COMA; ZOLPIDEM; SCALE; REHABILITATION	Survivors of severe acquired brain injury often experience prolonged disturbance in consciousness following emergence from coma. Most individuals pass through the vegetative or minimally conscious states en route to eventual recovery of consciousness, although either condition may be permanent. Rehabilitation clinicians charged with the care of these patients face numerous challenges as there are many open questions concerning diagnostic and prognostic accuracy, the natural history of recovery, and the most effective approaches to prevent medical complications and facilitate functional recovery. The last 5 years have been witness to a marked increase in well-designed empirical investigations concerning the rehabilitation of patients with disorders of consciousness. In this article, the authors review recent evidence concerning key factors that influence the course of recovery, present a model of care designed to mitigate medical complications, describe a systematic approach to assessment, and review the effectiveness of treatment interventions utilized in the rehabilitation setting.	[Giacino, Joseph T.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Katz, Douglas I.] Braintree Rehabil, Acquired Brain Injury Program, Braintree, MA USA; [Whyte, John] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Elkins Pk, PA USA	Giacino, JT (corresponding author), Spaulding Rehabil Hosp, 300 1st Ave, Charlestown, MA 02129 USA.	jgiacino@partners.org	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Whyte, John/0000-0002-4381-1474; Katz, Douglas/0000-0002-7502-8505	National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education [H133A120085, H133A070030, H133A070040]	The content of this manuscript was developed under grants from the National Institute on Disability and Rehabilitation Research, United States Department of Education H133A120085 [Spaulding Rehabilitation Hospital]; H133A070030 [JFK-Johnson Rehabilitation Institute TBI Model System]; and H133A070040 [Moss TBI Model System]. However, this content does not necessarily represent the policy of the Department of Education, and endorsement by the federal government should not be assumed.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; [Anonymous], 2006, MOHONK REPORT DISORD; [Anonymous], 2004, HEADACHE, V44, P628; [Anonymous], 2012, OCTOBER; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; ASHWAL S, 1995, NEW ENGL J MED, V333, P130, DOI 10.1056/NEJM199507133330216; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Cohen SI, 2008, AM J PHYS MED REHAB, V87, P229, DOI 10.1097/PHM.0b013e318161971b; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; DiPasquale MC, 1996, J HEAD TRAUMA REHAB, V11, P9, DOI 10.1097/00001199-199612000-00004; Eifert B, ARCH PHYS M IN PRESS; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Formisano R, 2001, Ann Ist Super Sanita, V37, P627; Fridman EA, 2010, BRAIN INJURY, V24, P636, DOI 10.3109/02699051003610433; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giacino JT, 2005, REHABILITATION TRAUM, P305; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Hagen C, 1979, REHABILITATION HEAD; HALL M E, 1992, Brain Injury, V6, P435, DOI 10.3109/02699059209008139; Hamilton B. B., 1987, UNIFORM NATL DATA SY; JOHNSON DA, 1993, BRAIN INJURY, V7, P491, DOI 10.3109/02699059309008176; KANNO T, 1987, PACE, V10, P207, DOI 10.1111/j.1540-8159.1987.tb05949.x; Kanno T, 2009, NEUROMODULATION, V12, P33, DOI 10.1111/j.1525-1403.2009.00185.x; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kawecki Zdzislaw, 2007, Przegl Lek, V64 Suppl 2, P13; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Koeda T, 1998, BRAIN DEV-JPN, V20, P124, DOI 10.1016/S0387-7604(98)00004-7; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Leong B, 2002, BRAIN INJURY, V16, P217, DOI 10.1080/02699050110103283; Lombardi F, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001427; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Martin RT, 2007, AM J PHYS MED REHAB, V86, P613, DOI 10.1097/PHM.0b013e3181154a84; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V15, P414, DOI 10.1080/09602010443000588; McNamee S, 2012, J HEAD TRAUMA REHAB, V27, P244, DOI 10.1097/HTR.0b013e31825e12c8; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Nakase-Richardson R, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127795; Nakase-Richardson R, 2011, J NEUROTRAUM, V28, P1; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Piccione F, 2011, NEUROREHAB NEURAL RE, V25, P98, DOI 10.1177/1545968310369802; PIERCE J P, 1990, Brain Injury, V4, P191, DOI 10.3109/02699059009026165; Plum F, 1982, DIAGNOSIS STUPOR COM; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; Sara M, 2009, ARCH PHYS MED REHAB, V90, P1245, DOI 10.1016/j.apmr.2009.01.012; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Smart CM, 2008, NAT CLIN PRACT NEURO, V4, P448, DOI 10.1038/ncpneuro0823; Soddu A, 2009, PROG BRAIN RES, V177, P261, DOI 10.1016/S0079-6123(09)17718-X; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Taira T, 2007, ACTA NEUROCHIR SUPPL, V97, P227; Taira T, 2009, PROG BRAIN RES, V177, P317, DOI 10.1016/S0079-6123(09)17721-X; TANHEHCO J, 1982, ARCH PHYS MED REHAB, V63, P36; TEASDALE G, 1974, LANCET, V2, P81; Timmons M, 1987, J HEAD TRAUMA REHAB, V2, P64; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; Tsubokawa T, 1990, Brain Inj, V4, P315; Vanhaudenhuyse A, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.121624; Volker J, 2012, BIOMED TECH BERL; Wang MC, 2007, J TRAUMA, V62, P1250, DOI 10.1097/01.ta.0000215581.50234.56; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5; Whyte J, 2010, DELISAS PHYS MED REH, P575; Whyte J, ARCH PHYS M IN PRESS; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WILSON S L, 1991, Brain Injury, V5, P393, DOI 10.3109/02699059109008112; Wilson SL, 1996, BRAIN INJURY, V10, P807, DOI 10.1080/026990596123927; Wood R L, 1992, Brain Inj, V6, P411, DOI 10.3109/02699059209008137; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353	101	20	20	1	14	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	APR	2013	33	2					142	156		10.1055/s-0033-1348960			15	Clinical Neurology	Neurosciences & Neurology	188VS	WOS:000322225300008	23888398				2021-06-18	
J	Lin, C; Wang, N; Shen, ZP; Zhao, ZY				Lin, Chao; Wang, Ning; Shen, Zhi-Peng; Zhao, Zheng-Yan			Plasma copeptin concentration and outcome after pediatric traumatic brain injury	PEPTIDES			English	Article						Copeptin; Traumatic brain injury; Functional outcome; Mortality	UMBILICAL-CORD BLOOD; STABLE PEPTIDE; VASOPRESSIN PRECURSOR; PROGNOSTIC VALUE; PRACTICAL SCALE; PRETERM INFANTS; HEART-FAILURE; SEVERITY; SHOCK; HEMORRHAGE	Higher plasma copeptin level has been associated with poor outcomes of critical illness. The present study was undertaken to investigate the plasma copeptin concentrations in children with traumatic brain injury (TBI) and to analyze the correlation of copeptin with disease outcome. Plasma copeptin concentrations of 126 healthy children and 126 children with acute severe TBI were measured by enzyme-linked immunosorbent assay. Twenty-one patients (16.7%) died and 38 patients (30.2%) had an unfavorable outcome (Glasgow Outcome Scale score of 1-3) at 6 months. Plasma copeptin level was obviously higher in patients than in healthy children (46.2 +/- 20.8 pmol/L vs. 9.6 +/- 3.0 pmol/L, P < 0.001). Plasma copeptin level was identified as an independent predictor for 6-month mortality [odds ratio (OR) 1.261, 95% confidence interval (CI) 1.112-1.538, P=0.005] and unfavorable outcome (OR 1.313, 95% CI 1.146-1.659, P=0.003). The predictive value of copeptin was similar to that of Glasgow Coma Scale (GCS) score for 6-month mortality [area under curve (AUC) 0.832, 95% CI 0.755-0.892 vs. AUC 0.873, 95% CI 0.802-0.926, P=0.412] and unfavorable outcome (AUC 0.863, 95% CI 0.790-0.918 vs. AUC 0.885, 95% CI 0.816-0.935, P=0.596). Copeptin improved the AUC of GCS score for 6-month unfavorable outcome (AUC 0.929, 95% CI 0.869-0.967, P=0.013), but not for 6-month mortality (AUC 0.887, 95% CI 0.818-0.936, P=0.600). Thus, plasma copeptin level represents a novel biomarker for predicting 6-month clinical outcome in children with TBI. (c) 2013 Elsevier Inc. All rights reserved.	[Lin, Chao; Wang, Ning; Shen, Zhi-Peng] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Zheng-Yan] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Child Hlth Care, Hangzhou 310003, Zhejiang, Peoples R China	Zhao, ZY (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Dept Child Hlth Care, 57 Zhugan Lane, Hangzhou 310003, Zhejiang, Peoples R China.	hzzzylc@163.com					Asfar P, 2006, CRIT CARE CLIN, V22, P131, DOI 10.1016/j.ccc.2005.08.007; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benzing J, 2011, J CLIN ENDOCR METAB, V96, pE982, DOI 10.1210/jc.2010-2858; Choong K, 2008, PEDIATR CRIT CARE ME, V9, P372, DOI 10.1097/PCC.0b013e318172d7c8; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; Itoi K, 2004, J NEUROENDOCRINOL, V16, P348, DOI 10.1111/j.0953-8194.2004.01172.x; JENNETT B, 1975, LANCET, V1, P480; Jochberger S, 2009, INTENS CARE MED, V35, P489, DOI 10.1007/s00134-008-1279-1; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kelly D, 2008, J CARD FAIL, V14, P739, DOI 10.1016/j.cardfail.2008.07.231; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P221, DOI 10.1007/978-3-211-98811-4_41; Koch L, 2011, HORM RES PAEDIAT, V76, P234, DOI 10.1159/000329285; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Schlapbach LJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-38; Stoiser B, 2006, EUR J CLIN INVEST, V36, P771, DOI 10.1111/j.1365-2362.2006.01724.x; Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.019; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Treschan TA, 2006, ANESTHESIOLOGY, V105, P599, DOI 10.1097/00000542-200609000-00026; Urwyler SA, 2010, STROKE, V41, P1564, DOI 10.1161/STROKEAHA.110.584649; Wellmann S, 2010, J CLIN ENDOCR METAB, V95, P5091, DOI 10.1210/jc.2010-1331; Yu GF, 2012, PEPTIDES, V33, P164, DOI 10.1016/j.peptides.2011.11.017; Zhu XD, 2011, CRIT CARE, V15, DOI 10.1186/cc10575; Zweifel C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-34	27	20	22	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781			PEPTIDES	Peptides	APR	2013	42						43	47		10.1016/j.peptides.2013.01.015			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	165OI	WOS:000320492800006	23402790				2021-06-18	
J	Williams, MW; Rapport, LJ; Hanks, RA; Millis, SR; Greene, HA				Williams, Michael W.; Rapport, Lisa J.; Hanks, Robin A.; Millis, Scott R.; Greene, Hillary A.			Incremental Validity of Neuropsychological Evaluations to Computed Tomography in Predicting Long-Term Outcomes after Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Traumatic brain injury; Neuropsychological testing; Cognitive functioning; Computed tomography; Disability; Outcomes; Rehabilitation	SEVERE HEAD-INJURY; PRACTICAL SCALE; UNITED-STATES; FOLLOW-UP; REHABILITATION; PRODUCTIVITY; 1-YEAR; TESTS; CLASSIFICATION; SATISFACTION	This study evaluated the incremental utility of neuropsychological tests to computed tomography (CT) in predicting long-term outcomes of adults with moderate to severe traumatic brain injury (TBI). Participants were 288 adults with mild complicated, moderate, and severe TBI. Longitudinal data were evaluated during inpatient status in an urban rehabilitation hospital with a TBI Model System, as well as 1 and 2 years post injury. Predictors including demographic characteristics, injury severity, CT characteristics, and neuropsychological evaluations were regressed to outcomes of disability, life satisfaction, and employment at 1 and 2 years post injury. Prediction of life satisfaction was not improved with the use of CT characteristics or neuropsychological tests, but prediction of return to work was improved by these variables at 2 years post injury. Neuropsychological evaluations uniquely contributed to outcome predictions of functional disability, even after considering demographic and injury severity characteristics, including information from CT. In contrast, CT characteristics were not predictive of long-term functional disability at 1 or 2 years post TBI. Taken together, the findings indicate that neuropsychological tests add unique predictive information for long-term functional outcomes after TBI.	[Williams, Michael W.; Rapport, Lisa J.; Greene, Hillary A.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Hanks, Robin A.; Millis, Scott R.] Wayne State Univ, Sch Med, Detroit, MI USA	Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 5057 Woodward Ave,7th Floor, Detroit, MI 48202 USA.	rapport@wayne.edu		Parker, Hillary/0000-0002-8610-5975	Wayne State University Graduate School; National Institute of General Medicine - Initiative for Maximizing Student Development [GM058905-11]; National Institute on Disability & Rehabilitation Research Traumatic Brain Injury Model Systems Project [H133A080044]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM058905] Funding Source: NIH RePORTER	This project was supported by Wayne State University Graduate School, National Institute of General Medicine - Initiative for Maximizing Student Development (GM058905-11), and the National Institute on Disability & Rehabilitation Research Traumatic Brain Injury Model Systems Project (H133A080044). We would like to acknowledge Robert Kotasek for his work managing the dataset.	Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benton A, 1989, MULTILINGUAL APHASIA; Benton A. L., 1994, CONTRIBUTIONS NEUROP; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Corral L, 2009, BRAIN INJURY, V23, P403, DOI 10.1080/02699050902788477; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 1987, CALIFORNIA VERBAL LE; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JENNETT B, 1976, LANCET, V1, P1031; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUMA, V9, P287; Marshall SB, 1991, J NEUROSURG S, V75, P14; Matthews C, 1964, INSTRUCTION MANUAL A; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan RM., 1985, HALSTEAD REITAN NEUR; Robertson IH, 2008, ARCH PHYS MED REHAB, V89, pS1, DOI 10.1016/j.apmr.2008.10.001; Ryu WHA, 2010, INT J REHABIL RES, V33, P84, DOI 10.1097/MRR.0b013e32832e6b4b; Schatz P, 2001, NEUROREHABILITATION, V16, P281; Schmidt M., 1996, REY AUDITORY VERBAL; Servadei F, 2000, NEUROSURGERY, V46, P70; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Smith A., 1982, SYMBOL DIGIT MODALIT; SmithKnapp K, 1996, BRAIN INJURY, V10, P651, DOI 10.1080/026990596124070; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tabachnick BG, 2007, USING MULTIVARIATE S; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Uniform Data System for Medical Rehabilitation (UDSMR), 1997, GUID UN DAT SET MED; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402	52	20	20	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	APR 1	2013	27	3					356	375		10.1080/13854046.2013.765507			20	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	129JK	WOS:000317835100002	23391004				2021-06-18	
J	Jones, L; Morris, R				Jones, Lisa; Morris, Reg			Experiences of adult stroke survivors and their parent carers: a qualitative study	CLINICAL REHABILITATION			English	Article						Stroke; carers; survivors; qualitative; parents	TRAUMATIC BRAIN-INJURY; INTERPRETATIVE PHENOMENOLOGICAL ANALYSIS; FAMILY CAREGIVERS; INFORMAL CARERS; OF-LIFE; PSYCHOLOGY; PEOPLE; IMPACT; INTERVENTION; DEPRESSION	Objective: To explore the experiences of adult stroke survivors and their parent carers. Design: Qualitative methodology: interpretative phenomenological analysis. Setting: Six residential areas across England and south Wales. Participants: Six adult stroke survivors (aged 27-46), six mothers (aged 59-76) and five fathers (aged 55-76). Method: Semi-structured interviews to explore the relationship and interactions between parent and survivor prior to and after a stroke, with opportunities to explore both positive and negative changes. All interviews were transcribed and analysed by a six step interpretative phenomenological analysis process. Survivors, mothers and fathers were analysed as three separate groups and the results were synthesised. Results: Identical and interconnected themes emerged from the three groups, permitting synthesis into a single organising framework with four superordinate themes capturing the key issues for all three groups. The four superordinate themes were: 'emotional turmoil'; 'significance of parents'; 'negotiating independence versus dependence' and 'changed relationships'. Conclusions: Parents reported adjusting to caring with relative ease. Survivors did not adjust to being cared for with such ease and felt positioned in a child role. Balancing independence and dependence was a challenge for survivors and parents and is considered within a systemic theory framework. Implications for service developments and guidelines are considered.	[Jones, Lisa] Rookwood Hosp, Cardiff, S Glam, Wales; [Morris, Reg] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales; [Jones, Lisa] Vale NHS Trust, Cardiff, S Glam, Wales	Morris, R (corresponding author), Cardiff Univ, Sch Psychol, 11th Floor,Tower Bldg,70 Pk Pl, Cardiff CF10, S Glam, Wales.	reg.morris@wales.nhs.uk		Morris, Reg/0000-0002-8250-9315	National Leadership and Innovation Agency for Health (Wales)	This research was undertaken in partial fulfilment of a doctor of clinical psychology programme funded by the National Leadership and Innovation Agency for Health (Wales).	Berg A, 2005, STROKE, V36, P639, DOI 10.1161/01.STR.0000155690.04697.c0; Brocki JM, 2006, PSYCHOL HEALTH, V21, P87, DOI 10.1080/14768320500230185; Buckner L, 2007, VALUING CARERS CALCU; Bulley C, 2010, DISABIL REHABIL, V32, P1406, DOI 10.3109/09638280903531238; Buschenfeld K, 2009, DISABIL REHABIL, V31, P1643, DOI 10.1080/09638280902736338; CARNWATH TCM, 1987, BRIT MED J, V294, P409, DOI 10.1136/bmj.294.6569.409; Carter E. A., 1999, EXPANDED FAMILY LIFE; Cramer P, 2000, AM PSYCHOL, V55, P637, DOI 10.1037//0003-066X.55.6.637; Department of Health, 2005, NAT SERV FRAM LONG T; Draper P, 2007, J CLIN NURS, V16, P264, DOI 10.1111/j.1365-2702.2006.01575.x; Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782; Evans R L, 1994, Disabil Rehabil, V16, P110; EVANS RL, 1987, ARCH PHYS MED REHAB, V68, P508; Gaugler JE, 2010, REHABIL PSYCHOL, V55, P108, DOI 10.1037/a0019023; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Gillen G, 2005, AM J OCCUP THER, V59, P346, DOI 10.5014/ajot.59.3.346; Gillespie David, 2011, Nurs Stand, V26, P39; Grant JS, 2004, REHABIL PSYCHOL, V49, P172, DOI 10.1037/0090-5550.49.2.172; Greenwood N, 2008, DISABIL REHABIL, V30, P1329, DOI 10.1080/09638280701602178; Greenwood N, 2010, MATURITAS, V66, P268, DOI 10.1016/j.maturitas.2010.03.017; Greenwood N, 2009, DISABIL REHABIL, V31, P337, DOI 10.1080/09638280802051721; Haley WE, 2009, STROKE, V40, P2129, DOI 10.1161/STROKEAHA.108.545269; Han B, 1999, STROKE, V30, P1478, DOI 10.1161/01.STR.30.7.1478; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Hunt D, 2004, DISABIL REHABIL, V26, P1000, DOI 10.1080/09638280410001702423; Kao Hsueh-Fen S, 2004, J Neurosci Nurs, V36, P73; KARPMAN T, 1985, J APPL REHABILITATIO, V17, P28; Kersten P, 2002, DISABIL REHABIL, V24, P860, DOI 10.1080/09638280210142167; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kwakkel G, 1996, AGE AGEING, V25, P479, DOI 10.1093/ageing/25.6.479; Low JTS, 1999, SOC SCI MED, V49, P711, DOI 10.1016/S0277-9536(99)00194-X; Mackenzie A, 2007, DISABIL REHABIL, V29, P111, DOI 10.1080/09638280600731599; McCullagh E, 2005, STROKE, V36, P2181, DOI 10.1161/01.STR.0000181755.23914.53; McKevitt C, 2004, STROKE, V35, P1499, DOI 10.1161/01.STR.0000127532.64840.36; Molloy GJ, 2008, HEALTH PSYCHOL, V27, P286, DOI 10.1037/0278-6133.27.2.286; Morris R, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/534812; Murray J, 2003, BRIT J GEN PRACT, V53, P137; National Institute for Health and Clinical excellence, 2011, STROK QUAL STAND ADV; Oddy M, 2003, NEUROPSYCHOL REHABIL, V13, P259, DOI 10.1080/09602010244000345; Palmer S, 2003, REHABIL PSYCHOL, V48, P255, DOI 10.1037/0090-5550.48.4.255; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Robinson L, 2005, CLIN REHABIL, V19, P560, DOI 10.1191/0269215505cr787oa; ROLLAND JS, 1987, FAM PROCESS, V26, P203, DOI 10.1111/j.1545-5300.1987.00203.x; Segal D, 2010, INT J CHILD YOUTH FA, V1, P293, DOI 10.18357/ijcyfs13/420102093; Smith J.A., 2009, INTERPRETATIVE PHENO; Strudwick A, 2010, CLIN REHABIL, V24, P159, DOI 10.1177/0269215509343847; van Heugten C, 2006, J REHABIL MED, V38, P153, DOI 10.1080/16501970500441898; White CL, 2004, QUAL LIFE RES, V13, P625, DOI 10.1023/B:QURE.0000021312.37592.4f; Wongvatunyu S, 2008, QUAL HEALTH RES, V18, P1062, DOI 10.1177/1049732308320111; Yin R., 2009, CASE STUDY RES DESIG, V5	51	20	20	0	19	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	MAR	2013	27	3					272	280		10.1177/0269215512455532			9	Rehabilitation	Rehabilitation	089FH	WOS:000314895100009	22850756				2021-06-18	
J	Safain, M; Roguski, M; Antoniou, A; Schirmer, CS; Malek, AM; Riesenburger, R				Safain, Mina; Roguski, Marie; Antoniou, Alexander; Schirmer, Clemens S.; Malek, Adel M.; Riesenburger, Ron			A single center's experience with the bedside subdural evacuating port system: a useful alternative to traditional methods for chronic subdural hematoma evacuation	JOURNAL OF NEUROSURGERY			English	Article						chronic subdural hematoma; subdural evacuating port system; bur hole; craniotomy; subdural drain; traumatic brain injury	TWIST-DRILL CRANIOSTOMY; BURR-HOLE; DRAINAGE; MANAGEMENT; HYGROMA	Object. The traditional methods for managing symptomatic chronic subdural hematoma (SDH) include evacuation via a bur hole or craniotomy, both with or without drain placement. Because chronic SDH frequently occurs in elderly patients with multiple comorbidities, the bedside approach afforded by the subdural evacuating port system (SEPS) is an attractive alternative method that is performed under local anesthesia and conscious sedation. The goal of this study was to evaluate the radiographic and clinical outcomes of SEPS as compared with traditional methods. Methods. A prospectively maintained database of 23 chronic SDHs treated by bur hole or craniotomy and of 23 chronic SDHs treated by SEPS drainage at Tufts Medical Center was compiled, and a retrospective chart review was performed. Information regarding demographics, comorbidities, presenting symptoms, and outcome was collected. The volume of SDH before and after treatment was semiautomatically measured using imaging software. Results. There was no significant difference in initial SDH volume (94.5 cm(3) vs 112.6 cm(3), respectively; p = 0.25) or final SDH volume (31.9 cm(3) vs 28.2 cm(3), respectively; p = 0.65) between SEPS drainage and traditional methods. In addition, there was no difference in mortality (4.3% vs 9.1%, respectively; p = 0.61), length of stay (11 days vs 9.1 days, respectively; p = 0.48), or stability of subdural evacuation (94.1% vs 83.3%, respectively; p = 0.60) for the SEPS and traditional groups at an average follow-up of 12 and 15 weeks, respectively. Only 2 of 23 SDHs treated by SEPS required further treatment by bur hole or craniotomy due to inadequate evacuation of subdural blood. Conclusions. The SEPS is a safe and effective alternative to traditional methods of evacuation of chronic SDHs and should be considered in patients presenting with a symptomatic chronic SDH. (http://thejns.org/doi/abs/10.3171/2012.11.JNS12689)	[Safain, Mina; Roguski, Marie; Antoniou, Alexander; Malek, Adel M.; Riesenburger, Ron] Tufts Med Ctr, Dept Neurosurg, Boston, MA USA; [Schirmer, Clemens S.] Baystate Med Ctr, Div Neurosurg, Springfield, MA 01199 USA; [Safain, Mina; Roguski, Marie; Antoniou, Alexander; Malek, Adel M.; Riesenburger, Ron] Tufts Univ, Sch Med, Dept Neurosurg, Boston, MA 02111 USA	Riesenburger, R (corresponding author), Dept Neurosurg, Proger 7,800 Washington St, Boston, MA 02110 USA.	rriesenburger@tuftsmedicalcenter.org		Schirmer, Clemens/0000-0003-1743-8781; Safain, Mina/0000-0003-1077-8062			Asfora WT, 2003, SURG NEUROL, V59, P329, DOI 10.1016/S0090-3019(03)00039-9; Aydin MD, 2004, NEUROL INDIA, V52, P121; Ernestus RI, 1997, SURG NEUROL, V48, P220, DOI 10.1016/S0090-3019(97)80031-6; Gazzeri R, 2007, ACTA NEUROCHIR, V149, P487, DOI 10.1007/s00701-007-1139-8; Gokmen M, 2008, ZBL NEUROCHIR, V69, P129, DOI 10.1055/s-2007-1004587; Gurelik M, 2007, CAN J NEUROL SCI, V34, P84, DOI 10.1017/S0317167100005849; HASEGAWA M, 1992, NEUROSURGERY, V31, P580, DOI 10.1227/00006123-199209000-00024; KAUFMAN HH, 1984, ACTA NEUROCHIR, V72, P197, DOI 10.1007/BF01406870; Tyler JK, 2010, J NEUROSURG, V113, P1004, DOI 10.3171/2010.5.JNS1083; Lee JK, 2009, J KOREAN NEUROSURG S, V46, P210, DOI 10.3340/jkns.2009.46.3.210; Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026; Lee KS, 1998, BRAIN INJURY, V12, P901; Lee KS, 2004, BRAIN INJURY, V18, P351, DOI 10.1080/02699050310001645801; LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947; Lee Kyeong-Seok, 1996, Journal of Korean Medical Science, V11, P55; Lega BC, 2010, J NEUROSURG, V113, P615, DOI 10.3171/2009.9.JNS08825; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Murata Keiji, 1993, Neurologia Medico-Chirurgica, V33, P691, DOI 10.2176/nmc.33.691; Muzii V F, 2005, J Neurosurg Sci, V49, P41; Okada Y, 2002, SURG NEUROL, V57, P405, DOI 10.1016/S0090-3019(02)00720-6; Rughani AI, 2010, J NEUROSURG, V113, P609, DOI 10.3171/2009.11.JNS091244; Santos-Ditto RA, 2007, GAC MED MEX, V143, P203; SATO S, 1975, J NEUROSURG, V43, P569, DOI 10.3171/jns.1975.43.5.0569; STJOHN JN, 1981, NEUROSURGERY, V9, P621, DOI 10.1227/00006123-198112000-00002; Takeda N, 2006, ACTA NEUROCHIR, V148, P541, DOI 10.1007/s00701-005-0689-x; van Eck ATCJ, 2002, J CLIN NEUROSCI, V9, P573, DOI 10.1054/jocn.2001.1061	26	20	21	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2013	118	3					694	700		10.3171/2012.11.JNS12689			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	094DW	WOS:000315244200034	23259822				2021-06-18	
J	Li, Y; Song, JN; Liu, XB; Zhang, M; An, JY; Sun, P; Li, DD; Jin, T; Wang, JF				Li, Yu; Song, Jinning; Liu, Xiaobin; Zhang, Ming; An, Jiyang; Sun, Peng; Li, Dandong; Jin, Tao; Wang, Junfeng			High expression of STIM1 in the early stages of diffuse axonal injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Diffuse axonal injury; STIM1; SOCE; Calcium	TRAUMATIC BRAIN-INJURY; CALCIUM DYSREGULATION; TRPC CHANNELS; STORE; CRAC; DEPLETION; RELEASE; AXOTOMY; MODEL	Increased intracellular calcium ([Ca2+](i)) is a key pathological mechanism involved in secondary neuronal injury and cell death due to diffuse axonal injury (DAI). To date, this increased [Ca2+](i) is believed to be mainly caused by dysfunction of voltage-gated sodium channels and mechanoporation of the plasma membrane. Store-operated calcium entry (SOCE) is another source of Ca2+ influx, and stromal interaction molecule 1 (STIM1) is considered as a sensor and a regulator of SOCE. In this study, we established a DAI in vivo model in rats by lateral head rotation. Using immunohistochemistry, real-time RT-PCR and Western blot, we investigated STIM1 expression levels in the cerebral cortex of rats after lateral head rotational injury. Results revealed notably high STIM1 expression in neurons in the early stages (within 24 h) of DAI. STIM1 began to increase at 6 h post-injury (PI) peaked at 12 h PI, and then gradually decreased. At 2 days PI, STIM1 expression in the injury group showed no significant difference compared with that of the control group. These results indicate that abnormal SOCE may participate in Ca2+ overload of neurons in the early stages after DAI via enhanced STIM1 expression. (C) 2012 Elsevier B.V. All rights reserved.	[Li, Yu; Song, Jinning; Liu, Xiaobin; Zhang, Ming; An, Jiyang; Sun, Peng; Li, Dandong; Jin, Tao; Wang, Junfeng] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Xian 710061, Peoples R China	Song, JN (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Xian 710061, Peoples R China.	Jinnings@126.com		Li, Dan-Dong/0000-0003-4973-8818	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30471774]	This work was supported by the National Natural Science Foundation of China (Project 30471774).	BANIK NL, 1987, NEUROCHEM PATHOL, V7, P57, DOI 10.1007/BF02834292; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; He X.S., 2004, J CLIN NEUROSCI, V14, P8; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kachoei B.A., 2006, J NEUROPHYSIOL, V96, P2698; [刘晓斌 Liu Xiaobin], 2008, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V29, P595; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; McIntosh TK, 1996, LAB INVEST, V74, P315; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Skibinska-Kijek A, 2009, ACTA NEUROBIOL EXP, V69, P413; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Song JN, 2011, NEURAL REGEN RES, V6, P1530, DOI 10.3969/j.issn.1673-5374.2011.20.002; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	34	20	40	0	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 7	2013	1495						95	102		10.1016/j.brainres.2012.12.005			8	Neurosciences	Neurosciences & Neurology	085OQ	WOS:000314624500010	23261659				2021-06-18	
J	Lam, PK; Lo, AWI; Wang, KKW; Lau, HCH; Leung, KKC; Li, KTC; Lai, PBS; Poon, WS				Lam, Ping Kuen; Lo, Anthony Wing Ip; Wang, Kevin Ka Wan; Lau, Henry Chi Ho; Leung, Kevin Kai Chung; Li, Kathy Tung Ching; Lai, Paul Bo San; Poon, Wai Sang			Transplantation of mesenchymal stem cells to the brain by topical application in an experimental traumatic brain injury model	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Mesenchymal stem cell; Topical application; Traumatic brain injury	NEUROLOGICAL DISEASES; MIGRATION; THERAPY	Mesenchymal stem cells (MSCs) have been shown in various animal models to be capable of neurorepair and neuroprotection. To carry out a therapeutic function, MSCs must be delivered to the target organ. MSCs are administered to patients via systemic infusion, which has many drawbacks, including a low engraftment rate and the migration of MSCs to non-target organs. However, other approaches such as direct intracerebral injection of MSCs might cause cerebral bleeding. In this study, a traumatic brain injury (TBI) was induced over the right parietal cerebral cortex in Sprague Dawley rats, and green fluorescent protein (GFP)-expressing MSCs (GFP-MSCs), together with a thin layer of fibrin, were applied to the external surface of the contralateral side 2 days later. Within 5 days of topical application, the GFP-MSCs had migrated from the site of application on the cortical surface, through the white matter, and had emerged at the cortical surface of the TBI site on the contralateral cerebral hemisphere, apparently following axons along the corpus callosum. In sham-injured control animals, the topically applied GFP-MSCs proliferated superficially on the cortex at the site of application, and no GFP-MSCs were found at the contralateral cortical surface. In all instances, GFP-MSCs were not detected in other organs of either the test or the control animals. Our study demonstrated that MSCs topically applied to the brain surface can migrate to a TBI site. (C) 2012 Published by Elsevier Ltd.	[Lam, Ping Kuen; Wang, Kevin Ka Wan; Lau, Henry Chi Ho; Leung, Kevin Kai Chung; Li, Kathy Tung Ching; Lai, Paul Bo San; Poon, Wai Sang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; [Lam, Ping Kuen] Chinese Univ Hong Kong, Prince Wales Hosp, Chow Tai Fook Cheng Yu Tung Surg Stem Cell Res Ct, Shatin, Hong Kong, Peoples R China; [Lo, Anthony Wing Ip] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Wang, Kevin Ka Wan] Banyan Biomarkers, Ctr Innovat Res, Alachua, FL USA; [Wang, Kevin Ka Wan] Univ Florida, Ctr Neuroprote & Biomarkers Res, Dept Psychiat & Neurosci, Gainesville, FL USA	Poon, WS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China.	wpoon@surgery.cuhk.edu.hk	Poon, Wai Sang/F-1558-2011; Lo, Anthony/G-5414-2015; LAI, Paul Bo-San/K-8556-2015	Lo, Anthony/0000-0002-9388-310X; LAI, Paul Bo-San/0000-0002-9469-6728; Wang, Kevin/0000-0002-9343-6473			Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Barone FC, 2006, CLIN NEUROSCI RES, V6, P329, DOI 10.1016/j.cnr.2006.09.010; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jackson MR, 2001, AM J SURG, V182, p1S, DOI 10.1016/S0002-9610(01)00770-X; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Lam PK, 2011, TRANSPLANTATION, V92, pE9, DOI 10.1097/TP.0b013e318221d3b7; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Mendick R, BABY DEATH SCANDAL S; Poon WS, 2006, ACT NEUR S, V99, P123, DOI 10.1007/978-3-211-35205-2_23; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198	15	20	23	0	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2013	20	2					300	303		10.1016/j.jocn.2012.03.028			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	097LX	WOS:000315476700023	23219830				2021-06-18	
J	Lin, C; Dong, Y; Lv, LQ; Yu, MK; Hou, LJ				Lin, Chao; Dong, Yan; Lv, Liquan; Yu, Mingkun; Hou, Lijun			Clinical features and functional recovery of traumatic isolated oculomotor nerve palsy in mild head injury with sphenoid fracture	JOURNAL OF NEUROSURGERY			English	Article						mild head trauma; oculomotor nerve palsy; sphenoid fracture; surgical treatment; outcome measure; traumatic brain injury	SUPERIOR ORBITAL FISSURE	Object. The aim of this study was to provide information about long-term functional outcome in patients with isolated oculomotor nerve palsy following minor head injury and to discuss surgical treatment of these patients, especially those with accompanying sphenoid fracture. Methods. A retrospective analysis was made of 26 patients with traumatic isolated oculomotor nerve palsy. The severity of oculomotor nerve palsy and the functional recovery were evaluated based on extraocular muscle movement, eyelid movement, and pupil size. On average, patients were evaluated 3.6 days after the initial,injury, and the average follow-up period was 14.2 months (range 3 months-2 years). Results. Twenty men and six women were enrolled in this study. The most common cause of trauma was motor vehicle accident in 17 (65.4%) of 26. Among all the recorded symptoms, internal ophthalmoplegia was most frequently seen. The recovery rates of ptosis, external ophthalmoplegia, and internal ophthalmoplegia were 95% (19 of 20 patients), 83.3% (15 of 18 patients), and 50% (13 of 26 patients), respectively. The 6 patients with sphenoid fracture underwent surgical decompression of the superior orbital fissure, after which all patients experienced recovery from ptosis and external ophthalmoplegia and 66.7% (4 of 6 patients) recovered from internal ophthalmoplegia. Conclusions. Limited eye movement may be a major factor that negatively affects functional recovery after mild head injury. Sphenoid fracture might be one of the potential mechanisms involved in traumatic isolated oculomotor nerve palsy after mild head injury. Surgical decompression should be considered when there is evidence of bone compression of the superior orbital fissure. (http://thejns.org/doi/abs/10.3171/2012.9.JNS12702)	[Lin, Chao; Dong, Yan; Lv, Liquan; Yu, Mingkun; Hou, Lijun] Second Mil Med Univ, Dept Neurosurg, Changzheng Hosp, Shanghai Neurosurg Inst, Shanghai 200003, Peoples R China	Hou, LJ (corresponding author), Second Mil Med Univ, Dept Neurosurg, Changzheng Hosp, Shanghai Neurosurg Inst, 415 Fengyang Rd, Shanghai 200003, Peoples R China.	lijunhou@smmu.edu.cn					Acarturk S, 2004, ANN PLAS SURG, V53, P60, DOI 10.1097/01.sap.0000106424.54415.dc; Bagheri A, 2006, J AAPOS, V10, P385, DOI 10.1016/j.jaapos.2006.06.014; Chen CC, 2005, BJ SPORT MED, V39, P34; Chen CT, 2010, PLAST RECONSTR SURG, V126, P205, DOI 10.1097/PRS.0b013e3181dab658; Cheng YS, 2008, CHINESE MED J-PEKING, V121, P276, DOI 10.1097/00029330-200802010-00020; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Jin H, 2010, INJURY, V41, P918, DOI 10.1016/j.injury.2010.03.007; Kaido T, 2006, J CLIN NEUROSCI, V13, P852, DOI 10.1016/j.jocn.2005.08.020; Kuo LT, 2010, J NEUROTRAUM, V27, P1959, DOI 10.1089/neu.2010.1407; Levy RL, 2005, NEUROLOGY, V65, P169, DOI 10.1212/01.wnl.0000167288.10702.03; Liu Yo-Tsen, 2004, J Chin Med Assoc, V67, P149; McCulley TJ, 2002, AM J OPHTHALMOL, V134, P626, DOI 10.1016/S0002-9394(02)01625-2; Miller NR, 1996, CURR OPIN NEUROL, V9, P21, DOI 10.1097/00019052-199602000-00005; Muthu P, 2001, EMERG MED J, V18, P310, DOI 10.1136/emj.18.4.310; NAGASEKI Y, 1989, ACTA NEUROCHIR, V97, P117, DOI 10.1007/BF01772821; Ng YSP, 2005, CAN J OPHTHALMOL, V40, P645, DOI 10.1016/S0008-4182(05)80062-6; Park UC, 2008, EYE, V22, P691, DOI 10.1038/sj.eye.6702720; POSTMA MP, 1990, J ORAL MAXIL SURG, V48, P503, DOI 10.1016/0278-2391(90)90241-S; Takeuchi Satoru, 2008, Brain and Nerve (Tokyo), V60, P555; TOKUNO T, 1995, NEUROL SURG TOKYO, V23, P497	21	20	23	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	FEB	2013	118	2					364	369		10.3171/2012.9.JNS12702			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	076DY	WOS:000313937900021	23121431				2021-06-18	
J	Lockie, FD; Dalton, S; Oakley, E; Babl, FE				Lockie, Francis D.; Dalton, Sarah; Oakley, Ed; Babl, Franz E.		Paediat Res Emergency Dept Int	Triggers for head computed tomography following paediatric head injury: Comparison of physicians' reported practice and clinical decision rules	EMERGENCY MEDICINE AUSTRALASIA			English	Article						clinical decision rule; clinical practice guideline; computed tomography; emergency department; paediatric head injury; research network	TRAUMATIC BRAIN-INJURY; DELAYED DIAGNOSIS; CHILDREN; PREDICTION; RADIATION; ADOLESCENTS	Objective To compare head computed tomography (CT) triggers for paediatric head injury as reported by senior paediatric emergency physicians in Australia and New Zealand with triggers in published evidence-based clinical decision rules (CDRs). Methods A survey of CT triggers after head injury was distributed to senior emergency physicians at PREDICT (Paediatric Research in Emergency Departments International Collaborative) sites in Australia and New Zealand. Results were compared with recommendations for CT scans in CATCH, CHALICE and PECARN CDRs. Clinical practice guidelines (CPGs) from each site were also reviewed. Results The response rate was 93% (130/140). No published trigger for head CT was identified by 100% of survey participants and each CDR included several triggers not identified by many respondents. Abnormal examination findings, including depressed skull fracture and base of skull fracture, were most likely to prompt respondents to order a head CT (>90%). A concerning mechanism of injury, such as a fall greater than 3 feet or five stairs, triggered a CT response only in approximately 10% of respondents. Eight different head injury CPGs were used across the 13 PREDICT sites. These were highly variable between sites and CPGs were not explicitly based on published CDRs. Conclusion High-quality, published CDRs exist for head CT use after paediatric head injury. Physician-reported CT triggers differ from CDR-recommended triggers. The major published head injury CDRs should be prospectively validated in the Australasian setting before incorporating them into local practice and CPGs.	[Lockie, Francis D.; Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, Sydney, NSW, Australia; [Oakley, Ed; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Oakley, Ed; Babl, Franz E.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Oakley, Ed] Monash Univ, Dept Paediat, Clayton, Vic, Australia; [Babl, Franz E.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	Lockie, FD (corresponding author), Womens & Childrens Hosp, Emergency Dept, Adelaide, SA 5006, Australia.	franlockie@gmail.com					Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Conners GP, 1999, PEDIATR EMERG CARE, V15, P241; Connors JM, 2001, PEDIATR EMERG CARE, V17, P1, DOI 10.1097/00006565-200102000-00001; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; Hall P, 2004, BMJ-BRIT MED J, V328, P19, DOI 10.1136/bmj.328.7430.19; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; National Center for Health Statistics Centers for Disease Control and Prevention, 2005, PUBL US DAT FIL EM D; National Center for Health Statistics Centers for Disease Control and Prevention, 1995, PUBL US DAT FIL EM D; National Collaborating Centre for Acute Care, 2003, HEAD INJ TRIAG ASS I; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond M. H., 2006, ACAD EMERG MED, V13, pS11, DOI DOI 10.1197/j.aem.2006.03.008; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	27	20	22	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-6731	1742-6723		EMERG MED AUSTRALAS	Emerg. Med. Australas.	FEB	2013	25	1					75	82		10.1111/1742-6723.12019			8	Emergency Medicine	Emergency Medicine	087GD	WOS:000314748400012	23379456				2021-06-18	
J	Nielsen, TH; Bindslev, TT; Pedersen, SM; Toft, P; Olsen, NV; Nordstrom, CH				Nielsen, T. H.; Bindslev, T. T.; Pedersen, S. M.; Toft, P.; Olsen, N. V.; Nordstrom, C. H.			Cerebral energy metabolism during induced mitochondrial dysfunction	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							TRAUMATIC BRAIN-INJURY; GLYCOLYTIC METABOLITES; AMINO-ACIDS; INTRACEREBRAL MICRODIALYSIS; VOLATILE ANESTHETICS; COMPLETE ISCHEMIA; MECHANISMS; RAT; RESTITUTION; COMMON	Background In patients with traumatic brain injury as well as stroke, impaired cerebral oxidative energy metabolism may be an important factor contributing to the ultimate degree of tissue damage. We hypothesize that mitochondrial dysfunction can be diagnosed bedside by comparing the simultaneous changes in brain tissue oxygen tension (PbtO2) and cerebral cytoplasmatic redox state. The study describes cerebral energy metabolism during mitochondrial dysfunction induced by sevoflurane in piglets. Methods Ten piglets were included, seven in the experimental group (anesthetized with sevoflurane) and three in the control group (anesthetized with midazolam). PbtO2 and cerebral levels of glucose, lactate, and pyruvate were monitored bilaterally. The biochemical variables were obtained by intracerebral microdialysis. Results All global variables were within normal range and did not differ significantly between the groups except for blood lactate that was slightly higher in the experimental group. Mitochondrial dysfunction was observed in the group of animals initially anesthetized with sevoflurane. Cerebral glucose was significantly lower in the experimental group than in the control group whereas lactate and lactate/pyruvate ratio were significantly higher. Pyruvate and tissue oxygen tension remained within normal range in both groups. Changes of intracerebral variables indicating mitochondrial dysfunction were present already from the very start of the monitoring period. Conclusion Intracerebral microdialysis revealed mitochondrial dysfunction by marked increases in cerebral lactate and lactate/pyruvate ratio simultaneously with normal levels of pyruvate and a normal PbtO2. This metabolic pattern is distinctively different from cerebral ischemia, which is characterized by simultaneous decreases in PbtO2 and intracerebral pyruvate.	Odense Univ Hosp, Dept Anaesthesiol, DK-5000 Odense C, Denmark; [Nielsen, T. H.] Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense C, Denmark	Nielsen, TH (corresponding author), Odense Univ Hosp, Dept Neurosurg, Sdr Blvd 29, DK-5000 Odense C, Denmark.	troels.nielsen@ouh.regionsyddanmark.dk	Nielsen, Troels Halfeld/G-3456-2015	Nielsen, Troels Halfeld/0000-0002-3943-8128; Toft, Palle/0000-0002-3188-449X	Odense University Hospital; A.P. Moller Foundation	The project was supported by grants from Odense University Hospital and the A.P. Moller Foundation.	Amer-Wahlin I, 2010, J MATERN-FETAL NEO M, V23, P158, DOI 10.3109/14767050903067360; Bains R, 2006, ACTA ANAESTH SCAND, V50, P572, DOI 10.1111/j.1399-6576.2006.00988.x; Bains R, 2009, ACTA ANAESTH SCAND, V53, P1354, DOI 10.1111/j.1399-6576.2009.02047.x; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COHEN PJ, 1973, ANESTHESIOLOGY, V39, P153, DOI 10.1097/00000542-197308000-00007; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; FOLBERGR.J, 1974, BRAIN RES, V80, P265, DOI 10.1016/0006-8993(74)90690-8; Gardenfors A, 2002, ACTA NEUROCHIR, V144, P601, DOI 10.1007/s00701-002-0954-1; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Horn T, 2010, NEUROCHEM INT, V57, P940, DOI 10.1016/j.neuint.2010.09.014; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kopterides P, 2011, INTENS CARE MED, V37, P1756, DOI 10.1007/s00134-011-2336-8; Levy B, 2005, LANCET, V365, P871, DOI 10.1016/S0140-6736(05)71045-X; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Nielsen TH, 2011, NEUROCRIT CARE, V15, P585, DOI 10.1007/s12028-011-9563-2; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; NORBERG K, 1975, BRAIN RES, V86, P31, DOI 10.1016/0006-8993(75)90635-6; NORDSTROM CH, 1978, J NEUROCHEM, V30, P479, DOI 10.1111/j.1471-4159.1978.tb06553.x; NORDSTROM CH, 1978, STROKE, V9, P335, DOI 10.1161/01.STR.9.4.335; NORDSTROM CH, 1978, STROKE, V9, P327, DOI 10.1161/01.STR.9.4.327; NORDSTROM CH, 1978, ACTA PHYSIOL SCAND, V104, P271, DOI 10.1111/j.1748-1716.1978.tb06279.x; Nowak G, 2002, BRIT J SURG, V89, P1169, DOI 10.1046/j.1365-2168.2002.02187.x; Powers WJ, 2010, STROKE, V41, pS107, DOI 10.1161/STROKEAHA.110.595058; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Siesjo BK, 1999, ACTA NEUROCHIR SUPPL, V73, P7; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	36	20	22	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	FEB	2013	57	2					229	235		10.1111/j.1399-6576.2012.02783.x			7	Anesthesiology	Anesthesiology	066WY	WOS:000313253800014	23017022				2021-06-18	
J	Tong, J; Liu, WM; Wang, XW; Han, XD; Hyrien, O; Samadani, U; Smith, DH; Huang, JH				Tong, Jing; Liu, Weimin; Wang, Xiaowei; Han, Xiaodi; Hyrien, Ollivier; Samadani, Uzma; Smith, Douglas H.; Huang, Jason H.			Inhibition of Nogo-66 Receptor 1 Enhances Recovery of Cognitive Function after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; locomotor function; Nogo receptors; recovery	MYELIN-ASSOCIATED GLYCOPROTEIN; SPINAL-CORD-INJURY; CONTROLLED CORTICAL IMPACT; MONOCLONAL-ANTIBODY IN-1; PROMOTES AXONAL REGENERATION; NEURITE GROWTH-INHIBITORS; GENE-EXPRESSION; OBJECT RECOGNITION; VOLUNTARY EXERCISE; NERVOUS-SYSTEM	Central nervous system (CNS) axons recover poorly following injury because of the expression of myelin-derived inhibitors of axonal outgrowth such as Nogo, myelin-associated glycoprotein (MAG), and oligodendrocyte-myelin glycoprotein (OMgp), all of which bind to the Nogo-66 receptor 1 (NgR1). Herein we examine the role of NgR1 in the recovery of motor and cognitive function after traumatic brain injury (TBI) using a controlled cortical impact (CCI) model in NgR1 knockout (KO) and wild-type (WT) mice. Four weeks post-injury, scores on the Novel Object Recognition test were significantly increased in NgR1 KO mice compared with WT mice (p < 0.05), but motor behavior test scores did not differ significantly between the two groups. Nissl staining showed that NgR1 KO mice had less brain injury volume 2 weeks after CCI (p < 0.05). Histological analysis revealed more doublecortin (DCX+) cells (p < 0.01) and more Ki-67+ cells in the contralateral dentate gyrus (DG) (p < 0.05) 2 weeks after CCI in NgR1 KO mice than in WT. Furthermore, DCX+ cells still retained their longer processes in KO mice (p < 0.01) 4 weeks following trauma. The number of bromodeoxyuridine (BrdU) + cells did not differ between the two groups at 4 weeks post-trauma, but KO mice had higher numbers of cells that co-stained with NeuN, a marker of mature neurons. Increased transcription of growth-associated protein (GAP)-43 in both the injured and contralateral sides of the hippocampus (both p < 0.05) was detected in NgR1 KO mice relative to WT. These data suggest that NgR1 negatively influences plasticity and cognitive recovery after TBI.	[Tong, Jing; Liu, Weimin; Wang, Xiaowei; Han, Xiaodi; Huang, Jason H.] Univ Rochester, Dept Neurosurg, Med Ctr, Rochester, NY 14642 USA; [Hyrien, Ollivier] Univ Rochester, Dept Biostat & Computat Biol, Med Ctr, Rochester, NY 14642 USA; [Tong, Jing; Liu, Weimin; Wang, Xiaowei; Huang, Jason H.] Univ Rochester, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Tong, Jing] Hebei Med Univ, Dept Neurosurg, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China; [Han, Xiaodi] Beijing Tiantan Puhua Hosp, Beijing, Peoples R China; [Samadani, Uzma] NYU, Dept Neurosurg, New York, NY 10016 USA; [Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA	Huang, JH (corresponding author), Univ Rochester, Dept Neurosurg, 601 Elmwood Ave,Box 670, Rochester, NY 14642 USA.	Jason_huang@urmc.rochester.edu	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168	University of Rochester institutional grant;  [NIH-R01-NS-067435]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS067435] Funding Source: NIH RePORTER	The authors thank Dr. Roman J. Giger for providing NgR1 KO mice, and Mr. Jiankai Yang, and Drs. Xiaolin Chen and Patricia Smith for help with data collection and analysis. This work was supported, in part, by a University of Rochester institutional grant (JHH), and by NIH-R01-NS-067435 (JHH).	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bomze HM, 2001, NAT NEUROSCI, V4, P38; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Bruns J. Jr., 2003, EPILEPSIA, V10, P2, DOI DOI 10.1046/J.1528-1157.44.S10.3.X; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Cao Y, 2008, NEUROREHAB NEURAL RE, V22, P262, DOI 10.1177/1545968307308550; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Chivatakarn O, 2007, J NEUROSCI, V27, P7117, DOI 10.1523/JNEUROSCI.1541-07.2007; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dimou L, 2006, J NEUROSCI, V26, P5591, DOI 10.1523/JNEUROSCI.1103-06.2006; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Emery DL, 2003, J NEUROTRAUM, V20, P1271, DOI 10.1089/089771503322686085; Ennaceur A, 2005, BEHAV BRAIN RES, V159, P247, DOI 10.1016/j.bbr.2004.11.006; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P355, DOI 10.1097/01.WCB.0000046144.31247.33; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fox GB, 1998, J NEUROSCI RES, V53, P718, DOI 10.1002/(SICI)1097-4547(19980915)53:6<718::AID-JNR9>3.0.CO;2-8; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Harvey PA, 2009, J NEUROSCI, V29, P6285, DOI 10.1523/JNEUROSCI.5885-08.2009; Karlen A, 2009, P NATL ACAD SCI USA, V106, P20476, DOI 10.1073/pnas.0905390106; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Li SX, 2003, J NEUROSCI, V23, P4219; Li SX, 2005, MOL CELL NEUROSCI, V29, P26, DOI 10.1016/j.mcn.2004.12.008; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loncarevic-Vasiljkovic N, 2009, EXP NEUROL, V220, P198, DOI 10.1016/j.expneurol.2009.08.024; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Miyake K, 2002, BRAIN RES, V935, P24, DOI 10.1016/S0006-8993(02)02420-4; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Ng CEL, 2002, J NEUROSCI RES, V67, P559, DOI 10.1002/jnr.10134; Onose G, 2009, SPINAL CORD, V47, P716, DOI 10.1038/sc.2009.52; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Petrinovic MM, 2010, DEVELOPMENT, V137, P2539, DOI 10.1242/dev.048371; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; SAVIO T, 1990, P NATL ACAD SCI USA, V87, P4130, DOI 10.1073/pnas.87.11.4130; Schlager GW, 2011, EXP NEUROL, V230, P67, DOI 10.1016/j.expneurol.2010.11.021; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Searle S., 2006, VARIANCE COMPONENTS; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95, DOI 10.1016/j.bbr.2008.12.034; Tanic N, 2007, J MOL NEUROSCI, V32, P38, DOI 10.1007/s12031-007-0006-7; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Venkatesh K, 2007, J CELL BIOL, V177, P393, DOI 10.1083/jcb.200702102; Walker CT, 2010, BRAIN RES, V1347, P125, DOI 10.1016/j.brainres.2010.05.075; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Winking H, 2004, CYTOGENET GENOME RES, V105, P251, DOI 10.1159/000078196; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yu PP, 2008, NEUROBIOL DIS, V32, P535, DOI 10.1016/j.nbd.2008.09.012	79	20	25	0	16	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2013	30	4					247	258		10.1089/neu.2012.2493			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	093CM	WOS:000315169300002	22967270	Green Published			2021-06-18	
J	Ulfarsson, T; Gudnason, GA; Rosen, T; Blomstrand, C; Sunnerhagen, KS; Lundgren-Nilsson, A; Nilsson, M				Ulfarsson, Trandur; Gudnason, Gudni Arnar; Rosen, Thord; Blomstrand, Christian; Sunnerhagen, Katharina Stibrant; Lundgren-Nilsson, Asa; Nilsson, Michael			Pituitary Function and Functional Outcome in Adults after Severe Traumatic Brain Injury: The Long-Term Perspective	JOURNAL OF NEUROTRAUMA			English	Article						functioning; hypopituitarism; long-term outcome; quality of life; TBI	GROWTH-HORMONE DEFICIENCY; QUALITY-OF-LIFE; REACTION LEVEL SCALE; GLASGOW COMA SCALE; PREMATURE MORTALITY; POSTTRAUMATIC HYPOPITUITARISM; NATURAL-HISTORY; HEAD-INJURY; FOLLOW-UP; PREVALENCE	Post-traumatic hypopituitarism (PTHP) has been linked to disability and decreased quality of life. However, no studies have addressed the long-term consequences of PTHP in adults with severe traumatic brain injury (TBI) only. In this study, we evaluated the relationship between pituitary function, quality of life, and functioning in 51 patients (16-65 years of age) with severe TBI who were admitted to Sahlgrenska University Hospital, Gothenburg from 1999 to 2002. The patients were assessed once, 2-10 years after trauma. Data from the time of injury were collected retrospectively to adjust for injury severity. Outcome measures included hormonal testing, the Short Form-36 Health Survey, the Glasgow Outcome Scale-Extended, and a self-report questionnaire specifically designed for this study and based on the International Classification of Functioning, Disability and Health. Of 51 patients, 14 (27.5%) presented with PTHP, and 11 (21.6%) had isolated growth hormone deficiency. Patients with PTHP were more often overweight at follow-up (p = 0.01); the higher body mass index was partially explained by PTHP (R 2 change = 0.07, p = 0.001). Otherwise no significant correlation was found among PTHP, functioning, or patient-reported quality of life. This study-which is unique in the homogeneity of the patients, the long follow-up time, and the use of injury severity as an outcome predictor-did not confirm results from previous studies linking PTHP to a worse outcome. Therefore, screening for PTHP might be restricted to specific subgroups such as overweight patients, indicating growth hormone deficiency.	[Ulfarsson, Trandur; Blomstrand, Christian; Nilsson, Michael] Univ Gothenburg, Ctr Brain Repair & Rehabil CBR, Gothenburg, Sweden; [Sunnerhagen, Katharina Stibrant; Lundgren-Nilsson, Asa] Univ Gothenburg, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden; [Ulfarsson, Trandur; Blomstrand, Christian; Sunnerhagen, Katharina Stibrant; Lundgren-Nilsson, Asa] Sahlgrens Univ Hosp, Dept Rehabil Med, SE-40043 Gothenburg, Sweden; [Gudnason, Gudni Arnar; Rosen, Thord] Sahlgrens Univ Hosp, Dept Endocrinol, SE-40043 Gothenburg, Sweden	Ulfarsson, T (corresponding author), Sahlgrens Univ Hosp, Dept Rehabil Med, Box 30110, SE-40043 Gothenburg, Sweden.	trandur.ulfarsson@vgregion.se	NILSSON, MICHAEL/ABE-7821-2020; Sunnerhagen, Katharina Stibrant/AAE-2405-2020	NILSSON, MICHAEL/0000-0002-8826-1621; Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400; Blomstrand, Christian/0000-0003-3503-860X	ALF Goteborg; AFA Insurance; Sten A Olsson Foundation; Swedish Cancer & Traffic Injury Society Fund; Lansforsakringar Alliance; PfizerPfizer; insurance company Lansforsakringar Alliance	This study was based on data from the Sahlgrenska University Hospital. The authors acknowledge research support from ALF Goteborg, AFA Insurance, Sten A Olsson Foundation for Research and Culture, the Swedish Cancer & Traffic Injury Society Fund, and the Lansforsakringar Alliance. The authors gratefully acknowledge the participants and their next of kin for their participation in the study. They also thank Ingrid Morberg at the Rehabilitation Medicine, Olof Ehn and Olof Strandberg at the Department of Endocrinology, and Helene Seeman-Lodding at the NICU, the Sahlgrenska University Hospital, for their support and practical assistance, as well as Anna Ekmans for statistical advice.; Thord Rosen has received honoraria for lecturing for the pharmaceutical companies Pfizer, Novo Nordisk, and Bayer Schering Pharma. He has received a grant from Pfizer and the insurance company Lansforsakringar Alliance. No competing financial interests exist for Trandur Ulfarsson, Gudni Arnar Gudnason, Christian Blomstrand, Katharina Stibrant Sunnerhagen, A sa Lundgren-Nilsson, and Michael Nilsson.	Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bengtsson BA, 1998, GROWTH HORM IGF RES, V8, P77, DOI 10.1016/S1096-6374(98)80014-2; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; Blair JC, 2010, BRIT J NEUROSURG, V24, P10, DOI 10.3109/02688690903536637; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Feldt-Rasmussen U, 2004, GROWTH HORM IGF RES, V14, pS51, DOI 10.1016/j.ghir.2004.03.013; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jeong JH, 2010, J NEUROSURG, V113, P532, DOI 10.3171/2009.10.JNS091152; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Moock J, 2009, EUR J ENDOCRINOL, V160, P17, DOI 10.1530/EJE-08-0738; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Olczyk J, 2010, NEUROENDOCRINOL LETT, V31, P700; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Pavlovic D, 2010, EUR J NEUROL, V17, P696, DOI 10.1111/j.1468-1331.2009.02910.x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pijl H, 2001, J CLIN ENDOCR METAB, V86, P5509, DOI 10.1210/jc.86.11.5509; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; ROSEN T, 1993, CLIN ENDOCRINOL, V38, P63, DOI 10.1111/j.1365-2265.1993.tb00974.x; ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P195, DOI 10.1530/acta.0.1290195; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Sullivan M., 2002, SWEDISH MANUAL INTER; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; VELDHUIS JD, 1995, J CLIN ENDOCR METAB, V80, P3209, DOI 10.1210/jc.80.11.3209; Verhelst J, 2009, EUR J ENDOCRINOL, V161, pS41, DOI 10.1530/EJE-09-0291; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009; Wallymahmed ME, 1999, CLIN ENDOCRINOL, V51, P333; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	52	20	20	2	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2013	30	4					271	280		10.1089/neu.2012.2494			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	093CM	WOS:000315169300004	23121499				2021-06-18	
J	Yokobori, S; Mazzeo, AT; Hosein, K; Gajavelli, S; Dietrich, WD; Bullock, MR				Yokobori, Shoji; Mazzeo, Anna T.; Hosein, Khadil; Gajavelli, Shyam; Dietrich, W. Dalton; Bullock, M. Ross			Preconditioning for Traumatic Brain Injury	TRANSLATIONAL STROKE RESEARCH			English	Article						Preconditioning; Traumatic brain injury; Neuroprotection; Pathophysiology	ACUTE SUBDURAL-HEMATOMA; METHYL-D-ASPARTATE; INDUCED AXONAL INJURY; REGULATED-KINASE 1/2; CLOSED-HEAD INJURY; CEREBRAL-ISCHEMIA; INDUCED NEUROPROTECTION; INTRACRANIAL-PRESSURE; NEURONAL APOPTOSIS; THERAPEUTIC TARGET	Traumatic brain injury (TBI) treatment is now focused on the prevention of primary injury and reduction of secondary injury. However, no single effective treatment is available as yet for the mitigation of traumatic brain damage in humans. Both chemical and environmental stresses applied before injury have been shown to induce consequent protection against post-TBI neuronal death. This concept termed "preconditioning" is achieved by exposure to different pre-injury stressors to achieve the induction of "tolerance" to the effect of the TBI. However, the precise mechanisms underlying this "tolerance" phenomenon are not fully understood in TBI, and therefore even less information is available about possible indications in clinical TBI patients. In this review, we will summarize TBI pathophysiology, and discuss existing animal studies demonstrating the efficacy of preconditioning in diffuse and focal type of TBI. We will also review other non-TBI preconditioning studies, including ischemic, environmental, and chemical preconditioning, which maybe relevant to TBI. To date, no clinical studies exist in this field, and we speculate on possible future clinical situations, in which pre-TBI preconditioning could be considered.	[Yokobori, Shoji; Mazzeo, Anna T.; Hosein, Khadil; Gajavelli, Shyam; Dietrich, W. Dalton; Bullock, M. Ross] Univ Miami, Miami Project Cure Paralysis, Dept Neurosurg, Miami, FL 33124 USA; [Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan; [Mazzeo, Anna T.] Univ Turin, Dept Anesthesia & Intens Care, Turin, Italy	Yokobori, S (corresponding author), Univ Miami, Miami Project Cure Paralysis, Dept Neurosurg, Miami, FL 33124 USA.	SYokobori@med.miami.edu	Gajavelli, Shyam/AAI-1374-2019	Gajavelli, Shyam/0000-0002-5947-6973; Mazzeo, Anna Teresa/0000-0002-8454-7243	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS 042133]; Miami Project to Cure Paralysis; General Insurance Association of Japan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042133] Funding Source: NIH RePORTER	The part of this work was supported by funds from NINDS RO1 NS 042133 and the Miami Project to Cure Paralysis. The corresponding author (S.Y.) was also partially supported by The General Insurance Association of Japan.	ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ALKHULAIFI AM, 1993, CARDIOSCIENCE, V4, P163; Badruddin A, 2011, CURR NEUROL NEUROSCI, V11, P104, DOI 10.1007/s11910-010-0156-9; Bickler PE, 2005, ANESTHESIOLOGY, V103, P532, DOI 10.1097/00000542-200509000-00016; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Boeck CR, 2007, AMINO ACIDS, V33, P439, DOI 10.1007/s00726-006-0455-2; BOLLI R, 1989, CIRC RES, V65, P607, DOI 10.1161/01.RES.65.3.607; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Burger R, 2004, NEUROSURGERY, V54, P701, DOI 10.1227/01.NEU.0000108784.80585.EE; Busija DW, 2008, ADV DRUG DELIVER REV, V60, P1471, DOI 10.1016/j.addr.2008.03.020; Chaudhry K, 2010, NEUROSCI LETT, V474, P109, DOI 10.1016/j.neulet.2010.03.020; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Correia SC, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00138; Correia SC, 2010, J ALZHEIMERS DIS, V20, pS475, DOI 10.3233/JAD-2010-100669; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Curry A, 2010, NEUROL RES, V32, P756, DOI 10.1179/174313209X459101; Dave KR, 2005, J NEUROSCI RES, V82, P665, DOI 10.1002/jnr.20674; Davis W, 2007, NEUROL RES, V29, P382, DOI 10.1179/016164107X204701; DeFazio RA, 2009, J CEREBR BLOOD F MET, V29, P375, DOI 10.1038/jcbfm.2008.126; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Ding Y, 2004, NEUROSCIENCE, V124, P583, DOI 10.1016/j.neuroscience.2003.12.029; Ding YH, 2004, CURR NEUROVASC RES, V1, P411, DOI 10.2174/1567202043361875; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dornbos D, 2012, CURR DRUG TARGETS, V13, P247; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; FREYTAG E, 1963, ARCH PATHOL, V76, P215; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Hu SL, 2008, ACTA NEUROCHIR SUPPL, V105, P191; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; Huang YF, 2007, CELL IMMUNOL, V248, P4, DOI 10.1016/j.cellimm.2007.03.009; Jadhav V, 2009, STROKE, V40, P3139, DOI 10.1161/STROKEAHA.109.549774; JANOFF A, 1964, Int Anesthesiol Clin, V2, P251, DOI 10.1097/00004311-196402000-00008; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jung JE, 2010, MOL NEUROBIOL, V41, P172, DOI 10.1007/s12035-010-8102-z; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; KATO H, 1992, BRAIN RES BULL, V29, P559, DOI 10.1016/0361-9230(92)90123-F; Kawai N, 2000, J NEUROTRAUM, V17, P193, DOI 10.1089/neu.2000.17.193; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kawano T, 2007, J CEREBR BLOOD F MET, V27, P1453, DOI 10.1038/sj.jcbfm.9600449; Kersten JR, 1997, ANESTHESIOLOGY, V87, P361, DOI 10.1097/00000542-199708000-00024; KHALID MA, 1993, CIRC RES, V72, P725, DOI 10.1161/01.RES.72.4.725; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kinni H, 2011, BRAIN RES, V1388, P48, DOI 10.1016/j.brainres.2011.02.076; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; KURODA Y, 1992, NEUROSURGERY, V30, P687; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Liebelt B, 2010, NEUROSCIENCE, V166, P1091, DOI 10.1016/j.neuroscience.2009.12.067; LIN BW, 1992, J NEUROCHEM, V59, P2213; LIN BW, 1993, J CEREBR BLOOD F MET, V13, P925, DOI 10.1038/jcbfm.1993.115; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Luo Y, 2008, ANESTHESIOLOGY, V109, P782, DOI 10.1097/ALN.0b013e3181895f88; Lv M, 2011, NEUROSCIENCE, V176, P162, DOI 10.1016/j.neuroscience.2010.11.066; MALONEY AFJ, 1969, BRIT J SURG, V56, P23, DOI 10.1002/bjs.1800560106; Mar J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-46; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Moojen VKM, 2012, BRAIN RES, V1466, P82, DOI 10.1016/j.brainres.2012.05.041; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Okauchi M, 2002, J NEUROTRAUM, V19, P741, DOI 10.1089/08977150260139110; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perez-Pinzon MA, 2004, J BIOENERG BIOMEMBR, V36, P323, DOI 10.1023/B:JOBB.0000041762.47544.ff; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ravati A, 2000, BRAIN RES, V866, P23, DOI 10.1016/S0006-8993(00)02210-1; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Shields DC, 2000, J NEUROSCI RES, V61, P146; SHOHAMI E, 1994, ACTA NEUROCHIR, P443; Simon RP, 2006, ARCH NEUROL-CHICAGO, V63, P1368, DOI 10.1001/archneur.63.10.1368; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Su ZJ, 2009, J NEUROTRAUM, V26, P1695, DOI 10.1089/neu.2008.0519; Sugawara T, 2003, ANTIOXID REDOX SIGN, V5, P597, DOI 10.1089/152308603770310266; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1317, DOI 10.2174/156802609789869646; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wahlgren NG, 2004, CEREBROVASC DIS, V17, P153, DOI 10.1159/000074808; Wang YC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-134; Willis C., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003986.PUB2; Wong CHY, 2008, CURR MED CHEM, V15, P1; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yokobori S, 2011, THER HYPOTHERMIA TEM, V1, P185, DOI 10.1089/ther.2011.0012; Zhang B, 2011, J TRAUMA, V71, P1680, DOI 10.1097/TA.0b013e318231bce7; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003	111	20	21	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	FEB	2013	4	1					25	39		10.1007/s12975-012-0226-1			15	Clinical Neurology; Neurosciences	Neurosciences & Neurology	109WG	WOS:000316399900005	24323189	Green Accepted			2021-06-18	
J	Lei, C; Lin, S; Zhang, C; Tao, W; Dong, W; Hao, Z; Liu, M; Wu, B				Lei, C.; Lin, S.; Zhang, C.; Tao, W.; Dong, W.; Hao, Z.; Liu, M.; Wu, B.			ACTIVATION OF CEREBRAL RECOVERY BY MATRIX METALLOPROTEINASE-9 AFTER INTRACEREBRAL HEMORRHAGE	NEUROSCIENCE			English	Article						intracerebral hemorrhage; matrix metalloproteinase-9; neurogenesis; angiogenesis	ENDOTHELIAL GROWTH-FACTOR; MATRIX-METALLOPROTEINASE EXPRESSION; NEURAL PROGENITOR CELLS; SUBVENTRICULAR ZONE; FOCAL ISCHEMIA; BRAIN-INJURY; ANGIOGENESIS; NEUROGENESIS; INHIBITION; PROTEASES	Cerebral ischemia, traumatic brain injury, intracerebral hemorrhage and other brain insults trigger neurogenesis in the subventricular zone and hippocampal subgranular zone, and newly formed blood vessels promote the migration of these new neuronal cells to damaged brain regions. The molecular steps involved in brain injury-induced angiogenesis and neurogenesis are unclear. Here we used a rat model of collagenase-induced intracerebral hemorrhage (ICH) to examine whether matrix metalloproteinase-9 (MMP-9), a zinc endopeptidase that regulates growth factor levels during recovery from brain injury, is involved in neurogenesis and angiogenesis following ICH. Induction of ICH led to significant increases in the levels of MMP-9, vascular endothelial growth factor (VEGF), and nerve growth factor (NGF), as well as in the numbers of 5-bromo-2-deoxyuridine (BrdU)- and doublecortin (DCX)-positive cells, in the ipsilateral brain. Intracerebroventricular injection of MMP-9 siRNA reduced these ICH-induced increases. These findings suggest that MMP-9 may promote angiogenesis and neurogenesis during recovery from ICH. (C) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Lei, C.; Lin, S.; Zhang, C.; Tao, W.; Dong, W.; Hao, Z.; Liu, M.; Wu, B.] Sichuan Univ, Stroke Clin Res Unit, Dept Neurol, W China Hosp, Chengdu 610041, Sichuan Provinc, Peoples R China; [Liu, M.; Wu, B.] Sichuan Univ, Key Lab Human Dis Biotherapy State, Chengdu 610041, Peoples R China; [Liu, M.; Wu, B.] Sichuan Univ, Minist Educ, Chengdu 610041, Peoples R China	Liu, M (corresponding author), Sichuan Univ, Stroke Clin Res Unit, Dept Neurol, W China Hosp, 37 Guo Xue Xiang, Chengdu 610041, Sichuan Provinc, Peoples R China.	leichunyan328@163.com; wumu8413@163.com; zhangcanfei2003@163.com; annietao-tao@gmail.com; toto.topig@hotmail.com; zhilong1983@126.com; wyplmh@hotmail.com; dragonwbtxf@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30900472]; Department of Science and Technology of Sichuan Province [2012FZ0006]; Ph.D. Programs Foundation of the Ministry of Education of ChinaMinistry of Education, China [20110181110026]	This research was supported by the National Natural Science Foundation of China (30900472), the Science and Technology Support Program of the Department of Science and Technology of Sichuan Province (2012FZ0006), and the Ph.D. Programs Foundation of the Ministry of Education of China (20110181110026).	Aleksandrova NP, 2010, EUR J MED RES, V15, P3; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bausch D, 2011, ANGIOGENESIS, V14, P235, DOI 10.1007/s10456-011-9207-3; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; del Zoppo GJ, 2010, ANN NY ACAD SCI, V1207, P46, DOI 10.1111/j.1749-6632.2010.05760.x; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Font MA, 2010, CURR CARDIOL REV, V6, P238, DOI 10.2174/157340310791658802; Fu LB, 2011, NEUROSCI LETT, V491, P174, DOI 10.1016/j.neulet.2011.01.030; Fukuda S, 2004, STROKE, V35, P998, DOI 10.1161/01.STR.0000119383.76447.05; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Hao Q, 2011, STROKE, V42, P453, DOI 10.1161/STROKEAHA.110.596452; Hu Q, 2009, EXP NEUROL, V216, P35, DOI 10.1016/j.expneurol.2008.11.007; Jayanth P, 2010, CELL SIGNAL, V22, P1193, DOI 10.1016/j.cellsig.2010.03.011; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Krum JM, 2008, EXP NEUROL, V212, P108, DOI 10.1016/j.expneurol.2008.03.019; Lee CHZ, 2007, STROKE, V38, P2563, DOI 10.1161/STROKEAHA.106.481515; Lee SR, 2006, J NEUROSCI, V26, P3491, DOI 10.1523/JNEUROSCI.4085-05.2006; Montaner J, 2001, STROKE, V32, P1759, DOI 10.1161/01.STR.32.8.1759; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nico B, 2009, NEUROSCIENCE, V161, P1057, DOI 10.1016/j.neuroscience.2009.04.028; Okauchi M, 2009, STROKE, V40, P1858, DOI 10.1161/STROKEAHA.108.535765; Park KP, 2009, STROKE, V40, P2836, DOI 10.1161/STROKEAHA.109.554824; Pratheeshkumar P, 2011, J ENVIRON PATHOL TOX, V30, P139, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i2.50; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2008, CURR OPIN PHARMACOL, V8, P82, DOI 10.1016/j.coph.2007.12.001; Shen JF, 2008, J CEREBR BLOOD F MET, V28, P1460, DOI 10.1038/jcbfm.2008.37; Shimotake J, 2010, STROKE, V41, P343, DOI 10.1161/STROKEAHA.109.564229; Shubayev VI, 2004, J NEUROSCI RES, V77, P229, DOI 10.1002/jnr.20160; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Tang T, 2007, BRAIN RES, V1175, P134, DOI 10.1016/j.brainres.2007.08.028; Tete S, 2012, CLIN ORAL IMPLAN RES, V23, P1254, DOI 10.1111/j.1600-0501.2011.02300.x; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Xue MZ, 2008, NEUROL RES, V30, P775, DOI 10.1179/174313208X341102; Yagi K, 2009, STROKE, V40, P626, DOI 10.1161/STROKEAHA.108.520262; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhao BQ, 2007, STROKE, V38, P748, DOI 10.1161/01.STR.0000253500.32979.d1; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	40	20	22	1	23	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JAN 29	2013	230						86	93		10.1016/j.neuroscience.2012.11.008			8	Neurosciences	Neurosciences & Neurology	082JH	WOS:000314387600010	23201258				2021-06-18	
J	Grin'kina, NM; Abdel-Baki, SG; Bergold, PJ				Grin'kina, Natalia M.; Abdel-Baki, Samah G.; Bergold, Peter J.			Reversible Behavioral Deficits in Rats during a Cycle of Demyelination-Remyelination of the Fimbria	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; MORRIS WATER MAZE; COGNITIVE FUNCTION; HIPPOCAMPUS; MEMORY; NAVIGATION; PLACE; SEGREGATION; AVOIDANCE	Traumatic brain injury (TBI) selectively damages white matter. White matter damage does not produce deficits in many behavioral tests used to analyze experimental TBI. Rats were impaired on an active place avoidance task following inactivation of one hippocampal injection of tetrodotoxin. The need for both hippocampi suggests that acquisition of the active place avoidance task may require interhippocampal communication. The controlled cortical impact model of TBI demyelinates midline white matter and impairs rats on the active place avoidance task. One white matter region that is demyelinated is the fimbria that contains hippocampal commissural fibers. We therefore tested whether demyelination of the fimbria produces deficits in active place avoidance. Lysophosphatidylcholine (LPC) was injected stereotaxically to produce a cycle of demyelination-remyelination of the fimbria. At 4 days, myelin loss was observed in the fimbria of LPC-, but not saline-injected rats. Fourteen days after injection, myelin content increased in LPC-, but not saline-injected rats. Three days after injection, both saline- and LPC-injected rats had similar performance on an open field and passive place avoidance task in which the rat avoided a stationary shock zone on a stationary arena. The following day, on the active place avoidance task, LPC-injected rats had a significantly higher number of shock zone entrances suggesting learning was impaired. At 14 days after injection, saline- and LPC-injected rats had similar performance on open field and passive place avoidance. On active place avoidance, however, saline-and LPC-injected rats had a similar number of total entrances suggesting that the impairment seen at 4 days was no longer present at 14 days. These data suggest that active place avoidance is highly sensitive to white matter injury.	[Grin'kina, Natalia M.; Abdel-Baki, Samah G.; Bergold, Peter J.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Abdel-Baki, Samah G.; Bergold, Peter J.] Suny Downstate Med Ctr, Dept Physiol Pharmacol & Neurol, Brooklyn, NY 11203 USA	Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural Sci, Brooklyn, NY 11203 USA.	pbergold@downstate.edu		Bergold, Peter/0000-0002-6335-1380	United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-10-2-0171]	This work was supported by contract W81XWH-10-2-0171 from the United States Army Medical Research and Materiel Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P., 2007, HIPPOCAMPUS BOOK; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Duarte FS, 2010, PSYCHOPHARMACOLOGY, V212, P653, DOI 10.1007/s00213-010-1985-6; Easton A, 2010, BEHAV BRAIN RES, V215, P310, DOI 10.1016/j.bbr.2009.10.019; FENTON AA, 1993, BEHAV NEUROSCI, V107, P552, DOI 10.1037/0735-7044.107.4.552; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Jean I, 2003, BRAIN RES, V972, P110, DOI 10.1016/S0006-8993(03)02510-1; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; OLTON DS, 1982, BRAIN RES, V233, P241, DOI 10.1016/0006-8993(82)91200-8; Olypher AV, 2006, J NEUROSCI, V26, P158, DOI 10.1523/JNEUROSCI.2064-05.2006; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Skelton RW, 1998, BEHAV BRAIN RES, V96, P13, DOI 10.1016/S0166-4328(97)00199-X; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Wesierska M, 2009, NEUROBIOL LEARN MEM, V91, P41, DOI 10.1016/j.nlm.2008.09.005; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L	27	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53775	10.1371/journal.pone.0053775			6	Multidisciplinary Sciences	Science & Technology - Other Topics	077HS	WOS:000314019100031	23349742	DOAJ Gold, Green Published			2021-06-18	
J	Jung, J; Shin, YH; Konishi, H; Lee, SJ; Kiyama, H				Jung, Junyang; Shin, Youn Ho; Konishi, Hiroyuki; Lee, Seo Jin; Kiyama, Hiroshi			Possible ATP release through lysosomal exocytosis from primary sensory neurons	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						ATP; Lysosomal exocytosis; Dorsal root ganglion; Vesicular nucleotide transporter	DORSAL-ROOT GANGLIA; NEUROTRANSMITTER RELEASE; ADENOSINE-TRIPHOSPHATE; CENTRAL SYNAPSES; SCHWANN-CELLS; QUINACRINE; RAT; ASTROCYTES; MECHANISM; NERVES	The adenosine triphosphate (ATP) plays important roles under physiological and pathological conditions such as traumatic brain injury, neuroinflammation and neuropathic pain. In the present study, we set out to study the role of lysosomal vesicles on ATP release from the dorsal root ganglion neurons. We found that the lysosomal vesicles, which contain the quinacrine-positive fluorescence and express the vesicular nucleotide transporter (VNUT), were localized within the soma and growth cone of the cultured dorsal root ganglion neurons. In addition, the number of the quinacrine staining was decreased by application of lysosomal exocytosis activators, and this decrease was suppressed by the metformin and vacuolin-1, which suppressed lysosomal exocytosis. Thus, these findings suggest that ATP release via the lysosomal exocytosis may be one of the pathways for ATP release in response to stimulation. (C) 2012 Elsevier Inc. All rights reserved.	[Jung, Junyang; Shin, Youn Ho; Lee, Seo Jin] Kyung Hee Univ, Dept Anat, Coll Med, Seoul 130701, South Korea; [Jung, Junyang; Konishi, Hiroyuki; Kiyama, Hiroshi] Nagoya Univ, Dept Funct Anat & Neurosci, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Jung, Junyang; Konishi, Hiroyuki; Kiyama, Hiroshi] Nagoya Univ, CREST, JST, Grad Sch Med,Showa Ku, Nagoya, Aichi 4668550, Japan	Kiyama, H (corresponding author), Nagoya Univ, Dept Funct Anat & Neurosci, Grad Sch Med, Showa Ku, 65 Tsurumaicho, Nagoya, Aichi 4668550, Japan.	Kiyama@med.nagoya-u.ac.jp	KONISHI, Hiroyuki/M-8871-2014; Kiyama, Hiroshi/M-8867-2014	Kiyama, Hiroshi/0000-0001-5963-046X; Konishi, Hiroyuki/0000-0002-4321-8339	CREST, JST, JapanJapan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST); Ministry of Education, Science, Sports and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	This study was partially supported by CREST, JST, Japan and a Grant-in-Aid for Scientific Research on Innovative Areas (Brain Environment) from the Ministry of Education, Science, Sports and Culture of Japan.	ALUND M, 1979, BRAIN RES, V166, P121, DOI 10.1016/0006-8993(79)90654-1; Andrews NW, 2000, TRENDS CELL BIOL, V10, P316, DOI 10.1016/S0962-8924(00)01794-3; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Dou Y, 2012, CELL RES, V22, P1022, DOI 10.1038/cr.2012.10; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Gonzales E, 2010, J HEPATOL, V52, P54, DOI 10.1016/j.jhep.2009.10.005; HOLTON P, 1959, J PHYSIOL-LONDON, V145, P494, DOI 10.1113/jphysiol.1959.sp006157; IIJIMA T, 1983, CELL TISSUE RES, V230, P639, DOI 10.1007/BF00216207; Labuzek K, 2010, N-S ARCH PHARMACOL, V381, P171, DOI 10.1007/s00210-009-0477-x; Liu GJ, 2003, NEUROREPORT, V14, P2079, DOI 10.1097/00001756-200311140-00014; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Matsuka Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-66; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; Pankratov Y., 2002, J PHYSL, V512, P1702; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Pryazhnikov E, 2008, GLIA, V56, P38, DOI 10.1002/glia.20590; RICHES DWH, 1983, BIOCHEM J, V212, P869, DOI 10.1042/bj2120869; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Soeda H, 1997, NEUROSCIENCE, V77, P1187, DOI 10.1016/S0306-4522(96)00465-4; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Sundler R, 1997, ACTA PHYSIOL SCAND, V161, P553, DOI 10.1046/j.1365-201X.1997.00262.x; Suzuki Y, 2003, J NEUROCHEM, V86, P1042, DOI 10.1046/j.1471-4159.2003.01920.x; Takenouchi T, 2009, J IMMUNOL, V182, P2051, DOI 10.4049/jimmunol.0802577; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; WEISBLUM B, 1972, P NATL ACAD SCI USA, V69, P629, DOI 10.1073/pnas.69.3.629; WHITE PN, 1995, HEARING RES, V90, P97, DOI 10.1016/0378-5955(95)00151-1; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	38	20	20	0	19	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JAN 11	2013	430	2					488	493		10.1016/j.bbrc.2012.12.009			6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	080QH	WOS:000314257800008	23237805				2021-06-18	
J	Choi, CI; Lee, YD; Kim, H; Kim, SH; Suh-Kim, H; Kim, SS				Choi, Chan-Il; Lee, Young-Don; Kim, Heejaung; Kim, Seung Hyun; Suh-Kim, Haeyoung; Kim, Sung-Soo			Neural Induction With Neurogenin 1 Enhances the Therapeutic Potential of Mesenchymal Stem Cells in an Amyotrophic Lateral Sclerosis Mouse Model	CELL TRANSPLANTATION			English	Article						Mesenchymal stem cells (MSCs); Amyotrophic lateral sclerosis (ALS); Ce2+/Zn2+ superoxide dismutase; Superoxide dismutase-1 (SOD1); Neurogenin 1 (Ngn1)	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; IN-VITRO DIFFERENTIATION; BONE-MARROW; SPINAL-CORD; TRANSGENIC MICE; CEREBROSPINAL-FLUID; HNT NEURONS; DISEASE PROGRESSION; FUNCTIONAL RECOVERY	Amyotrophic lateral sclerosis (ALS) is characterized by progressive dysfunction and degeneration of motor neurons in the central nervous system (CNS). In the absence of effective drug treatments for ALS, stem cell treatment has emerged as a candidate therapy for this disease. To date, however, there is no consensus protocol that stipulates stem cell types, transplantation timing, or frequency. Using an ALS mouse model carrying a high copy number of a mutant human superoxide dismutase-1 (SOD1)(G93A) transgene, we investigated the effect of neural induction on the innate therapeutic potential of mesenchymal stem cells (MSCs) in relation to preclinical transplantation parameters. In our study, the expression of monocyte chemoattractant protein-1 (MCP-1) was elevated in the ALS mouse spinal cord. Neural induction of MSCs with neurogenin 1 (Ngn1) upregulated the expression level of the MCP-1 receptor, CCR2, and enhanced the migration activity toward MCP-1 in vitro. Ngn1-expressing MSCs (MSCs-Ngn1) showed a corresponding increase in tropism to the CNS after systemic transplantation in ALS mice. Notably, MSCs-Ngn1 delayed disease onset if transplanted during preonset ages, whereas unprocessed MSCs failed to do so. If transplanted near the onset ages, a single treatment with MSCs-Ngn1 was sufficient to enhance motor functions during the symptomatic period (15-17 weeks), whereas unprocessed MSCs required repeated transplantation to achieve similar levels of motor function improvement. Our data indicate that systemically transplanted MSCs-Ngn1 can migrate to the CNS and exert beneficial effects on host neural cells for an extended period of time through paracrine functions, suggesting a potential benefit of neural induction of transplanted MSCs in long-term treatment of ALS.	[Choi, Chan-Il; Lee, Young-Don; Suh-Kim, Haeyoung; Kim, Sung-Soo] Ajou Univ, Sch Med, Dept Anat, Suwon 443749, South Korea; [Choi, Chan-Il; Suh-Kim, Haeyoung] Ajou Univ, Sch Med, Grad Program Neurosci, Suwon 443749, South Korea; [Choi, Chan-Il; Suh-Kim, Haeyoung] Ajou Univ, Sch Med, Div Cell Transformat & Restorat BK21, Suwon 443749, South Korea; [Lee, Young-Don] Ajou Univ, Sch Med, Ctr Cell Death Regulating Biodrug, Suwon 443749, South Korea; [Lee, Young-Don] Ajou Univ, Sch Med, Dept Mol Sci & Technol, Suwon 443749, South Korea; [Kim, Heejaung; Kim, Seung Hyun] Hanyang Univ, Coll Med, Inst Biomed Sci, Dept Neurol, Seoul 133791, South Korea	Kim, SS (corresponding author), Ajou Univ, Sch Med, Dept Anat, San 5, Suwon 443749, South Korea.	hysuh@ajou.ac.kr; kimdmg@ajou.ac.kr	Kim, Seung Hyun/T-5133-2017	Kim, Seung Hyun/0000-0001-9644-9598; Kim, Heejaung/0000-0002-0755-1740; Kim, Sung-Soo/0000-0003-3591-5932; Suh-Kim, Haeyoung/0000-0001-8175-1209	Brain Research Center of the 21st Century Frontier Research ProgramMinistry of Education, Science and Technology, Republic of Korea [2011K000262]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2010-0020406, 2010-0023676]; Basic Science Research Program through NRF	This work was partly supported by Brain Research Center of the 21st Century Frontier Research Program (2011K000262) and the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology (2010-0020406) to HSK and by Basic Science Research Program through NRF funded by the Ministry of Education, Science and Technology (2010-0023676) to SSK. Conflicts of Interest: The authors declare no financial or other competing interests.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; APPEL SH, 1995, ADV NEUROL, V68, P47; Bakshi A, 2006, J NEUROTRAUM, V23, P55, DOI 10.1089/neu.2006.23.55; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Barneoud P, 1997, NEUROREPORT, V8, P2861, DOI 10.1097/00001756-199709080-00012; Berger MM, 2000, NEUROLOGY, V54, P20, DOI 10.1212/WNL.54.1.20; Bradley WG, 1996, CLIN NEUROSCI, V3, P323; Brown RH, 2001, SEMIN NEUROL, V21, P131; Chen LC, 2004, AMYOTROPH LATERAL SC, V5, P164, DOI 10.1080/14660820410017091; Cho KJ, 1999, NEUROREPORT, V10, P3939, DOI 10.1097/00001756-199912160-00039; Choi CI, 2008, J NEUROL SCI, V268, P40, DOI 10.1016/j.jns.2007.10.024; Corti S, 2007, BRAIN, V130, P1289, DOI 10.1093/brain/awm043; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Deng YB, 2006, CYTOTHERAPY, V8, P210, DOI 10.1080/14653240600760808; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Ferrero I, 2008, CELL TRANSPLANT, V17, P255, DOI 10.3727/096368908784153940; Garbuzova-Davis S, 2001, AMYOTROPH LATERAL SC, V2, P175, DOI 10.1080/14660820152882179; Garbuzova-Davis S, 2002, EXP NEUROL, V174, P169, DOI 10.1006/exnr.2002.7860; Garbuzova-Davis S, 2006, AMYOTROPH LATERAL SC, V7, P221, DOI 10.1080/17482960600864470; Garbuzova-Davis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002494; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Habisch HJ, 2007, J NEURAL TRANSM, V114, P1395, DOI 10.1007/s00702-007-0748-y; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Hou Ling-Ling, 2003, Shengli Xuebao, V55, P153; Ji JF, 2004, NEUROSCI LETT, V355, P236, DOI 10.1016/j.neulet.2003.11.024; Kim SS, 2005, NEUROREPORT, V16, P1357, DOI 10.1097/01.wnr.0000175243.12966.f5; Kim SS, 2008, STEM CELLS, V26, P2217, DOI 10.1634/stemcells.2008-0108; Ko Il-Kwon, 2008, Int J Stem Cells, V1, P49; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Martin LJ, 2007, J NEUROPATH EXP NEUR, V66, P1002, DOI 10.1097/nen.0b013e318158822b; Mazo M, 2010, CELL TRANSPLANT, V19, P313, DOI 10.3727/096368909X480323; Mazzini L, 2008, J NEUROL SCI, V265, P78, DOI 10.1016/j.jns.2007.05.016; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Menzies FM, 2002, NEUROCHEM INT, V40, P543, DOI 10.1016/S0197-0186(01)00125-5; Miana-Mena FJ, 2005, AMYOTROPH LATERAL SC, V6, P55, DOI 10.1080/14660820510026162; Migheli A, 1999, NEUROSCI LETT, V261, P25, DOI 10.1016/S0304-3940(98)01001-5; Mitrecic D, 2010, CELL TRANSPLANT, V19, P537, DOI 10.3727/096368910X498269; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Nagai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001272; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/1076327041887754; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Przedborski Serge, 2003, Curr Neurol Neurosci Rep, V3, P70, DOI 10.1007/s11910-003-0041-x; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Rothstein JD, 2003, ANN NEUROL, V53, P423, DOI 10.1002/ana.10561; Satake K, 2004, SPINE, V29, P1971, DOI 10.1097/01.brs.0000138273.02820.0a; Shaw PJ, 1997, J NEUROL, V244, pS3, DOI 10.1007/BF03160574; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Tohill M, 2004, BIOTECHNOL APPL BIOC, V40, P17, DOI 10.1042/BA20030173; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Wang L, 2002, EXP HEMATOL, V30, P831, DOI 10.1016/S0301-472X(02)00829-9; Wang Lei, 2002, Hematology, V7, P113; Warita H, 1999, BRAIN RES, V819, P120, DOI 10.1016/S0006-8993(98)01351-1; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; Wieczorek G, 2003, CELL TISSUE RES, V311, P227, DOI 10.1007/s00441-002-0671-3; Willing AE, 2001, BRAIN RES BULL, V56, P525, DOI 10.1016/S0361-9230(01)00625-6; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387; Zhang C, 2009, CYTOTHERAPY, V11, P299, DOI 10.1080/14653240902806986; Zhao CP, 2007, CYTOTHERAPY, V9, P414, DOI 10.1080/14653240701376413; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073	74	20	22	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2013	22	5					855	870		10.3727/096368912X637019			16	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Cell Biology; Research & Experimental Medicine; Transplantation	139LX	WOS:000318585300008	22472631				2021-06-18	
J	Daggett, VS; Bakas, T; Buelow, J; Habermann, B; Murray, LL				Daggett, Virginia S.; Bakas, Tamilyn; Buelow, Janice; Habermann, Barbara; Murray, Laura L.			Needs and concerns of male combat Veterans with mild traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						activities of daily living; adaptation; Afghanistan; behavioral symptoms; cognitive symptoms; environment; Iraq; interpersonal interactions; needs; theoretical model; traumatic brain injury; Veterans	QUALITY-OF-LIFE; COMMUNITY REINTEGRATION; CONCEPTUAL-MODEL; HEALTH-SERVICES; MILITARY TBI; EXPERIENCES; IRAQ; AFGHANISTAN; MANAGEMENT; FAMILIES	Traumatic brain injury (TBI) has emerged as a major cause of morbidity among U.S. servicemembers who have served in Iraq and Afghanistan. Even mild TBI (mTBI) can result in cognitive impairments that can affect the community reintegration of Veterans postdeployment. The purpose of this study was to explore the needs and concerns of combat Veterans with mTBI to provide support for an mTBI-specific conceptual model (Conceptual Model in the Context of mTBI) derived from Ferrans et al.'s health-related quality of life model and the TBI literature. Content analysis of qualitative interview data was conducted using a thematic matrix with a predetermined code list. Data saturation was achieved after interviews with eight male Veterans. Six key categories and predominant themes emerged: cognitive impairments, physical symptoms, emotions and behaviors, instrumental activities of daily living, interpersonal interactions, and community reintegration. Findings provide preliminary support for a new, context-specific conceptual model that has the potential to identify areas for future interventions to enhance community reintegration of combat Veterans with mTBI.	[Daggett, Virginia S.] Richard L Roudebush VA Med Ctr, Dept Vet Affairs VA Hlth Serv Res, Indianapolis, IN 46202 USA; [Daggett, Virginia S.] Richard L Roudebush VA Med Ctr, Dev Ctr Excellence Implementing Evidence Based Pr, Indianapolis, IN 46202 USA; [Daggett, Virginia S.; Bakas, Tamilyn; Buelow, Janice; Habermann, Barbara] Indiana Univ, Sch Nursing, Indianapolis, IN 46204 USA; [Murray, Laura L.] Indiana Univ, Dept Speech & Hearing Sci, Bloomington, IN 47405 USA	Daggett, VS (corresponding author), Richard L Roudebush VA Med Ctr, VISN VA Ctr Appl Syst Engn VA CASE 11, HSR&D Mail Code 11H,1481 West 10th St, Indianapolis, IN 46202 USA.	Virginia.Daggett2@va.gov	Bakas, Tamilyn/ABC-5664-2020		VA Health Services Research and Development Center of Excellence on Implementing Evidence-Based PracticeUS Department of Veterans Affairs; Indiana University School of Nursing; Indiana University Graduate Affairs	This material is based on work supported by the VA Health Services Research and Development Center of Excellence on Implementing Evidence-Based Practice, the Indiana University School of Nursing, and Indiana University Graduate Affairs.	[Anonymous], 2008, MILD TRAUM BRAIN INJ; [Anonymous], 2008, POL BLAST REL INJ PT; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Bakas Tamilyn, 2002, J Neurosci Nurs, V34, P242; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Carlson K, 2009, ASSESSMENT TREATMENT; Cavendish Roberta, 2007, Holist Nurs Pract, V21, P89; Ceranic BJ, 1998, J NEUROL NEUROSUR PS, V65, P523, DOI 10.1136/jnnp.65.4.523; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Daggett V, 2009, J NEUROSCI NURS, V41, P59, DOI 10.1097/JNN.0b013e31819a7133; Daggett VS, 2010, THESIS INDIANA U SCH; de Riesthal M, 2009, PERSPECTIVES NEUROPH, V19, P58; Doyle ME, 2005, PSYCHIAT QUART, V76, P361, DOI 10.1007/s11126-005-4972-z; Ferrans CE, 2005, J NURS SCHOLARSHIP, V37, P336, DOI 10.1111/j.1547-5069.2005.00058.x; Fraas M, 2007, BRAIN INJURY, V21, P1267, DOI 10.1080/02699050701721794; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Henry JA, 2005, J REHABIL RES DEV, V42, P95, DOI 10.1682/JRRD.2005.01.0005; Hill O, 2008, ONCOL NURS FORUM, V35, P81, DOI 10.1188/08.ONF.81-88; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Huang XY, 2008, J CLIN NURS, V17, P817, DOI 10.1111/j.1365-2702.2007.02130.x; Institute of Medicine (US) Committee on the Initial Assessment of Readjustment Needs of Military Personnel V and Their Families, 2010, RET HOM IR AFGH PREL; Kilcullen N, 2007, J CLIN NURS, V16, P1029, DOI 10.1111/j.1365-2702.2007.01661.x; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Man DWK, 2004, BRAIN INJURY, V18, P577, DOI 10.1080/02699050310001646143; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Mavundla TR, 2000, J ADV NURS, V32, P1569, DOI 10.1046/j.1365-2648.2000.01661.x; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Miles MB, 1994, QUALITATIVE DATA ANA, P37; Miller NK, 2008, RURAL REMOTE HEALTH, V8; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parrish C., 2009, SIG 2 PERSPECTIVES N, V19, P47, DOI DOI 10.1044/NNS1D19.2.47; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Roehrs C, 2008, JOGNN-J OBST GYN NEO, V37, P631, DOI 10.1111/j.1552-6909.2008.00290.x; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; SANDELOWSKI M, 1993, RES NURS HEALTH, V16, P213, DOI 10.1002/nur.4770160308; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; SHUCART WA, 1981, J LARYNGOL OTOL, P166; Sloane MM, 2006, NURSING SPECTRUM; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Zeitzer MB, 2008, AAOHN J, V56, P347, DOI 10.3928/08910162-20080801-03	60	20	21	0	7	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	3					327	340		10.1682/JRRD.2011.09.0168			14	Rehabilitation	Rehabilitation	AR1IS	WOS:000343339500006	23881759	Bronze			2021-06-18	
J	Dams-O'Connor, K; Spielman, L; Hammond, FM; Sayed, N; Culver, C; Diaz-Arrastia, R				Dams-O'Connor, K.; Spielman, L.; Hammond, F. M.; Sayed, N.; Culver, C.; Diaz-Arrastia, R.			An exploration of clinical dementia phenotypes among individuals with and without traumatic brain injury	NEUROREHABILITATION			English	Article						Dementia; traumatic brain injury (TBI); National Alzheimer's Coordinating Center (NACC)	DATA SET UDS; ALZHEIMERS-DISEASE; OLDER-ADULTS; AGE; ENCEPHALOPATHY; MORTALITY; IMPACT; RISK	OBJECTIVE: To characterize the clinical profiles of individuals with dementia who do and do not report a history of TBI. INTRODUCTION: Some evidence suggests that a history of traumatic brain injury (TBI) is associated with an increased risk of dementia later in life. The clinical features of dementia associated with TBI have not been well investigated. While there is some evidence that TBI is associated with increased risk of Alzheimer's disease (AD), there are also indications that dementia associated with TBI has prominent behavioral, affective, and motor symptoms, making it distinct from AD. METHODS: The current study involves secondary analysis of baseline data from the National Alzheimer's Coordinating Center (NACC) Uniform Data Set (UDS). RESULTS: Individuals with dementia who reported a history of TBI had higher fluency and verbal memory scores and later onset of decline, but they are on more medications, had worse cardiovascular and cerebrovascular health, were more likely to have received medical attention for depression, and were more likely to have a gait disorder, falls, and motor slowness. CONCLUSION: These findings suggest that dementia among individuals with a history of TBI may represent a unique clinical phenotype that is distinct from known dementia subtypes.	[Dams-O'Connor, K.; Spielman, L.] Ichan Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Hammond, F. M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Sayed, N.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Culver, C.; Diaz-Arrastia, R.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA	Dams-O'Connor, K (corresponding author), Ichan Sch Med Mt Sinai, Brain Injury Res Ctr, Dept Rehabil Med, 1 Gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	kristen.dams-o'connor@mountsinai.org		Diaz-Arrastia, Ramon/0000-0001-6051-3594	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG016976]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG016976] Funding Source: NIH RePORTER	The NACC database is funded by NIA Grant U01 AG016976.	Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Ashman TA, 2006, MT SINAI J MED, V73, P999; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breed S, 2008, J HEAD TRAUMA REHAB, V23, P149, DOI 10.1097/01.HTR.0000319931.76966.ff; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; BUTTERS N, 1987, J CLIN EXP NEUROPSYC, V9, P479, DOI 10.1080/01688638708410764; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gordon WA, 2005, TXB TRAUMATIC BRAIN, P655; Hibbard M. R., 2005, COGNITIVE BEHAV THER, P189; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Institute of Medicine Committee on Gulf War and Health, 2009, PSYCHIATRIC OUTCOMES; Kaplan E., 1983, BOSTON NAMING TEST; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/jnp.12.2.233; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEZAK M, 2004, NEUROPSYCOLOGICAL AS; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Reitan R, 1985, THE HALSTEAD REITAN; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wechsler D., 1987, WECHSLER ADULT INTEL; Wechsler D., 1987, WMS R WECHSLER MEMOR; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554	45	20	20	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	2					199	209		10.3233/NRE-130838			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	115ZT	WOS:000316851900002	23535782	Green Accepted			2021-06-18	
J	El-Matbouly, M; El-Menyar, A; Al-Thani, H; Tuma, M; El-Hennawy, H; AbdulRahman, H; Parchani, A; Peralta, R; Asim, M; El-Faramawy, A; Zarour, A; Latifi, R				El-Matbouly, Moamena; El-Menyar, Ayman; Al-Thani, Hassan; Tuma, Mazin; El-Hennawy, Hany; AbdulRahman, Husham; Parchani, Ashok; Peralta, Ruben; Asim, Mohammad; El-Faramawy, Ahmed; Zarour, Ahmad; Latifi, Rifat			Traumatic Brain Injury in Qatar: Age Matters-Insights from a 4-Year Observational Study	SCIENTIFIC WORLD JOURNAL			English	Article							UNITED-STATES; EPIDEMIOLOGY	Background. Overall traumatic brain injury (TBI) incidence and related death rates vary across different age groups. Objectives. To evaluate the incidence, causes, and outcome of TBI in adolescents and young adult population in Qatar. Method. This was a retrospective review of all TBIs admitted to the trauma center between January 2008 and December 2011. Demographics, mechanism of injury, morbidity, and mortality were analyzed in different age groups. Results. A total of 1665 patients with TBI were admitted; the majority were males (92%) with a mean age of 28 +/- 16 years. The common mechanism of injury was motor vehicle crashes and falls from height (51% and 35%, resp.). TBI was incidentally higher in young adults (34%) and middle age group (21%). The most frequent injuries were contusion (40%), subarachnoid (25%), subdural (24%), and epidural hemorrhage (18%). The mortality rate was 11% among TBI patients. Mortality rates were 8% and 12% among adolescents and young adults, respectively. The highest mortality rate was observed in elderly patients (35%). Head AIS, ISS, and age were independent predictors for mortality. Conclusion. Adolescents and adults sustain significant portions of TBI, whereas mortality is much higher in the older group. Public awareness and injury prevention campaigns should target young population.	[El-Matbouly, Moamena] Weill Cornell Med Coll, Doha 24144, Qatar; [El-Menyar, Ayman; Asim, Mohammad] Hamad Gen Hosp, Clin Res, Trauma Surg Sect, Doha 3050, Qatar; [El-Menyar, Ayman] Weill Cornell Med Coll, Med Clin, Doha 24144, Qatar; [Al-Thani, Hassan; Tuma, Mazin; El-Hennawy, Hany; AbdulRahman, Husham; Parchani, Ashok; Peralta, Ruben; El-Faramawy, Ahmed; Zarour, Ahmad; Latifi, Rifat] Hamad Gen Hosp, Trauma Surg Sect, Doha 3050, Qatar; [Latifi, Rifat] Univ Arizona, Dept Surg, Tucson, AZ USA	El-Menyar, A (corresponding author), Hamad Gen Hosp, Clin Res, Trauma Surg Sect, Doha 3050, Qatar.	aymanco65@yahoo.com	El-Menyar, Ayman/F-6734-2015	El-Menyar, Ayman/0000-0003-2584-953X; El-Matbouly, Moamena/0000-0003-1313-6612; Latifi, Rifat/0000-0003-1091-3682			Alves O. L., 2001, BRAIN INJURY; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Carli P, 2004, LANCET, V363, P584, DOI 10.1016/S0140-6736(04)15626-2; CDC, 2006, MMWR-MORBID MORTAL W, V59, P303; CDC, 2006, MORT DAT MULT CAUS O; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2007, TRAUMATIC BRAIN INJU; Chesnutt R. M., 1999, INTRO BACKGROUND REH; Collins C., 2002, OCCUPATIONAL THERAPY, P395; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Granacher R. P., 2008, TRAUMATIC BRAIN INJU, VSecond; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hannay HJ, 2004, NEUROPHYSIOLOGICAL A, P158; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Necajauskaite Olga, 2005, Medicina (Kaunas), V41, P457; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Valadka A. B., 2004, TRAUMA, P385; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; Zitnay GA, 2005, ACT NEUR S, V93, P131	28	20	21	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1537-744X			SCI WORLD J	Sci. World J.		2013									354920	10.1155/2013/354920			6	Multidisciplinary Sciences	Science & Technology - Other Topics	195KC	WOS:000322700000001	23983630	DOAJ Gold, Green Published			2021-06-18	
J	Greve, KW; Bianchini, KJ; Brewer, ST				Greve, Kevin W.; Bianchini, Kevin J.; Brewer, Steve T.			The Assessment of Performance and Self-report Validity in Persons Claiming Pain-related Disability	CLINICAL NEUROPSYCHOLOGIST			English	Article						Chromic pain; Malingering; Assessment	ADULT INTELLIGENCE SCALE; MALINGERED NEUROCOGNITIVE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; FAKE BAD SCALE; MIXED GROUP VALIDATION; VERBAL-LEARNING TEST; RELIABLE DIGIT SPAN; CLASSIFICATION ACCURACY; HEAD-INJURY; UNITED-STATES	One third of all people will experience spinal pain in their lifetime and half of these will experience chronic pain. Pain often occurs in the context of a legally compensable event with back pain being the most common reason for filing a Workers Compensation claim in the United States. When financial incentives to appear disabled exist, malingered pain-related disability is a potential problem. Malingering may take the form of exaggerated physical, emotional, or cognitive symptoms and/or under-performance on measures of cognitive and physical capacity. Essential to the accurate detection of Malingered Pain-related Disability is the understanding that malingering is an act of will, the goal of which is to increase the appearance of disability beyond that which would naturally arise from the injury in question. This paper will review a number of Symptom Validity Tests (SVTs) that have been developed to detect malingering in patients claiming pain-related disability and will conclude with a review of studies showing the diagnostic benefit of combining SVT findings from a comprehensive malingering assessment. The utilization of a variety of tools sensitive to the multiple manifestations of malingering increases the odds of detecting invalid claims while reducing the risk of rejecting a valid claim.	[Greve, Kevin W.; Bianchini, Kevin J.; Brewer, Steve T.] Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; [Greve, Kevin W.; Bianchini, Kevin J.] Jefferson Neurobehav Grp, Metairie, LA 70002 USA	Greve, KW (corresponding author), Jefferson Neurobehav Grp, 2901 N I-10 Serv Rd East, Metairie, LA 70002 USA.	kgreve@uno.edu					Aguerrevere LE, 2009, CLIN NEUROPSYCHOL, V23, P567; Aguerrevere LE, 2011, J CLIN EXP NEUROPSYC, V33, P497, DOI 10.1080/13803395.2010.535503; Aguerrevere LE, 2008, ARCH CLIN NEUROPSYCH, V23, P831, DOI 10.1016/j.acn.2008.06.008; American Psychiatric Association, 2000, DIAGN STAT MAN, V4th; Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Arnold G., 2007, ASSESSMENT FEIGNED C, P178; Ashendorf L, 2003, CLIN NEUROPSYCHOL, V17, P255, DOI 10.1076/clin.17.2.255.16502; Bagby R. M., 1991, J COUNSELING CLIN PS, V3, P496; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Ben-Porath Y. S., 2008, MMPI 2 RESTRUCTURED; Ben-Porath Y.S., 2012, INTERPRETING MMPI 2; Ben-Porath YS, 2009, PSYCHOL INJ LAW, V2, P62, DOI 10.1007/s12207-009-9037-4; Bianchini K. J., 2012, ACCURACY MODIF UNPUB; Bianchini KJ, 2008, ASSESSMENT, V15, P435, DOI 10.1177/1073191108317341; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1992, ARCH PHYS MED REHAB, V73, P377, DOI 10.1016/0003-9993(92)90013-M; BINDER LM, 1992, ARCH CLIN NEUROPSYCH, V7, P155, DOI 10.1016/0887-6177(92)90009-C; BINDER LM, 1987, J CLIN EXP NEUROPSYC, V9, P167, DOI 10.1080/01688638708405357; BINDER LM, 1993, PORTLAND DIGIT RECOG; Boone, 2007, ASSESSMENT FEIGNED C; Boone KB, 2003, CLIN NEUROPSYCHOL, V17, P244, DOI 10.1076/clin.17.2.244.16497; BOONE KB, 2007, ASSESSMENT MALINGERE, P27; BRADY JP, 1961, ARCH GEN PSYCHIAT, V4, P331; Bruns D., 2003, BATTERY HLTH IMPROVE; Butcher J. N., 1989, MMPI 2 MANUAL ADM SC; Butters N, 1980, ALCOHOLIC KORSAKOFFS; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; CHENGALUR SN, 1990, AM J PHYS MED REHAB, V69, P148, DOI 10.1097/00002060-199006000-00010; Curtis K. L., 2008, 36 ANN M INT NEUR SO; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Daubert SD, 2000, PSYCHOL ASSESSMENT, V12, P418, DOI 10.1037/1040-3590.12.4.418; DAWES RM, 1966, PSYCHOL BULL, V66, P63, DOI 10.1037/h0023584; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; DEARDORFF WW, 1993, PAIN, V54, P153, DOI 10.1016/0304-3959(93)90203-2; Delis DC, 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fishbain DA, 1999, CLIN J PAIN, V15, P244, DOI 10.1097/00002508-199912000-00002; Frederick RI, 2000, BEHAV SCI LAW, V18, P693, DOI 10.1002/bsl.432; Frederick RI, 2007, ASSESSMENT, V14, P3, DOI 10.1177/1073191106292009; Frederick RI, 2009, ASSESSMENT, V16, P215, DOI 10.1177/1073191108325005; FRIEDMAN AF, 1983, J CONSULT CLIN PSYCH, V51, P629, DOI 10.1037/0022-006X.51.4.629; GATCHEL RJ, 1995, HEALTH PSYCHOL, V14, P415, DOI 10.1037/0278-6133.14.5.415; Gatchel RJ, 2004, AM PSYCHOL, V59, P795, DOI 10.1037/0003-066X.59.8.795; Green P., 2005, GREENS WORD MEMORY T; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; GREIFFENSTEIN MF, 2007, ASSESSMENT MALINGERE, P100; Greve K. W., 2012, COPING PSYCHIAT PSYC, P587, DOI DOI 10.1093/MED:PSYCH/9780195174113.003.0026; Greve K. W., 2009, ANN M AM AC CLIN NEU; Greve K. W., 2009, 29 ANN M NAT AC NEUR; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2007, ASSESSMENT, V14, P12, DOI 10.1177/1073191106295095; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P850, DOI 10.1080/13854040802585055; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2003, ARCH PHYS MED REHAB, V84, P1233, DOI 10.1016/S0003-9993(03)00145-X; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; GROSSMAN LS, 1995, J PERS ASSESS, V64, P384, DOI 10.1207/s15327752jpa6402_17; GROSZ HJ, 1965, ARCH GEN PSYCHIAT, V13, P255; Guo HR, 1999, AM J PUBLIC HEALTH, V89, P1029, DOI 10.2105/AJPH.89.7.1029; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Iverson G.L., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401, DOI 10.1177/107319119400100401]; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Keller L. S., 1991, MMPI 2 MONOGRAPHS; Larrabee G.J., 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; LARRABEE GJ, 2005, FORENSIC NEUROPSYCHO, P115; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P813, DOI 10.1080/13854040701625846; LAWLIS GF, 1989, SPINE, V14, P511, DOI 10.1097/00007632-198905000-00007; Lechner DE, 1998, PHYS THER, V78, P867, DOI 10.1093/ptj/78.8.867; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; LEESHALEY PR, 2003, J FORENSIC NEUROPSYC, V3, P167, DOI DOI 10.1300/J151V03N01_01; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; LUBIN B, 1984, AM PSYCHOL, V39, P451, DOI 10.1037/0003-066X.39.4.451; MAIN CJ, 1983, J PSYCHOSOM RES, V27, P503, DOI 10.1016/0022-3999(83)90040-5; MARKS PA, 1963, ACTUARIAL DESCRIPTIO; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McCusker PJ, 2003, INT J OFFENDER THER, V47, P585, DOI 10.1177/0306624X03254013; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Meyers J, 2000, TELEPHONY, V239, P7; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; MILLIS SR, 1997, M INT NEUR SOC BERG; Millon T., 1994, MILLON CLIN MULTIAXI; Millon T, 1997, MILLON CLIN MULTIAXI, V2; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Morgan J., 2009, NEUROSPYCHOLOGY MALI; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; Nitch S. R., 2007, ASSESSMENT FEIGNED C, P78; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; PANKRATZ L, 1975, J CONSULT CLIN PSYCH, V43, P421, DOI 10.1037/h0076722; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; RETZLAFF P, 1991, J PERS ASSESS, V56, P466, DOI 10.1207/s15327752jpa5603_8; Reynolds CR, 1998, CRIT ISS NE, P261; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Robinson M E, 1993, J Occup Rehabil, V3, P45, DOI 10.1007/BF01076741; ROBINSON ME, 1989, PAIN, V37, P211, DOI 10.1016/0304-3959(89)90132-2; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Schoenberg MR, 2003, PSYCHOL ASSESSMENT, V15, P198, DOI 10.1037/1040-3590.15.2.198; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; Sellbom M, 2012, PSYCHIAT RES, V197, P295, DOI 10.1016/j.psychres.2011.12.043; Slesinger D, 2002, ASSESSMENT, V9, P406, DOI 10.1177/1073191102238153; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; SMITH GA, 1989, AM J PHYS MED REHAB, V68, P73, DOI 10.1097/00002060-198904000-00006; Suhr J. A., 2007, ASSESSMENT MALINGERE; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; TAIT RC, 1990, PAIN, V40, P171, DOI 10.1016/0304-3959(90)90068-O; Tombaugh TN, 1996, TEST MEMORY MALINGER; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Von Korff M, 2005, PAIN, V113, P331, DOI 10.1016/j.pain.2004.11.010; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	142	20	22	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 1	2013	27	1			SI		108	137		10.1080/13854046.2012.739646			30	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	106AU	WOS:000316114600008	23157188				2021-06-18	
J	Heringhaus, A; Blom, MD; Wigert, H				Heringhaus, Alina; Blom, Michaela Dellenmark; Wigert, Helena			Becoming a parent to a child with birth asphyxia-From a traumatic delivery to living with the experience at home	INTERNATIONAL JOURNAL OF QUALITATIVE STUDIES ON HEALTH AND WELL-BEING			English	Article						Hypothermia treatment; neonatal care; nursing; infant; traumatic delivery; qualitative content analysis	INTENSIVE-CARE-UNIT; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; PERINATAL ASPHYXIA; POSTTRAUMATIC STRESS; INDUCED HYPOTHERMIA; PREMATURE-INFANTS; MOTHERS; FATHERS; NEWBORN; NURSES	The aim of this study is to describe the experiences of becoming a parent to a child with birth asphyxia treated with hypothermia in the neonatal intensive care unit (NICU). In line with the medical advances, the survival of critically ill infants with increased risk of morbidity is increasing. Children who survive birth asphyxia are at a higher risk of functional impairments, cerebral palsy (CP), or impaired vision and hearing. Since 2006, hypothermia treatment following birth asphyxia is used in many of the Swedish neonatal units to reduce the risk of brain injury. To date, research on the experience of parenthood of the child with birth asphyxia is sparse. To improve today's neonatal care delivery, health-care providers need to better understand the experiences of becoming a parent to a child with birth asphyxia. A total of 26 parents of 16 children with birth asphyxia treated with hypothermia in a Swedish NICU were interviewed. The transcribed interview texts were analysed according to a qualitative latent content analysis. We found that the experience of becoming a parent to a child with birth asphyxia treated with hypothermia at the NICU was a strenuous journey of overriding an emotional rollercoaster, that is, from being thrown into a chaotic situation which started with a traumatic delivery to later processing the difficult situation of believing the child might not survive or was to be seriously affected by the asphyxia. The prolonged parent-infant separation due to the hypothermia treatment and parents' fear of touching the infant because of the high-tech equipment seemed to hamper the parent-infant bonding. The adaption of the everyday life at home seemed to be facilitated by the follow-up information of the doctor after discharge. The results of this study underline the importance of family-centered support during and also after the NICU discharge.	[Heringhaus, Alina; Blom, Michaela Dellenmark; Wigert, Helena] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, SE-41685 Gothenburg, Sweden; [Wigert, Helena] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden	Heringhaus, A (corresponding author), Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Div Neonataol, Gothenburg SU Ostra Smorslottsgatan 1, SE-41685 Gothenburg, Sweden.	alina.heringhaus@live.se		Dellenmark-Blom, Michaela/0000-0002-1467-9427			[Anonymous], EARLY HUM DEV, DOI DOI 10.1016/J.EARLHUMDEV.2010.09.006; Arockiasamy V, 2008, PEDIATRICS, V121, pE215, DOI 10.1542/peds.2007-1005; Azzopardi D, 2010, EARLY HUM DEV, V86, P345, DOI 10.1016/j.earlhumdev.2010.05.008; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Battin MR, 2001, PEDIATRICS, V107, P480, DOI 10.1542/peds.107.3.480; Beck C.T, 2012, NURSING RES GENERATI; Beck CT, 2004, NURS RES, V53, P28, DOI 10.1097/00006199-200401000-00005; Black BP, 2009, RES NURS HEALTH, V32, P38, DOI 10.1002/nur.20298; Blackmon LR, 2006, PEDIATRICS, V117, P942, DOI 10.1542/peds.2005-2950; Bowlby J., 1982, ATTACHMENT LOSS ATTA; Brummelte S, 2011, EARLY HUM DEV, V87, P273, DOI 10.1016/j.earlhumdev.2011.01.030; Callery Peter, 2002, Evid Based Nurs, V5, P91, DOI 10.1136/ebn.5.3.91; Cleveland LM, 2008, JOGNN-J OBST GYN NEO, V37, P666, DOI 10.1111/j.1552-6909.2008.00288.x; Conz CA, 2009, REV ESC ENFERM USP, V43, P846; Cullberg J., 2006, KRIS UTVECKLING; Dahlberg K, 2008, REFLECTIVE LIFEWORLD; Edwards AD, 2006, ARCH DIS CHILD-FETAL, V91, pF127, DOI 10.1136/adc.2005.071787; Ehrenstein V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-14; Eiser C, 2005, J CHILD PSYCHOL PSYC, V46, P1169, DOI 10.1111/j.1469-7610.2005.00415.x; Fenwick J, 2001, J PERINAT NEONAT NUR, V15, P49, DOI 10.1097/00005237-200109000-00005; Forcada-Guex M, 2011, EARLY HUM DEV, V87, P21, DOI 10.1016/j.earlhumdev.2010.09.006; Garel M, 2007, CHILD CARE HLTH DEV, V33, P137, DOI 10.1111/j.1365-2214.2006.00663.x; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Groenendaal F, 2009, EARLY HUM DEV, V85, P73, DOI 10.1016/j.earlhumdev.2008.11.006; Hall EOC, 2005, SCAND J CARING SCI, V19, P179, DOI 10.1111/j.1471-6712.2005.00352.x; HARRISON H, 1993, PEDIATRICS, V92, P643; Heermann Judith A, 2005, Pediatr Nurs, V31, P176; Iversen AS, 2013, INT J QUAL STUD HEAL, V8, DOI 10.3402/qhw.v8i0.20007; Jackson K, 2003, J ADV NURS, V43, P120, DOI 10.1046/j.1365-2648.2003.02686.x; Jamsa K, 1998, Technol Health Care, V6, P225; Jolley Jeremy, 2009, J Pediatr Nurs, V24, P164, DOI 10.1016/j.pedn.2008.03.010; Kowalski WJ, 2006, J PERINATOL, V26, P44, DOI 10.1038/sj.jp.7211409; Lagercrantz H., 2008, NEONATOLOGI; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lefkowitz DS, 2010, J CLIN PSYCHOL MED S, V17, P230, DOI 10.1007/s10880-010-9202-7; Lindberg B, 2008, SCAND J CARING SCI, V22, P79, DOI 10.1111/j.1471-6712.2007.00563.x; Lindseth A, 2004, SCAND J CARING SCI, V18, P145, DOI 10.1111/j.1471-6712.2004.00258.x; Long M, 2007, JOGNN-J OBST GYN NEO, V36, P293, DOI 10.1111/J.1552-6909.2007.00150.x; Merlau-Ponty Maurice, 1995, PHENOMENOLOGY PERCEP; Mok E, 2006, J CLIN NURS, V15, P726, DOI 10.1111/j.1365-2702.2006.01359.x; Nassef SK, 2013, JOGNN-J OBST GYN NEO, V42, P38, DOI 10.1111/j.1552-6909.2012.01429.x; Palmer L, 2010, INT J QUAL STUD HEAL, V5, P1, DOI 10.3402/qhw.v5i3.5397; Perlman JM, 2006, PEDIATRICS, V117, pS28, DOI 10.1542/peds.2005-0620E; Pinelli J, 2008, J NEONATAL NURSING, V14, P156, DOI DOI 10.1016/J.JNN.2008.03.015; Roka A, 2010, EARLY HUM DEV, V86, P361, DOI 10.1016/j.earlhumdev.2010.05.013; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Shankaran S, 2007, CLIN OBSTET GYNECOL, V50, P624, DOI 10.1097/GRF.0b013e31811eba5e; Swedish Paediatric Society, 2005, HYP TREATM ASPH NEWB; Treyvaud K, 2011, EARLY HUM DEV, V87, P427, DOI 10.1016/j.earlhumdev.2011.03.008; Wigert H, 2006, SCAND J CARING SCI, V20, P35, DOI 10.1111/j.1471-6712.2006.00377.x; Wigert H, 2007, INT J QUALITATIVE ST, V2, P45; Wigert H, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-3; Yager JY, 2004, BRAIN RES, V1011, P48, DOI 10.1016/j.brainres.2004.02.070; Ziegert K., 2011, INT J QUALITATIVE ST, V6, P1	54	20	24	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1748-2623	1748-2631		INT J QUAL STUD HEAL	Int. J. Qual. Stud. Health Well-Being		2013	8								20539	10.3402/qhw.v8i0.20539			13	Public, Environmental & Occupational Health; Nursing; Social Sciences, Biomedical	Public, Environmental & Occupational Health; Nursing; Biomedical Social Sciences	138BQ	WOS:000318483700001	23639330	DOAJ Gold, Green Published			2021-06-18	
J	Huang, Q; Dai, WM; Jie, YQ; Yu, GF; Fan, XF; Wu, A				Huang, Qiang; Dai, Wei-Min; Jie, Yuan-Qing; Yu, Guo-Feng; Fan, Xiao-Feng; Wu, An			High concentrations of visfatin in the peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome	PEPTIDES			English	Article						Visfatin; Intracerebral hemorrhage; Outcome; Mortality	COLONY-ENHANCING FACTOR; HUMAN FETAL MEMBRANES; CLONING; GROWTH; LEVEL; FAT	Higher plasma visfatin concentration has been associated with clinical outcomes of traumatic brain injury. No published information exists to date about change in plasma visfatin after intracerebral hemorrhage. This study included one hundred and twenty-eight healthy controls and 128 patients with intracerebral hemorrhage. The unfavorable outcome was defined as modified Rankin Scale score >2 at 6 months. The patients had higher plasma visfatin measurements than control subjects. Plasma visfatin levels were highly correlated with National Institutes of Health Stroke Scale score and plasma C-reactive protein levels in the patients. A multivariate analysis identified plasma visfatin level as an independent predictor for 6-month mortality and unfavorable outcome. According to receiver operating characteristic curve analysis, the predictive value of the plasma visfatin concentration was similar to National Institutes of Health Stroke Scale score. In a combined logistic-regression model, visfatin improved the predictive value of National Institutes of Health Stroke Scale score for 6-month unfavorable outcome. Thus, increased plasma visfatin level is associated with 6-month clinical outcomes after intracerebral hemorrhage. (C) 2012 Elsevier Inc. All rights reserved.	[Huang, Qiang; Dai, Wei-Min; Jie, Yuan-Qing; Yu, Guo-Feng; Fan, Xiao-Feng; Wu, An] Quzhou Peoples Hosp, Dept Neurosurg, Quzhou 324100, Peoples R China	Yu, GF (corresponding author), Quzhou Peoples Hosp, Dept Neurosurg, 2 Zhongloudi Rd, Quzhou 324100, Peoples R China.	quzhouguofengyu@163.com					Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Chen J, 2012, PEPTIDES, V38, P8, DOI 10.1016/j.peptides.2012.08.016; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Haider DG, 2006, J CLIN ENDOCR METAB, V91, P1578, DOI 10.1210/jc.2005-2248; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Liu P, 2009, J BIOL CHEM, V284, P27344, DOI 10.1074/jbc.M109.002519; Liu P, 2009, CELL BIOL INT, V33, P19, DOI 10.1016/j.cellbi.2008.10.015; Lu LF, 2009, J STROKE CEREBROVASC, V18, P354, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.003; McGlothlin JR, 2005, BIOCHEM GENET, V43, P127, DOI 10.1007/s10528-005-1505-2; Ognjanovic S, 2001, J MOL ENDOCRINOL, V26, P107, DOI 10.1677/jme.0.0260107; Ognjanovic S, 2003, AM J OBSTET GYNECOL, V189, P1187, DOI 10.1067/S0002-9378(03)00591-X; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431	16	20	21	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JAN	2013	39						55	58		10.1016/j.peptides.2012.11.006			4	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	102IW	WOS:000315839300009	23174347				2021-06-18	
J	McBride, J; Zhao, X; Nichols, T; Vagnini, V; Munro, N; Berry, D; Jiang, Y				McBride, J.; Zhao, X.; Nichols, T.; Vagnini, V.; Munro, N.; Berry, D.; Jiang, Y.			Scalp EEG-Based Discrimination of Cognitive Deficits After Traumatic Brain Injury Using Event-Related Tsallis Entropy Analysis	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Biomedical signal processing; EEG; medical diagnosis; traumatic brain injury (TBI)	BIOPHYSICAL LINKAGE; ATTENTION; INDEX; TIME; TBI; MRI	Traumatic brain injury (TBI) is the leading cause of death and disability in children and adolescents in the U. S. This is a pilot study, which explores the discrimination of chronic TBI from normal controls using scalp EEG during a memory task. Tsallis entropies are computed for responses during an old-new memory recognition task. A support vector machinemodel is constructed to discriminate between normal andmoderate/severe TBI individuals using Tsallis entropies as features. Numerical analyses of 30 records (15 normal and 15 TBI) show amaximum discrimination accuracy of 93% (p-value = 7.8557E-5) using four features. These results suggest the potential of scalp EEG as an efficacious method for noninvasive diagnosis of TBI.	[McBride, J.; Zhao, X.] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA; [Nichols, T.; Munro, N.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Vagnini, V.; Jiang, Y.] Univ Kentucky, Coll Med, Dept Behav Sci, Lexington, KY 40536 USA; [Berry, D.] Univ Kentucky, Dept Psychol, Lexington, KY 40536 USA	Zhao, X (corresponding author), Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.	jmcbrid4@utk.edu; xzhao9@utk.edu; nicholstl@ornl.gov; tory.vagnini@gmail.com; munronb@ornl.gov; dtrb@pop.uky.edu; yjiang@uky.edu	Zhao, Xiaopeng/A-4419-2008	Zhao, Xiaopeng/0000-0003-1207-5379; JIANG, Yang/0000-0003-4589-0097	National Science FoundationNational Science Foundation (NSF) [CMMI-0845753]; Department of Behavioral Science, University of Kentucky College of Medicine	Manuscript received May 22, 2012; revised July 20, 2012 and September 1, 2012; accepted September 23, 2012. Date of publication October 10, 2012; date of current version December 14, 2012. This work was supported in part by the National Science Foundation under Grant CMMI-0845753 and in part by a pilot grant from the Department of Behavioral Science, University of Kentucky College of Medicine. Asterisk indicates corresponding author.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Angelakis E, 2004, CLIN NEUROPHYSIOL, V115, P887, DOI 10.1016/j.clinph.2003.11.034; Bezerianos A, 2003, ANN BIOMED ENG, V31, P221, DOI 10.1114/1.1541013; Bishop C. M., 2008, NEURAL NETWORKS PATT, P295; Brain Trauma Foundation, 2011, FACTS TBI US; Cao C, 2011, CLIN NEUROPHYSIOL, V122, P1314, DOI 10.1016/j.clinph.2010.12.042; Cerutti S., 2011, ADV METHODS BIOMEDIC, P357; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Fu SM, 2009, NEUROIMAGE, V48, P191, DOI 10.1016/j.neuroimage.2009.06.028; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Herron JE, 2004, NEUROIMAGE, V21, P302, DOI 10.1016/j.neuroimage.2003.09.039; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Leon-Carrion J, 2008, BRAIN INJURY, V22, P61, DOI 10.1080/02699050701824143; MOULTON RJ, 1988, CAN J NEUROL SCI, V15, P82, DOI 10.1017/S0317167100027244; Paul Danie B, 2006, J Clin Monit Comput, V20, P399, DOI 10.1007/s10877-006-9045-9; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sneddon R, 2005, CLIN EEG NEUROSCI, V36, P141, DOI 10.1177/155005940503600304; Sneddon R, 2007, PHYSICA A, V386, P101, DOI 10.1016/j.physa.2007.05.065; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Tong S, 2002, PHYSICA A, V305, P619, DOI 10.1016/S0378-4371(01)00621-5; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; TYSZKA JM, 1994, ANN NEUROL, V35, P746, DOI 10.1002/ana.410350617; Vagnini VL, 2008, J CLIN EXP NEUROPSYC, V30, P766, DOI 10.1080/13803390701754746; Van Egren L., 1996, CLIN ELECTROENCEPHAL, V27, P164; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Zhang DD, 2010, IEEE T BIO-MED ENG, V57, P867, DOI 10.1109/TBME.2009.2029082	30	20	20	0	10	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	JAN	2013	60	1	1				90	96		10.1109/TBME.2012.2223698			7	Engineering, Biomedical	Engineering	062CV	WOS:000312897600012	23070292				2021-06-18	
J	Roka, A; Beko, G; Halasz, J; Toldi, G; Lakatos, P; Azzopardi, D; Tulassay, T; Szabo, M				Roka, Aniko; Beko, Gabriella; Halasz, Jozsef; Toldi, Gergely; Lakatos, Petra; Azzopardi, Denis; Tulassay, Tivadar; Szabo, Miklos			Changes in serum cytokine and cortisol levels in normothermic and hypothermic term neonates after perinatal asphyxia	INFLAMMATION RESEARCH			English	Article						Asphyxia; Cytokine; Cortisol; Hypothermia; Neonate	HYPOXIC-ISCHEMIC ENCEPHALOPATHY; TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; MODERATE HYPOTHERMIA; INFLAMMATORY MEDIATORS; ADRENAL INSUFFICIENCY; MILD HYPOTHERMIA; EXPRESSION; INFECTION; NEWBORN	Perinatal asphyxia is characterized by an inflammatory response that contributes to cerebral injury. Therapeutic hypothermia improves neurological outcome in asphyxiated term neonates, but its clear effect on the inflammatory response is unknown. A range of cytokines and cortisol levels were measured at the 6th, 12th and 24th postnatal hours in neonates with hypoxic-ischemic encephalopathy treated with standard intensive care on hypothermia (n = 10) or normothermia (n = 8). The influence of postnatal age and hypothermia on serum cytokine and cortisol levels was evaluated. Interleukin (IL)-6 levels (at 6 h of age) and IL-4 levels (at all time points) were significantly lower in asphyxiated neonates treated with hypothermia compared to normothermic neonates. Vascular endothelial growth factor levels were higher in the hypothermia than in the normothermia group at the 6th and 12th postnatal hours. IL-10 levels decreased significantly between 6 and 24 h of age in both groups. However, no difference of IL-10 levels was observed between the study groups. The duration of hypothermia before 6 hours of age correlated with lower levels of IL-6, interferon-gamma and tumor necrosis factor-alpha measured at 6 h of age and IL-10 levels at 12 h of age. Cortisol levels did not differ between the study groups, but did gradually decrease in both groups during the study period. At 6 and 24 h of age, a positive correlation was observed between cortisol and IL-10 levels. Therapeutic hypothermia may rapidly suppress and modify the immediate cytokine response to asphyxia. The correlation between cytokine levels and duration of hypothermia suggests that the earlier hypothermia is introduced, the more pronounced its beneficial immunomodulatory effect.	[Roka, Aniko; Toldi, Gergely; Lakatos, Petra; Tulassay, Tivadar; Szabo, Miklos] Semmelweis Univ, Dept Pediat 1, H-1083 Budapest, Hungary; [Beko, Gabriella] Semmelweis Univ, Dept Lab Med, H-1083 Budapest, Hungary; [Halasz, Jozsef] Vadaskert Child Psychiat Hosp, H-1021 Budapest, Hungary; [Azzopardi, Denis] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Clin Sci, London W12 0NN, England	Toldi, G (corresponding author), Semmelweis Univ, Dept Pediat 1, Bokay U 53, H-1083 Budapest, Hungary.	toldigergely@yahoo.com		Toldi, Gergely/0000-0003-0178-1243; Halasz, Jozsef/0000-0002-3040-495X	Hungarian Scientific Research Foundation (OTKA)Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [K76316]; United Kingdom Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Department of HealthEuropean Commission; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0200270, G0100126] Funding Source: researchfish	This study was supported by the Hungarian Scientific Research Foundation (OTKA Grant no. K76316). The TOBY trial was supported by the United Kingdom Medical Research Council and the Department of Health.	Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Aly H, 2006, BRAIN DEV-JPN, V28, P178, DOI 10.1016/j.braindev.2005.06.006; Aly H, 2009, BRAIN DEV-JPN, V31, P600, DOI 10.1016/j.braindev.2008.09.004; Azzopardi D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-17; Azzopardi D, 2007, SEMIN FETAL NEONAT M, V12, P303, DOI 10.1016/j.siny.2007.01.022; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; Fernandez EF, 2009, J PERINATOL, V29, pS44, DOI 10.1038/jp.2009.24; Fotopoulos S, 2001, BIOL NEONATE, V79, P213; Groschl M, 2003, CLIN CHEM, V49, P1688, DOI 10.1373/49.10.1688; Grow J, 2002, CLIN PERINATOL, V29, P585, DOI 10.1016/S0095-5108(02)00059-3; Jacobs S, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003311.PUB2; Kamath BD, 2010, J PEDIATR-US, V156, P495, DOI 10.1016/j.jpeds.2009.10.044; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Mastorakos G, 2006, ANN NY ACAD SCI, V1088, P373, DOI 10.1196/annals.1366.021; Matsui T, 2006, J NEUROSURG ANESTH, V18, P32; Matsui T, 2008, J NEUROTRAUM, V25, P709, DOI 10.1089/neu.2007.0482; Morita Y, 2009, CYTOKINE, V47, P48, DOI 10.1016/j.cyto.2009.04.004; Okazaki K, 2006, BIOL NEONATE, V89, P183, DOI 10.1159/000089180; PROCIANOY RS, 1988, ACTA PAEDIATR SCAND, V77, P671, DOI 10.1111/j.1651-2227.1988.tb10728.x; Protonotariou E, 1999, EARLY HUM DEV, V56, P31, DOI 10.1016/S0378-3782(99)00029-8; Qing M, 2006, CRIT CARE, V10, DOI 10.1186/cc4886; Quintos JB, 2010, CURR OPIN ENDOCRINOL, V17, P8, DOI 10.1097/MED.0b013e32833363cc; Roka A, 2008, PEDIATRICS, V121, pE844, DOI 10.1542/peds.2007-1987; Russwurm S, 2002, J INTERF CYTOK RES, V22, P215, DOI 10.1089/107999002753536185; Saliba E, 2001, BIOL NEONATE, V79, P224; Sarandakou A, 1998, MEDIAT INFLAMM, V7, P309, DOI 10.1080/09629359890811; Scher M, 2001, Curr Neurol Neurosci Rep, V1, P175, DOI 10.1007/s11910-001-0014-x; Seron-Ferre M, 2001, AM J OBSTET GYNECOL, V184, P1278, DOI 10.1067/mob.2001.113322; Shah PS, 2010, SEMIN FETAL NEONAT M, V15, P238, DOI 10.1016/j.siny.2010.02.003; Sipos W, 2010, RESUSCITATION, V81, P603, DOI 10.1016/j.resuscitation.2010.01.014; SZAFLARSKI J, 1995, STROKE, V26, P1093, DOI 10.1161/01.STR.26.6.1093; Xanthou M, 2002, ACTA PAEDIATR, V91, P92, DOI 10.1080/080352502320764256; Yanagawa Y, 2002, RESUSCITATION, V53, P93, DOI 10.1016/S0300-9572(01)00499-3; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016	39	20	20	0	3	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	JAN	2013	62	1					81	87		10.1007/s00011-012-0554-3			7	Cell Biology; Immunology	Cell Biology; Immunology	063NC	WOS:000313005500011	22986466				2021-06-18	
J	Wortzel, HS; Arciniegas, DB				Wortzel, Hal S.; Arciniegas, David B.			A Forensic Neuropsychiatric Approach to Traumatic Brain Injury, Aggression, and Suicide	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							FRONTAL-SUBCORTICAL CIRCUITS; POSTTRAUMATIC-STRESS-DISORDER; WHITE-MATTER HYPERINTENSITIES; LONG-TERM DISABILITY; HEAD-INJURY; PSYCHIATRIC-DISORDERS; PREFRONTAL CORTEX; UNITED-STATES; NEUROPSYCHOLOGICAL OUTCOMES; INTRACRANIAL INJURY	Aggression is a common neuropsychiatric sequela of traumatic brain injury (TBI), one which interferes with rehabilitation efforts, disrupts social support networks, and compromises optimal recovery. Aggressive behavior raises critical safety concerns, potentially placing patients and care providers in harm's way. Such aggression may be directed outwardly, manifesting as assaultive behavior, or directed inwardly, resulting in suicidal behavior. Given the frequency of TBI and posttraumatic aggression and the potential medicolegal questions surrounding the purported causal relationships between the two, forensic psychiatrists need to understand and recognize posttraumatic aggression. They also must be able to offer cogent formulations about the relative contributions of neurotrauma versus other relevant neuropsychiatric factors versus combinations of both to any specific act of violence. This article reviews the relationships between TBI and aggression and discusses neurobiological and cognitive factors that influence the occurrence and presentation of posttraumatic aggression. Thereafter, a heuristic is offered that may assist forensic psychiatrists attempting to characterize the relationships between TBI and externally or internally directed violent acts.	[Wortzel, Hal S.] Denver Vet Med Ctr, VISN MIRECC 19, Mental Illness Res Educ & Clin Ctr, Denver, CO 80220 USA; [Arciniegas, David B.] Univ Colorado, Sch Med, Denver, CO USA	Wortzel, HS (corresponding author), Denver Vet Hosp, VISN MIRECC 19, 1055 Clermont St, Denver, CO 80220 USA.	hal.wortzel@ucdenver.edu					Aguilar EJ, 2008, PROG NEURO-PSYCHOPH, V32, P1673, DOI 10.1016/j.pnpbp.2008.06.016; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anisman H, 2008, J PSYCHIATR NEUROSCI, V33, P131; ARANGO V, 1995, BRAIN RES, V688, P121, DOI 10.1016/0006-8993(95)00523-S; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Arciniegas DB, 2002, CURR TREAT OPTION NE, V2, P169; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Austin MC, 2002, NEUROSCIENCE, V114, P807, DOI 10.1016/S0306-4522(02)00289-0; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Barnfield TV, 1998, BRAIN INJURY, V12, P951, DOI 10.1080/026990598122007; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Colantonio A, 2007, BRAIN INJURY, V21, P1353, DOI 10.1080/02699050701785054; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Courville C., 1950, PATHOLOGY CENTRAL NE, V3rd; Cummings JL, 1998, J PSYCHOSOM RES, V44, P627; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Department of Veterans Affairs, 2009, CLIN PRACT GUID MAN; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Ehrlich S, 2005, J AFFECT DISORDERS, V86, P281, DOI 10.1016/j.jad.2005.01.007; Ernst C, 2009, PROG NEUROBIOL, V89, P315, DOI 10.1016/j.pneurobio.2009.09.001; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Filley CM, 2001, NEUROPSY NEUROPSY BE, V14, P1; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Gurdjian ES, 1975, IMPACT HEAD INJURY M; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Helmick K, 2006, DEFENSE VETERANS BRA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Johnston JJE, 2007, EUR J EMERG MED, V14, P130, DOI 10.1097/MEJ.0b013e32801219a6; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kerr DCR, 2007, J ABNORM CHILD PSYCH, V35, P817, DOI 10.1007/s10802-007-9132-5; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ., 1997, SEMIN CLIN NEUROPSYC, V2, P196, DOI [10.1053/SCNP00200196, DOI 10.1053/SCNP00200196]; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mann JJ, 2000, ARCH GEN PSYCHIAT, V57, P729, DOI 10.1001/archpsyc.57.8.729; Marr A, 2002, CENTRAL NERVOUS SYST; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Matsuo K, 2010, NEUROSCI LETT, V469, P75, DOI 10.1016/j.neulet.2009.11.047; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 1998, BRAIN INJURY, V12, P41; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Monkul ES, 2007, MOL PSYCHIATR, V12, P360, DOI 10.1038/sj.mp.4001919; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Pardini M, 2011, NEUROLOGY, V76, P1038, DOI 10.1212/WNL.0b013e318211c33e; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Petrides M, 2002, PRINCIPLES FRONTAL L, V1, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Pompili M, 2007, EUR ARCH PSY CLIN N, V257, P494, DOI 10.1007/s00406-007-0755-x; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Reid WH, 2008, TXB VIOLENCE ASSESSM; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Silver JM, 2005, TXB TRAUMATIC BRAIN, P259; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Skopp Nancy A, 2012, MSMR, V19, P7; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Tanielian T, 2012, INVISIBLE WOUNDS WAR; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Warnken W J, 1994, Violence Vict, V9, P153; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; YUDOFSKY SC, 1990, J CLIN PSYCHIAT, V51, P22; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	121	20	21	0	26	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2013	41	2					274	286					13	Law; Psychiatry	Government & Law; Psychiatry	185CJ	WOS:000321942500013	23771941				2021-06-18	
J	Zielinski, MD; Smoot, DL; Stubbs, JR; Jenkins, DH; Park, MS; Zietlow, SP				Zielinski, Martin D.; Smoot, Dustin L.; Stubbs, James R.; Jenkins, Donald H.; Park, Myung S.; Zietlow, Scott P.			The development and feasibility of a remote damage control resuscitation prehospital plasma transfusion protocol for warfarin reversal for patients with traumatic brain injury	TRANSFUSION			English	Article							MASSIVE TRANSFUSION; THAWED PLASMA; BLOOD; MORTALITY; RATIO; PREDICTION; MORBIDITY; PRODUCTS; SURVIVAL	Background The rapid reversal of warfarin in the setting of traumatic brain injury (TBI) has been associated with improved outcomes. Until now, remote reversal of hypocoagulable states has not been possible in the prehospital environment. This manuscript describes the development and analysis of a prehospital plasma transfusion protocol to reverse warfarin at the earliest possible moment after TBI. Study Design and Methods A retrospective review of all TBI patients receiving plasma transfusion(s) in the prehospital environment for warfarin reversal between February 2009 and September 2010 was conducted. Thawed plasma was carried on every air ambulance flight centered at the main campus. Results A total of 2836 flights carried over 2500 units of thawed plasma throughout the study period. During this time, 16 patients received prehospital plasma resuscitation, five of who were on warfarin with a concurrent TBI. The median Injury Severity Score was 17 (8.5-27.5) with a median Glasgow Coma Score of 13 (8-15) and a mortality rate of 40%. A median of 2 (1.5-2.0) units of thawed plasma and 0 (0-0) units of RBCs were transfused en route. The pretransfusion point-of-care international normalized ratio improved from 3.1 (2.3-4.0) to 1.9 (1.3-3.6) upon trauma center admission (serum sample). One hundred percent of the transported, but unused, thawed plasma underwent subsequent transfusion prior to expiration. Conclusions Remote prehospital plasma transfusions effectively reverse anticoagulation secondary to warfarin administration in TBI patients. It is feasible to transfuse thawed plasma in the prehospital setting via remote damage control techniques without increasing waste. Prospective studies are needed to determine if this practice can improve outcomes in this population.	[Zielinski, Martin D.] Mayo Clin, Div Trauma Crit Care & Gen Surg, Dept Surg, Rochester, MN 55905 USA; Mayo Clin, Dept Lab Med, Rochester, MN 55905 USA	Zielinski, MD (corresponding author), Mayo Clin, Div Trauma Crit Care & Gen Surg, Dept Surg, 200 1st St SW, Rochester, MN 55905 USA.	zielinski.martin@mayo.edu			NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08 GM093133] Funding Source: Medline		Berns K S, 1998, Air Med J, V17, P105, DOI 10.1016/S1067-991X(98)90104-3; Blackbourne LH, 2011, J TRAUMA, V70, pS1, DOI 10.1097/TA.0b013e31821b587f; Borgman MA, 2011, VOX SANG, V101, P44, DOI 10.1111/j.1423-0410.2011.01466.x; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bussey HI, 1997, PHARMACOTHERAPY, V17, P861; de Biasi AR, 2011, TRANSFUSION, V51, P1925, DOI 10.1111/j.1537-2995.2010.03050.x; Derksen M, 2010, TRANSFUSION, V50, p265A; Duchesne JC, 2008, J TRAUMA, V65, P272, DOI 10.1097/TA.0b013e31817e5166; Fatovich DM, 2009, J TRAUMA, V67, P910, DOI 10.1097/TA.0b013e3181815a26; Inaba K, 2010, ARCH SURG-CHICAGO, V145, P899, DOI 10.1001/archsurg.2010.175; Isaak E J, 2011, Immunohematology, V27, P61; Karafin MS, 2012, TRANSFUSION, V52, P2087, DOI 10.1111/j.1537-2995.2012.03574.x; Kim BD, 2012, J TRAUMA ACUTE CARE, V73, pS49, DOI 10.1097/TA.0b013e31826060ff; Krumrei NJ, 2012, J TRAUMA ACUTE CARE, V72, P211, DOI 10.1097/TA.0b013e318240507b; Maschoff P, 2009, TRANSFUSION, V49, p265A; Murad MH, 2010, TRANSFUSION, V50, P1370, DOI 10.1111/j.1537-2995.2010.02630.x; Nunez TC, 2009, J TRAUMA, V66, P346, DOI 10.1097/TA.0b013e3181961c35; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Sperry JL, 2008, J TRAUMA, V65, P986, DOI 10.1097/TA.0b013e3181878028; Spinella PC, 2009, J TRAUMA, V66, pS69, DOI 10.1097/TA.0b013e31819d85fb; Vandromme MJ, 2010, J AM COLL SURGEONS, V210, P861, DOI 10.1016/j.jamcollsurg.2010.01.012; Zielinski MD, 2010, TRANSFUSION, V50, P2762, DOI 10.1111/j.1537-2995.2010.02806.x	22	20	20	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	JAN	2013	53			1	SI		59S	64S		10.1111/trf.12037			6	Hematology	Hematology	071SR	WOS:000313615000010	23301974				2021-06-18	
J	Sellmann, T; Miersch, D; Kienbaum, P; Flohe, S; Schneppendahl, J; Lefering, R				Sellmann, Timur; Miersch, Daniel; Kienbaum, Peter; Flohe, Sascha; Schneppendahl, Johannes; Lefering, Rolf		DGU Trauma Registry	The Impact of Arterial Hypertension on Polytrauma and Traumatic Brain Injury	DEUTSCHES ARZTEBLATT INTERNATIONAL			English	Article							SUBDURAL HEMATOMAS; MANAGEMENT; COAGULOPATHY; INTUBATION; PREVENTION; DIAGNOSIS; MORTALITY	Background: Pre-hospital hypotension in trauma patients is associated with high mortality. Especially for patients with severe traumatic brain injury (TBI), arterial normotension or even hypertension (AHT) is considered an important mechanism for sustaining adequate cerebral perfusion pressure. The effect of pre-hospital arterial hypertension (pAHT) on in-hospital mortality after trauma has not been studied to date. Methods: We retrospectively analyzed data in the trauma registry of the German Society for Trauma Surgery (DGU) on all trauma patients in Germany from 1993 to 2008 who were 16 to 80 years old at the time of the trauma and had an injury severity score (ISS) of 9 or above (total, 42 500 patient data sets). For the analysis, we divided the patients into two groups: those with and those without TBI. We further divided the TBI patients into five subgroups depending on the course of their systolic blood pressure up to the moment of their arrival at the hospital. We also analyzed the patients' demographic data, patterns of injury, and accident mechanisms. Results: Trauma patients with TBI and pAHT (142 of 561 patients) had a significantly higher mortality than normotensive TBI patients (25.3% vs. 13.5%, p<0.001). Arterial hypertension that either rises or falls before the patient reaches the hospital is associated with higher in-hospital mortality. A logistical regression analysis of 5384 patients revealed that patients with pAHT (n = 561) had an odds ratio of 1.9 (95% confidence interval, 1.4 to 1.6) for death in the hospital compared to normotensive patients (n = 6020). Conclusion: Systolic blood pressure values above 160 mm Hg before arrival in the hospital worsen the outcome of trauma patients with TBI. Cite this as: Sellmann T, Miersch D, Kienbaum P, Flohe S, Schneppendahl J, Lefering R, and the DGU trauma registry: The impact of arterial hypertension on polytrauma and traumatic brain injury. Dtsch Arztebl Int 2012; 109(49): 849-56. DOI: 10.3238/arztebl.2012.0849	[Sellmann, Timur] Ev Krankenhaus Bethesda Duisburg gGmbH, Dept Anaesthesiol & Intens Care Med, Bethesda, MD USA; [Miersch, Daniel] Neuwerk Hosp Maria von den Aposteln, Div Orthoped, Monchengladbach, Germany; [Schneppendahl, Johannes] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM Cologne, Fac Hlth, Dept Med, Witten, Germany; [Kienbaum, Peter] Univ Dusseldorf, Dusseldorf Univ Hosp, Dept Anaesthesiol, Dusseldorf, Germany; [Flohe, Sascha] Univ Dusseldorf, Dusseldorf Univ Hosp, Dept Trauma & Hand Surg, Dusseldorf, Germany	Miersch, D (corresponding author), Krankenhaus Neuwerk Maria von den Aposteln, Abt Orthopad, Dunner Str 214-216, D-41066 Monchengladbach, Germany.	d.miersch@kh-neuwerk.de	Kienbaum, Peter/ABG-7729-2020	Kienbaum, Peter/0000-0002-0655-9177; Flohe, Sascha/0000-0002-8033-1242	AUC GmbH	Professor Kienbaum is a consultant for Baxter, Air Liquide, and Molnlycke. Rolf Lefering has received reimbursement of conference fees and travel costs from AUC GmbH.	Araujo João Luiz Vitorino, 2012, Rev. Col. Bras. Cir., V39, P268, DOI 10.1590/S0100-69912012000400005; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bullock MR, 2006, NEUROSURGERY, V58, P16, DOI [10.1227/01.NEU.0000210364.29290.C9, DOI 10.1227/01.NEU.0000210364.29290.C9]; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; Cushing H, 1901, B J HOPKINS HOSP, V126, P289; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Dewall Jeremy, 2010, JEMS, V35, P54, DOI 10.1016/S0197-2510(10)70095-4; Fields AM, 2009, J TRAUMA, V67, P867, DOI 10.1097/TA.0b013e3181b021c5; Franschman G, 2010, RESUSCITATION, V81, P261, DOI 10.1016/j.resuscitation.2009.11.004; Freeman WD, 2012, NEUROL CLIN, V30, P211, DOI 10.1016/j.ncl.2011.09.002; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Gennarelli T.A., 2008, ABBREVIATED INJURY S; Glaeske G, 2008, GEK ARZNEIMITTEL REP; Grandhi R, 2012, NEUROSURGERY, V71, pE559, DOI 10.1227/01.neu.0000417738.39794.95; Lier H, 2009, ANAESTHESIST, V58, P1010, DOI 10.1007/s00101-009-1595-z; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Maegele M, 2011, DTSCH ARZTEBL INT, V108, P827, DOI [10.3238/arztebl.2011.0827, 10.3238/arztebl.2011.0836a]; Mann V, 2010, ANAESTHESIST, V59, P739, DOI 10.1007/s00101-010-1771-1; Mayer SA, 2002, J INTENSIVE CARE MED, V17, P55, DOI 10.1046/j.1525-1489.2002.17201.x; Minardi J, 2009, MT SINAI J MED, V76, P138, DOI 10.1002/msj.20105; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Muhm M, 2011, ANAESTHESIST, V60, P534, DOI 10.1007/s00101-010-1846-z; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Rixen D, 2012, UNFALLCHIRURG, V115, P22, DOI 10.1007/s00113-011-2104-9; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Rowell SE, 2011, J TRAUMA, V71, pS384, DOI 10.1097/TA.0b013e3182287c8d; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Stahel PF, 2005, ORTHOPADE, V34, P852, DOI 10.1007/s00132-005-0844-3; Stahel PF, 2008, INTENS CARE MED, V34, P402, DOI 10.1007/s00134-007-0889-3; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; TEASDALE G, 1974, LANCET, V2, P81; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; Zollner C, 2008, ANAESTHESIST, V57, P729, DOI 10.1007/s00101-008-1408-9	36	20	20	0	2	DEUTSCHER AERZTE-VERLAG GMBH	COLOGNE	DIESELSTRABE 2, POSTFACH 400265, D-50859 COLOGNE, GERMANY	1866-0452			DTSCH ARZTEBL INT	Dtsch. Arztebl. Int.	DEC 7	2012	109	49					849	856		10.3238/arztebl.2012.0849			8	Medicine, General & Internal	General & Internal Medicine	057QP	WOS:000312578400002	23267410	Green Published			2021-06-18	
J	Hatta, T; Yoshizaki, K; Ito, Y; Mase, M; Kabasawa, H				Hatta, Takeshi; Yoshizaki, Kazuhito; Ito, Yasuhiro; Mase, Mitsuhito; Kabasawa, Hidehiro			RELIABILITY AND VALIDITY OF THE DIGIT CANCELLATION TEST, A BRIEF SCREEN OF ATTENTION	PSYCHOLOGIA			English	Article						screening test for attention; digit cancellation test; traumatic brain injury; test-reliability; test-validity	TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; TASK; PERFORMANCE; SYMPTOMS; SEARCH	The reliability and validity of a screening test called the D-CAT (Digit Cancellation Test) were evaluated across two studies. The D-CAT was developed to provide a highly practical and user-friendly assessment of various aspects of prefrontal cortex functioning, including information processing speed, the ability to focus attention, and executive functioning. Participants perform the D-CAT by deleting given target numbers on a sheet of randomly arranged possibilities. In Study 1, the reliability of the D-CAT was evaluated using a test-retest paradigm. Reasonably high correlations between scores on the two test sessions were obtained. In Study 2, construct validity was examined using a sample of participants with traumatic brain injury. TBI participants showed significantly lower D-CAT performance than age and education level matched healthy controls. On the basis of these findings, the D-CAT can be regarded as a reliable and valid screening test for attentional functioning.	[Hatta, Takeshi] Kansai Univ Welf Sci, Osaka, Japan; [Yoshizaki, Kazuhito] Aichi Shukutoku Univ, Dept Psychol, Nagakute, Aichi 4801197, Japan; [Ito, Yasuhiro] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Mase, Mitsuhito] Nagoya City Univ, Nagoya, Aichi, Japan; [Kabasawa, Hidehiro] Nagoya City Rehabil Ctr, Nagoya, Aichi, Japan	Yoshizaki, K (corresponding author), Aichi Shukutoku Univ, Dept Psychol, 9 Katahira, Nagakute, Aichi 4801197, Japan.	yoshizak@asu.aasa.ac.jp					Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Ballard JC, 1996, J CLIN EXP NEUROPSYC, V18, P843, DOI 10.1080/01688639608408307; BRICKENKAMP R, 1981, TEST D2 CONCENTRATIO; Cabeza R, 2003, NEUROPSYCHOLOGIA, V41, P390, DOI 10.1016/S0028-3932(02)00170-7; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Charter RA, 1999, J CLIN EXP NEUROPSYC, V21, P559, DOI 10.1076/jcen.21.4.559.889; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Egelko S, 1988, Arch Clin Neuropsychol, V3, P213, DOI 10.1016/0887-6177(88)90015-7; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fisk J. D., 1998, J INT NEUROPSYCH SOC, V7, P363; Geffen G. M., 1994, J CLIN NEUROPSYCHOLO, V3, P257; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; Geldmacher DS, 2000, AGING NEUROPSYCHOL C, V7, P194, DOI 10.1076/1382-5585(200009)7:3;1-Q;FT194; GELDMACHER DS, 1995, NEUROPSY NEUROPSY BE, V8, P259; Geldmacher DS, 1998, BRAIN COGNITION, V36, P346, DOI 10.1006/brcg.1997.0978; Hatta T., 2006, D CAT SCREENING TEST; Hatta T., 2004, J HUM ENV STUD, V2, P15; Hatta T., 2001, D CAT SCREENING TEST; Hatta T., 2009, TRAINING MANUALS COG; Ito Y, 2003, PSYCHOLOGIA, V46, P199, DOI 10.2117/psysoc.2003.199; Iwahara A., 2006, P 30 ANN M NEUR ASS, P121; Kabasawa H, 2008, B RES I NATL REHABIL, V28, P51; Leonards U, 2000, J COGNITIVE NEUROSCI, V12, P61, DOI 10.1162/089892900564073; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Mateer CA, 2000, NEUROPSYCHOLOGICAL M, P73; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mellers JDC, 1995, NEUROREPORT, V7, P109, DOI 10.1097/00001756-199512290-00026; Nagoya City Rehabilitation Center, 2003, REP NAT MOD PROJ SUP; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Rapport LJ, 1997, J CLIN EXP NEUROPSYC, V19, P655, DOI 10.1080/01688639708403751; Rasmussen X., 1995, ARCH CLIN NEUROLOGY, V10, P21; Schretlen D, 1996, CLIN NEUROPSYCHOL, V10, P80, DOI 10.1080/13854049608406666; Smith A., 1991, SYMBOL DIGIT MODALIT; Sohlberg M. M., 1989, INTRO COGNITIVE REHA; Spreen O., 1998, COMPENDIUM NEUROPSYC; Trenerry MR., 1990, VISUAL SEARCH ATTENT; UCHIYAMA CL, 1995, ARCH CLIN NEUROPSYCH, V10, P133, DOI 10.1016/0887-6177(94)E0034-M; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Weintraub S., 1988, ARCH NEUROL-CHICAGO, V44, P621; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013	42	20	21	2	23	PSYCHOLOGIA SOC	KYOTO	DEPT EDUC PSYCHOL FAC EDUC KYOTO UNIV, KYOTO, 606, JAPAN	0033-2852	1347-5916		PSYCHOLOGIA	Psychologia	DEC	2012	55	4					246	256		10.2117/psysoc.2012.246			11	Psychology, Multidisciplinary	Psychology	063BG	WOS:000312970200002		Bronze			2021-06-18	
J	Kazemi, H; Hashemi-Fesharaki, S; Razaghi, S; Najafi, M; Kolivand, PH; Kovac, S; Gorji, A				Kazemi, Hadi; Hashemi-Fesharaki, Sohrab; Razaghi, Soodeh; Najafi, Masomeh; Kolivand, Peir Hossein; Kovac, Stjepana; Gorji, Ali			Intractable epilepsy and craniocerebral trauma: Analysis of 163 patients with blunt and penetrating head injuries sustained in war	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Gunshot injury; Seizure; Metal fragments; Refractory epilepsy	POSTTRAUMATIC EPILEPSY; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; BRAIN-INJURY; RISK-FACTORS; OPERATION; RESECTION; CONFLICT	Post-traumatic epileptic seizure is a common complication of brain trauma including military injuries. We present clinical characteristics and correlates of post-traumatic epilepsy in 163 head-injured veterans suffering from intractable epilepsy due to blunt or penetrating head injuries sustained during the Iraq-Iran war. The medical records of 163 war veterans who were admitted by the Epilepsy Department of the Shefa Neuroscience Center between 2005 and 2009 were retrospectively reviewed. The mean follow-up period after developing epilepsy was 17.2 years. The time interval between the trauma and the first seizure was shorter and the seizure frequency was higher in epileptic patients suffering from penetrating head trauma. There was no difference in seizure type between epileptic patients traumatised by blunt or penetrating injury. Patients with seizure frequency of more than 30 per month mostly had simple partial seizure. Frontal and parietal semiologies were observed more frequently in patients with penetrating trauma, whereas patients with blunt trauma showed a higher temporal semiology. The most common brain lesion observed by CT scan was encephalomalacia followed by porencephaly and focal atrophy. There was no association between intracerebral retained fragments and different characteristic features of epilepsy. Patients with military brain injury carry a high risk of intractable post-traumatic epilepsy decades after their injury, and thus require a long-term medical follow-up. (c) 2012 Elsevier Ltd. All rights reserved.	[Gorji, Ali] Univ Munster, Inst Physiol 1, D-48149 Munster, Germany; [Kazemi, Hadi; Hashemi-Fesharaki, Sohrab; Razaghi, Soodeh; Najafi, Masomeh; Kolivand, Peir Hossein; Gorji, Ali] Shefa Neurosci Res Ctr, Tehran, Iran; [Kazemi, Hadi] Shahed Univ, Dept Pediat, Tehran, Iran; [Kovac, Stjepana] Univ Klinikum Munster, Klin & Poliklin Neurol, Munster, Germany	Gorji, A (corresponding author), Univ Munster, Inst Physiol 1, Robert Koch Str 27A, D-48149 Munster, Germany.	gorjial@uni-muenster.de					Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers J.F., 1996, TREATMENT EPILEPSY P, P165; Ascroft PB, 1943, LANCET, V2, P211; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CHAUDHRI KA, 1994, ACTA NEUROCHIR, V126, P120, DOI 10.1007/BF01476420; Cukiert A, 1996, CAN J NEUROL SCI, V23, P114, DOI 10.1017/S0317167100038828; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Eftekhar B, 2009, J NEUROSURG, V110, P319, DOI 10.3171/2008.4.17519; Foerster O, 1930, BRAIN, V53, P99, DOI 10.1093/brain/53.2.99; Gorji A, 2001, NEUROSCI BIOBEHAV R, V25, P455, DOI 10.1016/S0149-7634(01)00025-2; Hartzfeld P, 2008, BRIT J NEUROSURG, V22, P224, DOI 10.1080/02688690701818901; Kazemi NJ, 1997, EPILEPSIA, V38, P670, DOI 10.1111/j.1528-1157.1997.tb01236.x; Langendorf F, 1997, EPILEPSY COMPREHENSI, P2469; LEVI L, 1990, ISRAEL J MED SCI, V26, P548; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Soares HD, 1995, J NEUROSCI, V15, P8223; Splavski B, 1998, SURG NEUROL, V50, P194, DOI 10.1016/S0090-3019(98)00047-0; WEIDENHEIM KM, 1995, J NEUROPATH EXP NEUR, V54, P268, DOI 10.1097/00005072-199503000-00013; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; WILLMORE LJ, 1992, NEUROL CLIN, V10, P869	23	20	20	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	DEC	2012	43	12					2132	2135		10.1016/j.injury.2012.06.007			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	028XM	WOS:000310458600029	22763317				2021-06-18	
J	Kriz, PK; Comstock, RD; Zurakowski, D; Almquist, JL; Collins, CL; d'Hemecourt, PA				Kriz, Peter K.; Comstock, R. Dawn; Zurakowski, David; Almquist, Jon L.; Collins, Christy L.; d'Hemecourt, Pierre A.			Effectiveness of Protective Eyewear in Reducing Eye Injuries Among High School Field Hockey Players	PEDIATRICS			English	Article						girls' field hockey; eye injuries; protective eyewear; injury prevention; injury surveillance	LACROSSE; EPIDEMIOLOGY; HEAD; FACE	OBJECTIVE: To determine if injury rates differ among high school field hockey players in states that mandated protective eyewear (MPE) versus states with no protective eyewear mandate (no MPE). METHODS: We analyzed field hockey exposure and injury data collected over the 2009-2010 and 2010-2011 scholastic seasons from national and regional databases. RESULTS: Incidence of all head and face injuries (including eye injuries, concussion) was significantly higher in no-MPE states compared with MPE states, 0.69 vs 0.47 injuries per 1000 athletic exposures (incidence rate ratio [IRR] 1.47; 95% confidence interval [CI]: 1.04-2.15, P = .048). Players in the no-MPE group had a 5.33-fold higher risk of eye injury than players in the MPE group (IRR 5.33; 95% CI: 0.71-39.25, P = .104). There was no significant difference in concussion rates for the 2 groups (IRR 1.04; 95% CI: 0.63-1.75, P = .857). A larger percentage of injuries sustained by athletes in the no-MPE group required >10 days to return to activity (32%) compared with athletes in the MPE group (17%), but this difference did not reach statistical significance (P = .060). CONCLUSIONS: Among high school field hockey players, playing in a no-MPE state results in a statistically significant higher incidence of head and face injuries versus playing in an MPE state. Concussion rates among players in MPE and no-MPE states were similar, indicating that addition of protective eyewear did not result in more player-player contact injuries, challenging a perception in contact/collision sports that increased protective equipment yields increased injury rates. Pediatrics 2012;130:1069-1075	[Kriz, Peter K.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch,Hasbro Childrens Hosp, Div Sports Med,Dept Orthoped,Injury Prevent Ctr, Providence, RI 02903 USA; [Comstock, R. Dawn; Collins, Christy L.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH USA; [Comstock, R. Dawn] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Comstock, R. Dawn] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Zurakowski, David] Harvard Univ, Sch Med, Dept Anesthesia, Boston Childrens Hosp, Boston, MA 02115 USA; [d'Hemecourt, Pierre A.] Harvard Univ, Sch Med, Div Sports Med, Boston Childrens Hosp, Boston, MA USA; [Almquist, Jon L.] Fairfax Cty Publ Sch, Falls Church, VA USA	Kriz, PK (corresponding author), 2 Dudley St,Suite 200, Providence, RI 02905 USA.	peter_kriz@brown.edu			Prevent Blindness America (PBA) [701-5215]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE001172-01]; National Operating Committee on Standards for Athletic Equipment	Funded in part by Prevent Blindness America (PBA) grant 701-5215 and the Centers for Disease Control and Prevention grant R49/CE001172-01. The authors also acknowledge the generous research funding contributions of the National Operating Committee on Standards for Athletic Equipment. The content of this report is solely the responsibility of the authors and does not necessarily reflect the official views of Prevent Blindness America or the Centers for Disease Control and Prevention.	Amer Acad Pediat, 2004, OPHTHALMOLOGY, V111, P600, DOI 10.1016/j.ophtha.2003.12.027; American Optometric Association, SPORTS VIS EYE PROT; American Society for Testing and Materials International, F271309 ASTM INT; [Anonymous], 2020, HLTH PEOPL 2020; Browning DG, EYE FACE INJURIES FI; Dick R, 2007, J ATHL TRAINING, V42, P211; ELLIOTT AJ, 1984, BRIT MED J, V289, P21, DOI 10.1136/bmj.289.6436.21-a; FROME EL, 1983, BIOMETRICS, V39, P665, DOI 10.2307/2531094; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hendrickson CD, 2008, CLIN J SPORT MED, V18, P399, DOI 10.1097/JSM.0b013e318188b89d; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; International Federation of Sports Medicine, FIMS POS STAT EYE IN; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Meyers J, 2012, USA HOCKEY MAGAZ APR, V35, P26; Murtaugh K, 2001, MED SCI SPORT EXER, V33, P201; National Center for Catastrophic Sport Injury Research, 1982, 28 NAT CTR CAT SPORT; National Federation of State High School Associations, PART FIG HIST; National Federation of State High School Associations, NFHS FIELD HOCK RUL; Prevent Blindness America, PREV EYE INJ; Vinger PF, MECH PREVENTION SPOR; Yard EE, 2006, J ATHL TRAINING, V41, P441	22	20	20	0	17	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	DEC	2012	130	6					1069	1075		10.1542/peds.2012-1492			7	Pediatrics	Pediatrics	087YZ	WOS:000314802000056	23147982				2021-06-18	
J	Bushnik, T; Englander, J; Wright, J; Kolakowsky-Hayner, SA				Bushnik, Tamara; Englander, Jeffrey; Wright, Jerry; Kolakowsky-Hayner, Stephanie A.			Traumatic Brain Injury With and Without Late Posttraumatic Seizures: What Are the Impacts in the Post-Acute Phase: A NIDRR Traumatic Brain Injury Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						late posttraumatic seizures; outcomes; traumatic brain injury	QUALITY-OF-LIFE; DISABILITY RATING-SCALE; GLASGOW OUTCOME SCALE; HEAD-INJURY; RISK-FACTORS; EPILEPSY; COMMUNITY; ADULTS; SATISFACTION; INDIVIDUALS	Objective: To compare and contrast the levels of impairment, disability, and community participation of individuals with traumatic brain injury (TBI) with or without late posttraumatic seizures (LPTS). Design: Prospective survey study. Setting: Community. Participants: Two groups of 91 individuals with TBI, with and without LPTS, were enrolled in the TBI Model Systems National Database between 1989 and 2002 and interviewed at years 1, 2, and 5 postinjury. Interventions: Not applicable. Main Outcome Measures: Demographic, injury severity, productivity, and psychosocial outcomes. Results: The majority of the demographic and productivity outcomes up to 5 years postinjury were similar between individuals in the LPTS and non-LPTS groups. Both the LPTS and non-LPTS groups showed an increasing percentage of individuals who began to live alone after the first year postinjury and a decreasing percentage of individuals who were living with family members at 5 years postinjury compared with the first year post-TBI. A higher percentage of individuals in the LPTS group reported using more dependent forms of transportation such as riding with others or using public transportation. Individuals in the LPTS group had higher Disability Rating Scale scores at all time points, denoting greater functional disability, than individuals in the non-LPTS group, despite the 2 groups having similar Disability Rating Scale scores at discharge from rehabilitation. Satisfaction With Life Scale scores showed no changes over time but were significantly different between both groups at all time points, with individuals in the LPTS group reporting lower Satisfaction With Life Scale score than individuals in the non-LPTS group. Conclusions: It does appear that the development of LPTS following a TBI is associated with poorer functional and psychosocial outcomes in the first 5 years after injury. It remains to be determined whether there are other factors that also may account for these differences and that may be amenable to intervention.	[Bushnik, Tamara] NYU Langone Sch Med, Rusk Inst Rehabil Med, New York, NY 10016 USA; [Englander, Jeffrey; Wright, Jerry; Kolakowsky-Hayner, Stephanie A.] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA	Bushnik, T (corresponding author), NYU Langone Sch Med, Rusk Inst Rehabil Med, 240 E 38th St,17th Floor, New York, NY 10016 USA.	tamara.bushnik@nyumc.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Bushnik, Tamara/0000-0003-3328-257X	National Institute on Disability and Rehabilitation Research [H133A070038]	This study was funded by grants (H133A070038) from the National Institute on Disability and Rehabilitation Research.	Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Baker GA, 1997, EPILEPSIA, V38, pS1, DOI 10.1111/j.1528-1157.1997.tb04511.x; Baker GA, 1997, EPILEPSIA, V38, P353, DOI 10.1111/j.1528-1157.1997.tb01128.x; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; DICKEY W, 1993, J ROY SOC MED, V86, P566; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Jacoby A, 2008, EPILEPSY BEHAV, V12, P557, DOI 10.1016/j.yebeh.2007.11.013; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lehrner J, 1999, SEIZURE-EUR J EPILEP, V8, P88, DOI 10.1053/seiz.1999.0272; Leidy NK, 1999, NEUROLOGY, V53, P162, DOI 10.1212/WNL.53.1.162; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; O'Donoghue MF, 1998, BRAIN, V121, P317, DOI 10.1093/brain/121.2.317; O'Donoghue MF, 1999, BRIT J GEN PRACT, V49, P211; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SALINSKY MC, 1992, ELECTROEN CLIN NEURO, V83, P358, DOI 10.1016/0013-4694(92)90071-O; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Stavem K, 2000, QUAL LIFE RES, V9, P865, DOI 10.1023/A:1008993821253; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Vickrey BG, 2000, EPILEPSIA, V41, P760, DOI 10.1111/j.1528-1157.2000.tb00239.x; VITALIANO PP, 1991, PSYCHOL AGING, V6, P392, DOI 10.1037/0882-7974.6.3.392; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594	41	20	20	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					E36	E44		10.1097/HTR.0b013e318273375c			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200004	23131969				2021-06-18	
J	Chung, EM; Biko, DM; Schroeder, JW; Cube, R; Conran, RM				Chung, Ellen M.; Biko, David M.; Schroeder, Jason W.; Cube, Regino; Conran, Richard M.			From the Radiologic Pathology Archives Precocious Puberty: Radiologic-Pathologic Correlation	RADIOGRAPHICS			English	Article							SERTOLI-CELL TUMOR; CONGENITAL ADRENAL-HYPERPLASIA; PRIMARY ADRENOCORTICAL CARCINOMA; HYPOTHALAMIC-PITUITARY FUNCTION; MCCUNE-ALBRIGHT-SYNDROME; TRAUMATIC BRAIN-INJURY; NEUROFIBROMATOSIS TYPE-1; SONOGRAPHIC APPEARANCE; CLINICAL PRESENTATION; IMAGING FINDINGS	Precocious puberty represents a unique diagnostic problem in which imaging plays an important role. Development of secondary sex characteristics may result from inappropriate activation of the hypothalamic-pituitary axis with release of gonadotropin, or from gonadotropin-independent secretion of sex steroids by the adrenal glands or gonads. A variety of lesions can manifest with precocious puberty, including various central nervous system (CNS) lesions, adrenal lesions, and sex cord-stromal tumors of the testis or ovary. CNS lesions causing precocious puberty are much more common in boys than in girls and are well evaluated with brain magnetic resonance imaging. Neoplastic (hypothalamic-chiasmatic astrocytoma, suprasellar germinoma) and nonneoplastic (hypothalamic hamartoma, hydrocephalus, trauma, empty sella, infection, congenital midline anomalies) conditions may affect the function of the hypothalamic-pituitary axis. The adrenal cortex may produce sex hormones. Some adrenal cortical neoplasms (ACNs) in patients under 5 years of age are related to a mutation of the tumor suppressor gene p53 and represent a disease that is distinct from ACNs in older children and adults. Adrenal cortical hyperplasia secondary to an enzymatic defect in steroid biosynthesis causes virilization and salt wasting, which usually manifest in the neonatal period; however, milder forms of the disease may manifest in childhood. Female precocious puberty may be caused by an autonomously functioning ovarian cyst or a juvenile granulosa cell tumor of the ovary. Male precocious puberty may be caused by a sex steroid-producing Leydig or Sertoli cell tumor of the testis. Ultrasonography is the primary modality for evaluating the sex organs and may also be used to evaluate for adrenal abnormalities.	[Chung, Ellen M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Radiol & Radiol Sci, Bethesda, MD 20814 USA; [Conran, Richard M.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Pathol, Bethesda, MD 20814 USA; [Chung, Ellen M.] Amer Inst Radiol Pathol, Pediat Radiol Sect, Silver Spring, MD USA; [Biko, David M.; Schroeder, Jason W.] Walter Reed Natl Mil Med Ctr, Dept Radiol, Bethesda, MD USA; [Cube, Regino] Madigan Army Med Ctr, Dept Radiol, Tacoma, WA 98431 USA	Chung, EM (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Radiol & Radiol Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	ellen.chung@usuhs.edu			American Institute for Radiologic Pathology (AIRP); Joint Pathology Center (JPC); Uniformed Services University of the Health Sciences (USU)	Supported by the American Institute for Radiologic Pathology (AIRP), the Joint Pathology Center (JPC), and Uniformed Services University of the Health Sciences (USU).	Abdolvahabi RM, 2000, NEUROL RES, V22, P123; Acar C, 2009, UROLOGY, V73, P1165, DOI 10.1016/j.urology.2008.10.036; Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Adan L, 2000, EUR J PEDIATR, V159, P348, DOI 10.1007/s004310051285; Al-Agha OM, 2007, ARCH PATHOL LAB MED, V131, P311; Al-Alwan I, 1999, J PEDIATR-US, V135, P71, DOI 10.1016/S0022-3476(99)70330-6; Antonini SRR, 2002, J PEDIATR ENDOCR MET, V15, P1525; AVERY GR, 1991, CLIN RADIOL, V43, P260, DOI 10.1016/S0009-9260(05)80251-X; Avila NA, 1999, AM J ROENTGENOL, V172, P1003, DOI 10.2214/ajr.172.4.10587136; AVNI EF, 1993, PEDIATR RADIOL, V23, P88, DOI 10.1007/BF02012391; Bharwani N, 2011, AM J ROENTGENOL, V196, pW706, DOI 10.2214/AJR.10.5540; Binning Mandy J, 2007, Neurosurg Focus, V23, pE2; Boland GWL, 2009, AM J ROENTGENOL, V192, P956, DOI 10.2214/AJR.08.1431; Borer JG, 2000, UROL CLIN N AM, V27, P529, DOI 10.1016/S0094-0143(05)70100-2; Boyce AM, 2012, J CLIN ENDOCR METAB, V97, pE1782, DOI 10.1210/jc.2012-1791; Brauner R, 1999, CHILD NERV SYST, V15, P662, DOI 10.1007/s003810050455; Burger PC, 2007, TUMORS CENTRAL NERVO; Buzi F, 1998, ACTA PAEDIATR, V87, P1138; CACCIARI E, 1994, J CLIN ENDOCR METAB, V78, P767, DOI 10.1210/jc.78.3.767; Caoili EM, 2007, ACAD RADIOL, V14, P468, DOI 10.1016/j.acra.2007.01.009; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Cassidy FH, 2010, RADIOGRAPHICS, V30, P665, DOI 10.1148/rg.303095049; Chalumeau M, 2002, PEDIATRICS, V109, P61, DOI 10.1542/peds.109.1.61; Chemaitilly W, 2001, CLIN ENDOCRINOL, V54, P289, DOI 10.1046/j.1365-2265.2001.01229.x; COHEN HL, 1993, AM J ROENTGENOL, V160, P583, DOI 10.2214/ajr.160.3.8430559; COHEN HL, 1992, AM J ROENTGENOL, V159, P89, DOI 10.2214/ajr.159.1.1609728; Cohen HL, 2007, CAFFEYS PEDIAT DIAGN, P2456; Conkey DS, 2005, CLIN ONCOL-UK, V17, P322, DOI 10.1016/j.clon.2005.04.009; Conran RM, 2010, STOCKER DEHNERS PEDI, P911; Cronje H S, 1998, Obstet Gynecol Surv, V53, P240, DOI 10.1097/00006254-199804000-00022; DANEMAN A, 1983, PEDIATR RADIOL, V13, P11, DOI 10.1007/BF00975660; De Sanctis V, 2000, J PEDIATR ENDOCR MET, V13, P687; de Sousa G, 2008, HORM-INT J ENDOCRINO, V7, P170, DOI 10.1007/BF03401509; Debeneix C, 2001, HORM RES, V56, P12, DOI 10.1159/000048084; Defilippi C, 2006, J PEDIATR ENDOCR MET, V19, P561; Drevelangas A, 1999, EUR RADIOL, V9, P1934, DOI 10.1007/s003300050954; DUNNICK NR, 1994, RADIOL CLIN N AM, V32, P99; DUNNICK NR, 1982, J COMPUT ASSIST TOMO, V6, P978, DOI 10.1097/00004728-198210000-00020; Echevarria ME, 2008, ONCOLOGIST, V13, P690, DOI 10.1634/theoncologist.2008-0037; Falhammar H, 2012, ENDOCRINE, V41, P355, DOI 10.1007/s12020-011-9591-x; Fernandez GC, 2004, BRIT J RADIOL, V77, P521, DOI 10.1259/bjr/31653779; FISHMAN EK, 1987, AM J ROENTGENOL, V148, P531, DOI 10.2214/ajr.148.3.531; GABRILOVE JL, 1980, J UROLOGY, V124, P757, DOI 10.1016/S0022-5347(17)55652-9; Garel L, 2001, RADIOGRAPHICS, V21, P1393, DOI 10.1148/radiographics.21.6.g01nv041393; GIERKE CL, 1994, AM J ROENTGENOL, V163, P373, DOI 10.2214/ajr.163.2.8037034; Giglio M, 2003, UROL INT, V70, P205, DOI 10.1159/000068770; Gittleman AM, 2003, CLIN IMAG, V27, P221, DOI 10.1016/S0899-7071(02)00586-7; Groussin L, 2009, J CLIN ENDOCR METAB, V94, P1713, DOI 10.1210/jc.2008-2302; Grunt JA, 2004, J PEDIATR ENDOCR MET, V17, P775; Guillamo JS, 2003, BRAIN, V126, P152, DOI 10.1093/brain/awg016; HAMPER UM, 1987, AM J ROENTGENOL, V148, P915, DOI 10.2214/ajr.148.5.915; Hanson JA, 1996, PEDIATR RADIOL, V26, P794, DOI 10.1007/BF01396204; HEDLUND GL, 1994, SEMIN ULTRASOUND CT, V15, P49, DOI 10.1016/S0887-2171(05)80029-0; Herman-Giddens ME, 2004, PEDIATRICS, V113, P911, DOI 10.1542/peds.113.4.911; Hernanz-Schulman M, 2002, PEDIATR RADIOL, V32, P130, DOI 10.1007/s00247-001-0592-4; Herter LD, 2002, J ULTRAS MED, V21, P1237, DOI 10.7863/jum.2002.21.11.1237; HRICAK H, 1985, RADIOLOGY, V156, P415, DOI 10.1148/radiology.156.2.4011904; HUSEMAN CA, 1978, J PEDIATR-US, V92, P748, DOI 10.1016/S0022-3476(78)80142-5; JABRA AA, 1993, CLIN IMAG, V17, P199, DOI 10.1016/0899-7071(93)90110-9; Jou P, 2009, J UROLOGY, V181, P2299, DOI 10.1016/j.juro.2009.02.051; Kaplowitz P, 2002, PEDIATRICS, V109, P139, DOI 10.1542/peds.109.1.139; Kaplowitz PB, 1999, PEDIATRICS, V104, P936, DOI 10.1542/peds.104.4.936; KING LR, 1993, J ULTRAS MED, V12, P577, DOI 10.7863/jum.1993.12.10.577; KORNREICH L, 1995, PEDIATR RADIOL, V25, P7, DOI 10.1007/BF02020830; Kornreich L, 2001, AM J NEURORADIOL, V22, P1963; Krebs TL, 1998, RADIOGRAPHICS, V18, P1425, DOI 10.1148/radiographics.18.6.9821192; Lack EE, 2007, TUMORS ADRENAL GLAND, P161; Lack EE, 2007, TUMORS ADRENAL GLAND; Leyva-Carmona M, 2009, J PEDIAT HEMATOL ONC, V31, P304, DOI 10.1097/MPH.0b013e318196a70e; Liang L, 2002, NEURORADIOLOGY, V44, P382, DOI 10.1007/s00234-001-0752-0; LISTERNICK R, 1995, J PEDIATR-US, V127, P718, DOI 10.1016/S0022-3476(95)70159-1; Listernick R, 2007, ANN NEUROL, V61, P189, DOI 10.1002/ana.21107; LIU P, 1993, PEDIATR RADIOL, V23, P127, DOI 10.1007/BF02012404; Love S., 2008, GREENFIELDS NEUROPAT, V8th; Maixner W, 2006, CHILD NERV SYST, V22, P867, DOI 10.1007/s00381-006-0129-0; Maizlin ZV, 2004, J ULTRAS MED, V23, P959, DOI 10.7863/jum.2004.23.7.959; MASSA G, 1989, EUR J PEDIATR, V148, P742, DOI 10.1007/BF00443099; McDonnell CM, 2003, J PAEDIATR CHILD H, V39, P682, DOI 10.1046/j.1440-1754.2003.00268.x; Merke DP, 1996, ARCH DIS CHILD, V75, P269, DOI 10.1136/adc.75.4.269; Mohn A, 1999, PEDIATR NEUROSURG, V31, P316, DOI 10.1159/000028882; Naing Soe, 2007, Pediatr Endocrinol Rev, V4, P335; Ng SM, 2003, ARCH DIS CHILD, V88, P414, DOI 10.1136/adc.88.5.414; NUSSBAUM AR, 1986, RADIOLOGY, V160, P641, DOI 10.1148/radiology.160.3.3526401; Oltmann SC, 2010, J PEDIATR SURG, V45, P135, DOI 10.1016/j.jpedsurg.2009.10.021; ORSINI LF, 1984, RADIOLOGY, V153, P113, DOI 10.1148/radiology.153.1.6473771; Osborn AG, 1994, DIAGNOSTIC NEURORADI; Outwater EK, 2000, ULTRASOUND OBST GYN, V15, P365, DOI 10.1046/j.1469-0705.2000.00123.x; Outwater EK, 1998, RADIOGRAPHICS, V18, P1523, DOI 10.1148/radiographics.18.6.9821198; Paterson A, 2002, EUR RADIOL, V12, P2491, DOI 10.1007/s00330-002-1311-8; Perlman EJ, 2010, STOCKER DEHNERS PEDI, P837; PESCOVITZ OH, 1986, J PEDIATR-US, V108, P47, DOI 10.1016/S0022-3476(86)80767-3; PRANDO A, 1990, PEDIATR RADIOL, V20, P163, DOI 10.1007/BF02012962; Premkumar A, 1997, J CLIN ULTRASOUND, V25, P211, DOI 10.1002/(SICI)1097-0096(199705)25:4<211::AID-JCU10>3.0.CO;2-N; REINGES MHT, 1994, UROLOGY, V44, P540, DOI 10.1016/S0090-4295(94)80054-5; Ribeiro J, 2000, PEDIATR RADIOL, V30, P45, DOI 10.1007/s002470050013; Ricci ZJ, 2004, PEDIATR RADIOL, V34, P177, DOI 10.1007/s00247-003-1035-1; RIETH KG, 1987, AM J ROENTGENOL, V148, P1231, DOI 10.2214/ajr.148.6.1231; Rivarola MA, 2001, ACTA PAEDIATR, V90, P751, DOI 10.1080/080352501750315654; ROBBEN SGF, 1995, BRIT J RADIOL, V68, P34, DOI 10.1259/0007-1285-68-805-34; Rodriguez-Macias KA, 1999, ARCH DIS CHILD, V81, P53, DOI 10.1136/adc.81.1.53; SCHLUND JF, 1995, JMRI-J MAGN RESON IM, V5, P171, DOI 10.1002/jmri.1880050211; Scully RE, 1996, TUMORS OVARY MALDEVE; Setian N, 2002, J PEDIATR ENDOCR MET, V15, P1487; Shenoy SN, 2004, PEDIATR NEUROSURG, V40, P249, DOI 10.1159/000082302; Shin SL, 2007, AM J ROENTGENOL, V189, pW65, DOI 10.2214/AJR.07.2089; Sivasankaran Sujatha, 2009, J Pediatr Adolesc Gynecol, V22, pe114, DOI 10.1016/j.jpag.2008.08.001; SOCKALOSKY JJ, 1987, J PEDIATR-US, V110, P373, DOI 10.1016/S0022-3476(87)80497-3; Starzyk J, 2003, J PEDIATR ENDOCR MET, V16, P447; Stikkelbroeck NMML, 2003, EUR RADIOL, V13, P1597, DOI 10.1007/s00330-002-1786-3; SURRATT JT, 1991, RADIOGRAPHICS, V11, P533, DOI 10.1148/radiographics.11.4.1887110; Taffel M, 2012, RADIOL CLIN N AM, V50, P219, DOI 10.1016/j.rcl.2012.02.009; Tanaka YO, 2004, RADIOGRAPHICS, V24, pS147, DOI 10.1148/rg.24si045501; Thomas JC, 2001, J UROLOGY, V166, P2338, DOI 10.1016/S0022-5347(05)65583-8; Trivin C, 2006, CLIN ENDOCRINOL, V65, P239, DOI 10.1111/j.1365-2265.2006.02582.x; Ulbright TM, 1999, SEX CORD STROMAL TUM, P193; VANZULLI A, 1992, RADIOLOGY, V183, P425, DOI 10.1148/radiology.183.2.1561344; Vieira TC, 2007, J PEDIATR ENDOCR MET, V20, P1141; Virdis R, 2000, J PEDIATR ENDOCR MET, V13, P841; Wasniewska M, 2006, J PEDIATR ENDOCR MET, V19, P619; Wasniewska M, 2004, J PEDIATR-US, V145, P670, DOI 10.1016/j.jpeds.2004.06.083; Wieneke JA, 2003, AM J SURG PATHOL, V27, P867, DOI 10.1097/00000478-200307000-00001; WILSON CB, 1980, PEDIATRICS, V66, P767; Woodward PJ, 2002, RADIOGRAPHICS, V22, P189, DOI 10.1148/radiographics.22.1.g02ja14189	124	20	22	0	9	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0271-5333			RADIOGRAPHICS	Radiographics	NOV-DEC	2012	32	7					2071	2099		10.1148/rg.327125146			29	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	036MT	WOS:000311031100023	23150859	Bronze			2021-06-18	
J	Kokjohn, TA; Maarouf, CL; Roher, AE				Kokjohn, Tyler A.; Maarouf, Chera L.; Roher, Alex E.			Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?	ALZHEIMERS & DEMENTIA			English	Article						Alzheimer's disease; Amyloid-beta; Brain microvasculature; Brain microhemorrhages; Brain hypoperfusion	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; MILD COGNITIVE IMPAIRMENT; FLUID DRAINAGE PATHWAYS; BETA-PEPTIDE; A-BETA; PRECURSOR PROTEIN; PERFUSION SPECT; MICROVASCULAR PATHOLOGY; VENOUS THROMBOEMBOLISM	Here, we synthesize several lines of evidence supporting the hypothesis that at least one function of amyloid-beta is to serve as a part of the acute response to brain hemodynamic disturbances intended to seal vascular leakage. Given the resilient and adhesive physicochemical properties of amyloid, an abluminal hemostatic repair system might be highly advantageous, if deployed on a limited and short-term basis, in young individuals. However, in the aged, inevitable cardiovascular dysfunction combined with brain microvascular lesions may yield global chronic hypoperfusion that may lead to continuous amyloid deposition and consequential negative effects on neuronal viability. A large body of experimental evidence supports the hypothesis of an amyloid-beta rescue function gone astray. Preventing or inducing the removal of amyloid in Alzheimer's disease (AD) has been simultaneously successful and disappointing. Amyloid deposits clearly play major roles in AD, but they may not represent the preeminent factor in dementia pathogenesis. Successful application of AD preventative approaches may hinge on an accurate and comprehensive view of comorbidities, including cardiovascular disease, diabetes, and head trauma. (C) 2012 The Alzheimer's Association. All rights reserved.	[Kokjohn, Tyler A.; Maarouf, Chera L.; Roher, Alex E.] Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ USA; [Kokjohn, Tyler A.] Midwestern Univ, Dept Microbiol, Glendale, AZ USA	Roher, AE (corresponding author), Banner Sun Hlth Res Inst, Longtine Ctr Neurodegenerat Biochem, Sun City, AZ USA.	alex.roher@bannerhealth.com			National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG019795, R21 AG035078]; State of Arizona Alzheimer Disease Research Consortium; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG035078, R01AG019795] Funding Source: NIH RePORTER	This study was supported by the National Institute on Aging grants R01 AG019795 and R21 AG035078 and by the State of Arizona Alzheimer Disease Research Consortium. The authors thank Ian D. Daugs for assistance with the figures and Dr. Walter M. Kalback and Dr. Dean C. Luehrs for critical review of the manuscript.	[Anonymous], 2005, SHORT VERS LONG TERM; Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Atamna H, 2006, J ALZHEIMERS DIS, V10, P255; Atri A, 2005, NEURODEGENER DIS, V2, P305, DOI 10.1159/000092317; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2003, BRAIN RES REV, V43, P164, DOI 10.1016/S0165-0173(03)00206-6; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Barlow DE, 2010, LANGMUIR, V26, P6549, DOI 10.1021/la9041309; Belohlavek M, 2009, J ULTRAS MED, V28, P1493, DOI 10.7863/jum.2009.28.11.1493; Bishop GM, 2004, BRAIN PATHOL, V14, P448; Bishop GM, 2002, DEV NEUROSCI-BASEL, V24, P184, DOI 10.1159/000065696; Bishop GM, 2001, BRAIN RES, V907, P175, DOI 10.1016/S0006-8993(01)02303-4; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Brown WR, 2009, J NEUROL SCI, V283, P28, DOI 10.1016/j.jns.2009.02.328; Carlsson CM, 2010, J ALZHEIMERS DIS, V20, P711, DOI 10.3233/JAD-2010-100012; Chaney MO, 1998, PROTEIN ENG, V11, P761, DOI 10.1093/protein/11.9.761; Cohuet G, 2006, PHARMACOL THERAPEUT, V111, P81, DOI 10.1016/j.pharmthera.2005.09.002; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Craft S, 2007, CURR ALZHEIMER RES, V4, P147, DOI 10.2174/156720507780362137; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; de la Monte SM, 2006, J ALZHEIMERS DIS, V10, P89; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; de la Torre JC, 2004, NEUROL RES, V26, P517, DOI 10.1179/016164104225016254; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; delaTorre JC, 1997, ANN NY ACAD SCI, V826, P75; Devanand DP, 2010, AM J GERIAT PSYCHIAT, V18, P959, DOI 10.1097/JGP.0b013e3181ec8696; Dickinson GH, 2009, J EXP BIOL, V212, P3499, DOI 10.1242/jeb.029884; Dickstein DL, 2010, MT SINAI J MED, V77, P82, DOI 10.1002/msj.20155; Fagan T, 2010, LILLY HALTS IDENTITY; Feihl F, 2009, CURR HYPERTENS REP, V11, P182, DOI 10.1007/s11906-009-0033-6; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Freeman JS, 2010, J AM OSTEOPATH ASSOC, V110, pES2; GAZIANO JM, 2005, BRAUNWALDS HEART DIS, P1; Grammas P, 2004, J ALZHEIMERS DIS, V6, P275; Hanyu H, 2003, J NEUROL SCI, V209, P25, DOI 10.1016/S0022-510X(02)00456-2; HARDY JA, 1986, NEUROBIOL AGING, V7, P489, DOI 10.1016/0197-4580(86)90086-2; Henskens LHG, 2008, HYPERTENSION, V51, P62, DOI 10.1161/HYPERTENSIONAHA.107.100610; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Horani MH, 2003, CURR PHARM DESIGN, V9, P833, DOI 10.2174/1381612033455314; House E, 2004, J ALZHEIMERS DIS, V6, P291; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Imabayashi E, 2004, J NUCL MED, V45, P1450; Inoue S, 2001, INT REV CYTOL, V210, P121; Inzitari M, 2007, J NEUROL SCI, V257, P166, DOI 10.1016/j.jns.2007.01.026; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Jefferson AL, 2010, CIRCULATION, V122, P690, DOI 10.1161/CIRCULATIONAHA.109.905091; Jefferson AL, 2010, J ALZHEIMERS DIS, V20, P813, DOI 10.3233/JAD-2010-100081; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Kalaria RN, 1996, PHARMACOL THERAPEUT, V72, P193, DOI 10.1016/S0163-7258(96)00116-7; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kerchner GA, 2010, EXPERT OPIN BIOL TH, V10, P1121, DOI 10.1517/14712598.2010.493872; Kobayashi S, 2008, J NEUROL SCI, V264, P27, DOI 10.1016/j.jns.2007.07.015; Kogure D, 2000, J NUCL MED, V41, P1155; Kokjohn TA, 2009, ALZHEIMERS DEMENT, V5, P340, DOI 10.1016/j.jalz.2009.03.002; Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011; Lowenson JD, 1999, METHOD ENZYMOL, V309, P89; Luchsinger JA, 2010, J NEUROL SCI, V299, P35, DOI 10.1016/j.jns.2010.08.063; Luo F, 2010, J PHARMACOL EXP THER, V335, P580, DOI 10.1124/jpet.110.172932; Maarouf CL, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-39; Marchesi VT, 2011, FASEB J, V25, P5, DOI 10.1096/fj.11-0102ufm; MARIN J, 1995, MECH AGEING DEV, V79, P71, DOI 10.1016/0047-6374(94)01551-V; Matsuda H, 2002, EUR J NUCL MED MOL I, V29, P1502, DOI 10.1007/s00259-002-0930-2; Merkle DL, 1996, BLOOD COAGUL FIBRIN, V7, P650, DOI 10.1097/00001721-199609000-00011; Miller G, 2009, SCIENCE, V326, P1337, DOI 10.1126/science.326.5958.1338; Mooradian AD, 1997, BRAIN RES REV, V23, P210, DOI 10.1016/S0165-0173(97)00003-9; MOORADIAN AD, 1988, NEUROBIOL AGING, V9, P31, DOI 10.1016/S0197-4580(88)80013-7; Nishimura T, 2007, ANN NUCL MED, V21, P15, DOI 10.1007/BF03033995; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Paris D, 2000, NEUROBIOL AGING, V21, P183, DOI 10.1016/S0197-4580(00)82162-4; Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf; Paris D, 2010, INT J PEPT RES THER, V16, P23, DOI 10.1007/s10989-010-9198-8; Patton RL, 2006, AM J PATHOL, V169, P1048, DOI 10.2353/ajpath.2006.060269; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Raby CA, 1998, J NEUROCHEM, V71, P2505; Rhodin J, 2001, MICROCIRCULATION, V8, P207, DOI 10.1080/713774033; Robinson SR, 2009, REDOX REP, V14, P228, DOI 10.1179/135100009X12525712409931; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Roher AE, 2003, MOL MED, V9, P112, DOI 10.1007/BF03402043; Roher AE, 1999, METHOD ENZYMOL, V309, P58; Roher Alex E., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P85, DOI 10.2174/1568013033358590; Roher AE, 2011, ALZHEIMERS DEMENT, V7, P436, DOI 10.1016/j.jalz.2010.08.228; Roher AE, 2011, ALZHEIMERS DEMENT, V7, P445, DOI 10.1016/j.jalz.2010.09.002; Roher AE, 2011, J ALZHEIMERS DIS, V24, P315, DOI 10.3233/JAD-2011-101809; Roher AE, 2009, ALZHEIMERS DEMENT, V5, P18, DOI 10.1016/j.jalz.2008.10.004; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; SCHEIBEL AB, 1989, ANN MED, V21, P103, DOI 10.3109/07853898909149194; Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Spencer FA, 2006, J GEN INTERN MED, V21, P722, DOI 10.1111/j.1525-1497.2006.00458.x; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Streitparth F, 2008, RADIOLOGE, V48, P175, DOI 10.1007/s00117-006-1443-y; Strobel G., 2008, FLURIZAN POSTMORTEM; Suo Z., 2004, Current Drug Targets - Inflammation and Allergy, V3, P105, DOI 10.2174/1568010043483953; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Townsend KP, 2002, ANN NY ACAD SCI, V977, P65, DOI 10.1111/j.1749-6632.2002.tb04799.x; Turgeon VL, 1997, BRAIN RES REV, V25, P85, DOI 10.1016/S0165-0173(97)00015-5; Uro-Coste E, 2010, CLIN NEUROPATHOL, V29, P209; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; Vasileyko V, 2010, ANN NY ACAD SCI, V1207, P58, DOI 10.1111/j.1749-6632.2010.05786.x; Waldstein SR, 2008, HYPERTENSION, V51, P99, DOI 10.1161/HYPERTENSIONAHA.107.093674; Weir Dr, 2009, NATL FOOTBALL LEAGUE; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Weller RO, 2000, ANN NY ACAD SCI, V903, P110, DOI 10.1111/j.1749-6632.2000.tb06356.x; Wilcock DM, 2009, CNS NEUROL DISORD-DR, V8, P50, DOI 10.2174/187152709787601858; Wimo A, 2010, WORLD ALZHEIMER REPO; WONG GT, 2007, FDA DEEMS US ALZHEME; Wu CW, 2004, NEUROBIOL DIS, V17, P367, DOI 10.1016/j.nbd.2004.08.014; Yang Y, 2011, PROG MOL BIOL TRANSL, V99, P241, DOI 10.1016/S1877-1173(11)99006-1; Yin XL, 2010, AM J PATHOL, V176, P1600, DOI 10.2353/ajpath.2010.090406; Zlokovic BV, 2010, NAT MED, V16, P1370, DOI 10.1038/nm1210-1370; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x	129	20	20	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260			ALZHEIMERS DEMENT	Alzheimers. Dement.	NOV	2012	8	6					574	583		10.1016/j.jalz.2011.05.2429			10	Clinical Neurology	Neurosciences & Neurology	038KW	WOS:000311174600015	22047632	Green Accepted			2021-06-18	
J	Martin, RC; Triebel, K; Dreer, LE; Novack, TA; Turner, C; Marson, DC				Martin, Roy C.; Triebel, Kristen; Dreer, Laura E.; Novack, Thomas A.; Turner, Crystal; Marson, Daniel C.			Neurocognitive Predictors of Financial Capacity in Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cognitive function; financial capacity; financial decision making; head injury; traumatic brain injury	DECISION-MAKING CAPACITY; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTION; MONEY MANAGEMENT; HEAD-INJURY; COMPETENCE; DEMENTIA; RECOVERY; MODERATE	Objective: To develop cognitive models of financial capacity (FC) in patients with traumatic brain injury (TBI). Design: Longitudinal design. Setting: Inpatient brain injury rehabilitation unit. Participants: Twenty healthy controls, and 24 adults with moderate-to-severe TBI were assessed at baseline (30 days postinjury) and 6 months postinjury. Main Outcome Measures: The FC instrument (FCI) and a neuropsychological test battery. Univariate correlation and multiple regression procedures were employed to develop cognitive models of FCI performance in the TBI group, at baseline and 6-month time follow-up. Results: Three cognitive predictor models of FC were developed. At baseline, measures of mental arithmetic/working memory and immediate verbal memory predicted baseline FCI performance (R-2 = 0.72). At 6-month follow-up, measures of executive function and mental arithmetic/working memory predicted 6-month FCI performance (R-2 = 0.79), and a third model found that these 2 measures at baseline predicted 6-month FCI performance (R-2 = 0.71). Conclusions: Multiple cognitive functions are associated with initial impairment and partial recovery of FC in moderate-to-severe TBI patients. In particular, arithmetic, working memory, and executive function skills appear critical to recovery of FC in TBI. The study results represent an initial step toward developing a neurocognitive model of FC in patients with TBI.	[Marson, Daniel C.] Univ Alabama Birmingham, Dept Neurol, Sparks Ctr 650K, Birmingham, AL 35294 USA; [Martin, Roy C.; Triebel, Kristen; Turner, Crystal; Marson, Daniel C.] Univ Alabama Birmingham, Alzheimers Dis Ctr, Birmingham, AL 35294 USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA	Marson, DC (corresponding author), Univ Alabama Birmingham, Dept Neurol, Sparks Ctr 650K, 1720 7th Ave S, Birmingham, AL 35294 USA.	dmarson@uab.edu	triebel, kristen/A-6569-2019	triebel, kristen/0000-0001-9161-7847	UAB Traumatic Brain Injury Models System grant (NIDDR) [H133A980010]; related project "Medical and Financial Decision Making Following TBI"; National Institute on Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074]; National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [2RO1 AG021927]; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23 EY017327-05]; EyeSight Foundation of Alabama; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Lakeshore Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23EY017327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021927] Funding Source: NIH RePORTER	Study supported primarily by a UAB Traumatic Brain Injury Models System grant (NIDDR, H133A980010) (Novack, PI) and related project "Medical and Financial Decision Making Following TBI" (Marson, Project Leader). Other sources of support include the National Institute on Child Health and Human Development (R01HD053074) (Marson, PI), National Institute on Aging (NIA, 2RO1 AG021927 (Marson, PI), the National Eye Institute (K23 EY017327-05, Dreer PI), the EyeSight Foundation of Alabama (ESFA, Dreer PI), Research to Prevent Blindness (RPB, Dreer, PI), and Lakeshore Foundation (Dreer-Malone, Co-PIs).	Benton A, 1989, MULTILINGUAL APHASIA; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Crowe SF, 2004, ARCH CLIN NEUROPSYCH, V19, P673, DOI 10.1016/j.acn.2003.09.002; Crowe SF, 2003, NEUROPSYCHOL REHABIL, V13, P497, DOI 10.1080/09602010343000075; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dreer LE, 2012, REHABIL PSYCHOL, V57, P5, DOI 10.1037/a0025818; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Earnst KS, 2001, AGING NEUROPSYCHOL C, V8, P109, DOI 10.1076/anec.8.2.109.839; Earnst KS, 2000, J AM GERIATR SOC, V48, P919, DOI 10.1111/j.1532-5415.2000.tb06888.x; Fisk GD, 1998, BRAIN INJURY, V12, P683; Gaudette M, 2002, BRAIN INJURY, V16, P133, DOI 10.1080/02699050110102068; Heaton R., 1993, WISCONSIN CARD SORTI; Heaton R.K., 1991, COMPREHENSIVE NORMS; Hoskin K. M., 2005, PSYCHIAT PSYCHOL LAW, V12, P56, DOI [http://dx.doi.org/10.1375/pplt.2005.12.1.56, DOI 10.1375/PPLT.2005.12.1.56]; Hoskin KM, 2005, REHABIL PSYCHOL, V50, P355, DOI 10.1037/0090-5550.50.4.355; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Levin H, 1979, J NERV MENT DIS, V20, P694; LEVIN HS, 1990, NEUROBEHAVIORAL SEQU; Lillie RA, 2010, NEUROPSYCHOLOGY EVER; Mahurin RK, 2006, CLIN NEUROPSYCHOL, V20, P271, DOI 10.1080/13854040590947498; Marson D, 2001, ARCH CLIN NEUROPSYCH, V16, P754; Marson DC, 2000, ARCH NEUROL-CHICAGO, V57, P877, DOI 10.1001/archneur.57.6.877; Marson DC, 2001, AGING NEUROPSYCHOL C, V8, P164, DOI 10.1076/anec.8.3.164.827; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; Rao S., 1990, MANUAL BRIEF REPEATA; Rey A, 1964, EXAMEN CLIN PSYCHOL; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Sherod MG, 2009, J INT NEUROPSYCH SOC, V15, P258, DOI 10.1017/S1355617709090365; Smith A., 1982, SYMBOL DIGIT MODALIT; Spreen O., 1998, COMPENDIUM NEUROPSYC; TEASDALE G, 1974, LANCET, V2, P81; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Voss SE, 2004, DEMENT GERIATR COGN, V18, P207, DOI 10.1159/000079202; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wolfson D., 1993, HALSTEAD REITAN NEUR	39	20	20	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					E81	E90		10.1097/HTR.0b013e318273de49			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200008	23131973	Green Accepted			2021-06-18	
J	Turkstra, LS; Quinn-Padron, M; Johnson, JE; Workinger, MS; Antoniotti, N				Turkstra, Lyn S.; Quinn-Padron, Maura; Johnson, Jacqueline E.; Workinger, Marilyn S.; Antoniotti, Nina			In-Person Versus Telehealth Assessment of Discourse Ability in Adults With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; brain injury; communication; language; rehabilitation; telehealth; telerehabilitation	SOCIAL COMMUNICATION-SKILLS; NARRATIVE DISCOURSE; PRACTICE GUIDELINES; LANGUAGE THERAPY; TELEREHABILITATION; REHABILITATION; DISORDERS; PEOPLE; INDIVIDUALS; DIAGNOSIS	Objectives: To compare in-person versus telehealth (TH) assessment of discourse ability in adults with chronic traumatic brain injury (TBI). Design: Repeated-measures design with random order of conditions. Participants: Twenty adults withmoderate-to-severe TBI. Method: Participants completed conversation, picture description, story-generation, and procedural description tasks. Sessions were video-recorded and transcribed. Measures: Measures of productivity and quality of discourse. Results: Significant differences between conditions were not detected in this sample, and feedback from participants was positive. Conclusions: These preliminary results support the use of TH for the assessment of discourse ability in adults with TBI, at least for individuals with sufficient cognitive skills to follow TH procedures.	[Turkstra, Lyn S.; Johnson, Jacqueline E.] Univ Wisconsin, Dept Commun Disorders, Madison, WI 53706 USA; [Quinn-Padron, Maura; Workinger, Marilyn S.; Antoniotti, Nina] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA	Turkstra, LS (corresponding author), Univ Wisconsin, Dept Commun Disorders, 1975 Willow Dr, Madison, WI 53706 USA.	lsturkstra@wisc.edu			Clinical and Translational Science Award program of the National Center for Research Resources, National Institutes of Health [1UL1RR025011]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025011] Funding Source: NIH RePORTER	This work was supported by Grant 1UL1RR025011 from the Clinical and Translational Science Award program of the National Center for Research Resources, National Institutes of Health.	American Speech-Language-Hearing Association, 2010, PROF ISS TEL SPEECH; American Speech- Language- Hearing Association, 2005, SPEECH LANG PATH PRO; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Brennan DM, 2004, TELEMED J E-HEALTH, V10, P147, DOI 10.1089/1530562041641237; Brown J, 2006, ASHA LEADER; Bureau of Labor Statistics, 2011, OCC OUTL HDB 2010 20; Cherney L.R., 1998, ANAL DISCOURSE COMMU; Cherney LR, 2008, J SPEECH LANG HEAR R, V51, P1282, DOI 10.1044/1092-4388(2008/07-0206); Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Cullum CM, 2006, ASSESSMENT, V13, P385, DOI 10.1177/1073191106289065; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Darkins A, 2008, ARCH PHYS MED REHAB, V89, P182, DOI 10.1016/j.apmr.2007.07.027; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Duffy JR, 1997, MAYO CLIN PROC, V72, P1116, DOI 10.4065/72.12.1116; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Georgeadis AC, 2004, APHASIOLOGY, V18, P639, DOI 10.1080/02687030444000075; Girard P, 2007, J REHABIL RES DEV, V44, P1017, DOI 10.1682/JRRD.2006.12.0174; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hagan C, 1978, RANCHO LOS AMIGOS LE; Hengst JA, 2007, TOP LANG DISORD, V27, P37, DOI 10.1097/00011363-200701000-00005; JENNETT B, 1975, LANCET, V1, P480; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Loban W., 1976, 18 NAT COUNC TEACH E; Loh PK, 2007, J TELEMED TELECARE, V13, P90, DOI 10.1258/135763307780096159; MacWhinney B., 2000, CHILDES PROJECT TOOL CHILDES PROJECT TOOL CHILDES PROJECT TOOL CHILDES PROJECT TOOL CHILDES PROJECT CHILDES PROJECT TOOL CHILDES PROJECT TOOL CHILDES PROJECT TOOL CHILDES PROJECT TOOL; Mashima Pauline A, 2008, Telemed J E Health, V14, P1101, DOI 10.1089/tmj.2008.0080; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Nelson EL, 2006, EVAL PROGRAM PLANN, V29, P419, DOI 10.1016/j.evalprogplan.2006.02.001; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Prensky M., 2001, HORIZON, V9, P1, DOI DOI 10.1108/10748120110424816; Randolph C., 2001, REPEATABLE BATTERY A; Ricker JH, 2003, NEUROREHABILITATION, V18, P179; Ricker JH, 2002, J HEAD TRAUMA REHAB, V17, P242, DOI 10.1097/00001199-200206000-00005; Torsney K, 2003, NEUROREHABILITATION, V18, P183; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Wade J, 2003, APHASIOLOGY, V17, P1031, DOI 10.1080/02687030344000373; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Wellek S., 2010, TESTING STAT HYPOTHE; WORKINGER M S, 1992, Brain Injury, V6, P183, DOI 10.3109/02699059209029657; Workinger MS, 1995, PERSPECTIVES NEUROPH, V5, P2; World Health Organization, 2001, INT CLASS FUNCT DIS; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	49	20	20	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					424	432		10.1097/HTR.0b013e31823346fc			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200013	22190010	Green Accepted			2021-06-18	
J	Waldron-Perrine, B; McGuire, AP; Spencer, RJ; Drag, LL; Pangilinan, PH; Bieliauskas, LA				Waldron-Perrine, Brigid; McGuire, Adam P.; Spencer, Robert J.; Drag, Lauren L.; Pangilinan, Percival H.; Bieliauskas, Linas A.			The Influence of Sleep and Mood on Cognitive Functioning Among Veterans Being Evaluated for Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							POSTCONCUSSION SYNDROME; TEST-PERFORMANCE; SYMPTOMS; INSOMNIA; ADULTS	Objective: Veterans undergoing evaluation for mild traumatic brain injury commonly report insomnia, psychiatric symptoms, and cognitive dysfunction. This study examines the effects of self-reported amount of sleep and subjective sleep quality on neuropsychological test performance. Method: 262 veterans were seen for neuropsychological assessment in a Veterans Affairs traumatic brain injury clinic. All participants completed measures of depression, anxiety, and sleep satisfaction, and also estimated the number of hours they slept the night before the assessment. Factor scores of attention/concentration and memory were created using factor analyses. Data were analyzed with linear regression. Results: Depression and anxiety were significantly correlated with sleep satisfaction and predictive of cognitive ability. Both sleep satisfaction and hours slept were significantly correlated with memory, but not attention. After controlling for the effects of depression and anxiety, hours slept but not sleep satisfaction was predictive of memory test performance. Conclusions: Perceived sleep quality is heavily influenced by psychiatric symptoms; therefore, veterans' report of sleep satisfaction may merely reflect their overall level of distress. Sleep quantity, however, appears to uniquely contribute to memory performance. Thus, assessment of sleep is important and provides clinicians with useful information, especially among individuals with psychiatric comorbidities.	[Waldron-Perrine, Brigid; McGuire, Adam P.; Spencer, Robert J.; Pangilinan, Percival H.; Bieliauskas, Linas A.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA; [Drag, Lauren L.; Bieliauskas, Linas A.] Univ Michigan Hlth Syst, Dept Psychiat, Neuropsychol Sect, Ann Arbor, MI 48109 USA; [Pangilinan, Percival H.] Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA	Waldron-Perrine, B (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.			McGuire, Adam/0000-0002-4512-1207			Alapin I, 2000, J PSYCHOSOM RES, V49, P381, DOI 10.1016/S0022-3999(00)00194-X; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bower B, 2010, J SLEEP RES, V19, P323, DOI 10.1111/j.1365-2869.2009.00816.x; Castaneda AE, 2008, J AFFECT DISORDERS, V110, P36, DOI 10.1016/j.jad.2007.12.239; Chiu Hsiao-Yean, 2010, Hu Li Za Zhi, V57, P106; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Douglas KM, 2009, AUST NZ J PSYCHIAT, V43, P1105, DOI 10.3109/00048670903279887; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; Franzen PL, 2010, PSYCHIAT RES, V177, P240, DOI 10.1016/j.psychres.2009.02.011; Harvey AG, 2011, ANNU REV CLIN PSYCHO, V7, P297, DOI 10.1146/annurev-clinpsy-032210-104550; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kronholm E, 2011, J SLEEP RES, V20, P288, DOI 10.1111/j.1365-2869.2010.00899.x; Kronholm E, 2009, J SLEEP RES, V18, P436, DOI 10.1111/j.1365-2869.2009.00765.x; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lee EK, 2010, CAN J PSYCHIAT, V55, P403, DOI 10.1177/070674371005500703; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Meyers J., 1995, REY COMPLEX FIGURE T; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Neu D, 2011, PSYCHIAT RES, V189, P128, DOI 10.1016/j.psychres.2010.12.005; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Reitan R. M., 1992, TRAIL MAKING TEST MA; Rosekind MR, 2010, AM J MANAG CARE, V16, P617; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Tombaugh TN, 1996, TEST MEMORY MALINGER; Wechsler D, 2008, WAIS 4 ADM SCOR MAN; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; ZACHARY RA, 2000, SHIPLEY I LIVING SCA; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	20	20	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV	2012	177	11					1293	1301		10.7205/MILMED-D-12-00169			9	Medicine, General & Internal	General & Internal Medicine	V33OF	WOS:000209027400010	23198504	Bronze			2021-06-18	
J	Rhine, T; Wade, SL; Makoroff, KL; Cassedy, A; Michaud, LJ				Rhine, Tara; Wade, Shari L.; Makoroff, Kathi L.; Cassedy, Amy; Michaud, Linda J.			Clinical predictors of outcome following inflicted traumatic brain injury in children	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Inflicted traumatic brain injury; child abuse; outcomes	NONACCIDENTAL HEAD-INJURY; SEVERITY; HYPERGLYCEMIA; MECHANISMS; CHILDHOOD	BACKGROUND: The study aimed to determine which acute injury variables were predictors of long-term functional outcome following inflicted traumatic brain injury (iTBI). METHODS: A retrospective case review of 35 children with iTBI was performed. After controlling for age at injury and time since injury, the generalized estimation equations method was used to identify acute injury variables that were significantly related to the Glasgow Outcome Scale scores at the initial follow-up assessments. When available, functional sequelae at these and longer-term follow-ups were also examined. RESULTS: In bivariate generalized estimation equations analyses, a low Glasgow Coma Scale (GCS) eye component score, a low GCS motor component score, a low GCS verbal component score, need for neurosurgical intervention, seizures in the first week after injury, need for mechanical ventilation for more than 10 days, length of intensive care unit stay of more than 10 days, initial hyperglycemia, and neuroimaging findings of cerebral edema or loss of gray-white matter differentiation were significantly (p <= 0.05) related to having a poor outcome, as defined by their Glasgow Outcome Scale score at the initial follow-up. In multivariable analyses, considering the significant predictors while controlling for age at injury and time since injury, the presence of cerebral edema on neuroimaging (odds ratio, 27.21; 95% confidence interval, 4.40-168.22), and length of intensive care unit stay of more than 10 days (odds ratio, 21.57; 95% confidence interval, 3.09-150.48) were significantly related to having a poor outcome. CONCLUSION: Early clinical data following iTBI help predict long-term functional outcome. Further research to support these findings may help delineate acutely after injury which children with iTBI are at risk for a poor prognosis and should be more closely followed up over time. (J Trauma Acute Care Surg. 2012;73: S248-S253. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Rhine, Tara; Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Dept Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Wade, Shari L.; Makoroff, Kathi L.; Michaud, Linda J.] Univ Cincinnati, Coll Med, Cincinnati, OH USA	Rhine, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Biostat & Epidemiol, 3333 Burnet Ave,ML 3008, Cincinnati, OH 45229 USA.	tara.rhine@cchmc.org					Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; Chiaretti A, 1998, CHILD NERV SYST, V14, P455, DOI 10.1007/s003810050259; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; JENNETT B, 1975, LANCET, V1, P480; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; KLEIN M, 1971, AM J DIS CHILD, V122, P15, DOI 10.1001/archpedi.1971.02110010051005; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Kocher M S, 2000, J Am Acad Orthop Surg, V8, P10; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Morad Y, 2003, J AAPOS, P521; Nesbitt L, 2006, ACAD EMERG MED S, V13, P171; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Salehi-Had H, 2006, PEDIATRICS, V117, pE1039, DOI 10.1542/peds.2005-0811; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; SILLS JA, 1977, DEV MED CHILD NEUROL, V19, P26; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Togioka BM, 2009, J EMERG MED, V37, P98, DOI 10.1016/j.jemermed.2008.06.022	32	20	21	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2012	73			3			S248	S253		10.1097/TA.0b013e31826b0062			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	029OP	WOS:000310505500004	23026962				2021-06-18	
J	Scalzo, F; Hamilton, R; Asgari, S; Kim, S; Hu, X				Scalzo, Fabien; Hamilton, Robert; Asgari, Shadnaz; Kim, Sunghan; Hu, Xiao			Intracranial hypertension prediction using extremely randomized decision trees	MEDICAL ENGINEERING & PHYSICS			English	Article						Intracranial pressure; Intracranial hypertension; Cerebral autoregulation; Traumatic brain injury; Prediction; Forecast; Decision trees; Classification	APPROXIMATE ENTROPY; PRESSURE	Intracranial pressure (ICP) elevation (intracranial hypertension, IH) in neurocriticaI care is typically treated in a reactive fashion; it is only delivered after bedside clinicians notice prolonged ICP elevation. A proactive solution is desirable to improve the treatment of intracranial hypertension. Several studies have shown that the waveform morphology of the intracranial pressure pulse holds predictors about future intracranial hypertension and could therefore be used to alert the bedside clinician of a likely occurrence of the elevation in the immediate future. In this paper, a computational framework is proposed to predict prolonged intracranial hypertension based on morphological waveform features computed from the ICP. A key contribution of this work is to exploit an ensemble classifier method based on extremely randomized decision trees (Extra-Trees). Experiments on a representative set of 30 patients admitted for various intracranial pressure related conditions demonstrate the effectiveness of the predicting framework on ICP pulses acquired under clinical conditions and the superior results of the proposed approach in comparison to linear and AdaBoost classifiers. (c) 2011 IPEM. Published by Elsevier Ltd. All rights reserved.	[Scalzo, Fabien; Hamilton, Robert; Asgari, Shadnaz; Kim, Sunghan; Hu, Xiao] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neurosurg Neural Syst & Dynam Lab, Los Angeles, CA 90095 USA	Scalzo, F (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neurosurg Neural Syst & Dynam Lab, Los Angeles, CA 90095 USA.	fabien.scalzo@gmail.com	Scalzo, Fabien/AAM-6328-2020	Scalzo, Fabien/0000-0001-9755-8104	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS066008] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS066008, R01 NS066008-04] Funding Source: Medline		Afonso VX, 1999, IEEE T BIO-MED ENG, V46, P192, DOI 10.1109/10.740882; ALLEN R, 1983, J BIOMED ENG, V5, P5, DOI 10.1016/0141-5425(83)90073-0; Asgari S, 2009, PHYSIOL MEAS, V30, P1211, DOI 10.1088/0967-3334/30/11/006; Azzerboni B, 2002, P ANN INT IEEE EMBS, P1343; Chatterjee S., 1986, STAT SCI, V1, P379, DOI 10.1214/ss/1177013622; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; HAMILTON R, 2009, EMBC 2009 ANN INT C, P4331; Hornero R, 2005, IEEE T BIO-MED ENG, V52, P1671, DOI 10.1109/TBME.2005.855722; Hu X, 2008, PHYSIOL MEAS, V29, P459, DOI 10.1088/0967-3334/29/4/004; Hu X, 2008, MED ENG PHYS, V30, P631, DOI 10.1016/j.medengphy.2007.07.002; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; McNames J, 2002, 4 INT WORKSH BIOS IN, P303; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; PORTNOY HD, 1981, NEUROSURGERY, V9, P14, DOI 10.1227/00006123-198107000-00004; Price D, 1980, INTRACRANIAL PRESSUR, P395; Rosner Michael J., 1993, P57; Scalzo F, 2011, ARTIF INTEL IN PRESS; Scalzo F, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-61; Scalzo F, 2009, MED BIOL ENG COMPUT, V47, P967, DOI 10.1007/s11517-009-0505-5; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Swiercz M, 2000, ACTA NEUROCHIR, V142, P401, DOI 10.1007/s007010050449; Szewczykowski J, 1975, INTRACRANIAL PRESSUR, P392; Tsui F-C, 1995, P 1995 IEEE ENG MED, P1045; Turner J, 1976, INTRACRANIAL PRESSUR, P283; ZWEIG MH, 1993, CLIN CHEM, V39, P561	27	20	21	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1350-4533	1873-4030		MED ENG PHYS	Med. Eng. Phys.	OCT	2012	34	8					1058	1065		10.1016/j.medengphy.2011.11.010			8	Engineering, Biomedical	Engineering	009MB	WOS:000309028800005	22401795	Green Accepted			2021-06-18	
J	Egea-Guerrero, JJ; Gordillo-Escobar, E; Revuelto-Rey, J; Enamorado-Enamorado, J; Vilches-Arenas, A; Pacheco-Sanchez, M; Dominguez-Roldan, JM; Murillo-Cabezas, F				Egea-Guerrero, J. J.; Gordillo-Escobar, E.; Revuelto-Rey, J.; Enamorado-Enamorado, J.; Vilches-Arenas, A.; Pacheco-Sanchez, M.; Dominguez-Roldan, J. M.; Murillo-Cabezas, F.			Clinical Variables and Neuromonitoring Information (Intracranial Pressure and Brain Tissue Oxygenation) as Predictors of Brain-Death Development After Severe Traumatic Brain Injury	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	35th Annual Congress of the Italian-Society-of-Organ-Transplantation (SITO)	OCT 27-29, 2011	Rome, ITALY	Italian Soc Organ Transplantat, Cathol Univ Sch Med Policlinico A. Gemelli, Div Organ Transplantat				Background and purpose. The aim of this study was to ascertain the role of clinical variables and neuromonitoring data as predictors of brain death (BD) after severe traumatic brain injury (TBI). Patients and methods. This prospective observational study involved severe TBI patients admitted to the intensive care unit between October 2009 and May 2011. The following variables were recorded: gender, age, reference Glasgow Coma Scale after resuscitation, pupillary reactivity, prehospital hypotension and desaturation, injury severity score, computed tomography (CT) findings, intracranial hypertension, and low brain tissue oxygenation (Pti02) levels (<16 mm Hg), as well as the final result of BD. Results. Among 61 patients (86.9% males) who met the inclusion criteria, the average age was 37.69 +/- 16.44 years. Traffic accidents were the main cause of TBI (62.3%). The patients at risk of progressing to BD (14.8% of the entire cohort) were those with a mass lesion on CT (odds ratio [OR] 33.6; 95% confidence interval [CI]: 3.75-300.30; P = .002), altered pupillary reaction at admission (OR 25.5; 95% CI: 2.27-285.65; P = .009), as well low Pti02 levels on admission (OR 20.41; 95% CI: 3.52-118.33; P < .001) and during the first 24 hours of neuromonitoring (OR 20; 95% CI: 2.90-137.83; P < .001). Multivariate logistic regression showed that a low Pti02 level on admission was the best independent predictor for BD (OR 20.41; 95% CI: 3.53-118.33; P = .001). Conclusions. Clinical variables and neuromonitoring information may identify TBI patients at risk of deterioration to BD.	[Egea-Guerrero, J. J.; Gordillo-Escobar, E.; Revuelto-Rey, J.; Enamorado-Enamorado, J.; Pacheco-Sanchez, M.; Dominguez-Roldan, J. M.; Murillo-Cabezas, F.] Virgen del Rocio Univ Hosp, NeuroCrit Care Unit, Seville 41013, Spain; [Vilches-Arenas, A.] Univ Seville, Dept Prevent Med & Publ Hlth, Seville, Spain	Egea-Guerrero, JJ (corresponding author), Virgen del Rocio Univ Hosp, NeuroCrit Care Unit, Avda Manuel Siurot S-N, Seville 41013, Spain.	juanjoegea@hotmail.com	Vilches-Arenas, Angel/C-1167-2015; Dominguez-Roldan, Jose-Maria/M-1728-2016; Murillo-Cabezas, Francisco/AAO-3348-2021; IBIS, NEUROCRITICOS/C-1805-2016; Egea-Guerrero, Juan Jose/P-5080-2014	Vilches-Arenas, Angel/0000-0003-2197-3760; Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478; Revuelto-Rey, Jaume/0000-0001-8350-9555; Egea-Guerrero, Juan Jose/0000-0002-4166-313X			Figaji AA, 2010, NEUROCRIT CARE, V12, P56, DOI 10.1007/s12028-009-9298-5; Egea-Guerrero JJ, 2011, NEUROLOGY, V76, P489, DOI 10.1212/WNL.0b013e3181fe77fa; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; Munoz-Cespedes JM, 2001, REV NEUROLOGIA, V32, P351, DOI 10.33588/rn.3204.2000456; Revuelto-Rey J, 2012, MED INTENSIVA, V36, P213, DOI 10.1016/j.medin.2011.08.002; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606	6	20	20	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345			TRANSPL P	Transplant. Proc.	SEP	2012	44	7					2050	2052		10.1016/j.transproceed.2012.07.070			3	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	011ET	WOS:000309148300065	22974906				2021-06-18	
J	Gaetani, P; Revay, M; Sciacca, S; Pessina, F; Aimar, E; Levi, D; Morenghi, E				Gaetani, P.; Revay, M.; Sciacca, S.; Pessina, F.; Aimar, E.; Levi, D.; Morenghi, E.			Traumatic brain injury in the elderly: considerations in a series of 103 patients older than 70	JOURNAL OF NEUROSURGICAL SCIENCES			English	Article						Brain injuries; Aged; Anticoagulants; Sub-arachnoid hemorrhage	PREINJURY WARFARIN USE; CLOSED-HEAD INJURIES; INTRACRANIAL HEMORRHAGE; MORTALITY; AGE; ANTICOAGULATION; IMPACT; ANTIPLATELET; OUTCOMES	Aim. Mortality and morbidity due to brain injury in the elderly population is a growing clinical problem: among older patients, those >70 years have a considerably higher risk both in terms of mortality and morbidity. Thereafter, the reasons influencing outcome have not been clearly examined: in the present study we addressed these questions considering the main clinical characteristics exerting a significant impact on the outcome of patients aged > 70, with emphasis for the severity of brain injury and anticoagulant (CAW) treatments. Methods. We performed a retrospective analysis of 103 consecutive isolated head injury patients older than 70, admitted at our Department in the period November 2004-November 2009. The clinical variables considered were as follow: age, sex, type of TBI, GCS, pre-TBI use of anti-coagulants (aspirin, warfarin, clopidogrel), INR at admission (INR values were subdivided in values >1.25 as at risk for hemorrhagic events and <1.25 as normal), initial CT scan classification looking at the presence of subarachnoid hemorrhage (t-SAH) or mass lesions; the main outcome measure was the Glasgow Outcome Scale. Results. The most frequent cause of TBI was accidental fall (65%): 39 were in CAW therapies and in 36 cases the cause of falling down injury was recorded due to a sincopal event (arterial hypotension, atrial fibrillation); in the older patients an accidental fall is significantly related to the TBI, while in the patients aged 70-75 years, TBI is related to a traffic accident (P=0.002). Moreover the cause of TBI correlates with the CAW treatment, the accidental fall being significantly more frequent in patients in CAW treatment (P=0.003). Overall mortality rate is significantly related to an elevated INR class, to presence of t-SAH (16/50 patients) and subdural hematoma (26/46). Conclusion. The results of the present study show that in a population of patients aged > 70, TBI is a high risk event if patient has concurrent treatment with CAW therapies and if an accidental fall is the cause of TBI. In these cases the finding of t-SAH represents a high-risk parameter for mortality but not for morbidity.	[Gaetani, P.; Revay, M.; Sciacca, S.; Pessina, F.; Aimar, E.] IRCCS Ist Clin Humanitas, Dept Neurosurg, I-20089 Milan, Italy; [Levi, D.] Univ LU de S, Lugano, Switzerland; [Morenghi, E.] IRCCS Ist Clin Humanitas, Biostat Unit, I-20089 Milan, Italy	Gaetani, P (corresponding author), IRCCS Ist Clin Humanitas, Dept Neurosurg, Via Manzoni 56, I-20089 Milan, Italy.	neuro.gaetani@gmail.com	; Pessina, Federico/K-7198-2016	Revay, Martina/0000-0003-2270-5733; Pessina, Federico/0000-0002-8717-4999; Gaetani, Paolo/0000-0003-0662-5872			Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; AMACHER AL, 1987, NEUROSURGERY, V20, P954; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Inamasu J, 2010, NEUROL MED-CHIR, V50, P1051, DOI 10.2176/nmc.50.1051; Karni A, 2001, AM SURGEON, V67, P1098; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Williams TM, 2008, J TRAUMA, V65, P772, DOI 10.1097/TA.0b013e3181877ff7; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	18	20	20	0	5	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0390-5616			J NEUROSURG SCI	J. Neurosurg. Sci.	SEP	2012	56	3					231	237					7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	157JP	WOS:000319892700007	22854591				2021-06-18	
J	Post, A; Hoshizaki, TB; Gilchrist, M; Brien, S				Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael; Brien, Susan			Analysis of the influence of independent variables used for reconstruction of a traumatic brain injury incident	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Finite element modelling; traumatic brain injury; reconstruction; injury biomechanics; subdural hematoma	MULTIBODY DYNAMICS; HEAD; FALLS; MILD; BIOMECHANICS; MODELS	Traumatic brain injuries contribute to a high degree of morbidity and mortality in society. To study traumatic brain injuries researchers reconstruct the event using both physical and FE models. The purpose of these reconstructions is to correlate the brain deformation metric to the type of injury as a measure for prediction. These reconstructions are guided by a series of independent variables which all have influence upon the outcome variables. This research uses a combination of physical and FE modelling to quantify how independent variables such as velocity and impact vector (angle) contribute to the resulting variance in brain deformation metrics. The results indicated that using a Hybrid III neck controls the rotational acceleration response from an impact. Also, it was found that strain rate and product of strain and strain rate were more sensitive to changes in impact angle. Linear acceleration decreased with increasing impact angle, while brain deformations did not follow this trend, which suggests that peak linear acceleration may not be the only factor in the production of larger brain deformations.	[Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael] Univ Ottawa, Neurotrauma Impact Sci Lab, Ottawa, ON K1S 5S9, Canada; [Gilchrist, Michael] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland	Post, A (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, 200 Lees Ave,A-106, Ottawa, ON K1S 5S9, Canada.	apost@uottawa.ca	Gilchrist, Michael D/B-6100-2017	Gilchrist, Michael D/0000-0003-1765-429X; Post, Andrew/0000-0002-5960-5552			Brooks C, 1997, ARCH PHYS MED REH S4, V78, P26; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holbourn AHS, 1943, LANCET, V2, P438; Horgan T, 2005, THESIS U COLL DUBLIN; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kleiven S., 2001, P INT C BIOM IMP IRC, P161; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Miller RT, 1998, P 42 STAPP CAR CRASH; Nahum A. M., 1977, P 21 STAPP CAR CRASH; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Oeur A, 2011, 23 INT SOC BIOM C BR; Ommaya A, 1967, 11 P STAPP CAR CRASH, P47; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Post A., 2010, 8 C INT SPORTS ENG A; Post A, 2011, J BIOMECH IN PRESS; Post A, 2011, COMPUT METH IN PRESS; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P89, DOI 10.1243/17543371JSET34; Rousseau P, 2009, J ASTM INT, V6, P159; RUAN JS, 1994, THESIS WAYNE STATE U; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Sosin DM, 1996, BRAIN INJURY, V10, P47; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/cras.8.6.605.19261; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C., 1995, P 39 STAPP CAR CRASH, P121	32	20	20	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371			P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP-DEC	2012	226	P3-4			SI		290	298		10.1177/1754337112436629			9	Engineering, Mechanical; Sport Sciences	Engineering; Sport Sciences	999NH	WOS:000308320000018					2021-06-18	
J	Ruseckaite, R; Gabbe, B; Vogel, AP; Collie, A				Ruseckaite, R.; Gabbe, B.; Vogel, A. P.; Collie, A.			Health care utilisation following hospitalisation for transport-related injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Compensation; Road traffic injury; Hospitalization; Health service use	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; COMPENSATION; FATALITIES; SERVICES; CHILDREN; ONTARIO; COSTS	Background: Transport injuries are a substantial cause of disability and death internationally. There is little published information regarding patterns of healthcare utilisation following transport injury. Aims: To investigate patterns of in-hospital and post-discharge healthcare use following transport injury. Methods: Analysis of all accepted adult claims from the database of the transport accident compensation regulator in Victoria, Australia between 1995 and 2008. The analyses focused on injuries resulting in hospitalisation. Indicators of in-hospital and post-discharge healthcare utilisation (e. g. number of services per practitioner group) within the first 12-months were summarised. Results: More than a third (33.6%, n = 68,639) of all accepted compensable transport injuries resulted in admission to an acute care facility within 28 days of injury. In this group, the compensation authority paid for a total of 4.5 million healthcare services in the 12 months post-discharge (median of 19 services per claim). Services provided by medical practitioners were accessed by nearly all claimants (95.7%) at a median of 11 (5-26) per claimant. Less than half of claimants (46.7%) accessed paramedical or allied health services but the median number of services accessed was higher at 29 (9-82) per claimant. Conclusion: Transport-related injury cases require a substantial interaction with multiple components of the healthcare system in the year following hospital discharge. Compensation system datamay provide adetailed understanding of healthcare utilisation, a key element of injury burden. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.	[Ruseckaite, R.; Vogel, A. P.; Collie, A.] Monash Univ, Inst Safety Compensat & Recovery Res, Melbourne, Vic 3004, Australia; [Gabbe, B.; Collie, A.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia	Collie, A (corresponding author), Monash Univ, Inst Safety Compensat & Recovery Res, Level 11,499 St,Kilda Rd, Melbourne, Vic 3004, Australia.	alex.collie@monash.edu	Vogel, Adam/ABD-7685-2020; Ruseckaite, Rasa/H-4060-2014	Vogel, Adam/0000-0002-3505-2631; Ruseckaite, Rasa/0000-0002-9078-2696; Gabbe, Belinda/0000-0001-7096-7688; Collie, Alex/0000-0003-2617-9339	Transport Accident Commission (TAC); WorkSafe Victoria; National Health and Medical Research Council (NHMRC) of AustraliaNational Health and Medical Research Council of Australia	The authors would like to acknowledge the assistance provided by the Transport Accident Commission in interpreting the compensation data presented in this report. The Institute for Safety Compensation and Recovery Research (ISCRR) is partly funded by an establishment grant from the Transport Accident Commission (TAC) and WorkSafe Victoria. Dr. Gabbe's involvement in this study was supported by a National Health and Medical Research Council (NHMRC) of Australia Career Development Award.	AIHW, 1997, HLTH SERV SER, V33; AIIIW, 2009, HLTH SERV SER, V33; [Anonymous], 2009, EC COST SPINAL CORD; Boufous S, 2003, AUST NZ J PUBL HEAL, V27, P352, DOI 10.1111/j.1467-842X.2003.tb00406.x; Brown J, 2007, HEALTHC POLICY, V2; BULL JP, 1975, ACCIDENT ANAL PREV, V7, P249, DOI 10.1016/0001-4575(75)90026-3; BULL JP, 1985, ACCIDENT ANAL PREV, V17, P387, DOI 10.1016/0001-4575(85)90093-4; Butler DJ, 1999, AM FAM PHYSICIAN, V60, P524; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; D.o. Health, 2010, VICT HOSP ADM POL; Driscoll T, 2003, OCCUP ENVIRON MED, V60, P195, DOI 10.1136/oem.60.3.195; Dryden DM, 2005, J TRAUMA, V59, P441, DOI 10.1097/01.ta.0000174732.90517.df; Gabbe BJ, 2007, AUST HEALTH REV, V31, P628, DOI 10.1071/AH070628; Guilcher SJT, 2010, SPINAL CORD, V48, P45, DOI 10.1038/sc.2009.78; Harris IA, 2009, MED J AUSTRALIA, V190, P619, DOI 10.5694/j.1326-5377.2009.tb02589.x; Henley G., 2009, SERIUOS INJURY DUE L; Katz SJ, 1996, AM J PUBLIC HEALTH, V86, P520, DOI 10.2105/AJPH.86.4.520; Li L, 1998, TRENDS ROAD TRAFFIC; Littleton S, 2010, INJURY, V41, P904, DOI DOI 10.1016/J.INJURY.2010.02.011; Mayou R, 2002, PSYCHOL MED, V32, P671, DOI 10.1017/S0033291702005470; Miller RS, 2000, J TRAUMA, V48, P229, DOI 10.1097/00005373-200002000-00006; Munce SEP, 2009, SPINAL CORD, V47, P470, DOI 10.1038/sc.2008.173; Parry WR, 2009, J CLIN PATHOL, V62, P561, DOI 10.1136/jcp.2009.065318; Petersen C, 2006, BRAIN INJURY, V20, P321, DOI 10.1080/02699050500488108; Rainville J, 1997, SPINE, V22, P2016, DOI 10.1097/00007632-199709010-00016; REDELMEIER DA, 1993, J GEN INTERN MED, V8, P199, DOI 10.1007/BF02599267; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sluys K, 2005, J TRAUMA, V59, P223, DOI 10.1097/01.TA.0000173832.01547.CB; State Government of Victoria, 2009, 2008 VICT ROAD TOLL; TAC, 2009, TAC ANN REP; Vangel SJ, 2005, AM J PHYS MED REHAB, V84, P153, DOI 10.1097/01.PHM.0000154896.55045.E7; Willemse-van Son AHP, 2009, J REHABIL MED, V41, P59, DOI 10.2340/16501977-0294; Winston FK, 2004, ACCIDENT ANAL PREV, V36, P507, DOI 10.1016/S0001-4575(03)00056-3	33	20	20	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2012	43	9					1600	1605		10.1016/j.injury.2011.03.011			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	977MK	WOS:000306666100048	21466883				2021-06-18	
J	Vuille-Dit-Bille, RN; Ha-Huy, R; Stover, JF				Vuille-Dit-Bille, Raphael N.; Ha-Huy, Riem; Stover, John F.			Changes in plasma phenylalanine, isoleucine, leucine, and valine are associated with significant changes in intracranial pressure and jugular venous oxygen saturation in patients with severe traumatic brain injury	AMINO ACIDS			English	Article						Critical care; Monitoring; Neuromonitoring; Nutrition	CHAIN AMINO-ACIDS; SYSTEM L; MUSCLE; EXCHANGERS; GLUTAMATE; SJVO(2); SEPSIS; BLOOD; VEIN	Changes in plasma aromatic amino acids (AAA = phenylalanine, tryptophan, tyrosine) and branched chain amino acids (BCAA = isoleucine, leucine, valine) levels possibly influencing intracranial pressure (ICP) and cerebral oxygen consumption (SjvO(2)) were investigated in 19 sedated patients up to 14 days following severe traumatic brain injury (TBI). Compared to 44 healthy volunteers, jugular venous plasma BCAA were significantly decreased by 35% (p < 0.001) while AAA were markedly increased in TBI patients by 19% (p < 0.001). The BCAA to AAA ratio was significantly decreased by 55% (p < 0.001) which persisted during the entire study period. Elevated plasma phenylalanine was associated with decreased ICP and increased SjvO(2), while higher plasma isoleucine and leucine levels were associated with increased ICP and higher plasma leucine and valine were linked to decreased SjvO(2). The amount of enterally administered amino acids was associated with significantly increased plasma levels with the exception of phenylalanine. Contrary to the initial assumption that elevated AAA and decreased BCAA levels are detrimental, increased plasma phenylalanine levels were associated with beneficial signs in terms of decreased ICP and reduced cerebral oxygen consumption reflected by increased SjvO(2); concomitantly, elevated plasma isoleucine and leucine levels were associated with increased ICP while leucine and valine were associated with decreased SjvO(2) following severe TBI, respectively. The impact of enteral nutrition on this observed pattern must be examined prospectively to determine if higher amounts of phenylalanine should be administered to promote beneficial effects on brain metabolism and if normalization of plasma BCAA levels is without cerebral side effects.	[Vuille-Dit-Bille, Raphael N.; Ha-Huy, Riem; Stover, John F.] Univ Spital Zurich, CH-8091 Zurich, Switzerland	Stover, JF (corresponding author), Univ Spital Zurich, CH-8091 Zurich, Switzerland.	john.stover@access.uzh.ch		Vuille-dit-Bille, Raphael/0000-0002-0884-9493	Swiss National Science Foundation (SNF)Swiss National Science Foundation (SNSF); SUVA Fonds	The help of the nursing staff in collecting plasma samples is gratefully acknowledged. The study was supported by grants from the Swiss National Science Foundation (SNF) and the SUVA Fonds to JFS.	Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; ASKANAZI J, 1980, ANN SURG, V192, P78, DOI 10.1097/00000658-198007000-00014; ASKANAZI J, 1980, ANN SURG, V191, P465, DOI 10.1097/00000658-198004000-00013; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Basler T, 2002, INTENS CARE MED, V28, P293, DOI 10.1007/s00134-002-1217-6; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Blomstrand E, 2005, ACTA PHYSIOL SCAND, V185, P203, DOI 10.1111/j.1365-201X.2005.01482.x; Bohe J, 2003, J PHYSIOL-LONDON, V552, P315, DOI 10.1113/jphysiol.2003.050674; CANGIANO C, 1982, EUR J CLIN INVEST, V12, P15, DOI 10.1111/j.1365-2362.1982.tb00934.x; CHAPLIN ER, 1976, J NEUROCHEM, V26, P701, DOI 10.1111/j.1471-4159.1976.tb04440.x; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Dejong CHC, 2007, J NUTR, V137, p1579S, DOI 10.1093/jn/137.6.1579S; FEIGIN RD, 1971, AM J CLIN NUTR, V24, P329; Fernstrom JD, 2005, J NUTR, V135, p1539S, DOI 10.1093/jn/135.6.1539S; Fernstrom JD, 2000, AM J CLIN NUTR, V71, p1669S, DOI 10.1093/ajcn/71.6.1669S; Fernstrom JD, 2007, J NUTR, V137, p1539S, DOI 10.1093/jn/137.6.1539S; FISCHER JE, 1976, SURGERY, V80, P77; FREUND H, 1979, ANN SURG, V190, P571, DOI 10.1097/00000658-197911000-00003; FREUND H, 1982, ANN SURG, V196, P209, DOI 10.1097/00000658-198208000-00015; FREUND HR, 1978, ANN SURG, V188, P423, DOI 10.1097/00000658-197809000-00017; Lieberman HR, 2003, APPETITE, V40, P245, DOI 10.1016/S0195-6663(03)00010-2; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; Miyazaki T, 2003, HEPATOL RES, V27, P230, DOI 10.1016/S1386-6346(03)00242-0; Oertel MF, 2009, J CLIN NEUROSCI, V16, P1161, DOI 10.1016/j.jocn.2008.11.013; Petersen SR, 1996, J TRAUMA, V41, P687, DOI 10.1097/00005373-199610000-00015; Riggio O, 1989, Recenti Prog Med, V80, P591; Roberts LM, 2008, NEUROSCIENCE, V155, P423, DOI 10.1016/j.neuroscience.2008.06.015; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; Rossetti P, 2008, DIABETES, V57, P1905, DOI 10.2337/db08-0276; Scarna A, 2005, PSYCHOPHARMACOLOGY, V179, P761, DOI 10.1007/s00213-004-2105-2; Shikata N, 2010, AMINO ACIDS, V38, P179, DOI 10.1007/s00726-008-0226-3; STINNETT JD, 1982, ANN SURG, V195, P75, DOI 10.1097/00000658-198201001-00012; Stover J.F., 2005, EUR, V31, P308, DOI [10.1007/s00068-005-2055-3, DOI 10.1007/S00068-005-2055-3]; Stover JF, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13245; Suzuki M, 2002, J NEUROTRAUM, V19, P285, DOI 10.1089/08977150252807027; Valerio A, 2011, AGING-US, V3, P464, DOI 10.18632/aging.100322; VENTE JP, 1989, ANN SURG, V209, P57, DOI 10.1097/00000658-198901000-00009; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Vuille-Dit-Bille RN, 2011, MINERVA ANESTESIOL, V77, P870	39	20	20	1	10	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	SEP	2012	43	3					1287	1296		10.1007/s00726-011-1202-x			10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	989BV	WOS:000307536100025	22189890	Green Accepted			2021-06-18	
J	Xu, H; Zhang, SL; Tan, GW; Zhu, HW; Huang, CQ; Zhang, FF; Wang, ZX				Xu, H.; Zhang, S. L.; Tan, G. W.; Zhu, H. W.; Huang, C. Q.; Zhang, F. F.; Wang, Z. X.			REACTIVE GLIOSIS AND NEUROINFLAMMATION IN RATS WITH COMMUNICATING HYDROCEPHALUS	NEUROSCIENCE			English	Article						hydrocephalus; pathogenesis; gliosis; neuroinflammation	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; CONGENITAL HYDROCEPHALUS; ASTROCYTES; MICROGLIA; EXPRESSION; INFLAMMATION; DAMAGE; MICE; ACTIVATION	Reactive gliosis has been implicated in injury and recovery patterns associated with hydrocephalus. The roles that these mechanisms play in the pathophysiology of hydrocephalus are still not clear in terms of cytopathology and gene expression. In this paper, we investigated the relationship between reactive gliosis and neuroinflammation of hydrocephalic rats of different severity at both cellular and molecular levels. Therefore 35 adult SD (standard deviation) rats were randomly divided into the normal group (n = 5), the sham operation group (n = 5) and the model group (n = 25). Hydrocephalic rat models were induced by intraventricular injections of 3% kaolin, and the ventricular dilatation was examined by MRI (magnetic resonance imaging) at 2-week postoperation. Then the model group was subdivided into the mild group (n = 5), the moderate group (n = 7) and the severe group (n = 9) according to the degree of ventricular dilatation. While IL-18 (interlukin 18), GFAP (glial fibrillary acidic protein), and Iba-1 (ionized calcium bindingadaptor molecule-1) were detected by ELISA (enzyme-linked immunosorbent assay), RT-PCR, immunohistochemistry, Western blot and correlation analysis were conducted at the same time. According to the result comparison between the normal group and the sham operation group, the ventricle of model group was obviously enlarged (P < 0.01). The expression of GFAP and Iba-1 was increased (P < 0.05) in brain tissue of the model group and IL-18 was also increased in CSF (cerebrosinal fluid) sample of model group. It was revealed by correlation analysis that the increase was positively correlated with the severity of ventricular dilatation. Conclusion: These results indicate that gliosis and inflammation continue to rise dramatically in experimental hydrocephalus and can be regarded as the main factors of hydrocephalus. Regulating the level of gliosis and alleviating inflammation may provide new therapeutic methods of hydrocephalus. (C) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Xu, H.; Zhang, S. L.; Tan, G. W.; Zhu, H. W.; Huang, C. Q.; Zhang, F. F.; Wang, Z. X.] Xiamen Univ, Affiliate Hosp 1, Dept Neurosurg, Xiamen 361003, Fujian Province, Peoples R China	Wang, ZX (corresponding author), Xiamen Univ, Affiliate Hosp 1, Dept Neurosurg, Xiamen 361003, Fujian Province, Peoples R China.	wangzx@xmbrain.com					Aoyama Y, 2006, J NEUROSURG, V104, P332, DOI 10.3171/ped.2006.104.5.332; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Bulat M, 2011, BRAIN RES REV, V65, P99, DOI 10.1016/j.brainresrev.2010.08.002; Bush TGNP, 1999, ACTA NEUROPATHOL, V23, P297; Ciccarelli R, 2000, GLIA, V29, P202, DOI 10.1002/(SICI)1098-1136(20000201)29:3<202::AID-GLIA2>3.0.CO;2-C; Conde JR, 2006, J NEUROPATH EXP NEUR, V65, P199, DOI 10.1097/01.jnen.0000202887.22082.63; Cristina A, 2007, MOL PHARMACOL, V72, P1228, DOI 10.1124/mol.107.037127; Del Bigio MR, 2010, DEV DISABIL RES REV, V16, P16, DOI 10.1002/ddrr.94; Del Bigio MR, 2001, NEUROSURG CLIN N AM, V12, P639, DOI 10.1016/S1042-3680(18)30022-6; Deren KE, 2010, EXP NEUROL, V226, P110, DOI 10.1016/j.expneurol.2010.08.010; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Escartin C, 2008, MOL NEUROBIOL, V38, P231, DOI 10.1007/s12035-008-8043-y; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fetler L, 2005, SCIENCE, V309, P392, DOI 10.1126/science.1114852; Fukui O, 2006, BRAIN RES, V1121, P35, DOI 10.1016/j.brainres.2006.08.121; Girard S, 2009, PEDIATR NEUROL, V40, P168, DOI 10.1016/j.pediatrneurol.2008.09.016; Heales SJR, 2004, NEUROCHEM RES, V29, P513, DOI 10.1023/B:NERE.0000014822.69384.0f; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hoshi A, 2011, EXP NEUROL, V227, P89, DOI 10.1016/j.expneurol.2010.09.016; Huang TT, 2009, NEUROTHERAPEUTICS, V6, P500, DOI 10.1016/j.nurt.2009.04.008; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; Kikuchi K, 2009, BIOCHEM BIOPH RES CO, V385, P132, DOI 10.1016/j.bbrc.2009.04.041; Klarica M, 2009, NEUROSCIENCE, V158, P1397, DOI 10.1016/j.neuroscience.2008.11.041; Liao CW, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-84; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Lopes LD, 2009, EXP NEUROL, V219, P187, DOI 10.1016/j.expneurol.2009.05.015; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Mangano FT, 1998, NEUROL RES, V20, P697; Mao XY, 2006, EUR J NEUROSCI, V23, P2929, DOI 10.1111/j.1460-9568.2006.04829.x; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; McAllister James P 2nd, 2010, Cerebrospinal Fluid Res, V7, P7, DOI 10.1186/1743-8454-7-7; Michael VS, 2010, ACTA NEUROPATHOL, V119, P7; Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5; Miller JM, 2006, BRAIN RES, V1075, P36, DOI 10.1016/j.brainres.2005.12.094; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; Nagra G, 2008, AM J PHYSIOL-REG I, V294, pR1752, DOI 10.1152/ajpregu.00748.2007; Oreskovic D, 2011, PROG NEUROBIOL, V94, P238, DOI 10.1016/j.pneurobio.2011.05.005; Oreskovic D, 2010, BRAIN RES REV, V64, P241, DOI 10.1016/j.brainresrev.2010.04.006; Paul L, 2011, NEUROSURGERY, V68, P462, DOI 10.1227/NEU.0b013e3182011860; Ricci G, 2009, J BIOL PHYS, V35, P317, DOI 10.1007/s10867-009-9157-9; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Schmitz T, 2007, PEDIATR RES, V61, P722, DOI 10.1203/pdr.0b013e31805341f1; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Sival Deborah A, 2008, Cerebrospinal Fluid Res, V5, P21, DOI 10.1186/1743-8454-5-21; Slobodian Ili, 2007, Cerebrospinal Fluid Res, V4, P9, DOI 10.1186/1743-8454-4-9; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wu JM, 2009, NEUROL RES, V31, P183, DOI 10.1179/174313209X385680; Xue MZ, 2010, AM J PATHOL, V176, P1193, DOI 10.2353/ajpath.2010.090361; YAMADA H, 1992, J NEUROSURG, V76, P856, DOI 10.3171/jns.1992.76.5.0856; Yuan WH, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-19	65	20	22	0	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 30	2012	218						317	325		10.1016/j.neuroscience.2012.05.004			9	Neurosciences	Neurosciences & Neurology	058CY	WOS:000312612900030	22583796				2021-06-18	
J	Feng, JF; Gurkoff, GG; Van, KC; Song, M; Lowe, DA; Zhou, J; Lyeth, BG				Feng, Jun-feng; Gurkoff, Gene G.; Van, Ken C.; Song, Minsoo; Lowe, David A.; Zhou, Jia; Lyeth, Bruce G.			NAAG peptidase inhibitor reduces cellular damage in a model of TBI with secondary hypoxia	BRAIN RESEARCH			English	Article						Traumatic brain injury (TBI); Hypoxia; Hippocampus; Neuronal degeneration; Glutamate; N-acetylaspartylglutamate (NAAG); Astrocyte	TRAUMATIC BRAIN-INJURY; FLUID PERCUSSION INJURY; METABOTROPIC GLUTAMATE RECEPTORS; N-ACETYLASPARTYLGLUTAMATE NAAG; AMINO-ACID RELEASE; HUMAN HEAD-INJURY; NEURONAL DEGENERATION; CARBOXYPEPTIDASE-II; FLUORO-JADE; RAT	Traumatic brain injury (TBI) leads to a rapid and excessive glutamate elevation in the extracellular milieu, resulting in neuronal degeneration and astrocyte damage. Posttraumatic hypoxia is a clinically relevant secondary insult that increases the magnitude and duration of glutamate release following TBI. N-acetyl-aspartyl glutamate (NAAG), a prevalent neuropeptide in the CNS, suppresses presynaptic glutamate release by its action at the mGluR3 (a group II metabotropic glutamate receptor). However, extracellular NAAG is rapidly converted into NAA and glutamate by the catalytic enzyme glutamate carboxypeptidase U (GCPII) reducing presynaptic inhibition. We previously reported that the GCPII inhibitor ZJ-43 and its prodrug di-ester PGI-02776 reduce the deleterious effects of excessive extracellular glutamate when injected systemically within the first 30 min following injury. We now report that PGI-02776 (10 mg/kg) is neuroprotective when administered 30 min post-injury in a model of TB! plus 30 min of hypoada (FiO(2)=11%). 24 h following TBI with hypoxia, significant increases in neuronal cell death in the CA1, CA2/3, CA3c, hilus and dentate gyrus were observed in the ipsilateral hippocampus. Additionally, there was a significant reduction in the number of astrocytes in the ipsilateral CA1, CA2/3 and in the CA3c/hilus/dentate gyrus. Administration of PGI-02776 immediately following the cessation of hypoxia significantly reduced neuronal and astrocytic cell death across all regions of the hippocampus. These findings indicate that NAAG peptidase inhibitors administered post-injury can significantly reduce the deleterious effects of TBI combined with a secondary hypmdc insult. (C) 2012 Elsevier B.V. All rights reserved.	[Feng, Jun-feng; Gurkoff, Gene G.; Van, Ken C.; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Feng, Jun-feng] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200027, Peoples R China; [Song, Minsoo; Lowe, David A.] PsychoGenics Inc, Tarrytown, NY 10591 USA; [Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Gurkoff, Gene G.] Univ Calif Davis, NSF Ctr Biophon & Sci Technol, Sacramento, CA 95817 USA	Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1 Shields Ave, Davis, CA 95616 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS61352, NS29995]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R43NS061352, R01NS029995] Funding Source: NIH RePORTER	This research was supported by NIH NS61352 (JZ) and NIH NS29995 (BGL).	Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Bauman RA, 2000, J NEUROTRAUM, V17, P679, DOI 10.1089/089771500415427; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Bzdega T, 2004, J NEUROCHEM, V89, P627, DOI 10.1111/j.1471-4159.2004.02361.x; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Feng JF, 2011, BRAIN RES, V1395, P62, DOI 10.1016/j.brainres.2011.04.022; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Koura SS, 1998, ACT NEUR S, V71, P244; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Luthi-Carter R, 1998, BRAIN RES, V795, P341, DOI 10.1016/S0006-8993(98)00244-3; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Olszewski RT, 2004, J NEUROCHEM, V89, P876, DOI 10.1111/j.1471-4159.2004.02358.x; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Sanabria ERG, 2004, J NEUROPHYSIOL, V91, P182, DOI 10.1152/jn.00465.2003; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schweitzer C, 2000, NEUROPHARMACOLOGY, V39, P1700, DOI 10.1016/S0028-3908(99)00265-8; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Tsukamoto T, 2007, DRUG DISCOV TODAY, V12, P767, DOI 10.1016/j.drudis.2007.07.010; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Wroblewska B, 2006, ADV EXP MED BIOL, V576, P317; Wroblewska B, 1998, GLIA, V24, P172, DOI 10.1002/(SICI)1098-1136(199810)24:2<172::AID-GLIA2>3.0.CO;2-6; Xi ZX, 2002, J PHARMACOL EXP THER, V300, P162, DOI 10.1124/jpet.300.1.162; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	50	20	21	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 21	2012	1469						144	152		10.1016/j.brainres.2012.06.021			9	Neurosciences	Neurosciences & Neurology	998UE	WOS:000308265100015	22750589	Green Accepted			2021-06-18	
J	Feyen, BFE; Sener, S; Jorens, PG; Menovsky, T; Maas, AIR				Feyen, B. F. E.; Sener, S.; Jorens, P. G.; Menovsky, T.; Maas, A. I. R.			Neuromonitoring in traumatic brain injury	MINERVA ANESTESIOLOGICA			English	Article						Brain injuries; Monitoring; Intensive Care Unit	CEREBRAL PERFUSION-PRESSURE; TISSUE OXYGEN-TENSION; INTRACRANIAL-PRESSURE; BLOOD-FLOW; CEREBROSPINAL-FLUID; HEAD-INJURY; AUTOREGULATION; REACTIVITY; GLUCOSE; MICRODIALYSIS	Current approaches to monitoring in severe traumatic brain injury (TBI) include a wide array of modalities, providing insight into pressure parameters, oxygenation, perfusion, electrophysiology and metabolism of the brain. The intent of "multimodality monitoring" is to obtain a better understanding of what is going on within the brain of an individual patient in order to target treatment more appropriately,. In this review we highlight the current status of neuromonitoring for TBI with a specific focus on how advanced analysis and integration of these parameters may be used to implement more personalized treatment approaches. In particular, combining information from different parameters and performing dynamic testing offers the potential to better understand the pathophysiological mechanisms active in the brain of a particular patient. Rather than persisting in a standardized "one size fits all" approach to therapy or continuing down the separate tracts of goal directed therapy, we suggest to think more in terms of "individualized therapeutic strategies" more focused on the specific requirements of each patient. Given the considerable data overload in multimodality monitoring and the complexity in interpretation of signals from multiple sources, specific attention needs to be directed to data processing and user-friendly displays. Intense collaboration and interaction between clinicians, basic researchers, IT-experts, nurses and industry will be required to further advance the fields towards more personalized approaches. (Minerva Anestesiol 2012;78:949-58)	[Feyen, B. F. E.; Sener, S.; Menovsky, T.; Maas, A. I. R.] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Feyen, B. F. E.; Sener, S.; Jorens, P. G.; Menovsky, T.; Maas, A. I. R.] Univ Antwerp, B-2020 Antwerp, Belgium; [Jorens, P. G.] Univ Antwerp Hosp, Dept Intens Care Med, Antwerp, Belgium	Maas, AIR (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	andrew.maas@uza.be	Maas, Andrew IR/C-5584-2013	Maas, Andrew IR/0000-0003-1612-1264	IWT-TBMInstitute for the Promotion of Innovation by Science and Technology in Flanders (IWT) [80660]	The work of the authors on multimodality monitoring was supported by a grant from the IWT-TBM funding: IWT project number 80660: "Individualized Targeted Management in Neurocritical Care".	Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P103, DOI 10.1111/j.1399-6576.1995.tb04285.x; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Bechir M, 2010, MINERVA ANESTESIOL, V76, P896; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Bohman LE, 2011, NEUROCRIT CARE, V14, P361, DOI 10.1007/s12028-011-9526-7; Bouras TIM, 2011, J NEUROTRAUMA; Brain Trauma Foundation, 2001, J NEUROTRAUMA S2, V51, pS1; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 2007, J NEUROTRAUMA SUPPL, V24, P1; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Chieregato A, 2003, J NEUROL NEUROSUR PS, V74, P784, DOI 10.1136/jnnp.74.6.784; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; GUILLAUME J, 1951, REV NEUROL, V84, P131; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kim DH, 2006, NEUROCRIT CARE, V4, P83, DOI 10.1385/NCC:4:1:083; Kim MN, 2010, NEUROCRIT CARE, V12, P173, DOI 10.1007/s12028-009-9305-x; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Longhi L, 2002, ACT NEUR S, V81, P315; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, INTENS CARE MED, V36, P1283, DOI 10.1007/s00134-010-1921-6; Magnoni S, 2011, BRAIN; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Miller JD, 1972, INTRACRANIAL PRESSUR, P270; Nangunoori R, NEUROCRIT CARE; Owen-Reece H, 1999, BRIT J ANAESTH, V82, P418, DOI 10.1093/bja/82.3.418; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahuquillo J, 2008, EUR J ANAESTH, V25, P83, DOI 10.1017/S0265021507003353; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stocchetti N, 2010, CRIT CARE MED, V38, P318, DOI 10.1097/CCM.0b013e3181b9d5ac; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 2008, CRIT CARE, V12, DOI 10.1186/cc6986; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wong GKC, 2010, J NEUROL NEUROSUR PS, V81, P1064, DOI 10.1136/jnnp.2009.198523; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388	71	20	20	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	AUG	2012	78	8					949	958					10	Anesthesiology; Critical Care Medicine	Anesthesiology; General & Internal Medicine	010FN	WOS:000309080200012	22643541				2021-06-18	
J	Mo, SJ; Zhong, Q; Zhou, YF; Deng, DB; Zhang, XQ				Mo, Shi-Jing; Zhong, Qian; Zhou, Yan-Fang; Deng, David B.; Zhang, Xiu-Quan			Bone marrow-derived mesenchymal stem cells prevent the apoptosis of neuron-like PC12 cells via erythropoietin expression	NEUROSCIENCE LETTERS			English	Article						Bone marrow-derived mesenchymal stem cells; PC12 cells; Erythropoietin; Apoptosis; Neuronal stress	TRAUMATIC BRAIN-INJURY; SIGNALING PATHWAY; MECHANISMS; PROTECTION; HYPOXIA; ACTIVATION; LINES	It is known that bone marrow-derived mesenchymal stem cells (BM-MSCs) are able to improve neuronal function through secretion of trophic factors in animal models of middle cerebral artery occlusion (MCAo). In this study, we demonstrated that incubation of BM-MSCs protects PC12 cells against apoptosis induced by CoCl2 via the production of erythropoietin (EPO). Addition of CoCl2 to BM-MSCs cultures induced the expression of EPO in a time-dependent manner. Additionally, BM-MSCs co-culture protected PC12 cells against apoptosis induced by CoCl2 in a ratio-dependent manner. To explore whether expression of EPO induced by CoCl2 is required for BM-MSCs-mediated cytoprotection, we transfected BM-MSCs with EPO small interfering RNA (siRNA). Knocking-down EPO abrogated increases in EPO expression induced by CoCl2, and the cytoprotective effect of BM-MSCs. Reverse transcriptase polymerase chain reaction results showed that EPO siRNA reversed upregulation of Bcl-2, BcI-X-L expression and downregulation of Bax. Bak, caspase-9, and caspase-3 expression. Our results revealed that the protective effect of BM-MSCs against PC12 cell apoptosis induced by CoCl2 might be dependent on EPO expression, at least in part, via the regulation of Bcl-2 family members and caspases. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Mo, Shi-Jing; Zhou, Yan-Fang; Deng, David B.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Guangzhou 510089, Guangdong, Peoples R China; [Zhong, Qian] Sun Yat Sen Univ, Dept Res Lab, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China; [Deng, David B.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Translat Med Lab,Affiliated Hosp 1, Guangzhou 510089, Guangdong, Peoples R China; [Zhang, Xiu-Quan] Univ Utah, Dept Surg, Salt Lake City, UT 84132 USA	Deng, DB (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Translat Med Lab,Affiliated Hosp 1, Guangzhou 510089, Guangdong, Peoples R China.	dengyub@mail.sysu.edu.cn			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30973093, 801171711]; Ministry of Education Fund for the Doctoral [01711100480]; Natural Science Foundation of Guangdong Province in ChinaNational Natural Science Foundation of Guangdong Province [2009B050200010]	This work was financially supported by the Natural Science Foundation of China (Nos. 30973093, 801171711), Ministry of Education Fund for the Doctoral (No. 01711100480) and the Natural Science Foundation of Guangdong Province in China (No. 2009B050200010).	Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.3.CO;2-8; Bin Deng Y, 2010, NEUROL RES, V32, P148, DOI 10.1179/174313209X414434; Crispo JAG, 2010, CAN J PHYSIOL PHARM, V88, P429, DOI [10.1139/Y09-137, 10.1139/y09-137]; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; GOLDBERG MA, 1987, P NATL ACAD SCI USA, V84, P7972, DOI 10.1073/pnas.84.22.7972; Guo LX, 2009, CHINESE MED J-PEKING, V122, P2886, DOI 10.3760/cma.j.issn.0366-6999.2009.23.016; Hillion JA, 2005, J CEREBR BLOOD F MET, V25, P154, DOI 10.1038/sj.jcbfm.9600003; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Jin W, 2011, J TRAUMA, V71, P680, DOI 10.1097/TA.0b013e3181f6b984; Jung JY, 2007, LIFE SCI, V80, P1355, DOI 10.1016/j.lfs.2006.11.033; Li G, 2008, NEUROSCI LETT, V442, P143, DOI 10.1016/j.neulet.2008.07.007; Lu YR, 2010, CELL BIOCHEM FUNCT, V28, P637, DOI 10.1002/cbf.1701; Lykissas MG, 2007, CLIN NEUROL NEUROSUR, V109, P639, DOI 10.1016/j.clineuro.2007.05.013; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Minano A, 2008, J NEUROSCI RES, V86, P1734, DOI 10.1002/jnr.21633; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pereira WO, 2011, SCAND J IMMUNOL, V73, P401, DOI 10.1111/j.1365-3083.2011.02513.x; POLAK M, 1993, P NATL ACAD SCI USA, V90, P5781, DOI 10.1073/pnas.90.12.5781; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Tang XQ, 2005, BRAIN RES, V1057, P57, DOI 10.1016/j.brainres.2005.07.072; van der Kooij MA, 2008, BRAIN RES REV, V59, P22, DOI 10.1016/j.brainresrev.2008.04.007; Wang XF, 2010, LEUKEMIA RES, V34, P1325, DOI 10.1016/j.leukres.2010.05.006; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166; Wenger RH, 1998, INT J MOL MED, V2, P317; Wu Y, 2007, APOPTOSIS, V12, P1365, DOI 10.1007/s10495-007-0065-9; Zaman K, 1999, J NEUROSCI, V19, P9821; Zhong Q., 2012, STEM CELLS DEV	27	20	27	0	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 1	2012	522	2					92	97		10.1016/j.neulet.2012.06.002			6	Neurosciences	Neurosciences & Neurology	982IG	WOS:000307035800003	22698588				2021-06-18	
J	Pal, D; Gupta, RK; Agarwal, S; Yadav, A; Ojha, BK; Awasthi, A; Rathore, RKS; Pandey, CM; Narayana, PA				Pal, Deepa; Gupta, Rakesh K.; Agarwal, Shruti; Yadav, Abhishek; Ojha, Bal K.; Awasthi, Ashish; Rathore, Ram K. S.; Pandey, Chandra M.; Narayana, Ponnada A.			Diffusion tensor tractography indices in patients with frontal lobe injury and its correlation with neuropsychological tests	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Tractography; Frontal lobe injury; Fractional anisotropy; Mean diffusivity; Neuropsychological test	TRAUMATIC BRAIN-INJURY; AXONAL INJURY; WHITE-MATTER; CORPUS-CALLOSUM; HEAD-INJURIES; MILD; SEQUELAE; STATE; NEUROPATHOLOGY; DEGENERATION	Objectives: Diffusion tensor tractography (DTT) was performed to quantify diffuse axonal injury (DAI) in major white matter (WM) fiber bundles (FBs) of patients with frontal lobe injury and to correlate these changes with neuropsychological tests (NPT) at 6 month follow-up. Patients and Methods: DTT was performed in 21 patients with moderate traumatic brain injury (TBI) within week and after 6 month follow-up, and in controls. DTI indices were calculated from the entire FBs in patients as well as controls. Bonferroni multiple comparisons Post hoc test was performed for determining the changes in DTI indices. Paired t-test was performed between DTI indices at baseline and follow-up. Pearson's correlation was performed between NPT scores and DTI indices. Results: Significant changes in DTI indices were observed in some of the FBs as compared to controls which incompletely recovered at 6 month follow-up. DTI indices of different WM FBs correlated significantly with some of the NPT. Conclusion: We conclude that DTT based quantification helps in assessment of DAI in patients with moderate frontal lobe injury. Some of the FBs recover partially at 6 month follow-up and correlate with NPT scores. (C) 2011 Elsevier B.V. All rights reserved.	[Gupta, Rakesh K.] Sanjay Gandhi Postgrad Inst Med Sci, MRI Sect, Dept Radiodiag, Lucknow 226014, Uttar Pradesh, India; [Awasthi, Ashish; Pandey, Chandra M.] Sanjay Gandhi Postgrad Inst Med Sci, Dept Biostat, Lucknow 226014, Uttar Pradesh, India; [Agarwal, Shruti; Rathore, Ram K. S.] Indian Inst Technol, Dept Math & Stat, Kanpur 208016, Uttar Pradesh, India; [Ojha, Bal K.] Chhatrapati Shahuji Maharaj Med Univ, Dept Neurosurg, Lucknow, Uttar Pradesh, India; [Narayana, Ponnada A.] Univ Texas Med Sch, Dept Diagnost & Intervent Imaging, Houston, TX USA	Gupta, RK (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, MRI Sect, Dept Radiodiag, Lucknow 226014, Uttar Pradesh, India.	rgupta@sgpgi.ac.in	Awasthi, Ashish/Y-5915-2019; Awasthi, Ashish/P-3966-2018	Awasthi, Ashish/0000-0002-9308-9782; Awasthi, Ashish/0000-0002-9308-9782; Agarwal, Shruti/0000-0003-0902-5354	Indian Council of Medical Research, New Delhi, IndiaIndian Council of Medical Research (ICMR); Department of Science and technology, New Delhi, IndiaDepartment of Science & Technology (India)	Deepa Pal and Abhishek Yadav acknowledge the financial assistance from the Indian Council of Medical Research, New Delhi, India. Ashish Awasthi acknowledges the financial assistance from Department of Science and technology, New Delhi, India.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Barron KD, 2004, J NEUROL SCI, V220, P119, DOI 10.1016/j.jns.2004.03.009; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bendszus M, 2004, EXP NEUROL, V188, P171, DOI 10.1016/j.expneurol.2004.03.025; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DHIMAN RK, 1995, J GASTROEN HEPATOL, V10, P14, DOI 10.1111/j.1440-1746.1995.tb01041.x; Floden D, 2008, NEUROPSYCHOLOGIA, V46, P213, DOI 10.1016/j.neuropsychologia.2007.07.020; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Harris GJ, 2008, ALCOHOL CLIN EXP RES, V32, P1001, DOI 10.1111/j.1530-0277.2008.00661.x; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ramalingaswamy P, 1974, MANUAL INDIAN ADAPTA, P20; Rathore RK, 2011, MAGN RESON IMAGING; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; Silver JM, 2005, TXB TRAUMATIC BRAIN, P3; Song SK, 2004, NEUROBIOL DIS, V15, P640, DOI 10.1016/j.nbd.2003.12.003; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TEASDALE G, 1974, LANCET, V2, P81; Trivedi R, 2009, PEDIATR RES, V66, P636, DOI 10.1203/PDR.0b013e3181bbc6b5; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	43	20	21	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUL	2012	114	6					564	571		10.1016/j.clineuro.2011.12.002			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	969GY	WOS:000306044900008	22209144				2021-06-18	
J	Rodgers, KM; Bercum, FM; McCallum, DL; Rudy, JW; Frey, LC; Johnson, KW; Watkins, LR; Barth, DS				Rodgers, Krista M.; Bercum, Florencia M.; McCallum, Danielle L.; Rudy, Jerry W.; Frey, Lauren C.; Johnson, Kirk W.; Watkins, Linda R.; Barth, Daniel S.			Acute Neuroimmune Modulation Attenuates the Development of Anxiety-Like Freezing Behavior in an Animal Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						lateral fluid percussion injury; neuroinflammation; post-traumatic stress disorder; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; POSITRON-EMISSION-TOMOGRAPHY; FLUID PERCUSSION INJURY; CHRONIC MILD STRESS; PREFRONTAL CORTEX; OXIDATIVE STRESS; NERVOUS-SYSTEM; NITRIC-OXIDE; CELL-DEATH; RAT-BRAIN	Chronic anxiety is a common and debilitating result of traumatic brain injury (TBI) in humans. While little is known about the neural mechanisms of this disorder, inflammation resulting from activation of the brain's immune response to insult has been implicated in both human post-traumatic anxiety and in recently developed animal models. In this study, we used a lateral fluid percussion injury (LFPI) model of TBI in the rat and examined freezing behavior as a measure of post-traumatic anxiety. We found that LFPI produced anxiety-like freezing behavior accompanied by increased reactive gliosis (reflecting neuroimmune inflammatory responses) in key brain structures associated with anxiety: the amygdala, insula, and hippocampus. Acute peri-injury administration of ibudilast (MN166), a glial cell activation inhibitor, suppressed both reactive gliosis and freezing behavior, and continued neuroprotective effects were apparent several months post-injury. These results support the conclusion that inflammation produced by neuroimmune responses to TBI play a role in post-traumatic anxiety, and that acute suppression of injury-induced glial cell activation may have promise for the prevention of post-traumatic anxiety in humans.	[Rodgers, Krista M.; Bercum, Florencia M.; McCallum, Danielle L.; Rudy, Jerry W.; Watkins, Linda R.; Barth, Daniel S.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Frey, Lauren C.] Univ Colorado, Dept Neurol, Denver, CO 80202 USA; [Frey, Lauren C.] Colorado Injury Control Res Ctr, Denver, CO USA; [Johnson, Kirk W.] MediciNova Inc, San Diego, CA USA	Barth, DS (corresponding author), Univ Colorado, Dept Psychol & Neurosci, UCB 345, Boulder, CO 80309 USA.	dbarth@psych.colorado.edu	Rodgers, Krista/AAC-5063-2020	RODGERS, KRISTA/0000-0003-4393-6389	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [PR100040]; Craig Hospital Gift Fund; University of Colorado Innovative Seed Grant; Autism Speaks Pilot Study grant [7153]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS36981, DA024044, DA01767]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K05DA024044] Funding Source: NIH RePORTER	This work was supported by U.S. Army Medical Research and Material Command grant PR100040, the Craig Hospital Gift Fund, a University of Colorado Innovative Seed Grant, Autism Speaks Pilot Study grant 7153, National Institutes of Health grant NS36981 to D.S.B., and National Institutes of Health grants DA024044, DA01767 to L.R.W.	Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Beattie MS, 2010, EUR J NEUROSCI, V32, P290, DOI 10.1111/j.1460-9568.2010.07343.x; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.psych.39.1.43; Bland ST, 2001, BEHAV BRAIN RES, V126, P33, DOI 10.1016/S0166-4328(01)00243-1; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; Canteras NS, 2010, CURR TOP BEHAV NEURO, V2, P77, DOI 10.1007/7854_2009_7; Carlson JM, 2011, SOC COGN AFFECT NEUR, V6, P74, DOI 10.1093/scan/nsq017; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; Dellu F, 1996, PSYCHONEUROENDOCRINO, V21, P441, DOI 10.1016/0306-4530(96)00017-0; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Frank M, 1996, GLIA, V16, P227, DOI 10.1002/(SICI)1098-1136(199603)16:3<227::AID-GLIA5>3.0.CO;2-Z; Frey LC, 2009, J NEUROSCI METH, V177, P267, DOI 10.1016/j.jneumeth.2008.10.022; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Gehrmann J, 1996, RES VIROLOGY, V147, P79, DOI 10.1016/0923-2516(96)80220-2; GEHRMANN J, 1991, ACTA NEUROPATHOL, V82, P442, DOI 10.1007/BF00293378; Gibson LCD, 2006, EUR J PHARMACOL, V538, P39, DOI 10.1016/j.ejphar.2006.02.053; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GRAEBER MB, 1988, J NEUROCYTOL, V17, P209, DOI 10.1007/BF01674208; Gueorguieva I, 2008, BRIT J CLIN PHARMACO, V65, P317, DOI 10.1111/j.1365-2125.2007.03026.x; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hoge EA, 2009, DEPRESS ANXIETY, V26, P447, DOI 10.1002/da.20564; Ikeda K, 2003, J NEUROSCI, V23, P4667; Iravani MM, 2005, EUR J NEUROSCI, V22, P317, DOI 10.1111/j.1460-9568.2005.04220.x; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kung JC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-29; Ledeboer A, 2007, EXPERT OPIN INV DRUG, V16, P935, DOI 10.1517/13543784.16.7.935; Lee J.Y., 2011, BRAIN RES; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Liberatore GT, 1999, NAT MED, V5, P1403; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Loram LC, 2009, J NEUROSCI, V29, P14015, DOI 10.1523/JNEUROSCI.3447-09.2009; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; McCann MJ, 1996, NEUROSCIENCE, V72, P273, DOI 10.1016/0306-4522(95)00526-9; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; MONLEON S, 1995, PSYCHOPHARMACOLOGY, V117, P453, DOI 10.1007/BF02246218; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; MORRISSEY TK, 1989, BEHAV BRAIN RES, V35, P195, DOI 10.1016/S0166-4328(89)80141-X; NITZ AJ, 1986, EXP NEUROL, V94, P264, DOI 10.1016/0014-4886(86)90101-9; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; PELLIS SM, 1991, BEHAV BRAIN RES, V46, P151, DOI 10.1016/S0166-4328(05)80108-1; PELLIS SM, 1991, BEHAV BRAIN RES, V45, P185, DOI 10.1016/S0166-4328(05)80084-1; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Rodgers KM, 2009, BRAIN, V132, P2478, DOI 10.1093/brain/awp177; Rolan P, 2009, EXPERT OPIN PHARMACO, V10, P2897, DOI 10.1517/14656560903426189; Rosen JB, 2006, BIOL PSYCHOL, V73, P49, DOI 10.1016/j.biopsycho.2006.01.007; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; SANBERG PR, 1988, BEHAV NEUROSCI, V102, P748, DOI 10.1037/0735-7044.102.5.748; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schafers M, 2008, NEUROSCI LETT, V437, P188, DOI 10.1016/j.neulet.2008.03.052; SCHALLERT T, 1979, EXP NEUROL, V64, P33, DOI 10.1016/0014-4886(79)90003-7; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Spivak B, 1997, BIOL PSYCHIAT, V42, P345, DOI 10.1016/S0006-3223(96)00375-7; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Sternberg EM, 1997, J CLIN INVEST, V100, P2641, DOI 10.1172/JCI119807; Sullivan RM, 2004, STRESS, V7, P131, DOI 10.1080/102538900410001679310; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Tucker P, 2004, BIOL PSYCHIAT, V56, P121, DOI 10.1016/j.biopsych.2004.03.009; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; von Kanel R, 2007, J PSYCHIATR RES, V41, P744, DOI 10.1016/j.jpsychires.2006.06.009; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Wang FZ, 2011, ANESTHESIOLOGY, V114, P643, DOI 10.1097/ALN.0b013e31820a4bf3; Wheaton P., 2011, J PSYCHOPHARMACOL; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Yagi K, 2010, NEUROSURGERY, V66, P551, DOI 10.1227/01.NEU.0000365771.89576.77; Yan Fang, 2002, Zhonghua Yi Xue Za Zhi, V82, P1025; YAN HQ, 1992, EUR J IMMUNOL, V22, P2963, DOI 10.1002/eji.1830221131; Yanase H, 1996, CLIN EXP PHARMACOL P, V23, P317, DOI 10.1111/j.1440-1681.1996.tb02830.x; Yoshioka M, 2002, PHARMACOL RES, V45, P305, DOI 10.1006/phrs.2002.0949; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhang D, 2009, TOXICOL APPL PHARM, V238, P64, DOI 10.1016/j.taap.2009.04.015	123	20	20	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	10					1886	1897		10.1089/neu.2011.2273			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	971YV	WOS:000306244400393	22435644	Green Published			2021-06-18	
J	Schneider, JW; Goetsch, SC; Leng, XY; Ludwig, SM; Russell, JL; Yang, CP; Zhang, QJ				Schneider, Jay W.; Goetsch, Sean C.; Leng, Xiuyu; Ludwig, Sara M.; Russell, Jamie L.; Yang, Cui-Ping; Zhang, Qing-Jun			Coupling Hippocampal Neurogenesis to Brain pH through Proneurogenic Small Molecules That Regulate Proton Sensing G Protein-Coupled Receptors	ACS CHEMICAL NEUROSCIENCE			English	Article						Small molecules; acidosis; G protein-coupled receptors; hippocampal neurogenesis; traumatic brain injury	NEURONAL DIFFERENTIATION; GENE-EXPRESSION; STEM-CELLS; EXERCISE; INJURY; RAT; IDENTIFICATION; PROLIFERATION; ACIDOSIS; DISEASE	Acidosis, a critical aspect of central nervous system (CNS) pathophysiology and a metabolic corollary of the hypoxic stem cell niche, could be an expedient trigger for hippocampal neurogenesis and brain repair. We recently tracked the function of our isoxazole stem cell-modulator small molecules (Isx) through a chemical biology-target discovery strategy to GPR68, a proton (pH) sensing G protein-coupled receptor with no known function in brain. Isx and GPR68 coregulated neuronal target genes such as Bex1 (brain-enriched X-linked protein-1) in hippocampal neural progenitors (HCN cells), which further amplified GPR68 signaling by producing metabolic acid in response to Isx. To evaluate this proneurogenic small molecule/proton signaling circuit in vivo, we explored GPR68 and BEX1 expression in brain and probed brain function with Isx. We localized proton-sensing GPR68 to radial processes of hippocampal type 1 neural stem cells (NSCs) and, conversely, localized BEX1 to neurons. At the transcriptome level, Isx demonstrated unrivaled proneurogenic activity in primary hippocampal NSC cultures. In vivo, Isx pharmacologically targeted type 1 NSCs, promoting neurogenesis in young mice, depleting the progenitor pool without adversely affecting hippocampal learning and memory function. After traumatic brain injury, cerebral cortical astrocytes abundantly expressed GPR68, suggesting an additional role for proton-GPCR signaling in reactive astrogliosis. Thus, probing a novel proneurogenic synthetic small molecule's mechanism-of-action, candidate target, and pharmacological activity, we identified a new GPR68 regulatory pathway for integrating neural stem and astroglial cell functions with brain pH.	[Schneider, Jay W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA	Schneider, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, NB 11-200F,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Jay.schneider@utsouthwestern.edu			American Heart Association-Jon Holden DeHaan Cardiac Myogenesis Research Network; NIH/NHLBI U01 Progenitor Cell Biology Consortium [HL100401]; LoneStar Heart, Inc. Sponsored Research Agreement; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL100401] Funding Source: NIH RePORTER	Funding for these studies was derived from the American Heart Association-Jon Holden DeHaan Cardiac Myogenesis Research Network, NIH/NHLBI U01 Progenitor Cell Biology Consortium (HL100401), and a LoneStar Heart, Inc. Sponsored Research Agreement to J.W.S.	AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Carter BD, 2006, EMBO REP, V7, P382, DOI 10.1038/sj.embor.7400675; Chen J, 2009, GENESIS, V47, P122, DOI 10.1002/dvg.20465; Chen YJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-39; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chu Xiang-Ping, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P288; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Dioum EM, 2011, P NATL ACAD SCI USA, V108, P20713, DOI 10.1073/pnas.1118526109; Everts HB, 2002, IUBMB LIFE, V53, P295, DOI 10.1080/15216540213465; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Huang CW, 2007, MOL CELL NEUROSCI, V36, P195, DOI 10.1016/j.mcn.2007.06.010; JOHNSON JE, 1992, DEVELOPMENT, V114, P75; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; MacMillan KS, 2011, J AM CHEM SOC, V133, P1428, DOI 10.1021/ja108211m; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Nation DA, 2011, MED HYPOTHESES, V76, P847, DOI 10.1016/j.mehy.2011.02.034; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; Rishton Gilbert M, 2008, Recent Pat CNS Drug Discov, V3, P200, DOI 10.2174/157488908786242425; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; Russell J. L., 2012, ACS CHEM BI IN PRESS; Russell JL, 2011, CIRC RES, V108, P51, DOI 10.1161/CIRCRESAHA.110.233262; Sadek H, 2008, P NATL ACAD SCI USA, V105, P6063, DOI 10.1073/pnas.0711507105; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; Selwood D, 2012, CHEM BIOL DRUG DES, V79, P1, DOI 10.1111/j.1747-0285.2011.01273.x; SHERMAN DR, 1987, P NATL ACAD SCI USA, V84, P3209, DOI 10.1073/pnas.84.10.3209; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Warashina M, 2006, ANGEW CHEM INT EDIT, V45, P591, DOI 10.1002/anie.200503089; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107; Xu Y, 1996, GENOMICS, V35, P397, DOI 10.1006/geno.1996.0377; Yang CP, 2011, DEVELOPMENT, V138, P4351, DOI 10.1242/dev.065540; Zhang L, 2011, DIFFERENTIATION, V81, P233, DOI 10.1016/j.diff.2011.02.005	44	20	20	0	19	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	JUL	2012	3	7					557	568		10.1021/cn300025a			12	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	975VO	WOS:000306539800009	22860225	Green Published			2021-06-18	
J	Shiner, B; Drake, RE; Watts, BV; Desai, RA; Schnurr, PP				Shiner, Brian; Drake, Robert E.; Watts, Bradley V.; Desai, Rani A.; Schnurr, Paula P.			Access to VA Services for Returning Veterans With PTSD	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NATIONAL-GUARD SOLDIERS; MENTAL-HEALTH TREATMENT; TRAUMATIC BRAIN-INJURY; MEDICAL-CARE; AFGHANISTAN VETERANS; ADMINISTRATIVE DATA; MILITARY PERSONNEL; ENDURING FREEDOM; IRAQI FREEDOM	Objective: In order to understand access to treatment services for post-traumatic stress disorder (PTSD) in the Veterans Health Administration (VHA), we reviewed existing literature to estimate the proportion of Iraq and Afghanistan veterans who have used VHA services. Methods: We reviewed studies regarding the prevalence of PTSD among Iraq and Afghanistan War veterans to estimate the need for treatment. We then compared need to Veterans Affairs utilization in order to estimate the proportion accessing care. Results: Access to VHA services is high, with 58% of the estimated population of Iraq and Afghanistan veterans accessing some PTSD-related service. However, there is insufficient information about the quality of these services. Conclusions: The Veterans Affairs has been successful in providing access to treatment services for Iraq and Afghanistan Veterans with PTSD. Additional studies are needed to further characterize the quality of services provided.	[Shiner, Brian] VA Med Ctr, White River Jct, VT 05009 USA; [Drake, Robert E.] Dartmouth Psychiat Res Ctr, Lebanon, NH 03766 USA; [Watts, Bradley V.] VA Natl Ctr, Patient Safety Field Off, White River Jct, VT 05009 USA; [Desai, Rani A.] VA Northeast Program Evaluat Ctr, West Haven, CT 06516 USA; [Schnurr, Paula P.] VA Natl Ctr, PTSD Execut Div, White River Jct, VT 05009 USA	Shiner, B (corresponding author), VA Med Ctr, 215 Main St, White River Jct, VT 05009 USA.		Drake, Robert/AAS-3310-2020		VA-New England Early Career Development Award [V1CDA2010-03]	This work was supported by a VA-New England Early Career Development Award to Dr. Shiner (V1CDA2010-03).	Abt Associates, 2006, ACTIVE DUTY HEALTH S; Alonso J, 2007, BRIT J PSYCHIAT, V190, P299, DOI 10.1192/bjp.bp.106.022004; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; ANDERSON HR, 1983, J EPIDEMIOL COMMUN H, V37, P180, DOI 10.1136/jech.37.3.180; [Anonymous], 2009, DEPRESS ANXIETY, V26, P493, DOI 10.1002/da.20581; Blanchard EB, 1996, BEHAV RES THER, V34, P775, DOI 10.1016/0005-7967(96)00038-1; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bliese PD, 2007, PSYCHOL SERV, V76, P27281; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Britt TW, 2000, J APPL SOC PSYCHOL, V30, P1599, DOI 10.1111/j.1559-1816.2000.tb02457.x; Chard KM, 2010, J TRAUMA STRESS, V23, P25, DOI 10.1002/jts.20500; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Engelhard IM, 2007, BRIT J PSYCHIAT, V191, P140, DOI 10.1192/bjp.bp.106.034884; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Frayne SM, 2010, AM J MED QUAL, V25, P42, DOI 10.1177/1062860609346347; Friedman MJ, 2004, NEW ENGL J MED, V351, P75, DOI 10.1056/NEJMe048129; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Gravely AA, 2011, J REHABIL RES DEV, V48, P21, DOI 10.1682/JRRD.2009.08.0116; Grieger TA, 2007, MIL MED, V172, P451, DOI 10.7205/MILMED.172.5.451; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Helmer DA, 2007, J OCCUP ENVIRON MED, V49, P475, DOI 10.1097/JOM.0b013e318042d682; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Institute of Medicine, 2006, IMPROVING THE QUALIT; Institute of Medicine Committee on Quality of Healthcare in America, 2001, CROSSING THE QUALITY; Jakupcak M, 2008, J NERV MENT DIS, V196, P425, DOI 10.1097/NMD.0b013e31817108ed; Kang HK, 2005, NEW ENGL J MED, V352, P1289, DOI 10.1056/NEJMp058024; Kehle SM, 2010, J TRAUMA STRESS, V23, P33, DOI 10.1002/jts.20480; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Kimerling R, 2010, AM J PUBLIC HEALTH, V100, P1409, DOI 10.2105/AJPH.2009.171793; Kline A, 2010, AM J PUBLIC HEALTH, V100, P276, DOI 10.2105/AJPH.2009.162925; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Lindley S, 2010, ANN NY ACAD SCI, V1208, P104, DOI 10.1111/j.1749-6632.2010.05692.x; Martin C, 2007, NATION, V285, P2; Mattocks KM, 2010, J WOMENS HEALTH, V19, P2159, DOI 10.1089/jwh.2009.1892; MCFARLANE AC, 1988, J NERV MENT DIS, V176, P30, DOI 10.1097/00005053-198801000-00004; McGhee LL, 2008, J TRAUMA, V64, pS195, DOI 10.1097/TA.0b013e318160ba1d; Meis LA, 2010, J FAM PSYCHOL, V24, P560, DOI 10.1037/a0020925; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Norris FH, 2004, ASSESSING PSYCHOLOGI; Ouimette P., 2008, TRAUMATOLOGY, V14, P51, DOI [10.1177/1534765608320330, DOI 10.1177/1534765608320330]; Pincus HA, 2007, AM J PSYCHIAT, V164, P712, DOI 10.1176/appi.ajp.164.5.712; Prins A, 2004, PRIMARY CARE PSYCHIA, V9, P151, DOI 10.1185/135525703125002360; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Ramchand R., 2008, INVISIBLE WOUNDS WAR, P35; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Rundell JR, 2006, GEN HOSP PSYCHIAT, V28, P352, DOI 10.1016/j.genhosppsych.2006.04.006; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayer NA, 2009, PSYCHIATRY, V72, P238, DOI 10.1521/psyc.2009.72.3.238; Schell TL, 2008, INVISIBLE WOUNDS OF; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2008, AM J PUBLIC HEALTH, V98, P714, DOI 10.2105/AJPH.2007.115519; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Stecker T, 2007, PSYCHIAT SERV, V58, P1358, DOI 10.1176/appi.ps.58.10.1358; Stecker T, 2010, PATIENT PREFER ADHER, V4, P45; Thornicroft G, 2011, OXFORD TEXTBOOK OF C; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vogt D, 2011, PSYCHIAT SERV, V62, P135, DOI 10.1176/ps.62.2.pss6202_0135; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P603, DOI 10.1001/archpsyc.62.6.603; Watkins Katherine E, 2010, J Healthc Qual, V32, P33, DOI 10.1111/j.1945-1474.2010.00109.x; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	73	20	20	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL	2012	177	7					814	822		10.7205/MILMED-D-12-00009			9	Medicine, General & Internal	General & Internal Medicine	V33NZ	WOS:000209026800009	22808888	Bronze			2021-06-18	
J	Julien, C; Marcouiller, F; Bretteville, A; El Khoury, NB; Baillargeon, J; Hebart, SS; Planel, E				Julien, Carl; Marcouiller, Francois; Bretteville, Alexis; El Khoury, Noura B.; Baillargeon, Joanie; Hebart, Sebastien S.; Planel, Emmanuel			Dimethyl Sulfoxide Induces Both Direct and Indirect Tau Hyperphosphorylation	PLOS ONE			English	Article							NEURONAL CELL-DEATH; COLD-WATER STRESS; ALZHEIMERS-DISEASE; IN-VIVO; NEUROFIBRILLARY PATHOLOGY; PROTEIN PHOSPHATASE-2A; PHOSPHORYLATION SITES; INHIBITION; HYPOTHERMIA; KINASE	Dimethyl sulfoxide (DMSO) is widely used as a solvent or vehicle for biological studies, and for treatment of specific disorders, including traumatic brain injury and several forms of amyloidosis. As Alzheimer's disease (AD) brains are characterized by deposits of beta-amyloid peptides, it has been suggested that DMSO could be used as a treatment for this devastating disease. AD brains are also characterized by aggregates of hyperphosphorylated tau protein, but the effect of DMSO on tau phosphorylation is unknown. We thus investigated the impact of DMSO on tau phosphorylation in vitro and in vivo. One hour following intraperitoneal administration of 1 or 2 ml/kg DMSO in mice, no change was observed in tau phosphorylation. However, at 4 ml/kg, tau was hyperphosphorylated at AT8 (Ser(202)/Thr(205)), PHF-1 (Ser(396)/Ser(404)) and AT180 (Thr(231)) epitopes. At this dose, we also noticed that the animals were hypothermic. When the mice were maintained normothermic, the effect of 4 ml/kg DMSO on tau hyperphosphorylation was prevented. On the other hand, in SH-SY5Y cells, 0.1% DMSO induced tau hyperphosphorylation at AT8 and AT180 phosphoepitopes in normothermic conditions. Globally, these findings demonstrate that DMSO can induce tau hyperphosphorylation indirectly via hypothermia in vivo, and directly in vitro. These data should caution researchers working with DMSO as it can induce artifactual results both in vivo and in vitro.	[Julien, Carl; Marcouiller, Francois; Bretteville, Alexis; El Khoury, Noura B.; Baillargeon, Joanie; Hebart, Sebastien S.; Planel, Emmanuel] Univ Laval, Fac Med, Dept Neurosci & Psychiat, Quebec City, PQ G1K 7P4, Canada; [Julien, Carl; Marcouiller, Francois; Bretteville, Alexis; El Khoury, Noura B.; Baillargeon, Joanie; Hebart, Sebastien S.; Planel, Emmanuel] Univ Quebec, Ctr Hosp, Ctr Rech, Axe Neurosci, Quebec City, PQ, Canada	Julien, C (corresponding author), Univ Laval, Fac Med, Dept Neurosci & Psychiat, Quebec City, PQ G1K 7P4, Canada.	carl.julien@crchul.ulaval.ca; emmanuel@planel.org	Hebert, Sebastien S./Q-2729-2017	Hebert, Sebastien/0000-0002-0391-9325	Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-106423, PCN-102993]; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [354722]; Fonds de la recherche en sante du QuebecFonds de la Recherche en Sante du Quebec [16205, 20048]; Alzheimer Society of Canada; Alzheimer Society of Saskatchewan	This work was supported by grants to EP from the Canadian Institute of Health Research (MOP-106423, PCN-102993) (www.cihr-irsc.gc.ca), the Natural Sciences and Engineering Research Council of Canada (354722) (www.nserc-crsng.gc.ca), the Fonds de la recherche en sante du Quebec (16205, 20048) (www.frsq.gouv.qc.ca). CJ was supported by Postdoctoral Awards from the Alzheimer Society of Canada and the Alzheimer Society of Saskatchewan (www.alzheimer.ca). NBEK was supported by a Doctoral Award from the Alzheimer Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTLAND PD, 1966, P SOC EXP BIOL MED, V123, P853; ASHWOODS.MJ, 1967, ANN NY ACAD SCI, V141, P45, DOI 10.1111/j.1749-6632.1967.tb34865.x; Balakin KV, 2006, CURR MED CHEM, V13, P223, DOI 10.2174/092986706775197917; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BROADWELL RD, 1982, SCIENCE, V217, P164, DOI 10.1126/science.7089551; CAUJOLLE F, 1964, CR HEBD ACAD SCI, V258, P2224; de Oliveira ACP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-2; Delobel P, 2002, J NEUROCHEM, V83, P412, DOI 10.1046/j.1471-4159.2002.01143.x; Dugo L, 2005, CRIT CARE MED, V33, P1903, DOI 10.1097/01.CCM.0000178350.21839.44; FARRANT J, 1964, J PHARM PHARMACOL, V16, P472, DOI 10.1111/j.2042-7158.1964.tb07496.x; Feng Q, 2005, NEUROSCI LETT, V388, P13, DOI 10.1016/j.neulet.2005.06.022; Goedert M, 1996, ANN NY ACAD SCI, V777, P121, DOI 10.1111/j.1749-6632.1996.tb34410.x; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; Goldbaum O, 2002, GLIA, V40, P271, DOI 10.1002/glia.10119; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Hamdane M, 2005, J CELL SCI, V118, P1291, DOI 10.1242/jcs.01724; Hamdane M, 2003, J BIOL CHEM, V278, P34026, DOI 10.1074/jbc.M302872200; Jacob SW, 2009, PHARMACOL REP, V61, P225, DOI 10.1016/S1734-1140(09)70026-X; KORNEYEV A, 1995, NEUROSCI LETT, V191, P19, DOI 10.1016/0304-3940(95)11546-3; LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0; Mailliot C, 2000, ANN NY ACAD SCI, V920, P107; Martins DF, 2011, J PAIN, V12, P315, DOI 10.1016/j.jpain.2010.06.007; Okawa Y, 2003, FEBS LETT, V535, P183, DOI 10.1016/S0014-5793(02)03883-8; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Patel SJ, 2012, NAT BIOTECHNOL, V30, P179, DOI 10.1038/nbt.2089; Pegg David E, 2007, Methods Mol Biol, V368, P39; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Pohjanvirta R, 2002, FOOD CHEM TOXICOL, V40, P1023, DOI 10.1016/S0278-6915(02)00067-4; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Regelson W, 1997, ANN NY ACAD SCI, V826, P348, DOI 10.1111/j.1749-6632.1997.tb48485.x; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Roller J, 2010, LANGENBECK ARCH SURG, V395, P387, DOI 10.1007/s00423-010-0603-8; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Selenica ML, 2007, BRIT J PHARMACOL, V152, P959, DOI 10.1038/sj.bjp.0707471; SU JH, 1994, NEUROREPORT, V5, P2358, DOI 10.1097/00001756-199411000-00037; Villarreal JS, 2006, NEUROBIOL LEARN MEM, V85, P44, DOI 10.1016/j.nlm.2005.08.005; Wang JZ, 1996, MOL BRAIN RES, V38, P200, DOI 10.1016/0169-328X(95)00316-K; Watanabe E, 2000, BIOL PHARM BULL, V23, P838; Whittington RA, 2010, CURR ALZHEIMER RES, V7, P717; Whittington RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016648; WOOD DC, 1975, ANN NY ACAD SCI, V243, P7, DOI 10.1111/j.1749-6632.1975.tb25339.x; Zhu GC, 2006, TRANSPLANT P, V38, P3307, DOI 10.1016/j.transproceed.2006.10.114	50	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e40020	10.1371/journal.pone.0040020			10	Multidisciplinary Sciences	Science & Technology - Other Topics	967FO	WOS:000305892100174	22768202	DOAJ Gold, Green Published			2021-06-18	
J	Jiang, PF; Sun, Y; Zhu, T; Zhan, CY; Gu, WZ; Yuan, TM; Yu, HM				Jiang, Peifang; Sun, Yi; Zhu, Tao; Zhan, Canyang; Gu, Weizhong; Yuan, Tianming; Yu, Huimin			Endogenous neurogenesis in the hippocampus of developing rat after intrauterine infection	BRAIN RESEARCH			English	Article						Neurogenesis; Bromodeoxyuridine; Hippocampus; Intrauterine infection; PI3K/Akt	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; NEURAL STEM-CELLS; ADULT NEUROGENESIS; WHITE-MATTER; OLIGODENDROCYTE PROGENITORS; ENHANCES NEUROGENESIS; SUBVENTRICULAR ZONE; PERINATAL HYPOXIA; DENTATE GYRUS	Perinatal infection is a major cause of neonatal neurologic morbidity. The goal of this study is to examine the effects of intrauterine infection on hippocampal neurogenesis and self-repair during early developmental stages. The animals were randomly divided into two groups: E. coli infected group and control group. Neurogenesis was examined by incorporation of BrdU, a marker of proliferating cells and their progeny. Rats were sacrificed on P3, P7, P14 and P28, and their brains were prepared for histological analysis of cell proliferation. To evaluate hippocampus neurogenesis, rats were sacrificed on P7 and P28, and their brains were prepared for evaluation of newly generated neural stem cells using double labeling of BrdU and Nestin, newly formed neurons using double labeling of BrdU and NeuN, and newly formed astrocytes using double labeling of BrdU and GFAP. In intrauterine E. coli infected group, there was significant increase in numbers of BrdU-labeled cells (about 2-fold at P7) than that of the control group (P < 0.05). Confocal microscopy showed that there was a significant difference in BrdU/Nestin coexpression between the control and E. coli infected groups (P < 0.01). Evaluation of the phenotype of the surviving cells showed that E. coli infected and control groups had a similar proportion of neuronal and glial differentiation. No significant difference was found in the percentage of newborn cells expressing neuronal and glial phenotype in the control and E. coli infected groups (P > 0.05). Real-time RT-PCR and Western blot analysis showed that there was a significant increase of BDNF, TrkB, p-Akt and Survivin mRNA and protein expression during postnatal 7 days in the E. coli infected group (P < 0.05). Our results suggest that endogenous neurogenesis may occur in hippocampus in early postnatal period and may be enhanced by neonatal inflammation reactive syndrome. The PI3K/Akt signaling pathway may be involved in regulation of BDNF and is important in the potential activation of neuroprotective and repair pathways during critical time windows of hippocampal development. (C) 2012 Elsevier B.V. All rights reserved.	[Sun, Yi; Zhan, Canyang; Yuan, Tianming; Yu, Huimin] Zhejiang Univ, Childrens Hosp, Sch Med, Dept Neonatol, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Peifang] Zhejiang Univ, Childrens Hosp, Sch Med, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Tao] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Crit Care Med, Hangzhou 310016, Zhejiang, Peoples R China; [Gu, Weizhong] Zhejiang Univ, Childrens Hosp, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Yu, HM (corresponding author), Zhejiang Univ, Childrens Hosp, Sch Med, Dept Neonatol, Zhugan Xiang 57, Hangzhou 310003, Zhejiang, Peoples R China.	yuhuimin@yahoo.com.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30973222]; Health Bureau of Zhejiang Province [2010KYB064]; Key Science and Technology Innovation Team of Zhejiang Province [2010R50045]	The work of the authors is supported by Grants from National Natural Science Foundation of China (30973222), Health Bureau of Zhejiang Province (2010KYB064) and Key Science and Technology Innovation Team of Zhejiang Province for early screening and intervention of birth defects (2010R50045). We are also grateful to Kewen Jiang for advice during the first part of this study. We sincerely thank Guifeng Xiao for assistance with the confocal imaging. We also thank the members of the Central Laboratory for helpful discussions.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Bartley J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-15; Bauer S, 2005, NEUROSCIENCE, V130, P75, DOI 10.1016/j.neuroscience.2004.08.047; Boehme F, 2011, EUR J NEUROSCI, V33, P1799, DOI 10.1111/j.1460-9568.2011.07676.x; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Chan CB, 2011, J NEUROSCI, V31, P8083, DOI 10.1523/JNEUROSCI.1129-11.2011; Chavali PL, 2011, J BIOL CHEM, V286, P9393, DOI 10.1074/jbc.M110.167445; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Fatemi SH, 1999, MOL PSYCHIATR, V4, P145, DOI 10.1038/sj.mp.4000520; Fatemi SH, 2002, MOL PSYCHIATR, V7, P633, DOI 10.1038/sj.mp.4001046; Felling RJ, 2006, J NEUROSCI, V26, P4359, DOI 10.1523/JNEUROSCI.1898-05.2006; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P229; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Gualco E, 2010, CELL DEATH DIFFER, V17, P439, DOI 10.1038/cdd.2009.146; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Joannides AJ, 2007, BRAIN, V130, P1263, DOI 10.1093/brain/awm070; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Magavi SS, 2000, NATURE, V405, P951; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ness JK, 2001, DEV NEUROSCI-BASEL, V23, P203, DOI 10.1159/000046144; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Parent JM, 2007, ANN NEUROL, V61, P185, DOI 10.1002/ana.21088; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Shen Y, 2009, NEUROPATHOLOGY, V29, P528, DOI 10.1111/j.1440-1789.2009.01005.x; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Song WY, 2010, J NEUROSCI, V30, P15608, DOI 10.1523/JNEUROSCI.2581-10.2010; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Villapol S, 2008, NEUROSCIENCE, V153, P108, DOI 10.1016/j.neuroscience.2008.01.054; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Yang Z, 2006, NEUROSCIENCE, V139, P555, DOI 10.1016/j.neuroscience.2005.12.059; Yu HM, 2004, NEUROPATHOLOGY, V24, P136, DOI 10.1111/j.1440-1789.2003.00539.x; Yuan TM, 2005, J PERINAT MED, V33, P415, DOI 10.1515/JPM.2005.074; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang YH, 2007, AM J PHYSIOL-HEART C, V292, pH2573, DOI 10.1152/ajpheart.01098.2006	48	20	21	1	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 12	2012	1459						1	14		10.1016/j.brainres.2012.03.058			14	Neurosciences	Neurosciences & Neurology	961XW	WOS:000305503800001	22569202				2021-06-18	
J	Eriksson, EA; Barletta, JF; Figueroa, BE; Bonnell, BW; Vanderkolk, WE; McAllen, KJ; Ott, MM				Eriksson, Evert A.; Barletta, Jeffrey F.; Figueroa, Bryan E.; Bonnell, Bruce W.; Vanderkolk, Wayne E.; McAllen, Karen J.; Ott, Mickey M.			Cerebral perfusion pressure and intracranial pressure are not surrogates for brain tissue oxygenation in traumatic brain injury	CLINICAL NEUROPHYSIOLOGY			English	Article						Trauma; pBtO(2); Traumatic brain injury; Brain tissue oxygenation; Intracranial pressure; Intracranial monitor; Cerebral perfusion pressure	SEVERE HEAD-INJURY; BLOOD-FLOW; AUTOREGULATION; REACTIVITY; TENSION; HYPOXIA; VOLUME; PO2	Objective: Utilization of brain tissue oxygenation (pBtO(2)) is an important but controversial variable in the treatment of traumatic brain injury (TBI). We evaluated the correlation between pBtO(2)/CPP and pBtO(2)/ICP and determined the parameter most closely related to survival. Methods: Consecutive, adult patients with severe TBI and pBtO(2) monitors were retrospectively identified. Time-indexed measurements of pBtO(2), CPP and ICP were collected and correlation coefficients were determined. Patients were then stratified according to survival and pBtO(2), CPP and ICP values were compared between groups. Results: There were 4169 time-indexed data points (i.e., pBtO(2) with respective CPP and ICP values) in 15 patients. The cohort consisted of a mean age of 37 +/- 17 years, ISS of 27 +/- 7 and GCS of 4.5 +/- 1.5. Survival was 53% (8/15). In a normal regression models, neither the ICP (p = 0.58) nor the CPP (p = 0.71) predict pBtO(2) significantly. There was a significant difference in pBtO(2) in survivors (31.5 +/- 3.1 vs. 25.2 +/- 4.8, p = 0.010) but not in CPP or ICP. Survivors had a lower proportion of time with pBtO(2) < 25 mmHg [20% (3.4-44.6) vs. 40% (16.2-89), p = 0.049]. In contrast, survivors had a greater proportion of time with CPP < 70 and no difference in the proportion of time with and ICP > 20. Conclusions: CPP and ICP should not be used as surrogates for pBtO(2) since cerebral oxygenation varies independently of cerebral hemodynamics and pressures. Brain tissue oxygen monitoring in patients with TBI provides unique information regarding cerebral oxygenation the utility of which remains to be fully described. Significance: CPP and ICP are not surrogates for pBtO(2). Brain tissue oxygenation monitoring provides unique information for the treatment of traumatically injured patients. (C) 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Eriksson, Evert A.] Med Univ S Carolina, Dept Trauma Crit Care, GRMERC MSU Surg Crit Care, Charleston, SC 29425 USA; [Barletta, Jeffrey F.] Midwestern Univ, Coll Pharm Glendale, Dept Pharm Practice, Downers Grove, IL USA; [Ott, Mickey M.] Vanderbilt Univ, Dept Trauma, GRMERC MSU Surg Crit Care, Nashville, TN USA	Eriksson, EA (corresponding author), Med Univ S Carolina, Dept Trauma Crit Care, GRMERC MSU Surg Crit Care, 96 Jonathan Lucas St,Suite 420, Charleston, SC 29425 USA.	evsurgery@gmail.com	Barletta, Jeffrey F./B-2644-2013	Barletta, Jeffrey/0000-0002-9054-8218; Eriksson, Evert/0000-0002-4099-325X			Artru F, 1998, NEUROL RES, V20, pS48; Bardt TF, 1998, ACT NEUR S, V71, P153; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Czosnyka M, 2003, ACT NEUR S, V86, P581; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Sarrafzadeh A S, 2000, Neurosurg Focus, V9, pe2; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007	28	20	21	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	JUN	2012	123	6					1255	1260		10.1016/j.clinph.2011.08.035			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	947QV	WOS:000304445500024	22104471				2021-06-18	
J	Finkel, AG; Yerry, J; Scher, A; Choi, YS				Finkel, Alan G.; Yerry, Juanita; Scher, Ann; Choi, Young S.			Headaches in Soldiers With Mild Traumatic Brain Injury: Findings and Phenomenologic Descriptions	HEADACHE			English	Article						headache diagnosis; post-traumatic headache; traumatic brain injury; blast; continuous headache; migraine	TEMPOROMANDIBULAR DISORDER; CUTANEOUS ALLODYNIA; CHRONIC PAIN; MIGRAINE; EPIDEMIOLOGY; FIBROMYALGIA; COMORBIDITY; MECHANISMS; ASSOCIATION; PREVALENCE	Objective.-The primary goal of this study was to use headache criteria-based classification for headache types described by service members. Background.-Headache is common in soldiers returning from the wars in Afghanistan and Iraq. To date, few papers have provided detailed descriptions of these headaches. Methods.-The first 25 patients seen by a certified headache specialist at the Traumatic Brain Injury Center at Womack Army Medical Center, Fort Bragg, NC, between August 2008 and December 2009 are reported. Results.-Service members described a total of 55 headaches. Most, but not all, headaches began within 1 week after injury. Migraine type was most common. Aura occurred in 5 soldiers. Continuous headaches were described in 88%. Uncommon headache types including cluster type were diagnosed. Additional symptoms and service outcomes are described. Conclusions.-We conclude that headaches occurring after various types of head injury, including explosions, can be assigned primary and secondary headache diagnoses using standard classifications not necessarily available to larger survey-based studies.	[Finkel, Alan G.] Carolina Headache Inst, Chapel Hill, NC 27516 USA; [Finkel, Alan G.; Yerry, Juanita; Choi, Young S.] Womack Army Med Ctr, Ft Bragg, NC USA; [Scher, Ann] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; [Finkel, Alan G.] Def & Vet Brain Injury Ctr, Rockville, MD USA	Finkel, AG (corresponding author), Carolina Headache Inst, 103 Market St, Chapel Hill, NC 27516 USA.	finkela@carolinaheadacheinstitute.com		Scher, Ann/0000-0003-4599-9834			Anderson GC, 2011, PAIN, V152, P765, DOI 10.1016/j.pain.2010.11.007; Ashkenazi A, 2007, CEPHALALGIA, V27, P325, DOI 10.1111/j.1468-2982.2007.01291.x; Ayesh EE, 2007, J DENT RES, V86, P1187, DOI 10.1177/154405910708601209; Bahra A, 2003, HEADACHE, V43, P179, DOI 10.1046/j.1526-4610.2003.03041.x; Baranauskas G, 1998, PROG NEUROBIOL, V54, P349, DOI 10.1016/S0301-0082(97)00067-1; Bevilaqua-Grossi D, 2010, CEPHALALGIA, V30, P425, DOI 10.1111/j.1468-2982.2009.01928.x; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Calhoun AH, 2010, HEADACHE, V50, P1273, DOI 10.1111/j.1526-4610.2009.01608.x; Centonze V, 2004, NEUROL SCI, V25, pS291, DOI 10.1007/s10072-004-0314-4; Crystal SC, 2010, CURR PAIN HEADACHE R, V14, P449, DOI 10.1007/s11916-010-0146-2; de Tommaso M, 2009, CEPHALALGIA, V29, P453, DOI 10.1111/j.1468-2982.2008.01754.x; Edelmayer RM, 2009, ANN NEUROL, V65, P184, DOI 10.1002/ana.21537; Geppetti P, 2010, INTERN EMERG MED, V5, pS7, DOI 10.1007/s11739-010-0461-y; Goncalves DAG, 2010, HEADACHE, V50, P231, DOI 10.1111/j.1526-4610.2009.01511.x; Jonsson P, 2011, CEPHALALGIA, V31, P1015, DOI 10.1177/0333102411410082; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Lidbeck Jan, 2002, Pain Res Manag, V7, P81; Lim PF, 2010, CLIN J PAIN, V26, P116, DOI 10.1097/AJP.0b013e3181c507ef; Lipton RB, 2008, ANN NEUROL, V63, P148, DOI 10.1002/ana.21211; Mathew NT, 2004, NEUROLOGY, V63, P848, DOI 10.1212/01.WNL.0000137107.27585.F7; National Center for Health Statistics, 2005, DAT FIL DOC NAT HLTH; Nilsson IM, 2006, J OROFAC PAIN, V20, P138; Plesh O, 2002, PAIN, V99, P515, DOI 10.1016/S0304-3959(02)00262-2; Plesh O, 2011, J OROFAC PAIN, V25, P25; Research Triangle Institute, 2004, SUDAAN MAN REL 9 0; Rhee Hyekyun, 2005, J Pediatr Nurs, V20, P153, DOI 10.1016/j.pedn.2005.01.003; Robbins MS, 2010, SEMIN NEUROL, V30, P107, DOI 10.1055/s-0030-1249220; Scher AI, 2005, CURR OPIN NEUROL, V18, P305, DOI 10.1097/01.wco.0000169750.52406.a2; Scher AI, 2008, HEADACHE, V48, P16, DOI 10.1111/j.1526-4610.2007.00970.x; Scher AI, 2006, HEADACHE, V46, P1416, DOI 10.1111/j.1526-4610.2006.00584.x; Schiffman EL, 2010, J OROFAC PAIN, V24, P7; Sessle Barry J., 2005, Reviews in Analgesia, V8, P85, DOI 10.3727/000000005783992881; Sessle BJ, 2000, CRIT REV ORAL BIOL M, V11, P57, DOI 10.1177/10454411000110010401; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Staud R, 2006, NAT CLIN PRACT RHEUM, V2, P90, DOI 10.1038/ncprheum0091; Stewart WF, 1996, NEUROLOGY, V47, P52, DOI 10.1212/WNL.47.1.52; Tietjen GE, 2009, HEADACHE, V49, P1333, DOI 10.1111/j.1526-4610.2009.01521.x; Victor TW, 2010, CEPHALALGIA, V30, P1065, DOI 10.1177/0333102409355601; VONKORFF M, 1988, PAIN, V32, P173, DOI 10.1016/0304-3959(88)90066-8	40	20	20	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUN	2012	52	6					957	965		10.1111/j.1526-4610.2012.02167.x			9	Clinical Neurology	Neurosciences & Neurology	952OA	WOS:000304800600004	22568576				2021-06-18	
J	Fujii, D; Fujii, DC				Fujii, Daryl; Fujii, Daniel C.			Psychotic Disorder Due to Traumatic Brain Injury: Analysis of Case Studies in the Literature	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							SCHIZOPHRENIA-LIKE PSYCHOSIS; NEGATIVE SYMPTOMS; HEAD-INJURY; PSYCHIATRIC-DISORDERS; VISUAL HALLUCINATIONS; MENTAL-ILLNESS; RISK; METAANALYSIS; PATIENT; PREVALENCE	The present study utilized methodology from a previous descriptive study that analyzed case studies of psychotic disorder due to traumatic brain injury (PD-TBI) reported in psychiatry and neurology journals. The purpose was to replicate findings from the PD-TBI literature and to elucidate a pattern of characteristics that would differentiate PD-TBI from schizophrenia. The findings supported both objectives. PD-TBI data were highly consistent with previous studies: PD-TBI differed from schizophrenia in showing more focal frontal and temporal abnormalities on neurological studies and a lower rate of negative symptoms. The authors discuss implications of these findings for conceptualizing psychosis as a neurobiological syndrome. (The Journal of Neuropsychiatry and Clinical Neurosciences 2012; 24:278-289)		Fujii, D (corresponding author), Pacific Isl Hlth Care Syst Vet Affairs, Community Living Ctr, Honolulu, HI USA.	dfujii07@gmail.com					AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Aleman A, 2003, ARCH GEN PSYCHIAT, V60, P565, DOI 10.1001/archpsyc.60.6.565; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, DIAGN STAT MAN MENT, V4th; Bennouna M, 2005, J CLIN PSYCHOPHARM, V25, P505, DOI 10.1097/01.jcp.0000177851.31157.66; Bloom KK, 1998, AM J PHYS MED REHAB, V77, P157, DOI 10.1097/00002060-199803000-00017; Bobes J, 2010, J CLIN PSYCHIAT, V71, P280, DOI 10.4088/JCP.08m04250yel; Boutros NN, 2008, SCHIZOPHR RES, V99, P225, DOI 10.1016/j.schres.2007.11.020; BREIER A, 1991, ARCH GEN PSYCHIAT, V48, P239; Burke JG, 1999, J PSYCHIATR NEUROSCI, V24, P456; Butler PV, 2000, AUST NZ J PSYCHIAT, V34, P684, DOI 10.1046/j.1440-1614.2000.00758.x; Campbell BA, 2011, J PEDIAT HEMATOL ONC, V33, pE125, DOI 10.1097/MPH.0b013e3182036e06; Catalano G, 2009, J PSYCHIATR PRACT, V15, P484, DOI 10.1097/01.pra.0000364292.93704.65; CAZZULLO CL, 1989, PSYCHIAT RES, V29, P257, DOI 10.1016/0165-1781(89)90055-3; Chen YH, 2010, PSYCHOL MED, V22, P1; Coronado VG, 2006, JAMA-J AM MED ASSOC, V295, P1764; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Davidson LL, 2003, PSYCHIAT RES-NEUROIM, V122, P69, DOI 10.1016/S0925-4927(02)00118-X; Davison K, 1969, CURRENT PROBLEMS NEU, P113; Duggal HS, 2004, J NEUROPSYCH CLIN N, V16, P543, DOI 10.1176/appi.neuropsych.16.4.543; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Feinberg TE, 1999, CORTEX, V35, P373, DOI 10.1016/S0010-9452(08)70806-2; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; FORNAZZARI L, 1992, J NEUROPSYCH CLIN N, V4, P42; Francisco GE, 1996, AM J PHYS MED REHAB, V75, P63, DOI 10.1097/00002060-199601000-00016; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii D, SPECTRUM PSYCHOTIC D, P535; Fujii D, SPECTRUM PSYCHOTIC D, P3; Fujii Daryl, 2002, Cogn Neuropsychiatry, V7, P41, DOI 10.1080/135468000143000131; Fujii DE, 2004, CAN J PSYCHIAT, V49, P713, DOI 10.1177/070674370404901101; Fujii DE, 2004, SCHIZOPHR RES, V69, P67, DOI 10.1016/S0920-9964(03)00122-1; Fujii DE, 2003, SCHIZOPHR RES, V59, P219, DOI 10.1016/S0920-9964(01)00328-0; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Fujii DF, 2004, PROGR SCHIZOPHRENIA, P77; GEREZ M, 1995, BIOL PSYCHIAT, V38, P34, DOI 10.1016/0006-3223(94)00205-H; Greene MB, 2010, J CLIN PSYCHIAT, V71, P506, DOI 10.4088/JCP.09l05685yel; Guenedi Amr A, 2009, J Med Case Rep, V3, P9325, DOI 10.1186/1752-1947-3-9325; Guerreiro DF, 2009, BRAIN INJURY, V23, P1; GUREJE O, 1994, AM J PSYCHIAT, V151, P368; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Henderson AS, 1998, INT J GERIATR PSYCH, V13, P484, DOI 10.1002/(SICI)1099-1166(199807)13:7<484::AID-GPS808>3.3.CO;2-Z; Hien LT, 2005, J AM GERIATR SOC, V53, P1290, DOI 10.1111/j.1532-5415.2005.53403.x; Hwu HG, 2002, SCHIZOPHR RES, V56, P105, DOI 10.1016/S0920-9964(01)00251-1; Jardri R, 2011, AM J PSYCHIAT, V168, P73, DOI 10.1176/appi.ajp.2010.09101522; Jaskiw GE, 2002, SCHIZOPHR RES, V58, P205, DOI 10.1016/S0920-9964(02)00152-4; KENDLER KS, 1994, AM J PSYCHIAT, V151, P27; Kim E, 2002, J NEUROPSYCH CLIN N, V14, P202, DOI 10.1176/appi.neuropsych.14.2.202; Knobel A, 2008, EUR ARCH PSY CLIN N, V258, P76, DOI 10.1007/s00406-008-5008-0; Koponen H, 2003, INT CLIN PSYCHOPHARM, V18, P355, DOI 10.1097/00004850-200311000-00007; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Leboyer M, 2008, SCHIZOPHR RES, V102, P21, DOI 10.1016/j.schres.2008.04.003; LEWIS SW, 1990, BRIT J PSYCHIAT, V157, P16, DOI 10.1192/S0007125000291824; Makinen J, 2008, NORD J PSYCHIAT, V62, P334, DOI 10.1080/08039480801959307; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Mattioli F, 1999, CORTEX, V35, P413, DOI 10.1016/S0010-9452(08)70809-8; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; Miller J, 2009, PSYCHOSOMATICS, V50, P426, DOI 10.1176/appi.psy.50.4.426; NASRALLAH HA, 1983, J CLIN PSYCHIAT, V44, P407; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; OWENS DGC, 1980, J NEUROL NEUROSUR PS, V43, P1065, DOI 10.1136/jnnp.43.12.1065; Pearlson GD, 1999, BIOL PSYCHIAT, V46, P627, DOI 10.1016/S0006-3223(99)00071-2; Ritchie E C, 1989, J Neuropsychiatry Clin Neurosci, V1, P449; ROUSSEAUX M, 1994, J NEUROL NEUROSUR PS, V57, P1268, DOI 10.1136/jnnp.57.10.1268; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Sheehan W, 2006, ACTA PSYCHIAT SCAND, V114, P140, DOI 10.1111/j.1600-0447.2006.00869.x; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stephane M, 2004, BRAIN LANG, V89, P503, DOI 10.1016/j.bandl.2004.01.001; Stewart B, 2005, J NEUROPSYCH CLIN N, V17, P243, DOI 10.1176/appi.neuropsych.17.2.243; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tiwari Arun K, 2010, Dialogues Clin Neurosci, V12, P289; Tremeau F, 2011, PROG NEURO-PSYCHOPH, V35, P280, DOI 10.1016/j.pnpbp.2010.09.011; Viana BD, 2010, PROG NEURO-PSYCHOPH, V34, P233, DOI 10.1016/j.pnpbp.2009.08.026; VIOLON A, 1987, ACTA NEUROCHIR, V85, P96, DOI 10.1007/BF01456104; VITA A, 1991, AM J PSYCHIAT, V148, P1577; VITA A, 1988, SCHIZOPHR RES, V1, P329, DOI 10.1016/0920-9964(88)90046-1; Webb J, 2010, CNS SPECTRUMS, V15, P539, DOI 10.1017/S109285290000050X; White C, 2009, PSYCHOL MED, V39, P1447, DOI 10.1017/S003329170800514X; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353; Zaidi SHH, 2008, BRAIN INJURY, V22, P99, DOI 10.1080/02699050701822493	89	20	23	0	10	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2012	24	3					278	289		10.1176/appi.neuropsych.11070176			12	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	057VS	WOS:000312592800038	23037642				2021-06-18	
J	Watkins, AC; Vedula, GV; Horan, J; Dellicarpini, K; Pak, SW; Daly, T; Samstein, B; Kato, T; Emond, JC; Guarrera, JV				Watkins, A. C.; Vedula, G. V.; Horan, J.; Dellicarpini, K.; Pak, S. -W.; Daly, T.; Samstein, B.; Kato, T.; Emond, J. C.; Guarrera, J. V.			The deceased organ donor with an "open abdomen": proceed with caution	TRANSPLANT INFECTIOUS DISEASE			English	Article						Pseudomonas aeruginosa; donor-derived infection; multidrug-resistant bacteria; solid organ transplantation	RESISTANT PSEUDOMONAS-AERUGINOSA; EXTENDED CRITERIA; INFECTIONS; EXPERIENCE; CLOSURE; IMPACT	In solid organ transplantation, the disparity between donor supply and patients awaiting transplant continues to increase. The organ shortage has led to relaxation of historic contraindications to organ donation. A large percentage of deceased organ donors have been subjected to traumatic injuries, which can often result in intervention that leads to abdominal packing and intensive care unit resuscitation. The donor with this "open abdomen" (OA) presents a situation in which the risk of organ utilization is difficult to quantify. There exists a concern for the potential of a higher risk for both bacterial and fungal infections, including multidrug-resistant (MDR) pathogens because of the prevalence of antibiotic use and critical illness in this population. No recommendations have been established for utilization of organs from these OA donors, because data are limited. Herein, we report a case of a 21-year-old donor who had sustained a gunshot wound to his abdomen, resulting in a damage-control laparotomy and abdominal packing. The donor subsequently suffered brain death, and the family consented to organ donation. A multiorgan procurement was performed with respective transplantation of the procured organs (heart, liver, and both kidneys) into 4 separate recipients. Peritoneal swab cultures performed at the time of organ recovery grew out MDR Pseudomonas aeruginosa on the day after procurement, subsequently followed by positive blood and sputum cultures as well. All 4 transplant recipients subsequently developed infections with MDR P. aeruginosa, which appeared to be donor-derived with similar resistance patterns. Appropriate antibiotic coverage was initiated in all of the patients. Although 2 of the recipients died, mortality did not appear to be clearly associated with the donor-derived infections. This case illustrates the potential infectious risk associated with organs from donors with an OA, and suggests that aggressive surveillance for occult infections should be pursued.	[Watkins, A. C.; Vedula, G. V.; Samstein, B.; Kato, T.; Emond, J. C.; Guarrera, J. V.] Columbia Univ, Div Abdominal Organ Transplantat, Dept Med, Med Ctr, New York, NY USA; [Horan, J.] Columbia Univ, Div Infect Dis, Dept Med, Med Ctr, New York, NY USA; [Dellicarpini, K.] New York Organ Donor Network, New York, NY USA; [Pak, S. -W.; Daly, T.] Columbia Univ, Div Cardiothorac Surg, Dept Surg, Med Ctr, New York, NY USA	Guarrera, JV (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Liver Dis & Transplantat, 622 W 168th St,PH 14 Ctr,Room 202, New York, NY 10032 USA.	jjg46@columbia.edu	Samstein, Benjamin/AAJ-5846-2020	Samstein, Benjamin/0000-0002-3934-2564			Abikhaled JA, 1997, AM SURGEON, V63, P1109; Alkofer B, 2006, SEMIN LIVER DIS, V26, P221, DOI 10.1055/s-2006-947292; Aloush V, 2006, ANTIMICROB AGENTS CH, V50, P43, DOI 10.1128/AAC.50.1.43-48.2006; Barker DE, 2000, J TRAUMA, V48, P201, DOI 10.1097/00005373-200002000-00001; Blumberg E, 2010, SESS INF DIS SOC AM; Cameron AM, 2006, ANN SURG, V243, P748, DOI 10.1097/01.sla.0000219669.84192.b3; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Carmeli Y, 1999, ANTIMICROB AGENTS CH, V43, P1379, DOI 10.1128/AAC.43.6.1379; Fridkin SK, 1999, CLIN CHEST MED, V20, P303, DOI 10.1016/S0272-5231(05)70143-X; Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI [10.1586/erp.10.49, 10.1586/ERP.10.49]; Kubak BM, 2009, J HEART LUNG TRANSPL, V28, P260, DOI 10.1016/j.healun.2008.11.911; Lopez-Navidad A, 2003, CLIN TRANSPLANT, V17, P308, DOI 10.1034/j.1399-0012.2003.00119.x; MORRISON AJ, 1984, REV INFECT DIS, V6, pS627; Orlando G, 2009, TRANSPL INFECT DIS, V11, P442, DOI 10.1111/j.1399-3062.2009.00412.x; Subramonia S, 2009, WORLD J SURG, V33, P931, DOI 10.1007/s00268-009-9947-z	15	20	21	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1398-2273			TRANSPL INFECT DIS	Transpl. Infect. Dis.	JUN	2012	14	3					311	315		10.1111/j.1399-3062.2011.00712.x			5	Immunology; Infectious Diseases; Transplantation	Immunology; Infectious Diseases; Transplantation	956FY	WOS:000305076700014	22283979				2021-06-18	
J	Sise, MJ; Sise, CB; Thorndike, JF; Kahl, JE; Calvo, RY; Shackford, SR				Sise, Michael J.; Sise, C. Beth; Thorndike, Jonathan F.; Kahl, Jessica E.; Calvo, Richard Y.; Shackford, Steven R.			Withdrawal of care: A 10-year perspective at a Level I trauma center	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	70th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 14-17, 2011	Chicago, IL	Amer Assoc Surg Trauma		End-of-life care; futility; limitation of care; withdrawal of care; trauma center	OF-LIFE CARE; SUSTAINING TREATMENT; PALLIATIVE CARE; UNIT; DECISIONS; THERAPY; PATIENT; ICU; COMMUNICATION; SUPPORT	BACKGROUND: Withdrawal or limitation of care (WLC) in trauma patients has not been well studied. We reviewed 10 years of deaths at our adult Level I trauma center to identify the patients undergoing WLC and to describe the process of trauma surgeon-managed WLC. METHODS: This is a retrospective review of WLC. Each patient was assigned to one of three modes of WLC: care withdrawn, limited or no resuscitation, or organ harvest. Frequency, timing, and circumstances of WLC, including family involvement, ethics committee consultation, palliative care, and hospice, were reviewed. RESULTS: From 2000 through 2009, 375 patients died with WLC (54% of all deaths; 93% at >= 24 hours). For age >= 65 years, 80% were WLC. Overall, 15% had advance directive documents. Traumatic brain or high cervical spine injury was the cause of death in 63%. Factors associated with WLC included age, comorbidities, injury mechanism and severity, and nontrauma activation status. At time of death, 316 (84%) WLC were under trauma surgeon management. In this group, mode of WLC was care withdrawn in 74%, organ harvest in 20%, and limited or no resuscitation in 6%. Rationale for WLC in non-organ harvest patients was poor neurologic prognosis in 86% and futility in 76%. When family was identified, end-of-life discussions with physicians occurred in 100%. Conflicts over WLC occurred in 6.6% and were not associated with any demographic group. Ethics committee was involved in 2.8%. For care-withdrawn patients, median time to death from first WLC order was 6.6 hours. Palliative care and hospice consults (6% and 9%) increased yearly. CONCLUSIONS: WLC occurred in over 50% of all trauma deaths and exceeded 90% at >= 24 hours. Hospice and palliative care were increasingly important adjuncts to WLC. Guidelines for WLC should be developed to ensure quality end-of-life care for trauma patients in whom further care is futile. (J Trauma. 2012; 72: 1186-1193. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Sise, Michael J.; Sise, C. Beth; Thorndike, Jonathan F.; Kahl, Jessica E.; Calvo, Richard Y.; Shackford, Steven R.] Scripps Mercy Hosp, Trauma Serv, San Diego, CA 92103 USA	Sise, MJ (corresponding author), Scripps Mercy Hosp, Trauma Serv, 4077 5th Ave, San Diego, CA 92103 USA.	sise.mike@scrippshealth.org		Calvo, Richard/0000-0001-9147-2668			Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; Barnato AE, 2011, CRIT CARE MED, V39, P1663, DOI 10.1097/CCM.0b013e3182186e98; Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Breen CM, 2001, J GEN INTERN MED, V16, P283, DOI 10.1046/j.1525-1497.2001.00419.x; Burns KJ, 2011, J TRAUMA NURS, V18, P97; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooper Z, 2009, J TRAUMA, V66, P1327, DOI 10.1097/TA.0b013e31819ea047; Cronin M, 2006, 2 TRAUMA PROGRAM ART; Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Dunn Geoffrey P, 2010, Bull Am Coll Surg, V95, P16; Dunn GP, 2009, SURG PALLIATIVE CARE; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Gay EB, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.10.003; Hamel MB, 1999, ANN INTERN MED, V130, P116, DOI 10.7326/0003-4819-130-2-199901190-00005; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Kwak J, 2005, GERONTOLOGIST, V45, P634, DOI 10.1093/geront/45.5.634; Mack JW, 2010, ARCH INTERN MED, V170, P1533, DOI 10.1001/archinternmed.2010.322; Mosenthal AC, 2008, J TRAUMA, V64, P1587, DOI 10.1097/TA.0b013e318174f112; Muni S, 2011, CHEST, V139, P1025, DOI 10.1378/chest.10-3011; Nathens AB, 2008, J TRAUMA, V64, P81, DOI 10.1097/TA.0b013e31815dd4d7; Nelson JE, 2006, QUAL SAF HEALTH CARE, V15, P264, DOI 10.1136/qshc.2005.017707; Nelson JE, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.02.007; Nelson JE, 2010, CRIT CARE MED, V38, P1765, DOI 10.1097/CCM.0b013e3181e8ad23; OCALLAHAN JG, 1995, CRIT CARE MED, V23, P1567, DOI 10.1097/00003246-199509000-00018; Plaisier BR, 2002, AM SURGEON, V68, P159; Qaseem A, 2009, ANN INTERN MED, V150, P148; SHACKFORD SR, 1987, J TRAUMA, V27, P866, DOI 10.1097/00005373-198708000-00004; Trunkey DD, 2000, ARCH SURG-CHICAGO, V135, P34, DOI 10.1001/archsurg.135.1.34; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Watch LS, 2005, J TRAUMA, V59, P1320, DOI 10.1097/01.ta.0000196003.41799.41	31	20	20	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2012	72	5					1186	1191		10.1097/TA.0b013e31824d0e57			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	944JD	WOS:000304195100015	22673244				2021-06-18	
J	Larson, BE; Stockwell, DW; Boas, S; Andrews, T; Wellman, GC; Lockette, W; Freeman, K				Larson, Brett E.; Stockwell, David W.; Boas, Stefan; Andrews, Trevor; Wellman, George C.; Lockette, Warren; Freeman, Kalev			Cardiac Reactive Oxygen Species After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						traumatic brain injury; reactive oxygen species; adrenergic receptor antagonist	HEART-RATE-VARIABILITY; SUBARACHNOID HEMORRHAGE; BETA-ADRENOCEPTORS; PROPRANOLOL; BLOCKADE; STRESS; CATECHOLAMINES; ABNORMALITIES; HYPERTENSION; ATENOLOL	Background. Cardiovascular complications after traumatic brain injury (TBI) contribute to morbidity and mortality and may provide a target for therapy. We examined blood pressure and left ventricle contractility after TBI, and tested the hypothesis that beta-adrenergic blockade would decrease oxidative stress after TBI. Material and Methods. Rodents received fluid-percussioninjury or sham surgery, confirmed with magnetic resonance imaging (MRI) and histopathology. We followed recovery with sensorimotor coordination testing and blood pressure measurements. We assessed left ventricular ejection fraction using ECG-gated cardiac MRI and measured myocardial reactive oxygen species (ROS) with dihydroethidium. We randomized additional TBI and sham animals to postoperative treatment with propranolol or control, for measurement of ROS. Results. Blood pressure and cardiac contractility were elevated 48 h after TBI. Myocardial tissue sections showed increased ROS. Treatment with propranolol diminished ROS levels following TBI. Conclusions. TBI is associated with increased cardiac contractility and myocardial ROS; decreased myocardial ROS after beta-blockade suggests that sympathetic stimulation is a mechanism of oxidative stress. (C) 2012 Elsevier Inc. All rights reserved.	[Larson, Brett E.; Stockwell, David W.; Boas, Stefan; Wellman, George C.; Freeman, Kalev] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Andrews, Trevor] Univ Vermont, Dept Radiol, Burlington, VT 05405 USA; [Wellman, George C.] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA; [Lockette, Warren] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Andrews, Trevor] Philips Healthcare, Cleveland, OH USA	Freeman, K (corresponding author), Univ Vermont, Dept Surg, Burlington, VT 05405 USA.	Kalev.Freeman@uvm.edu		Andrews, Trevor/0000-0003-0331-1798	National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM098795]; US Department of EnergyUnited States Department of Energy (DOE) [SC 0001753]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL095488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM098795] Funding Source: NIH RePORTER	The project described was supported by grant number K08GM098795 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The MRI was supported in part by US Department of Energy SC 0001753. The authors acknowledge MRI technician: Jay Gonyea; ECG gating/ LVEF analysis: Tim Christian, M. D.; Surgery technician: Sheila Russell; Students: Angus Beal, Chary Loadholt, Peter Andriakos, Tabitha Trahan.	Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CONNOR RCR, 1969, AM HEART J, V78, P145, DOI 10.1016/0002-8703(69)90001-5; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; CRUICKSHANK JM, 1987, LANCET, V2, P585, DOI 10.1016/s0140-6736(87)92984-9; CRUICKSHANK JM, 1974, BRIT HEART J, V36, P395; Cushing H., 1901, B J HOPKINS HOSP, V12, P3; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Freeman N., 1939, AM J PHYSIOL, V128, P10; Grimson K., 1937, ANN SURG, V106, P25; Horinouchi T, 2007, LIFE SCI, V81, P399, DOI 10.1016/j.lfs.2007.06.003; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; Kakinuma Y, 1998, NAT MED, V4, P1078, DOI 10.1038/2070; KASTE M, 1981, J NEUROSURG, V55, P511, DOI 10.3171/jns.1981.55.4.0511; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Ley EJ, 2010, J SURG RES, V163, P142, DOI 10.1016/j.jss.2010.04.046; Maramattom BV, 2006, MAYO CLIN PROC, V81, P192, DOI 10.4065/81.2.192; Marano G, 2002, J HYPERTENS, V20, P763, DOI 10.1097/00004872-200204000-00036; Martin M, 2005, J TRAUMA, V59, P1086, DOI 10.1097/01.ta.0000190249.19668.37; Morris JA, 2006, J TRAUMA, V60, P1165, DOI 10.1097/01.ta.0000220384.04978.3b; Murakami K, 2011, TRANSL STROKE RES, V2, P72, DOI 10.1007/s12975-010-0052-2; NEILDWYER G, 1978, BRIT MED J, V2, P990, DOI 10.1136/bmj.2.6143.990; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Reichenbach DB, 1970, HUM PATHOL, V1, P26; ROBERTSON CS, 1984, NEUROSURGERY, V15, P307, DOI 10.1227/00006123-198409000-00003; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; SINGAL PK, 1983, ADV EXP MED BIOL, V161, P391; TAKITA M, 1995, PHARMACOL BIOCHEM BE, V50, P225, DOI 10.1016/0091-3057(94)00301-X; Troncoso Brindeiro CM, 2007, AM J PHYSIOL, V293, pH2971; Walker A., 1944, J NEUROSURG, V1, P14; Wisbach G, 2007, J TRAUMA, V63, P26, DOI 10.1097/TA.0b013e31806864e2	39	20	22	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	APR	2012	173	2					E73	E81		10.1016/j.jss.2011.09.056			9	Surgery	Surgery	906IQ	WOS:000301339100004	22172132	Green Accepted			2021-06-18	
J	Zhang, JY; Si, YL; Liao, J; Yan, GT; Deng, ZH; Xue, H; Wang, LH; Zhang, K				Zhang, Jin-Ying, Jr.; Si, Yi-Ling; Liao, Jie; Yan, Guang-Tao; Deng, Zi-Hui; Xue, Hui; Wang, Lu-Huan; Zhang, Kai			Leptin administration alleviates ischemic brain injury in mice by reducing oxidative stress and subsequent neuronal apoptosis	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Leptin; reperfusion injury; brain; oxidative stress; neuronal apoptosis	CEREBRAL-ISCHEMIA; REPERFUSION INJURY; RATS; PROTEIN; MECHANISMS	BACKGROUND: Recent research has indicates that leptin plays a protective role in traumatic brain injury. We studied the protective effect of leptin on cerebral ischemia/reperfusion injury by using mice transient focal cerebral ischemia/reperfusion injury model. METHODS: The distribution of I-125-leptin in the mouse brain was assessed by radioimmunoassay method. Mouse models of transient focal cerebral ischemia were established by occlusion of the right middle cerebral artery for two hours followed by 24 hours reperfusion. The neurologic deficits and infarct volume were determined using the Longa's score and 2,3,5-triphenyltetrazolium chloride staining, respectively. Regional cerebral blood flow was monitored by a laser-Doppler blood flowmeter. The levels of malondialdehyde, nitric oxide, nitric oxide synthase, and superoxide dismutase were detected according to respective assay kit. The histologic changes and neuronal apoptosis were observed with hematoxylin and eosin and transferase-mediated dUTP-biotin nick end labeling staining, respectively. The expression of B-cell lymphoma/lewkmia-2 (Bcl-2) and cysteineasparateprotease-3 (caspase-3) were investigated by Western blot and real-time polymerase chain reaction assay. RESULTS: Leptin decreased infarct volume and neurologic defects and improved regional cerebral blood flow and microvascular branch blood flow after injury. The malondialdehyde and nitric oxide levels were reduced, and superoxide dismutase level was increased after leptin treatment, which also minimized histologic changes and neuronal apoptosis, led to the upregulation of Bcl-2 and downregulation of caspase-3 expression after injury. CONCLUSIONS: Peripherally administered leptin crossed the blood-brain barrier and was distributed into multiple regions of the brain; in the brain, leptin directly alleviated the injury-evoked damages by reducing oxidative stress and neuronal apoptosis. (J Trauma. 2012;72:982-991. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Zhang, Jin-Ying, Jr.; Yan, Guang-Tao; Deng, Zi-Hui; Xue, Hui; Wang, Lu-Huan; Zhang, Kai] Chinese Gen Hosp PLA, Basic Med Inst, Biochem Res Lab, Beijing 100853, Peoples R China; [Si, Yi-Ling] Chinese Gen Hosp PLA, Basic Med Inst, Res Lab Mol Biol, Beijing 100853, Peoples R China; [Liao, Jie] Chinese Gen Hosp PLA, Basic Med Inst, Res Lab Med Expt & Test Ctr, Beijing 100853, Peoples R China	Zhang, JY (corresponding author), Chinese Gen Hosp PLA, Basic Med Inst, Biochem Res Lab, 28 Fuxing Rd, Beijing 100853, Peoples R China.	yan301@263.net			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30670821]	Supported by the National Natural Science Foundation of China (No. 30670821).	Avraham Y, 2010, CURR NEUROVASC RES, V7, P136, DOI 10.2174/156720210791184943; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; Eguchi M, 2008, FEBS J, V275, P3136, DOI 10.1111/j.1742-4658.2008.06465.x; Erkasap N, 2003, PEPTIDES, V24, P1181, DOI 10.1016/j.peptides.2003.06.007; Fliedner S, 2006, ENDOCRINOLOGY, V147, P2088, DOI 10.1210/en.2005-1016; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li Q, 2009, J MOL NEUROSCI, V37, P67, DOI 10.1007/s12031-008-9121-3; Lin J, 2005, WORLD J GASTROENTERO, V11, P1000, DOI 10.3748/wjg.v11.i7.1000; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Maness LM, 1998, ENDOCRINOLOGY, V139, P4556, DOI 10.1210/en.139.11.4556; Martijn C, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-27; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Nakka VP, 2008, MOL NEUROBIOL, V37, P7, DOI 10.1007/s12035-007-8013-9; Signore AP, 2008, J NEUROCHEM, V106, P1977, DOI 10.1111/j.1471-4159.2008.05457.x; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Woitzik J, 2008, FRONT BIOSCI-LANDMRK, V13, P1500, DOI 10.2741/2776; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yan GT, 2009, EUR J PHARMACOL, V616, P244, DOI 10.1016/j.ejphar.2009.06.039; Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985; Zhang F, 2008, J NEUROCHEM, V107, P578, DOI 10.1111/j.1471-4159.2008.05645.x; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	24	20	21	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2012	72	4					982	991		10.1097/TA.0b013e3182405459			10	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	925TO	WOS:000302784600041	22491615				2021-06-18	
J	Skotak, M; Wang, F; Chandra, N				Skotak, Maciej; Wang, Fang; Chandra, Namas			An in vitro injury model for SH-SY5Y neuroblastoma cells: Effect of strain and strain rate	JOURNAL OF NEUROSCIENCE METHODS			English	Article						In vitro TBI model; Strain and strain rate effect; Viability scale; Stretch induced injury	TRAUMATIC BRAIN-INJURY; MECHANICALLY INDUCED TRAUMA; STRETCH INJURY; SLICE CULTURES; NEURAL TRAUMA; LIVING BRAIN; CALCIUM; NEURONS; SYSTEM; DEFORMATION	There is a great need to have in vitro cell injury model wherein a wide range of strain (6) and strain rate ((epsilon)over dot) can be precisely and independently applied. Such a model will enable exploration of various biomechanical loading conditions cells normally encounter during either blunt or blast impact-induced traumatic brain injuries (TBIs). In combination with a highly automated data acquisition and analysis system, this method can quickly generate a large data set of experimental results to yield identification of bio-mechanical and chemical sequelae following injury. A proper understanding of these sequelae will enable the discovery of the time window of opportunity available for pharmacological interventions. In this study we present such an injury model, a modified version of the Cultured Axonal Injury (CAI) device, and demonstrate its efficacy through viability of SH-SY5Y cells at different ranges of strain (0-140%) and strain rate (15-68 s(-1)). We identified three different regimes in the stretch-induced dose-response of curves of SH-SY5Y cells, with a very sharp decline from live to dead in a narrow range of strain (30-55%). The effect of strain rate is minimal when the final strain in the cells was fixed at 50%. The model further shows that time-after-injury plays a vital role in the determination of recovery-deterioration pathways and the biological selection depends on the severity of initial injury. These data point out the initial strain level is vital to the cell fate and emphasize the need to study the various mechanisms triggered by different magnitudes of initial injuries. (C) 2012 Elsevier B.V. All rights reserved.	[Skotak, Maciej; Wang, Fang; Chandra, Namas] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA	Chandra, N (corresponding author), Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA.	nchandra2@unl.edu	Skotak, Maciej/H-4769-2019	Skotak, Maciej/0000-0003-2584-7294	US Army Research Office "Army-UNL Center of Trauma Mechanics" [W911NF-08-10483]; College of Engineering	Financial support under the US Army Research Office project "Army-UNL Center of Trauma Mechanics" (Contract No. W911NF-08-10483) is gratefully acknowledged. Partial financial support provided by the College of Engineering is acknowledged. We are grateful to Dr. Douglas Smith (University of Pennsylvania) for helpful comments during development of the injury model.	Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bose A, 2011, BRAIN PATHOL, V21, P189, DOI 10.1111/j.1750-3639.2010.00437.x; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Cargill RS, 1999, BIOMATERIALS, V20, P2417, DOI 10.1016/S0142-9612(99)00169-6; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Decressac M., NEUROBIOL AGING; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Engel DC, 2005, NEUROPHARMACOLOGY, V49, P985, DOI 10.1016/j.neuropharm.2005.05.021; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Harnett MM, 2007, NAT REV IMMUNOL, V7, P897, DOI 10.1038/nri2188; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; OLIVER JD, 1992, J AM SOC NEPHROL, V3, P214; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Slemmer JE, 2004, NEUROBIOL DIS, V15, P563, DOI 10.1016/j.nbd.2003.11.027; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 1999, J NEUROSCI, V19, P4263; Stroetz RW, 2001, J APPL PHYSIOL, V90, P2361; WINSTON FK, 1989, J APPL PHYSIOL, V67, P397; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	39	20	20	1	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAR 30	2012	205	1					159	168		10.1016/j.jneumeth.2012.01.001			10	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	911AB	WOS:000301688600017	22257521				2021-06-18	
J	Archambault, PM; Bilodeau, A; Gagnon, MP; Aubin, K; Lavoie, A; Lapointe, J; Poitras, J; Croteau, S; Pham-Dinh, M; Legare, F				Archambault, Patrick Michel; Bilodeau, Andrea; Gagnon, Marie-Pierre; Aubin, Karine; Lavoie, Andre; Lapointe, Jean; Poitras, Julien; Croteau, Sylvain; Pham-Dinh, Martin; Legare, France			Health Care Professionals' Beliefs About Using Wiki-Based Reminders to Promote Best Practices in Trauma Care	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						Wiki; Collaborative writing applications; Web 2.0; traumatic brain injury; interprofessional collaboration; reminders; computerized clinical decision-support system; knowledge translation; evidence-based medicine; theory of planned behavior	CLINICAL DECISION-SUPPORT; BRAIN-INJURY GUIDELINES; INFORMATION-TECHNOLOGY; PATIENT OUTCOMES; PLANNED BEHAVIOR; AUDIT FILTERS; RESOURCE UTILIZATION; LONGITUDINAL-FIELD; AMERICAN-COLLEGE; USER ACCEPTANCE	Background : Wikis are knowledge translation tools that could help health professionals implement best practices in acute care. Little is known about the factors influencing professionals' use of wikis. Objectives : To identify and compare the beliefs of emergency physicians (EPs) and allied health professionals (AHPs) about using a wiki-based reminder that promotes evidence-based care for traumatic brain injuries. Methods : Drawing on the theory of planned behavior, we conducted semistructured interviews to elicit EPs' and AHPs' beliefs about using a wiki-based reminder. Previous studies suggested a sample of 25 EPs and 25 AHPs. We purposefully selected participants from three trauma centers in Quebec, Canada, to obtain a representative sample. Using univariate analyses, we assessed whether our participants' gender, age, and level of experience were similar to those of all eligible individuals. Participants viewed a video showing a clinician using a wiki-based reminder, and we interviewed participants about their behavioral, control, and normative beliefs-that is, what they saw as advantages, disadvantages, barriers, and facilitators to their use of a reminder, and how they felt important referents would perceive their use of a reminder. Two reviewers independently analyzed the content of the interview transcripts. We considered the 75% most frequently mentioned beliefs as salient. We retained some less frequently mentioned beliefs as well. Results : Of 66 eligible EPs and 444 eligible AHPs, we invited 55 EPs and 39 AHPs to participate, and 25 EPs and 25 AHPs (15 nurses, 7 respiratory therapists, and 3 pharmacists) accepted. Participating AHPs had more experience than eligible AHPs (mean 14 vs 11 years; P =.04). We noted no other significant differences. Among EPs, the most frequently reported advantage of using a wiki-based reminder was that it refreshes the memory (n = 14); among AHPs, it was that it provides rapid access to protocols (n = 16). Only 2 EPs mentioned a disadvantage (the wiki added stress). The most frequently reported favorable referent was nurses for EPs (n = 16) and EPs for AHPs (n = 19). The most frequently reported unfavorable referents were people resistant to standardized care for EPs (n = 8) and people less comfortable with computers for AHPs (n = 11). The most frequent facilitator for EPs was ease of use (n = 19); for AHPs, it was having a bedside computer (n = 20). EPs' most frequently reported barrier was irregularly updated wiki-based reminders (n = 18); AHPs'was undetermined legal responsibility (n = 10). Conclusions : We identified EPs' and AHPs' salient beliefs about using a wiki-based reminder. We will draw on these beliefs to construct a questionnaire to measure the importance of these determinants to EPs' and AHPs' intention to use a wiki-based reminder promoting evidence-based care for traumatic brain injuries.	[Archambault, Patrick Michel; Bilodeau, Andrea; Aubin, Karine; Lapointe, Jean; Poitras, Julien] Ctr Hosp Affilie Univ Levis, Ctr Sante & Serv Sociaux Alphonse Desjardins, Levis, PQ G6V 3Z1, Canada; [Archambault, Patrick Michel; Poitras, Julien; Legare, France] Univ Laval, Fac Med, Dept Med Familiale & Med Urgence, Quebec City, PQ G1K 7P4, Canada; [Archambault, Patrick Michel; Lavoie, Andre; Poitras, Julien] CHA Univ Quebec, Ctr Rech FRQS, Quebec City, PQ, Canada; [Archambault, Patrick Michel; Gagnon, Marie-Pierre; Legare, France] Ctr Hosp Univ Quebec CRCHUQ, Ctr Rech, Quebec City, PQ, Canada; [Bilodeau, Andrea; Gagnon, Marie-Pierre; Aubin, Karine] Univ Laval, Fac Sci Infirmieres, Quebec City, PQ, Canada; [Lapointe, Jean] Inst Natl Excellence Sante & Serv Sociaux, Montreal, PQ, Canada; [Croteau, Sylvain; Pham-Dinh, Martin] Hop Gatineau, Gatineau, PQ, Canada	Archambault, PM (corresponding author), Ctr Hosp Affilie Univ Levis, Ctr Sante & Serv Sociaux Alphonse Desjardins, 143 Rue Wolfe, Levis, PQ G6V 3Z1, Canada.	patrick.m.archambault@gmail.com	legare, france/O-6971-2017; Gagnon, Marie-Pierre/I-3013-2019	legare, france/0000-0002-2296-6696; Gagnon, Marie-Pierre/0000-0002-0782-5457	CADRE [PDA 1850]; Canadian Health Services Research Foundation; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); KT Canada; Departement de medecine familiale et medecine d'urgence at Universite Laval; CSSS Alphonse-Desjardins (CHAU de Levis)	Funding for this project was provided by a CADRE program (reference number: PDA 1850) (supported by a partnership between the Canadian Health Services Research Foundation and the Canadian Institutes of Health Research). KT Canada, the Departement de medecine familiale et medecine d'urgence at Universite Laval and CSSS Alphonse-Desjardins (CHAU de Levis) also contributed funding. The funding agencies and organizations did not influence the content of the manuscript. France Legare holds the Canada Research Chair in Implementation of Shared Decision Making in Primary Care and is a member of KT Canada. Marie-Pierre Gagnon holds the Tier 2 Canada Research Chair in Technologies and Practices in Health and is a KT Canada member. We thank Jennifer Petrela for editing the manuscript, Yves Lessard for drawing the cartoons for the video, Alain Audet for filming the video, and Amelie Bourassa for sharing parts of a video she produced. We also thank Lee LeFever and Common Craft for permitting us to adapt the original Wikis in Plain English video for our study. We thank all the actors in the video: Isabelle Bertrand, Marie-Maude Couture, Renee Turgeon, Amelie Bourassa, Mathieu Simon, Robert Doucet, and Andre Villeneuve. We also thank Jean-Francois Rancourt, Luc Genier, Marcel Emond, Alexis Turgeon, Natalie Lesage, Manon Vallieres, Caroline Boutin, and Cynthia Fournier for their help in organizing this project. We are also very grateful to all the emergency physicians, nurses, respiratory therapists, and pharmacists who volunteered to answer our survey.	Agha Riaz, 2006, Int J Surg, V4, P140, DOI 10.1016/j.ijsu.2006.07.002; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1988, ATTITUDES PERSONALIT; Alch ML, 2000, FUTURIST, V34, P42; Ammenwerth Elske, 2006, BMC Med Inform Decis Mak, V6, P3, DOI 10.1186/1472-6947-6-3; [Anonymous], 2005, QUICKCALCS ONLINE CA; Archambault PM, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-45; Balas EA, 2000, ARCH INTERN MED, V160, P301, DOI 10.1001/archinte.160.3.301; Barwick MA, 2009, J CAN ACAD CHILD ADO, V18, P16; Berner ES, 2009, CLIN DECISION SUPPOR; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Boulos Maged N Kamel, 2006, BMC Med Educ, V6, P41, DOI 10.1186/1472-6920-6-41; BUNTINX F, 1993, FAM PRACT, V10, P219, DOI 10.1093/fampra/10.2.219; Conner M., 1996, PREDICTING HLTH BEHA; COPES WS, 1995, J TRAUMA, V38, P432, DOI 10.1097/00005373-199503000-00027; Cresswell KM, 2011, BMJ QUAL SAF, V20, P625, DOI 10.1136/bmjqs.2010.048934; Croskerry P, 2011, J ROY COLL PHYS EDIN, V41, P155, DOI 10.4997/JRCPE.2011.208; Cryer HG, 1996, J TRAUMA, V41, P389, DOI 10.1097/00005373-199609000-00003; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Deshpande Amol, 2009, Open Med, V3, pe69; Dijkstra R, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-53; Eichner J, 2010, CHALLENGES BARRIERS; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Eysenbach G, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1030; Faber MJ, 2011, MED 2 0 SEP 17 18 20; Gagnon Marie-Pierre, 2007, Inform Prim Care, V15, P83; Gagnon MP, 2012, J MED SYST, V36, P241, DOI 10.1007/s10916-010-9473-4; Gagnon MP, 2003, INT J MED INFORM, V71, P103, DOI 10.1016/S1386-5056(03)00094-7; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; GODIN G, 1992, MED CARE, V30, P199, DOI 10.1097/00005650-199203000-00002; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Graham ID, 2007, ACAD EMERG MED, V14, P936, DOI 10.1197/j.aem.2007.07.004; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; Gupta S, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1833; HARTWICK J, 1994, MANAGE SCI, V40, P440, DOI 10.1287/mnsc.40.4.440; Heilman JM, 2011, J MED INTERNET RES, V13, P153, DOI 10.2196/jmir.1589; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hoffmann R, 2008, NAT GENET, V40, P1047, DOI 10.1038/ng.f.217; Hughes B, 2009, INT J MED INFORM, V78, P645, DOI 10.1016/j.ijmedinf.2009.04.008; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Johnston, 2004, CONSTRUCTING QUESTIO; JOHNSTON ME, 1994, ANN INTERN MED, V120, P135, DOI 10.7326/0003-4819-120-2-199401150-00007; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Lapointe L, 2006, CAN MED ASSOC J, V174, P1573, DOI 10.1503/cmaj.050281; LeFever L, WIKIS PLAIN ENGLISH; Liabsuetrakul T, 2003, SOC SCI MED, V57, P1665, DOI 10.1016/S0277-9536(02)00550-6; Lupianez-Villanueva F, 2009, INFORM HEALTH SOC CA, V34, P117, DOI 10.1080/17538150903102265; MANDELBLATT J, 1995, J FAM PRACTICE, V40, P162; Masters K, 2008, INT J MED INFORM, V77, P4, DOI 10.1016/j.ijmedinf.2006.10.002; Mavergames C, 2009, WEB 2 0 COCHRANE COL; McDermott FT, 2001, BRIT J SURG, V88, P1099, DOI 10.1046/j.0007-1323.2001.01835.x; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; Mcgowan B, 2011, MED 2 0 SEP 17 18 20; Millstein SG, 1996, HEALTH PSYCHOL, V15, P398, DOI 10.1037/0278-6133.15.5.398; Morris MG, 2000, PERS PSYCHOL, V53, P375, DOI 10.1111/j.1744-6570.2000.tb00206.x; NAYDUCH D, 1994, J TRAUMA, V37, P565, DOI 10.1097/00005373-199410000-00008; O'Keefe GE, 1999, J TRAUMA, V46, P473, DOI 10.1097/00005373-199903000-00023; Overhage JM, 1997, J AM MED INFORM ASSN, V4, P364, DOI 10.1136/jamia.1997.0040364; Ovretveit J, 2007, INT J QUAL HEALTH C, V19, P259, DOI 10.1093/intqhc/mzm031; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Park ER, 2003, ANN BEHAV MED, V25, P120, DOI 10.1207/S15324796ABM2502_08; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Renold E., 2002, BUILD RES CAPACITY, V3, P3; RHODES M, 1990, J TRAUMA, V30, P724, DOI 10.1097/00005373-199006000-00012; Rogers EM., 2003, DIFFUSION INNOVATION, V5th ed; Rutter D, 2002, CHANGING HLTH BEHAV, P1; Sahota N, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-91; Sandars J, 2007, POSTGRAD MED J, V83, P759, DOI 10.1136/pgmj.2007.063123; Shojania KG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001096.pub2; Sittig DF, 2008, J BIOMED INFORM, V41, P387, DOI 10.1016/j.jbi.2007.09.003; Sittig Dean F, 2006, BMC Med Inform Decis Mak, V6, P6, DOI 10.1186/1472-6947-6-6; Sittig DF, 2010, INT J MED INFORM, V79, P44, DOI 10.1016/j.ijmedinf.2009.09.003; TAYLOR S, 1995, INFORM SYST RES, V6, P144, DOI 10.1287/isre.6.2.144; Teich JM, 2000, ARCH INTERN MED, V160, P2741, DOI 10.1001/archinte.160.18.2741; THOMPSON RL, 1991, MIS QUART, V15, P125, DOI 10.2307/249443; Tierney WM, 2003, J GEN INTERN MED, V18, P967, DOI 10.1111/j.1525-1497.2003.30635.x; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V, 2003, MIS QUART, V27, P425; Venkatesh V, 2000, ORGAN BEHAV HUM DEC, V83, P33, DOI 10.1006/obhd.2000.2896; Verhoeven F, 2009, INT J MED INFORM, V78, P663, DOI 10.1016/j.ijmedinf.2009.06.001; Walker AE, 2001, BRIT J HEALTH PSYCH, V6, P347, DOI 10.1348/135910701169250; WARSHAW PR, 1980, J MARKETING RES, V17, P153, DOI 10.2307/3150927; Webb TL, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1376; Weingart SN, 2003, ARCH INTERN MED, V163, P2625, DOI 10.1001/archinte.163.21.2625; Wensing M, 1994, Int J Qual Health Care, V6, P115; Wright A, 2009, J BIOMED INFORM, V42, P334, DOI 10.1016/j.jbi.2008.09.003; Yusof MM, 2008, INT J MED INFORM, V77, P386, DOI 10.1016/j.ijmedinf.2007.08.011	90	20	20	0	29	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	MAR-APR	2012	14	2							e49	10.2196/jmir.1983			22	Health Care Sciences & Services; Medical Informatics	Health Care Sciences & Services; Medical Informatics	948VL	WOS:000304530800022	22515985	DOAJ Gold, Green Published			2021-06-18	
J	Bernocchi, P; Scalvini, S; Tridico, C; Borghi, G; Zanaboni, P; Masella, C; Glisenti, F; Marzegalli, M				Bernocchi, Palmira; Scalvini, Simonetta; Tridico, Caterina; Borghi, Gabriella; Zanaboni, Paolo; Masella, Cristina; Glisenti, Fulvio; Marzegalli, Maurizio			Healthcare Continuity From Hospital to Territory in Lombardy: TELEMACO Project	AMERICAN JOURNAL OF MANAGED CARE			English	Article							RESPIRATORY-FAILURE PATIENTS; CHRONIC HEART-FAILURE; DISEASE; METAANALYSIS; MANAGEMENT; TRIAL; QUESTIONNAIRE; TELEMEDICINE; TELEHEALTH; ASSISTANCE	Objectives: To verify implementation and use of TELEMACO (TELEMedicina Ai piccoli COmunilombardi; http://www.telemaco.regione.lombardia.it/), which provides specialized continuity of care with innovative healthcare services in remote areas of the Lombardy region of Italy; to design a network in the territory for sharing of continuityof- care programs; and to allow the relevant health authorities to collect cost data to establish a model for sustainable pricing for implementing these services. Methods: TELEMACO provides home-based telemanagement services for patients with chronic heart failure and chronic obstructive pulmonary disease (COPD), as well as second-opinion teleconsultations in cardiology, dermatology, diabetology, and pulmonology for general practitioners and second-opinion teleconsultations on digital images in cases of traumatic brain injury and stroke. A total of 2 service centers, 10 cardiology and pneumology departments, 30 specialists, 176 general practitioners, 40 nurses, 2 emergency departments, and 2 consultant hospitals were involved. Results: A total of 166 patients with chronic heart failure and 474 patients with COPD were enrolled. There were 4830, 51, and 44 second-opinion teleconsultations for cardiologic, dermatologic, and diabetic conditions, respectively. There were 147 second-opinion teleconsultations on digital images, 68 for stroke, and 79 for traumatic brain injury. Implementation of TELEMACO introduced innovations on working methods and provided evidence to the health authorities for allocating funds for such services. Conclusions: TELEMACO provided evidence that there is a growing need for home management of patients using telemedicine, a common and efficacious approach that can ensure care continuity, especially in chronic diseases.	[Bernocchi, Palmira; Scalvini, Simonetta] Fdn Salvatore Maugeri, IRCCS, Telemed Serv, Ctr Lumezzane, I-25066 Lumezzane, Brescia, Italy; [Tridico, Caterina] San Carlo Borromeo Hosp, Hlth Directorate, Milan, Italy; [Borghi, Gabriella] CEFRIEL, Milan, Italy; [Zanaboni, Paolo; Masella, Cristina] Politecn Milan, Dept Management Econ & Ind Engn, I-20133 Milan, Italy; [Glisenti, Fulvio] Hlth Telemat Network, Brescia, Italy; [Marzegalli, Maurizio] San Carlo Borromeo Hosp, Dept Cardiol, Milan, Italy	Bernocchi, P (corresponding author), Fdn Salvatore Maugeri, IRCCS, Telemed Serv, Ctr Lumezzane, Via Giuseppe Mazzini 129, I-25066 Lumezzane, Brescia, Italy.	palmira.bernocchi@fsm.it	Bernocchi, Palmira/R-6523-2019; Scalvini, Simonetta/AAB-8992-2020; scalvini, simonetta/ABG-9872-2020; Bernocchi, Palmira/AAB-8661-2020	scalvini, simonetta/0000-0001-7387-505X; Bernocchi, Palmira/0000-0003-0875-2007	Ministry of Health, Ministry of Innovation and Technologies and Lombardy region [VII/19768]; INTESA ISTITUZIONALE di PROGRAMMA tra il Governo della Repubblica Italiana e la regione Lombardia II Atto integrativo dell accordo di programma Quadro in Materia di Societa dell Informazione nella regione Lombardia; Ministry of Health [E1,600,000.00]; Ministry of Innovation and Technologies [450,000.00]; Lombardy regionRegione Lombardia [E1,386,084.86]	Ministry of Health, Ministry of Innovation and Technologies and Lombardy region: regional Law 11/2004; DGR No VII/19768 of 10/12/2004 and INTESA ISTITUZIONALE di PROGRAMMA tra il Governo della Repubblica Italiana e la regione Lombardia II Atto integrativo dell accordo di programma Quadro in Materia di Societa dell Informazione nella regione Lombardia. Funding received for the TELEMACO Project is summarized as follows: Funding from Ministry of Health: E1,600,000.00. Funding from Ministry of Innovation and Technologies: 450,000.00. Funding from Lombardy region E1,386,084.86. Total: E3,436,084.86.	Backman W, 2010, J ROY SOC MED, V103, P442, DOI 10.1258/jrsm.2010.100301; Beretta L, 2007, RHEUMATOLOGY, V46, P296, DOI 10.1093/rheumatology/kel221; Bove AA, 2011, AM HEART J, V161, P351, DOI 10.1016/j.ahj.2010.11.008; Giordano A, 2009, INT J CARDIOL, V131, P192, DOI 10.1016/j.ijcard.2007.10.027; Glisenti Fulvio, 2005, Monaldi Arch Chest Dis, V64, P139; Hines PA, 2010, NURS ECON, V28, P74; Inglis SC, 2011, EUR J HEART FAIL, V13, P1028, DOI 10.1093/eurjhf/hfr039; Martinelli Giovanna, 2005, Monaldi Arch Chest Dis, V64, P140; McLean S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d120; Moffatt JJ, 2010, AUST HEALTH REV, V34, P276, DOI 10.1071/AH09794; Peake SL, 2007, CURR OPIN CRIT CARE, V13, P720, DOI 10.1097/MCC.0b013e3282f1bb21; Pezzella FR, 2009, STROKE, V40, P2557, DOI 10.1161/STROKEAHA.108.534495; Polisena J, 2010, J TELEMED TELECARE, V16, P120, DOI 10.1258/jtt.2009.090812; RECTOR TS, 1992, AM HEART J, V124, P1017, DOI 10.1016/0002-8703(92)90986-6; Roccaforte R, 2005, EUR J HEART FAIL, V7, P1133, DOI 10.1016/j.ejheart.2005.08.005; Rygh E M, 2007, Rural Remote Health, V7, P766; Scalvini S, 2005, J TELEMED TELECARE, V11, P325, DOI 10.1258/135763305774472051; Scalvini S, 2009, TELEMED J E-HEALTH, V15, P261, DOI 10.1089/tmj.2008.0109; Sibbald Bonnie, 2007, J Health Serv Res Policy, V12, P110; Taylor P, 1998, J TELEMED TELECARE, V4, P63, DOI 10.1258/1357633981931948; TEASDALE G, 1974, LANCET, V2, P81; Vitacca M, 2009, EUR RESPIR J, V33, P411, DOI 10.1183/09031936.00005608; Vitacca M, 2010, TELEMED J E-HEALTH, V16, P299, DOI 10.1089/tmj.2009.0115; While A, 2011, INT J NURS STUD, V48, P1302, DOI 10.1016/j.ijnurstu.2011.02.020; Zanaboni P, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-238	25	20	20	1	18	MANAGED CARE & HEALTHCARE COMMUNICATIONS LLC	PLAINSBORO	666 PLAINSBORO RD, STE 300, PLAINSBORO, NJ 08536 USA	1088-0224			AM J MANAG CARE	Am. J. Manag. Care	MAR	2012	18	3					E101	E108					8	Health Care Sciences & Services; Health Policy & Services; Medicine, General & Internal	Health Care Sciences & Services; General & Internal Medicine	001EH	WOS:000308442600009	22435961				2021-06-18	
J	Li, DR; Zhang, F; Wang, Y; Tan, XH; Qiao, DF; Wang, HJ; Michiue, T; Maeda, H				Li, Dong-Ri; Zhang, Fu; Wang, Yao; Tan, Xiao-Hui; Qiao, Dong-Fang; Wang, Hui-Jun; Michiue, Tomomi; Maeda, Hitoshi			Quantitative analysis of GFAP- and S100 protein-immunopositive astrocytes to investigate the severity of traumatic brain injury	LEGAL MEDICINE			English	Article						Forensic pathology; Brain injury; Astrocyte; Glial fibrillary acidic protein; S100 protein; Immunohistochemistry	DIFFUSE AXONAL INJURY; FIBRILLARY ACIDIC PROTEIN; DELAYED NEURONAL DEATH; DURET HEMORRHAGE; WHITE-MATTER; RAT-BRAIN; EDEMA; EXPRESSION; HERNIATION; ISCHEMIA	Previous studies have shown that diffuse cortical astrocyte damage is seen in acute deaths due to brain injury and mechanical asphyxiation. The present study quantitatively investigated the number of astrocytes that showed GFAP- and S100-protein immunopositivity in the cerebral white matter and hippocampus at the sites distant from primary injury with regard to survival time, complication, and the immediate cause of death of brain injury cases. Autopsy cases of brain injury (8-48 h postmortem) comprising acute/subacute deaths (survival time, <3/6 h-3 days; n = 27/42) and delayed deaths (survival time >3 days) with/without complications (n = 30/22) were examined. Delayed death cases with complications were subdivided into those in which the immediate cause of death had been determined as cerebral dysfunction (n = 22) and those that had been determined as due to fatal complications (n = 8). For controls, natural deaths from pneumonias (n = 12) and sudden cardiac deaths (n = 27) were used. In brain injury cases, the numbers of astrocytes in the cerebral white matter and hippocampal CA4 region were significantly lower for subacute death and delayed death without complications (p < 0.05-0.001). Delayed death with fatal complications showed a significant increase in the number of astrocytes (p < 0.05). Among delayed death cases, the numbers of astrocytes were higher in the cases with fatal complications than in those without complications and with non-fatal complications, although the latter cases showed large variations in the numbers of these astrocytes. These findings suggest that critical brain injury causes acute death without evident astrocyte pathology and that subacute death is associated with progressive brain damage accompanied by an astrocyte loss. In delayed death cases, the numbers astrocytes might be closely related to the severity of posttraumatic brain injury. GFAP and S100-immunopositivity might be useful for elucidating the cause and process of deaths due to brain injury. (C) 2012 Published by Elsevier Ireland Ltd.	[Li, Dong-Ri; Zhang, Fu; Wang, Yao; Tan, Xiao-Hui; Qiao, Dong-Fang; Wang, Hui-Jun] So Med Univ, Dept Forens Med, Guangzhou 510515, Guangdong, Peoples R China; [Li, Dong-Ri; Michiue, Tomomi; Maeda, Hitoshi] Osaka City Univ, Sch Med, Dept Legal Med, Osaka 5458585, Japan	Wang, HJ (corresponding author), So Med Univ, Dept Forens Med, Guangzhou 510515, Guangdong, Peoples R China.	lidongri0828@hotmail.com			Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [22590642] Funding Source: KAKEN		ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; AMADUCCI L, 1981, NEUROSCI LETT, V21, P27, DOI 10.1016/0304-3940(81)90052-5; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Baldwin SA, 1996, GLIA, V16, P266; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; DONATO R, 1986, CELL CALCIUM, V7, P123, DOI 10.1016/0143-4160(86)90017-5; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; GRAHAM DI, 1992, J CLIN PATHOL, V45, P840, DOI 10.1136/jcp.45.9.840; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; Jenkins LW, 1982, RECENT PROGR STUDY T, P525; Kakinuma Y, 1998, NAT MED, V4, P1078, DOI 10.1038/2070; Kamijo Y, 2005, AM J EMERG MED, V23, P908, DOI 10.1016/j.ajem.2005.07.014; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; Kubo Shin-Ichi, 1998, Journal of Medical Investigation, V44, P109; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; Li Dong-Ri, 2006, Legal Medicine, V8, P71, DOI 10.1016/j.legalmed.2005.07.004; Li Dong-Ri, 2006, Legal Medicine, V8, P78, DOI 10.1016/j.legalmed.2005.09.002; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Lipton P, 1999, PHYSIOL REV, V79, P1431; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; LONG DM, 1966, J NEUROPATH EXP NEUR, V25, P373, DOI 10.1097/00005072-196607000-00003; Nelson LR, 1982, COMP ANIMAL HEAD INJ, P117; OBRENOVITCH TP, 1995, CEREBROVAS BRAIN MET, V7, P1; Oehmichen M, 2006, FORENSIC NEUROPATHOL, P7; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; Pittella JEH, 2003, J FORENSIC SCI, V48, P626; Privat Alain, 1995, P3; Stewart W, 2004, FORENSIC SCI INT, V146, P125, DOI 10.1016/j.forsciint.2004.06.025; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; SWANSON RA, 1992, NEUROSCI LETT, V147, P143, DOI 10.1016/0304-3940(92)90580-Z; Swanson RA, 1997, GLIA, V21, P142, DOI 10.1002/(SICI)1098-1136(199709)21:1<142::AID-GLIA16>3.0.CO;2-S; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Walz W, 2000, GLIA, V31, P95, DOI 10.1002/1098-1136(200008)31:2<95::AID-GLIA10>3.0.CO;2-6; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	42	20	21	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	MAR	2012	14	2					84	92		10.1016/j.legalmed.2011.12.007			9	Medicine, Legal; Social Sciences, Biomedical	Legal Medicine; Biomedical Social Sciences	902KU	WOS:000301037800005	22301378				2021-06-18	
J	Vincent, AS; Roebuck-Spencer, T; Lopez, MS; Twillie, DA; Logan, BW; Grate, SJ; Friedl, KE; Schlegel, RE; Gilliland, K				Vincent, Andrea S.; Roebuck-Spencer, Tresa; Lopez, Mary S.; Twillie, David A.; Logan, Bret W.; Grate, Stephen J.; Friedl, Karl E.; Schlegel, Robert E.; Gilliland, Kirby			Effects of Military Deployment on Cognitive Functioning	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; PERFORMANCE; IRAQ; MOOD; ANAM; WAR; AFGHANISTAN; VALIDATION; DECREMENTS	Military deployment poses many risks for cognitive functioning. When deployed individuals are compared to a nondeployed control group, there is some evidence that deployment may be associated with declines in cognitive functioning. The current study examined cognitive performance before and following deployment in a large sample of active duty military personnel (N = 8,002) who reported no traumatic brain injury (TBI). Cognition was assessed using the Automated Neuropsychological Assessment Metrics version 4 TBI Military (ANAM4 TBI-MIL) battery, a computer-based battery of tests measuring attention, processing speed, and general cognitive efficiency. Pre- and postdeployment scores were compared using repeated measures analyses. Although statistically significant differences were observed for all tests (with 5 of 7 tests demonstrating performance improvement), effect sizes were very small for all but I test, indicating that performance differences had minimal clinical significance. Likewise, determination of change for individuals using reliable change indices revealed that a very small percentage (<3%) of this presumed healthy sample showed meaningful decline in cognition following deployment. Analyses indicated that despite risks for cognitive decline while in theater, deployment had minimal to no lasting effect on cognition as measured by ANAM4 TBI-Mil upon return from deployment.	[Vincent, Andrea S.; Roebuck-Spencer, Tresa; Schlegel, Robert E.; Gilliland, Kirby] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73072 USA; [Lopez, Mary S.] US Army Bavaria Med Dept Act BMEDDAC, Rose Barracks, Vilseck, Germany; [Twillie, David A.; Logan, Bret W.] Blanchfield Army Community Hosp, Ft Campbell, KY 42223 USA; [Grate, Stephen J.; Friedl, Karl E.] USA, Telemed & Adv Res Ctr, Med Res & Mat Command, Ft Detrick, MD 21702 USA	Vincent, AS (corresponding author), Univ Oklahoma, Cognit Sci Res Ctr, 3200 Marshall Ave,Suite 260, Norman, OK 73072 USA.		Friedl, Karl/M-1803-2019	Friedl, Karl/0000-0002-3134-8427	DoDUnited States Department of Defense; Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick [W8IXWH-07-2-0097]	This data analysis was conducted by the Cognitive Science Research Center (CSRC) at the University of Oklahoma and is made possible by a DoD Grant awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD, under contract number W8IXWH-07-2-0097.	Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Bradshaw D, 2007, US ARMY TRAUMATIC BR; Brunner HI, 2007, ARTHRIT RHEUM-ARTHR, V57, P1174, DOI 10.1002/art.23005; Casscells SW, 2008, MEMORANDUM BASELINE; Chelune GJ, 1993, NEUROPSYCHOLOGY, V7, P41, DOI DOI 10.1037/0894-4105.7.1.41; Cohen J, 1988, STAT POWER BEHAV SCI; Farmer K, 2001, HEADACHE, V41, P377, DOI 10.1046/j.1526-4610.2001.111006377.x; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Harris WC, 2005, MIL PSYCHOL, V17, P115, DOI 10.1207/s15327876mp1702_4; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holliday SL, 2003, LUPUS, V12, P697, DOI 10.1191/0961203303lu442oa; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kane RL, 1996, J INT NEUROPSYCH SOC, V2, P68; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kay GG, 1997, ARCH INTERN MED, V157, P2350, DOI 10.1001/archinte.157.20.2350; Labutta RJ, 2007, USE AUTOMATED NEUROP; Lieberman HR, 2005, AVIAT SPACE ENVIR MD, V76, pC7; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; Lowe M, 2007, ARCH CLIN NEUROPSYCH, V22, pS89, DOI 10.1016/j.acn.2006.10.010; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McDiarmid MA, 2004, J TOXICOL ENV HEAL A, V67, P277, DOI 10.1080/15287390490273541; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Roebuck-Spencer TM, 2006, ARTHRIT RHEUM-ARTHR, V55, P434, DOI 10.1002/art.21992; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; Wilken JA, 2002, NEUROLOGY, V58, pA210; Wilken JA, 2007, ARCH CLIN NEUROPSYCH, V22, pS127, DOI 10.1016/j.acn.2006.10.007; Woodard J, 2002, J INT NEUROPSYCH SOC, V8, P175	45	20	20	0	16	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2012	177	3					248	255		10.7205/MILMED-D-11-00156			8	Medicine, General & Internal	General & Internal Medicine	906CW	WOS:000301323500003	22479911				2021-06-18	
J	Albright, G; Goldman, R; Shockley, KM; McDevitt, F; Akabas, S				Albright, Glenn; Goldman, Ron; Shockley, Kristen M.; McDevitt, Fiona; Akabas, Sam			Using an Avatar-Based Simulation to Train Families to Motivate Veterans with Post-Deployment Stress to Seek Help at the VA	GAMES FOR HEALTH JOURNAL			English	Article							SUICIDE-PREVENTION; IMPACT; EFFICACY; DISORDER	Objective: This study examines the effectiveness of "Family of Heroes,'' an online avatar-based post-deployment stress and resiliency training simulation, in increasing families' engagement in motivating their veterans who exhibit signs of post-deployment stress, including post-traumatic stress disorder (PTSD), traumatic brain injury (TBI), depression, and suicide ideation, to seek help at the Veterans Administration (VA). Materials and Methods: Participants were randomly assigned to an experimental group (n = 50) that completed the online training and pre- and post-intervention and 1-month follow-up surveys or a control group (n = 44) who only completed a pre-test and a 1-month follow-up survey. Results: The experimental group exhibited significantly greater changes in its preparedness and likelihood to recognize signs of post-deployment stress and in approaching their veteran to discuss their concern and motivate them to seek help at the VA. This group also reported significant change in actual behavior in terms of discussing their concern with their veteran (79 percent approached to discuss vs. 56 percent for the control group). Finally, seven (22 percent) of the veterans who were approached by the experimental group started to receive mental health treatment (five at the VA). All seven were previously diagnosed with PTSD and/or depression but never before started treatment at the VA. Conclusion: Results strongly suggest that "Family of Heroes'' is an effective tool to engage families in taking an active role in motivating their veterans who exhibit signs of post-deployment stress to seek help at the VA. Results also suggest that the training can increase the actual number of veterans experiencing post-deployment stress who begin to receive treatment at the VA.	[Albright, Glenn; Shockley, Kristen M.] CUNY Bernard M Baruch Coll, Dept Psychol, New York, NY 10010 USA; [Albright, Glenn; Goldman, Ron; McDevitt, Fiona; Akabas, Sam] Kognito Interact, New York, NY 10001 USA	Albright, G (corresponding author), Kognito Interact, 130 West 25th St,Suite 1001, New York, NY 10001 USA.	info@kognito.com			Kognito Interactive	The authors wish to thank the many families of veterans who participated in this study. The study was funded by Kognito Interactive and conducted in June-July 2011.	BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bolton EE, 2002, MIL PSYCHOL, V14, P241, DOI 10.1207/S15327876MP1403_4; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Cross W, 2007, SUICIDE LIFE-THREAT, V37, P659, DOI 10.1521/suli.2007.37.6.659; Dekel R, 2010, AGGRESS VIOLENT BEH, V15, P303, DOI 10.1016/j.avb.2010.03.001; Department of Defence Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Department of Veteran's Affairs, 2010, VA SUIC PREV PROGR F; Department of Veterans Affairs, 2011, FACT SHEET VA SERV P; EDEN D, 1993, J APPL PSYCHOL, V78, P352, DOI 10.1037/0021-9010.78.3.352; Eden D, 2010, J MANAGE, V36, P687, DOI 10.1177/0149206308321553; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Glenn D Michael, 2002, Violence Vict, V17, P473, DOI 10.1891/vivi.17.4.473.33685; Keller DP, 2009, PROF PSYCHOL-RES PR, V40, P126, DOI 10.1037/a0014889; King DW, 2006, J APPL SOC PSYCHOL, V36, P2980, DOI 10.1111/j.0021-9029.2006.00138.x; KIRKPATRICK DL, 1979, TRAIN DEV J, V33, P78; Lester P, 2011, MIL MED, V176, P19, DOI 10.7205/MILMED-D-10-00122; Peterson H, 2001, FAMILIES EASE VA PRO; Ray SL, 2009, INT J NURS STUD, V46, P838, DOI 10.1016/j.ijnurstu.2009.01.002; Riggs DS, 2000, EFFECTIVE TREATMENTS FOR PTSD, P280; SELVIN S, 1991, STAT ANAL EPIDEMIOLO; Tanielian T, 2008, INVISIBLE WOUNDS WAR; U.S. Census Bureau, 2000, AM FACT FIND VET; Wyman PA, 2008, J CONSULT CLIN PSYCH, V76, P104, DOI 10.1037/0022-006X.76.1.104	23	20	20	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2161-783X	2161-7856		GAMES HEALTH J	Games Health J.	FEB	2012	1	1					21	28		10.1089/g4h.2011.0003			8	Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	V40YN	WOS:000209514000006	26196429				2021-06-18	
J	Argandona, EG; Bengoetxea, H; Ortuzar, N; Bulnes, S; Rico-Barrio, I; Lafuente, JV				Argandona, Enrike G.; Bengoetxea, Harkaitz; Ortuzar, Naiara; Bulnes, Susana; Rico-Barrio, Irantzu; Vicente Lafuente, Jose			Vascular Endothelial Growth Factor: Adaptive Changes in the Neuroglialvascular Unit	CURRENT NEUROVASCULAR RESEARCH			English	Article						Angioglioneurins; environmental enrichment; neurogliovascular unit; neuroprotection; neurorestoration; VEGF	RAT VISUAL-CORTEX; TRAUMATIC BRAIN-INJURY; EXPERIENCE-DEPENDENT PLASTICITY; AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; ENVIRONMENTAL ENRICHMENT; POSTNATAL-DEVELOPMENT; GENE-EXPRESSION; CEREBRAL-CORTEX; NERVOUS-SYSTEM	Brain postnatal development is modulated by adaptation and experience. Experience-mediated changes increase neuronal activity leading to increased metabolic demands that involve adaptive changes including ones at the microvascular network. Therefore, vascular environment plays a key role in central nervous system (CNS) development and function in health and disease. Trophic factors are crucial in CNS development and cell survival in adults. They participate in protection and proliferation of neuronal, glial and endothelial cells. Among the most important molecules are: the proangiogenic vascular endothelial growth factor (VEGF), the neurotrophin brain derived neurotrophic factor (BDNF), insulin growth factor (IGF-I) and the glycoprotein erythropoietin (EPO). We propose the term angioglioneurins to define molecules acting on the three components of the neurogliovascular unit. We have previously reported the effects of environmental modifications on the three components of the neurogliovascular unit during the postnatal development. We have also described the main role played by VEGF in the experience-induced postnatal changes. Angioglioneurin administration, alone or in combination with other neuroprotective strategies such as environmental enrichment, has been proposed as a non-invasive therapeutic strategy against several CNS diseases.	[Argandona, Enrike G.] Univ Fribourg, Dept Med, Unit Anat, CH-1700 Fribourg, Switzerland; [Bengoetxea, Harkaitz; Ortuzar, Naiara; Bulnes, Susana; Rico-Barrio, Irantzu; Vicente Lafuente, Jose] Univ Basque Country UPV EHU, Lab Expt Neurosci LaNCE, Dept Neurosci, E-48940 Leioa, Spain	Argandona, EG (corresponding author), Univ Fribourg, Dept Med, Unit Anat, Rue Albert Gockel 1, CH-1700 Fribourg, Switzerland.	enrique.argandona@unifr.ch	Bulnes, Susana/AAJ-3381-2020; Bulnes, Susana/F-4130-2016; Bengoetxea, Harkaitz/AAD-5751-2021; Rico Barrio, Irantzu/H-6757-2015; Lafuente, Jose-Vicente/O-6395-2014	Bulnes, Susana/0000-0002-9059-0758; Rico Barrio, Irantzu/0000-0003-4908-1182; Lafuente, Jose-Vicente/0000-0001-7246-0987	Basque GovernmentBasque Government [MV-2010-1-23]	This work has been supported by the Basque Government grant MV-2010-1-23. NO is predoctoral fellow from the Spanish Government and IRB is predoctoral fellow from the Gangoiti foundation.	Amaral OB, 2008, PHYSIOL BEHAV, V93, P388, DOI 10.1016/j.physbeh.2007.09.009; Angely CJ, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-26; Argandona E. G., 2011, 8 INT BRAIN RES ORG, V2, p[992, F1000]; Argandona EG, 2005, DEV BRAIN RES, V156, P158, DOI 10.1016/j.devbraines.2005.02.007; Argandona EG, 2003, DEV BRAIN RES, V141, P63, DOI 10.1016/S0165-3806(02)00643-0; Argandona EG, 1996, BRAIN RES, V732, P43, DOI 10.1016/0006-8993(96)00485-4; Argandona EG, 2009, J ANAT, V215, P132, DOI 10.1111/j.1469-7580.2009.01103.x; Bartoletti A, 2004, NAT NEUROSCI, V7, P215, DOI 10.1038/nn1201; BEDI KS, 1989, J ANAT, V167, P71; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Bengoetxea H, 2008, CEREB CORTEX, V18, P1630, DOI 10.1093/cercor/bhm190; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; Bezard E, 2003, J NEUROSCI, V23, P10999; BLACK JE, 1987, NEUROSCI LETT, V83, P351, DOI 10.1016/0304-3940(87)90113-3; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; BORGES S, 1978, J COMP NEUROL, V180, P277, DOI 10.1002/cne.901800207; Briner A, 2010, J COMP NEUROL, V518, P1711, DOI 10.1002/cne.22297; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Briones TL, 2009, J NEUROTRAUM, V26, P613, DOI 10.1089/neu.2008.0707; Bugg JM, 2011, NEUROBIOL AGING, V32, P506, DOI 10.1016/j.neurobiolaging.2009.03.008; Caleo M, 2002, NEUROSCIENTIST, V8, P52, DOI 10.1177/107385840200800110; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; Chauvet C, 2011, NEUROSCIENCE, V184, P88, DOI 10.1016/j.neuroscience.2011.03.068; Choi BH, 2007, J NEUROSURG-SPINE, V7, P54, DOI 10.3171/SPI-07/07/054; COMERY TA, 1995, NEUROBIOL LEARN MEM, V63, P217, DOI 10.1006/nlme.1995.1025; Coq JO, 1998, EXP BRAIN RES, V121, P191, DOI 10.1007/s002210050452; Cracchiolo JR, 2007, NEUROBIOL LEARN MEM, V88, P277, DOI 10.1016/j.nlm.2007.07.007; CRAGG BG, 1967, NATURE, V215, P251, DOI 10.1038/215251a0; Dahlqvist P, 2004, EUR J NEUROSCI, V19, P2288, DOI 10.1111/j.0953-816X.2004.03248.x; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Davis A E, 2000, Crit Care Nurs Q, V23, P1; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; DEHAY C, 1989, NATURE, V337, P265, DOI 10.1038/337265a0; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrer Isidro, 2006, Cerebrovasc Dis, V21 Suppl 2, P9, DOI 10.1159/000091699; FIFKOVA E, 1970, J COMP NEUROL, V140, P431, DOI 10.1002/cne.901400404; Foeller E, 2005, J NEUROPHYSIOL, V94, P4387, DOI 10.1152/jn.00553.2005; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Franklin TB, 2006, BRAIN RES, V1095, P1, DOI 10.1016/j.brainres.2006.04.025; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Gilbert CD, 1998, PHYSIOL REV, V78, P467; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; GREENOUGH WT, 1973, EXP NEUROL, V41, P371, DOI 10.1016/0014-4886(73)90278-1; GREENOUGH WT, 1986, BRAIN RES, V380, P136, DOI 10.1016/0006-8993(86)91437-X; Grunfeld JF, 2007, EXP NEUROL, V204, P260, DOI 10.1016/j.expneurol.2006.11.002; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Harrigan MR, 2003, ACTA NEUROCHIR, V145, P49, DOI 10.1007/s00701-002-1035-1; Harrison RV, 2002, CEREB CORTEX, V12, P225, DOI 10.1093/cercor/12.3.225; Hawkins BT, 2003, PHARMACOL REV, V57, P173; Hebb D. O., 1947, AM PSYCHOL, V2, P306, DOI DOI 10.1037/H0028720; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hensch TK, 2004, SCIENCE, V303, P1678, DOI 10.1126/science.1091031; Herring A, 2008, BRAIN PATHOL, V18, P32, DOI 10.1111/j.1750-3639.2007.00094.x; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hooks BM, 2007, NEURON, V56, P312, DOI 10.1016/j.neuron.2007.10.003; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Kral A, 2007, BRAIN RES REV, V56, P259, DOI 10.1016/j.brainresrev.2007.07.021; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lee SH, 2007, J NEUROPHYSIOL, V97, P4380, DOI 10.1152/jn.01217.2006; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Lojovich JM, 2010, J HEAD TRAUMA REHAB, V25, P184, DOI 10.1097/HTR.0b013e3181dc78cd; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185, DOI 10.1016/S0166-4328(02)00026-8; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; Mu DZ, 2003, NEUROBIOL DIS, V14, P524, DOI 10.1016/j.nbd.2003.08.020; Naka F, 2005, BRAIN DEV-JPN, V27, P275, DOI 10.1016/j.braindev.2004.07.006; Neufeld G, 1999, FASEB J, V13, P9; Nikolaev E, 2002, BRAIN RES, V957, P91, DOI 10.1016/S0006-8993(02)03606-5; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Ortuzar N, 2010, ACTA NEUROCHIR SUPPL, V106, P55, DOI 10.1007/978-3-211-98811-4_9; Ortuzar N, 2011, J NEURAL TRANSM, V118, P135, DOI 10.1007/s00702-010-0496-2; Penn PR, 2009, DEV NEUROREHABIL, V12, P32, DOI 10.1080/17518420902739365; Petrosini L, 2009, BRAIN RES REV, V61, P221, DOI 10.1016/j.brainresrev.2009.07.002; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P654, DOI 10.1097/00005072-199906000-00010; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; RICCIO RV, 1985, NEUROSCIENCE, V16, P1027, DOI 10.1016/0306-4522(85)90113-7; Royo NC, 2003, J NEUROPATH EXP NEUR, V62, P801, DOI 10.1093/jnen/62.8.801; Sathasivam S, 2008, NEUROSCI RES, V62, P71, DOI 10.1016/j.neures.2008.06.008; Saucier DM, 2010, BEHAV BRAIN RES, V214, P48, DOI 10.1016/j.bbr.2010.04.039; Segovia G, 2009, J NEURAL TRANSM, V116, P1007, DOI 10.1007/s00702-009-0214-0; Shibuya M, 2009, FEBS J, V276, P4636, DOI 10.1111/j.1742-4658.2009.07175.x; Shoykhet M, 2005, J NEUROPHYSIOL, V94, P3987, DOI 10.1152/jn.00569.2005; SIREVAAG AM, 1988, DEV BRAIN RES, V43, P299, DOI 10.1016/0165-3806(88)90107-1; SIREVAAG AM, 1991, BRAIN RES, V540, P273, DOI 10.1016/0006-8993(91)90517-Y; SIREVAAG AM, 1987, BRAIN RES, V424, P320, DOI 10.1016/0006-8993(87)91477-6; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Solerte SB, 2005, DEMENT GERIATR COGN, V19, P1, DOI 10.1159/000080963; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Thiriet N, 2008, BRAIN RES, V1222, P31, DOI 10.1016/j.brainres.2008.05.030; Tieman SB, 2004, BRAIN RES, V998, P100, DOI 10.1016/j.brainres.2003.11.023; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Yao HS, 2005, NEUROSCIENTIST, V11, P206, DOI 10.1177/1073858404272404; Yasuhara T, 2005, BRAIN RES, V1053, P10, DOI 10.1016/j.brainres.2005.05.027; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	125	20	22	0	12	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.	FEB	2012	9	1					72	81					10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	888YK	WOS:000300040400009	22272767				2021-06-18	
J	Ordonez, C; Navarro, A; Perez, C; Martinez, E; del Valle, E; Tolivia, J				Ordonez, Cristina; Navarro, Ana; Perez, Cristina; Martinez, Eva; del Valle, Eva; Tolivia, Jorge			Gender differences in apolipoprotein D expression during aging and in Alzheimer disease	NEUROBIOLOGY OF AGING			English	Article						Apolipoprotein D; Aging; Alzheimer disease; Human; Frontal cortex; Entorhinal cortex; Hippocampus; Immunohistochemistry	RNA TISSUE DISTRIBUTION; MESSENGER-RNA; MOLECULAR CHARACTERIZATION; PARAFFIN SECTIONS; PERIPHERAL-NERVE; BREAST-CANCER; LIFE-SPAN; D GENE; CORTEX; BRAIN	Apolipoprotein D (Apo D) is a lipocalin expressed in a wide variety of mammalian tissues. Different studies have shown that this protein is upregulated in the central nervous system (CNS) in several neuropathological conditions, after traumatic brain injury and in aging. The Apo D promoter shows 3 estrogen response elements and it has been shown that its expression is influenced by estrogens in breast cyst fluid. The aim of this work is to study the possible relationship between gender and Apo D expression in human hippocampus and in the entorhinal and frontal cortices during aging and Alzheimer's disease (AD). We visualized Apo D immunohistochemically and then performed a quantification of the chromogen signal strength. Our findings show that Apo D expression is influenced by age, Braak stage, and sex. In most of the studied areas, Apo D expression is increased with age in women but not in men, and in AD progression in both genders. Apo D is always expressed by neurons with no signs of degeneration or death. (C) 2012 Elsevier Inc. All rights reserved.	[Ordonez, Cristina; Navarro, Ana; Perez, Cristina; Martinez, Eva; del Valle, Eva; Tolivia, Jorge] Univ Oviedo, Fac Biol & Med, Dpt Morfol & Biol Celular, E-33006 Oviedo, Spain	Tolivia, J (corresponding author), Univ Oviedo, Fac Biol & Med, Dpt Morfol & Biol Celular, Julian Claveria S-N, E-33006 Oviedo, Spain.	jtolivia@uniovi.es	Navarro, Ana/N-2092-2014; Tolivia, Jorge/D-2248-2010; del Valle, Eva/D-6820-2012; Martinez-Pinilla, Eva/C-7907-2013	Navarro, Ana/0000-0001-6206-6505; Tolivia, Jorge/0000-0001-8984-8849; del Valle, Eva/0000-0002-7959-4790; Martinez-Pinilla, Eva/0000-0002-0572-0926	MECEuropean Commission; FEDEREuropean Commission [SAF2007-64076/]	This work was supported by a MEC and FEDER (SAF2007-64076/) grant. CO was a predoctoral fellow from "Gobierno del Principado de Asturias" Spain (BP05-064). CP and EM were predoctoral fellows from "Ministerio de Educacion y Ciencia" Spain (AP-2004-0854 and AP-2005-3815).	Belloir B, 2001, J NEUROSCI RES, V64, P61, DOI 10.1002/jnr.1054; BISHOP RE, 1995, J BIOL CHEM, V270, P23097, DOI 10.1074/jbc.270.39.23097; BOYLES JK, 1990, J BIOL CHEM, V265, P17805; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Brinton RD, 2004, CNS DRUGS, V18, P405, DOI 10.2165/00023210-200418070-00001; Desai PP, 2005, NEUROBIOL DIS, V20, P574, DOI 10.1016/j.nbd.2005.04.012; DIEZITZA I, 1994, AM J PATHOL, V144, P310; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Ganfornina MD, 2005, DEV DYNAM, V232, P191, DOI 10.1002/dvdy.20193; Glockner F, 2003, NEUROSCIENCE, V122, P103, DOI 10.1016/S0306-4522(03)00529-3; Henderson VW, 2009, SEMIN REPROD MED, V27, P283, DOI 10.1055/s-0029-1216281; Hu CY, 2001, J NEUROCYTOL, V30, P209, DOI 10.1023/A:1012797623620; Kalman J, 2000, NEUROL RES, V22, P330; LAMBERT J, 1993, BIOCHIM BIOPHYS ACTA, V1172, P190, DOI 10.1016/0167-4781(93)90292-L; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; MCCONATH.WJ, 1973, FEBS LETT, V37, P178, DOI 10.1016/0014-5793(73)80453-3; Navarro A, 1998, NEUROSCI LETT, V254, P17, DOI 10.1016/S0304-3940(98)00639-9; Navarro A, 1999, J HISTOTECHNOL, V22, P305, DOI 10.1179/his.1999.22.4.305; Navarro A, 2003, EXP NEUROL, V184, P697, DOI 10.1016/S0014-4886(03)00315-7; Navarro A, 2008, HISTOL HISTOPATHOL, V23, P995, DOI 10.14670/HH-23.995; Navarro A, 2010, AGE, V32, P85, DOI 10.1007/s11357-009-9117-0; Ong WY, 1997, NEUROSCIENCE, V79, P359, DOI 10.1016/S0306-4522(96)00608-2; Ordonez C, 2006, HISTOL HISTOPATHOL, V21, P361, DOI 10.14670/HH-21.361; PATEL SC, 1995, NEUROREPORT, V6, P653, DOI 10.1097/00001756-199503000-00017; PROVOST PR, 1991, FEBS LETT, V290, P139, DOI 10.1016/0014-5793(91)81244-3; PROVOST PR, 1995, MOL CELL ENDOCRINOL, V109, P225, DOI 10.1016/0303-7207(95)03506-3; PROVOST PR, 1990, J LIPID RES, V31, P2057; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; REUSCHE E, 1991, PATHOL RES PRACT, V187, P1045, DOI 10.1016/S0344-0338(11)81084-8; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Sanchez D, 2002, MECH DEVELOP, V110, P225, DOI 10.1016/S0925-4773(01)00578-0; Sanchez D, 2000, INT J DEV BIOL, V44, P349; SEGUIN D, 1995, MOL BRAIN RES, V30, P242, DOI 10.1016/0169-328X(95)00008-G; SIMARD J, 1992, ENDOCRINOLOGY, V130, P1115, DOI 10.1210/en.130.3.1115; SMITH KM, 1990, J LIPID RES, V31, P995; SPREYER P, 1990, EMBO J, V9, P2479, DOI 10.1002/j.1460-2075.1990.tb07426.x; Suresh S, 1998, J NEUROCHEM, V70, P242; Terrisse L, 1998, J NEUROCHEM, V71, P1643; Thomas EA, 2003, BIOL PSYCHIAT, V54, P136, DOI 10.1016/S0006-3223(02)01976-5; Thomas EA, 2001, P NATL ACAD SCI USA, V98, P4066, DOI 10.1073/pnas.071056198; Tolivia J, 2006, ANAL QUANT CYTOL, V28, P43	42	20	21	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580			NEUROBIOL AGING	Neurobiol. Aging	FEB	2012	33	2							433.e11	10.1016/j.neurobiolaging.2011.01.010			10	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	863NR	WOS:000298171800054	21429623				2021-06-18	
J	Schneiders, AG; Sullivan, SJ; Handcock, P; Gray, A; McCrory, PR				Schneiders, A. G.; Sullivan, S. J.; Handcock, P.; Gray, A.; McCrory, P. R.			Sports concussion assessment: the effect of exercise on dynamic and static balance	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						athletic injuries; motor performance; brain concussion; exercise; reliability	ERROR SCORING SYSTEM; STABILITY FOLLOWING CONCUSSION; FUNCTIONAL ANKLE INSTABILITY; POSTURAL STABILITY; TREADMILL EXERCISE; PERFORMANCE; FATIGUE; GAIT; EXERTION; DEFICITS	This study determined the effect of exercise on measures of static and dynamic balance used in the assessment of sports-related concussion (SRC). A balanced three-group cross-over randomized design was used with three levels of exercise verified by blood-lactate, heart rate and perceived-exertion: no exercise/rest (NE), moderate-intensity exercise (ME), and high-intensity exercise (HE). Participants performed two timed balance tasks: tandem gait (TG) and single-leg stance (SLS); pre- and post-exercise and 15 min after exercise. Linear mixed-models with adjusted means and contrasts compared exercise effects. Ninety asymptomatic participants (45?:45?) were recruited. When times were contrasted with NE; HE resulted in a significant decrease in SLS (P<0.001) and TG (P<0.001) performance immediately following exercise. Fifteen minutes of recovery improved SLS (P<0.001) and TG (P=0.011) from post-exercise performance. ME caused a significant decrease in performance in SLS (P=0.038) but not TG (P=0.428). No statistically significant change occurred following ME in any tasks after 15-min recovery (SLS P=0.064; TG P=0.495). Testretest reliability was considerably higher for the dynamic task compared with the static task. The reliability of static and dynamic balance tasks, and the change in performance following exercise, have implications for the immediate assessment of SRC, as these measures are utilized in concussion assessment instruments.	[Schneiders, A. G.] Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, Dunedin 9054, New Zealand; [Handcock, P.] Univ Otago, Sch Phys Educ, Dunedin 9054, New Zealand; [Gray, A.] Univ Otago, Dept Prevent & Social Med, Dunedin 9054, New Zealand; [McCrory, P. R.] Univ Melbourne, Ctr Hlth & Exercise Sports Med, Melbourne, Vic 3010, Australia	Schneiders, AG (corresponding author), Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, POB 56, Dunedin 9054, New Zealand.	tony.schneiders@otago.ac.nz	Handcock, Phil/P-2400-2019; Gray, Andrew Robert/L-9161-2015; McCrory, Paul/Q-8688-2019; Schneiders, Anthony/F-4212-2015	Handcock, Phil/0000-0002-0753-1117; Gray, Andrew Robert/0000-0003-4299-2194; Schneiders, Anthony/0000-0002-1583-3879; McCrory, Paul/0000-0003-4850-0568	University of Otago	This study was funded by a University of Otago Research Grant.	American College of Sports Medicine, 2005, ACSMS HLTH REL PHYS; [Anonymous], 1999, SAS STAT V8 SOFTW US; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Crowell DH, 2001, J ATHL TRAINING, V36, pS; Derave W, 2002, INT J SPORTS MED, V23, P44, DOI 10.1055/s-2002-19374; Derave W, 1998, ERGONOMICS, V41, P782, DOI 10.1080/001401398186630; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hamilton RT, 2008, J ATHL TRAINING, V43, P144, DOI 10.4085/1062-6050-43.2.144; Jankovic J, 2001, ADV NEUROL, V87, P119; Kingma H, 2006, CURR OPIN NEUROL, V19, P21, DOI 10.1097/01.wco.0000199021.48538.d9; Kinzey SJ, 1998, J ORTHOP SPORT PHYS, V27, P356, DOI 10.2519/jospt.1998.27.5.356; Lepers R, 1997, EUR J APPL PHYSIOL, V76, P55, DOI 10.1007/s004210050212; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Nakagawa L, 2004, J SPORT REHABIL, V13, P255, DOI 10.1123/jsr.13.3.255; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; Nardone A, 1998, ARCH PHYS MED REHAB, V79, P920, DOI 10.1016/S0003-9993(98)90088-0; Onate JA, 2007, J ATHL TRAINING, V42, P446; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; SELIGA R, 1991, AM IND HYG ASSOC J, V52, P417, DOI 10.1202/0002-8894(1991)052<0417:EOWLAR>2.0.CO;2; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Susco TM, 2004, J ATHL TRAINING, V39, P241; THOMAS JR, 1975, MED SCI SPORT EXER, V7, P203; Warren J, 2006, PHYS THER SPORT, V7, P185, DOI 10.1016/j.ptsp.2006.06.002; Wikstrom EA, 2005, MED SCI SPORT EXER, V37, P169, DOI 10.1249/01.MSS.0000149887.84238.6C; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Yaggie JA, 2002, ARCH PHYS MED REHAB, V83, P224, DOI 10.1053/apmr.2002.28032	33	20	20	0	23	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0905-7188			SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	FEB	2012	22	1					85	90		10.1111/j.1600-0838.2010.01141.x			6	Sport Sciences	Sport Sciences	874UT	WOS:000298984300012	20561282				2021-06-18	
J	Alao, A; Selvarajah, J; Razi, S				Alao, Adekola; Selvarajah, Jennifer; Razi, Syed			THE USE OF CLONIDINE IN THE TREATMENT OF NIGHTMARES AMONG PATIENTS WITH CO-MORBID PTSD AND TRAUMATIC BRAIN INJURY	INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE			English	Article						clonidine; nightmares; PTSD; traumatic brain injury; norepinephrine	POSTTRAUMATIC-STRESS-DISORDER; NOREPINEPHRINE	Objective: To describe the successful treatment of PTSD associated nightmares in two patients with PTSD. Case Summaries: The report of the successful use of clonidine to treat PTSD associated nightmares among two Veterans following combat exposure. Discussion: Clonidine, a centrally acting alpha-agonist agent used to treat hypertension, stimulates alpha-adrenoreceptors in the brain stem. This action results in reduced sympathetic outflow from the central nervous system. We hypothesize that this central mechanism of action is why clonidine may be more effective in treating nightmares among patients with PTSD when compared with other agents. Conclusion: Clonidine should be considered as an alternative in the treatment of nightmares among patients with PTSD. (Int'l. J. Psychiatry in Medicine 2012;44:165-169)	VA Med Ctr, Syracuse, NY USA; SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA	Selvarajah, J (corresponding author), SUNY Upstate Med Univ, Dept Psychiat, 750 E Adams St, Syracuse, NY 13210 USA.	Selvaraj@upstate.edu					American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Aurora RN, 2010, J CLIN SLEEP MED, V6, P389; Byers MG, 2010, J CLIN PSYCHOPHARM, V30, P225, DOI 10.1097/JCP.0b013e3181dac52f; Debiec J, 2011, DEPRESS ANXIETY, V28, P186, DOI 10.1002/da.20803; Geracioti TD, 2001, AM J PSYCHIAT, V158, P1227, DOI 10.1176/appi.ajp.158.8.1227; MELLMAN TA, 1995, BIOL PSYCHIAT, V38, P174, DOI 10.1016/0006-3223(94)00238-X; Pervanidou P, 2010, PROG BRAIN RES, V182, P149, DOI 10.1016/S0079-6123(10)82005-9; Pitman RK, 2005, CNS SPECTRUMS, V10, P99, DOI 10.1017/S109285290001943X; Wells TS, 2011, INT REV PSYCHIATR, V23, P144, DOI 10.3109/09540261.2011.558833; Yehuda R, 1998, BIOL PSYCHIAT, V44, P56, DOI 10.1016/S0006-3223(98)80007-3	10	20	20	0	13	BAYWOOD PUBL CO INC	AMITYVILLE	26 AUSTIN AVE, PO BOX 337, AMITYVILLE, NY 11701 USA	0091-2174			INT J PSYCHIAT MED	Int. J. Psychiatr. Med.		2012	44	2					165	169		10.2190/PM.44.2.g			5	Psychiatry	Psychiatry	082XR	WOS:000314427800007	23413663				2021-06-18	
J	Beyer, JA; Rowson, S; Duma, SM				Beyer, Jeffrey A.; Rowson, Steven; Duma, Stefan M.			Concussions Experienced by Major League Baseball Catchers and Umpires: Field Data and Experimental Baseball Impacts	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Mild traumatic brain injury; Linear; Rotational; Angular; Acceleration; Impact; Biomechanics	TRAUMATIC BRAIN-INJURY; HEAD ACCELERATIONS; FOOTBALL; EPIDEMIOLOGY; RISK	Some reports have shown that head injuries in baseball may comprise up to 18.5% of all competitive sports-related head injuries. The objective of this study was to evaluate the response of catcher and umpire masks to impacts at these different regions to discover the impact conditions that represent the greatest risk of injury. A series of 10 events in which a catcher or umpire in Major League Baseball, who experienced a foul ball to the mask that resulted in a concussion, were analyzed through video and data on pitch characteristics. It was found that the impacts were distributed across the face, and the median plate speed was approximately 38 m/s (84 mph). To determine the relative severity of each identified impact location, an instrumented Hybrid III head outfitted with a catcher or umpire mask was impacted with baseballs. Testing at 27 and 38 m/s (60 and 84 mph) suggested that impacts to the center-eyebrow and chin locations were the most severe. Peak linear and rotational accelerations were found to be lower than the suggested injury thresholds. While impacts to a mask result in head accelerations which are near or below levels commonly associated with the lower limits for head injury, the exact injury mechanism is unclear, as concussions are still experienced by the mask wearers.	[Beyer, Jeffrey A.; Rowson, Steven; Duma, Stefan M.] Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA	Rowson, S (corresponding author), Virginia Tech Wake Forest Univ, Sch Biomed Engn & Sci, 440 ICTAS Bldg,Stanger St, Blacksburg, VA 24061 USA.	srowson@vt.edu	Rowson, Steven/B-1270-2012; Duma, Stefan/A-8368-2012	Rowson, Steven/0000-0002-3227-0596; 			Adair R. K., 1990, PHYS TODAY, V43, P103; Agel J, 2007, J ATHL TRAINING, V42, P241; Albert J., 2010, J STAT ED, V18, P1; Albert J, 2010, J QUANT ANAL SPORTS, V6, DOI 10.2202/1559-0410.1279; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Brooks D., 2011, BROOKSBASEBALL NET P; Cormier J, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003312; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2011, EXERC SPORT SCI REV, V39, P2, DOI 10.1097/JES.0b013e318203dfdb; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Gadd CW, 1966, P 10 STAPP CAR CRASH; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; HEALD JH, 1994, AM SOC TEST MATER, V1229, P223, DOI 10.1520/STP12816S; Jones I. S., 1984, HEAD IMPACT TOLERANC; King A.I., 2003, P INT RES C BIOM IMP; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Melvin J. W., 1984, BASEBALL IMPACTS DUM; NOCSAE, 2010, 02410M10B NOCSAE DOC; NOCSAE, 2009, 02198M09 NOCSAE DOC; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2008, CLIN J SPORT MED, V18, P316, DOI 10.1097/JSM.0b013e31817f016a; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2010, CLIN J SPORT MED, V20, P344, DOI 10.1097/JSM.0b013e3181ed7e50; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Versace J., 1971, SAE TECHNICAL PAPER; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	31	20	20	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2012	40	1			SI		150	159		10.1007/s10439-011-0412-4			10	Engineering, Biomedical	Engineering	895HJ	WOS:000300486700014	22012084				2021-06-18	
J	Caglio, M; Latini-Corazzini, L; D'Agata, F; Cauda, F; Sacco, K; Monteverdi, S; Zettin, M; Duca, S; Geminiani, G				Caglio, M.; Latini-Corazzini, L.; D'Agata, F.; Cauda, F.; Sacco, K.; Monteverdi, S.; Zettin, M.; Duca, S.; Geminiani, G.			Virtual navigation for memory rehabilitation in a traumatic brain injured patient	NEUROCASE			English	Article						Memory rehabilitation; Computer-based training; Virtual reality; Traumatic brain injury; fMRI	EPISODIC MEMORY; HIPPOCAMPAL; ALZHEIMERS; MODERATE; SCORES	The use of 3D video games in memory rehabilitation has been explored very little. A virtual navigation task allows participants to encode the spatial layout of the virtual environment and activate areas involved in memory processing. We describe the rehabilitation of a 24-year-old man with traumatic brain injury presenting memory deficits, and evaluate the efficacy of a navigational training program measuring neuropsychological changes and fMRI modification cerebral activations. Memory improvement appears to be present both after navigational training and in follow-up testing. Furthermore, fMRI data suggest that this training may increase activation of the hippocampal and parahippocampal brain regions. The results suggest that intensive training in virtual navigational tasks may result in an enhancement of memory function in brain-damaged adults.	[Caglio, M.; Latini-Corazzini, L.; D'Agata, F.; Cauda, F.; Sacco, K.; Zettin, M.; Geminiani, G.] Univ Turin, Dept Psychol, I-10123 Turin, Italy; [D'Agata, F.; Cauda, F.; Sacco, K.; Duca, S.; Geminiani, G.] Koelliker Hosp, CCS fMRI, Turin, Italy; [Monteverdi, S.; Zettin, M.] Puzzle Rehabil Ctr, Turin, Italy	Caglio, M (corresponding author), Univ Turin, Dept Psychol, Via 14, I-10123 Turin, Italy.	marcella.caglio@unito.it	Cauda, Franco/G-5021-2010; Sacco, Katiuscia/J-2133-2012	Cauda, Franco/0000-0003-1526-8475; Sacco, Katiuscia/0000-0002-9660-5236; D'Agata, Federico/0000-0001-9432-0248	University of Turin; 'Progetto Lagrange-Fondazione C.R.T.', Turin, Italy	Marcella Caglio was supported by a doctoral grant from the University of Turin and the 'Progetto Lagrange-Fondazione C.R.T.', Turin, Italy. The manuscript is original, previously unpublished, and not under concurrent consideration elsewhere. We confirm that the requirements of authorship have been met and that there is no conflict of interests. We thank Stephan Cooper for checking the English.	Annoni J. M., 1992, DISABILITY REHABILIT, V14, P23; Brooks BM, 1999, NEUROPSYCHOL REHABIL, V9, P63, DOI 10.1080/713755589; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; CAPITANI E, 1988, DEV NEUROPSYCHOL, V4, P325, DOI 10.1080/87565648809540416; CARLESIMO GA, 1993, INT J NEUROSCI, V73, P1, DOI 10.3109/00207459308987206; Deipolyi AR, 2007, NEUROLOGY, V69, P986, DOI 10.1212/01.wnl.0000271376.19515.c6; Fernandez G, 1998, J NEUROSCI, V18, P1841; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Henke K, 1999, J COGNITIVE NEUROSCI, V11, P682, DOI 10.1162/089892999563643; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; O'Keefe J., 1978, HIPPOCAMPUS COGNITIV; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Rosen W. G., 1996, ADAS ALZHEIMERS DIS; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Spiers HJ, 2007, NEUROSCIENCE, V149, P7, DOI 10.1016/j.neuroscience.2007.06.056; Spinnler H. A., 1987, ITALIAN J ENV PSYCHO, V9, P233; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Wolk DA, 2011, NEUROIMAGE, V54, P1530, DOI 10.1016/j.neuroimage.2010.09.005; Woollett K, 2008, HIPPOCAMPUS, V18, P981, DOI 10.1002/hipo.20465	26	20	25	0	23	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2012	18	2					123	131		10.1080/13554794.2011.568499			9	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	920JP	WOS:000302400900006	22352998				2021-06-18	
J	Jeter, CB; Hergenroeder, GW; Ward, NH; Moore, AN; Dash, PK				Jeter, Cameron B.; Hergenroeder, Georgene W.; Ward, Norman H., III; Moore, Anthony N.; Dash, Pramod K.			Human Traumatic Brain Injury Alters Circulating L-Arginine and Its Metabolite Levels: Possible Link to Cerebral Blood Flow, Extracellular Matrix Remodeling, and Energy Status	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; biomarker; extracellular matrix; intracranial pressure; metabolism	CONTROLLED CORTICAL IMPACT; NITRIC-OXIDE SYNTHASE; HEAD-INJURY; RATS; EXPRESSION; CREATINE	Altered cerebral blood flow, cell-matrix interactions, and energy metabolism are secondary pathologies contributing to outcome after traumatic brain injury (TBI). Because L-arginine serves as the precursor for metabolites that are critical to these processes, we measured their plasma levels using LC-MS/GC-MS. Samples were collected from healthy volunteers (n = 20), and patients with mild TBI (n = 18), severe TBI (n = 20), or orthopedic injury without a TBI (n = 15), within the first 24 hours of injury. Severe TBI levels of L-arginine, citrulline, ornithine, and hydroxyproline were significantly reduced compared to the other groups. In contrast, the levels of plasma creatine were significantly increased in severe TBI patients compared to healthy volunteers and orthopedic injury subjects. Of interest, the levels of creatine were found to be higher in severe TBI patients (GCS score <= 8) whose intracranial pressure (ICP) remained below 25mm Hg throughout the 5-day monitoring period, compared to TBI patients (GCS score <= 8) who subsequently developed elevated ICP (>= 25mm Hg). The changes in L-arginine and its metabolite levels were not detected in subjects with mild TBI. The altered levels of arginine and its metabolites may contribute to secondary pathologies following severe TBI, and plasma levels of creatine may have prognostic value in identifying patients at risk for ICP elevation.	[Jeter, Cameron B.; Hergenroeder, Georgene W.; Ward, Norman H., III; Moore, Anthony N.; Dash, Pramod K.] Univ Texas Houston, Dept Neurobiol & Anat, Med Sch Houston, Vivian L Smith Dept Neurosurg, Houston, TX 77225 USA	Dash, PK (corresponding author), Univ Texas Houston, Dept Neurobiol & Anat, Med Sch Houston, Vivian L Smith Dept Neurosurg, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu	Jeter, Cameron B./AAO-1797-2021	Jeter, Cameron B./0000-0001-5303-5897; Dash, Pramod/0000-0001-6746-1002; Hergenroeder, Georgene/0000-0002-6170-2191	Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [R38OT10585]; Mission Connect/TIRR Foundation; Vivian L. Smith Foundation; Gilson-Longenbaugh Foundation	We would like to thank the nurses at Memorial Hermann Hospital-Texas Medical Center, and Elizabeth B. Jones, M.D., Toby T. Thomas, M.D., and Brad Jacobson, M.D. for assistance with recruiting patients. This study was supported by the Health Resources and Services Administration (R38OT10585), Mission Connect/TIRR Foundation, The Vivian L. Smith Foundation, and the Gilson-Longenbaugh Foundation.	Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; American Association for Automotive Medicine, 2001, ABBR INJ SCAL AIS; Avila MA, 2008, J CEREBR BLOOD F MET, V28, P1733, DOI 10.1038/jcbfm.2008.66; Bell Scott E, 2006, Curr Treat Options Neurol, V8, P167, DOI 10.1007/s11940-006-0007-9; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Bouzat P, 2011, NEUROSURGERY, V68, P1603, DOI 10.1227/NEU.0b013e31820cd43e; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Castillo L, 1996, P NATL ACAD SCI USA, V93, P11460, DOI 10.1073/pnas.93.21.11460; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; GRODY WW, 1987, ISOZYMES-CURR T BIOL, V13, P181; Hallemeesch MM, 2002, CLIN NUTR, V21, P273, DOI 10.1054/clnu.2002.0571; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Hlatky R, 2002, ACT NEUR S, V81, P331; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Klein Autumn M., 2007, V46, P205; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; Muellner A, 2003, J NEUROTRAUM, V20, P745, DOI 10.1089/089771503767869971; Rangel-Castilla L, 2010, NEUROL RES, V32, P1033, DOI 10.1179/016164110X12767786356598; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; TEASDALE G, 1974, LANCET, V2, P81; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807	40	20	20	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2012	29	1					119	127		10.1089/neu.2011.2029			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	879GI	WOS:000299317300014	21942884				2021-06-18	
S	North, SH; Shriver-Lake, LC; Taitt, CR; Ligler, FS		Cooks, RG; Yeung, ES		North, Stella H.; Shriver-Lake, Lisa C.; Taitt, Chris R.; Ligler, Frances S.			Rapid Analytical Methods for On-Site Triage for Traumatic Brain Injury	ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 5	Annual Review of Analytical Chemistry		English	Article; Book Chapter						TBI; biomarkers; biosensors; pathophysiology; rapid detection	OF-CARE TESTS; CEREBROSPINAL-FLUID; BIOMARKER DISCOVERY; CELL-DEATH; DIAGNOSING INFECTIONS; PROTEIN BIOMARKERS; PLASMA PROTEOME; SERUM; NEUROPROTEOMICS; PATHOPHYSIOLOGY	Traumatic brain injury (TBI) results from an event that causes rapid acceleration and deceleration of the brain or penetration of the skull with an object. Responses to stimuli and questions, loss of consciousness, and altered behavior are symptoms currently used to justify brain imaging for diagnosis and therapeutic guidance. Tests based on such symptoms are susceptible to false-positive and false-negative results due to stress, fatigue, and medications. Biochemical markers of neuronal damage and the physiological response to that damage are being identified. Biosensors capable of rapid measurement of such markers in the circulation offer a solution for on-site triage, as long as three criteria are met: (a) Recognition reagents can be identified that are sufficiently sensitive and specific, (b) the biosensor can provide quantitative assessment of multiple markers rapidly and simultaneously, and (c) both the sensor and reagents are designed for use outside the laboratory.	[North, Stella H.; Shriver-Lake, Lisa C.; Taitt, Chris R.; Ligler, Frances S.] USN, Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA	North, SH (corresponding author), USN, Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA.	stella.north@nrl.navy.mil; lisa.shriverlake@nrl.navy.mil; chris.taitt@nrl.navy.mil; frances.ligler@nrl.navy.mil		Taitt, Chris/0000-0002-0125-9239			Adkins JN, 2002, MOL CELL PROTEOMICS, V1, P947, DOI 10.1074/mcp.M200066-MCP200; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P883, DOI 10.1074/mcp.R800015-MCP200; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; Bele S, 2009, NEUROTRAUMA CRITICAL, P42; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2006, CLIN PEDIATR EMERG M, V7, P186, DOI 10.1016/j.cpem.2006.06.001; Bissonnette L, 2010, CLIN MICROBIOL INFEC, V16, P1044, DOI 10.1111/j.1469-0691.2010.03282.x; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; Brain Inj. Assoc. Am, 2011, LIV BRAIN INJ; Brain Trauma Found. n.d, TBI STAT FACTS TBI U; Brewin B., 2011, BATTL BRAIN INJ ASS; Cadosch D, 2010, ANZ J SURG, V80, P542, DOI 10.1111/j.1445-2197.2010.05268.x; Centers for Disease Control and Prevention, 2011, INJ PREV CONTR TRAUM; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cheng CM, 2009, LAB CHIP, V9, P2339, DOI 10.1039/b907860f; Clerc O, 2010, CLIN MICROBIOL INFEC, V16, P1054, DOI 10.1111/j.1469-0691.2010.03281.x; Conrads TP, 2006, BIOTECHNIQUES, V40, P799, DOI 10.2144/000112196; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; Def. Cent. Excell, 2011, AUT NEUR ASS METR; Def. Veterans Brain Inj. Cent, 2007, MIL AC CONC EV MACE; Defense and Veterans Brain Injury Center, 2009, MIL AC CONC EV MACE; Defense and Veterans Brain Injury Center, 2011, DOD WORLDW NUMB TRAU; Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56; Emanuel P, 2011, CHEM BIOL RAD TECHN; Frink M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/797383; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Gouix E, 2009, MOL CELL NEUROSCI, V40, P463, DOI 10.1016/j.mcn.2009.01.002; Griesmaier E, 2009, FUTUR NEUROL, V4, P469, DOI 10.2217/FNL.09.28; Halamek J, 2010, MOL BIOSYST, V6, P2554, DOI 10.1039/c0mb00153h; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Haskins WE, 2005, J NEUROTRAUM, V22, P629, DOI 10.1089/neu.2005.22.629; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holder S., 2008, MRI VERSUS CT SCAN D; Holder S., 2008, GLASGOW COMA SCALE; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; ImPACT Appl, 2011, OV FEAT IMPACT TEST; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Inst. Med. Natl. Acad, 2008, GULF WAR HLTH, V7; Int. Brain Inj. Assoc, 2010, BRAIN INJ FACTS; JANKOVIC BD, 1991, INT J NEUROSCI, V60, P119, DOI 10.3109/00207459109082042; JANKOVIC BD, 1991, INT J NEUROSCI, V58, P113, DOI 10.3109/00207459108987188; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Korfias S, 2009, MINI-REV MED CHEM, V9, P227, DOI 10.2174/138955709787315994; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Leland A, 2010, FK32492 C REP SERV; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Manesh KM, 2009, BIOSENS BIOELECTRON, V24, P3569, DOI 10.1016/j.bios.2009.05.019; Matt P, 2008, PHYSIOL GENOMICS, V33, P12, DOI 10.1152/physiolgenomics.00282.2007; Mehta SS., 2009, CLIN NEUROSURG, V57, P134; Melo MR, 2011, CLIN CHEM LAB MED, V49, P581, DOI 10.1515/CCLM.2011.092; Mohammed MI, 2011, LAB CHIP, V11, P569, DOI 10.1039/c0lc00204f; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; North SH, 2011, FED INT C TRAUM BRAI; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pedersen BK, 2000, IMMUNOL CELL BIOL, V78, P532, DOI 10.1046/j.1440-1711.2000.00962.x; Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x; Petzold A, 2007, NEUROL RES, V29, P691, DOI 10.1179/016164107X240080; Poletaev AB, 2000, AUTOIMMUNITY, V32, P33, DOI 10.3109/08916930008995985; Radi R., 2000, NITRIC OXIDE BIOL PA, P57, DOI [10.1016/B978-012370420-7/50005-8, DOI 10.1016/B978]; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Romeo MJ, 2005, EXPERT REV PROTEOMIC, V2, P57, DOI 10.1586/14789450.2.1.57; Ryan L., 2005, TRAUMATIC BRAIN INJU; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salisbury D, 2005, TBI INFORM TRAUMATIC; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Sanfilippo Filippo, 2010, Front Biosci (Schol Ed), V2, P623; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Streeter J, 2011, P SOC PHOTO-OPT INS, V8029; Sun FN, 2010, MOL CELL PROTEOMICS, V9, P963, DOI 10.1074/mcp.R900003-MCP200; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; US Dep. Def, 2011, DOD REP C EXP ACT TR; Venkatasubbarao S, 2011, P SOC PHOTO-OPT INS, V8029; Vista Life Sci, 2011, AUT NEUR ASS METR AN; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yeo LY, 2011, SMALL, V7, P12, DOI 10.1002/smll.201000946; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; Zupanc GKH, 2007, PROTEOM CLIN APPL, V1, P1362, DOI 10.1002/prca.200700420	109	20	21	0	38	ANNUAL REVIEWS	PALO ALTO	4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA	1936-1327		978-0-8243-4405-4	ANNU REV ANAL CHEM	Annu. Rev. Anal. Chem.		2012	5						35	56		10.1146/annurev-anchem-062011-143105			22	Chemistry, Analytical; Spectroscopy	Chemistry; Spectroscopy	BBR12	WOS:000307956200004	22462400				2021-06-18	
J	Roebuck-Spencer, TM; Vincent, AS; Twillie, DA; Logan, BW; Lopez, M; Friedl, KE; Grate, SJ; Schlegel, RE; Gilliland, K				Roebuck-Spencer, Tresa M.; Vincent, Andrea S.; Twillie, David A.; Logan, Bret W.; Lopez, Mary; Friedl, Karl E.; Grate, Stephen J.; Schlegel, Robert E.; Gilliland, Kirby			Cognitive Change Associated with Self-Reported Mild Traumatic Brain Injury Sustained During the OEF/OIF Conflicts	CLINICAL NEUROPSYCHOLOGIST			English	Article						Military deployment; Mild traumatic brain injury; Computerized testing; ANAM; Military TBI	POSTTRAUMATIC-STRESS-DISORDER; SYMPTOM VALIDITY TEST; HEAD-INJURY; IRAQ-WAR; NEUROPSYCHOLOGICAL OUTCOMES; POSTCONCUSSIVE SYMPTOMS; SPORTS CONCUSSION; DIAGNOSIS THREAT; ENDURING FREEDOM; TEST-PERFORMANCE	Traumatic brain injury (TBI) has received much attention due to high rates of this injury in Service Members returning from the Iraq/Afghanistan conflicts. This study examined cognitive performance in Service Members tested with ANAM prior to and following deployment. The sample was divided into a control group (n = 400) reporting no TBI injury prior to or during most recent deployment, and a group who self-reported a TBI injury (n = 502) during most recent deployment. This latter group was divided further based on self-report of post-concussion symptoms at post-deployment testing. All three groups performed similarly at pre-deployment. The group reporting TBI with active symptoms performed worst at post-deployment and included the highest percentage of individuals showing significant decline in cognitive performance over time (30.5%). A small sample of symptomatic individuals with a non-TBI reported injury did not demonstrate similar declines in performance, suggesting that active symptoms alone cannot account for these findings. Of those reporting a TBI injury during deployment, 70% demonstrated no significant change in cognitive performance compared with baseline. Although the exact etiology of observed declines is uncertain, findings indicate that individuals who self-report TBI during deployment with active symptomatology at post-deployment are at greatest risk for declines in cognitive performance. These individuals can be identified using self-report and brief computer-based testing. Importantly, the majority of active-duty individuals reporting TBI during deployment do not present with lasting significant cognitive impairment, a finding consistent with the civilian literature on mild TBI.	[Roebuck-Spencer, Tresa M.; Vincent, Andrea S.; Schlegel, Robert E.; Gilliland, Kirby] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73072 USA; [Twillie, David A.; Logan, Bret W.] Blanchfield Army Community Hosp, Ft Campbell, KY USA; [Lopez, Mary] US Army Bavaria Med Dept Act BMEDDAC, Vilseck, Germany; [Friedl, Karl E.; Grate, Stephen J.] USA, Telemed & Adv Res Ctr, Med Res & Mat Command, Ft Detrick, MD USA		tresa@ou.edu	Friedl, Karl/M-1803-2019	Friedl, Karl/0000-0002-3134-8427	DoDUnited States Department of Defense; Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD [W81XWH-07-2-0097]; ANAM	This data analysis was conducted by the Center for the Study of Human Operator Performance (C-SHOP) at the University of Oklahoma and is made possible by a DoD Grant awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC) at Fort Detrick, MD under Contract Number W81XWH-07-2-0097.; The University of Oklahoma (OU) holds the exclusive license for the Automated Neuropsychological Assessment Metrics (ANAM). The Cognitive Science Research Center (formerly C-SHOP) at OU is responsible for research and development of ANAM. VistaLifeSciences holds the exclusive license for ANAM commercialization. Author Friedl is a co-inventor on United States Patent 7,837,472 and has received royalties in connection with this patent. Authors Gilliland and Schlegel have standard university royalty agreements for the sale of ANAM. No other authors of this manuscript receive funds or salary support from ANAM sales.	Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Chelune GJ, 1993, NEUROPSYCHOLOGY, V7, P41, DOI DOI 10.1037/0894-4105.7.1.41; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Johnson D. R., 2009, NAT AC NEUR NEW ORL; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Marr AL., 2004, CENTRAL NERVOUS SYST; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McCrea M, 2008, MILD TRAUMATIC BRAIN; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Roebuck-Spencer T., 2008, TXB CLIN NEUROPSYCHO, P411; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vincent A. S., MILITARY ME IN PRESS; Vincent A. S., 2010, NAT AC NEUR C; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	41	20	20	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	3					473	489		10.1080/13854046.2011.650214			17	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	936ER	WOS:000303574200164	22268558				2021-06-18	
J	da Silva, SG; de Almeida, AA; Araujo, BHS; Scorza, FA; Cavalheiro, EA; Arida, RM				da Silva, Sergio Gomes; de Almeida, Alexandre Aparecido; Silva Araujo, Bruno Henrique; Scorza, Fulvio Alexandre; Cavalheiro, Esper Abrao; Arida, Ricardo Mario			Early physical exercise and seizure susceptibility later in life	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Exercise; Development; Brain; Plasticity; Seizure; Epilepsy	TRAUMATIC BRAIN-INJURY; COGNITIVE RESERVE; ENVIRONMENTAL ENRICHMENT; PREADOLESCENT CHILDREN; KINDLING DEVELOPMENT; ALZHEIMERS-DISEASE; ADOLESCENT PERIOD; SPATIAL MEMORY; OLD-AGE; EPILEPSY	We conducted a study to examine whether physical exercise undertaken during the period of postnatal brain development could modify seizure susceptibility later in life. Male Wistar rats aged 21 postnatal days (P21) were divided into two groups: exercise and control. Animals in the exercise group were submitted to daily exercise on the treadmill between P21 and P60. Running time and speed gradually increased over this period, reaching a maximum of 18 m/min for 60min. After the final exercise session (P60), animals from exercise group were maintained non-trained for 90 days. This "period without stimulus" was used to observe the influence of early physical exercise on susceptibility to seizures induced by the pilocarpine model of epilepsy at P150. The results showed that the exercise program undertaken during the period of postnatal brain development delayed the onset and reduced the intensity of pilocarpine-induced motor symptoms in midlife rats. These findings suggest that early exercise interferes positively in the later ictogenesis process, and support the hypothesis that physical activity in early life may build a neural reserve against brain disorders. (C) 2011 ISDN. Published by Elsevier Ltd. All rights reserved.	[da Silva, Sergio Gomes; de Almeida, Alexandre Aparecido; Arida, Ricardo Mario] Univ Fed Sao Paulo UNIFESP, Dept Fisiol, BR-04023900 Sao Paulo, Brazil; [Silva Araujo, Bruno Henrique; Scorza, Fulvio Alexandre; Cavalheiro, Esper Abrao] Univ Fed Sao Paulo UNIFESP, Dept Neurol & Neurosurg, BR-04023900 Sao Paulo, Brazil	da Silva, SG (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Fisiol, Rua Botucatu 862,Ed Ciencias Biomed,5 Andar, BR-04023900 Sao Paulo, Brazil.	sergio.gomes@unifesp.br; arida.nexp@epm.br	Neurociencia, Inct/I-1011-2013; Cavalheiro, Esper/N-3985-2019; da Silva, Sergio Gomes/F-1847-2013; Scorza, Fulvio/C-7048-2013; de Almeida, Alexandre/E-8771-2016; Araujo, Bruno/B-8741-2013; Arida, Ricardo Mario/P-7408-2016; Araujo, Bruno/P-9975-2019; Arida, Ricardo M/E-2667-2013; Cavalheiro, Esper A/I-3084-2016; Cavalheiro, Esper A/F-4325-2014	Cavalheiro, Esper/0000-0002-0854-3582; da Silva, Sergio Gomes/0000-0002-9650-809X; Scorza, Fulvio/0000-0002-0694-8674; de Almeida, Alexandre/0000-0002-9045-7826; Araujo, Bruno/0000-0003-0012-4217; Arida, Ricardo Mario/0000-0002-7771-6133; Araujo, Bruno/0000-0003-0012-4217; Arida, Ricardo M/0000-0002-0908-3274; Cavalheiro, Esper A/0000-0002-0854-3582; Cavalheiro, Esper A/0000-0002-0854-3582	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Cooperacao Interinstitucional de Apoio a Pesquisa sobre o Cerebro (CInAPCe); Instituto Nacional de Neurociencia Translacional (INNT) (Brazil)	This study was supported by research grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Cooperacao Interinstitucional de Apoio a Pesquisa sobre o Cerebro (CInAPCe) and Instituto Nacional de Neurociencia Translacional (INNT) (Brazil).	Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Arida RM, 2007, PHYSIOL BEHAV, V90, P629, DOI 10.1016/j.physbeh.2006.11.016; Arida RM, 2011, AM J PHYS MED REHAB, V90, P452, DOI 10.1097/PHM.0b013e3182063a9c; Arida RM, 2010, EPILEPSY BEHAV, V17, P432, DOI 10.1016/j.yebeh.2010.01.013; Arida RM, 1998, EPILEPSY RES, V30, P127, DOI 10.1016/S0920-1211(97)00102-2; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Barnett JH, 2006, PSYCHOL MED, V36, P1053, DOI 10.1017/S0033291706007501; Buck SM, 2008, MED SCI SPORT EXER, V40, P166, DOI 10.1249/mss.0b013e318159b035; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; da Silva SG, 2010, NEUROCHEM INT, V57, P492, DOI 10.1016/j.neuint.2010.07.001; da Silva SG, 2010, BRAIN DEV-JPN, V32, P137, DOI 10.1016/j.braindev.2008.12.012; Dawson KS, 2007, BRAIN INJURY, V21, P943, DOI 10.1080/02699050701553171; Dik MG, 2003, J CLIN EXP NEUROPSYC, V25, P643, DOI 10.1076/jcen.25.5.643.14583; ERIKSEN HR, 1994, EPILEPSIA, V35, P1256, DOI 10.1111/j.1528-1157.1994.tb01797.x; ESQUIVEL E, 1991, ELECTROEN CLIN NEURO, V79, P127, DOI 10.1016/0013-4694(91)90050-E; Farinpour R, 2003, J CLIN EXP NEUROPSYC, V25, P654, DOI 10.1076/jcen.25.5.654.14577; Gomes da Silva S, HIPPOCAMPUS IN PRESS; Graves AB, 1996, BRIT J PSYCHIAT, V169, P86, DOI 10.1192/bjp.169.1.86; Hillman CH, 2009, NEUROSCIENCE, V159, P1044, DOI 10.1016/j.neuroscience.2009.01.057; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kim YP, 2004, NEUROSCI LETT, V355, P152, DOI 10.1016/j.neulet.2003.11.005; Lores-Arnaiz S, 2007, BEHAV BRAIN RES, V184, P117, DOI 10.1016/j.bbr.2007.06.024; Middleton LE, 2010, J AM GERIATR SOC, V58, P1322, DOI 10.1111/j.1532-5415.2010.02903.x; Nakken KO, 1999, EPILEPSIA, V40, P643, DOI 10.1111/j.1528-1157.1999.tb05568.x; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Pai MC, 2005, EPILEPSIA, V46, P7, DOI 10.1111/j.0013-9580.2005.461003.x; Racine RJ, 1972, CLIN NEUROPHYSIOL, V32, P281, DOI DOI 10.1016/0013-4694(72)90177-0; Raine A, 2003, AM J PSYCHIAT, V160, P1627, DOI 10.1176/appi.ajp.160.9.1627; Richards M, 2003, SOC SCI MED, V56, P785, DOI 10.1016/S0277-9536(02)00075-8; Riviere S, 2001, J Nutr Health Aging, V5, P295; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Scarmeas N, 2003, J CLIN EXP NEUROPSYC, V25, P625, DOI 10.1076/jcen.25.5.625.14576; Setkowicz Z, 2006, EPILEPSY RES, V71, P142, DOI 10.1016/j.eplepsyres.2006.06.002; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Uysal N, 2005, NEUROSCI LETT, V383, P241, DOI 10.1016/j.neulet.2005.04.054; Vancini RL, 2010, EPILEPSY BEHAV, V19, P504, DOI 10.1016/j.yebeh.2010.09.007; Werz MA, 2005, EPILEPSY BEHAV, V6, P98, DOI 10.1016/j.yebeh.2004.11.008; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; Williams BM, 2001, PHYSIOL BEHAV, V73, P649, DOI 10.1016/S0031-9384(01)00543-1; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	45	20	20	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748			INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	DEC	2011	29	8					861	865		10.1016/j.ijdevneu.2011.07.011			5	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	858DC	WOS:000297775100011	21840389				2021-06-18	
J	Iverson, GL; Hakulinen, U; Waljas, M; Dastidar, P; Lange, RT; Soimakallio, S; Ohman, J				Iverson, Grant L.; Hakulinen, Ullamari; Waljas, Minna; Dastidar, Prasun; Lange, Rael T.; Soimakallio, Seppo; Ohman, Juha			To exclude or not to exclude: White matter hyperintensities in diffusion tensor imaging research	BRAIN INJURY			English	Article						Diffusion tensor imaging; methodology; traumatic brain injury	TRAUMATIC BRAIN-INJURY; AXONAL INJURY; CORPUS-CALLOSUM; MILD; PREVALENCE; CHILDREN; ABNORMALITIES; MODERATE; BIPOLAR; REPRODUCIBILITY	Objective: A practical methodological issue for diffusion tensor imaging (DTI) researchers is determining what to do about incidental findings, such as white matter hyperintensities (WMHI). The purpose of this study was to compare healthy control subjects with or without WMHIs on whole brain DTI. Method: Participants were 30 subjects (age=37.7, SD=11.3, Range=18-60; 70% female) who had no known developmental, general medical, neurological or psychiatric condition that could have had an adverse affect on brain morphology. Results: MRI (3 Tesla) revealed, at minimum, a WMHI in eight subjects (26.7%). Fractional anisotropy (FA) was calculated for 19 regions of interest (ROI). Frequency distributions of FA scores for the 19 ROIs were calculated. The 10th percentile for each ROI was selected as a cut-off score. Having four or more low FA scores occurred in 16.7%. More subjects with incidental findings met criterion for low FA scores (37.5%), compared to 9.1% of subjects with no findings. When subjects with minor WMHIs were retained and only those with multiple incidental findings were excluded, 8.3% of the retained subjects met criterion for low FA scores compared to 50.0% of the excluded subjects. Conclusions: The decision to include or exclude subjects who have incidental findings can influence the results of a study.	[Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; [Iverson, Grant L.] British Columbia Mental Hlth & Addict Serv, Vancouver, BC, Canada; [Hakulinen, Ullamari; Dastidar, Prasun; Soimakallio, Seppo] Pirkanmaa Hosp Dist, Med Imaging Ctr, Tampere, Finland; [Waljas, Minna; Ohman, Juha] Tampere Univ Hosp, Tampere, Finland; [Dastidar, Prasun; Soimakallio, Seppo; Ohman, Juha] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Lange, Rael T.] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA	Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	giverson@interchange.ubc.ca		Iverson, Grant/0000-0001-7348-9570; Ohman, Juha/0000-0002-6592-1367	Pirkanmaa Hospital District, Tampere University Hospital	This study was supported by Competitive Research Funding of the Pirkanmaa Hospital District, Tampere University Hospital. Grant Iverson, PhD has been reimbursed by the government, professional scientific bodies and commercial organizations for discussing or presenting research relating to MTBI and sport-related concussion at meetings, scientific conferences and symposiums. He is a co-investigator, collaborator or consultant on grants relating to TBI funded by several organizations. Dr Lange notes that the views expressed in this article are those of the authors and do not reflect the official policy of the Department of Defense or US Government.	Agid R, 2003, INT J NEUROPSYCHOPH, V6, P215, DOI 10.1017/S146114570300347X; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Brander A, 2010, ACTA RADIOL, V51, P800, DOI 10.3109/02841851.2010.495351; Cao QJ, 2010, BRAIN RES, V1310, P172, DOI 10.1016/j.brainres.2009.10.031; Carter JC, 2009, PSYCHIAT RES-NEUROIM, V172, P215, DOI 10.1016/j.pscychresns.2008.09.005; Cooney BS, 1996, HEADACHE, V36, P616, DOI 10.1046/j.1526-4610.1996.3610616.x; Dalby RB, 2010, PSYCHIAT RES-NEUROIM, V184, P38, DOI 10.1016/j.pscychresns.2010.06.008; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Ehrlich S, 2005, J AFFECT DISORDERS, V86, P281, DOI 10.1016/j.jad.2005.01.007; Feldman HM, 2010, J DEV BEHAV PEDIATR, V31, P346, DOI 10.1097/DBP.0b013e3181dcaa8b; Greenwald BS, 2001, J AM GERIATR SOC, V49, P1218, DOI 10.1046/j.1532-5415.2001.49240.x; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Jacobus J, 2009, NEUROTOXICOL TERATOL, V31, P349, DOI 10.1016/j.ntt.2009.07.006; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Konrad A, 2010, EUR J NEUROSCI, V31, P912, DOI 10.1111/j.1460-9568.2010.07110.x; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lee CEC, 2009, NEURORADIOLOGY, V51, P3, DOI 10.1007/s00234-008-0441-3; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; Lyoo IK, 2002, COMPR PSYCHIAT, V43, P361, DOI 10.1053/comp.2002.34636; Ma LS, 2009, DRUG ALCOHOL DEPEN, V104, P262, DOI 10.1016/j.drugalcdep.2009.05.020; Marenco S, 2006, PSYCHIAT RES-NEUROIM, V147, P69, DOI 10.1016/j.pscychresns.2006.01.008; Moore PB, 2001, BRIT J PSYCHIAT, V178, P172, DOI 10.1192/bjp.178.2.172; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Odegard TN, 2009, NEUROPSYCHOLOGIA, V47, P1972, DOI 10.1016/j.neuropsychologia.2009.03.009; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Pillai JJ, 2002, PSYCHIAT RES-NEUROIM, V114, P51, DOI 10.1016/S0925-4927(01)00129-9; Rimrodt SL, 2010, CORTEX, V46, P739, DOI 10.1016/j.cortex.2009.07.008; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sassi RB, 2003, J AFFECT DISORDERS, V77, P237, DOI 10.1016/S0165-0327(02)00170-2; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Soderlund H, 2003, CORTEX, V39, P1093, DOI 10.1016/S0010-9452(08)70879-7; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; Widjaja E, 2010, EPILEPSY RES, V89, P246, DOI 10.1016/j.eplepsyres.2010.01.008; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; Zhou B, 2010, J NEUROL, V257, P405, DOI 10.1007/s00415-009-5334-9	48	20	20	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2011	25	13-14					1325	1332		10.3109/02699052.2011.608409			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	847MI	WOS:000296976600008	22077537				2021-06-18	
J	Blume, HK; Lucas, S; Bell, KR				Blume, Heidi K.; Lucas, Sylvia; Bell, Kathleen R.			Subacute Concussion-Related Symptoms in Youth	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Concussion; Child; Subacute symptoms; Postconcussive symptoms; Post-traumatic headache; Post-concussive syndrome	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; SEX-DIFFERENCES; POSTCONCUSSIVE SYMPTOMS; POSTTRAUMATIC HEADACHE; UNITED-STATES; SLEEP; CHILDREN; RECOVERY	Most athletes who experience a sports-related concussion recover from the acute effects within a few weeks. However, some children and adolescents with concussion experience symptoms for many weeks, or even months after the injury. Subacute and chronic symptoms related to concussion are particularly concerning in children, because cognitive deficits, headache or neck pain, sleep dysfunction, and emotional dysregulation can affect school performance and social function at a critical period of development and maturation. This article reviews the epidemiology of subacute symptoms after pediatric concussion and the current recommendations for the assessment and management cif these symptoms in children and adolescents.	[Blume, Heidi K.; Lucas, Sylvia; Bell, Kathleen R.] Seattle Childrens Hosp, Div Pediat Neurol, Seattle, WA 98105 USA	Blume, HK (corresponding author), Seattle Childrens Hosp, Div Pediat Neurol, B-5552 Sand Point Way NE, Seattle, WA 98105 USA.	heidi.blume@seattlechildrens.org		Bell, Kathleen/0000-0002-0928-2046	Department of Education, National Institute on Disability and Rehabilitation Research, TBI Model Systems: University of Washington Traumatic Brain Injury Model System [H133A070032]	This paper was supported in part by the Department of Education, National Institute on Disability and Rehabilitation Research, TBI Model Systems: University of Washington Traumatic Brain Injury Model System H133A070032.	Abend NS, 2008, J CHILD NEUROL, V23, P438, DOI 10.1177/0883073807309772; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2005, LANCET NEUROL, V4, P673, DOI 10.1016/S1474-4422(05)70196-4; Baumann Robert J, 2002, Paediatr Drugs, V4, P555; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hermann C, 2002, APPL PSYCHOPHYS BIOF, V27, P143, DOI 10.1023/A:1016295727345; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Meyer JS, 2000, HEADACHE, V40, P638, DOI 10.1046/j.1526-4610.2000.040008638.x; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Millman RP, 2005, PEDIATRICS, V115, P1774, DOI 10.1542/peds.2005-0772; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; O'Bryant SE, 2006, HEADACHE, V46, P1364, DOI 10.1111/j.1526-4610.2006.00579.x; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; RUBIN AM, 1995, AM J OTOL, V16, P216; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; TYLER GS, 1980, HEADACHE, V20, P213, DOI 10.1111/j.1526-4610.1980.hed2004213.x; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	67	20	20	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2011	22	4					665	+		10.1016/j.pmr.2011.08.007			19	Rehabilitation	Rehabilitation	858SI	WOS:000297822600008	22050942				2021-06-18	
J	Boffano, P; Boffano, M; Gallesio, C; Roccia, F; Cignetti, R; Piana, R				Boffano, Paolo; Boffano, Michele; Gallesio, Cesare; Roccia, Fabio; Cignetti, Riccardo; Piana, Raimondo			Rugby Players' Awareness of Concussion	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Rugby; concussion; sport injuries	MANAGEMENT; SPORTS; FOOTBALL; UNION	Purpose: Concussion is a common issue in most contact sports, such as rugby, being one of the most troublesome injuries facing the sports medicine physician. The aim of this article was to survey the knowledge and beliefs concerning concussion in a sample of young rugby athletes in the northwest of Italy. Methods: The athletes of 4 amateur rugby teams completed a questionnaire about their knowledge about the signs and symptoms of concussion and of return-to-play strategies and protocols. Results: Twenty-five athletes reported that they had not been informed by anyone about symptoms of concussion and its consequences. Among these, 7 players thought they could return to play immediately after a concussion during the very same match. Conclusions: The surveyed group in this study presented a general lack of knowledge of concussion. Rugby athletes and coaches must be made aware about signs and symptoms of concussion to suspect this injury. It would be desirable that rugby players are educated regarding the potential risks of playing while symptomatic.	[Boffano, Paolo] Univ Turin, San Giovanni Battista Hosp, Head & Neck Dept, Div Maxillofacial Surg,Maxillofacial Surg Unit, I-10126 Turin, Italy; [Boffano, Michele] CTO Hosp, Turin, Italy; [Cignetti, Riccardo; Piana, Raimondo] Univ Turin, Univ Sch Sports Sci, I-10126 Turin, Italy; [Piana, Raimondo] AO CTO M, Turin, Italy	Boffano, P (corresponding author), Univ Turin, San Giovanni Battista Hosp, Head & Neck Dept, Div Maxillofacial Surg,Maxillofacial Surg Unit, Corso Dogliotti 14, I-10126 Turin, Italy.	paolo.boffano@gmail.com	Boffano, Paolo/J-1094-2016	Roccia, Fabio/0000-0002-4765-6395; GALLESIO, CESARE/0000-0003-3863-3009; Boffano, Paolo/0000-0002-0782-9933			Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Goldberg LD, 2006, SPORTS MED ARTHROSC, V14, P199, DOI 10.1097/01.jsa.0000212326.23560.09; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; *INT RUGB BOARD, LAWS GAM; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI 10.1016/j.jocn.2009.02.002; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910	13	20	21	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1049-2275			J CRANIOFAC SURG	J. Craniofac. Surg.	NOV	2011	22	6					2053	2056		10.1097/SCS.0b013e318231988d			4	Surgery	Surgery	857TE	WOS:000297741900040	22067860				2021-06-18	
J	Dengler, J; Frenzel, C; Vajkoczy, P; Wolf, S; Horn, P				Dengler, Julius; Frenzel, Christin; Vajkoczy, Peter; Wolf, Stefan; Horn, Peter			Cerebral tissue oxygenation measured by two different probes: challenges and interpretation	INTENSIVE CARE MEDICINE			English	Article						Licox; Raumedic; Cerebral tissue oxygenation; PbrO(2); Cerebral autoregulation	TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR AUTOREGULATION; SUBARACHNOID HEMORRHAGE; PRESSURE REACTIVITY; AGREEMENT; METAANALYSIS; THERAPY; MODEL; PO2	Purpose: Cerebral tissue oxygenation (PbrO(2)) is most frequently monitored using a Licox CC1.SB system (LX, Integra Neuroscience, France) but recently a new probe-the Neurovent-PTO (NV)-was introduced by a different manufacturer (Raumedic, Germany). There are no prospective data on how these probes compare in clinical routine. We therefore compared both probes in comatose patients suffering from traumatic brain injury (TBI) or subarachnoid haemorrhage (SAH) during dynamic changes of inspirational oxygen fraction (FiO(2)) and mean arterial pressure (MAP). Methods: PbrO(2) in 11 patients was recorded continuously using an LX and NV probe placed side by side into the same cerebrovascular region. Once a steady baseline value was reached FiO(2) was increased by 20% for 10 min. Once the baseline values were re-established MAP was increased by 20 mmHg for 10 min. Evaluation was performed using a four-parameter logistic function and Bland-Altman analyses. Results: PbrO(2) values of both probes differed significantly at all times. The LX probe reacted significantly faster to changes in FiO(2) and MAP. Limits of agreement ranged between -32.1 and 20.0 mmHg. Mean LX values were 6.1 mmHg lower than NV values. Conclusions: Since the examined patient cohort was rather small, this study's results are preliminary. However, they suggest that LX and NV probes measure different PbrO(2) values in routine monitoring as well as during phases of dynamic changes in FiO(2) and MAP. These data therefore do not support the view that both probes can be used interchangeably.	[Dengler, Julius; Frenzel, Christin; Vajkoczy, Peter; Wolf, Stefan; Horn, Peter] Charite, Dept Neurosurg, CVK, D-13553 Berlin, Germany	Dengler, J (corresponding author), Charite, Dept Neurosurg, CVK, Augustenburger Pl 1, D-13553 Berlin, Germany.	julius.dengler@charite.de			Department of Neurosurgery of the Charite, Berlin	The study was exclusively funded by the Department of Neurosurgery of the Charite, Berlin.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Critchley LAH, 1999, J CLIN MONIT COMPUT, V15, P85, DOI 10.1023/A:1009982611386; Dings J, 1996, ZBL NEUROCHIR, V57, P177; Huschak G, 2009, J NEUROSURG ANESTH, V21, P155, DOI 10.1097/ANA.0b013e31818f2eac; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Jaeger M, 2010, NEUROCRIT CARE, V13, P163, DOI 10.1007/s12028-010-9348-z; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Orakcioglu B, 2010, NEUROSURGERY, V67, P1716, DOI 10.1227/NEU.0b013e3181f9bb5b; Pinheiro J., 2009, MIXED EFFECTS MODELS; Purins K, 2005, ACTA NEUROCHIR WIEN, V152, P681; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; The R Project for Statistical Computing, 2010, R PROJ STAT COMP R 2; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6	22	20	21	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	NOV	2011	37	11					1809	1815		10.1007/s00134-011-2316-z			7	Critical Care Medicine	General & Internal Medicine	849WU	WOS:000297156900013	21809108				2021-06-18	
J	Graumann, U; Ritz, MF; Hausmann, O				Graumann, Ursula; Ritz, Marie-Francoise; Hausmann, Oliver			Necessity for Re-Vascularization after Spinal Cord Injury and the Search for Potential Therapeutic Options	CURRENT NEUROVASCULAR RESEARCH			English	Article						Angiogenic factors; angiogenesis; blood vessels; cell-based therapy; re-vascularization; spinal cord injury	ENDOTHELIAL PROGENITOR CELLS; HEPATOCYTE GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; IN-VITRO; CONTUSION INJURY; LESIONAL EXPRESSION; FUNCTIONAL RECOVERY; VENTRAL HORN; TGF-BETA	Disruption of the blood-spinal cord barrier (BSCB) and microvascular changes leading to reduction of blood supply represent hallmarks of spinal cord secondary injury causing further deterioration of the traumatized patient. Injury to the blood vessels starts with prominent hemorrhage and generation of inflammation. Furthermore, spinal cord ischemia and extravasation of blood components contribute to edema formation resulting in death of neural cells. Endogenous attempts of re-vascularization have been observed although these newly formed vessels display morphological and functional abnormalities. The unfavorable regulation of angiogenic and counterregulatory anti-angiogenic factors during the complicated course of vessel remodeling after SCI is suspected to participate in the failure of re-vascularization and vessel stabilization. Repression of the expression of angiogenic factors such as vascular endothelial growth factor-A (VEGF-A), placental growth factor (PlGF), angiopoietin-1 (Ang1), and platelet-derived growth factor-BB (PDGF-BB) contributes to vessel regression. Therefore, therapeutic applications of angiogenic factors following SCI are promising strategies to restore blood flow in the lesion.	[Ritz, Marie-Francoise] Pharmacenter, Brain Tumor Biol Lab, Dept Biomed, CH-4056 Basel, Switzerland; [Graumann, Ursula] Spinal Injury Res, Swiss Parapleg Res, CH-6207 Nottwil, Switzerland; [Hausmann, Oliver] Hirslanden Clin St Anna, Neuro & Spine Ctr, CH-6006 Luzern, Switzerland	Ritz, MF (corresponding author), Pharmacenter, Brain Tumor Biol Lab, Dept Biomed, Klingelbergstr 50, CH-4056 Basel, Switzerland.	marie-francoise.ritz@unibas.ch					Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bartholdi D, 1997, EUR J NEUROSCI, V9, P2549, DOI 10.1111/j.1460-9568.1997.tb01684.x; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Benton RL, 2003, NEUROCHEM RES, V28, P1693, DOI 10.1023/A:1026013106016; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; BUCKLEYSTURROCK A, 1989, J CELL PHYSIOL, V138, P70, DOI 10.1002/jcp.1041380111; Buss A, 2008, SPINAL CORD, V46, P364, DOI 10.1038/sj.sc.3102148; Cai XX, 2009, STEM CELL REV REP, V5, P437, DOI 10.1007/s12015-009-9097-6; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Casella GTB, 2002, EXP NEUROL, V173, P63, DOI 10.1006/exnr.2001.7827; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chang SY, 2002, J BIOL CHEM, V277, P8388, DOI 10.1074/jbc.M108792200; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Choi JS, 2007, J HISTOCHEM CYTOCHEM, V55, P821, DOI 10.1369/jhc.6A7139.2007; Finney MR, 2010, CYTOTHERAPY, V12, P67, DOI 10.3109/14653240903300658; Frontczak-Baniewicz M, 2006, NEUROENDOCRINOL LETT, V27, P539; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; George J, 2005, CARDIOVASC RES, V68, P299, DOI 10.1016/j.cardiores.2005.06.022; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Graumann U, 2010, CURR NEUROVASC RES, V7, P144, DOI 10.2174/156720210791184907; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Herrera JJ, 2010, J NEUROTRAUM, V27, P2067, DOI 10.1089/neu.2010.1403; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; ImperatoKalmar EL, 1997, EXP NEUROL, V145, P322, DOI 10.1006/exnr.1997.6449; Javaherian K, 2002, J BIOL CHEM, V277, P45211, DOI 10.1074/jbc.M206358200; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Kang CE, 2010, J NEUROTRAUM, V27, P2041, DOI 10.1089/neu.2010.1345; Kitamura K, 2007, J NEUROSCI RES, V85, P2332, DOI 10.1002/jnr.21372; Lagord C, 2002, MOL CELL NEUROSCI, V20, P69, DOI 10.1006/mcne.2002.1121; Li XL, 2008, J NEUROL SCI, V268, P163, DOI 10.1016/j.jns.2007.12.005; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; Liu Y, 2007, J PATHOL, V212, P12, DOI 10.1002/path.2155; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Maikos JT, 2007, J NEUROTRAUM, V24, P492, DOI 10.1089/neu.2006.0149; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Mueller CA, 2007, EXP NEUROL, V208, P228, DOI 10.1016/j.expneurol.2007.07.020; Mueller CA, 2003, J NEUROTRAUM, V20, P1007, DOI 10.1089/089771503770195858; Mund JA, 2009, CYTOTHERAPY, V11, P103, DOI 10.1080/14653240802714827; Nakagawa T, 2004, KIDNEY INT, V66, P605, DOI 10.1111/j.1523-1755.2004.00780.x; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Pan WH, 2000, EXP NEUROL, V170, P357, DOI 10.1006/exnr.2001.7702; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Patel CB, 2009, J NEUROTRAUM, V26, P1005, DOI 10.1089/neu.2008.0860; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Ramsauer M, 2007, J CELL SCI, V120, P1810, DOI 10.1242/jcs.003533; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Rieckmann P, 2003, NAT MED, V9, P828, DOI 10.1038/nm0703-828; Ritz MF, 2010, CURR NEUROVASC RES, V7, P301, DOI 10.2174/156720210793180756; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Sasaki H, 2009, SPINE, V34, P249, DOI 10.1097/BRS.0b013e3181913cde; SCHREIER T, 1993, RES EXP MED, V193, P195, DOI 10.1007/BF02576227; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; Shimamura M, 2007, BRAIN RES, V1151, P188, DOI 10.1016/j.brainres.2007.03.022; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Skovseth DK, 2005, BLOOD, V105, P1044, DOI 10.1182/blood-2004-03-1164; Takahashi T, 1999, NAT MED, V5, P434; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Xiyang YB, 2009, J NEUROTRAUM, V26, P275, DOI 10.1089/neu.2007.0374; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417; Zeng X, 2011, CELL TANSPL IN PRESS; Zorner B, 2010, ANN NY ACAD SCI, V1198, pE22, DOI 10.1111/j.1749-6632.2010.05566.x	77	20	20	1	13	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026			CURR NEUROVASC RES	Curr. Neurovasc. Res.	NOV	2011	8	4					334	341		10.2174/156720211798121007			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	883FE	WOS:000299618800008	22023610				2021-06-18	
J	Sut, N; Simsek, O				Sut, Necdet; Simsek, Osman			Comparison of regression tree data mining methods for prediction of mortality in head injury	EXPERT SYSTEMS WITH APPLICATIONS			English	Article						Data mining; Regression tree; Classification; Head injury; Mortality	TRAUMATIC BRAIN-INJURY; CLASSIFICATION; VARIABLES	With this research, we sought to examine the performance of six different regression tree data mining methods to predict mortality in head injury. Using a data set consisting of 1603 head injury cases, we assessed the performance of: the Classification and Regression Trees (CART) method; the Chi-squared Automatic Interaction Detector (CHAID) method; the Exhaustive CHAID (E-CHAID) method; the Quick, Unbiased, Efficient Statistical Tree (QUEST) method; the Random Forest Regression and Classification (RFRC) method; and the Boosted Tree Classifiers and Regression (BTCR) method, in each case based on sensitivity, specificity, positive/negative predictive, and accuracy rates. Next, we compared their areas under the (Receiver Operating Characteristic) ROC curves. Finally, we examined whether they could be grouped in meaningful clusters with hierarchical cluster analysis. Areas under the ROC curves of regression tree data mining methods ranged from 0.801 to 0.954 (p < 0.001 for all). In predicting mortality in head injury under the ROC curve, the BTCR method achieved both the highest area (0.954) and accuracy rate (93.0%), while the CART method achieved both the lowest area (0.801) and accuracy rate (91.1%). All of the regression tree data mining methods were clustered in the same grouping, but the BTCR method was at the origin of the cluster while the CART and QUEST methods produced results that were least like the others. The BTCR, demonstrating a 93.0% accuracy rate and showing statistically significantly differences from the others, may be a helpful tool in medical decision-making for predicting mortality in head injury. (C) 2011 Elsevier Ltd. All rights reserved.	[Sut, Necdet] Trakya Univ, Fac Med, Dept Biostat & Med Informat, TR-22030 Edirne, Turkey; [Simsek, Osman] Trakya Univ, Dept Neurosurg, Fac Med, TR-22030 Edirne, Turkey	Sut, N (corresponding author), Trakya Univ, Fac Med, Dept Biostat & Med Informat, TR-22030 Edirne, Turkey.	nsut@trakya.edu.tr; gosimsek@trakya.edu.tr	Simsek, Osman/D-4906-2012	Simsek, Osman/0000-0002-8716-5187			Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Biggs D, 1991, THE J, V18, P49, DOI DOI 10.1080/02664769100000005; Bilgin CC, 2010, DATA MIN KNOWL DISC, V20, P416, DOI 10.1007/s10618-009-0153-2; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; DAWSONSAUNDERS B, 1993, BASIC CLIN BIOSTATIS; Ho SH, 2004, EXPERT SYST APPL, V27, P97, DOI 10.1016/j.eswa.2003.12.005; Kass G., 1980, J R STAT SOC C-APPL, V29, P119, DOI DOI 10.2307/2986296; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Li H, 2010, EXPERT SYST APPL, V37, P5895, DOI 10.1016/j.eswa.2010.02.016; Li XB, 2001, INFORMS J COMPUT, V13, P332, DOI 10.1287/ijoc.13.4.332.9732; Loh WY, 1997, STAT SINICA, V7, P815; Michael JA., 1997, DATA MINING TECHNIQU; Motulsky H., 1995, INTUITIVE BIOSTATIST; Olshen RA, 1984, CLASSIFICATION REGRE; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Schaan M, 2002, J TRAUMA, V52, P667, DOI 10.1097/00005373-200204000-00009; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Spurgeon SEF, 2006, J UROLOGY, V175, P918, DOI 10.1016/S0022-5347(05)00353-8; Ture M, 2005, EXPERT SYST APPL, V29, P583, DOI 10.1016/j.eswa.2005.04.014; 2010, STATSOFT ELECT STAT	20	20	20	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0957-4174	1873-6793		EXPERT SYST APPL	Expert Syst. Appl.	NOV-DEC	2011	38	12					15534	15539		10.1016/j.eswa.2011.06.006			6	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic; Operations Research & Management Science	Computer Science; Engineering; Operations Research & Management Science	824HQ	WOS:000295193400123					2021-06-18	
J	Gabrielian, L; Willshire, LW; Helps, SC; van den Heuvel, C; Mathias, J; Vink, R				Gabrielian, Levon; Willshire, Luke W.; Helps, Stephen C.; van den Heuvel, Corinna; Mathias, Jane; Vink, Robert			Intracranial Pressure Changes following Traumatic Brain Injury in Rats: Lack of Significant Change in the Absence of Mass Lesions or Hypoxia	JOURNAL OF NEUROTRAUMA			English	Article						brain swelling; fluid percussion; hemorrhage; impact-acceleration; neurotrauma	CEREBRAL PERFUSION-PRESSURE; CORTICAL IMPACT INJURY; SEVERE HEAD-INJURY; FLUID-PERCUSSION; TIME-COURSE; EDEMA; ICP; HYPERTENSION; HYPOTENSION; ANESTHESIA	Traumatic brain injury (TBI) often causes raised intracranial pressure (ICP), with > 50% of all TBI-related deaths being associated with this increase in ICP. To date, there is no effective pharmacological treatment for TBI, partly because widely used animal models of TBI may not replicate many of the pathophysiological responses observed in humans, and particularly the ICP response. Generally, rodents are the animal of choice in neurotrauma research, and edema formation has been demonstrated in rat models; however, few studies in rats have specifically explored the effects of TBI on ICP. The aim of the current study was to investigate the ICP response of rats in two different, focal and diffuse, injury models of TBI. Adult male Sprague-Dawley rats were subjected to brain trauma by either lateral fluid percussion or impact-acceleration induced injury, in the presence or absence of secondary hypoxia. ICP, mean arterial blood pressure (MABP), and cerebral perfusion pressure (CPP) were monitored for 4 h after TBI. TBI alone or coupled with hypoxia did not result in any significant increase of ICP in rats unless there was an intracranial hemorrhage. At all other times, changes in CPP were the result of changes in MABP and not ICP. Our results suggest that rats may be able to compensate for the intracranial expansion associated with cerebral edema after TBI, and that they only develop a consistent post-traumatic increase in ICP in the presence of a mass lesion. Therefore, they are an inappropriate model for the investigation of ICP changes after TBI, and for the development of therapies targeting ICP.	[Gabrielian, Levon; Willshire, Luke W.; Helps, Stephen C.; van den Heuvel, Corinna; Vink, Robert] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurol Dis, Adelaide, SA 5005, Australia; [Mathias, Jane] Univ Adelaide, Sch Psychol, Adelaide Ctr Neurol Dis, Adelaide, SA 5005, Australia	Vink, R (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurol Dis, Adelaide, SA 5005, Australia.	Robert.Vink@adelaide.edu.au	AM, Robert Vink/S-5616-2019; Vink, Robert/J-7351-2012; Mathias, J L/L-6295-2013	AM, Robert Vink/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; , Corinna/0000-0003-0664-8935; Mathias, Jane/0000-0001-8957-8594	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	We would thank Dr. Emma Thornton for her helpful comments during the preparation of this manuscript. This research was funded, in part, by a grant from the National Health and Medical Research Council of Australia.	Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Atkinson JLD, 1998, J TRAUMA, V45, P941, DOI 10.1097/00005373-199811000-00016; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BULL JWD, 1969, P ROY SOC MED, V62, P1301, DOI 10.1177/003591576906201242; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Fish R, 1997, ANESTHESIA ANALGESIA, P6; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gardenfors A, 2002, ACTA NEUROCHIR, V144, P601, DOI 10.1007/s00701-002-0954-1; Go K G, 1997, Adv Tech Stand Neurosurg, V23, P47; Goren S, 2001, J NEUROSURG ANESTH, V13, P113, DOI 10.1097/00008506-200104000-00008; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Kahveci FS, 2001, SURG NEUROL, V56, P206, DOI 10.1016/S0090-3019(01)00555-9; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLINTWORTH GK, 1968, ANAT RECORD, V160, P635, DOI 10.1002/ar.1091600312; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; MAGGI CA, 1986, EXPERIENTIA, V42, P109, DOI 10.1007/BF01952426; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; NIDA TY, 1995, J NEUROTRAUM, V12, P77, DOI 10.1089/neu.1995.12.77; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; Papadopoulos M.C., 2004, FASEB J, V10, P1; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Rogatsky G, 1996, J Basic Clin Physiol Pharmacol, V7, P23; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Rolett EL, 2000, AM J PHYSIOL-REG I, V279, pR9; Schilling L, 1999, ADV EXP MED BIOL, V474, P123; SCHNEIDER GH, 1992, CAN J PHYSIOL PHARM, V70, pS334, DOI 10.1139/y92-280; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soustiel JF, 2010, NEUROTHERAPEUTICS, V7, P13, DOI 10.1016/j.nurt.2009.11.001; Stahl N, 2001, INTENS CARE MED, V27, P1215, DOI 10.1007/s001340101004; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Thomas S, 1998, ACT NEUR S, V71, P135; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1602/neurorx.1.1.71; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378; Zweckberger K, 2009, NEUROSCI LETT, V454, P115, DOI 10.1016/j.neulet.2009.02.014	59	20	21	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2011	28	10					2103	2111		10.1089/neu.2011.1785			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	839OX	WOS:000296378500011	21657835				2021-06-18	
J	Ji, SB; Ford, JC; Greenwald, RM; Beckwith, JG; Paulsen, KD; Flashman, LA; McAllister, TW				Ji, Songbai; Ford, James C.; Greenwald, Richard M.; Beckwith, Jonathan G.; Paulsen, Keith D.; Flashman, Laura A.; McAllister, Thomas W.			Automated subject-specific, hexahedral mesh generation via image registration	FINITE ELEMENTS IN ANALYSIS AND DESIGN			English	Article						Subject-specific; Automatic mesh generation; Hexahedral; Mesh quality; Finite element analysis; Traumatic brain injury; Biomechanics; Mutual information	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT; ALGORITHM	Generating subject-specific, all-hexahedral meshes for finite element analysis continues to be of significant interest in biomechanical research communities. To date, most automated methods "morph" an existing atlas mesh to match with a subject anatomy, which usually result in degradation in mesh quality because of mesh distortion. We present an automated meshing technique that produces satisfactory mesh quality and accuracy without mesh repair. An atlas mesh is first developed using a script. A subject-specific mesh is generated with the same script after transforming the geometry into the atlas space following rigid image registration, and is transformed back into the subject space. By meshing the brain in 11 subjects, we demonstrate that the technique's performance is satisfactory in terms of both mesh quality (99.5% of elements had a scaled Jacobian >0.6 while <0.01% were between 0 and 0.2) and accuracy (average distance between mesh boundary and geometrical surface was 0.07 mm while <1% greater than 0.5 mm). The combined computational cost for image registration and meshing was <4 min. Our results suggest that the technique is effective for generating subject-specific, all-hexahedral meshes and that it may be useful for meshing a variety of anatomical structures across different biomechanical research fields. Published by Elsevier B.V.	[Ji, Songbai; Greenwald, Richard M.; Paulsen, Keith D.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03766 USA; [Ford, James C.; Flashman, Laura A.; McAllister, Thomas W.] Dartmouth Med Sch, Dept Psychiat, Lebanon, NH USA; [Greenwald, Richard M.; Beckwith, Jonathan G.] Simbex, Lebanon, NH USA; [Paulsen, Keith D.] Norris Cotton Canc Ctr, Lebanon, NH USA	Ji, SB (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03766 USA.	Songbai.Ji@Dartmouth.EDU	Ford, James/AAF-7039-2020		Institute for Computational Science at Dartmouth College, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD048638, R01NS055020]; CDCCentre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R01CE001254]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055020] Funding Source: NIH RePORTER	This research was supported in part by William H. Neukom 1964 Institute for Computational Science at Dartmouth College, NIH Grants R01HD048638, R01NS055020, and CDC grant R01CE001254.	Anderson AE, 2005, J BIOMECH ENG-T ASME, V127, P364, DOI 10.1115/1.1894148; Benzley SE, 1995, P 4 INT MESH ROUNDT; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bucki M, 2010, MED IMAGE ANAL, V14, P303, DOI 10.1016/j.media.2010.02.003; Castellano-Smith AD, 2001, LECT NOTES COMPUTER, P1091, DOI DOI 10.1007/3-540-45468-3_130; Cattaneo PM, 2009, ORTHOD CRANIOFAC RES, V12, P120, DOI 10.1111/j.1601-6343.2009.01445.x; Cebral JR, 2001, INT J NUMER METH ENG, V51, P985, DOI 10.1002/nme.205; Couteau B, 2000, J BIOMECH, V33, P1005, DOI 10.1016/S0021-9290(00)00055-5; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fuentes D, 2009, ANN BIOMED ENG, V37, P763, DOI 10.1007/s10439-008-9631-8; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Grosland NM, 2009, COMPUT METHOD BIOMEC, V12, P35, DOI 10.1080/10255840903065134; *HIBB KARLSS SOR, 2008, ABAQUS AN US MAN VER; Horgan T.J., 2005, FINITE ELEMENT MODEL; Ji SB, 2009, MED IMAGE ANAL, V13, P659, DOI 10.1016/j.media.2009.05.007; Knupp PM, 2001, SIAM J SCI COMPUT, V23, P193, DOI 10.1137/S1064827500371499; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Neal ML, 2010, BRIEF BIOINFORM, V11, P111, DOI 10.1093/bib/bbp049; O'Reilly MA, 2008, SPINE, V33, P1876, DOI 10.1097/BRS.0b013e31817d9ce5; Portnoy S, 2008, J BIOMECH, V41, P1897, DOI 10.1016/j.jbiomech.2008.03.035; Schonning A, 2009, COMPUT AIDED DESIGN, V41, P566, DOI 10.1016/j.cad.2007.10.007; Shepherd JF, 2010, FINITE ELEM ANAL DES, V46, P17, DOI 10.1016/j.finel.2009.06.024; Sigal IA, 2008, J BIOMECH, V41, P1381, DOI 10.1016/j.jbiomech.2008.02.019; Sigal IA, 2010, J BIOMECH, V43, P254, DOI 10.1016/j.jbiomech.2009.08.036; Southern J, 2008, PROG BIOPHYS MOL BIO, V96, P60, DOI 10.1016/j.pbiomolbio.2007.07.019; Taylor CA, 2009, ANNU REV BIOMED ENG, V11, P109, DOI 10.1146/annurev.bioeng.10.061807.160521; Wenk JF, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000165; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; *XYZ SCI APPL INC, TRUEGRID US MAN VERS	30	20	20	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-874X			FINITE ELEM ANAL DES	Finite Elem. Anal. Des.	OCT	2011	47	10					1178	1185		10.1016/j.finel.2011.05.007			8	Mathematics, Applied; Mechanics	Mathematics; Mechanics	782TS	WOS:000292035200006	21731153	Green Accepted			2021-06-18	
J	Liu, AA; Voss, HU; Dyke, JP; Heier, LA; Schiff, ND				Liu, A. A.; Voss, H. U.; Dyke, J. P.; Heier, L. A.; Schiff, N. D.			Arterial spin labeling and altered cerebral blood flow patterns in the minimally conscious state	NEUROLOGY			English	Article							ROUTINE CLINICAL-PRACTICE; BRAIN-FUNCTION; PERFUSION MRI; PARKINSONS-DISEASE; GLUCOSE-METABOLISM; ALZHEIMERS-DISEASE; VEGETATIVE STATE; DEFAULT MODE; AGE; HYPERPERFUSION	Objective: To use arterial spin labeling (ASL) to compare cerebral blood flow (CBF) patterns in minimally conscious state (MCS) patients with those in normal controls in an observational study design. Methods: Subjects meeting MCS criteria and normal controls were identified. A pseudocontinuous ASL sequence was performed with subjects and controls in the resting awake state. Multiple CBF values for 10 predetermined regions of interest were sampled and average CBF was calculated and compared between controls and subjects. Results: Ten normal controls were identified, with ages ranging from 26 to 54 years. Four subjects met the MCS criteria and received an ASL study, with one patient receiving a second study at a later date. Subjects ranged in age from 19 to 58 years and had traumatic brain injury, stroke, or hypoxic-ischemic encephalopathy. Regional CBF for controls ranged from 21.6 to 57.2 mL/100 g/min, with a pattern of relatively increased blood flow posteriorly including the posterior cingulate, parietal, and occipital cortices. CBF patterns for MCS subjects showed greater variability (from 7.7 to 33.1 mL/100 g/min), demonstrating globally decreased CBF in gray matter compared with that in normal controls, especially in the medial prefrontal and midfrontal regions. In the one subject studied longitudinally, global CBF values increased over time, which correlated with clinical improvement. Conclusions: We identified globally decreased CBF and a selective reduction of CBF within the medial prefrontal and midfrontal cortical regions as well as gray matter in MCS patients. ASL may serve as an adjunctive method to assess functional reserve in patients recovering from severe brain injuries. Neurology (R) 2011;77:1518-1523	[Liu, A. A.; Heier, L. A.; Schiff, N. D.] New York Presbyterian Cornell, Dept Neurol, New York, NY USA; [Voss, H. U.; Dyke, J. P.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA	Liu, AA (corresponding author), Beth Israel Deaconess Harvard Univ, Kirstein 2,330 Brookline Ave, Boston, MA 02215 USA.	aaliu@bidmc.harvard.edu	Dyke, Jonathan P/AAX-4362-2020; Voss, Henning/C-2194-2009	Dyke, Jonathan P/0000-0001-7170-488X; Voss, Henning/0000-0003-2811-2074; Liu, Anli/0000-0002-1118-981X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD51912]; James S. McDonnell Foundation; NSFNational Science Foundation (NSF); NIH/NCCFUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH (NINDS, NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD051912] Funding Source: NIH RePORTER	The authors thank David Alsop for providing the ASL pulse sequence for our MRI scanner and acknowledge the support of the NIH (HD51912) and the James S. McDonnell Foundation.; Dr. Liu reports no disclosures. Dr. Voss receives research support from the NIH and the NSF. Dr. Dyke reports no disclosures. Dr. Heier receives research support from the NIH/NCCF. Dr. Schiff has received travel support from and serves as a scientific consultant for Boston Scientific; receives publishing royalties for Plum and Posner's Diagnosis of Stupor and Coma 4th Edition (Oxford University Press, 2007); receives research support from the NIH (NINDS, NICHD) and the James S. McDonnell Foundation; is listed as an author on numerous patents re: Deep brain stimulation technology; and receives royalties for patents issued to Cornell University and licensed to Boston Scientific.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alsop DC, 2008, NEUROIMAGE, V42, P1267, DOI 10.1016/j.neuroimage.2008.06.006; Balkin TJ, 2002, BRAIN, V125, P2308, DOI 10.1093/brain/awf228; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Cauda F, 2009, J NEUROL NEUROSUR PS, V80, P429, DOI 10.1136/jnnp.2007.142349; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Deibler AR, 2008, AM J NEURORADIOL, V29, P1428, DOI 10.3174/ajnr.A1034; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; Deibler AR, 2008, AM J NEURORADIOL, V29, P1235, DOI 10.3174/ajnr.A1033; DEVOLDER AG, 1990, ARCH NEUROL-CHICAGO, V47, P197, DOI 10.1001/archneur.1990.00530020103022; Dupui P, 1984, Monogr Neural Sci, V11, P131; Dyke JP, 2007, AM J NEURORADIOL, V28, P1232, DOI 10.3174/ajnr.A0551; Floyd TF, 2003, J MAGN RESON IMAGING, V18, P649, DOI 10.1002/jmri.10416; Giacino JT, 2005, PROG BRAIN RES, V150, P381, DOI 10.1016/S0079-6123(05)50027-X; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Jiang L, 2010, MAGN RESON IMAGING, V28, P1283, DOI 10.1016/j.mri.2010.05.002; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Lee C, 2009, J NEUROIMAGING, V19, P344, DOI 10.1111/j.1552-6569.2008.00277.x; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; Ma Y, 2007, MOL IMAGING BIOL, V9, P223, DOI 10.1007/s11307-007-0085-4; Ma YL, 2010, J CEREBR BLOOD F MET, V30, P505, DOI 10.1038/jcbfm.2009.256; MAMO H, 1983, ARCH NEUROL-CHICAGO, V40, P626, DOI 10.1001/archneur.1983.04050090062010; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schiff ND, 2005, PROG BRAIN RES, V150, P473, DOI 10.1016/S0079-6123(05)50033-5; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; TOMMASINO C, 1995, J NEUROSURG ANESTH, V7, P109, DOI 10.1097/00008506-199504000-00006; Tshibanda L, 2010, NEURORADIOLOGY, V52, P15, DOI 10.1007/s00234-009-0614-8; TSUDA Y, 1989, STROKE, V20, P1667, DOI 10.1161/01.STR.20.12.1667; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; WILLIAMS S, 2009, ABSTR SOC NEUR; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462	37	20	23	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	OCT	2011	77	16					1518	1523		10.1212/WNL.0b013e318233b229			6	Clinical Neurology	Neurosciences & Neurology	839TL	WOS:000296392000007	21940616	Green Published			2021-06-18	
J	Bukur, M; Kurtovic, S; Berry, C; Tanios, M; Margulies, DR; Ley, EJ; Salim, A				Bukur, Marko; Kurtovic, Silvia; Berry, Cherisse; Tanios, Mina; Margulies, Daniel R.; Ley, Eric J.; Salim, Ali			Pre-Hospital Intubation is Associated with Increased Mortality After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	Annual Meeting of the Association-of-Academic-Surgery (AAS)/6th Annual Academic-Surgical Congress	FEB 01-03, 2011	Huntington Beach, CA	Assoc Acad Surg (AAS), Acad Surg		traumatic brain injury; pre-hospital intubation; mortality; outcomes	ENDOTRACHEAL INTUBATION; EARLY VENTILATION; HYPOTENSION; MODERATE; HYPOXIA; FIELD	Background. Early endotracheal intubation in patients sustaining moderate to severe traumatic brain injury (TBI) is considered the standard of care. Yet the benefit of pre-hospital intubation (PHI) in patients with TBI is questionable. The purpose of this study was to investigate the relationship between pre-hospital endotracheal intubation and mortality in patients with isolated moderate to severe TBI. Methods. The Los Angeles County Trauma System Database was queried for all patients > 14 y of age with isolated moderate to severe TBI admitted between 2005 and 2009. The study population was then stratified into two groups: those patients requiring intubation in the field (PHI group) and those patients with delayed airway management (No-PHI group). Demographic characteristics and outcomes were compared between groups. Multivariate analysis was used to determine the relationship between pre-hospital endotracheal intubation and mortality. Results. A total of 2549 patients were analyzed and then stratified into the two groups: PHI and No-PHI. There was a significant difference noted in overall mortality (90.2% versus 12.4%), with the PHI group being more likely to succumb to their injuries. After adjusting for possible confounding factors, multivariable logistic regression analysis demonstrated that PHI was independently associated with increased mortality (AOR 5, 95% CI: 1.7-13.7, P = 0.004). Conclusions. Pre-hospital endotracheal intubation in isolated, moderate to severe TBI patients is associated with a nearly 5-fold increase in mortality. Further prospective studies are required to establish guidelines for optimal pre-hospital management of this critically injured patient population. (C) 2011 Elsevier Inc. All rights reserved.	[Bukur, Marko; Kurtovic, Silvia; Berry, Cherisse; Tanios, Mina; Margulies, Daniel R.; Ley, Eric J.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA	Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Berry, Cherisse/AAO-5701-2020	Bukur, Marko/0000-0002-1850-7147			Barnes SL, 2008, J TRAUMA, V64, pS129, DOI 10.1097/TA.0b013e318160a5b4; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bernard Stephen A, 2006, Emerg Med Australas, V18, P221, DOI 10.1111/j.1742-6723.2006.00850.x; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Brain Trauma Foundation Guidelines, MAN PROGN SEV TRAUM; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS7, DOI DOI 10.1089/NEU.2007.9995; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Combes X, 2011, ANESTHESIOLOGY, V114, P105, DOI 10.1097/ALN.0b013e318201c42e; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; GRAHAM DI, 1971, LANCET, V1, P265; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Wang HE, 2005, CRIT CARE MED, V33, P1718, DOI 10.1097/01.CCM.0000171208.07895.2A; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	20	20	22	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2011	170	1					E117	E121		10.1016/j.jss.2011.04.005			5	Surgery	Surgery	804BD	WOS:000293627800015	21601884				2021-06-18	
J	Lancioni, GE; O'Reilly, MF; Singh, NN; Sigafoos, J; Buonocunto, F; Sacco, V; Colonna, F; Navarro, J; Lanzilotti, C; de Pace, C; Megna, M; Oliva, D				Lancioni, Giulio E.; O'Reilly, Mark F.; Singh, Nirbhay N.; Sigafoos, Jeff; Buonocunto, Francesca; Sacco, Valentina; Colonna, Fabio; Navarro, Jorge; Lanzilotti, Crocifissa; de Pace, Claudia; Megna, Marisa; Oliva, Doretta			Communication opportunities via special messaging technology for two post-coma persons with multiple disabilities	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						Messaging technology; Microswitches; Acquired brain injury; Emergence from minimally conscious state	TRAUMATIC BRAIN-INJURY; MINIMALLY CONSCIOUS STATE; ASSISTIVE TECHNOLOGY; REHABILITATION; PEOPLE; INDIVIDUALS; IMPAIRMENTS; MOTOR; EMERGENCE; RECOVERY	This study extended the assessment of a special messaging technology with two additional post-coma adults who had emerged from a minimally conscious state, but showed multiple disabilities including profound motor and communication impairments. For each participant, the study involved an ABAB design, in which the A represented baseline phases and the B represented intervention phases with the special messaging technology. The technology involved a net-book computer provided with specific software, a global system for mobile communication (GSM) modem, microswitches, and prerecorded verbal lists of persons' names and messages. Both participants learned to send out and receive (listen to) messages independently during the intervention, thus providing clear support for previous data in the area. They sent out means of about three and 17 messages and received means of about two and six messages per 20- and 30-min session, respectively. The positive impact of the technology was discussed in relation to previous data in this area and the possibility of helping post-coma persons with multiple disabilities engage in basic communication with distant partners. (C) 2011 Elsevier Ltd. All rights reserved.	[Lancioni, Giulio E.] Univ Bari, Dept Psychol, I-70100 Bari, Italy; [O'Reilly, Mark F.] Univ Texas Austin, Meadows Ctr Preventing Educ Risk, Austin, TX 78712 USA; [Singh, Nirbhay N.] ONE Res Inst, Midlothian, VA USA; [Sigafoos, Jeff] Victoria Univ Wellington, Wellington, New Zealand; [Buonocunto, Francesca; Sacco, Valentina; Colonna, Fabio; Navarro, Jorge; Lanzilotti, Crocifissa] S Raffaele Rehabil Ctr, Ceglie Messapica, Italy; [Oliva, Doretta] Lega F DOro Res Ctr, Osimo, Italy	Lancioni, GE (corresponding author), Univ Bari, Dept Psychol, Via Quintino Sella 268, I-70100 Bari, Italy.	g.lancioni@psico.uniba.it	Megna, Marisa/ABE-8907-2020; Singh, Nouratan/N-9377-2017	Singh, Nouratan/0000-0002-8063-8375; Megna, Marisa/0000-0002-8486-103X; Lancioni, Giulio/0000-0002-6515-5690; Navarro solano, Jorge/0000-0003-1508-6727			Baker PMA, 2008, ASSIST TECHNOL, V20, P149, DOI 10.1080/10400435.2008.10131942; Bekinschtein T, 2005, NEUROPSYCHOL REHABIL, V15, P307, DOI 10.1080/09602010443000443; Callahan K, 2008, J AUTISM DEV DISORD, V38, P678, DOI 10.1007/s10803-007-0434-9; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Durando J, 2008, J VISUAL IMPAIR BLIN, V102, P40, DOI 10.1177/0145482X0810200105; Egan J, 2006, BRAIN INJURY, V20, P1283, DOI 10.1080/02699050601049692; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Giacino JT, 2007, CURR OPIN NEUROL, V20, P614, DOI 10.1097/WCO.0b013e3282f189ef; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Greig CA, 2008, TOP STROKE REHABIL, V15, P307, DOI 10.1310/tsr1504-307; Hagen C, 1998, LEVELS COGNITIVE FUN; Haggstrom A, 2008, J REHABIL MED, V40, P89, DOI 10.2340/16501977-0138; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Hersen M., 2009, SINGLE CASE EXPT DES; Jumisko E, 2009, J CLIN NURS, V18, P2273, DOI 10.1111/j.1365-2702.2008.02738.x; Keren O, 2001, BRAIN INJURY, V15, P633, DOI 10.1080/02699050010009568; Lancioni G, 2011, DEV NEUROREHABIL, V14, P8, DOI 10.3109/17518423.2010.519760; Lancioni GE, 2010, RES DEV DISABIL, V31, P1121, DOI 10.1016/j.ridd.2010.06.019; Lancioni GE, 2010, BRAIN INJURY, V24, P1236, DOI 10.3109/02699052.2010.506857; Lancioni GE, 2010, RES DEV DISABIL, V31, P777, DOI 10.1016/j.ridd.2010.02.001; Lancioni GE, 2009, RES DEV DISABIL, V30, P1459, DOI 10.1016/j.ridd.2009.07.006; Mumford N, 2009, BRAIN INJURY, V23, P179, DOI 10.1080/02699050802695566; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Naude K, 2005, NEUROPSYCHOL REHABIL, V15, P514, DOI 10.1080/09602010443000470; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Sohlberg MM, 2003, BRAIN INJURY, V17, P609, DOI 10.1080/0269905031000070189; Taylor CM, 2007, ARCH PHYS MED REHAB, V88, P521, DOI 10.1016/j.apmr.2007.01.013; Todis B, 2005, BRAIN INJURY, V19, P389, DOI 10.1080/02699050400003957; Wehman P, 2009, J REHABIL RES DEV, V46, P909, DOI 10.1682/JRRD.2008.08.0105	32	20	20	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	SEP-OCT	2011	32	5					1703	1708		10.1016/j.ridd.2011.02.025			6	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	799UC	WOS:000293310600034	21440412				2021-06-18	
J	Yu, CH; Yhee, JY; Kim, JH; Im, KS; Kim, NH; Jung, DI; Lee, HC; Chon, SK; Sur, JH				Yu, Chi-Ho; Yhee, Ji-Young; Kim, Jong-Hyuk; Im, Keum-Soon; Kim, Na-Hyun; Jung, Dong-In; Lee, Hee-Chun; Chon, Seung-Ki; Sur, Jung-Hyang			Pro- and anti-inflammatory cytokine expression and histopathological characteristics in canine brain with traumatic brain injury	JOURNAL OF VETERINARY SCIENCE			English	Article						interleukin-1; interleukin-6; transforming growth factor-beta; traumatic brain injury; tumor necrosis factor-alpha	DOG; HYPOTHERMIA; RAT	We analyzed the expression level and cellular localization of pro- and anti-inflammatory cytokines and histopathologically characterized canine traumatic brain injury (TBI). Canine TBI brains revealed subarachnoid and cerebral cortical hemorrhage, neutrophilic infiltration, neuronal necrosis, astrocytosis, and vasogenic edema. Immunohistochemical evaluations suggested that both pro-inflammatory cytokines [interleukin (IL)-1 beta, IL-6, and tumor necrosis factor-alpha] and anti-inflammatory cytokines [IL-10 and transforming growth factor-beta (TGF-beta)] were highly expressed in neurons and neutrophils. In particular, the highest magnitude of expression was identified for IL-1 beta and TGF-beta. This data helps describe the pathologic characteristics of canine TBI, and may help in the design of potential therapeutic approaches to control secondary damage by inflammatory cytokines.	[Yu, Chi-Ho; Yhee, Ji-Young; Kim, Jong-Hyuk; Im, Keum-Soon; Kim, Na-Hyun; Sur, Jung-Hyang] Konkuk Univ, Dept Pathobiol, Small Anim Tumor Diagnost Ctr, Coll Vet Med, Seoul 143701, South Korea; [Jung, Dong-In] Gyeongsang Natl Univ, Dept Internal Med, Coll Vet Med, Jinju 660701, South Korea; [Lee, Hee-Chun] Gyeongsang Natl Univ, Dept Med Imaging, Coll Vet Med, Jinju 660701, South Korea; [Chon, Seung-Ki] Hyu Anim Clin, Iksan 570973, South Korea	Sur, JH (corresponding author), Konkuk Univ, Dept Pathobiol, Small Anim Tumor Diagnost Ctr, Coll Vet Med, Seoul 143701, South Korea.	jsur@konkuk.ac.kr	KIM, JONG HYUK/AAC-7433-2020	KIM, JONG HYUK/0000-0002-1645-0036; Sur, Jung-Hyang/0000-0003-4496-7582	Konkuk University	We thank to Ms. R. H Jang for excellent technical assistance. This paper was supported by Konkuk University Research Fund in 2009. This report represents part of the thesis submitted by Dr. C. H Yu to fulfill the requirements of a Ph.D.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Foley C, 2009, J VET EMERG CRIT CAR, V19, P269, DOI 10.1111/j.1476-4431.2009.00409.x; FOSSUM T, 2007, SMALL ANIMAL SURG, P1379; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Hayes GM, 2009, J VET EMERG CRIT CAR, V19, P629, DOI 10.1111/j.1476-4431.2009.00478.x; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Kitagawa M, 2005, J VET MED SCI, V67, P843, DOI 10.1292/jvms.67.843; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Laurent S, 2010, J COMP PATHOL, V143, P75, DOI 10.1016/j.jcpa.2009.12.008; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MCGAVIN MD, 2006, PATHOLOGIC BASIS VET, P938; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101	13	20	22	0	4	KOREAN SOC VETERINARY SCIENCE	SEOUL	SEOUL NATL UNIV,  COLLEGE VETERINARY MEDICINE,, SEOUL, 151-742, SOUTH KOREA	1229-845X	1976-555X		J VET SCI	J. Vet. Sci.	SEP	2011	12	3					299	301		10.4142/jvs.2011.12.3.299			3	Veterinary Sciences	Veterinary Sciences	822BA	WOS:000295017500016	21897106	DOAJ Gold, Green Published			2021-06-18	
J	Bourdeaux, CP; Brown, JM				Bourdeaux, Chris P.; Brown, Jules M.			Randomized Controlled Trial Comparing the Effect of 8.4% Sodium Bicarbonate and 5% Sodium Chloride on Raised Intracranial Pressure after Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Brain edema; Intracranial hypertension; Sodium bicarbonate; Saline solution; Hypertonic; Acidosis	CEREBRAL EDEMA; INFUSION	Hypertonic sodium chloride solutions are routinely used to control raised intracranial pressure (ICP) after traumatic brain injury but have the potential to cause a hyperchloremic metabolic acidosis. Sodium bicarbonate 8.4% has previously been shown to reduce ICP and we have therefore conducted a randomized controlled trial to compare these two solutions. Patients with severe traumatic brain injury were randomly allocated to receive an equiosmolar dose of either 100 ml of sodium chloride 5% or 85 ml of sodium bicarbonate 8.4% for each episode of intracranial hypertension. ICP and blood pressure were measured continuously. Arterial pCO(2), sodium, chloride, osmolality, and pH were measured at intervals. We studied 20 episodes of intracranial hypertension in 11 patients. Treatments with 8.4% sodium bicarbonate and 5% sodium chloride reduced raised ICP effectively with a significant fall in ICP from baseline at all time points (P < 0.001). There was no significant difference in ICP with time between those episodes treated with 5% sodium chloride or 8.4% sodium bicarbonate, P = 0.504. Arterial pH was raised after treatment with 8.4% sodium bicarbonate. An equiosmolar infusion of 8.4% sodium bicarbonate is as effective as 5% sodium chloride for reduction of raised ICP after traumatic brain injury when infused over 30 min.	[Bourdeaux, Chris P.; Brown, Jules M.] Frenchay Hosp, Intens Care Unit, Bristol BS16 1LE, Avon, England	Brown, JM (corresponding author), Frenchay Hosp, Intens Care Unit, Frenchay Pk Rd, Bristol BS16 1LE, Avon, England.	jules.brown@nbt.nhs.uk			Frenchay Hospital	We are grateful to Paul White from the University of the West of England for his help with the statistical analysis. This study was supported by a small grant from the Frenchay Hospital anaesthetic department research fund.	Bourdeaux C, 2010, NEUROCRIT CARE, V13, P24, DOI 10.1007/s12028-010-9368-8; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Weed LH, 1919, AM J PHYSIOL, V48, P512; Weed LH, 1919, AM J PHYSIOL, V48, P531; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; YOUNG RSK, 1984, ACTA NEUROPATHOL, V65, P124, DOI 10.1007/BF00690465	8	20	20	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	AUG	2011	15	1					42	45		10.1007/s12028-011-9512-0			4	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	789XI	WOS:000292552100007	21298358				2021-06-18	
J	Al-Jishi, A; Saluja, RS; Al-Jehani, H; Lamoureux, J; Maleki, M; Marcoux, J				Al-Jishi, Ahmed; Saluja, Rajeet Singh; Al-Jehani, Hosam; Lamoureux, Julie; Maleki, Mohammad; Marcoux, Judith			Primary or Secondary Decompressive Craniectomy: Different Indication and Outcome	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; CEREBRAL PERFUSION-PRESSURE; MANAGEMENT; CHILDREN; IMPACT; ICP; CLASSIFICATION; COMPLICATIONS	Background: Intracranial hypertension can cause secondary damage after a traumatic brain injury. Aggressive medical management might not be sufficient to alleviate the increasing intracranial pressure (ICP), and decompressive craniectomy (DC) can be considered. Decompressive craniectomy can be divided into categories, according to the timing and rationale for performing the procedure: primary (done at the time of mass lesion evacuation) and secondary craniectomy (done to treat refractory ICP). Most studies analyze primary and secondary DC together. Our hypothesis is that these two groups are distinct and the aim of this retrospective study is to evaluate the differences in order to better predict outcome after DC. Methods: Seventy patients had DC over a period of four years at our center. They were divided into two groups based on the timing of the DC. Primary DC (44 patients) was done within 24 hours of the injury for mass lesion evacuation. Secondary DC (26 patients) was done after 24 hours and purely for the treatment of refractory ICP. Pre-op characteristics and post-op outcomes were compared between the two groups. Results: There was a significant difference in the mechanism of injury, the pupil abnormalities and Marshall grade between primary and secondary DC. There was also a significant difference in outcome with primary DC showing 45.5% good outcome and 40.9% mortality and secondary DC showing 73.1% good outcome and 15.4% mortality. Conclusions: Primary and secondary DC have different indications and patients characteristics. Outcome prediction following DC should be adjusted according to the surgical indication.	[Marcoux, Judith] McGill Univ, Ctr Hlth, Dept Neurol & Neurosurg, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Al-Jishi, Ahmed; Saluja, Rajeet Singh; Al-Jehani, Hosam] McGill Univ, Ctr Hlth, Dept Neurol & Neurosurg, Montreal Neurol Hosp, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Montreal, PQ, Canada; [Al-Jehani, Hosam] Dammam Univ, King Fahad Univ Hosp, Dept Neurosurg, Al Khobar, Saudi Arabia	Marcoux, J (corresponding author), McGill Univ, Ctr Hlth, Dept Neurol & Neurosurg, Montreal Gen Hosp, 1650 Cedar Ave,Room L7-524, Montreal, PQ H3G 1A4, Canada.						Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Csokay A, 2002, NEUROL RES, V24, P157, DOI 10.1179/016164102101199701; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Faleiro RM, 2005, ARQ NEURO-PSIQUIAT, V63, P508, DOI 10.1590/S0004-282X2005000300026; Faleiro RM, 2008, ARQ NEURO-PSIQUIAT, V66, P369, DOI 10.1590/S0004-282X2008000300017; Figaji AA, 2008, ACTA NEUROCHIR SUPPL, V102, P77, DOI 10.1007/978-3-211-85578-2_15; Grinkeviciute DE, 2008, MEDICINA-LITHUANIA, V44, P119, DOI 10.3390/medicina44020015; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Guerra WKW, 1999, INTENS CARE MED, V25, P1327; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Kunze E, 1998, ACT NEUR S, V71, P16; Li G, 2008, CHIN J TRAUMATOL, V11, P253, DOI 10.1016/S1008-1275(08)60052-8; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Meier U, 2005, ACT NEUR S, V95, P55; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315; Murr R, 1996, ACTA NEUROCHIR, V138, P928, DOI 10.1007/BF01411281; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Sahuquillo J, 2009, COCHRANE DATABASE SY; Schneider GH, 2002, ACT NEUR S, V81, P77; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEASDALE G, 1974, LANCET, V2, P81; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Young Jeffrey S, 2003, Neurosurg Focus, V15, pE2	52	20	20	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JUL	2011	38	4					612	620		10.1017/S0317167100012154			9	Clinical Neurology	Neurosciences & Neurology	802AT	WOS:000293482400013	21672701	Bronze			2021-06-18	
J	Chiou, KS; Carlson, RA; Arnett, PA; Cosentino, SA; Hillary, FG				Chiou, Kathy S.; Carlson, Richard A.; Arnett, Peter A.; Cosentino, Stephanie A.; Hillary, Frank G.			Metacognitive Monitoring in Moderate and Severe Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Awareness; Brain injury; Metacognition; Confidence judgments; Self-monitoring; Executive functioning	IMPAIRED SELF-AWARENESS; EXECUTIVE FUNCTION; COGNITIVE DEFICIT; METAMEMORY; METACOMPREHENSION; ACCURACY; JUDGMENTS; MEMORY; ANOSOGNOSIA; PREDICTIONS	The ability to engage in self-reflective processes is a capacity that may be disrupted after neurological compromise; research to date has demonstrated that patients with traumatic brain injury (TBI) show reduced awareness of their deficits and functional ability compared to caretaker or clinician reports. Assessment of awareness of deficit, however, has been limited by the use of subjective measures (without comparison to actual performance) that are susceptible to report bias. This study used concurrent measurements from cognitive testing and confidence judgments about performance to investigate in-the-moment metacognitive experiences after moderate and severe traumatic brain injury. Deficits in metacognitive accuracy were found in adults with TBI for some but not all indices, suggesting that metacognition may not be a unitary construct. Findings also revealed that not all indices of executive functioning reliably predict metacognitive ability. (JINS, 2011, 17, 720-731)	[Chiou, Kathy S.; Carlson, Richard A.; Arnett, Peter A.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Cosentino, Stephanie A.] Columbia Univ, Gertrude H Sergievsky Ctr, Med Ctr, Cognit Neurosci Div, New York, NY 10027 USA	Chiou, KS (corresponding author), Penn State Univ, Dept Psychol, 610 Moore Bldg, University Pk, PA 16802 USA.	ksc167@psu.edu	Hillary, Frank/AAN-8622-2021		New Jersey Commission on Brain Injury Research [0120090178]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG032899] Funding Source: NIH RePORTER	Much appreciation to Philip Schatz, Ph.D., for his consultation and to Neal Fitzpatrick, Tia Bochnakova, Julia Slocomb, and Britney Wardecker for their assistance in recruitment and data collection. The authors declare that there are no conflicts of interest associated with this study and manuscript. This research was funded in part by a grant from the New Jersey Commission on Brain Injury Research (grant number 0120090178).	ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; AMADOR XF, 1993, AM J PSYCHIAT, V150, P873; Anderson JW, 2009, J CLIN EXP NEUROPSYC, V31, P425, DOI 10.1080/13803390802232667; Augustyn JS, 2005, PSYCHON B REV, V12, P911, DOI 10.3758/BF03196785; Babinski MJ., 1914, REV NEUROL, V27, P845; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barrett AM, 2005, NEUROLOGY, V64, P693, DOI 10.1212/01.WNL.0000151959.64379.1B; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Chen Q, 2006, J COGNITIVE NEUROSCI, V18, P1937, DOI 10.1162/jocn.2006.18.11.1937; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Chua EF, 2009, J COGNITIVE NEUROSCI, V21, P1751, DOI 10.1162/jocn.2009.21123; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Cosentino S, 2005, J INT NEUROPSYCH SOC, V11, P910, DOI 10.1017/S1355617705050964; COSENTINO SA, NEUROPSYCHO IN PRESS; de Frias CM, 2006, NEUROPSYCHOLOGY, V20, P206, DOI 10.1037/0894-4105.20.2.206; Delis DC, 2001, DELISKAPLAN EXECUTIV; Dunlosky J., 2009, METACOGNITION; Dunlosky J, 2006, PSYCHOL AGING, V21, P390, DOI 10.1037/0882-7974.21.2.390; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming JM, 1996, BRAIN INJURY, V10, P1; GALLUP GG, 1991, J COMP PSYCHOL, V105, P376, DOI 10.1037/0735-7036.105.4.376; Garmoe W, 2005, J HEAD TRAUMA REHAB, V20, P348, DOI 10.1097/00001199-200507000-00006; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GOLDENBERG G, 1995, NEUROPSYCHOLOGIA, V33, P1373, DOI 10.1016/0028-3932(95)00070-J; Gonzalez R, 1996, PSYCHOL BULL, V119, P159, DOI 10.1037/0033-2909.119.1.159; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Griffin TD, 2008, MEM COGNITION, V36, P93, DOI 10.3758/MC.36.1.93; Griffin TD, 2009, MEM COGNITION, V37, P1001, DOI 10.3758/MC.37.7.1001; HAGER W, 1992, PSYCHOL RES-PSYCH FO, V54, P110, DOI 10.1007/BF00937139; Halstead WC, 1985, HALSTEAD REITAN NEUR; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Heilman KM, 1998, PHILOS T R SOC B, V353, P1903, DOI 10.1098/rstb.1998.0342; HERTZOG C, 1990, PSYCHOL AGING, V5, P215, DOI 10.1037/0882-7974.5.2.215; Howell D., 1987, STAT METHODS PSYCHOL; Karpicke JD, 2009, J EXP PSYCHOL GEN, V138, P469, DOI 10.1037/a0017341; Kaszniak AW, 1996, LEARN INDIVID DIFFER, V8, P355, DOI 10.1016/S1041-6080(96)90023-0; Kennedy MRT, 2004, AM J SPEECH-LANG PAT, V13, P142, DOI 10.1044/1058-0360(2004/015); Kennedy MRT, 2003, BRAIN INJURY, V17, P1043, DOI 10.1080/0269905031000110436; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050120517; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kervick RB, 2005, BRAIN INJURY, V19, P881, DOI 10.1080/02699050400025273; Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; Koren D, 2004, SCHIZOPHR RES, V70, P195, DOI 10.1016/j.schres.2004.02.004; Koriat A, 2007, EVERYDAY MEMORY, P251; LEBRUN Y, 1987, CORTEX, V23, P251, DOI 10.1016/S0010-9452(87)80035-7; Lefevre N, 2004, MEM COGNITION, V32, P1238, DOI 10.3758/BF03206315; LEONESIO RJ, 1990, J EXP PSYCHOL LEARN, V16, P464, DOI 10.1037/0278-7393.16.3.464; Leritz E, 2004, CLIN NEUROPSYCHOL, V18, P352, DOI 10.1080/1385404049052412; MAKI RH, 1984, J EXP PSYCHOL LEARN, V10, P663, DOI 10.1037/0278-7393.10.4.663; Markela-Lerenc J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI 10.1016/j.cogbrainres.2003.10.013; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; McDonaldMiszczak L, 1995, PSYCHOL AGING, V10, P553, DOI 10.1037/0882-7974.10.4.553; McGlynn SM, 1997, PSYCHIAT ANN, V27, P806, DOI 10.3928/0048-5713-19971201-10; Metcalfe J, 2009, CURR DIR PSYCHOL SCI, V18, P159, DOI 10.1111/j.1467-8721.2009.01628.x; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nelson T. O., 1992, METACOGNITION CORE R; Nelson T. O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI DOI 10.1016/S0079-7421(08)60053-5; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Norman D.A., 1986, CONSCIOUSNESS SELF R, V4, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Perrotin A, 2006, ACTA PSYCHOL, V122, P58, DOI 10.1016/j.actpsy.2005.10.003; Perrotin A, 2008, BRAIN COGNITION, V67, P76, DOI 10.1016/j.bandc.2007.11.006; Perrotin A, 2007, NEUROPSYCHOLOGIA, V45, P2811, DOI 10.1016/j.neuropsychologia.2007.05.003; Pia L, 2006, PSYCHIAT CLIN NEUROS, V60, P531, DOI 10.1111/j.1440-1819.2006.01576.x; Prigatano G.P, 1997, NEUROPSYCHOLOGICAL R; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; PRINGLE RK, 1971, J CLIN PSYCHOL, V27, P479, DOI 10.1002/1097-4679(197110)27:4<479::AID-JCLP2270270422>3.0.CO;2-C; Rawson KA, 2000, MEM COGNITION, V28, P1004, DOI 10.3758/BF03209348; Redford JS, 2010, J EXP PSYCHOL LEARN, V36, P248, DOI 10.1037/a0017809; Rickelman Bonnie L, 2004, Issues Ment Health Nurs, V25, P227, DOI 10.1080/01612840490274741; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Shimamura AP, 2000, CONSCIOUS COGN, V9, P313, DOI 10.1006/ccog.2000.0450; Shipley W. C., 1946, I LIVING SCALE; Souchay C, 2004, EXP AGING RES, V30, P47, DOI 10.1080/03610730490251478; Souchay C, 2000, NEUROPSYCHOLOGY, V14, P299, DOI 10.1037/0894-4105.14.2.299; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55, DOI DOI 10.1177/030802269505800204; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; THIEDE KW, 2010, BRIT J ED PSYCHOL; Tiede HL, 2009, MEMORY, V17, P288, DOI 10.1080/09658210802665837; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Trenerry M.R., 1989, STROOP NEUROPSYCHOLO; Wagner MT, 1997, ALZ DIS ASSOC DIS, V11, P125, DOI 10.1097/00002093-199709000-00004; *WARD DEP ADJ GEN, 1944, MAN DIR SCOR; Wechsler D, 1997, WAIS 3 ADM SCORING M; Whyte J, 1993, REHABILITATION MED P, P825	100	20	20	0	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2011	17	4					720	731		10.1017/S1355617711000658			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	781NL	WOS:000291939900016	21554787				2021-06-18	
J	Coste, C; Agar, N; Petitfour, E; Quinette, P; Guillery-Girard, B; Azouvi, P; Piolino, P				Coste, Cecile; Agar, Nathalie; Petitfour, Elise; Quinette, Peggy; Guillery-Girard, Berengere; Azouvi, Philippe; Piolino, Pascale			Exploring the roles of the executive and short-term feature-binding functions in retrieval of retrograde autobiographical memories in severe traumatic brain injury	CORTEX			English	Article						Traumatic brain injury; Autobiographical memory; Executive functions; Short-term binding; Verbal fluency	WORKING-MEMORY; EPISODIC MEMORY; AUTONOETIC CONSCIOUSNESS; FRONTAL VARIANT; AGE; SELF; RECOVERY; BUFFER; DISSOCIATION; INFORMATION	Conway's autobiographical memory (AM) model postulates that memories are not stored in a crystallised form in long-term memory but are reconstructed at time of retrieval via executive and binding processes, to create a temporary multimodal representation from different AM knowledge. Traumatic brain injury (TB!) impairs AM recollection. However, no study has yet considered the distinct roles of executive and short-term feature-binding functions in the retrieval deficits of retrograde AMs after TBI. Examining a group of 33 TBI patients and 33 controls, our study addresses these roles through a first-ever exploration of the links between performance on an AM verbal fluency evaluation that distinguishes four levels of representation, from semantic to episodic (lifetime periods, general events, specific events, specific details of a specific event), and three executive functions (shifting, inhibition and updating) and two short-term feature-binding functions (short-term formation and maintenance of multimodal representations). The results showed that TBI patients were impaired compared to controls in the retrieval of both semantic and episodic retrograde AM representations, but especially for the most episodic level of AM, in the three executive functions and the short-term maintenance of multimodal representations. Regression analyses indicated that the executive predictors (mainly updating) mediated a large proportion (over 70%) of TBI-related deficit on the retrieval of lifetime periods, general events and specific events, in contrast with the main impairment on generation of specific details which were only mildly (just 12%) predicted by the short-term maintenance of multimodal representations. Additional analyses in a subgroup of patients point to episodic memory abilities and time since injury in predicting the retrieval of specific events and details. In summary, the present study mainly emphasizes that the executive deficits in TBI are involved in the disruption of the first levels of AM generative processes that give access to the multiple episodic details recollection. (C) 2010 Elsevier Srl. All rights reserved.	[Coste, Cecile; Piolino, Pascale] CNRS, FRE 3292, Memory & Learning Grp, Cognit Psychol & Neuropsychol Lab, F-92774 Boulogne, France; [Coste, Cecile; Petitfour, Elise; Piolino, Pascale] Paris Descartes Univ, Paris, France; [Agar, Nathalie; Azouvi, Philippe] Hop Raymond Poincare, Phys Med & Rehabil Serv, Garches, France; [Quinette, Peggy; Guillery-Girard, Berengere; Piolino, Pascale] Univ Caen, EPHE, INSERM, U923, F-14032 Caen, France	Piolino, P (corresponding author), CNRS, FRE 3292, Memory & Learning Grp, Cognit Psychol & Neuropsychol Lab, 71 Ave Edouard Vaillant, F-92774 Boulogne, France.	pascale.piolino@parisdescartes.fr	Piolino, pascale/F-8075-2014; Quinette, Peggy/L-8780-2015	Piolino, pascale/0000-0002-7787-924X; Quinette, Peggy/0000-0002-7520-7159; Guillery-Girard, Berengere/0000-0002-2316-4716	French Research MinistryMinistry of Research, France	We wish to thank all patients and controls for their participation and Susan Biggin for grammar/style corrections. This study was funding by a thesis grant awarded to Cecile Coste by the French Research Ministry.	Avants B, 2008, ACAD RADIOL, V15, P1360, DOI 10.1016/j.acra.2008.07.007; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A. D., 1986, WORKING MEMORY; Baddeley AD, 2002, EUR PSYCHOL, V7, P85, DOI 10.1027//1016-9040.7.2.85; BADDELEY AD, 1974, RECENT ADV LEARNING, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Baddeley A, 2010, NEUROPSYCHOLOGIA, V48, P1089, DOI 10.1016/j.neuropsychologia.2009.12.009; Baudouin A, 2009, BRAIN COGNITION, V71, P240, DOI 10.1016/j.bandc.2009.08.007; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Brickenkamp R., 1998, D2 TEST ATTENTION CO; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Carlesimo GA, 1998, CORTEX, V34, P1, DOI 10.1016/S0010-9452(08)70734-2; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Collinson SL, 2009, BRAIN INJURY, V23, P71, DOI 10.1080/02699050802649647; Colzato LS, 2006, J EXP PSYCHOL HUMAN, V32, P705, DOI 10.1037/0096-1523.32.3.705; Conway M, 2004, MEMORY, V12, P525, DOI 10.1080/09658210444000151; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Conway MA, 2003, MEMORY, V11, P217, DOI 10.1080/741938205; Conway MA, 2001, PHILOS T R SOC B, V356, P1375, DOI 10.1098/rstb.2001.0940; CONWAY MA, 2000, HDB NEUROPSYCHOLOGY, V2, P281; Conway MA, 2009, NEUROPSYCHOLOGIA, V47, P2305, DOI 10.1016/j.neuropsychologia.2009.02.003; Dalgleish T, 2007, MEMORY, V15, P225, DOI 10.1080/09658210701256399; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Dritschel BH, 1998, BRAIN INJURY, V12, P875; DRITSCHEL BH, 1992, MEM COGNITION, V20, P133, DOI 10.3758/BF03197162; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Greene JDW, 1995, NEUROPSYCHOLOGIA, V33, P1647, DOI 10.1016/0028-3932(95)00046-1; Hayes SM, 2004, BEHAV NEUROSCI, V118, P885, DOI 10.1037/0735-7044.118.5.885; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Knight RG, 2009, J CLIN EXP NEUROPSYC, V31, P575, DOI 10.1080/13803390802363710; Kopelman MD, 2001, PHILOS T R SOC B, V356, P1409, DOI 10.1098/rstb.2001.0942; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Lemogne C, 2006, CONSCIOUS COGN, V15, P258, DOI 10.1016/j.concog.2005.07.005; Levine B, 2004, J COGNITIVE NEUROSCI, V16, P1633, DOI 10.1162/0898929042568587; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Matuszewski V, 2006, NEUROPSYCHOLOGIA, V44, P2386, DOI 10.1016/j.neuropsychologia.2006.04.031; Mcwilliams J, 2008, BRAIN INJURY, V22, P243, DOI 10.1080/02699050801935252; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; MORRIS N, 1990, PERCEPT PSYCHOPHYS, V47, P291, DOI 10.3758/BF03205003; Moscovitch M, 1995, ANN NY ACAD SCI, V769, P119, DOI 10.1111/j.1749-6632.1995.tb38135.x; Moscovitch M, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P331; Nadel L, 2001, TRENDS COGN SCI, V5, P228, DOI 10.1016/S1364-6613(00)01664-8; Naveh-Benjamin M, 2000, J EXP PSYCHOL LEARN, V26, P1170, DOI 10.1037/0278-7393.26.5.1170; Norman D.A., 1986, CONSCIOUSNESS SELF R, V4, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Pak R, 2008, COMPUT HUM BEHAV, V24, P3045, DOI 10.1016/j.chb.2008.05.010; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Picard L, 2009, CONSCIOUS COGN, V18, P864, DOI 10.1016/j.concog.2009.07.008; Piolino P, 2005, COGN NEUROPSYCHOL, V22, P1005, DOI 10.1080/02643290442000428; Piolino P, 2003, BRAIN, V126, P2203, DOI 10.1093/brain/awg222; Piolino P, 2002, MEMORY, V10, P239, DOI 10.1080/09658210143000353; Piolino P, 2007, NEUROPSYCHOLOGIA, V45, P2730, DOI 10.1016/j.neuropsychologia.2007.04.013; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Piolino P, 2010, NEUROPSYCHOLOGIA, V48, P429, DOI 10.1016/j.neuropsychologia.2009.09.035; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Plancher G, 2010, NEUROPSYCHOLOGY, V24, P379, DOI 10.1037/a0018680; Plancher G, 2009, NEUROPSYCHOLOGIA, V47, P2527, DOI 10.1016/j.neuropsychologia.2009.04.026; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Quinette P, 2003, BRAIN, V126, P1917, DOI 10.1093/brain/awg201; Quinette P, 2006, NEUROPSYCHOLOGIA, V44, P2508, DOI 10.1016/j.neuropsychologia.2006.03.031; Repovs G, 2006, NEUROSCIENCE, V139, P5, DOI 10.1016/j.neuroscience.2005.12.061; Rieger M, 2002, NEUROPSYCHOLOGIA, V40, P76, DOI 10.1016/S0028-3932(01)00068-9; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rosenbaum RS, 2004, NEUROPSYCHOLOGIA, V42, P1619, DOI 10.1016/j.neuropsychologia.2004.04.010; Rudner M, 2008, COGN PROCESS, V9, P19, DOI 10.1007/s10339-007-0183-x; Rudner M, 2007, NEUROPSYCHOLOGIA, V45, P2258, DOI 10.1016/j.neuropsychologia.2007.02.017; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Souchay C, 2004, BRAIN COGNITION, V56, P89, DOI 10.1016/j.bandc.2004.06.002; SPECTOR A, 1976, AM J PSYCHOL, V89, P669, DOI 10.2307/1421465; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; Treisman A, 2006, VIS COGN, V14, P411, DOI 10.1080/13506280500195250; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; VILKKI J, 1988, J NEUROL NEUROSUR PS, V51, P1452, DOI 10.1136/jnnp.51.11.1452; Wechsler D., 2000, ECHELLE INTELLIGENCE	91	20	22	1	22	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	JUL-AUG	2011	47	7					771	786		10.1016/j.cortex.2010.07.004			16	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	785ID	WOS:000292221800002	20817159				2021-06-18	
J	Fujita, M; Oda, Y; Wei, EP; Povlishock, JT				Fujita, Motoki; Oda, Yasutaka; Wei, Enoch P.; Povlishock, John T.			The Combination of Either Tempol or FK506 with Delayed Hypothermia: Implications for Traumatically Induced Microvascular and Axonal Protection	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; pial vessels; vascular reactivity; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; STABLE NITROXIDE TEMPOL; FREE-RADICAL PRODUCTION; BRAIN-INJURY; POSTTRAUMATIC HYPOTHERMIA; ANTIOXIDANT TEMPOL; MODEL; RATS; DAMAGE; CONSEQUENCES	Following traumatic brain injury (TBI), inhibition of reactive oxygen species and/or calcineurin can exert axonal and vascular protection. This protection proves optimal when these strategies are used early post-injury. Recent work has shown that the combination of delayed drug administration and delayed hypothermia extends this protection. Here we revisit this issue in TBI using the nitroxide antioxidant Tempol, or the immunophilin ligand FK506, together with delayed hypothermia, to determine their effects upon cerebral vascular reactivity and axonal damage. Animals were subjected to TBI and treated with Tempol at 30 or 90 min post-injury, or 90 min post-injury with concomitant mild hypothermia (33 degrees C). Another group of animals were treated in the same fashion with the exception that they received FK506. Cranial windows were placed to assess vascular reactivity over 6 h post-injury, when the animals were assessed for traumatically induced axonal damage. Vasoreactivity was preserved by early Tempol administration; however, this benefit declined with time. The coupling of hypothermia and delayed Tempol, however, exerted significant vascular protection. The use of early and delayed FK506 provided significant vascular protection which was not augmented by hypothermia. The early administration of Tempol provided dramatic axonal protection that was not enhanced with hypothermia. Early and delayed FK506 provided significant axonal protection, although this protection was not enhanced by delayed hypothermia. The current investigation supports the premise that Tempol coupled with hypothermia extends its benefits. While FK506 proved efficacious with early and delayed administration, it did not provide either increased vascular or axonal benefit with hypothermia. These studies illustrate the potential benefits of Tempol coupled to delayed hypothermia. However, these findings do not transfer to the use of FK506, which in previous studies proved beneficial when coupled with hypothermia. These divergent results may be a reflection of the different animal models used and/or their associated injury severity.	[Fujita, Motoki; Oda, Yasutaka; Wei, Enoch P.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Fujita, Motoki; Oda, Yasutaka] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Yamaguchi, Japan	Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD055813, NS047463, NS 057175]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047463, R21NS057175] Funding Source: NIH RePORTER	We thank Susan Walker and Lynn Davis for their excellent technical assistance. This study is supported by National Institutes of Health (NIH) grants HD055813, NS047463, and NS 057175.	Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Behringer W, 2002, J CEREBR BLOOD F MET, V22, P105, DOI 10.1097/00004647-200201000-00013; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Carroll RT, 2000, CHEM RES TOXICOL, V13, P294, DOI 10.1021/tx990159t; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; ELLIS EF, 1983, PROSTAGLANDINS, V26, P917, DOI 10.1016/0090-6980(83)90154-5; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Kato N, 2003, BRAIN RES, V979, P188, DOI 10.1016/S0006-8993(03)02918-4; Koda Y, 2010, BRAIN RES, V1311, P197, DOI 10.1016/j.brainres.2009.11.028; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KONTOS HA, 1983, ADV EXP MED BIOL, V161, P365; KONTOS HA, 1988, AM J PHYSIOL, V255, pH1259; Krishna MC, 1996, J BIOL CHEM, V271, P26026, DOI 10.1074/jbc.271.42.26026; Kwon TH, 2003, J NEUROTRAUM, V20, P337, DOI 10.1089/089771503765172291; Leker RR, 2002, EXP NEUROL, V176, P355, DOI 10.1006/exnr.2002.7910; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Rak R, 2000, J NEUROSURG, V92, P646, DOI 10.3171/jns.2000.92.4.0646; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; WEI EP, 1992, STROKE, V23, P1623, DOI 10.1161/01.STR.23.11.1623	40	20	21	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1209	1218		10.1089/neu.2011.1852			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600009	21521034	Green Published			2021-06-18	
J	Fuller, G; Bouamra, O; Woodford, M; Jenks, T; Patel, H; Coats, TJ; Oakley, P; Mendelow, AD; Pigott, T; Hutchinson, PJ; Lecky, F				Fuller, Gordon; Bouamra, Omar; Woodford, Maralyn; Jenks, Tom; Patel, Hirin; Coats, Timothy J.; Oakley, Peter; Mendelow, A. David; Pigott, Tim; Hutchinson, Peter J.; Lecky, Fiona			The Effect of Specialist Neurosciences Care on Outcome in Adult Severe Head Injury: A Cohort Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						critical care; neurosurgery; craniocerebral trauma; cohort studies; patient transfer	TRAUMATIC BRAIN-INJURY; MANAGEMENT; UNIT; EPIDEMIOLOGY; MORTALITY; ADMISSION; SURVIVAL; MODERATE; PATIENT; IMPACT	Background: Head injury is the leading cause of death in trauma. UK national guidelines have recommended that all patients with severe head injury (SHI) should be treated in neuroscience centers. The aim of this study was to investigate the effect of specialist neuroscience care on mortality after SHI. Methods: We conducted a cohort study using prospectively recorded data from the largest European trauma registry, for adult patients presenting with blunt trauma between 2003 and 2009. Mortality and unadjusted odds of death were compared for patients with SHI treated in neuroscience units (NSU) versus nonspecialist centers. To control for confounding, odds of death associated with non-NSU care were calculated using propensity score-adjusted multivariate logistic regression (explanatory covariates: age, Glasgow Coma Score, Injury Severity Score, treatment center). Sensitivity analyses were performed to study possible bias arising from selective enrollment, from loss to follow-up, and from hidden confounders. Results: 5411 patients were identified with SHI between 2003 and 2009, with 1485 (27.4%) receiving treatment entirely in non-NSU centers. SHI management in a non-NSU was associated with a 11% increase in crude mortality (P < 0.001) and 1.72-fold (95% confidence interval: 1.52-1.96) increase in odds of death. The case mix adjusted odds of death for patients treated in a non-NSU unit with SHI was 1.85 (95% confidence interval: 1.57-2.19). These results were not significantly changed in sensitivity analyses examining selective enrollment or loss to follow-up, and were robust to potential bias from unmeasured confounders. Conclusions: Our data support current national guidelines and suggest that increasing transfer rates to NSUs represents an important strategy in improving outcomes in patients with SHI.	[Fuller, Gordon; Bouamra, Omar; Woodford, Maralyn; Jenks, Tom; Lecky, Fiona] Univ Manchester, Trauma Audit & Res Network, Hlth Sci Res Grp, Manchester Acad Hlth Sci Ctr, Salford, Lancs, England; [Patel, Hirin] Salford Royal Hosp, Dept Neurosurg, Salford, Lancs, England; [Coats, Timothy J.] Univ Leicester, Emergency Med Acad Grp, Dept Cardiovasc Sci, Accid & Emergency Dept,Leicester Royal Infirm, Leicester, Leics, England; [Oakley, Peter] N Staffordshire NHS Trust Stoke On Trent, N Staffordshire Hosp, Stoke On Trent, Staffs, England; [Mendelow, A. David] Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Pigott, Tim] Walton Ctr NHS Fdn Trust, Dept Neurosurg, Liverpool, Merseyside, England; [Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 1TN, England	Fuller, G (corresponding author), Univ Manchester, Trauma Audit & Res Network, Hlth Sci Res Grp, Salford Royal Hosp,Manchester Acad Hlth Sci Ctr, Clin Sci Bldg,Eccles Old Rd, Loughborough LE12 5PE, Leics, England.	gordonwfuller@doctors.net.uk		Coats, Timothy/0000-0003-2736-2784; bouamra, omar/0000-0002-3155-4634	Academy of Medical Sciences/Health Foundation	The authors declare that they have no conflicts of interest in relation to publication of this paper. PJH is supported by an Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship.	*AAAM COMM INJ SCA, 2008, ABBR INJ SCAL 2008 R; Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; CAIRNS HWB, 1947, NOTES NEUROSURGICAL; Crimmins DW, 2000, J NEUROL NEUROSUR PS, V68, P8, DOI 10.1136/jnnp.68.1.8; *DEP HLTH, HOSP EP STAT; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Greenland S, 2005, J R STAT SOC A STAT, V168, P267, DOI 10.1111/j.1467-985X.2004.00349.x; Groenwold RHH, 2010, INT J EPIDEMIOL, V39, P107, DOI 10.1093/ije/dyp332; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2005, INTENS CARE MED, V31, P799, DOI 10.1007/s00134-005-2628-y; Hutchinson P J, 2004, Curr Opin Crit Care, V10, P101, DOI 10.1097/00075198-200404000-00004; JENNETT B, 1975, LANCET, V1, P480; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; LEACH P, 2009, J TRAUMA MANAG OUTCO, V3, P3; LESKO M, 2008, COMMUNICATION; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mendelow AD, 2008, LANCET, V372, P685, DOI 10.1016/S0140-6736(08)61280-5; Mirski MA, 2001, J NEUROSURG ANESTH, V13, P83, DOI 10.1097/00008506-200104000-00004; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; *NAT I CLIN EXC, 2007, CLIN GUID NAT I CLIN, V56; *NEUR CAR STAK GRO, NEUR CAR CAP DEM REP; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Petsas A, 2010, J NEUROSURG ANESTH, V22, P354, DOI 10.1097/ANA.0b013e3181f0da95; Royston P, 2005, STATA J, V5, P279, DOI 10.1177/1536867X0500500212; Rubin DB., 1987, MULTIPLE IMPUTATION; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schafer JL., 1997, ANAL INCOMPLETE MULT; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Teig M, 2010, J NEUROSURG ANESTH, V22, P357, DOI 10.1097/ANA.0b013e3181f0dada; Trojano M, 2009, Int MS J, V16, P90; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; Westaby S, 2007, BRIT MED J, V335, P759, DOI 10.1136/bmj.39318.644549.AE	46	20	21	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2011	23	3					198	205		10.1097/ANA.0b013e3182161816			8	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	774YY	WOS:000291423900007	21546855	Green Accepted			2021-06-18	
J	Kouvarellis, AJ; Rohlwink, UK; Sood, V; Van Breda, D; Gowen, MJ; Figaji, AA				Kouvarellis, Alison J.; Rohlwink, Ursula K.; Sood, Vishesh; Van Breda, Devon; Gowen, Michael J.; Figaji, Anthony A.			The relationship between basal cisterns on CT and time-linked intracranial pressure in paediatric head injury	CHILDS NERVOUS SYSTEM			English	Article						Basal cisterns; Traumatic brain injury; Children; Computed tomography; Head injury; Intracranial pressure monitoring	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; CHILDREN; HYPERTENSION; CARE	Although intracranial pressure (ICP) monitoring is a cornerstone of care for severe traumatic brain injury (TBI), the indications for ICP monitoring in children are unclear. Often, decisions are based on head computed tomography (CT) scan characteristics. Arguably, the patency of the basal cisterns is the most commonly used of these signs. Although raised ICP is more likely with obliterated basal cisterns, the implications of open cisterns are less clear. We examined the association between the status of perimesencephalic cisterns and time-linked ICP values in paediatric severe TBI. ICP data linked to individual head CT scans were reviewed. Basal cisterns were classified as open or closed by blinded reviewers. For the initial CT scan, we examined ICP values for the first 6 h after monitor insertion. For follow-up scans, we examined ICP values 3 h before and after scanning. Mean ICP and any episode of ICP a parts per thousand yenaEuro parts per thousand 20 mmHg during this period were recorded. Data from 104 patients were examined. Basal cisterns were patent in 51.72% of scans, effaced in 34.48% and obliterated in 13.79%. Even when cisterns were open, more than 40% of scans had at least one episode of ICP a parts per thousand yenaEuro parts per thousand 20 mmHg, and 14% of scans had a mean ICP a parts per thousand yenaEuro parts per thousand 20 mmHg. The specificity of open cisterns in predicting ICP < 20 mmHg was poor (57.9%). Age-related data were worse. Children with severe TBI frequently may have open basal cisterns on head CT despite increased ICP. Open cisterns should not discourage ICP monitoring.	[Kouvarellis, Alison J.; Rohlwink, Ursula K.; Sood, Vishesh; Van Breda, Devon; Gowen, Michael J.; Figaji, Anthony A.] Univ Cape Town, Div Neurosurg, Sch Child & Adolescent Hlth, Red Cross War Mem Childrens Hosp, ZA-7925 Cape Town, South Africa	Figaji, AA (corresponding author), Univ Cape Town, Div Neurosurg, Sch Child & Adolescent Hlth, Red Cross War Mem Childrens Hosp, ZA-7925 Cape Town, South Africa.	Anthony.Figaji@uct.ac.za	Rohlwink, Ursula/AAE-2513-2020; Rohlwink, Ursula Karin/U-8917-2019	Figaji, Anthony/0000-0002-3357-6490; Sood, Vishesh/0000-0003-1566-5681			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Chesnut R M, 1995, New Horiz, V3, P366; Chesnut RM, 2007, SURG CLIN N AM, V87, P119, DOI 10.1016/j.suc.2006.09.018; COLQUHOUN IR, 1989, CLIN RADIOL, V40, P13, DOI 10.1016/S0009-9260(89)80006-6; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hirsch W, 2000, PEDIATR RADIOL, V30, P439, DOI 10.1007/s002470000255; HOLLIDAY PO, 1982, NEUROSURGERY, V10, P25, DOI 10.1227/00006123-198201000-00005; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; SADHU VK, 1979, RADIOLOGY, V133, P507, DOI 10.1148/133.2.507; Salim A, 2008, AM SURGEON, V74, P1088; Segal S, 2001, INTENS CARE MED, V27, P236, DOI 10.1007/s001340000717; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; TEASDALE E, 1984, J NEUROL NEUROSUR PS, V47, P600, DOI 10.1136/jnnp.47.6.600; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; 2000, J NEUROTRAUMA, V17, P479	30	20	21	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2011	27	7					1139	1144		10.1007/s00381-011-1464-3			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	775RH	WOS:000291480300016	21538131				2021-06-18	
J	Merzagora, AC; Schultheis, MT; Onaral, B; Izzetoglu, M				Merzagora, Anna C.; Schultheis, Maria T.; Onaral, Banu; Izzetoglu, Meltem			FUNCTIONAL NEAR-INFRARED SPECTROSCOPY-BASED ASSESSMENT OF ATTENTION IMPAIRMENTS AFTER TRAUMATIC BRAIN INJURY	JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES			English	Article						fNIR; attention; traumatic brain injury; NIRS; TBI	POSITRON-EMISSION-TOMOGRAPHY; COGNITIVE-CONTROL; HEAD-INJURY; MEMORY; ACTIVATION; TIME; PET; REHABILITATION; AROUSAL	A frequent consequence of traumatic brain injury (TBI) is cognitive impairment, which results in significant disruption of an individual's everyday living. To date, most clinical rehabilitation interventions still rely on behavioral observation, with little or no quantitative information about physiological changes produced at the brain level. Functional brain imaging has been extensively used in the study of cognitive impairments following TBI. However, its applications to rehabilitation have been limited. This is due in part to the expensive or invasive nature of these modalities. The objective of this study is to apply functional near-infrared spectroscopy (fNIR) to the assessment of attention impairments following TBI. fNIR provides a localized measure of prefrontal hemodynamic activation, which is susceptible to TBI, and it does so in a noninvasive, affordable and wearable way, thus partially overcoming the limitations of other modalities. Participants included 5 TBI subjects and 11 healthy controls. Brain activation measurements were collected during a target categorization task. Significant differences were found in the hemodynamic response between healthy and TBI subjects. In particular, the elicited responses exhibited reduced amplitude in the TBI group. Overall, the results provide first evidence of the ability of fNIR to reveal differences between TBI and healthy subjects in an attention task. fNIR is therefore a promising neuroimaging technique in the field of neurorehabilitation. The use of fNIR in neurorehabilitation applications would benefit from its noninvasiveness and cost-effectiveness and the neurophysiological information obtained through the evaluation of the hemodynamic activation could provide invaluable information to guide the choice of intervention.	[Merzagora, Anna C.; Schultheis, Maria T.; Onaral, Banu; Izzetoglu, Meltem] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Schultheis, Maria T.] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA	Merzagora, AC (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	a.merzagora@drexel.edu		Schultheis, Maria/0000-0002-6558-548X			Alloway KD, 2007, MED NEUROSCIENCE; Ardekani BA, 2002, COGNITIVE BRAIN RES, V14, P347, DOI 10.1016/S0926-6410(02)00137-4; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Butti Michele, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1944; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chance B, 1998, OPT EXPRESS, V2, P411, DOI 10.1364/OE.2.000411; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Conners C, 1999, ADHD ADULTS CHILDREN; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Dubroff JG, 2008, SEMIN NEUROL, V28, P548, DOI 10.1055/s-0028-1083698; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Harrison-Felix C., 1996, DESCRIPTIVE FINDINGS, P1; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Izzetoglu K., 2003, 36th Hawaii International Conference on Systems Sciences; Izzetoglu M, 2005, IEEE T NEUR SYS REH, V13, P153, DOI 10.1109/TNSRE.2005.847377; Izzetoglu M, 2007, IEEE ENG MED BIOL, V26, P38, DOI 10.1109/MEMB.2007.384094; Kennan RP, 2002, NEUROIMAGE, V16, P587, DOI 10.1006/nimg.2002.1060; Kim YH, 2004, YONSEI MED J, V45, P241, DOI 10.3349/ymj.2004.45.2.241; Kirkby BS, 1996, NEUROPSYCHOLOGIA, V34, P689; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Lombardi WJ, 1999, J CLIN EXP NEUROPSYC, V21, P2, DOI 10.1076/jcen.21.1.2.940; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Pessoa L, 2003, J NEUROSCI, V23, P3990; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; RUFF RM, 1985, J CLIN EXP NEUROPSYC, V7, P645; Russell KC, 2011, J CLIN EXP NEUROPSYC, V33, P538, DOI 10.1080/13803395.2010.537253; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Wechsler D, 1997, WAIS 3 ADM SCORING M; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3	46	20	20	0	9	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-5458	1793-7205		J INNOV OPT HEAL SCI	J. Innov. Opt. Health Sci.	JUL	2011	4	3					251	260		10.1142/S1793545811001551			10	Optics; Radiology, Nuclear Medicine & Medical Imaging	Optics; Radiology, Nuclear Medicine & Medical Imaging	V27YK	WOS:000208648300007					2021-06-18	
J	Sehgal, N; Agarwal, V; Valli, RK; Joshi, SD; Antonovic, L; Strobel, HW; Ravindranath, V				Sehgal, Neha; Agarwal, Varsha; Valli, Rupanagudi Khader; Joshi, Shanker Dutt; Antonovic, Leposava; Strobel, Henry W.; Ravindranath, Vijayalakshmi			Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation	BIOCHEMICAL PHARMACOLOGY			English	Article						Neuroinflammation; Microglia; Cytokines; Cytochrome P450; Leukotriene	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; DORSAL-ROOT GANGLION; LEUKOTRIENE B4; RAT-BRAIN; INFLAMMATION; EXPRESSION; DISEASE; INVOLVEMENT; METABOLISM	Inflammatory processes are involved in the pathogenesis and/or progression of acute central nervous system (CNS) infection, traumatic brain injury and neurodegenerative disorders among others indicating the need for novel strategies to limit neuroinflammation. Eicosanoids including leukotrienes, particularly leukotriene B-4 (LTB4) are principle mediator(s) of inflammatory response, initiating and amplifying the generation of cytokines and chemokines. Cytochrome P450 (Cyp), a family of heme proteins mediate metabolism of xenobiotics and endogenous compounds, such as eicosanoids and leukotrienes. Cytochrome P4504F (Cyp4f) subfamily includes five functional enzymes in mouse. We cloned and expressed the mouse Cyp4f enzymes, assayed their relative expression in brain and examined their ability to hydroxylate the inflammatory cascade prompt LTB4 to its inactive 20-hydroxylated product. We then examined the role of Cyp4fs in regulating inflammatory response in vitro, in microglial cells and in vivo, in mouse brain using lipopolysacharide (LPS), as a model compound to generate inflammatory response. We demonstrate that mouse brain Cyp4fs are expressed ubiquitously in several cell types in the brain, including neurons and microglia, and modulate inflammatory response triggered by LPS, in vivo and in microglial cells, in vitro through metabolism of LTB4 to the inactive 20-hydroxy LTB4. Chemical inhibitor or shRNA to Cyp4fs enhance and inducer of Cyp4fs attenuates inflammatory response. Further, induction of Cyp4f expression lowers LTB4 levels and affords neuroprotection in microglial cells or mice exposed to LPS. Thus, catalytic activity of Cyp4fs is a novel target for modulating neuroinflammation through hydroxylation of LTB4. (C) 2011 Elsevier Inc. All rights reserved.	[Sehgal, Neha; Agarwal, Varsha; Valli, Rupanagudi Khader; Joshi, Shanker Dutt; Ravindranath, Vijayalakshmi] Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Manesar 122050, Haryana, India; [Antonovic, Leposava; Strobel, Henry W.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Ravindranath, V (corresponding author), Indian Inst Sci, Ctr Neurosci, Bangalore 560012, Karnataka, India.	viji@cns.iisc.emet.in			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH 70054]; Bose National Fellowship; CSIRCouncil of Scientific & Industrial Research (CSIR) - India; NBRCDepartment of Biotechnology (DBT) India; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH070054] Funding Source: NIH RePORTER	The authors thank Smitha Karunakaran, Lalitha Durgadoss, Uzma Saeed and Manoj Kumar Mishra for their help in this study. This work was supported by National Institutes of Health grant MH 70054 to H.W.S. & V.R., J.C. Bose National Fellowship to V.R., Senior Research fellowship from CSIR to N.S., and CORE grant from NBRC.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Andoh T, 2005, MOL BRAIN RES, V137, P263, DOI 10.1016/j.molbrainres.2005.02.029; Azab AN, 2004, PROSTAG LEUKOTR ESS, V70, P67, DOI 10.1016/j.plefa.2003.08.005; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chinta SJ, 2005, MOL BRAIN RES, V135, P81, DOI 10.1016/j.molbrainres.2004.12.014; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Crooks SW, 1998, INT J BIOCHEM CELL B, V30, P173, DOI 10.1016/S1357-2725(97)00123-4; Deplanque D, 2003, J NEUROSCI, V23, P6264; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Kalsotra A, 2004, TOXICOL APPL PHARM, V199, P295, DOI 10.1016/j.taap.2003.12.033; Kalsotra A, 2007, ARCH BIOCHEM BIOPHYS, V461, P104, DOI 10.1016/j.abb.2007.02.027; Kalsotra A, 2006, PHARMACOL THERAPEUT, V112, P589, DOI 10.1016/j.pharmthera.2006.03.008; Kikuta Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P225, DOI 10.1006/abbi.2000.2078; Kipp M, 2008, J MOL NEUROSCI, V35, P235, DOI 10.1007/s12031-008-9057-7; KOLLER H, 1993, BRAIN RES, V628, P313, DOI 10.1016/0006-8993(93)90971-O; Kreisler A, 2007, BRAIN RES, V1135, P77, DOI 10.1016/j.brainres.2006.12.011; Kroetz DL, 2005, ANNU REV PHARMACOL, V45, P413, DOI 10.1146/annurev.pharmtox.45.120403.100045; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Morgan D M, 1998, Methods Mol Biol, V79, P179; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Neve EPA, 2008, ANAL BIOANAL CHEM, V392, P1075, DOI 10.1007/s00216-008-2200-z; Okubo M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-57; Okubo M, 2010, GLIA, V58, P599, DOI 10.1002/glia.20948; Pai HV, 2004, J BIOL CHEM, V279, P27383, DOI 10.1074/jbc.M402337200; Paul L, 1999, AM J PHYSIOL-REG I, V276, pR52; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Ravindranath V, 1998, BIOCHEM PHARMACOL, V56, P547, DOI 10.1016/S0006-2952(97)00671-0; Ravindranath V, 2006, J NEURAL TRANSM-SUPP, P167; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; SOBERMAN RJ, 1990, METHOD ENZYMOL, V187, P319; Soldan SS, 2004, J NEUROIMMUNOL, V146, P209, DOI 10.1016/j.jneuroim.2003.10.033; Toda A, 2002, PROSTAG OTH LIPID M, V68-9, P575, DOI 10.1016/S0090-6980(02)00056-4; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; van Neerven S, 2008, PROG NEUROBIOL, V85, P433, DOI 10.1016/j.pneurobio.2008.04.006; Wang Y, 2008, J NEUROTRAUM, V25, P1187, DOI 10.1089/neu.2008.0542; Wendt W, 2009, J NEUROCHEM, V110, P1931, DOI 10.1111/j.1471-4159.2009.06283.x; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484	45	20	20	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0006-2952	1873-2968		BIOCHEM PHARMACOL	Biochem. Pharmacol.	JUL 1	2011	82	1					53	64		10.1016/j.bcp.2011.03.025			12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	774IX	WOS:000291380000007	21466787				2021-06-18	
J	Smith, AM; Stuart, MJ; Greenwald, RM; Benson, BW; Dodick, DW; Emery, CA; Finnoff, JT; Mihalik, JP; Roberts, WO; Sullivan, CA; Meeuwisse, WH				Smith, Aynsley M.; Stuart, Michael J.; Greenwald, Richard M.; Benson, Brian W.; Dodick, David W.; Emery, Carolyn A.; Finnoff, Jonathan T.; Mihalik, Jason P.; Roberts, William O.; Sullivan, Carol-Anne; Meeuwisse, Willem H.			Proceedings From the Ice Hockey Summit on Concussion: A Call to Action	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; hockey	SPORTS-RELATED CONCUSSION; NEURON-SPECIFIC ENOLASE; RETURN-TO-PLAY; HIGH-SCHOOL; INJURY PREVENTION; BODY-CHECKING; HEAD-INJURIES; RECURRENT CONCUSSION; RULE INFRACTIONS; NORTH-AMERICAN	Objective: The objective of this proceeding is to integrate the concussion in sport literature and sport science research on safety in ice hockey to develop an action plan to reduce the risk, incidence, severity, and consequences of concussion in ice hockey. Methods: A rationale paper outlining a collaborative action plan to address concussions in hockey was posted for review two months prior to the Ice Hockey Summit: Action on Concussion. Focused presentations devoted specifically to concussion in ice hockey were presented during the Summit and breakout sessions were used to develop strategies to reduce concussion in the sport. This proceedings and a detailed scientific review (a matrix of solutions) were written to disseminate the evidence-based information and resulting concussion reduction strategies. The manuscripts were reviewed by the authors, advisors and contributors to ensure that the opinions and recommendations reflect the current level of knowledge on concussion in hockey. Results: Six components of a potential solution were articulated in the Rationale paper and became the topics for breakout groups that followed the professional, scientific lectures. Topics that formed the core of the action plan were: metrics and databases; recognizing, managing, and return to play; hockey equipment and ice arenas; prevention and education; rules and regulations; and expedient communication of the outcomes. The attendees in breakout sessions identified action items for each section. The most highly ranked action items were brought to a vote in the open assembly, using an Audience Response System (ARS). The strategic planning process was conducted to assess: Where are we at?; Where must we get to?; and What strategies are necessary to make progress on the prioritized action items? Conclusions: Three prioritized action items for each component of the solution and the percentage of the votes received are listed in the body of this proceeding.	[Smith, Aynsley M.; Stuart, Michael J.; Finnoff, Jonathan T.] Mayo Clin, Ctr Sports Med, Rochester, MN 55905 USA; [Greenwald, Richard M.] SIMBEX, LCC, Lebanon, NH USA; [Benson, Brian W.; Emery, Carolyn A.; Meeuwisse, Willem H.] Univ Calgary, Sport Med Ctr, Calgary, AB, Canada; [Dodick, David W.] Mayo Clin, Coll Med, Scottsdale, AZ USA; [Mihalik, Jason P.] Univ N Carolina, Chapel Hill, NC USA; [Roberts, William O.] Univ Minnesota, St Paul, MN 55108 USA; [Sullivan, Carol-Anne] Ontario Neurotrauma Fdn, Toronto, ON, Canada	Smith, AM (corresponding author), Mayo Clin, Ctr Sports Med, 200 1st St SW, Rochester, MN 55905 USA.	smith.aynsley@mayo.edu	Emery, Carolyn/AAI-2761-2020; Wiese-Bjornstal, Diane M./L-1408-2019	Wiese-Bjornstal, Diane M./0000-0003-4824-3311; Mihalik, Jason/0000-0001-6085-8322; Roberts, William O/0000-0003-4517-4330	Team Wendy; Johannson-Gund Endowment; Hockey Equipment Certification Council; International Ice Hockey Federation; Ontario Neurotrauma Foundation; USA Hockey	Partially support by the Team Wendy and the Johannson-Gund Endowment.; Joint sponsors are the Hockey Equipment Certification Council, International Ice Hockey Federation, Ontario Neurotrauma Foundation, and USA Hockey.	Ackery A, 2009, CAN J NEUROL SCI, V36, P207, DOI 10.1017/S0317167100120281; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], FACTS PREV TIPS; [Anonymous], 2009, BRIT J SPORT MED, V43, pi85; ASHARE A, 2009, SAFETY ICE HOCKEY, V5; ASHARE AB, 2000, SAFETY ICE HOCKEY, V3; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; BAZARIAN J, BLOOD TEST BRAIN INJ; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Bernard D, 2004, AM SOC TEST MATER, V1446, P152, DOI 10.1520/STP11616S; Bernstein R., 2006, CODE UNWRITTEN RULES; BISHOP PJ, 2009, J ASTM INT, V6, P5; BISHOP PJ, 2009, J ASTM INT, V6, P4; Bloom GA, 2004, AM SOC TEST MATER, V1446, P12, DOI 10.1520/STP11605S; Brunelle JP, 2005, J SCI MED SPORT, V8, P294, DOI 10.1016/S1440-2440(05)80040-4; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CASTALDI CR, 1993, SAFETY ICE HOCKEY, V2; CASTALDI CR, 1989, SAFETY ICE HOCKEY, V1; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Ciavarro C, 2008, COMPUT HUM BEHAV, V24, P2862, DOI 10.1016/j.chb.2008.04.011; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Coulson NR, 2009, AM SOC TEST MATER, V1516, P141, DOI 10.1520/JAI101890; Crawford BJ, 2004, AM SOC TEST MATER, V1446, P26, DOI 10.1520/STP11606S; Creighton DW, 2010, CLIN J SPORT MED, V20, P379, DOI 10.1097/JSM.0b013e3181f3c0fe; CUSIMANO M, 2002, CAN J NEUROL SCI, V29, pS23; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick RW, 2008, MED SCI SPORT EXER, V40, pS231, DOI 10.1249/01.mss.0000322493.95532.98; Dorsch KD, 2007, PSYCHOL SPORT EXERC, V8, P585, DOI 10.1016/j.psychsport.2006.06.003; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2006, SPORTS NEUROPSYCHOLO; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; FAUGHT BE, 2009, J ASTM INT, V6; Ferrara MS, 2001, J ATHL TRAINING, V36, P145; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fraser K, 2010, FINAL CALL; Gee CJ, 2007, PSYCHOL SPORT EXERC, V8, P567, DOI 10.1016/j.psychsport.2006.06.006; Gilbert WD, 2000, AM SOC TEST MATER, V1341, P291, DOI 10.1520/STP15246S; Gioia G., 2008, BRAIN INJURY PROFESS, V4, P14; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gladwell M., 2000, TIPPING POINT LITTLE; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; GOODMAN D, 2004, STP, V1446, P11; Gordon KE, 2010, CLIN J SPORT MED, V20, P405, DOI 10.1097/JSM.0b013e318202de6b; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead PD, 2000, AM SOC TEST MATER, V1341, P93, DOI 10.1520/STP15230S; *INJ PREV CONTR TR, HEADS CONC YOUTH SPO; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Klugl M, 2010, CLIN J SPORT MED, V20, P407, DOI 10.1097/JSM.0b013e3181f4a99c; LaPrade RF, 2000, AM SOC TEST MATER, V1341, P124, DOI 10.1520/STP15234S; Leape LL, 2000, JAMA-J AM MED ASSOC, V284, P95, DOI 10.1001/jama.284.1.95; LINK A, 2008, ROCHESTER YOUTH  JAN; LINK A, 2007, HOCKEY ED PROGRA NOV; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; MARCOTTE G, 1993, STP, V1212, P100; Mariconda J, 2004, AM SOC TEST MATER, V1446, P135, DOI 10.1520/STP11614S; Matheson GO, 2010, CLIN J SPORT MED, V20, P399, DOI 10.1097/JSM.0b013e318203114c; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M., 1997, STANDARDIZED ASSESSM; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCPHERSON MN, 2009, J ASTM INT, V28, P6; *MEDSC, ERR IS HUM BUILD SAF; Middleton K, 2010, CLIN J SPORT MED, V20, P491, DOI 10.1097/JSM.0b013e3181fac088; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; *MN HOCK HEP, 2010, HOCK ED PROGR; Montelpare W, 2010, INT J SPORTS SCI COA, V5, P61; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; MUELLER F, 2002, 19 ANN REPORT NATL C; PEARSALL DJ, 2004, SAFETY ICE HOCKEY, V4; Pocket SCAT2, 2009, BR J SPORTS MED, V43, pi89; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Roberts WO, 2010, CLIN J SPORT MED, V20, P318, DOI 10.1097/JSM.0b013e3181e6301d; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Rousseau P, 2008, J ASTM INT, V6, P152; RUDOLPH M, 1989, STP, V1050, P35; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; SCAPINELLO R, 2006, LINES NOT SO TALL TA; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Smith A, 2009, J ASTM INT, V6, P1; Smith AM, 2000, AM SOC TEST MATER, V1341, P199, DOI 10.1520/STP15240S; SMITH AM, 1999, POWER PLAY MENTAL TO; SMITH AM, ZERO TOLERANCE CONCU; SMITH MD, 1975, CAN REV SOC ANTHROP, V12, P72; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; STJOHN A, ANATOMY NASCAR CRASH; Stuart MJ, 2009, CLIN J SPORT MED, V19, P494, DOI 10.1097/JSM.0b013e3181c0aaa4; Stuart MJ, 2004, AM SOC TEST MATER, V1446, P52, DOI 10.1520/STP11608S; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Stuart MJ, 2000, AM SOC TEST MATER, V1341, P19, DOI 10.1520/STP15224S; STUART MJ, 2008, J ASTM INT, V5, P10; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tator CH, 2000, AM SOC TEST MATER, V1341, P150, DOI 10.1520/STP15236S; Tegner Y, 2000, AM SOC TEST MATER, V1341, P165, DOI 10.1520/STP15237S; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Visek A, 2005, SPORT PSYCHOL, V19, P178, DOI 10.1123/tsp.19.2.178; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Watson RC, 1996, CLIN J SPORT MED, V6, P108, DOI 10.1097/00042752-199604000-00008; Watson RC, 1997, CLIN J SPORT MED, V7, P192, DOI 10.1097/00042752-199707000-00007; Wennberg R, 2004, CAN J NEUROL SCI, V31, P373, DOI 10.1017/S0317167100003474; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; WILLIAMSON IJS, 2009, J ASTM INT, V6, P3; HEADS HOCKEY	136	20	20	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2011	21	4					281	287		10.1097/JSM.0b013e318225bc15			7	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	786DY	WOS:000292284700001	21847809				2021-06-18	
J	van Noordt, S; Good, D				van Noordt, Stefon; Good, Dawn			Mild head injury and sympathetic arousal: Investigating relationships with decision-making and neuropsychological performance in university students	BRAIN INJURY			English	Article						Head trauma; emotion; cognition; physiological arousal	TRAUMATIC BRAIN-INJURY; CEREBRAL GLUCOSE-METABOLISM; ORBITOFRONTAL CORTEX; FACIAL EXPRESSION; EMOTION; CONCUSSION; DEFICITS; RECOGNITION; MECHANISMS; PROGNOSIS	A: The purpose of this study was to examine the relationships between neuropsychological performance, physiological arousal and decision-making in university students who have or have not reported a history of mild head injury (MHI). Methods: Forty-four students, 18 (41%) reporting a history of MHI, performed a design fluency task and the Iowa Gambling Task (IGT) while electrodermal activity (EDA) was recorded. Results: General cognitive ability and overall choice outcomes did not differ between groups. However, self-reported MHI severity predicted decision-making performance such that the greater the neural indices of trauma, the more disadvantageous the choices made by participants. As expected, both groups exhibited similar base levels of autonomic arousal and physiological responses to reward and punishment outcomes; however, those reporting MHI produced significantly lower levels of EDA during the anticipatory stages of decision-making. Conclusions: Overall, these findings encourage the acceptance of head injury as being on a continuum of brain injury severity, as MHI can emulate neurophysiological and neuropsychological features of more traumatic cases and may be impacting mechanisms which sustain adaptive social decision-making.	[van Noordt, Stefon; Good, Dawn] Brock Univ, Dept Psychol, Neuropsychol Cognit Res Lab, St Catharines, ON L2S 3A1, Canada	van Noordt, S (corresponding author), Brock Univ, Dept Psychol, Neuropsychol Cognit Res Lab, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	sv05lz@brocku.ca			Ontario Neurotrauma Foundation (ONF) [2008-ABI-SR-603]	This research was supported by grant 2008-ABI-SR-603, afforded to Dr Dawn Good from the Ontario Neurotrauma Foundation (ONF). S. van Noordt reports no conflicts of interest. The authors declare that abstracts related to this work have been published as supplementary materials to conference proceedings [74].	BARBAS H, 2003, BIOMED CENTRAL NEURO, V4, P1471; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bechara A, 2007, IOWA GAMBLING TASK; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Colombetti G, 2008, BRIT J PHILOS SCI, V59, P51, DOI 10.1093/bjps/axm045; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Critchley HD, 2000, J NEUROSCI, V20, P3033; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DEBONO A, 2008, THESIS BROCK U ST CA; Delis DC, 2001, DELISKAPLAN EXECUTIV; Denburg NL, 2007, ANN NY ACAD SCI, V1121, P480, DOI 10.1196/annals.1401.031; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; FOWLES DC, 1981, PSYCHOPHYSIOLOGY, V18, P232, DOI 10.1111/j.1469-8986.1981.tb03024.x; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jansari A, 1999, J COGNITIVE NEUROSCI, P18; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; LYKKEN DT, 1961, AM J PSYCHOL, V74, P293, DOI 10.2307/1419417; Matis GK, 2009, MED SCI MONITOR, V15, pCR62; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; MORALES D, BRAIN CONTUSION IMAG; Murray EA, 2007, J NEUROSCI, V27, P8166, DOI 10.1523/JNEUROSCI.1556-07.2007; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Northoff G, 2006, HUM BRAIN MAPP, V27, P572, DOI 10.1002/hbm.20202; Oya H, 2005, P NATL ACAD SCI USA, V102, P8351, DOI 10.1073/pnas.0500899102; POOL JL, 1949, J NEUROPHYSIOL, V12, P385; Roberts AC, 2006, TRENDS COGN SCI, V10, P83, DOI 10.1016/j.tics.2005.12.002; Robertson RH, 2008, NEUROPSYCHOL REHABIL, V18, P236, DOI 10.1080/09602010701734438; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; SPSS, 2009, STAT PACK SOC SCI; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tellier A, 1999, BRAIN INJURY, V13, P463; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; VANNOORDT S, 2010, FRONTIERS HUMAN NEUR; VANNOORDT SJR, 2010, BRAIN INJURY, V24, P219; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950; Yechiam E, 2008, PSYCHON B REV, V15, P44, DOI 10.3758/PBR.15.1.44	73	20	21	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2011	25	7-8					707	716		10.3109/02699052.2011.580312			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	769RJ	WOS:000291035600007	21619460				2021-06-18	
J	Galton, C; Deem, S; Yanez, ND; Souter, M; Chesnut, R; Dagal, A; Treggiari, M				Galton, Christopher; Deem, Steven; Yanez, N. David; Souter, Michael; Chesnut, Randall; Dagal, Armagan; Treggiari, Miriam			Open-Label Randomized Trial of the Safety and Efficacy of a Single Dose Conivaptan to Raise Serum Sodium in Patients with Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Conivaptan; Hyponatremia; Intracranial pressure; Sodium; Arginine vasopressin; Vasopressin-receptor antagonists; Human; Clinical trial	ARGININE-VASOPRESSIN V-1; RECEPTOR ANTAGONIST; HYPONATREMIA; EXPRESSION; EDEMA	Background Conivaptan is an arginine-vasopressin-receptor antagonist approved for the treatment of hyponatremia. We hypothesized that administration of conivaptan to normonatremic patients with traumatic brain injury (TBI) is safe and could reduce intracranial pressure (ICP). Methods Open-label, randomized, controlled trial enrolling 10 subjects within 24 h of severe TBI to receive a single 20 mg dose of conivaptan (n = 5) or usual care (n = 5). The primary endpoint was the evaluation of the safety profile defined by serum sodium increases averaging > 1 mEq/h when measured every 4 h and any adverse events. Secondary endpoints were 48-h serum sodium, sodium load, change in ICP, and urine output. Results Ten patients were included in the intention-to-treat analysis. Three patients (2 conivaptan, 1 usual care group) experienced brief sodium increases averaging > 1 mEq/h, with no patients achieving Na > 160 mEq/l. There were no drug-related serious adverse events. At 48 h, the mean sodium was 142 +/- A 6 mEq/l (conivaptan) and 144 +/- A 10 mEq/l (usual care, P = 0.71). 48-h sodium load was 819 +/- A 724 mEq in the conivaptan and 1,137 +/- A 1,165 mEq in the usual care group (P = 0.62). At 4 h, serum sodium was higher (P = 0.02) and ICP was lower (P = 0.046) in the conivaptan compared with usual care group. 24-h but not 48-h urine output was different between the two groups (P < 0.01 and P = 0.20, respectively). Conclusions These data suggest that a single dose conivaptan is safe in non-hyponatremic patients with severe TBI and may reduce ICP. Further studies are needed to establish the effect of conivaptan on clinically relevant endpoints, and its role in the management of intracranial hypertension.	[Treggiari, Miriam] Univ Washington, Sch Med, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA; [Galton, Christopher] Univ Colorado Denver, Sch Med, Aurora, CO USA; [Deem, Steven; Souter, Michael; Dagal, Armagan; Treggiari, Miriam] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Yanez, N. David] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Souter, Michael; Chesnut, Randall; Treggiari, Miriam] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Treggiari, Miriam] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA	Treggiari, M (corresponding author), Univ Washington, Sch Med, Harborview Med Ctr, Dept Anesthesiol, Box 359724,325 9th Ave, Seattle, WA 98104 USA.	treggmm@uw.edu	Souter, Michael/ABE-1890-2020	Chesnut, Randall/0000-0001-6377-3666	AstellasAstellas Pharmaceuticals	Financial support for this investigator initiated study was provided by Astellas. The sponsor had no role in the design, interpretation, and reporting of the study findings.	ADLER S, 1995, BRAIN RES, V679, P135, DOI 10.1016/0006-8993(95)00245-L; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; Dhar R, 2011, NEUROCRIT CARE, V14, P97, DOI 10.1007/s12028-010-9366-x; Fernandez N, 2001, BRIT J PHARMACOL, V132, P1837, DOI 10.1038/sj.bjp.0704034; Kagawa M, 1996, J NEUROTRAUM, V13, P273, DOI 10.1089/neu.1996.13.273; Kozniewska E, 2008, J PHYSIOL PHARMACOL, V59, P109; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; LLUCH S, 1984, J PHARMACOL EXP THER, V228, P749; Murphy T, 2009, NEUROCRIT CARE, V11, P14, DOI 10.1007/s12028-008-9179-3; Naidech AM, 2010, NEUROCRIT CARE, V13, P57, DOI 10.1007/s12028-010-9379-5; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; SUZUKI Y, 1994, J AUTONOM NERV SYST, V49, pS129; SUZUKI Y, 1992, J NEUROSURG, V77, P424, DOI 10.3171/jns.1992.77.3.0424; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; TSUGANE S, 1994, LIFE SCI, V54, pPL241, DOI 10.1016/0024-3205(94)00424-2; Wright WL, 2009, NEUROCRIT CARE, V11, P6, DOI 10.1007/s12028-008-9152-1	17	20	20	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2011	14	3					354	360		10.1007/s12028-011-9525-8			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	759FT	WOS:000290226800005	21409494				2021-06-18	
J	Shadli, RM; Pieter, MS; Yaacob, MJ; Rashid, FA				Shadli, Rahida Mohd; Pieter, Maria Socorro; Yaacob, Mohd Jamil; Rashid, Faridah Abdul			APOE genotype and neuropsychological outcome in mild-to-moderate traumatic brain injury: A pilot study	BRAIN INJURY			English	Article						APOE; APOE epsilon 4; neuropsychology; TBI	APOLIPOPROTEIN-E POLYMORPHISM; HEAD-INJURY; ASSOCIATION; GENE; RECOVERY; E-EPSILON-4; EPSILON-4; IMPACT; ALLELE; VOLUME	Primary objective: The influence of apolipoprotein (APOE) on neuropsychological outcome was investigated in 19 patients (25.79 +/- 7.22 years) with mild-to-moderate traumatic brain injury and 14 matched healthy control subjects (27.43 +/- 6.65 years). Research design: Within- and between-group comparisons were employed. Methods and procedure: APOE genotype was determined using the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism method. Verbal learning and memory, speed of processing and executive function were assessed at 6 weeks and 6 months post-injury. A three-way [Group(star)Type(star)Time] ANOVA with repeated measures on the third factor was employed to determine the differences between groups and APOE genotype. Main outcomes and results: No Group(star)APOE Genotype(star)Time interaction was found for all neuropsychological measures, Auditory Verbal Learning Test (p = 0.484, eta(2) = 0.017), Trail Making Test-B (p = 0.454, eta(2) = 0.019), Controlled Oral Word Association (p = 0.107, eta(2) = 0.087) and Wisconsin Card Sorting Test-64 (p = 0.291, eta(2) = 0.038). The results of this pilot study support earlier findings that showed no relationship between APOE epsilon 4 and poor recovery in the same population. Conclusion: The preliminary findings suggest no clear APOE genotype influence on neuropsychological outcome in mild and moderate TBI patients. Large-scale studies with longer follow-up duration are warranted.	[Pieter, Maria Socorro] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia	Pieter, MS (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia.	maria@kb.usm.my	Yaacob, Mohd Jamil/B-4378-2014; Rashid, Faridah Abdul/N-9768-2019; Abdul Rashid, Faridah/B-8667-2011	Yaacob, Mohd Jamil/0000-0001-6194-6551; Abdul Rashid, Faridah/0000-0003-0701-9559	university grant	Initial data from this research were presented at the 7th International Congress on Brain Injury, April 2008, Lisbon, Portugal. This project was funded by a university grant.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Collie A, 2004, NEUROLOGY, V63, P2460, DOI 10.1212/WNL.63.12.2460; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Goldberg D, 1988, USERS GUIDE GEN HLTH; Golden CJ., 2000, NEUROPSYCHOLOGICAL I; GOLDSTEIN FC, 2004, 32 ANN M INT NEUR SO; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; HIXSON JE, 1990, J LIPID RES, V31, P545; Hodgkinson A, 2009, BRAIN IMPAIR, V10, P162, DOI 10.1375/brim.10.2.162; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; KEYS B, 2004, 32 ANN M INT NEUR SO; Kongs SK, 2000, WISCONSIN CARD SORTI; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Levi O, 2007, J NEUROCHEM, V100, P202, DOI 10.1111/j.1471-4159.2006.04189.x; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Maezawa I, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-10; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Mitrushina M., 1999, HDB NORMATIVE DATA N; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Raven J., 1991, MANUAL RAVENS PROGRE; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Samatovicz RA, 2000, J HEAD TRAUMA REHAB, V15, P869, DOI 10.1097/00001199-200006000-00002; SCHMIDT M, 2004, AUDITORY VERBAL LEAR; SmithSeemiller L, 1997, BRAIN INJURY, V11, P191; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stengard JH, 2002, AM J HUM GENET, V71, P501, DOI 10.1086/342217; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teasdale TW, 2008, J NEUROL NEUROSUR PS, V79, P364, DOI 10.1136/jnnp.2007.138081; Tzourio C, 2008, NEUROLOGY, V70, P1322, DOI 10.1212/01.wnl.0000308819.43401.87; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	60	20	20	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2011	25	6					596	603		10.3109/02699052.2011.572947			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	758FF	WOS:000290146300006	21534737				2021-06-18	
J	Tong, WS; Zheng, P; Xu, JF; Guo, YJ; Zeng, JS; Yang, WJ; Li, GY; He, B; Yu, H				Tong, Wu-song; Zheng, Ping; Xu, Jun-fa; Guo, Yi-jun; Zeng, Jing-song; Yang, Wen-jin; Li, Gao-yi; He, Bin; Yu, Hui			Early CT signs of progressive hemorrhagic injury following acute traumatic brain injury	NEURORADIOLOGY			English	Article						Traumatic brain injury (TBI); Progressive hemorrhagic injury (PHI); Early CTscan; CTsigns	HEAD-INJURY; PREDICTORS; LESIONS	Since progressive hemorrhagic injury (PHI) was introduced in neurosurgical literatures, several studies have been performed, the results of which have influenced doctors but do not define guidelines for the best treatment of PHI. PHI may be confirmed by a serial computerized tomography (CT) scan, and it has been shown to be associated with a fivefold increase in the risk of clinical worsening and is a significant cause of morbidity and mortality as well. So, early detection of PHI is practically important in a clinical situation. To analyze the early CT signs of progressive hemorrhagic injury following acute traumatic brain injury (TBI) and explore their clinical significances, PHI was confirmed by comparing the first and repeated CT scans. Data were analyzed and compared including times from injury to the first CT and signs of the early CT scan. Logistic regression analysis was used to show the risk factors related to PHI. A cohort of 630 TBI patients was evaluated, and there were 189 (30%) patients who suffered from PHI. For patients with their first CT scan obtained as early as 2 h post-injury, there were 116 (77.25%) cases who suffered from PHI. The differences between PHIs and non-PHIs were significant in the initial CT scans showing fracture, subarachnoid hemorrhage (SAH), brain contusion, epidural hematoma (EDH), subdural hematoma (SDH), and multiple hematoma as well as the times from injury to the first CT scan (P < 0.01). Logistic regression analysis showed that early CT scans (EDH, SDH, SAH, fracture, and brain contusion) were predictors of PHI (P < 0.01). For patients with the first CT scan obtained as early as 2 h post-injury, a follow-up CT scan should be performed promptly. If the initial CT scan shows SAH, brain contusion, and primary hematoma with brain swelling, an earlier and dynamic CT scan should be performed for detection of PHI as early as possible and the medical intervention would be enforced in time.	[Tong, Wu-song; Zheng, Ping; Xu, Jun-fa; Guo, Yi-jun; Zeng, Jing-song; Yang, Wen-jin; Li, Gao-yi; He, Bin; Yu, Hui] Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai 201200, Peoples R China	Tong, WS (corresponding author), Pudong New Area Peoples Hosp, Dept Neurosurg, 490 S Chuanhuan Rd, Shanghai 201200, Peoples R China.	tongws0599@yahoo.com.cn; jojo_ras@hotmail.com					Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Jiang J., 2008, CLIN GUIDELINES MANA, P1; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; LIANG YM, 2006, CHIN J TRAUMA, V22, pL56; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Sanus GZ, 2004, NEUROSURG QUART, V14, P97, DOI 10.1097/01.wnq.0000127718.06183.12; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004	11	20	27	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	MAY	2011	53	5					305	309		10.1007/s00234-010-0659-8			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	750SU	WOS:000289569100001	20131047				2021-06-18	
J	Apori, AA; Herr, AE				Apori, Akwasi A.; Herr, Amy E.			Homogeneous Immunosubtraction Integrated with Sample Preparation Enabled by a Microfluidic Format	ANALYTICAL CHEMISTRY			English	Article							CEREBROSPINAL-FLUID; CAPILLARY-ELECTROPHORESIS; POLYACRYLAMIDE-GELS; PROTEIN-LEVELS; S100 PROTEIN; SERUM; S-100; IMMUNOASSAYS; DISEASE; INJURY	Immunosubtraction is a powerful and resource-intensive laboratory medicine assay that reports both protein mobility and binding specificity. To expedite and automate this electrophoretic assay, we report on advances to the electrophoretic immunosubtraction assay by introducing a homogeneous, not heterogeneous, format with integrated sample preparation. To accomplish homogeneous immunosubtraction, a step-decrease in separation matrix pore-size at the head of a polyacrylamide gel electrophoresis (PAGE) separation channel enables "subtraction" of target analyte when capture antibody is present (as the large immune-complex is excluded from PAGE), but no subtraction when capture antibody is absent. Inclusion of sample preparation functionality via small pore size polyacrylamide membranes is also key to automated operation (i.e., sample enrichment, fluorescence sample labeling, and mixing of sample with free capture antibody). Homogeneous sample preparation and assay operation allows on-the-fly, integrated subtraction of one to multiple protein targets and reuse of each device. Optimization of the assay is detailed which allowed for similar to 95% subtraction of target with 20% non-specific extraction of large species at the optimal antibody antigen ratio, providing conditions needed for selective target identification. We demonstrate the assay on putative markers of injury and inflammation in cerebrospinal fluid (CSF), an emerging area of diagnostics research, by rapidly reporting protein mobility and binding specificity within the sample matrix. We simultaneously detect S100B and C-reactive protein, suspected biomarkers for traumatic brain injury (TBI), in similar to 2 min. Lastly, we demonstrate S100B detection (65 nM) in raw human CSF with an estimated lower limit of detection of 3.25 nM, within the clinically relevant concentration range for detecting TBI in CSF. Beyond the novel CSF assay introduced here, a fully automated immunosubtraction assay would impact a spectrum of routine but labor and time-intensive laboratory medicine assays.	[Apori, Akwasi A.; Herr, Amy E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	Herr, AE (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aeh@berkeley.edu		Herr, Amy/0000-0002-6906-2985	Defense Advanced Research Projects Agency (DARPA)United States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N66001-09-1-2118]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1DP2OD007294]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP2OD007294] Funding Source: NIH RePORTER	This material is based upon work supported by the Defense Advanced Research Projects Agency (DARPA) under Award N66001-09-1-2118 and the National Institutes of Health through the NIH Director's New Innovator Award Program (AEH, 1DP2OD007294). A.A.A. is a National Defense Science and Engineering Graduate (NDSEG) Fellow and UNCF/Merck Fellow. A.E.H. is an Alfred P. Sloan Foundation Research Fellow in chemistry.	AGUZZI F, 1977, B I SIEROTER MILAN, V56, P212; Beyor N, 2009, ANAL CHEM, V81, P3523, DOI 10.1021/ac900060r; Bienvenu J, 1998, CLIN CHEM, V44, P599; Bossuyt X, 1998, CLIN CHEM, V44, P760; CATON JE, 1973, ABSTR PAP AM CHEM S, P31; Clark R, 1998, ELECTROPHORESIS, V19, P2479, DOI 10.1002/elps.1150191421; CZERNICKI Z, 2009, BRAIN EDEMA, V14, P247; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Hatch AV, 2006, ANAL CHEM, V78, P4976, DOI 10.1021/ac0600454; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Herr AE, 2005, ANAL CHEM, V77, P585, DOI 10.1021/ac0489768; Herr AE, 2007, P NATL ACAD SCI USA, V104, P5268, DOI 10.1073/pnas.0607254104; Hickman JL, 2004, CUR CLIN NEUROL, P571; Hou CL, 2010, ANAL CHEM, V82, P3343, DOI 10.1021/ac100182j; Hutchison CA, 2009, NAT REV NEPHROL, V5, P621, DOI 10.1038/nrneph.2009.151; Infante JR, 2000, TUMOR BIOL, V21, P38, DOI 10.1159/000030109; Irani DN, 2009, CEREBROSPINAL FLUID; KABAT EA, 1948, AM J MED, V4, P653, DOI 10.1016/S0002-9343(48)90389-1; Keren DF, 1999, ARCH PATHOL LAB MED, V123, P126; Keren DF, 2003, PROTEIN ELECTROPHORE; Kunihara T, 2001, J THORAC CARDIOV SUR, V122, P1019, DOI 10.1067/mtc.2001.115151; Marshall T, 1999, ELECTROPHORESIS, V20, P1307, DOI 10.1002/(SICI)1522-2683(19990601)20:7<1307::AID-ELPS1307>3.0.CO;2-P; Mussack T, 2006, CLIN BIOCHEM, V39, P349, DOI 10.1016/j.clinbiochem.2005.12.007; NEILSEN PK, 2007, NURSING CARE PEDIAT; Nygaard O, 1997, CLIN CHEM, V43, P541; Otto M, 1997, J NEUROL, V244, P566, DOI 10.1007/s004150050145; PALFREY SM, 1999, CLIN APPL CAPILLARY, P39; Paquette DM, 2001, ELECTROPHORESIS, V22, P2391, DOI 10.1002/1522-2683(200107)22:12<2391::AID-ELPS2391>3.0.CO;2-B; Serot JM, 1997, J NEUROL NEUROSUR PS, V63, P506, DOI 10.1136/jnnp.63.4.506; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Sun XH, 2008, ANAL CHEM, V80, P5126, DOI 10.1021/ac800322f; Thorngren-Jerneck K, 2004, PEDIATR RES, V55, P406, DOI 10.1203/01.PDR.0000106806.75086.D3; Tsakadze NL, 1998, J NEUROCHEM, V71, pS72; Woodward S, 2002, Br J Nurs, V11, P47; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	36	20	20	0	22	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700			ANAL CHEM	Anal. Chem.	APR 1	2011	83	7					2691	2698		10.1021/ac103219x			8	Chemistry, Analytical	Chemistry	741TM	WOS:000288887700041	21375345	Green Accepted			2021-06-18	
J	de Groot, YJ; Wijdicks, EFM; van der Jagt, M; Bakker, J; Lingsma, HF; IJzermans, JNM; Kompanje, EJO				de Groot, Yorick J.; Wijdicks, Eelco F. M.; van der Jagt, Mathieu; Bakker, Jan; Lingsma, Hester F.; IJzermans, Jan N. M.; Kompanje, Erwin J. O.			Donor conversion rates depend on the assessment tools used in the evaluation of potential organ donors	INTENSIVE CARE MEDICINE			English	Article						Brain death; Critical care organisation; Ethics; Neurotrauma; Stroke; Transplantation	ANEURYSMAL SUBARACHNOID HEMORRHAGE; UNITED-STATES; BRAIN-DEATH; COMA SCALE; 4 SCORE; DONATION; CARE; VALIDATION; AUDIT	Purpose: It is desirable to identify a potential organ donor (POD) as early as possible to achieve a donor conversion rate (DCR) as high as possible which is defined as the actual number of organ donors divided by the number of patients who are regarded as a potential organ donor. The DCR is calculated with different assessment tools to identify a POD. Obviously, with different assessment tools, one may calculate different DCRs, which make comparison difficult. Our aim was to determine which assessment tool can be used for a realistic estimation of a POD pool and how they compare to each other with regard to DCR. Methods: Retrospective chart review of patients diagnosed with a subarachnoid haemorrhage, traumatic brain injury or intracerebral haemorrhage. We applied three different assessment tools on this cohort of patients. Results: We identified a cohort of 564 patients diagnosed with a subarachnoid haemorrhage, traumatic brain injury or intracerebral haemorrhage of whom 179/564 (31.7%) died. After applying the three different assessment tools the number of patients, before exclusion of medical reasons or age, was 76 for the IBD-FOUR definition, 104 patients for the IBD-GCS definition and 107 patients based on the OPTN definition of imminent neurological death. We noted the highest DCR (36.5%) in the IBD-FOUR definition. Conclusion: The definition of imminent brain death based on the FOUR-score is the most practical tool to identify patients with a realistic chance to become brain dead and therefore to identify the patients most likely to become POD.	[de Groot, Yorick J.; van der Jagt, Mathieu; Bakker, Jan; Kompanje, Erwin J. O.] Erasmus MC Univ, Med Ctr, Dept Intens Care, NL-3000 CA Rotterdam, Netherlands; [Wijdicks, Eelco F. M.] Mayo Clin, Div Crit Care Neurol, Rochester, MN USA; [Lingsma, Hester F.] Erasmus MC Univ, Med Ctr Rotterdam, Dept Publ Hlth, Ctr Med Decis Making, NL-3000 CA Rotterdam, Netherlands; [IJzermans, Jan N. M.] Erasmus MC Univ, Med Ctr Rotterdam, Dept Surg, NL-3000 CA Rotterdam, Netherlands	Kompanje, EJO (corresponding author), Erasmus MC Univ, Med Ctr, Dept Intens Care, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.j.o.kompanje@erasmusmc.nl	Bakker, Jan/A-4011-2009	Bakker, Jan/0000-0003-2236-7391			Barber K, 2006, BMJ-BRIT MED J, V332, P1124, DOI 10.1136/bmj.38804.658183.55; Connolly E S Jr, 1999, J Stroke Cerebrovasc Dis, V8, P248, DOI 10.1016/S1052-3057(99)80074-3; Cuende N, 2007, AM J TRANSPLANT, V7, P1526, DOI 10.1111/j.1600-6143.2007.01792.x; de Groot YJ, 2010, INTENS CARE MED, V36, P1488, DOI 10.1007/s00134-010-1848-y; Goldacre MJ, 2008, STROKE, V39, P2197, DOI 10.1161/STROKEAHA.107.509695; Gortmaker SL, 1996, CRIT CARE MED, V24, P432, DOI 10.1097/00003246-199603000-00012; Jansen NE, 2009, TRANSPL INT, V22, P1064, DOI 10.1111/j.1432-2277.2009.00930.x; Kompanje EJO, 2006, INTENS CARE MED, V32, P217, DOI 10.1007/s00134-005-0001-9; KOMPANJE EJO, 2010, HUMAN RIGHTS BIOMEDI, P235; Lytle FT, 2009, AM J TRANSPLANT, V9, P1446, DOI 10.1111/j.1600-6143.2009.02575.x; Jimenez-Yepes CM, 2008, STROKE, V39, P1344, DOI 10.1161/STROKEAHA.107.504019; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Opdam HI, 2004, INTENS CARE MED, V30, P1390, DOI 10.1007/s00134-004-2185-9; Raja PV, 2008, NEUROSURGERY, V62, P1187, DOI 10.1227/01.neu.0000333291.67362.0b; Rodrigue JR, 2006, AM J TRANSPLANT, V6, P190, DOI 10.1111/j.1600-6143.2005.01130.x; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; Sheehy E, 2003, NEW ENGL J MED, V349, P667, DOI 10.1056/NEJMsa021271; Tuttle-Newhall JE, 2009, AM J TRANSPLANT, V9, P879, DOI 10.1111/j.1600-6143.2009.02565.x; Wesslau C, 2007, TRANSPL INT, V20, P147, DOI 10.1111/j.1432-2277.2006.00413.x; Wijdicks EFM, 2008, NEUROLOGY, V70, P1234, DOI 10.1212/01.wnl.0000289762.50376.b6; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wijdicks EFM, 2005, MAYO CLIN PROC, V80, P550, DOI 10.4065/80.4.550; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435	24	20	20	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	APR	2011	37	4					665	670		10.1007/s00134-011-2131-6			6	Critical Care Medicine	General & Internal Medicine	747FM	WOS:000289305700016	21267542	Green Published, Other Gold			2021-06-18	
J	Sundberg, LM; Herrera, JJ; Narayana, PA				Sundberg, Laura M.; Herrera, Juan J.; Narayana, Ponnada A.			Effect of Vascular Endothelial Growth Factor Treatment in Experimental Traumatic Spinal Cord Injury: In Vivo Longitudinal Assessment	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assays; diffusion tensor imaging; magnetic resonance imaging; spinal cord injury; vascular endothelial growth factor	STIMULATES AXONAL OUTGROWTH; VASOGENIC BRAIN EDEMA; BARRIER PERMEABILITY; NERVOUS-SYSTEM; DIFFUSION; RAT; VEGF; MRI; MECHANISMS; BIOLOGY	Vascular endothelial growth factor (VEGF) is thought to provide neuroprotection to the traumatically injured spinal cord. We examined whether supplementing the injured environment with VEGF(165) via direct intraspinal injection into the lesion epicenter during the acute phase of spinal cord injury (SCI) results in improved outcome. The effect of treatment was investigated using longitudinal multi-modal magnetic resonance imaging (MRI), neurobehavioral assays, and end-point immunohistochemistry. We observed on MRI that rats treated with VEGF(165) after SCI had increased tissue sparing compared to vehicle-treated animals at the earlier time points. However, these favorable effects were not maintained into the chronic phase. Histology revealed that VEGF(165) treatment resulted in increased oligodendrogenesis and/or white matter sparing, and therefore may eventually lead to improved functional outcome. The increase in spared tissue as demonstrated by MRI, coupled with the possible remyelination and increased neurosensory sensitivity, suggests that VEGF(165) treatment may play a role in promoting plasticity in the sensory pathways following SCI. However, VEGF-treated animals also demonstrated an increased incidence of persistent allodynia, as indicated on the von Frey filament test.	[Sundberg, Laura M.; Herrera, Juan J.; Narayana, Ponnada A.] Univ Texas Houston, Sch Med, Dept Diagnost & Intervent Imaging, Houston, TX 77030 USA	Narayana, PA (corresponding author), Univ Texas Houston, Sch Med, Dept Diagnost & Intervent Imaging, 6431 Fannin St, Houston, TX 77030 USA.	ponnada.a.narayana@uth.tmc.edu					BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Benton RL, 2003, NEUROCHEM RES, V28, P1693, DOI 10.1023/A:1026013106016; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Bockhorst KH, 2010, J NEUROSCI RES, V88, P1146, DOI 10.1002/jnr.22273; BOCKHORST KH, 2010, 18 ANN M INT SOC MAG; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; Brockington A, 2004, NEUROPATH APPL NEURO, V30, P427, DOI 10.1111/j.1365-2990.2004.00600.x; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Cohen DM, 2009, NMR BIOMED, V22, P332, DOI 10.1002/nbm.1343; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; DEMEDIUK P, 1987, NEUROCHEM PATHOL, V7, P79, DOI 10.1007/BF02834293; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; Dijkers M, 2009, J REHABIL RES DEV, V46, P13, DOI 10.1682/JRRD.2008.04.0053; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; Fenyes DA, 1998, MAGN RESON IMAGING, V16, P1249, DOI 10.1016/S0730-725X(98)00093-9; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Goldsmith HS, 1999, SURG NEUROL, V51, P231, DOI 10.1016/S0090-3019(97)00330-3; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; HAHN K, 2004, INT SOC MAGNETIC RES, P1208; HAHN K, 2005, INT SOC MAGNETIC RES, P161; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kozlowski P, 2008, J NEUROTRAUM, V25, P653, DOI 10.1089/neu.2007.0462; Madi S, 2005, MAGN RESON MED, V53, P118, DOI 10.1002/mrm.20304; Mihai G, 2008, J NEUROTRAUM, V25, P1, DOI 10.1089/neu.2007.0338; Mills CD, 2001, J NEUROTRAUM, V18, P1091, DOI 10.1089/08977150152693773; NESICTAYLOR DO, 2010, J NEUROTRAUM, V27, P1793; NOBLE LJ, 1987, BRAIN RES, V424, P177, DOI 10.1016/0006-8993(87)91208-X; NOLAN RT, 1969, BRIT MED J, V1, P710, DOI 10.1136/bmj.1.5645.710; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Patel CB, 2009, J NEUROTRAUM, V26, P1005, DOI 10.1089/neu.2008.0860; Peng XM, 2006, ANN NEUROL, V59, P843, DOI 10.1002/ana.20855; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; REULEN HJ, 1976, BRIT J ANAESTH, V48, P741, DOI 10.1093/bja/48.8.741; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sundberg LM, 2010, J NEUROTRAUM, V27, P1753, DOI 10.1089/neu.2010.1369; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Twisk J, 2002, J CLIN EPIDEMIOL, V55, P329, DOI 10.1016/S0895-4356(01)00476-0; van Neerven S, 2010, J NEUROTRAUM, V27, P1781, DOI 10.1089/neu.2010.1484; WEIRICH SD, 1990, SPINE, V15, P630, DOI 10.1097/00007632-199007000-00004; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; YASHON D, 1973, J NEUROSURG, V38, P693, DOI 10.3171/jns.1973.38.6.0693; YE F, 2007, INT SOC MAGNETIC RES, P1841; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	58	20	21	0	8	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2011	28	4					565	578		10.1089/neu.2010.1533			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	746IW	WOS:000289240200007	21299336	Green Published			2021-06-18	
J	Boelen, DHE; Spikman, JM; Fasotti, L				Boelen, D. H. E.; Spikman, J. M.; Fasotti, L.			Rehabilitation of executive disorders after brain injury: Are interventions effective?	JOURNAL OF NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; FRONTAL-LOBE DAMAGE; PAGING SYSTEM; COGNITIVE REHABILITATION; DYSEXECUTIVE SYNDROME; GOAL MANAGEMENT; MEMORY AID; BEHAVIOR; PEOPLE; DEFICITS	In this paper, the effectiveness of interventions for executive disorders was reviewed. The objective was to evaluate the internal and external validity of intervention studies. A total of 46 papers, describing 54 studies, conducted in the last two decades meeting several preset inclusion criteria, was included in this review. The studies were categorized into three treatment approaches in order to enhance comparability. The overall results show that many interventions yield positive outcomes and seem to be effective in reducing executive problems in brain-injured subjects. However, several studies have only an explorative intent and are based on less sophisticated experimental designs. The verification of their results is generally more tenuous. The internal validity, or the set-up of experimental conditions necessary to draw valid conclusions about treatment effectiveness, including the choice of well-matched control groups, or the randomization of patients over treatment and control conditions, is not always strong. The same conclusion can be drawn for the external validity of a number of the intervention studies; often evidence of generalization to real-life situations, long-term follow-up, and transfer to non-trained situations, were (partially) lacking in the studies under review. The authors are aware that the design of proper randomized controlled trials for the investigation of the treatment effectiveness of executive disorders is cumbersome and time consuming. Nonetheless, the provisional results of several well-designed studies described in this review make the effort worthwhile.	[Boelen, D. H. E.; Fasotti, L.] St Maartensklin Res Dev & Educ, NL-6500 GM Nijmegen, Netherlands; [Boelen, D. H. E.; Fasotti, L.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Boelen, D. H. E.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands; [Spikman, J. M.] Univ Med Ctr Groningen, Dept Neurol, Neuropsychol Unit, Groningen, Netherlands; [Spikman, J. M.] Univ Groningen, Dept Psychol, NL-9700 AB Groningen, Netherlands	Boelen, DHE (corresponding author), St Maartensklin Res Dev & Educ, POB 9011, NL-6500 GM Nijmegen, Netherlands.	d.boelen@maartenskliniek.nl		Spikman, Jacoba/0000-0002-6477-0763	Netherlands Organization of Health Research and Development (ZonMw)Netherlands Organization for Health Research and Development [1435.0009]	Supported by The Netherlands Organization of Health Research and Development (ZonMw), Rehabilitation Research Programme (Grant No. 1435.0009).	ALDERMAN N, 1995, NEUROPSYCHOL REHABIL, V5, P193, DOI 10.1080/09602019508401467; ALDERMAN N, 1991, Brain Injury, V5, P77, DOI 10.3109/02699059108998516; ALDERMAN N, 1994, NEUROPSYCHOL REHABIL, V4, P31, DOI 10.1080/09602019408401454; Alderman N, 1997, BRAIN INJURY, V11, P79, DOI 10.1080/026990597123683; ALDERMAN N, 1991, NEUROPSYCHOL REHABIL, V1, P65, DOI DOI 10.1080/09602019108401380; Alvarez JB, 2006, GENET RESOUR CROP EV, V53, P1061, DOI 10.1007/s10722-004-7940-9; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Burgess P. W., 2002, PRINCIPLES FRONTAL L, P557, DOI 10.1093/acprof:oso/9780195134971.003.0033; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; CARAMAZZA A, 1986, BRAIN COGNITION, V5, P41, DOI 10.1016/0278-2626(86)90061-8; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CICERONE KD, 2005, EFFECTIVENESS REHABI, P43; Cicerone KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Coltheart M., 2005, EFFECTIVENESS REHABI, P11, DOI [DOI 10.1093/ACPROF:OSO/9780198526544.003.0002, 10.1093/acprof:oso/9780198526544.003.0002]; Darling S, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, P53; Dayus B, 2000, NEUROPSYCHOL REHABIL, V10, P415, DOI 10.1080/096020100411998; Delazer M, 1998, NEUROPSYCHOL REHABIL, V8, P401; Dritschel BH, 1998, BRAIN INJURY, V12, P875; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Ehlhardt LA, 2005, BRAIN INJURY, V19, P569, DOI 10.1080/002699050400013550; Emslie H, 2007, NEUROPSYCHOL REHABIL, V17, P567, DOI 10.1080/09602010701381933; Evans J, 2005, EFFECTIVENESS REHABI, P247; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Fasotti L., 1992, NEUROPSYCHOL REHABIL, V2, P3, DOI DOI 10.1080/09602019208401392; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Fish J, 2008, J INT NEUROPSYCH SOC, V14, P154, DOI 10.1017/S1355617708080120; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; HANLON R, 1993, NEUROPSYCHOL REHABIL, V3, P63; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; KIRSCH NL, 1992, J HEAD TRAUMA REHAB, V7, P13, DOI DOI 10.1097/00001199-199209000-00004; Knight C, 2002, BRAIN INJURY, V16, P75, DOI 10.1080/02699050110082188; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Luria, 1973, WORKING BRAIN INTRO; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Man DWK, 2006, NEUROREHABILITATION, V21, P205; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Manchester D, 1997, BRAIN INJURY, V11, P605, DOI 10.1080/026990597123296; Manly T, 2004, NEUROPSYCHOL REHABIL, V14, P89, DOI 10.1080/09602010343000110; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Marshall RC, 2004, APHASIOLOGY, V18, P659, DOI 10.1080/02687030444000237; Matthey S, 1996, BRAIN INJURY, V10, P219, DOI 10.1080/026990596124539; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nezu A., 2008, EVIDENCE BASED OUTCO; Oddy M. A. W., 2009, REHABILITATION EXECU, P37; POLLENS RD, 1988, COGNITIVE REHABILITA, V5, P26; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Robertson IH, 1996, GOAL MANAGEMENT TRAI; Satish U, 2008, DISABIL REHABIL, V30, P468, DOI 10.1080/09638280701625401; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Simons J.S., 2005, EFFECTIVENESS REHABI, V211, DOI [10.1093/acprof:oso/9780198526544.003.0018, DOI 10.1093/ACPROF:OSO/9780198526544.001.0001]; SOHLBERG M M, 1992, Brain Injury, V6, P139, DOI 10.3109/02699059209029652; Soong W, 2005, INT J REHABIL RES, V28, P341, DOI 10.1097/00004356-200512000-00006; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; Stablum F, 2007, NEUROPSYCHOL REHABIL, V17, P1, DOI 10.1080/13506280500411111; Stuss D. T., 2009, REHABILITATION EXECU, P3; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Turkstra LS, 2002, J COMMUN DISORD, V35, P467, DOI 10.1016/S0021-9924(02)00118-1; Turner GR, 2004, SCI PRACT NEUROPSYCH, P224; VONCRAMON DY, 1994, NEUROPSYCHOL REHABIL, V4, P399, DOI 10.1080/09602019408401608; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Watson C, 2001, BRAIN INJURY, V15, P1003, DOI 10.1080/02699050010022662; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 1996, BEHAV ASSESSMENT DYS; World Health Organization, 2001, INT CLASS FUNCT DIS; WORTHINGTON A, 2005, EFFECTIVENESS REHABI, P257; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU	86	20	20	0	28	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1748-6645			J NEUROPSYCHOL	J. Neuropsychol.	MAR	2011	5		1				73	113		10.1348/174866410X516434			41	Psychology; Psychology, Experimental	Psychology	739NK	WOS:000288724600005	21366888				2021-06-18	
J	Dionysus, KE; Denney, RL; Halfaker, DA				Dionysus, Kimberly E.; Denney, Robert L.; Halfaker, Dale A.			Detecting Negative Response Bias with the Fake Bad Scale, Response Bias Scale, and Henry-Heilbronner Index of the Minnesota Multiphasic Personality Inventory-2	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Symptom validity testing; Traumatic brain injury; Forensic neuropsychology; Assessment	MMPI-2 VALIDITY SCALES; INJURY LITIGANTS; RBS; VALIDATION; UTILITY	The 28-item Response Bias Scale (RBS) and 15-item Henry-Heilbronner Index (HHI) are new validity scales within the Minnesota Multiphasic Personality Inventory-2, designed to detect over-reporting of cognitive and somatic symptomology, respectively. The 43-item Lees-Haley Fake Bad Scale (FBS) was designed to detect noncredible symptom presentations within a personal injury setting. The current study examined the predictive validity of these scales in a criterion-groups design involving head-injured litigants. Archival data were collected and two groups were created using the Slick, Sherman, and Iverson ([1999]. Diagnostic criteria for malingered neurocognitive dysfunction: Proposed standards for clinical practice and research. The Clinical Neuropsychologist, 13, 545-561) Criteria for Probable Negative Response Bias. Results yielded excellent to acceptable discrimination ability for the validity scales, including an area under the curve of 0.83 for FBS, 0.82 for RBS, and 0.73 for HHI. Findings suggest that the FBS, RBS, and HHI perform as well as the other validity scales in discriminating over-reporting within a head-injured litigant setting.	[Dionysus, Kimberly E.; Denney, Robert L.] Forest Inst, Sch Profess Psychol, Springfield, MO USA; [Halfaker, Dale A.] Neuropsychol Associates SW Missouri, Springfield, MO USA	Dionysus, KE (corresponding author), 73 B Mt Ave, Springfield, NJ 07081 USA.	cheyanne412@hotmail.com					Allen L.M., 1997, CARB 97 MANUAL COMPU; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Butcher JN, 2003, ARCH CLIN NEUROPSYCH, V18, P473, DOI 10.1016/S0887-6177(02)00142-7; Butcher JN, 1989, MANUAL ADM SCORING M; FRANZEN MD, 2000, CLIN NEUROPSYCHOLOGY; GERVAIS R, 2010, ARCH CLIN NEUROPSYCH, V25, P1; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Green, 2004, GREENS MED SYMPTOM V; Green P., 2005, GREENS WORD MEMORY T; Green P., 2004, MEMORY COMPLAINTS IN; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; GREIFFENSTEIN MF, 2007, ASSESSMENT FEIGNED C; Hathaway S.R., 1943, MINNESOTA MULTIPHASI; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P919, DOI 10.1080/13854040701625853; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; LARRABEE GJ, 2005, FORENSIC NEUROPSYCHO, P115; Lees-Haley PR, 2004, ARCH CLIN NEUROPSYCH, V19, P333, DOI 10.1016/j.acn.2003.12.004; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; Nelson NW, 2007, J CLIN EXP NEUROPSYC, V29, P67, DOI 10.1080/13803390500488546; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Rey A, 1964, EXAMEN CLIN PSYCHOL; Rogers R., 1995, ASSESSMENT, V2, P81; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Tombaugh TN, 1996, TEST MEMORY MALINGER; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; WYGANT DB, 2010, PSYCHOL ASSESSMENT, V10, P1040; Zhou X.-H., 2002, STAT METHODS DIAGNOS	39	20	20	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2011	26	2					81	88		10.1093/arclin/acq096			8	Psychology, Clinical; Psychology	Psychology	726RX	WOS:000287744900001	21148668	Bronze			2021-06-18	
J	Mena, OJ; Paul, I; Reichard, RR				Mena, Othon J.; Paul, Ian; Reichard, R. Ross			Ocular Findings in Raised Intracranial Pressure A Case of Terson Syndrome in a 7-Month-Old Infant	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						Terson syndrome; intracranial pressure; subarachnoid hemorrhage; aneurysm	HEMORRHAGE	We present the case of a 7-month-old female infant who was found crying and limp. She was transported to a hospital where a possible subarachnoid hemorrhage was diagnosed radiologically. Before further studies could be pursued, her condition worsened and she died. The autopsy demonstrated diffuse subarachnoid hemorrhage of the brain and along the spinal cord. The brain, spinal cord, and eyes were retained and examined postfixation. An aneurysm of the middle cerebral artery was identified. Examination of the eyes demonstrated bilateral optic nerve sheath hemorrhage and extensive retinal hemorrhages extending to the ora serrata. A rapid increase in intracranial pressure secondary to subarachnoid hemorrhage following rupture of an aneurysm can result in sequelae similar to those found in inflicted traumatic brain injury. In this case, the rise in intracranial pressure resulted in marked hemorrhage within the optic nerve sheaths as well as intra-and preretinal hemorrhages. Patients with subarachnoid hemorrhage, or other causes of rapidly increased intracranial pressure, may develop ocular hemorrhage (Terson syndrome). This case illustrates the importance of ruling out natural disease before attributing the autopsy findings to trauma, as well as the importance of postmortem fixation of pediatric brains and eyes prior to examination.	[Mena, Othon J.; Paul, Ian; Reichard, R. Ross] New Mexico Off Med Investigator, Albuquerque, NM USA	Mena, OJ (corresponding author), Cty San Diego Med Examiners Off, 5570 Overland Ave, San Diego, CA 92123 USA.	othon.mena@sdcounty.ca.gov					GIANGIACOMO J, 2005, CHILD MALTREATMENT, P83; JAY V, 1998, FORENSIC PATHOLOGY, V40; KAUR B, 1990, ARCH DIS CHILD, V65, P1369, DOI 10.1136/adc.65.12.1369; Medele RJ, 1998, J NEUROSURG, V88, P851, DOI 10.3171/jns.1998.88.5.0851; MULLER PJ, 1974, J NEUROSURG, V41, P160, DOI 10.3171/jns.1974.41.2.0160; OU R, 2008, TERSON SYNDROME	6	20	20	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	MAR	2011	32	1					55	57		10.1097/PAF.0b013e3181edee5b			3	Medicine, Legal; Pathology	Legal Medicine; Pathology	718ML	WOS:000287126800012	20661124				2021-06-18	
J	Numminen, HJ				Numminen, H. J.			The incidence of traumatic brain injury in an adult population - how to classify mild cases?	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						adult; incidence; population; risk factor; traumatic brain injury	TASK-FORCE; EPIDEMIOLOGY; ACCURACY	Background: The incidence of traumatic brain injury (TBI) varies considerably between reports mainly because of variable methods used in recruiting of cases and especially in defining mild TBI. This study was carried out to evaluate the incidence in a given population according to published criteria for mild TBIs. Methods: All cases with symptoms of brain injury after a head trauma were collected from the health centres serving a defined population in South East Finland and from the one hospital taking care of all corresponding TBI cases. After reviewing the health records, the author classified the TBIs according to the guidelines of European Federation of Neurological Societies (EFNS). Results: A total of 370 patients were enrolled. The total crude annual incidence rate was 221 per 100.000 (95% CI: 176-265). A mild TBI was defined in 71% of the patients. According to the EFNS criteria, one-third of them should be classified only with head traumas because of the lack of either loss consciousness (LOC) or post-traumatic amnesia (PTA). This would reduce the total crude incidence rate to 137 per 100.000(95% CI: 101-172), an effect of the same magnitude as excluding mild TBIs treated out of hospital. Conclusions: The incidence rate falls within the wide range of previous published figures. Use of LOC or PTA as a criterion for mild TBI affects the incidence rate considerably as does the exclusion of mild cases treated out of hospital.	Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere 33521, Finland	Numminen, HJ (corresponding author), Tampere Univ Hosp, Dept Neurosci & Rehabil, PL 2000, Tampere 33521, Finland.	heikki.numminen@pshp.fi			Maire Tapola Foundation; South Karelia Central Hospital	I thank Sirpa Valpas for collecting the patient data. This work was supported by the Maire Tapola Foundation and by South Karelia Central Hospital.	Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; WINQVIST S, 2006, J ADOLESC HLTH, V39; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	13	20	20	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	MAR	2011	18	3					460	464		10.1111/j.1468-1331.2010.03179.x			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	722RB	WOS:000287450900017	20722703				2021-06-18	
J	Piras, F; Borella, E; Incoccia, C; Carlesimo, GA				Piras, F.; Borella, E.; Incoccia, C.; Carlesimo, G. A.			Evidence-based practice recommendations for memory rehabilitation	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Memory disorders; Rehabilitation; Practice guidelines as topic	TRAUMATIC BRAIN-INJURY; FACE-NAME ASSOCIATIONS; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; IMPAIRED PATIENTS; COGNITIVE REHABILITATION; ELECTRONIC MEMORY; PAGING SYSTEM; NEUROPSYCHOLOGICAL REHABILITATION; OLDER-ADULTS	Memory impairment is a common consequence of neurological injury or disease, causing significant disability in everyday life, and is therefore a critical target for rehabilitation intervention. Here we report a review of the available evidence on the efficacy of restitution-oriented therapies and compensatory approaches for memory rehabilitation. A total of 110 studies was systematically classified and analyzed in order to generate evidence-based clinical recommendations for treatment providers. Different key aspects, such as types of brain damage, treatments characteristics and outcome measurements guided the evaluation of the literature as to appraise the potential interaction between patients characteristics, interventions and outcomes. The general conclusion is that memory re-training programs and compensatory approaches are probably effective in ameliorating memory disorders in patients with focal brain lesions, with some evidences of changes in memory functioning extending beyond the trained skills. Externally directed assistive devices and specific learning strategies are effective (with a level D and B of evidence, respectively) in retaining information relevant for daily needs also in patients with degenerative diseases. Some methodological concerns, such as the heterogeneity of subjects, interventions and outcomes studied, may limit the generalization of the present recommendations.	[Piras, F.] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72074 Tubingen, Germany; [Piras, F.; Incoccia, C.; Carlesimo, G. A.] Santa Lucia Fdn, Rome, Italy; [Borella, E.] Univ Padua, Dept Gen Psychol, I-35100 Padua, Italy; [Carlesimo, G. A.] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy	Piras, F (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Gartenstr 29, D-72074 Tubingen, Germany.	PirasFPhD@gmail.com	Borella, Erika/D-1278-2014	Borella, Erika/0000-0001-5481-6601; Incoccia, Chiara/0000-0003-4068-6548	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [PITN-G-2008-214570]	FP was funded by a three year European Commission fellowship, PITN-G-2008-214570.	Abrisqueta-Gomez J, 2004, ARQ NEURO-PSIQUIAT, V62, P778, DOI 10.1590/S0004-282X2004000500007; Allen DN, 1998, J REHABIL RES DEV, V35, P405; Avila R, 2004, BRAZ J MED BIOL RES, V37, P1721, DOI 10.1590/S0100-879X2004001100018; BACKMAN L, 1991, PSYCHOL AGING, V6, P489; Baddeley A, 1990, HUMAN MEMORY THEORY; Bakke B. L., 2004, CLIN GERONTOLOGIST, V27, P159, DOI DOI 10.1300/J018V27N01_12; Belleville S, 2006, DEMENT GERIATR COGN, V22, P486, DOI 10.1159/000096316; BENEDICT RHB, 1993, NEUROPSYCHOL REHABIL, V3, P37; Berg I. J., 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI [DOI 10.1080/09602019108401384, 10.1080/09602019108401384]; Berry E, 2007, NEUROPSYCHOL REHABIL, V17, P582, DOI 10.1080/09602010601029780; Boman IL, 2007, DISABIL REHABIL-ASSI, V2, P23, DOI 10.1080/17483100600856213; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Bourgeois MS, 2003, J COMMUN DISORD, V36, P361, DOI 10.1016/S0021-9924(03)00051-0; BROOKS DN, 1976, NEUROPSYCHOLOGIA, V14, P111, DOI 10.1016/0028-3932(76)90012-9; Burke DT, 2001, J HEAD TRAUMA REHAB, V16, P284, DOI 10.1097/00001199-200106000-00007; Cahn-Weiner DA, 2003, APPL NEUROPSYCHOL, V10, P215, DOI 10.1207/s15324826an1004_3; Camp CJ, 1992, EVERYDAY MEMORY AGIN, P155; Cappa SF, 2005, EUR J NEUROL, V12, P665; CARLESIMO GA, 1996, MANUALE NEUROPSICOLO, P1156; Cavaco S, 2005, BRAIN INJURY, V19, P853, DOI 10.1080/01449290500109917; Cherry KE, 2005, EXP AGING RES, V31, P261, DOI 10.1080/03610730590948186; CHERRY KE, 1999, J CLIN GEROPSYCHOLOG, V5, P159, DOI DOI 10.1023/A:1022983131186; CHERRY KE, 2004, CLIN GERONTOLOGIST, V27, P139, DOI DOI 10.1300/J018V27N01_11; Chiaravalloti ND, 2005, MULT SCLER, V11, P58, DOI 10.1191/1352458505ms1118oa; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cipriani G, 2006, ARCH GERONTOL GERIAT, V43, P327, DOI 10.1016/j.archger.2005.12.003; Clare L, 2001, NEUROPSYCHOL REHABIL, V11, P477, DOI 10.1080/09602010042000213; Clare L, 2000, J CLIN EXP NEUROPSYC, V22, P132, DOI 10.1076/1380-3395(200002)22:1;1-8;FT132; Clare L, 1999, NEUROCASE, V5, P37, DOI 10.1080/13554799908404063; CLARE L, 2004, Z GERONTOPSYCHOLOGIE, V17, P109, DOI DOI 10.1024/1011-6877.17.2.109; Cowles A, 2003, NEUROCASE, V9, P493, DOI 10.1076/neur.9.6.493.29378; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; CROSSON B, 1984, J CLIN NEUROPSYCHOL, V6, P287, DOI 10.1080/01688638408401219; CROVITZ HF, 1979, CORTEX, V15, P225, DOI 10.1016/S0010-9452(79)80027-1; DAVIS RN, 2001, ALZ DIS ASSOC DIS, V5, P1; Donaghy S, 1998, BRAIN INJURY, V12, P1061, DOI 10.1080/026990598121963; Doornhein K, 1998, NEUROPSYCHOL REHABIL, V8, P393, DOI 10.1080/713755579; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; DOUGAN DR, 1984, INT J NEUROSCI, V23, P215, DOI 10.3109/00207458408985365; Ehlhardt LA, 2005, BRAIN INJURY, V19, P569, DOI 10.1080/002699050400013550; Emslie H, 2007, NEUROPSYCHOL REHABIL, V17, P567, DOI 10.1080/09602010701381933; Evans J, 1992, CLIN REHABIL, V6, P75, DOI DOI 10.1177/026921559200600110; Fernandez AL, 2006, NEUROPSYCHOL REHABIL, V16, P96, DOI 10.1080/09602010443000164; Fillingham JK, 2003, NEUROPSYCHOL REHABIL, V13, P337, DOI 10.1080/09602010343000020; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Fluharty George, 1993, Brain Injury, V7, P85, DOI 10.3109/02699059309008160; FRAAS M, 2006, INT J COGNIT TECH, V11, P10; GIANUTSOS R, 1981, Journal of Clinical Neuropsychology, V3, P143, DOI 10.1080/01688638108403119; GIANUTSOS R, 1979, J CLIN NEUROPSYCHOL, V14, P117; GLASGOW RE, 1977, J CLIN PSYCHOL, V33, P1049, DOI 10.1002/1097-4679(197710)33:4<1049::AID-JCLP2270330429>3.0.CO;2-V; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; GLISKY EL, 1987, NEUROPSYCHOLOGIA, V25, P893, DOI 10.1016/0028-3932(87)90094-7; GLISKY EL, 1992, NEUROPSYCHOLOGIA, V30, P899, DOI 10.1016/0028-3932(92)90034-J; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; GLISKY EL, 1995, NEUROPSYCHOL REHABIL, V5, P299, DOI 10.1080/09602019508401474; GLISKY EL, 1988, NEUROPSYCHOLOGIA, V26, P173, DOI 10.1016/0028-3932(88)90041-3; GODFREY HPD, 1985, J CONSULT CLIN PSYCH, V53, P555, DOI 10.1037/0022-006X.53.4.555; Goldstein G, 1998, J REHABIL RES DEV, V35, P238; Gupta A, 2003, BRAIN INJURY, V17, P161, DOI 10.1080/0269905021000010195; Hannon R, 1989, Arch Clin Neuropsychol, V4, P227, DOI 10.1016/0887-6177(89)90015-2; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Haslam C, 2006, NEUROPSYCHOL REHABIL, V16, P505, DOI 10.1080/09602010500231867; Hawley KS, 2004, BEHAV MODIF, V28, P276, DOI 10.1177/0145445503259283; HEINRICHS RW, 1992, NEUROPSYCHOL REHABIL, V2, P43; HEISS WD, 1994, DEMENTIA, V5, P88, DOI 10.1159/000106702; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; Hildebrandt H, 2007, RESTOR NEUROL NEUROS, V25, P33; HILL RD, 1987, PSYCHOL AGING, V2, P204, DOI 10.1037/0882-7974.2.2.204; HT P, 2001, BRAIN INJURY, V15, P787; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P1255, DOI 10.1016/0028-3932(95)00061-7; Hux K, 2000, BRAIN INJURY, V14, P907; Inzitari D, 2006, NEUROL SCI, V27, pS225, DOI 10.1007/s10072-006-0622-y; Jennett S M, 1991, Int Disabil Stud, V13, P83; JONSSON A, 1993, ACTA NEUROL SCAND, V88, P394, DOI 10.1111/j.1600-0404.1993.tb05366.x; Kapur N, 2004, NEUROPSYCHOL REHABIL, V14, P41, DOI 10.1080/09602010343000138; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Kime SK, 1996, BRAIN INJURY, V10, P17; Kirsch NL, 2004, REHABIL PSYCHOL, V49, P200, DOI 10.1037/0090-5550.49.3.200; Kirsch NL, 2004, BRAIN INJURY, V18, P725, DOI 10.1080/02699050310001646161; Koltai DC, 2001, NEUROPSYCHOL REHABIL, V11, P455, DOI 10.1080/09602010042000097; KOVNER R, 1983, J CLIN NEUROPSYCHOL, V5, P65, DOI 10.1080/01688638308401151; Landauer T.K., 1978, PRACTICAL ASPECTS ME, P625; MALEC J, 1983, ARCH PHYS MED REHAB, V64, P436; Malone M. L., 2007, ALZHEIMERS CARE Q, V8, P65; Manasse NJ, 2005, BRAIN INJURY, V19, P633, DOI 10.1080/02699050400013667; McKerracher G, 2005, NEUROPSYCHOL REHABIL, V15, P115, DOI 10.1080/09602010443000056; MCKITRICK LA, 1992, J GERONTOL, V47, pP337, DOI 10.1093/geronj/47.5.P337; McMahon C. M., 2003, CLIN PSYCHOL, V7, P50, DOI DOI 10.1080/13284200410001707483; Melton AK, 2005, APHASIOLOGY, V19, P353, DOI 10.1080/02687030444000804; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Miotto EC, 2007, NEUROPSYCHOL REHABIL, V17, P551, DOI 10.1080/09602010701202188; Moore S, 2001, NEUROPSYCHOL REHABIL, V11, P245, DOI 10.1080/09602010042000222; MOSCOVITCH M, 1982, HUMAN MEMORY AMNESIA; Mount J, 2007, NEUROREHABILITATION, V22, P123; Oriani M, 2003, AGING MENT HEALTH, V7, P22, DOI 10.1080/1360786021000045863; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Paivio A., 1971, IMAGERY VERBAL PROCE; Pitel AL, 2006, BRAIN INJURY, V20, P1099, DOI 10.1080/02699050600909961; QOCARROLL RE, 1999, PSYCHOL MED, V29, P105; QSQUIRES EJ, 1996, NEUROPSYCHOL REHABIL, V6, P55; Quittre A, 2005, ACTA NEUROL BELG, V105, P30; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Solari A, 2004, J NEUROL SCI, V224, P113, DOI 10.1016/j.jns.2004.07.001; Stapleton S, 2007, BRAIN INJURY, V21, P401, DOI 10.1080/02699050701252030; STEINGASS HP, 1994, NEUROPSYCHOL REHABIL, V4, P49, DOI 10.1080/09602019408401455; Sykes R.N, 1988, PRACTICAL ASPECTS ME, V1, P396; Tam SF, 2004, BRAIN INJURY, V18, P461, DOI 10.1080/02699050310001646099; Tam Sing-Fai, 2003, Occup Ther Int, V10, P20, DOI 10.1002/oti.175; Tesar N, 2005, WIEN KLIN WOCHENSCHR, V117, P747, DOI 10.1007/s00508-005-0470-4; Thickpenny-Davis KL, 2007, J HEAD TRAUMA REHAB, V22, P303, DOI 10.1097/01.HTR.0000290975.09496.93; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; TOPPINO TC, 1991, MEM COGNITION, V19, P159, DOI 10.3758/BF03197112; Tulving E, 1983, ELEMENTS EPISODIC ME; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Van Hulle A, 2006, BRAIN INJURY, V20, P101, DOI 10.1080/02699050500309684; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 2003, NEUROREHABILITATION, V18, P3; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006; Yasuda K, 2002, NEUROPSYCHOL REHABIL, V12, P155, DOI 10.1080/09602010143000239; YOHMAN JR, 1988, J CONSULT CLIN PSYCH, V56, P67	129	20	21	2	43	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	MAR	2011	47	1					149	175					27	Rehabilitation	Rehabilitation	751CO	WOS:000289595300013	21448125				2021-06-18	
J	Alla, S; Sullivan, SJ; McCrory, P; Hale, L				Alla, Sridhar; Sullivan, S. John; McCrory, Paul; Hale, Leigh			Spreading the word on sports concussion: citation analysis of summary and agreement, position and consensus statements on sports concussion	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							2ND INTERNATIONAL-CONFERENCE; NOVEMBER 2008; ZURICH; MANAGEMENT; RECOMMENDATIONS; SCIENCE	Background The growing concern over concussion in sports has led to the publication of five major summary and agreement, position and consensus statements since 2000. The dissemination of information from these statements is largely unknown and difficult to quantify, but their impact on the research community can be quantified by analysing the number of citations to these key publications. The purpose of this review is to report the number and pattern of citations to the key published statements on sports concussion. Methods Web of Science, Scopus and PubMed were searched from 2000 to mid-December 2009 using two different search strategies. The first strategy used the search terms 'concussion' and 'first author' of the statement article, while the second used the 'title' of the target article as the key search term. Results The publications resulting from the three 'Concussion in Sport' (CIS) group conferences were cited by 532 journal articles, while the National Athletic Trainers' Association position statement was cited 123 times. The highest number of citations to each of the five identified statements was seen in 2009. British Journal of Sports Medicine was the most frequently cited journal. Conclusion The citation analysis of the key statements on sports concussion has shown that the target papers have been widely cited in the research literature, with the highest number of citations being from the publications arising from the CIS group conferences. The authors have shown their preference to cite source articles published in the British Journal of Sports Medicine.	[Alla, Sridhar] Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, Dunedin 9054, New Zealand; [McCrory, Paul] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia	Alla, S (corresponding author), Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, POB 56, Dunedin 9054, New Zealand.	allsr357@student.otago.ac.nz	McCrory, Paul/Q-8688-2019	McCrory, Paul/0000-0003-4850-0568	International Rugby Board	The authors would like to thank G Forsyth, for assisting with the literature search, and the International Rugby Board, for financial support.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Bakkalbasi Nisa, 2006, Biomed Digit Libr, V3, P7, DOI 10.1186/1742-5581-3-7; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Cantu Robert C, 2006, Neurosurg Focus, V21, pE3; Cantu RC, 2009, NEUROSURGERY, V64, P786, DOI 10.1227/01.NEU.0000348539.13887.D3; Dvorak J, 2009, BRIT J SPORT MED, V43, pI1, DOI 10.1136/bjsm.2009.059360; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; HERRING S, 2006, MED SCI SPORTS EXERC, V38, P395, DOI DOI 10.1249/01.MSS.0000202025.48774.31; HERRING SA, 2005, MED SCI SPORTS EXERC, V37, P2012; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI 10.1016/j.jocn.2009.02.002; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory Paul, 2009, Scand J Med Sci Sports, V19, P452, DOI 10.1111/j.1600-0838.2009.00978.x; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Noruzi A, 2005, LIBRI, V55, P170, DOI 10.1515/LIBR.2005.170; Perneger TV, 2010, J CLIN EPIDEMIOL, V63, P660, DOI 10.1016/j.jclinepi.2009.09.012; Renear AH, 2009, SCIENCE, V325, P828, DOI 10.1126/science.1157784; Roth DL, 2005, CURR SCI INDIA, V89, P1531; Schmoch U, 2008, SCIENTOMETRICS, V74, P361, DOI 10.1007/s11192-007-1818-5; WADE N, 1975, SCIENCE, V188, P429, DOI 10.1126/science.188.4187.429	28	20	20	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	FEB	2011	45	2					132	135		10.1136/bjsm.2010.074088			4	Sport Sciences	Sport Sciences	709FJ	WOS:000286423000012	21081639				2021-06-18	
J	Han, BJ; Wang, QG; Cui, GY; Shen, X; Zhu, ZF				Han, Bojun; Wang, Qingguang; Cui, Guiyun; Shen, Xia; Zhu, Zufu			Post-treatment of Bax-inhibiting peptide reduces neuronal death and behavioral deficits following global cerebral ischemia	NEUROCHEMISTRY INTERNATIONAL			English	Article						Cerebral ischemia; Bax-inhibiting peptide; Neuroprotection; Learning and memory	TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL PERMEABILITY TRANSITION; TRANSIENT FOREBRAIN ISCHEMIA; DELAYED CELL-DEATH; CYTOCHROME-C; NEURODEGENERATIVE DISORDERS; SELECTIVE VULNERABILITY; SIGNALING PATHWAY; OXIDATIVE DAMAGE; RAT	Cerebral ischemia is a major cause of adult disability and death worldwide. Evidence suggests that Bax-dependent initiation and activation of intrinsic apoptotic pathways contribute to ischemic brain injury. We investigated the Bax-inhibiting peptide VPALR, designed from the rat Ku70-Bax inhibiting domain, on the apoptotic neuronal cell death and behavioral deficits following global cerebral ischemia. The pentapeptide was infused into the left lateral ventricle of the rat brain by intracerebroventricular (icv) injection 1 h after cerebral ischemia, and results showed that it highly permeated hippocampal neurons and bound to Bax protein in vivo. Post-treatment with VPALR reduced the delayed neuronal damage by approximately 78% compared to the non-treated ischemic control and scrambled peptide-treated rats. TUNEL analysis revealed that VPALR markedly reduced the ischemia-induced increase in apoptotic neuronal death in rat hippocampal CA1 region. VPALR post-treatment also significantly attenuated Bax activation and its mitochondrial translocation as compared with scrambled peptide-treated animals. Concomitantly, Bax-inhibiting peptide-treated rats showed reduced cytochrome c release from mitochondria to cytosol and reduced caspase-3 activation in response to cerebral ischemia, indicating that activation of the intrinsic apoptotic pathway was reduced. Furthermore, Bax-inhibiting peptide improved spatial learning and memory performance in the Morris water maze, which was seriously affected by global cerebral ischemia. In conclusion, Bax inhibition by cell-permeable pentapeptides reduced apoptotic neuronal injury in the hippocampal CA1 region and behavioral deficits following global ischemia. These results suggest that Bax is a potential target for pharmacological neuroprotection and that Bax-inhibiting peptide may be a promising neuroprotective strategy for cerebral ischemia. (C) 2010 Elsevier Ltd. All rights reserved.	[Han, Bojun; Wang, Qingguang; Zhu, Zufu] Southeast Univ, Affiliated Jiangyin Hosp, Dept Neurol, Coll Med, Jiangyin 214400, Jiangsu Prov, Peoples R China; [Cui, Guiyun; Shen, Xia] Xuzhou Med Coll, Affiliated Hosp, Dept Neurol, Xuzhou 221002, Jiangsu Prov, Peoples R China	Zhu, ZF (corresponding author), Southeast Univ, Affiliated Jiangyin Hosp, Dept Neurol, Coll Med, 163 Shoushan Rd, Jiangyin 214400, Jiangsu Prov, Peoples R China.	zufuzhu@gmail.com			Educational Commission of Jiangsu Province of China [05KJD320229]	This work was supported by a grant from the Educational Commission of Jiangsu Province of China (no. 05KJD320229).	Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bakalkin G, 1998, NEUROREPORT, V9, P2147, DOI 10.1097/00001756-199806220-00044; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321, DOI 10.1097/00004647-200104000-00001; Cao GD, 2002, J CEREBR BLOOD F MET, V22, P534, DOI 10.1097/00004647-200205000-00005; Chechlacz M, 2001, J NEUROCHEM, V78, P141, DOI 10.1046/j.1471-4159.2001.00380.x; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Feng YZ, 2003, NEUROSCI LETT, V344, P201, DOI 10.1016/S0304-3940(03)00466-X; Fewell JW, 1996, J CELL SCI, V109, P1937; Flynn RWV, 2008, NEUROPHARMACOLOGY, V55, P250, DOI 10.1016/j.neuropharm.2008.05.031; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Galluzzi L, 2009, BBA-BIOENERGETICS, V1787, P402, DOI 10.1016/j.bbabio.2008.09.006; Gao YQ, 2010, STROKE, V41, P166, DOI 10.1161/STROKEAHA.109.561852; Gomez JA, 2007, BIOCHEM SOC T, V35, P797, DOI 10.1042/BST0350797; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hagberg H, 2009, J CHILD NEUROL, V24, P1141, DOI 10.1177/0883073809338212; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P1117, DOI 10.1097/01.WCB.0000089600.87125.AD; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Iriyama T, 2009, NEUROSCI LETT, V451, P11, DOI 10.1016/j.neulet.2008.12.021; Jemmerson R, 2005, ANTIOXID REDOX SIGN, V7, P1158, DOI 10.1089/ars.2005.7.1158; Jin KL, 2001, J CEREBR BLOOD F MET, V21, P1411, DOI 10.1097/00004647-200112000-00005; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Kim SH, 1999, CANCER RES, V59, P4012; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P201, DOI 10.1007/BF00691853; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Mishra OP, 2001, MENT RETARD DEV D R, V7, P249, DOI 10.1002/mrdd.1034; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mouw G, 2002, METAB BRAIN DIS, V17, P143, DOI 10.1023/A:1019921904378; Nishimura M, 2003, J CEREBR BLOOD F MET, V23, P1052, DOI 10.1097/01.WCB.0000084251.20114.65; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Plesnila N, 2004, ACTA NEUROCHIR SUPPL, V89, P15; PLUM F, 1988, NEUROCHEM PATHOL, V9, P139; Polster BM, 2001, J BIOL CHEM, V276, P37887; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rathaus M, 2009, CELL CYCLE, V8, P1843, DOI 10.4161/cc.8.12.8864; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; ROSENTHAL RE, 1987, J CEREBR BLOOD F MET, V7, P752, DOI 10.1038/jcbfm.1987.130; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; SIMS NR, 1991, J NEUROCHEM, V56, P1836, DOI 10.1111/j.1471-4159.1991.tb03438.x; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Sugawara T, 1999, J NEUROSCI, V19, part. no.; Velier JJ, 1999, J NEUROSCI, V19, P5932, DOI 10.1523/JNEUROSCI.19-14-05932.1999; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wang XY, 2010, STROKE, V41, P2050, DOI 10.1161/STROKEAHA.110.589051; Yoshida T, 2004, BIOCHEM BIOPH RES CO, V321, P961, DOI 10.1016/j.bbrc.2004.07.054; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	58	20	23	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	FEB	2011	58	2					224	233		10.1016/j.neuint.2010.12.008			10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	718ZV	WOS:000287166800012	21167243				2021-06-18	
J	Harris, RA; Amor, S				Harris, Robert A.; Amor, Sandra			Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Oxidative stress; advanced glycation endproducts; advanced oxidation protein products; multiple sclerosis; neurodegeneration	GLYCATION END-PRODUCTS; AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID-BETA-PEPTIDE; PROGRESSIVE SUPRANUCLEAR PALSY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; CREUTZFELDT-JAKOB-DISEASE; ENDOPLASMIC-RETICULUM STRESS; TRAUMATIC BRAIN-INJURY; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS	The nervous system is a unique network of different cell types and comprises a variety of proteins, lipids, and carbohydrates that have an important interplay with all major organs in the body. Homeostatic regulation of nervous tissue turnover must be carefully controlled, taking into account interactions of the nervous, endocrine, and immune systems. Clinical conditions affecting the nervous system range from mild cognitive perturbations such as headache, to life-threatening acute courses such as meningitis and glioblastoma, and to chronic neurodegenerative diseases such as multiple sclerosis. One unifying feature in normal developmental or homeostatic functions and clinical dysfunctions within the nervous system is redox regulation, with an imbalance in oxidative/carbonyl stress versus antioxidants being characteristic of pathological conditions. In this review we consider the state of current knowledge regarding structural, genetic, proteomic, histopathological, clinical, and therapeutic perspectives of oxidative and carbonyl stress within the nervous system.	[Harris, Robert A.] Karolinska Hosp Solna, Dept Clin Neurosci, Karolinska Inst, Ctr Mol Med, Solna, Sweden; [Amor, Sandra] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands; [Amor, Sandra] Queen Mary Univ London, Neuroimmunol Unit, Ctr Neurosci, Blizard Inst Cell & Mol Sci,Barts & London Sch Me, London, England	Harris, RA (corresponding author), Karolinska Hosp, Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med L8 04, S-17176 Stockholm, Sweden.	Robert.Harris@ki.se	Harris, Robert A./I-6234-2019	Harris, Robert A./0000-0003-4990-509X; Amor, Sandra/0000-0001-6169-9845	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission; Dutch Multiple Sclerosis society - Stichting MS Research; Multiple Sclerosis society of Great Britain; Multiple Sclerosis society of Northern Ireland; DANA foundation	The authors gratefully acknowledge the support of the Swedish Medical Research Council, the Dutch Multiple Sclerosis society - Stichting MS Research, the Multiple Sclerosis society of Great Britain and Northern Ireland, and the DANA foundation.	Abdul-Majid KB, 2000, J NEUROIMMUNOL, V111, P23, DOI 10.1016/S0165-5728(00)00360-X; Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Agnello D, 2002, CYTOKINE, V18, P231, DOI 10.1006/cyto.2002.0890; Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Albers DS, 2001, TRENDS NEUROSCI, V24, P347, DOI 10.1016/S0166-2236(00)01794-X; Alderson NL, 2004, DIABETOLOGIA, V47, P1385, DOI 10.1007/s00125-004-1474-8; Aldini G, 2007, MED RES REV, V27, P817, DOI 10.1002/med.20073; Andersson A, 2008, J LEUKOCYTE BIOL, V84, P1248, DOI 10.1189/jlb.1207844; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Ando Y, 1997, BIOCHEM BIOPH RES CO, V232, P497, DOI 10.1006/bbrc.1996.5997; Andreazza AC, 2008, J AFFECT DISORDERS, V111, P135, DOI 10.1016/j.jad.2008.04.013; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Aoyama K, 2006, EUR J NEUROL, V13, P89, DOI 10.1111/j.1468-1331.2006.01139.x; Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Arbus C, 2010, PSYCHOL NEUROPSYCHIA, V8, P7, DOI 10.1684/pnv.2010.0205; Arlt S, 2002, CURR OPIN LIPIDOL, V13, P289, DOI 10.1097/00041433-200206000-00009; Arlt S, 2002, NEUROBIOL DIS, V10, P150, DOI 10.1006/nbdi.2002.0496; ARMSTRONG JS, 2010, FASEB J IN PRESS; Arnulf I, 2005, SLEEP, V28, P349; Atwood CS, 1999, MET IONS BIOL SYST, V36, P309; Aycicek A, 2006, BRAIN RES BULL, V69, P666, DOI 10.1016/j.brainresbull.2006.03.014; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Beisswenger PJ, 2003, BIOCHEM SOC T, V31, P1358; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bierhaus A, 2004, J CLIN INVEST, V114, P1741, DOI 10.1172/JCI200418058; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Biering-Sorensen F, 2009, RESP PHYSIOL NEUROBI, V169, P165, DOI 10.1016/j.resp.2009.08.014; Bizzozero OA, 2005, J NEUROSCI RES, V81, P687, DOI 10.1002/jnr.20587; Bolognesi ML, 2009, NEUROTHERAPEUTICS, V6, P152, DOI 10.1016/j.nurt.2008.10.042; Bolton WK, 2004, AM J NEPHROL, V24, P32, DOI 10.1159/000075627; Bopp C, 2008, CRIT CARE, V12, DOI 10.1186/cc6164; Bostanci MO, 2010, CELL MOL NEUROBIOL, V30, P389, DOI 10.1007/s10571-009-9461-8; Bradley JL, 2004, NEUROCHEM RES, V29, P561, DOI 10.1023/B:NERE.0000014826.00881.c3; Bradley MA, 2010, FREE RADICAL BIO MED, V48, P1570, DOI 10.1016/j.freeradbiomed.2010.02.016; Brass SD, 2010, SLEEP MED REV, V14, P121, DOI 10.1016/j.smrv.2009.07.005; BRETT J, 1993, AM J PATHOL, V143, P1699; BRETT R, 1993, NEUROCHEM INT, V23, P35, DOI 10.1016/0197-0186(93)90141-Q; Bro S, 2008, ATHEROSCLEROSIS, V201, P274, DOI 10.1016/j.atherosclerosis.2008.01.015; BROWN MK, 2010, MOL NEUROBI IN PRESS; BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117; Bruce-Keller AJ, 1998, J NEUROPATH EXP NEUR, V57, P257, DOI 10.1097/00005072-199803000-00007; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; CALABRESE V, 1994, INT J CLIN PHARM RES, V14, P119; Calabrese Vittorio, 2006, Ital J Biochem, V55, P263; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Candido R, 2003, CIRC RES, V92, P785, DOI 10.1161/01.RES.0000065620.39919.20; Capeillere-Blandin C, 2004, BBA-MOL BASIS DIS, V1689, P91, DOI 10.1016/j.bbadis.2004.02.008; Castellani RJ, 2002, NEUROSCI LETT, V319, P25, DOI 10.1016/S0304-3940(01)02514-9; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Cheng CM, 2005, MODERN PATHOL, V18, P1385, DOI 10.1038/modpathol.3800450; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chou DKH, 2004, J NEUROCHEM, V90, P1389, DOI 10.1111/j.1471-4159.2004.02609.x; COLACO CALS, 1994, NEUROREPORT, V5, P859, DOI 10.1097/00001756-199404000-00001; Costello CE, 2007, J AM SOC MASS SPECTR, V18, P1799, DOI 10.1016/j.jasms.2007.07.016; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; Crocker PR, 2008, BIOCHEM SOC T, V36, P1467, DOI 10.1042/BST0361467; Cu XP, 2008, J NUTR SCI VITAMINOL, V54, P321; Dalfo E, 2005, J NEUROPATH EXP NEUR, V64, P816, DOI 10.1097/01.jnen.0000179050.54522.5a; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; de Arriba SG, 2006, FREE RADICAL BIO MED, V40, P779, DOI 10.1016/j.freeradbiomed.2005.09.038; Deane R, 2004, STROKE, V35, P2628, DOI 10.1161/01.STR.0000143452.85382.d1; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deepa D, 2008, ANN INDIAN ACAD NEUR, V11, P44, DOI 10.4103/0972-2327.40225; Dehmer T, 2004, J NEUROCHEM, V88, P494, DOI 10.1046/j.1471-4159.2003.02210.x; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Ding QX, 2005, BBA-MOL CELL RES, V1746, P18, DOI 10.1016/j.bbamcr.2005.08.006; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Dobrowsky RT, 2005, J PHARMACOL EXP THER, V313, P485, DOI 10.1124/jpet.104.079921; Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Emanuele E, 2005, ARCH NEUROL-CHICAGO, V62, P1734, DOI 10.1001/archneur.62.11.1734; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Espejo C, 2001, NEUROSCIENCE, V105, P1055, DOI 10.1016/S0306-4522(01)00252-4; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; Fang F, 2010, FASEB J, V24, P1043, DOI 10.1096/fj.09-139634; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Figarola JL, 2003, DIABETOLOGIA, V46, P1140, DOI 10.1007/s00125-003-1162-0; Fitzmaurice PS, 2003, MOVEMENT DISORD, V18, P969, DOI 10.1002/mds.10486; Floor E, 1998, J NEUROCHEM, V70, P268; Forbes JM, 2004, DIABETES, V53, P1813, DOI 10.2337/diabetes.53.7.1813; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Freitas RM, 2009, NEUROSCI LETT, V462, P225, DOI 10.1016/j.neulet.2009.07.037; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Goldstein RS, 2006, SHOCK, V25, P571, DOI 10.1097/01.shk.0000209540.99176.72; GOMES R, 2005, BIOCHEM J, V385, P9; Gonsette RE, 2008, J NEUROL SCI, V274, P48, DOI 10.1016/j.jns.2008.06.029; Goodman AOG, 2010, J NEUROL, V257, P882, DOI 10.1007/s00415-010-5517-4; GORELL JM, 1995, NEUROLOGY, V45, P1138, DOI 10.1212/WNL.45.6.1138; Gow A, 2003, NEUROMOL MED, V4, P73, DOI 10.1385/NMM:4:1-2:73; Guazzi S, 2003, GENE EXPR PATTERNS, V3, P29, DOI 10.1016/S1567-133X(02)00093-5; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; Guo ZY, 2008, ANTIOXID REDOX SIGN, V10, P127, DOI 10.1089/ars.2007.1860; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hamanishi T, 2004, DIABETES, V53, P2455, DOI 10.2337/diabetes.53.9.2455; Hartzler AW, 2002, NEUROBIOL AGING, V23, P855, DOI 10.1016/S0197-4580(02)00029-5; Haugen AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000812; Hedreul MT, 2009, J NEUROIMMUNOL, V210, P30, DOI 10.1016/j.jneuroim.2009.02.010; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Herold K, 2007, J LEUKOCYTE BIOL, V82, P204, DOI 10.1189/jlb.1206751; Hirohata M, 2005, NEUROPHARMACOLOGY, V49, P1088, DOI 10.1016/j.neuropharm.2005.07.004; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hooper DC, 2000, FASEB J, V14, P691; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Horiuchi S, 1996, DIABETES, V45, pS73, DOI 10.2337/diab.45.3.S73; Hudson BI, 2001, DIABETES, V50, pA236; Huizinga R, 2007, J NEUROPATH EXP NEUR, V66, P295, DOI 10.1097/nen.0b013e318040ad5c; Huizinga R, 2008, NEUROBIOL DIS, V32, P461, DOI 10.1016/j.nbd.2008.08.009; Hunot S, 1999, J NEUROSCI, V19, P3440; HUNTER MIS, 1985, NEUROCHEM RES, V10, P1645, DOI 10.1007/BF00988606; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Iacobini C, 2009, J PATHOL, V218, P360, DOI 10.1002/path.2536; Ilzecka J, 2009, ACTA NEUROL SCAND, V120, P119, DOI 10.1111/j.1600-0404.2008.01133.x; Imai H, 2003, FREE RADICAL BIO MED, V34, P56, DOI 10.1016/S0891-5849(02)01180-2; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Jang SI, 2003, PLANTA MED, V69, P1057, DOI 10.1055/s-2003-45157; Jang Y, 2007, METABOLISM, V56, P199, DOI 10.1016/j.metabol.2006.09.013; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; JENSEN GE, 1984, J NEUROL SCI, V63, P45, DOI 10.1016/0022-510X(84)90107-2; Jinnouchi Y, 2006, CLIN EXP MED, V6, P191, DOI 10.1007/s10238-006-0115-6; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kalea AZ, 2009, FASEB J, V23, P1766, DOI 10.1096/fj.08-117739; Kalea AZ, 2009, CLIN SCI, V116, P621, DOI 10.1042/CS20080494; Kalousova M, 2005, MUTAT RES-FUND MOL M, V579, P37, DOI 10.1016/j.mrfmmm.2005.03.024; Kanazawa N, 2007, J DERMATOL SCI, V45, P77, DOI 10.1016/j.jdermsci.2006.09.001; Kaufmann E, 2004, NEUROSCI LETT, V371, P226, DOI 10.1016/j.neulet.2004.08.071; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; KEARNEY M, 2009, COCHRANE DB SYST REV, V4; Keller JN, 1997, J NEUROCHEM, V69, P1073; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kimura T, 1996, NEUROSCI LETT, V219, P95, DOI 10.1016/S0304-3940(96)13173-6; Kimura T, 1998, PATHOL INT, V48, P575, DOI 10.1111/j.1440-1827.1998.tb03953.x; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; Kreisler A, 2007, BRAIN RES, V1135, P77, DOI 10.1016/j.brainres.2006.12.011; Kruman I, 1997, J NEUROSCI, V17, P5089; Kunz M, 2008, PROG NEURO-PSYCHOPH, V32, P1677, DOI 10.1016/j.pnpbp.2008.07.001; LANGEMANN H, 1992, EUR NEUROL, V32, P248, DOI 10.1159/000116835; Lassmann H, 2003, J NEUROL NEUROSUR PS, V74, P695, DOI 10.1136/jnnp.74.6.695; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; LI JJ, 1995, NEUROBIOL AGING, V16, P69, DOI 10.1016/0197-4580(95)80009-G; LI JJ, 1994, BRAIN RES, V641, P285, DOI 10.1016/0006-8993(94)90156-2; Li KS, 2010, J NEURAL TRANSM, V117, P97, DOI 10.1007/s00702-009-0334-6; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Limousin N, 2009, SLEEP MED, V10, P690, DOI 10.1016/j.sleep.2008.08.003; Liu JSH, 2001, AM J PATHOL, V158, P2057, DOI 10.1016/S0002-9440(10)64677-9; Lo Coco D, 2009, MOVEMENT DISORD, V24, P1555, DOI 10.1002/mds.22629; Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Lovell MA, 2001, NEUROBIOL AGING, V22, P187, DOI 10.1016/S0197-4580(00)00235-9; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; Lu CY, 2009, BBA-MOL BASIS DIS, V1792, P1052, DOI 10.1016/j.bbadis.2009.07.011; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Ma L, 2004, BRAIN RES, V1018, P10, DOI 10.1016/j.brainres.2004.05.052; Ma L, 2003, BRAIN RES, V966, P167, DOI 10.1016/S0006-8993(02)04149-5; Mackic JB, 1998, J CLIN INVEST, V102, P734, DOI 10.1172/JCI2029; Mancuso M, 2010, CURR DRUG TARGETS, V11, P111, DOI 10.2174/138945010790031018; Mangas A, 2009, CURR MED CHEM, V16, P3203, DOI 10.2174/092986709788803259; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Mark RJ, 1997, J NEUROSCI, V17, P1046; Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8; Martinez A, 2008, J NEURAL TRANSM, V115, P59, DOI 10.1007/s00702-007-0800-y; Matsui T, 2010, PHARMACOL RES, V61, P34, DOI 10.1016/j.phrs.2009.07.004; Matsui T, 2009, BIOCHEM BIOPH RES CO, V385, P269, DOI 10.1016/j.bbrc.2009.05.061; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; McEwen JE, 2005, CURR OPIN CARDIOL, V20, P399, DOI 10.1097/01.hco.0000175517.50181.89; Meiners I, 2004, J NEURAL TRANSM, V111, P441, DOI 10.1007/s00702-003-0066-y; Miller MC, 2008, BRAIN RES, V1230, P273, DOI 10.1016/j.brainres.2008.06.124; Miyata T, 2002, J AM SOC NEPHROL, V13, p218A; Montine KS, 1997, J NEUROPATH EXP NEUR, V56, P866, DOI 10.1097/00005072-199708000-00004; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Moreau C, 2005, NEUROLOGY, V65, P1958, DOI 10.1212/01.wnl.0000188907.97339.76; Muntane G, 2006, J NEUROCHEM, V99, P177, DOI 10.1111/j.1471-4159.2006.04032.x; Nagai R, 2000, DIABETES, V49, P1714, DOI 10.2337/diabetes.49.10.1714; Naidoo N, 2009, REV NEUROSCIENCE, V20, P23; NAIDOO R, 1992, CLIN CHEM, V38, P2449; Navarro A, 2009, FREE RADICAL BIO MED, V46, P1574, DOI 10.1016/j.freeradbiomed.2009.03.007; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; NEWCOMBE J, 1994, NEUROPATH APPL NEURO, V20, P152, DOI 10.1111/j.1365-2990.1994.tb01174.x; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Nicholl ID, 1998, CELL MOL BIOL, V44, P1025; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; O'Connor KA, 2003, CYTOKINE, V24, P254, DOI 10.1016/j.cyto.2003.08.001; Odetti P, 1998, BIOCHEM BIOPH RES CO, V243, P849, DOI 10.1006/bbrc.1998.8186; Odetti P, 2000, J NEUROPATH EXP NEUR, V59, P393, DOI 10.1093/jnen/59.5.393; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Ouslimani N, 2007, METABOLISM, V56, P308, DOI 10.1016/j.metabol.2006.10.010; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200; Pamplona R, 2008, FREE RADICAL BIO MED, V45, P1159, DOI 10.1016/j.freeradbiomed.2008.07.009; PARISI P, 2010, DEV MED CHI IN PRESS; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Passalacqua M, 1998, NEUROSCIENCE, V82, P1021; PATTEN SB, 1992, J AM ACAD CHILD PSY, V31, P100, DOI 10.1097/00004583-199201000-00015; Pedersen MO, 2009, BIOFACTORS, V35, P315, DOI 10.1002/biof.44; Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518; Pedrazzi M, 2006, J NEUROCHEM, V99, P827, DOI 10.1111/j.1471-4159.2006.04120.x; Penkowa M, 2003, CELL MOL LIFE SCI, V60, P185, DOI 10.1007/s000180300013; Penkowa M, 2003, CELL MOL LIFE SCI, V60, P1258, DOI 10.1007/s00018-003-3021-z; Penkowa M, 2001, J NEUROIMMUNOL, V119, P248, DOI 10.1016/S0165-5728(01)00357-5; Perrone L, 2008, J CELL PHYSIOL, V217, P60, DOI 10.1002/jcp.21474; PETRONILHO F, 2009, J SURG RES IN PRESS; Pichiule P, 2007, J BIOL CHEM, V282, P36330, DOI 10.1074/jbc.M706407200; Pilobello KT, 2007, CURR OPIN CHEM BIOL, V11, P300, DOI 10.1016/j.cbpa.2007.05.002; Pinel-Marie ML, 2009, FREE RADICAL BIO MED, V47, P825, DOI 10.1016/j.freeradbiomed.2009.06.025; Power JHT, 2009, ACTA NEUROPATHOL, V117, P63, DOI 10.1007/s00401-008-0438-3; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; Previtali SC, 2003, J NEUROSCI, V23, P5520; PRIEGOCAPOTE F, 2009, MASS SPECTROM REV, V28; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Puccio H, 2009, J NEUROL, V256, P18, DOI 10.1007/s00415-009-1004-1; Pullerits R, 2009, RHEUMATOLOGY, V48, P785, DOI 10.1093/rheumatology/kep079; Qin JD, 2008, J NEUROSCI RES, V86, P2414, DOI 10.1002/jnr.21692; Ramanan S, 2010, PPAR RES, V2010, DOI 10.1155/2010/234975; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Rezin GT, 2009, NEUROCHEM RES, V34, P1021, DOI 10.1007/s11064-008-9865-8; Rhodes D A, 1999, Rev Immunogenet, V1, P21; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Rockwell P, 2000, ARCH BIOCHEM BIOPHYS, V374, P325, DOI 10.1006/abbi.1999.1646; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Roriz JS, 2009, BBA-MOL BASIS DIS, V1792, P432, DOI 10.1016/j.bbadis.2008.12.003; Rossi F, 1996, BIOCHEM BIOPH RES CO, V225, P474, DOI 10.1006/bbrc.1996.1197; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0; RUULS SR, 1995, J NEUROIMMUNOL, V56, P207, DOI 10.1016/0165-5728(94)00154-G; Salminen A, 2009, J MOL MED, V87, P697, DOI 10.1007/s00109-009-0472-1; SALVI F, 1990, J NEUROL NEUROSUR PS, V53, P522, DOI 10.1136/jnnp.53.6.522; SANTOS R, 2010, ANTIOXID RE IN PRESS; Sasaki N, 2002, NEUROSCI LETT, V326, P117, DOI 10.1016/S0304-3940(02)00310-5; Sasaki N, 2001, BRAIN RES, V888, P256, DOI 10.1016/S0006-8993(00)03075-4; Sasaki N, 1998, AM J PATHOL, V153, P1149, DOI 10.1016/S0002-9440(10)65659-3; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI200114002; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; Selley ML, 2002, NEUROBIOL AGING, V23, P383, DOI 10.1016/S0197-4580(01)00327-X; SHAW PJ, 1995, ANN NEUROL, V38, P691, DOI 10.1002/ana.410380424; Shibata N, 2001, BRAIN RES, V917, P97, DOI 10.1016/S0006-8993(01)02926-2; Shibata T, 2006, J BIOL CHEM, V281, P1196, DOI 10.1074/jbc.M509065200; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Shoham S, 2000, CELL MOL BIOL, V46, P743; Shringarpure R, 2000, CELL MOL LIFE SCI, V57, P1802, DOI 10.1007/PL00000660; SHUKLA VKS, 1977, ACTA NEUROL SCAND, V56, P542; Sidoti A, 2007, MULT SCLER J, V13, P446, DOI 10.1177/13524585070130040201; Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com; Smerjac SM, 2008, J NEUROCHEM, V105, P763, DOI 10.1111/j.1471-4159.2007.05178.x; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; Sousa MM, 2003, PROG NEUROBIOL, V71, P385, DOI 10.1016/j.pneurobio.2003.11.002; Sousa MM, 2001, J NEUROSCI, V21, P7576; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Spitsin SV, 2002, FREE RADICAL BIO MED, V33, P1363, DOI 10.1016/S0891-5849(02)01048-1; Srikrishna G, 2002, J NEUROCHEM, V80, P998, DOI 10.1046/j.0022-3042.2002.00796.x; Staedt J, 2010, FORTSCHR NEUROL PSYC, V78, P70, DOI 10.1055/s-0028-1109967; Steinbrecher UP, 1999, BBA-MOL CELL BIOL L, V1436, P279, DOI 10.1016/S0005-2760(98)00127-1; Steiner J, 2009, BIOL PSYCHIAT, V65, P1107, DOI 10.1016/j.biopsych.2008.10.044; Sternberg Z, 2008, MULT SCLER J, V14, P759, DOI 10.1177/1352458507088105; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Sturchler E, 2008, J NEUROSCI, V28, P5149, DOI 10.1523/JNEUROSCI.4878-07.2008; SUGAYA K, 1994, GENOMICS, V23, P408, DOI 10.1006/geno.1994.1517; Takazawa T, 2010, INTERNAL MED, V49, P183, DOI 10.2169/internalmedicine.49.2720; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Timmer MSM, 2007, CURR OPIN CHEM BIOL, V11, P59, DOI 10.1016/j.cbpa.2006.11.040; Tiszlavicz Z, 2009, J MOL NEUROSCI, V39, P360, DOI 10.1007/s12031-009-9291-7; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; vanderVeen RC, 1997, J NEUROIMMUNOL, V77, P1, DOI 10.1016/S0165-5728(97)00013-1; Vankova J, 2003, SLEEP, V26, P427, DOI 10.1093/sleep/26.4.427; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Vladimirova O, 1998, MULT SCLER, V4, P413, DOI 10.1177/135245859800400503; VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604; Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859; Vucic S, 2009, CURR MOL MED, V9, P255, DOI 10.2174/156652409787847173; Waldbaum S, 2010, EPILEPSY RES, V88, P23, DOI 10.1016/j.eplepsyres.2009.09.020; Wallberg M, 2007, EUR J IMMUNOL, V37, P1986, DOI 10.1002/eji.200636912; Wang JF, 2009, BIPOLAR DISORD, V11, P523, DOI 10.1111/j.1399-5618.2009.00717.x; Wang L, 2010, BRAIN RES, V1321, P143, DOI 10.1016/j.brainres.2009.12.046; Wang LY, 2008, J NEUROSCI RES, V86, P1254, DOI 10.1002/jnr.21578; Wang MY, 2009, ACTA NEUROPATHOL, V118, P381, DOI 10.1007/s00401-009-0513-4; Wang X, 2009, CNS NEUROSCI THER, V15, P345, DOI 10.1111/j.1755-5949.2009.00105.x; Whitnall Megan, 2006, Semin Pediatr Neurol, V13, P186, DOI 10.1016/j.spen.2006.08.008; Willemsen S, 2010, EUR J HEART FAIL, V12, P294, DOI 10.1093/eurjhf/hfp207; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Wolfe D, 2009, PAIN MED, V10, P1325, DOI 10.1111/j.1526-4637.2009.00720.x; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Xia JR, 2008, INT J MOL SCI, V9, P638, DOI 10.3390/ijms9040638; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Yamagishi SI, 2008, EXPERT OPIN INV DRUG, V17, P983, DOI 10.1517/13543784.17.7.983 ; Yamagishi S, 2008, CURR PHARM DESIGN, V14, P962, DOI 10.2174/138161208784139729; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; YAN SD, 1995, NAT MED, V1, P693, DOI 10.1038/nm0795-693; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SF, 2009, J MOL MED, V87, P235, DOI 10.1007/s00109-009-0439-2; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; Yis U, 2009, EPILEPSY RES, V84, P232, DOI 10.1016/j.eplepsyres.2009.02.003; Yokota C, 2009, J NEUROL SCI, V287, P41, DOI 10.1016/j.jns.2009.09.013; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Yoshida T, 2006, DIABETOLOGIA, V49, P3094, DOI 10.1007/s00125-006-0437-7; Yu ZF, 1998, J NEUROSCI RES, V53, P613, DOI 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1; Zarkovic Kamelija, 2003, Molecular Aspects of Medicine, V24, P293, DOI 10.1016/S0098-2997(03)00024-4; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhao JP, 2007, J NEUROSCI, V27, P13649, DOI 10.1523/JNEUROSCI.3153-07.2007; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506; ZIMMERMAN GA, 1995, P NATL ACAD SCI USA, V92, P3744, DOI 10.1073/pnas.92.9.3744	334	20	20	0	8	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	FEB	2011	10	1					82	107					26	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	715HE	WOS:000286872800008	21143140				2021-06-18	
B	Iverson, GL; Lange, RT		Schoenberg, MR; Scott, JG		Iverson, Grant L.; Lange, Rael T.			Moderate and Severe Traumatic Brain Injury	LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH			English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; DIFFUSE AXONAL INJURY; MILD HEAD-INJURY; SAN-DIEGO-COUNTY; MAJOR DEPRESSION; AXIS-I; PSYCHIATRIC-DISORDERS; MOTOR-PERFORMANCE; NATURAL-HISTORY; DAMAGE	Traumatic brain injuries arise from open or closed head injuries. Most traumatic brain injuries result from closed head injuries (an example of an open head injury is an object penetrating the skull). Brain injuries occur as the result of acceleration-deceleration forces (linear or angular), blunt trauma, or both. Traumatic brain injuries occur on a broad continuum of severity, from very mild transient injuries to catastrophic injuries resulting in death or severe disability. The continuum of severity of traumatic brain injury is illustrated in Fig. 21.1.	[Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Iverson, Grant L.; Lange, Rael T.] British Columbia Mental Hlth & Addict Serv, Coquitlam, BC, Canada	Iverson, GL (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	giverson@interchange.ubc.ca; rlange@dvbic.org					AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; BARKLEY JM, 2007, BRAIN INJURY MED PRI, P129; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; BERROL S, 1986, J HEAD TRAUMA REHAB, V1, P7; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BIGLER ED, 2005, STRUCTURAL IMAGING; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Breslau N, 2003, NEUROLOGY, V60, P1308, DOI 10.1212/01.WNL.0000058907.41080.54; *BRIT MED ASS MED, 1992, DISC PAP PAT PERS VE; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; CAVALLO MM, 2005, TXB TRAUMATIC BRAIN, P533; CELESIA, 1993, ANN NEUROL, V33, P386; CHARNESS ME, 1993, ALCOHOL CLIN EXP RES, V17, P2, DOI 10.1111/j.1530-0277.1993.tb00718.x; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Corcoran C, 2005, TXB TRAUMATIC BRAIN, P213; Corrigan J, 2003, TECHNICAL REPORT PRO; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CORRIGAN JD, 2007, BRAIN INJURY MED, P1105; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; ERB DE, 1991, EXP BRAIN RES, V83, P253; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Fellus J, 2007, BRAIN INJURY MED, P545; Flashman L., 2005, TXB TRAUMATIC BRAIN, P353; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; GEAN AD, 1994, IMAGING HEAD TRAUMA, P207; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Gorrie C, 2001, J NEUROTRAUM, V18, P849, DOI 10.1089/089771501750451776; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; GUREJE O, 1994, AM J PSYCHIAT, V151, P368; HARRIS JH, 2000, RADIOLOGY EMERGENCY; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; HILLBOM E, 1960, Acta Psychiatr Scand Suppl, V35, P1; Hillier SL, 1997, BRAIN INJURY, V11, P661; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1996, CATASTROPHIC BRAIN I; JONES GA, 1989, ALCOHOL HEALTH RES W, V13, P104; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KAPOOR N, 2005, TXB TRAUMATIC BRAIN, P405; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KNEIPP S, 2007, BRAIN INJURY MED, P1085; KOCHANEK PM, 2007, BRAIN INJURY MED PRI, P81; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; KRAUS JF, 2005, TXB TRAUMATIC BRAIN, P3; KRAUSS J, 2007, BRAIN INJURY MED PRI, P469; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; LAHMEYER HW, 1987, J PSYCHIAT RES, V21, P1, DOI 10.1016/0022-3956(87)90004-5; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; LUCAS JA, 1998, CLIN NEUROPSYCHOLOGY, P243; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MacKenzie E J, 1989, Md Med J, V38, P725; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; MEARNS J, 1993, J CLIN PSYCHOL, V49, P714, DOI 10.1002/1097-4679(199309)49:5<714::AID-JCLP2270490515>3.0.CO;2-H; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; MILLER NS, 1991, PHARM ALCOHOL DRUGS; Mitsikostas DD, 1999, CEPHALALGIA, V19, P211, DOI 10.1046/j.1468-2982.1999.019004211.x; Morales D., 2007, BRAIN CONTUSION; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; OSHANICK GJ, 2005, TXB TRAUMATIC BRAIN, P245; PADULA W, 2007, BRAIN INJURY MED, P511; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pine DS, 1996, J CHILD ADOL PSYCHOP, V6, P153, DOI 10.1089/cap.1996.6.153; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Rao V, 2005, TXB TRAUMATIC BRAIN, P369; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Robinson RG, 2005, TXB TRAUMATIC BRAIN, P201; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; SANDEL ME, 2007, BRAIN INJURY MED PRI, P673; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SCHWARTZ JH, 1991, PRINCIPLES NEURAL SC, P49; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 1999, J NEUROSCI, V19, P4263; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; STRICH SJ, 1961, LANCET, V2, P443; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; THAXTON L, 2007, BRAIN INJURY MED PRI, P557; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 2007, BRAIN INJURY MED PRI, P45; UZZELL BP, 1987, SURG NEUROL, V27, P419, DOI 10.1016/0090-3019(87)90247-3; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; WARDEN DL, 2005, TXB TRAUMATIC BRAIN, P231; West M., 2007, BRAIN INJURY MED PRI, P1131; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; ZASLER ND, 2007, BRAIN INJURY MED PRI, P697; Zwart JA, 2003, EUR J NEUROL, V10, P147, DOI 10.1046/j.1468-1331.2003.00551.x	165	20	20	0	8	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-70703-7				2011							663	696		10.1007/978-0-387-76978-3_21	10.1007/978-0-387-76978-3		34	Clinical Neurology; Neurosciences; Psychology	Neurosciences & Neurology; Psychology	BTF43	WOS:000286799800021					2021-06-18	
J	Lankford, A				Lankford, Adam			Could Suicide Terrorists Actually Be Suicidal?	STUDIES IN CONFLICT & TERRORISM			English	Article							TRAUMATIC BRAIN-INJURY; POPULATION; ATTACKS; BOMBERS	For years, it has been widely agreed on that suicide terrorists are not suicidal individuals, and that behaviorally, they are more similar to noble soldiers who are willing to sacrifice themselves for a cause. However, upon closer examination, it appears that the foundation of this conventional wisdom is extraordinarily shaky. There are many reasons to think that both event-based and psychological risk factors for suicide may drive the behavior of suicide terrorists. Furthermore, there is growing evidence that more than 75 individual suicide terrorists have exhibited these classic suicidal traits. Given the power that the stigma of suicide may have to deter future suicide terrorists, it is critical that governments, scholars, and practitioners examine this issue once again.	Univ Alabama, Dept Criminal Justice, Tuscaloosa, AL 35487 USA	Lankford, A (corresponding author), Univ Alabama, Dept Criminal Justice, POB 870320, Tuscaloosa, AL 35487 USA.	Adam.Lankford@ua.edu					Al-San'ani Abu M., 2006, MEMRI TV        0504; ALZAHAR M, 2006, MEMRI TV        0406; American Foundation for Suicide Prevention, 2010, RISK FACT SUIC; [Anonymous], 2010, FOX NEWS        0318; [Anonymous], 2007, FOX NEWS        0924; [Anonymous], 2007, BBC NEWS        0129; [Anonymous], 2009, TIMES ONLINE    1106; [Anonymous], 2006, SUNDAY TRIBUNE  0917; [Anonymous], 2009, BBC NEWS        0204; Baer R., 2008, CULT SUICIDE BOMBER, V2; Baer Robert, 2005, CULT SUICIDE BOMBER; BBC News, 2008, BBC NEWS        0404; Berko A., 2007, PATH PARADISE INNER, P7; Berko Anat, 2005, Violence Vict, V20, P603, DOI 10.1891/088667005780927467; Berko A, 2008, CONTEMP TERROR STUD, P146; Byman Daniel, 2010, ATLANTIC MAGAZIN JUL; Caplan B, 2006, PUBLIC CHOICE, V128, P91, DOI 10.1007/s11127-006-9046-8; CHARNY IW, 2007, FIGHTING SUICIDE BOM; CNN, 1997, CNN             1112; CNN, 2008, CNN             0203; Dao James, 2009, NY TIMES        1105; Davies Christie, 2000, DURKHEIMS SUICIDE CE; DUNCAN SM, 2004, WAR DIFFERENT KIND M; Durkheim E., 1897, SUICIDE ETUDE SOCIOL; EVANS G, 1988, ENCY SUICIDE; Fair Christine, 2007, CARNEGIE ENDOWM 1019; Farber M. L., 1968, THEORY SUICIDE; Fatah Sonya, 2001, GLOBE MAIL      0507; Gambetta D, 2005, MAKING SENSE SUICIDE; Grossman Dave, 1995, KILLING PSYCHOL COST; Hafez MM, 2006, PERSPECT SER, P3; Hoffman B., 2006, INSIDE TERRORISM; Iraq Body Count, 2005, DOSS CIV CAS 2003 20; Israeli R, 1997, TERROR POLIT VIOLENC, V9, P96, DOI 10.1080/09546559708427418; Jacobson Philip, 2001, TELEGRAPH       0819; Kruglanski AW, 2009, POLIT PSYCHOL, V30, P331, DOI 10.1111/j.1467-9221.2009.00698.x; Lankford A, 2010, AGGRESS VIOLENT BEH, V15, P334, DOI 10.1016/j.avb.2010.06.001; Lankford Adam, 2009, HUMAN KILLING MACHIN; Lester, 2003, HATING 1 PERSON PLUR; LESTER D, 1997, MAKING SENSE SUICIDE; Lester David, 2004, STUDIES CONFLICT TER, V27, P290; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; MARIS RW, 1981, PATHWAYS SUICIDE SUR; McGirk Tim, 2004, TIME            0802; Merari A, 2010, TERROR POLIT VIOLENC, V22, P87, DOI 10.1080/09546550903409312; *NAT I MENT HLTH, 2009, SUIC US STAT PREV; National Consortium for the Study of Terrorism and Responses to Terrorism (START), 2010, GLOB TERR DAT; Nelson Soraya Sarhaddi, 2007, NATL PUBLIC RAD 1015; Ohnuki-Tierney Emiko, 2006, KAMIKAZE DIARIES REF, pxvi; Pape Robert A., 2005, DYING WIN STRATEGIC; Pastor LH, 2004, PSYCHIAT ANN, V34, P701, DOI 10.3928/0048-5713-20040901-15; Pedahzur A., 2005, SUICIDE TERRORISM; Post JM, 2009, PSYCHIATRY, V72, P13, DOI 10.1521/psyc.2009.72.1.13; Rowley CK, 2006, PUBLIC CHOICE, V128, P1, DOI 10.1007/s11127-006-9042-z; Rubin Barry, 2002, ANTIAMERICAN TERRORI, P149; Shneidman Edwin S., 1979, SUICIDE THEORY CLIN; Slackman Michael, 2006, NY TIMES        0206; Speckhard A, 2006, STUD CONFL TERROR, V29, P429, DOI 10.1080/10576100600698550; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Townsend E, 2007, SUICIDE LIFE-THREAT, V37, P35, DOI 10.1521/suli.2007.37.1.35; Tyson Ann S., 2007, WASHINGTON POST 0102; U.S. Army, 2010, TOT ARM SUIC CY2001; United Nations Office on Drugs and Crime, 2010, WORLD DRUG REP 2010; Warrick Joby, 2010, WASHINGTON POST 0318; Yellow Ribbon Suicide Prevention Program, 2009, WARN SIGNS RISK FACT	65	20	20	1	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1057-610X	1521-0731		STUD CONFL TERROR	Stud. Confl. Terror.		2011	34	4					337	366	PII 934984933	10.1080/1057610X.2011.551721			30	International Relations; Political Science	International Relations; Government & Law	738XH	WOS:000288675400004					2021-06-18	
